Annexes to COM(2007)355 - Classification, labelling and packaging of substances and mixtures, and amending Directive 67/548/EEC and Regulation (EC) No 1907/2006 [SEC(2007) 853] [SEC(2007) 854]

Please note

This page contains a limited version of this dossier in the EU Monitor.

ANNEX I

CLASSIFICATION AND LABELLING REQUIREMENTS FOR HAZARDOUS SUBSTANCES AND MIXTURES

This annex sets out the criteria for classification in hazard classes and in their differentiations and sets out additional provisions on how the criteria may be met.

1. PART 1: GENERAL PRINCIPLES FOR CLASSIFICATION AND LABELLING

1.0.   Definitions

Gas means a substance which:

(i)at 50 oC has a vapour pressure greater than 300 kPa (absolute); or

(ii)is completely gaseous at 20 oC at a standard pressure of 101,3 kPa;

Liquid means a substance or mixture which:

(i)at 50 oC has a vapour pressure of not more than 300 kPa (3 bar);

(ii)is not completely gaseous at 20 oC and at a standard pressure of 101,3 kPa; and

(iii)which has a melting point or initial melting point of 20 oC or less at a standard pressure of 101,3 kPa;

Solid means a substance or mixture which does not meet the definitions of liquid or gas.

1.1.   Classification of substances and mixtures

1.1.0.   Cooperation to meet the requirements in this Regulation

Suppliers in a supply chain shall cooperate to meet the requirements for classification, labelling and packaging set out in this Regulation.

Suppliers in an industry sector may cooperate to manage the transitional arrangements in Article 61 for substances and mixtures placed on the market.

Suppliers in an industry sector may cooperate through formation of a network or by other means to share data and expertise when classifying substances and mixtures in accordance with Title II of this Regulation. In these circumstances suppliers in an industry sector shall document fully the basis on which classification decisions are made and shall make available to the competent authorities and, on request, to the relevant enforcement authorities the documentation, together with the data and information on which classifications are based. However, where suppliers in an industry sector cooperate in this way, each supplier shall remain fully responsible for the classification, labelling and packaging of substances and mixtures he places on the market, and for meeting any other requirements of this Regulation.

The network may also be used to exchange information and best practices with a view to simplifying fulfilment of the notification obligations.

1.1.1.   The role and application of expert judgement and weight of evidence determination

1.1.1.1.Where the criteria cannot be applied directly to available identified information, or where only the information referred to in Article 6(5) is available, the weight of evidence determination using expert judgment shall be applied in accordance with Article 9(3) or 9(4) respectively.

1.1.1.2.The approach to classifying mixtures may include the application of expert judgement in a number of areas in order to ensure existing information can be used for as many mixtures as possible in order to provide protection for human health and the environment. Expert judgement may also be required in interpreting data for hazard classification of substances, especially where weight of evidence determinations are needed.

1.1.1.3.A weight of evidence determination means that all available information bearing on the determination of hazard is considered together, such as the results of suitable in vitro tests, relevant animal data, information from the application of the category approach (grouping, read-across), (Q)SAR results, human experience such as occupational data and data from accident databases, epidemiological and clinical studies and well-documented case reports and observations. The quality and consistency of the data shall be given appropriate weight. Information on substances or mixtures related to the substance or mixture being classified shall be considered as appropriate, as well as site of action and mechanism or mode of action study results. Both positive and negative results shall be assembled together in a single weight of evidence determination.

1.1.1.4.For the purpose of classification for health hazards (Part 3) established hazardous effects seen in appropriate animal studies or from human experience that are consistent with the criteria for classification shall normally justify classification. Where evidence is available from both humans and animals and there is a conflict between the findings, the quality and reliability of the evidence from both sources shall be evaluated in order to resolve the question of classification. Generally, adequate, reliable and representative data on humans (including epidemiological studies, scientifically valid case studies as specified in this Annex or statistically backed experience) shall have precedence over other data. However, even well-designed and conducted epidemiological studies may lack a sufficient number of subjects to detect relatively rare but still significant effects, to assess potentially confounding factors. Therefore, positive results from well-conducted animal studies are not necessarily negated by the lack of positive human experience but require an assessment of the robustness, quality and statistical power of both the human and animal data.

1.1.1.5.For the purpose of classification for health hazards (Part 3) route of exposure, mechanistic information and metabolism studies are pertinent to determining the relevance of an effect in humans. When such information, as far as there is reassurance about the robustness and quality of the data, raises doubt about relevance in humans, a lower classification may be warranted. When there is scientific evidence that the mechanism or mode of action is not relevant to humans, the substance or mixture should not be classified.

1.1.2.   Specific concentration limits, M-factors and generic cut-off values

1.1.2.1.Specific concentration limits or M-factors shall be applied in accordance with Article 10.

1.1.2.2.   Cut-off values

1.1.2.2.1.Cut-off values indicate when the presence of a substance needs to be taken into account for the purposes of classification of a substance or a mixture containing that hazardous substance, whether as an identified impurity, additive, or individual constituent (see Article 11).

1.1.2.2.2.The cut-off values referred to in Article 11 shall be the following:

(a)For health and environmental hazards in Parts 3, 4 and 5 of this Annex:

(i)for substances where a specific concentration limit is set for the relevant hazard class or differentiation either in Part 3 of Annex VI or in the classification and labelling inventory referred to in Article 42, and where the hazard class or differentiation is mentioned in Table 1.1, the lower of the specific concentration limit and the relevant generic cut-off value in Table 1.1; or

(ii)for substances where a specific concentration limit is set for the relevant hazard class or differentiation either in Part 3 of Annex VI or in the classification and labelling inventory referred to in Article 42, and where the hazard class or differentiation is not mentioned in Table 1.1, the specific concentration limit set either in Part 3 of Annex VI or in the classification and labelling inventory; or

(iii)for substances where no specific concentration limit is set for the relevant hazard class or differentiation either in Part 3 of Annex VI or in the classification and labelling inventory referred to in Article 42, and where the hazard class or differentiation is mentioned in Table 1.1, the relevant generic cut-off value set out in that table; or

(iv)for substances where no specific concentration limit is set for the relevant hazard class or differentiation either in Part 3 of Annex VI or in the classification and labelling inventory referred to in Article 42, and where the hazard class or differentiation is not mentioned in Table 1.1, the generic concentration limit for classification in the relevant sections of Parts 3, 4 and 5 of this Annex.

(b)For aquatic environmental hazards in section 4.1 of this Annex:

(i)for substances where an M-factor has been set for the relevant hazard category either in Part 3 of Annex VI, or in the classification and labelling inventory referred to in Article 42, the generic cut-off value in Table 1.1 adjusted using the calculation set out in section 4.1 of this Annex; or

(ii)for substances where no M-factor is set for the relevant hazard category either in Part 3 of Annex VI or in the classification and labelling inventory referred to in Article 42, the relevant generic cut-off value set out in Table 1.1.

Table 1.1

Generic cut-off values

Hazard classGeneric cut-off values to be taken into account
Acute Toxicity:
Category 1-3
0,1 %
Category 4
1 %
Skin corrosion/Irritation1 % (1)
Serious damage to eyes/eye irritation1 % (2)
Hazardous to Aquatic Environment
Acute Category 1
0,1 % (3)
Chronic Category 1
0,1 % (3)
Chronic Category 2-4
1 %

Note

Generic cut-off values are in weight percentages except for gaseous mixtures where they are in volume percentage.

1.1.3.   Bridging principles for the classification of mixtures where test data are not available for the complete mixture

Where the mixture itself has not been tested to determine its hazardous properties, but there are sufficient data on similar tested mixtures and individual hazardous ingredient substances to adequately characterise the hazards of the mixture, these data shall be used in accordance with the following bridging rules referred to in Article 9(4) for each individual hazard class in Part 3 and Part 4 of this Annex, subject to any specific provisions for mixtures in each hazard class.

1.1.3.1.   Dilution

If a mixture is diluted with a substance (diluent) which has an equivalent or lower hazard category classification than the least hazardous original ingredient substance and which is not expected to affect the hazard classification of other ingredient substances, then one of the following shall be applied:

the new mixture shall be classified as equivalent to the original mixture;

the method explained in each section of Part 3 and in Part 4 for classification of mixtures when data are available for all components or only some components of the mixture;

in the case of acute toxicity, the method for classification of mixtures based on ingredients of the mixture (additivity formula).

1.1.3.2.   Batching

The hazard category of one production batch of a mixture can be assumed to be substantially equivalent to that of another production batch of the same commercial product, and produced by or under the control of the same supplier, unless there is reason to believe there is significant variation such that the hazard classification of the batch has changed. If the latter occurs, a new evaluation is necessary.

1.1.3.3.   Concentration of highly hazardous mixtures

In the case of the classification of mixtures covered by sections 3.1, 3.2, 3.3, 3.8, 3.9, 3.10 and 4.1, if a mixture is classified in the highest hazard category or sub-category, and the concentration of the ingredients of the mixture that are in that category or sub-category is increased, the new mixture shall be classified in that category or sub-category without additional testing.

1.1.3.4.   Interpolation within one toxicity category

In the case of the classification of mixtures covered by sections 3.1, 3.2, 3.3, 3.8, 3.9, 3.10 and 4.1, for three mixtures with identical hazardous ingredients, where mixtures A and B are in the same hazard category and mixture C has the same active hazardous ingredients with concentrations intermediate to the concentrations of those hazardous ingredients in mixtures A and B, then mixture C is assumed to be in the same hazard category as A and B.

1.1.3.5.   Substantially similar mixtures

Given the following:

(a)two mixtures each containing two ingredients:

(i)A + B

(ii)C + B;

(b)the concentration of ingredient B is essentially the same in both mixtures;

(c)the concentration of ingredient A in mixture (i) equals that of ingredient C in mixture (ii);

(d)hazard data for A and C are available and substantially equivalent, i.e. they are in the same hazard category and are not expected to affect the hazard classification of B.

If mixture (i) is already classified in a particular hazard class based on test data, mixture (ii) shall be assigned the same hazard category.

1.1.3.6.   Review of classification where the composition of a mixture has changed

The following variations in initial concentration are defined for the application of Article 15(2)(a):

Table 1.2

Bridging Principle for changes in the composition of a mixture

Initial concentration range of the constituentPermitted variation in initial concentration of the constituent
≤ 2,5 %± 30 %
2,5 < C ≤  10 %± 20 %
10 < C ≤  25 %± 10 %
25 < C ≤  100 %± 5 %

1.1.3.7.   Aerosols

In the case of the classification of mixtures covered by sections 3.1, 3.2, 3.3, 3.4, 3.8 and 3.9, an aerosol form of a mixture shall be classified in the same hazard category as the non-aerosolised form of the mixture, provided that the added propellant does not affect the hazardous properties of the mixture upon spraying and scientific evidence is available demonstrating that the aerosolised form is not more hazardous than the nonaerosolised form.

1.2.   Labelling

1.2.1.   Dimensions and make-up of the label elements

1.2.1.1.Hazard pictograms as laid down in Annex V shall have a black symbol on a white background with a red frame sufficiently wide to be clearly visible.

1.2.1.2.Hazard pictograms shall be in the shape of a square set at a point. Each hazard pictogram shall cover at least one fifteenth of the surface area of the harmonised label but the minimum area shall not be less than 1 cm2.

1.2.1.3.The dimensions of the label shall be as follows:

Table 1.3

Dimension of labels

Capacity of the packageDimensions (in millimetres)
Not exceeding 3 litres:If possible, at least 52 × 74
Greater than 3 litres but, not exceeding 50 litres:At least 74 × 105
Greater than 50 litres but not exceeding 500 litres:At least 105 × 148
Greater than 500 litres:At least 148 × 210

1.3.   Derogations from labelling requirements for special cases

In accordance with Article 23 the following derogations shall apply:

1.3.1.   Transportable gas cylinders

For transportable gas cylinders, one of the following shall be permitted to be used for gas cylinders with a water capacity of less than or equal to 150 litres:

(a)A format and dimensions following the prescriptions of the current edition of Standard ISO 7225 relating to ‘Gas cylinders — Precautionary labels’. In this case, the label can bear the generic name or industrial or commercial name of the substance or mixture provided that the hazardous substances in a mixture are shown on the body of the gas cylinder in a clear and indelible way.

(b)The information specified in Article 17 provided on a durable information disc or label held captive on the cylinder.

1.3.2.   Gas containers intended for propane, butane or liquefied petroleum gas (LPG)

1.3.2.1.If propane, butane and liquefied petroleum gas or a mixture containing these substances classified in accordance with the criteria of this Annex, is placed on the market in closed refillable cylinders or in non-refillable cartridges within the scope of EN 417 as fuel gases which are only released for combustion (current edition of EN 417, relating to ‘Non-refillable metallic gas cartridges for liquefied petroleum gases, with or without a valve, for use with portable appliances; construction, inspection, testing and marking’), these cylinders or cartridges shall only be labelled with the appropriate pictogram and the hazard and precautionary statements concerning flammability.

1.3.2.2.No information concerning the effects on human health and the environment is required on the label. Instead the supplier shall provide the information concerning effects on human health and the environment to downstream users or distributors by means of the safety data sheet (SDS).

1.3.2.3.For consumers, sufficient information shall be transmitted to enable them to take all necessary measures for health and safety.

1.3.3.   Aerosols and containers fitted with a sealed spray attachment and containing substances or mixtures classified as presenting an aspiration hazard

With regard to the application of section 3.10.4, substances or mixtures classified in accordance with the criteria of sections 3.10.2 and 3.10.3 need not be labelled for this hazard when placed on the market in aerosol containers or in containers fitted with a sealed spray attachment.

1.3.4.   Metals in massive form, alloys, mixtures containing polymers, mixtures containing elastomers

1.3.4.1.Metals in massive form, alloys, mixtures containing polymers and mixtures containing elastomers do not require a label according to this Annex, if they do not present a hazard to human health by inhalation, ingestion or contact with skin or to the aquatic environment in the form in which they are placed on the market, although classified as hazardous in accordance with the criteria of this Annex.

1.3.4.2.Instead, the supplier shall provide the information to downstream users or distributors by means of the SDS.

1.3.5.   Explosives placed on the market with a view to obtaining an explosive or pyrotechnic effect

Explosives, as referred to in section 2.1, placed on the market with a view to obtaining an explosive or pyrotechnic effect shall be labelled and packaged in accordance with the requirements for explosives only.

1.4.   Request for use of an alternative chemical name

1.4.1.   Requests for use of an alternative chemical name under Article 24 may be granted only where

(I)the substance has not been assigned a Community workplace exposure limit; and

(II)the manufacturer, importer or downstream user can demonstrate that the use of the alternative chemical name meets the need to provide enough information for necessary health and safety precautions to be taken in the workplace and the need to ensure that risks from handling the mixture can be controlled; and

(III)the substance is classified exclusively as one or more of the following hazard categories:

(a)any of the hazard categories referred to in Part 2 of this Annex;

(b)Acute toxicity, Category 4;

(c)Skin corrosion/irritation, Category 2;

(d)Serious eye damage/eye irritation, Category 2;

(e)Specific target organ toxicity — Single exposure, Category 2 or 3;

(f)Specific target organ toxicity — Repeated exposure, Category 2;

(g)Hazardous to the aquatic environment — Chronic, Category 3 or 4.

1.4.2.   The choice of the chemical name(s) for mixtures intended for the fragrance or perfume industry

In the case of substances occurring in nature, a chemical name or chemical names of the type ‘essential oil of …’ or ‘extract of …’ may be used instead of the chemical names of the components of that essential oil or extract as referred to in Article 18(3)(b).

1.5.   Exemptions from labelling and packaging requirements

1.5.1.   Exemptions from Article 31 [(Article 29(1))]

1.5.1.1.Where Article 29(1) applies, the label elements mentioned in Article 17 may be provided in one of the following ways:

(a)in fold-out labels; or

(b)on tie-on tags; or

(c)on an outer packaging.

1.5.1.2.The label on any inner packaging shall contain at least hazard pictograms, the product identifier referred to in Article 18 and name and telephone number of the supplier of the substance or mixture.

1.5.2.   Exemptions from Article 17 [(Article 29(2)]

1.5.2.1.   Labelling of packages where the contents do not exceed 125 ml

1.5.2.1.1.The hazard statements and the precautionary statements linked to the hazard categories listed below may be omitted from the label elements required by Article 17 where:

(a)the contents of the package do not exceed 125 ml; and

(b)the substance or mixture is classified in one or more of the following hazard categories:

1)Oxidising gases of category 1;

2)Gases under pressure;

3)Flammable liquids of category 2 or 3;

4)Flammable solids of category 1 or 2;

5)Self-reactive substances or mixtures Types C to F;

6)Self-heating substances or mixtures of category 2;

7)Substances and mixtures which, in contact with water, emit flammable gases of categories 1, 2 or 3;

8)Oxidising liquids of category 2 or 3;

9)Oxidising solids of category 2 or 3;

10)Organic peroxides Types C to F;

11)Acute toxicity of category 4, if the substances or mixtures are not supplied to the general public;

12)Skin irritation of category 2;

13)Eye irritation of category 2;

14)Specific target organ toxicity — single exposure of category 2 or 3, if the substance or mixture is not supplied to the general public;

15)Specific target organ toxicity — repeated exposure of category 2, if the substance or mixture is not supplied to the general public;

16)Hazardous to the aquatic environment — Acute of category 1;

17)Hazardous to the aquatic environment — Chronic of category 1 or 2.

The exemptions for labelling of small packages of aerosols as flammable laid down in Directive 75/324/EEC shall apply to aerosol dispensers.

1.5.2.1.2.The precautionary statements linked to the hazard categories listed below may be omitted from the label elements required by Article 17 where:

(a)the contents of the package do not exceed 125 ml; and

(b)the substance or mixture is classified in one or more of the following hazard categories:

1)Flammable gases of category 2;

2)Reproductive toxicity: effects on or via lactation;

3)Hazardous to the aquatic environment — Chronic of category 3 or 4.

1.5.2.1.3.The pictogram, the hazard statement and the precautionary statement linked to the hazard categories listed below may be omitted from the label elements required by Article 17 where:

(a)the contents of the package do not exceed 125 ml; and

(b)the substance or mixture is classified in one or more of the following hazard categories:

1)Corrosive to metals.

1.5.2.2.   Labelling of soluble packaging for single use

The label elements required by Article 17 may be omitted from soluble packaging intended for single use where:

(a)The content of each soluble packaging does not exceed a volume of 25 ml;

(b)The classification of the contents of the soluble packaging is exclusively one or more of the hazard categories in 1.5.2.1.1 (b); and

(c)The soluble packaging is contained within outer packaging that fully meets the requirements of Article 17.

1.5.2.3.Section 1.5.2.2 shall not apply to substances or mixtures within the scope of Directives 91/414/EEC or 98/8/EC.

2. PART 2: PHYSICAL HAZARDS

2.1.   Explosives

2.1.1.   Definitions

2.1.1.1.The class of explosives comprises

(a)explosive substances and mixtures;

(b)explosive articles, except devices containing explosive substances or mixtures in such quantity or of such a character that their inadvertent or accidental ignition or initiation shall not cause any effect external to the device either by projection, fire, smoke, heat or loud noise; and

(c)substances, mixtures and articles not mentioned in points (a) and (b) which are manufactured with a view to producing a practical, explosive or pyrotechnic effect.

2.1.1.2.For the purposes of this Regulation the following definitions shall apply:

An explosive substance or mixture is a solid or liquid substance or mixture of substances which is in itself capable by chemical reaction of producing gas at such a temperature and pressure and at such a speed as to cause damage to the surroundings. Pyrotechnic substances are included even when they do not evolve gases.

A pyrotechnic substance or mixture is a substance or mixture of substances designed to produce an effect by heat, light, sound, gas or smoke or a combination of these as the result of non-detonative self-sustaining exothermic chemical reactions.

An unstable explosive is an explosive substance or mixture which is thermally unstable and/or too sensitive for normal handling, transport and use.

An explosive article is an article containing one or more explosive substances or mixtures.

A pyrotechnic article is an article containing one or more pyrotechnic substances or mixtures.

An intentional explosive is a substance, mixture or article which is manufactured with a view to producing a practical, explosive or pyrotechnic effect.

2.1.2.   Classification criteria

2.1.2.1.Substances, mixtures and articles of this class are classified as an unstable explosive on the basis of the flowchart in Figure 2.1.2. The test methods are described in Part I of the UN Recommendations on the Transport of Dangerous Goods, Manual of Tests and Criteria.

2.1.2.2.Substances, mixtures and articles of this class, which are not classified as an unstable explosive, shall be assigned to one of the following six divisions depending on the type of hazard they present:

(a)Division 1.1 Substances, mixtures and articles which have a mass explosion hazard (a mass explosion is one which affects almost the entire quantity present virtually instantaneously);

(b)Division 1.2 Substances, mixtures and articles which have a projection hazard but not a mass explosion hazard;

(c)Division 1.3 Substances, mixtures and articles which have a fire hazard and either a minor blast hazard or a minor projection hazard or both, but not a mass explosion hazard:

(i)combustion of which gives rise to considerable radiant heat; or

(ii)which burn one after another, producing minor blast or projection effects or both;

(d)Division 1.4 Substances, mixtures and articles which present no significant hazard:

substances, mixtures and articles which present only a small hazard in the event of ignition or initiation. The effects are largely confined to the package and no projection of fragments of appreciable size or range is to be expected. An external fire shall not cause virtually instantaneous explosion of almost the entire contents of the package;

(e)Division 1.5 Very insensitive substances or mixtures which have a mass explosion hazard:

substances and mixtures which have a mass explosion hazard but are so insensitive that there is very little probability of initiation or of transition from burning to detonation under normal conditions;

(f)Division 1.6 Extremely insensitive articles which do not have a mass explosion hazard:

articles which contain only extremely insensitive detonating substances or mixtures and which demonstrate a negligible probability of accidental initiation or propagation.

2.1.2.3.Explosives, which are not classified as an unstable explosive, shall be classified in one of the six divisions referred to in paragraph 2.1.2.2 of this Annex based on Test Series 2 to 8 in Part I of the UN Recommendations on the Transport of Dangerous Goods, Manual of Tests and Criteria according to the results of the tests laid down in Table 2.1.1:

Table 2.1.1

Criteria for explosives

CategoryCriteria
Unstable explosives or explosives of Divisions 1.1 to 1.6For explosives of Divisions 1.1 to 1.6, the following are the core set of tests that need to be performed:
Explosibility: according to UN Test Series 2 (section 12 of the UN Recommendations on the Transport of Dangerous Goods, Manual of Tests and Criteria). Intentional explosives (4) shall not be subject to UN Test Series 2.
Sensitiveness: according to UN Test Series 3 (section 13 of the UN Recommendations on the Transport of Dangerous Goods, Manual of Tests and Criteria).
Thermal stability: according to UN Test 3(c) (sub-section 13.6.1 of the UN Recommendations on the Transport of Dangerous Goods, Manual of Tests and Criteria).

Further tests are necessary to allocate the correct Division.

2.1.2.4.If explosives are unpackaged or repacked in packaging other than the original or similar packaging, they shall be retested.

2.1.3.   Hazard Communication

Label elements shall be used for substances, mixtures or articles meeting the criteria for classification in this hazard class in accordance with Table 2.1.2.

NOTE to Table 2.1.2: Unpackaged explosives or explosives repacked in packaging other than the original or similar packaging shall include all of the following label elements:

(a)the pictogram: exploding bomb;

(b)the signal word: ‘Danger’; and

(c)the hazard statement: ‘explosive; mass explosion hazard’

unless the hazard is shown to correspond to one of the hazard categories in Table 2.1.2, in which case the corresponding symbol, the signal word and/or the hazard statement shall be assigned.

Table 2.1.2

Label elements for explosives

ClassificationUnstable ExplosiveDivision 1.1Division 1.2Division 1.3Division 1.4Division 1.5Division 1.6
GHS Pictograms
Signal WordDangerDangerDangerDangerWarningDangerNo signal word
Hazard StatementH200: Unstable ExplosiveH201: Explosive; mass explosion hazardH202: Explosive; severe projection hazardH203: Explosive; fire, blast or projection hazardH204: Fire or projection hazardH205: May mass explode in fireNo hazard statement
Precautionary Statement

Prevention
P201

P202

P281
P210

P230

P240

P250

P280
P210

P230

P240

P250

P280
P210

P230

P240

P250

P280
P210

P240

P250

P280
P210

P230

P240

P250

P280
No precautionary statement
Precautionary Statement

Response
P372

P373

P380
P370+P380

P372

P373
P370+P380

P372

P373
P370+P380

P372

P373
P370+P380

P372

P373
P370+P380

P372

P373
No precautionary statement
Precautionary Statement

Storage
P401P401P401P401P401P401No precautionary statement
Precautionary Statement

Disposal
P501P501P501P501P501P501No precautionary statement

2.1.4.   Additional Classification Considerations

2.1.4.1.The classification of substances, mixtures and articles in the explosives hazard class and further allocation to a division is a very complex, three step procedure. Reference to Part I of the UN Recommendations on the Transport of Dangerous Goods, Manual of Tests and Criteria is necessary.

The first step is to ascertain whether the substance or mixture has explosive effects (Test Series 1). The second step is the acceptance procedure (Test Series 2 to 4) and the third step is the assignment to a hazard division (Test Series 5 to 7). The assessment whether a candidate for ‘ammonium nitrate emulsion or suspension or gel, intermediate for blasting explosives (ANE)’ is insensitive enough for inclusion as an oxidising liquid (section 2.13) or an oxidising solid (section 2.14) is answered by Test Series 8 tests.

Explosive substances and mixtures wetted with water or alcohols, or diluted with other substances to suppress their explosive properties, may be treated differently in terms of classification and other hazard classes may apply, according to their physical properties (see also Annex II section 1.1.).

Certain physical hazards (due to explosive properties) are altered by dilution, as is the case for desensitised explosives, by inclusion in a mixture or article, packaging or other factors.

The classification procedure is set out in the following decision logic (see Figures 2.1.1 to 2.1.4).

Figure 2.1.1

Overall scheme of the procedure for classifying a substance, mixture or article in the class of explosives (Class 1 for transport)



Figure 2.1.2

Procedure for provisional acceptance of a substance, mixture or article in the class of explosives (Class 1 for transport)



Figure 2.1.3

Procedure for assignment to a division in the class of explosives (Class 1 for transport)



Figure 2.1.4

Procedure for classification of ammonium nitrate emulsions, suspensions or gels



2.1.4.2.   Screening procedure

Explosive properties are associated with the presence of certain chemical groups in a molecule which can react to produce very rapid increases in temperature or pressure. The screening procedure is aimed at identifying the presence of such reactive groups and the potential for rapid energy release. If the screening procedure identifies the substance or mixture to be a potential explosive, the acceptance procedure (see section 10.3 of the UN Recommendations on the Transport of Dangerous Goods, Manual of Tests and Criteria) has to be performed.

Note

Neither a Series 1 type (a) propagation of detonation test nor a Series 2 type (a) test of sensitivity to detonative shock is required if the exothermic decomposition energy of organic materials is less than 800 J/g.

2.1.4.3.A substance or mixture shall not be classified as explosive if:

(a)There are no chemical groups associated with explosive properties present in the molecule. Examples of groups which may indicate explosive properties are given in Table A6.1 in Appendix 6 of the UN Recommendations on the Transport of Dangerous Goods, Manual of Tests and Criteria; or

(b)The substance contains chemical groups associated with explosive properties which include oxygen and the calculated oxygen balance is less than - 200;

The oxygen balance is calculated for the chemical reaction:

CxHyOz+ [x+ (y/4)-(z/2)] O2 → x CO2 + (y/2) H2O

Using the formula:

Oxygen balance = -1 600 [2x + (y/2)-z]/molecular weight;

(c)When the organic substance or a homogenous mixture of organic substances contains chemical groups associated with explosive properties but the exothermic decomposition energy is less than 500 J/g and the onset of exothermic decomposition is below 500 oC. The exothermic decomposition energy can be determined using a suitable calorimetric technique; or

(d)For mixtures of inorganic oxidising substances with organic material(s), the concentration of the inorganic oxidising substance is:

less than 15 % by mass, if the oxidising substance is assigned to Categories 1 or 2;

less than 30 % by mass, if the oxidising substance is assigned to Category 3.

2.1.4.4.In the case of mixtures containing any known explosives, the acceptance procedure has to be performed.

2.2.   Flammable gases

2.2.1.   Definition

Flammable gas means a gas or gas mixture having a flammable range with air at 20 oC and a standard pressure of 101,3 kPa.

2.2.2.   Classification criteria

2.2.2.1.A flammable gas shall be classified in this class in accordance with Table 2.2.1:

Table 2.2.1

Criteria for flammable gases

CategoryCriteria
1Gases, which at 20 oC and a standard pressure of 101,3 kPa:

(a)are ignitable when in a mixture of 13 % or less by volume in air; or

(b)have a flammable range with air of at least 12 percentage points regardless of the lower flammable limit.
2Gases, other than those of Category 1, which, at 20 oC and a standard pressure of 101,3 kPa, have a flammable range while mixed in air.

Note

For the classification of aerosols, see 2.3.

2.2.3.   Hazard Communication

Label elements shall be used for substances and mixtures meeting the criteria for classification in this hazard class in accordance with Table 2.2.2.

Table 2.2.2

Label elements for flammable gases

ClassificationCategory 1Category 2
GHS PictogramNo pictogram
Signal WordDangerWarning
Hazard StatementH220: Extremely flammable gasH221: Flammable gas
Precautionary Statement

Prevention
P210P210
Precautionary Statement

Response
P377

P381
P377

P381
Precautionary Statement

Storage
P403P403
Precautionary Statement

Disposal

2.2.4.   Additional Classification Considerations

2.2.4.1.Flammability shall be determined by tests or, for mixtures where there are sufficient data available, by calculation in accordance with the methods adopted by ISO (see ISO 10156 as amended, Gases and gas mixtures — Determination of fire potential and oxidising ability for the selection of cylinder valve outlet). Where insufficient data are available to use these methods, test method EN 1839 as amended (Determination of explosion limits of gases and vapours) can be used.

2.3.   Flammable aerosols

2.3.1.   Definitions

Aerosols, this means aerosol dispensers, are any non-refillable receptacles made of metal, glass or plastics and containing a gas compressed, liquefied or dissolved under pressure, with or without a liquid, paste or powder, and fitted with a release device allowing the contents to be ejected as solid or liquid particles in suspension in a gas, as a foam, paste or powder or in a liquid state or in a gaseous state.

2.3.2.   Classification criteria

2.3.2.1.Aerosols shall be considered for classification as flammable in accordance with 2.3.2.2 if they contain any component which is classified as flammable according to the criteria contained in this Part, i.e.:

Liquids with a flash point ≤ 93 oC, which includes Flammable Liquids according to section 2.6;

Flammable gases (see 2.2);

Flammable solids (see 2.7).

Note

Flammable components do not cover pyrophoric, self-heating or water-reactive substances and mixtures because such components are never used as aerosol contents.

2.3.2.2.A flammable aerosol shall be classified in one of the two categories for this Class on the basis of its components, of its chemical heat of combustion and, if applicable, of the results of the foam test (for foam aerosols) and of the ignition distance test and enclosed space test (for spray aerosols) in accordance with Figure 2.3.1 and the UN Recommendations on the Transport of Dangerous Goods, Manual of Tests and Criteria, Part III, sub-sections 31.4, 31.5 and 31.6.

Figure 2.3.1

Figure 2.3.1(a) for flammable aerosols



For spray aerosols, go to decision logic 2.3.1 (b);

For foam aerosols, got to decision logic 2.3.1 (c).

Figure 2.3.1(b) for spray aerosols



Figure 2.3.1(c) for foam aerosols



2.3.3.   Hazard Communication

Label elements shall be used for substances or mixtures meeting the criteria for classification in this hazard class in accordance with Table 2.3.2.

Table 2.3.2

Label elements for flammable aerosols

ClassificationCategory 1Category 2
GHS Pictograms
Signal WordDangerWarning
Hazard StatementH222: Extremely flammable aerosolH223: Flammable aerosol
Precautionary Statement

Prevention
P210

P211

P251
P210

P211

P251
Precautionary Statement

Response
Precautionary Statement

Storage
P410 + P412P410 + P412
Precautionary Statement

Disposal

2.3.4.   Additional Classification Considerations

2.3.4.1.The chemical heat of combustion (ΔHc), in kilojoules per gram (kJ/g), is the product of the theoretical heat of combustion (ΔHcomb), and a combustion efficiency, usually less than 1,0 (a typical combustion efficiency is 0,95 or 95 %).

For a composite aerosol formulation, the chemical heat of combustion is the summation of the weighted heats of combustion for the individual components, as follows:



where:

ΔHc=chemical heat of combustion (kJ/g);
wi %=mass fraction of component i in the product;
ΔHc(i)=specific heat of combustion (kJ/g)of component i in the product.

The chemical heats of combustion can be found in the literature, calculated or determined by tests (see ASTM D 240 as amended — Standard Test Methods for Heat of Combustion of Liquid Hydrocarbon Fuels by Bomb Calorimeter, EN/ISO 13943 as amended, 86.l to 86.3 — Fire safety — Vocabulary, and NFPA 30B as amended — Code for the Manufacture and Storage of Aerosol Products).

2.4.   Oxidising gases

2.4.1.   Definitions

Oxidising gas means any gas or gas mixture which may, generally by providing oxygen, cause or contribute to the combustion of other material more than air does.

2.4.2.   Classification criteria

2.4.2.1.An oxidising gas shall be classified in a single category for this class in accordance with Table 2.4.1.:

Table 2.4.1

Criteria for oxidising gases

CategoryCriteria
1Any gas which may, generally by providing oxygen, cause or contribute to the combustion of other material more than air does.

Note

‘Gases which cause or contribute to the combustion of other material more than air’ means pure gases or gas mixtures with an oxidising power greater than 23,5 % as determined by a method specified in ISO 10156 as amended or 10156-2 as amended.

2.4.3.   Hazard Communication

Label elements shall be used for substances or mixtures meeting the criteria for classification in this hazard class in accordance with Table 2.4.2.

Table 2.4.2

Label elements for oxidising gases

ClassificationCategory 1
GHS Pictogram
Signal WordDanger
Hazard StatementH270: May cause or intensify fire; oxidiser
Precautionary Statement

Prevention
P220

P244
Precautionary Statement

Response
P370 + P376
Precautionary Statement

Storage
P403
Precautionary Statement

Disposal

2.4.4.   Additional Classification Considerations

To classify an oxidising gas, tests or calculation methods as described in ISO 10156 as amended, gases and gas mixtures — Determination of fire potential and oxidising ability for the selection of cylinder valve outlet and ISO 10156-2 as amended, gas cylinders — gases and gas mixtures — Determination of oxidising ability of toxic and corrosive gases and gas mixtures — shall be performed.

2.5.   Gases under pressure

2.5.1.   Definition

2.5.1.1.Gases under pressure are gases which are contained in a receptacle at a pressure of 200 kPa (gauge) or more, or which are liquefied or liquefied and refrigerated.

They comprise compressed gases, liquefied gases, dissolved gases and refrigerated liquefied gases.

2.5.1.2.The critical temperature is the temperature above which a pure gas cannot be liquefied, regardless of the degree of compression.

2.5.2.   Classification criteria

Gases shall be classified, according to their physical state when packaged, in one of four groups in accordance with Table 2.5.1:

Table 2.5.1

Criteria for gases under pressure

GroupCriteria
Compressed gasA gas which when packaged under pressure is entirely gaseous at - 50 oC; including all gases with a critical temperature ≤ - 50 oC.
Liquefied gasA gas which, when packaged under pressure, is partially liquid at temperatures above - 50 oC. A distinction is made between:

(i)high pressure liquefied gas: a gas with a critical temperature between - 50 oC and + 65 oC; and

(ii)low pressure liquefied gas: a gas with a critical temperature above + 65 oC.
Refrigerated liquefied gasA gas which when packaged is made partially liquid because of its low temperature.
Dissolved gasA gas which when packaged under pressure is dissolved in a liquid phase solvent.

2.5.3.   Hazard Communication

Label elements shall be used for substances or mixtures meeting the criteria for classification in this hazard class in accordance with Table 2.5.2.

Table 2.5.2

Label elements for gases under pressure

ClassificationCompressed gasLiquefied gasRefrigerated liquefied gasDissolved gas
GHS Pictograms
Signal WordWarningWarningWarningWarning
Hazard StatementH280: Contains gas under pressure; may explode if heatedH280: Contains gas under pressure; may explode if heatedH281: Contains refrigerated gas; may cause cryogenic burns or injuryH280: Contains gas under pressure; may explode if heated
Precautionary Statement

Prevention
P282
Precautionary Statement

Response
P336

P315
Precautionary Statement

Storage
P410 + P403P410 + P403P403P410 + P403
Precautionary Statement

Disposal

2.5.4.   Additional Classification Considerations

For this group of gases, the following information is required to be known:

the vapour pressure at 50 oC;

the physical state at 20 oC at standard ambient pressure;

the critical temperature.

Data can be found in the literature, calculated or determined by testing. Most pure gases are already classified in the UN Recommendations on the Transport of Dangerous Goods, Model Regulations.

2.6.   Flammable liquids

2.6.1.   Definition

Flammable liquid means a liquid having a flash point of not more than 60 oC.

2.6.2.   Classification criteria

2.6.2.1.A flammable liquid shall be classified in one of the three categories for this class in accordance with Table 2.6.1:

Table 2.6.1

Criteria for flammable liquids

CategoryCriteria
1Flash point < 23 oC and initial boiling point ≤ 35 oC
2Flash point < 23 oC and initial boiling point > 35 oC
3Flash point ≥ 23 oC and ≤ 60 oC (5)

2.6.3.   Hazard Communication

Label elements shall be used for substances or mixtures meeting the criteria for classification in this hazard class in accordance with Table 2.6.2.

Table 2.6.2

Label elements for flammable liquids

ClassificationCategory 1Category 2Category 3
GHS Pictograms
Signal WordDangerDangerWarning
Hazard StatementH224: Extremely flammable liquid and vapourH225: Highly flammable liquid and vapourH226: Flammable liquid and vapour
Precautionary Statement

Prevention
P210

P233

P240

P241

P242

P243

P280
P210

P233

P240

P241

P242

P243

P280
P210

P233

P240

P241

P242

P243

P280
Precautionary Statement

Response
P303 + P361 + P353

P370 + P378
P303 + P361 + P353

P370 + P378
P303 + P361 + P353

P370 + P378
Precautionary Statement

Storage
P403 + P235P403 + P235P403 + P235
Precautionary Statement

Disposal
P501P501P501

2.6.4.   Additional Classification Considerations

2.6.4.1.For the classification of flammable liquids data on flash point and initial boiling point are needed. Data can be determined by testing, found in literature or calculated. If data are not available, the flash point and the initial boiling point shall be determined through testing. For flash point determination a closed-cup method shall be used.

2.6.4.2.In the case of mixtures (6) containing known flammable liquids in defined concentrations, although they may contain non-volatile components e.g. polymers, additives, the flash point need not be determined experimentally if the calculated flash point of the mixture, using the method given in 2.6.4.3, is at least 5 oC (7) greater than the relevant classification criterion and provided that:

(a)the composition of the mixture is accurately known (if the material has a specified range of composition, the composition with the lowest calculated flash point shall be selected for assessment);

(b)the lower explosion limit of each component is known (an appropriate correlation has to be applied when these data are extrapolated to other temperatures than test conditions) as well as a method for calculating the lower explosion limit;

(c)the temperature dependence of the saturated vapour pressure and of the activity coefficient is known for each component as present in the mixture;

(d)the liquid phase is homogeneous.

2.6.4.3.One suitable method is described in Gmehling and Rasmussen (Ind. Eng. Fundament, 21, 186, (1982)). For a mixture containing non-volatile components the flash point is calculated from the volatile components. It is considered that a non-volatile component only slightly decreases the partial pressure of the solvents and the calculated flash point is only slightly below the measured value.

2.6.4.4.Possible test methods for determining the flash point of flammable liquids are listed in Table 2.6.3.

Table 2.6.3

Methods for determining the flash point of flammable liquids

European standards:EN ISO 1516 as amended

Determination of flash/no flash — Closed cup equilibrium method
EN ISO 1523 as amended

Determination of flash point — Closed cup equilibrium method
EN ISO 2719 as amended

Determination of flash point — Pensky-Martens closed cup method
EN ISO 3679 as amended

Determination of flash point — Rapid equilibrium closed cup method
EN ISO 3680 as amended

Determination of flash/no flash — Rapid equilibrium closed cup method
EN ISO 13736 as amended

Petroleum products and other liquids — Determination of flash point — Abel closed cup method
National standards:
Association française de normalisation, AFNOR:NF M07-036 as amended

Détermination du point d'éclair — Vase clos Abel-Pensky

(identical to DIN 51755)
British Standards Institute,BS 2000 Part 170 as amended

(identical to EN ISO 13736)
Deutsches Institut für NormungDIN 51755 (flash points below 65 C) as amended Prüfung von Mineralölen und anderen brennbaren Flüssigkeiten; Bestimmung des Flammpunktes im geschlossenen Tiegel, nach Abel-Pensky

(identical to NF M07-036)

2.6.4.5.Liquids with a flash point of more than 35 oC need not be classified in Category 3 if negative results have been obtained in the sustained combustibility test L.2, Part III, section 32 of the UN Recommendations on the Transport of Dangerous Goods, Manual of Tests and Criteria.

2.7.   Flammable solids

2.7.1.   Definition

2.7.1.1.A flammable solid means a solid which is readily combustible, or may cause or contribute to fire through friction.

Readily combustible solids are powdered, granular, or pasty substances or mixtures which are dangerous if they can be easily ignited by brief contact with an ignition source, such as a burning match, and if the flame spreads rapidly.

2.7.2.   Classification criteria

2.7.2.1.Powdered, granular or pasty substances or mixtures (except powders of metals or metal alloys — see 2.7.2.2) shall be classified as readily combustible solids when the time of burning of one or more of the test runs, performed in accordance with the test method described in Part III, sub-section 33.2.1, of the UN Recommendations on the Transport of Dangerous Goods, Manual of Tests and Criteria, is less than 45 seconds or the rate of burning is more than 2,2 mm/s.

2.7.2.2.Powders of metals or metal alloys shall be classified as flammable solids when they can be ignited and the reaction spreads over the whole length of the sample in 10 minutes or less.

2.7.2.3.A flammable solid shall be classified in one of the two categories for this class using Method N.1 as described in 33.2.1 of the UN Recommendations on the Transport of Dangerous Goods, Manual of Tests and Criteria in accordance with Table 2.7.1:

Table 2.7.1

Criteria for flammable solids

CategoryCriteria
1Burning rate test

Substances and mixtures other than metal powders:

(a)wetted zone does not stop fire and

(b)burning time < 45 seconds or burning rate > 2,2 mm/s

Metal powders

burning time ≤ 5 minutes
2Burning rate test

Substances and mixtures other than metal powders:

(a)wetted zone stops the fire for at least 4 minutes and

(b)burning time < 45 seconds or burning rate > 2,2 mm/s

Metal powders

burning time > 5 minutes and ≤ 10 minutes

Note

The test shall be performed on the substance or mixture in its physical form as presented. If, for example, for the purposes of supply or transport, the same chemical is to be presented in a physical form different from that which was tested and which is considered likely to materially alter its performance in a classification test, the substance shall also be tested in the new form.

2.7.3.   Hazard Communication

Label elements shall be used for substances or mixtures meeting the criteria for classification in this hazard class in accordance with Table 2.7.2.

Table 2.7.2

Label elements for flammable solids

ClassificationCategory 1Category 2
GHS Pictograms
Signal WordDangerWarning
Hazard StatementH228: Flammable SolidH228: Flammable Solid
Precautionary Statement

Prevention
P210

P240

P241

P280
P210

P240

P241

P280
Precautionary Statement

Response
P370 + P378P370 + P378
Precautionary Statement

Storage
Precautionary Statement

Disposal

2.8.   Self-reactive substances and mixtures

2.8.1.   Definition

2.8.1.1.Self-reactive substances or mixtures are thermally unstable liquid or solid substances or mixtures liable to undergo a strongly exothermic decomposition even without participation of oxygen (air). This definition excludes substances and mixtures classified according to this Part as explosives, organic peroxides or as oxidising.

2.8.1.2.A self-reactive substance or mixture is regarded as possessing explosive properties when in laboratory testing the formulation is liable to detonate, to deflagrate rapidly or to show a violent effect when heated under confinement.

2.8.2.   Classification criteria

2.8.2.1.Any self-reactive substance or mixture shall be considered for classification in this class as a self-reactive substance or mixture unless:

(a)they are explosives, according to the criteria given in 2.1;

(b)they are oxidising liquids or solids, according to the criteria given in 2.13 or 2.14, except that mixtures of oxidising substances, which contain 5 % or more of combustible organic substances shall be classified as self-reactive substances according to the procedure defined in 2.8.2.2;

(c)they are organic peroxides, according to the criteria given in 2.15;

(d)their heat of decomposition is less than 300 J/g; or

(e)their self-accelerating decomposition temperature (SADT) is greater than 75 oC for a 50 kg package (8).

2.8.2.2.Mixtures of oxidising substances, meeting the criteria for classification as oxidising substances, which contain 5 % or more of combustible organic substances and which do not meet the criteria mentioned in (a), (c), (d) or (e) in 2.8.2.1, shall be subjected to the self-reactive substances classification procedure;

Such a mixture showing the properties of a self-reactive substance type B to F (see 2.8.2.3) shall be classified as a self-reactive substance.

Where the test is conducted in the package form and the packaging is changed, a further test shall be conducted where it is considered that the change in packaging will affect the outcome of the test.

2.8.2.3.Self-reactive substances and mixtures shall be classified in one of the seven categories of ‘types A to G’ for this class, according to the following principles:

(a)any self-reactive substance or mixture which can detonate or deflagrate rapidly, as packaged, shall be defined as self-reactive substance TYPE A;

(b)any self-reactive substance or mixture possessing explosive properties and which, as packaged, neither detonates nor deflagrates rapidly, but is liable to undergo a thermal explosion in that package shall be defined as self-reactive substance TYPE B;

(c)any self-reactive substance or mixture possessing explosive properties when the substance or mixture as packaged cannot detonate or deflagrate rapidly or undergo a thermal explosion shall be defined as self-reactive substance TYPE C;

(d)any self-reactive substance or mixture which in laboratory testing:

(i)detonates partially, does not deflagrate rapidly and shows no violent effect when heated under confinement; or

(ii)does not detonate at all, deflagrates slowly and shows no violent effect when heated under confinement; or

(iii)does not detonate or deflagrate at all and shows a medium effect when heated under confinement;

shall be defined as self-reactive substance TYPE D;

(e)any self-reactive substance or mixture which, in laboratory testing, neither detonates nor deflagrates at all and shows low or no effect when heated under confinement shall be defined as self-reactive substance TYPE E;

(f)any self-reactive substance or mixture which, in laboratory testing, neither detonates in the cavitated state nor deflagrates at all and shows only a low or no effect when heated under confinement as well as low or no explosive power shall be defined as self-reactive substance TYPE F;

(g)any self-reactive substance or mixture which, in laboratory testing, neither detonates in the cavitated state nor deflagrates at all and shows no effect when heated under confinement nor any explosive power, provided that it is thermally stable (SADT is 60 oC to 75 oC for a 50 kg package), and, for liquid mixtures, a diluent having a boiling point not less than 150 oC is used for desensitisation shall be defined as self-reactive substance TYPE G. If the mixture is not thermally stable or a diluent having a boiling point less than 150 oC is used for desensitisation, the mixture shall be defined as self-reactive substance TYPE F.

Where the test is conducted in the package form and the packaging is changed, a further test shall be conducted where it is considered that the change in packaging will affect the outcome of the test.

2.8.2.4.   Criteria for temperature control

Self-reactive substances need to be subjected to temperature control if their SADT is less than or equal to 55 oC. Test methods for determining the SADT as well as the derivation of control and emergency temperatures are given in, Part II, section 28 of the UN Recommendations on the Transport of Dangerous Goods, Manual of Tests and Criteria. The test selected shall be conducted in a manner which is representative, both in size and material, of the package.

2.8.3.   Hazard Communication

Label elements shall be used for substances or mixtures meeting the criteria for classification in this hazard class in accordance with Table 2.8.1.

Table 2.8.1

Label elements for self-reactive substances and mixtures

ClassificationType AType BType C & DType E & FType G
GHS Pictograms


There are no label elements allocated to this hazard category
Signal WordDangerDangerDangerWarning
Hazard StatementH240: Heating may cause an explosionH241: Heating may cause a fire or explosionH242: Heating may cause a fireH242: Heating may cause a fire
Precautionary Statement

Prevention
P210

P220

P234

P280
P210

P220

P234

P280
P210

P220

P234

P280
P210

P220

P234

P280
Precautionary Statement

Response
P370 + P378

P370 + P380 + P375
P370 + P378

P370 + P380 + P375
P370 + P378P370 + P378
Precautionary Statement

Storage
P403 + P235

P411

P420
P403 + P235

P411

P420
P403 + P235

P411

P420
P403 + P235 P411

P420
Precautionary Statement

Disposal
P501P501P501P501

Type G has no hazard communication elements assigned but shall be considered for properties belonging to other hazard classes.

2.8.4.   Additional Classification Considerations

2.8.4.1.The properties of self-reactive substances or mixtures which are decisive for their classification shall be determined experimentally. The classification of a self reactive substance or mixture shall be performed in accordance with test series A to H as described in Part II of the UN Recommendations on the Transport of Dangerous Goods, Manual of Tests and Criteria. The procedure for classification is described in Figure 2.8.1.

2.8.4.2.The classification procedures for self-reactive substances and mixtures need not be applied if:

(a)There are no chemical groups present in the molecule associated with explosive or self reactive properties. Examples of such groups are given in Tables A6.1 and A6.2 in Appendix 6 of the UN Recommendations on the Transport of Dangerous Goods, Manual of Tests and Criteria; or

(b)For a single organic substance or a homogeneous mixture of organic substances, the estimated SADT for a 50 kg package is greater than 75 oC or the exothermic decomposition energy is less than 300J/g. The onset temperature and decomposition energy can be estimated using a suitable calorimetric technique (see Part II, sub-section 20.3.3.3 of the UN Recommendations on the Transport of Dangerous Goods, Manual of Tests and Criteria).

Figure 2.8.1

Self-reactive substances and mixtures



2.9.   Pyrophoric liquids

2.9.1.   Definition

Pyrophoric liquid means a liquid substance or mixture which, even in small quantities, is liable to ignite within five minutes after coming into contact with air.

2.9.2.   Classification criteria

2.9.2.1.A pyrophoric liquid shall be classified in a single category for this class using test N.3 in Part III, sub-section 33.3.1.5 of the UN Recommendations on the Transport of Dangerous Goods, Manual of Tests and Criteria according to Table 2.9.1:

Table 2.9.1

Criteria for pyrophoric liquids

CategoryCriteria
1The liquid ignites within 5 min when added to an inert carrier and exposed to air, or it ignites or chars a filter paper on contact with air within 5 min.

2.9.3.   Hazard Communication

Label elements shall be used for substances or mixtures meeting the criteria for classification in this hazard class in accordance with Table 2.9.2.

Table 2.9.2

Label elements for pyrophoric liquids

ClassificationCategory 1
GHS Pictogram
Signal WordDanger
Hazard StatementH250: Catches fire spontaneously if exposed to air
Precautionary Statement

Prevention
P210

P222

P280
Precautionary Statement

Response
P302 + P334

P370 + P378
Precautionary Statement

Storage
P422
Precautionary Statement

Disposal

2.9.4.   Additional Classification Considerations

2.9.4.1.The classification procedure for pyrophoric liquids need not be applied when experience in manufacture or handling shows that the substance or mixture does not ignite spontaneously on coming into contact with air at normal temperatures (i.e. the substance is known to be stable at room temperature for prolonged periods of time (days)).

2.10.   Pyrophoric solids

2.10.1.   Definition

Pyrophoric solid means a solid substance or mixture which, even in small quantities, is liable to ignite within five minutes after coming into contact with air.

2.10.2.   Classification criteria

2.10.2.1.A pyrophoric solid shall be classified in a single category for this class using test N.2 in Part III, sub-section 33.3.1.4 of the UN Recommendations on the Transport of Dangerous Goods, Manual of Tests and Criteria in accordance with Table 2.10.1:

Table 2.10.1

Criteria for pyrophoric solids

CategoryCriteria
1The solid ignites within 5 minutes of coming into contact with air.

Note

The test shall be performed on the substance or mixture in its physical form as presented. If, for example, for the purposes of supply or transport, the same chemical is to be presented in a physical form different from that which was tested and which is considered likely to materially alter its performance in a classification test, the substance shall also be tested in the new form.

2.10.3.   Hazard Communication

Label elements shall be used for substances or mixtures meeting the criteria for classification in this hazard class in accordance with Table 2.10.2.

Table 2.10.2

Label elements for pyrophoric solids

ClassificationCategory 1
GHS Pictogram
Signal WordDanger
Hazard StatementH250: Catches fire spontaneously if exposed to air
Precautionary Statement

Prevention
P210

P222

P280
Precautionary Statement

Response
P335 + P334

P370 +P378
Precautionary Statement

Storage
P422
Precautionary Statement

Disposal

2.10.4.   Additional Classification Considerations

2.10.4.1.The classification procedure for pyrophoric solids need not be applied when experience in manufacture or handling shows that the substance or mixture does not ignite spontaneously on coming into contact with air at normal temperatures (i.e. the substance is known to be stable at room temperature for prolonged periods of time (days)).

2.11.   Self-heating substances and mixtures

2.11.1.   Definition

2.11.1.1.A self-heating substance or mixture is a liquid or solid substance or mixture, other than a pyrophoric liquid or solid, which, by reaction with air and without energy supply, is liable to self-heat; this substance or mixture differs from a pyrophoric liquid or solid in that it will ignite only when in large amounts (kilograms) and after long periods of time (hours or days).

2.11.1.2.Self-heating of substances or mixtures, leading to spontaneous combustion, is caused by reaction of the substance or mixture with oxygen (in the air) and the heat developed not being conducted away rapidly enough to the surroundings. Spontaneous combustion occurs when the rate of heat production exceeds the rate of heat loss and the auto-ignition temperature is reached.

2.11.2.   Classification criteria

2.11.2.1.A substance or mixture shall be classified as a self-heating substance or mixture of this class, if in the tests performed in accordance with the test method given in the UN Recommendations on the Transport of Dangerous Goods, Manual of Tests and Criteria, Part III, sub-section 33.3.1.6:

(a)a positive result is obtained using a 25 mm cube sample at 140 oC;

(b)a positive result is obtained in a test using a 100 mm sample cube at 140 oC and a negative result is obtained in a test using a 100 mm cube sample at 120 oC and the substance or mixture is to be packed in packages with a volume of more than 3 m3;

(c)a positive result is obtained in a test using a 100 mm sample cube at 140 oC and a negative result is obtained in a test using a 100 mm cube sample at 100 oC and the substance or mixture is to be packed in packages with a volume of more than 450 litres;

(d)a positive result is obtained in a test using a 100 mm sample cube at 140 oC and a positive result is obtained in a test using a 100 mm cube sample at 100 oC.

2.11.2.2.A self-heating substance or mixture shall be classified in one of the two categories for this class if, in a test performed in accordance with test method N.4 in Part III, sub-section 33.3.1.6 of the UN Recommendations on the Transport of Dangerous Goods, Manual of Tests and Criteria, the result meets the criteria according to Table 2.11.1:

Table 2.11.1

Criteria for self-heating substances and mixtures

CategoryCriteria
1A positive result is obtained in a test using a 25 mm sample cube at 140 oC
2
(a)a positive result is obtained in a test using a 100 mm sample cube at 140 oC and a negative result is obtained in a test using a 25 mm cube sample at 140 oC and the substance or mixture is to be packed in packages with a volume of more than 3 m3; or

(b)a positive result is obtained in a test using a 100 mm sample cube at 140 oC and a negative result is obtained in a test using a 25 mm cube sample at 140 oC, a positive result is obtained in a test using a 100 mm cube sample at 120 oC and the substance or mixture is to be packed in packages with a volume of more than 450 litres; or

(c)a positive result is obtained in a test using a 100 mm sample cube at 140 oC and a negative result is obtained in a test using a 25 mm cube sample at 140 oC and a positive result is obtained in a test using a 100 mm cube sample at 100 oC.

Note

The test shall be performed on the substance or mixture in its physical form as presented. If, for example, for the purposes of supply or transport, the same chemical is to be presented in a physical form different from that which was tested and which is considered likely to materially alter its performance in a classification test, the substance shall also be tested in the new form.

2.11.2.3.Substances and mixtures with a temperature of spontaneous combustion higher than 50 oC for a volume of 27 m3 shall not be classified as a self-heating substance or mixture.

2.11.2.4.Substances and mixtures with a spontaneous ignition temperature higher than 50 oC for a volume of 450 litres shall not be assigned to Category 1 of this class.

2.11.3.   Hazard Communication

Label elements shall be used for substances or mixtures meeting the criteria for classification in this hazard class in accordance with Table 2.11.2.

Table 2.11.2

Label elements for self-heating substances and mixtures

ClassificationCategory 1Category 2
GHS Pictograms
Signal WordDangerWarning
Hazard StatementH251: Self-heating; may catch fireH252: Self-heating in large quantities; may catch fire
Precautionary Statement

Prevention
P235 + P410

P280
P235 + P410

P280
Precautionary Statement

Response
Precautionary Statement

Storage
P407

P413

P420
P407

P413

P420
Precautionary Statement

Disposal

2.11.4.   Additional Classification Considerations

2.11.4.1.For detailed schemes for the decision logic for classification and the tests to be carried out for ascertaining the different categories, see Figure 2.11.1.

2.11.4.2.The classification procedure for self-heating substances or mixtures need not be applied if the results of a screening test can be adequately correlated with the classification test and an appropriate safety margin is applied. Examples of screening tests are:

(a)The Grewer Oven test (VDI guideline 2263, Part 1, 1990, Test methods for the Determination of the Safety Characteristics of Dusts) with an onset temperature 80 K above the reference temperature for a volume of 1 l;

(b)The Bulk Powder Screening Test (Gibson, N. Harper, D.J. Rogers, R.Evaluation of the fire and explosion risks in drying powders, Plant Operations Progress, 4 (3), 181-189, 1985) with an onset temperature 60 K above the reference temperature for a volume of 1 l.

Figure 2.11.1.

Self-heating substances and mixtures



2.12.   Substances and mixtures which in contact with water emit flammable gases

2.12.1.   Definition

Substances or mixtures which, in contact with water, emit flammable gases means solid or liquid substances or mixtures which, by interaction with water, are liable to become spontaneously flammable or to give off flammable gases in dangerous quantities.

2.12.2.   Classification criteria

2.12.2.1.A substance or mixture which, in contact with water, emits flammable gases shall be classified in one of the three categories for this class, using test N.5 in Part III, sub-section 33.4.1.4 of the UN Recommendations on the Transport of Dangerous Goods, Manual of Tests and Criteria, in accordance with Table 2.12.1:

Table 2.12.1

Criteria for substances or mixtures which in contact with water emit flammable gases

CategoryCriteria
1Any substance or mixture which reacts vigorously with water at ambient temperatures and demonstrates generally a tendency for the gas produced to ignite spontaneously, or which reacts readily with water at ambient temperatures such that the rate of evolution of flammable gas is equal to or greater than 10 litres per kilogram of substance over any one minute.
2Any substance or mixture which reacts readily with water at ambient temperatures such that the maximum rate of evolution of flammable gas is equal to or greater than 20 litres per kilogram of substance per hour, and which does not meet the criteria for Category 1.
3Any substance or mixture which reacts slowly with water at ambient temperatures such that the maximum rate of evolution of flammable gas is equal to or greater than 1 litre per kilogram of substance per hour, and which does not meet the criteria for Categories 1 and 2.

Note:

The test shall be performed on the substance or mixture in its physical form as presented. If, for example, for the purposes of supply or transport, the same chemical is to be presented in a physical form different from that which was tested and which is considered likely to materially alter its performance in a classification test, the substance must also be tested in the new form.

2.12.2.2.A substance or mixture shall be classified as a substance or mixture which in contact with water emits flammable gases if spontaneous ignition takes place in any step of the test procedure.

2.12.3.   Hazard Communication

Label elements shall be used for substances or mixtures meeting the criteria for classification in this hazard class in accordance with Table 2.12.2.

Table 2.12.2

Label elements for substances or mixtures which in contact with water emit flammable gases

ClassificationCategory 1Category 2Category 3
GHS Pictograms
Signal WordDangerDangerWarning
Hazard StatementH260: In contact with water releases flammable gases which may ignite spontaneouslyH261: In contact with water releases flammable gasesH261: In contact with water releases flammable gases
Precautionary Statement

Prevention
P223

P231 + P232

P280
P223

P231 + P232

P280
P231 + P232

P280
Precautionary Statement

Response
P335 + P334

P370 + P378
P335 + P334

P370 + P378
P370 + P378
Precautionary Statement

Storage
P402 + P404P402 + P404P402 + P404
Precautionary Statement

Disposal
P501P501P501

2.12.4.   Additional Classification Considerations

2.12.4.1.The classification procedure for this class need not be applied if:

(a)the chemical structure of the substance or mixture does not contain metals or metalloids; or

(b)experience in production or handling shows that the substance or mixture does not react with water, e.g. the substance is manufactured with water or washed with water; or

(c)the substance or mixture is known to be soluble in water to form a stable mixture.

2.13.   Oxidising liquids

2.13.1.   Definition

Oxidising liquid means a liquid substance or mixture which, while in itself not necessarily combustible, may, generally by yielding oxygen, cause, or contribute to, the combustion of other material.

2.13.2.   Classification criteria

2.13.2.1.An oxidising liquid shall be classified in one of the three categories for this class using test O.2 in Part III, sub-section 34.4.2 of the UN Recommendations on the Transport of Dangerous Goods, Manual of Tests and Criteria in accordance with Table 2.13.1:

Table 2.13.1

Criteria for oxidising liquids

CategoryCriteria
1Any substance or mixture which, in the 1:1 mixture, by mass, of substance (or mixture) and cellulose tested, spontaneously ignites; or the mean pressure rise time of a 1:1 mixture, by mass, of substance (or mixture) and cellulose is less than that of a 1:1 mixture, by mass, of 50 % perchloric acid and cellulose.
2Any substance or mixture which, in the 1:1 mixture, by mass, of substance (or mixture) and cellulose tested, exhibits a mean pressure rise time less than or equal to the mean pressure rise time of a 1:1 mixture, by mass, of 40 % aqueous sodium chlorate solution and cellulose; and the criteria for Category 1 are not met.
3Any substance or mixture which, in the 1:1 mixture, by mass, of substance (or mixture) and cellulose tested, exhibits a mean pressure rise time less than or equal to the mean pressure rise time of a 1:1 mixture, by mass, of 65 % aqueous nitric acid and cellulose; and the criteria for Category 1 and 2 are not met.

2.13.3.   Hazard Communication

Label elements shall be used for substances or mixtures meeting the criteria for classification in this hazard class in accordance with Table 2.13.2.

Table 2.13.2

Label elements for oxidising liquids

ClassificationCategory 1Category 2Category 3
GHS Pictograms
Signal WordDangerDangerWarning
Hazard StatementH271:May cause fire or explosion; strong oxidiserH272: May intensify fire; oxidiserH272: May intensify fire; oxidiser
Precautionary Statement

Prevention
P210

P220

P221

P280

P283
P210

P220

P221

P280
P210

P220

P221

P280
Precautionary Statement

Response
P306 + P360

P371 + P380 + P375

P370 + P378
P370 + P378P370 + P378
Precautionary Statement

Storage
Precautionary Statement

Disposal
P501P501P501

2.13.4.   Additional Classification Considerations

2.13.4.1.For organic substances or mixtures the classification procedure for this class shall not apply if:

(a)the substance or mixture does not contain oxygen, fluorine or chlorine; or

(b)the substance or mixture contains oxygen, fluorine or chlorine and these elements are chemically bonded only to carbon or hydrogen.

2.13.4.2.For inorganic substances or mixtures the classification procedure for this class shall not apply if they do not contain oxygen or halogen atoms.

2.13.4.3.In the event of divergence between test results and known experience in the handling and use of substances or mixtures which shows them to be oxidising, judgments based on known experience shall take precedence over test results.

2.13.4.4.In cases where substances or mixtures generate a pressure rise (too high or too low), caused by chemical reactions not characterising the oxidising properties of the substance or mixture, the test described in Part III, sub-section 34.4.2 of the UN Recommendations on the Transport of Dangerous Goods, Manual of Tests and Criteria shall be repeated with an inert substance, e.g. diatomite (kieselguhr), in place of the cellulose in order to clarify the nature of the reaction and to check for a false positive result.

2.14.   Oxidising solids

2.14.1.   Definition

Oxidising solid means a solid substance or mixture which, while in itself is not necessarily combustible, may, generally by yielding oxygen, cause, or contribute to, the combustion of other material.

2.14.2.   Classification criteria

2.14.2.1.An oxidising solid shall be classified in one of the three categories for this class using test O.1 in Part III, sub-section 34.4.1 of the UN Recommendations on the Transport of Dangerous Goods, Manual of Tests and Criteria in accordance with Table 2.14.1:

Table 2.14.1

Criteria for oxidising solids

CategoryCriteria
1Any substance or mixture which, in the 4:1 or 1:1 sample-to-cellulose ratio (by mass) tested, exhibits a mean burning time less than the mean burning time of a 3:2 mixture, by mass, of potassium bromate and cellulose.
2Any substance or mixture which, in the 4:1 or 1:1 sample-to-cellulose ratio (by mass) tested, exhibits a mean burning time equal to or less than the mean burning time of a 2:3 mixture (by mass) of potassium bromate and cellulose and the criteria for Category 1 are not met.
3Any substance or mixture which, in the 4:1 or 1:1 sample-to-cellulose ratio (by mass) tested, exhibits a mean burning time equal to or less than the mean burning time of a 3:7 mixture (by mass) of potassium bromate and cellulose and the criteria for Categories 1 and 2 are not met.

Note 1

Some oxidising solids also present explosion hazards under certain conditions (when stored in large quantities). Some types of ammonium nitrate may give rise to an explosion hazard under extreme conditions and the ‘Resistance to detonation test’ (BC Code, Annex 3, Test 5) can be used to assess this hazard. Appropriate information shall be made in the SDS.

Note 2

The test shall be performed on the substance or mixture in its physical form as presented. If, for example, for the purposes of supply or transport, the same chemical is to be presented in a physical form different from that which was tested and which is considered likely to materially alter its performance in a classification test, the substance shall also be tested in the new form.

2.14.3.   Hazard Communication

Label elements shall be used for substances or mixtures meeting the criteria for classification in this hazard class in accordance with Table 2.14.2.

Table 2.14.2

Label elements for oxidising solids

Category 1Category 2Category 3
GHS Pictograms
Signal WordDangerDangerWarning
Hazard StatementH271: May cause fire or explosion; strong oxidiserH272: May intensify fire; oxidiserH272: May intensify fire; oxidiser
Precautionary Statement

Prevention
P210

P220

P221

P280

P283
P210

P220

P221

P280
P210

P220

P221

P280
Precautionary Statement

Response
P306 + P360

P371 + P380 + P375

P370 + P378
P370 + P378P370 + P378
Precautionary Statement

Storage
Precautionary Statement

Disposal
P501P501P501

2.14.4.   Additional Classification Considerations

2.14.4.1.For organic substances or mixtures the classification procedure for this class shall not apply if:

(a)the substance or mixture does not contain oxygen, fluorine or chlorine; or

(b)the substance or mixture contains oxygen, fluorine or chlorine and these elements are chemically bonded only to carbon or hydrogen.

2.14.4.2.For inorganic substances or mixtures the classification procedure for this class shall not apply if they do not contain oxygen or halogen atoms.

2.14.4.3.In the event of divergence between test results and known experience in the handling and use of substances or mixtures which shows them to be oxidising, judgments based on known experience shall take precedence over test results.

2.15.   Organic peroxides

2.15.1.   Definition

2.15.1.1.Organic peroxides means liquid or solid organic substances which contain the bivalent -O-O- structure and may be considered derivatives of hydrogen peroxide, where one or both of the hydrogen atoms have been replaced by organic radicals. The term organic peroxide includes organic peroxide mixtures (formulations) containing at least one organic peroxide. Organic peroxides are thermally unstable substances or mixtures, which can undergo exothermic self-accelerating decomposition. In addition, they can have one or more of the following properties:

(i)be liable to explosive decomposition;

(ii)burn rapidly;

(iii)be sensitive to impact or friction;

(iv)react dangerously with other substances.

2.15.1.2.An organic peroxide is regarded as possessing explosive properties when in laboratory testing the mixture (formulation) is liable to detonate, to deflagrate rapidly or to show a violent effect when heated under confinement.

2.15.2.   Classification criteria

2.15.2.1.Any organic peroxide shall be considered for classification in this class, unless it contains:

(a)not more than 1,0 % available oxygen from the organic peroxides when containing not more than 1,0 % hydrogen peroxide; or

(b)not more than 0,5 % available oxygen from the organic peroxides when containing more than 1,0 % but not more than 7,0 % hydrogen peroxide.

Note

The available oxygen content ( %) of an organic peroxide mixture is given by the formula:



where:

ni=number of peroxygen groups per molecule of organic peroxide i;
ci=concentration (mass %) of organic peroxide i;
mi=molecular mass of organic peroxide i.

2.15.2.2.Organic peroxides shall be classified in one of the seven categories of ‘Types A to G’ for this class, according to the following principles:

(a)any organic peroxide which, as packaged, can detonate or deflagrate rapidly shall be defined as organic peroxide TYPE A;

(b)any organic peroxide possessing explosive properties and which, as packaged, neither detonates nor deflagrates rapidly, but is liable to undergo a thermal explosion in that package shall be defined as organic peroxide TYPE B;

(c)any organic peroxide possessing explosive properties when the substance or mixture as packaged cannot detonate or deflagrate rapidly or undergo a thermal explosion shall be defined as organic peroxide TYPE C;

(d)any organic peroxide which in laboratory testing:

(i)detonates partially, does not deflagrate rapidly and shows no violent effect when heated under confinement; or

(ii)does not detonate at all, deflagrates slowly and shows no violent effect when heated under confinement; or

(iii)does not detonate or deflagrate at all and shows a medium effect when heated under confinement;

shall be defined as organic peroxide TYPE D;

(e)any organic peroxide which, in laboratory testing, neither detonates nor deflagrates at all and shows low or no effect when heated under confinement shall be defined as organic peroxide TYPE E;

(f)any organic peroxide which, in laboratory testing, neither detonates in the cavitated state nor deflagrates at all and shows only a low or no effect when heated under confinement as well as low or no explosive power shall be defined as organic peroxide TYPE F;

(g)any organic peroxide which, in laboratory testing, neither detonates in the cavitated state nor deflagrates at all and shows no effect when heated under confinement nor any explosive power, provided that it is thermally stable, i.e. the SADT is 60 oC or higher for a 50 kg package (9), and, for liquid mixtures, a diluent having a boiling point of not less than 150 oC is used for desensitisation, shall be defined as organic peroxide TYPE G. If the organic peroxide is not thermally stable or a diluent having a boiling point less than 150 oC is used for desensitisation, the organic peroxide shall be defined as organic peroxide TYPE F.

Where the test is conducted in the package form and the packaging is changed, a further test shall be conducted where it is considered that the change in packaging will affect the outcome of the test.

2.15.2.3.   Criteria for temperature control

The following organic peroxides need to be subjected to temperature control:

(a)Organic peroxide types B and C with an SADT ≤ 50 C;

(b)Organic peroxide type D showing a medium effect when heated under confinement (10) with an SADT ≤ 50 oC or showing a low or no effect when heated under confinement with an SADT ≤ 45 oC; and

(c)Organic peroxide types E and F with an SADT ≤ 45 oC.

Test methods for determining the SADT as well as the derivation of control and emergency temperatures are given in the UN Recommendations on the Transport of Dangerous Goods, Manual of Tests and Criteria, Part II, section 28. The test selected shall be conducted in a manner which is representative, both in size and material, of the package.

2.15.3.   Hazard Communication

Label elements shall be used for substances or mixtures meeting the criteria for classification in this hazard class in accordance with Table 2.15.1.

Table 2.15.1

Label elements for organic peroxides

ClassificationType AType BType C & DType E & FType G
GHS Pictograms


There are no label elements allocated to this hazard category
Signal WordDangerDangerDangerWarning
Hazard StatementH240: Heating may cause an explosionH241: Heating may cause a fire or explosionH242: Heating may cause a fireH242: Heating may cause a fire
Precautionary Statement

Prevention
P210

P220

P234

P280
P210

P220

P234

P280
P210

P220

P234

P280
P210

P220

P234

P280
Precautionary Statement

Response
Precautionary Statement

Storage
P411 + P235

P410

P420
P411 + P235

P410

P420
P411 + P235

P410

P420
P411 + P235

P410

P420
Precautionary Statement

Disposal
P501P501P501P501

Type G has no hazard communication elements assigned but shall be considered for properties belonging to other hazard classes.

2.15.4.   Additional Classification Considerations

2.15.4.1.Organic peroxides are classified by definition based on their chemical structure and on the available oxygen and hydrogen peroxide contents of the mixture (see 2.15.2.1). The properties of organic peroxides which are necessary for their classification shall be determined experimentally. The classification of organic peroxides shall be performed in accordance with test series A to H as described in Part II of the UN Recommendations on the Transport of Dangerous Goods, Manual of Tests and Criteria. The procedure for classification is described in Figure 2.15.1.

2.15.4.2.Mixtures of already classified organic peroxides may be classified as the same type of organic peroxide as that of the most dangerous component. However, as two stable components can form a thermally less stable mixture, the SADT of the mixture shall be determined.

Note: The sum of the individual parts can be more hazardous than the individual components.

Figure 2.15.1

Organic Peroxides



2.16.   Corrosive to metals

2.16.1.   Definition

A substance or a mixture that is corrosive to metals means a substance or a mixture which by chemical action will materially damage, or even destroy, metals.

2.16.2.   Classification criteria

2.16.2.1.A substance or a mixture which is corrosive to metals is classified in a single category for this class, using the test in Part III, sub-section 37.4 of the UN Recommendations on the Transport of Dangerous Goods, Manual of Tests and Criteria, in accordance with Table 2.16.1:

Table 2.16.1

Criteria for substances and mixtures corrosive to metals

CategoryCriteria
1Corrosion rate on either steel or aluminium surfaces exceeding 6,25 mm per year at a test temperature of 55 oC when tested on both materials.

Note

Where an initial test on either steel or aluminium indicates the substance or mixture being tested is corrosive the follow up test on the other metal is not required.

2.16.3.   Hazard Communication

Label elements shall be used for substances and mixtures meeting the criteria for classification in this hazard class in accordance with Table 2.16.2.

Table 2.16.2

Label elements for substances and mixtures corrosive to metals

ClassificationCategory 1
GHS Pictogram
Signal WordWarning
Hazard StatementH290: May be corrosive to metals
Precautionary Statement

Prevention
P234
Precautionary Statement

Response
P390
Precautionary Statement

Storage
P406
Precautionary Statement

Disposal

2.16.4.   Additional Classification Considerations

2.16.4.1.The corrosion rate can be measured according to the test method of Part III sub-section 37.4 of the UN Recommendations on the Transport of Dangerous Goods, Manual of Tests and Criteria. The specimen to be used for the test shall be made of the following materials:

(a)for the purposes of testing steel, steel types

S235JR+CR (1.0037 resp.St 37-2),

S275J2G3+CR (1.0144 resp.St 44-3), ISO 3574 as amended, Unified Numbering System (UNS) G 10200, or SAE 1020;

(b)for the purposes of testing aluminium: non-clad types 7075-T6 or AZ5GU-T6.

3. PART 3: HEALTH HAZARDS

3.1.   Acute toxicity

3.1.1.   Definitions

3.1.1.1.Acute toxicity means those adverse effects occurring following oral or dermal administration of a single dose of a substance or a mixture, or multiple doses given within 24 hours, or an inhalation exposure of 4 hours.

3.1.1.2.The hazard class Acute Toxicity is differentiated into:

Acute oral toxicity;

Acute dermal toxicity;

Acute inhalation toxicity.

3.1.2.   Criteria for classification of substances as acutely toxic

3.1.2.1.Substances can be allocated to one of four toxicity categories based on acute toxicity by the oral, dermal or inhalation route according to the numeric criteria shown in Table 3.1.1. Acute toxicity values are expressed as (approximate) LD50 (oral, dermal) or LC50 (inhalation) values or as acute toxicity estimates (ATE). Explanatory notes are shown following Table 3.1.1.

Table 3.1.1

Acute toxicity hazard categories and acute toxicity estimates (ATE) defining the respective categories

Exposure RouteCategory 1Category 2Category 3Category 4
Oral (mg/kg bodyweight)

See Note (a)
ATE ≤ 55 < ATE ≤ 5050 < ATE ≤ 300300 < ATE ≤ 2 000
Dermal (mg/kg

bodyweight)

See Note (a)
ATE ≤ 5050 < ATE ≤ 200200 < ATE ≤ 1 0001 000 < ATE ≤ 2 000
Gases (ppmV (11)
see:Note (a)

Note (b)
ATE ≤ 100100 < ATE ≤ 500500 < ATE ≤ 2 5002 500 < ATE ≤ 20 000
Vapours (mg/l)
see:Note (a)

Note (b)

Note (c)
ATE ≤ 0,50,5 < ATE ≤ 2,02,0 < ATE ≤ 10,010,0 < ATE ≤ 20,0
Dusts and Mists (mg/l)
see:Note (a)

Note (b)
ATE ≤ 0,050,05 < ATE ≤ 0,50,5 < ATE ≤ 1,01,0 < ATE ≤ 5,0

Notes to Table 3.1.1

(a)The acute toxicity estimate (ATE) for the classification of a substance or ingredient in a mixture is derived using:

the LD50/LC50 where available,

the appropriate conversion value from Table 3.1.2 that relates to the results of a range test, or

the appropriate conversion value from Table 3.1.2 that relates to a classification category.

(b)Generic concentration limits for inhalation toxicity in the table are based on 4 hour testing exposures. Conversion of existing inhalation toxicity data which have been generated using a 1 hour exposure can be carried out by dividing by a factor of 2 for gases and vapours and 4 for dusts and mists.

(c)For some substances or mixtures the test atmosphere will not just be a vapour but will consist of a mixture of liquid and vapour phases. For other substances or mixtures the test atmosphere may consist of a vapour which is near the gaseous phase. In these latter cases, classification shall be based on ppmV as follows: Category 1 (100 ppmV), Category 2 (500 ppmV), Category 3 (2 500 ppmV), Category 4 (20 000 ppmV).

The terms ‘dust’, ‘mist’ and ‘vapour’ are defined as follows:

Dust: solid particles of a substance or mixture suspended in a gas (usually air);

Mist: liquid droplets of a substance or mixture suspended in a gas (usually air);

Vapour: the gaseous form of a substance or mixture released from its liquid or solid state.

Dust is generally formed by mechanical processes. Mist is generally formed by condensation of supersaturated vapours or by physical shearing of liquids. Dusts and mists generally have sizes ranging from less than 1 to about 100 μm.

3.1.2.2.   Specific considerations for classification of substances as acutely toxic

3.1.2.2.1.The preferred test species for evaluation of acute toxicity by the oral and inhalation routes is the rat, while the rat or rabbit are preferred for evaluation of acute dermal toxicity. When experimental data for acute toxicity are available in several animal species, scientific judgement shall be used in selecting the most appropriate LD50 value from among valid, well-performed tests.

3.1.2.3.   Specific considerations for classification of substances as acutely toxic by the inhalation route

3.1.2.3.1.Units for inhalation toxicity are a function of the form of the inhaled material. Values for dusts and mists are expressed in mg/l. Values for gases are expressed in ppmV. Acknowledging the difficulties in testing vapours, some of which consist of mixtures of liquid and vapour phases, the table provides values in units of mg/l. However, for those vapours which are near the gaseous phase, classification shall be based on ppmV.

3.1.2.3.2.Of particular importance in classifying for inhalation toxicity is the use of well articulated values in the high toxicity categories for dusts and mists. Inhaled particles between 1 and 4 microns mean mass aerodynamic diameter (MMAD) will deposit in all regions of the rat respiratory tract. This particle size range corresponds to a maximum dose of about 2 mg/l. In order to achieve applicability of animal experiments to human exposure, dusts and mists would ideally be tested in this range in rats.

3.1.2.3.3.In addition to classification for inhalation toxicity, if data are available that indicates that the mechanism of toxicity was corrosivity, the substance or mixture shall also be labelled as ‘corrosive to the respiratory tract’ (see note 1 in 3.1.4.1). Corrosion of the respiratory tract is defined by destruction of the respiratory tract tissue after a single, limited period of exposure analogous to skin corrosion; this includes destruction of the mucosa. The corrosivity evaluation can be based on expert judgment using such evidence as: human and animal experience, existing (in vitro) data, pH values, information from similar substances or any other pertinent data.

3.1.3.   Criteria for classification of mixtures as acutely toxic

3.1.3.1.The criteria for classification of substances for acute toxicity as outlined in section 3.1.2 are based on lethal dose data (tested or derived). For mixtures, it is necessary to obtain or derive information that allows the criteria to be applied to the mixture for the purpose of classification. The approach to classification for acute toxicity is tiered, and is dependent upon the amount of information available for the mixture itself and for its ingredients. The flow chart of Figure 3.1.1 outlines the process to be followed.

3.1.3.2.For acute toxicity each route of exposure shall be considered for the classification of mixtures, but only one route of exposure is needed as long as this route is followed (estimated or tested) for all ingredients. If the acute toxicity is determined for more than one route of exposure, the more severe hazard category will be used for classification. All available information shall be considered and all relevant routes of exposure shall be identified for hazard communication.

3.1.3.3.In order to make use of all available data for purposes of classifying the hazards of the mixtures, certain assumptions have been made and are applied where appropriate in the tiered approach:

(a)the ‘relevant ingredients’ of a mixture are those which are present in concentrations of 1 % (w/w for solids, liquids, dusts, mists and vapours and v/v for gases) or greater, unless there is a reason to suspect that an ingredient present at a concentration of less than 1 % is still relevant for classifying the mixture for acute toxicity (see Table 1.1).

(b)where a classified mixture is used as an ingredient of another mixture, the actual or derived acute toxicity estimate (ATE) for that mixture may be used, when calculating the classification of the new mixture using the formulas in section 3.1.3.6.1 and paragraph 3.1.3.6.2.3.

Figure 3.1.1

Tiered approach to classification of mixtures for acute toxicity



3.1.3.4.   Classification of mixtures where acute toxicity data are available for the complete mixture

3.1.3.4.1.Where the mixture itself has been tested to determine its acute toxicity, it shall be classified according to the same criteria as those used for substances, presented in Table 3.1.1. If test data for the mixture are not available, the procedures presented under sections 3.1.3.5 and 3.1.3.6 shall be followed.

3.1.3.5.   Classification of mixtures where acute toxicity data are available for the complete mixture: bridging principles

3.1.3.5.1.Where the mixture itself has not been tested to determine its acute toxicity, but there are sufficient data on the individual ingredients and similar tested mixtures to adequately characterise the hazards of the mixture, these data shall be used in accordance with the bridging rules set out in section 1.1.3.

3.1.3.5.2.If a mixture is diluted with water or other totally non-toxic material, the toxicity of the mixture can be calculated from test data on the undiluted mixture.

3.1.3.6.   Classification of mixtures based on ingredients of the mixture (Additivity formula)

3.1.3.6.1.   Data available for all ingredients

In order to ensure that classification of the mixture is accurate, and that the calculation need only be performed once for all systems, sectors, and categories, the acute toxicity estimate (ATE) of ingredients shall be considered as follows:

(a)include ingredients with a known acute toxicity, which fall into any of the acute toxicity categories shown in Table 3.1.1;

(b)ignore ingredients that are presumed not acutely toxic (e.g., water, sugar);

(c)ignore ingredients if the oral limit test does not show acute toxicity at 2 000 mg/kg bodyweight.

Ingredients that fall within the scope of this paragraph are considered to be ingredients with a known acute toxicity estimate (ATE).

The ATE of the mixture is determined by calculation from the ATE values for all relevant ingredients according to the following formula for Oral, Dermal or Inhalation Toxicity:



where:

Ci=concentration of ingredient i ( % w/w or % v/v)
i=the individual ingredient from 1 to n
n=the number of ingredients
ATEi=Acute Toxicity Estimate of ingredient i.

3.1.3.6.2.   Classification of mixtures when data are not available for all components

3.1.3.6.2.1.Where an ATE is not available for an individual ingredient of the mixture, but available information, such as that listed below, can provide a derived conversion value such as those laid out in Table 3.1.2, the formula in section 3.1.3.6.1 shall be applied.

This includes evaluation of:

(a)extrapolation between oral, dermal and inhalation acute toxicity estimates (12). Such an evaluation could require appropriate pharmacodynamic and pharmacokinetic data;

(b)evidence from human exposure that indicates toxic effects but does not provide lethal dose data;

(c)evidence from any other toxicity tests/assays available on the substance that indicates toxic acute effects but does not necessarily provide lethal dose data; or

(d)data from closely analogous substances using structure/activity relationships.

This approach generally requires substantial supplemental technical information, and a highly trained and experienced expert (expert judgement, see section 1.1.1), to reliably estimate acute toxicity. If such information is not available, proceed to paragraph 3.1.3.6.2.3.

3.1.3.6.2.2.In the event that an ingredient without any useable information at all is used in a mixture at a concentration of 1 % or greater, it is concluded that the mixture cannot be attributed a definitive acute toxicity estimate. In this situation the mixture shall be classified based on the known ingredients only, with the additional statement that x percent of the mixture consists of ingredient(s) of unknown toxicity.

3.1.3.6.2.3.If the total concentration of the ingredient(s) with unknown acute toxicity is ≤ 10 % then the formula presented in section 3.1.3.6.1 shall be used. If the total concentration of the ingredient(s) with unknown toxicity is > 10 %, the formula presented in section 3.1.3.6.1 shall be corrected to adjust for the total percentage of the unknown ingredient(s) as follows:



Table 3.1.2

Conversion from experimentally obtained acute toxicity range values (or acute toxicity hazard categories) to acute toxicity point estimates for classification for the respective routes of exposure

Exposure routesClassification Category or experimentally obtained acute toxicity range estimateConverted acute toxicity point estimate

(see Note 1)
Oral

(mg/kg bodyweight)
0 < Category 1 ≤ 5

5 < Category 2 ≤ 50

50 < Category 3 ≤ 300

300 < Category 4 ≤ 2 000
0,5

5

100

500
Dermal

(mg/kg bodyweight)
0 < Category 1 ≤ 50

50 < Category 2 ≤ 200

200 < Category 3 ≤ 1 000

1 000 < Category 4 ≤ 2 000
5

50

300

1 100
Gases

(ppmV)
0 < Category 1 ≤ 100

100 < Category 2 ≤ 500

500 < Category 3 ≤ 2 500

2 500 < Category 4 ≤ 20 000
10

100

700

4 500
Vapours

(mg/l)
0 < Category 1 ≤ 0,5

0,5 < Category 2 ≤ 2,0

2,0 < Category 3 ≤ 10,0

10,0 < Category 4 ≤ 20,0
0,05

0,5

3

11
Dust/mist

(mg/l)
0< Category 1 ≤ 0,05

0,05 < Category 2 ≤ 0,5

0,5 < Category 3 ≤ 1,0

1,0 < Category 4 ≤ 5,0
0,005

0,05

0,5

1,5

Note 1

These values are designed to be used in the calculation of the ATE for classification of a mixture based on its components and do not represent test results.

3.1.4.   Hazard Communication

3.1.4.1.Label elements shall be used for substances or mixtures meeting the criteria for classification in this hazard class in accordance with Table 3.1.3.

Table 3.1.3

Acute toxicity label elements

ClassificationCategory 1Category 2Category 3Category 4
GHS Pictograms
Signal WordDangerDangerDangerWarning
Hazard Statement:

Oral
H300:

Fatal if swallowed
H300:

Fatal if swallowed
H301:

Toxic if swallowed
H302:

Harmful if swallowed
Dermal
H310:Fatal in contact with skinH310:Fatal in contact with skinH311: Toxic in contact with skinH312: Harmful in contact with skin
Inhalation

(see Note 1)
H330:Fatal if inhaledH330: Fatal if inhaledH331: Toxic if inhaledH332: Harmful if inhaled
Precautionary Statement Prevention (oral)P264

P270
P264

P270
P264

P270
P264

P270
Precautionary Statement Response (oral)P301 + P310

P321

P330
P301 + P310

P321

P330
P301 + P310

P321

P330
P301 + P312

P330
Precautionary Statement Storage (oral)P405P405P405
Precautionary Statement Disposal (oral)P501P501P501P501
Precautionary Statement Prevention (dermal)P262

P264

P270

P280
P262

P264

P270

P280
P280P280
Precautionary Statement Response (dermal)P302 + P350

P310

P322

P361

P363
P302 + P350

P310

P322

P361

P363
P302 + P352

P312

P322

P361

P363
P302 + P352

P312

P322

P363
Precautionary Statement Storage (dermal)P405P405P405
Precautionary Statement Disposal (dermal)P501P501P501P501
Precautionary Statement Prevention (inhalation)P260

P271

P284
P260

P271

P284
P261

P271
P261

P271
Precautionary Statement Response (inhalation)P304 + P340

P310

P320
P304 + P340

P310

P320
P304 + P340

P311

P321
P304 + P340

P312
Precautionary Statement Storage (inhalation)P403 + P233

P405
P403 + P233

P405
P403 + P233

P405
Precautionary Statement Disposal (inhalation)P501P501P501

Note 1

In addition to classification for inhalation toxicity, if data are available that indicates that the mechanism of toxicity is corrosivity, the substance or mixture shall also be labelled as EUH071: ‘corrosive to the respiratory tract’ — see advice at 3.1.2.3.3. In addition to an appropriate acute toxicity pictogram, a corrosivity pictogram (used for skin and eye corrosivity) may be added together with the statement ‘corrosive to the respiratory tract’.

Note 2

In the event that an ingredient without any useable information at all is used in a mixture at a concentration of 1 % or greater, the mixture shall be labelled with the additional statement that ‘x percent of the mixture consists of ingredient(s) of unknown toxicity’ — see advice at 3.1.3.6.2.2.

3.2.   Skin corrosion/irritation

3.2.1.   Definitions

3.2.1.1.Skin Corrosion means the production of irreversible damage to the skin; namely, visible necrosis through the epidermis and into the dermis, following the application of a test substance for up to 4 hours. Corrosive reactions are typified by ulcers, bleeding, bloody scabs, and, by the end of observation at 14 days, by discolouration due to blanching of the skin, complete areas of alopecia, and scars. Histopathology shall be considered to evaluate questionable lesions.

Skin Irritation means the production of reversible damage to the skin following the application of a test substance for up to 4 hours.

3.2.2.   Classification criteria for substances

3.2.2.1.Several factors need to be considered in determining the corrosion and irritation potential of substances before testing is undertaken. Solid substances (powders) may become corrosive or irritant when moistened or in contact with moist skin or mucous membranes. Existing human experience and animal data from single or repeated exposure shall be the first line of analysis, as they give information directly relevant to effects on the skin. In vitro alternatives that have been validated and accepted may also be used to help make classification decisions (see Article 5). In some cases enough information may be available from structurally related compounds to make classification decisions.

3.2.2.2.Likewise, pH extremes like ≤ 2 and ≥ 11,5 may indicate the potential to cause skin effects, especially when buffering capacity is known, although the correlation is not perfect. Generally, such substances are expected to produce significant effects on the skin. If consideration of alkali/acid reserve suggests the substance may not be corrosive despite the low or high pH value, then further testing shall be carried out to confirm this, preferably by use of an appropriate validated in vitro test.

3.2.2.3.If a substance is highly toxic by the dermal route, a skin irritation/corrosion study is not practicable since the amount of test substance to be applied considerably exceeds the toxic dose and, consequently, results in the death of the animals. When observations are made of skin irritation/corrosion in acute toxicity studies and are observed up through the limit dose, additional testing is not needed, provided that the dilutions used and species tested are equivalent.

3.2.2.4.All the above information that is available on a substance shall be used in determining the need for in vivo skin irritation testing.

Although information might be gained from the evaluation of single parameters within a tier (see paragraph 3.2.2.5), e.g. caustic alkalis with extreme pH shall be considered as skin corrosives, there is merit in considering the totality of existing information and making an overall weight of evidence determination. This is especially true when there is information available on some but not all parameters. Generally, primary emphasis shall be placed upon existing human experience and data, followed by animal experience and testing data, followed by other sources of information, but case-by-case determinations are necessary.

3.2.2.5.A tiered approach to the evaluation of initial information shall be considered, where applicable, recognising that all elements may not be relevant in certain cases.

3.2.2.6.   Corrosion

3.2.2.6.1.On the basis of the results of animal testing a substance is classified as corrosive, as shown in Table 3.2.1. A corrosive substance is a substance that produces destruction of skin tissue, namely, visible necrosis through the epidermis and into the dermis, in at least 1 tested animal after exposure up to a 4 hour duration. Corrosive reactions are typified by ulcers, bleeding, bloody scabs and, by the end of observation at 14 days, by discoloration due to blanching of the skin, complete areas of alopecia and scars. Histopathology shall be considered to discern questionable lesions.

3.2.2.6.2.Three subcategories are provided within the corrosive category: subcategory 1A — where responses are noted following up to 3 minutes exposure and up to 1 hour observation; subcategory 1B — where responses are described following exposure between 3 minutes and 1 hour and observations up to 14 days; and subcategory 1C — where responses occur after exposures between 1 hour and 4 hours and observations up to 14 days.

3.2.2.6.3.The use of human data is discussed in paragraphs 3.2.2.1 and 3.2.2.4 and also in paragraphs 1.1.1.3, 1.1.1.4 and.1.1.1.5.

Table 3.2.1

Skin Corrosive category and subcategories

Corrosive in > 1 of 3 animals
Corrosive subcategoriesExposureObservation
Category 1: Corrosive1A≤ 3 minutes≤ 1 hour
1B> 3 minutes - ≤ 1 hour≤ 14 days
1C> 1 hour - ≤ 4 hours≤ 14 days

3.2.2.7.   Irritation

3.2.2.7.1.Using the results of animal testing a single irritant category (Category 2) is presented in Table 3.2.2. The use of human data is discussed in paragraphs 3.2.2.1 and 3.2.2.4 and also in paragraphs 1.1.1.3, 1.1.1.4 and.1.1.1.5. The major criterion for the irritant category is that at least 2 of 3 tested animals have a mean score of ≥ 2,3 - ≤ 4,0.

Table 3.2.2

Skin irritation category

CategoryCriteria
Category 2: Irritant
(1)Mean value of ≥ 2,3 - ≤ 4,0 for erythema/eschar or for oedema in at least 2 of 3 tested animals from gradings at 24, 48 and 72 hours after patch removal or, if reactions are delayed, from grades on 3 consecutive days after the onset of skin reactions; or

(2)Inflammation that persists to the end of the observation period normally 14 days in at least 2 animals, particularly taking into account alopecia (limited area), hyperkeratosis, hyperplasia, and scaling; or

(3)In some cases where there is pronounced variability of response among animals, with very definite positive effects related to chemical exposure in a single animal but less than the criteria above.

3.2.2.8.   Comments on responses obtained in skin irritation tests in animals

3.2.2.8.1.Animal irritant responses within a test can be quite variable, as they are with corrosion. The major criterion for classification of a substance as irritant to skin, as shown in paragraph 3.2.2.7.1, is the mean value of the scores for either erythema/eschar or oedema calculated in at least 2 of 3 tested animals. A separate irritant criterion accommodates cases when there is a significant irritant response but less than the mean score criterion for a positive test. For example, a test material might be designated as an irritant if at least 1 of 3 tested animals shows a very elevated mean score throughout the study, including lesions persisting at the end of an observation period of normally 14 days. Other responses could also fulfil this criterion. However, it should be ascertained that the responses are the result of chemical exposure.

3.2.2.8.2.Reversibility of skin lesions is another consideration in evaluating irritant responses. When inflammation persists to the end of the observation period in 2 or more test animals, taking into consideration alopecia (limited area), hyperkeratosis, hyperplasia and scaling, then a material shall be considered to be an irritant.

3.2.3.   Classification criteria for mixtures

3.2.3.1.   Classification of mixtures when data are available for the complete mixture

3.2.3.1.1.The mixture will be classified using the criteria for substances, and taking into account the testing and evaluation strategies to develop data for these hazard classes.

3.2.3.1.2.Unlike other hazard classes, there are alternative tests available for skin corrosivity of certain types of substances and mixtures that can give an accurate result for classification purposes, as well as being simple and relatively inexpensive to perform. When considering testing of the mixture, classifiers are encouraged to use a tiered weight of evidence strategy as included in the criteria for classification of substances for skin corrosion and irritation (paragraph 3.2.2.5), to help ensure an accurate classification as well as avoid unnecessary animal testing. A mixture is considered corrosive to skin (Skin Corrosive Category 1) if it has a pH of 2 or less or a pH of 11,5 or greater. If consideration of alkali/acid reserve suggests the substance or mixture may not be corrosive despite the low or high pH value, then further testing shall be carried out to confirm this, preferably by use of an appropriate validated in vitro test.

3.2.3.2.   Classification of mixtures when data are not available for the complete mixture: bridging principles

3.2.3.2.1.Where the mixture itself has not been tested to determine its skin irritation/corrosion hazards, but there are sufficient data on the individual ingredients and similar tested mixtures to adequately characterise the hazards of the mixture, these data shall be used in accordance with the bridging rules set out in section 1.1.3.

3.2.3.3.   Classification of mixtures when data are available for all components or only for some components of the mixture

3.2.3.3.1.In order to make use of all available data for purposes of classifying the skin irritation/corrosion hazards of mixtures, the following assumption has been made and is applied where appropriate in the tiered approach:

Assumption: the ‘relevant ingredients’ of a mixture are those which are present in concentrations of 1 % (w/w for solids, liquids, dusts, mists and vapours and v/v for gases) or greater, unless there is a presumption (e.g., in the case of corrosive ingredients) that an ingredient present at a concentration of less than 1 % can still be relevant for classifying the mixture for skin irritation/corrosion.

3.2.3.3.2.In general, the approach to classification of mixtures as irritant or corrosive to skin when data are available on the components, but not on the mixture as a whole, is based on the theory of additivity, such that each corrosive or irritant component contributes to the overall irritant or corrosive properties of the mixture in proportion to its potency and concentration. A weighting factor of 10 is used for corrosive components when they are present at a concentration below the generic concentration limit for classification with Category 1, but are at a concentration that will contribute to the classification of the mixture as an irritant. The mixture is classified as corrosive or irritant when the sum of the concentrations of such components exceeds a concentration limit.

3.2.3.3.3.Table 3.2.3 provides the generic concentration limits to be used to determine if the mixture is considered to be an irritant or a corrosive to the skin.

3.2.3.3.4.1.Particular care must be taken when classifying certain types of mixtures containing substances such as acids and bases, inorganic salts, aldehydes, phenols, and surfactants. The approach explained in paragraphs 3.2.3.3.1 and 3.2.3.3.2 may not be applicable given that many of such substances are corrosive or irritant at concentrations < 1 %.

3.2.3.3.4.2.For mixtures containing strong acids or bases the pH shall be used as a classification criterion (see paragraph 3.2.3.1.2) since pH is a better indicator of corrosion than the concentration limits of Table 3.2.3.

3.2.3.3.4.3.A mixture containing ingredients that are corrosive or irritant to the skin and that cannot be classified on the basis of the additivity approach (Table 3.2.3), due to chemical characteristics that make this approach unworkable, shall be classified as Skin Corrosive Category 1A, 1B or 1C if it contains ≥ 1 % of an ingredient classified in Category 1A, 1B or 1C respectively or as Category 2 when it contains ≥ 3 % of an irritant ingredient. Classification of mixtures with ingredients for which the approach in Table 3.2.3 does not apply is summarised in Table 3.2.4.

3.2.3.3.5.On occasion, reliable data may show that the skin corrosion/irritation hazard of an ingredient will not be evident when present at a level above the generic concentration limits mentioned in Tables 3.2.3 and 3.2.4. In these cases the mixture shall be classified according to that data (see also Articles 10 and 11). On other occasions, when it is expected that the skin corrosion/irritation hazard of an ingredient is not evident when present at a level above the generic concentration limits mentioned in Tables 3.2.3 and 3.2.4, testing of the mixture shall be considered. In those cases the tiered weight of evidence strategy shall be applied, as described in paragraph 3.2.2.5.

3.2.3.3.6.If there are data showing that (an) ingredient(s) is/are corrosive or irritant at a concentration of < 1 % (corrosive) or < 3 % (irritant), the mixture shall be classified accordingly.

Table 3.2.3

Generic concentration limits of ingredients classified for skin corrosive/irritant hazard (Category 1 or 2) that trigger classification of the mixture as corrosive/irritant to skin

Sum of ingredients classified as:Concentration triggering classification of a mixture as:
Skin CorrosiveSkin Irritant
Category 1

(see note below)
Category 2
Skin Corrosive Categories 1A, 1B, 1C≥ 5 %≥ 1 % but < 5 %
Skin irritant Category 2≥ 10 %
(10 × Skin Corrosive Category 1A, 1B, 1C) + Skin irritant Category 2≥ 10 %

Note

The sum of all ingredients of a mixture classified as Skin Corrosive Category 1A, 1B or 1C respectively, shall each be ≥ 5 % respectively in order to classify the mixture as either Skin Corrosive Category 1A, 1B or 1C. If the sum of the Skin Corrosive Category 1A ingredients is < 5 % but the sum of Category 1A+1B ingredients is ≥ 5 %, the mixture shall be classified as Skin Corrosive Category 1B. Similarly, if the sum of Skin Corrosive Category 1A+1B ingredients is < 5 % but the sum of Category 1A+1B+1C ingredients is ≥ 5 % the mixture shall be classified as Skin Corrosive Category 1C.

Table 3.2.4

Generic concentration limits of ingredients of a mixture for which the additivity approach does not apply, that trigger classification of the mixture as corrosive/irritant to skin

Ingredient:Concentration:Mixture classified as: Skin
Acid with pH ≤ 2≥ 1 %Category 1
Base with pH ≥ 11,5≥ 1 %Category 1
Other corrosive (Categories 1A, 1B, 1C) ingredients for which additivity does not apply≥ 1 %Category 1
Other irritant (Category 2) ingredients for which additivity does not apply, including acids and bases≥ 3 %Category 2

3.2.4.   Hazard Communication

3.2.4.1.Label elements shall be used for substances or mixtures meeting the criteria for classification in this hazard class in accordance with Table 3.2.5.

Table 3.2.5

Label elements for skin corrosion/irritation

ClassificationCategory 1 A/1 B/1 CCategory 2
GHS Pictograms
Signal WordDangerWarning
Hazard StatementH314: Causes severe skin burns and eye damageH315: Causes skin irritation
Precautionary Statement

Prevention
P260

P264

P280
P264

P280
Precautionary Statement

Response
P301 + P330 + P331

P303 + P361 + P353

P363

P304 + P340

P310

P321

P305 + P351 + P338
P302 + P352

P321

P332 + P313

P362
Precautionary Statement

Storage
P405
Precautionary Statement

Disposal
P501

3.3.   Serious eye damage/eye irritation

3.3.1.   Definitions

3.3.1.1.Serious eye damage means the production of tissue damage in the eye, or serious physical decay of vision, following application of a test substance to the anterior surface of the eye, which is not fully reversible within 21 days of application.

Eye irritation means the production of changes in the eye following the application of test substance to the anterior surface of the eye, which are fully reversible within 21 days of application.

3.3.2.   Classification criteria for substances

3.3.2.1.The classification system for substances involves a tiered testing and evaluation scheme, combining pre-existing information on serious ocular tissue damage and on eye irritation (including data relating to historical human or animal experience) as well as considerations on (Q)SAR and the output of validated in vitro tests in order to avoid unnecessary animal testing.

3.3.2.2.Before any in vivo testing for serious eye damage/eye irritation is carried out, all existing information on a substance shall be reviewed. Preliminary decisions can often be made from existing data as to whether a substance causes serious (i.e. irreversible) damage to the eyes. If a substance can be classified on the basis of these data, no testing is required.

3.3.2.3.Several factors need to be considered in determining the serious eye damage or irritation potential of a substance before testing is undertaken. Accumulated human and animal experience shall be the first line of analysis, as it gives information directly relevant to effects on the eye. In some cases enough information may be available from structurally related compounds to make hazard decisions. Likewise, pH extremes like ≤ 2 and ≥ 11,5 may produce serious eye damage, especially when associated with significant buffering capacity. Such substances are expected to produce significant effects on the eyes. Possible skin corrosion has to be evaluated prior to consideration of serious eye damage/eye irritation in order to avoid testing for local effects on eyes with skin corrosive substances. Skin corrosive substances shall be considered as leading to serious damage to the eyes as well (Category 1), while skin irritant substances may be considered as leading to eye irritation (Category 2). In vitro alternatives that have been validated and accepted can be used to make classification decisions (see Article 5).

3.3.2.4.All the above information that is available on a substance shall be used in determining the need for in vivo eye irritation testing. Although information may be gained from the evaluation of single parameters within a tier (e.g. caustic alkalis with extreme pH shall be considered as local corrosives), the totality of existing information shall be considered in making an overall weight of evidence determination, particularly when there is information available on some but not all parameters. Generally, primary emphasis shall be placed upon expert judgement, considering human experience with the substance, followed by the outcome of skin irritation testing and of well-validated alternative methods. Animal testing with corrosive substances or mixtures shall be avoided whenever possible.

3.3.2.5.A tiered approach to the evaluation of initial information shall be considered where applicable, while recognising that all elements may not be relevant in certain cases.

3.3.2.6.   Irreversible effects on the eye/serious damage to eyes (Category 1)

3.3.2.6.1.Substances that have the potential to seriously damage the eyes are classified in Category 1 (irreversible effects on the eye). Substances are classified in this hazard category on the basis of the results of animal testing, in accordance with the criteria listed in Table 3.3.1. These observations include animals with grade 4 cornea lesions and other severe reactions (e.g., destruction of cornea) observed at any time during the test, as well as persistent corneal opacity, discoloration of the cornea by a dye substance, adhesion, pannus, and interference with the function of the iris or other effects that impair sight. In this context, persistent lesions are considered those which are not fully reversible within an observation period of normally 21 days. Substances are also classified in Category 1 if they fulfil the criteria of corneal opacity ≥ 3 or iritis > 1,5 detected in a Draize eye test with rabbits, recognising that such severe lesions usually do not reverse within a 21-day observation period.

Table 3.3.1

Category for irreversible eye effects

CategoryCriteria
Irreversible effects on the eye

(Category 1)
If, when applied to the eye of an animal, a substance produces:

at least in one animal effects on the cornea, iris or conjunctiva that are not expected to reverse or have not fully reversed within an observation period of normally 21 days; and/or

at least in 2 of 3 tested animals, a positive response of:

corneal opacity ≥ 3 and/or

iritis > 1,5

calculated as the mean scores following grading at 24, 48 and 72 hours after installation of the test material.

3.3.2.6.2.The use of human data is discussed in paragraphs 3.3.2.1, 3.3.2.4, and also in paragraphs 1.1.1.3, 1.1.1.4 and 1.1.1.5.

3.3.2.7.   Reversible effects on the eye (Category 2)

3.3.2.7.1.Substances that have the potential to induce reversible eye irritation are classified in Category 2 (irritating to eyes).

Table 3.3.2

Category for reversible eye effects

CategoryCriteria
Irritating to eyes

(Category 2)
if, when applied to the eye of an animal, a substance produces:

at least in 2 of 3 tested animals, a positive response of:

corneal opacity ≥ 1 and/or

iritis ≥ 1, and/or

conjunctival redness ≥ 2 and/or

conjunctival oedema (chemosis) ≥ 2

calculated as the mean scores following grading at 24, 48 and 72 hours after installation of the test material, and which fully reverses within an observation period of 21 days

3.3.2.7.2.For those substances where there is pronounced variability among animal responses, this information shall be taken into account in determining the classification.

3.3.3.   Classification criteria for mixtures

3.3.3.1.   Classification of mixtures when data are available for the complete mixture

3.3.3.1.1.The mixture will be classified using the criteria for substances, and taking into account the testing and evaluation strategies used to develop data for these hazard classes.

3.3.3.1.2.Unlike other hazard classes, there are alternative tests available for skin corrosivity of certain types of mixtures that give an accurate result for classification purposes, as well as being simple and relatively inexpensive to perform. When considering testing of the mixture classifiers are encouraged to use a tiered weight of evidence strategy as included in the criteria for classification of substances for skin corrosion and serious eye damage and eye irritation to help ensure an accurate classification, as well as avoid unnecessary animal testing. A mixture is considered to cause serious eye damage (Category 1) if it has a pH ≤ 2,0 or ≥ 11,5. If consideration of alkali/acid reserve suggests the mixture may not have the potential to cause serious eye damage despite the low or high pH value, then further testing needs to be carried out to confirm this, preferably by use of an appropriate validated in vitro test.

3.3.3.2.   Classification of mixtures when data are not available for the complete mixture: bridging principles

3.3.3.2.1.Where the mixture itself has not been tested to determine its skin corrosivity or potential to cause serious eye damage or irritation, but there are sufficient data on the individual ingredients and similar tested mixtures to adequately characterise the hazards of the mixture, these data shall be used in accordance with the bridging rules set out in section 1.1.3.

3.3.3.3.   Classification of mixtures when data are available for all components or only for some components of the mixture

3.3.3.3.1.In order to make use of all available data for purposes of classifying the eye irritation/serious eye damaging properties of the mixtures, the following assumption has been made and is applied where appropriate in the tiered approach:

Assumption: The ‘relevant ingredients’ of a mixture are those which are present in concentrations of 1 % (w/w for solids, liquids, dusts, mists and vapours and v/v for gases) or greater, unless there is a presumption (e.g. in the case of corrosive ingredients) that an ingredient present at a concentration of less than 1 % is still relevant for classifying the mixture for eye irritation/serious eye damage.

3.3.3.3.2.In general, the approach to classification of mixtures as eye irritant or seriously damaging to the eye when data are available on the components, but not on the mixture as a whole, is based on the theory of additivity, such that each corrosive or irritant component contributes to the overall irritant or corrosive properties of the mixture in proportion to its potency and concentration. A weighting factor of 10 is used for corrosive components when they are present at a concentration below the generic concentration limit for classification in Category 1, but are at a concentration that will contribute to the classification of the mixture as an irritant. The mixture is classified as seriously damaging to the eye or eye irritant when the sum of the concentrations of such components exceeds a concentration limit.

3.3.3.3.3.Table 3.3.3 provides the generic concentration limits to be used to determine if the mixture shall be classified as irritant or as seriously damaging to the eye.

3.3.3.3.4.1.Particular care must be taken when classifying certain types of mixtures containing substances such as acids and bases, inorganic salts, aldehydes, phenols, and surfactants. The approach explained in paragraphs 3.3.3.3.1 and 3.3.3.3.2 might not work given that many of such substances are corrosive or irritant at concentrations < 1 %.

3.3.3.3.4.2.For mixtures containing strong acids or bases the pH shall be used as classification criteria (see paragraph 3.3.2.3) since pH will be a better indicator of serious eye damage than the generic concentration limits of Table 3.3.3.

3.3.3.3.4.3.A mixture containing corrosive or irritant ingredients that cannot be classified based on the additivity approach (Table 3.3.3), due to chemical characteristics that make this approach unworkable, shall be classified as Category 1 for effects on the eye if it contains ≥ 1 % of a corrosive ingredient and as Category 2 when it contains ≥ 3 % of an irritant ingredient. Classification of mixtures with ingredients for which the approach in Table 3.3.3 does not apply is summarised in Table 3.3.4.

3.3.3.3.5.On occasion, reliable data may show that the reversible/irreversible eye effects of an ingredient will not be evident when present at a level above the generic concentration limits mentioned in Tables 3.3.3 and 3.3.4. In these cases the mixture shall be classified according to those data. On other occasions, when it is expected that the skin corrosion/irritation hazards or the reversible/irreversible eye effects of an ingredient will not be evident when present at a level above the generic concentration limits mentioned in Tables 3.3.3 and 3.3.4, testing of the mixture shall be considered. In those cases, the tiered weight of evidence strategy shall be applied.

3.3.3.3.6.If there are data showing that (an) ingredient(s) may be corrosive or irritant at a concentration of < 1 % (corrosive) or < 3 % (irritant), the mixture shall be classified accordingly.

Table 3.3.3

Generic concentration limits of ingredients of a mixture classified as Skin corrosive Category 1 and/or eye Category 1 or 2 for effects on the eye that trigger classification of the mixture for effects on the eye (Category 1 or 2)

Sum of ingredients classified as:Concentration triggering classification of a mixture as:
Irreversible Eye EffectsReversible Eye Effects
Category 1Category 2
Eye Effects Category 1 or Skin Corrosive Category 1A, 1B, 1C≥ 3 %≥ 1 % but < 3 %
Eye Effects Category 2≥ 10 %
(10 × Eye Effects Category 1) + Eye effects Category 2≥ 10 %
Skin Corrosive Category 1A, 1B, 1C + Eye effects Category 1≥ 3 %≥ 1 % but < 3 %
10 × (Skin Corrosive Category 1A, 1B, 1C + Eye Effects Category 1) + Eye Effects Category 2≥ 10 %


Table 3.3.4

Generic concentration limits of ingredients of a mixture for which the additivity approach does not apply, that trigger classification of the mixture as hazardous to the eye

IngredientConcentrationMixture classified as: Eye
Acid with pH ≤ 2≥ 1 %Category 1
Base with pH ≥ 11,5≥ 1 %Category 1
Other corrosive (Category 1) ingredients for which additivity does not apply≥ 1 %Category 1
Other irritant (Category 2) ingredients for which additivity does not apply, including acids and bases≥ 3 %Category 2

3.3.4.   Hazard Communication

3.3.4.1.Label elements shall be used for substances or mixtures meeting the criteria for classification in this hazard class in accordance with Table 3.3.5.

Table 3.3.5

Label elements for serious eye damage/eye irritation

ClassificationCategory 1Category 2
GHS Pictograms
Signal WordDangerWarning
Hazard StatementH318: Causes serious eye damageH319: Causes serious eye irritation
Precautionary Statement

Prevention
P280P264

P280
Precautionary Statement

Response
P305 + P351 + P338

P310
P305 + P351 + P338

P337 + P313
Precautionary Statement

Storage
Precautionary Statement

Disposal

3.4.   Respiratory or skin sensitisation

3.4.1.   Definitions and general considerations

3.4.1.1.Respiratory sensitiser means a substance that will lead to hypersensitivity of the airways following inhalation of the substance.

3.4.1.2.Skin sensitiser means a substance that will lead to an allergic response following skin contact.

3.4.1.3.For the purpose of section 3.4, sensitisation includes two phases: the first phase is induction of specialised immunological memory in an individual by exposure to an allergen. The second phase is elicitation, i.e. production of a cell-mediated or antibody-mediated allergic response by exposure of a sensitised individual to an allergen.

3.4.1.4.For respiratory sensitisation, the pattern of induction followed by elicitation phases is shared in common with skin sensitisation. For skin sensitisation, an induction phase is required in which the immune system learns to react; clinical symptoms can then arise when subsequent exposure is sufficient to elicit a visible skin reaction (elicitation phase). As a consequence, predictive tests usually follow this pattern in which there is an induction phase, the response to which is measured by a standardised elicitation phase, typically involving a patch test. The local lymph node assay is the exception, directly measuring the induction response. Evidence of skin sensitisation in humans normally is assessed by a diagnostic patch test.

3.4.1.5.Usually, for both skin and respiratory sensitisation, lower levels are necessary for elicitation than are required for induction. Provisions for alerting sensitised individuals to the presence of a particular sensitiser in a mixture can be found at section 3.4.4.

3.4.1.6.The hazard class Respiratory or Skin Sensitisation is differentiated into:

Respiratory Sensitisation;

Skin Sensitisation.

3.4.2.   Classification criteria for substances

3.4.2.1.   Respiratory sensitisers

Substances shall be classified as respiratory sensitisers (Category 1) in accordance with the criteria in Table 3.4.1:

Table 3.4.1

Hazard category for respiratory sensitisers

CategoryCriteria
Category 1Substances shall be classified as respiratory sensitisers (Category 1) in accordance with the following criteria:

(a)if there is evidence in humans that the substance can lead to specific respiratory hypersensitivity and/or

(b)if there are positive results from an appropriate animal test.

3.4.2.1.1   Human evidence

3.4.2.1.1.1.Evidence that a substance can induce specific respiratory hypersensitivity will normally be based on human experience. In this context, hypersensitivity is normally seen as asthma, but other hypersensitivity reactions such as rhinitis/conjunctivitis and alveolitis are also considered. The condition will have the clinical character of an allergic reaction. However, immunological mechanisms do not have to be demonstrated.

3.4.2.1.1.2.When considering the human evidence, it is necessary for a decision on classification to take into account, in addition to the evidence from the cases:

(a)the size of the population exposed;

(b)the extent of exposure.

The use of human data is discussed in paragraphs 1.1.1.3, 1.1.1.4 and 1.1.1.5.

3.4.2.1.1.3.The evidence referred to above could be

(a)clinical history and data from appropriate lung function tests related to exposure to the substance, confirmed by other supportive evidence which may include:

(i)in vivo immunological test (e.g. skin prick test);

(ii)in vitro immunological test (e.g. serological analysis);

(iii)studies that indicate other specific hypersensitivity reactions where immunological mechanisms of action have not been proven, e.g. repeated low-level irritation, pharmacologically mediated effects;

(iv)a chemical structure related to substances known to cause respiratory hypersensitivity;

(b)data from one or more positive bronchial challenge tests with the substance conducted according to accepted guidelines for the determination of a specific hypersensitivity reaction.

3.4.2.1.1.4.Clinical history shall include both medical and occupational history to determine a relationship between exposure to a specific substance and development of respiratory hypersensitivity. Relevant information includes aggravating factors both in the home and workplace, the onset and progress of the disease, family history and medical history of the patient in question. The medical history shall also include a note of other allergic or airway disorders from childhood, and smoking history.

3.4.2.1.1.5.The results of positive bronchial challenge tests are considered to provide sufficient evidence for classification on their own. It is however recognised that in practice many of the examinations listed above will already have been carried out.

3.4.2.1.2.   Animal studies

3.4.2.1.2.1.Data from appropriate animal studies (13) which may be indicative of the potential of a substance to cause sensitisation by inhalation in humans (14) may include:

(i)measurements of Immunoglobulin E (IgE) and other specific immunological parameters in mice;

(ii)specific pulmonary responses in guinea pigs.

3.4.2.2.   Skin sensitisers

3.4.2.2.1.Substances shall be classified as skin sensitisers (Category 1) in accordance with the criteria in Table 3.4.2:

Table 3.4.2

Hazard category for skin sensitisers

CategoryCriteria
Category 1Substances shall be classified as skin sensitisers (Category 1) in accordance with the following criteria:

(i)if there is evidence in humans that the substance can lead to sensitisation by skin contact in a substantial number of persons, or

(ii)if there are positive results from an appropriate animal test (see specific criteria in paragraph 3.4.2.2.4.1).

3.4.2.2.2.   Specific considerations

3.4.2.2.2.1.For classification of a substance as a skin sensitiser, evidence shall include any or all of the following:

(a)positive data from patch testing, normally obtained in more than one dermatology clinic;

(b)epidemiological studies showing allergic contact dermatitis caused by the substance; Situations in which a high proportion of those exposed exhibit characteristic symptoms are to be looked at with special concern, even if the number of cases is small;

(c)positive data from appropriate animal studies;

(d)positive data from experimental studies on humans (see Article 7(3));

(e)well documented episodes of allergic contact dermatitis, normally obtained in more than one dermatology clinic.

The use of human data is discussed in paragraphs 1.1.1.3, 1.1.1.4 and 1.1.1.5.

3.4.2.2.2.2.Positive effects seen in either humans or animals will normally justify classification. Evidence from animal studies (see section 3.4.2.2.4) is usually much more reliable than evidence from human exposure. However, in cases where evidence is available from both sources, and there is conflict between the results, the quality and reliability of the evidence from both sources must be assessed in order to resolve the question of classification on a case-by-case basis. Normally, human data are not generated in controlled experiments with volunteers for the purpose of hazard classification but rather as part of risk assessment to confirm lack of effects seen in animal tests. Consequently, positive human data on skin sensitisation are usually derived from case-control or other, less defined studies. Evaluation of human data must therefore be carried out with caution, as the frequency of cases reflect, in addition to the intrinsic properties of the substances, factors such as the exposure situation, bioavailability, individual predisposition and preventive measures taken. Negative human data can not normally be used to negate positive results from animal studies.

3.4.2.2.2.3.If none of the above mentioned conditions are met the substance need not be classified as a skin sensitiser. However, a combination of two or more indicators of skin sensitisation as listed below may alter the decision, which shall be considered on a case-by-case basis:

(a)isolated episodes of allergic contact dermatitis;

(b)epidemiological studies of limited power, e.g. where chance, bias or confounders have not been ruled out fully with reasonable confidence;

(c)data from animal tests, performed according to existing guidelines, which do not meet the criteria for a positive result described in paragraph 3.4.2.2.4.1, but which are sufficiently close to the limit to be considered significant;

(d)positive data from non-standard methods;

(e)positive results from close structural analogues.

3.4.2.2.3.   Immunological contact urticaria

3.4.2.2.3.1.Some substances meeting the criteria for classification as respiratory sensitisers may in addition cause immunological contact urticaria. Consideration shall be given to classifying these substances also as skin sensitisers and including information concerning contact urticaria on the label or in the SDS using appropriate warning information.

3.4.2.2.3.2.For substances which produce signs of immunological contact urticaria but which do not fulfil the criteria as a respiratory sensitiser, consideration shall be given to classification as a skin sensitiser. There is no recognised animal model available to identify substances which cause immunological contact urticaria. Therefore, classification will normally be based on human evidence, which will be similar to that for skin sensitisation.

3.4.2.2.4.   Animal studies

3.4.2.2.4.1.When an adjuvant type guinea pig test method for skin sensitisation is used, a response of at least 30 % of the animals is considered as positive. For a non-adjuvant guinea pig test method a response of at least 15 % of the animals is considered positive. Test methods for skin sensitisation described in Regulation (EC) No 440/2008 adopted in accordance with Article 13(3) of Regulation (EC) No 1907/2006 (‘Test Method Regulation’) shall be used, or other methods provided that they are well-validated and scientific justification is given.

3.4.3.   Classification criteria for mixtures

3.4.3.1.   Classification of mixtures when data are available for the complete mixture

3.4.3.1.1.When reliable and good quality evidence from human experience or appropriate studies in experimental animals, as described in the criteria for substances, is available for the mixture, then the mixture can be classified by weight of evidence evaluation of these data. Care shall be exercised in evaluating data on mixtures, that the dose used does not render the results inconclusive.

3.4.3.2.   Classification of mixtures when data are not available for the complete mixture: bridging principles

3.4.3.2.1.Where the mixture itself has not been tested to determine its sensitising properties, but there are sufficient data on the individual ingredients and similar tested mixtures to adequately characterise the hazards of the mixture, these data shall be used in accordance with the bridging rules set out in section 1.1.3.

3.4.3.3.   Classification of mixtures when data are available for all ingredients or only for some ingredients of the mixture

3.4.3.3.1.The mixture shall be classified as a respiratory or skin sensitiser when at least one ingredient has been classified as a respiratory or skin sensitiser and is present at or above the appropriate generic concentration limit as shown in Table 3.4.3 for solid/liquid and gas respectively.

3.4.3.3.2.Some substances that are classified as sensitisers may elicit a response, when present in a mixture in quantities below the concentrations established in Table 3.4.1, in individuals who are already sensitised to the substance or mixture (see Note 1 to Table 3.4.3).

Table 3.4.3

Generic concentration limits of ingredients of a mixture classified as either skin sensitisers or respiratory sensitisers that trigger classification of the mixture

Ingredient classified as:Concentration triggering classification of a mixture as:
Skin SensitiserRespiratory Sensitiser
All physical statesSolid/LiquidGas
Skin Sensitiser≥ 0,1 %

(Note 1)
≥ 1,0 %

(Note 2)
Respiratory Sensitiser≥ 0,1 %

(Note 1)
≥ 0,1 %

(Note 1)
≥ 1,0 %

(Note 3)
≥ 0,2 %

(Note 3)

Note 1

This concentration limit is generally used for the application of the special labelling requirements of Annex II section 2.8 to protect already sensitised individuals. A SDS is required for the mixture containing an ingredient above this concentration.

Note 2

This concentration limit is used to trigger classification of a mixture as a skin sensitiser.

Note 3

This concentration limit is used to trigger classification of a mixture as a respiratory sensitiser.

3.4.4.   Hazard communication

3.4.4.1.Label elements shall be used for substances or mixtures meeting the criteria for classification in this hazard class in accordance with Table 3.4.4.

Table 3.4.4

Respiratory or skin sensitisation label elements.

ClassificationRespiratory sensitisationSkin sensitisation
Category 1Category 1
GHS Pictograms
Signal WordDangerWarning
Hazard StatementH334: May cause allergy or asthma symptoms or breathing difficulties if inhaledH317: May cause an allergic skin reaction
Precautionary Statement PreventionP261

P285
P261

P272

P280
Precautionary Statement ResponseP304 + P341

P342+ P311
P302 + P352

P333 + P313

P321

P363
Precautionary Statement Storage
Precautionary Statement DisposalP501P501

3.5.   Germ cell mutagenicity

3.5.1.   Definitions and general considerations

3.5.1.1.A mutation means a permanent change in the amount or structure of the genetic material in a cell. The term ‘mutation’ applies both to heritable genetic changes that may be manifested at the phenotypic level and to the underlying DNA modifications when known (including specific base pair changes and chromosomal translocations). The term ‘mutagenic’ and ‘mutagen’ will be used for agents giving rise to an increased occurrence of mutations in populations of cells and/or organisms.

3.5.1.2.The more general terms ‘genotoxic’ and ‘genotoxicity’ apply to agents or processes which alter the structure, information content, or segregation of DNA, including those which cause DNA damage by interfering with normal replication processes, or which in a non-physiological manner (temporarily) alter its replication. Genotoxicity test results are usually taken as indicators for mutagenic effects.

3.5.2.   Classification criteria for substances

3.5.2.1.This hazard class is primarily concerned with substances that may cause mutations in the germ cells of humans that can be transmitted to the progeny. However, the results from mutagenicity or genotoxicity tests in vitro and in mammalian somatic and germ cells in vivo are also considered in classifying substances and mixtures within this hazard class.

3.5.2.2.For the purpose of classification for germ cell mutagenicity, substances are allocated to one of two categories as shown in Table 3.5.1.

Table 3.5.1

Hazard categories for germ cell mutagens

CategoriesCriteria
CATEGORY 1:Substances known to induce heritable mutations or to be regarded as if they induce heritable mutations in the germ cells of humans.

Substances known to induce heritable mutations in the germ cells of humans.
Category 1A:The classification in Category 1A is based on positive evidence from human epidemiological studies.

Substances to be regarded as if they induce heritable mutations in the germ cells of humans.
Category 1B:The classification in Category 1B is based on:

positive result(s) from in vivo heritable germ cell mutagenicity tests in mammals; or

positive result(s) from in vivo somatic cell mutagenicity tests in mammals, in combination with some evidence that the substance has potential to cause mutations to germ cells. It is possible to derive this supporting evidence from mutagenicity/genotoxicity tests in germ cells in vivo, or by demonstrating the ability of the substance or its metabolite(s) to interact with the genetic material of germ cells; or

positive results from tests showing mutagenic effects in the germ cells of humans, without demonstration of transmission to progeny; for example, an increase in the frequency of aneuploidy in sperm cells of exposed people.
CATEGORY 2:Substances which cause concern for humans owing to the possibility that they may induce heritable mutations in the germ cells of humans

The classification in Category 2 is based on:

positive evidence obtained from experiments in mammals and/or in some cases from in vitro experiments, obtained from:

somatic cell mutagenicity tests in vivo, in mammals; or

other in vivo somatic cell genotoxicity tests which are supported by positive results from in vitro mutagenicity assays.

Note: Substances which are positive in in vitro mammalian mutagenicity assays, and which also show chemical structure activity relationship to known germ cell mutagens, shall be considered for classification as Category 2 mutagens.

3.5.2.3.   Specific considerations for classification of substances as germ cell mutagens

3.5.2.3.1.To arrive at a classification, test results are considered from experiments determining mutagenic and/or genotoxic effects in germ and/or somatic cells of exposed animals. Mutagenic and/or genotoxic effects determined in in vitro tests shall also be considered.

3.5.2.3.2.The system is hazard based, classifying substances on the basis of their intrinsic ability to induce mutations in germ cells. The scheme is, therefore, not meant for the (quantitative) risk assessment of substances.

3.5.2.3.3.Classification for heritable effects in human germ cells is made on the basis of well conducted, sufficiently validated tests, preferably as described in Regulation (EC) No 440/2008 adopted in accordance with Article 13(3) of Regulation (EC) No 1907/2006 (‘Test Method Regulation’) such as those listed in the following paragraphs. Evaluation of the test results shall be done using expert judgement and all the available evidence shall be weighed in arriving at a classification.

3.5.2.3.4.In vivo heritable germ cell mutagenicity tests, such as:

rodent dominant lethal mutation test;

mouse heritable translocation assay.

3.5.2.3.5.In vivo somatic cell mutagenicicty tests, such as:

mammalian bone marrow chromosome aberration test;

mouse spot test;

mammalian erythrocyte micronucleus test.

3.5.2.3.6.Mutagenicity/genotoxicity tests in germ cells, such as:

(a)mutagenicity tests:

mammalian spermatogonial chromosome aberration test;

spermatid micronucleus assay;

(b)Genotoxicity tests:

sister chromatid exchange analysis in spermatogonia;

unscheduled DNA synthesis test (UDS) in testicular cells.

3.5.2.3.7.Genotoxicity tests in somatic cells such as:

liver Unscheduled synthesis test (UDS) in vivo;

mammalian bone marrow Sister Chromatid Exchanges (SCE);

3.5.2.3.8.In vitro mutagenicity tests such as:

in vitro mammalian chromosome aberration test;

in vitro mammalian cell gene mutation test;

bacterial reverse mutation tests.

3.5.2.3.9.The classification of individual substances shall be based on the total weight of evidence available, using expert judgement (See 1.1.1). In those instances where a single well-conducted test is used for classification, it shall provide clear and unambiguously positive results. If new, well validated, tests arise these may also be used in the total weight of evidence to be considered. The relevance of the route of exposure used in the study of the substance compared to the route of human exposure shall also be taken into account.

3.5.3.   Classification criteria for mixtures

3.5.3.1.   Classification of mixtures when data are available for all ingredients or only for some ingredients of the mixture

3.5.3.1.1.The mixture shall be classified as a mutagen when at least one ingredient has been classified as a Category 1A, Category 1B or Category 2 mutagen and is present at or above the appropriate generic concentration limit as shown in Table 3.5.2 for Category 1A, Category 1B and Category 2 respectively.

Table 3.5.2

Generic concentration limits of ingredients of a mixture classified as germ cell mutagens that trigger classification of the mixture.

Concentration limits triggering classification of a mixture as:
Ingredient classified as:Category 1A mutagenCategory 1B mutagenCategory 2 mutagen
Category 1A mutagen≥ 0,1 %
Category 1B mutagen≥ 0,1 %
Category 2 mutagen≥ 1,0 %

Note

The concentration limits in the table above apply to solids and liquids (w/w units) as well as gases (v/v units).

3.5.3.2.   Classification of mixtures when data are available for the complete mixture

3.5.3.2.1.Classification of mixtures will be based on the available test data for the individual ingredients of the mixture using concentration limits for the ingredients classified as germ cell mutagens. On a case-by-case basis, test data on mixtures may be used for classification when demonstrating effects that have not been established from the evaluation based on the individual ingredients. In such cases, the test results for the mixture as a whole must be shown to be conclusive taking into account dose and other factors such as duration, observations, sensitivity and statistical analysis of germ cell mutagenicity test systems. Adequate documentation supporting the classification shall be retained and made available for review upon request.

3.5.3.3.   Classification of mixtures when data are not available for the complete mixture: bridging principles

3.5.3.3.1.Where the mixture itself has not been tested to determine its germ cell mutagenicity hazard, but there are sufficient data on the individual ingredients and similar tested mixtures (subject to paragraph 3.5.3.2.1), to adequately characterise the hazards of the mixture, these data shall be used in accordance with the applicable bridging rules set out in section 1.1.3.

3.5.4.   Hazard communication

3.5.4.1.Label elements shall be used in accordance with Table 3.5.3, for substances or mixtures meeting the criteria for classification in this hazard class.

Table 3.5.3

Label elements of germ cell mutagenicity

ClassificationCategory 1A or Category 1BCategory 2
GHS Pictograms
Signal WordDangerWarning
Hazard StatementH340: May cause genetic defects (state route of exposure if it is conclusively proven that no other routes of exposure cause the hazard)H341: Suspected of causing genetic defects (state route of exposure if it is conclusively proven that no other routes of exposure cause the hazard)
Precautionary Statement

Prevention
P201

P202

P281
P201

P202

P281
Precautionary Statement

Response
P308 + P313P308 + P313
Precautionary Statement

Storage
P405P405
Precautionary Statement

Disposal
P501P501

3.5.5.   Additional classification considerations

It is increasingly accepted that the process of chemical-induced tumorigenesis in humans and animals involves genetic changes for example in proto-oncogenes and/or tumour suppresser genes of somatic cells. Therefore, the demonstration of mutagenic properties of substances in somatic and/or germ cells of mammals in vivo may have implications for the potential classification of these substances as carcinogens (see also Carcinogenicity, section 3.6, paragraph 3.6.2.2.6).

3.6.   Carcinogenicity

3.6.1.   Definition

3.6.1.1.Carcinogen means a substance or a mixture of substances which induce cancer or increase its incidence. Substances which have induced benign and malignant tumours in well performed experimental studies on animals are considered also to be presumed or suspected human carcinogens unless there is strong evidence that the mechanism of tumour formation is not relevant for humans.

3.6.2.   Classification criteria for substances

3.6.2.1.For the purpose of classification for carcinogenicity, substances are allocated to one of two categories based on strength of evidence and additional considerations (weight of evidence). In certain instances, route-specific classification may be warranted, if it can be conclusively proved that no other route of exposure exhibits the hazard.

Table 3.6.1

Hazard categories for carcinogens

CategoriesCriteria
CATEGORY 1:Known or presumed human carcinogens

A substance is classified in Category 1 for carcinogenicity on the basis of epidemiological and/or animal data. A substance may be further distinguished as:
Category 1A:Category 1A, known to have carcinogenic potential for humans, classification is largely based on human evidence, or
Category 1B:Category 1B, presumed to have carcinogenic potential for humans, classification is largely based on animal evidence.
The classification in Category 1A and 1B is based on strength of evidence together with additional considerations (see section 3.6.2.2). Such evidence may be derived from:

human studies that establish a causal relationship between human exposure to a substance and the development of cancer (known human carcinogen); or

animal experiments for which there is sufficient (15) evidence to demonstrate animal carcinogenicity (presumed human carcinogen).
In addition, on a case-by-case basis, scientific judgement may warrant a decision of presumed human carcinogenicity derived from studies showing limited evidence of carcinogenicity in humans together with limited evidence of carcinogenicity in experimental animals.
CATEGORY 2:Suspected human carcinogens

The placing of a substance in Category 2 is done on the basis of evidence obtained from human and/or animal studies, but which is not sufficiently convincing to place the substance in Category 1A or 1B, based on strength of evidence together with additional considerations (see section 3.6.2.2). Such evidence may be derived either from limited (15) evidence of carcinogenicity in human studies or from limited evidence of carcinogenicity in animal studies.

3.6.2.2.   Specific considerations for classification of substances as carcinogens

3.6.2.2.1.Classification as a carcinogen is made on the basis of evidence from reliable and acceptable studies and is intended to be used for substances which have an intrinsic property to cause cancer. The evaluations shall be based on all existing data, peer-reviewed published studies and additional acceptable data.

3.6.2.2.2.Classification of a substance as a carcinogen is a process that involves two interrelated determinations: evaluations of strength of evidence and consideration of all other relevant information to place substances with human cancer potential into hazard categories.

3.6.2.2.3.Strength of evidence involves the enumeration of tumours in human and animal studies and determination of their level of statistical significance. Sufficient human evidence demonstrates causality between human exposure and the development of cancer, whereas sufficient evidence in animals shows a causal relationship between the substance and an increased incidence of tumours. Limited evidence in humans is demonstrated by a positive association between exposure and cancer, but a causal relationship cannot be stated. Limited evidence in animals is provided when data suggest a carcinogenic effect, but are less than sufficient. The terms ‘sufficient’ and ‘limited’ have been used here as they have been defined by the International Agency for Research on Cancer (IARC) and read as follows:

(a)Carcinogenicity in humans

The evidence relevant to carcinogenicity from studies in humans is classified into one of the following categories:

sufficient evidence of carcinogenicity: a causal relationship has been established between exposure to the agent and human cancer. That is, a positive relationship has been observed between the exposure and cancer in studies in which chance, bias and confounding could be ruled out with reasonable confidence;

limited evidence of carcinogenicity: a positive association has been observed between exposure to the agent and cancer for which a causal interpretation is considered to be credible, but chance, bias or confounding could not be ruled out with reasonable confidence.

(b)Carcinogenicity in experimental animals

Carcinogenicity in experimental animals can be evaluated using conventional bioassays, bioassays that employ genetically modified animals, and other in-vivo bioassays that focus on one or more of the critical stages of carcinogenesis. In the absence of data from conventional long-term bioassays or from assays with neoplasia as the end-point, consistently positive results in several models that address several stages in the multistage process of carcinogenesis should be considered in evaluating the degree of evidence of carcinogenicity in experimental animals. The evidence relevant to carcinogenicity in experimental animals is classified into one of the following categories:

sufficient evidence of carcinogenicity: a causal relationship has been established between the agent and an increased incidence of malignant neoplasms or of an appropriate combination of benign and malignant neoplasms in (a) two or more species of animals or (b) two or more independent studies in one species carried out at different times or in different laboratories or under different protocols. An increased incidence of tumours in both sexes of a single species in a well-conducted study, ideally conducted under Good Laboratory Practices, can also provide sufficient evidence. A single study in one species and sex might be considered to provide sufficient evidence of carcinogenicity when malignant neoplasms occur to an unusual degree with regard to incidence, site, type of tumour or age at onset, or when there are strong findings of tumours at multiple sites;

limited evidence of carcinogenicity: the data suggest a carcinogenic effect but are limited for making a definitive evaluation because, e.g. (a) the evidence of carcinogenicity is restricted to a single experiment; (b) there are unresolved questions regarding the adequacy of the design, conduct or interpretation of the studies; (c) the agent increases the incidence only of benign neoplasms or lesions of uncertain neoplastic potential; or (d) the evidence of carcinogenicity is restricted to studies that demonstrate only promoting activity in a narrow range of tissues or organs.

3.6.2.2.4.Additional considerations (as part of the weight of evidence approach (see 1.1.1)). Beyond the determination of the strength of evidence for carcinogenicity, a number of other factors need to be considered that influence the overall likelihood that a substance poses a carcinogenic hazard in humans. The full list of factors that influence this determination would be very lengthy, but some of the more important ones are considered here.

3.6.2.2.5.The factors can be viewed as either increasing or decreasing the level of concern for human carcinogenicity. The relative emphasis accorded to each factor depends upon the amount and coherence of evidence bearing on each. Generally there is a requirement for more complete information to decrease than to increase the level of concern. Additional considerations should be used in evaluating the tumour findings and the other factors in a case-by-case manner.

3.6.2.2.6.Some important factors which may be taken into consideration, when assessing the overall level of concern are:

(a)tumour type and background incidence;

(b)multi-site responses;

(c)progression of lesions to malignancy;

(d)reduced tumour latency;

(e)whether responses are in single or both sexes;

(f)whether responses are in a single species or several species;

(g)structural similarity to a substance(s) for which there is good evidence of carcinogenicity;

(h)routes of exposure;

(i)comparison of absorption, distribution, metabolism and excretion between test animals and humans;

(j)the possibility of a confounding effect of excessive toxicity at test doses;

(k)mode of action and its relevance for humans, such as cytotoxicity with growth stimulation, mitogenesis, immunosuppression, mutagenicity.

Mutagenicity: it is recognised that genetic events are central in the overall process of cancer development. Therefore evidence of mutagenic activity in vivo may indicate that a substance has a potential for carcinogenic effects.

3.6.2.2.7.A substance that has not been tested for carcinogenicity may in certain instances be classified in Category 1A, Category 1B or Category 2 based on tumour data from a structural analogue together with substantial support from consideration of other important factors such as formation of common significant metabolites, e.g. for benzidine congener dyes.

3.6.2.2.8.The classification shall take into consideration whether or not the substance is absorbed by a given route(s); or whether there are only local tumours at the site of administration for the tested route(s), and adequate testing by other major route(s) show lack of carcinogenicity.

3.6.2.2.9.It is important that whatever is known of the physico-chemical, toxicokinetic and toxicodynamic properties of the substances, as well as any available relevant information on chemical analogues, i.e. structure activity relationship, is taken into consideration when undertaking classification.

3.6.3.   Classification criteria for mixtures

3.6.3.1.   Classification of mixtures when data are available for all ingredients or only for some ingredients of the mixture

3.6.3.1.1.The mixture will be classified as a carcinogen when at least one ingredient has been classified as a Category 1A, Category 1B or Category 2 carcinogen and is present at or above the appropriate generic concentration limit as shown in Table 3.6.2 for Category 1A, Category 1B and Category 2 respectively.

Table 3.6.2

Generic concentration limits of ingredients of a mixture classified as carcinogen that trigger classification of the mixture

Ingredient classified as:Generic concentration limits triggering classification of a mixture as:
Category 1A carcinogenCategory 1B carcinogenCategory 2 carcinogen
Category 1A carcinogen≥ 0,1 %
Category 1B carcinogen≥ 0,1 %
Category 2 carcinogen≥ 1,0 % [Note 1]

Note

The concentration limits in the table above apply to solids and liquids (w/w units) as well as gases (v/v units).

Note 1

If a Category 2 carcinogen is present in the mixture as an ingredient at a concentration ≥ 0,1 % a SDS shall be available for the mixture upon request.

3.6.3.2.   Classification of mixtures when data are available for the complete mixture

3.6.3.2.1.Classification of mixtures will be based on the available test data for the individual ingredients of the mixture using concentration limits for the ingredients classified as carcinogens. On a case-by-case basis, test data on mixtures may be used for classification when demonstrating effects that have not been established from the evaluation based on the individual ingredients. In such cases, the test results for the mixture as a whole must be shown to be conclusive taking into account dose and other factors such as duration, observations, sensitivity and statistical analysis of carcinogenicity test systems. Adequate documentation supporting the classification shall be retained and made available for review upon request.

3.6.3.3.   Classification of mixtures when data are not available for the complete mixture: bridging principles

3.6.3.3.1.Where the mixture itself has not been tested to determine its carcinogenic hazard, but there are sufficient data on the individual ingredients and similar tested mixtures (subject to paragraph 3.6.3.2.1) to adequately characterise the hazards of the mixture, these data shall be used in accordance with the applicable bridging rules set out in section 1.1.3.

3.6.4.   Hazard Communication

3.6.4.1.Label elements shall be used in accordance with Table 3.6.3, for substances or mixtures meeting the criteria for classification in this hazard class.

Table 3.6.3

Label elements for carcinogenicity

ClassificationCategory 1A or Category 1BCategory 2
GHS Pictograms
Signal WordDangerWarning
Hazard StatementH350: May cause cancer (state route of exposure if it is conclusively proven that no other routes of exposure cause the hazard)H351: Suspected of causing cancer (state route of exposure if it is conclusively proven that no other routes of exposure cause the hazard)
Precautionary Statement

Prevention
P201

P202

P281
P201

P202

P281
Precautionary Statement

Response
P308 + P313P308 + P313
Precautionary Statement

Storage
P405P405
Precautionary Statement

Disposal
P501P501

3.7.   Reproductive toxicity

3.7.1.   Definitions and general considerations

3.7.1.1.Reproductive toxicity includes adverse effects on sexual function and fertility in adult males and females, as well as developmental toxicity in the offspring. The definitions presented below are adapted from those agreed as working definitions in IPCS/EHC Document No 225, Principles for Evaluating Health Risks to Reproduction Associated with Exposure to Chemicals. For classification purposes, the known induction of genetically based heritable effects in the offspring is addressed in Germ Cell Mutagenicity (section 3.5), since in the present classification system it is considered more appropriate to address such effects under the separate hazard class of germ cell mutagenicity.

In this classification system, reproductive toxicity is subdivided under two main headings:

(a)adverse effects on sexual function and fertility;

(b)adverse effects on development of the offspring.

Some reproductive toxic effects cannot be clearly assigned to either impairment of sexual function and fertility or to developmental toxicity. Nonetheless, substances with these effects, or mixtures containing them, shall be classified as reproductive toxicants.

3.7.1.2.For the purpose of classification the hazard class Reproductive Toxicity is differentiated into:

adverse effects

on sexual function and fertility, or

on development;

effects on or via lactation.

3.7.1.3.   Adverse effects on sexual function and fertility

Any effect of substances that has the potential to interfere with sexual function and fertility. This includes, but is not limited to, alterations to the female and male reproductive system, adverse effects on onset of puberty, gamete production and transport, reproductive cycle normality, sexual behaviour, fertility, parturition, pregnancy outcomes, premature reproductive senescence, or modifications in other functions that are dependent on the integrity of the reproductive systems.

3.7.1.4.   Adverse effects on development of the offspring

Developmental toxicity includes, in its widest sense, any effect which interferes with normal development of the conceptus, either before or after birth, and resulting from exposure of either parent prior to conception, or exposure of the developing offspring during prenatal development, or postnatally, to the time of sexual maturation. However, it is considered that classification under the heading of developmental toxicity is primarily intended to provide a hazard warning for pregnant women, and for men and women of reproductive capacity. Therefore, for pragmatic purposes of classification, developmental toxicity essentially means adverse effects induced during pregnancy, or as a result of parental exposure. These effects can be manifested at any point in the life span of the organism. The major manifestations of developmental toxicity include (1) death of the developing organism, (2) structural abnormality, (3) altered growth, and (4) functional deficiency.

3.7.1.5.Adverse effects on or via lactation are also included in reproductive toxicity, but for classification purposes, such effects are treated separately (see Table 3.7.1 (b)). This is because it is desirable to be able to classify substances specifically for an adverse effect on lactation so that a specific hazard warning about this effect can be provided for lactating mothers.

3.7.2.   Classification criteria for substances

3.7.2.1.   Hazard categories

3.7.2.1.1.For the purpose of classification for reproductive toxicity, substances are allocated to one of two categories. Within each category, effects on sexual function and fertility, and on development, are considered separately. In addition, effects on lactation are allocated to a separate hazard category.

Table 3.7.1(a)

Hazard categories for reproductive toxicants

CategoriesCriteria
CATEGORY 1Known or presumed human reproductive toxicant

Substances are classified in Category 1 for reproductive toxicity when they are known to have produced an adverse effect on sexual function and fertility, or on development in humans or when there is evidence from animal studies, possibly supplemented with other information, to provide a strong presumption that the substance has the capacity to interfere with reproduction in humans. The classification of a substance is further distinguished on the basis of whether the evidence for classification is primarily from human data (Category 1A) or from animal data (Category 1B).
Category 1AKnown human reproductive toxicant

The classification of a substance in Category 1A is largely based on evidence from humans.
Category 1BPresumed human reproductive toxicant

The classification of a substance in Category 1B is largely based on data from animal studies. Such data shall provide clear evidence of an adverse effect on sexual function and fertility or on development in the absence of other toxic effects, or if occurring together with other toxic effects the adverse effect on reproduction is considered not to be a secondary non-specific consequence of other toxic effects. However, when there is mechanistic information that raises doubt about the relevance of the effect for humans, classification in Category 2 may be more appropriate.
CATEGORY 2Suspected human reproductive toxicant

Substances are classified in Category 2 for reproductive toxicity when there is some evidence from humans or experimental animals, possibly supplemented with other information, of an adverse effect on sexual function and fertility, or on development, and where the evidence is not sufficiently convincing to place the substance in Category 1. If deficiencies in the study make the quality of evidence less convincing, Category 2 could be the more appropriate classification.

Such effects shall have been observed in the absence of other toxic effects, or if occurring together with other toxic effects the adverse effect on reproduction is considered not to be a secondary non-specific consequence of the other toxic effects.

Table 3.7.1(b)

Hazard category for lactation effects

EFFECTS ON OR VIA LACTATION
Effects on or via lactation are allocated to a separate single category. It is recognised that for many substances there is no information on the potential to cause adverse effects on the offspring via lactation. However, substances which are absorbed by women and have been shown to interfere with lactation, or which may be present (including metabolites) in breast milk in amounts sufficient to cause concern for the health of a breastfed child, shall be classified and labelled to indicate this property hazardous to breastfed babies. This classification can be assigned on the:

(a)human evidence indicating a hazard to babies during the lactation period; and/or

(b)results of one or two generation studies in animals which provide clear evidence of adverse effect in the offspring due to transfer in the milk or adverse effect on the quality of the milk; and/or

(c)absorption, metabolism, distribution and excretion studies that indicate the likelihood that the substance is present in potentially toxic levels in breast milk.

3.7.2.2.   Basis of classification

3.7.2.2.1.Classification is made on the basis of the appropriate criteria, outlined above, and an assessment of the total weight of evidence (see 1.1.1). Classification as a reproductive toxicant is intended to be used for substances which have an intrinsic, specific property to produce an adverse effect on reproduction and substances shall not be so classified if such an effect is produced solely as a non-specific secondary consequence of other toxic effects.

The classification of a substance is derived from the hazard categories in the following order of precedence: Category 1A, Category 1B, Category 2 and the additional Category for effects on or via lactation. If a substance meets the criteria for classification into both of the main categories (for example Category 1B for effects on sexual function and fertility and also Category 2 for development) then both hazard differentiations shall be communicated by the respective hazard statements. Classification in the additional category for effects on or via lactation will be considered irrespective of a classification into Category 1A, Category 1B or Category 2.

3.7.2.2.2.In the evaluation of toxic effects on the developing offspring, it is important to consider the possible influence of maternal toxicity (see section 3.7.2.4).

3.7.2.2.3.For human evidence to provide the primary basis for a Category 1A classification there must be reliable evidence of an adverse effect on reproduction in humans. Evidence used for classification shall ideally be from well conducted epidemiological studies which include the use of appropriate controls, balanced assessment, and due consideration of bias or confounding factors. Less rigorous data from studies in humans shall be supplemented with adequate data from studies in experimental animals and classification in Category 1B shall be considered.

3.7.2.3.   Weight of evidence

3.7.2.3.1.Classification as a reproductive toxicant is made on the basis of an assessment of the total weight of evidence, see section 1.1.1. This means that all available information that bears on the determination of reproductive toxicity is considered together, such as epidemiological studies and case reports in humans and specific reproduction studies along with sub-chronic, chronic and special study results in animals that provide relevant information regarding toxicity to reproductive and related endocrine organs. Evaluation of substances chemically related to the substance under study may also be included, particularly when information on the substance is scarce. The weight given to the available evidence will be influenced by factors such as the quality of the studies, consistency of results, nature and severity of effects, the presence of maternal toxicity in experimental animal studies, level of statistical significance for inter-group differences, number of endpoints affected, relevance of route of administration to humans and freedom from bias. Both positive and negative results are assembled together into a weight of evidence determination. A single, positive study performed according to good scientific principles and with statistically or biologically significant positive results may justify classification (see also 3.7.2.2.3).

3.7.2.3.2.Toxicokinetic studies in animals and humans, site of action and mechanism or mode of action study results may provide relevant information which reduces or increases concerns about the hazard to human health. If it is conclusively demonstrated that the clearly identified mechanism or mode of action has no relevance for humans or when the toxicokinetic differences are so marked that it is certain that the hazardous property will not be expressed in humans then a substance which produces an adverse effect on reproduction in experimental animals should not be classified.

3.7.2.3.3.If, in some reproductive toxicity studies in experimental animals the only effects recorded are considered to be of low or minimal toxicological significance, classification may not necessarily be the outcome. These effects include small changes in semen parameters or in the incidence of spontaneous defects in the foetus, small changes in the proportions of common foetal variants such as are observed in skeletal examinations, or in foetal weights, or small differences in postnatal developmental assessments.

3.7.2.3.4.Data from animal studies ideally shall provide clear evidence of specific reproductive toxicity in the absence of other systemic toxic effects. However, if developmental toxicity occurs together with other toxic effects in the dam, the potential influence of the generalised adverse effects shall be assessed to the extent possible. The preferred approach is to consider adverse effects in the embryo/foetus first, and then evaluate maternal toxicity, along with any other factors which are likely to have influenced these effects, as part of the weight of evidence. In general, developmental effects that are observed at maternally toxic doses shall not be automatically discounted. Discounting developmental effects that are observed at maternally toxic doses can only be done on a case-by-case basis when a causal relationship is established or refuted.

3.7.2.3.5.If appropriate information is available it is important to try to determine whether developmental toxicity is due to a specific maternally mediated mechanism or to a non-specific secondary mechanism, like maternal stress and the disruption of homeostasis. Generally, the presence of maternal toxicity shall not be used to negate findings of embryo/foetal effects, unless it can be clearly demonstrated that the effects are secondary non-specific effects. This is especially the case when the effects in the offspring are significant, e.g. irreversible effects such as structural malformations. In some situations it can be assumed that reproductive toxicity is due to a secondary consequence of maternal toxicity and discount the effects, if the substance is so toxic that dams fail to thrive and there is severe inanition, they are incapable of nursing pups; or they are prostrate or dying.

3.7.2.4.   Maternal toxicity

3.7.2.4.1.Development of the offspring throughout gestation and during the early postnatal stages can be influenced by toxic effects in the mother either through non-specific mechanisms related to stress and the disruption of maternal homeostasis, or by specific maternally-mediated mechanisms. In the interpretation of the developmental outcome to decide classification for developmental effects it is important to consider the possible influence of maternal toxicity. This is a complex issue because of uncertainties surrounding the relationship between maternal toxicity and developmental outcome. Expert judgement and a weight of evidence approach, using all available studies, shall be used to determine the degree of influence that shall be attributed to maternal toxicity when interpreting the criteria for classification for developmental effects. The adverse effects in the embryo/foetus shall be first considered, and then maternal toxicity, along with any other factors which are likely to have influenced these effects, as weight of evidence, to help reach a conclusion about classification.

3.7.2.4.2.Based on pragmatic observation, maternal toxicity may, depending on severity, influence development via non-specific secondary mechanisms, producing effects such as depressed foetal weight, retarded ossification, and possibly resorptions and certain malformations in some strains of certain species. However, the limited number of studies which have investigated the relationship between developmental effects and general maternal toxicity have failed to demonstrate a consistent, reproducible relationship across species. Developmental effects which occur even in the presence of maternal toxicity are considered to be evidence of developmental toxicity, unless it can be unequivocally demonstrated on a case-by-case basis that the developmental effects are secondary to maternal toxicity. Moreover, classification shall be considered where there is a significant toxic effect in the offspring, e.g. irreversible effects such as structural malformations, embryo/foetal lethality, significant post-natal functional deficiencies.

3.7.2.4.3.Classification shall not automatically be discounted for substances that produce developmental toxicity only in association with maternal toxicity, even if a specific maternally-mediated mechanism has been demonstrated. In such a case, classification in Category 2 may be considered more appropriate than Category 1. However, when a substance is so toxic that maternal death or severe inanition results, or the dams are prostrate and incapable of nursing the pups, it is reasonable to assume that developmental toxicity is produced solely as a secondary consequence of maternal toxicity and discount the developmental effects. Classification is not necessarily the outcome in the case of minor developmental changes, when there is only a small reduction in foetal/pup body weight or retardation of ossification when seen in association with maternal toxicity.

3.7.2.4.4.Some of the end points used to assess maternal effects are provided below. Data on these end points, if available, need to be evaluated in light of their statistical or biological significance and dose response relationship.

Maternal mortality:

an increased incidence of mortality among the treated dams over the controls shall be considered evidence of maternal toxicity if the increase occurs in a dose-related manner and can be attributed to the systemic toxicity of the test material. Maternal mortality greater than 10 % is considered excessive and the data for that dose level shall not normally be considered for further evaluation.

Mating index

(no. animals with seminal plugs or sperm/no. mated × 100) (16)

Fertility index

(no. animals with implants/no. of matings × 100)

Gestation length

(if allowed to deliver)

Body weight and body weight change:

Consideration of the maternal body weight change and/or adjusted (corrected) maternal body weight shall be included in the evaluation of maternal toxicity whenever such data are available. The calculation of an adjusted (corrected) mean maternal body weight change, which is the difference between the initial and terminal body weight minus the gravid uterine weight (or alternatively, the sum of the weights of the foetuses), may indicate whether the effect is maternal or intrauterine. In rabbits, the body weight gain may not be useful indicators of maternal toxicity because of normal fluctuations in body weight during pregnancy.

Food and water consumption (if relevant):

The observation of a significant decrease in the average food or water consumption in treated dams compared to the control group is useful in evaluating maternal toxicity, particularly when the test material is administered in the diet or drinking water. Changes in food or water consumption need to be evaluated in conjunction with maternal body weights when determining if the effects noted are reflective of maternal toxicity or more simply, unpalatability of the test material in feed or water.

Clinical evaluations (including clinical signs, markers, haematology and clinical chemistry studies):

The observation of increased incidence of significant clinical signs of toxicity in treated dams relative to the control group is useful in evaluating maternal toxicity. If this is to be used as the basis for the assessment of maternal toxicity, the types, incidence, degree and duration of clinical signs shall be reported in the study. Clinical signs of maternal intoxication include: coma, prostration, hyperactivity, loss of righting reflex, ataxia, or laboured breathing.

Post-mortem data:

Increased incidence and/or severity of post-mortem findings may be indicative of maternal toxicity. This can include gross or microscopic pathological findings or organ weight data, including absolute organ weight, organ-to-body weight ratio, or organ-to-brain weight ratio. When supported by findings of adverse histopathological effects in the affected organ(s), the observation of a significant change in the average weight of suspected target organ(s) of treated dams, compared to those in the control group, may be considered evidence of maternal toxicity.

3.7.2.5.   Animal and experimental data

3.7.2.5.1.A number of internationally accepted test methods are available; these include methods for developmental toxicity testing (e.g. OECD Test Guideline 414), and methods for one or two-generation toxicity testing (e.g. OECD Test Guidelines 415, 416).

3.7.2.5.2.Results obtained from Screening Tests (e.g. OECD Guidelines 421 — Reproduction/Developmental Toxicity Screening Test, and 422 — Combined Repeated Dose Toxicity Study with Reproduction/Development Toxicity Screening Test) can also be used to justify classification, although it is recognised that the quality of this evidence is less reliable than that obtained through full studies.

3.7.2.5.3.Adverse effects or changes, seen in short- or long-term repeated dose toxicity studies, which are judged likely to impair reproductive function and which occur in the absence of significant generalised toxicity, may be used as a basis for classification, e.g. histopathological changes in the gonads.

3.7.2.5.4.Evidence from in vitro assays, or non-mammalian tests, and from analogous substances using structure-activity relationship (SAR), can contribute to the procedure for classification. In all cases of this nature, expert judgement must be used to assess the adequacy of the data. Inadequate data shall not be used as a primary support for classification.

3.7.2.5.5.It is preferable that animal studies are conducted using appropriate routes of administration which relate to the potential route of human exposure. However, in practice, reproductive toxicity studies are commonly conducted using the oral route, and such studies will normally be suitable for evaluating the hazardous properties of the substance with respect to reproductive toxicity. However, if it can be conclusively demonstrated that the clearly identified mechanism or mode of action has no relevance for humans or when the toxicokinetic differences are so marked that it is certain that the hazardous property will not be expressed in humans then a substance which produces an adverse effect on reproduction in experimental animals shall not be classified.

3.7.2.5.6.Studies involving routes of administration such as intravenous or intraperitoneal injection, which result in exposure of the reproductive organs to unrealistically high levels of the test substance, or elicit local damage to the reproductive organs, including irritation, must be interpreted with extreme caution and on their own are not normally the basis for classification.

3.7.2.5.7.There is general agreement about the concept of a limit dose, above which the production of an adverse effect is considered to be outside the criteria which lead to classification, but not regarding the inclusion within the criteria of a specific dose as a limit dose. However, some guidelines for test methods, specify a limit dose, others qualify the limit dose with a statement that higher doses may be necessary if anticipated human exposure is sufficiently high that an adequate margin of exposure is not achieved. Also, due to species differences in toxicokinetics, establishing a specific limit dose may not be adequate for situations where humans are more sensitive than the animal model.

3.7.2.5.8.In principle, adverse effects on reproduction seen only at very high dose levels in animal studies (for example doses that induce prostration, severe inappetence, excessive mortality) would not normally lead to classification, unless other information is available, e.g. toxicokinetics information indicating that humans may be more susceptible than animals, to suggest that classification is appropriate. Please also refer to the section on maternal toxicity (3.7.2.4) for further guidance in this area.

3.7.2.5.9.However, specification of the actual ‘limit dose’ will depend upon the test method that has been employed to provide the test results, e.g. in the OECD Test Guideline for repeated dose toxicity studies by the oral route, an upper dose of 1 000 mg/kg has been recommended as a limit dose, unless expected human response indicates the need for a higher dose level.

3.7.3.   Classification criteria for mixtures

3.7.3.1.   Classification of mixtures when data are available for all ingredients or only for some ingredients of the mixture

3.7.3.1.1.The mixture shall be classified as a reproductive toxicant when at least one ingredient has been classified as a Category 1A, Category 1B or Category 2 reproductive toxicant and is present at or above the appropriate generic concentration limit as shown in Table 3.7.2 for Category 1A, Category 1B and Category 2 respectively.

3.7.3.1.2.The mixture shall be classified for effects on or via lactation when at least one ingredient has been classified for effects on or via lactation and is present at or above the appropriate generic concentration limit as shown in Table 3.7.2 for the additional category for effects on or via lactation.

Table 3.7.2

Generic concentration limits of ingredients of a mixture classified as reproduction toxicants or for effects on or via lactation that trigger classification of the mixture

Ingredient classified as:Generic concentration limits triggering classification of a mixture as:
Category 1A reproductive toxicantCategory 1B reproductive toxicantCategory 2 reproductive toxicantAdditional category for effects on or via lactation
Category 1A reproductive toxicant≥ 0,3 %

[Note 1]
Category 1B reproductive toxicant≥ 0,3 %

[Note 1]
Category 2 reproductive toxicant≥ 3,0 %

[Note 1]
Additional category for effects on or via lactation≥ 0,3 %

[Note 1]

Note

The concentration limits in the table above apply to solids and liquids (w/w units) as well as gases (v/v units).

Note 1

If a Category 1 or Category 2 reproductive toxicant or a substance classified for effects on or via lactation is present in the mixture as an ingredient at a concentration above 0,1 %, a SDS shall be available for the mixture upon request.

3.7.3.2.   Classification of mixtures when data are available for the complete mixture

3.7.3.2.1.Classification of mixtures will be based on the available test data for the individual ingredients of the mixture using concentration limits for the ingredients of the mixture. On a case-by-case basis, test data on mixtures may be used for classification when demonstrating effects that have not been established from the evaluation based on the individual components. In such cases, the test results for the mixture as a whole must be shown to be conclusive taking into account dose and other factors such as duration, observations, sensitivity and statistical analysis of reproduction test systems. Adequate documentation supporting the classification shall be retained and made available for review upon request.

3.7.3.3.   Classification of mixtures when data are not available for the complete mixture: bridging principles

3.7.3.3.1.Subject to paragraph 3.7.3.2.1, where the mixture itself has not been tested to determine its reproductive toxicity, but there are sufficient data on the individual ingredients and similar tested mixtures to adequately characterise the hazards of the mixture, these data shall be used in accordance with the applicable bridging rules set out in section 1.1.3.

3.7.4.   Hazard Communication

3.7.4.1.Label elements shall be used for substances or mixtures meeting the criteria for classification in this hazard class in accordance with Table 3.7.3

Table 3.7.3

Label elements for reproductive toxicity

ClassificationCategory 1A or Category 1BCategory 2Additional category for effects on or via lactation
GHS PictogramsNo pictogram
Signal WordDangerWarningNo signal word
Hazard StatementH360: May damage fertility or the unborn child (state specific effect if known)(state route of exposure if it is conclusively proven that no other routes of exposure cause the hazard)H361: Suspected of damaging fertility or the unborn child (state specific effect if known) (state route of exposure if it is conclusively proven that no other routes of exposure cause the hazard)H362: May cause harm to breast-fed children.
Precautionary Statement PreventionP201

P202

P281
P201

P202

P281
P201

P260

P263

P264

P270
Precautionary Statement ResponseP308 + P313P308 + P313P308 + P313
Precautionary Statement StorageP405P405
Precautionary Statement DisposalP501P501

3.8.   Specific target organ toxicity — single exposure

3.8.1.   Definitions and general considerations

3.8.1.1.Specific target organ toxicity (single exposure) is defined as specific, non lethal target organ toxicity arising from a single exposure to a substance or mixture. All significant health effects that can impair function, both reversible and irreversible, immediate and/or delayed and not specifically addressed in sections 3.1 to 3.7 and 3.10 are included (see also 3.8.1.6).

3.8.1.2.Classification identifies the substance or mixture as being a specific target organ toxicant and, as such, it may present a potential for adverse health effects in people who are exposed to it.

3.8.1.3.These adverse health effects produced by a single exposure include consistent and identifiable toxic effects in humans, or, in experimental animals, toxicologically significant changes which have affected the function or morphology of a tissue/organ, or have produced serious changes to the biochemistry or haematology of the organism, and these changes are relevant for human health.

3.8.1.4.Assessment shall take into consideration not only significant changes in a single organ or biological system but also generalised changes of a less severe nature involving several organs.

3.8.1.5.Specific target organ toxicity can occur by any route that is relevant for humans, i.e. principally oral, dermal or inhalation.

3.8.1.6.Specific target organ toxicity following a repeated exposure is classified as described in Specific target organ toxicity — Repeated exposure (section 3.9) and is therefore excluded from section 3.8. Other specific toxic effects, listed below, are assessed separately and consequently are not included here:

(a)Acute toxicity (section 3.1);

(b)Skin corrosion/irritation (section 3.2);

(c)Serious eye damage/eye irritation (section 3.3);

(d)Respiratory or skin sensitisation (section 3.4);

(e)Germ cell mutagenicity (section 3.5);

(f)Carcinogenicity (section 3.6);

(g)Reproductive toxicity (section 3.7); and

(h)Aspiration toxicity (section 3.10).

3.8.1.7.The hazard class Specific Target Organ Toxicity — Single Exposure is differentiated into:

Specific target organ toxicity — single exposure, Category 1 and 2;

Specific target organ toxicity — single exposure, Category 3.

See Table 3.8.1.

Table 3.8.1

Categories for specific target organ toxicity-single exposure

CategoriesCriteria
Category 1Substances that have produced significant toxicity in humans or that, on the basis of evidence from studies in experimental animals, can be presumed to have the potential to produce significant toxicity in humans following single exposure

Substances are classified in Category 1 for specific target organ toxicity (single exposure) on the basis of:

(a)reliable and good quality evidence from human cases or epidemiological studies; or

(b)observations from appropriate studies in experimental animals in which significant and/or severe toxic effects of relevance to human health were produced at generally low exposure concentrations. Guidance dose/concentration values are provided below (see 3.8.2.1.9) to be used as part of weight-of-evidence evaluation.
Category 2Substances that, on the basis of evidence from studies in experimental animals can be presumed to have the potential to be harmful to human health following single exposure

Substances are classified in Category 2 for specific target organ toxicity (single exposure) on the basis of observations from appropriate studies in experimental animals in which significant toxic effects, of relevance to human health, were produced at generally moderate exposure concentrations. Guidance dose/concentration values are provided below (see 3.8.2.1.9) in order to help in classification.

In exceptional cases, human evidence can also be used to place a substance in Category 2 (see 3.8.2.1.6).
Category 3Transient target organ effects

This category only includes narcotic effects and respiratory tract irritation. These are target organ effects for which a substance does not meet the criteria to be classified in Categories 1 or 2 indicated above. These are effects which adversely alter human function for a short duration after exposure and from which humans may recover in a reasonable period without leaving significant alteration of structure or function. Substances are classified specifically for these effects as laid down in 3.8.2.2.
Note: Attempts shall be made to determine the primary target organ of toxicity and to classify for that purpose, such as hepatotoxicants, neurotoxicants. The data shall be carefully evaluated and, where possible, secondary effects should not be included (e.g. a hepatotoxicant can produce secondary effects in the nervous or gastro-intestinal systems).

3.8.2.   Classification criteria for substances

3.8.2.1.   Substances of Category 1 and Category 2

3.8.2.1.1.Substances are classified for immediate or delayed effects separately, by the use of expert judgement (see 1.1.1) on the basis of the weight of all evidence available, including the use of recommended guidance values (see 3.8.2.1.9). Substances are then placed in Category 1 or 2, depending upon the nature and severity of the effect(s) observed (Table 3.8.1).

3.8.2.1.2.The relevant route or routes of exposure by which the classified substance produces damage shall be identified (see 3.8.1.5).

3.8.2.1.3.Classification is determined by expert judgement (see section 1.1.1), on the basis of the weight of all evidence available including the guidance presented below.

3.8.2.1.4.Weight of evidence of all data (see section 1.1.1), including human incidents, epidemiology, and studies conducted in experimental animals, is used to substantiate specific target organ toxic effects that merit classification.

3.8.2.1.5.The information required to evaluate specific target organ toxicity comes either from single exposure in humans, such as: exposure at home, in the workplace or environmentally, or from studies conducted in experimental animals. The standard animal studies in rats or mice that provide this information are acute toxicity studies which can include clinical observations and detailed macroscopic and microscopic examination to enable the toxic effects on target tissues/organs to be identified. Results of acute toxicity studies conducted in other species may also provide relevant information.

3.8.2.1.6.In exceptional cases, based on expert judgement, it is appropriate to place certain substances with human evidence of target organ toxicity in Category 2:

(a)when the weight of human evidence is not sufficiently convincing to warrant Category 1 classification, and/or

(b)based on the nature and severity of effects.

Dose/concentration levels in humans shall not be considered in the classification and any available evidence from animal studies shall be consistent with the Category 2 classification. In other words, if there are also animal data available on the substance that warrant Category 1 classification, the substance shall be classified as Category 1.

3.8.2.1.7.   Effects considered to support classification for Category 1 and 2

3.8.2.1.7.1.Classification is supported by evidence associating single exposure to the substance with a consistent and identifiable toxic effect.

3.8.2.1.7.2.Evidence from human experience/incidents is usually restricted to reports of adverse health consequence, often with uncertainty about exposure conditions, and may not provide the scientific detail that can be obtained from well-conducted studies in experimental animals.

3.8.2.1.7.3.Evidence from appropriate studies in experimental animals can furnish much more detail, in the form of clinical observations, and macroscopic and microscopic pathological examination, and this can often reveal hazards that may not be life-threatening but could indicate functional impairment. Consequently all available evidence, and relevance to human health, must be taken into consideration in the classification process, including but not limited to the following effects in humans and/or animals:

(a)morbidity resulting from single exposure;

(b)significant functional changes, more than transient in nature, in the respiratory system, central or peripheral nervous systems, other organs or other organ systems, including signs of central nervous system depression and effects on special senses (such as sight, hearing and sense of smell);

(c)any consistent and significant adverse change in clinical biochemistry, haematology, or urinalysis parameters;

(d)significant organ damage noted at necropsy and/or subsequently seen or confirmed at microscopic examination;

(e)multi-focal or diffuse necrosis, fibrosis or granuloma formation in vital organs with regenerative capacity;

(f)morphological changes that are potentially reversible but provide clear evidence of marked organ dysfunction;

(g)evidence of appreciable cell death (including cell degeneration and reduced cell number) in vital organs incapable of regeneration.

3.8.2.1.8.   Effects considered not to support classification for Category 1 and 2

It is recognised that effects may be seen that does not justify classification. Such effects in humans and/or animals include, but are not limited to:

(a)clinical observations or small changes in bodyweight gain, food consumption or water intake that may have some toxicological importance but that do not, by themselves, indicate ‘significant’ toxicity;

(b)small changes in clinical biochemistry, haematology or urinalysis parameters and/or transient effects, when such changes or effects are of doubtful or minimal toxicological importance;

(c)changes in organ weights with no evidence of organ dysfunction;

(d)adaptive responses that are not considered toxicologically relevant;

(e)substance-induced species-specific mechanisms of toxicity, i.e. demonstrated with reasonable certainty to be not relevant for human health, shall not justify classification.

3.8.2.1.9.   Guidance values to assist with classification based on the results obtained from studies conducted in experimental animals for Category 1 and 2

3.8.2.1.9.1.In order to help reach a decision about whether a substance shall be classified or not, and to what degree it shall be classified (Category 1 or Category 2), dose/concentration ‘guidance values’ are provided for consideration of the dose/concentration which has been shown to produce significant health effects. The principal argument for proposing such guidance values is that all substances are potentially toxic and there has to be a reasonable dose/concentration above which a degree of toxic effect is acknowledged.

3.8.2.1.9.2.Thus, in animal studies, when significant toxic effects are observed that indicate classification, consideration of the dose/concentration at which these effects were seen, in relation to the suggested guidance values, provides useful information to help assess the need to classify (since the toxic effects are a consequence of the hazardous property(ies) and also the dose/concentration).

3.8.2.1.9.3.The guidance value (C) ranges for single-dose exposure which has produced a significant non-lethal toxic effect are those applicable to acute toxicity testing, as indicated in Table 3.8.2.

Table 3.8.2

Guidance value ranges for single-dose exposures a

Guidance value ranges for:
Route of exposureUnitsCategory 1Category 2Category 3
Oral (rat)mg/kg body weightC ≤ 3002 000 ≥ C > 300Guidance values do not apply b
Dermal (rat or rabbit)mg/kg body weightC ≤ 1 0002 000 ≥ C > 1 000
Inhalation (rat) gasppmV/4hC ≤ 2 50020 000 ≥ C > 2 500
Inhalation (rat) vapourmg/l/4hC ≤ 1020 ≥ C > 10
Inhalation (rat) dust/mist/fumemg/l/4hC ≤ 1,05,0 ≥ C > 1,0

Note

(a)The guidance values and ranges mentioned in Table 3.8.2 are intended only for guidance purposes, i.e. to be used as part of the weight of evidence approach, and to assist with decision about classification. They are not intended as strict demarcation values.

(b)Guidance values are not provided for Category 3 substances since this classification is primarily based on human data. Animal data, if available, shall be included in the weight of evidence evaluation.

3.8.2.1.10.   Other considerations

3.8.2.1.10.1.When a substance is characterised only by use of animal data (typical of new substances, but also true for many existing substances), the classification process includes reference to dose/concentration guidance values as one of the elements that contribute to the weight of evidence approach.

3.8.2.1.10.2.When well-substantiated human data are available showing a specific target organ toxic effect that can be reliably attributed to single exposure to a substance, the substance shall normally be classified. Positive human data, regardless of probable dose, predominates over animal data. Thus, if a substance is unclassified because specific target organ toxicity observed was considered not relevant or significant to humans, if subsequent human incident data become available showing a specific target organ toxic effect, the substance shall be classified.

3.8.2.1.10.3.A substance that has not been tested for specific target organ toxicity may, where appropriate, be classified on the basis of data from a validated structure activity relationship and expert judgement-based extrapolation from a structural analogue that has previously been classified together with substantial support from consideration of other important factors such as formation of common significant metabolites.

3.8.2.1.10.4.Saturated vapour concentration shall be considered, where appropriate, as an additional element to provide for specific health and safety protection

3.8.2.2.   Substances of Category 3: Transient target organ effects

3.8.2.2.1.   Criteria for respiratory tract irritation

The criteria for classifying substances as Category 3 for respiratory tract irritation are:

(a)respiratory irritant effects (characterised by localised redness, oedema, pruritis and/or pain) that impair function with symptoms such as cough, pain, choking, and breathing difficulties are included. This evaluation will be based primarily on human data;

(b)subjective human observations could be supported by objective measurements of clear respiratory tract irritation (RTI) (such as electrophysiological responses, biomarkers of inflammation in nasal or bronchoalveolar lavage fluids);

(c)the symptoms observed in humans shall also be typical of those that would be produced in the exposed population rather than being an isolated idiosyncratic reaction or response triggered only in individuals with hypersensitive airways. Ambiguous reports simply of ‘irritation’ shall be excluded as this term is commonly used to describe a wide range of sensations including those such as smell, unpleasant taste, a tickling sensation, and dryness, which are outside the scope of classification for respiratory irritation;

(d)there are currently no validated animal tests that deal specifically with RTI, however, useful information may be obtained from the single and repeated inhalation toxicity tests. For example, animal studies may provide useful information in terms of clinical signs of toxicity (dyspnoea, rhinitis etc) and histopathology (e.g. hyperemia, edema, minimal inflammation, thickened mucous layer) which are reversible and may be reflective of the characteristic clinical symptoms described above. Such animal studies can be used as part of weight of evidence evaluation;

(e)this special classification would occur only when more severe organ effects including in the respiratory system are not observed.

3.8.2.2.2   Criteria for narcotic effects

The criteria for classifying substances as Category 3 for narcotic effects are:

(a)central nervous system depression including narcotic effects in humans such as drowsiness, narcosis, reduced alertness, loss of reflexes, lack of coordination, and vertigo are included. These effects can also be manifested as severe headache or nausea, and can lead to reduced judgment, dizziness, irritability, fatigue, impaired memory function, deficits in perception and coordination, reaction time, or sleepiness;

(b)narcotic effects observed in animal studies may include lethargy, lack of coordination, loss of righting reflex, and ataxia. If these effects are not transient in nature, then they shall be considered to support classification for Category 1 or 2 specific target organ toxicity single exposure.

3.8.3.   Classification criteria for mixtures

3.8.3.1.Mixtures are classified using the same criteria as for substances, or alternatively as described below. As with substances, mixtures shall be classified for specific target organ toxicity following single exposure.

3.8.3.2.   Classification of mixtures when data are available for the complete mixture

3.8.3.2.1.When reliable and good quality evidence from human experience or appropriate studies in experimental animals, as described in the criteria for substances, is available for the mixture, then the mixture shall be classified by weight of evidence evaluation of these data (see 1.1.1.4). Care shall be exercised in evaluating data on mixtures, that the dose, duration, observation or analysis, do not render the results inconclusive.

3.8.3.3.   Classification of mixtures when data are not available for the complete mixture: bridging principles

3.8.3.3.1.Where the mixture itself has not been tested to determine its specific target organ toxicity, but there are sufficient data on the individual ingredients and similar tested mixtures to adequately characterise the hazards of the mixture, these data shall be used in accordance with the bridging principles set out in section 1.1.3.

3.8.3.4.   Classification of mixtures when data are available for all components or only for some components of the mixture

3.8.3.4.1.Where there is no reliable evidence or test data for the specific mixture itself, and the bridging principles cannot be used to enable classification, then classification of the mixture is based on the classification of the ingredient substances. In this case, the mixture shall be classified as a specific target organ toxicant (specific organ specified), following single exposure, when at least one ingredient has been classified as a Category 1 or Category 2 specific target organ toxicant and is present at or above the appropriate generic concentration limit as mentioned in Table 3.8.3 for Category 1 and 2 respectively.

3.8.3.4.2.These generic concentration limits and consequent classifications shall be applied appropriately to single-dose specific target organ toxicants.

3.8.3.4.3.Mixtures shall be classified for either or both single- and repeated-dose toxicity independently.

Table 3.8.3

Generic concentration limits of ingredients of a mixture classified as a specific target organ toxicant that trigger classification of the mixture as Category 1 or 2

Ingredient classified as:Generic concentration limits triggering classification of the mixture as:
Category 1Category 2
Category 1

Specific Target Organ Toxicant
Concentration ≥ 10 %1,0 % ≤ concentration < 10 %
Category 2

Specific Target Organ Toxicant
Concentration ≥ 10 % [(Note 1)]

Note 1

If a Category 2 specific target organ toxicant is present in the mixture as an ingredient at a concentration ≥ 1,0 % a SDS shall be available for the mixture upon request.

3.8.3.4.4.Care shall be exercised when toxicants affecting more than one organ system are combined that the potentiation or synergistic interactions are considered, because certain substances can cause target organ toxicity at < 1 % concentration when other ingredients in the mixture are known to potentiate its toxic effect.

3.8.3.4.5.Care shall be exercised when extrapolating toxicity of a mixture that contains Category 3 ingredient(s). A generic concentration limit of 20 % is appropriate; however, it shall be recognised that this concentration limit may be higher or lower depending on the Category 3 ingredient(s) and that some effects such as respiratory tract irritation may not occur below a certain concentration while other effects such as narcotic effects may occur below this 20 % value. Expert judgement shall be exercised.

3.8.4.   Hazard Communication

3.8.4.1Label elements shall be used in accordance with Table 3.8.4., for substances or mixtures meeting the criteria for classification in this hazard class.

Table 3.8.4

Label elements for specific target organ toxicity after single exposure

ClassificationCategory 1Category 2Category 3
GHS Pictograms
Signal WordDangerWarningWarning
Hazard StatementH370: Causes damage to organs (or state all organs affected, if known) (state route of exposure if it is conclusively proven that no other routes of exposure cause the hazard)H371: May cause damage to organs (or state all organs affected, if known) (state route of exposure if it is conclusively proven that no other routes of exposure cause the hazard)H335: May cause respiratory irritation; or

H336: May cause drowsiness or dizziness
Precautionary Statement PreventionP260

P264

P270
P260

P264

P270
P261

P271
Precautionary Statement ResponseP307 + P311

P321
P309 + P311P304 + P340

P312
Precautionary Statement StorageP405P405P403 + P233

P405
Precautionary Statement DisposalP501P501P501

3.9.   Specific target organ toxicity — repeated exposure

3.9.1.   Definitions and general considerations

3.9.1.1.Target organ toxicity (repeated exposure) means specific, target organ toxicity arising from a repeated exposure to a substance or mixture. All significant health effects that can impair function, both reversible and irreversible, immediate and/or delayed are included. However, other specific toxic effects that are specifically addressed in sections 3.1 to 3.8 and 3.10 are not included here.

3.9.1.2.Classification for target organ toxicity (repeated exposure) identifies the substance as being a specific target organ toxicant and, as such, it may present a potential for adverse health effects in people who are exposed to it.

3.9.1.3.These adverse health effects include consistent and identifiable toxic effects in humans, or, in experimental animals, toxicologically significant changes which have affected the function or morphology of a tissue/organ, or have produced serious changes to the biochemistry or haematology of the organism and these changes are relevant for human health.

3.9.1.4.Assessment shall take into consideration not only significant changes in a single organ or biological system but also generalised changes of a less severe nature involving several organs.

3.9.1.5.Specific target organ toxicity can occur by any route that is relevant for humans, i.e. principally oral, dermal or inhalation.

3.9.1.6.Non-lethal toxic effects observed after a single-event exposure are classified as described in Specific target organ toxicity — Single exposure (section 3.8) and are therefore excluded from section 3.9.

3.9.2.   Classification criteria for substances

3.9.2.1.Substances are classified as specific target organ toxicants following repeated exposure by the use of expert judgement (see 1.1.1), on the basis of the weight of all evidence available, including the use of recommended guidance values which take into account the duration of exposure and the dose/concentration which produced the effect(s), (see 3.9.2.9), and are placed in one of two categories, depending upon the nature and severity of the effect(s) observed (Table 3.9.1).

Table 3.9.1

Categories for specific target organ toxicity-repeated exposure

CategoriesCriteria
Category 1Substances that have produced significant toxicity in humans or that, on the basis of evidence from studies in experimental animals, can be presumed to have the potential to produce significant toxicity in humans following repeated exposure.

Substances are classified in Category 1 for target organ toxicity (repeat exposure) on the basis of:

reliable and good quality evidence from human cases or epidemiological studies; or

observations from appropriate studies in experimental animals in which significant and/or severe toxic effects, of relevance to human health, were produced at generally low exposure concentrations. Guidance dose/concentration values are provided below (see 3.9.2.9), to be used as part of a weight-of- evidence evaluation.
Category 2Substances that, on the basis of evidence from studies in experimental animals can be presumed to have the potential to be harmful to human health following repeated exposure.

Substances are classified in category 2 for target organ toxicity (repeat exposure) on the basis of observations from appropriate studies in experimental animals in which significant toxic effects, of relevance to human health, were produced at generally moderate exposure concentrations. Guidance dose/concentration values are provided below (see 3.9.2.9) in order to help in classification.

In exceptional cases human evidence can also be used to place a substance in Category 2 (see 3.9.2.6).

Note

Attempts shall be made to determine the primary target organ of toxicity and classify for that purpose, such as hepatotoxicants, neurotoxicants. One shall carefully evaluate the data and, where possible, not include secondary effects (a hepatotoxicant can produce secondary effects in the nervous or gastro-intestinal systems).

3.9.2.2.The relevant route or routes of exposure by which the classified substance produces damage shall be identified.

3.9.2.3.Classification is determined by expert judgement (see section 1.1.1), on the basis of the weight of all evidence available including the guidance presented below.

3.9.2.4.Weight of evidence of all data (see section 1.1.1), including human incidents, epidemiology, and studies conducted in experimental animals, is used to substantiate specific target organ toxic effects that merit classification. This taps the considerable body of industrial toxicology data collected over the years. Evaluation shall be based on all existing data, including peer-reviewed published studies and additional acceptable data.

3.9.2.5.The information required to evaluate specific target organ toxicity comes either from repeated exposure in humans, such as exposure at home, in the workplace or environmentally, or from studies conducted in experimental animals. The standard animal studies in rats or mice that provide this information are 28 day, 90 day or lifetime studies (up to 2 years) that include haematological, clinicochemical and detailed macroscopic and microscopic examination to enable the toxic effects on target tissues/organs to be identified. Data from repeat dose studies performed in other species shall also be used, if available. Other long-term exposure studies, such as on carcinogenicity, neurotoxicity or reproductive toxicity, may also provide evidence of specific target organ toxicity that could be used in the assessment of classification.

3.9.2.6.In exceptional cases, based on expert judgement, it is appropriate to place certain substances with human evidence of specific target organ toxicity in Category 2:

(a)when the weight of human evidence is not sufficiently convincing to warrant Category 1 classification; and/or

(b)based on the nature and severity of effects.

Dose/concentration levels in humans shall not be considered in the classification and any available evidence from animal studies shall be consistent with the Category 2 classification. In other words, if there are also animal data available on the substance that warrant Category 1 classification, the substance shall be classified as Category 1.

3.9.2.7.   Effects considered to support classification for specific target organ toxicity following repeated exposure

3.9.2.7.1.Reliable evidence associating repeated exposure to the substance with a consistent and identifiable toxic effect demonstrates support for the classification.

3.9.2.7.2.Evidence from human experience/incidents is usually restricted to reports of adverse health consequence, often with uncertainty about exposure conditions, and may not provide the scientific detail that can be obtained from well-conducted studies in experimental animals.

3.9.2.7.3.Evidence from appropriate studies in experimental animals can furnish much more detail, in the form of clinical observations, haematology, clinical chemistry, and macroscopic and microscopic pathological examination, and this can often reveal hazards that may not be life-threatening but could indicate functional impairment. Consequently all available evidence, and relevance to human health, shall be taken into consideration in the classification process, including but not limited to the following toxic effects in humans and/or animals:

(a)morbidity or death resulting from repeated or long-term exposure. Morbidity or death may result from repeated exposure, even to relatively low doses/concentrations, due to bioaccumulation of the substance or its metabolites, and/or due to the overwhelming of the de-toxification process by repeated exposure to the substance or its metabolites;

(b)significant functional changes in the central or peripheral nervous systems or other organ systems, including signs of central nervous system depression and effects on special senses (e.g. sight, hearing and sense of smell);

(c)any consistent and significant adverse change in clinical biochemistry, haematology, or urinalysis parameters;

(d)significant organ damage noted at necropsy and/or subsequently seen or confirmed at microscopic examination;

(e)multi-focal or diffuse necrosis, fibrosis or granuloma formation in vital organs with regenerative capacity;

(f)morphological changes that are potentially reversible but provide clear evidence of marked organ dysfunction (e.g., severe fatty change in the liver);

(g)evidence of appreciable cell death (including cell degeneration and reduced cell number) in vital organs incapable of regeneration.

3.9.2.8.   Effects considered not to support classification for specific target organ toxicity following repeated exposure

3.9.2.8.1.It is recognised that effects may be seen in humans and/or animals that do not justify classification. Such effects include, but are not limited to:

(a)clinical observations or small changes in bodyweight gain, food consumption or water intake that have toxicological importance but that do not, by themselves, indicate ‘significant’ toxicity;

(b)small changes in clinical biochemistry, haematology or urinalysis parameters and/or transient effects, when such changes or effects are of doubtful or minimal toxicological importance;

(c)changes in organ weights with no evidence of organ dysfunction;

(d)adaptive responses that are not considered toxicologically relevant;

(e)substance-induced species-specific mechanisms of toxicity, i.e. demonstrated with reasonable certainty to be not relevant for human health, shall not justify classification.

3.9.2.9.   Guidance values to assist with classification based on the results obtained from studies conducted in experimental animals

3.9.2.9.1.In studies conducted in experimental animals, reliance on observation of effects alone, without reference to the duration of experimental exposure and dose/concentration, omits a fundamental concept of toxicology, i.e. all substances are potentially toxic, and what determines the toxicity is a function of the dose/concentration and the duration of exposure. In most studies conducted in experimental animals the test guidelines use an upper limit dose value.

3.9.2.9.2.In order to help reach a decision about whether a substance shall be classified or not, and to what degree it shall be classified (Category 1 or Category 2), dose/concentration ‘guidance values’ are provided for consideration of the dose/concentration which has been shown to produce significant health effects. The principal argument for proposing such guidance values is that all substances are potentially toxic and there has to be a reasonable dose/concentration above which a degree of toxic effect is acknowledged. Also, repeated-dose studies conducted in experimental animals are designed to produce toxicity at the highest dose used in order to optimise the test objective and so most studies will reveal some toxic effect at least at this highest dose. What is therefore to be decided is not only what effects have been produced, but also at what dose/concentration they were produced and how relevant is that for humans.

3.9.2.9.3.Thus, in animal studies, when significant toxic effects are observed that indicate classification, consideration of the duration of experimental exposure and the dose/concentration at which these effects were seen, in relation to the suggested guidance values, can provide useful information to help assess the need to classify (since the toxic effects are a consequence of the hazardous property(ies) and also the duration of exposure and the dose/concentration).

3.9.2.9.4.The decision to classify at all can be influenced by reference to the dose/concentration guidance values at or below which a significant toxic effect has been observed.

3.9.2.9.5.The guidance values refer to effects seen in a standard 90-day toxicity study conducted in rats. They can be used as a basis to extrapolate equivalent guidance values for toxicity studies of greater or lesser duration, using dose/exposure time extrapolation similar to Haber's rule for inhalation, which states essentially that the effective dose is directly proportional to the exposure concentration and the duration of exposure. The assessment shall be done on a case-by-case basis; for a 28-day study the guidance values below is increased by a factor of three.

3.9.2.9.6.Thus classification in Category 1 is applicable, when significant toxic effects observed in a 90-day repeated-dose study conducted in experimental animals are seen to occur at or below the guidance values (C) as indicated in Table 3.9.2:

Table 3.9.2

Guidance values to assist in Category 1 classification

Route of exposureUnitsGuidance values (dose/concentration)
Oral (rat)mg/kg body weight/dayC ≤ 10
Dermal (rat or rabbit)mg/kg body weight/dayC ≤ 20
Inhalation (rat)gasppmV/6h/dayC ≤ 50
Inhalation (rat)vapourmg/litre/6h/dayC ≤ 0,2
Inhalation (rat) dust/mist/fumemg/litre/6h/dayC ≤ 0,02

3.9.2.9.7.Classification in Category 2 is applicable, when significant toxic effects observed in a 90-day repeated-dose study conducted in experimental animals are seen to occur within the guidance value ranges as indicated in Table 3.9.3:

Table 3.9.3

Guidance values to assist in Category 2 classification

Route of ExposureUnitsGuidance Value Ranges:

(dose/concentration)
Oral (rat)mg/kg body weight/day10 < C ≤ 100
Dermal (rat or rabbit)mg/kg body weight/day20 < C ≤ 200
Inhalation (rat) gasppmV/6h/day50 < C ≤ 250
Inhalation (rat)vapourmg/litre/6h/day0,2 < C ≤ 1,0
Inhalation (rat) dust/mist/fumemg/litre/6h/day0,02 < C ≤ 0,2

3.9.2.9.8.The guidance values and ranges mentioned in paragraphs 3.9.2.9.6 and 3.9.2.9.7 are intended only for guidance purposes, i.e. to be used as part of the weight of evidence approach, and to assist with decisions about classification. They are not intended as strict demarcation values.

3.9.2.9.9.Thus it is feasible that a specific profile of toxicity occurs in repeat-dose animal studies at a dose/concentration below the guidance value, such as < 100 mg/kg bw/day by the oral route, however the nature of the effect, such as nephrotoxicity seen only in male rats of a particular strain known to be susceptible to this effect may result in the decision not to classify. Conversely, a specific profile of toxicity may be seen in animal studies occurring at above a guidance value, such as ≥ 100 mg/kg bw/day by the oral route, and in addition there is supplementary information from other sources, such as other long-term administration studies, or human case experience, which supports a conclusion that, in view of the weight of evidence, classification is the prudent action to take.

3.9.2.10.   Other considerations

3.9.2.10.1.When a substance is characterised only by use of animal data (typical of new substances, but also true for many existing substances), the classification process includes reference to dose/concentration guidance values as one of the elements that contribute to the weight of evidence approach.

3.9.2.10.2.When well-substantiated human data are available showing a specific target organ toxic effect that can be reliably attributed to repeated or prolonged exposure to a substance, the substance shall normally be classified. Positive human data, regardless of probable dose, predominates over animal data. Thus, if a substance is unclassified because no specific target organ toxicity was seen at or below the dose/concentration guidance value for animal testing, if subsequent human incident data become available showing a specific target organ toxic effect, the substance shall be classified.

3.9.2.10.3.A substance that has not been tested for specific target organ toxicity may, where appropriate, be classified on the basis of data from a validated structure activity relationship and expert judgement-based extrapolation from a structural analogue that has previously been classified together with substantial support from consideration of other important factors such as formation of common significant metabolites.

3.9.2.10.4.Saturated vapour concentration shall be considered, where appropriate, as an additional element to provide for specific health and safety protection

3.9.3.   Classification criteria for mixtures

3.9.3.1.Mixtures are classified using the same criteria as for substances, or alternatively as described below. As with substances, mixtures shall be classified for specific target organ toxicity following repeated exposure.

3.9.3.2.   Classification of mixtures when data are available for the complete mixture

3.9.3.2.1.When reliable and good quality evidence from human experience or appropriate studies in experimental animals, as described in the criteria for substances, is available for the mixture (see 1.1.1.4), then the mixture shall be classified by weight of evidence evaluation of these data. Care shall be exercised in evaluating data on mixtures, that the dose, duration, observation or analysis, do not render the results inconclusive.

3.9.3.3.   Classification of mixtures when data are not available for the complete mixture: bridging principles

3.9.3.3.1.Where the mixture itself has not been tested to determine its specific target organ toxicity, but there are sufficient data on the individual ingredients and similar tested mixtures to adequately characterise the hazards of the mixture, these data shall be used in accordance with the bridging principles set out in section 1.1.3.

3.9.3.4.   Classification of mixtures when data are available for all components or only for some components of the mixture

3.9.3.4.1.Where there is no reliable evidence or test data for the specific mixture itself, and the bridging principles cannot be used to enable classification, then classification of the mixture is based on the classification of the ingredient substances. In this case, the mixture shall be classified as a specific target organ toxicant (specific organ specified), following single exposure, repeat exposure, or both when at least one ingredient has been classified as a Category 1 or Category 2 specific target organ toxicant and is present at or above the appropriate generic concentration limit as laid out in Table 3.9.4 for Category 1 and 2 respectively.

Table 3.9.4

Generic concentration limits of ingredients of a mixture classified as a specific target organ toxicant that trigger classification of the mixture

Ingredient classified as:Generic concentration limits triggering classification of the mixture as:
Category 1Category 2
Category 1

Specific Target Organ Toxicant
Concentration ≥ 10 %1,0 % ≤ concentration < 10 %
Category 2

Specific Target Organ Toxicant
Concentration ≥ 10 % [(Note 1)]

Note 1

If a Category 2 specific target organ toxicant is present in the mixture as an ingredient at a concentration ≥ 1,0 % a SDS shall be available for the mixture upon request.

3.9.3.4.2.These generic concentration limits and consequent classifications apply to repeated-dose target organ toxicants.

3.9.3.4.3.Mixtures shall be classified for either or both single- and repeated-dose toxicity independently.

3.9.3.4.4.Care shall be exercised when toxicants affecting more than one organ system are combined that the potentiation or synergistic interactions are considered, because certain substances can cause target organ toxicity at < 1 % concentration when other ingredients in the mixture are known to potentiate its toxic effect.

3.9.4.   Hazard Communication

3.9.4.1.Label elements shall be used in accordance with Table 3.9.5 for substances or mixtures meeting the criteria for classification in this hazard class.

Table 3.9.5

Label elements for specific target organ toxicity after repeated exposure

ClassificationCategory 1Category 2
GHS Pictograms
Signal wordDangerWarning
Hazard StatementH372: Causes damage to organs (state all organs affected, if known) through prolonged or repeated exposure (state route of exposure if it is conclusively proven that no other routes of exposure cause the hazard)H373: May cause damage to organs (state all organs affected, if known) through prolonged or repeated exposure (state route of exposure if it is conclusively proven that no other routes of exposure cause the hazard)
Precautionary Statement PreventionP260

P264

P270
P260
Precautionary Statement ResponseP314P314
Precautionary Statement Storage
Precautionary Statement DisposalP501P501

3.10.   Aspiration hazard

3.10.1.   Definitions and general considerations

3.10.1.1.These criteria provide a means of classifying substances or mixtures that may pose an aspiration toxicity hazard to humans.

3.10.1.2‘Aspiration’ means the entry of a liquid or solid substance or mixture directly through the oral or nasal cavity, or indirectly from vomiting, into the trachea and lower respiratory system.

3.10.1.3.Aspiration toxicity includes severe acute effects such as chemical pneumonia, varying degrees of pulmonary injury or death following aspiration.

3.10.1.4.Aspiration is initiated at the moment of inspiration, in the time required to take one breath, as the causative material lodges at the crossroad of the upper respiratory and digestive tracts in the laryngopharyngeal region.

3.10.1.5.Aspiration of a substance or mixture can occur as it is vomited following ingestion. This has consequences for labelling, particularly where, due to acute toxicity, a recommendation may be considered to induce vomiting after ingestion. However, if the substance/mixture also presents an aspiration toxicity hazard, the recommendation to induce vomiting shall be modified.

3.10.1.6.   Specific considerations

3.10.1.6.1.A review of the medical literature on chemical aspiration revealed that some hydrocarbons (petroleum distillates) and certain chlorinated hydrocarbons have been shown to pose an aspiration hazard in humans.

3.10.1.6.2.The classification criteria refer to kinematic viscosity. The following provides the conversion between dynamic and kinematic viscosity:



3.10.1.6.3.   Classification of aerosol/mist products

Aerosol and mist forms of a substance or a mixture (product) are usually dispensed in containers such as self-pressurised containers, trigger and pump sprayers. The key to classifying these products is whether a pool of product is formed in the mouth, which then may be aspirated. If the mist or aerosol from a pressurised container is fine, a pool may not be formed. On the other hand, if a pressurised container dispenses product in a stream, a pool may be formed that may then be aspirated. Usually, the mist produced by trigger and pump sprayers is coarse and therefore, a pool may be formed that then may be aspirated. When the pump mechanism may be removed, and the contents are available to be swallowed then the classification of the substance or mixture shall be considered.

3.10.2.   Classification criteria for substances

Table 3.10.1

Hazard category for aspiration toxicity

CategoryCriteria
Category 1Substances known to cause human aspiration toxicity hazards or to be regarded as if they cause human aspiration toxicity hazard

A substance is classified in Category 1:

(a)based on reliable and good quality human evidence

or

(b)if it is a hydrocarbon and has a kinematic viscosity of 20,5 mm2/s or less, measured at 40 oC.

Note:

Substances in Category 1 include but are not limited to certain hydrocarbons, turpentine and pine oil.

3.10.3.   Classification criteria for mixtures

3.10.3.1.   Classification when data are available for the complete mixture

A mixture is classified in Category 1 based on reliable and good quality human evidence.

3.10.3.2.   Classification when data are not available for the complete mixture: bridging principles

3.10.3.2.1.Where the mixture itself has not been tested to determine its aspiration toxicity, but there are sufficient data on the individual ingredients and similar tested mixtures to adequately characterise the hazard of the mixture, these data shall be used in accordance with the bridging principles set out in section 1.1.3. However, in the case of application of the dilution bridging principle, the concentration of aspiration toxicant(s) shall be 10 % or more.

3.10.3.3.   Classification when data are available for all components or only some components of the mixture

3.10.3.3.1.   Category 1

3.10.3.3.1.1.A mixture which contains a total of 10 % or more of a substance or substances classified in Category 1, and has a kinematic viscosity of 20,5 mm2 /s or less, measured at 40 oC, shall be classified in Category 1.

3.10.3.3.1.2.In the case of a mixture which separates into two or more distinct layers, one of which contains 10 % or more of a substance or substances classified in Category 1 and has a kinematic viscosity of 20,5 mmo /s or less, measured at 40 oC, then the entire mixture is classified in Category 1.

3.10.4.   Hazard Communication

3.10.4.1.Label elements shall be used for substances or mixtures meeting the criteria for classification in this hazard class in accordance with Table 3.10.2.

Table 3.10.2

Aspiration toxicity label elements

ClassificationCategory 1
GHS Pictogram
Signal WordDanger
Hazard StatementH304: May be fatal if swallowed and enters airways
Precautionary Statement

Prevention
Precautionary Statement

Response
P301 + P310

P331
Precautionary Statement

Storage
P405
Precautionary Statement

Disposal
P501

4. PART 4: ENVIRONMENTAL HAZARDS

4.1.   Hazardous to the aquatic environment

4.1.1.   Definitions and General Considerations

4.1.1.1.   Definitions

Acute aquatic toxicity means the intrinsic property of a substance to be injurious to an organism in a short-term exposure to that substance.

Availability of a substance means the extent to which this substance becomes a soluble or disaggregate species. For metal availability, the extent to which the metal ion portion of a metal (Mo) compound can disaggregate from the rest of the compound (molecule).

Bioavailability (or biological availability) means the extent to which a substance is taken up by an organism, and distributed to an area within the organism. It is dependent upon physico-chemical properties of the substance, anatomy and physiology of the organism, pharmacokinetics, and route of exposure. Availability is not a prerequisite for bioavailability.

Bioaccumulation means the net result of uptake, transformation and elimination of a substance in an organism due to all routes of exposure (i.e. air, water, sediment/soil and food).

Bioconcentration means the net result of uptake, transformation and elimination of a substance in an organism due to waterborne exposure.

Chronic aquatic toxicity means the intrinsic property of a substance to cause adverse effects to aquatic organisms during exposures which are determined in relation to the life-cycle of the organism.

Degradation means the decomposition of organic molecules to smaller molecules and eventually to carbon dioxide, water and salts.

4.1.1.2.   Basic elements

4.1.1.2.0.Hazardous to the Aquatic Environment is differentiated into:

Acute aquatic hazard;

Chronic (long term) aquatic hazard.

4.1.1.2.1.The basic elements used for classification for aquatic environmental hazards are:

Acute aquatic toxicity;

Potential for or actual bioaccumulation;

Degradation (biotic or abiotic) for organic chemicals; and

Chronic aquatic toxicity.

4.1.1.2.2.Preferably data shall be derived using the standardised test methods referred to in Article 8(3). In practice data from other standardised test methods such as national methods shall also be used where they are considered as equivalent. Where valid data are available from non-standard testing and from non-testing methods, these shall be considered in classification provided they fulfil the requirements specified in section 1 of Annex XI to Regulation (EC) No 1907/2006. In general, both freshwater and marine species toxicity data are considered suitable for use in classification provided the test method used are equivalent. Where such data are not available classification shall be based on the best available data. See also Part 1.

4.1.1.3.   Other considerations

4.1.1.3.1.Classification of substances and mixtures for environmental hazards requires the identification of the hazards they present to the aquatic environment. The aquatic environment is considered in terms of the aquatic organisms that live in the water, and the aquatic ecosystem of which they are part. The basis, therefore, of the identification of hazard is the aquatic toxicity of the substance or mixture, although this shall be modified by taking account of further information on the degradation and bioaccumulation behaviour, if appropriate.

4.1.1.3.2.While the classification system applies to all substances and mixtures, it is recognised that for special cases the Agency will issue guidance.

4.1.2.   Classification criteria for substances

4.1.2.1.The core classification system for substances consists of one acute classification category and three chronic classification categories. The acute and the chronic classification categories are applied independently. The criteria for classification of a substance in acute Category 1 are defined on the basis of acute aquatic toxicity data only (EC50 or LC50). The criteria for classification of a substance into the chronic categories combine two types of information, i.e. acute aquatic toxicity data and environmental fate data (degradability and bioaccumulation data).

4.1.2.2.The system also introduces a ‘safety net’ classification (referred to as Chronic Category 4) for use when the data available do not allow classification under the formal criteria but there are nevertheless some grounds for concern (see example in table 4.1.0).

4.1.2.3.The system for classification recognises that the core intrinsic hazard to aquatic organisms is represented by both the acute and chronic toxicity of a substance. Separate hazard categories are defined for both properties representing a gradation in the level of hazard identified. The lowest of the available toxicity values shall normally be used to define the appropriate hazard category(ies). There are circumstances, however, when a weight of evidence approach is appropriate.

4.1.2.4.The principal hazard of a ‘hazardous to the aquatic environment’ substance is defined by chronic toxicity, although acute toxicity at L(E)C50 levels ≤ 1 mg/l are also considered hazardous. The intrinsic properties of a lack of rapid degradability and/or a potential to bioconcentrate in combination with acute toxicity are used to assign a substance to a chronic (long term) hazard category.

4.1.2.5.Substances with acute toxicities well below 1 mg/l contribute as components of a mixture to the toxicity of the mixture even at a low concentration and shall normally be given increased weight in applying the summation of classification approach (see note 1 of Table 4.1.0 and 4.1.3.5.5).

4.1.2.6.The criteria for classifying and categorising substances as ‘hazardous to the aquatic environment’ are summarised in Table 4.1.0.

Table 4.1.0

Classification categories for hazardous to the aquatic environment

Acute (short-term) aquatic hazard
Acute Category 1(Note 1)
96 hr LC50 (for fish)≤ 1 mg/l and/or
48 hr EC50 (for crustacea)≤ 1 mg/l and/or
72 or 96 hr ErC50 (for algae or other aquatic plants)≤ 1 mg/l.(Note 2)
Chronic (long-term) aquatic hazard
Chronic Category 1(Note 1)
96 hr LC50 (for fish)≤ 1 mg/l and/or
48 hr EC50 (for crustacea)≤ 1 mg/l and/or
72 or 96 hr ErC50 (for algae or other aquatic plants)≤ 1 mg/l(Note 2)
and the substance is not rapidly degradable and/or the experimentally determined BCF ≥ 500 (or, if absent, the log Kow ≥ 4).
Chronic Category 2
96 hr LC50 (for fish)> 1 to ≤ 10 mg/l and/or
48 hr EC50 (for crustacea)> 1 to ≤ 10 mg/l and/or
72 or 96 hr ErC50 (for algae or other aquatic plants)> 1 to ≤ 10 mg/l(Note 2)
and the substance is not rapidly degradable and/or the experimentally determined BCF ≥ 500 (or, if absent, the log Kow ≥ 4), unless the chronic toxicity NOECs are > 1 mg/l.
Chronic Category 3
96 hr LC50 (for fish)> 10 to ≤ 100 mg/l and/or
48 hr EC50 (for crustacea)> 10 to ≤ 100 mg/l and/or
72 or 96 hr ErC50 (for algae or other aquatic plants)> 10 to ≤ 100 mg/l(Note 2)
and the substance is not rapidly degradable and/or the experimentally determined BCF ≥ 500 (or, if absent, the log Kow ≥ 4) unless the chronic toxicity NOECs are > 1 mg/l.
‘Safety net’ classification

Chronic Category 4

Cases when data do not allow classification under the above criteria but there are nevertheless some grounds for concern. This includes, for example, poorly soluble substances for which no acute toxicity is recorded at levels up to the water solubility (note 3), and which are not rapidly degradable and have an experimentally determined BCF ≥ 500 (or, if absent, a log Kow ≥ 4), indicating a potential to bioaccumulate, will be classified in this category unless other scientific evidence exists showing classification to be unnecessary. Such evidence includes chronic toxicity NOECs > water solubility or > 1 mg/l, or evidence of rapid degradation in the environment.

Note 1

When classifying substances as Acute Category 1 and/or Chronic Category 1 it is necessary at the same time to indicate an appropriate M-factor (see table 4.1.3).

Note 2

Classification shall be based on the ErC50 [= EC50 (growth rate)]. In circumstances where the basis of the EC50 is not specified or no ErC50 is recorded, classification shall be based on the lowest EC50 available.

Note 3

‘No acute toxicity’ is taken to mean that the L(E)C50(s) is/are above the water solubility. Also for poorly soluble substances, (water solubility < 1 mg/l), where there is evidence that the acute test does not provide a true measure of the intrinsic toxicity.

4.1.2.7.   Aquatic toxicity

4.1.2.7.1.Acute aquatic toxicity is normally determined using a fish 96 hour LC50, a crustacea species 48 hour EC50 and/or an algal species 72 or 96 hour EC50. These species cover a range of trophic levels and taxa and are considered as surrogate for all aquatic organisms. Data on other species (e.g. Lemna spp.) shall also be considered if the test methodology is suitable. The aquatic plant growth inhibition tests are normally considered as chronic tests but the EC50s are treated as acute values for classification purposes (see note 2).

4.1.2.7.2.For determining chronic aquatic toxicity for classification purposes data generated according to the standardised test methods referred to in Article 8(3) shall be accepted, as well as results obtained from other validated and internationally accepted test methods. The NOECS or other equivalent L(E)Cx (e.g. EC10) shall be used.

4.1.2.8.   Bioaccumulation

4.1.2.8.1.Bioaccumulation of substances within aquatic organisms can give rise to toxic effects over longer time scales even when actual water concentrations are low. For organic substances the potential for bioaccumulation shall normally be determined by using the octanol/water partition coefficient, usually reported as a log Kow. The relationship between the log Kow of an organic substance and its bioconcentration as measured by the bioconcentration factor (BCF) in fish has considerable scientific literature support. Using a cut-off value of log Kow ≥ 4 is intended to identify only those substances with a real potential to bioconcentrate. While this represents a potential to bioaccumulate, an experimentally determined BCF provides a better measure and shall be used in preference if available. A BCF in fish of ≥ 500 is indicative of the potential to bioconcentrate for classification purposes.

4.1.2.9.   Rapid degradability of organic substances

4.1.2.9.1.Substances that rapidly degrade can be quickly removed from the environment. While effects of such substances can occur, particularly in the event of a spillage or accident, they are localised and of short duration. In the absence of rapid degradation in the environment a substance in the water has the potential to exert toxicity over a wide temporal and spatial scale.

4.1.2.9.2.One way of demonstrating rapid degradation utilises the biodegradation screening tests designed to determine whether an organic substance is ‘readily biodegradable’. Where such data are not available, a BOD(5 days)/COD ratio ≥ 0,5 is considered as indicative of rapid degradation. Thus, a substance which passes this screening test is considered likely to biodegrade ‘rapidly’ in the aquatic environment, and is thus unlikely to be persistent. However, a fail in the screening test does not necessarily mean that the substance will not degrade rapidly in the environment. Other evidence of rapid degradation in the environment may therefore also be considered and are of particular importance where the substances are inhibitory to microbial activity at the concentration levels used in standard testing. Thus, a further classification criterion is included which allows the use of data to show that the substance did actually degrade biotically or abiotically in the aquatic environment by > 70 % in 28 days. Thus, if degradation is demonstrated under environmentally realistic conditions, then the criterion of ‘rapid degradability’ is met.

4.1.2.9.3.Many degradation data are available in the form of degradation half-lives and these can be used in defining rapid degradation provided that ultimate biodegradation of the substance, i.e. full mineralisation, is achieved. Primary biodegradation does not normally suffice in the assessment of rapid degradability unless it can be demonstrated that the degradation products do not fulfil the criteria for classification as hazardous to the aquatic environment.

4.1.2.9.4.The criteria used reflect the fact that environmental degradation may be biotic or abiotic. Hydrolysis can be considered if the hydrolysis products do not fulfil the criteria for classification as hazardous to the aquatic environment.

4.1.2.9.5.Substances are considered rapidly degradable in the environment if one of the following criteria holds true:

(a)if, in 28-day ready biodegradation studies, at least the following levels of degradation are achieved;

(i)tests based on dissolved organic carbon: 70 %

(ii)tests based on oxygen depletion or carbon dioxide generation: 60 % of theoretical maximum.

These levels of biodegradation must be achieved within 10 days of the start of degradation which point is taken as the time when 10 % of the substance has been degraded; or

(b)if, in those cases where only BOD and COD data are available, when the ratio of BOD5/COD is ≥ 0,5; or

(c)if other convincing scientific evidence is available to demonstrate that the substance can be degraded (biotically and/or abiotically) in the aquatic environment to a level > 70 % within a 28-day period.

4.1.2.10.   Inorganic compounds and metals

4.1.2.10.1.For inorganic compounds and metals, the concept of degradability as applied to organic compounds has limited or no meaning. Rather, such substances may be transformed by normal environmental processes to either increase or decrease the bioavailability of the toxic species. Equally the use of bioaccumulation data shall be treated with care (17).

4.1.2.10.2.Poorly soluble inorganic compounds and metals may be acutely or chronically toxic in the aquatic environment depending on the intrinsic toxicity of the bioavailable inorganic species and the rate and amount of this species which enter solution.

4.1.3.   Classification criteria for mixtures

4.1.3.1.The classification system for mixtures covers all classification categories which are used for substances, i.e. Acute Category 1 and Chronic Categories 1 to 4. In order to make use of all available data for purposes of classifying the aquatic environmental hazards of the mixture, the following is applied where appropriate:

The ‘relevant components’ of a mixture are those which are classified ‘Acute Category 1’ or ‘Chronic Category 1’ and present in a concentration of 0,1 % (w/w) or greater, and those which are classified ‘Chronic Category 2’, ‘Chronic Category 3’ or ‘Chronic Category 4’ and present in a concentration of 1 % (w/w) or greater, unless there is a presumption (such as in the case of highly toxic components (see 4.1.3.5.5.5)) that a component present in a lower concentration can still be relevant for classifying the mixture for aquatic environmental hazards. Generally, for substances classified as ‘Acute Category 1’ or ‘Chronic Category 1’ the concentration to be taken into account is (0,1/M) %. (For explanation M-factor see 4.1.3.5.5.5).

4.1.3.2.The approach for classification of aquatic environmental hazards is tiered, and is dependent upon the type of information available for the mixture itself and for its components. Figure 4.1.2 outlines the process to be followed.

Elements of the tiered approach include:

classification based on tested mixtures;

classification based on bridging principles;

the use of ‘summation of classified components’ and/or an ‘additivity formula’.

Figure 4.1.2

Tiered approach to classification of mixtures for acute and chronic (long term) aquatic environmental hazards



4.1.3.3.   Classification of mixtures when data are available for the complete mixture

4.1.3.3.1.When the mixture as a whole has been tested to determine its aquatic toxicity, it is classified according to the criteria that have been agreed for substances, but only for acute hazard. The classification is normally based on the data for fish, crustacea and algae/plants. Classification of mixtures by using LC50 or EC50 data for the mixture as a whole is not possible for chronic categories since both toxicity data and environmental fate data are needed, and there are no degradability and bioaccumulation data for mixtures as a whole. It is not possible to apply the criteria for chronic classification because the data from degradability and bioaccumulation tests of mixtures cannot be interpreted; they are meaningful only for single substances.

4.1.3.3.2.When there is acute toxicity test data (LC50 or EC50) available for the mixture as a whole, these data as well as information with respect to the classification of components for chronic (long-term) hazard shall be used to complete the classification for tested mixtures as follows. When chronic toxicity data (NOEC) is also available, this shall be used too.

(a)L(E)C50 (LC50 or EC50) of the tested mixture ≤ 100 mg/l and NOEC of the tested mixture ≤ 1 mg/l or unknown:

Classify mixture as Acute Category 1 (LC50 or EC50 of the tested mixture ≤ 1 mg/l) or no need for acute classification (LC50 and EC50 of the tested mixture > 1 mg/l).

Apply summation method (see 4.1.3.5.5) for chronic classification (Chronic Category 1, 2, 3, 4 or no need for chronic classification).

(b)L(E)C50 of the tested mixture ≤ 100 mg/l and NOEC(s) of the tested mixture > 1 mg/l:

No need to classify for acute hazard

Apply summation method (see 4.1.3.5.5) for classification as Chronic Category 1. If the mixture is not classified as Chronic Category 1, then there is no need for chronic classification.

(c)L(E)C50(s) of the tested mixture > 100 mg/l, or above the water solubility, and NOEC of the tested mixture ≤ 1 mg/l or unknown:

No need to classify for acute hazard

Apply summation method (see 4.1.3.5.5) for Chronic classification (Chronic Category 4 or no need for chronic classification).

(d)L(E)C50(s) of the tested mixture > 100 mg/l, or above the water solubility, and NOEC(s) of the tested mixture > 1 mg/l:

No need to classify for acute or chronic (long-term) hazard.

4.1.3.4.   Classification of mixtures when data are not available for the complete mixture: Bridging principles

4.1.3.4.1.Where the mixture itself has not been tested to determine its aquatic environmental hazard, but there are sufficient data on the individual components and similar tested mixtures to adequately characterise the hazards of the mixture, this data shall be used in accordance with the bridging rules set out in section 1.1.3. However, in relation to application of the bridging rule for dilution, paragraphs 4.1.3.4.2 and 4.1.3.4.3 shall be used.

4.1.3.4.2.Dilution: if a mixture is formed by diluting another mixture or a substance classified for its aquatic environmental hazard with a diluent which has an equivalent or lower aquatic hazard classification than the least toxic original component and which is not expected to affect the aquatic hazards of other components, then the mixture may be classified as equivalent to the original mixture or substance.

4.1.3.4.3.If a mixture is formed by diluting another classified mixture or substance with water or other totally non-toxic material, the toxicity of the mixture can be calculated from the original mixture or substance

4.1.3.5.   Classification of mixtures when data are available for all components or only for some components of the mixture

4.1.3.5.1.The classification of a mixture is based on summation of the classification of its components. The percentage of components classified as ‘Acute’ or ‘Chronic’ is fed straight in to the summation method. Details of the summation method are described in 4.1.3.5.5.

4.1.3.5.2.When a mixture consists of components that are not (yet) classified (as Acute Category 1 and/or Chronic Category 1, 2, 3 or 4) adequate data for these components shall be taken into account when available. When adequate toxicity data are available for more than one component in the mixture, the combined toxicity of those components is calculated using the following additivity formula, and the calculated toxicity is used to assign that portion of the mixture an acute category which is then subsequently used in applying the summation method.



where:

Ci=concentration of component i (weight percentage)
L(E)C50 i=(mg/l) LC50 or EC50 for component i
η=number of components
L(E)C50 m=L(E) C50 of the part of the mixture with test data

4.1.3.5.3.When applying the additivity formula for part of the mixture, it is preferable to calculate the toxicity of this part of the mixture using for each substance toxicity values that relate to the same taxonomic group (i.e. fish, daphnia, algae or equivalent) and then to use the highest toxicity (lowest value) obtained (i.e. use the most sensitive of the three taxonomic groups). However, when toxicity data for each component are not available in the same taxonomic group, the toxicity value of each component is selected in the same manner that toxicity values are selected for the classification of substances, i.e. the higher toxicity (from the most sensitive test organism) is used. The calculated acute toxicity is then used to assess whether this part of the mixture shall be classified as Acute Category 1 using the same criteria described for substances.

4.1.3.5.4.If a mixture is classified in more than one way, the method yielding the more conservative result shall be used.

4.1.3.5.5.   Summation method

4.1.3.5.5.1.   Rationale

4.1.3.5.5.1.1.In case of the substance classification categories Acute Category 1 or Chronic Category 1 to Chronic Category 3, the underlying toxicity criteria differ by a factor of 10 in moving from one category to another. Substances with a classification in a high toxicity band therefore contribute to the classification of a mixture in a lower band. The calculation of these classification categories therefore needs to consider the contribution of all substances classified as Acute Category 1/Chronic Category 1, Chronic Category 2 and Chronic Category 3 together.

4.1.3.5.5.1.2.When a mixture contains components classified as Acute Category 1 or Chronic Category 1, attention must be paid to the fact that such components, when their acute toxicity is below 1 mg/l contribute to the toxicity of the mixture even at a low concentration. Active ingredients in pesticides often possess such high aquatic toxicity but also some other substances like organometallic compounds. Under these circumstances the application of the normal generic concentration limits leads to an ‘under-classification’ of the mixture. Therefore, multiplying factors shall be applied to account for highly toxic components, as described in paragraph 4.1.3.5.5.5.

4.1.3.5.5.2.   Classification procedure

4.1.3.5.5.2.1.In general a more severe classification for mixtures overrides a less severe classification, e.g. a classification for chronic toxicity with Chronic Category 1 overrides a classification with Chronic Category 2. As a consequence, in this example, the classification procedure is already completed if the result of the classification is Chronic Category 1. A more severe classification than Chronic Category 1 is not possible. Therefore it is not necessary to undergo the further classification procedure.

4.1.3.5.5.3.   Classification for Acute Category 1

4.1.3.5.5.3.1.First all components classified as Acute Category 1 are considered. If the sum of these components is greater than 25 % the whole mixture is classified as Acute Category 1.

4.1.3.5.5.3.2.The classification of mixtures for acute hazards based on this summation of classified components, is summarised in Table 4.1.1.

Table 4.1.1

Classification of a mixture for acute hazards, based on summation of classified components

Sum of components classified as:Mixture is classified as:
Acute Category 1 × M (18) ≥ 25 %Acute Category 1

4.1.3.5.5.4.   Classification for the Chronic Categories 1, 2, 3 and 4

4.1.3.5.5.4.1.First all components classified as Chronic Category 1 are considered. If the sum of these components multiplied by their corresponding M-factors is equal to or greater than 25 % the mixture is classified as Chronic Category 1. If the result of the calculation is a classification of the mixture as Chronic Category 1 the classification procedure is completed.

4.1.3.5.5.4.2.In cases where the mixture is not classified as Chronic Category 1, classification of the mixture as Chronic Category 2 is considered. A mixture is classified as Chronic Category 2 if 10 times the sum of all components classified as Chronic Category 1 multiplied by their corresponding M-factors plus the sum of all components classified as Chronic Category 2 is equal to or greater than 25 %. If the result of the calculation is classification of the mixture as Chronic Category 2, the classification process is completed.

4.1.3.5.5.4.3.In cases where the mixture is not classified either as Chronic Category 1 or Chronic Category 2, classification of the mixture as Chronic Category 3 is considered. A mixture is classified as Chronic Category 3 if 100 times the sum of all components classified as Chronic Category 1 multiplied by their corresponding M-factors plus 10 times the sum of all components classified with Chronic Category 2 plus the sum of all components classified as Chronic Category 3 is ≥ 25 %.

4.1.3.5.5.4.4.If the mixture is still not classified in Chronic Category 1, 2 or 3, classification of the mixture as Chronic Category 4 shall be considered. A mixture is classified as Chronic Category 4 if the sum of the percentages of components classified as Chronic Category 1, 2, 3 and 4 is equal to or greater than 25 %.

4.1.3.5.5.4.5.The classification of mixtures for chronic (long term) hazards, based on this summation of classified components, is summarised in Table 4.1.2.

Table 4.1.2

Classification of a mixture for chronic (long term) hazards, based on summation of classified components

Sum of components classified as:Mixture is classified as:
Chronic Category 1 × M (19) ≥ 25 %Chronic Category 1
(M × 10 × Chronic Category 1) + Chronic Category 2 ≥ 25 %Chronic Category 2
(M × 100 × Chronic Category 1) + (10 × Chronic Category 2) + Chronic Category 3 ≥ 25 %Chronic Category 3
Chronic Category 1 + Chronic Category 2 + Chronic Category 3 + Chronic Category 4 ≥ 25 %Chronic Category 4

4.1.3.5.5.5.   Mixtures with highly toxic components

4.1.3.5.5.5.1.Acute Category 1 and Chronic Category 1 components with toxicities below 1 mg/l contribute to the toxicity of the mixture even at a low concentration and shall normally be given increased weight in applying the summation of classification approach. When a mixture contains components classified as Acute or Chronic Category 1, one of the following shall be applied:

The tiered approach described in 4.1.3.5.5.3 and 4.1.3.5.5.4 using a weighted sum by multiplying the concentrations of Acute Category 1 and Chronic Category 1 components by a factor, instead of merely adding up the percentages. This means that the concentration of ‘Acute Category 1’ in the left column of Table 4.1.1 and the concentration of ‘Chronic Category 1’ in the left column of Table 4.1.2 are multiplied by the appropriate multiplying factor. The multiplying factors to be applied to these components are defined using the toxicity value, as summarised in Table 4.1.3. Therefore, in order to classify a mixture containing Acute/Chronic Category 1 components, the classifier needs to be informed of the value of the M-factor in order to apply the summation method;

The additivity formula (see 4.1.3.5.2) provided that toxicity data are available for all highly toxic components in the mixture and there is convincing evidence that all other components, including those for which specific acute toxicity data are not available, are of low or no toxicity and do not significantly contribute to the environmental hazard of the mixture.

Table 4.1.3

Multiplying factors for highly toxic components of mixtures

L(E)C50 valueMultiplying factor (M)
0,1 < L(E) C50 ≤ 11
0,01 < L(E) C50 ≤ 0,110
0,001 < L(E) C50 ≤ 0,01100
0,0001 < L(E) C50 ≤ 0,0011 000
0,00001 < L(E) C50 ≤ 0,000110 000
(continue in factor 10 intervals)

4.1.3.6.   Classification of mixtures with components without any useable information

4.1.3.6.1.In the event that no useable information on acute and/or chronic (long term) aquatic hazard is available for one or more relevant components, it is concluded that the mixture cannot be attributed to one or more definitive hazard category(ies). In this situation the mixture shall be classified based on the known components only, with the additional statement in the SDS that: ‘Contains x % of components with unknown hazards to the aquatic environment’.

4.1.4.   Hazard Communication

4.1.4.1.Label elements shall be used for substances or mixtures meeting the criteria for classification in this hazard class in accordance with Table 4.1.4.

Table 4.1.4

Label elements for hazardous to the aquatic environment

ACUTE
Category 1
GHS Pictogram
Signal WordWarning
Hazard StatementH400: Very toxic to aquatic life
Precautionary Statement PreventionP273
Precautionary Statement ResponseP391
Precautionary Statement Storage
Precautionary Statement DisposalP501

CHRONIC
Category 1Category 2Category 3Category 4
GHS PictogramsNo pictogram is usedNo pictogram is used
Signal WordWarningNo signal word is usedNo signal word is usedNo signal word is used
Hazard StatementH410: Very toxic to aquatic life with long lasting effectsH411: Toxic to aquatic life with long lasting effectsH412: Harmful to aquatic life with long lasting effectsH413: May cause long lasting harmful effects to aquatic life
Precautionary Statement PreventionP273P273P273P273
Precautionary Statement ResponseP391P391
Precautionary Statement Storage
Precautionary Statement DisposalP501P501P501P501

5. PART 5: ADDITIONAL EU HAZARD CLASS

5.1.   Hazardous to the ozone layer

5.1.1.   Definitions and general considerations

5.1.1.1.Substance Hazardous to the Ozone Layer means a substance which, on the basis of the available evidence concerning its properties and its predicted or observed environmental fate and behaviour may present a danger to the structure and/or the functioning of the stratospheric ozone layer. This includes substances which are listed in Annex I to Regulation (EC) No 2037/2000 of the European Parliament and of the Council of 29 June 2000 on substances that deplete the ozone layer (20) and its subsequent amendments.

5.1.2.   Classification criteria for substances

5.1.2.1.A substance shall be classified as Hazardous to the Ozone Layer if the available evidence concerning its properties and its predicted or observed environmental fate and behaviour indicate that it may present a danger to the structure and/or the functioning of the stratospheric ozone layer.

5.1.3.   Classification criteria for mixtures

5.1.3.1.Mixtures shall be classified as Hazardous to the Ozone Layer on the basis of the individual concentration of the substance(s) contained therein that are also classified as Hazardous to the Ozone Layer, in accordance with Table 5.1.

Table 5.1

Generic concentration limits for substances (in a mixture), classified as Hazardous to the Ozone Layer, that trigger classification of the mixture as Hazardous to the Ozone Layer

Classification of the substanceClassification of the mixture
Hazardous to the ozone layerC > 0,1 %

5.1.4.   Hazard Communication

5.1.4.1.Label elements shall be used for substances or mixtures meeting the criteria for classification in this hazard class in accordance with Table 5.2

Table 5.2

Label elements for Hazardous to the Ozone Layer

Symbol/pictogram
Signal WordDanger
Hazard StatementEUH059: Hazardous to the Ozone Layer
Precautionary StatementsP273

P501



(1) Or < 1 % where relevant, see 3.2.3.3.1.

(2) Or < 1 % where relevant, see 3.3.3.3.1.

(3) Or < 0,1 % where relevant, see 4.1.3.1.

(4) This comprises substances, mixtures and articles which are manufactured with a view to producing a practical, explosive or pyrotechnic effect.

(5) For the purpose of this Regulation gas oils, diesel and light heating oils having a flash point between ≥ 55 oC and ≤ 75 oC may be regarded as Category 3.

(6) To date, the calculation method has been validated for mixtures containing up to 6 volatile components. These components may be flammable liquids like hydrocarbons, ethers, alcohols, esters (except acrylates), and water. It is however not yet validated for mixtures containing halogenated sulphurous, and/or phosphoric compounds as well as reactive acrylates.

(7) If the calculated flash point is less than 5 oC greater than the relevant classification criterion, the calculation method may not be used and the flash point should be determined experimentally.

(8) See UN Recommendations on the Transport of Dangerous Goods, Manual of Tests and Criteria, sub-sections 28.1, 28.2, 28.3 and Table 28.3.

(9) See UN Recommendations on the Transport of Dangerous Goods, Manual of Tests and Criteria, sub-sections 28.1, 28.2, 28.3 and Table 28.3.

(10) As determined by test series E as prescribed in UN Recommendations on the Transport of Dangerous Goods, Manual of Tests and Criteria, Part II.

(11) Gas concentrations are expressed in parts per million per volume (ppmV).

(12) For ingredients with acute toxicity estimates available for other than the most appropriate exposure route, values may be extrapolated from the available exposure route(s) to the most appropriate route. Dermal and inhalation route data are not always required for ingredients. However, in case data requirements for specific ingredients include acute toxicity estimates for the dermal and inhalation route, the values to be used in the formula need to be from the required exposure route.

(13) At present recognised animal models for the testing of respiratory hypersensitivity are not available.

(14) The mechanisms by which substances induce symptoms of asthma are not yet fully known. For preventative measures, these substances are considered respiratory sensitisers. However, if on the basis of the evidence, it can be demonstrated that these substances induce symptoms of asthma by irritation only in people with bronchial hyper reactivity, they should not be considered as respiratory sensitisers.

(15) Note: See 3.6.2.2.4.

(16) It is recognised that the Mating index and the Fertility index can also be affected by the male.

(17) Specific guidance will be provided by the Agency on how these data for such substances may be used in meeting the requirements of the classification criteria.

(18) For explanation of the M-factor, see 4.1.3.5.5.5.

(19) For explanation of the M-factor, see 4.1.3.5.5.5.

(20) OJ L 244, 29.9.2000, p. 1.



ANNEX II

SPECIAL RULES FOR LABELLING AND PACKAGING OF CERTAIN SUBSTANCES AND MIXTURES

This Annex consists of 5 parts:

Part 1 contains special rules for the labelling of certain classified substances and mixtures.

Part 2 sets out rules for additional hazard statements to be included on the label of certain mixtures.

Part 3 sets out special rules for packaging.

Part 4 sets out a special rule for the labelling of plant protection products.

Part 5 sets up a list of hazardous substances and mixtures to which Article 29(3) applies.

1. PART 1: SUPPLEMENTAL HAZARD INFORMATION

The statements set out in sections 1.1 and 1.2 shall be assigned in accordance with Article 25(1) to substances and mixtures classified for physical, health or environmental hazards.

1.1.   Physical properties

1.1.1.   EUH001 — ‘Explosive when dry’

For explosive substances and mixtures as referred to in section 2.1 of Annex I, placed on the market wetted with water or alcohols or diluted with other substances to suppress their explosive properties.

1.1.2.   EUH006 — ‘Explosive with or without contact with air’

For substances and mixtures which are unstable at ambient temperatures, such as acetylene.

1.1.3.   EUH014 — ‘Reacts violently with water’

For substances and mixtures which react violently with water, such as acetyl chloride, alkali metals, titanium tetrachloride.

1.1.4.   EUH018 — ‘In use, may form flammable/explosive vapour-air mixture’

For substances and mixtures not classified as flammable themselves, which may form flammable/explosive vapour-air mixtures. For substances this might be the case for halogenated hydrocarbons and for mixtures this might be the case due to a volatile flammable component or due to the loss of a volatile non-flammable component.

1.1.5.   EUH019 — ‘May form explosive peroxides’

For substances and mixtures which may form explosive peroxides during storage, such as diethyl ether, 1,4-dioxane.

1.1.6.   EUH044 — ‘Risk of explosion if heated under confinement’

For substances and mixtures not in themselves classified as explosive in accordance with section 2.1 of Annex I, but which may nevertheless display explosive properties in practice if heated under sufficient confinement. In particular, substances which decompose explosively if heated in a steel drum do not show this effect if heated in less-strong containers.

1.2.   Health properties

1.2.1.   EUH029 — ‘Contact with water liberates toxic gas’

For substances and mixtures which in contact with water or damp air, evolve gases classified for acute toxicity in category 1, 2 or 3 in potentially dangerous amounts, such as aluminium phosphide, phosphorus pentasulphide.

1.2.2.   EUH031 — ‘Contact with acids liberates toxic gas’

For substances and mixtures which react with acids to evolve gases classified for acute toxicity in category 3 in dangerous amounts, such as sodium hypochlorite, barium polysulphide.

1.2.3.   EUH032 — ‘Contact with acids liberates very toxic gas’

For substances and mixtures which react with acids to evolve gases classified for acute toxicity in category 1 or 2 in dangerous amounts, such as salts of hydrogen cyanide, sodium azide.

1.2.4.   EUH066 — ‘Repeated exposure may cause skin dryness or cracking’

For substances and mixtures which may cause concern as a result of skin dryness, flaking or cracking but which do not meet the criteria for skin irritancy in section 3.2 of Annex I, based on either:

practical observations; or

relevant evidence concerning their predicted effects on the skin.

1.2.5.   EUH070 — ‘Toxic by eye contact’

For substances or mixtures where an eye irritation test has resulted in overt signs of systemic toxicity or mortality among the animals tested, which is likely to be attributed to absorption of the substance or mixture through the mucous membranes of the eye. The statement shall also be applied if there is evidence in humans for systemic toxicity after eye contact.

The statement shall also be applied where a substance or a mixture contains another substance labelled for this effect, if the concentration of this substance is equal to, or greater than 0,1 %, unless otherwise specified in part 3 of Annex VI.

1.2.6.   EUH071 — ‘Corrosive to the respiratory tract’

For substances and mixtures in addition to classification for inhalation toxicity, if data are available that indicate that the mechanism of toxicity is corrosivity, in accordance with section 3.1.2.3.3 and Note 1 of Table 3.1.3 in Annex I.

For substances and mixtures in addition to classification for skin corrosivity, if no acute inhalation test data are available and which may be inhaled.

2. PART 2: SPECIAL RULES FOR SUPPLEMENTAL LABEL ELEMENTS FOR CERTAIN MIXTURES

The statements set out in sections 2.1 to 2.10 shall be assigned to mixtures in accordance with Article 25(6).

2.1.   Mixtures containing lead

The label on the packaging of paints and varnishes containing lead in quantities exceeding 0,15 % (expressed as weight of metal) of the total weight of the mixture, as determined in accordance with ISO standard 6503, shall bear the following statement:

EUH201 — ‘Contains lead. Should not be used on surfaces liable to be chewed or sucked by children’

In the case of packages the contents of which are less than 125 ml, the statement may be as follows:

EUH201A — ‘Warning! Contains lead’

2.2.   Mixtures containing cyanoacrylates

The label on the immediate packaging of adhesives based on cyanoacrylate shall bear the following statement:

EUH202 — ‘Cyanoacrylate. Danger. Bonds skin and eyes in seconds. Keep out of the reach of children’

Appropriate advice on safety shall accompany the package.

2.3.   Cements and cement mixtures

Unless cements or cement mixtures are already classified and labelled as a sensitiser with the hazard statement H317, ‘May cause an allergic skin reaction’, the label on the packaging of cements and cement mixtures that contain, when they are hydrated, more than 0,0002 % soluble chromium (VI) of the total dry weight of the cement shall bear the statement:

EUH203 — ‘Contains chromium (VI). May produce an allergic reaction’

If reducing agents are used, then the packaging of cement or cement-containing mixtures shall include information on the packing date, the storage conditions and the storage period appropriate to maintaining the activity of the reducing agent and to keeping the content of soluble chromium VI below 0,0002 %.

2.4.   Mixtures containing isocyanates

Unless already identified on the label of the packaging, mixtures containing isocyanates (as monomers, oligomers, prepolymers, etc., or as mixtures thereof) shall bear the following statement:

EUH204 — ‘Contains isocyanates. May produce an allergic reaction.’

2.5.   Mixtures containing epoxy constituents with an average molecular weight ≤ 700

Unless already identified on the label of the packaging, mixtures containing epoxy constituents with an average molecular weight ≤ 700 shall bear the following statement:

EUH205 — ‘Contains epoxy constituents. May produce an allergic reaction.’

2.6.   Mixtures sold to the general public which contain active chlorine

The label on the packaging of mixtures containing more than 1 % of active chlorine shall bear the following statement:

EUH206 — ‘Warning! Do not use together with other products. May release dangerous gases (chlorine)’

2.7.   Mixtures containing cadmium (alloys) and intended to be used for brazing or soldering

The label on the packaging of the above mentioned mixtures shall bear the following statement:

EUH207 — ‘Warning! Contains cadmium. Dangerous fumes are formed during use. See information supplied by the manufacturer. Comply with the safety instructions’

2.8.   Mixtures not classified as sensitising but containing at least one sensitising substance

The label on the packaging of mixtures containing at least one substance classified as sensitising and present in a concentration equal to or greater than 0,1 % or in a concentration equal to or greater than that specified under a specific note for the substance in part 3 of Annex VI shall bear the statement:

EUH208 — ‘Contains (name of sensitising substance). May produce an allergic reaction’

2.9.   Liquid mixtures containing halogenated hydrocarbons

For liquid mixtures which show no flashpoint or a flashpoint higher than 60 oC but not more than 93 oC and contain a halogenated hydrocarbon and more than 5 % highly flammable or flammable substances, the label on the packaging shall bear one of the following statements, depending on whether the substances referred to above are highly flammable or flammable:

EUH209 — ‘Can become highly flammable in use’ or

EUH209A — ‘Can become flammable in use’

2.10.   Mixtures not intended for the general public

For mixtures not classified as hazardous but which contain:

≥ 0,1 % of a substance classified as skin sensitiser category 1, respiratory sensitiser category 1, or carcinogenic category 2; or

≥ 0,1 % of a substance classified as toxic to reproduction categories 1A, 1B or 2, or with effects on or via lactation; or

at least one substance in an individual concentration of ≥ 1 % by weight for non-gaseous mixtures and ≥ 0,2 % by volume for gaseous mixtures either:

classified with other health or environmental hazards; or

for which there are Community workplace exposure limits

the label on the packaging shall bear the statement:

EUH210 — ‘Safety data sheet available on request’.

2.11   Aerosols

Note that aerosols are also subject to the labelling provisions in accordance with points 2.2 and 2.3 in the Annex to Directive 75/324/EEC.

3. PART 3: SPECIAL RULES ON PACKAGING

3.1.   Provisions relating to child-resistant fastenings

3.1.1.   Packaging to be fitted with child-resistant fastenings

3.1.1.1.Packaging of whatever capacity containing a substance or mixture supplied to the general public and classified for acute toxicity, categories 1 to 3, STOT — single exposure category 1, STOT — repeated exposure category 1, or skin corrosion category 1 shall be fitted with child-resistant fastenings.

3.1.1.2.Packaging of whatever capacity containing a substance or mixture supplied to the general public presenting an aspiration hazard and classified according to sections 3.10.2 and 3.10.3 of Annex I and labelled according to section 3.10.4.1 of Annex I, with the exception of substances and mixtures placed on the market in the form of aerosols or in a container fitted with a sealed spray attachment, shall be fitted with child-resistant fastenings.

3.1.1.3Where a substances or mixture has at least one of the substances mentioned below present in a concentration equal to or greater than the maximum individual concentrations specified, which are supplied to the general public, the packaging of whatever capacity shall be fitted with child-resistant fastenings.

NoIdentification of the substanceConcentration limit
CAS NoNameEC No
167-56-1methanol200-659-6≥ 3 %
275-09-2dichloromethane200-838-9≥ 1 %

3.1.2   Reclosable packages

Child-resistant fastenings used on reclosable packages shall comply with EN ISO standard 8317 as amended relating to ‘Child-resistant packages — Requirements and methods of testing for reclosable packages’ adopted by the European Committee for standardisation (CEN) and the International Standard Organisation (ISO).

3.1.3   Non-reclosable packages

Child-resistant fastenings used on non-reclosable packages shall comply with CEN standard EN 862 as amended relating to ‘Packaging — Child-resistant packaging — Requirements and testing procedures for non-reclosable packages for non-pharmaceutical products’ adopted by the European Committee for Standardisation (CEN).

3.1.4   Notes

3.1.4.1.Evidence of conformity with the above standards may be certified only by laboratories which conform with Standard EN ISO/IEC 17025 as amended.

3.1.4.2.   Specific cases

If it seems obvious that packaging is sufficiently safe for children because they cannot get access to the contents without the help of a tool, the test referred to in section 3.1.2 or 3.1.3 does not need to be performed.

In all other cases and when there are sufficient grounds for doubting the security of the closure for a child, the national authority may ask the person responsible for putting the product on the market to give it a certificate from a certifying laboratory, referred to in section 3.1.4.1, stating that either:

the type of closure is such that it is not necessary to perform the test referred to in section 3.1.2. or 3.1.3; or

the closure has been tested and has been found to conform with the standards referred to above.

3.2.   Tactile warnings

3.2.1.   Packaging to be fitted with a tactile warning

Where substances or mixtures are supplied to the general public and classified for acute toxicity, skin corrosion, germ cell mutagenicity category 2, carcinogenicity category 2, reproductive toxicity category 2, respiratory sensitisation, or Stot, categories 1 and 2, aspiration hazard, or flammable gases, liquids and solids in categories 1 and 2, the packaging of whatever capacity, shall be fitted with a tactile warning of danger.

3.2.2   Provisions relating to tactile warning

3.2.2.1This provision does not apply to aerosols which are only classified and labelled as ‘extremely flammable aerosols’ or ‘flammable aerosols’.

3.2.2.2.The technical specifications for tactile warning devices shall conform to EN ISO standard 11683 as amended ‘Packaging — Tactile warnings of danger-Requirements’.

4. PART 4: SPECIAL RULE FOR LABELLING OF PLANT PROTECTION PRODUCTS

Without prejudice to the information required in accordance with Article 16 of Directive 91/414/EEC and Annex V of that Directive, the labelling for plant protection products subject to Directive 91/414/EEC shall also include the following wording:

EUH401 — ‘To avoid risks to human health and the environment, comply with the instructions for use’

5. PART 5: LIST OF HAZARDOUS SUBSTANCES AND MIXTURES TO WHICH ARTICLE 29(3) APPLIES

Ready mixed cement and concrete in the wet state.



ANNEX III

LIST OF HAZARD STATEMENTS, SUPPLEMENTAL HAZARD INFORMATION AND SUPPLEMENTAL LABEL ELEMENTS

1. Part 1: hazard statements

The hazard statements shall be applied in accordance with Parts 2, 3 and 4 of Annex I.

Table 1.1

Hazard statements for physical hazards

H200 (1)Language
2.1 —Explosives, Unstable explosives
BGНестабилен експлозив.
ESExplosivo inestable.
CSNestabilní výbušnina.
DAUstabilt eksplosiv.
DEInstabil, explosiv.
ETEbapüsiv lõhkeaine.
ELΑσταθή εκρηκτικά.
ENUnstable explosives.
FRExplosif instable.
GAPléascáin éagobhsaí.
ITEsplosivo instabile.
LVNestabili sprādzienbīstami materiāli.
LTNestabilios sprogios medžiagos.
HUInstabil robbanóanyagok.
MTSplussivi instabbli.
NLInstabiele ontplofbare stof.
PLMateriały wybuchowe niestabilne.
PTExplosivo instável.
ROExploziv instabil.
SKNestabilné výbušniny.
SLNestabilni eksplozivi.
FIEpästabiili räjähde.
SVInstabilt explosivt.

H201Language
2.1 —Explosives, Division 1.1
BGЕксплозив; опасност от масова експлозия.
ESExplosivo; peligro de explosión en masa.
CSVýbušnina; nebezpečí masivního výbuchu.
DAEksplosiv, masseeksplosionsfare.
DEExplosiv, Gefahr der Massenexplosion.
ETPlahvatusohtlik; massiplahvatusoht.
ELΕκρηκτικό· κίνδυνος μαζικής έκρηξης.
ENExplosive; mass explosion hazard.
FRExplosif; danger d'explosion en masse.
GAPléascach; guais mhórphléasctha.
ITEsplosivo; pericolo di esplosione di massa.
LVSprādzienbīstams; masveida sprādzienbīstamība.
LTSprogios medžiagos, kelia masinio sprogimo pavojų.
HURobbanóanyag; teljes tömeg felrobbanásának veszélye.
MTSplussiv; periklu li jisplodu kollha f'daqqa.
NLOntplofbare stof; gevaar voor massa-explosie.
PLMateriał wybuchowy; zagrożenie wybuchem masowym.
PTExplosivo; perigo de explosão em massa.
ROExploziv; pericol de explozie în masă.
SKVýbušnina, nebezpečenstvo rozsiahleho výbuchu.
SLEksplozivno; nevarnost eksplozije v masi.
FIRäjähde; massaräjähdysvaara.
SVExplosivt. Fara för massexplosion.

H202Language
2.1 —Explosives, Division 1.2
BGЕксплозив; сериозна опасност от разпръскване.
ESExplosivo; grave peligro de proyección.
CSVýbušnina; vážné nebezpečí zasažení částicemi.
DAEksplosiv, alvorlig fare for udslyngning af fragmenter.
DEExplosiv; große Gefahr durch Splitter, Spreng- und Wurfstücke.
ETPlahvatusohtlik; suur laialipaiskumisoht.
ELΕκρηκτικό· σοβαρός κίνδυνος εκτόξευσης.
ENExplosive, severe projection hazard.
FRExplosif; danger sérieux de projection.
GAPléascach, guais throm teilgin.
ITEsplosivo; grave pericolo di proiezione.
LVSprādzienbīstams; augsta izmetes bīstamība.
LTSprogios medžiagos, kelia didelį išsvaidymo pavojų.
HURobbanóanyag; kivetés súlyos veszélye.
MTSplussiv, periklu serju ta' projezzjoni.
NLOntplofbare stof, ernstig gevaar voor scherfwerking.
PLMateriał wybuchowy, poważne zagrożenie rozrzutem.
PTExplosivo, perigo grave de projecções.
ROExploziv; pericol grav de proiectare.
SKVýbušnina, závažné nebezpečenstvo rozletenia úlomkov.
SLEksplozivno, velika nevarnost za nastanek drobcev.
FIRäjähde; vakava sirpalevaara.
SVExplosivt. Allvarlig fara för splitter och kaststycken.

H203Language
2.1 —Explosives, Division 1.3
BGЕксплозив; опасност от пожар, взрив или разпръскване.
ESExplosivo; peligro de incendio, de onda expansiva o de proyección.
CSVýbušnina; nebezpečí požáru, tlakové vlny nebo zasažení částicemi.
DAEksplosiv, fare for brand, eksplosion eller udslyngning af fragmenter.
DEExplosiv; Gefahr durch Feuer, Luftdruck oder Splitter, Spreng- und Wurfstücke.
ETPlahvatusohtlik; süttimis-, plahvatus- või laialipaiskumisoht.
ELΕκρηκτικό· κίνδυνος πυρκαγιάς, ανατίναξης ή εκτόξευσης.
ENExplosive; fire, blast or projection hazard.
FRExplosif; danger d'incendie, d'effet de souffle ou de projection.
GAPléascach; guais dóiteáin, phléasctha nó teilgin.
ITEsplosivo; pericolo di incendio, di spostamento d'aria o di proiezione.
LVSprādzienbīstams; uguns, triecienviļņa vai izmetes bīstamība.
LTSprogios medžiagos, kelia gaisro, sprogimo arba išsvaidymo pavojų.
HURobbanóanyag; tűz, robbanás vagy kivetés veszélye.
MTSplussiv; periklu ta' nar, blast jew projezzjoni.
NLOntplofbare stof; gevaar voor brand, luchtdrukwerking of scherfwerking.
PLMateriał wybuchowy; zagrożenie pożarem, wybuchem lub rozrzutem.
PTExplosivo; perigo de incêndio, sopro ou projecções.
ROExploziv; pericol de incendiu, detonare sau proiectare.
SKVýbušnina, nebezpečenstvo požiaru, výbuchu alebo rozletenia úlomkov.
SLEksplozivno; nevarnost za nastanek požara, udarnega vala ali drobcev.
FIRäjähde; palo-, räjähdys- tai sirpalevaara.
SVExplosivt. Fara för brand, tryckvåg eller splitter och kaststycken.

H204Language
2.1 —Explosives, Division 1.4
BGОпасност от пожар или разпръскване.
ESPeligro de incendio o de proyección.
CSNebezpečí požáru nebo zasažení částicemi.
DAFare for brand eller udslyngning af fragmenter.
DEGefahr durch Feuer oder Splitter, Spreng- und Wurfstücke.
ETSüttimis- või laialipaiskumisoht.
ELΚίνδυνος πυρκαγιάς ή εκτόξευσης.
ENFire or projection hazard.
FRDanger d'incendie ou de projection.
GAGuais dóiteáin nó teilgin.
ITPericolo di incendio o di proiezione.
LVUguns vai izmetes bīstamība.
LTGaisro arba išsvaidymo pavojus.
HUTűz vagy kivetés veszélye.
MTPeriklu ta' nar jew ta' projezzjoni.
NLGevaar voor brand of scherfwerking.
PLZagrożenie pożarem lub rozrzutem.
PTPerigo de incêndio ou projecções.
ROPericol de incendiu sau de proiectare.
SKNebezpečenstvo požiaru alebo rozletenia úlomkov.
SLNevarnost za nastanek požara ali drobcev.
FIPalo- tai sirpalevaara.
SVFara för brand eller splitter och kaststycken.

H205Language
2.1 —Explosives, Division 1.5
BGМоже да предизвика масова експлозия при пожар.
ESPeligro de explosión en masa en caso de incendio.
CSPři požáru může způsobit masivní výbuch.
DAFare for masseeksplosion ved brand.
DEGefahr der Massenexplosion bei Feuer.
ETSüttimise korral massiplahvatusoht.
ELΚίνδυνος μαζικής έκρηξης σε περίπτωση πυρκαγιάς.
ENMay mass explode in fire.
FRDanger d'explosion en masse en cas d'incendie.
GAD'fhéadfadh sé go mbeadh mórphléascadh i dtine.
ITPericolo di esplosione di massa in caso d'incendio.
LVUgunī var masveidā eksplodēt.
LTPer gaisrą gali sukelti masinį sprogimą.
HUTűz hatására a teljes tömeg felrobbanhat.
MTJista' jisplodi f'daqqa fin-nar.
NLGevaar voor massa-explosie bij brand.
PLMoże wybuchać masowo w przypadku pożaru.
PTPerigo de explosão em massa em caso de incêndio.
ROPericol de explozie în masă în caz de incendiu.
SKNebezpečenstvo rozsiahleho výbuchu pri požiari.
SLPri požaru lahko eksplodira v masi.
FIKoko massa voi räjähtää tulessa.
SVFara för massexplosion vid brand.

H220Language
2.2 —Flammable gases, Hazard Category 1
BGИзключително запалим газ.
ESGas extremadamente inflamable.
CSExtrémně hořlavý plyn.
DAYderst brandfarlig gas.
DEExtrem entzündbares Gas.
ETEriti tuleohtlik gaas.
ELΕξαιρετικά εύφλεκτο αέριο.
ENExtremely flammable gas.
FRGaz extrêmement inflammable.
GAGás fíor-inadhainte.
ITGas altamente infiammabile.
LVĪpaši viegli uzliesmojoša gāze.
LTYpač degios dujos.
HURendkívül tűzveszélyes gáz.
MTGass li jaqbad malajr ħafna.
NLZeer licht ontvlambaar gas.
PLSkrajnie łatwopalny gaz.
PTGás extremamente inflamável.
ROGaz extrem de inflamabil.
SKMimoriadne horľavý plyn.
SLZelo lahko vnetljiv plin.
FIErittäin helposti syttyvä kaasu.
SVExtremt brandfarlig gas.

H221Language
2.2 —Flammable gases, Hazard Category 2
BGЗапалим газ.
ESGas inflamable.
CSHořlavý plyn.
DABrandfarlig gas.
DEEntzündbares Gas.
ETTuleohtlik gaas.
ELΕύφλεκτο αέριο.
ENFlammable gas.
FRGaz inflammable.
GAGás inadhainte.
ITGas infiammabile.
LVUzliesmojoša gāze.
LTDegios dujos.
HUTűzveszélyes gáz.
MTGass li jaqbad.
NLOntvlambaar gas.
PLGaz łatwopalny.
PTGás inflamável.
ROGaz inflamabil.
SKHorľavý plyn.
SLVnetljiv plin.
FISyttyvä kaasu.
SVBrandfarlig gas.

H222Language
2.3 —Flammable aerosols, Hazard Category 1
BGИзключително запалим аерозол.
ESAerosol extremadamente inflamable.
CSExtrémně hořlavý aerosol.
DAYderst brandfarlig aerosol.
DEExtrem entzündbares Aerosol.
ETEriti tuleohtlik aerosool.
ELΕξαιρετικά εύφλεκτο αερόλυμα.
ENExtremely flammable aerosol.
FRAérosol extrêmement inflammable.
GAAerasól fíor-inadhainte.
ITAerosol altamente infiammabile.
LVĪpaši viegli uzliesmojošs aerosols.
LTYpač degus aerozolis.
HURendkívül tűzveszélyes aeroszol.
MTAerosol li jaqbad malajr ħafna.
NLZeer licht ontvlambare aerosol.
PLSkrajnie łatwopalny aerozol.
PTAerossol extremamente inflamável.
ROAerosol extrem de inflamabil.
SKMimoriadne horľavý aerosól.
SLZelo lahko vnetljiv aerosol.
FIErittäin helposti syttyvä aerosoli.
SVExtremt brandfarlig aerosol.

H223Language
2.3 —Flammable aerosols, Hazard Category 2
BGЗапалим аерозол.
ESAerosol inflamable.
CSHořlavý aerosol.
DABrandfarlig aerosol.
DEEntzündbares Aerosol.
ETTuleohtlik aerosool.
ELΕύφλεκτο αερόλυμα.
ENFlammable aerosol.
FRAérosol inflammable.
GAAerasól inadhainte.
ITAerosol infiammabile.
LVUzliesmojošs aerosols.
LTDegus aerozolis.
HUTűzveszélyes aeroszol.
MTAerosol li jaqbad.
NLOntvlambare aerosol.
PLAerozol łatwopalny.
PTAerossol inflamável.
ROAerosol inflamabil.
SKHorľavý aerosól.
SLVnetljiv aerosol.
FISyttyvä aerosoli.
SVBrandfarlig aerosol.

H224Language
2.6 —Flammable liquids, Hazard Category 1
BGИзключително запалими течност и пари.
ESLíquido y vapores extremadamente inflamables.
CSExtrémně hořlavá kapalina a páry.
DAYderst brandfarlig væske og damp.
DEFlüssigkeit und Dampf extrem entzündbar.
ETEriti tuleohtlik vedelik ja aur.
ELΥγρό και ατμοί εξαιρετικά εύφλεκτα.
ENExtremely flammable liquid and vapour.
FRLiquide et vapeurs extrêmement inflammables.
GALeacht fíor-inadhainte agus gal fhíor-inadhainte.
ITLiquido e vapori altamente infiammabili.
LVĪpaši viegli uzliesmojošs šķidrums un tvaiki.
LTYpač degūs skystis ir garai.
HURendkívül tűzveszélyes folyadék és gőz.
MTLikwidu u fwar li jaqbdu malajr ħafna.
NLZeer licht ontvlambare vloeistof en damp.
PLSkrajnie łatwopalna ciecz i pary.
PTLíquido e vapor extremamente inflamáveis.
ROLichid şi vapori extrem de inflamabili.
SKMimoriadne horľavá kvapalina a pary.
SLZelo lahko vnetljiva tekočina in hlapi.
FIErittäin helposti syttyvä neste ja höyry.
SVExtremt brandfarlig vätska och ånga.

H225Language
2.6 —Flammable liquids, Hazard Category 2
BGСилно запалими течност и пари.
ESLíquido y vapores muy inflamables.
CSVysoce hořlavá kapalina a páry.
DAMeget brandfarlig væske og damp.
DEFlüssigkeit und Dampf leicht entzündbar.
ETVäga tuleohtlik vedelik ja aur.
ELΥγρό και ατμοί πολύ εύφλεκτα.
ENHighly flammable liquid and vapour.
FRLiquide et vapeurs très inflammables.
GALeacht an-inadhainte agus gal an-inadhainte.
ITLiquido e vapori facilmente infiammabili.
LVViegli uzliesmojošs šķidrums un tvaiki.
LTLabai degūs skystis ir garai.
HUFokozottan tűzveszélyes folyadék és gőz.
MTLikwidu u fwar li jaqbdu malajr ħafna.
NLLicht ontvlambare vloeistof en damp.
PLWysoce łatwopalna ciecz i pary.
PTLíquido e vapor facilmente inflamáveis.
ROLichid şi vapori foarte inflamabili.
SKVeľmi horľavá kvapalina a pary.
SLLahko vnetljiva tekočina in hlapi.
FIHelposti syttyvä neste ja höyry.
SVMycket brandfarlig vätska och ånga.

H226Language
2.6 —Flammable liquids, Hazard Category 3
BGЗапалими течност и пари.
ESLíquidos y vapores inflamables.
CSHořlavá kapalina a páry.
DABrandfarlig væske og damp.
DEFlüssigkeit und Dampf entzündbar.
ETTuleohtlik vedelik ja aur.
ELΥγρό και ατμοί εύφλεκτα.
ENFlammable liquid and vapour.
FRLiquide et vapeurs inflammables.
GALeacht inadhainte agus gal inadhainte.
ITLiquido e vapori infiammabili.
LVUzliesmojošs šķidrums un tvaiki.
LTDegūs skystis ir garai.
HUTűzveszélyes folyadék és gőz.
MTLikwidu u fwar li jaqbdu.
NLOntvlambare vloeistof en damp.
PLŁatwopalna ciecz i pary.
PTLíquido e vapor inflamáveis.
ROLichid şi vapori inflamabili.
SKHorľavá kvapalina a pary.
SLVnetljiva tekočina in hlapi.
FISyttyvä neste ja höyry.
SVBrandfarlig vätska och ånga.

H228Language
2.7 —Flammable solids, Hazard Category 1, 2
BGЗапалимо твърдо вещество.
ESSólido inflamable.
CSHořlavá tuhá látka.
DABrandfarligt fast stof.
DEEntzündbarer Feststoff.
ETTuleohtlik tahke aine.
ELΕύφλεκτο στερεό.
ENFlammable solid.
FRMatière solide inflammable.
GASolad inadhainte.
ITSolido infiammabile.
LVUzliesmojoša cieta viela.
LTDegi kietoji medžiaga.
HUTűzveszélyes szilárd anyag.
MTSolidu li jaqbad.
NLOntvlambare vaste stof.
PLSubstancja stała łatwopalna.
PTSólido inflamável.
ROSolid inflamabil.
SKHorľavá tuhá látka.
SLVnetljiva trdna snov.
FISyttyvä kiinteä aine.
SVBrandfarligt fast ämne.

H240Language
2.8 —Self-Reactive Substances and Mixtures, Type A

2.1.5 —Organic Peroxides, Type A
BGМоже да предизвика експлозия при нагряване.
ESPeligro de explosión en caso de calentamiento.
CSZahřívání může způsobit výbuch.
DAEksplosionsfare ved opvarmning.
DEErwärmung kann Explosion verursachen.
ETKuumenemisel võib plahvatada.
ELΗ θέρμανση μπορεί να προκαλέσει έκρηξη.
ENHeating may cause an explosion.
FRPeut exploser sous l'effet de la chaleur.
GAD'fhéadfadh téamh a bheith ina chúis le pléascadh.
ITRischio di esplosione per riscaldamento.
LVSakaršana var izraisīt eksploziju.
LTKaitinant gali sprogti.
HUHő hatására robbanhat.
MTIt-tisħin jista' jikkawża splużjoni.
NLOntploffingsgevaar bij verwarming.
PLOgrzanie grozi wybuchem.
PTRisco de explosão sob a acção do calor.
ROPericol de explozie în caz de încălzire.
SKZahrievanie môže spôsobiť výbuch.
SLSegrevanje lahko povzroči eksplozijo.
FIRäjähdysvaarallinen kuumennettaessa.
SVExplosivt vid uppvärmning.

H241Language
2.8 —Self-Reactive Substances and Mixtures, Type B

2.1.5 —Organic Peroxides, Type B
BGМоже да предизвика пожар или експлозия при нагряване.
ESPeligro de incendio o explosión en caso de calentamiento.
CSZahřívání může způsobit požár nebo výbuch.
DABrand- eller eksplosionsfare ved opvarmning.
DEErwärmung kann Brand oder Explosion verursachen.
ETKuumenemisel võib süttida või plahvatada.
ELΗ θέρμανση μπορεί να προκαλέσει πυρκαγιά ή έκρηξη.
ENHeating may cause a fire or explosion.
FRPeut s'enflammer ou exploser sous l'effet de la chaleur.
GAD'fhéadfadh téamh a bheith ina chúis le dóiteán nó le pléascadh.
ITRischio d'incendio o di esplosione per riscaldamento.
LVSakaršana var izraisīt degšanu vai eksploziju.
LTKaitinant gali sukelti gaisrą arba sprogti.
HUHő hatására meggyulladhat vagy robbanhat.
MTIt-tisħin jista' jikkawża nar jew splużjoni.
NLBrand- of ontploffingsgevaar bij verwarming.
PLOgrzanie może spowodować pożar lub wybuch.
PTRisco de explosão ou de incêndio sob a acção do calor.
ROPericol de incendiu sau de explozie în caz de încălzire.
SKZahrievanie môže spôsobiť požiar alebo výbuch.
SLSegrevanje lahko povzroči požar ali eksplozijo.
FIRäjähdys- tai palovaarallinen kuumennettaessa.
SVBrandfarligt eller explosivt vid uppvärmning.

H242Language
2.8 —Self-Reactive Substances and Mixtures, Types C, D, E, F

2.1.5 —Organic Peroxides, Types C, D, E, F
BGМоже да предизвика пожар при нагряване.
ESPeligro de incendio en caso de calentamiento.
CSZahřívání může způsobit požár.
DABrandfare ved opvarmning.
DEErwärmung kann Brand verursachen.
ETKuumenemisel võib süttida.
ELΗ θέρμανση μπορεί να προκαλέσει πυρκαγιά.
ENHeating may cause a fire.
FRPeut s'enflammer sous l'effet de la chaleur.
GAD'fhéadfadh téamh a bheith ina chúis le dóiteán.
ITRischio d'incendio per riscaldamento.
LVSakaršana var izraisīt degšanu.
LTKaitinant gali sukelti gaisrą.
HUHő hatására meggyulladhat.
MTIt-tisħin jista' jikkawża nar.
NLBrandgevaar bij verwarming.
PLOgrzanie może spowodować pożar.
PTRisco de incêndio sob a acção do calor.
ROPericol de incendiu în caz de încălzire.
SKZahrievanie môže spôsobiť požiar.
SLSegrevanje lahko povzroči požar.
FIPalovaarallinen kuumennettaessa.
SVBrandfarligt vid uppvärmning.

H250Language
2.9 —Pyrophoric Liquids, Hazard Category 1

2.10 —Pyorphoric Solids, Hazard Category 1
BGСамозапалва се при контакт с въздух.
ESSe inflama espontáneamente en contacto con el aire.
CSPři styku se vzduchem se samovolně vznítí.
DASelvantænder ved kontakt med luft.
DEEntzündet sich in Berührung mit Luft von selbst.
ETKokkupuutel õhuga süttib iseenesest.
ELΑυταναφλέγεται εάν εκτεθεί στον αέρα.
ENCatches fire spontaneously if exposed to air.
FRS'enflamme spontanément au contact de l'air.
GATéann trí thine go spontáineach má nochtar don aer.
ITSpontaneamente infiammabile all'aria.
LVSpontāni aizdegas saskarē ar gaisu.
LTVeikiami oro savaime užsidega.
HULevegővel érintkezve önmagától meggyullad.
MTJieħu n-nar spontanjament jekk ikun espost għall-arja.
NLVat spontaan vlam bij blootstelling aan lucht.
PLZapala się samorzutnie w przypadku wystawienia na działanie powietrza.
PTRisco de inflamação espontânea em contacto com o ar.
ROSe aprinde spontan, în contact cu aerul.
SKPri kontakte so vzduchuom sa spontánne vznieti.
SLSamodejno se vžge na zraku.
FISyttyy itsestään palamaan joutuessaan kosketuksiin ilman kanssa.
SVSpontanantänder vid kontakt med luft.

H251Language
2.11 —Self-Heating Substances and Mixtures, Hazard Category 1
BGСамонагряващо се: може да се запали.
ESSe calienta espontáneamente; puede inflamarse.
CSSamovolně se zahřívá: může se vznítit.
DASelvopvarmende, kan selvantænde.
DESelbsterhitzungsfähig; kann in Brand geraten.
ETIsekuumenev, võib süttida.
ELΑυτοθερμαίνεται: μπορεί να αναφλεγεί.
ENSelf-heating: may catch fire.
FRMatière auto-échauffante; peut s'enflammer.
GAFéintéamh: d'fhéadfadh sé dul trí thine.
ITAutoriscaldante; può infiammarsi.
LVPašsasilstošs; var aizdegties.
LTSavaime kaistančios, gali užsidegti.
HUÖnmelegedő: meggyulladhat.
MTJisħon waħdu: jista' jieħu n-nar.
NLVatbaar voor zelfverhitting: kan vlam vatten.
PLSubstancja samonagrzewająca się: może się zapalić.
PTSusceptível de auto-aquecimento: risco de inflamação.
ROSe autoîncălzeşte, pericol de aprindere.
SKSamovoľne sa zahrieva; môže sa vznietiť.
SLSamosegrevanje: lahko povzroči požar.
FIItsestään kuumeneva; voi syttyä palamaan.
SVSjälvupphettande. Kan börja brinna.

H252Language
2.11 —Self-Heating Substances and Mixtures, Hazard Category 2
BGСамонагряващо се в големи количества; може да се запали.
ESSe calienta espontáneamente en grandes cantidades; puede inflamarse.
CSVe velkém množství se samovolně zahřívá; může se vznítit.
DASelvopvarmende i store mængder, kan selvantænde.
DEIn großen Mengen selbsterhitzungsfähig; kann in Brand geraten.
ETSuurtes kogustes isekuumenev, võib süttida.
ELΣε μεγάλες ποσότητες αυτοθερμαίνεται: μπορεί να αναφλεγεί.
ENSelf-heating in large quantities; may catch fire.
FRMatière auto-échauffante en grandes quantités; peut s'enflammer.
GAFéintéamh ina mhórchainníochtaí; d'fhéadfadh sé dul trí thine.
ITAutoriscaldante in grandi quantità; può infiammarsi.
LVLielos apjomos pašsasilstošs; var aizdegties.
LTLaikant dideliais kiekiais savaime kaista, gali užsidegti.
HUNagy mennyiségben önmelegedő; meggyulladhat.
MTJisħon waħdu f'kwantitajiet kbar; jista' jieħu n-nar.
NLIn grote hoeveelheden vatbaar voor zelfverhitting; kan vlam vatten.
PLSubstancja samonagrzewająca się w dużych ilościach; może się zapalić.
PTSusceptível de auto-aquecimento em grandes quantidades: risco de inflamação.
ROSe autoîncălzeşte, în cantităţi mari pericol de aprindere.
SKVo veľkých množstvách sa samovoľne zahrieva; môže sa vznietiť.
SLSamosegrevanje v velikih količinah; lahko povzroči požar.
FISuurina määrinä itsestään kuumeneva; voi syttyä palamaan.
SVSjälvupphettande i stora mängder. Kan börja brinna.

H260Language
2.12 —Substances and Mixtures which, in contact with water, emit flammable gases, Hazard Category 1
BGПри контакт с вода отделя запалими газове, които могат да се самозапалят.
ESEn contacto con el agua desprende gases inflamables que pueden inflamarse espontáneamente.
CSPři styku s vodou uvolňuje hořlavé plyny, které se mohou samovolně vznítit.
DAVed kontakt med vand udvikles brandfarlige gasser, som kan selvantænde.
DEIn Berührung mit Wasser entstehen entzündbare Gase, die sich spontan entzünden können.
ETKokkupuutel veega eraldab tuleohtlikke gaase, mis võivad iseenesest süttida.
ELΣε επαφή με το νερό ελευθερώνει εύφλεκτα αέρια τα οποία μπορούν να αυτοαναφλεγούν.
ENIn contact with water releases flammable gases which may ignite spontaneously.
FRDégage au contact de l'eau des gaz inflammables qui peuvent s'enflammer spontanément.
GAI dteagmháil le huisce scaoiltear gáis inadhainte a d'fhéadfadh uathadhaint.
ITA contatto con l'acqua libera gas infiammabili che possono infiammarsi spontaneamente.
LVNonākot saskarē ar ūdeni, izdala uzliesmojošas gāzes, kas var spontāni aizdegties.
LTKontaktuodami su vandeniu išskiria degias dujas, kurios gali savaime užsidegti.
HUVízzel érintkezve öngyulladásra hajlamos tűzveszélyes gázokat bocsát ki.
MTMeta jmiss ma' l-ilma jerħi gassijiet li jaqbdu li jistgħu jieħdu n-nar spontanjament.
NLIn contact met water komen ontvlambare gassen vrij die spontaan kunnen ontbranden.
PLW kontakcie z wodą uwalniają łatwopalne gazy, które mogą ulegać samozapaleniu.
PTEm contacto com a água liberta gases que se podem inflamar espontaneamente.
ROÎn contact cu apa degajă gaze inflamabile care se pot aprinde spontan.
SKPri kontakte s vodou uvoľňuje horľavé plyny, ktoré sa môžu spontánne zapáliť.
SLV stiku z vodo se sproščajo vnetljivi plini, ki se lahko samodejno vžgejo.
FIKehittää itsestään syttyviä kaasuja veden kanssa.
SVVid kontakt med vatten utvecklas brandfarliga gaser som kan självantända.

H261Language
2.12 —Substances and Mixtures which, in contact with water, emit flammable gases, Hazard Category 2
BGПри контакт с вода отделя запалими газове.
ESEn contacto con el agua desprende gases inflamables.
CSPři styku s vodou uvolňuje hořlavé plyny.
DAVed kontakt med vand udvikles brandfarlige gasser.
DEIn Berührung mit Wasser entstehen entzündbare Gase.
ETKokkupuutel veega eraldab tuleohtlikke gaase.
ELΣε επαφή με το νερό ελευθερώνει εύφλεκτα αέρια.
ENIn contact with water releases flammable gases.
FRDégage au contact de l'eau des gaz inflammables.
GAI dteagmháil le huisce scaoiltear gáis inadhainte.
ITA contatto con l'acqua libera gas infiammabili.
LVNonākot saskarē ar ūdeni, izdala uzliesmojošu gāzi.
LTKontaktuodami su vandeniu išskiria degias dujas
HUVízzel érintkezve tűzveszélyes gázokat bocsát ki.
MTMeta jmiss ma' l-ilma jerħi gassijiet li jaqbdu.
NLIn contact met water komen ontvlambare gassen vrij.
PLW kontakcie z wodą uwalnia łatwopalne gazy.
PTEm contacto com a água liberta gases inflamáveis.
ROÎn contact cu apa degajă gaze inflamabile.
SKPri kontakte s vodou uvoľňuje horľavé plyny.
SLV stiku z vodo se sproščajo vnetljivi plini.
FIKehittää syttyviä kaasuja veden kanssa.
SVVid kontakt med vatten utvecklas brandfarliga gaser.

H270Language
2.4 —Oxidising Gases, Hazard Category 1
BGМоже да предивзика или усили пожар; окислител.
ESPuede provocar o agravar un incendio; comburente.
CSMůže způsobit nebo zesílit požár; oxidant.
DAKan forårsage eller forstærke brand, brandnærende.
DEKann Brand verursachen oder verstärken; Oxidationsmittel.
ETVõib põhjustada süttimise või soodustada põlemist; oksüdeerija.
ELΜπορεί να προκαλέσει ή να αναζωπυρώσει πυρκαγιά· οξειδωτικό.
ENMay cause or intensify fire; oxidiser.
FRPeut provoquer ou aggraver un incendie; comburant.
GAD'fhéadfadh sé a bheith ina chúis le tine nó cur le tine; ocsaídeoir.
ITPuò provocare o aggravare un incendio; comburente.
LVVar izraisīt vai pastiprināt degšanu, oksidētājs.
LTGali sukelti arba padidinti gaisrą, oksidatorius.
HUTüzet okozhat vagy fokozhatja a tűz intenzitását, oxidáló hatású.
MTJista' jikkawża jew iżid in-nar; ossidant.
NLKan brand veroorzaken of bevorderen; oxiderend.
PLMoże spowodować lub intensyfikować pożar; utleniacz.
PTPode provocar ou agravar incêndios; comburente.
ROPoate provoca sau agrava un incendiu; oxidant.
SKMôže spôsobiť alebo prispieť k rozvoju požiaru; oxidačné činidlo.
SLLahko povzroči ali okrepi požar; oksidativna snov.
FIAiheuttaa tulipalon vaaran tai edistää tulipaloa; hapettava.
SVKan orsaka eller intensifiera brand. Oxiderande.

H271Language
2.13 —Oxidising Liquids, Hazard Category 1

2.14 —Oxidising Solids, Hazard Category 1
BGМоже да предизвика пожар или експлозия; силен окислител.
ESPuede provocar un incendio o una explosión; muy comburente.
CSMůže způsobit požár nebo výbuch; silný oxidant.
DAKan forårsage brand eller eksplosion, stærkt brandnærende.
DEKann Brand oder Explosion verursachen; starkes Oxidationsmittel.
ETVõib põhjustada süttimise või plahvatuse; tugev oksüdeerija.
ELΜπορεί να προκαλέσει πυρκαγιά ή έκρηξη· ισχυρό οξειδωτικό.
ENMay cause fire or explosion; strong oxidiser.
FRPeut provoquer un incendie ou une explosion; comburant puissant.
GAD'fhéadfadh sé a bheith ina chúis le tine nó le pléascadh; an-ocsaídeoir.
ITPuò provocare un incendio o un'esplosione; molto comburente.
LVVar izraisīt degšanu vai eksploziju, oksidētājs.
LTGali sukelti gaisrą arba sprogimą, stiprus oksidatorius.
HUTüzet vagy robbanást okozhat; erősen oxidáló hatású.
MTJista' jikkawża nar jew splużjoni; ossidant qawwi.
NLKan brand of ontploffingen veroorzaken; sterk oxiderend.
PLMoże spowodować pożar lub wybuch; silny utleniacz.
PTRisco de incêndio ou de explosão; muito comburente.
ROPoate provoca un incendiu sau o explozie; oxidant puternic.
SKMôže spôsobiť požiar alebo výbuch; silné oxidačné činidlo.
SLLahko povzroči požar ali eksplozijo; močna oksidativna snov.
FIAiheuttaa tulipalo- tai räjähdysvaaran; voimakkaasti hapettava.
SVKan orsaka brand eller explosion. Starkt oxiderande.

H272Language
2.13 —Oxidising Liquids, Hazard Category 2, 3

2.14 —Oxidising Solids, Hazard Category 2, 3
BGМоже да усили пожара; окислител.
ESPuede agravar un incendio; comburente.
CSMůže zesílit požár; oxidant.
DAKan forstærke brand, brandnærende.
DEKann Brand verstärken; Oxidationsmittel.
ETVõib soodustada põlemist; oksüdeerija.
ELΜπορεί να αναζωπυρώσει την πυρκαγιά· οξειδωτικό.
ENMay intensify fire; oxidiser.
FRPeut aggraver un incendie; comburant.
GAD'fhéadfadh sé cur le tine; ocsaídeoir.
ITPuò aggravare un incendio; comburente.
LVVar pastiprināt degšanu; oksidētājs.
LTGali padidinti gaisrą, oksidatorius.
HUFokozhatja a tűz intenzitását; oxidáló hatású.
MTJista' jżid in-nar; ossidant.
NLKan brand bevorderen; oxiderend.
PLMoże intensyfikować pożar; utleniacz.
PTPode agravar incêndios; comburente.
ROPoate agrava un incendiu; oxidant.
SKMôže prispieť k rozvoju požiaru; oxidačné činidlo.
SLLahko okrepi požar; oksidativna snov.
FIVoi edistää tulipaloa; hapettava.
SVKan intensifiera brand. Oxiderande.

H280Language
2.5 —Gases under pressure:

Compressed gas

Liquefied gas

Dissolved gas
BGСъдържа газ под налягане; може да експлодира при нагряване.
ESContiene gas a presión; peligro de explosión en caso de calentamiento.
CSObsahuje plyn pod tlakem; při zahřívání může vybuchnout.
DAIndeholder gas under tryk, kan eksplodere ved opvarmning.
DEEnthält Gas unter Druck; kann bei Erwärmung explodieren.
ETSisaldab rõhu all olevat gaasi, kuumenemisel võib plahvatada.
ELΠεριέχει αέριο υπό πίεση· εάν θερμανθεί, μπορεί να εκραγεί.
ENContains gas under pressure; may explode if heated.
FRContient un gaz sous pression; peut exploser sous l'effet de la chaleur.
GAGás istigh ann, faoi bhrú; d'fhéadfadh sé pléascadh, má théitear.
ITContiene gas sotto pressione; può esplodere se riscaldato.
LVSatur gāzi zem spiediena; karstumā var eksplodēt.
LTTuri slėgio veikiamų dujų, kaitinant gali sprogti.
HUNyomás alatt lévő gázt tartalmaz; hő hatására robbanhat.
MTFih gass taħt pressjoni; jista' jisplodi jekk jissaħħan.
NLBevat gas onder druk; kan ontploffen bij verwarming.
PLZawiera gaz pod ciśnieniem; ogrzanie grozi wybuchem.
PTContém gás sob pressão; risco de explosão sob a acção do calor.
ROConţine un gaz sub presiune; pericol de explozie în caz de încălzire.
SKObsahuje plyn pod tlakom, pri zahriatí môže vybuchnúť.
SLVsebuje plin pod tlakom; segrevanje lahko povzroči eksplozijo.
FISisältää paineen alaista kaasua; voi räjähtää kuumennettaessa.
SVInnehåller gas under tryck. Kan explodera vid uppvärmning.

H281Language
2.5 —Gases under pressure: Refrigerated liquefied gas
BGСъдържа охладен газ; може да причини криогенни изгаряния или наранявания.
ESContiene un gas refrigerado; puede provocar quemaduras o lesiones criogénicas.
CSObsahuje zchlazený plyn; může způsobit omrzliny nebo poškození chladem.
DAIndeholder nedkølet gas, kan forårsage kuldeskader.
DEEnthält tiefkaltes Gas; kann Kälteverbrennungen oder -Verletzungen verursachen.
ETSisaldab külmutatud gaasi; võib põhjustada külmapõletusi või -kahjustusi.
ELΠεριέχει αέριο υπό ψύξη· μπορεί να προκαλέσει εγκαύματα ψύχους ή τραυματισμούς.
ENContains refrigerated gas; may cause cryogenic burns or injury.
FRContient un gaz réfrigéré; peut causer des brûlures ou blessures cryogéniques.
GAGás cuisnithe istigh ann; d'fhéadfadh sé a bheith ina chúis le dónna crióigineacha nó le díobháil chrióigineach.
ITContiene gas refrigerato; può provocare ustioni o lesioni criogeniche.
LVSatur atdzesētu gāzi; var radīt kriogēnus apdegumus vai ievainojumus.
LTTuri atšaldytų dujų, gali sukelti kriogeninius nušalimus arba pažeidimus.
HUMélyhűtött gázt tartalmaz; fagymarást vagy sérülést okozhat.
MTFih gass imkessaħ; jista' jikkawża ħruq jew dannu minn temperaturi baxxi.
NLBevat sterk gekoeld gas; kan cryogene brandwonden of letsel veroorzaken.
PLZawiera schłodzony gaz; może spowodować oparzenia kriogeniczne lub obrażenia.
PTContém gás refrigerado; pode provocar queimaduras ou lesões criogénicas.
ROConţine un gaz răcit; poate cauza arsuri sau leziuni criogenice.
SKObsahuje schladený plyn; môže spôsobiť kryogénne popáleniny alebo poranenia.
SLVsebuje ohlajen utekočinjen plin; lahko povzroči ozebline ali poškodbe.
FISisältää jäähdytettyä kaasua; voi aiheuttaa jäätymisvamman.
SVInnehåller kyld gas. Kan orsaka svåra köldskador.

H290Language
2.16 —Corrosive to metals, Hazard Category 1
BGМоже да бъде корозивно за металите.
ESPuede ser corrosivo para los metales.
CSMůže být korozivní pro kovy.
DAKan ætse metaller.
DEKann gegenüber Metallen korrosiv sein.
ETVõib söövitada metalle.
ELΜπορεί να διαβρώσει μέταλλα.
ENMay be corrosive to metals.
FRPeut être corrosif pour les métaux.
GAD'fhéadfadh sé a bheith creimneach do mhiotail.
ITPuò essere corrosivo per i metalli.
LVVar kodīgi iedarboties uz metāliem.
LTGali ėsdinti metalus.
HUFémekre korrozív hatású lehet.
MTJista' jkun korrużiv għall-metalli.
NLKan bijtend zijn voor metalen.
PLMoże powodować korozję metali.
PTPode ser corrosivo para os metais.
ROPoate fi corosiv pentru metale.
SKMôže byť korozívna pre kovy.
SLLahko je jedko za kovine.
FIVoi syövyttää metalleja.
SVKan vara korrosivt för metaller.


Table 1.2

Hazard statements for health hazards

H300Language
3.1 —Acute toxicity (oral), Hazard Category 1, 2
BGСмъртоносeн при поглъщане.
ESMortal en caso de ingestión.
CSPři požití může způsobit smrt.
DALivsfarlig ved indtagelse.
DELebensgefahr bei Verschlucken.
ETAllaneelamisel surmav.
ELΘανατηφόρο σε περίπτωση κατάποσης.
ENFatal if swallowed.
FRMortel en cas d'ingestion.
GAMarfach má shlogtar.
ITLetale se ingerito.
LVNorijot iestājas nāve.
LTMirtina prarijus.
HULenyelve halálos.
MTFatali jekk jinbela’.
NLDodelijk bij inslikken.
PLPołknięcie grozi śmiercią.
PTMortal por ingestão.
ROMortal în caz de înghiţire.
SKSmrteľný po požití.
SLSmrtno pri zaužitju.
FITappavaa nieltynä.
SVDödligt vid förtäring.

H301Language
3.1 —Acute toxicity (oral), Hazard Category 3
BGТоксичен при поглъщане.
ESTóxico en caso de ingestión.
CSToxický při požití.
DAGiftig ved indtagelse.
DEGiftig bei Verschlucken.
ETAllaneelamisel mürgine.
ELΤοξικό σε περίπτωση κατάποσης.
ENToxic if swallowed.
FRToxique en cas d'ingestion.
GATocsaineach má shlogtar.
ITTossico se ingerito.
LVToksisks, ja norij.
LTToksiška prarijus.
HULenyelve mérgező.
MTTossiku jekk jinbela’.
NLGiftig bij inslikken.
PLDziała toksycznie po połknięciu.
PTTóxico por ingestão.
ROToxic în caz de înghiţire.
SKToxický po požití.
SLStrupeno pri zaužitju.
FIMyrkyllistä nieltynä.
SVGiftigt vid förtäring.

H302Language
3.1— Acute toxicity (oral), Hazard Category 4
BGВреден при поглъщане.
ESNocivo en caso de ingestión.
CSZdraví škodlivý při požití.
DAFarlig ved indtagelse.
DEGesundheitsschädlich bei Verschlucken.
ETAllaneelamisel kahjulik.
ELΕπιβλαβές σε περίπτωση κατάποσης.
ENHarmful if swallowed.
FRNocif en cas d'ingestion.
GADíobhálach má shlogtar.
ITNocivo se ingerito.
LVKaitīgs, ja norij.
LTKenksminga prarijus.
HULenyelve ártalmas.
MTJagħmel il-ħsara jekk jinbela’.
NLSchadelijk bij inslikken.
PLDziała szkodliwie po połknięciu.
PTNocivo por ingestão.
RONociv în caz de înghiţire.
SKŠkodlivý po požití.
SLZdravju škodljivo pri zaužitju.
FIHaitallista nieltynä.
SVSkadligt vid förtäring.

H304Language
3.10— Aspiration hazard, Hazard Category 1
BGМоже да бъде смъртоносен при поглъщане и навлизане в дихателните пътища.
ESPuede ser mortal en caso de ingestión y penetración en las vías respiratorias.
CSPři požití a vniknutí do dýchacích cest může způsobit smrt.
DAKan være livsfarligt, hvis det indtages og kommer i luftvejene.
DEKann bei Verschlucken und Eindringen in die Atemwege tödlich sein.
ETAllaneelamisel või hingamisteedesse sattumisel võib olla surmav.
ELΜπορεί να προκαλέσει θάνατο σε περίπτωση κατάποσης και διείσδυσης στις αναπνευστικές οδούς.
ENMay be fatal if swallowed and enters airways.
FRPeut être mortel en cas d'ingestion et de pénétration dans les voies respiratoires.
GAD'fhéadfadh sé a bheith marfach má shlogtar é agus má théann sé isteach sna haerbhealaí.
HULenyelve és a légutakba kerülve halálos lehet.
ITPuò essere letale in caso di ingestione e di penetrazione nelle vie respiratorie.
LVVar izraisīt nāvi, ja norij vai iekļūst elpceļos.
LTPrarijus ir patekus į kvėpavimo takus, gali sukelti mirtį.
MTJista’ jkun fatali jekk jinbela’ u jidħol fil-pajpijiet tan-nifs.
NLKan dodelijk zijn als de stof bij inslikken in de luchtwegen terechtkomt.
PLPołknięcie i dostanie się przez drogi oddechowe może grozić śmiercią.
PTPode ser mortal por ingestão e penetração nas vias respiratórias.
ROPoate fi mortal în caz de înghiţire şi de pătrundere în căile respiratorii.
SKMôže byť smrteľný po požití a vniknutí do dýchacích ciest.
SLPri zaužitju in vstopu v dihalne poti je lahko smrtno.
FIVoi olla tappavaa nieltynä ja joutuessaan hengitysteihin.
SVKan vara dödligt vid förtäring om det kommer ner i luftvägarna.

H310Language
3.1— Acute toxicity (dermal), Hazard Category 1, 2
BGСмъртоносeн при контакт с кожата.
ESMortal en contacto con la piel.
CSPři styku s kůží může způsobit smrt.
DALivsfarlig ved hudkontakt.
DELebensgefahr bei Hautkontakt.
ETNahale sattumisel surmav.
ELΘανατηφόρο σε επαφή με το δέρμα.
ENFatal in contact with skin.
FRMortel par contact cutané.
GAMarfach i dteagmháil leis an gcraiceann.
HUBőrrel érintkezve halálos.
ITLetale per contatto con la pelle.
LVNonākot saskarē ar ādu, iestājas nāve.
LTMirtina susilietus su oda.
MTFatali jekk imiss mal-ġilda.
NLDodelijk bij contact met de huid.
PLGrozi śmiercią w kontacie ze skórą.
PTMortal em contacto com a pele.
ROMortal în contact cu pielea.
SKSmrteľný pri kontakte s pokožkou.
SLSmrtno v stiku s kožo.
FITappavaa joutuessaan iholle.
SVDödligt vid hudkontakt.

H311Language
3.1— Acute toxicity (dermal), Hazard Category 3
BGТоксичен при контакт с кожата.
ESTóxico en contacto con la piel.
CSToxický při styku s kůží.
DAGiftig ved hudkontakt.
DEGiftig bei Hautkontakt.
ETNahale sattumisel mürgine.
ELΤοξικό σε επαφή με το δέρμα.
ENToxic in contact with skin.
FRToxique par contact cutané.
GATocsaineach i dteagmháil leis an gcraiceann.
ITTossico per contatto con la pelle.
LVToksisks, ja nonāk saskarē ar ādu.
LTToksiška susilietus su oda.
HUBőrrel érintkezve mérgező.
MTTossiku meta jmiss mal-ġilda.
NLGiftig bij contact met de huid.
PLDziała toksycznie w kontakcie ze skórą.
PTTóxico em contacto com a pele.
ROToxic în contact cu pielea.
SKToxický pri kontakte s pokožkou.
SLStrupeno v stiku s kožo.
FIMyrkyllistä joutuessaan iholle.
SVGiftigt vid hudkontakt.

H312Language
3.1— Acute toxicity (dermal), Hazard Category 4
BGВреден при контакт с кожата.
ESNocivo en contacto con la piel.
CSZdraví škodlivý při styku s kůží.
DAFarlig ved hudkontakt.
DEGesundheitsschädlich bei Hautkontakt.
ETNahale sattumisel kahjulik.
ELΕπιβλαβές σε επαφή με το δέρμα.
ENHarmful in contact with skin.
FRNocif par contact cutané.
GADíobhálach i dteagmháil leis an gcraiceann.
ITNocivo per contatto con la pelle.
LVKaitīgs, ja nonāk saskarē ar ādu.
LTKenksminga susilietus su oda.
HUBőrrel érintkezve ártalmas.
MTJagħmel il-ħsara meta jmiss mal-ġilda.
NLSchadelijk bij contact met de huid.
PLDziała szkodliwie w kontakcie ze skórą.
PTNocivo em contacto com a pele.
RONociv în contact cu pielea.
SKŠkodlivý pri kontakte s pokožkou.
SLZdravju škodljivo v stiku s kožo.
FIHaitallista joutuessaan iholle.
SVSkadligt vid hudkontakt.

H314Language
3.2— Skin corrosion/irritation, Hazard Category 1A, 1B, 1C
BGПричинява тежки изгаряния на кожата и сериозно увреждане на очите.
ESProvoca quemaduras graves en la piel y lesiones oculares graves.
CSZpůsobuje těžké poleptání kůže a poškození očí.
DAForårsager svære forbrændinger af huden og øjenskader.
DEVerursacht schwere Verätzungen der Haut und schwere Augenschäden.
ETPõhjustab rasket nahasöövitust ja silmakahjustusi.
ELΠροκαλεί σοβαρά δερματικά εγκαύματα και οφθαλμικές βλάβες.
ENCauses severe skin burns and eye damage.
FRProvoque des brûlures de la peau et des lésions oculaires graves.
GAIna chúis le dónna tromchúiseacha craicinn agus le damáiste don tsúil.
ITProvoca gravi ustioni cutanee e gravi lesioni oculari.
LVIzraisa smagus ādas apdegumus un acu bojājumus.
LTSmarkiai nudegina odą ir pažeidžia akis.
HUSúlyos égési sérülést és szemkárosodást okoz.
MTJagħmel ħruq serju lill-ġilda u ħsara lill-għajnejn.
NLVeroorzaakt ernstige brandwonden en oogletsel.
PLPowoduje poważne oparzenia skóry oraz uszkodzenia oczu.
PTProvoca queimaduras na pele e lesões oculares graves.
ROProvoacă arsuri grave ale pielii şi lezarea ochilor.
SKSpôsobuje vážne poleptanie kože a poškodenie očí.
SLPovzroča hude opekline kože in poškodbe oči.
FIVoimakkaasti ihoa syövyttävää ja silmiä vaurioittavaa.
SVOrsakar allvarliga frätskador på hud och ögon.

H315Language
3.2— Skin corrosion/irritation, Hazard Category 2
BGПредизвиква дразнене на кожата.
ESProvoca irritación cutánea.
CSDráždí kůži.
DAForårsager hudirritation.
DEVerursacht Hautreizungen.
ETPõhjustab nahaärritust.
ELΠροκαλεί ερεθισμό του δέρματος.
ENCauses skin irritation.
FRProvoque une irritation cutanée.
GAIna chúis le greannú craicinn.
ITProvoca irritazione cutanea.
LVKairina ādu.
LTDirgina odą.
HUBőrirritáló hatású.
MTJagħmel irritazzjoni tal-ġilda.
NLVeroorzaakt huidirritatie.
PLDziała drażniąco na skórę.
PTProvoca irritação cutânea.
ROProvoacă iritarea pielii.
SKDráždi kožu.
SLPovzroča draženje kože.
FIÄrsyttää ihoa.
SVIrriterar huden.

H317Language
3.4— Sensitisation — Skin, Hazard Category 1
BGМоже да причини алергична кожна реакция.
ESPuede provocar una reacción alérgica en la piel.
CSMůže vyvolat alergickou kožní reakci.
DAKan forårsage allergisk hudreaktion.
DEKann allergische Hautreaktionen verursachen.
ETVõib põhjustada allergilist nahareaktsiooni.
ELΜπορεί να προκαλέσει αλλεργική δερματική αντίδραση.
ENMay cause an allergic skin reaction.
FRPeut provoquer une allergie cutanée.
GAD'fhéadfadh sé a bheith ina chúis le frithghníomh ailléirgeach craicinn.
ITPuò provocare una reazione allergica cutanea.
LVVar izraisīt alerģisku ādas reakciju.
LTGali sukelti alerginę odos reakciją.
HUAllergiás bőrreakciót válthat ki.
MTJista’ jikkawża reazzjoni allerġika tal-ġilda.
NLKan een allergische huidreactie veroorzaken.
PLMoże powodować reakcję alergiczną skóry.
PTPode provocar uma reacção alérgica cutânea.
ROPoate provoca o reacţie alergică a pielii.
SKMôže vyvolať alergickú kožnú reakciu.
SLLahko povzroči alergijski odziv kože.
FIVoi aiheuttaa allergisen ihoreaktion.
SVKan orsaka allergisk hudreaktion.

H318Language
3.3— Serious eye damage/eye irritation, Hazard Category 1
BGПредизвиква сериозно увреждане на очите.
ESProvoca lesiones oculares graves.
CSZpůsobuje vážné poškození očí.
DAForårsager alvorlig øjenskade.
DEVerursacht schwere Augenschäden.
ETPõhjustab raskeid silmakahjustusi.
ELΠροκαλεί σοβαρή οφθαλμική βλάβη.
ENCauses serious eye damage.
FRProvoque des lésions oculaires graves.
GAIna chúis le damáiste tromchúiseach don tsúil.
ITProvoca gravi lesioni oculari.
LVIzraisa nopietnus acu bojājumus.
LTSmarkiai pažeidžia akis.
HUSúlyos szemkárosodást okoz.
MTJagħmel ħsara serja lill-għajnejn.
NLVeroorzaakt ernstig oogletsel.
PLPowoduje poważne uszkodzenie oczu.
PTProvoca lesões oculares graves.
ROProvoacă leziuni oculare grave.
SKSpôsobuje vážne poškodenie očí.
SLPovzroča hude poškodbe oči.
FIVaurioittaa vakavasti silmiä.
SVOrsakar allvarliga ögonskador.

H319Language
3.3— Serious eye damage/eye irritation, Hazard Category 2
BGПредизвиква сериозно дразнене на очите.
ESProvoca irritación ocular grave.
CSZpůsobuje vážné podráždění očí.
DAForårsager alvorlig øjenirritation.
DEVerursacht schwere Augenreizung.
ETPõhjustab tugevat silmade ärritust.
ELΠροκαλεί σοβαρό οφθαλμικό ερεθισμό.
ENCauses serious eye irritation.
FRProvoque une sévère irritation des yeux.
GAIna chúis le greannú tromchúiseach don tsúil.
ITProvoca grave irritazione oculare.
LVIzraisa nopietnu acu kairinājumu.
LTSukelia smarkų akių dirginimą.
HUSúlyos szemirritációt okoz.
MTJagħmel irritazzjoni serja lill-għajnejn.
NLVeroorzaakt ernstige oogirritatie.
PLDziała drażniąco na oczy.
PTProvoca irritação ocular grave.
ROProvoacă o iritare gravă a ochilor.
SKSpôsobuje vážne podráždenie očí.
SLPovzroča hudo draženje oči.
FIÄrsyttää voimakkaasti silmiä.
SVOrsakar allvarlig ögonirritation.

H330Language
3.1— Acute toxicity (inhal.), Hazard Category 1, 2
BGСмъртоносен при вдишване.
ESMortal en caso de inhalación.
CSPři vdechování může způsobit smrt.
DALivsfarlig ved indånding.
DELebensgefahr bei Einatmen.
ETSissehingamisel surmav.
ELΘανατηφόρο σε περίπτωση εισπνοής.
ENFatal if inhaled.
FRMortel par inhalation.
GAMarfach má ionanálaítear.
ITLetale se inalato.
LVIeelpojot, iestājas nāve.
LTMirtina įkvėpus.
HUBelélegezve halálos.
MTFatali jekk jinxtamm.
NLDodelijk bij inademing.
PLWdychanie grozi śmiercią.
PTMortal por inalação.
ROMortal în caz de inhalare.
SKSmrteľný pri vdýchnutí.
SLSmrtno pri vdihavanju.
FITappavaa hengitettynä.
SVDödligt vid inandning.

H331Language
3.1— Acute toxicity (inhal.), Hazard Category 3
BGТоксичен при вдишване.
ESTóxico en caso de inhalación.
CSToxický při vdechování.
DAGiftig ved indånding.
DEGiftig bei Einatmen.
ETSissehingamisel mürgine.
ELΤοξικό σε περίπτωση εισπνοής.
ENToxic if inhaled.
FRToxique par inhalation.
GATocsaineach má ionanálaítear.
ITTossico se inalato.
LVToksisks ieelpojot.
LTToksiška įkvėpus.
HUBelélegezve mérgező.
MTTossiku jekk jinxtamm.
NLGiftig bij inademing.
PLDziała toksycznie w następstwie wdychania.
PTTóxico por inalação.
ROToxic în caz de inhalare.
SKToxický pri vdýchnutí.
SLStrupeno pri vdihavanju.
FIMyrkyllistä hengitettynä.
SVGiftigt vid inandning.

H332Language
3.1— Acute toxicity (inhal.), Hazard Category 4
BGВреден при вдишване.
ESNocivo en caso de inhalación.
CSZdraví škodlivý při vdechování.
DAFarlig ved indånding.
DEGesundheitsschädlich bei Einatmen.
ETSissehingamisel kahjulik.
ELΕπιβλαβές σε περίπτωση εισπνοής.
ENHarmful if inhaled.
FRNocif par inhalation.
GADíobhálach má ionanálaítear.
ITNocivo se inalato.
LVKaitīgs ieelpojot.
LTKenksminga įkvėpus.
HUBelélegezve ártalmas.
MTJagħmel il-ħsara jekk jinxtamm.
NLSchadelijk bij inademing.
PLDziała szkodliwie w następstwie wdychania.
PTNocivo por inalação.
RONociv în caz de inhalare.
SKŠkodlivý pri vdýchnutí.
SLZdravju škodljivo pri vdihavanju.
FIHaitallista hengitettynä.
SVSkadligt vid inandning.

H334Language
3.4— Sensitisation — Respirat., Hazard Category 1
BGМоже да причини алергични или астматични симптоми или затруднения в дишането при вдишване.
ESPuede provocar síntomas de alergia o asma o dificultades respiratorias en caso de inhalación.
CSPři vdechování může vyvolat příznaky alergie nebo astmatu nebo dýchací potíže.
DAKan forårsage allergi- eller astmasymptomer eller åndedrætsbesvær ved indånding.
DEKann bei Einatmen Allergie, asthmaartige Symptome oder Atembeschwerden verursachen.
ETSissehingamisel võib põhjustada allergia- või astma sümptomeid või hingamisraskusi.
ELΜπορεί να προκαλέσει αλλεργία ή συμπτώματα άσθματος ή δύσπνοια σε περίπτωση εισπνοής.
ENMay cause allergy or asthma symptoms or breathing difficulties if inhaled.
FRPeut provoquer des symptômes allergiques ou d'asthme ou des difficultés respiratoires par inhalation.
GAD'fhéadfadh sé a bheith ina chúis le siomptóim ailléirge nó asma nó le deacrachtaí análaithe má ionanálaítear é.
ITPuò provocare sintomi allergici o asmatici o difficoltà respiratorie se inalato.
LVJa ieelpo, var izraisīt alerģiju vai astmas simptomus, vai apgrūtināt elpošanu.
LTĮkvėpus gali sukelti alerginę reakciją, astmos simptomus arba apsunkinti kvėpavimą.
HUBelélegezve allergiás és asztmás tüneteket, és nehéz légzést okozhat.
MTJista’ jikkawża sintomi ta' allerġija jew ta’ ażma jew diffikultajiet biex jittieħed in-nifs jekk jinxtamm.
NLKan bij inademing allergie- of astmasymptomen of ademhalingsmoeilijkheden veroorzaken.
PLMoże powodować objawy alergii lub astmy lub trudności w oddychaniu w następstwie wdychania.
PTQuando inalado, pode provocar sintomas de alergia ou de asma ou dificuldades respiratórias.
ROPoate provoca simptome de alergie sau astm sau dificultăţi de respiraţie în caz de inhalare.
SKPri vdýchnutí môže vyvolať alergiu alebo príznaky astmy, alebo dýchacie ťažkosti.
SLLahko povzroči simptome alergije ali astme ali težave z dihanjem pri vdihavanju.
FIVoi aiheuttaa hengitettynä allergia- tai astmaoireita tai hengitysvaikeuksia.
SVKan orsaka allergi- eller astmasymtom eller andningssvårigheter vid inandning.

H335Language
3.8— Specific target organ toxicity — Single exposure, Hazard Category 3, Respiratory tract irritation
BGМоже да предизвика дразнене на дихателните пътища.
ESPuede irritar las vías respiratorias.
CSMůže způsobit podráždění dýchacích cest.
DAKan forårsage irritation af luftvejene.
DEKann die Atemwege reizen.
ETVõib põhjustada hingamisteede ärritust.
ELΜπορεί να προκαλέσει ερεθισμό της αναπνευστικής οδού.
ENMay cause respiratory irritation.
FRPeut irriter les voies respiratoires.
GAD'fhéadfadh sé a bheith ina chúis le greannú riospráide.
ITPuò irritare le vie respiratorie.
LVVar izraisīt elpceļu kairinājumu.
LTGali dirginti kvėpavimo takus.
HULégúti irritációt okozhat.
MTJista’ jikkawża irritazzjoni respiratorja.
NLKan irritatie van de luchtwegen veroorzaken.
PLMoże powodować podrażnienie dróg oddechowych.
PTPode provocar irritação das vias respiratórias.
ROPoate provoca iritarea căilor respiratorii.
SKMôže spôsobiť podráždenie dýchacích ciest.
SLLahko povzroči draženje dihalnih poti.
FISaattaa aiheuttaa hengitysteiden ärsytystä.
SVKan orsaka irritation i luftvägarna.

H336Language
3.8— Specific target organ toxicity — Single exposure, Hazard Category 3, Narcosis
BGМоже да предизвика сънливост или световъртеж.
ESPuede provocar somnolencia o vértigo.
CSMůže způsobit ospalost nebo závratě.
DAKan forårsage sløvhed eller svimmelhed.
DEKann Schläfrigkeit und Benommenheit verursachen.
ETVõib põhjustada unisust või peapööritust.
ELΜπορεί να προκαλέσει υπνηλία ή ζάλη.
ENMay cause drowsiness or dizziness.
FRPeut provoquer somnolence ou vertiges.
GAD'fhéadfadh sé a bheith ina chúis le codlatacht nó le meadhrán.
ITPuò provocare sonnolenza o vertigini.
LVVar izraisīt miegainību vai reiboņus.
LTGali sukelti mieguistumą arba galvos svaigimą.
HUÁlmosságot vagy szédülést okozhat.
MTJista’ jikkawża ħedla jew sturdament.
NLKan slaperigheid of duizeligheid veroorzaken.
PLMoże wywoływać uczucie senności lub zawroty głowy.
PTPode provocar sonolência ou vertigens.
ROPoate provoca somnolenţă sau ameţeală.
SKMôže spôsobiť ospalosť alebo závraty.
SLLahko povzroči zaspanost ali omotico.
FISaattaa aiheuttaa uneliaisuutta ja huimausta.
SVKan göra att man blir dåsig eller omtöcknad.

H340Language
3.5— Germ cell mutagenicity, Hazard Category 1A, 1B
BGМоже да причини генетични дефекти < да се посочи пътят на експозицията, ако е доказано убедително, че няма друг път на експозиция, който води до същата опасност >.
ESPuede provocar defectos genéticos <Indíquese la vía de exposición si se ha demostrado concluyentemente que el peligro no se produce por ninguna otra vía >.
CSMůže vyvolat genetické poškození <uveďte cestu expozice, je-li přesvědčivě prokázáno, že ostatní cesty expozice nejsou nebezpečné>.
DAKan forårsage genetiske defekter <angiv eksponeringsvej, hvis det er endeligt påvist, at faren ikke kan frembringes ad nogen anden eksponeringsvej>.
DEKann genetische Defekte verursachen <Expositionsweg angeben, sofern schlüssig belegt ist, dass diese Gefahr bei keinem anderen Expositionsweg besteht>.
ETVõib põhjustada geneetilisi defekte <märkida kokkupuuteviis, kui on veenvalt tõestatud, et muud kokkupuuteviisid ei ole ohtlikud>.
ELΜπορεί να προκαλέσει γενετικά ελαττώματα < αναφέρεται η οδός έκθεσης αν έχει αποδειχθεί αδιαμφισβήτητα ότι δεν υπάρχει κίνδυνος από τις άλλες οδούς έκθεσης >.
ENMay cause genetic defects <state route of exposure if it is conclusively proven that no other routes of exposure cause the hazard>.
FRPeut induire des anomalies génétiques <indiquer la voie d'exposition s'il est formellement prouvé qu'aucune autre voie d'exposition ne conduit au même danger>.
GAD'fhéadfadh sé a bheith ina chúis le héalanga géiniteacha <tabhair an bealach nochta má tá sé cruthaithe go cinntitheach nach bealach nochta ar bith eile is cúis leis an nguais>.
ITPuò provocare alterazioni genetiche <indicare la via di esposizione se è accertato che nessun'altra via di esposizione comporta il medesimo pericolo>.
LVVar izraisīt ģenētiskus bojājumus <norādīt iedarbības ceļu, ja ir nepārprotami pierādīts, ka citi iedarbības ceļi nerada bīstamību>.
LTGali sukelti genetinius defektus <nurodyti veikimo būdą, jeigu įtikinamai nustatyta, kad kiti veikimo būdai nepavojingi>.
HUGenetikai károsodást okozhat < meg kell adni az expozíciós útvonalat, ha meggyőzően bizonyított, hogy más expozíciós útvonal nem okozza a veszélyt >.
MTJista’ jikkawża difetti ġenetiċi <semmi l-mod ta' espożizzjoni jekk ikun pruvat b'mod konklużiv li l-ebda mod ta' espożizzjoni ieħor ma jikkawża l-periklu>.
NLKan genetische schade veroorzaken <blootstellingsroute vermelden indien afdoende bewezen is dat het gevaar bij andere blootstellingsroutes niet aanwezig is>.
PLMoże powodować wady genetyczne <podać drogę narażenia, jeżeli definitywnie udowodniono, że inna droga narażenia nie powoduje zagrożenia>.
PTPode provocar anomalias genéticas <indicar a via de exposição se existirem provas concludentes de que o perigo não decorre de nenhuma outra via de exposição>.
ROPoate provoca anomalii genetice <indicaţi calea de expunere, dacă există probe concludente că nicio altă cale de expunere nu provoacă acest pericol>.
SKMôže spôsobovať genetické poškodenie <uveďte spôsob expozície, ak sa presvedčivo preukáže, že iné spôsoby expozície nevyvolávajú nebezpečenstvo>.
SLLahko povzroči genetske okvare <navesti način izpostavljenosti, če je prepričljivo dokazano, da noben drug način izpostavljenosti ne povzroča takšne nevarnosti>.
FISaattaa aiheuttaa perimävaurioita <mainitaan altistumisreitti, jos on kiistatta osoitettu, että vaara ei voi aiheutua muiden altistumisreittien kautta>.
SVKan orsaka genetiska defekter <ange exponeringsväg om det är definitivt bevisat att faran inte kan orsakas av några andra exponeringsvägar>.

H341Language
3.5— Germ cell mutagenicity, Hazard Category 2
BGПредполага се, че причинява генетични дефекти < да се посочи пътят на експозицията, ако е доказано убедително, че няма друг път на експозиция, който води до същата опасност >.
ESSe sospecha que provoca defectos genéticos <Indíquese la vía de exposición si se ha demostrado concluyentemente que el peligro no se produce por ninguna otra vía>.
CSPodezření na genetické poškození <uveďte cestu expozice, je-li přesvědčivě prokázáno, že ostatní cesty expozice nejsou nebezpečné>.
DAMistænkt for at forårsage genetiske defekter <angiv eksponeringsvej, hvis det er endeligt påvist, at faren ikke kan frembringes ad nogen anden eksponeringsvej>.
DEKann vermutlich genetische Defekte verursachen <Expositionsweg angeben, sofern schlüssig belegt ist, dass diese Gefahr bei keinem anderen Expositionsweg besteht>.
ETArvatavasti põhjustab geneetilisi defekte <märkida kokkupuuteviis, kui on veenvalt tõestatud, et muud kokkupuuteviisid ei ole ohtlikud>.
ELΎποπτο για πρόκληση γενετικών ελαττωμάτων <αναφέρεται η οδός έκθεσης αν έχει αποδειχθεί αδιαμφισβήτητα ότι δεν υπάρχει κίνδυνος από τις άλλες οδούς έκθεσης>.
ENSuspected of causing genetic defects <state route of exposure if it is conclusively proven that no other routes of exposure cause the hazard>.
FRSusceptible d'induire des anomalies génétiques <indiquer la voie d'exposition s'il est formellement prouvé qu'aucune autre voie d'exposition ne conduit au même danger>.
GACeaptar go bhféadfadh sé a bheith ina chúis le héalanga géiniteacha <tabhair an bealach nochta má tá sé cruthaithe go cinntitheach nach bealach nochta ar bith eile is cúis leis an nguais>.
ITSospettato di provocare alterazioni genetiche <indicare la via di esposizione se è accertato che nessun'altra via di esposizione comporta il medesimo pericolo>.
LVIr aizdomas, ka var izraisīt ģenētiskus bojājumus <norādīt iedarbības ceļu, ja ir nepārprotami pierādīts, ka citi iedarbības ceļi nerada bīstamību>.
LTĮtariama, kad gali sukelti genetinius defektus <nurodyti veikimo būdą, jeigu įtikinamai nustatyta, kad kiti veikimo būdai nepavojingi>.
HUFeltehetően genetikai károsodást okoz < meg kell adni az expozíciós útvonalat, ha meggyőzően bizonyított, hogy más expozíciós útvonal nem okozza a veszélyt >.
MTSuspettat li jikkawża difetti ġenetiċi <semmi l-mod ta' espożizzjoni jekk ikun pruvat b'mod konklużiv li l-ebda mod ta' espożizzjoni ieħor ma jikkawża l-periklu>.
NLVerdacht van het veroorzaken van genetische schade <blootstellingsroute vermelden indien afdoende bewezen is dat het gevaar bij andere blootstellingsroutes niet aanwezig is>.
PLPodejrzewa się, że powoduje wady genetyczne <podać drogę narażenia, jeżeli definitywnie udowodniono, że inna droga narażenia nie powoduje zagrożenia>.
PTSuspeito de provocar anomalias genéticas <indicar a via de exposição se existirem provas concludentes de que o perigo não decorre de nenhuma outra via de exposição>.
ROSusceptibil de a provoca anomalii genetice < indicaţi calea de expunere, dacă există probe concludente că nicio altă cale de expunere nu provoacă acest pericol>.
SKPodozrenie, že spôsobuje genetické poškodenie <uveďte spôsob expozície, ak sa presvedčivo preukáže, že iné spôsoby expozície nevyvolávajú nebezpečenstvo>.
SLSum povzročitve genetskih okvar <navesti način izpostavljenosti, če je prepričljivo dokazano, da noben drug način izpostavljenosti ne povzroča takšne nevarnosti>.
FIEpäillään aiheuttavan perimävaurioita <mainitaan altistumisreitti, jos on kiistatta osoitettu, että vaara ei voi aiheutua muiden altistumisreittien kautta>.
SVMisstänks kunna orsaka genetiska defekter <ange exponeringsväg om det är definitivt bevisat att faran inte kan orsakas av några andra exponeringsvägar>.

H350Language
3.6— Carcinogenicity, Hazard Category 1A, 1B
BGМоже да причини рак < да се посочи пътят на експозицията, ако е доказано убедително, че няма друг път на експозиция, който води до същата опасност >.
ESPuede provocar cáncer <indíquese la vía de exposición si se ha demostrado concluyentemente que el peligro no se produce por ninguna otra vía>.
CSMůže vyvolat rakovinu <uveďte cestu expozice, je-li přesvědčivě prokázáno, že ostatní cesty expozice nejsou nebezpečné>.
DAKan fremkalde kræft <angiv eksponeringsvej, hvis det er endeligt påvist, at faren ikke kan frembringes ad nogen anden eksponeringsvej>.
DEKann Krebs erzeugen <Expositionsweg angeben, sofern schlüssig belegt ist, dass diese Gefahr bei keinem anderen Expositionsweg besteht>.
ETVõib põhjustada vähktõbe <märkida kokkupuuteviis, kui on veenvalt tõestatud, et muud kokkupuuteviisid ei ole ohtlikud>.
ELΜπορεί να προκαλέσει καρκίνο <αναφέρεται η οδός έκθεσης αν έχει αποδειχθεί αδιαμφισβήτητα ότι δεν υπάρχει κίνδυνος από τις άλλες οδούς έκθεσης>.
ENMay cause cancer <state route of exposure if it is conclusively proven that no other routes of exposure cause the hazard>.
FRPeut provoquer le cancer <indiquer la voie d'exposition s'il est formellement prouvé qu'aucune autre voie d'exposition ne conduit au même danger>.
GAD'fhéadfadh sé a bheith ina chúis le hailse <tabhair an bealach nochta má tá sé cruthaithe go cinntitheach nach bealach nochta ar bith eile is cúis leis an nguais>.
ITPuò provocare il cancro<indicare la via di esposizione se è accertato che nessun'altra via di esposizione comporta il medesimo pericolo>.
LVVar izraisīt vēzi <norādīt iedarbības ceļu, ja ir nepārprotami pierādīts, ka citi iedarbības ceļi nerada bīstamību>.
LTGali sukelti vėžį <nurodyti veikimo būdą, jeigu įtikinamai nustatyta, kad kiti veikimo būdai nepavojingi>.
HURákot okozhat < meg kell adni az expozíciós útvonalat, ha meggyőzően bizonyított, hogy más expozíciós útvonal nem okozza a veszélyt >.
MTJista’ jikkawża l-kanċer <semmi l-mod ta' espożizzjoni jekk ikun pruvat b'mod konklużiv li l-ebda mod ta' espożizzjoni ieħor ma jikkawża l-periklu>.
NLKan kanker veroorzaken <blootstellingsroute vermelden indien afdoende bewezen is dat het gevaar bij andere blootstellingsroutes niet aanwezig is>
PLMoże powodować raka <podać drogę narażenia, jeżeli definitywnie udowodniono, że inna droga narażenia nie powoduje zagrożenia>.
PTPode provocar cancro <indicar a via de exposição se existirem provas concludentes de que o perigo não decorre de nenhuma outra via de exposição>.
ROPoate provoca cancer <indicaţi calea de expunere, dacă există probe concludente că nicio altă cale de expunere nu provoacă acest pericol>.
SKMôže spôsobiť rakovinu <uveďte spôsob expozície, ak sa presvedčivo preukáže, že iné spôsoby expozície nevyvolávajú nebezpečenstvo>.
SLLahko povzroči raka <navesti način izpostavljenosti, če je prepričljivo dokazano, da noben drug način izpostavljenosti ne povzroča takšne nevarnosti>.
FISaattaa aiheuttaa syöpää <mainitaan altistumisreitti, jos on kiistatta osoitettu, että vaara ei voi aiheutua muiden altistumisreittien kautta>.
SVKan orsaka cancer <ange exponeringsväg om det är definitivt bevisat att faran inte kan orsakas av några andra exponeringsvägar>.

H351Language
3.6— Carcinogenicity, Hazard Category 2
BGПредполага се, че причинява рак < да се посочи пътят на експозицията, ако е доказано убедително, че няма друг път на експозиция, който води до същата опасност >.
ESSe sospecha que provoca cáncer <indíquese la vía de exposición si se se ha demostrado concluyentemente que el peligro no se produce por ninguna otra vía>.
CSPodezření na vyvolání rakoviny <uveďte cestu expozice, je-li přesvědčivě prokázáno, že ostatní cesty expozice nejsou nebezpečné>.
DAMistænkt for at fremkalde kræft <angiv eksponeringsvej, hvis det er endeligt påvist, at faren ikke kan frembringes ad nogen anden eksponeringsvej>.
DEKann vermutlich Krebs erzeugen <Expositionsweg angeben, sofern schlüssig belegt ist, dass diese Gefahr bei keinem anderen Expositionsweg besteht>.
ETArvatavasti põhjustab vähktõbe <märkida kokkupuuteviis, kui on veenvalt tõestatud, et muud kokkupuuteviisid ei ole ohtlikud>.
ELΎποπτο για πρόκληση καρκίνου <αναφέρεται η οδός έκθεσης αν έχει αποδειχθεί αδιαμφισβήτητα ότι δεν υπάρχει κίνδυνος από τις άλλες οδούς έκθεσης>.
ENSuspected of causing cancer <state route of exposure if it is conclusively proven that no other routs of exposure cause the hazard>.
FRSusceptible de provoquer le cancer <indiquer la voie d'exposition s'il est formellement prouvé qu'aucune autre voie d'exposition ne conduit au même danger>.
GACeaptar go bhféadfadh sé a bheith ina chúis le hailse <tabhair an bealach nochta má tá sé cruthaithe go cinntitheach nach bealach nochta ar bith eile is cúis leis an nguais>.
ITSospettato di provocare il cancro <indicare la via di esposizione se è accertato che nessun'altra via di esposizione comporta il medesimo pericolo>.
LVIr aizdomas, ka var izraisīt vēzi <norādīt iedarbības ceļu, ja ir nepārprotami pierādīts, ka citi iedarbības ceļi nerada bīstamību>.
LTĮtariama, kad sukelia vėžį <nurodyti veikimo būdą, jeigu įtikinamai nustatyta, kad kiti veikimo būdai nepavojingi>.
HUFeltehetően rákot okoz < meg kell adni az expozíciós útvonalat, ha meggyőzően bizonyított, hogy más expozíciós útvonal nem okozza a veszélyt >.
MTSuspettat li jikkawża l-kanċer <ara l-mod ta’ espożizzjoni jekk ikun pruvat b'mod konklużiv li l-ebda mod ta' espożizzjoni ieħor ma jikkawża l-periklu >.
NLVerdacht van het veroorzaken van kanker <blootstellingsroute vermelden indien afdoende bewezen is dat het gevaar bij andere blootstellingsroutes niet aanwezig is>.
PLPodejrzewa się, że powoduje raka <podać drogę narażenia, jeżeli definitywnie udowodniono, że inna droga narażenia nie powoduje zagrożenia>.
PTSuspeito de provocar cancro <indicar a via de exposição se existirem provas concludentes de que o perigo não decorre de nenhuma outra via de exposição>.
ROSusceptibil de a provoca cancer <indicaţi calea de expunere, dacă există probe concludente că nicio altă cale de expunere nu provoacă acest pericol>.
SKPodozrenie, že spôsobuje rakovinu <uveďte spôsob expozície, ak sa presvedčivo preukáže, že iné spôsoby expozície nevyvolávajú nebezpečenstvo>.
SLSum povzročitve raka <navesti način izpostavljenosti, če je prepričljivo dokazano, da noben drug način izpostavljenosti ne povzroča takšne nevarnosti>.
FIEpäillään aiheuttavan syöpää <mainitaan altistumisreitti, jos on kiistatta osoitettu, että vaara ei voi aiheutua muiden altistumisreittien kautta>.
SVMisstänks kunna orsaka cancer <ange exponeringsväg om det är definitivt bevisat att faran inte kan orsakas av några andra exponeringsvägar>.

H360Language
3.7— Reproductive toxicity, Hazard Category 1A, 1B
BGМоже да увреди оплодителната способност или плода < да се посочи конкретното въздействие, ако е известно > < да се посочи пътят на експозицията, ако е доказано убедително, че няма друг път на експозиция, който води до същата опасност >.
ESPuede perjudicar la fertilidad o dañar al feto <indíquese el efecto específico si se conoce> <indíquese la vía de exposición si se ha demostrado concluyentemente que el peligro no se produce por ninguna otra vía>.
CSMůže poškodit reprodukční schopnost nebo plod v těle matky <uveďte specifický účinek, je-li znám> <uveďte cestu expozice, je-li přesvědčivě prokázáno, že ostatní cesty expozice nejsou nebezpečné>.
DAKan skade forplantningsevnen eller det ufødte barn <angiv specifik effekt, hvis kendt> <angiv eksponeringsvej, hvis det er endeligt påvist, at faren ikke kan frembringes ad nogen anden eksponeringsvej>.
DEKann die Fruchtbarkeit beeinträchtigen oder das Kind im Mutterleib schädigen <konkrete Wirkung angeben, sofern bekannt> <Expositionsweg angeben, sofern schlüssig belegt ist, dass die Gefahr bei keinem anderen Expositionsweg besteht>.
ETVõib kahjustada viljakust või loodet <märkida spetsiifiline toime, kui see on teada> <märkida kokkupuuteviis, kui on veenvalt tõestatud, et muud kokkupuuteviisid ei ole ohtlikud>.
ELΜπορεί να βλάψει τη γονιμότητα ή το έμβρυο <αναφέρεται η ειδική επίπτωση εάν είναι γνωστή> <αναφέρεται η οδός έκθεσης αν έχει αποδειχθεί αδιαμφισβήτητα ότι δεν υπάρχει κίνδυνος από τις άλλες οδούς έκθεσης>.
ENMay damage fertility or the unborn child <state specific effect if known > <state route of exposure if it is conclusively proven that no other routes of exposure cause the hazard>.
FRPeut nuire à la fertilité ou au fœtus <indiquer l'effet spécifique s'il est connu> <indiquer la voie d'exposition s'il est formellement prouvé qu'aucune autre voie d'exposition ne conduit au même danger>.
GAD'fhéadfadh sé damáiste a dhéanamh do thorthúlacht nó don leanbh sa bhroinn <tabhair an tsainéifeacht más eol > <tabhair an bealach nochta má tá sé cruthaithe go cinntitheach nach bealach nochta ar bith eile is cúis leis an nguais>.
ITPuò nuocere alla fertilità o al feto <indicare l'effetto specifico, se noto><indicare la via di esposizione se è accertato che nessun'altra via di esposizione comporta il medesimo pericolo>.
LVVar kaitēt auglībai vai nedzimušajam bērnam <norādīt īpašo ietekmi, ja tā ir zināma> <norādīt iedarbības ceļu, ja ir nepārprotami pierādīts, ka citi iedarbības ceļi nerada bīstamību>.
LTGali pakenkti vaisingumui arba negimusiam vaikui <nurodyti konkretų poveikį, jeigu žinomas> <nurodyti veikimo būdą, jeigu įtikinamai nustatyta, kad kiti veikimo būdai nepavojingi>.
HUKárosíthatja a termékenységet vagy a születendő gyermeket < ha ismert, meg kell adni a konkrét hatást > < meg kell adni az expozíciós útvonalat, ha meggyőzően bizonyított, hogy más expozíciós útvonal nem okozza a veszélyt >.
MTJista' jagħmel ħsara lill-fertilità jew lit-tarbija li għadha fil-ġuf <semmi l-effett speċifiku jekk ikun magħruf> <semmi l-mod ta' espożizzjoni jekk ikun pruvat b'mod konklużiv li l-ebda mod ta' espożizzjoni ieħor ma jikkawża l-periklu>.
NLKan de vruchtbaarheid of het ongeboren kind schaden <specifiek effect vermelden indien bekend> <blootstellingsroute vermelden indien afdoende bewezen is dat het gevaar bij andere blootstellingsroutes niet aanwezig is>.
PLMoże działać szkodliwie na płodność lub na dziecko w łonie matki <podać szczególny skutek, jeżeli jest znany> <podać drogę narażenia, jeżeli definitywnie udowodniono, że inne drogi narażenia nie stwarzają zagrożenia>.
PTPode afectar a fertilidade ou o nascituro <indicar o efeito específico se este for conhecido> <indicar a via de exposição se existirem provas concludentes de que o perigo não decorre de nenhuma outra via de exposição>.
ROPoate dăuna fertilităţii sau fătului <indicaţi efectul specific, dacă este cunoscut><indicaţi calea de expunere, dacă există probe concludente că nicio altă cale de expunere nu provoacă acest pericol>.
SKMôže spôsobiť poškodenie plodnosti alebo nenarodeného dieťaťa <uveďte konkrétny účinok, ak je známy > <uveďte spôsob expozície, ak sa presvedčivo preukáže, že iné spôsoby expozície nevyvolávajú nebezpečenstvo>.
SLLahko škoduje plodnosti ali nerojenemu otroku <navesti posebni učinek, če je znan> <navesti način izpostavljenosti, če je prepričljivo dokazano, da noben drug način izpostavljenosti ne povzroča takšne nevarnosti>.
FISaattaa heikentää hedelmällisyyttä tai vaurioittaa sikiötä <mainitaan tiedetty spesifinen vaikutus> <mainitaan altistumisreitti, jos on kiistatta osoitettu, että vaara ei voi aiheutua muiden altistumisreittien kautta>.
SVKan skada fertiliteten eller det ofödda barnet <ange specifik effekt om denna är känd> <ange exponeringsväg om det är definitivt bevisat att faran inte kan orsakas av några andra exponeringsvägar>.

H361Language
3.7— Reproductive toxicity, Hazard Category 2
BGПредполага се, че уврежда оплодителната способност или плода < да се посочи конкретното въздействие, ако е известно > < да се посочи пътят на експозицията, ако е доказано убедително, че няма друг път на експозиция, който води до същата опасност >.
ESSe sospecha que perjudica la fertilidad o daña al feto <indíquese el efecto específico si se conoce> <indíquese la vía de exposición si se ha demostrado concluyentemente que el peligro no se produce por ninguna otra vía>.
CSPodezření na poškození reprodukční schopnosti nebo plodu v těle matky <uveďte specifický účinek, je-li znám> <uveďte cestu expozice, je-li přesvědčivě prokázáno, že ostatní cesty expozice nejsou nebezpečné>.
DAMistænkt for at skade forplantningsevnen eller det ufødte barn <angiv specifik effekt, hvis kendt> <angiv eksponeringsvej, hvis det er endeligt påvist, at faren ikke kan frembringes ad nogen anden eksponeringsvej>.
DEKann vermutlich die Fruchtbarkeit beeinträchtigen oder das Kind im Mutterleib schädigen < konkrete Wirkung angebe, n sofern bekannt > <Expositionsweg angeben, sofern schlüssig belegt ist, dass die Gefahr bei keinem anderen Expositionsweg besteht>
ETArvatavasti kahjustab viljakust või loodet <märkida spetsiifiline toime, kui see on teada> <märkida kokkupuuteviis, kui on veenvalt tõestatud, et muud kokkupuuteviisid ei ole ohtlikud>.
ELΎποπτο για πρόκληση βλάβης στη γονιμότητα ή στο έμβρυο <αναφέρεται η ειδική επίπτωση εάν είναι γνωστή> <αναφέρεται η οδός έκθεσης αν έχει αποδειχθεί αδιαμφισβήτητα ότι δεν υπάρχει κίνδυνος από τις άλλες οδούς έκθεσης>.
ENSuspected of damaging fertility or the unborn child <state specific effect if known> <state route of exposure if it is conclusively proven that no other routes of exposure cause the hazard>.
FRSusceptible de nuire à la fertilité ou au fœtus <indiquer l'effet s'il est connu> <indiquer la voie d'exposition s'il est formellement prouvé qu'aucune autre voie d'exposition ne conduit au même danger>.
GACeaptar go bhféadfadh sé damáiste a dhéanamh do thorthúlacht nó don leanbh sa bhroinn <tabhair an tsainéifeacht más eol > <tabhair an bealach nochta má tá sé cruthaithe go cinntitheach nach bealach nochta ar bith eile is cúis leis an nguais>.
ITSospettato di nuocere alla fertilità o al feto <indicare l'effetto specifico, se noto> <indicare la via di esposizione se è accertato che nessun'altra via di esposizione comporta il medesimo pericolo>.
LVIr aizdomas, ka var kaitēt auglībai vai nedzimušajam bērnam <norādīt īpašo ietekmi, ja tā ir zināma> <norādīt iedarbības ceļu, ja ir nepārprotami pierādīts, ka citi iedarbības ceļi nerada bīstamību>.
LTĮtariama, kad kenkia vaisingumui arba negimusiam vaikui <nurodyti konkretų poveikį, jeigu žinomas> <nurodyti veikimo būdą, jeigu įtikinamai nustatyta, kad kiti veikimo būdai nepavojingi>.
HUFeltehetően károsítja a termékenységet vagy a születendő gyermeket < ha ismert, meg kell adni a konkrét hatást > < meg kell adni az expozíciós útvonalat, ha meggyőzően bizonyított, hogy más expozíciós útvonal nem okozza a veszélyt >.
MTSuspettat li jagħmel ħsara lill-fertilità jew lit-tarbija li għadha fil-ġuf <semmi l-effett speċifiku jekk ikun magħruf> <semmi l-mod ta' espożizzjoni jekk ikun pruvat b'mod konklużiv li l-ebda mod ta' espożizzjoni ieħor ma jikkawża l-periklu >.
NLKan mogelijks de vruchtbaarheid of het ongeboren kind schaden <specifiek effect vermelden indien bekend> <blootstellingsroute vermelden indien afdoende bewezen is dat het gevaar bij andere blootstellingsroutes niet aanwezig is>.
PLPodejrzewa się, że działa szkodliwie na płodność lub na dziecko w łonie matki <podać szczególny skutek, jeżeli jest znany> <podać drogę narażenia, jeżeli definitywnie udowodniono, że inne drogi narażenia nie stwarzają zagrożenia>.
PTSuspeito de afectar a fertilidade ou o nascituro <indicar o efeito específico se este for conhecido> <indicar a via de exposição se existirem provas concludentes de que o perigo não decorre de nenhuma outra via de exposição>.
ROSusceptibil de a dăuna fertilităţii sau fătului <indicaţi efectul specific, dacă este cunoscut><indicaţi calea de expunere, dacă există probe concludente că nicio altă cale de expunere nu provoacă acest pericol>.
SKPodozrenie, že spôsobuje poškodenie plodnosti alebo nenarodeného dieťaťa <uveďte konkrétny účinok, ak je známy > <uveďte spôsob expozície, ak sa presvedčivo preukáže, že iné spôsoby expozície nevyvolávajú nebezpečenstvo>.
SLSum škodljivosti za plodnost ali nerojenega otroka <navesti posebni učinek, če je znan> <navesti način izpostavljenosti, če je prepričljivo dokazano, da noben drug način izpostavljenosti ne povzroča takšne nevarnosti>.
FIEpäillään heikentävän hedelmällisyyttä tai vaurioittavan sikiötä <mainitaan tiedetty spesifinen vaikutus> <mainitaan altistumisreitti, jos on kiistatta osoitettu, että vaara ei voi aiheutua muiden altistumisreittien kautta>.
SVMisstänks kunna skada fertiliteten eller det ofödda barnet <ange specifik effekt om denna är känd> <ange exponeringsväg om det är definitivt bevisat att faran inte kan orsakas av några andra exponeringsvägar>.

H362Language
3.7— Reproductive toxicity, Additional category, Effects on or via lactation
BGМоже да бъде вреден за кърмачета.
ESPuede perjudicar a los niños alimentados con leche materna.
CSMůže poškodit kojence prostřednictvím mateřského mléka.
DAKan skade børn, der ammes.
DEKann Säuglinge über die Muttermilch schädigen.
ETVõib kahjustada rinnaga toidetavat last.
ELΜπορεί να βλάψει τα βρέφη που τρέφονται με μητρικό γάλα.
ENMay cause harm to breast-fed children.
FRPeut être nocif pour les bébés nourris au lait maternel.
GAD'fhéadfadh sé díobháil a dhéanamh do leanaí diúil.
ITPuò essere nocivo per i lattanti allattati al seno.
LVVar radīt kaitējumu ar krūti barotam bērnam.
LTGali pakenkti žindomam vaikui.
HUA szoptatott gyermeket károsíthatja.
MTJista’ jagħmel ħsara lit-tfal imreddgħa.
NLKan schadelijk zijn via borstvoeding.
PLMoże działać szkodliwie na dzieci karmione piersią.
PTPode ser nocivo para as crianças alimentadas com leite materno.
ROPoate dăuna copiilor alăptaţi la sân.
SKMôže spôsobiť poškodenie u dojčených detí.
SLLahko škoduje dojenim otrokom.
FISaattaa aiheuttaa haittaa rintaruokinnassa oleville lapsille.
SVKan skada spädbarn som ammas.

H370Language
3.8— Specific target organ toxicity — single exposure, Hazard Category 1
BGПричинява увреждане на органите < или да се посочат всички засегнати органи, ако са известни> < да се посочи пътят на експозицията, ако е доказано убедително, че няма друг път на експозиция, който води до същата опасност >.
ESProvoca daños en los órganos <o indíquense todos los órganos afectados, si se conocen> <indíquese la vía de exposición si se ha demostrado concluyentemente que el peligro no se produce por ninguna otra vía>.
CSZpůsobuje poškození orgánů <nebo uvést všechny postižené orgány, jsou-li známy> <uveďte cestu expozice, je-li přesvědčivě prokázáno, že ostatní cesty expozice nejsou nebezpečné>.
DAForårsager organskader <eller angiv alle berørte organer, hvis de kendes> <angiv eksponeringsvej, hvis det er endeligt påvist, at faren ikke kan frembringes ad nogen anden eksponeringsvej>.
DESchädigt die Organe <oder alle betroffenen Organe nennen, sofern bekannt> <Expositionsweg angeben, sofern schlüssig belegt ist, dass diese Gefahr bei keinem anderen Expositionsweg besteht>.
ETKahjustab elundeid <või märkida kõik mõjutatud elundid, kui need on teada> <märkida kokkupuuteviis, kui on veenvalt tõestatud, et muud kokkupuuteviisid ei ole ohtlikud>.
ELΠροκαλεί βλάβες στα όργανα <ή αναφέρονται όλα τα όργανα που βλάπτονται, εάν είναι γνωστά> < αναφέρεται η οδός έκθεσης αν έχει αποδειχθεί αδιαμφισβήτητα ότι δεν υπάρχει κίνδυνος από τις άλλες οδούς έκθεσης >.
ENCauses damage to organs <or state all organs affected, if known> <state route of exposure if it is conclusively proven that no other routes of exposure cause the hazard>.
FRRisque avéré d'effets graves pour les organes <ou indiquer tous les organes affectés, s'ils sont connus> <indiquer la voie d'exposition s'il est formellement prouvé qu'aucune autre voie d'exposition ne conduit au même danger>.
GADéanann sé damáiste d'orgáin <nó tabhair na horgáin go léir a bhuailtear, más eol> <tabhair an bealach nochta má tá sé cruthaithe go cinntitheach nach bealach nochta ar bith eile is cúis leis an nguais>.
ITProvoca danni agli organi <o indicare tutti gli organi interessati, se noti> <indicare la via di esposizione se è accertato che nessun'altra via di esposizione comporta il medesimo pericolo>.
LVRada orgānu bojājumus <vai norādīt visus skartos orgānus, ja tie ir zināmi> <norādīt iedarbības ceļu, ja ir nepārprotami pierādīts, ka citi iedarbības ceļi nerada bīstamību>.
LTKenkia organams <arba nurodyti visus veikiamus organus, jeigu žinomi> <nurodyti veikimo būdą, jeigu įtikinamai nustatyta, kad kiti veikimo būdai nepavojingi>.
HUKárosítja a szerveket < vagy meg kell adni az összes érintett szervet, ha ismertek > < meg kell adni az expozíciós útvonalat, ha meggyőzően bizonyított, hogy más expozíciós útvonal nem okozza a veszélyt >.
MTJagħmel ħsara lill-organi <jew semmi l-organi kollha affettwati, jekk ikunu magħrufa> <semmi l-mod ta' espożizzjoni jekk ikun pruvat b'mod konklużiv li l-ebda mod ta' espożizzjoni ieħor ma jikkawża l-periklu>.
NLVeroorzaakt schade aan organen <of alle betrokken organen vermelden indien bekend> <blootstellingsroute vermelden indien afdoende bewezen is dat het gevaar bij andere blootstellingsroutes niet aanwezig is>.
PLPowoduje uszkodzenie narządów <podać szczególny skutek, jeśli jest znany> <podać drogę narażenia, jeżeli udowodniono, że inne drogi narażenia nie stwarzają zagrożenia>.
PTAfecta os órgãos <ou indicar todos os órgãos afectados, se forem conhecidos> <indicar a via de exposição se existirem provas concludentes de que o perigo não decorre de nenhuma outra via de exposição>.
ROProvoacă leziuni ale organelor <sau indicaţi toate organele afectate, dacă sunt cunoscute> <indicaţi calea de expunere, dacă există probe concludente că nicio altă cale de expunere nu provoacă acest pericol>.
SKSpôsobuje poškodenie orgánov <alebo uveďte všetky zasiahnuté orgány, ak sú známe> <uveďte spôsob expozície, ak sa presvedčivo preukáže, že iné spôsoby expozície nevyvolávajú nebezpečenstvo>.
SLŠkoduje organom <ali navesti vse organe, na katere vpliva, če je znano> <navesti način izpostavljenosti, če je prepričljivo dokazano, da noben drug način izpostavljenosti ne povzroča takšne nevarnosti>.
FIVahingoittaa elimiä <tai mainitaan kaikki tiedetyt kohde-elimet> <mainitaan altistumisreitti, jos on kiistatta osoitettu, että vaara ei voi aiheutua muiden altistumisreittien kautta>.
SVOrsakar organskador <eller ange vilka organ som påverkas om detta är känt> <ange exponeringsväg om det är definitivt bevisat att faran inte kan orsakas av några andra exponeringsvägar>.

H371Language
3.8— Specific target organ toxicity — Single exposure, Hazard Category 2
BGМоже да причини увреждане на органите < или да се посочат всички засегнати органи, ако са известни> < да се посочи пътят на експозицията, ако е доказано убедително, че няма друг път на експозиция, който води до същата опасност >.
ESPuede provocar daños en los órganos <o indíquense todos los órganos afectados, si se conocen> <indíquese la vía de exposición si se ha demostrado concluyentemente que el peligro no se produce por ninguna otra vía>.
CSMůže způsobit poškození orgánů <nebo uvést všechny postižené orgány, jsou-li známy> <uveďte cestu expozice, je-li přesvědčivě prokázáno, že ostatní cesty expozice nejsou nebezpečné>.
DAKan forårsage organskader <eller angiv alle berørte organer, hvis de kendes> <angiv eksponeringsvej, hvis det er endeligt påvist, at faren ikke kan frembringes ad nogen anden eksponeringsvej>.
DEKann die Organe schädigen <oder alle betroffenen Organe nennen, sofern bekann> <Expositionsweg angeben, sofern schlüssig belegt ist, dass diese Gefahr bei keinem anderen Expositionsweg besteht>.
ETVõib kahjustada elundeid <või märkida kõik mõjutatud elundid, kui need on teada> <märkida kokkupuuteviis, kui on veenvalt tõestatud, et muud kokkupuuteviisid ei ole ohtlikud>.
ELΜπορεί να προκαλέσει βλάβες στα όργανα <ή αναφέρονται όλα τα όργανα που βλάπτονται, εάν είναι γνωστά> <αναφέρεται η οδός έκθεσης αν έχει αποδειχθεί αδιαμφισβήτητα ότι δεν υπάρχει κίνδυνος από τις άλλες οδούς έκθεσης>.
ENMay cause damage to organs <or state all organs affected, if known> <state route of exposure if it is conclusively proven that no other routes of exposure cause the hazard>.
FRRisque présumé d'effets graves pour les organes <ou indiquer tous les organes affectés, s'ils sont connus> <indiquer la voie d'exposition s'il est formellement prouvé qu'aucune autre voie d'exposition ne conduit au même danger>.
GAD'fhéadfadh damáiste a dhéanamh d'orgáin <nó tabhair na horgáin go léir a bhuailtear, más eol> <tabhair an bealach nochta má tá sé cruthaithe go cinntitheach nach bealach nochta ar bith eile is cúis leis an nguais>.
ITPuò provocare danni agli organi <o indicare tutti gli organi interessati, se noti> <indicare la via di esposizione se è accertato che nessun'altra via di esposizione comporta il medesimo pericolo>.
LVVar izraisīt orgānu bojājumus <vai norādīt visus skartos orgānus, ja tie ir zināmi> <norādīt iedarbības ceļu, ja ir nepārprotami pierādīts, ka citi iedarbības ceļi nerada bīstamību>.
LTGali pakenkti organams <arba nurodyti visus veikiamus organus, jeigu žinomi> <nurodyti veikimo būdą, jeigu įtikinamai nustatyta, kad kiti veikimo būdai nepavojingi>.
HUKárosíthatja a szerveket < vagy meg kell adni az összes érintett szervet, ha ismertek > < meg kell adni az expozíciós útvonalat, ha meggyőzően bizonyított, hogy más expozíciós útvonal nem okozza a veszélyt >.
MTJista’ jikkawża ħsara lill-organi <jew semmi l-organi kollha affettwati, jekk ikunu magħrufa> <semmi l-mod ta' espożizzjoni jekk ikun pruvat b'mod konklużiv li l-ebda mod ta'’ espożizzjoni ieħor ma jikkawża l-periklu>.
NLKan schade aan organen <of alle betrokken organen vermelden indien bekend> veroorzaken <blootstellingsroute vermelden indien afdoende bewezen is dat het gevaar bij andere blootstellingsroutes niet aanwezig is>.
PLMoże powodować uszkodzenie narządów <podać wszystkie znane narządy, których to dotyczy> <podać drogę narażenia, jeżeli udowodniono, że inne drogi narażenia nie stwarzają zagrożenia>.
PTPode afectar os órgãos <ou indicar todos os órgãos afectados, se forem conhecidos> <indicar a via de exposição se existirem provas concludentes de que o perigo não decorre de nenhuma outra via de exposição>.
ROPoate provoca leziuni ale organelor <sau indicaţi toate organele afectate, dacă sunt cunoscute> <indicaţi calea de expunere, dacă există probe concludente că nicio altă cale de expunere nu provoacă acest pericol>.
SKMôže spôsobiť poškodenie orgánov <alebo uveďte všetky zasiahnuté orgány, ak sú známe> <uveďte spôsob expozície, ak sa presvedčivo preukáže, že iné spôsoby expozície nevyvolávajú nebezpečenstvo>.
SLLahko škoduje organom <ali navesti vse organe, na katere vpliva, če je znano> <navesti način izpostavljenosti, če je prepričljivo dokazano, da noben drug način izpostavljenosti ne povzroča takšne nevarnosti>.
FISaattaa vahingoittaa elimiä <tai mainitaan kaikki tiedetyt kohde-elimet> <mainitaan altistumisreitti, jos on kiistatta osoitettu, että vaara ei voi aiheutua muiden altistumisreittien kautta>.
SVKan orsaka organskador <eller ange vilka organ som påverkas om detta är känt> <ange exponeringsväg om det är definitivt bevisat att faran inte kan orsakas av några andra exponeringsvägar>.

H372Language
3.9— Specific target organ toxicity — Repeated exposure, Hazard Category 1
BGПричинява увреждане на органите < или да се посочат всички засегнати органи, ако са известни > посредством продължителна или повтаряща се експозиция < да се посочи пътят на експозицията, ако е доказано убедително, че няма друг път на експозиция, който води до същата опасност >.
ESProvoca daños en los órganos <indíquense todos los órganos afectados, si se conocen> tras exposiciones prolongadas o repetidas <indíquese la vía de exposición si se ha demostrado concluyentemente que el peligro no se produce por ninguna otra vía>.
CSZpůsobuje poškození orgánů <nebo uvést všechny postižené orgány, jsou-li známy> při prodloužené nebo opakované expozici <uveďte cestu expozice, je-li přesvědčivě prokázáno, že ostatní cesty expozice nejsou nebezpečné>.
DAForårsager organskader <eller angiv alle berørte organer, hvis de kendes> ved længerevarende eller gentagen eksponering <angiv eksponeringsvej, hvis det er endeligt påvist, at faren ikke kan frembringes ad nogen anden eksponeringsvej>.
DESchädigt die Organe <alle betroffenen Organe nennen> bei längerer oder wiederholter Exposition <Expositionsweg angeben, wenn schlüssig belegt ist, dass diese Gefahr bei keinem anderen Expositionsweg besteht>.
ETKahjustab elundeid <või märkida kõik mõjutatud elundid, kui need on teada> pikaajalisel või korduval kokkupuutel <märkida kokkupuuteviis, kui on veenvalt tõestatud, et muud kokkupuuteviisid ei ole ohtlikud>.
ELΠροκαλεί βλάβες στα όργανα <ή αναφέρονται όλα τα όργανα που βλάπτονται, εάν είναι γνωστά> ύστερα από παρατεταμένη ή επανειλημμένη έκθεση < αναφέρεται η οδός έκθεσης αν έχει αποδειχθεί αδιαμφισβήτητα ότι δεν υπάρχει κίνδυνος από τις άλλες οδούς έκθεσης >.
ENCauses damage to organs <or state all organs affected, if known> through prolonged or repeated exposure <state route of exposure if it is conclusively proven that no other routes of exposure cause the hazard>.
FRRisque avéré d'effets graves pour les organes <indiquer tous les organes affectés, s'ils sont connus> à la suite d'expositions répétées ou d'une exposition prolongée <indiquer la voie d'exposition s'il est formellement prouvé qu'aucune autre voie d'exposition ne conduit au même danger>.
GADéanann damáiste d'orgáin <nó tabhair na horgáin go léir a bhuailtear, más eol> trí nochtadh fada nó ilnochtadh <tabhair an bealach nochta má tá sé cruthaithe go cinntitheach nach bealach nochta ar bith eile is cúis leis an nguais>.
ITProvoca danni agli organi <o indicare tutti gli organi interessati, se noti> in caso di esposizione prolungata o ripetuta <indicare la via di esposizione se è accertato che nessun'altra via di esposizione comporta il medesimo pericolo>.
LVIzraisa orgānu bojājumus <vai norādīt visus skartos orgānus, ja tie ir zināmi> ilgstošas vai atkārtotas iedarbības rezultātā <norādīt iedarbības ceļu, ja ir nepārprotami pierādīts, ka citi iedarbības ceļi nerada bīstamību>.
LTKenkia organams <arba nurodyti visus veikiamus organus, jeigu žinoma>, jeigu medžiaga veikia ilgai arba kartotinai <nurodyti veikimo būdą, jeigu įtikinamai nustatyta, kad kiti veikimo būdai nepavojingi>.
HUIsmétlődő vagy hosszabb expozíció esetén < meg kell adni az expozíciós útvonalat, ha meggyőzően bizonyított, hogy más expozíciós útvonal nem okozza a veszélyt > károsítja a szerveket < vagy meg kell adni az összes érintett szervet, ha ismertek >.
MTJikkawża ħsara lill-organi <jew semmi l-organi kollha affettwati, jekk ikunu magħrufa> minħabba espożizzjoni fit-tul jew ripetuta <semmi l-mod ta' espożizzjoni jekk ikun pruvat b'mod konklużiv li l-ebda mod ta' espożizzjoni ieħor ma jikkawża l-periklu>.
NLVeroorzaakt schade aan organen <of alle betrokken organen vermelden indien bekend> bij langdurige of herhaalde blootstelling <blootstellingsroute vermelden indien afdoende bewezen is dat het gevaar bij andere blootstellingsroutes niet aanwezig is>.
PLPowoduje uszkodzenie narządów <podać wszystkie znane narządy, których to dotyczy > poprzez długotrwałe lub powtarzane narażenie <podać drogę narażenia, jeżeli udowodniono, że inne drogi narażenia nie stwarzają zagrożenia>.
PTAfecta os órgãos <ou indicar todos os órgãos afectados, se forem conhecidos> após exposição prolongada ou repetida <indicar a via de exposição se existirem provas concludentes de que o perigo não decorre de nenhuma outra via de exposição>.
ROProvoacă leziuni ale organelor <sau indicaţi toate organele afectate, dacă sunt cunoscute> în caz de expunere prelungită sau repetată <indicaţi calea de expunere, dacă există probe concludente că nicio altă cale de expunere nu provoacă acest pericol>.
SKSpôsobuje poškodenie orgánov <alebo uveďte všetky zasiahnuté orgány, ak sú známe>pri dlhšej alebo opakovanej expozícii <uveďte spôsob expozície, ak sa presvedčivo preukáže, že iné spôsoby expozície nevyvolávajú nebezpečenstvo>.
SLŠkoduje organom <ali navesti vse organe, na katere vpliva, če je znano> pri dolgotrajni ali ponavljajoči se izpostavljenosti <navesti način izpostavljenosti, če je prepričljivo dokazano, da noben drug način izpostavljenosti ne povzroča takšne nevarnosti>.
FIVahingoittaa elimiä <tai mainitaan kaikki tiedetyt kohde-elimet> pitkäaikaisessa tai toistuvassa altistumisessa <mainitaan altistumisreitti, jos on kiistatta osoitettu, että vaara ei voi aiheutua muiden altistumisreittien kautta>.
SVOrsakar organskador <eller ange vilka organ som påverkas om detta är känt> genom lång eller upprepad exponering <ange exponeringsväg om det är definitivt bevisat att faran inte kan orsakas av några andra exponeringsvägar>.

H373Language
3.9— Specific target organ toxicity — Repeated exposure, Hazard Category 2
BGМоже да причини увреждане на органите < или да се посочат всички засегнати органи, ако са известни > при продължителна или повтаряща се експозиция < да се посочи пътят на експозицията, ако е доказано убедително, че няма друг път на експозиция, който води до същата опасност >.
ESPuede provocar daños en los órganos <indíquense todos los órganos afectados, si se conocen> tras exposiciones prolongadas o repetidas <indíquese la vía de exposición si se ha demostrado concluyentemente que el peligro no se produce por ninguna otra vía>.
CSMůže způsobit poškození orgánů <nebo uvést všechny postižené orgány, jsou-li známy> při prodloužené nebo opakované expozici <uveďte cestu expozice, je-li přesvědčivě prokázáno, že ostatní cesty expozice nejsou nebezpečné>.
DAKan forårsage organskader <eller angiv alle berørte organer, hvis de kendes> ved længerevarende eller gentagen eksponering <angiv eksponeringsvej, hvis det er endeligt påvist, at faren ikke kan frembringes ad nogen anden eksponeringsvej>.
DEKann die Organe schädigen <alle betroffenen Organe nennen, sofern bekannt> bei längerer oder wiederholter Exposition <Expositionsweg angeben, wenn schlüssig belegt ist, dass diese Gefahr bei keinem anderen Expositionsweg besteht>.
ETVõib kahjustada elundeid <või märkida kõik mõjutatud elundid, kui need on teada> pikaajalisel või korduval kokkupuutel <märkida kokkupuuteviis, kui on veenvalt tõestatud, et muud kokkupuuteviisid ei ole ohtlikud>.
ELΜπορεί να προκαλέσει βλάβες στα όργανα <ή αναφέρονται όλα τα όργανα που βλάπτονται, εάν είναι γνωστά> ύστερα από παρατεταμένη ή επανειλημμένη έκθεση <αναφέρεται η οδός έκθεσης αν έχει αποδειχθεί αδιαμφισβήτητα ότι δεν υπάρχει κίνδυνος από τις άλλες οδούς έκθεσης>.
ENMay cause damage to organs <or state all organs affected, if known> through prolonged or repeated exposure <state route of exposure if it is conclusively proven that no other routes of exposure cause the hazard>.
FRRisque présumé d'effets graves pour les organes <ou indiquer tous les organes affectés, s'ils sont connus> à la suite d'expositions répétées ou d'une exposition prolongée <indiquer la voie d'exposition s'il est formellement prouvé qu'aucune autre voie d'exposition ne conduit au même danger>.
GAD'fhéadfadh sé damáiste a dhéanamh d'orgáin <nó tabhair na horgáin go léir a bhuailtear, más eol> trí nochtadh fada nó ilnochtadh <tabhair an bealach nochta má tá sé cruthaithe go cinntitheach nach bealach nochta ar bith eile is cúis leis an nguais>.
ITPuò provocare danni agli organi <o indicare tutti gli organi interessati, se noti> in caso di esposizione prolungata o ripetuta <indicare la via di esposizione se è accertato che nessun'altra via di esposizione comporta il medesimo pericolo>.
LVVar izraisīt orgānu bojājumus <vai norādīt visus skartos orgānus, ja tie ir zināmi> ilgstošas vai atkārtotas iedarbības rezultātā <norādīt iedarbības ceļu, ja ir nepārprotami pierādīts, ka citi iedarbības ceļi nerada bīstamību>.
LTGali pakenkti organams <arba nurodyti visus veikiamus organus, jeigu žinomi>, jeigu medžiaga veikia ilgai arba kartotinai <nurodyti veikimo būdą, jeigu įtikinamai nustatyta, kad kiti veikimo būdai nepavojingi>.
HUIsmétlődő vagy hosszabb expozíció esetén < meg kell adni az expozíciós útvonalat, ha meggyőzően bizonyított, hogy más expozíciós útvonal nem okozza a veszélyt > károsíthatja a szerveket > vagy meg kell adni az összes érintett szervet, ha ismertek >.
MTJista’ jikkawża ħsara lill-organi <jew semmi l-organi kollha affettwati, jekk ikunu magħrufa> minħabba espożizzjoni fit-tul jew ripetuta <semmi l-mod ta' espożizzjoni jekk ikun pruvat b'mod konklużiv li l-ebda mod ta' espożizzjoni ieħor ma jikkawża l-periklu>.
NLKan schade aan organen <of alle betrokken organen vermelden indien bekend> veroorzaken bij langdurige of herhaalde blootstelling <blootstellingsroute vermelden indien afdoende bewezen is dat het gevaar bij andere blootstellingsroutes niet aanwezig is>.
PLMoże powodować uszkodzenie narządów <podać wszystkie znane narządy, których to dotyczy > poprzez długotrwałe lub narażenie powtarzane <podać drogę narażenia, jeśli udowodniono, że inne drogi narażenia nie stwarzają zagrożenia>.
PTPode afectar os órgãos <ou indicar todos os órgãos afectados, se forem conhecidos> após exposição prolongada ou repetida <indicar a via de exposição se existirem provas concludentes de que o perigo não decorre de nenhuma outra via de exposição>.
ROPoate provoca leziuni ale organelor <sau indicaţi toate organele afectate, dacă sunt cunoscute> în caz de expunere prelungită sau repetată <indicaţi calea de expunere, dacă există probe concludente că nicio altă cale de expunere nu provoacă acest pericol>.
SKMôže spôsobiť poškodenie orgánov <alebo uveďte všetky zasiahnuté orgány, ak sú známe>pri dlhšej alebo opakovanej expozícii <uveďte spôsob expozície, ak sa presvedčivo preukáže, že iné spôsoby expozície nevyvolávajú nebezpečenstvo>.
SLLahko škoduje organom <ali navesti vse organe, na katere vpliva, če je znano> pri dolgotrajni ali ponavljajoči se izpostavljenosti <navesti način izpostavljenosti, če je prepričljivo dokazano, da noben drug način izpostavljenosti ne povzroča takšne nevarnosti>.
FISaattaa vahingoittaa elimiä <tai mainitaan kaikki tiedetyt kohde-elimet> pitkäaikaisessa tai toistuvassa altistumisessa <mainitaan altistumisreitti, jos on kiistatta osoitettu, että vaara ei voi aiheutua muiden altistumisreittien kautta>
SVKan orsaka organskador <eller ange vilka organ som påverkas om detta är känt> genom lång eller upprepad exponering <ange exponeringsväg om det är definitivt bevisat att faran inte kan orsakas av några andra exponeringsvägar>.


Table 1.3

Hazard statements for environmental hazards

H400Language
4.1— Hazardous to the aquatic environment — AcuteHazard, Category 1
BGСилно токсичен за водните организми.
ESMuy tóxico para los organismos acuáticos.
CSVysoce toxický pro vodní organismy.
DAMeget giftig for vandlevende organismer.
DESehr giftig für Wasserorganismen.
ETVäga mürgine veeorganismidele.
ELΠολύ τοξικό για τους υδρόβιους οργανισμούς.
ENVery toxic to aquatic life.
FRTrès toxique pour les organismes aquatiques.
GAAn-tocsaineach don saol uisceach.
ITMolto tossico per gli organismi acquatici.
LVĻoti toksisks ūdens organismiem.
LTLabai toksiška vandens organizmams.
HUNagyon mérgező a vízi élővilágra.
MTTossiku ħafna għall-organiżmi akwatiċi.
NLZeer giftig voor in het water levende organismen.
PLDziała bardzo toksycznie na organizmy wodne.
PTMuito tóxico para os organismos aquáticos.
ROFoarte toxic pentru mediul acvatic.
SKVeľmi toxický pre vodné organizmy.
SLZelo strupeno za vodne organizme.
FIErittäin myrkyllistä vesieliöille.
SVMycket giftigt för vattenlevande organismer.

H410Language
4.1— Hazardous to the aquatic environment — Chronic Hazard, Category 1
BGСилно токсичен за водните организми, с дълготраен ефект.
ESMuy tóxico para los organismos acuáticos, con efectos nocivos duraderos.
CSVysoce toxický pro vodní organismy, s dlouhodobými účinky.
DAMeget giftig med langvarige virkninger for vandlevende organismer.
DESehr giftig für Wasserorganismen mit langfristiger Wirkung.
ETVäga mürgine veeorganismidele, pikaajaline toime.
ELΠολύ τοξικό για τους υδρόβιους οργανισμούς, με μακροχρόνιες επιπτώσεις.
ENVery toxic to aquatic life with long lasting effects.
FRTrès toxique pour les organismes aquatiques, entraîne des effets néfastes à long terme.
GAAn-tocsaineach don saol uisceach, le héifeachtaí fadtréimhseacha.
ITMolto tossico per gli organismi acquatici con effetti di lunga durata.
LVĻoti toksisks ūdens organismiem ar ilgstošām sekām.
LTLabai toksiška vandens organizmams, sukelia ilgalaikius pakitimus.
HUNagyon mérgező a vízi élővilágra, hosszan tartó károsodást okoz.
MTTossiku ħafna għall-organiżmi akwatiċi b'mod li jħalli effetti dejjiema.
NLZeer giftig voor in het water levende organismen, met langdurige gevolgen.
PLDziała bardzo toksycznie na organizmy wodne, powodując długotrwałe skutki.
PTMuito tóxico para os organismos aquáticos com efeitos duradouros.
ROFoarte toxic pentru mediul acvatic cu efecte pe termen lung.
SKVeľmi toxický pre vodné organizmy, s dlhodobými účinkami.
SLZelo strupeno za vodne organizme, z dolgotrajnimi učinki.
FIErittäin myrkyllistä vesieliöille, pitkäaikaisia haittavaikutuksia.
SVMycket giftigt för vattenlevande organismer med långtidseffekter.

H411Language
4.1— Hazardous to the aquatic environment — Chronic Hazard, Category 2
BGТоксичен за водните организми, с дълготраен ефект.
ESTóxico para los organismos acuáticos, con efectos nocivos duraderos.
CSToxický pro vodní organismy, s dlouhodobými účinky.
DAGiftig for vandlevende organismer, med langvarige virkninger.
DEGiftig für Wasserorganismen, mit langfristiger Wirkung.
ETMürgine veeorganismidele, pikaajaline toime.
ELΤοξικό για τους υδρόβιους οργανισμούς, με μακροχρόνιες επιπτώσεις.
ENToxic to aquatic life with long lasting effects.
FRToxique pour les organismes aquatiques, entraîne des effets néfastes à long terme.
GATocsaineach don saol uisceach, le héifeachtaí fadtréimhseacha.
ITTossico per gli organismi acquatici con effetti di lunga durata.
LVToksisks ūdens organismiem ar ilgstošām sekām.
LTToksiška vandens organizmams, sukelia ilgalaikius pakitimus.
HUMérgező a vízi élővilágra, hosszan tartó károsodást okoz.
MTTossiku għall-organiżmi akwatiċi b'mod li jħalli effetti dejjiema.
NLGiftig voor in het water levende organismen, met langdurige gevolgen.
PLDziała toksycznie na organizmy wodne, powodując długotrwałe skutki.
PTTóxico para os organismos aquáticos com efeitos duradouros.
ROToxic pentru mediul acvatic cu efecte pe termen lung.
SKToxický pre vodné organizmy, s dlhodobými účinkami.
SLStrupeno za vodne organizme, z dolgotrajnimi učinki.
FIMyrkyllistä vesieliöille, pitkäaikaisia haittavaikutuksia.
SVGiftigt för vattenlevande organismer med långtidseffekter.

H412Language
4.1— Hazardous to the aquatic environment — Chronic Hazard, Category 3
BGВреден за водните организми, с дълготраен ефект.
ESNocivo para los organismos acuáticos, con efectos nocivos duraderos.
CSŠkodlivý pro vodní organismy, s dlouhodobými účinky.
DASkadelig for vandlevende organismer, med langvarige virkninger.
DESchädlich für Wasserorganismen, mit langfristiger Wirkung.
ETOhtlik veeorganismidele, pikaajaline toime.
ELΕπιβλαβές για τους υδρόβιους οργανισμούς, με μακροχρόνιες επιπτώσεις.
ENHarmful to aquatic life with long lasting effects.
FRNocif pour les organismes aquatiques, entraîne des effets néfastes à long terme.
GADíobhálach don saol uisceach, le héifeachtaí fadtréimhseacha.
ITNocivo per gli organismi acquatici con effetti di lunga durata.
LVKaitīgs ūdens organismiem ar ilgstošām sekām.
LTKenksminga vandens organizmams, sukelia ilgalaikius pakitimus.
HUÁrtalmas a vízi élővilágra, hosszan tartó károsodást okoz.
MTJagħmel ħsara lill-organiżmi akwatiċi b'mod li jħalli effetti dejjiema.
NLSchadelijk voor in het water levende organismen, met langdurige gevolgen.
PLDziała szkodliwie na organizmy wodne, powodując długotrwałe skutki.
PTNocivo para os organismos aquáticos com efeitos duradouros.
RONociv pentru mediul acvatic cu efecte pe termen lung.
SKŠkodlivý pre vodné organizmy, s dlhodobými účinkami.
SLŠkodljivo za vodne organizme, z dolgotrajnimi učinki.
FIHaitallista vesieliöille, pitkäaikaisia haittavaikutuksia.
SVSkadliga långtidseffekter för vattenlevande organismer.

H413Language
4.1— Hazardous to the aquatic environment — Chronic Hazard, Category 4
BGМоже да причини дълготраен вреден ефект за водните организми.
ESPuede ser nocivo para los organismos acuáticos, con efectos nocivos duraderos.
CSMůže vyvolat dlouhodobé škodlivé účinky pro vodní organismy.
DAKan forårsage langvarige skadelige virkninger for vandlevende organismer.
DEKann für Wasserorganismen schädlich sein, mit langfristiger Wirkung.
ETVõib avaldada veeorganismidele pikaajalist kahjulikku toimet.
ELΜπορεί να προκαλέσει μακροχρόνιες επιπτώσεις στους υδρόβιους οργανισμούς.
ENMay cause long lasting harmful effects to aquatic life.
FRPeut être nocif à long terme pour les organismes aquatiques.
GAD'fhéadfadh sé a bheith ina chúis le héifeachtaí fadtréimhseacha díobhálacha ar an saol uisceach.
ITPuò essere nocivo per gli organismi acquatici con effetti di lunga durata.
LVVar radīt ilgstošas kaitīgas sekas ūdens organismiem.
LTGali sukelti ilgalaikį kenksmingą poveikį vandens organizmams.
HUHosszan tartó ártalmas hatást gyakorolhat a vízi élővilágra.
MTJista’ jikkawża effetti ta' ħsara dejjiema lill-organiżmi akwatiċi.
NLKan langdurige schadelijke gevolgen voor in het water levende organismen hebben.
PLMoże powodować długotrwałe szkodliwe skutki dla organizmów wodnych.
PTPode provocar efeitos nocivos duradouros nos organismos aquáticos.
ROPoate provoca efecte nocive pe termen lung asupra mediului acvatic.
SKMôže mať dlhodobé škodlivé účinky na vodné organizmy.
SLLahko ima dolgotrajne škodljive učinke na vodne organizme.
FIVoi aiheuttaa pitkäaikaisia haittavaikutuksia vesieliöille.
SVKan ge skadliga långtidseffekter på vattenlevande organismer.

2. Part 2: supplemental hazard information

Table 2.1

Physical properties

EUH 001Language
BGЕксплозивен в сухо състояние.
ESExplosivo en estado seco.
CSVýbušný v suchém stavu.
DAEksplosiv i tør tilstand.
DEIn trockenem Zustand explosionsgefährlich.
ETPlahvatusohtlik kuivana.
ELΕκρηκτικό σε ξηρή κατάσταση.
ENExplosive when dry.
FRExplosif à l'état sec.
GAPléascach agus é tirim.
ITEsplosivo allo stato secco.
LVSprādzienbīstams sausā veidā.
LTSausos būsenos gali sprogti.
HUSzáraz állapotban robbanásveszélyes.
MTJisplodi meta jinxef.
NLIn droge toestand ontplofbaar.
PLProdukt wybuchowy w stanie suchym.
PTExplosivo no estado seco.
ROExploziv în stare uscată.
SKV suchom stave výbušný.
SLEksplozivno v suhem stanju.
FIRäjähtävää kuivana.
SVExplosivt i torrt tillstånd.

EUH 006Language
BGЕксплозивен при или без контакт с въздуха.
ESExplosivo en contacto o sin contacto con el aire.
CSVýbušný za přístupu i bez přístupu vzduchu.
DAEksplosiv ved og uden kontakt med luft.
DEMit und ohne Luft explosionsfähig.
ETPlahvatusohtlik õhuga kokkupuutel või kokkupuuteta.
ELΕκρηκτικό σε επαφή ή χωρίς επαφή με τον αέρα.
ENExplosive with or without contact with air.
FRDanger d'explosion en contact ou sans contact avec l'air.
GAPléascach i dteagmháil le haer nó gan é.
ITEsplosivo a contatto o senza contatto con l'aria.
LVSprādzienbīstams gaisa un bezgaisa vidē.
LTGali sprogti ore arba beorėje erdvėje.
HULevegővel érintkezve vagy anélkül is robbanásveszélyes.
MTJista' jisplodi b'kuntatt jew bla kuntatt ma' l-ajra.
NLOntplofbaar met en zonder lucht.
PLProdukt wybuchowy z dostępem lub bez dostępu powietrza.
PTPerigo de explosão com ou sem contacto com o ar.
ROExploziv în contact sau fără contactul cu aerul.
SKVýbušné pri kontakte alebo bez kontaktu so vzduchom.
SLEksplozivno v stiku z zrakom ali brez stika z zrakom.
FIRäjähtävää sellaisenaan tai ilman kanssa.
SVExplosivt vid eller utan kontakt med luft.

EUH 014Language
BGРеагира бурно с вода.
ESReacciona violentamente con el agua.
CSPrudce reaguje s vodou.
DAReagerer voldsomt med vand.
DEReagiert heftig mit Wasser.
ETReageerib ägedalt veega.
ELΑντιδρά βίαια με νερό.
ENReacts violently with water.
FRRéagit violemment au contact de l'eau.
GAImoibríonn go foirtil le huisce.
ITReagisce violentemente con l'acqua.
LVAktīvi reaģē ar ūdeni.
LTSmarkiai reaguoja su vandeniu.
HUVízzel hevesen reagál.
MTJirreaġixxi bil-qawwa meta jmiss l-ilma.
NLReageert heftig met water.
PLReaguje gwałtownie z wodą.
PTReage violentamente em contacto com a água.
ROReacţionează violent în contact cu apa.
SKPrudko reaguje s vodou.
SLBurno reagira z vodo.
FIReagoi voimakkaasti veden kanssa.
SVReagerar häftigt med vatten.

EUH 018Language
BGПри употреба може да се образува запалима/експлозивна паровъздушнa смес.
ESAl usarlo pueden formarse mezclas aire-vapor explosivas o inflamables.
CSPři používání může vytvářet hořlavé nebo výbušné směsi par se vzduchem.
DAVed brug kan brandbarlige dampe/eksplosive damp-luftblandinger dannes.
DEKann bei Verwendung explosionsfähige/entzündbare Dampf/Luft-Gemische bilden.
ETKasutamisel võib moodustuda tule-/plahvatusohtlik auru-õhu segu.
ELΚατά τη χρήση μπορεί να σχηματίσει εύφλεκτα/εκρηκτικά μείγματα ατμού-αέρος.
ENIn use may form flammable/explosive vapour-air mixture.
FRLors de l'utilisation, formation possible de mélange vapeur-air inflammable/explosif.
GAAgus é á úsáid d'fhéadfaí meascán inadhainte/pléascach gaile-aeir a chruthú.
ITDurante l'uso può formarsi una miscela vapore-aria esplosiva/infiammabile.
LVIzmantojot var veidot uzliesmojošu vai sprādzienbīstamu tvaiku un gaisa maisījumu.
LTNaudojama gali sudaryti degius (sprogius) garų-oro mišinius.
HUA használat során tűzveszélyes/robbanásveszélyes gőz/levegő elegy keletkezhet.
MTMeta jintuża jista' jifforma taħlitiet esplussivi jew li jaqbdu jekk jitħallat ma' l-arja.
NLKan bij gebruik een ontvlambaar/ontplofbaar damp-luchtmengsel vormen.
PLPodczas stosowania mogą powstawać łatwopalne lub wybuchowe mieszaniny par z powietrzem.
PTPode formar mistura vapor-ar explosiva/inflamável durante a utilização.
ROÎn timpul utilizării poate forma un amestec vapori-aer, inflamabil/exploziv.
SKPri použití môže vytvárat’ horľavú/výbušnú zmes pár so vzduchom.
SLPri uporabi lahko tvori vnetljivo/eksplozivno zmes hlapi-zrak.
FIKäytössä voi muodostua syttyvä/räjähtävä höyry-ilmaseos.
SVVid användning kan brännbara/explosiva ång-luftblandningar bildas.

EUH 019Language
BGМоже да образува експлозивни пероксиди.
ESPuede formar peróxidos explosivos.
CSMůže vytvářet výbušné peroxidy.
DAKan danne eksplosive peroxider.
DEKann explosionsfähige Peroxide bilden.
ETVõib moodustada plahvatusohtlikke peroksiide.
ELΜπορεί να σχηματίσει εκρηκτικά υπεροξείδια.
ENMay form explosive peroxides.
FRPeut former des peroxydes explosifs.
GAD'fhéadfadh sé sárocsaídí pléascacha a chruthú.
ITPuò formare perossidi esplosivi.
LVVar veidot sprādzienbīstamus peroksīdus.
LTGali sudaryti sprogius peroksidus.
HURobbanásveszélyes peroxidokat képezhet.
MTJista' jifforma perossidi esplussivi.
NLKan ontplofbare peroxiden vormen.
PLMoże tworzyć wybuchowe nadtlenki.
PTPode formar peróxidos explosivos.
ROPoate forma peroxizi explozivi.
SKMôže vytvárat’ výbušné peroxidy.
SLLahko tvori eksplozivne perokside.
FISaattaa muodostaa räjähtäviä peroksideja.
SVKan bilda explosiva peroxider.

EUH 044Language
BGРиск от експлозия при нагряване в затворено пространство.
ESRiesgo de explosión al calentarlo en ambiente confinado.
CSNebezpečí výbuchu při zahřátí v uzavřeném obalu.
DAEksplosionsfarlig ved opvarmning under indeslutning.
DEExplosionsgefahr bei Erhitzen unter Einschluss.
ETPlahvatusohtlik kuumutamisel kinnises mahutis.
ELΚίνδυνος εκρήξεως εάν θερμανθεί υπό περιορισμό.
ENRisk of explosion if heated under confinement.
FRRisque d'explosion si chauffé en ambiance confinée.
GABaol pléasctha arna théamh i limistéar iata.
ITRischio di esplosione per riscaldamento in ambiente confinato.
LVSprādziena draudi, karsējot slēgtā vidē.
LTGali sprogti, jei kaitinama sandariai uždaryta.
HUZárt térben hő hatására robbanhat.
MTRiskju ta' splużjoni jekk jissaħħan fil-magħluq.
NLOntploffingsgevaar bij verwarming in afgesloten toestand.
PLZagrożenie wybuchem po ogrzaniu w zamkniętym pojemniku.
PTRisco de explosão se aquecido em ambiente fechado.
RORisc de explozie, dacă este încălzit în spaţiu închis.
SKRiziko výbuchu pri zahrievaní v uzavretom priestore.
SLNevarnost eksplozije ob segrevanju v zaprtem prostoru.
FIRäjähdysvaara kuumennettaessa suljetussa astiassa.
SVExplosionsrisk vid uppvärmning i sluten behållare.


Table 2.2

Health properties

EUH 029Language
BGПри контакт с вода се отделя токсичен газ.
ESEn contacto con agua libera gases tóxicos.
CSUvolňuje toxický plyn při styku s vodou.
DAUdvikler giftig gas ved kontakt med vand.
DEEntwickelt bei Berührung mit Wasser giftige Gase.
ETKokkupuutel veega eraldub mürgine gaas.
ELΣε επαφή με το νερό ελευθερώνονται τοξικά αέρια.
ENContact with water liberates toxic gas.
FRAu contact de l'eau, dégage des gaz toxiques.
GAI dteagmháil le huisce scaoiltear gás tocsaineach.
ITA contatto con l'acqua libera un gas tossico.
LVSaskaroties ar ūdeni, izdala toksiskas gāzes.
LTKontaktuodama su vandeniu išskiria toksiškas dujas.
HUVízzel érintkezve mérgező gázok képződnek.
MTJitfa' gass tossiku meta jmiss l-ilma.
NLVormt giftig gas in contact met water.
PLW kontakcie z wodą uwalnia toksyczne gazy.
PTEm contacto com a água liberta gases tóxicos.
ROÎn contact cu apa, degajă un gaz toxic.
SKPri kontakte s vodou uvoľňuje toxický plyn.
SLV stiku z vodo se sprošča strupen plin.
FIKehittää myrkyllistä kaasua veden kanssa.
SVUtvecklar giftig gas vid kontakt med vatten.

EUH 031Language
BGПри контакт с киселини се отделя токсичен газ.
ESEn contacto con ácidos libera gases tóxicos.
CSUvolňuje toxický plyn při styku s kyselinami.
DAUdvikler giftig gas ved kontakt med syre.
DEEntwickelt bei Berührung mit Säure giftige Gase.
ETKokkupuutel hapetega eraldub mürgine gaas.
ELΣε επαφή με οξέα ελευθερώνονται τοξικά αέρια.
ENContact with acids liberates toxic gas.
FRAu contact d'un acide, dégage un gaz toxique.
GAI dteagmháil le haigéid scaoiltear gás tocsaineach.
ITA contatto con acidi libera gas tossici.
LVSaskaroties ar skābēm, izdala toksiskas gāzes.
LTKontaktuodama su rūgštimis išskiria toksiškas dujas.
HUSavval érintkezve mérgező gázok képződnek.
MTJitfa' gass tossiku meta jmiss l-aċidi.
NLVormt giftig gas in contact met zuren.
PLW kontakcie z kwasami uwalnia toksyczne gazy.
PTEm contacto com ácidos liberta gases tóxicos.
ROÎn contact cu acizi, degajă un gaz toxic.
SKPri kontakte s kyselinami uvoľňuje toxický plyn.
SLV stiku s kislinami se sprošča strupen plin.
FIKehittää myrkyllistä kaasua hapon kanssa.
SVUtvecklar giftig gas vid kontakt med syra.

EUH 032Language
BGПри контакт с киселини се отделя силно токсичен газ.
ESEn contacto con ácidos libera gases muy tóxicos.
CSUvolňuje vysoce toxický plyn při styku s kyselinami.
DAUdvikler meget giftig gas ved kontakt med syre.
DEEntwickelt bei Berührung mit Säure sehr giftige Gase.
ETKokkupuutel hapetega eraldub väga mürgine gaas.
ELΣε επαφή με οξέα ελευθερώνονται πολύ τοξικά αέρια.
ENContact with acids liberates very toxic gas.
FRAu contact d'un acide, dégage un gaz très toxique.
GAI dteagmháil le haigéid scaoiltear gás an-tocsaineach.
ITA contatto con acidi libera gas molto tossici.
LVSaskaroties ar skābēm, izdala ļoti toksiskas gāzes.
LTKontaktuodama su rūgštimis išskiria labai toksiškas dujas.
HUSavval érintkezve nagyon mérgező gázok képződnek.
MTJitfa' gass tossiku ħafna meta jmiss l-aċidi.
NLVormt zeer giftig gas in contact met zuren.
PLW kontakcie z kwasami uwalnia bardzo toksyczne gazy.
PTEm contacto com ácidos liberta gases muito tóxicos.
ROÎn contact cu acizi, degajă un gaz foarte toxic.
SKPri kontakte s kyselinami uvoľňuje veľmi toxický plyn.
SLV stiku s kislinami se sprošča zelo strupen plin.
FIKehittää erittäin myrkyllistä kaasua hapon kanssa.
SVUtvecklar mycket giftig gas vid kontakt med syra.

EUH 066Language
BGПовтарящата се експозиция може да предизвика изсушаване или напукване на кожата.
ESLa exposición repetida puede provocar sequedad o formación de grietas en la piel.
CSOpakovaná expozice může způsobit vysušení nebo popraskání kůže.
DAGentagen kontakt kan give tør eller revnet hud.
DEWiederholter Kontakt kann zu spröder oder rissiger Haut führen.
ETKorduv kokkupuude võib põhjustada naha kuivust või lõhenemist.
ELΠαρατεταμένη έκθεση μπορεί να προκαλέσει ξηρότητα δέρματος ή σκάσιμο.
ENRepeated exposure may cause skin dryness or cracking.
FRL'exposition répétée peut provoquer dessèchement ou gerçures de la peau.
GAD'fhéadfadh tirimeacht chraicinn nó scoilteadh craicinn a bheith mar thoradh ar ilnochtadh.
ITL'esposizione ripetuta può provocare secchezza o screpolature della pelle.
LVAtkārtota iedarbība var radīt sausu ādu vai izraisīt tās sprēgāšanu.
LTPakartotinis poveikis gali sukelti odos džiūvimą arba skilinėjimą.
HUIsmétlődő expozíció a bőr kiszáradását vagy megrepedezését okozhatja.
MTEspożizzjoni ripetuta tista' tikkaġuna nxif jew qsim tal-ġilda.
NLHerhaalde blootstelling kan een droge of een gebarsten huid veroorzaken.
PLPowtarzające się narażenie może powodować wysuszanie lub pękanie skóry.
PTPode provocar pele seca ou gretada, por exposição repetida.
ROExpunerea repetată poate provoca uscarea sau crăparea pielii.
SKOpakovaná expozícia môže spôsobit’ vysušenie alebo popraskanie pokožky.
SLPonavljajoča izpostavljenost lahko povzroči nastanek suhe ali razpokane kože.
FIToistuva altistus voi aiheuttaa ihon kuivumista tai halkeilua.
SVUpprepad kontakt kan ge torr hud eller hudsprickor.

EUH 070Language
BGТоксично при контакт с очите.
ESTóxico en contacto con los ojos.
CSToxický při styku s očima.
DAGiftig ved kontakt med øjnene.
DEGiftig bei Berührung mit den Augen.
ETSilma sattumisel mürgine.
ELΤοξικό σε επαφή με τα μάτια.
ENToxic by eye contact.
FRToxique par contact oculaire.
GATocsaineach trí theagmháil leis an tsúil.
ITTossico per contatto oculare.
LVToksisks saskarē ar acīm.
LTToksiška patekus į akis.
HUSzembe kerülve mérgező.
MTTossiku meta jmiss ma’ l-għajnejn.
NLGiftig bij oogcontact.
PLDziała toksycznie w kontakcie z oczami.
PTTóxico por contacto com os olhos.
ROToxic în caz de contact cu ochii.
SKToxické pri kontakte s očami.
SLStrupeno ob stiku z očmi.
FIMyrkyllistä joutuessaan silmään.
SVGiftigt vid kontakt med ögonen.

EUH 071Language
BGКорозивен за дихателните пътища.
ESCorrosivo para las vías respiratorias.
CSZpůsobuje poleptání dýchacích cest.
DAÆtsende for luftvejene.
DEWirkt ätzend auf die Atemwege.
ETSöövitav hingamisteedele.
ELΔιαβρωτικό της αναπνευστικής οδού.
ENCorrosive to the respiratory tract.
FRCorrosif pour les voies respiratoires.
GACreimneach don chonair riospráide.
ITCorrosivo per le vie respiratorie.
LVKodīgs elpceļiem.
LTĖsdina kvėpavimo takus.
HUMaró hatású a légutakra.
MTKorrużiv għas-sistema respiratorja.
NLBijtend voor de luchtwegen.
PLDziała żrąco na drogi oddechowe.
PTCorrosivo para as vias respiratórias.
ROCorosiv pentru căile respiratorii.
SKŽieravé pre dýchacie cesty.
SLJedko za dihalne poti.
FIHengityselimiä syövyttävää.
SVFrätande på luftvägarna.


Table 2.3

Environmental properties

EUH 059LanguageAdditional EU Hazard Class
BGОпасно за озоновия слой.
ESPeligroso para la capa de ozono.
CSNebezpečný pro ozonovou vrstvu.
DAFarlig for ozonlaget.
DEDie Ozonschicht schädigend.
ETOhtlik osoonikihile.
ELΕπικίνδυνο για τη στιβάδα του όζοντος.
ENHazardous to the ozone layer.
FRDangereux pour la couche d'ozone.
GAGuaiseach don chiseal ózóin.
ITPericoloso per lo strato di ozono.
LVBīstams ozona slānim.
LTPavojinga ozono sluoksniui.
HUVeszélyes az ózonrétegre.
MTPerikoluż għas-saff ta' l-ożonu.
NLGevaarlijk voor de ozonlaag.
PLStwarza zagrożenie dla warstwy ozonowej.
PTPerigoso para a camada de ozono.
ROPericulos pentru stratul de ozon.
SKNebezpečný pre ozónovú vrstvu.
SLNevarno za ozonski plašč.
FIVaarallista otsonikerrokselle.
SVFarligt för ozonskiktet.

3. Part 3: supplemental label elements/information on certain substances and mixtures

EUH 201/ 201ALanguage
201

201A
BGСъдържа олово. Да не се използва върху повърхност, която евентуално може да се дъвче или смуче от деца.

Внимание! Съдържа олово.
201

201A
ESContiene plomo. No utilizar en objetos que los niños puedan masticar o chupar.

¡Atención! Contiene plomo.
201

201A
CSObsahuje olovo. Nemá se používat na povrchy, které mohou okusovat nebo olizovat děti.

Pozor! Obsahuje olovo.
201

201A
DAIndeholder bly. Må ikke anvendes på genstande, som børn vil kunne tygge eller sutte på.

Advarsel! Indeholder bly.
201

201A
DEEnthält Blei. Nicht für den Anstrich von Gegenständen verwenden, die von Kindern gekaut oder gelutscht werden könnten.

Achtung! Enthält Blei.
201

201A
ETSisaldab pliid. Mitte kasutada pindadel, mida lapsed võivad närida või imeda.

Ettevaatust! Sisaldab pliid.
201

201A
ELΠεριέχει μόλυβδο. Να μη χρησιμοποιείται σε επιφάνειες που είναι πιθανόν να μασήσουν ή να πιπιλίσουν τα παιδιά.

Προσοχή! Περιέχει μόλυβδο.
201

201A
ENContains lead. Should not be used on surfaces liable to be chewed or sucked by children.

Warning! Contains lead.
201

201A
FRContient du plomb. Ne pas utiliser sur les objets susceptibles d'être mâchés ou sucés par des enfants.

Attention! Contient du plomb.
201

201A
GALuaidhe ann. Níor chóir a úsáid ar dhromchlaí a d'fhéadfadh a bheith á gcogaint nó á sú ag leanaí.

Rabhadh! Luaidhe ann.
201

201A
ITContiene piombo. Non utilizzare su oggetti che possono essere masticati o succhiati dai bambini.

Attenzione! Contiene piombo.
201

201A
LVSatur svinu. Nedrīkst lietot uz virsmām, kuras var nonākt bērnam mutē.

Brīdinājums! Satur svinu.
201

201A
LTSudėtyje yra švino. Nenaudoti paviršiams, kurie gali būti vaikų kramtomi arba čiulpiami.

Atsargiai! Sudėtyje yra švino.
201

201A
HUÓlmot tartalmaz. Tilos olyan felületeken használni, amelyeket gyermekek szájukba vehetnek.

Figyelem! Ólmot tartalmaz.
201

201A
MTFih iċ-ċomb. M'għandux jintuża' fuq uċuh li x'aktarx jomogħduhom jew jerdgħuhom it-tfal.

Twissija! Fih iċ-ċomb.
201

201A
NLBevat lood. Mag niet worden gebruikt voor voorwerpen waarin kinderen kunnen bijten of waaraan kinderen kunnen zuigen.

Let op! Bevat lood.
201

201A
PLZawiera ołów. Nie należy stosować na powierzchniach, które mogą być gryzione lub ssane przez dzieci.

Uwaga! Zawiera ołów.
201

201A
PTContém chumbo. Não utilizar em superfícies que possam ser mordidas ou chupadas por crianças.

Atenção! Contém chumbo.
201

201A
ROConţine plumb. A nu se utiliza pe obiecte care pot fi mestecate sau supte de copii.

Atenţie! Conţine plumb.
201

201A
SKObsahuje olovo. Nepoužívajte na povrchy, ktoré by mohli žuť alebo oblizovať deti.

Pozor! Obsahuje olovo.
201

201A
SLVsebuje svinec. Ne sme se nanašati na površine, ki bi jih lahko žvečili ali sesali otroci.

Pozor! Vsebuje svinec.
201

201A
FISisältää lyijyä. Ei saa käyttää pintoihin, joita lapset voivat pureskella tai imeä.

Varoitus! Sisältää lyijyä.
201

201A
SVInnehåller bly. Bör inte användas på ytor där barn kan komma åt att tugga eller suga.

Varning! Innehåller bly.

EUH 202Language
BGЦианокрилат. Опасно. Залепва кожата и очите за секунди. Да се съхранява извън обсега на деца.
ESCianoacrilato. Peligro. Se adhiere a la piel y a los ojos en pocos segundos. Mantener fuera del alcance de los niños.
CSKyanoakrylát. Nebezpečí. Okamžitě slepuje kůži a oči. Uchovávejte mimo dosah dětí.
DACyanoacrylat. Farligt. Klæber til huden og øjnene på få sekunder. Opbevares utilgængeligt for børn.
DECyanacrylat. Gefahr. Klebt innerhalb von Sekunden Haut und Augenlider zusammen. Darf nicht in die Hände von Kindern gelangen.
ETTsüanoakrülaat. Ohtlik. Liimib naha ja silmad hetkega. Hoida lastele kättesaamatus kohas.
ELΚυανοακρυλική ένωση. Κίνδυνος. Κολλάει στην επιδερμίδα και στα μάτια μέσα σε λίγα δευτερόλεπτα. Να φυλάσσεται μακριά από παιδιά.
ENCyanoacrylate. Danger. Bonds skin and eyes in seconds. Keep out of the reach of children.
FRCyanoacrylate. Danger. Colle à la peau et aux yeux en quelques secondes. À conserver hors de portée des enfants.
GACianaicrioláit. Contúirt. Nascann craiceann agus súile laistigh de shoicindí. Coimeád as aimsiú leanaí.
ITCianoacrilato. Pericolo. Incolla la pelle e gli occhi in pochi secondi. Tenere fuori dalla portata dei bambini.
LVCiānakrilāts. Bīstami. Iedarbība uz acīm un ādu tūlītēja. Sargāt no bērniem.
LTCianakrilatas. Pavojinga. Staigiai suklijuoja odą ir akis. Laikyti vaikams neprieinamoje vietoje.
HUCianoakrilát. Veszély! Néhány másodperc alatt a bőrre és a szembe ragad. Gyermekektől elzárva tartandó.
MTCyanoacrylate. Periklu. Iwaħħal il-ġilda u l-għajnejn fi ftit sekondi. Żomm ‘il bogħod minn fejn jistgħu jilħquh it-tfal.
NLCyanoacrylaat. Gevaarlijk. Kleeft binnen enkele seconden aan huid en oogleden. Buiten het bereik van kinderen houden.
PLCyjanoakrylany. Niebezpieczeństwo. Skleja skórę i powieki w ciągu kilku sekund. Chronić przed dziećmi.
PTCianoacrilato. Perigo. Cola à pele e aos olhos em poucos segundos. Manter fora do alcance das crianças.
ROCianoacrilat. Pericol. Se lipeşte de piele şi ochi în câteva secunde. A nu se lăsa la îndemâna copiilor.
SKKyanoakrylát. Nebezpečenstvo. V priebehu niekoľkých sekúnd zlepí pokožku a oči. Uchovávajte mimo dosahu detí.
SLCianoakrilat. Nevarno. Kožo in oči zlepi v nekaj sekundah. Hraniti zunaj dosega otrok.
FISyanoakrylaattia. Vaara. Liimaa ihon ja silmät hetkessä. Säilytettävä lasten ulottumattomissa.
SVCyanoakrylat. Fara. Fäster snabbt på hud och ögon. Förvaras oåtkomligt för barn.

EUH 203Language
BGСъдържа хром (VI). Може да причини алергична реакция.
ESContiene cromo (VI). Puede provocar una reacción alérgica.
CSObsahuje chrom (VI). Může vyvolat alergickou reakci.
DAIndeholder krom (VI). Kan udløse allergisk reaktion.
DEEnthält Chrom (VI). Kann allergische Reaktionen hervorrufen.
ETSisaldab kroomi (VI). Võib esile kutsuda allergilise reaktsiooni.
ELΠεριέχει χρώμιο (VI). Μπορεί να προκαλέσει αλλεργική αντίδραση.
ENContains chromium (VI). May produce an allergic reaction.
FRContient du chrome (VI). Peut produire une réaction allergique.
GACróimiam (VI) ann. D'fhéadfadh sé a bheith ina chúis le frithghníomh ailléirgeach.
ITContiene cromo (VI). Può provocare una reazione allergica.
LVSatur hromu (VI). Var izraisīt alerģisku reakciju.
LTSudėtyje yra chromo (VI). Gali sukelti alerginę reakciją.
HUKrómot (VI) tartalmaz. Allergiás reakciót válthat ki.
MTFih il-kromju (VI). Jista’ joħloq reazzjoni allerġika.
NLBevat zeswaardig chroom. Kan een allergische reactie veroorzaken.
PLZawiera chrom (VI). Może powodować wystąpienie reakcji alergicznej.
PTContém crómio (VI). Pode provocar uma reacção alérgica.
ROConţine crom (VI). Poate provoca o reacţie alergică.
SKObsahuje chróm (VI). Môže vyvolať alergickú reakciu.
SLVsebuje krom (VI). Lahko povzroči alergijski odziv.
FISisältää kromi(VI)-yhdisteitä. Voi aiheuttaa allergisen reaktion.
SVInnehåller krom (VI). Kan orsaka en allergisk reaktion.

EUH 204Language
BGСъдържа изоцианати. Може да причини алергична реакция.
ESContiene isocianatos. Puede provocar una reacción alérgica.
CSObsahuje isokyanáty. Může vyvolat alergickou reakci.
DAIndeholder isocyanater. Kan udløse allergisk reaktion.
DEEnthält Isocyanate. Kann allergische Reaktionen hervorrufen.
ETSisaldab isotsüanaate. Võib esile kutsuda allergilise reaktsiooni.
ELΠεριέχει ισοκυανικές ενώσεις. Μπορεί να προκαλέσει αλλεργική αντίδραση.
ENContains isocyanates. May produce an allergic reaction.
FRContient des isocyanates. Peut produire une réaction allergique.
GAIsicianaítí ann. D'fhéadfadh sé a bheith ina chúis le frithghníomh ailléirgeach.
ITContiene isocianati. Può provocare una reazione allergica.
LVSatur izocianātus. Var izraisīt alerģisku reakciju.
LTSudėtyje yra izocianatų. Gali sukelti alerginę reakciją.
HUIzocianátokat tartalmaz. Allergiás reakciót válthat ki.
MTFih l-isocyanates. Jista’ jagħmel reazzjoni allerġika.
NLBevat isocyanaten. Kan een allergische reactie veroorzaken.
PLZawiera izocyjaniany. Może powodować wystąpienie reakcji alergicznej.
PTContém isocianatos. Pode provocar uma reacção alérgica.
ROConţine izocianaţi. Poate provoca o reacţie alergică.
SKObsahuje izokyanáty. Môže vyvolať alergickú reakciu.
SLVsebuje izocianate. Lahko povzroči alergijski odziv.
FISisältää isosyanaatteja. Voi aiheuttaa allergisen reaktion.
SVInnehåller isocyanater. Kan orsaka en allergisk reaktion.

EUH 205Language
BGСъдържа епоксидни съставки. Може да причини алергична реакция.
ESContiene componentes epoxídicos. Puede provocar una reacción alérgica.
CSObsahuje epoxidové složky. Může vyvolat alergickou reakci.
DAIndeholder epoxyforbindelser. Kan udløse allergisk reaktion.
DEEnthält epoxidhaltige Verbindungen. Kann allergische Reaktionen hervorrufen.
ETSisaldab epoksükomponente. Võib esile kutsuda allergilise reaktsiooni.
ELΠεριέχει εποξειδικές ενώσεις. Μπορεί να προκαλέσει αλλεργική αντίδραση.
ENContains epoxy constituents. May produce an allergic reaction.
FRContient des composés époxydiques. Peut produire une réaction allergique.
GAComhábhair eapocsacha ann. D'fhéadfadh sé a bheith ina chúis le frithghníomh ailléirgeach.
ITContiene componenti epossidici. Può provocare una reazione allergica.
LVSatur epoksīda sastāvdaļas. Var izraisīt alerģisku reakciju.
LTSudėtyje yra epoksidinių komponentų. Gali sukelti alerginę reakciją.
HUEpoxid tartalmú vegyületeket tartalmaz. Allergiás reakciót válthat ki.
MTFih kostitwenti ta’ l-eposside. Jista’ jagħmel reazzjoni allerġika.
NLBevat epoxyverbindingen. Kan een allergische reactie veroorzaken.
PLZawiera składniki epoksydowe. Może powodować wystąpienie reakcji alergicznej.
PTContém componentes epoxídicos. Pode provocar uma reacção alérgica.
ROConţine componenţi epoxidici. Poate provoca o reacţie alergică.
SKObsahuje epoxidové zložky. Môže vyvolať alergickú reakciu.
SLVsebuje epoksidne sestavine. Lahko povzroči alergijski odziv.
FISisältää epoksihartseja. Voi aiheuttaa allergisen reaktion.
SVInnehåller epoxiförening. Kan orsaka en allergisk reaktion.

EUH 206Language
BGВнимание! Да не се използва заедно с други продукти. Може да отдели опасни газове (хлор).
ES¡Atención! No utilizar junto con otros productos. Puede desprender gases peligrosos (cloro).
CSPozor! Nepoužívejte společně s jinými výrobky. Může uvolňovat nebezpečné plyny (chlor).
DAAdvarsel! Må ikke anvendes i forbindelse med andre produkter. Farlige luftarter (chlor) kan frigøres.
DEAchtung! Nicht zusammen mit anderen Produkten verwenden, da gefährliche Gase (Chlor) freigesetzt werden können.
ETEttevaatust! Mitte kasutada koos teiste toodetega. Segust võib eralduda ohtlikke gaase (kloori).
ELΠροσοχή! Να μην χρησιμοποιείται σε συνδυασμό με άλλα προϊόντα. Μπορεί να ελευθερωθούν επικίνδυνα αέρια (χλώριο).
ENWarning! Do not use together with other products. May release dangerous gases (chlorine).
FRAttention! Ne pas utiliser en combinaison avec d'autres produits. Peut libérer des gaz dangereux (chlore).
GARabhadh! Ná húsáid in éineacht le táirgí eile. D'fhéadfadh sé go scaoilfí gáis chontúirteacha (clóirín).
ITAttenzione! Non utilizzare in combinazione con altri prodotti. Possono liberarsi gas pericolosi (cloro).
LVBrīdinājums! Nelietot kopā ar citiem produktiem. Var izdalīt bīstamas gāzes (hloru).
LTAtsargiai! Nenaudoti kartu su kitais produktais. Gali išskirti pavojingas dujas (chlorą).
HUFigyelem! Tilos más termékekkel együtt használni. Veszélyes gázok (klór) szabadulhatnak fel.
MTTwissija! Tużahx flimkien ma’ prodotti oħra. Jista’ jerħi gassijiet perikolużi (kloru).
NLLet op! Niet in combinatie met andere producten gebruiken. Er kunnen gevaarlijke gassen (chloor) vrijkomen.
PLUwaga! Nie stosować razem z innymi produktami. Może wydzielać niebezpieczne gazy (chlor).
PTAtenção! Não utilizar juntamente com outros produtos. Podem libertar-se gases perigosos (cloro).
ROAtenţie! A nu se folosi împreună cu alte produse. Poate elibera gaze periculoase (clor).
SKPozor! Nepoužívajte spolu s inými výrobkami. Môžu uvoľňovať nebezpečné plyny (chlór).
SLPozor! Ne uporabljajte skupaj z drugimi izdelki. Lahko se sproščajo nevarni plini (klor).
FIVaroitus! Älä käytä yhdessä muiden tuotteiden kanssa. Tuotteesta voi vapautua vaarallista kaasua (klooria).
SVVarning! Får ej användas tillsammans med andra produkter. Kan avge farliga gaser (klor).

EUH 207Language
BGВнимание! Съдържа кадмий. При употреба се образуват опасни пари. Вижте информацията, предоставена от производителя. Спазвайте инструкциите за безопасност.
ES¡Atención! Contiene cadmio. Durante su utilización se desprenden vapores peligrosos. Ver la información facilitada por el fabricante. Seguir las instrucciones de seguridad.
CSPozor! Obsahuje kadmium. Při používání vznikají nebezpečné výpary. Viz informace dodané výrobcem. Dodržujte bezpečnostní pokyny.
DAAdvarsel! Indeholder cadmium. Der udvikles farlige dampe under anvendelsen. Se producentens oplysninger. Overhold sikkerhedsforskrifterne.
DEAchtung! Enthält Cadmium. Bei der Verwendung entstehen gefährliche Dämpfe. Hinweise des Herstellers beachten. Sicherheitsanweisungen einhalten.
ETEttevaatust! Sisaldab kaadmiumi. Kasutamisel moodustuvad ohtlikud aurud. Vt tootja esitatud teavet. Järgida ohutuseeskirju.
ELΠροσοχή! Περιέχει κάδμιο. Κατά τη χρήση αναπτύσσονται επικίνδυνες αναθυμιάσεις. Βλέπετε πληροφορίες του κατασκευαστή. Τηρείτε τις οδηγίες ασφαλείας.
ENWarning! Contains cadmium. Dangerous fumes are formed during use. See information supplied by the manufacturer. Comply with the safety instructions.
FRAttention! Contient du cadmium. Des fumées dangereuses se développent pendant l'utilisation. Voir les informations fournies par le fabricant. Respectez les consignes de sécurité.
GARabhadh! Caidmiam ann. Cruthaítear múch chontúirteach le linn a úsáide. Féach an fhaisnéis atá curtha ar fáil ag an monaróir. Cloígh leis na treoracha sábháilteachta.
ITAttenzione! Contiene cadmio. Durante l'uso si sviluppano fumi pericolosi. Leggere le informazioni fornite dal fabbricante. Rispettare le disposizioni di sicurezza.
LVBrīdinājums! Satur kadmiju. Lietojot veidojas bīstami izgarojumi. Sk. ražotāja sniegto informāciju. Ievērot drošības instrukcijas.
LTAtsargiai! Sudėtyje yra kadmio. Naudojant susidaro pavojingi garai. Žiūrėti gamintojo pateiktą informaciją. Vykdyti saugos instrukcijas.
HUFigyelem! Kadmiumot tartalmaz! A használat során veszélyes füstök képződnek. Lásd a gyártó által közölt információt. Be kell tartani a biztonsági előírásokat.
MTTwissija! Fih il-kadmju. Waqt li jintuża jiffurmaw dħaħen perikolużi. Ara l-informazzjoni mogħtija mill-fabbrikant. Ħares l-istruzzjonijiet dwar is-sigurtà.
NLLet op! Bevat cadmium. Bij het gebruik ontwikkelen zich gevaarlijke dampen. Zie de aanwijzingen van de fabrikant. Neem de veiligheidsvoorschriften in acht.
PLUwaga! Zawiera kadm. Podczas stosowania wydziela niebezpieczne pary. Zapoznaj się z informacją dostarczoną przez producenta. Przestrzegaj instrukcji bezpiecznego stosowania.
PTAtenção! Contém cádmio. Libertam-se fumos perigosos durante a utilização. Ver as informações fornecidas pelo fabricante. Respeitar as instruções de segurança.
ROAtenţie! Conţine cadmiu. În timpul utilizării se degajă un fum periculos. A se vedea informaţiile furnizate de producător. A se respecta instrucţiunile privind siguranţa.
SKPozor! Obsahuje kadmium. Pri používaní sa tvorí nebezpečný dym. Pozri informácie od výrobcu. Dodržiavajte bezpečnostné pokyny.
SLPozor! Vsebuje kadmij. Med uporabo nastajajo nevarni dimi. Preberite informacije proizvajalca. Upoštevajte navodila za varno uporabo.
FIVaroitus! Sisältää kadmiumia. Käytettäessä muodostuu vaarallisia huuruja. Noudata valmistajan antamia ohjeita. Noudata turvallisuusohjeita.
SVVarning! Innehåller kadmium. Farliga ångor bildas vid användning. Se information från tillverkaren. Följ skyddsanvisningarna.

EUH 208Language
BGСъдържа < наименование на сенсибилизиращото вещество>. Може да предизвика алергична реакция.
ESContiene <nombre de la sustancia sensibilizante>. Puede provocar una reacción alérgica.
CSObsahuje <název senzibilizující látky>. Může vyvolat alergickou reakci.
DAIndeholder <navn på det sensibiliserende stof>. Kan udløse allergisk reaktion.
DEEnthält <Name des sensibilisierenden Stoffes>. Kann allergische Reaktionen hervorrufen.
ETSisaldab <sensibiliseeriva aine nimetus>. Võib esile kutsuda allergilise reaktsiooni.
ELΠεριέχει <όνομα της ευαισθητοποιητικής ουσίας>. Μπορεί να προκαλέσει αλλεργική αντίδραση.
ENContains <name of sensitising substance>. May produce an allergic reaction.
FRContient <nom de la substance sensibilisante>. Peut produire une réaction allergique.
GA<Ainm na substainte íograithe> ann. D'fhéadfadh sé a bheith ina chúis le frithghníomh ailléirgeach.
ITContiene <denominazione della sostanza sensibilizzante>. Può provocare una reazione allergica.
LVSatur <sensibilizējošās vielas nosaukums>. Var izraisīt alerģisku reakciju.
LTSudėtyje yra <jautrinančios medžiagos pavadinimas>. Gali sukelti alerginę reakciją.
HU<Allergén anyag neve>-t tartalmaz. Allergiás reakciót válthat ki.
MTFih <l-isem tas-sustanza sensibbli>. Jista’ jagħmel reazzjoni allerġika.
NLBevat <naam van de sensibiliserende stof>. Kan een allergische reactie veroorzaken.
PLZawiera <nazwa substancji uczulającej>. Może powodować wystąpienie reakcji alergicznej.
PTContém <nome da substância sensibilizante em questão>. Pode provocar uma reacção alérgica.
ROConţine <denumirea substanţei sensibilizante>. Poate provoca o reacţie alergică.
SKObsahuje <názov senzibilizujúcej látky>. Môže vyvolať alergickú reakciu.
SLVsebuje <ime snovi, ki povzroča preobčutljivost>. Lahko povzroči alergijski odziv.
FISisältää <herkistävän aineen nimi>. Voi aiheuttaa allergisen reaktion.
SVInnehåller <namnet på det sensibiliserande ämnet>. Kan orsaka en allergisk reaktion.

EUH 209/ 209ALanguage
209

209A
BGПри употреба може да стане силно запалимо.

При употреба може да стане запалимо.
209

209A
ESPuede inflamarse fácilmente al usarlo

Puede inflamarse al usarlo.
209

209A
CSPři používání se může stát vysoce hořlavým.

Při používání se může stát hořlavým.
209

209A
DAKan blive meget brandfarlig ved brug.

Kan blive brandfarlig ved brug.
209

209A
DEKann bei Verwendung leicht entzündbar werden.

Kann bei Verwendung entzündbar werden.
209

209A
ETKasutamisel võib muutuda väga tuleohtlikuks.

Kasutamisel võib muutuda tuleohtlikuks.
209

209A
ELΜπορεί να γίνει πολύ εύφλεκτο κατά τη χρήση.

Mπορεί να γίνει εύφλεκτο κατά τη χρήση.
209

209A
ENCan become highly flammable in use.

Can become flammable in use.
209

209A
FRPeut devenir facilement inflammable en cours d'utilisation.

Peut devenir inflammable en cours d'utilisation.
209

209A
GAD'fhéadfadh sé éirí an-inadhainte agus é á úsáid.

D'fhéadfadh sé éirí inadhainte agus é á úsáid.
209

209A
ITPuò diventare facilmente infiammabile durante l'uso.

Può diventare infiammabile durante l'uso.
209

209A
LVLietojot var viegli uzliesmot.

Kļūt uzliesmojošs.
209

209A
LTNaudojama gali tapti labai degi.

Naudojama gali tapti degi.
209

209A
HUA használat során fokozottan tűzveszélyessé válhat.

A használat során tűzveszélyessé válhat.
209

209A
MTJista’ jieħu n-nar faċilment meta jintuża.

Jista’ jieħu n-nar meta jintuża.
209

209A
NLKan bij gebruik licht ontvlambaar worden.

Kan bij gebruik ontvlambaar worden.
209

209A
PLPodczas stosowania może przekształcić się w substancję wysoce łatwopalną.

Podczas stosowania może przekształcić się w substancję łatwopalną.
209

209A
PTPode tornar-se facilmente inflamável durante o uso.

Pode tornar-se inflamável durante o uso.
209

209A
ROPoate deveni foarte inflamabil în timpul utilizării.

Poate deveni inflamabil în timpul utilizării.
209

209A
SKPri používaní sa môže stať veľmi horľavou.

Pri používaní sa môže stať horľavou.
209

209A
SLMed uporabo utegne postati lahko vnetljivo.

Med uporabo utegne postati vnetljivo.
209

209A
FIVoi muuttua helposti syttyväksi käytössä.

Voi muuttua syttyväksi käytössä.
209

209A
SVKan bli mycket brandfarligt vid användning.

Kan bli brandfarligt vid användning.

EUH 210Language
BGИнформационен лист за безопасност ще бъде представен при поискване.
ESPuede solicitarse la ficha de datos de seguridad.
CSNa vyžádání je kodispozici bezpečnostní list.
DASikkerhedsdatablad kan på anmodning rekvireres.
DESicherheitsdatenblatt auf Anfrage erhältlich.
ETOhutuskaart nõudmisel kättesaadav.
ELΔελτίο δεδομένων ασφαλείας παρέχεται εφόσον ζητηθεί.
ENSafety data sheet available on request.
FRFiche de données de sécurité disponible sur demande.
GABileog sonraí sábháilteachta ar fáil arna iarraidh sin.
ITScheda dati di sicurezza disponibile su richiesta.
LVDrošības datu lapa ir pieejama pēc pieprasījuma.
LTSaugos duomenų lapą galima gauti paprašius.
HUKérésre biztonsági adatlap kapható.
MTIl-karta tad-data dwar is-sikurezza hija disponibbli meta tintalab.
NLVeiligheidsinformatieblad op verzoek verkrijgbaar.
PLKarta charakterystyki dostępna na żądanie.
PTFicha de segurança fornecida a pedido.
ROFişa cu date de securitate disponibilă la cerere.
SKNa požiadanie možno poskytnúť kartu bezpečnostných údajov.
SLVarnosti list na voljo na zahtevo.
FIKäyttöturvallisuustiedote toimitetaan pyynnöstä.
SVSäkerhetsdatablad finns att rekvirera.

EUH 401Language
BGЗа да се избегнат рискове за човешкото здраве и околната среда, спазвайте инструкциите за употреба.
ESA fin de evitar riesgos para las personas y el medio ambiente, siga las instrucciones de uso.
CSDodržujte pokyny pro používání, abyste se vyvarovali rizik pro lidské zdraví a životní prostředí.
DABrugsanvisningen skal følges for ikke at bringe menneskers sundhed og miljøet i fare.
DEZur Vermeidung von Risiken für Mensch und Umwelt die Gebrauchsanleitung einhalten.
ETInimeste tervise ja keskkonna ohustamise vältimiseks järgida kasutusjuhendit.
ELΓια να αποφύγετε τους κινδύνους για την ανθρώπινη υγεία και το περιβάλλον, ακολουθήστε τις οδηγίες χρήσης.
ENTo avoid risks to human health and the environment, comply with the instructions for use.
FRRespectez les instructions d'utilisation pour éviter les risques pour la santé humaine et l'environnement.
GAChun priacail do shláinte an duine agus don chomhshaol a sheachaint, cloígh leis na treoracha maidir le húsáid.
ITPer evitare rischi per la salute umana e per l'ambiente, seguire le istruzioni per l'uso.
LTSiekiant išvengti žmonių sveikatai ir aplinkai keliamos rizikos, būtina vykdyti naudojimo instrukcijos nurodymus.
LVLai izvairītos no riska cilvēku veselībai un videi, ievērojiet lietošanas pamācību.
HUAz emberi egészség és a környezet veszélyeztetésének elkerülése érdekében be kell tartani a használati utasítás előírásait.
MTBiex jiġu evitati r-riskji għal saħħet il-bniedem u għall-ambjent, ħares l-istruzzjonijiet dwar l-użu.
NLVolg de gebruiksaanwijzing om gevaar voor de menselijke gezondheid en het milieu te voorkomen.
PLW celu uniknięcia zagrożeń dla zdrowia ludzi i środowiska, należy postępować zgodnie z instrukcją użycia.
PTPara evitar riscos para a saúde humana e para o ambiente, respeitar as instruções de utilização.
ROPentru a evita riscurile pentru sănătatea umană şi mediu, a se respecta instrucţiunile de utilizare.
SKDodržiavajte návod na používanie, aby ste zabránili vzniku rizík pre zdravie ľudí a životné prostredie.
SLDa bi se izognili tveganjem za ljudi in okolje, ravnajte v skladu z navodili za uporabo.
FINoudata käyttöohjeita ihmisen terveydelle ja ympäristölle aiheutuvien vaarojen välttämiseksi.
SVFör att undvika risker för människors hälsa och för miljön, följ bruksanvisningen.



(1) The codification system for GHS hazard statements is still under discussion in the UN Committee of Experts and therefore amendments might be needed.



ANNEX IV

LIST OF PRECAUTIONARY STATEMENTS

In selecting the precautionary statements in accordance with Articles 22 and 28(3), suppliers may combine the Precautionary Statements in the table below, having regard to clarity and comprehensibility of the precautionary advice.

1. Part 1: Criteria for the selection of precautionary statements

Table 6.1

Precautionary statements — General

CodeGeneral precautionary statementsHazard classHazard categoryConditions for use
(1)(2)(3)(4)(5)
P101If medical advice is needed, have product container or label at hand.as appropriateConsumer products
P102Keep out of reach of children.as appropriateConsumer products
P103Read label before use.as appropriateConsumer products


Table 6.2

Precautionary statements — Prevention

CodePrevention precautionary statementsHazard classHazard categoryConditions for use
(1)(2)(3)(4)(5)
P201Obtain special instructions before use.Explosives (section 2.1)Unstable explosive
Germ cell mutagenicity (section 3.5)1A, 1B, 2
Carcinogenicity (section 3.6)1A, 1B, 2
Reproductive toxicity (section 3.7)1A, 1B, 2
Reproductive toxicity — effects on or via lactation (section 3.7)Additional category
P202Do not handle until all safety precautions have been read and understood.Explosives (section 2.1)Unstable explosive
Germ cell mutagenicity (section 3.5)1A, 1B, 2
Carcinogenicity (section 3.6)1A, 1B, 2
Reproductive toxicity (section 3.7)1A, 1B, 2
P210Keep away from heat/sparks/open flames/hot surfaces. — No smoking.Explosives (section 2.1)Divisions 1.1, 1.2, 1.3, 1.4, 1.5Manufacturer/supplier to specify applicable ignition source(s).
Flammable gases (section 2.2)1, 2
Flammable aerosols (section 2.3)1, 2
Flammable liquids (section 2.6)1, 2, 3
Flammable solids (section 2.7)1, 2
Self-reactive substances and mixtures (section 2.8)Types A, B, C, D, E, F
Pyrophoric liquids (section 2.9)1
Pyrophoric solids (section 2.10)1
Organic peroxides (section 2.15)Types A, B, C, D, E, F
Oxidising liquids (section 2.13)1, 2, 3
Specify to keep away from heat.
Oxidising solids (section 2.14)1, 2, 3
P211Do not spray on an open flame or other ignition source.Flammable aerosols (section 2.3)1, 2
P220Keep/Store away from clothing/…/combustible materials.Oxidising gases (section 2.4)1… Manufacturer/supplier to specify incompatible materials.
Self-reactive substances and mixtures (section 2.8)Types A, B, C, D, E, F
Oxidising liquids (section 2.13)1… Manufacturer/supplier to specify incompatible materials.

specify to keep away from clothing as well as other incompatible materials.
2, 3… Manufacturer/supplier to specify incompatible materials.
Oxidising solids (section 2.14)1… Manufacturer/supplier to specify incompatible materials.

specify to keep away from clothing as well as other incompatible materials.
2, 3… Manufacturer/supplier to specify incompatible materials.
Organic peroxides (section 2.15)Types A, B, C, D, E, F
P221Take any precaution to avoid mixing with combustibles/…Oxidising liquids (section 2.13)1, 2, 3… Manufacturer/supplier to specify incompatible materials.
Oxidising solids (section 2.14)1, 2, 3
P222Do not allow contact with air.Pyrophoric liquids (section 2.9)1
Pyrophoric solids (section 2.10)1
P223Keep away from any possible contact with water, because of violent reaction and possible flash fire.Substances and mixtures which, in contact with water, emit flammable gases (section 2.12)1, 2
P230Keep wetted with …Explosives (section 2.1)Divisions 1.1, 1.2, 1.3, 1.5… Manufacturer/supplier to specify appropriate material.

if drying out increases explosion hazard, except as needed for manufacturing or operating processes (e.g. nitrocellulose).
P231Handle under inert gas.Substances and mixtures which, in contact with water, emit flammable gases (section 2.12)1, 2, 3
P232Protect from moisture.Substances and mixtures which, in contact with water, emit flammable gases (section 2.12)1, 2, 3
P233Keep container tightly closed.Flammable liquids (section 2.6)1, 2, 3
Acute toxicity — inhalation (section 3.1)1, 2, 3
if product is volatile so as to generate hazardous atmosphere.
Specific target organ toxicity — single exposure; respiratory tract irritation (section 3.8)3
Specific target organ toxicity — single exposure; narcosis (section 3.8)3
P234Keep only in original container.Self-reactive substances and mixtures (section 2.8)Types A, B, C, D, E, F
Organic peroxides (section 2.15)Types A, B, C, D, E, F
Corrosive to metals (section 2.16)1
P235Keep cool.Flammable liquids (section 2.6)1, 2, 3
Self-reactive substances and mixtures (Section 2.8)Types A, B, C, D, E, F
Self-heating substances and mixtures (section 2.11)1, 2
Organic peroxides (section 2.15)Types A, B, C, D, E, F
P240Ground/bond container and receiving equipment.Explosives (section 2.1)Divisions 1.1, 1.2, 1.3, 1.4, 1.5
if the explosive is electrostatically sensitive.
Flammable liquids (section 2.6)1, 2, 3
if electrostatically sensitive material is for reloading.

if product is volatile so as to generate hazardous atmosphere.
Flammable solids (section 2.7)1, 2
if electrostatically sensitive material is for reloading.
P241Use explosion-proof electrical/ventilating/lighting/…/equipment.Flammable liquids (section 2.6)1, 2, 3… Manufacturer/supplier to specify other equipment.
Flammable solids (section 2.7)1, 2… Manufacturer/supplier to specify other equipment.

if dust clouds can occur.
P242Use only non-sparking tools.Flammable liquids (section 2.6)1, 2, 3
P243Take precautionary measures against static discharge.Flammable liquids (section 2.6)1, 2, 3
P244Keep reduction valves free from grease and oil.Oxidising gases (section 2.4)1
P250Do not subject to grinding/shock/…/friction.Explosives (section 2.1)Divisions 1.1, 1.2, 1.3, 1.4, 1.5… Manufacturer/supplier to specify applicable rough handling.
P251Pressurized container: Do not pierce or burn, even after use.Flammable aerosols (section 2.3)1, 2
P260Do not breathe dust/fume/gas/mist/vapours/spray.Acute toxicity — inhalation (section 3.1)1, 2Manufacturer/supplier to specify applicable conditions.
Specific target organ toxicity — single exposure (section 3.8)1, 2
Specific target organ toxicity — repeated exposure (section 3.9)1, 2
Skin corrosion (section 3.2)1A, 1B, 1C
Specify do not breathe dusts or mists.

if inhalable particles of dusts or mists may occur during use.
Reproductive toxicity — effects on or via lactation (section 3.7)Additional category
P261Avoid breathing dust/fume/gas/mist/vapours/spray.Acute toxicity — inhalation (section 3.1)3, 4Manufacturer/supplier to specify applicable conditions.
Respiratory sensitisation (section 3.4)1
Skin sensitisation (section 3.4)1
Specific target organ toxicity — single exposure; respiratory tract irritation (section 3.8)3
Specific target organ toxicity — single exposure; narcosis (section 3.8)3
P262Do not get in eyes, on skin, or on clothing.Acute toxicity — dermal (section 3.1)1, 2
P263Avoid contact during pregnancy/while nursing.Reproductive toxicity — effects on or via lactation (section 3.7)Additional category
P264Wash … thoroughly after handling.Acute toxicity — oral (section 3.1)1, 2, 3, 4Manufacturer/supplier to specify parts of the body to be washed after handling.
Acute toxicity — dermal (section 3.1)1, 2
Skin corrosion (section 3.2)1A, 1B, 1C
Skin irritation (section 3.2)2
Eye irritation (section 3.3)2
Reproductive toxicity — effects on or via lactation (section 3.7)Additional category
Specific target organ toxicity — single exposure (section 3.8)1, 2
Specific target organ toxicity — repeated exposure (section 3.9)1
P270Do not eat, drink or smoke when using this product.Acute toxicity — oral (section 3.1)1, 2, 3, 4
Acute toxicity — dermal (section 3.1)1, 2
Reproductive toxicity — effects on or via lactation (section 3.7)Additional category
Specific target organ toxicity — single exposure (section 3.8)1, 2
Specific target organ toxicity — repeated exposure (section 3.9)1
P271Use only outdoors or in a well-ventilated area.Acute toxicity — inhalation (section 3.1)1, 2, 3, 4
Specific target organ toxicity — single exposure; respiratory tract irritation (section 3.8)3
Specific target organ toxicity — single exposure; narcosis (section 3.8)3
P272Contaminated work clothing should not be allowed out of the workplace.Skin sensitisation (section 3.4)1
P273Avoid release to the environment.Hazardous to the aquatic environment — acute aquatic hazard (section 4.1)1
if this is not the intended use.
Hazardous to the aquatic environment — chronic aquatic hazard (section 4.1)1, 2, 3, 4
Hazardous to the ozone layer (section 5.1)1
P280Wear protective gloves/protective clothing/eye protection/face protection.Explosives (section 2.1)Divisions 1.1, 1.2, 1.3, 1.4, 1.5Manufacturer/supplier to specify type of equipment.

Specify face protection.
Flammable liquids (section 2.6)1, 2, 3Manufacturer/supplier to specify type of equipment.

Specify protective gloves and eye/face protection.
Flammable solids (section 2.7)1, 2
Self-reactive substances and mixtures (section 2.8)Types A, B, C, D, E, F
Pyrophoric liquids (section 2.9)1
Pyrophoric solids (section 2.10)1
Self-heating substances and mixtures (section 2.11)1, 2
Substances and mixtures which, in contact with water, emit flammable gases (section 2.12)1, 2, 3
Oxidising liquids (section 2.13)1, 2, 3
Oxidising solids (section 2.14)1, 2, 3
Organic peroxides (section 2.15)Types A, B, C, D, E, F
Acute toxicity — dermal (section 3.1)1, 2, 3, 4Manufacturer/supplier to specify type of equipment.

Specify protective gloves/clothing.
Skin corrosion (section 3.2)1A, 1B, 1CManufacturer/supplier to specify type of equipment.

Specify protective gloves/clothing and eye/face protection.
Skin irritation (section 3.2)2Manufacturer/supplier to specify type of equipment.

Specify protective gloves.
Skin sensitisation (section 3.4)1
Serious eye damage/eye irritation (section 3.3)1Manufacturer/supplier to specify type of equipment.

Specify eye/face protection.
Eye irritation (section 3.3)2
P281Use personal protective equipment as required.Explosives (section 2.1)Unstable explosive
Germ cell mutagenicity (section 3.5)1A, 1B, 2
Carcinogenicity (section 3.6)1A, 1B, 2
Reproductive toxicity (section 3.7)1A, 1B, 2
P282Wear cold insulating gloves/face shield/eye protection.Gases under pressure (section 2.5)Refrigerated liquefied gas
P283Wear fire/flame resistant/retardant clothing.Oxidising liquids (section 2.13)1
Oxidising solids (section 2.14)1
P284Wear respiratory protection.Acute toxicity — inhalation (section 3.1)1, 2Manufacturer/supplier to specify equipment.
P285In case of inadequate ventilation wear respiratory protection.Respiratory sensitisation (section 3.4)1Manufacturer/supplier to specify equipment.
P231 + P232Handle under inert gas. Protect from moisture.Substances and mixtures which, in contact with water, emit flammable gases (section 2.12)1, 2, 3
P235 + P410Keep cool. Protect from sunlight.Self-heating substances and mixtures (section 2.11)1, 2


Table 6.3

Precautionary statements — Response

CodeResponse precautionary statementsHazard classHazard categoryConditions for use
(1)(2)(3)(4)(5)
P301IF SWALLOWED:Acute toxicity — oral (section 3.1)1, 2, 3, 4
Skin corrosion (section 3.2)1A, 1B, 1C
Aspiration Hazard (section 3.10)1
P302IF ON SKIN:Pyrophoric liquids (section 2.9)1
Acute toxicity — dermal (section 3.1)1, 2, 3, 4
Skin irritation (section 3.2)2
Skin sensitisation (section 3.4)1
P303IF ON SKIN (or hair):Flammable liquids (section 2.6)1, 2, 3
Skin corrosion (section 3.2)1A, 1B, 1C
P304IF INHALED:Acute toxicity — inhalation (section 3.1)1, 2, 3, 4
Skin corrosion (section 3.2)1A, 1B, 1C
Respiratory sensitisation (section 3.4)1
Specific target organ toxicity — single exposure; respiratory tract irritation (section 3.8)3
Specific target organ toxicity — single exposure; narcosis (section 3.8)3
P305IF IN EYES:Skin corrosion (section 3.2)1A, 1B, 1C
Serious eye damage/eye irritation (section 3.3)1
Eye irritation (section 3.3)2
P306IF ON CLOTHING:Oxidising liquids (section 2.13)1
Oxidising solids (section 2.14)1
P307IF exposed:Specific target organ toxicity — single exposure (section 3.8)1
P308IF exposed or concerned:Germ cell mutagenicity (section 3.5)1A, 1B, 2
Carcinogenicity (section 3.6)1A, 1B, 2
Reproductive toxicity (section 3.7)1A, 1B, 2
Reproductive toxicity — effects on or via lactation (section 3.7)Additional category
P309IF exposed or if you feel unwell:Specific target organ toxicity — single exposure (section 3.8)2
P310Immediately call a POISON CENTER or doctor/physician.Acute toxicity — oral (section 3.1)1, 2, 3
Acute toxicity — dermal (section 3.1)1, 2
Acute toxicity — inhalation (section 3.1)1, 2
Skin corrosion (section 3.2)1A, 1B, 1C
Serious eye damage/eye irritation (section 3.3)1
Aspiration hazard (section 3.10)1
P311Call a POISON CENTER or doctor/physician.Acute toxicity — inhalation (section 3.1)3
Respiratory sensitisation (section 3.4)1
Specific target organ toxicity — single exposure (section 3.8)1, 2
P312Call a POISON CENTER or doctor/physician if you feel unwell.Acute toxicity — oral (section 3.1)4
Acute toxicity — dermal (section 3.1)3, 4
Acute toxicity — inhalation (section 3.1)4
Specific target organ toxicity — single exposure; respiratory tract irritation (section 3.8)3
Specific target organ toxicity — single exposure; narcosis (section 3.8)3
P313Get medical advice/attention.Skin irritation (section 3.2)2, 3
Eye irritation (section 3.3)2
Skin sensitisation (section 3.4)1
Germ cell mutagenicity (section 3.5)1A, 1B, 2
Carcinogenicity (section 3.6)1A, 1B, 2
Reproductive toxicity (section 3.7)1A, 1B, 2
Reproductive toxicity — effects on or via lactation (section 3.7)Additional category
P314Get medical advice/attention if you feel unwell.Specific target organ toxicity — repeated exposure (section 3.9)1, 2
P315Get immediate medical advice/attention.Gases under pressure (section 2.5)Refrigerated liquefied gas
P320Specific treatment is urgent (see … on this label).Acute toxicity — inhalation (section 3.1)1, 2… Reference to supplemental first aid instruction.

if immediate administration of antidote is required.
P321Specific treatment (see … on this label).Acute toxicity — oral (section 3.1)1, 2, 3… Reference to supplemental first aid instruction.

if immediate administration of antidote is required.
Acute toxicity — inhalation (section 3.1)3… Reference to supplemental first aid instruction.

if immediate specific measures are required.
Specific target organ toxicity — single exposure (section 3.8)1… Reference to supplemental first aid instruction.

if immediate measures are required.
Skin sensitisation (section 3.4)1… Reference to supplemental first aid instruction.

manufacturer/supplier may specify a cleansing agent if appropriate.
Skin corrosion (section 3.2)1A, 1B, 1C
Skin irritation (section 3.2)2
P322Specific measures (see … on this label).Acute toxicity — dermal (section 3.1)1, 2… Reference to supplemental first aid instruction.

if immediate measures such as specific cleansing agent is advised.
Acute toxicity — dermal (section 3.1)3, 4… Reference to supplemental first aid instruction.

if measures such as specific cleansing agent is advised.
P330Rinse mouth.Acute toxicity — oral (section 3.1)1, 2, 3, 4
Skin corrosion (section 3.2)1A, 1B, 1C
P331Do NOT induce vomiting.Skin corrosion (section 3.2)1A, 1B, 1C
Aspiration hazard (section 3.10)1
P332If skin irritation occurs:Skin irritation (section 3.2)2, 3
P333If skin irritation or rash occurs:Skin sensitisation (section 3.4)1
P334Immerse in cool water/wrap in wet bandages.Pyrophoric liquids (section 2.9)1
Pyrophoric solids (section 2.10)1
Substances and mixtures which, in contact with water, emit flammable gases (section 2.12)1, 2
P335Brush off loose particles from skin.Pyrophoric solids (section 2.10)1
Substances and mixtures which, in contact with water, emit flammable gases (section 2.12)1, 2
P336Thaw frosted parts with lukewarm water. Do not rub affected area.Gases under pressure (section 2.5)Refrigerated liquefied gas
P337If eye irritation persists:Eye irritation (section 3.3)2
P338Remove contact lenses, if present and easy to do. Continue rinsing.Skin corrosion (section 3.2)1A, 1B, 1C
Serious eye damage/eye irritation (section 3.3)1
Eye irritation (section 3.3)2
P340Remove victim to fresh air and keep at rest in a position comfortable for breathing.Acute toxicity — inhalation (section 3.1)1, 2, 3, 4
Skin corrosion (section 3.2)1A, 1B, 1C
Specific target organ toxicity — single exposure; respiratory tract irritation (section 3.8)3
Specific target organ toxicity — single exposure; narcosis (section 3.8)3
P341If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing.Respiratory sensitisation (section 3.4)1
P342If experiencing respiratory symptoms:Respiratory sensitisation (section 3.4)1
P350Gently wash with plenty of soap and water.Acute toxicity — dermal (section 3.1)1, 2
P351Rinse cautiously with water for several minutes.Skin corrosion (section 3.2)1A, 1B, 1C
Serious eye damage/eye irritation (section 3.3)1
Eye irritation (section 3.3)2
P352Wash with plenty of soap and water.Acute toxicity — dermal (section 3.1)3, 4
Skin irritation (section 3.2)2
Skin sensitisation (section 3.4)1
P353Rinse skin with water/shower.Flammable liquids (section 2.6)1, 2, 3
Skin corrosion (section 3.2)1A, 1B, 1C
P360Rinse immediately contaminated clothing and skin with plenty of water before removing clothes.Oxidising liquids (section 2.13)1
Oxidising solids (section 2.14)1
P361Remove/Take off immediately all contaminated clothing.Flammable liquids (section 2.6)1, 2, 3
Acute toxicity — dermal (section 3.1)1, 2, 3
Skin corrosion (section 3.2)1A, 1B, 1C
P362Take off contaminated clothing and wash before reuse.Skin irritation (section 3.2)2
P363Wash contaminated clothing before reuse.Acute toxicity — dermal (section 3.1)1, 2, 3, 4
Skin corrosion (section 3.2)1A, 1B, 1C
Skin sensitisation (section 3.4)1
P370In case of fire:Explosives (section 2.1)Divisions 1.1, 1.2, 1.3, 1.4, 1.5
Oxidising gases (section 2.4)1
Flammable liquids (section 2.6)1, 2, 3
Flammable solids (section 2.7)1, 2
Self-reactive substances and mixtures (section 2.8)Types A, B, C, D, E, F
Pyrophoric liquids (section 2.9)1
Pyrophoric solids (section 2.10)1
Substances and mixtures which, in contact with water, emit flammable gases (section 2.12)1, 2, 3
Oxidising liquids (section 2.13)1, 2, 3
Oxidising solids (section 2.14)1, 2, 3
P371In case of major fire and large quantities:Oxidising liquids (section 2.13)1
Oxidising solids (section 2.14)1
P372Explosion risk in case of fire.Explosives (section 2.1)Unstable explosives and Divisions 1.1, 1.2, 1.3, 1.4, 1.5
except if explosives are 1.4S AMMUNITION AND COMPONENTS THEREOF.
P373DO NOT fight fire when fire reaches explosives.Explosives (section 2.1)Unstable explosives and Divisions 1.1, 1.2, 1.3, 1.4, 1.5
P374Fight fire with normal precautions from a reasonable distance.Explosives (section 2.1)Division 1.4
if explosives are 1.4S AMMUNITION AND COMPONENTS THEREOF.
P375Fight fire remotely due to the risk of explosion.Self-reactive substances and mixtures (section 2.8)Types A, B
Oxidising liquids (section 2.13)1
Oxidising solids (section 2.14)1
P376Stop leak if safe to do so.Oxidising gases (section 2.4)1
P377Leaking gas fire:

Do not extinguish, unless leak can be stopped safely.
Flammable gases (section 2.2)1, 2
P378Use … for extinction.Flammable liquids (section 2.6)1, 2, 3… Manufacturer/supplier to specify appropriate media

if water increases risk.
Flammable solids (section 2.7)1, 2
Self-reactive substances and mixtures (section 2.8)Types A, B, C, D, E, F
Pyrophoric liquids (section 2.9)1
Pyrophoric solids (section 2.10)1
Substances and mixtures which, in contact with water, emit flammable gases (section 2.12)1, 2, 3
Oxidising liquids (section 2.13)1, 2, 3
Oxidising solids (section 2.14)1, 2, 3
P380Evacuate area.Explosives (section 2.1)Unstable explosives
Explosives (section 2.1)Divisions 1.1, 1.2, 1.3, 1.4, 1.5
Self-reactive substances and mixtures (section 2.8)Types A, B
Oxidising liquids (section 2.13)1
Oxidising solids (section 2.14)1
P381Eliminate all ignition sources if safe to do so.Flammable gases (section 2.2)1, 2
P390Absorb spillage to prevent material damage.Corrosive to metals (section 2.16)1
P391Collect spillage.Hazardous to the aquatic environment – acute aquatic hazard (section 4.1)1
Hazardous to the aquatic environment – chronic aquatic hazard (section 4.1)1, 2
P301 + P310IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician.Acute toxicity — oral (section 3.1)1, 2, 3
Aspiration hazard (section 3.10)1
P301 + P312IF SWALLOWED: Call a POISON CENTER or doctor/physician if you feel unwell.Acute toxicity — oral (section 3.1)4
P301 + P330 + P331IF SWALLOWED: Rinse mouth. Do NOT induce vomiting.Skin corrosion (section 3.2)1A, 1B, 1C
P302 + P334IF ON SKIN: Immerse in cool water/wrap in wet bandages.Pyrophoric liquids (section 2.9)1
P302 + P350IF ON SKIN: Gently wash with plenty of soap and water.Acute toxicity — dermal (section 3.1)1, 2
P302 + P352IF ON SKIN: Wash with plenty of soap and water.Acute toxicity — dermal (section 3.1)3, 4
Skin irritation (section 3.2)2
Skin sensitisation (section 3.4)1
P303 + P361 + P353IF ON SKIN (or hair): Remove/Take off immediately all contaminated clothing. Rinse skin with water/shower.Flammable liquids (section 2.6)1, 2, 3
Skin corrosion (section 3.2)1A, 1B, 1C
P304 + P340IF INHALED: Remove victim to fresh air and keep at rest in a position comfortable for breathing.Acute toxicity — inhalation (section 3.1)1, 2, 3, 4
Skin corrosion (section 3.2)1A, 1B, 1C
Specific target organ toxicity — single exposure; respiratory tract irritation (section 3.8)3
Specific target organ toxicity — single exposure; narcosis (section 3.8)3
P304 + P341IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing.Respiratory sensitisation (section 3.4)1
P305 + P351 + P338IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.Skin corrosion (section 3.2)1A, 1B, 1C
Serious eye damage/eye irritation (section 3.3)1
Eye irritation (section 3.3)2
P306 + P360IF ON CLOTHING: Rinse immediately contaminated clothing and skin with plenty of water before removing clothes.Oxidising liquids (section 2.13)1
Oxidising solids (section 2.14)1
P307 + P311IF exposed: Call a POISON CENTER or doctor/physician.Specific target organ toxicity — single exposure (section 3.8)1
P308 + P313IF exposed or concerned: Get medical advice/attention.Germ cell mutagenicity (section 3.5)1A, 1B, 2
Carcinogenicity (section 3.6)1A, 1B, 2
Reproductive toxicity (section 3.7)1A, 1B, 2
Reproductive toxicity — effects on or via lactation (section 3.7)Additional category
P309 + P311IF exposed or if you feel unwell: Call a POISON CENTER or doctor/physician.Specific target organ toxicity — single exposure (section 3.8)2
P332 + P313If skin irritation occurs: Get medical advice/attention.Skin irritation (section 3.2)2
P333 + P313If skin irritation or rash occurs: Get medical advice/attention.Skin sensitisation (section 3.4)1
P335 + P334Brush off loose particles from skin. Immerse in cool water/wrap in wet bandages.Pyrophoric solids (section 2.10)1
Substances and mixtures which, in contact with water, emit flammable gases (section 2.12)1, 2
P337 + P313If eye irritation persists: Get medical advice/attention.Eye irritation (section 3.3)2
P342 + P311If experiencing respiratory symptoms: Call a POISON CENTER or doctor/physician.Respiratory sensitisation (section 3.4)1
P370 + P376In case of fire: Stop leak if safe to do so.Oxidizing gases (section 2.4)1
P370 + P378In case of fire: Use … for extinction.Flammable liquids (section 2.6)1, 2, 3… Manufacturer/supplier to specify appropriate media.

if water increases risk.
Flammable solids (section 2.7)1, 2
Self-reactive substances and mixtures (section 2.8)Types A, B, C, D, E, F
Pyrophoric liquids (section 2.9)1
Pyrophoric solids (section 2.10)1
Substances and mixtures which, in contact with water, emit flammable gases (section 2.12)1, 2, 3
Oxidising liquids (section 2.13)1, 2, 3
Oxidising solids (section 2.14)1, 2, 3
P370 + P380In case of fire: Evacuate area.Explosives (section 2.1)Divisions 1.1, 1.2, 1.3, 1.4, 1.5
P370 + P380 + P375In case of fire: Evacuate area. Fight fire remotely due to the risk of explosion.Self-reactive substances and mixtures (section 2.8)Types A, B
P371 + P380 + P375In case of major fire and large quantities: Evacuate area. Fight fire remotely due to the risk of explosion.Oxidising liquids (section 2.13)1
Oxidising solids (section 2.14)1


Table 6.4

Precautionary statements — Storage

CodeStorage precautionary statementsHazard classHazard categoryConditions for use
(1)(2)(3)(4)(5)
P401Store …Explosives (section 2.1)Unstable explosives and Divisions 1.1, 1.2, 1.3, 1.4, 1.5… in accordance with local/regional/national/international regulations (to be specified).
P402Store in a dry place.Substances and mixtures which, in contact with water, emit flammable gases (section 2.12)1, 2, 3
P403Store in a well-ventilated place.Flammable gases (section 2.2)1, 2
if product is volatile so as to generate hazardous atmosphere.
Oxidising gases (section 2.4)1
Gases under pressure (section 2.5)Compressed gas
Liquefied gas
Refrigerated Liquefied gas
Dissolved gas
Flammable liquids (section 2.6)1, 2, 3
Self-reactive substances and mixtures (section 2.8)Types A, B, C, D, E, F
Acute toxicity — inhalation (section 3.1)1, 2, 3
Specific target organ toxicity — single exposure; respiratory tract irritation (section 3.8)3
Specific target organ toxicity — single exposure; narcosis (section 3.8)3
P404Store in a closed container.Substances and mixtures which, in contact with water, emit flammable gases (section 2.12)1, 2, 3
P405Store locked up.Acute toxicity — oral (section 3.1)1, 2, 3
Acute toxicity — dermal (section 3.1)1, 2, 3
Acute toxicity — inhalation (section 3.1)1, 2, 3
Skin corrosion (section 3.2)1A, 1B, 1C
Germ cell mutagenicity (section 3.5)1A, 1B, 2
Carcinogenicity (section 3.6)1A, 1B, 2
Reproductive toxicity (section 3.7)1A, 1B, 2
Specific target organ toxicity — single exposure (section 3.8)1, 2
Specific target organ toxicity — single exposure; respiratory tract irritation (section 3.8)3
Specific target organ toxicity — single exposure; narcosis (section 3.8)3
Aspiration hazard (section 3.10)1
P406Store in corrosive resistant/… container with a resistant inner liner.Corrosive to metals (section 2.16)1… Manufacturer/supplier to specify other compatible materials.
P407Maintain air gap between stacks/pallets.Self-heating substances and mixtures (section 2.11)1, 2
P410Protect from sunlight.Flammable aerosols (section 2.3)1, 2
Gases under pressure (section 2.5)Compressed gas
Liquefied gas
Dissolved gas
Self-heating substances and mixtures (section 2.11)1, 2
Organic peroxides (section 2.15)Types A, B, C, D, E, F
P411Store at temperatures not exceeding … oC/…oF.Self-reactive substances and mixtures (section 2.8)Types A, B, C, D, E, F… Manufacturer/supplier to specify temperature
Organic peroxides (section 2.15)Types A, B, C, D, E, F
P412Do not expose to temperatures exceeding 50 oC/122 oF.Flammable aerosols (section 2.3)1, 2
P413Store bulk masses greater than … kg/…lbs at temperatures not exceeding … oC/…oF.Self-heating substances and mixtures (section 2.11)1, 2… Manufacturer/supplier to specify mass and temperature.
P420Store away from other materials.Self-reactive substances and mixtures (section 2.8)Types A, B, C, D, E, F
Self-heating substances and mixtures (section 2.11)1, 2
Organic peroxides (section 2.15)Types A, B, C, D, E, F
P422Store contents under …Pyrophoric liquids (section 2.9)1… Manufacturer/supplier to specify appropriate liquid or inert gas.
Pyrophoric solids (section 2.10)1
P402 + P404Store in a dry place. Store in a closed container.Substances and mixtures which, in contact with water, emit flammable gases (section 2.12)1, 2, 3
P403 + P233Store in a well-ventilated place. Keep container tightly closed.Acute toxicity — inhalation (section 3.1)1, 2, 3
if product is volatile so as to generate hazardous atmosphere.
Specific target organ toxicity — single exposure; respiratory tract irritation (section 3.8)3
Specific target organ toxicity — single exposure; narcosis (section 3.8)3
P403 + P235Store in a well-ventilated place. Keep cool.Flammable liquids (section 2.6)1, 2, 3
Self-reactive substances and mixtures (section 2.8)Types A, B, C, D, E, F
P410 + P403Protect from sunlight. Store in a well-ventilated place.Gases under pressure (section 2.5)Compressed gas
Liquefied gas
Dissolved gas
P410 + P412Protect from sunlight. Do not expose to temperatures exceeding 50 oC/122oF.Flammable aerosols (section 2.3)1, 2
P411 + P235Store at temperatures not exceeding … oC/…oF. Keep cool.Organic peroxides (section 2.15)Types A, B, C, D, E, F… Manufacturer/supplier to specify temperature.


Table 6.5

Precautionary statements — Disposal

CodeDisposal precautionary statementsHazard classHazard categoryConditions for use
(1)(2)(3)(4)(5)
P501Dispose of contents/container to …Explosives (section 2.1)Unstable explosives and Divisions 1.1, 1.2, 1.3, 1.4, 1.5… in accordance with local/regional/national/international regulation (to be specified).
Flammable liquids (section 2.6)1, 2, 3
Self-reactive substances and mixtures (section 2.8)Types A, B, C, D, E, F
Substances and mixtures which, in contact with water, emit flammable gases (section 2.12)1, 2, 3
Oxidising liquids (section 2.13)1, 2, 3
Oxidising solids (section 2.14)1, 2, 3
Organic peroxides (section 2.15)Types A, B, C, D, E, F
Acute toxicity — oral (section 3.1)1, 2, 3, 4
Acute toxicity — dermal (section 3.1)1, 2, 3, 4
Acute toxicity — inhalation (section 3.1)1, 2
Skin corrosion (section 3.2)1A, 1B, 1C
Respiratory sensitisation (section 3.4)1
Skin sensitisation (section 3.4)1
Germ cell mutagenicity (section 3.5)1A, 1B, 2
Carcinogenicity (section 3.6)1A, 1B, 2
Reproductive toxicity (section 3.7)1A, 1B, 2
Specific target organ toxicity — single exposure (section 3.8)1, 2
Specific target organ toxicity — single exposure; respiratory tract irritation (section 3.8)3
Specific target organ toxicity — single exposure; narcosis (section 3.8)3
Specific target organ toxicity — repeated exposure (section 3.9)1, 2
Aspiration hazard (section 3.10)1
Hazardous to the aquatic environment — acute aquatic hazard (section 4.1)1
Hazardous to the aquatic environment — chronic aquatic hazard (section 4.1)1, 2, 3, 4
Hazardous to the ozone layer (section 5.1)1

2. Part 2: precautionary statements

The precautionary statements shall be taken from this part of Annex IV and selected in accordance with Part 1.

Table 1.1

Precautionary statements — General

P101Language
BGПри необходимост от медицинска помощ, носете опаковката или етикета на продукта.
ESSi se necesita consejo médico, tener a mano el envase o la etiqueta.
CSJe-li nutná lékařská pomoc, mějte po ruce obal nebo štítek výrobku.
DAHvis der er brug for lægehjælp, medbring da beholderen eller etiketten.
DEIst ärztlicher Rat erforderlich, Verpackung oder Kennzeichnungsetikett bereithalten.
ETArsti poole pöördudes võtta kaasa toote pakend või etikett.
ELΕάν ζητήσετε ιατρική συμβουλή, να έχετε μαζί σας τον περιέκτη του προϊόντος ή την ετικέτα.
ENIf medical advice is needed, have product container or label at hand.
FREn cas de consultation d’un médecin, garder à disposition le récipient ou l’étiquette.
GAMás gá comhairle liachta, bíodh coimeádán nó lipéad an táirge ina aice láimhe.
ITIn caso di consultazione di un medico, tenere a disposizione il contenitore o l'etichetta del prodotto.
LVMedicīniska padoma nepieciešamības gadījumā attiecīgā informācija ir norādīta uz iepakojuma vai etiķetes.
LTJei reikalinga gydytojo konsultacija, su savimi turėkite produkto talpyklą ar jo etiketę.
HUOrvosi tanácsadás esetén tartsa kéznél a termék edényét vagy címkéjét.
MTJekk ikun meħtieġ parir mediku, ara li jkollok il-kontenitur jew it-tikketta tal-prodott fil-qrib.
NLBij het inwinnen van medisch advies, de verpakking of het etiket ter beschikking houden.
PLW razie konieczności zasięgnięcia porady lekarza należy pokazać pojemnik lub etykietę.
PTSe for necessário consultar um médico, mostre-lhe a embalagem ou o rótulo.
RODacă este necesară consultarea medicului, țineți la îndemână recipientul sau eticheta produsului.
SKAk je potrebná lekárska pomoc, majte k dispozícii obal alebo etiketu výrobku.
SLČe je potreben zdravniški nasvet, mora biti na voljo posoda ali etiketa proizvoda.
FIJos tarvitaan lääkinnällistä apua, näytä pakkaus tai varoitusetiketti.
SVHa förpackningen eller etiketten till hands om du måste söka läkarvård.

P102Language
BGДа се съхранява извън обсега на деца.
ESMantener fuera del alcance de los niños.
CSUchovávejte mimo dosah dětí.
DAOpbevares utilgængeligt for børn.
DEDarf nicht in die Hände von Kindern gelangen.
ETHoida lastele kättesaamatus kohas.
ELΜακριά από παιδιά.
ENKeep out of reach of children.
FRTenir hors de portée des enfants.
GACoimeád as aimsiú leanaí.
ITTenere fuori dalla portata dei bambini.
LVSargāt no bērniem.
LTLaikyti vaikams neprieinamoje vietoje.
HUGyermekektől elzárva tartandó.
MTŻommu ‘l bogħod minn fejn jistgħu jilħquh it-tfal.
NLBuiten het bereik van kinderen houden.
PLChronić przed dziećmi.
PTManter fora do alcance das crianças.
ROA nu se lăsa la îndemâna copiilor.
SKUchovávajte mimo dosahu detí.
SLHraniti zunaj dosega otrok.
FISäilytä lasten ulottumattomissa.
SVFörvaras oåtkomligt för barn.

P103Language
BGПреди употреба прочетете етикета.
ESLeer la etiqueta antes del uso.
CSPřed použitím si přečtěte údaje na štítku.
DALæs etiketten før brug.
DEVor Gebrauch Kennzeichnungsetikett lesen.
ETEnne kasutamist tutvuda etiketil oleva infoga.
ELΔιαβάστε την ετικέτα πριν από τη χρήση.
ENRead label before use.
FRLire l’étiquette avant utilisation.
GALéigh an lipéad roimh úsáid.
ITLeggere l’etichetta prima dell’uso.
LVPirms izmantošanas izlasīt etiķeti.
LTPrieš naudojimą perskaityti etiketę.
HUHasználat előtt olvassa el a címkén közölt információkat.
MTAqra t-tikketta qabel l-użu.
NLAlvorens te gebruiken, het etiket lezen.
PLPrzed użyciem przeczytać etykietę.
PTLer o rótulo antes da utilização.
ROCitiţi eticheta înainte de utilizare.
SKPred použitím si prečítajte etiketu.
SLPred uporabo preberite etiketo.
FILue merkinnät ennen käyttöä.
SVLäs etiketten före användning.


Table 1.2

Precautionary statements — Prevention

P201Language
BGПреди употреба се снабдете със специални инструкции.
ESPedir instrucciones especiales antes del uso.
CSPřed použitím si obstarejte speciální instrukce.
DAIndhent særlige anvisninger før brug.
DEVor Gebrauch besondere Anweisungen einholen.
ETEnne kasutamist tutvuda erijuhistega.
ELΕφοδιαστείτε με τις ειδικές οδηγίες πριν από τη χρήση.
ENObtain special instructions before use.
FRSe procurer les instructions avant utilisation.
GAFaigh treoracha speisialta roimh úsáid.
ITProcurarsi istruzioni specifiche prima dell’uso.
LVPirms lietošanas saņemt speciālu instruktāžu.
LTPrieš naudojimą gauti specialias instrukcijas.
HUHasználat előtt ismerje meg az anyagra vonatkozó különleges utasításokat.
MTIkseb struzzjonijiet speċjali qabel l-użu.
NLAlvorens te gebruiken de speciale aanwijzingen raadplegen.
PLPrzed użyciem zapoznać się ze specjalnymi środkami ostrożności.
PTPedir instruções específicas antes da utilização.
ROProcuraţi instrucţiuni speciale înainte de utilizare.
SKPred použitím sa oboznámte s osobitnými pokynmi.
SLPred uporabo pridobiti posebna navodila.
FILue erityisohjeet ennen käyttöä.
SVInhämta särskilda instruktioner före användning.

P202Language
BGНе използвайте преди да сте прочели и разбрали всички предпазни мерки за безопасност.
ESNo manipular la sustancia antes de haber leído y comprendido todas las instrucciones de seguridad.
CSNepoužívejte, dokud jste si nepřečetli všechny bezpečnostní pokyny a neporozuměli jim.
DAAnvend ikke produktet, før alle advarsler er læst og forstået.
DEVor Gebrauch alle Sicherheitshinweise lesen und verstehen.
ETMitte käidelda enne ohutusnõuetega tutvumist ja nendest arusaamist.
ELΜην το χρησιμοποιήσετε πριν διαβάσετε και κατανοήσετε τις οδηγίες προφύλαξης.
ENDo not handle until all safety precautions have been read and understood.
FRNe pas manipuler avant d’avoir lu et compris toutes les précautions de sécurité.
GANá láimhsigh go dtí go léifear agus go dtuigfear gach ráiteas réamhchúraim sábháilteachta.
ITNon manipolare prima di avere letto e compreso tutte le avvertenze.
LVNeizmantot pirms nav izlasīti un saprasti visi apzīmējumi.
LTNenaudoti, jeigu neperskaityti ar nesuprasti visi saugos įspėjimai.
HUNe használja addig, amíg az összes biztonsági óvintézkedést el nem olvasta és meg nem értette.
MTTmissux qabel ma tkun qrajt u fhimt l-istruzzjonijiet kollha ta' prekawzjoni.
NLPas gebruiken nadat u alle veiligheidsvoorschriften gelezen en begrepen heeft
PLNie używać przed zapoznaniem się i zrozumieniem wszystkich środków bezpieczeństwa.
PTNão manuseie o produto antes de ter lido e percebido todas as precauções de segurança.
ROA nu se manipula decât după ce au fost citite şi înţelese toate măsurile de securitate.
SKNepoužívajte, kým si neprečítate a nepochopíte všetky bezpečnostné opatrenia.
SLNe uporabljajte, dokler se ne seznanite z vsemi varnostnimi ukrepi.
FILue varoitukset huolellisesti ennen käsittelyä.
SVAnvänd inte produkten innan du har läst och förstått säkerhetsanvisningarna

P210Language
BGДа се пази от топлина/искри/открит пламък/нагорещени повърхности. — Тютюнопушенето забранено.
ESMantener alejado de fuentes de calor, chispas, llama abierta o superficies calientes. — No fumar.
CSChraňte před teplem/jiskrami/otevřeným plamenem/horkými povrchy. — Zákaz kouření.
DAHoldes væk fra varme/gnister/åben ild/varme overflader. Rygning forbudt.
DEVon Hitze/Funken/offener Flamme/heißen Oberflächen fernhalten. Nicht rauchen.
ETHoida eemal soojusallikast/sädemetest/leekidest/kuumadest pindadest. — Mitte suitsetada.
ELΜακριά από θερμότητα/σπινθήρες/γυμνές φλόγες/θερμές επιφάνειες. — Μην καπνίζετε.
ENKeep away from heat/sparks/open flames/hot surfaces. — No smoking.
FRTenir à l’écart de la chaleur/des étincelles/des flammes nues/des surfaces chaudes. — Ne pas fumer.
GACoimeád ó theas/splancacha/lasair gan chosaint/dromchlaí te. — Ná caitear tobac.
ITTenere lontano da fonti di calore/scintille/fiamme libere/superfici riscaldate. — Non fumare.
LVNelietot vietās, kur ir sastopams karstums/dzirksteles/atklāta uguns/…/karstas virsmas. Nesmēķēt.
LTLaikyti atokiau nuo šilumos šaltinių/žiežirbų/atviros liepsnos/karštų paviršių. — Nerūkyti.
HUHőtől/szikrától/nyílt lángtól/…/forró felületektől távol tartandó. Tilos a dohányzás.
MTŻomm ‘il bogħod mis-sħana/xrar tan-nar/fjammiet mikxufa/uċuħ jaħarqu. — Tpejjipx.
NLVerwijderd houden van warmte/vonken/open vuur/hete oppervlakken. — Niet roken.
PLPrzechowywać z dala od źródeł ciepła/iskrzenia/otwartego ognia/gorących powierzchni. Palenie wzbronione.
PTManter afastado do calor/faísca/chama aberta/superfícies quentes. — Não fumar.
ROA se păstra departe de surse de căldură/scântei/flăcări deschise/suprafeţe încinse. — Fumatul interzis.
SKUchovávajte mimo dosahu tepla/iskier/otvoreného ohňa/horúcich povrchov. Nefajčite.
SLHraniti ločeno od vročine/isker/odprtega ognja/vročih površin. — Kajenje prepovedano.
FISuojaa lämmöltä/kipinöiltä/avotulelta/kuumilta pinnoilta. — Tupakointi kielletty.
SVFår inte utsättas för värme/gnistor/öppen låga/heta ytor. — Rökning förbjuden.

P211Language
BGДа не се пръска към открит пламък или друг източник на запалване.
ESNo pulverizar sobre una llama abierta u otra fuente de ignición.
CSNestříkejte do otevřeného ohně nebo jiných zdrojů zapálení.
DASpray ikke mod åben ild eller andre antændelseskilder.
DENicht gegen offene Flamme oder andere Zündquelle sprühen.
ETMitte pihustada leekidesse või muusse süüteallikasse.
ELΜην ψεκάζετε κοντά σε γυμνή φλόγα ή άλλη πηγή ανάφλεξης.
ENDo not spray on an open flame or other ignition source.
FRNe pas vaporiser sur une flamme nue ou sur toute autre source d’ignition.
GANá spraeáil ar lasair gan chosaint ná ar fhoinse eile adhainte.
ITNon vaporizzare su una fiamma libera o altra fonte di accensione.
LVNeizsmidzināt uz atklātas uguns vai citiem aizdegšanās avotiem.
LTNepurkšti į atvirą liepsną arba kitus degimo šaltinius.
HUTilos nyílt lángra vagy más gyújtóforrásra permetezni.
MTTisprejjax fuq fjamma mikxufa jew sors ieħor li jaqbad.
NLNiet in een open vuur of op andere ontstekingsbronnen spuiten.
PLNie rozpylać nad otwartym ogniem lub innym źródłem zapłonu.
PTNão pulverizar sobre chama aberta ou outra fonte de ignição.
RONu pulverizaţi deasupra unei flăcări deschise sau unei alte surse de aprindere.
SKNestriekajte na otvorený oheň ani iný zdroj zapálenia.
SLNe pršiti proti odprtemu ognju ali drugemu viru vžiga.
FIEi saa suihkuttaa avotuleen tai muuhun sytytyslähteeseen.
SVSpreja inte över öppen låga eller andra antändningskällor.

P220Language
BGДа се държи/съхранява далеч от облекло/…/горими материали
ESMantener o almacenar alejado de la ropa/…/materiales combustibles.
CSUchovávejte/skladujte odděleně od oděvů/…/hořlavých materiálů.
DAMå ikke anvendes/opbevares i nærheden af tøj/…/brændbare materialer.
DEVon Kleidung/…/brennbaren Materialien fernhalten/entfernt aufbewahren.
ETHoida eemal rõivastest/…/süttivast materjalist.
ELΔιατηρείται/Φυλάσσεται μακριά από ενδύματα/…/καύσιμα υλικά.
ENKeep/Store away from clothing/…/combustible materials.
FRTenir/stocker à l’écart des vêtements/…/matières combustibles
GACoimeád/Stóráil glan ar éadaí/…/ábhair indóite.
ITTenere/conservare lontano da indumenti/…/materiali combustibili.
LVTurēt/uzglabāt vietās, kur nav piekļuves drēbēm/…/uzliesmojošiem materiāliem.
LTLaikyti/sandėliuoti atokiau nuo drabužių/…/degių medžiagų.
HURuhától/…/éghető anyagtól távol tartandó/tárolandó.
MTŻomm/Aħżen ‘il bogħod mill-ħwejjeġ/…/materjali li jaqbdu.
NLVan kleding/…/brandbare stoffen verwijderd houden/bewaren.
PLTrzymać/przechowywać z dala od odzieży/…/materiałów zapalnych.
PTManter/guardar afastado de roupa/…/matérias combustíveis.
ROA se păstra/depozita departe de îmbrăcăminte/…/materiale combustibile.
SKUchovávajte/skladujte mimo odevov/…/horľavých materiálov.
SLHraniti ločeno od oblačil/…/vnetljivih materialov.
FIPidä/Varastoi erillään vaatetuksesta/…/syttyvistä materiaaleista.
SVHålls/förvarad åtskilt från kläder/…/brännbara material.

P221Language
BGВземете всички предпазни мерки за избягване на смесването с горими материали…
ESTomar todas las precauciones necesarias para no mezclar con materias combustibles…
CSProveďte preventivní opatření proti smíchání s hořlavými materiály…
DAUndgå at blande med brændbare materialer…
DEMischen mit brennbaren Stoffen/… unbedingt verhindern.
ETRakendada ettevaatusabinõusid, et vältida segunemist põlevainetega…
ELΛάβετε κάθε προφύλαξη ώστε να μην αναμειχθεί με καύσιμα…
ENTake any precaution to avoid mixing with combustibles…
FRPrendre toutes précautions pour éviter de mélanger avec des matières combustibles…
GADéan gach réamhchúram chun meascadh le hábhair indóite a sheachaint…
ITPrendere ogni precauzione per evitare di miscelare con sostanze combustibili…
LVNekādā gadījumā nemaisīt ar viegli uzliesmojošām vielām…
LTImtis visų atsargumo priemonių, kad nebūtų sumaišyta su degiomis medžiagomis…
HUMinden óvintézkedést meg kell tenni, hogy ne keveredjen éghető anyagokkal.
MTĦu kull prekawzjoni biex tevita li jitħallat mal-kombustibbli…
NLVermenging met brandbare stoffen… absoluut vermijden.
PLZastosować wszelkie środki ostrożności w celu uniknięcia mieszania z innymi materiałami zapalnymi …
PTTomar todas as precauções para não misturar com combustíveis…
ROLuaţi toate măsurile de precauţie pentru a evita amestecul cu combustibili…
SKPrijmite opatrenia na zabránenie zmiešania s horľavými materiálmi…
SLPreprečiti mešanje z vnetljivimi snovmi …
FIVaro sekoittamasta syttyvien materiaalien… kanssa.
SVUndvik att blanda med med brännbara ämnen…

P222Language
BGНе допускайте конктакт с въздух.
ESNo dejar que entre en contacto con el aire.
CSZabraňte styku se vzduchem.
DAUndgå kontakt med luft.
DEKontakt mit Luft nicht zulassen.
ETHoida õhuga kokkupuute eest.
ELΝα μην έρθει σε επαφή με τον αέρα.
ENDo not allow contact with air.
FRNe pas laisser au contact de l’air.
GANá ceadaigh teagmháil le haer.
ITEvitare il contatto con l’aria.
LVNepieļaut kontaktu ar gaisu.
LTSaugoti nuo kontakto su oru.
HUNem érintkezhet levegővel.
MTTħallix li jkun hemm kuntatt ma' l-arja.
NLContact met de lucht vermijden.
PLNie dopuszczać do kontaktu z powietrzem.
PTNão deixar entrar em contacto com o ar.
ROA nu se lăsa în contact cu aerul.
SKZabráňte kontaktu so vzduchom.
SLPreprečiti stik z zrakom.
FIEi saa joutua kosketuksiin ilman kanssa.
SVUndvik kontakt med luft.

P223Language
BGДа се избягва всякакъв възможен контакт с вода поради бурна реакция и възможно внезапно запалване.
ESMantener alejado de cualquier posible contacto con el agua, pues reacciona violentamente y puede provocar una llamarada.
CSChraňte před možným stykem s vodou kvůli prudké reakci a možnému náhlému vzplanutí.
DAUndgå enhver kontakt med vand, da dette kan fremkalde voldsom reaktion og risiko for eksplosionsagtig brand.
DEKontakt mit Wasser wegen heftiger Reaktion und möglichem Aufflammen unbedingt verhindern.
ETHoida igasuguse kokkupuute eest veega, vastasel juhul reageerib ägedalt ja võib põhjustada hetkpõlemise.
ELΑποφύγετε κάθε πιθανή επαφή με το νερό, διότι αντιδρά βίαια και μπορεί να προκληθεί ανάφλεξη.
ENKeep away from any possible contact with water, because of violent reaction and possible flash fire.
FRÉviter tout contact avec l’eau, à cause du risque de réaction violente et d’inflammation spontanée.
GANá ceadaigh teagmháil de shaghas ar bith le huisce, mar gheall ar imoibriú foirtil agus splancthine a d’fhéadfadh a bheith ann.
ITEvitare qualsiasi contatto con l’acqua: pericolo di reazione violenta e di infiammazione spontanea.
LVNepieļaut kontaktu ar ūdeni īpaši stipras reakcijas un iespējamas eksplozijas dēļ.
LTSaugoti nuo bet kokio galimo kontakto su vandeniu, nes smarkiai reaguoja ir gali susidaryti ugnies pliūpsnis.
HUVízzel semmilyen formában nem érintkezhet, ellenkező esetben heves reakció és belobbanás fordulhat elő.
MTŻomm ‘il bogħod minn kull kuntatt possibbli ma' l-ilma, minħabba li jirreaġġixxi bil-qawwa u jista’ jkun hemm fjamma nar.
NLContact met water vermijden in verband met een heftige reactie en een mogelijke wolkbrand.
PLChronić przed wszelkim kontaktem z wodą z powodu gwałtownej reakcji i możliwości wystąpienia błyskawicznego pożaru.
PTNão deixar entrar em contacto com a água: risco de reacção violenta e possibilidade de formação de chama súbita.
ROA se evita orice contact cu apa, din cauza reacţiei violente şi a riscului de aprindere spontană.
SKZabráňte akémukoľvek kontaktu s vodou, aby nedošlo k prudkej reakcii a prípadnému zapáleniu.
SLHraniti ločeno od možnega stika z vodo zaradi burne reakcije in možnega bliskovitega požara.
FIEi saa joutua kosketuksiin veden kanssa voimakkaan reaktion ja mahdollisen leimahduksen takia.
SVUndvik all kontakt med vatten eftersom det kan framkalla en våldsam reaktion och explosionsartad brand.

P230Language
BGДа се държи навлажнен с…
ESMantener humedecido con…
CSUchovávejte ve zvlhčeném stavu…
DAHoldes befugtet med…
DEFeucht halten mit …
ETNiisutada …-ga.
ELΝα διατηρείται υγρό με …
ENKeep wetted with…
FRMaintenir humidifié avec…
GACoimeád fliuchta le…
ITMantenere umido con…
LVVienmēr samitrināt ar …
LTLaikyti sudrėkintą (kuo)
HU…-val/-vel nedvesítve tartandó.
MTŻommu mxarrab bi …
NLVochtig houden met…
PLPrzechowywać produkt zwilżony…
PTManter húmido com…
ROA se păstra umezit cu…
SKUchovávajte zvlhčené …
SLHraniti prepojeno z …
FISäilytä kostutettuna …
SVSka hållas fuktigt med…

P231Language
BGДа се използва под инертен газ.
ESManipular en gas inerte.
CSManipulace pod inertním plynem.
DAHåndteres under inaktiv gas.
DEUnter inertem Gas handhaben.
ETKäidelda inertgaasis.
ELΧειρισμός σε αδρανή ατμόσφαιρα.
ENHandle under inert gas.
FRManipuler sous gaz inerte.
GALáimhsigh faoi thriathghás.
ITManipolare in atmosfera di gas inerte.
LVRīkoties tikai inertas gāzes apstākļos.
LTTvarkyti inertinėse dujose.
HUInert gázban használandó.
MTImmaniġġja taħt gass inerti.
NLOnder inert gas werken.
PLUżywać w atmosferze obojętnego gazu.
PTManusear em atmosfera de gás inerte.
ROA se manipula sub un gaz inert.
SKManipulujte v prostredí s inertným plynom.
SLHraniti v ustreznem inertnem plinu.
FIKäsittele inertissä kaasussa.
SVHanteras under inert gas.

P232Language
BGДа се пази от влага.
ESProteger de la humedad.
CSChraňte před vlhkem.
DABeskyttes mod fugt.
DEVor Feuchtigkeit schützen.
ETHoida niiskuse eest.
ELΠροστετέψτε από την υγρασία.
ENProtect from moisture.
FRProtéger de l’humidité.
GACosain ar thaise.
ITProteggere dall’umidità.
LVAizsargāt no mitruma.
LTSaugoti nuo drėgmės.
HUNedvességtől védendő.
MTIpproteġi mill-umdità.
NLTegen vocht beschermen.
PLChronić przed wilgocią.
PTManter ao abrigo da humidade.
ROA se proteja de umiditate.
SKChráňte pred vlhkosťou.
SLZaščititi pred vlago.
FISuojaa kosteudelta.
SVSkyddas från fukt.

P233Language
BGСъдът да се съхранява плътно затворен.
ESMantener el recipiente herméticamente cerrado.
CSUchovávejte obal těsně uzavřený.
DAHold beholderen tæt lukket.
DEBehälter dicht verschlossen halten.
ETHoida pakend tihedalt suletuna.
ELΝα διατηρείται ο περιέκτης ερμητικά κλειστός.
ENKeep container tightly closed.
FRMaintenir le récipient fermé de manière étanche.
GACoimeád an coimeádán dúnta go docht.
ITTenere il recipiente ben chiuso.
LVTvertni stingri noslēgt.
LTTalpyklą laikyti sandariai uždarytą.
HUAz edény szorosan lezárva tartandó.
MTŻomm il-kontenitur magħluq sew.
NLIn goed gesloten verpakking bewaren.
PLPrzechowywać pojemnik szczelnie zamknięty.
PTManter o recipiente bem fechado.
ROPăstraţi recipientul închis etanş.
SKNádobu uchovávajte tesne uzavretú.
SLHraniti v tesno zaprti posodi.
FISäilytä tiiviisti suljettuna.
SVBehållaren ska vara väl tillsluten.

P234Language
BGДа се съхранява само в оригиналната опаковка.
ESConservar únicamente en el recipiente original.
CSUchovávejte pouze v původním obalu.
DAOpbevares kun i den originale beholder.
DENur im Originalbehälter aufbewahren.
ETHoida üksnes originaalpakendis.
ELΝα διατηρείται μόνο στον αρχικό περιέκτη.
ENKeep only in original container.
FRConserver uniquement dans le récipient d’origine.
GACoimeád sa choimeádán bunaidh amháin.
ITConservare soltanto nel contenitore originale.
LVTurēt tikai oriģinālā iepakojumā.
LTLaikyti tik originalioje talpykloje.
HUAz eredeti edényben tartandó.
MTŻomm biss fil-kontenitur oriġinali.
NLUitsluitend in de oorspronkelijke verpakking bewaren.
PLPrzechowywać wyłącznie w oryginalnym pojemniku.
PTConservar unicamente no recipiente de origem.
ROPăstraţi numai în recipientul original.
SKUchovávajte iba v pôvodnej nádobe.
SLHraniti samo v originalni posodi.
FISäilytä alkuperäispakkauksessa.
SVFörvaras endast i originalbehållaren.

P235Language
BGДа се държи на хладно.
ESMantener en lugar fresco.
CSUchovávejte v chladu.
DAOpbevares køligt.
DEKühl halten.
ETHoida jahedas.
ELΝα διατηρείται δροσερό.
ENKeep cool.
FRTenir au frais.
GACoimeád fionnuar é
ITConservare in luogo fresco.
LVTurēt vēsumā.
LTLaikyti vėsioje vietoje.
HUHűvös helyen tartandó.
MTŻomm frisk.
NLKoel bewaren.
PLPrzechowywać w chłodnym miejscu.
PTConservar em ambiente fresco.
ROA se păstra la rece.
SKUchovávajte v chlade.
SLHraniti na hladnem.
FISäilytä viileässä.
SVFörvaras svalt.

P240Language
BGЗаземяване/еквипотенциална връзка на съда и приемателното устройство.
ESConectar a tierra/enlace equipotencial del recipiente y del equipo de recepción.
CSUzemněte obal a odběrové zařízení.
DABeholder og modtageudstyr jordforbindes/potentialudlignes.
DEBehälter und zu befüllende Anlage erden.
ETMahuti ja vastuvõtuseade maandada/ühendada.
ELΓείωση/ισοδυναμική σύνδεση του περιέκτη και του εξοπλισμού δέκτη.
ENGround/bond container and receiving equipment.
FRMise à la terre/liaison équipotentielle du récipient et du matériel de réception.
GANasc an coimeádán agus an trealamh glactha leis an talamh.
ITMettere a terra/massa il contenitore e il dispositivo ricevente.
LVTvertnes un iekārtas saņemšanai ievietot zemē/sasaistīt
LTĮžeminti/įtvirtinti talpyklą ir priėmimo įrangą.
HUA tárolóedényt és a fogadóedényt le kell földelni/át kell kötni.
MTPoġġi ma' l-art/waħħal il-kontenitur u t-tagħmir li jirċievi.
NLOpslag- en opvangreservoir aarden.
PLUziemić/połączyć pojemnik i sprzęt odbiorczy.
PTLigação à terra/equipotencial do recipiente e do equipamento receptor.
ROLegătură la pământ/conexiune echipotenţială cu recipientul şi cu echipamentul de recepţie.
SKUzemnite/upevnite nádobu a plniace zariadenie.
SLOzemljiti posodo in opremo za sprejem tekočine.
FISäiliö ja vastaanottavat laitteet on maadoitettava/yhdistettävä.
SVJorda/potentialförbind behållare och mottagarutrustning.

P241Language
BGИзползвайте електрическо/проветряващо/осветително/…/оборудване, обезопасено срещу експлозия
ESUtilizar un material eléctrico, de ventilación o de iluminación/…/antideflagrante.
CSPoužívejte elektrické/ventilační/osvětlovací/…/zařízení do výbušného prostředí.
DAAnvend eksplosionssikkert elektrisk/ventilations-/lys-/…/udstyr.
DEExplosionsgeschützte elektrische Betriebsmittel/Lüftungsanlagen/Beleuchtung/… verwenden.
ETKasutada plahvatuskindlaid elektri-/ventilatsiooni-/valgustus-/…/seadmeid.
ELΝα χρησιμοποιείται αντιεκρηκτικός ηλεκτρολογικός/εξαερισμού/φωτιστικός/…/εξοπλισμός.
ENUse explosion-proof electrical/ventilating/lighting/…/equipment.
FRUtiliser du matériel électrique/de ventilation/d’éclairage/…/antidéflagrant.
GABain úsáid as trealamh pléascdhíonach leictreach/aerála/soilsiúcháin/…
ITUtilizzare impianti elettrici/di ventilazione/d’illuminazione/…/a prova di esplosione.
LVIzmantot sprādziendrošas elektriskas/ar ventilāciju/izgaismotas/…/iekārtas
LTNaudoti sprogimui atsparią elektros/ventiliacijos/apšvietimo/…/įrangą.
HURobbanásbiztos elektromos/szellőztető/világító/…/berendezés használandó.
MTUża’ tagħmir elettriku/ta’ ventilazzjoni/ta' dawl/…/li jiflaħ għal splużjoni.
NLExplosieveilige elektrische/ventilatie-/verlichtings-/…apparatuur gebruiken.
PLUżywać elektrycznego/wentylującego/oświetleniowego/…/. przeciwwybuchowego sprzętu.
PTUtilizar equipamento eléctrico/de ventilação/de iluminação/…/à prova de explosão.
ROUtilizaţi echipamente electrice/de ventilare/de iluminat/…/antideflagrante.
SKPoužívajte elektrické/ventilačné/osvetľovacie/…/zariadenie do výbušného prostredia.
SLUporabiti električno/prezračevalno opremo, opremo za razsvetljavo/…/, odporno proti eksplozijam.
FIKäytä räjähdysturvallisia sähkö/ilmanvaihto/valaisin/…/laitteita.
SVAnvänd explosionssäker elektrisk/ventilations-/belysnings-/…/utrustning.

P242Language
BGИзползвайте само инструменти, които не предизвикват искри.
ESUtilizar únicamente herramientas que no produzcan chispas.
CSPoužívejte pouze nářadí z nejiskřícího kovu.
DAAnvend kun værktøj, som ikke frembringer gnister.
DENur funkenfreies Werkzeug verwenden.
ETMitte kasutada seadmeid, mis võivad tekitada sädemeid.
ELΝα χρησιμοποιούνται μόνο εργαλεία που δεν παράγουν σπινθήρες.
ENUse only non-sparking tools.
FRNe pas utiliser d'outils produisant des étincelles.
GABain úsáid as uirlisí neamhspréachta amháin.
ITUtilizzare solo utensili antiscintillamento.
LVIzmantot instrumentus, kas nerada dzirksteles.
LTNaudoti tik kibirkščių nekeliančius įrankius.
HUSzikramentes eszközök használandók.
MTUża’ biss għodda li ma jtajrux żnied.
NLUitsluitend vonkvrij gereedschap gebruiken.
PLUżywać wyłącznie nieiskrzących narzędzi.
PTUtilizar apenas ferramentas antichispa.
RONu utilizaţi unelte care produc scântei.
SKPoužívajte iba neiskriace prístroje.
SLUporabiti le orodje, ki ne povzroča isker.
FIKäytä ainoastaan kipinöimättömiä työkaluja.
SVAnvänd endast verktyg som inte ger upphov till gnistor.

P243Language
BGВземете предпазни мерки срещу освобождаване на статично електричество.
ESTomar medidas de precaución contra descargas electrostáticas.
CSProveďte preventivní opatření proti výbojům statické elektřiny.
DATræf foranstaltninger mod statisk elektricitet.
DEMaßnahmen gegen elektrostatische Aufladungen treffen.
ETRakendada ettevaatusabinõusid staatilise elektri vastu.
ELΛάβετε προστατευτικά μέτρα έναντι ηλεκτροστατικών εκκενώσεων.
ENTake precautionary measures against static discharge.
FRPrendre des mesures de précaution contre les décharges électrostatiques.
GADéan bearta réamhchúraim in aghaidh díluchtú statach.
ITPrendere precauzioni contro le scariche elettrostatiche.
LVNodrošināties pret statiskās enerģijas izlādi.
LTImtis atsargumo priemonių statinei iškrovai išvengti.
HUAz elektrosztatikus kisülés megakadályozására óvintézkedéseket kell tenni.
MTĦu miżuri ta' prekawzjoni kontra l-ħruġ ta' elettriku statiku.
NLVoorzorgsmaatregelen treffen tegen ontladingen van statische elektriciteit.
PLPrzedsięwziąć środki ostrożności zapobiegające statycznemu rozładowaniu.
PTEvitar acumulação de cargas electrostáticas.
ROLuaţi măsuri de precauţie împotriva descărcărilor electrostatice.
SKUrobte preventívne opatrenia proti výbojom statickej elektriny.
SLPreprečiti statično naelektrenje.
FIEstä staattisen sähkön aiheuttama kipinöinti.
SVVidta åtgärder mot statisk elektricitet.

P244Language
BGПочиствайте редуциращите вентили от смазка и масло
ESMantener las válvulas de reducción limpias de grasa y aceite.
CSUdržujte redukční ventily bez maziva a oleje.
DAReduktionsventilerne holdes fri for fedt og olie.
DEDruckminderer frei von Fett und Öl halten.
ETHoida reduktsiooniklapid rasvast ja õlist puhtad.
ELΝα διατηρούνται καθαρές από γράσα και λάδια οι βαλβίδες μείωσης.
ENKeep reduction valves free from grease and oil.
FRS’assurer de l’absence de graisse ou d’huile sur les soupapes de réduction.
GACoimeád comhlaí brúlaghdaithe saor ó ghréisc agus ó ola.
ITMantenere le valvole di riduzione libere da grasso e olio.
LVTurēt reducēšanās vārstus tīrus no taukiem un eļļas.
LTSaugoti, kad ant redukcinių vožtuvų nepatektų riebalų ir tepalų.
HUA nyomáscsökkentő szelepeket zsírtól és olajtól mentesen kell tartani.
MTŻomm il-valvs ta' tnaqqis ħielsa mill-griż u ż-żejt.
NLReduceerventielen vrij van olie en vet houden.
PLChronić zawory redukcyjne przed tłuszczem i olejem.
PTManter as válvulas de redução isentas de óleo e massa lubrificantes.
ROProtejaţi supapele reductoare de grăsimi și ulei.
SKRedukčné ventily udržiavajte bez mazadiel a oleja.
SLPreprečiti stik reducirnih ventilov z mastjo in oljem.
FIPidä paineenalennusventtiilit vapaana rasvasta ja öljystä.
SVReducerventilerna ska hållas fria från fett och olja.

P250Language
BGДа не се подлага на стържене/удар/…/триене
ESEvitar la abrasión/el choque/…/la fricción.
CSNevystavujte obrušování/nárazům/…/tření.
DAMå ikke udsættes for slibning/stød/…/gnidning.
DENicht schleifen/stoßen/…/reiben.
ETHoida kriimustamise/põrutuse/…/hõõrdumise eest.
ELΝα αποφεύγεται άλεση/κρούση/…/τριβή.
ENDo not subject to grinding/shock/…/friction.
FRÉviter les abrasions/les chocs/…/les frottements.
GANá nocht do mheilt/do thurraing/…/do fhrithchuimilt.
ITEvitare le abrasioni/gli urti/…/gli attriti.
LVNepakļaut drupināšanai/triecienam/…/berzei
LTNešlifuoti/netrankyti/…/netrinti.
HUTilos csiszolásnak/ütésnek/…/súrlódásnak kitenni.
MTTissottoponihomx għal brix/xokk/…/frizzjoni.
NLMalen/schokken/…/wrijving vermijden.
PLNie poddawać szlifowaniu/wstrząsom/…/tarciu.
PTNão submeter a trituração/choque/…/fricção.
ROA nu supune la abraziuni/şocuri/…/frecare.
SKNevystavujte brúseniu/nárazu/…/treniu.
SLNe izpostavljati drgnjenju/udarcem/…/trenju.
FISuojele rasitukselta/iskuilta/…/hankaukselta.
SVFår inte utsättas för gnidning/stötar/…/friktion.

P251Language
BGСъд под налягане: да не се пробива и изгаря дори след употреба.
ESRecipiente a presión: no perforar ni quemar, aun después del uso.
CSTlakový obal: nepropichujte nebo nespalujte ani po použití.
DABeholder under tryk: Må ikke punkteres eller brændes, heller ikke efter brug.
DEBehälter steht unter Druck: Nicht durchstechen oder verbrennen, auch nicht nach der Verwendung.
ETMahuti on rõhu all: mitte purustada ega põletada isegi pärast kasutamist.
ELΠεριέκτης υπό πίεση. Να μην τρυπηθεί ή καεί ακόμη και μετά τη χρήση.
ENPressurized container: Do not pierce or burn, even after use.
FRRécipient sous pression: ne pas perforer, ni brûler, même après usage.
GACoimeádán brúchóirithe: Ná toll agus ná dóigh, fiú tar éis úsáide.
ITRecipiente sotto pressione: non perforare né bruciare, neppure dopo l’uso.
LVTvertne zem spiediena: nedurt vai nededzināt, arī pēc izlietošanas.
LTSlėginis indas. Nepradurti ir nedeginti net panaudoto.
HUNyomás alatti edény: ne lyukassza ki vagy égesse el, még használat után sem.
MTKontenitur taħt pressjoni: Ittaqqbux jew taħarqux, anki wara li tużah.
NLHouder onder druk: ook na gebruik niet doorboren of verbranden.
PLPojemnik pod ciśnieniem. Nie przekłuwać ani nie spalać, nawet po zużyciu.
PTRecipiente sob pressão. Não furar nem queimar, mesmo após utilização.
RORecipient sub presiune. Nu perforaţi sau ardeţi, chiar şi după utilizare.
SKNádoba je pod tlakom: neprepichujte alebo nespaľujte ju, a to ani po spotrebovaní obsahu.
SLPosoda je pod tlakom: ne preluknjajte ali sežigajte je niti, ko je prazna.
FIPainesäiliö: Ei saa puhkaista tai polttaa edes tyhjänä.
SVTryckbehållare: Får inte punkteras eller brännas, gäller även tömd behållare.

P260Language
BGНе вдишвайте прах/пушек/газ/дим/изпарения/аерозоли
ESNo respirar el polvo/el humo/el gas/la niebla/los vapores/el aerosol.
CSNevdechujte prach/dým/plyn/mlhu/páry/aerosoly.
DAIndånd ikke pulver/røg/gas/tåge/damp/spray.
DEStaub/Rauch/Gas/Nebel/Dampf/Aerosol nicht einatmen.
ETTolmu/suitsu/gaasi/udu/auru/pihustatud ainet mitte sisse hingata.
ELΜην αναπνέετε σκόνη/αναθυμιάσεις/αέρια/σταγονίδια/ατμούς/εκνεφώματα
ENDo not breathe dust/fume/gas/mist/vapours/spray.
FRNe pas respirer les poussières/fumées/gaz/brouillards/vapeurs/aérosols.
GANá hanálaigh deannach/múch/gás/ceo/gala/sprae.
ITNon respirare la polvere/i fumi/i gas/la nebbia/i vapori/gli aerosol.
LVNeieelpot putekļus/tvaikus/gāzi/dūmus/izgarojumus/smidzinājumu.
LTNeįkvėpti dulkių/dūmų/dujų/rūko/garų/aerozolio.
HUA por/füst/gáz/köd/gőzök/permet belélegzése tilos.
MTTiblax bin-nifs trabijiet/dħaħen/gass/raxx/fwar/sprej.
NLStof/rook/gas/nevel/damp/spuitnevel niet inademen.
PLNie wdychać pyłu/dymu/gazu/mgły/par/rozpylonej cieczy.
PTNão respirar as poeiras/fumos/gases/névoas/vapores/aerossóis.
RONu inspiraţi praful/fumul/gazul/ceața/vaporii/spray-ul.
SKNevdychujte prach/dym/plyn/hmlu/pary/aerosóly.
SLNe vdihavati prahu/dima/plina/meglice/hlapov/razpršila.
FIÄlä hengitä pölyä/savua/kaasua/sumua/höyryä/suihketta.
SVInandas inte damm/rök/gaser/dimma/ångor/sprej.

P261Language
BGИзбягвайте вдишване на прах/пушек/газ/дим/изпарения/аерозоли
ESEvitar respirar el polvo/el humo/el gas/la niebla/los vapores/el aerosol.
CSZamezte vdechování prachu/dýmu/plynu/mlhy/par/aerosolů.
DAUndgå indånding af pulver/røg/gas/tåge/damp/spray.
DEEinatmen von Staub/Rauch/Gas/Nebel/Dampf/Aerosol vermeiden.
ETVältida tolmu/suitsu/gaasi/udu/auru/pihustatud aine sissehingamist.
ELAποφεύγετε να αναπνέετε σκόνη/αναθυμιάσεις/αέρια/σταγονίδια/ατμούς/εκνεφώματα.
ENAvoid breathing dust/fume/gas/mist/vapours/spray.
FRÉviter de respirer les poussières/fumées/gaz/brouillards/vapeurs/aérosols.
GASeachain deannach/múch/gás/ceo/gala/sprae a análú.
ITEvitare di respirare la polvere/i fumi/i gas/la nebbia/i vapori/gli aerosol.
LVIzvairīties ieelpot putekļus/tvaikus/gāzi/dūmus/izgarojumus/smidzinājumu.
LTStengtis neįkvėpti dulkių/dūmų/dujų/rūko/garų/aerozolio.
HUKerülje a por/füst/gáz/köd/gőzök/permet belélegzését.
MTEvita li tibla' bin-nifs trabijiet/dħaħen/gass/raxx/fwar/sprej.
NLInademing van stof/rook/gas/nevel/damp/spuitnevel vermijden.
PLUnikać wdychania pyłu/dymu/gazu/mgły/par/rozpylonej cieczy.
PTEvitar respirar as poeiras/fumos/gases/névoas/vapores/aerossóis.
ROEvitaţi să inspirați praful/fumul/gazul/ceața/vaporii/spray-ul.
SKZabráňte vdychovaniu prachu/dymu/plynu/hmly/pár/aerosólov.
SLNe vdihavati prahu/dima/plina/meglice/hlapov/razpršila.
FIVältä pölyn/savun/kaasun/sumun/höyryn/suihkeen hengittämistä.
SVUndvik att inandas damm/rök/gaser/dimma/ångor/sprej.

P262Language
BGДа се избягва контакт с очите, кожата или облеклото.
ESEvitar el contacto con los ojos, la piel o la ropa.
CSZabraňte styku s očima, kůží nebo oděvem.
DAMå ikke komme i kontakt med øjne, hud eller tøj.
DENicht in die Augen, auf die Haut oder auf die Kleidung gelangen lassen.
ETVältida silma, nahale või rõivastele sattumist.
ELΝα μην έρθει σε επαφή με τα μάτια, με το δέρμα ή με τα ρούχα.
ENDo not get in eyes, on skin, or on clothing.
FRÉviter tout contact avec les yeux, la peau ou les vêtements.
GANá lig sna súile, ar an gcraiceann, ná ar éadaí.
ITEvitare il contatto con gli occhi, la pelle o gli indumenti.
LVNepieļaut nokļūšanu acīs, uz ādas vai uz drēbēm.
LTSaugotis, kad nepatektų į akis, ant odos ar drabužių.
HUSzembe, bőrre vagy ruhára nem kerülhet.
MTIddaħħalx fl-għajnejn, fuq il-ġilda, jew fuq il-ħwejjeġ.
NLContact met de ogen, de huid of de kleding vermijden.
PLNie wprowadzać do oczu, na skórę lub na odzież.
PTNão pode entrar em contacto com os olhos, a pele ou a roupa.
ROEvitaţi orice contact cu ochii, pielea sau îmbrăcămintea.
SKZabráňte kontaktu s očami, pokožkou alebo odevom.
SLPreprečiti stik z očmi, kožo ali oblačili.
FIVaro kemikaalin joutumista silmiin, iholle tai vaatteisiin.
SVFår inte komma i kontakt med ögonen, huden eller kläderna.

P263Language
BGДа се избягва контакт по време на бременност/при кърмене.
ESEvitar el contacto durante el embarazo/la lactancia.
CSZabraňte styku během těhotenství/kojení.
DAUndgå kontakt under graviditet/amning.
DEKontakt während der Schwangerschaft/und der Stillzeit vermeiden.
ETVältida kokkupuudet raseduse/imetamise ajal.
ELAποφεύγετε την επαφή στη διάρκεια της εγκυμοσύνης/γαλουχίας.
ENAvoid contact during pregnancy/while nursing.
FRÉviter tout contact avec la substance au cours de la grossesse/pendant l’allaitement.
GASeachain teagmháil le linn toirchis/agus an chíoch á tabhairt.
ITEvitare il contatto durante la gravidanza/l’allattamento.
LVIzvairīties no saskares grūtniecības laikā/barojot bērnu ar krūti.
LTVengti kontakto nėštumo metu/maitinant krūtimi.
HUA terhesség/szoptatás alatt kerülni kell az anyaggal való érintkezést.
MTEvita l-kuntatt waqt it-tqala/waqt it-treddigħ.
NLBij zwangerschap of borstvoeding aanraking vermijden.
PLUnikać kontaktu w czasie ciąży/karmienia piersią.
PTEvitar o contacto durante a gravidez/o aleitamento.
ROEvitaţi contactul în timpul sarcinii/alăptării.
SKZabráňte kontaktu počas tehotenstva a dojčenia.
SLPreprečiti stik med nosečnostjo/dojenjem.
FIVältä kosketusta raskauden tai imetyksen aikana.
SVUndvik kontakt under graviditet eller amning.

P264Language
BGДа се измие… старателно след употреба.
ESLavarse … concienzudamente tras la manipulación.
CSPo manipulaci důkladně omyjte …
DAVask … grundigt efter brug.
DENach Gebrauch … gründlich waschen.
ETPärast käitlemist pesta hoolega …
ELΠλύνετε … σχολαστικά μετά το χειρισμό.
ENWash … thoroughly after handling.
FRSe laver … soigneusement après manipulation.
GANigh … go lánchúramach tar éis láimhsithe.
ITLavare accuratamente … dopo l’uso.
LVPēc izmantošanas … kārtīgi nomazgāt.
LTPo naudojimo kruopščiai nuplauti …
HUA használatot követően a(z) … -t alaposan meg kell mosni.
MTAħsel … sew wara li timmaniġġjah.
NLNa het werken met dit product … grondig wassen.
PLDokładnie umyć … po użyciu.
PTLavar … cuidadosamente após manuseamento.
ROSpălaţi-vă … bine după utilizare.
SKPo manipulácii starostlivo umyte…
SLPo uporabi temeljito umiti …
FIPese … huolellisesti käsittelyn jälkeen.
SVTvätta … grundligt efter användning.

P270Language
BGДа не се яде, пие или пуши при употреба на продукта.
ESNo comer, beber ni fumar durante su utilización.
CSPři používání tohoto výrobku nejezte, nepijte ani nekuřte.
DADer må ikke spises, drikkes eller ryges under brugen af dette produkt.
DEBei Gebrauch nicht essen, trinken oder rauchen.
ETToote käitlemise ajal mitte süüa, juua ega suitsetada.
ELΜην τρώτε, πίνετεή καπνίζετε, όταν χρησιμοποιείτε αυτό το προϊόν.
ENDo no eat, drink or smoke when using this product.
FRNe pas manger, boire ou fumer en manipulant ce produit.
GANá hith, ná hól agus ná caitear tobac agus an táirge seo á úsáid.
ITNon mangiare, né bere, né fumare durante l’uso.
LVNeēst, nedzert un nesmēķēt produkta izmantošanas laikā.
LTNaudojant šį produktą, nevalgyti, negerti ir nerūkyti.
HUA termék használata közben tilos enni, inni vagy dohányozni.
MTTikolx, tixrobx u tpejjipx waqt li tuża’ dan il-prodott.
NLNiet eten, drinken of roken tijdens het gebruik van dit product.
PLNie jeść, nie pić i nie palić podczas używania produktu.
PTNão comer, beber ou fumar durante a utilização deste produto.
ROA nu mânca, bea sau fuma în timpul utilizării produsului.
SKPri používaní výrobku nejedzte, nepite ani nefajčite.
SLNe jesti, piti ali kaditi med uporabo tega izdelka.
FISyöminen, juominen ja tupakointi kielletty kemikaalia käytettäessä.
SVÄt inte, drick inte och rök inte när du använder produkten.

P271Language
BGДа се използва само на открито или на добре проветривомясто.
ESUtilizar únicamente en exteriores o en un lugar bien ventilado.
CSPoužívejte pouze venku nebo v dobře větraných prostorách.
DABrug kun udendørs eller i et rum med god udluftning.
DENur im Freien oder in gut belüfteten Räumen verwenden.
ETKäidelda üksnes välitingimustes või hästi ventileeritavas kohas.
ELΝα χρησιμοποιείται μόνο σε ανοικτό ή καλά αεριζόμενο χώρο.
ENUse only outdoors or in a well-ventilated area.
FRUtiliser seulement en plein air ou dans un endroit bien ventilé.
GAÚsáid amuigh faoin aer nó i limistéar dea-aerálaithe amháin.
ITUtilizzare soltanto all’aperto o in luogo ben ventilato.
LVIzmantot tikai ārā vai labi vēdināmās telpās.
LTNaudoti tik lauke arba gerai vėdinamoje patalpoje.
HUKizárólag szabadban vagy jól szellőző helyiségben használható.
MTUża biss barra jew f’post ventilat sew.
NLAlleen buiten of in een goed geventileerde ruimte gebruiken.
PLStosować wyłącznie na zewnątrz lub w dobrze wentylowanym pomieszczeniu
PTUtilizar apenas ao ar livre ou em locais bem ventilados.
ROA se utiliza numai în aer liber sau în spaţii bine ventilate.
SKPoužívajte iba na voľnom priestranstve alebo v dobre vetranom priestore.
SLUporabljati le zunaj ali v dobro prezračevanem prostoru.
FIKäytä ainoastaan ulkona tai tiloissa, joissa on hyvä ilmanvaihto.
SVAnvänds endast utomhus eller i väl ventilerade utrymmen.

P272Language
BGДа не се изнася замърсено работно облекло извън работното помещение.
ESLas prendas de trabajo contaminadas no podrán sacarse del lugar de trabajo.
CSKontaminovaný pracovní oděv neodnášejte z pracoviště.
DATilsmudset arbejdstøj bør ikke fjernes fra arbejdspladsen.
DEKontaminierte Arbeitskleidung nicht außerhalb des Arbeitsplatzes tragen.
ETSaastunud töörõivaid töökohast mitte välja viia.
ELΤα μολυσμένα ενδύματα εργασίας δεν πρέπει να βγαίνουν από το χώρο εργασίας.
ENContaminated work clothing should not be allowed out of the workplace.
FRLes vêtements de travail contaminés ne devraient pas sortir du lieu de travail.
GANíor chóir éadaí éillithe oibre a ligean amach as an láthair oibre.
ITGli indumenti da lavoro contaminati non devono essere portati fuori dal luogo di lavoro.
LVPiesārņoto darba apģērbu neiznest ārpus darba telpām.
LTUžterštų darbo drabužių negalima išnešti iš darbo vietos.
HUSzennyezett munkaruhát tilos kivinni a munkahely területéről.
MTIlbies tax-xogħol kontaminat m’għandux jitħalla joħroġ mill-post tax-xogħol.
NLVerontreinigde werkkleding mag de werkruimte niet verlaten.
PLZanieczyszczonej odzieży ochronnej nie wynosić poza miejsce pracy.
PTA roupa de trabalho contaminada não pode sair do local de trabalho.
RONu scoateţi îmbrăcămintea de lucru contaminată în afara locului de muncă.
SKJe zakázané vyniesť kontaminovaný pracovný odev z pracoviska.
SLKontaminirana delovna oblačila niso dovoljena zunaj delovnega mesta.
FISaastuneita työvaatteita ei saa viedä työpaikalta.
SVNedstänkta arbetskläder får inte avlägsnas från arbetsplatsen.

P273Language
BGДа се избягва изпускане в околната среда.
ESEvitar su liberación al medio ambiente.
CSZabraňte uvolnění do životního prostředí.
DAUndgå udledning til miljøet.
DEFreisetzung in die Umwelt vermeiden.
ETVältida sattumist keskkonda.
ELΝα αποφεύγεται η ελευθέρωση στο περιβάλλον.
ENAvoid release to the environment.
FRÉviter le rejet dans l’environnement.
GANá scaoiltear amach sa chomhshaol.
ITNon disperdere nell’ambiente.
LVIzvairīties no izplatīšanas apkārtējā vidē.
LTSaugoti, kad nepatektų į aplinką.
HUKerülni kell az anyagnak a környezetbe való kijutását.
MTEvita r-rilaxx fl-ambjent.
NLVoorkom lozing in het milieu.
PLUnikać uwolnienia do środowiska.
PTEvitar a libertação para o ambiente.
ROEvitaţi dispersarea în mediu.
SKZabráňte uvoľneniu do životného prostredia.
SLPreprečiti sproščanje v okolje.
FIVältettävä päästämistä ympäristöön.
SVUndvik utsläpp till miljön.

P280Language
BGИзползвайте предпазни ръкавици/предпазно облекло/предпазни очила/предпазна маска за лице.
ESLlevar guantes/prendas/gafas/máscara de protección.
CSPoužívejte ochranné rukavice/ochranný oděv/ochranné brýle/obličejový štít.
DABær beskyttelseshandsker/beskyttelsestøj/øjenbeskyttelse/ansigtsbeskyttelse
DESchutzhandschuhe/Schutzkleidung/Augenschutz/Gesichtsschutz tragen.
ETKanda kaitsekindaid/kaitserõivastust/kaitseprille/kaitsemaski.
ELΝα φοράτε προστατευτικά γάντια/προστατευτικά ενδύματα/μέσα ατομικής προστασίας για τα μάτια/πρόσωπο.
ENWear protective gloves/protective clothing/eye protection/face protection.
FRPorter des gants de protection/des vêtements de protection/un équipement de protection des yeux/du visage.
GACaith lámhainní cosanta/éadaí cosanta/cosaint súile/cosaint aghaidhe.
ITIndossare guanti/indumenti protettivi/Proteggere gli occhi/il viso.
LVIzmantot aizsargcimdus/aizsargdrēbes/acu aizsargus/sejas aizsargus.
LTMūvėti apsaugines pirštines/dėvėti apsauginius drabužius/naudoti akių (veido) apsaugos priemones.
HUVédőkesztyű/védőruha/szemvédő/arcvédő használata kötelező.
MTIlbes ingwanti protettivi/ilbies protettiv/protezzjoni għall-għajnejn/protezzjoni għall-wiċċ.
NLBeschermende handschoenen/beschermende kleding/oogbescherming/gelaatsbescherming dragen.
PLStosować rękawice ochronne/odzież ochronną/ochronę oczu/ochronę twarzy.
PTUsar luvas de protecção/vestuário de protecção/protecção ocular/protecção facial.
ROPurtaţi mănuşi de protecţie/îmbrăcăminte de protecţie/echipament de protecţie a ochilor/echipament de protecţie a feţei.
SKNoste ochranné rukavice/ochranný odev/ochranné okuliare/ochranu tváre.
SLNositi zaščitne rokavice/zaščitno obleko/zaščito za oči/zaščito za obraz.
FIKäytä suojakäsineitä/suojavaatetusta/silmiensuojainta/kasvonsuojainta.
SVAnvänd skyddshandskar/skyddskläder/ögonskydd/ansiktsskydd.

P281Language
BGИзползвайте предписаните лични предпазни средства.
ESUtilizar el equipo de protección individual obligatorio.
CSPoužívejte požadované osobní ochranné prostředky.
DAAnvend de påkrævede personlige værnemidler.
DEVorgeschriebene persönliche Schutzausrüstung verwenden.
ETKasutada vajalikke isikukaitsevahendeid.
ELΧρησιμοποιείτε μέσα ατομικής προστασίας όταν απαιτείται.
ENUse personal protective equipment as required.
FRUtiliser l’équipement de protection individuel requis.
GABain úsáid as an trealamh cosanta pearsanta faoi mar a éilítear.
ITUtilizzare il dispositivo di protezione individuale richiesto.
LVIzmantot personisko aizsargaprīkojumu atbilstoši prasībām.
LTNaudoti reikalaujamas asmenines apsaugos priemones.
HUAz előírt egyéni védőfelszerelés használata kötelező.
MTUża’ t-tagħmir personali protettiv kif meħtieġ.
NLDe nodige persoonlijke beschermingsuitrusting gebruiken.
PLStosować wymagane środki ochrony indywidualnej.
PTUsar o equipamento de protecção individual exigido.
ROUtilizaţi echipamentul de protecţie individuală conform cerinţelor.
SKPoužívajte predpísané osobné ochranné prostriedky.
SLUporabiti predpisano osebno zaščitno opremo.
FIKäytä vaadittuja henkilönsuojaimia.
SVAnvänd föreskriven personlig skyddsutrustning.

P282Language
BGНосете предпазващи от студ ръкавици/маска за лице/защитни очила.
ESLlevar guantes que aíslen del frío/gafas/máscara.
CSPoužívejte ochranné rukavice proti chladu/obličejový štít/ochranné brýle.
DABær kuldeisolerende handsker/ansigtsskærm/øjenbeskyttelse.
DESchutzhandschuhe/Gesichtsschild/Augenschutz mit Kälteisolierung tragen.
ETKanda külmakaitsekindaid/kaitsemaski/kaitseprille.
ELΦοράτε μονωτικά γάντια προστασίας από το ψύχος/προστατευτική μάσκα/προστατευτικά γυαλιά.
ENWear cold insulating gloves/face shield/eye protection.
FRPorter des gants isolants contre le froid/un équipement de protection du visage/des yeux.
GACaith lámhainní inslithe fuachta/aghaidhsciath/cosaint súile.
ITUtilizzare guanti termici/schermo facciale/Proteggere gli occhi.
LVIzmantot aizsargcimdus/sejas aizsargus/acu aizsargus ar aukstuma izolāciju.
LTMūvėti nuo šalčio izoliuojančias pirštines/naudoti veido skydelį/akių apsaugos priemones.
HUHidegszigetelő kesztyű/arcvédő/szemvédő használata kötelező.
MTIlbies ingwanti kiesħa li ma jinfedx minnhom/ilqugħ għall-wiċċ/protezzjoni għall-għajnejn.
NLKoude-isolerende handschoenen/gelaatsbescherming/oogbescherming dragen.
PLNosić rękawice izolujące od zimna/maski na twarz/ochronę oczu.
PTUsar luvas de protecção contra o frio/escudo facial/protecção ocular.
ROPurtaţi mănuşi izolante împotriva frigului/echipament de protecţie a feţei/ochilor.
SKPoužívajte termostabilné rukavice/ochranný štít/ochranné okuliare.
SLNositi hladne izolirne rokavice/zaščito za obraz/zaščito za oči.
FIKäytä kylmäeristäviä suojakäsineitä/kasvonsuojainta/silmiensuojainta.
SVAnvänd köldisolerande handskar/visir/ögonskydd.

P283Language
BGНосете огнеупорно/огнезащитно облекло.
ESLlevar prendas ignífugas/resistentes al fuego/resistentes a las llamas.
CSPoužívejte ohnivzdorný/nehořlavý oděv.
DABær brandbestandig/brandhæmmende beklædning.
DESchwer entflammbare/flammhemmende Kleidung tragen.
ETKanda tule-/leegikindlat/tule levikut aeglustavat rõivastust.
ELΦοράτε αντιπυρικά/αλεξίφλογα πυράντοχα/βραδυφλεγή ενδύματα.
ENWear fire/flame resistant/retardant clothing.
FRPorter des vêtements résistant au feu/aux flammes/ignifuges.
GACaith éadaí dódhíonacha/lasairdhíonacha nó dómhoillitheacha/lasairmhoillitheacha.
ITIndossare indumenti completamente ignifughi o in tessuti ritardanti di fiamma.
LVIzmantot aizsargapģērbu pret uguni/liesmām.
LTDėvėti ugniai/liepsnai atsparius/antipireninius drabužius.
HUTűz-/lángálló/-késleltető ruházat viselése kötelező.
MTIlbies ħwejjeġ reżistenti għan-nar/fjammi.
NLVuur/vlambestendige/brandwerende kleding dragen.
PLNosić odzież ognioodporną/płomienioodporną/opóźniającą zapalenie.
PTUsar vestuário ignífugo/retardador de fogo/chamas.
ROPurtaţi îmbrăcăminte rezistentă la foc/flacără/ignifugă.
SKNoste ohňovzdorný odev/odev so zníženou horľavosťou.
SLNositi negorljiva oblačila in oblačila, odporna proti ognju.
FIKäytä palosuojattua/paloturvallista vaatetusta.
SVAnvänd brand-/flamsäkra eller brand-/flamhämmande kläder.

P284Language
BGНосете респираторни предпазни средства.
ESLlevar equipo de protección respiratoria.
CSPoužívejte vybavení pro ochranu dýchacích cest.
DAAnvend åndedrætsværn.
DEAtemschutz tragen.
ETKanda hingamisteede kaitsevahendeid.
ELΦοράτε μέσα ατομικής προστασίας της αναπνοής.
ENWear respiratory protection.
FRPorter un équipement de protection respiratoire.
GACaith cosaint riospráide.
ITUtilizzare un apparecchio respiratorio.
LVIzmantot gāzmasku.
LTNaudoti kvėpavimo takų apsaugos priemones.
HULégzésvédelem használata kötelező.
MTIlbes protezzjoni respiratorja.
NLAdembescherming dragen.
PLStosować indywidualne środki ochrony dróg oddechowych.
PTUsar protecção respiratória.
ROPurtaţi echipament de protecţie respiratorie.
SKPoužívajte ochranu dýchacích ciest.
SLNositi opremo za zaščito dihal.
FIKäytä hengityksensuojainta.
SVAnvänd andningsskydd.

P285Language
BGВ случай на лоша вентилация носете респираторни предпазни средства.
ESEn caso de ventilación insuficiente, llevar equipo de protección respiratoria.
CSV případě nedostatečného větrání používejte vybavení pro ochranu dýchacích cest.
DAVed utilstrækkelig udluftning anvendes åndedrætsværn.
DEBei unzureichender Belüfung Atemschutz tragen.
ETEbapiisava ventilatsiooni korral kanda hingamisteede kaitsevahendeid.
ELΣε περίπτωση ανεπαρκούς αερισμού, να φοράτε μέσα ατομικής προστασίας της αναπνοής.
ENIn case of inadequate ventilation wear respiratory protection.
FRLorsque la ventilation du local est insuffisante, porter un équipement de protection respiratoire.
GAI gcás aerála uireasaigh caith cosaint riospráide.
ITIn caso di ventilazione insufficiente utilizzare un apparecchio respiratorio.
LVNeatbilstošas ventilācijas gadījumā izmantot gāzmasku.
LTEsant nepakankamam vėdinimui, naudoti kvėpavimo takų apsaugos priemones.
HUNem megfelelő szellőzés esetén légzésvédelem kötelező.
MTF’każ ta' ventilazzjoni inadegwata ilbes protezzjoni respiratorja.
NLBij ontoereikende ventilatie een geschikte adembescherming dragen.
PLW przypadku niedostatecznej wentylacji stosować indywidualne środki ochrony dróg oddechowych.
PTEm caso de ventilação inadequada, usar protecção respiratória.
ROÎn cazul în care ventilarea este insuficientă, purtaţi echipament de protecţie respiratorie.
SKV prípade nedostatočného vetrania, používajte ochranu dýchacích ciest.
SLOb nezadostnem prezračevanju nositi opremo za zaščito dihal.
FIKäytä hengityksensuojainta, jos ilmanvaihto on riittämätön.
SVAnvänd andningsskydd vid otillräcklig ventilation.

P231 + P232Language
BGДа се използва под инертен газ. Да се пази от влага.
ESManipular en gas inerte. Proteger de la humedad.
CSManipulace pod inertním plynem. Chraňte před vlhkem.
DAAnvendes under inaktiv gas. Beskyttes mod fugt.
DEUnter inertem Gas handhaben. Vor Feuchtigkeit schützen.
ETKäidelda inertgaasis. Hoida niiskuse eest.
ELΧειρισμός σε αδρανή ατμόσφαιρα. Προστατέψτε από την υγρασία.
ENHandle under inert gas. Protect from moisture.
FRManipuler sous gaz inerte. Protéger de l’humidité.
GALáimhsigh faoi thriathghás. Cosain ó thaise.
ITManipolare in atmosfera di gas inerte. Tenere al riparo dall’umidità.
LVIzmantot tikai inertas gāzes apstākļos. Aizsargāt no mitruma.
LTTvarkyti inertinėse dujose. Saugoti nuo drėgmės.
HUInert gázban használandó. Nedvességtől védendő.
MTUża’ taħt gass inerti. Ipproteġi mill-umdità.
NLOnder inert gas werken. Tegen vocht beschermen.
PLUżywać w atmosferze obojętnego gazu Chronić przed wilgocią.
PTManusear em atmosfera de gás inerte. Manter ao abrigo da humidade.
ROA se manipula sub un gaz inert. A se proteja de umiditate.
SKManipulujte v prostredí s inertným plynom. Chráňte pred vlhkosťou.
SLHraniti v ustreznem inertnem plinu. Zaščititi pred vlago.
FIKäsittele inertissä kaasussa. Suojaa kosteudelta.
SVHanteras under inert gas. Skyddas från fukt.

P235 + P410Language
BGДа се държи на хладно. Да се пази от пряка слънчева светлина.
ESConservar en un lugar fresco. Proteger de la luz del sol.
CSUchovávejte v chladu. Chraňte před slunečním zářením.
DAOpbevares køligt. Beskyttes mod sollys.
DEKühl halten. Vor Sonnenbestrahlung schützen.
ETHoida jahedas. Hoida päikesevalguse eest.
ELΝα διατηρείται δροσερό. Να προστατεύεται από τις ηλιακές ακτίνες.
ENKeep cool. Protect from sunlight.
FRTenir au frais. Protéger du rayonnement solaire.
GACoimeád fionnuar. Cosain ó sholas na gréine.
ITTenere in luogo fresco. Proteggere dai raggi solari.
LVTurēt vēsumā. Aizsargāt no saules gaismas.
LTLaikyti vėsioje vietoje. Saugoti nuo saulės šviesos.
HUHűvös helyen tartandó. Napfénytől védendő.
MTŻomm frisk. Ipproteġi mir-raġġi tax-xemx.
NLKoel bewaren. Tegen zonlicht beschermen.
PLPrzechowywać w chłodnym miejscu. Chronić przed światłem słonecznym.
PTConservar em ambiente fresco. Manter ao abrigo da luz solar.
ROA se păstra la rece. A se proteja de lumina solară.
SKUchovávajte v chlade. Chráňte pred slnečným žiarením.
SLHraniti na hladnem. Zaščititi pred sončno svetlobo.
FISäilytä viileässä. Suojaa auringonvalolta.
SVFörvaras svalt. Skyddas från solljus.


Table 1.3

Precautionary statements — Response

P301Language
BGПРИ ПОГЛЪЩАНЕ:
ESEN CASO DE INGESTIÓN:
CSPŘI POŽITÍ:
DAI TILFÆLDE AF INDTAGELSE:
DEBEI VERSCHLUCKEN:
ETALLANEELAMISE KORRAL:
ELΣΕ ΠΕΡΙΠΤΩΣΗ ΚΑΤΑΠΟΣΗΣ:
ENIF SWALLOWED:
FREN CAS D’INGESTION:
GAMÁ SHLOGTAR:
ITIN CASO DI INGESTIONE:
LVNORĪŠANAS GADĪJUMĀ:
LTPRARIJUS:
HULENYELÉS ESETÉN:
MTJEKK JINBELA’:
NLNA INSLIKKEN:
PLW PRZYPADKU POŁKNIĘCIA:
PTEM CASO DE INGESTÃO:
ROÎN CAZ DE ÎNGHIŢIRE:
SKPO POŽITÍ:
SLPRI ZAUŽITJU:
FIJOS KEMIKAALIA ON NIELTY:
SVVID FÖRTÄRING:

P302Language
BGПРИ КОНТАКТ С КОЖАТА:
ESEN CASO DE CONTACTO CON LA PIEL:
CSPŘI STYKU S KŮŽÍ:
DAVED KONTAKT MED HUDEN:
DEBEI BERÜHRUNG MIT DER HAUT:
ETNAHALE SATTUMISE KORRAL:
ELΣΕ ΠΕΡΙΠΤΩΣΗ ΕΠΑΦΗΣ ΜΕ ΤΟ ΔΕΡΜΑ:
ENIF ON SKIN:
FREN CAS DE CONTACT AVEC LA PEAU:
GAI gCÁS TEAGMHÁLA LEIS AN gCRAICEANN:
ITIN CASO DI CONTATTO CON LA PELLE:
LVSASKARĒ AR ĀDU:
LTPATEKUS ANT ODOS:
HUHA BŐRRE KERÜL:
MTF'KAŻ TA' KUNTATT MAL-ĠILDA:
NLBIJ CONTACT MET DE HUID:
PLW PRZYPADKU KONTAKTU ZE SKÓRĄ:
PTSE ENTRAR EM CONTACTO COM A PELE:
ROÎN CAZ DE CONTACT CU PIELEA:
SKPRI KONTAKTE S POKOŽKOU:
SLPRI STIKU S KOŽO:
FIJOS KEMIKAALIA JOUTUU IHOLLE:
SVVID HUDKONTAKT:

P303Language
BGПРИ КОНТАКТ С КОЖАТА (или косата):
ESEN CASO DE CONTACTO CON LA PIEL (o el pelo):
CSPŘI STYKU S KŮŽÍ (nebo s vlasy):
DAVED KONTAKT MED HUDEN (eller håret):
DEBEI BERÜHRUNG MIT DER HAUT (oder dem Haar):
ETNAHALE (või juustele) SATTUMISE KORRAL:
ELΣΕ ΠΕΡΙΠΤΩΣΗ ΕΠΑΦΗΣ ΜΕ ΤΟ ΔΕΡΜΑ (ή με τα μαλλιά):
ENIF ON SKIN (or hair):
FREN CAS DE CONTACT AVEC LA PEAU (ou les cheveux):
GAI gCÁS TEAGMHÁLA LEIS AN gCRAICEANN (nó le gruaig):
ITIN CASO DI CONTATTO CON LA PELLE (o con i capelli):
LVSASKARĒ AR ĀDU (vai matiem):
LTPATEKUS ANT ODOS (arba plaukų):
HUHA BŐRRE (vagy hajra) KERÜL:
MTF'KAŻ TA' KUNTATT MAL-ĠILDA (jew ix-xagħar):
NLBIJ CONTACT MET DE HUID (of het haar):
PLW PRZYPADKU KONTAKTU ZE SKÓRĄ (lub z włosami):
PTSE ENTRAR EM CONTACTO COM A PELE (ou o cabelo):
ROÎN CAZ DE CONTACT CU PIELEA (sau părul):
SKPRI KONTAKTE S POKOŽKOU (alebo vlasmi):
SLPRI STIKU S KOŽO (ali lasmi):
FIJOS KEMIKAALIA JOUTUU IHOLLE (tai hiuksiin):
SVVID HUDKONTAKT (även håret):

P304Language
BGПРИ ВДИШВАНЕ:
ESEN CASO DE INHALACIÓN:
CSPŘI VDECHNUTÍ:
DAVED INDÅNDING:
DEBEI EINATMEN:
ETSISSEHINGAMISE KORRAL:
ELΣΕ ΠΕΡΙΠΤΩΣΗ ΕΙΣΠΝΟΗΣ:
ENIF INHALED:
FREN CAS D’INHALATION:
GAMÁ IONANÁLAÍTEAR:
ITIN CASO DI INALAZIONE:
LVIEELPOJOT:
LTĮKVĖPUS:
HUBELÉLEGZÉS ESETÉN:
MTJEKK JINĠIBED MAN-NIFS:
NLNA INADEMING:
PLW PRZYPADKU DOSTANIA SIĘ DO DRÓG ODDECHOWYCH:
PTEM CASO DE INALAÇÃO:
ROÎN CAZ DE INHALARE:
SKPO VDÝCHNUTÍ:
SLPRI VDIHAVANJU:
FIJOS KEMIKAALIA ON HENGITETTY:
SVVID INANDNING:

P305Language
BGПРИ КОНТАКТ С ОЧИТЕ:
ESEN CASO DE CONTACTO CON LOS OJOS:
CSPŘI ZASAŽENÍ OČÍ:
DAVED KONTAKT MED ØJNENE:
DEBEI KONTAKT MIT DEN AUGEN:
ETSILMA SATTUMISE KORRAL:
ELΣΕ ΠΕΡΙΠΤΩΣΗ ΕΠΑΦΗΣ ΜΕ ΤΑ ΜΑΤΙΑ:
ENIF IN EYES:
FREN CAS DE CONTACT AVEC LES YEUX:
GAI gCÁS TEAGMHÁLA LEIS NA SÚILE:
ITIN CASO DI CONTATTO CON GLI OCCHI:
LVIEKĻŪSTOT ACĪS:
LTPATEKUS Į AKIS:
HUSZEMBE KERÜLÉS ESETÉN:
MTJEKK JIDĦOL FL-GĦAJNEJN:
NLBIJ CONTACT MET DE OGEN:
PLW PRZYPADKU DOSTANIA SIĘ DO OCZU:
PTSE ENTRAR EM CONTACTO COM OS OLHOS:
ROÎN CAZ DE CONTACT CU OCHII:
SKPO ZASIAHNUTÍ OČÍ:
SLPRI STIKU Z OČMI:
FIJOS KEMIKAALIA JOUTUU SILMIIN:
SVVID KONTAKT MED ÖGONEN:

P306Language
BGПРИ ПОПАДАНЕ ВЪРХУ ОБЛЕКЛОТО:
ESEN CASO DE CONTACTO CON LA ROPA:
CSPŘI STYKU S ODĚVEM:
DAVED KONTAKT MED TØJET:
DEBEI KONTAMINIERTER KLEIDUNG:
ETRÕIVASTELE SATTUMISE KORRAL:
ELΣΕ ΠΕΡΙΠΤΩΣΗ ΕΠΑΦΗΣ ΜΕ ΤΑ ΡΟΥΧΑ:
ENIF ON CLOTHING:
FREN CAS DE CONTACT AVEC LES VÊTEMENTS:
GAI gCÁS TEAGMHÁLA LE hÉADAÍ:
ITIN CASO DI CONTATTO CON GLI INDUMENTI:
LVSASKARĒ AR APĢĒRBU:
LTPATEKUS ANT DRABUŽIŲ:
HUHA RUHÁRA KERÜL:
MTF'KAŻ TA' KUNTATT MA' L-ILBIES:
NLNA MORSEN OP KLEDING:
PLW PRZYPADKU KONTAKTU Z ODZIEŻĄ:
PTSE ENTRAR EM CONTACTO COM A ROUPA:
ROÎN CAZ DE CONTACT CU ÎMBRĂCĂMINTEA:
SKPRI KONTAKTE S ODEVOM:
SLPRI STIKU Z OBLAČILI:
FIJOS KEMIKAALIA JOUTUU VAATTEISIIN:
SVVID KONTAKT MED KLÄDERNA:

P307Language
BGПРИ експозиция:
ESEN CASO DE exposición:
CSPŘI expozici:
DAVED eksponering:
DEBEI Exposition:
ETKokkupuute korral:
ELΣΕ ΠΕΡΙΠΤΩΣΗ έκθεσης:
ENIF exposed:
FREN CAS d’exposition:
GAI gCÁS nochta:
ITIN CASO di esposizione:
LVJA saskaras:
LTEsant sąlyčiui:
HUExpozíció esetén:
MTJEKK espost:
NLNA blootstelling:
PLW PRZYPADKU narażenia:
PTEM CASO DE exposição:
ROÎN CAZ DE expunere:
SKPO expozícii:
SLPRI izpostavljenosti:
FIAltistumisen tapahduttua:
SVOm du exponerats:

P308Language
BGПРИ явна или предполагаема експозиция:
ESEN CASO DE exposición manifiesta o presunta:
CSPŘI expozici nebo podezření na ni:
DAVED eksponering eller mistanke om eksponering:
DEBEI Exposition oder falls betroffen
ETKokkupuute või kokkupuutekahtluse korral:
ELΣΕ ΠΕΡΙΠΤΩΣΗ έκθεσης ή πιθανής έκθεσης:
ENIF exposed or concerned:
FREN CAS d’exposition prouvée ou suspectée:
GAI gCÁS nochta nó má mheastar a bheith nochtaithe:
ITIN CASO di esposizione o di possibile esposizione:
LVJa saskaras vai saistīts ar:
LTEsant sąlyčiui arba jeigu numanomas sąlytis:
HUExpozíció vagy annak gyanúja esetén:
MTJEKK espost jew konċernat:
NLNA (mogelijke) blootstelling:
PLW PRZYPADKU narażenia lub styczności:
PTEM CASO DE exposição ou suspeita de exposição:
ROÎN CAZ DE expunere sau de posibilă expunere:
SKPo expozícii alebo podozrení z nej:
SLPRI izpostavljenosti ali sumu izpostavljenosti:
FIAltistumisen tapahduttua tai jos epäillään altistumista:
SVVid exponering eller misstanke om exponering:

P309Language
BGПРИ експозиция или при неразположение:
ESEN CASO DE exposición o malestar:
CSPŘI expozici nebo necítíte-li se dobře:
DAVED eksponering eller ubehag:
DEBEI Exposition oder Unwohlsein:
ETKokkupuute või halva enesetunde korral:
ELΣΕ ΠΕΡΙΠΤΩΣΗ έκθεσης ή αδιαθεσίας:
ENIF exposed or if you feel unwell:
FREN CAS d’exposition ou d'un malaise:
GAI gCÁS nochta nó má bhraitear tinn:
ITIN CASO di esposizione o di malessere:
LVJA saskaras vai ja jums ir slikta pašsajūta:
LTEsant sąlyčiui arba blogai pasijutus:
HUExpozíció vagy rosszullét esetén:
MTJEKK espost jew tħossok ma tiflaħx:
NLNA blootstelling of bij onwel voelen:
PLW PRZYPADKU narażenia lub złego samopoczucia:
PTEM CASO DE exposição ou de indisposição:
ROÎN CAZ DE expunere sau dacă nu vă simţiţi bine:
SKPo expozícii alebo pri zdravotných problémoch.
SLPRI izpostavljenosti ali slabem počutju:
FIAltistumisen tapahduttua tai jos ilmenee pahoinvointia:
SVVid exponering eller obehag:

P310Language
BGНезабавно се обадете в ЦЕНТЪР ПО ТОКСИКОЛОГИЯ или на лекар.
ESLlamar inmediatamente a un CENTRO DE INFORMACION TOXICOLOGICA o a un médico.
CSOkamžitě volejte TOXIKOLOGICKÉ INFORMAČNÍ STŘEDISKO nebo lékaře.
DARing omgående til en GIFTINFORMATION eller en læge.
DESofort GIFTINFORMATIONSZENTRUM oder Arzt anrufen.
ETVõtta viivitamata ühendust MÜRGISTUSTEABEKESKUSE või arstiga.
ELΚαλέστε αμέσως το ΚΕΝΤΡΟ ΔΗΛΗΤΗΡΙΑΣΕΩΝ ή ένα γιατρό.
ENImmediately call a POISON CENTER or doctor/physician.
FRAppeler immédiatement un CENTRE ANTIPOISON ou un médecin.
GACuir glao láithreach ar IONAD NIMHE nó ar dhoctúir/lia.
ITContattare immediatamente un CENTRO ANTIVELENI o un medico.
LVNekavējoties sazinieties ar SAINDĒŠANĀS CENTRU vai ārstu.
LTNedelsiant skambinti į APSINUODIJIMŲ KONTROLĖS IR INFORMACIJOS BIURĄ arba kreiptis į gydytoją.
HUAzonnal forduljon TOXIKOLÓGIAI KÖZPONTHOZ vagy orvoshoz.
MTIkkuntattja ĊENTRU TA' L-AVVELENAMENT jew tabib.
NLOnmiddellijk een ANTIGIFCENTRUM of een arts raadplegen.
PLNatychmiast skontaktować się z OŚRODKIEM ZATRUĆ lub lekarzem.
PTContacte imediatamente um CENTRO DE INFORMAÇÃO ANTIVENENOS ou um médico.
ROSunaţi imediat la un CENTRU DE INFORMARE TOXICOLOGICĂ sau un medic.
SKOkamžite volajte NÁRODNÉ TOXIKOLOGICKÉ INFORMAČNÉ CENTRUM alebo lekára.
SLTakoj pokličite CENTER ZA ZASTRUPITVE ali zdravnika.
FIOta välittömästi yhteys MYRKYTYSTIETOKESKUKSEEN tai lääkäriin.
SVKontakta genast GIFTINFORMATIONSCENTRAL eller läkare.

P311Language
BGОбадете се в ЦЕНТЪР ПО ТОКСИКОЛОГИЯ или на лекар.
ESLlamar a un CENTRO DE INFORMACION TOXICOLOGICA o a un médico.
CSVolejte TOXIKOLOGICKÉ INFORMAČNÍ STŘEDISKO nebo lékaře.
DARing til en GIFTINFORMATION eller en læge.
DEGIFTINFORMATIONSZENTRUM oder Arzt anrufen.
ETVõtta ühendust MÜRGISTUSTEABEKESKUSE või arstiga.
ELΚαλέστε το ΚΕΝΤΡΟ ΔΗΛΗΤΗΡΙΑΣΕΩΝ ή ένα γιατρό.
ENCall a POISON CENTER or doctor/physician.
FRAppeler un CENTRE ANTIPOISON ou un médecin.
GACuir glao ar IONAD NIMHE nó ar dhoctúir/lia.
ITContattare un CENTRO ANTIVELENI o un medico.
LVSazinieties ar SAINDĒŠANĀS CENTRU vai ārstu.
LTSkambinti į APSINUODIJIMŲ KONTROLĖS IR INFORMACIJOS BIURĄ arba kreiptis į gydytoją.
HUForduljon TOXIKOLÓGIAI KÖZPONTHOZ vagy orvoshoz.
MTIkkuntattja ĊENTRU TA' L-AVVELENAMENT jew tabib.
NLEen ANTIGIFCENTRUM of een arts raadplegen.
PLSkontaktować się z OŚRODKIEM ZATRUĆ lub lekarzem.
PTContacte um CENTRO DE INFORMAÇÃO ANTIVENENOS ou um médico.
ROSunaţi la un CENTRU DE INFORMARE TOXICOLOGICĂ sau un medic.
SKVolajte NÁRODNÉ TOXIKOLOGICKÉ INFORMAČNÉ CENTRUM alebo lekára.
SLPokličite CENTER ZA ZASTRUPITVE ali zdravnika.
FIOta yhteys MYRKYTYSTIETOKESKUKSEEN tai lääkäriin.
SVKontakta GIFTINFORMATIONSCENTRAL eller läkare.

P312Language
BGПри неразположение се обадете в ЦЕНТЪР ПО ТОКСИКОЛОГИЯ или на лекар.
ESLlamar a un CENTRO DE INFORMACION TOXICOLOGICA o a un médico en caso de malestar.
CSNecítíte-li se dobře, volejte TOXIKOLOGICKÉ INFORMAČNÍ STŘEDISKO nebo lékaře.
DAI tilfælde af ubehag ring til en GIFTINFORMATION eller en læge.
DEBei Unwohlsein GIFTINFORMATIONSZENTRUM oder Arzt anrufen.
ETHalva enesetunde korral võtta ühendust MÜRGISTUSTEABEKESKUSE või arstiga.
ELΚαλέστε το ΚΕΝΤΡΟ ΔΗΛΗΤΗΡΙΑΣΕΩΝ ή ένα γιατρό εάν αισθανθείτε αδιαθεσία.
ENCall a POISON CENTER or doctor/physician if you feel unwell.
FRAppeler un CENTRE ANTIPOISON ou un médecin en cas de malaise.
GACuir glao ar IONAD NIMHE nó ar dhoctúir/lia má bhraitheann tú tinn.
ITIn caso di malessere, contattare un CENTRO ANTIVELENI o un medico.
LVSazinieties ar SAINDĒŠANĀS CENTRU vai ārstu, ja jums ir slikta pašsajūta.
LTPasijutus blogai, skambinti į APSINUODIJIMŲ KONTROLĖS IR INFORMACIJOS BIURĄ arba kreiptis į gydytoją.
HURosszullét esetén forduljon TOXIKOLÓGIAI KÖZPONTHOZ vagy orvoshoz.
MTIkkuntattja ĊENTRU TA' L-AVVELENAMENT jew tabib jekk tħossok ma tiflaħx.
NLBij onwel voelen een ANTIGIFCENTRUM of een arts raadplegen.
PLW przypadku złego samopoczucia skontaktować się z OŚRODKIEM ZATRUĆ lub z lekarzem.
PTCaso sinta indisposição, contacte um CENTRO DE INFORMAÇÃO ANTIVENENOS ou um médico.
ROSunaţi la un CENTRU DE INFORMARE TOXICOLOGICĂ sau un medic, dacă nu vă simţiţi bine.
SKPri zdravotných problémoch, volajte NÁRODNÉ TOXIKOLOGICKÉ INFORMAČNÉ CENTRUM alebo lekára.
SLOb slabem počutju pokličite CENTER ZA ZASTRUPITVE ali zdravnika.
FIOta yhteys MYRKYTYSTIETOKESKUKSEEN tai lääkäriin, jos ilmenee pahoinvointia.
SVVid obehag, kontakta GIFTINFORMATIONSCENTRAL eller läkare.

P313Language
BGПотърсете медицински съвет/помощ.
ESConsultar a un médico.
CSVyhledejte lékařskou pomoc/ošetření.
DASøg lægehjælp.
DEÄrztlichen Rat einholen/ärztliche Hilfe hinzuziehen.
ETPöörduda arsti poole.
ELΣυμβουλευθείτε/Επισκεφθείτε γιατρό.
ENGet medical advice/attention.
FRConsulter un médecin.
GAFaigh comhairle/cúram liachta.
ITConsultare un medico.
LVLūdziet palīdzību mediķiem.
LTKreiptis į gydytoją.
HUOrvosi ellátást kell kérni.
MTIkkonsulta tabib.
NLEen arts raadplegen.
PLZasięgnąć porady/zgłosić się pod opiekę lekarza.
PTConsulte um médico.
ROConsultaţi medicul.
SKVyhľadajte lekársku pomoc/starostlivosť.
SLPoiščite zdravniško pomoč/oskrbo.
FIHakeudu lääkäriin.
SVSök läkarhjälp.

P314Language
BGПри неразположение потърсете медицински съвет/помощ.
ESConsultar a un médico en caso de malestar.
CSNecítíte-li se dobře, vyhledejte lékařskou pomoc/ošetření.
DASøg lægehjælp ved ubehag.
DEBei Unwohlsein ärztlichen Rat einholen/ärztliche Hilfe hinzuziehen.
ETHalva enesetunde korral pöörduda arsti poole.
ELΣυμβουλευθείτε/Επισκεφθείτε γιατρό εάν αισθανθείτε αδιαθεσία.
ENGet medical advice/attention if you feel unwell.
FRConsulter un médecin en cas de malaise.
GAFaigh comhairle/cúram liachta má bhraitheann tú tinn.
ITIn caso di malessere, consultare un medico.
LVLūdziet palīdzību mediķiem, ja jums ir slikta pašsajūta.
LTPasijutus blogai, kreiptis į gydytoją.
HURosszullét esetén orvosi ellátást kell kérni.
MTIkkonsulta tabib jekk tħossok ma tiflaħx.
NLBij onwel voelen een arts raadplegen.
PLW przypadku złego samopoczucia zasięgnąć porady/zgłosić się pod opiekę lekarza.
PTEm caso de indisposição, consulte um médico.
ROConsultaţi medicul, dacă nu vă simţiţi bine.
SKAk pociťujete zdravotné problémy, vyhľadajte lekársku pomoc/starostlivosť.
SLOb slabem počutju poiščite zdravniško pomoč/oskrbo.
FIHakeudu lääkäriin, jos ilmenee pahoinvointia.
SVSök läkarhjälp vid obehag.

P315Language
BGНезабавно потърсете медицински съвет/помощ.
ESConsultar a un médico inmediatamente.
CSOkamžitě vyhledejte lékařskou pomoc/ošetření.
DASøg omgående lægehjælp.
DESofort ärztlichen Rat einholen/ärztliche Hilfe hinzuziehen.
ETPöörduda viivitamata arsti poole.
ELΣυμβουλευθείτε/Επισκεφθείτε αμέσως γιατρό.
ENGet immediate medical advice/attention.
FRConsulter immédiatement un médecin.
GAFaigh comhairle/cúram liachta láithreach.
ITConsultare immediatamente un medico.
LVNekavējoties lūdziet palīdzību mediķiem.
LTNedelsiant kreiptis į gydytoją.
HUAzonnal orvosi ellátást kell kérni.
MTIkkonsulta tabib minnufih.
NLOnmiddellijk een arts raadplegen.
PLNatychmiast zasięgnąć porady/zgłosić się pod opiekę lekarza.
PTConsulte imediatamente um médico.
ROConsultaţi imediat medicul.
SKOkamžite vyhľadajte lekársku pomoc/starostlivosť.
SLTakoj poiščite zdravniško pomoč/oskrbo.
FIHakeudu välittömästi lääkäriin.
SVSök omedelbart läkarhjälp.

P320Language
BGСпешна нужда от специализирано лечение (вж… на този етикет).
ESSe necesita urgentemente un tratamiento específico (ver … en esta etiqueta).
CSJe nutné odborné ošetření (viz … na tomto štítku).
DASærlig behandling straks påkrævet (se … på denne etiket).
DEBesondere Behandlung dringend erforderlich (siehe … auf diesem Kennzeichnungsetikett).
ETNõuab viivitamatut eriravi (vt … käesoleval etiketil).
ELΧρειάζεται επειγόντως ειδική αγωγή (βλέπε … στην ετικέτα).
ENSpecific treatment is urgent (see … on this label).
FRUn traitement spécifique est urgent (voir … sur cette étiquette).
GATá sé práinneach go bhfaightear cóir leighis ar leith (féach … ar an lipéad seo).
ITTrattamento specifico urgente (vedere… su questa etichetta).
LVSteidzami nepieciešama īpaša medicīniskā palīdzība (skat. … uz šīs etiķetes).
LTBūtinas skubus specialus gydymas (žr. … šioje etiketėje).
HUSürgős szakellátás szükséges (lásd … a címkén).
MTTrattament speċifiku hu urġenti (ara … fuq din it-tikketta).
NLSpecifieke behandeling dringend vereist (zie … op dit etiket).
PLPilnie zastosować określone leczenie (patrz … na etykiecie).
PTÉ urgente um tratamento específico (ver … no presente rótulo).
ROUn tratament specific este urgent (a se vedea … de pe această etichetă).
SKOdborné ošetrenie je naliehavé (pozri … na etikete).
SLPosebno zdravljenje je nujno (glejte … na tej etiketi).
FIErityishoitoa tarvitaan välittömästi (katso … pakkauksen merkinnöissä).
SVSärskild behandling krävs omedelbart (se … på etiketten).

P321Language
BGСпециализирано лечение (вж… на този етикет).
ESSe necesita un tratamiento específico (ver … en esta etiqueta).
CSOdborné ošetření (viz … na tomto štítku).
DASærlig behandling (se … på denne etiket).
DEBesondere Behandlung (siehe … auf diesem Kennzeichnungsetikett).
ETNõuab eriravi (vt … käesoleval etiketil).
ELΧρειάζεται ειδική αγωγή (βλέπε … στην ετικέτα).
ENSpecific treatment (see … on this label).
FRTraitement spécifique (voir … sur cette étiquette).
GACóir liachta ar leith (féach … ar an lipéad seo).
ITTrattamento specifico (vedere …su questa etichetta).
LVĪpaša medicīniskā palīdzība (skat. … uz šīs etiķetes).
LTSpecialus gydymas (žr. … šioje etiketėje).
HUSzakellátás (lásd … a címkén).
MTTrattament speċifiku (ara … fuq din it-tikketta).
NLSpecifieke behandeling vereist (zie … op dit etiket).
PLZastosować określone leczenie (patrz … na etykiecie).
PTTratamento específico (ver … no presente rótulo).
ROTratament specific (a se vedea … de pe această etichetă).
SKOdborné ošetrenie (pozri … na etikete).
SLPosebno zdravljenje (glejte … na tej etiketi).
FIErityishoitoa tarvitaan (katso … pakkauksen merkinnöissä).
SVSärskild behandling (se … på etiketten).

P322Language
BGСпециални мерки (вж… на този етикет).
ESSe necesitan medidas específicas (ver … en esta etiqueta).
CSSpecifické opatření (viz … na tomto štítku).
DASærlige foranstaltninger (se … på denne etiket).
DEGezielte Maßnahmen (siehe … auf diesem Kennzeichnungsetikett).
ETNõuab erimeetmeid (vt … käesoleval etiketil).
ELΧρειάζονται ειδικά μέτρα (βλέπε … στην ετικέτα).
ENSpecific measures (see … on this label).
FRMesures spécifiques (voir … sur cette étiquette).
GABearta ar leith (féach … ar an lipéad seo).
ITMisure specifiche (vedere …su questa etichetta).
LVĪpaši pasākumi (skat. … uz šīs etiķetes).
LTSpecialios priemonės (žr. … šioje etiketėje).
HUKülönleges intézkedések (lásd … a címkén).
MTMiżuri speċifiċi (ara … fuq din it-tikketta).
NLSpecifieke maatregelen (zie … op dit etiket).
PLŚrodki szczególne (patrz … na etykiecie).
PTMedidas específicas (ver … no presente rótulo).
ROMăsuri specifice (a se vedea … de pe această etichetă).
SKOsobitné opatrenia (pozri … na etikete).
SLPosebni ukrepi (glejte … na tej etiketi).
FIErityistoimenpiteitä tarvitaan (katso … pakkauksen merkinnöissä).
SVSärskilda åtgärder (se … på etiketten).

P330Language
BGИзплакнете устата.
ESEnjuagarse la boca.
CSVypláchněte ústa.
DASkyl munden.
DEMund ausspülen.
ETLoputada suud.
ELΞεπλύνετε το στόμα.
ENRinse mouth.
FRRincer la bouche.
GASruthlaítear an béal.
ITSciacquare la bocca.
LVIzskalot muti.
LTIšskalauti burną.
HUA szájat ki kell öblíteni.
MTLaħlaħ ħalqek.
NLDe mond spoelen.
PLWypłukać usta.
PTEnxaguar a boca.
ROClătiţi gura.
SKVypláchnite ústa.
SLIzprati usta.
FIHuuhdo suu.
SVSkölj munnen.

P331Language
BGНЕ предизвиквайте повръщане.
ESNO provocar el vómito.
CSNEVYVOLÁVEJTE zvracení.
DAFremkald IKKE opkastning.
DEKEIN Erbrechen herbeiführen.
ETMITTE kutsuda esile oksendamist.
ELΜΗΝ προκαλέσετε εμετό.
ENDo NOT induce vomiting.
FRNE PAS faire vomir.
GANÁ spreagtar urlacan.
ITNON provocare il vomito.
LVNEIZRAISĪT vemšanu.
LTNESKATINTI vėmimo.
HUTILOS hánytatni.
MTTIPPROVOKAX ir-remettar.
NLGEEN braken opwekken.
PLNIE wywoływać wymiotów.
PTNÃO provocar o vómito.
RONU provocaţi voma.
SKNevyvolávajte zvracanie.
SLNE izzvati bruhanja.
FIEI saa oksennuttaa.
SVFramkalla INTE kräkning.

P332Language
BGПри поява на кожно дразнене:
ESEn caso de irritación cutánea:
CSPři podráždění kůže:
DAVed hudirritation:
DEBei Hautreizung:
ETNahaärrituse korral:
ELΕάν παρατηρηθεί ερεθισμός του δέρματος:
ENIf skin irritation occurs:
FREn cas d’irritation cutanée:
GAI gcás greannú craicinn:
ITIn caso di irritazione della pelle:
LVJa rodas ādas iekaisums:
LTJeigu sudirginama oda:
HUBőrirritáció esetén:
MTJekk ikun hemm irritazzjoni tal-ġilda:
NLBij huidirritatie:
PLW przypadku wystąpienia podrażnienia skóry:
PTEm caso de irritação cutânea:
ROÎn caz de iritare a pielii:
SKAk sa prejaví podráždenie pokožky:
SLČe nastopi draženje kože:
FIJos ilmenee ihoärsytystä:
SVVid hudirritation:

P333Language
BGПри поява на кожно дразнене или обрив на кожата:
ESEn caso de irritación o erupción cutánea:
CSPři podráždění kůže nebo vyrážce:
DAVed hudirritation eller udslet:
DEBei Hautreizung oder -ausschlag:
ETNahaärrituse või _obe korral:
ELΕάν παρατηρηθεί ερεθισμός του δέρματος ή εμφανιστεί εξάνθημα:
ENIf skin irritation or rash occurs:
FREn cas d’irritation ou d’éruption cutanée:
GAI gcás greannú nó grís craicinn:
ITIn caso di irritazione o eruzione della pelle:
LVJa rodas ādas iekaisums vai izsitumi:
LTJeigu sudirginama oda arba ją išberia.
HUBőrirritáció vagy kiütések megjelenése esetén:
MTJekk ikun hemm irritazzjoni jew raxx tal-ġilda:
NLBij huidirritatie of uitslag:
PLW przypadku wystąpienia podrażnienia skóry lub wysypki:
PTEm caso de irritação ou erupção cutânea:
ROÎn caz de iritare a pielii sau de erupţie cutanată:
SKAk sa prejaví podráždenie pokožky alebo sa vytvoria vyrážky:
SLČe nastopi draženje kože ali se pojavi izpuščaj:
FIJos ilmenee ihoärsytystä tai ihottumaa:
SVVid hudirritation eller utslag:

P334Language
BGПотопете в хладка вода/сложете мокри компреси.
ESSumergir en agua fresca/aplicar compresas húmedas.
CSPonořte do studené vody/zabalte do vlhkého obvazu.
DASkyl under koldt vand/anvend våde omslag.
DEIn kaltes Wasser tauchen/nassen Verband anlegen.
ETHoida jahedas vees/panna peale niiske kompress.
ELΒυθίστε σε δροσερό νερό/τυλίξτε με βρεγμένους επιδέσμους.
ENImmerse in cool water/wrap in wet bandages.
FRRincer à l’eau fraîche/poser une compresse humide.
GATum in uisce fionnuar/cuir bréid fliuch air.
ITImmergere in acqua fredda/avvolgere con un bendaggio umido.
LVIegremdēt vēsā ūdenī/ietīt mitros apsējos.
LTĮmerkti į vėsų vandenį/apvynioti šlapiais tvarsčiais.
HUHideg vízzel/nedves kötéssel kell hűteni.
MTDaħħal fl-ilma kiesaħ/kebbeb f’faxex imxarrbin.
NLIn koud water onderdompelen/nat verband aanbrengen.
PLZanurzyć w zimnej wodzie/owinąć mokrym bandażem.
PTMergulhar em água fria/aplicar compressas húmidas.
ROIntroduceţi în apă rece/acoperiţi cu o compresă umedă.
SKPonorte do studenej vody/obviažte mokrými obväzmi.
SLPotopiti v hladno vodo/zaviti v mokre povoje.
FIUpota kylmään veteen/kääri märkiin siteisiin.
SVSkölj under kallt vatten/använd våta omslag.

P335Language
BGОтстранете от кожата посипаните частици.
ESSacudir las partículas que se hayan depositado en la piel.
CSVolné částice odstraňte z kůže.
DABørst løse partikler bort fra huden.
DELose Partikel von der Haut abbürsten.
ETPühkida lahtised osakesed nahalt maha.
ELΑφαιρέστε προσεκτικά τα σωματίδια που έχουν μείνει στο δέρμα.
ENBrush off loose particles from skin.
FREnlever avec précaution les particules déposées sur la peau.
GAGlan cáithníní scaoilte den chraiceann.
ITRimuovere le particelle depositate sulla pelle.
LVNoberzt no ādas nepiestiprinātās daļiņas.
LTNeprilipusias daleles nuvalyti nuo odos.
HUA bőrre lazán tapadó szemcséket óvatosan le kell kefélni.
MTFarfar il-frak mhux imwaħħla minn fuq il-ġilda.
NLLosse deeltjes van de huid afvegen.
PLNie związaną pozostałość strzepnąć ze skóry.
PTSacudir da pele as partículas soltas.
ROÎndepărtaţi particulele depuse pe piele.
SKZ pokožky oprášte sypké čiastočky.
SLS krtačo odstraniti razsute delce s kože.
FIPoista irtohiukkaset iholta.
SVBorsta bort lösa partiklar från huden.

P336Language
BGРазмразете замръзналите части в хладка вода. Не разтривайте засегнатото място.
ESDescongelar las partes heladas con agua tibia. No frotar la zona afectada.
CSOmrzlá místa ošetřete vlažnou vodou. Postižené místo netřete.
DAForsigtig opvarmning af frostskadede legemsdele i lunkent vand. Gnid ikke det angrebne område.
DEVereiste Bereiche mit lauwarmem Wasser auftauen. Betroffenen Bereich nicht reiben.
ETSulatada külmunud piirkonnad leige veega. Kannatada saanud piirkonda mitte hõõruda.
ELΞεπαγώστε τα παγωμένα μέρη με χλιαρό νερό. Μην τρίβετε την περιοχή που πάγωσε.
ENThaw frosted parts with lukewarm water. Do no rub affected area.
FRDégeler les parties gelées avec de l’eau tiède. Ne pas frotter les zones touchées.
GALeáigh codanna sioctha le huisce alabhog. Ná cuimil an réimse lena mbaineann.
ITSgelare le parti congelate usando acqua tiepida. Non sfregare la parte interessata.
LVAtkausēt sasalušās daļas ar remdenu ūdeni. Skarto zonu neberzt.
LTPrišalusias daleles atitirpinti drungnu vandeniu. Netrinti paveiktos zonos.
HUA fagyott részeket langyos vízzel fel kell melegíteni. Tilos az érintett terület dörzsölése.
MTĦoll il-partijiet kiesħa bl-ilma fietel. Togħrokx il-parti affettwata.
NLBevroren lichaamsdelen met lauw water ontdooien. Niet wrijven op de betrokken plaatsen.
PLRozmrozić oszronione obszary letnią wodą. Nie trzeć oszronionego obszaru.
PTDerreter as zonas congeladas com água morna. Não friccionar a zona afectada.
RODezgheţaţi părţile degerate cu apă călduţă. Nu frecaţi zona afectată.
SKZmrznuté časti ošetrite vlažnou vodou. Postihnuté miesto netrite.
SLZamrznjene dele odtaliti z mlačno vodo. Ne drgniti prizadetega mesta.
FISulata jäätyneet alueet haalealla vedellä. Vahingoittunutta aluetta ei saa hangata.
SVVärm det köldskadade området med ljummet vatten. Gnid inte det skadade området.

P337Language
BGПри продължително дразнене на очите:
ESSi persiste la irritación ocular:
CSPřetrvává-li podráždění očí:
DAVed vedvarende øjenirritation:
DEBei anhaltender Augenreizung:
ETKui silmade ärritus ei möödu:
ELΕάν δεν υποχωρεί ο οφθαλμικός ερεθισμός:
ENIf eye irritation persists:
FRSi l’irritation oculaire persiste:
GAMá mhaireann an greannú súile:
ITSe l’irritazione degli occhi persiste:
LVJa acu iekaisums nepāriet:
LTJei akių dirginimas nepraeina:
HUHa a szemirritáció nem múlik el:
MTJekk l-irritazzjoni ta' l-għajnejn tibqa’:
NLBij aanhoudende oogirritatie:
PLW przypadku utrzymywania się działania drażniącego na oczy:
PTCaso a irritação ocular persista:
RODacă iritarea ochilor persistă:
SKAk podráždenie očí pretrváva:
SLČe draženje oči ne preneha:
FIJos silmä-ärsytys jatkuu:
SVVid bestående ögonirritation:

P338Language
BGСвалете контактните лещи, ако има такива и доколкото това е възможно. Продължете с изплакването.
ESQuitar las lentes de contacto, si lleva y resulta fácil. Seguir aclarando.
CSVyjměte kontaktní čočky, jsou-li nasazeny a pokud je lze vyjmout snadno. Pokračujte ve vyplachování.
DAFjern eventuelle kontaktlinser, hvis dette kan gøres let. Fortsæt skylning.
DEEventuell Vorhandene Kontaktlinsen nach Möglichkeit entfernen. Weiter ausspülen.
ETEemaldada kontaktläätsed, kui neid kasutatakse ja kui neid on kerge eemaldada. Loputada veel kord.
ELΕάν υπάρχουν φακοί επαφής, αφαιρέστε τους, εφόσον είναι εύκολο. Συνεχίστε να ξεπλένετε.
ENRemove contact lenses, if present and easy to do. Continue rinsing.
FREnlever les lentilles de contact si la victime en porte et si elles peuvent être facilement enlevées. Continuer à rincer.
GATóg amach na tadhall-lionsaí, más ann dóibh agus más furasta é sin a dhéanamh. Lean den sruthlú.
ITTogliere le eventuali lenti a contatto se è agevole farlo. Continuare a sciacquare.
LVIzņemiet kontaktlēcas, ja tās ir ievietotas un to ir viegli izdarīt. Turpiniet skalot.
LTIšimti kontaktinius lęšius, jeigu jie yra ir jeigu lengvai galima tai padaryti. Toliau plauti akis.
HUAdott esetben kontaktlencsék eltávolítása, ha könnyen megoldható. Az öblítés folytatása.
MTNeħħi l-lentijiet tal-kuntatt, jekk ikun hemm u jkunu faċli biex tneħħihom. Kompli laħlaħ.
NLContactlenzen verwijderen, indien mogelijk. Blijven spoelen.
PLWyjąć soczewki kontaktowe, jeżeli są i można je łatwo usunąć. Nadal płukać.
PTSe usar lentes de contacto, retire-as, se tal lhe for possível. Continue a enxaguar.
ROScoateţi lentilele de contact, dacă este cazul şi dacă acest lucru se poate face cu uşurinţă. Continuaţi să clătiţi.
SKAk používate kontaktné šošovky a ak je to možné, odstráňte ich. Pokračujte vo vyplachovaní.
SLOdstranite kontaktne leče, če jih imate in če to lahko storite brez težav. Nadaljujte z izpiranjem.
FIPoista piilolinssit, jos sen voi tehdä helposti. Jatka huuhtomista.
SVTa ur eventuella kontaktlinser om det går lätt. Fortsätt att skölja.

P340Language
BGИзведете пострадалия на чист въздух и го поставете в позиция, улесняваща дишането.
ESTransportar a la víctima al exterior y mantenerla en reposo en una posición confortable para respirar.
CSPřeneste postiženého na čerstvý vzduch a ponechte jej v klidu v poloze usnadňující dýchání.
DAFlyt personen til et sted med frisk luft og sørg for, at vedkommende hviler i en stilling, som letter vejrtrækningen.
DEDie betroffene Person an die frische Luft bringen und in einer Position ruhigstellen, die das Atmen erleichtert.
ETToimetada kannatanu värske õhu kätte ja asetada mugavasse puhkeasendisse, mis võimaldab kergesti hingata.
ELΜεταφέρετε τον παθόντα στον καθαρό αέρα και αφήστε τον να ξεκουραστεί σε στάση που διευκολύνει την αναπνοή.
ENRemove victim to fresh air and keep at rest in a position comfortable for breathing.
FRTransporter la victime à l'extérieur et la maintenir au repos dans une position où elle peut confortablement respirer.
GATabhair amach faoin aer an duine agus coimeád socair é, i riocht ina bhféadfaidh sé anáil a tharraingt go réidh.
ITTrasportare l'infortunato all’aria aperta e mantenerlo a riposo in posizione che favorisca la respirazione.
LVIzvest cietušo svaigā gaisā un turēt miera stāvoklī, lai būtu ērti elpot.
LTIšnešti nukentėjusįjį į gryną orą; jam būtina ramybė ir padėtis, leidžianti laisvai kvėpuoti.
HUAz érintett személyt friss levegőre kell vinni és olyan nyugalmi testhelyzetbe kell helyezni, hogy könnyen tudjon lélegezni.
MTEsponi lill-vittma għall-arja friska u żommha mistrieħa f’pożizzjoni komda biex tkun tista’ tieħu n-nifs.
NLHet slachtoffer in de frisse lucht brengen en laten rusten in een houding die het ademen vergemakkelijkt.
PLWyprowadzić lub wynieść poszkodowanego na świeże powietrze i zapewnić warunki do odpoczynku w pozycji umożliwiającej swobodne oddychanie.
PTRetirar a vítima para uma zona ao ar livre e mantê-la em repouso numa posição que não dificulte a respiração.
ROTransportaţi victima la aer liber şi menţineţi-o în stare de repaus într-o poziţie confortabilă pentru respiraţie.
SKPresuňte postihnutého na čerstvý vzduch a nechajte ho oddychovať v polohe, ktorá mu umožní pohodlné dýchanie.
SLPrenesti žrtev na svež zrak in jo pustiti počivati v položaju, ki olajša dihanje.
FISiirrä henkilö raittiiseen ilmaan ja pidä lepoasennossa, jossa on helppo hengittää.
SVFlytta personen till frisk luft och se till att han eller hon vilar i en ställning som underlättar andningen

P341Language
BGПри затруднено дишане изведете пострадалия на чист въздух и го поставете в позиция, улесняваща дишането.
ESSi respira con dificultad, transportar a la víctima al exterior y mantenerla en reposo en una posición confortable para respirar.
CSPři obtížném dýchání přeneste postiženého na čerstvý vzduch a ponechte jej v klidu v poloze usnadňující dýchání.
DAVed vejrtrækningsbesvær: Flyt personen til et sted med frisk luft og sørg for, at vedkommende hviler i en stilling, som letter vejrtrækningen.
DEBei Atembeschwerden an die frische Luft bringen und in einer Position ruhigstellen, die das Atmen erleichtert.
ETHingamisraskuste korral toimetada kannatanu värske õhu kätte ja asetada mugavasse puhkeasendisse, mis võimaldab kergesti hingata.
ELΕάν ο παθών έχει δύσπνοια, μεταφέρετέ τον στον καθαρό αέρα και αφήστε τον να ξεκουραστεί σε στάση που διευκολύνει την αναπνοή.
ENIf breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing.
FRS'il y a difficulté à respirer, transporter la victime à l'extérieur et la maintenir au repos dans une position où elle peut confortablement respirer.
GAMás deacair don duine análú, tabhair amach faoin aer é agus coimeád socair é, i riocht ina bhféadfaidh sé anáil a tharraingt go réidh.
ITSe la respirazione è difficile, trasportare l'infortunato all’aria aperta e mantenerlo a riposo in posizione che favorisca la respirazione.
LVJa elpošana ir apgrūtināta, izvest cietušo svaigā gaisā un turēt miera stāvoklī, lai būtu ērti elpot.
LTJeigu nukentėjusiajam sunku kvėpuoti, išnešti jį į gryną orą; jam būtina ramybė ir padėtis, leidžianti laisvai kvėpuoti.
HULégzési nehézségek esetén az érintett személyt friss levegőre kell vinni és olyan nyugalmi testhelyzetbe kell helyezni, hogy könnyen tudjon lélegezni.
MTJekk in-nifs ikun diffiċli, esponi lill-vittma għall-arja friska u żommha mistrieħa f’pożizzjoni komda biex tkun tista' tieħu n-nifs.
NLBij ademhalingsmoeilijkheden het slachtoffer in de frisse lucht brengen en laten rusten in een houding die het ademen vergemakkelijkt.
PLW przypadku trudności z oddychaniem, wyprowadzić lub wynieść poszkodowanego na świeże powietrze i zapewnić warunki do odpoczynku w pozycji umożliwiającej swobodne oddychanie.
PTEm caso de dificuldade respiratória, retirar a vítima para uma zona ao ar livre e mantê-la em repouso numa posição que não dificulte a respiração.
RODacă respiraţia este dificilă, transportaţi victima la aer liber şi menţineţi-o în stare de repaus într-o poziţie confortabilă pentru respiraţie.
SKAk nastanú ťažkosti s dýchaním, presuňte postihnutého na čerstvý vzduch a nechajte ho oddychovať v polohe, ktorá mu umožní pohodlné dýchanie.
SLPri oteženem dihanju prenesti žrtev na svež zrak in jo pustiti počivati v položaju, ki olajša dihanje.
FIJos hengitysvaikeuksia, siirrä henkilö raittiiseen ilmaan ja pidä lepoasennossa, jossa on helppo hengittää.
SVVid andningsbesvär, flytta personen till frisk luft och se till att han eller hon vilar i en ställning som underlättar andningen.

P342Language
BGПри симптоми на затруднено дишане:
ESEn caso de síntomas respiratorios:
CSPři dýchacích potížích:
DAVed luftvejssymptomer:
DEBei Symptomen der Atemwege:
ETHingamisteede probleemide ilmnemise korral:
ELΕάν παρουσιάζονται αναπνευστικά συμπτώματα:
ENIf experiencing respiratory symptoms:
FREn cas de symptômes respiratoires:
GAI gcás siomptóm riospráide:
ITIn caso di sintomi respiratori:
LVJa rodas elpošanas traucējumu simptomi:
LTJeigu pasireiškia respiraciniai simptomai:
HULégzési problémák esetén:
MTJekk tkun qed tbati minn sintomi respiratorji:
NLBij ademhalingssymptomen:
PLW przypadku wystąpienia objawów ze strony układu oddechowego:
PTEm caso de sintomas respiratórios:
ROÎn caz de simptome respiratorii:
SKPri sťaženom dýchaní:
SLPri respiratornih simptomih:
FIJos ilmenee hengitysoireita:
SVVid besvär i luftvägarna:

P350Language
BGИзмийте внимателно и обилно със сапун и вода.
ESLavar suavemente con agua y jabón abundantes.
CSJemně omyjte velkým množstvím vody a mýdla.
DAVask forsigtigt med rigeligt sæbe og vand.
DEBehutsam mit viel Wasser und Seife waschen.
ETPesta õrnalt rohke vee ja seebiga.
ELΠλύνετε απαλά με άφθονο νερό και σαπούνι.
ENGently wash with plenty of soap and water.
FRLaver avec précaution et abondamment à l’eau et au savon.
GANigh go bog le neart gallúnaí agus uisce.
ITLavare delicatamente e abbondantemente con acqua e sapone.
LVMaigi izskalot ar lielu daudzumu ziepēm un ūdeni.
LTAtsargiai nuplauti dideliu kiekiu muilo ir vandens.
HUÓvatos lemosás bő szappanos vízzel.
MTAħsel bil-mod b’ħafna sapun u ilma.
NLVoorzichtig wassen met veel water en zeep.
PLDelikatnie umyć dużą ilością wody z mydłem.
PTLavar suavemente com sabonete e água abundantes.
ROSpălaţi uşor cu multă apă și săpun.
SKOpatrne umyte veľkým množstvom vody a mydla.
SLNežno umiti z veliko mila in vode.
FIPese varovasti runsaalla vedellä ja saippualla.
SVTvätta försiktigt med mycket tvål och vatten.

P351Language
BGПромивайте внимателно с вода в продължение на няколко минути.
ESAclarar cuidadosamente con agua durante varios minutos.
CSNěkolik minut opatrně oplachujte vodou.
DASkyl forsigtigt med vand i flere minutter.
DEEinige Minuten lang behutsam mit Wasser ausspülen.
ETLoputada mitme minuti jooksul ettevaatlikult veega.
ELΞεπλύνετε προσεκτικά με νερό για αρκετά λεπτά.
ENRinse cautiously with water for several minutes.
FRRincer avec précaution à l’eau pendant plusieurs minutes.
GASruthlaítear go faichilleach le huisce ar feadh roinnt nóiméad.
ITSciacquare accuratamente per parecchi minuti.
LVUzmanīgi skalot ar ūdeni vairākas minūtes.
LTAtsargiai plauti vandeniu kelias minutes.
HUÓvatos öblítés vízzel több percen keresztül.
MTLaħlaħ b'attenzjoni bl-ilma għal diversi minuti.
NLVoorzichtig afspoelen met water gedurende een aantal minuten.
PLOstrożnie płukać wodą przez kilka minut.
PTEnxaguar cuidadosamente com água durante vários minutos.
ROClătiţi cu atenţie cu apă, timp de mai multe minute.
SKOpatrne niekoľko minút oplachujte vodou.
SLPrevidno izpirati z vodo nekaj minut.
FIHuuhdo huolellisesti vedellä usean minuutin ajan.
SVSkölj försiktigt med vatten i flera minuter.

P352Language
BGИзмийте обилно със сапун и вода.
ESLavar con agua y jabón abundantes.
CSOmyjte velkým množstvím vody a mýdla.
DAVask med rigeligt sæbe og vand.
DEMit viel Wasser und Seife waschen.
ETPesta rohke vee ja seebiga.
ELΠλύνετε με άφθονο σαπούνι και νερό.
ENWash with plenty of soap and water.
FRLaver abondamment à l’eau et au savon.
GANigh le neart gallúnaí agus uisce.
ITLavare abbondantemente con acqua e sapone.
LVMazgāt ar lielu daudzmu ziepēm un ūdeni.
LTPlauti dideliu kiekiu muilo ir vandens.
HULemosás bő szappanos vízzel.
MTAħsel b’ħafna sapun u ilma.
NLMet veel water en zeep wassen.
PLUmyć dużą ilością wody z mydłem.
PTLavar com sabonete e água abundantes.
ROSpălaţi cu multă apă și săpun.
SKUmyte veľkým množstvom vody a mydla.
SLUmiti z veliko mila in vode.
FIPese runsaalla vedellä ja saippualla.
SVTvätta med mycket tvål och vatten.

P353Language
BGОблейте кожата с вода/вземете душ.
ESAclararse la piel con agua/ducharse.
CSOpláchněte kůži vodou/osprchujte.
DASkyl/brus huden med vand.
DEHaut mit Wasser abwaschen/duschen.
ETLoputada nahka veega/loputada duši all.
ELΞεπλύνετε την επιδερμίδα με νερό/στο ντους.
ENRinse skin with water/shower.
FRRincer la peau à l’eau/se doucher.
GASruthlaítear an craiceann le huisce/glac cithfholcadh.
ITSciacquare la pelle/fare una doccia.
LVNoskalot ādu ar ūdeni/dušā.
LTOdą nuplauti vandeniu/čiurkšle.
HUA bőrt le kell öblíteni vízzel/zuhanyozás.
MTLaħlaħ il-ġilda bl-ilma/bix-xawer.
NLHuid met water afspoelen/afdouchen.
PLSpłukać skórę pod strumieniem wody/prysznicem.
PTEnxaguar a pele com água/tomar um duche.
ROClătiţi pielea cu apă/faceţi duş.
SKPokožku opláchnite vodou/sprchou.
SLKožo izprati z vodo/prho.
FIHuuhdo/suihkuta iho vedellä.
SVSkölj huden med vatten/duscha.

P360Language
BGНезабавно облейте замърсеното облекло и кожата обилно с вода, преди да свалите дрехите.
ESAclarar inmediatamente con agua abundante las prendas y la piel contaminadas antes de quitarse la ropa.
CSKontaminovaný oděv a kůži okamžitě omyjte velkým množstvím vody a potom oděv odložte.
DASkyl omgående tilsmudset tøj og hud med rigeligt vand, før tøjet fjernes.
DEKontaminierte Kleidung und Haut sofort mit viel Wasser abwaschen und danach Kleidung ausziehen.
ETSaastunud rõivad ja nahk loputada viivitamata rohke veega ning alles seejärel rõivad eemaldada.
ELΞεπλύνετε αμέσως τα μολυσμένα ρούχα και την επιδερμίδα με άφθονο νερό πριν αφαιρέσετε τα ρούχα.
ENRinse immediately contaminated clothing and skin with plenty of water before removing clothes.
FRRincer immédiatement et abondamment avec de l’eau les vêtements contaminés et la peau avant de les enlever.
GASruthlaítear éadaí éillithe agus an craiceann láithreach le neart uisce sula mbaineann an duine na héadaí de.
ITSciacquare immediatamente e abbondantemente gli indumenti contaminati e la pelle prima di togliersi gli indumenti.
LVNekavējoties noskalot piesārņoto apģērbu un skarto ādu ar lielu daudzumu ūdens pirms apģērba novilkšanas.
LTPrieš nuvelkant užterštus drabužius, nedelsiant juos ir odą nuplauti dideliu kiekiu vandens.
HUA ruhák levetése előtt a szennyezett ruházatot és a bőrt bő vízzel azonnal le kell öblíteni.
MTLaħlaħ mall-ewwel l-ilbies ikkontaminat u l-ġilda b’ħafna ilma qabel ma tneħħi l-ilbies.
NLVerontreinigde kleding en huid onmiddellijk met veel water afspoelen en pas daarna kleding uittrekken.
PLNatychmiast spłukać zanieczyszczoną odzież i skórę dużą ilością wody przed zdjęciem odzieży.
PTEnxaguar imediatamente com muita água a roupa e a pele contaminadas antes de se despir.
ROClătiţi imediat îmbrăcămintea contaminată şi pielea cu multă apă, înainte de scoaterea îmbrăcămintei.
SKKontaminovaný odev a pokožku ihneď opláchnite veľkým množstvom vody a potom odev odstráňte.
SLTakoj izprati kontaminirana oblačila in kožo z veliko vode pred odstranitvijo oblačil.
FIHuuhdo saastunut vaatetus ja iho välittömästi runsaalla vedellä ennen vaatetuksen riisumista.
SVSkölj genast nedstänkta kläder och hud med mycket vatten innan du tar av dig kläderna.

P361Language
BGНезабавно свалете цялото замърсено облекло.
ESQuitarse inmediatamente las prendas contaminadas.
CSVeškeré kontaminované části oděvu okamžitě svlékněte.
DATilsmudset tøj tages straks af/fjernes.
DEAlle kontaminierten Kleidungsstücke sofort ausziehen.
ETKõik saastunud rõivad viivitamata seljast võtta.
ELΑφαιρέστε/Βγάλτε αμέσως όλα τα μολυσμένα ρούχα.
ENRemove/Take off immediately all contaminated clothing.
FREnlever immédiatement les vêtements contaminés.
GABain díot láithreach na héadaí éillithe go léir.
ITTogliersi di dosso immediatamente tutti gli indumenti contaminati.
LVNoņemt/Novilkt nekavējoties visu piesārņoto apģērbu.
LTNedelsiant nuvilkti/pašalinti visus užterštus drabužius.
HUAz összes szennyezett ruhadarabot azonnal el kell távolítani/le kell vetni.
MTNeħħi/Inża’ mall-ewwel l-ilbies ikkontaminat.
NLVerontreinigde kleding onmiddellijk uittrekken.
PLNatychmiast usunąć/zdjąć całą zanieczyszczoną odzież.
PTDespir/retirar imediatamente toda a roupa contaminada.
ROScoateţi imediat toată îmbrăcămintea contaminată.
SKIhneď odstráňte/vyzlečte všetky kontaminované časti odevu.
SLTakoj odstraniti/sleči vsa kontaminirana oblačila.
FIRiisu saastunut vaatetus välittömästi.
SVTa omedelbart av alla nedstänkta kläder.

P362Language
BGСвалете замърсеното облекло и го изперете преди повторна употреба.
ESQuitarse las prendas contaminadas y lavarlas antes de volver a usarlas.
CSKontaminovaný oděv svlékněte a před opětovným použitím ho vyperte.
DAForurenet tøj tages af og vaskes, før det bruges igen.
DEKontaminierte Kleidung ausziehen und vor erneutem Tragen waschen.
ETVõtta saastunud rõivad seljast ja pesta neid enne järgmist kasutamist.
ELΒγάλτε τα μολυσμένα ρούχα και πλύνετέ τα πριν τα ξαναχρησιμοποιήσετε.
ENTake off contaminated clothing and wash before reuse.
FREnlever les vêtements contaminés et les laver avant réutilisation
GABain díot láithreach na héadaí éillithe go léir agus nigh iad sula ndéanfar iad a athúsáid.
ITTogliersi di dosso gli indumenti contaminati e lavarli prima di indossarli nuovamente.
LVNovilkt piesārņoto apģērbu un pirms atkārtotas lietošanas izmazgāt.
LTNusivilkti užterštus drabužius ir išskalbti prieš vėl juos apsivelkant.
HUA szennyezett ruhát le kell vetni és az újbóli használat előtt ki kell mosni.
MTInża' l-ħwejjeġ kontaminati u aħsilhom qabel ma terġa' tużahom.
NLVerontreinigde kleding uittrekken en wassen alvorens deze opnieuw te gebruiken.
PLZanieczyszczoną odzież zdjąć i wyprać przed ponownym użyciem.
PTRetirar a roupa contaminada e lavá-la antes de a voltar a usar.
ROScoateţi îmbrăcămintea contaminată şi spălaţi-o înainte de reutilizare.
SKKontaminovaný odev vyzlečte a pred ďalším použitím vyperte.
SLSleči kontaminirana oblačila in jih oprati pred ponovno uporabo.
FIRiisu ja pese saastunut vaatetus ennen uudelleenkäyttöä.
SVNedstänkta kläder tas av och tvättas innan de används igen.

P363Language
BGИзперете замърсеното облекло преди повторна употреба.
ESLavar las prendas contaminadas antes de volver a usarlas.
CSKontaminovaný oděv před opětovným použitím vyperte.
DATilsmudset tøj skal vaskes, før det kan anvendes igen.
DEKontaminierte Kleidung vor erneutem Tragen waschen.
ETSaastunud rõivad enne järgmist kasutamist pesta.
ELΠλύνετε τα μολυσμένα ενδύματα πριν τα ξαναχρησιμοποιήσετε.
ENWash contaminated clothing before reuse.
FRLaver les vêtements contaminés avant réutilisation.
GANigh éadaí éillithe sula ndéanfar iad a athúsáid.
ITLavare gli indumenti contaminati prima di indossarli nuovamente.
LVPirms atkārtotas lietošanas piesārņoto apģērbu izmazgāt.
LTUžterštus drabužius išskalbti prieš vėl juos apsivelkant.
HUA szennyezett ruhát újbóli használat előtt ki kell mosni.
MTAħsel il-ħwejjeġ kontaminati qabel terġa’ tużahom.
NLVerontreinigde kleding wassen alvorens deze opnieuw te gebruiken.
PLWyprać zanieczyszczoną odzież przed ponownym użyciem.
PTLavar a roupa contaminada antes de a voltar a usar.
ROSpălaţi îmbracămintea contaminată, înainte de reutilizare.
SKKontaminovaný odev pred ďalším použitím vyperte.
SLKontaminirana oblačila oprati pred ponovno uporabo.
FIPese saastunut vaatetus ennen uudelleenkäyttöä.
SVNedstänkta kläder ska tvättas innan de används igen.

P370Language
BGПри пожар:
ESEn caso de incendio:
CSV případě požáru:
DAVed brand:
DEBei Brand:
ETTulekahju korral:
ELΣε περίπτωση πυρκαγιάς:
ENIn case of fire:
FREn cas d’incendie:
GAI gcás dóiteáin:
ITIn caso di incendio:
LVUgunsgrēka gadījumā:
LTGaisro atveju:
HUTűz esetén:
MTF’każ ta' nar:
NLIn geval van brand:
PLW przypadku pożaru:
PTEm caso de incêndio:
ROÎn caz de incendiu:
SKV prípade požiaru:
SLOb požaru:
FITulipalon sattuessa:
SVVid brand:

P371Language
BGПри голям пожар и значителни количества:
ESEn caso de incendio importante y en grandes cantidades:
CSV případě velkého požáru a velkého množství:
DAVed større brand og store mængder:
DEBei Großbrand und großen Mengen:
ETSuure tulekahju korral ning kui on tegemist suurte kogustega:
ELΣε περίπτωση σοβαρής πυρκαγιάς και εάν πρόκειται για μεγάλες ποσότητες:
ENIn case of major fire and large quantities:
FREn cas d’incendie important et s’il s’agit de grandes quantités:
GAI gcás mórdhóiteáin agus má tá cainníochtaí móra i gceist:
ITIn caso di incendio grave e di quantità rilevanti:
LVUgunsgrēka un lielu apjomu gadījumā:
LTDidelio gaisro ir didelių kiekių atveju:
HUNagyobb tűz és nagy mennyiség esetén:
MTF’każ ta' nar kbir u kwantitajiet kbar:
NLIn geval van grote brand en grote hoeveelheden:
PLW przypadku poważnego pożaru i dużych ilości:
PTEm caso de incêndio importante e de grandes quantidades:
ROÎn caz de incendiu de proporţii şi de cantităţi mari de produs:
SKV prípade veľkého požiaru a veľkého množstva:
SLOb velikem požaru in velikih količinah:
FIJos tulipalo ja ainemäärät ovat suuret:
SVVid större brand och stora mängder:

P372Language
BGОпасност от експлозия при пожар.
ESRiesgo de explosión en caso de incendio.
CSNebezpečí výbuchu v případě požáru.
DAEksplosionsfare ved brand.
DEExplosionsgefahr bei Brand.
ETTulekahju korral plahvatusoht.
ELΚίνδυνος έκρηξης σε περίπτωση πυρκαγιάς.
ENExplosion risk in case of fire.
FRRisque d’explosion en cas d’incendie.
GABaol pléasctha i gcás dóiteáin.
ITRischio di esplosione in caso di incendio.
LVEksplozijas risks ugunsgrēka gadījumā:
LTSprogimo pavojus gaisro atveju.
HUTűz esetén robbanásveszély.
MTRiskju ta' splużjoni f’każ ta' nar.
NLOntploffingsgevaar in geval van brand.
PLRyzyko wybuchu w razie pożaru.
PTRisco de explosão em caso de incêndio.
RORisc de explozie în caz de incendiu.
SKV prípade požiaru hrozí riziko výbuchu.
SLNevarnost eksplozije ob požaru.
FITulipalon sattuessa räjähdysvaara.
SVExplosionsrisk vid brand.

P373Language
BGНЕ се опитвайте да гасите пожара, ако огънят наближи експлозиви.
ESNO luchar contra el incendio cuando el fuego llega a los explosivos.
CSPožár NEHASTE, dostane-li se k výbušninám.
DABEKÆMP IKKE branden, hvis denne når eksplosiverne.
DEKEINE Brandbekämpfung, wenn das Feuer explosive Stoffe/Gemische/Erzeugnisse erreicht.
ETKui tuli jõuab lõhkeaineteni, MITTE teha kustutustöid.
ELΜΗΝ προσπαθείτε να σβήσετε την πυρκαγιά, όταν η φωτιά πλησιάζει σε εκρηκτικά.
ENDO NOT fight fire when fire reaches explosives.
FRNE PAS combattre l’incendie lorsque le feu atteint les explosifs.
GANÁ DÉAN an dóiteán a chomhrac má shroicheann sé pléascáin.
ITNON utilizzare mezzi estinguenti se l’incendio raggiunge materiali esplosivi.
LVNECENSTIES dzēst ugunsgrēku, ja uguns piekļūst sprādzienbīstamām vielām.
LTNEGESINTI gaisro, jeigu ugnis pasiekia sprogmenis.
HUTILOS a tűz oltása, ha az robbanóanyagra átterjedt.
MTTIPPRUVAX TITFI n-nar meta n-nar jilħaq l-isplussivi.
NLNIET blussen wanneer het vuur de ontplofbare stoffen bereikt.
PLNIE gasić pożaru, jeżeli ogień dosięgnie materiały wybuchowe
PTSe o fogo atingir os explosivos, NÃO tentar combatê-lo.
RONU încercaţi să stingeţi incendiul atunci când focul a ajuns la explozivi.
SKPožiar NEHASTE, ak sa oheň priblížil k výbušninám.
SLNE gasiti, ko ogenj doseže eksploziv.
FITulta EI SAA yrittää sammuttaa sen saavutettua räjähteet.
SVFörsök INTE bekämpa branden när den når explosiva varor.

P374Language
BGГасете пожара с обичайните предпазни мерки от разумно разстояние.
ESLuchar contra el incendio desde una distancia razonable, tomando las precauciones habituales.
CSHaste z přiměřené vzdálenosti a dodržujte běžná opatření.
DATræf normale foranstaltninger mod brand og bekæmp den på en fornuftig afstand.
DEBrandbekämpfung mit üblichen Vorsichtsmaßnahmen aus angemessener Entfernung.
ETKustutustöid teha tavaliste ettevaatusabinõudega ja mõistlikust kaugusest.
ELΠροσπαθήστε να σβήσετε την πυρκαγιά λαμβάνοντας τις κατάλληλες προφυλάξεις και από εύλογη απόσταση.
ENFight fire with normal precautions from a reasonable distance.
FRCombattre l’incendie à distance en prenant les précautions normales.
GADéan na gnáth-réamhchúraimí chun an dóiteán a chomhrac gan a bheith níos gaire dó ná mar atá réasúnta.
ITUtilizzare i mezzi estinguenti con le precauzioni abituali a distanza ragionevole.
LVDzēst ugunsgrēku, ņemot vērā parastos drošības nosacījumus un no saprātīga attāluma.
LTGaisrą gesinti laikantis įprastinio atsargumo pakankamu atstumu.
HUTűzoltás megfelelő távolságból a szokásos óvintézkedések betartásával.
MTItfi n-nar bil-prekawzjonijiet normali minn distanza raġonevoli.
NLMet normale voorzorgen vanaf een redelijke afstand blussen.
PLGasić pożar z rozsądnej odległości z zachowaniem zwykłych środków ostrożności.
PTCombater o incêndio tomando as precauções normais e a partir de uma distância razoável.
ROStingeţi incendiul de la o distanţă rezonabilă, luând măsuri normale de precauţie.
SKPožiar haste z primeranej vzdialenosti pri dodržiavaní bežných bezpečnostných opatrení.
SLGasiti z običajno previdnostjo in s primerne razdalje.
FISammuta palo kohtuullisen välimatkan päästä tavanomaisin varotoimin.
SVBekämpa branden på vanligt sätt på behörigt avstånd.

P375Language
BGГасете пожара от разстояние поради опасност от експлозия.
ESLuchar contra el incendio a distancia, dado el riesgo de explosión.
CSKvůli nebezpečí výbuchu haste z dostatečné vzdálenosti.
DABekæmp branden på afstand på grund af eksplosionsfare.
DEWegen Explosionsgefahr Brand aus der Entfernung bekämpfen.
ETPlahvatusohu tõttu teha kustutustöid eemalt.
ELΠροσπαθήστε να σβήσετε την πυρκαγιά από απόσταση, επειδή υπάρχει κίνδυνος έκρηξης.
ENFight fire remotely due to the risk of explosion.
FRCombattre l’incendie à distance à cause du risque d’explosion.
GATéigh i gcianghleic leis an dóiteán mar gheall ar an mbaol pléasctha.
ITRischio di esplosione. Utilizzare i mezzi estinguenti a grande distanza.
LVDzēst ugunsgrēku no attāluma eksplozijas riska dēļ.
LTGaisrą gesinti iš toli dėl sprogimo pavojaus.
HUA tűz oltását robbanásveszély miatt távolból kell végezni.
MTItfi n-nar mill-bogħod minħabba r-riskju ta' splużjoni.
NLOp afstand blussen omwille van ontploffingsgevaar.
PLZ powodu ryzyka wybuchu gasić pożar z odległości.
PTCombater o incêndio à distância, devido ao risco de explosão.
ROStingeţi incendiul de la distanţă din cauza pericolului de explozie.
SKZ dôvodu nebezpečenstva výbuchu požiar haste z diaľky.
SLGasiti z večje razdalje zaradi nevarnosti eksplozije.
FISammuta palo etäältä räjähdysvaaran takia.
SVBekämpa branden på avstånd på grund av explosionsrisken.

P376Language
BGСпрете теча, ако е безопасно.
ESDetener la fuga, si no hay peligro en hacerlo.
CSZastavte únik, můžete-li tak učinit bez rizika.
DAStands lækagen, hvis dette er sikkert.
DEUndichtigkeit beseitigen, wenn gefahrlos möglich.
ETLeke peatada, kui seda on võimalik teha ohutult.
ELΣταματήστε τη διαρροή, εφόσον δεν υπάρχει κίνδυνος.
ENStop leak if safe to do so.
FRObturer la fuite si cela peut se faire sans danger.
GACuir stop leis an sceitheadh má tá sé sábháilte é sin a dhéanamh.
ITBloccare la perdita se non c’è pericolo.
LVApstādināt noplūdi, ja to var izdarīt drošā veidā.
LTSustabdyti nuotėkį, jeigu galima saugiai tai padaryti.
HUMeg kell szüntetni a szivárgást, ha ez biztonságosan megtehető.
MTWaqqaf it-tnixxija jekk ma jkunx hemm periklu.
NLHet lek dichten als dat veilig gedaan kan worden.
PLJeżeli jest to bezpieczne zahamować wyciek.
PTDeter a fuga se tal puder ser feito em segurança.
ROOpriţi scurgerea, dacă acest lucru se poate face în siguranţă.
SKZastavte únik, ak je to bezpečné.
SLZaustaviti puščanje, če je varno.
FISulje vuoto, jos sen voi tehdä turvallisesti.
SVStoppa läckan om det kan göras på ett säkert sätt.

P377Language
BGПожар от изтекъл газ:

Не гасете освен при възможност за безопасно отстраняване на теча.
ESFuga de gas en llamas:

No apagar, salvo si la fuga puede detenerse sin peligro.
CSPožár unikajícího plynu:

Nehaste, nelze-li únik bezpečně zastavit.
DABrand fra udsivende gas:

Sluk ikke, medmindre det er sikkert at stoppe lækagen.
DEBrand von ausströmendem Gas:

Nicht löschen, bis Undichtigkeit gefahrlos beseitigt werden kann.
ETLekkiva gaasi põlemise korral mitte kustutada, välja arvatud juhul, kui leket on võimalik ohutult peatada.
ELΔιαρροή φλεγόμενου αερίου:

Μην την σβήσετε, εκτός εάν μπορείτε να σταματήσετε τη διαρροή χωρίς κίνδυνο.
ENLeaking gas fire:

Do not extinguish, unless leak can be stopped safely.
FRFuite de gaz enflammé:

Ne pas éteindre si la fuite ne peut pas être arrêtée sans danger.
GATine gháis ag sceitheadh:

Ná múch, mura i ndán agus gur féidir stop a chur leis an sceitheadh go sábháilte.
ITIn caso d’incendio dovuto a perdita di gas, non estinguere a meno che non sia possibile bloccare la perdita senza pericolo.
LVDegšanas gāzes noplūde:

Nedzēst, ja vien noplūdi var apstādināt drošā veidā.
LTDujų nuotėkio sukeltas gaisras:

Negesinti, nebent nuotėkį būtų galima saugiai sustabdyti.
HUÉgő szivárgó gáz:

Csak akkor szabad a tüzet oltani, ha a szivárgás biztonságosan megszüntethető.
MTTnixxija ta' gass tan-nar:

Tippruvax titfiha, sakemm it-tnixxija ma tkunx tista' titwaqqaf bla periklu.
NLBrand door lekkend gas:

niet blussen, tenzij het lek veilig gedicht kan worden.
PLW przypadku płonięcia wyciekającego gazu:

Nie gasić, jeżeli nie można bezpiecznie zahamować wycieku.
PTIncêndio por fuga de gás: não apagar, a menos que se possa deter a fuga em segurança.
ROIncendiu cauzat de o scurgere de gaz: nu încercaţi să stingeţi, decât dacă scurgerea poate fi oprită în siguranţă.
SKPožiar unikajúceho plynu: Nehaste, pokiaľ únik nemožno bezpečne zastaviť.
SLPožar zaradi uhajanja plina:

Ne gasiti, če puščanja ni mogoče varno zaustaviti.
FIVuotavasta kaasusta johtuva palo:

Ei saa sammuttaa, jollei vuotoa voida pysäyttää turvallisesti.
SVLäckande gas som brinner:

Försök inte släcka branden om inte läckan kan stoppas på ett säkert sätt.

P378Language
BGИзползвайте … за гасене.
ESUtilizar … para apagarlo.
CSK hašení použijte …
DAAnvend … til brandslukning.
DE… zum Löschen verwenden.
ETKustutamiseks kasutada …
ELΧρησιμοποιήστε … για την κατάσβεση.
ENUse … for extinction.
FRUtiliser … pour l’extinction.
GAÚsáid … le haghaidh múchta.
ITEstinguere con…
LVNodzēšanai izmantot…
LTGesinimui naudoti …
HUAz oltáshoz … használandó.
MTUża’ … biex titfi.
NLBlussen met …
PLUżyć … do gaszenia.
PTPara a extinção utilizar …
ROUtilizați… pentru stingere.
SKNa hasenie použite …
SLZa gašenje uporabiti …
FIKäytä palon sammuttamiseen …
SVSläck branden med …

P380Language
BGЕвакуирайте зоната.
ESEvacuar la zona.
CSVykliďte _roctor.
DAEvakuer området.
DEUmgebung räumen.
ETAla evakueerida.
ELΕκκενώστε την περιοχή.
ENEvacuate area.
FRÉvacuer la zone.
GAAslonnaigh gach duine as an limistéar.
ITEvacuare la zona.
LVEvakuēt zonu.
LTEvakuoti zoną.
HUA területet ki kell üríteni.
MTEvakwa ż-żona.
NLEvacueren.
PLEwakuować teren.
PTEvacuar a zona.
ROEvacuaţi zona.
SKPriestory evakuujte.
SLIzprazniti območje.
FIEvakuoi alue.
SVUtrym området.

P381Language
BGПремахнете всички източници на запалване, ако е безопасно.
ESEliminar todas las fuentes de ignición si no hay peligro en hacerlo.
CSOdstraňte všechny zdroje zapálení, můžete-li tak učinit bez rizika.
DAFjern alle antændelseskilder, hvis dette kan gøres sikkert.
DEAlle Zündquellen entfernen, wenn gefahrlos möglich.
ETEemaldada kõik süüteallikad, kui seda on võimalik teha ohutult.
ELΑπομακρύνετε τις πηγές ανάφλεξης, εάν αυτό μπορεί να γίνει χωρίς κίνδυνο.
ENEliminate all ignition sources if safe to do so.
FRÉliminer toutes les sources d’ignition si cela est faisable sans danger.
GADíothaigh gach foinse adhainte, má tá sé sábháilte é sin a dhéanamh.
ITEliminare ogni fonte di accensione se non c’è pericolo.
LVNovērst visus uzliesmošanas avotus, ja to var izdarīt droši.
LTPašalinti visus uždegimo šaltinius, jeigu galima saugiai tai padaryti.
HUMeg kell szüntetni az összes gyújtóforrást, ha ez biztonságosan megtehető.
MTElimina s-sorsi kollha li jqabbdu sakemm ma jkunx perikoluż li tagħmel dan.
NLAlle ontstekingsbronnen wegnemen als dat veilig gedaan kan worden.
PLWyeliminować wszystkie źródła zapłonu, jeżeli jest to bezpieczne.
PTEliminar todas as fontes de ignição se tal puder ser feito em segurança.
ROEliminaţi toate sursele de aprindere, dacă acest lucru se poate face în siguranţă.
SKAk je to bezpečné, odstráňte všetky zdroje zapálenia.
SLOdstraniti vse vire vžiga, če je varno.
FIPoista kaikki sytytyslähteet, jos sen voi tehdä turvallisesti.
SVAvlägsna alla antändningskällor om det kan göras på ett säkert sätt.

P390Language
BGПопийте разлятото, за да се предотвратят материални вреди.
ESAbsorber el vertido para que no dañe otros materiales.
CSUniklý produkt absorbujte, aby se zabránilo materiálním škodám.
DAAbsorber udslip for at undgå materielskade.
DEVerschüttete Mengen aufnehmen, um Materialschäden zu vermeiden.
ETMahavoolanud toode absorbeerida, et see ei kahjustaks teisi materjale.
ELΣκουπίστε τη χυμένη ποσότητα για να προλάβετε υλικές ζημιές.
ENAbsorb spillage to prevent material damage.
FRAbsorber toute substance répandue pour éviter qu’elle attaque les matériaux environnants.
GAIonsúigh doirteadh chun damáiste d’ábhar a chosc.
ITAssorbire la fuoriuscita per evitare danni materiali.
LVUzsūkt izšļakstījumus, lai novērstu materiālus zaudējumus.
LTAbsorbuoti išsiliejusią medžiagą, siekiant išvengti materialinės žalos.
HUA kiömlött anyagot fel kell itatni a körülvevő anyagok károsodásának megelőzése érdekében.
MTAssorbi t-tixrid biex tipprevjeni ħsara fil-materjal.
NLGelekte/gemorste stof opnemen om materiële schade te vermijden.
PLUsunąć wyciek, aby zapobiec szkodom materialnym.
PTAbsorver o produto derramado a fim de evitar danos materiais.
ROAbsorbiţi scurgerile de produs, pentru a nu afecta materialele din apropiere.
SKAbsorbujte uniknutý produkt, aby sa zabránilo materiálnym škodám.
SLOdpraviti razlitje, da se prepreči materialna škoda.
FIImeytä valumat vahinkojen estämiseksi.
SVSug upp spill för att undvika materiella skador.

P391Language
BGСъберете разлятото.
ESRecoger el vertido.
CSUniklý produkt seberte.
DAUdslip opsamles.
DEVerschüttete Mengen aufnehmen.
ETMahavoolanud toode kokku koguda.
ELΜαζέψτε τη χυμένη ποσότητα.
ENCollect spillage.
FRRecueillir le produit répandu.
GABailigh doirteadh.
ITRaccogliere il materiale fuoriuscito.
LVSavākt izšļakstīto šķidrumu.
LTSurinkti ištekėjusią medžiagą.
HUA kiömlött anyagot össze kell gyűjteni.
MTIġbor it-tixrid.
NLGelekte/gemorste stof opruimen.
PLZebrać wyciek.
PTRecolher o produto derramado.
ROColectaţi scurgerile de produs.
SKZozbierajte uniknutý produkt.
SLPrestreči razlito tekočino.
FIValumat on kerättävä.
SVSamla upp spill.

P301 + P310Language
BGПРИ ПОГЛЪЩАНЕ: Незабавно се обадете в ЦЕНТЪР ПО ТОКСИКОЛОГИЯ или на лекар.
ESEN CASO DE INGESTIÓN: Llamar inmediatamente a un CENTRO DE INFORMACIÓN TOXICOLÓGICA o a un médico.
CSPŘI POŽITÍ: Okamžitě volejte TOXIKOLOGICKÉ INFORMAČNÍ STŘEDISKO nebo lékaře.
DAI TILFÆLDE AF INDTAGELSE: Ring omgående til en GIFTINFORMATION eller en læge.
DEBEI VERSCHLUCKEN: Sofort GIFTINFORMATIONSZENTRUM oder Arzt anrufen.
ETALLANEELAMISE KORRAL: võtta viivitamata ühendust MÜRGISTUSTEABEKESKUSE või arstiga.
ELΣΕ ΠΕΡΙΠΤΩΣΗ ΚΑΤΑΠΟΣΗΣ: Καλέστε αμέσως το ΚΕΝΤΡΟ ΔΗΛΗΤΗΡΙΑΣΕΩΝ ή ένα γιατρό.
ENIF SWALLOWED: Immediately call a POISON CENTER or doctor/physician.
FREN CAS D’INGESTION: appeler immédiatement un CENTRE ANTIPOISON ou un médecin.
GAMÁ SHLOGTAR: Cuir glao láithreach ar IONAD NIMHE nó ar dhoctúir/lia.
ITIN CASO DI INGESTIONE: contattare immediatamente un CENTRO ANTIVELENI o un medico
LVNORĪŠANAS GADĪJUMĀ: Nekavējoties sazināties ar SAINDĒŠANĀS CENTRU vai ārstu.
LTPRARIJUS: Nedelsiant skambinti į APSINUODIJIMŲ KONTROLĖS IR INFORMACIJOS BIURĄ arba kreiptis į gydytoją.
HULENYELÉS ESETÉN: azonnal forduljon TOXIKOLÓGIAI KÖZPONTHOZ vagy orvoshoz.
MTJEKK JINBELA’: Ikkuntattja ĊENTRU TA' L-AVVELENAMENT jew tabib.
NLNA INSLIKKEN: onmiddellijk een ANTIGIFCENTRUM of een arts raadplegen.
PLW PRZYPADKU POŁKNIĘCIA: Natychmiast skontaktować się z OŚRODKIEM ZATRUĆ lub z lekarzem.
PTEM CASO DE INGESTÃO: contacte imediatamente um CENTRO DE INFORMAÇÃO ANTIVENENOS ou um médico.
ROÎN CAZ DE ÎNGHIŢIRE: sunaţi imediat la un CENTRU DE INFORMARE TOXICOLOGICĂ sau un medic.
SKPO POŽITÍ: okamžite volajte NÁRODNÉ TOXIKOLOGICKÉ INFORMAČNÉ CENTRUM alebo lekára.
SLPRI ZAUŽITJU: takoj pokličite CENTER ZA ZASTRUPITVE ali zdravnika.
FIJOS KEMIKAALIA ON NIELTY: Ota välittömästi yhteys MYRKYTYSTIETOKESKUKSEEN tai lääkäriin.
SVVID FÖRTÄRING: Kontakta genast GIFTINFORMATIONSCENTRAL eller läkare.

P301 + P312Language
BGПРИ ПОГЛЪЩАНЕ: Незабавно се обадете в ЦЕНТЪР ПО ТОСКИКОЛОГИЯ или на лекар при неразположение.
ESEN CASO DE INGESTIÓN: Llamar a un CENTRO DE INFORMACIÓN TOXICOLÓGICA o a un médico si se encuentra mal.
CSPŘI POŽITÍ: Necítíte-li s dobře, volejte TOXIKOLOGICKÉ INFORMAČNÍ STŘEDISKO nebo lékaře.
DAI TILFÆLDE AF INDTAGELSE: I tilfælde af ubehag ring til en GIFTINFORMATION eller en læge.
DEBEI VERSCHLUCKEN: Bei Unwohlsein GIFTINFORMATIONSZENTRUM oder Arzt anrufen.
ETALLANEELAMISE KORRAL: halva enesetunde korral võtta ühendust MÜRGISTUSTEABEKESKUSE või arstiga.
ELΣΕ ΠΕΡΙΠΤΩΣΗ ΚΑΤΑΠΟΣΗΣ: Καλέστε αμέσως το ΚΕΝΤΡΟ ΔΗΛΗΤΗΡΙΑΣΕΩΝ ή ένα γιατρό, εάν αισθανθείτε αδιαθεσία.
ENIF SWALLOWED: Call a POISON CENTER or doctor/physician if you feel unwell.
FREN CAS D’INGESTION: appeler un CENTRE ANTIPOISON ou un médecin en cas de malaise.
GAMÁ SHLOGTAR: Cuir glao ar IONAD NIMHE nó ar dhoctúir/lia má bhraitheann tú tinn.
ITIN CASO DI INGESTIONE accompagnata da malessere: contattare un CENTRO ANTIVELENI o un medico.
LVNORĪŠANAS GADĪJUMĀ: sazināties ar SAINDĒŠANĀS CENTRU vai ārstu, ja jums ir slikta pašsajūta.
LTPRARIJUS: Pasijutus blogai, skambinti į APSINUODIJIMŲ KONTROLĖS IR INFORMACIJOS BIURĄ arba kreiptis į gydytoją.
HULENYELÉS ESETÉN: rosszullét esetén azonnal forduljon TOXIKOLÓGIAI KÖZPONTHOZ vagy orvoshoz.
MTJEKK JINBELA’: Ikkuntattja ĊENTRU TA' L-AVVELENAMENT jew tabib jekk tħossok ma tiflaħx.
NLNA INSLIKKEN: bij onwel voelen een ANTIGIFCENTRUM of een arts raadplegen.
PLW PRZYPADKU POŁKNIĘCIA: W przypadku złego samopoczucia skontaktować się z OŚRODKIEM ZATRUĆ lub z lekarzem.
PTEM CASO DE INGESTÃO: caso sinta indisposição, contacte um CENTRO DE INFORMAÇÃO ANTIVENENOS ou um médico.
ROÎN CAZ DE ÎNGHIŢIRE: sunaţi la un CENTRU DE INFORMARE TOXICOLOGICĂ sau un medic, dacă nu vă simţiţi bine.
SKPO POŽITÍ: ak máte zdravotné problémy, okamžite volajte NÁRODNÉ TOXIKOLOGICKÉ INFORMAČNÉ CENTRUM alebo lekára.
SLPRI ZAUŽITJU: ob slabem počutju pokličite CENTER ZA ZASTRUPITVE ali zdravnika.
FIJOS KEMIKAALIA ON NIELTY: Ota yhteys MYRKYTYSTIETOKESKUKSEEN tai lääkäriin, jos ilmenee pahoinvointia.
SVVID FÖRTÄRING: Kontakta GIFTINFORMATIONSCENTRAL eller läkare om du mår dåligt.

P301 + P330 + P331Language
BGПРИ ПОГЛЪЩАНЕ: изплакнете устата. НЕ предизвиквайте повръщане.
ESEN CASO DE INGESTIÓN: Enjuagarse la boca. NO provocar el vómito.
CSPŘI POŽITÍ: Vypláchněte ústa. NEVYVOLÁVEJTE zvracení.
DAI TILFÆLDE AF INDTAGELSE: Skyl munden. Fremkald IKKE opkastning.
DEBEI VERSCHLUCKEN: Mund ausspülen. KEIN Erbrechen herbeiführen.
ETALLANEELAMISE KORRAL: loputada suud. MITTE kutsuda esile oksendamist.
ELΣΕ ΠΕΡΙΠΤΩΣΗ ΚΑΤΑΠΟΣΗΣ: Ξεπλύνετε το στόμα. ΜΗΝ προκαλέσετε εμετό.
ENIF SWALLOWED: rinse mouth. Do NOT induce vomiting.
FREN CAS D’INGESTION: rincer la bouche. NE PAS faire vomir.
GAMÁ SHLOGTAR: sruthlaítear an béal. NÁ déan urlacan a spreagadh.
ITIN CASO DI INGESTIONE: sciacquare la bocca. NON provocare il vomito.
LVNORĪŠANAS GADĪJUMĀ: izskalot muti. NEIZRAISĪT vemšanu.
LTPRARIJUS: išskalauti burną. NESKATINTI vėmimo.
HULENYELÉS ESETÉN: a szájat ki kell öblíteni. TILOS hánytatni.
MTJEKK JINBELA’: laħlaħ il-ħalq. TIPPROVOKAX ir-remettar.
NLNA INSLIKKEN: de mond spoelen — GEEN braken opwekken.
PLW PRZYPADKU POŁKNIĘCIA: wypłukać usta. NIE wywoływać wymiotów.
PTEM CASO DE INGESTÃO: enxaguar a boca. NÃO provocar o vómito.
ROÎN CAZ DE ÎNGHIŢIRE: clătiţi gura. NU provocaţi voma.
SKPO POŽITÍ: vypláchnite ústa. Nevyvolávajte zvracanie.
SLPRI ZAUŽITJU: izprati usta. NE izzvati bruhanja.
FIJOS KEMIKAALIA ON NIELTY: Huuhdo suu. EI saa oksennuttaa.
SVVID FÖRTÄRING: Skölj munnen. Framkalla INTE kräkning.

P302 + P334Language
BGПРИ КОНТАКТ С КОЖАТА: Потопете в студена вода/сложете мокри компреси.
ESEN CASO DE CONTACTO CON LA PIEL: Sumergir en agua fresca/aplicar compresas húmedas.
CSPŘI STYKU S KŮŽÍ: Ponořte do studené vody/zabalte do vlhkého obvazu.
DAVED KONTAKT MED HUDEN: Skyl under koldt vand/anvend våde omslag.
DEBEI KONTAKT MIT DER HAUT: In kaltes Wasser tauchen/nassen Verband anlegen.
ETNAHALE SATTUMISE KORRAL: hoida jahedas vees/panna peale niiske kompress.
ELΣΕ ΠΕΡΙΠΤΩΣΗ ΕΠΑΦΗΣ ΜΕ ΤΟ ΔΕΡΜΑ: Πλύντε με άφθονο δροσερό νερό/τυλίξτε με βρεγμένους επιδέσμους.
ENIF ON SKIN: Immerse in cool water/wrap in wet bandages.
FREN CAS DE CONTACT AVEC LA PEAU: rincer à l’eau fraîche/poser une compresse humide.
GAI gCÁS TEAGMHÁLA LEIS AN gCRAICEANN: Tum in uisce fionnuar/cuir bréid fliuch air.
ITIN CASO DI CONTATTO CON LA PELLE: immergere in acqua fredda/avvolgere con un bendaggio umido.
LVSASKARĒ AR ĀDU: iegremdēt vēsā ūdenī/ietīt mitros apsējos.
LTPATEKUS ANT ODOS: Įmerkti į vėsų vandenį/apvynioti šlapiais tvarsčiais.
HUHA BŐRRE KERÜL: Hideg vízzel/nedves kötéssel kell hűteni.
MTJEKK FUQ IL-ĠILDA: Daħħal fl-ilma frisk/kebbeb f’faxex imxarrbin.
NLBIJ CONTACT MET DE HUID: in koud water onderdompelen/nat verband aanbrengen.
PLW PRZYPADKU KONTAKTU ZE SKÓRĄ: Zanurzyć w zimnej wodzie/owinąć mokrym bandażem.
PTSE ENTRAR EM CONTACTO COM A PELE: mergulhar em água fria/aplicar compressas húmidas.
ROÎN CAZ DE CONTACT CU PIELEA: introduceţi în apă rece/acoperiţi cu o compresă umedă.
SKPRI KONTAKTE S POKOŽKOU: Ponorte do studenej vody/obviažte mokrými obväzmi.
SLPRI STIKU S KOŽO: potopiti v hladno vodo/zaviti v mokre povoje.
FIJOS KEMIKAALIA JOUTUU IHOLLE: Upota kylmään veteen/kääri märkiin siteisiin.
SVVID HUDKONTAKT: Skölj under kallt vatten/använd våta omslag.

P302 + P350Language
BGПРИ КОНТАКТ С КОЖАТА: Измийте внимателно и обилно със сапун и вода.
ESEN CASO DE CONTACTO CON LA PIEL: Lavar suavemente con agua y jabón abundantes.
CSPŘI STYKU S KŮŽÍ: Jemně omyjte velkým množstvím vody a mýdla.
DAVED KONTAKT MED HUDEN: Vask forsigtigt med rigeligt sæbe og vand.
DEBEI KONTAKT MIT DER HAUT: Behutsam mit viel Wasser und Seife waschen.
ETNAHALE SATTUMISE KORRAL: pesta õrnalt rohke vee ja seebiga.
ELΣΕ ΠΕΡΙΠΤΩΣΗ ΕΠΑΦΗΣ ΜΕ ΤΟ ΔΕΡΜΑ: Πλύντε απαλά με άφθονο νερό και σαπούνι.
ENIF ON SKIN: Gently wash with plenty of soap and water.
FREN CAS DE CONTACT AVEC LA PEAU: laver avec précaution et abondamment à l’eau et au savon.
GAI gCÁS TEAGMHÁLA LEIS AN gCRAICEANN: Nigh go bog le neart gallúnaí agus uisce.
ITIN CASO DI CONTATTO CON LA PELLE: lavare delicatamente e abbondantemente con acqua e sapone.
LVSASKARĒ AR ĀDU: maigi nomazgāt ar lielu ziepju un ūdens daudzumu.
LTPATEKUS ANT ODOS: Atsargiai nuplauti dideliu kiekiu muilo ir vandens.
HUHA BŐRRE KERÜL: Óvatos lemosás bő szappanos vízzel.
MTJEKK FUQ IL-ĠILDA: Aħsel bil-mod b’ħafna sapun u ilma.
NLBIJ CONTACT MET DE HUID: voorzichtig wassen met veel water en zeep.
PLW PRZYPADKU DOSTANIA SIĘ NA SKÓRĘ: Delikatnie umyć dużą iloścą wody z mydłem.
PTSE ENTRAR EM CONTACTO COM A PELE: lavar suavemente com sabonete e água abundantes.
ROÎN CAZ DE CONTACT CU PIELEA: spălaţi uşor cu multă apă şi săpun.
SKPRI KONTAKTE S POKOŽKOU: Opatrne umyte veľkým množstvom vody a mydla.
SLPRI STIKU S KOŽO: nežno umiti z veliko mila in vode.
FIJOS KEMIKAALIA JOUTUU IHOLLE: Pese varovasti runsaalla vedellä ja saippualla.
SVVID HUDKONTAKT: Tvätta försiktigt med mycket tvål och vatten.

P302 + P352Language
BGПРИ КОНТАКТ С КОЖАТА: Измийте обилно със сапун и вода.
ESEN CASO DE CONTACTO CON LA PIEL: Lavar con agua y jabón abundantes.
CSPŘI STYKU S KŮŽÍ: Omyjte velkým množstvím vody a mýdla.
DAVED KONTAKT MED HUDEN: Vask med rigeligt sæbe og vand.
DEBEI KONTAKT MIT DER HAUT: Mit viel Wasser und Seife waschen.
ETNAHALE SATTUMISE KORRAL: pesta rohke vee ja seebiga.
ELΣΕ ΠΕΡΙΠΤΩΣΗ ΕΠΑΦΗΣ ΜΕ ΤΟ ΔΕΡΜΑ: Πλύνετε με άφθονο νερό και σαπούνι.
ENIF ON SKIN: Wash with plenty of soap and water.
FREN CAS DE CONTACT AVEC LA PEAU: laver abondamment à l’eau et au savon.
GAI gCÁS TEAGMHÁLA LEIS AN gCRAICEANN: Nigh le neart gallúnaí agus uisce.
ITIN CASO DI CONTATTO CON LA PELLE: lavare abbondantemente con acqua e sapone.
LVSASKARĒ AR ĀDU: nomazgāt ar lielu ziepju un ūdens daudzumu.
LTPATEKUS ANT ODOS: Nuplauti dideliu kiekiu muilo ir vandens.
HUHA BŐRRE KERÜL: Lemosás bő szappanos vízzel.
MTJEKK FUQ IL-ĠILDA: Aħsel b’ħafna sapun u ilma.
NLBIJ CONTACT MET DE HUID: met veel water en zeep wassen.
PLW PRZYPADKU KONTAKTU ZE SKÓRĄ: Umyć dużą ilością wody z mydłem.
PTSE ENTRAR EM CONTACTO COM A PELE: lavar com sabonete e água abundantes.
ROÎN CAZ DE CONTACT CU PIELEA: spălaţi cu multă apă şi săpun.
SKPRI KONTAKTE S POKOŽKOU: Umyte veľkým množstvom vody a mydla.
SLPRI STIKU S KOŽO: umiti z veliko mila in vode.
FIJOS KEMIKAALIA JOUTUU IHOLLE: Pese runsaalla vedellä ja saippualla.
SVVID HUDKONTAKT: Tvätta med mycket tvål och vatten.

P303 + P361 + P353Language
BGПРИ КОНТАКТ С КОЖАТА (или косата): Незабавно свалете цялото замърсено облекло. Облейте кожата с вода/вземете душ
ESEN CASO DE CONTACTO CON LA PIEL (o el pelo): Quitarse inmediatamente las prendas contaminadas. Aclararse la piel con agua o ducharse.
CSPŘI STYKU S KŮŽÍ (nebo s vlasy): Veškeré kontaminované části oděvu okamžitě svlékněte. Opláchněte kůži vodou/osprchujte.
DAVED KONTAKT MED HUDEN (eller håret): Tilsmudset tøj tages straks af/fjernes. Skyl/brus huden med vand.
DEBEI KONTAKT MIT DER HAUT (oder dem Haar): Alle beschmutzten, getränkten Kleidungsstücke sofort ausziehen. Haut mit Wasser abwaschen/duschen.
ETNAHALE (või juustele) SATTUMISE KORRAL: võtta viivitamata kõik saastunud rõivad seljast. Loputada nahka veega/loputada duši all.
ELΣΕ ΠΕΡΙΠΤΩΣΗ ΕΠΑΦΗΣ ΜΕ ΤΟ ΔΕΡΜΑ (ή με τα μαλλιά): Αφαιρέστε αμέσως όλα τα μολυσμένα ενδύματα. Ξεπλύνετε το δέρμα με νερό/στο ντους.
ENIF ON SKIN (or hair): Remove/Take off immediately all contaminated clothing. Rinse skin with water/shower.
FREN CAS DE CONTACT AVEC LA PEAU (ou les cheveux): enlever immédiatement les vêtements contaminés. Rincer la peau à l’eau/se doucher.
GAI gCÁS TEAGMHÁLA LEIS AN gCRAICEANN(nó le gruaig): Bain díot láithreach na héadaí éillithe go léir. Sruthlaítear an craiceann le huisce/glac cithfholcadh.
ITIN CASO DI CONTATTO CON LA PELLE (o con i capelli): togliersi di dosso immediatamente tutti gli indumenti contaminati. Sciacquare la pelle/fare una doccia.
LVSASKARĒ AR ĀDU (vai matiem): noģērbt visu piesārņoto apģērbu. Noskalot ādu ar ūdeni/dušā.
LTPATEKUS ANT ODOS (arba plaukų): Nedelsiant nuvilkti/pašalinti visus užterštus drabužius. Odą nuplauti vandeniu/čiurkšle.
HUHA BŐRRE (vagy hajra) KERÜL: Az összes szennyezett ruhadarabot azonnal el kell távolítani/le kell vetni. A bőrt le kell öblíteni vízzel/zuhanyozás.
MTJEKK FUQ IL-ĠILDA (jew xagħar): Neħħi/inża’ minnufih l-ilbies kontaminat. Laħlaħ il-ġilda bl-ilma/bix-xawer.
NLBIJ CONTACT MET DE HUID (of het haar): verontreinigde kleding onmiddellijk uittrekken — huid met water afspoelen/afdouchen.
PLW PRZYPADKU KONTATKU ZE SKÓRĄ (lub z włosami): Natychmiast usunąć/zdjąć całą zanieczyszczoną odzież. Spłukać skórę pod strumieniem wody/prysznicem.
PTSE ENTRAR EM CONTACTO COM A PELE (ou o cabelo): despir/retirar imediatamente toda a roupa contaminada. Enxaguar a pele com água/tomar um duche.
ROÎN CAZ DE CONTACT CU PIELEA (sau părul): scoateţi imediat toată îmbrăcămintea contaminată. Clătiţi pielea cu apă/faceţi duş.
SKPRI KONTAKTE S POKOŽKOU (alebo vlasmi): Odstráňte/vyzlečte všetky kontaminované časti odevu. Pokožku ihneď opláchnite vodou/sprchou.
SLPRI STIKU S KOŽO (ali lasmi): takoj odstraniti/sleči vsa kontaminirana oblačila. Izprati kožo z vodo/prho.
FIJOS KEMIKAALIA JOUTUU IHOLLE (tai hiuksiin): Riisu saastunut vaatetus välittömästi. Huuhdo/suihkuta iho vedellä.
SVVID HUDKONTAKT (även håret): Ta omedelbart av alla nedstänkta kläder. Skölj huden med vatten/duscha.

P304 + P340Language
BGПРИ ВДИШВАНЕ: Изведете пострадалия на чист въздух и го поставете в позиция, улесняваща дишането.
ESEN CASO DE INHALACIÓN: Transportar a la víctima al exterior y mantenerla en reposo en una posición confortable para respirar.
CSPŘI VDECHNUTÍ: Přeneste postiženého na čerstvý vzduch a ponechte jej v klidu v poloze usnadňující dýchání.
DAVED INDÅNDING: Flyt personen til et sted med frisk luft og sørg for, at vedkommende hviler i en stilling, som letter vejrtrækningen.
DEBEI EINATMEN: An die frische Luft bringen und in einer Position ruhigstellen, die das Atmen erleichtert.
ETSISSEHINGAMISE KORRAL: toimetada kannatanu värske õhu kätte ja asetada mugavasse puhkeasendisse, mis võimaldab kergesti hingata.
ELΣΕ ΠΕΡΙΠΤΩΣΗ ΕΙΣΠΝΟΗΣ: Μεταφέρετε τον παθόντα στον καθαρό αέρα και αφήστε τον να ξεκουραστεί σε στάση που διευκολύνει την αναπνοή.
ENIF INHALED: Remove victim to fresh air and keep at rest in a position comfortable for breathing.
FREN CAS D’INHALATION: transporter la victime à l’extérieur et la maintenir au repos dans une position où elle peut confortablement respirer.
GAMÁ IONÁLAÍTEAR, tabhair amach faoin aer an duine agus coimeád socair é, i riocht ina bhféadfaidh sé anáil a tharraingt go réidh.
ITIN CASO DI INALAZIONE: trasportare l'infortunato all’aria aperta e mantenerlo a riposo in posizione che favorisca la respirazione.
LVIEELPOŠANAS GADĪJUMĀ: izvest cietušo svaigā gaisā un turēt miera stāvoklī, lai būtu ērti elpot.
LTĮKVĖPUS: Išnešti nukentėjusįjį į gryną orą; jam būtina ramybė ir padėtis, leidžianti laisvai kvėpuoti.
HUBELÉLEGZÉS ESETÉN: Az érintett személyt friss levegőre kell vinni és olyan nyugalmi testhelyzetbe kell helyezni, hogy könnyen tudjon lélegezni.
MTJEKK JITTIEĦED FIN-NIFS: Esponi lill-vittma għall-arja friska u żommha mistrieħa f’pożizzjoni komda biex tkun tista’ tieħu n-nifs.
NLNA INADEMING: het slachtoffer in de frisse lucht brengen en laten rusten in een houding die het ademen vergemakkelijkt.
PLW PRZYPADKU DOSTANIA SIĘ DO DRÓG ODDECHOWYCH: wyprowadzić lub wynieść poszkodowanego na świeże powietrze i zapewnić warunki do odpoczynku w pozycji umożliwiającej swobodne oddychanie.
PTEM CASO DE INALAÇÃO: retirar a vítima para uma zona ao ar livre e mantê-la em repouso numa posição que não dificulte a respiração.
ROÎN CAZ DE INHALARE: transportaţi victima la aer liber şi menţineţi-o în stare de repaus, într-o poziţie confortabilă pentru respiraţie.
SKPO VDÝCHNUTÍ: Presuňte postihnutého na čerstvý vzduch a nechajte ho oddychovať v polohe, ktorá mu umožní pohodlné dýchanie.
SLPRI VDIHAVANJU: prenesti žrtev na svež zrak in jo pustiti počivati v položaju, ki olajša dihanje.
FIJOS KEMIKAALIA ON HENGITETTY: Siirrä henkilö raittiiseen ilmaan ja pidä lepoasennossa, jossa on helppo hengittää.
SVVID INANDNING: Flytta personen till frisk luft och se till att han eller hon vilar i en ställning som underlättar andningen.

P304 + P341Language
BGПРИ ВДИШВАНЕ: При затруднено дишане изведете пострадалия на чист въздух и го поставете в позиция, улесняваща дишането.
ESEN CASO DE INHALACIÓN: Si respira con dificultad, transportar a la víctima al exterior y mantenerla en reposo en una posición confortable para respirar.
CSPŘI VDECHNUTÍ: Při obtížném dýchání přeneste postiženého na čerstvý vzduch a ponechte jej v klidu v poloze usnadňující dýchání.
DAVED INDÅNDING: Ved vejrtrækningsbesvær: Flyt personen til et sted med frisk luft og sørg for, at vedkommende hviler i en stilling, som letter vejrtrækningen.
DEBEI EINATMEN: Bei Atembeschwerden an die frische Luft bringen und in einer Position ruhigstellen, die das Atmen erleichtert.
ETSISSEHINGAMISE KORRAL: hingamisraskuste korral toimetada kannatanu värske õhu kätte ja asetada mugavasse puhkeasendisse, mis võimaldab kergesti hingata.
ELΣΕ ΠΕΡΙΠΤΩΣΗ ΕΙΣΠΝΟΗΣ: Εάν ο παθών έχει δύσπνοια, μεταφέρετέ τον στον καθαρό αέρα και αφήστε τον να ξεκουραστεί σε στάση που διευκολύνει την αναπνοή.
ENIF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing.
FREN CAS D’INHALATION: s'il y a difficulté à respirer, transporter la victime à l'extérieur et la maintenir au repos dans une position où elle peut confortablement respirer.
GAMÁ THÉANN AN TÁIRGE SEO LE hANÁIL DUINE, tabhair amach faoin aer an duine agus coimeád socair é, i riocht ina bhféadfaidh sé anáil a tharraingt go réidh.
ITIN CASO DI INALAZIONE: se la respirazione è difficile, trasportare l'infortunato all’aria aperta e mantenerlo a riposo in posizione che favorisca la respirazione.
LVIEELPOŠANAS GADĪJUMĀ: ja elpošana ir apgrūtināta, izvest cietušo svaigā gaisā un turēt miera stāvoklī, lai būtu ērti elpot.
LTĮKVĖPUS: Jeigu nukentėjusiajam sunku kvėpuoti, išnešti jį į gryną orą; jam būtina ramybė ir padėtis, leidžianti laisvai kvėpuoti.
HUBELÉLEGZÉS ESETÉN: Légzési nehézségek esetén az érintett személyt friss levegőre kell vinni és olyan nyugalmi testhelyzetbe kell helyezni, hogy könnyen tudjon lélegezni.
MTJEKK JITTIEĦED FIN-NIFS: Jekk in-nifs ikun diffiċli, esponi lill-vittma għall-arja friska u żommha mistrieħa f’pożizzjoni komda biex tkun tista’ tieħu n-nifs.
NLNA INADEMING: bij ademhalingsmoeilijkheden het slachtoffer in de frisse lucht brengen en laten rusten in een houding die het ademen vergemakkelijkt.
PLW PRZYPADKU DOSTANIA SIĘ DO DRÓG ODDECHOWYCH: W przypadku trudności z oddychaniem, wyprowadzić lub wynieść poszkodowanego na świeże powietrze i zapewnić warunki do odpoczynku w pozycji umożliwiającej swobodne oddychanie.
PTEM CASO DE INALAÇÃO: em caso de dificuldade respiratória, retirar a vítima para uma zona ao ar livre e mantê-la em repouso numa posição que não dificulte a respiração.
ROÎN CAZ DE INHALARE: dacă respiraţia este dificilă, transportaţi victima la aer liber şi menţineţi-o în stare de repaus, într-o poziţie confortabilă pentru respiraţie.
SKPO VDÝCHNUTÍ: Ak nastanú ťažkosti s dýchaním, presuňte postihnutého na čerstvý vzduch a nechajte ho oddychovať v polohe, ktorá mu umožní pohodlné dýchanie.
SLPRI VDIHAVANJU: prenesti žrtev pri oteženem dihanju na svež zrak in jo pustiti počivati v položaju, ki olajša dihanje.
FIJOS KEMIKAALIA ON HENGITETTY: Jos hengitysvaikeuksia, siirrä henkilö raittiiseen ilmaan ja pidä lepoasennossa, jossa on helppo hengittää.
SVVID INANDNING: Vid andningsbesvär, flytta personen till frisk luft och se till att han eller hon vilar i en ställning som underlättar andningen.

P305 + P351 + P338Language
BGПРИ КОНТАКТ С ОЧИТЕ: Промивайте внимателно с вода в продължение на няколко минути. Свалете контактните лещи, ако има такива и доколкото това е възможно. Продължавайте да промивате.
ESEN CASO DE CONTACTO CON LOS OJOS: Aclarar cuidadosamente con agua durante varios minutos. Quitar las lentes de contacto, si lleva y resulta fácil. Seguir aclarando.
CSPŘI ZASAŽENÍ OČÍ: Několik minut opatrně vyplachujte vodou. Vyjměte kontaktní čočky, jsou-li nasazeny a pokud je lze vyjmout snadno. Pokračujte ve vyplachování.
DAVED KONTAKT MED ØJNENE: Skyl forsigtigt med vand i flere minutter. Fjern eventuelle kontaktlinser, hvis dette kan gøres let. Fortsæt skylning.
DEBEI KONTAKT MIT DEN AUGEN: Einige Minuten lang behutsam mit Wasser spülen. Vorhandene Kontaktlinsen nach Möglichkeit entfernen. Weiter spülen.
ETSILMA SATTUMISE KORRAL: loputada mitme minuti jooksul ettevaatlikult veega. Eemaldada kontaktläätsed, kui neid kasutatakse ja kui neid on kerge eemaldada. Loputada veel kord.
ELΣΕ ΠΕΡΙΠΤΩΣΗ ΕΠΑΦΗΣ ΜΕ ΤΑ ΜΑΤΙΑ: Ξεπλύνετε προσεκτικά με νερό για αρκετά λεπτά. Εάν υπάρχουν φακοί επαφής, αφαιρέστε τους, εφόσον είναι εύκολο. Συνεχίστε να ξεπλένετε.
ENIF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.
FREN CAS DE CONTACT AVEC LES YEUX: rincer avec précaution à l’eau pendant plusieurs minutes. Enlever les lentilles de contact si la victime en porte et si elles peuvent être facilement enlevées. Continuer à rincer.
GAI gCÁS TEAGMHÁLA LEIS NA SÚILE: Sruthlaigh go cúramach le huisce ar feadh roinnt nóiméad. Tóg amach na tadhall-lionsaí, más ann dóibh agus más furasta. Lean den sruthlú.
ITIN CASO DI CONTATTO CON GLI OCCHI: sciacquare accuratamente per parecchi minuti. Togliere le eventuali lenti a contatto se è agevole farlo. Continuare a sciacquare.
LVSASKARĒ AR ACĪM: uzmanīgi izskalot ar ūdeni vairākas minūtes. Izņemt kontaktlēcas, ja tās ir ievietotas un ja to ir viegli izdarīt. Turpināt skalot.
LTPATEKUS Į AKIS: Kelias minutes atsargiai plauti vandeniu. Išimti kontaktinius lęšius, jeigu jie yra ir jeigu lengvai galima tai padaryti. Toliau plauti akis.
HUSZEMBE KERÜLÉS esetén: Több percig tartó óvatos öblítés vízzel. Adott esetben a kontaktlencsék eltávolítása, ha könnyen megoldható. Az öblítés folytatása.
MTJEKK JIDĦOL FL-GĦAJNEJN: Laħlaħ b'attenzjoni bl-ilma għal diversi minuti. Neħħi l-lentijiet tal-kuntatt, jekk ikun hemm u jkunu faċli biex tneħħihom. Kompli laħlaħ.
NLBIJ CONTACT MET DE OGEN: voorzichtig afspoelen met water gedurende een aantal minuten; contactlenzen verwijderen, indien mogelijk; blijven spoelen.
PLW PRZYPADKU DOSTANIA SIĘ DO OCZU: Ostrożnie płukać wodą przez kilka minut. Wyjąć soczewki kontaktowe, jeżeli są i można je łatwo usunąć. Nadal płukać.
PTSE ENTRAR EM CONTACTO COM OS OLHOS: enxaguar cuidadosamente com água durante vários minutos. Se usar lentes de contacto, retire-as, se tal lhe for possível. Continuar a enxaguar.
ROÎN CAZ DE CONTACT CU OCHII: clătiţi cu atenţie cu apă timp de mai multe minute. Scoateţi lentilele de contact, dacă este cazul şi dacă acest lucru se poate face cu uşurinţă. Continuaţi să clătiţi.
SKPO ZASIAHNUTÍ OČÍ: Niekoľko minút ich opatrne vyplachujte vodou. Ak používate kontaktné šošovky a ak je to možné, odstráňte ich. Pokračujte vo vyplachovaní.
SLPRI STIKU Z OČMI: previdno izpirajte z vodo nekaj minut. Odstranite kontaktne leče, če jih imate in če to lahko storite brez težav. Nadaljujte z izpiranjem.
FIJOS KEMIKAALIA JOUTUU SILMIIN: Huuhdo huolellisesti vedellä usean minuutin ajan. Poista piilolinssit, _edical voi tehdä helposti. Jatka huuhtomista.
SVVID KONTAKT MED ÖGONEN: Skölj försiktigt med vatten i flera minuter. Ta ur eventuella kontaktlinser om det går lätt. Fortsätt att skölja.

P306 + P360Language
BGПРИ ПОПАДАНЕ ВЪРХУ ОБЛЕКЛОТО: незабавно облейте замърсеното облекло и кожата обилно с вода, преди да свалите дрехите.
ESEN CASO DE CONTACTO CON LA ROPA: Aclarar inmediatamente con agua abundante las prendas y la piel contaminadas antes de quitarse la ropa.
CSPŘI STYKU S ODĚVEM: Kontaminovaný oděv a kůži oklamžitě omyjte velkým množstvím vody a potom oděv odložte.
DAVED KONTAKT MED TØJET: Skyl omgående tilsmudset tøj og hud med rigeligt vand, før tøjet fjernes.
DEBEI KONTAKT MIT DER KLEIDUNG: Kontaminierte Kleidung und Haut sofort mit viel Wasser abwaschen und danach Kleidung ausziehen.
ETRÕIVASTELE SATTUMISE KORRAL: saastunud rõivad ja nahk loputada viivitamata rohke veega ning alles seejärel rõivad eemaldada.
ELΣΕ ΠΕΡΙΠΤΩΣΗ ΕΠΑΦΗΣ ΜΕ ΤΑ ΡΟΥΧΑ: Ξεπλύντε αμέσως τα μολυσμένα ρούχα και την επιδερμίδα με άφθονο νερό πριν αφαιρέσετε τα ρούχα.
ENIF ON CLOTHING: rinse immediately contaminated clothing and skin with plenty of water before removing clothes.
FREN CAS DE CONTACT AVEC LES VÊTEMENTS: rincer immédiatement et abondamment avec de l’eau les vêtements contaminés et la peau avant de les enlever.
GAI gCÁS TEAGMHÁLA LE hÉADAÍ: sruthlaítear éadaí éillithe agus an craiceann láithreach le neart uisce sula ndéantar na héadaí a bhaint den duine.
ITIN CASO DI CONTATTO CON GLI INDUMENTI: sciacquare immediatamente e abbondantemente gli indumenti contaminati e la pelle prima di togliersi gli indumenti.
LVSASKARĒ AR APĢĒRBU: nekavējoties izskalot piesārņoto apģērbu un ādu ar lielu daudzumu ūdeni, pirms apģērba novilkšanas.
LTPATEKUS ANT DRABUŽIŲ: Prieš nuvelkant užterštus drabužius, nedelsiant juos ir odą nuplauti dideliu kiekiu vandens.
HUHA RUHÁRA KERÜL: A ruhák levetése előtt a szennyezett ruházatot és a bőrt bő vízzel azonnal le kell öblíteni.
MTJEKK FUQ L-ILBIES: laħlaħ mall-ewwel l-ilbies ikkontaminat u l-ġilda b’ħafna ilma qabel ma tneħħi l-ilbies.
NLNA MORSEN OP KLEDING: verontreinigde kleding en huid onmiddellijk met veel water afspoelen en pas daarna kleding uittrekken.
PLW PRZYPADKU KONTAKTU Z ODZIEŻĄ: natychmiast spłukać zanieczyszczoną odzież i skórę dużą ilością wody przed zdjęciem odzieży.
PTSE ENTRAR EM CONTACTO COM A ROUPA: enxaguar imediatamente com muita água a roupa e a pele contaminadas antes de se despir.
ROÎN CAZ DE CONTACT CU ÎMBRĂCĂMINTEA: clătiţi imediat îmbrăcămintea contaminată şi pielea cu multă apă, înainte de scoaterea îmbrăcămintei.
SKPRI KONTAKTE S ODEVOM: kontaminovaný odev a pokožku opláchnite veľkým množstvom vody a potom odev odstráňte.
SLPRI STIKU Z OBLAČILI: takoj izprati kontaminirana oblačila in kožo z veliko vode pred odstranitvijo oblačil.
FIJOS KEMIKAALIA JOUTUU VAATTEISIIN: Huuhdo saastunut vaatetus ja iho välittömästi runsaalla vedellä ennen vaatetuksen riisumista.
SVVID KONTAKT MED KLÄDERNA: Skölj omedelbart nedstänkta kläder och hud med mycket vatten innan du tar av dig kläderna.

P307 + P311Language
BGПРИ експозиция: Обадете се в ЦЕНТЪР ПО ТОКСИКОЛОГИЯ или на лекар.
ESEN CASO DE exposición: Llamar a un CENTRO DE INFORMACIÓN TOXICOLÓGICA o a un médico.
CSPŘI expozici: Volejte TOXIKOLOGICKÉ INFORMAČNÍ STŘEDISKO nebo lékaře.
DAVED eksponering: Ring til en GIFTINFORMATION eller en læge.
DEBEI Exposition: GIFTINFORMATIONSZENTRUM oder Arzt anrufen.
ETKokkupuute korral: võtta ühendust MÜRGISTUSTEABEKESKUSE või arstiga.
ELΣΕ ΠΕΡΙΠΤΩΣΗ έκθεσης: Καλέστε το ΚΕΝΤΡΟ ΔΗΛΗΤΗΡΙΑΣΕΩΝ ή ένα γιατρό.
ENIF exposed: Call a POISON CENTER or doctor/physician.
FREN CAS d’exposition: appeler un CENTRE ANTIPOISON ou un médecin.
GAI gCÁS nochta: Cuir glao ar IONAD NIMHE nó ar dhoctúir/lia.
ITIN CASO di esposizione, contattare un CENTRO ANTIVELENI o un medico.
LVJa ir saskarē: Sazināties ar SAINDĒŠANĀS CENTRU vai ārstu.
LTEsant sąlyčiui: Skambinti į APSINUODIJIMŲ KONTROLĖS IR INFORMACIJOS BIURĄ arba kreiptis į gydytoją.
HUExpozíció esetén: forduljon TOXIKOLÓGIAI KÖZPONTHOZ vagy orvoshoz.
MTJekk espost: Ikkuntattja ĊENTRU TA' L-AVVELENAMENT jew tabib.
NLNA blootstelling: een ANTIGIFCENTRUM of een arts raadplegen.
PLW przypadku narażenia: Skontaktować się z OŚRODKIEM ZATRUĆ lub z lekarzem.
PTEM CASO DE exposição: contacte um CENTRO DE INFORMAÇÃO ANTIVENENOS ou um médico.
ROÎN CAZ DE expunere: sunaţi la un CENTRU DE INFORMARE TOXICOLOGICĂ sau un medic.
SKPo expozícii: volajte NÁRODNÉ TOXIKOLOGICKÉ INFORMAČNÉ CENTRUM alebo lekára.
SLPRI izpostavljenosti: pokličite CENTER ZA ZASTRUPITVE ali zdravnika.
FIAltistumisen tapahduttua: Ota yhteys MYRKYTYSTIETOKESKUKSEEN tai lääkäriin.
SVOm du exponerats: Kontakta GIFTINFORMATIONSCENTRAL eller läkare.

P308 + P313Language
BGПРИ явна или предполагаема експозиция: Потърсете медицински съвет/помощ.
ESEN CASO DE exposición manifiesta o presunta: Consultar a un médico.
CSPŘI expozici nebo podezření na ni: Vyhledejte lékařskou pomoc/ošetření.
DAVED eksponering eller mistanke om eksponering: Søg lægehjælp.
DEBEI Exposition oder falls betroffen: Ärztlichen Rat einholen/ärztliche Hilfe hinzuziehen.
ETKokkupuute või kokkupuutekahtluse korral: pöörduda arsti poole.
ELΣΕ ΠΕΡΙΠΤΩΣΗ έκθεσης ή πιθανότητας έκθεσης: Συμβουλευθείτε/Επισκεφθείτε γιατρό.
ENIF exposed or concerned: Get medical advice/attention.
FREN CAS d’exposition prouvée ou suspectée: consulter un médecin.
GAI gCÀS nochta nó má mheastar a bheith nochtaithe: Faigh comhairle/cúram liachta.
ITIN CASO di esposizione o di possibile esposizione, consultare un medico.
LVJa nokļūst saskarē vai saistīts ar to: lūdziet mediķu palīdzību.
LTEsant sąlyčiui arba jeigu numanomas sąlytis: kreiptis į gydytoją.
HUExpozíció vagy annak gyanúja esetén: orvosi ellátást kell kérni.
MTJekk espost jew konċernat: Ikkonsulta tabib.
NLNA (mogelijke) blootstelling: een arts raadplegen.
PLW przypadku narażenia lub styczności: Zasięgnąć porady/zgłosić się pod opiekę lekarza.
PTEM CASO DE exposição ou suspeita de exposição: consulte um médico.
ROÎN CAZ DE expunere sau de posibilă expunere: consultaţi medicul.
SKPo expozícii alebo podozrení z nej: Vyhľadajte lekársku pomoc/starostlivosť.
SLPRI izpostavljenosti ali sumu izpostavljenosti: poiščite zdravniško pomoč/oskrbo.
FIAltistumisen tapahduttua tai jos epäillään altistumista: Hakeudu lääkäriin.
SVVid exponering eller misstanke om exponering Sök läkarhjälp.

P309 + P311Language
BGПРИ експозиция или неразположение: Обадете се в ЦЕНТЪР ПО ТОКСИКОЛОГИЯ или на лекар.
ESEN CASO DE exposición o si se encuentra mal: Llamar a un CENTRO DE INFORMACIÓN TOXICOLÓGICA o a un médico.
CSPŘI expozici nebo necítíte-li se dobře: Volejte TOXIKOLOGICKÉ INFORMAČNÍ STŘEDISKO nebo lékaře.
DAVED eksponering eller ubehag: Ring til en GIFTINFORMATION eller en læge.
DEBEI Exposition oder Unwohlsein: GIFTINFORMATIONSZENTRUM oder Arzt anrufen.
ETKokkupuute või halva enesetunde korral: võtta ühendust MÜRGISTUSTEABEKESKUSE või arstiga.
ELΣΕ ΠΕΡΙΠΤΩΣΗ έκθεσης ή αδιαθεσίας: Καλέστε το ΚΕΝΤΡΟ ΔΗΛΗΤΗΡΙΑΣΕΩΝ ή ένα γιατρό.
ENIF exposed or if you feel unwell: Call a POISON CENTER or doctor/physician.
FREN CAS d’exposition ou de malaise: appeler un CENTRE ANTIPOISON ou un médecin.
GAI gCÀS nochta nó má bhraitear tinn: Cuir glao ar IONAD NIMHE nó ar dhoctúir/lia.
ITIN CASO di esposizione o di malessere, contattare un CENTRO ANTIVELENI o un medico.
LVJa nokļūst saskarē vai jums ir slikta pašsajūta: sazinieties ar SAINDĒŠANĀS CENTRU vai ārstu.
LTEsant sąlyčiui arba pasijutus blogai: Skambinti į APSINUODIJIMŲ KONTROLĖS IR INFORMACIJOS BIURĄ arba kreiptis į gydytoją.
HUExpozíció vagy rosszullét esetén: forduljon TOXIKOLÓGIAI KÖZPONTHOZ vagy orvoshoz.
MTJEKK espost jew tħossok ma tiflaħx: Ikkuntattja ĊENTRU TA' L-AVVELENAMENT jew tabib.
NLNA blootstelling of bij onwel voelen: een ANTIGIFCENTRUM of een arts raadplegen.
PLW przypadku narażenia lub złego samopoczucia: Skontaktować się z OŚRODKIEM ZATRUĆ lub z lekarzem.
PTEM CASO DE exposição ou de indisposição: contacte um CENTRO DE INFORMAÇÃO ANTIVENENOS ou um médico.
ROÎN CAZ DE expunere sau dacă nu vă simţiţi bine: sunaţi la un CENTRU DE INFORMARE TOXICOLOGICĂ sau un medic.
SKPo expozícii alebo pri zdravotných problémoch: volajte NÁRODNÉ TOXIKOLOGICKÉ INFORMAČNÉ CENTRUM alebo lekára.
SLPRI izpostavljenosti ali slabem počutju: pokličite CENTER ZA ZASTRUPITVE ali zdravnika.
FIAltistumisen tapahduttua tai jos ilmenee pahoinvointia: Ota yhteys MYRKYTYSTIETOSKESKUKSEEN tai lääkäriin.
SVVid exponering eller obehag: Kontakta GIFTINFORMATIONSCENTRAL eller läkare.

P332 + P313Language
BGПри поява на кожно дразнене: Потърсете медицински съвет/помощ.
ESEn caso de irritación cutánea: Consultar a un médico.
CSPři podráždění kůže: Vyhledejte lékařskou pomoc/ošetření.
DAVed hudirritation: Søg lægehjælp.
DEBei Hautreizung: Ärztlichen Rat einholen/ärztliche Hilfe hinzuziehen.
ETNahaärrituse korral: pöörduda arsti poole.
ELΕάν παρατηρηθεί ερεθισμός του δέρματος: Συμβουλευθείτε/Επισκεφθείτε γιατρό.
ENIf skin irritation occurs: Get medical advice/attention.
FREn cas d’irritation cutanée: consulter un médecin.
GAI gcás greannú craicinn: Faigh comhairle/cúram liachta.
ITIn caso di irritazione della pelle: consultare un medico.
LVJa rodas ādas iekaisums: lūdziet mediķu palīdzību.
LTJeigu sudirginama oda: kreiptis į gydytoją.
HUBőrirritáció esetén: orvosi ellátást kell kérni.
MTJekk ikun hemm irritazzjoni tal-ġilda: Ikkonsulta tabib.
NLBij huidirritatie: een arts raadplegen.
PLW przypadku wystąpienia podrażnienia skóry: Zasięgnąć porady/zgłosić się pod opiekę lekarza.
PTEm caso de irritação cutânea: consulte um médico.
ROÎn caz de iritare a pielii: consultaţi medicul.
SKAk sa objaví podráždenie pokožky, vyhľadajte lekársku pomoc/starostlivosť.
SLČe nastopi draženje kože: poiščite zdravniško pomoč/oskrbo.
FIJos ilmenee ihoärsytystä: Hakeudu lääkäriin.
SVVid hudirritation: Sök läkarhjälp.

P333 + P313Language
BGПри поява на кожно дразнене или обрив на кожата: Потърсете медицински съвет/помощ.
ESEn caso de irritación o erupción cutánea: Consultar a un médico.
CSPři podráždění kůže nebo vyrážce: Vyhledejte lékařskou pomoc/ošetření.
DAVed hudirritation eller udslet: Søg lægehjælp.
DEBei Hautreizung oder -ausschlag: Ärztlichen Rat einholen/ärztliche Hilfe hinzuziehen.
ETNahaärrituse või _obe korral: pöörduda arsti poole.
ELΕάν παρατηρηθεί ερεθισμός του δέρματος ή εμφανιστεί εξάνθημα: Συμβουλευθείτε/Επισκεφθείτε γιατρό.
ENIf skin irritation or rash occurs: Get medical advice/attention.
FREn cas d’irritation ou d'éruption cutanée: consulter un médecin.
GAMá tharlaíonn greannú nó gríos craicinn: Faigh comhairle/cúram liachta.
ITIn caso di irritazione o eruzione della pelle: consultare un medico.
LVJa rodas ādas iekaisums vai izsitumi: lūdziet mediķu palīdzību.
LTJeigu sudirginama oda arba ją išberia: kreiptis į gydytoją.
HUBőrirritáció vagy kiütések megjelenése esetén: orvosi ellátást kell kérni.
MTJekk ikun hemm irritazzjoni jew raxx tal-ġilda: Ikkonsulta tabib.
NLBij huidirritatie of uitslag: een arts raadplegen.
PLW przypadku wystąpienia podrażnienia skóry lub wysypki: Zasięgnąć porady/zgłosić się pod opiekę lekarza.
PTEm caso de irritação ou erupção cutânea: consulte um médico.
ROÎn caz de iritare a pielii sau de erupţie cutanată: consultaţi medicul.
SKAk sa prejaví podráždenie pokožky alebo sa vytvoria vyrážky: vyhľadajte lekársku pomoc/starostlivosť.
SLČe nastopi draženje kože ali se pojavi izpuščaj: poiščite zdravniško pomoč/oskrbo.
FIJos ilmenee ihoärsytystä tai ihottumaa: Hakeudu lääkäriin.
SVVid hudirritation eller utslag: Sök läkarhjälp.

P335 + P334Language
BGОтстранете посипаните частици от кожата. Потопете в хладка вода/сложете мокри компреси.
ESSacudir las partículas que se hayan depositado en la piel. Sumergir en agua fresca/aplicar compresas húmedas.
CSVolné částice odstraňte z kůže. Ponořte do studené vody/zabalte do vlhkého obvazu.
DABørst løse partikler bort fra huden. Skyl under koldt vand/anvend våde omslag.
DELose Partikel von der Haut abbürsten. In kaltes Wasser tauchen/nassen Verband anlegen.
ETPühkida lahtised osakesed nahalt maha. Hoida jahedas vees / panna peale niiske kompress.
ELΑφαιρέστε προσεκτικά τα σωματίδια που έχουν μείνει στο δέρμα. Πλύντε με άφθονο δροσερό νερό/τυλίξτε με βρεγμένους επιδέσμους.
ENBrush off loose particles from skin. Immerse in cool water/wrap in wet bandages.
FREnlever avec précaution les particules déposées sur la peau. Rincer à l’eau fraîche/poser une compresse humide.
GAScuab cáithníní scaoilte den chraiceann. Tum in uisce fionnuar/cuir bréid fliuch air.
ITRimuovere le particelle depositate sulla pelle. Immergere in acqua fredda/avvolgere con un bendaggio umido.
LVNoberziet brīvās daļiņas no ādas. Iegremdējiet vēsā ūdenī/ietiniet mitros apsējos.
LTNeprilipusias daleles nuvalyti nuo odos. Įmerkti į vėsų vandenį/apvynioti šlapiais tvarsčiais.
HUA bőrre tapadó szemcséket óvatosan le kell kefélni. Hideg vízzel/nedves kötéssel kell hűteni.
MTFarfar il-frak mhux imwaħħal minn mal-ġilda. Daħħal fl-ilma frisk/kebbeb f’faxex imxarrbin.
NLLosse deeltjes van de huid afvegen. In koud water onderdompelen/nat verband aanbrengen.
PLNie związaną pozostałość strzepnąć ze skóry. Zanurzyć w zimnej wodzie/owinąć mokrym bandażem.
PTSacudir da pele as partículas soltas. Mergulhar em água fria/aplicar compressas húmidas.
ROÎndepărtaţi particulele depuse pe piele. Introduceţi în apă rece/acoperiţi cu o compresă umedă.
SKZ pokožky oprášte sypké čiastočky. Ponorte do studenej vody/obviažte mokrými obväzmi.
SLS krtačo odstraniti razsute delce s kože. Potopiti v hladno vodo/zaviti v mokre povoje.
FIPoista irtohiukkaset iholta. Upota kylmään veteen/kääri märkiin siteisiin.
SVBorsta bort lösa partiklar från huden. Skölj under kallt vatten/använd våta omslag.

P337 + P313Language
BGПри продължително дразнене на очите: Потърсете медицински съвет/помощ.
ESSi persiste la irritación ocular: Consultar a un médico.
CSPřetrvává-li podráždění očí: Vyhledejte lékařskou pomoc/ošetření.
DAVed vedvarende øjenirritation: Søg lægehjælp.
DEBei anhaltender Augenreizung: Ärztlichen Rat einholen/ärztliche Hilfe hinzuziehen.
ETKui silmade ärritus ei möödu: pöörduda arsti poole.
ELΕάν δεν υποχωρεί ο οφθαλμικός ερεθισμός: Συμβουλευθείτε/Επισκεφθείτε γιατρό.
ENIf eye irritation persists: Get medical advice/attention.
FRSi l’irritation oculaire persiste: consulter un médecin.
GAMá mhaireann an greannú súile: Faigh comhairle/cúram liachta.
ITSe l’irritazione degli occhi persiste, consultare un medico.
LVJa acu iekaisums nepāriet: lūdziet mediķu palīdzību.
LTJei akių dirginimas nepraeina: kreiptis į gydytoją.
HUHa a szemirritáció nem múlik el: orvosi ellátást kell kérni.
MTJekk l-irritazzjoni ta' l-għajnejn tippersisti: Ikkonsulta tabib.
NLBij aanhoudende oogirritatie: een arts raadplegen.
PLW przypadku utrzymywania się działania drażniącego na oczy: Zasięgnąć porady/zgłosić się pod opiekę lekarza.
PTCaso a irritação ocular persista: consulte um médico.
RODacă iritarea ochilor persistă: consultaţi medicul.
SKAk podráždenie očí pretrváva: vyhľadajte lekársku pomoc/starostlivosť.
SLČe draženje oči ne preneha: poiščite zdravniško pomoč/oskrbo.
FIJos silmä-ärsytys jatkuu: Hakeudu lääkäriin.
SVVid bestående ögonirritation: Sök läkarhjälp.

P342 + P311Language
BGПри симптоми на затруднено дишане: Обадете се в ЦЕНТЪР ПО ТОКСИКОЛОГИЯ или на лекар.
ESEn caso de síntomas respiratorios: Llamar a un CENTRO DE INFORMACIÓN TOXICOLÓGICA o a un médico.
CSPři dýchacích potížích: Volejte TOXIKOLOGICKÉ INFORMAČNÍ STŘEDISKO nebo lékaře.
DAVed luftvejssymptomer: Ring til en GIFTINFORMATION eller en læge.
DEBei Symptomen der Atemwege: GIFTINFORMATIONSZENTRUM oder Arzt anrufen.
ETHingamisteede probleemide ilmnemise korral: võtta ühendust MÜRGISTUSTEABEKESKUSE või arstiga.
ELΕάν παρουσιάζονται αναπνευστικά συμπτώματα: Καλέστε το ΚΕΝΤΡΟ ΔΗΛΗΤΗΡΙΑΣΕΩΝ ή ένα γιατρό.
ENIf experiencing respiratory symptoms: Call a POISON CENTER or doctor/physician.
FREn cas de symptômes respiratoires: appeler un CENTRE ANTIPOISON ou un médecin.
GAI gcás siomptóm riospráide: Cuir glao ar IONAD NIMHE nó ar dhoctúir/lia.
ITIn caso di sintomi respiratori: contattare un CENTRO ANTIVELENI o un medico.
LVJa rodas elpas trūkuma simptomi: sazinieties ar SAINDĒŠANĀS CENTRU vai ārstu.
LTJeigu pasireiškia respiraciniai simptomai: skambinti į APSINUODIJIMŲ KONTROLĖS IR INFORMACIJOS BIURĄ arba kreiptis į gydytoją.
HULégzési problémák esetén: forduljon TOXIKOLÓGIAI KÖZPONTHOZ vagy orvoshoz.
MTJekk ikollok sintomi respiratorji: Ikkuntattja ĊENTRU TA' L-AVVELENAMENT jew tabib.
NLBij ademhalingssymptomen: een ANTIGIFCENTRUM of een arts raadplegen.
PLW przypadku wystąpienia objawów ze strony układu oddechowego: Skontaktować się z OŚRODKIEM ZATRUĆ lub z lekarzem.
PTEm caso de sintomas respiratórios: contacte um CENTRO DE INFORMAÇÃO ANTIVENENOS ou um médico.
ROÎn caz de simptome respiratorii: sunaţi la un CENTRU DE INFORMARE TOXICOLOGICĂ sau un medic.
SKPri ťažkostiach s dýchaním: volajte NÁRODNÉ TOXIKOLOGICKÉ INFORMAČNÉ CENTRUM alebo lekára.
SLPri respiratornih simptomih: pokličite CENTER ZA ZASTRUPITVE ali zdravnika.
FIJos ilmenee hengitysoireita: Ota yhteys MYRKYTYSTIETOKESKUKSEEN tai lääkäriin.
SVVid besvär i luftvägarna: Kontakta GIFTINFORMATIONSCENTRAL eller läkare.

P370 + P376Language
BGПри пожар: Спрете теча, ако е безопасно.
ESEn caso de incendio: Detener la fuga, si no hay peligro en hacerlo.
CSV případě požáru: Zastavte únik, můžete-li tak učinit bez rizika.
DAVed brand: Stands lækagen, hvis dette er sikkert.
DEBei Brand: Undichtigkeit beseitigen, wenn gefahrlos möglich.
ETTulekahju korral: leke peatada, kui seda on võimalik teha ohutult.
ELΣε περίπτωση πυρκαγιάς: Σταματήστε τη διαρροή, εφόσον δεν υπάρχει κίνδυνος.
ENIn case of fire: Stop leak if safe to do so.
FREn cas d’incendie: obturer la fuite si cela peut se faire sans danger.
GAI gcás dóiteáin: Cuir stop leis an sceitheadh má tá sé sábháilte é sin a dhéanamh.
ITIn caso di incendio: bloccare la perdita se non c’è pericolo.
LVUgunsgrēka gadījumā: apturiet noplūdi, ja to darīt ir droši.
LTGaisro atveju: sustabdyti nuotėkį, jeigu galima saugiai tai padaryti.
HUTűz esetén: Meg kell szüntetni a szivárgást, ha ez biztonságosan megtehető.
MTF’każ ta' nar: Waqqaf it-tnixxija sakemm ma jkunx ta' periklu.
NLIn geval van brand: het lek dichten als dat veilig gedaan kan worden.
PLW przypadku pożaru: Jeżeli jest to bezpieczne zahamować wyciek.
PTEm caso de incêndio: deter a fuga se tal puder ser feito em segurança.
ROÎn caz de incendiu: opriţi scurgerea, dacă acest lucru se poate face în siguranţă.
SKV prípade požiaru: ak je to bezpečné, zastavte únik.
SLOb požaru: zaustaviti puščanje, če je varno.
FITulipalon sattuessa: Sulje vuoto, jos sen voi tehdä turvallisesti.
SVVid brand: Stoppa läckan om det kan göras på ett säkert sätt.

P370 + P378Language
BGПри пожар: Използвайте … за гасене.
ESEn caso de incendio: Utilizar … para apagarlo.
CSV případě požáru: K hašení použijte …
DAVed brand: Anvend … til brandslukning.
DEBei Brand: … zum Löschen verwenden.
ETTulekahju korral: kasutada kustutamiseks …
ELΣε περίπτωση πυρκαγιάς: Χρησιμοποιήστε … για την κατάσβεση.
ENIn case of fire: Use … for extinction.
FREn cas d’incendie: utiliser … pour l’extinction.
GAI gcás dóiteáin: Úsáid … le haghaidh múchta.
ITIn caso di incendio: estinguere con…
LVUgunsgrēka gadījumā: dzēšanai izmantojiet …
LTGaisro atveju: gesinimui naudoti …
HUTűz esetén: az oltáshoz …használandó.
MTF’każ ta' nar: Uża’ … għat-tifi.
NLIn geval van brand: blussen met …
PLW przypadku pożaru: Użyć … do gaszenia.
PTEm caso de incêndio: para a extinção utilizar …
ROÎn caz de incendiu: utilizaţi… pentru stingere.
SKV prípade požiaru: na hasenie použite …
SLOb požaru: za gašenje uporabiti …
FITulipalon sattuessa: Käytä palon sammuttamiseen …
SVVid brand: Släck branden med …

P370 + P380Language
BGПри пожар: Евакуирайте зоната.
ESEn caso de incendio: Evacuar la zona.
CSV případě požáru: Vykliďte prostor.
DAVed brand: Evakuer området.
DEBei Brand: Umgebung räumen.
ETTulekahju korral: ala evakueerida.
ELΣε περίπτωση πυρκαγιάς: Εκκενώστε την περιοχή.
ENIn case of fire: Evacuate area.
FREn cas d’incendie: évacuer la zone.
GAI gcás dóiteáin: Aslonnaigh gach duine as an limistéar.
ITEvacuare la zona in caso di incendio.
LVUgunsgrēka gadījumā: evakuēt zonu.
LTGaisro atveju: evakuoti zoną.
HUTűz esetén: Ki kell üríteni a területet.
MTF’każ ta' nar: Evakwa ż-żona.
NLIn geval van brand: evacueren.
PLW przypadku pożaru: Ewakuować teren.
PTEm caso de incêndio: evacuar a zona.
ROÎn caz de incendiu: evacuaţi zona.
SKV prípade požiaru: priestory evakuujte.
SLOb požaru: izprazniti območje.
FITulipalon sattuessa: Evakuoi alue.
SVVid brand: Utrym området.

P370 + P380 + P375Language
BGПри пожар: Евакуирайте зоната. Гасете пожара от разстояние поради опасност от експлозия.
ESEn caso de incendio: Evacuar la zona. Luchar contra el incendio a distancia, dado el riesgo de explosión.
CSV případě požáru: Vykliďte prostor. Kvůli nebezpečí výbuchu haste z dostatečné vzdálenosti.
DAVed brand: Evakuer området. Bekæmp branden på afstand på grund af eksplosionsfare.
DEBei Brand: Umgebung räumen. Wegen Explosionsgefahr Brand aus der Entfernung bekämpfen.
ETTulekahju korral: ala evakueerida. Plahvatusohu tõttu teha kustutustöid eemalt.
ELΣε περίπτωση πυρκαγιάς: Εκκενώστε την περιοχή. Προσπαθήστε να σβήσετε την πυρκαγιά από απόσταση, επειδή υπάρχει κίνδυνος έκρηξης.
ENIn case of fire: Evacuate area. Fight fire remotely due to the risk of explosion.
FREn cas d’incendie: évacuer la zone. Combattre l’incendie à distance à cause du risque d’explosion.
GAI gcás dóiteáin: Aslonnaigh gach duine as an limistéar. Téigh i gcianghleic leis an dóiteán mar gheall ar an mbaol pléasctha.
ITIn caso di incendio: evacuare la zona. Rischio di esplosione. Utilizzare i mezzi estinguenti a grande distanza.
LVUgunsgrēka gadījumā: evakuēt zonu. Dzēst uguni no attāluma eksplozijas riska dēļ.
LTGaisro atveju: evakuoti zoną. Gaisrą gesinti iš toli dėl sprogimo pavojaus.
HUTűz esetén: Ki kell üríteni a területet. A tűz oltását robbanásveszély miatt távolból kell végezni.
MTF’każ ta' nar: Evakwa ż-żona. Itfi n-nar mill-bogħod minħabba r-riskju ta' splużjoni.
NLIn geval van brand: evacueren. Op afstand blussen omwille van ontploffingsgevaar.
PLW przypadku pożaru: Ewakuować teren. Z powodu ryzyka wybuchu gasić pożar z odległości.
PTEm caso de incêndio: evacuar a zona. Combater o incêndio à distância, devido ao risco de explosão.
ROÎn caz de incendiu: evacuaţi zona. Stingeţi incendiul de la distanţă din cauza pericolului de explozie.
SKV prípade požiaru: priestory evakuujte. Z dôvodu nebezpečenstva výbuchu požiar haste z diaľky.
SLOb požaru: izprazniti območje. Gasiti z večje razdalje zaradi nevarnosti eksplozije.
FITulipalon sattuessa: Evakuoi alue. Sammuta palo etäältä räjähdysvaaran takia.
SVVid brand: Utrym området. Bekämpa branden på avstånd på grund av explosionsrisken.

P371 + P380 + P375Language
BGПри голям пожар и значителни количества: Евакуирайте зоната. Гасете пожара от разстояние поради опасност от експлозия.
ESEn caso de incendio importante y en grandes cantidades: Evacuar la zona. Luchar contra el incendio a distancia, dado el riesgo de explosión.
CSV případě velkého požáru a velkého množství: Vykliďte prostor. Kvůli nebezpečí výbuchu haste z dostatečné vzdálenosti.
DAVed større brand og store mængder: Evakuer området. Bekæmp branden på afstand på grund af eksplosionsfare.
DEBei Großbrand und großen Mengen: Umgebung räumen. Wegen Explosionsgefahr Brand aus der Entfernung bekämpfen.
ETSuure tulekahju korral ning kui on tegemist suurte kogustega: ala evakueerida. Plahvatusohu tõttu teha kustutustöid eemalt.
ELΣε περίπτωση σοβαρής πυρκαγιάς και εάν πρόκειται για μεγάλες ποσότητες: Εκκενώστε την περιοχή. Προσπαθήστε να σβήσετε την πυρκαγιά από απόσταση, επειδή υπάρχει κίνδυνος έκρηξης.
ENIn case of major fire and large quantities: Evacuate area. Fight fire remotely due to the risk of explosion.
FREn cas d’incendie important et s’il s’agit de grandes quantités: évacuer la zone. Combattre l’incendie à distance à cause du risque d’explosion.
GAI gcás mórdhóiteáin agus mórchainníochtaí: Aslonnaigh gach duine as an limistéar. Téigh i gcianghleic leis an dóiteán mar gheall ar an mbaol pléasctha.
ITIn caso di incendio grave e di grandi quantità: evacuare la zona. Rischio di esplosione. Utilizzare i mezzi estinguenti a grande distanza.
LVUgunsgrēka vai liela apjoma gadījumā: evakuēt zonu. Dzēst uguni no attāluma eksplozijas riska dēļ.
LTDidelio gaisro ir didelių kiekių atveju: evakuoti zoną. Gaisrą gesinti iš toli dėl sprogimo pavojaus.
HUNagyobb tűz és nagy mennyiség esetén: Ki kell üríteni a területet. A tűz oltását robbanásveszély miatt távolból kell végezni.
MTF’każ ta' nar kbir u kwantitajiet kbar: Evakwa ż-żona. Itfi n-nar mill-bogħod minħabba r-riskju ta' splużjoni.
NLIn geval van grote brand en grote hoeveelheden: evacueren. Op afstand blussen omwille van ontploffingsgevaar.
PLW przypadku poważnego pożaru i dużych ilości: Ewakuować teren. Z powodu ryzyka wybuchu gasić pożar z odległości.
PTEm caso de incêndio importante e de grandes quantidades: evacuar a zona. Combater o incêndio à distância, devido ao risco de explosão.
ROÎn caz de incendiu de proporţii şi de cantităţi mari de produs: evacuaţi zona. Stingeţi incendiul de la distanţă din cauza pericolului de explozie.
SKV prípade veľkého požiaru a značného množstva: priestory evakuujte. Z dôvodu nebezpečenstva výbuchu požiar haste z diaľky.
SLOb velikem požaru in velikih količinah: izprazniti območje. Gasiti z večje razdalje zaradi nevarnosti eksplozije.
FIJos tulipalo ja ainemäärät ovat suuret: Evakuoi alue. Sammuta palo etäältä räjähdysvaaran takia.
SVVid större brand och stora mängder: Utrym området. Bekämpa branden på avstånd på grund av explosionsrisken.


Table 1.4

Precautionary statements — Storage

P401Language
BGДа се съхранява…
ESAlmacenar …
CSSkladujte …
DAOpbevares …
DE… aufbewahren.
ETHoida …
ELΑποθηκεύεται …
ENStore …
FRStocker …
GAStóráil …
ITConservare…
LVGlabāt…
LTLaikyti…
HUTárolás: … .
MTAħżen …
NL… bewaren.
PLPrzechowywać …
PTArmazenar …
ROA se depozita…
SKUchovávajte …
SLHraniti …
FIVarastoi …
SVFörvaras …

P402Language
BGДа се съхранява на сухо място.
ESAlmacenar en un lugar seco.
CSSkladujte na suchém místě.
DAOpbevares et tørt sted.
DEAn einem trockenen Ort aufbewahren.
ETHoida kuivas.
ELΑποθηκεύεται σε στεγνό μέρος.
ENStore in a dry place.
FRStocker dans un endroit sec.
GAStóráil in áit thirim.
ITConservare in luogo asciutto.
LVGlabāt sausā vietā.
LTLaikyti sausoje vietoje.
HUSzáraz helyen tárolandó.
MTAħżen f’post niexef.
NLOp een droge plaats bewaren.
PLPrzechowywać w suchym miejscu.
PTArmazenar em local seco.
ROA se depozita într-un loc uscat.
SKUchovávajte na suchom mieste.
SLHraniti na suhem.
FIVarastoi kuivassa paikassa.
SVFörvaras torrt.

P403Language
BGДа се съхранява на добре проветриво място.
ESAlmacenar en un lugar bien ventilado.
CSSkladujte na dobře větraném místě.
DAOpbevares på et godt ventileret sted.
DEAn einem gut belüfteten Ort aufbewahren.
ETHoida hästi ventileeritavas kohas.
ELΑποθηκεύεται σε καλά αεριζόμενο χώρο.
ENStore in a well-ventilated place.
FRStocker dans un endroit bien ventilé.
GAStóráil in áit dhea-aeráilte.
ITConservare in luogo ben ventilato.
LVGlabāt labi vēdināmā vietā.
LTLaikyti gerai vėdinamoje vietoje.
HUJól szellőző helyen tárolandó.
MTAħżen f’post b'ventilazzjoni tajba.
NLOp een goed geventileerde plaats bewaren.
PLPrzechowywać w dobrze wentylowanym miejscu.
PTArmazenar em local bem ventilado.
ROA se depozita într-un spaţiu bine ventilat.
SKUchovávajte na dobre vetranom mieste.
SLHraniti na dobro prezračevanem mestu.
FIVarastoi paikassa, jossa on hyvä ilmanvaihto.
SVFörvaras på väl ventilerad plats.

P404Language
BGДа се съхранява в затворен съд.
ESAlmacenar en un recipiente cerrado.
CSSkladujte v uzavřeném obalu.
DAOpbevares i en lukket beholder.
DEIn einem geschlossenen Behälter aufbewahren.
ETHoida suletud mahutis.
ELΦυλάσσεται σε κλειστό περιέκτη.
ENStore in a closed container.
FRStocker dans un récipient fermé.
GAStóráil i gcoimeádán iata.
ITConservare in un recipiente chiuso.
LVGlabāt slēgtā tvertnē.
LTLaikyti uždaroje talpykloje.
HUZárt edényben tárolandó.
MTAħżen f’kontenitur magħluq.
NLIn gesloten verpakking bewaren.
PLPrzechowywać w zamkniętym pojemniku.
PTArmazenar em recipiente fechado.
ROA se depozita într-un recipient închis.
SKUchovávajte v uzavretej nádobe.
SLHraniti v zaprti posodi.
FIVarastoi suljettuna.
SVFörvaras i sluten behållare.

P405Language
BGДа се съхранява под ключ.
ESGuardar bajo llave.
CSSkladujte uzamčené.
DAOpbevares under lås.
DEUnter Verschluss aufbewahren.
ETHoida lukustatult.
ELΦυλάσσεται κλειδωμένο.
ENStore locked up.
FRGarder sous clef.
GAStóráil faoi ghlas.
ITConservare sotto chiave.
LVGlabāt slēgtā veidā.
LTLaikyti užrakintą.
HUElzárva tárolandó.
MTAħżen f'post imsakkar.
NLAchter slot bewaren.
PLPrzechowywać pod zamknięciem.
PTArmazenar em local fechado à chave.
ROA se depozita sub cheie.
SKUchovávajte uzamknuté.
SLHraniti zaklenjeno.
FIVarastoi lukitussa tilassa.
SVFörvaras inlåst.

P406Language
BGДа се съхранява в устойчив на разяждане съд/… съд с устойчива вътрешна облицовка.
ESAlmacenar en un recipiente resistente a la corrosión/… con revestimiento interior resistente.
CSSkladujte v obalu odolném proti korozi/… obalu s odolnou vnitřní vrstvou.
DAOpbevares i ætsningsbestandig/…beholder med modstandsdygtig indvendig belægning.
DEIn korrosionsbeständigem/… Behälter mit korrosionsbeständiger Auskleidung aufbewahren.
ETHoida sööbekindlas/…sööbekindla sisevooderdisega mahutis.
ELΑποθηκεύεται σε ανθεκτικό στη διάβρωση/… περιέκτη με ανθεκτική εσωτερική επένδυση.
ENStore in corrosive resistant/… container with a resistant inner liner.
FRStocker dans un récipient résistant à la corrosion/récipient en … avec doublure intérieure résistant à la corrosion.
GAStóráil i gcoimeádán … frithchreimneach/… le líneáil frithchreimneach laistigh.
ITConservare in recipiente resistente alla corrosione/… provvisto di rivestimento interno resistente.
LVGlabāt tvertnē, kas aizsargā pret koroziju/… tvertnes ar iekšējo pretkorozijas izolāciju.
LTLaikyti korozijai atsparioje talpykloje/…, turinčioje atsparią vidinę dangą.
HUSaválló/saválló bélésű … edényben tárolandó.
MTAħżen f'post reżistenti għall-korrużjoni/… kontenitur li huwa infurrat minn ġewwa b'materjal reżistenti.
NLIn corrosiebestendige/… houder met corrosiebestendige binnenbekleding bewaren.
PLPrzechowywać w pojemniku odpornym na korozję / … o odpornej powłoce wewnętrznej.
PTArmazenar num recipiente resistente à corrosão/… com um revestimento interior resistente.
RODepozitaţi într-un recipient rezistent la coroziune/recipient din… cu dublură interioară rezistentă la coroziune.
SKUchovávajte v nádobe odolnej proti korózii/… nádobe s odolnou vnútornou vrstvou.
SLHraniti v posodi, odporni proti koroziji/…, z odporno notranjo oblogo.
FIVarastoi syöpymättömässä/… säiliössä, jossa on kestävä sisävuoraus.
SVFörvaras i korrosionsbeständig/… behållare med beständigt innerhölje.

P407Language
BGДа се остави въздушно пространство между купчините/палетите.
ESDejar una separación entre los bloques/los palés de carga.
CSMezi stohy/paletami ponechte vzduchovou mezeru.
DAObevares med luftmellemrum mellem stakkene/pallerne.
DELuftspalt zwischen Stapeln/Paletten lassen.
ETJätta virnade/kaubaaluste vahele õhuvahe.
ELΝα υπάρχει κενό αέρος μεταξύ των σωρών/παλετών.
ENMaintain air gap between stacks/pallets.
FRMaintenir un intervalle d’air entre les piles/palettes.
GACoimeád bearna aeir idir chruacha/phailléid.
ITMantenere uno spazio libero tra gli scaffali/i pallet.
LVSaglabāt gaisa spraugu starp krāvumiem/paletēm.
LTPalikti oro tarpą tarp eilių/palečių.
HUA rakatok/raklapok között térközt kell hagyni.
MTĦalli l-arja tgħaddi bejn l-imniezel/il-palits.
NLRuimte laten tussen stapels/pallets.
PLZachować szczelinę powietrzną pomiędzy stosami/paletami.
PTRespeitar as distâncias mínimas entre pilhas/paletes.
ROPăstraţi un spaţiu gol între stive/paleți.
SKMedzi regálmi/paletami ponechajte vzduchovú medzeru.
SLOhraniti zračno režo med skladi/paletami.
FIJätä pinojen/kuormalavojen väliin ilmarako.
SVSe till att det finns luft mellan staplar/pallar.

P410Language
BGДа се пази от пряка слънчева светлина.
ESProteger de la luz del sol.
CSChraňte před slunečním zářením.
DABeskyttes mod sollys.
DEVor Sonnenbestrahlung schützen.
ETHoida päikesevalguse eest.
ELΝα προστατεύεται από τις ηλιακές ακτίνες.
ENProtect from sunlight.
FRProtéger du rayonnement solaire.
GACosain ó sholas na gréine.
ITProteggere dai raggi solari.
LVAizsargāt no saules gaismas.
LTSaugoti nuo saulės šviesos.
HUNapfénytől védendő.
MTIpproteġi mid-dawl tax-xemx.
NLTegen zonlicht beschermen.
PLChronić przed światłem słonecznym.
PTManter ao abrigo da luz solar.
ROA se proteja de lumina solară.
SKChráňte pred slnečným žiarením.
SLZaščititi pred sončno svetlobo.
FISuojaa auringonvalolta.
SVSkyddas från solljus.

P411Language
BGДа се съхранява при температури, не по-високи от … oC/…oF.
ESAlmacenar a temperaturas no superiores a … oC/…oF.
CSSkladujte při teplotě nepřesahující … oC/…oF.
DAOpbevares ved en temperatur, som ikke overstiger … oC/…oF.
DEBei Temperaturen von nicht mehr als … oC/…aufbewahren.
ETHoida temperatuuril mitte üle … oC/… oF.
ELΑποθηκεύεται σε θερμοκρασίες που δεν υπερβαίνουν τους … oC/…oF.
ENStore at temperatures not exceeding … oC/…oF.
FRStocker à une température ne dépassant pas … oC/… oF.
GAStóráil ag teocht nach airde ná … oC/…oF.
ITConservare a temperature non superiori a … oC/…oF.
LVUzglabāt temperatūrā, kas nepārsniedz … oC/…oF.
LTLaikyti ne aukštesnėje kaip … oC/…oF temperatūroje.
HUA tárolási hőmérséklet legfeljebb … oC/…oF lehet.
MTAħżen f’temperaturi li ma jeċċedux … oC/…oF.
NLBij maximaal … oC/…oF bewaren.
PLPrzechowywać w temperaturze nieprzekraczającej … oC/…oF.
PTArmazenar a uma temperatura não superior a … oC/…oF.
ROA se depozita la temperaturi care să nu depăşească … oC/…oF.
SKUchovávajte pri teplotách do … oC/…oF
SLHraniti pri temperaturi do … oC/… oF.
FIVarastoi alle … oC/…oF lämpötilassa.
SVFörvaras vid högst … oC/…oF.

P412Language
BGДа не се излага на температури, по-високи от 50 oC/122oF.
ESNo exponer a temperaturas superiores a 50 oC/122oF.
CSNevystavujte teplotě přesahující 50 oC/122 oF.
DAMå ikke udsættes for en temperatur, som overstiger 50 oC/122oF.
DENicht Temperaturen von mehr als 50 oC aussetzen.
ETMitte hoida temperatuuril üle 50 oC/122 oF.
ELΝα μην εκτίθεται σε θερμοκρασίες που υπερβαίνουν τους 50 oC/122oF.
ENDo not expose to temperatures exceeding 50 oC/122oF.
FRNe pas exposer à une température supérieure à 50 oC/122 oF.
GANá nocht do theocht níos airde ná 50 oC/122oF.
ITNon esporre a temperature superiori a 50 oC/122oF.
LVNepakļaut temperatūrai, kas pārsniedz 50 oC/122oF.
LTNelaikyti aukštesnėje kaip 50 oC/122oF temperatūroje.
HUNem érheti 50 oC/122oF hőmérsékletet meghaladó hő.
MTTesponix għal temperaturi li jeċċedu l-50 oC/122oF.
NLNiet blootstellen aan temperaturen boven 50 oC/122oF.
PLNie wystawiać na działanie temperatury przekraczającej 50 oC/122 oF.
PTNão expor a temperaturas superiores a 50 oC/122oF.
RONu expuneţi la temperaturi care depăşesc 50 oC/122 oF.
SKNevystavujte teplotám nad 50 oC/122 oF.
SLNe izpostavljati temperaturam nad 50 oC/122 oF.
FIEi saa altistaa yli 50 oC/122 oF lämpötiloille.
SVFår inte utsättas för temperaturer över 50 oC/122 oF.

P413Language
BGПри насипни количества, по-големи от … kg/… фунта, да се съхранява при температури, не по-високи от … oC/…oF.
ESAlmacenar las cantidades a granel superiores a … kg/… lbs a temperaturas no superiores a … oC/…oF.
CSMnožství větší než … kg/… liber skladujte při teplotě nepřesahující … oC/…oF.
DABulkmængder på over … kg/…lbs opbevares ved en temperatur, som ikke overstiger … oC/…oF.
DESchüttgut in Mengen von mehr als … kg bei Temperaturen von nicht mehr als … oC aufbewahren
ETKogust, mis on suurem kui … kg/… naela, hoida temperatuuril mitte üle … oC/… oF.
ELΟι σωροί χύδην με βάρος άνω των … kg/… lbs αποθηκεύονται σε θερμοκρασίες που δεν υπερβαίνουν τους … oC/…oF.
ENStore bulk masses greater than … kg/… lbs at temperatures not exceeding … oC/…oF.
FRStocker les quantités en vrac de plus de … kg/… lb à une température ne dépassant pas … oC/… oF.
GAStóráil bulcmhaiseanna os cionn … kg/… lb ag teocht nach airde ná … oC/…oF.
ITConservare le rinfuse di peso superiore a …kg/…lb a temperature non superiori a … oC/oF.
LVLielus apjomus, kas pārsniedz … kg/… lbs, uzglabāt temperatūrā, kas nepārsniedz … oC/…oF.
LTDidesnius kaip … kg/… lbs medžiagos kiekius laikyti ne aukštesnėje kaip … oC/…oF temperatūroje.
HUA … kg/… lb tömeget meghaladó ömlesztett anyag tárolási hőmérséklete legfeljebb … oC/…oF lehet.
MTAħżen il-kwantitajiet f’massa ta' akbar minn … kg/… lbs f’temperaturi ta' mhux aktar minn … oC/…oF.
NLBulkmateriaal, indien meer dan … kg/… lbs, bij temperaturen van maximaal … oC bewaren.
PLPrzechowywać luzem masy przekraczające … kg/… funtów w temperaturze nieprzekraczającej … oC/…oF.
PTArmazenar quantidades a granel superiores a … kg/… lbs a uma temperatura não superior a … oC/…oF.
RODepozitaţi cantităţile în vrac mai mari de … kg/… lbs la temperaturi care să nu depăşească … oC/…oF.
SKVeľké množstvo s hmotnosťou nad … kg/… lbs uchovávajte pri teplote do … oC/…oF.
SLRazsute količine, večje od … kg/… lbs, hraniti pri temperaturi do … oC/… oF.
FISäilytä yli … kg/…lbs painoinen irtotavara enintään … oC/…oF lämpötilassa.
SVBulkprodukter som väger mer än … kg/… lbs förvaras vid högst … oC/…oF.

P420Language
BGДа се съхранява на разстояние от други материали.
ESAlmacenar alejado de otros materiales.
CSSkladujte odděleně od ostatních materiálů.
DAMå ikke opbevares i nærheden af andre materialer.
DEVon anderen Materialien entfernt aufbewahren.
ETHoida eemal teistest materjalidest.
ELΑποθηκεύεται μακριά από άλλα υλικά.
ENStore away from other materials.
FRStocker à l’écart des autres matières.
GAStóráil glan ar ábhair eile.
ITConservare lontano da altri materiali.
LVGlabāt atsevišķi no citiem materiāliem.
LTLaikyti atokiau nuo kitų medžiagų.
HUMás anyagoktól távol tárolandó.
MTAħżen ‘l bogħod minn materjal ieħor.
NLGescheiden van ander materiaal bewaren.
PLPrzechowywać z dala od innych materiałów.
PTArmazenar afastado de outros materiais.
RODepozitaţi departe de alte materiale.
SKUchovávajte oddelene od iných materiálov.
SLHraniti ločeno od drugih materialov.
FIVarastoi erillään muista materiaaleista.
SVFörvaras åtskilt från andra material.

P422Language
BGСъдържанието да се съхранява при…
ESAlmacenar el contenido en …
CSSkladujte pod …
DAIndholdet skal opbevares under …
DEInhalt in/unter … aufbewahren
ETHoida sisu …
ELΤο περιεχόμενο αποθηκεύεται σε …
ENStore contents under …
FRStocker le contenu sous …
GAStóráil an t-ábhar faoi …
ITConservare sotto…
LVSaturu uzglabāt zem…
LTTurinį laikyti …
HUTartalma … -ban/-ben tárolandó.
MTAħżen il-kontenut taħt …
NLOnder … bewaren.
PLZawartość przechowywać w …
PTArmazenar o conteúdo em …
RODepozitaţi conţinutul sub …
SKObsah uchovávajte v …
SLVsebino hraniti v …
FIVarastoi sisältö …
SVFörvara innehållet i…

P402 + P404Language
BGДа се съхранява на сухо място. Да се съхранява в затворен съд.
ESAlmacenar en un lugar seco. Almacenar en un recipiente cerrado.
CSSkladujte na suchém místě. Skladujte v uzavřeném obalu.
DAOpbevares et tørt sted. Opbevares i en lukket beholder.
DEIn einem geschlossenen Behälter an einem trockenen Ort aufbewahren.
ETHoida kuivas. Hoida suletud mahutis.
ELΑποθηκεύεται σε στεγνό μέρος. Φυλάσσεται σε κλειστό περιέκτη.
ENStore in a dry place. Store in a closed container.
FRStocker dans un endroit sec. Stocker dans un récipient fermé.
GAStóráil in áit thirim. Stóráil i gcoimeádán iata.
ITConservare in luogo asciutto e in recipiente chiuso.
LVGlabāt sausā vietā. Glabāt aizvērtā tvertnē.
LTLaikyti sausoje vietoje. Laikyti uždaroje talpykloje.
HUSzáraz helyen tárolandó. Zárt edényben tárolandó.
MTAħżen f’post niexef. Aħżen f’kontenitur magħluq.
NLOp een droge plaats bewaren. In gesloten verpakking bewaren.
PLPrzechowywać w suchym miejscu. Przechowywać w zamkniętym pojemniku.
PTArmazenar em local seco. Armazenar em recipiente fechado.
ROA se depozita într-un loc uscat, într-un recipient închis.
SKUchovávajte na suchom mieste. Uchovávajte v uzavretej nádobe.
SLHraniti na suhem. Hraniti v zaprti posodi.
FIVarastoi kuivassa paikassa. Varastoi suljettuna.
SVFörvaras torrt. Förvaras i sluten behållare.

P403 + P233Language
BGДа се съхранява на добре проветриво място. Съдът да се съхранява плътно затворен.
ESAlmacenar en un lugar bien ventilado. Mantener el recipiente cerrado herméticamente.
CSSkladujte na dobře větraném místě. Uchovávejte obal těsně uzavřený.
DAOpbevares på et godt ventileret sted. Hold beholderen tæt lukket.
DEBehälter dicht verschlossen an einem gut belüfteten Ort aufbewahren.
ETHoida hästi ventileeritavas kohas. Hoida mahuti tihedalt suletuna.
ELΑποθηκεύεται σε καλά αεριζόμενο χώρο. Ο περιέκτης διατηρείται ερμητικά κλειστός.
ENStore in a well-ventilated place. Keep container tightly closed.
FRStocker dans un endroit bien ventilé. Maintenir le récipient fermé de manière étanche.
GAStóráil in áit dhea-aeráilte. Coimeád an coimeádán dúnta go docht.
ITTenere il recipiente ben chiuso e in luogo ben ventilato.
LVGlabāt labi vēdināmās telpās. Tvertni turēt cieši noslēgtu.
LTLaikyti gerai vėdinamoje vietoje. Talpyklą laikyti sandariai uždarytą.
HUJól szellőző helyen tárolandó. Az edény szorosan lezárva tartandó.
MTAħżen f'post b'ventilazzjoni tajba. Żomm il-kontenitur magħluq sew.
NLOp een goed geventileerde plaats bewaren. In goed gesloten verpakking bewaren.
PLPrzechowywać w dobrze wentylowanym miejscu. Przechowywać pojemnik szczelnie zamknięty.
PTArmazenar em local bem ventilado. Manter o recipiente bem fechado.
ROA se depozita într-un spaţiu bine ventilat. Păstraţi recipientul închis etanş.
SKUchovávajte na dobre vetranom mieste. Nádobu uchovávajte tesne uzavretú.
SLHraniti na dobro prezračevanem mestu. Hraniti v tesno zaprti posodi.
FIVarastoi paikassa, jossa on hyvä ilmanvaihto. Säilytä tiiviisti suljettuna.
SVFörvaras på väl ventilerad plats. Förpackningen ska förvaras väl tillsluten.

P403 + P235Language
BGДа се съхранява на добре проветриво място. Да се съхранява на хладно.
ESAlmacenar en un lugar bien ventilado. Mantener en lugar fresco.
CSSkladujte na dobře větraném místě. Uchovávejte v chladu.
DAOpbevares på et godt ventileret sted. Opbevares køligt.
DEKühl an einem gut belüfteten Ort aufgewahren.
ETHoida hästi ventileeritavas kohas. Hoida jahedas.
ELΑποθηκεύεται σε καλά αεριζόμενο χώρο. Διατηρείται δροσερό.
ENStore in a well-ventilated place. Keep cool.
FRStocker dans un endroit bien ventilé. Tenir au frais.
GAStóráil in áit dhea-aeráilte. Coimeád fionnuar.
ITConservare in luogo fresco e ben ventilato.
LVGlabāt labi vēdināmās telpās. Turēt vēsumā.
LTLaikyti gerai vėdinamoje vietoje. Laikyti vėsioje vietoje.
HUJól szellőző helyen tárolandó. Hűvös helyen tartandó.
MTAħżen f'post b'ventilazzjoni tajba. Żomm frisk.
NLOp een goed geventileerde plaats bewaren. Koel bewaren.
PLPrzechowywać w dobrze wentylowanym miejscu. Przechowywać w chłodnym miejscu.
PTArmazenar em local bem ventilado. Conservar em ambiente fresco.
ROA se depozita într-un spaţiu bine ventilat. A se păstra la rece.
SKUchovávajte na dobre vetranom mieste. Uchovávajte v chlade.
SLHraniti na dobro prezračevanem mestu. Hraniti na hladnem.
FIVarastoi paikassa, jossa on hyvä ilmanvaihto. Säilytä viileässä.
SVFörvaras på väl ventilerad plats. Förvaras svalt.

P410 + P403Language
BGДа се пази от пряка слънчева светлина. Да се съхранява на добре проветриво място.
ESProteger de la luz del sol. Almacenar en un lugar bien ventilado.
CSChraňte před slunečním zářením. Skladujte na dobře větraném místě.
DABeskyttes mod sollys. Opbevares på et godt ventileret sted.
DEVor Sonnenbestrahlung geschützt an einem gut belüfteten Ort aufbewahren.
ETHoida päikesevalguse eest. Hoida hästi ventileeritavas kohas.
ELΝα προστατεύεται από τις ηλιακές ακτίνες. Αποθηκεύεται σε καλά αεριζόμενο χώρο.
ENProtect from sunlight. Store in a well-ventilated place.
FRProtéger du rayonnement solaire. Stocker dans un endroit bien ventilé.
GACosain ó sholas na gréine. Stóráil in áit dhea-aeráilte.
ITProteggere dai raggi solari. Conservare in luogo ben ventilato.
LVAizsargāt no saules gaismas. Glabāt labi vēdināmās telpās.
LTSaugoti nuo saulės šviesos. Laikyti gerai vėdinamoje vietoje.
HUNapfénytől védendő. Jól szellőző helyen tárolandó.
MTIpproteġi mid-dawl tax-xemx. Aħżen f'post b'ventilazzjoni tajba.
NLTegen zonlicht beschermen. Op een goed geventileerde plaats bewaren.
PLChronić przed światłem słonecznym. Przechowywać w dobrze wentylowanym miejscu.
PTManter ao abrigo da luz solar. Armazenar em local bem ventilado.
ROA se proteja de lumina solară. A se depozita într-un spaţiu bine ventilat.
SKChráňte pred slnečným žiarením. Uchovávajte na dobre vetranom mieste.
SLZaščititi pred sončno svetlobo. Hraniti na dobro prezračevanem mestu.
FISuojaa auringonvalolta. Varastoi paikassa, jossa on hyvä ilmanvaihto.
SVSkyddas från solljus. Förvaras på väl ventilerad plats.

P410 + P412Language
BGДа се пази от пряка слънчева светлина. Да не се излага на температури, по-високи от 50 oC/122oF.
ESProteger de la luz del sol. No exponer a temperaturas superiores a 50 oC/122oF.
CSChraňte před slunečním zářením. Nevystavujte teplotě přesahující 50 oC/122oF.
DABeskyttes mod sollys. Må ikke udsættes for en temperatur, som overstiger 50 oC/122oF.
DEVor Sonnenbestrahlung schützen und nicht Temperaturen von mehr als 50 oC aussetzen.
ETHoida päikesevalguse eest. Mitte hoida temperatuuril üle 50 oC/122 oF.
ELΝα προστατεύεται από τις ηλιακές ακτίνες. Να μην εκτίθεται σε θερμοκρασίες που υπερβαίνουν τους 50 oC/122oF.
ENProtect from sunlight. Do no expose to temperatures exceeding 50 oC/122oF.
FRProtéger du rayonnement solaire. Ne pas exposer à une température supérieure à 50 oC/122 oF.
GACosain ó sholas na gréine. Ná nocht do theocht níos airde ná 50 oC/122oF.
ITProteggere dai raggi solari. Non esporre a temperature superiori a 50 oC/122oF.
LVAizsargāt no saules gaismas. Nepakļaut temperatūrai, kas pārsniedz 50 oC/122oF.
LTSaugoti nuo saulės šviesos. Nelaikyti aukštesnėje kaip 50 oC/122oF temperatūroje.
HUNapfénytől védendő. Nem érheti 50 oC/122oF hőmérsékletet meghaladó hő.
MTIpproteġi mid-dawl tax-xemx. Tesponix għal temperatura li teċċedi l-50 oC/122oF.
NLTegen zonlicht beschermen. Niet blootstellen aan temperaturen boven 50 oC/122oF.
PLChronić przed światłem słonecznym. Nie wystawiać na działanie temperatury przekraczającej 50 oC/122 oF.
PTManter ao abrigo da luz solar. Não expor a temperaturas superiores a 50 oC/122oF.
ROA se proteja de lumina solară. Nu expuneţi la temperaturi care depăşesc 50 oC/122 oF.
SKChráňte pred slnečným žiarením. Nevystavujte teplotám nad 50 oC/122 oF.
SLZaščititi pred sončno svetlobo. Ne izpostavljati temperaturam nad 50 oC/122 oF.
FISuojaa auringonvalolta. Ei saa altistaa yli 50 oC/122 oF lämpötiloille.
SVSkyddas från solljus. Får inte utsättas för temperaturer över 50 oC/122 oF.

P411 + P235Language
BGДа се съхранява при температури, не по-високи от … oC/…oF. Да се държи на хладно.
ESAlmacenar a temperaturas no superiores a … oC/…oF. Mantener en lugar fresco.
CSSkladujte při teplotě nepřesahující … oC/…oF. Uchovávejte v chladu.
DAOpbevares ved en temperatur, som ikke overstiger … oC/…oF. Opbevares køligt.
DEKühl und bei Temperaturen von nicht mehr als … oC aufbewahren.
ETHoida temperatuuril mitte üle … oC/… oF. Hoida jahedas.
ELΑποθηκεύεται σε θερμοκρασίες που δεν υπερβαίνουν τους … oC/…oF. Διατηρείται δροσερό.
ENStore at temperatures not exceeding … oC/…oF. Keep cool.
FRStocker à une température ne dépassant pas … oC/… oF. Tenir au frais.
GAStóráil ag teocht nach airde ná … oC/…oF. Coimeád fionnuar.
ITConservare in luogo fresco a temperature non superiori a … oC/…oF.
LVGlabāt temperatūrā, kas nepārsniedz … oC/…oF. Turēt vēsumā.
LTLaikyti ne aukštesnėje kaip … oC/…oF temperatūroje. Laikyti vėsioje vietoje.
HUA tárolási hőmérséklet legfeljebb … oC/…oF lehet. Hűvös helyen tartandó.
MTAħżen f’temperaturi li ma jeċċedux … oC/…oF. Żomm frisk.
NLBij maximaal … oC/…oF bewaren. Koel bewaren.
PLPrzechowywać w temperaturze nieprzekraczającej … oC/…oF. Przechowywać w chłodnym miejscu.
PTArmazenar a uma temperatura não superior a … oC/…oF. Conservar em ambiente fresco.
ROA se depozita la temperaturi care să nu depăşească … oC/…oF. A se păstra la rece.
SKUchovávajte pri teplotách do … oC/…oF. Uchovávajte v chlade.
SLHraniti pri temperaturi do … oC/… oF. Hraniti na hladnem.
FIVarastoi alle … oC/…oF lämpötilassa. Säilytä viileässä.
SVFörvaras vid högst … oC/…oF. Förvaras svalt.


Table 1.5

Precautionary statements — Disposal

P501Language
BGСъдържанието/съдът да се изхвърли в …
ESEliminar el contenido/el recipiente en …
CSOdstraňte obsah/obal …
DAIndholdet/beholderen bortskaffes i …
DEInhalt/Behälter … zuführen.
ETSisu/mahuti kõrvaldada …
ELΔιάθεση του περιεχομένου/περιέκτη σε …
ENDispose of contents/container to …
FRÉliminer le contenu/récipient dans …
GADiúscair an t-ábhar/an coimeádán i …
ITSmaltire il prodotto/recipiente in …
LVAtbrīvoties no satura/tvertnes…
LTTurinį/talpyklą išpilti (išmesti) į …
HUA tartalom/edény elhelyezése hulladékként: …
MTArmi l-kontenut/il-kontenitur fi …
NLInhoud/verpakking afvoeren naar …
PLZawartość/pojemnik usuwać do …
PTEliminar o conteúdo/recipiente em …
ROAruncaţi conţinutul/recipientul la …
SKZneškodnite obsah/nádobu …
SLOdstraniti vsebino/posodo …
FIHävitä sisältö/pakkaus …
SVInnehållet/behållaren lämnas till…



ANNEX V

HAZARD PICTOGRAMS

INTRODUCTION

The hazard pictograms for each hazard class, differentiation of a hazard class and hazard category shall satisfy the provisions of this Annex and Annex I, section 1.2 and conform, in terms of colour, symbols and general format, to the specimens shown.

1. PART 1: PHYSICAL HAZARDS

1.1.   Symbol: exploding bomb

Pictogram

(1)
Hazard class and hazard category

(2)
GHS01


Section 2.1

Unstable explosives

Explosives of Divisions 1.1, 1.2, 1.3, 1.4

Section 2.8

Self reactive substances and mixtures, Types A, B

Section 2.15

Organic peroxides, Types A, B

1.2.   Symbol: flame

Pictogram

(1)
Hazard class and hazard category

(2)
GHS02


Section 2.2

Flammable gases, hazard category 1

Section 2.3

Flammable aerosols, hazard categories 1, 2

Section 2.6

Flammable liquids, hazard categories 1, 2, 3

Section 2.7

Flammable solids, hazard categories 1, 2

Section 2.8

Self-reactive substances and mixtures, Types B, C, D, E, F

Section 2.9

Pyrophoric liquids, hazard category 1

Section 2.10

Pyrophoric solids, hazard category 1

Section 2.11

Self-heating substances and mixtures, hazard categories 1, 2

Section 2.12

Substances and mixtures, which in contact with water, emit flammable gases, hazard categories 1, 2, 3

Section 2.15

Organic peroxides, Types B, C, D, E, F

1.3.   Symbol: flame over circle

Pictogram

(1)
Hazard class and hazard category

(2)
GHS03


Section 2.4

Oxidising gases, hazard category 1

Section 2.13

Oxidising liquids, hazard categories 1, 2, 3

Section 2.14

Oxidising solids, hazard categories 1, 2, 3

1.4.   Symbol: gas cylinder

Pictogram

(1)
Hazard class and hazard category

(2)
GHS04


Section 2.5

Gases under pressure:

Compressed gases;

Liquefied gases;

Refrigerated liquefied gases;

Dissolved gases

1.5.   Symbol: corrosion

Pictogram

(1)
Hazard class and hazard category

(2)
GHS05


Section 2.16

Corrosive to metals, hazard category 1

1.6.   A pictogram is not required for the following physical hazard classes and hazard categories:

Section 2.1: Explosives of Division 1.5

Section 2.1: Explosives of Division 1.6

Section 2.2: Flammable gases, hazard Category 2

Section 2.8: Self-reactive substances and mixtures, Type G

Section 2.15: Organic peroxides, Type G

2. PART 2: HEALTH HAZARDS

2.1.   Symbol: skull and crossbones

Pictogram

(1)
Hazard class and hazard category

(2)
GHS06


Section 3.1

Acute toxicity (oral, dermal, inhalation), hazard categories 1, 2, 3

2.2.   Symbol: corrosion

Pictogram

(1)
Hazard class and hazard category

(2)
GHS05


Section 3.2

Skin corrosion, hazard categories 1A, 1B, 1C

Section 3.3

Serious eye damage, hazard category 1

2.3.   Symbol: exclamation mark

Pictogram

(1)
Hazard class and hazard category

(2)
GHS07


Section 3.1

Acute toxicity (oral, dermal, inhalation), hazard category 4

Section 3.2

Skin irritation, hazard category 2

Section 3.3

Eye irritation, hazard category 2

Section 3.4

Skin sensitisation, hazard category 1

Section 3.8

Specific Target Organ Toxicity — Single exposure, hazard category 3

Respiratory tract irritation

Narcotic effects

2.4.   Symbol: health hazard

Pictogram

(1)
Hazard class and hazard category

(2)
GHS08


Section 3.4

Respiratory sensitisation, hazard category 1

Section 3.5

Germ cell mutagenicity, hazard categories 1A, 1B, 2

Section 3.6

Carcinogenicity, hazard categories 1A, 1B, 2

Section 3.7

Reproductive toxicity, hazard categories 1A, 1B, 2

Section 3.8

Specific Target Organ Toxicity — Single exposure, hazard categories 1, 2

Section 3.9

Specific Target Organ Toxicity — Repeated exposure, hazard categories 1, 2

Section 3.10

Aspiration hazard, hazard category 1

2.5.   A pictogram is not required for the following health hazard categories:

Section 3.7: Reproductive toxicity, Effects on or via lactation, additional hazard category

3. PART 3: ENVIRONMENTAL HAZARDS

3.1.   Symbol: environment

Pictogram

(1)
Hazard class and hazard category

(2)
GHS09


Section 4.1

Hazardous to the aquatic environment

Acute hazard category 1

Chronic hazard categories 1, 2

A pictogram is not required for the following environmental hazard classes and hazard categories:

Section 4.1: Hazardous to the aquatic environment — Chronic hazard categories 3, 4



ANNEX VI

Harmonised classification and labelling for certain hazardous substances

Part 1 of this Annex provides an introduction to the list of harmonised classification and labelling, including information listed for each entry and related classifications and hazard statements in Table 3.1, subject to certain considerations arising from translating the classifications listed in Annex I to Directive 67/548/EEC.

Part 2 of this Annex lays down general principles for preparing dossiers to propose and justify harmonised classification and labelling of substances at Community level.

Part 3 of this Annex lists hazardous substances for which harmonised classification and labelling have been established at Community level. In Table 3.1 the classification and labelling are based on the criteria in Annex I to this Regulation. In Table 3.2 classification and labelling are based on the criteria in Annex VI to Directive 67/548/EEC.

1. PART 1: INTRODUCTION TO THE LIST OF HARMONISED CLASSIFICATIONS AND LABELLING

1.1.   Information listed for each entry

1.1.1.   Numbering of entries and identification of a substance

1.1.1.1.   Index numbers

Entries in Part 3 are listed according to the atomic number of the element most characteristic of the properties of the substance. Organic substances, because of their variety, have been placed in classes. The Index number for each substance is in the form of a digit sequence of the type ABC-RST-VW-Y. ABC corresponds to the atomic number of the most characteristic element or the most characteristic organic group in the molecule. RST is the consecutive number of the substance in the series ABC. VW denotes the form in which the substance is produced or placed on the market. Y is the check-digit calculated in accordance with the 10-digit ISBN method. This number is indicated in the column entitled ‘Index No’.

1.1.1.2.   EC numbers

The EC number, i.e. EINECS, ELINCS or NLP, is the official number of the substance within the European Union. The EINECS number can be obtained from the European Inventory of Existing Commercial Chemical Substance (EINECS) (1). The ELINCS number can be obtained from the European List of Notified Substances (as amended) (EUR 22543 EN, Office for Official Publications of the European Communities, 2006, ISSN 1018-5593). The NLP number can be obtained from the list of ‘No-longer-polymers’ (as amended) (Document, Office for Official Publications of the European Communities, 1997, ISBN 92-827-8995-0). The EC number is a seven-digit system of the type XXX-XXX-X which starts at 200-001-8 (EINECS), at 400-010-9 (ELINCS) and at 500-001-0 (NLP). This number is indicated in the column entitled ‘EC No’.

1.1.1.3.   CAS number

The Chemical Abstracts Service (CAS) number is also included to assist identification of the entry. It should be noted that the EINECS number includes both anhydrous and hydrated forms of a substance, and there are frequently different CAS numbers for anhydrous and hydrated forms. The CAS number included is for the anhydrous form only, and therefore the CAS number shown does not always describe the entry as accurately as the EINECS number. This number is indicated in the column entitled ‘CAS No’.

1.1.1.4.   International Chemical Identification

Wherever possible, hazardous substances are designated by their IUPAC names. Substances listed in EINECS, ELINCS or the list of ‘No-longer-polymers’ are designated using the names in these lists. Other names, such as usual or common names, are included in some cases. Whenever possible, plant protection products and biocides are designated by their ISO names.

Impurities, additives and minor components are normally not mentioned unless they contribute significantly to the classification of the substance.

Some substances are described with a specific percentage of purity. Substances containing a higher content of active material (e.g. organic peroxide) than this percentage are not included in the entry in Part 3 and may have other hazardous properties (e.g. explosive) and should be classified and labelled accordingly.

Where specific concentration limits are shown, these apply to the substance or substances shown in the entry. In particular, in the case of entries which are mixtures of substances or substances described with a specific percentage of purity, the limits apply to the substance as described in Part 3 and not the pure substance.

Without prejudice to Article 17(2), for substances appearing in Part 3, the name of the substance to be used on the label shall be one of the designations given there. For certain substances, additional information has been added in square brackets in order to help identify the substance. This additional information need not be included on the label.

Certain entries contain a reference to impurities; in these cases the name of the substance is followed by the text: ‘(containing ≥ xx % impurity)’. The reference in brackets is then to be considered as a part of the name, and must be included on the label.

1.1.1.5.   Entries for groups of substances

A number of group entries are included in Part 3. In these cases, the classification and labelling requirements will apply to all substances covered by the description.

In some cases, there are classification and labelling requirements for specific substances that would be covered by the group entry. In such cases a specific entry is included in Part 3 for the substance and the group entry will be annotated with the phrase ‘except those specified elsewhere in this Annex’.

In some cases, individual substances may be covered by more than one group entry. In these cases, the classification of the substance reflects the classification for each of the two group entries. In cases where different classifications for the same hazard are given, the most severe classification shall be applied.

Entries in Part 3 for salts (under any denomination) cover both anhydrous and hydrous forms, unless specified otherwise.

EC or CAS numbers are not usually included for entries which comprise more than four individual substances.

1.1.2.   Information related to the classification and labelling of each entry in Table 3.1

1.1.2.1.   Classification codes

1.1.2.1.1.   Hazard class and category codes

The classification for each entry is based on the criteria set out in Annex I, in accordance with Article 13(a) and is presented in the form of a code representing the hazard class and the category or categories/divisions/types within this hazard class.

The Hazard class and category codes used for each of the hazard categories/divisions/types included in a class are shown in Table 1.1.

Table 1.1

Hazard ClassHazard Class and Category Code
ExplosiveUnst. Expl.

Expl. 1.1

Expl. 1.2

Expl. 1.3

Expl. 1.4

Expl. 1.5

Expl. 1.6
Flammable gasFlam. Gas 1

Flam. Gas 2
Flammable aerosolFlam. Aerosol 1

Flam. Aerosol 2
Oxidising gasOx. Gas 1
Gases under pressurePress. Gas (2)
Flammable liquidFlam. Liq. 1

Flam. Liq. 2

Flam. Liq. 3
Flammable solidFlam. Sol. 1

Flam. Sol. 2
Self-reactive substance or mixtureSelf-react. A

Self-react. B

Self-react. CD

Self-react. EF

Self-react. G
Pyrophoric liquidPyr. Liq. 1
Pyrophoric solidPyr. Sol. 1
Self-heating substance or mixtureSelf-heat. 1

Self-heat. 2
Substance or mixture which in contact with water emits flammable gasWater-react. 1

Water-react. 2

Water-react. 3
Oxidising liquidOx. Liq. 1

Ox. Liq. 2

Ox. Liq. 3
Oxidising solidOx. Sol. 1

Ox. Sol. 2

Ox. Sol. 3
Organic peroxideOrg. Perox. A

Org. Perox. B

Org. Perox. CD

Org. Perox. EF

Org. Perox. G
Substance or mixture corrosive to metalsMet. Corr. 1
Acute toxicityAcute Tox. 1

Acute Tox. 2

Acute Tox. 3

Acute Tox. 4
Skin corrosion/irritationSkin Corr. 1A

Skin Corr. 1B

Skin Corr. 1C

Skin Irrit. 2
Serious eye damage/eye irritationEye Dam. 1

Eye Irrit. 2
Respiratory/skin sensitizationResp. Sens. 1

Skin Sens. 1
Germ cell mutagenicityMuta. 1A

Muta. 1B

Muta. 2
CarcinogenicityCarc. 1A

Carc. 1B

Carc. 2
Reproductive toxicityRepr. 1A

Repr. 1B

Repr. 2

Lact.
Specific target organ toxicity — single exposureSTOT SE 1

STOT SE 2

STOT SE 3
Specific target organ toxicity — repeated exposureSTOT RE 1

STOT RE 2
Aspiration hazardAsp. Tox. 1
Hazardous to the aquatic environmentAquatic Acute 1

Aquatic Chronic 1

Aquatic Chronic 2

Aquatic Chronic 3

Aquatic Chronic 4
Hazardous for the ozone layerOzone

1.1.2.1.2.   Hazard statement codes

The hazard statements assigned in accordance with Article 13(b), are indicated in accordance with Annex III. In addition, for certain hazard statements letters are added to the 3-digit code. The following additional codes are used:

H350iMay cause cancer by inhalation.
H360FMay damage fertility.
H360DMay damage the unborn child.
H361fSuspected of damaging fertility.
H361dSuspected of damaging the unborn child.
H360FDMay damage fertility. May damage the unborn child.
H361fdSuspected of damaging fertility. Suspected of damaging the unborn child.
H360FdMay damage fertility. Suspected of damaging the unborn child.
H360DfMay damage the unborn child. Suspected of damaging fertility.

1.1.2.2.   Labelling codes

In the labelling column, the following elements are listed:

(i)the hazard pictogram codes as specified in Annex V, in accordance with the precedence rules in Article 26;

(ii)the signal word code ‘Dgr’ for ‘Danger’or ‘Wng’ for ‘Warning’, in accordance with the precedence rule in Article 20(3);

(iii)the hazard statement codes as specified in Annex III, in accordance with the classification;

(iv)the codes for the supplemental statements assigned in accordance with Article 25(1) and the rules specified in Annex II, part 1.

1.1.2.3.   Specific concentration limits and M-factors

Specific concentration limits, where different from the generic concentration limits given in Annex I for a certain category, are given in a separate column together with the classification concerned using the same codes as under 1.1.2.1.1. Where no specific concentration limits are given in this Annex for a certain category, the generic concentration limits given in Annex I must be applied for the classification of substances containing impurities, additives or individual constituents or for mixtures. An asterisk (*) in this column indicates that the entry has specific concentration limits for acute toxicity under Directive 67/548/EEC (Table 3.2): see also section 1.2.1.

Unless otherwise shown, the concentration limits are a percentage by weight of the substance calculated with reference to the total weight of the mixture.

In case an M-factor has been harmonised for substances classified as hazardous to the aquatic environment in the categories Aquatic Acute 1 or Aquatic Chronic 1, this M-factor is given in the same column as the specific concentration limits. Where an M-factor is not given in Table 3.1, an M-factor based on available data for the substance shall be set by the manufacturer, importer or downstream user. When a mixture including the substance is classified by the manufacturer, importer or downstream user using the summation method, this M-factor shall be used. For the setting of M-factors, see paragraph 4.1.3.5.5.5 of Annex I.

1.1.3.   Notes assigned to an entry

The note(s) assigned to an entry are listed in the column entitled ‘Notes’. The meaning of the notes is as follows:

1.1.3.1.   Notes relating to the identification, classification and labelling of substances

Note A:

Without prejudice to Article 17(2), the name of the substance must appear on the label in the form of one of the designations given in Part 3.

In Part 3, use is sometimes made of a general description such as ‘... compounds’ or ‘... salts’. In this case, the supplier is required to state on the label the correct name, due account being taken of section 1.1.1.4.

Note B:

Some substances (acids, bases, etc.) are placed on the market in aqueous solutions at various concentrations and, therefore, these solutions require different classification and labelling since the hazards vary at different concentrations.

In Part 3 entries with Note B have a general designation of the following type: ‘nitric acid … %’.

In this case the supplier must state the percentage concentration of the solution on the label. Unless otherwise stated, it is assumed that the percentage concentration is calculated on a weight/weight basis.

Note C:

Some organic substances may be marketed either in a specific isomeric form or as a mixture of several isomers.

In this case the supplier must state on the label whether the substance is a specific isomer or a mixture of isomers.

Note D:

Certain substances which are susceptible to spontaneous polymerisation or decomposition are generally placed on the market in a stabilised form. It is in this form that they are listed in Part 3.

However, such substances are sometimes placed on the market in a non-stabilised form. In this case, the supplier must state on the label the name of the substance followed by the words ‘non-stabilised’.

Note E (Table 3.2):

Substances with specific effects on human health (see Chapter 4 of Annex VI to Directive 67/548/EEC) that are classified as carcinogenic, mutagenic and/or toxic for reproduction in categories 1 or 2 are ascribed Note E if they are also classified as very toxic (T+), toxic (T) or harmful (Xn). For these substances, the risk phrases R20, R21, R22, R23, R24, R25, R26, R27, R28, R39, R68 (harmful), R48 and R65 and all combinations of these risk phrases shall be preceded by the word ‘Also’.

Note F:

This substance may contain a stabiliser. If the stabiliser changes the hazardous properties of the substance, as indicated by the classification in Part 3, classification and labelling should be provided in accordance with the rules for classification and labelling of hazardous mixtures.

Note G:

This substance may be marketed in an explosive form in which case it must be evaluated using the appropriate test methods. The classification and labelling provided shall reflect the explosive properties.

Note H (Table 3.1):

The classification and labelling shown for this substance applies to the hazardous property(ies) indicated by the hazard statement(s) in combination with the hazard class(es) and category(ies) shown. The requirements of Article 4 for manufacturers, importers or downstream users of this substance apply to all other hazard classes and categories. For hazard classes where the route of exposure or the nature of the effects leads to a differentiation of the classification of the hazard class, the manufacturer, importer or downstream user is required to consider the routes of exposure or the nature of the effects not already considered.

The final label shall follow the requirements of Article 17 and of section 1.2 of Annex I.

Note H (Table 3.2):

The classification and label shown for this substance applies to the dangerous property(ies) indicated by the risk phrase(s) in combination with the category(ies) of danger shown. Manufacturers, importers and downstream users of this substance shall be obliged to carry out an investigation to make themselves aware of the relevant and accessible data which exists for all other properties to classify and label the substance. The final label shall follow the requirements of section 7 of Annex VI to Directive 67/548/EEC.

Note J:

The classification as a carcinogen or mutagen need not apply if it can be shown that the substance contains less than 0,1 % w/w benzene (EINECS No 200-753-7). This note applies only to certain complex coal- and oil-derived substances in Part 3.

Note K:

The classification as a carcinogen or mutagen need not apply if it can be shown that the substance contains less than 0,1 % w/w 1,3-butadiene (EINECS No 203-450-8). If the substance is not classified as a carcinogen or mutagen, at least the precautionary statements (P102-)P210-P403 (Table 3.1) or the S-phrases (2-)9-16 (Table 3.2) should apply. This note applies only to certain complex oil-derived substances in Part 3.

Note L:

The classification as a carcinogen need not apply if it can be shown that the substance contains less than 3 % DMSO extract as measured by IP 346 ‘Determination of polycyclic aromatics in unused lubricating base oils and asphaltene free petroleum fractions — Dimethyl sulphoxide extraction refractive index method’, Institute of Petroleum, London. This note applies only to certain complex oil-derived substances in Part 3.

Note M:

The classification as a carcinogen need not apply if it can be shown that the substance contains less than 0,005 % w/w benzo[a]-pyrene (EINECS No 200-028-5). This note applies only to certain complex coal-derived substances in Part 3.

Note N:

The classification as a carcinogen need not apply if the full refining history is known and it can be shown that the substance from which it is produced is not a carcinogen. This note applies only to certain complex oil-derived substances in Part 3.

Note P:

The classification as a carcinogen or mutagen need not apply if it can be shown that the substance contains less than 0,1 % w/w benzene (EINECS No 200-753-7).

When the substance is not classified as a carcinogen at least the precautionary statements (P102-)P260-P262-P301 + P310-P331 (Table 3.1) or the S-phrases (2-)23-24-62 (Table 3.2) shall apply.

This note applies only to certain complex oil-derived substances in Part 3.

Note Q:

The classification as a carcinogen need not apply if it can be shown that the substance fulfils one of the following conditions:

a short term biopersistence test by inhalation has shown that the fibres longer than 20 μm have a weighted half-life less than 10 days; or

a short term biopersistence test by intratracheal instillation has shown that the fibres longer than 20 μm have a weighted half-life less than 40 days; or

an appropriate intra-peritoneal test has shown no evidence of excess carcinogenicity; or

absence of relevant pathogenicity or neoplastic changes in a suitable long term inhalation test.

Note R:

The classification as a carcinogen need not apply to fibres with a length weighted geometric mean diameter less two standard geometric errors greater than 6 μm.

Note S:

This substance may not require a label according to Article 17 (see section 1.3 of Annex I) (Table 3.1).

This substance may not require a label according to Article 23 of Directive 67/548/EEC (see section 8 of Annex VI to that Directive) (Table 3.2).

Note T:

This substance may be marketed in a form which does not have the physical hazards as indicated by the classification in the entry in Part 3. If the results of the relevant method or methods in accordance with Part 2 of Annex I of this Regulation show that the specific form of substance marketed does not exhibit this physical property or these physical hazards, the substance shall be classified in accordance with the result or results of this test or these tests. Relevant information, including reference to the relevant test method(s) shall be included in the safety data sheet.

Note U (Table 3.1):

When put on the market gases have to be classified as ‘Gases under pressure’, in one of the groups compressed gas, liquefied gas, refrigerated liquefied gas or dissolved gas. The group depends on the physical state in which the gas is packaged and therefore has to be assigned case by case.

1.1.3.2.   Notes relating to the classification and labelling of mixtures

Note 1:

The concentration stated or, in the absence of such concentrations, the generic concentrations of this Regulation (Table 3.1) or the generic concentrations of Directive 1999/45/EC (Table 3.2), are the percentages by weight of the metallic element calculated with reference to the total weight of the mixture.

Note 2:

The concentration of isocyanate stated is the percentage by weight of the free monomer calculated with reference to the total weight of the mixture.

Note 3:

The concentration stated is the percentage by weight of chromate ions dissolved in water calculated with reference to the total weight of the mixture.

Note 5:

The concentration limits for gaseous mixtures are expressed as volume per volume percentage.

Note 7:

Alloys containing nickel are classified for skin sensitisation when the release rate of 0,5 μg Ni/cm2/week, as measured by the European Standard reference test method EN 1811, is exceeded.

1.1.4.   Information related to the classification and labelling of each entry in Table 3.2

1.1.4.1.   Classification codes

The classification for each category of danger (as defined in Article 2(2) of Directive 67/548/EEC) is normally presented in the form of an abbreviation representing the category of danger together with the appropriate risk phrase or phrases. However, in some cases (i.e. substances classified as flammable, sensitising and some substances classified as dangerous for the environment) the risk phrase alone is used;

The abbreviation for each of the categories of danger is shown below:

explosive: E

oxidising: O

extremely flammable: F+

highly flammable: F

flammable: R10

very toxic: T+

Toxic: T

harmful: Xn

corrosive: C

irritant: Xi

sensitising: R42 and/or R43

carcinogenic: Carc. Cat. (1, 2 or 3)

mutagenic: Muta. Cat. (1, 2 or 3)

toxic for reproduction: Repr. Cat. (1, 2 or 3)

dangerous for the environment: N or R52 and/or R53;

1.1.4.2.   Labelling codes

(i)the letter assigned to the substance in accordance with Annex II to Directive 67/548/EEC (see Article 23(2)(c) Directive 67/548/EEC). This acts as an abbreviation for the symbol and for the indication of danger (if these are assigned);

(ii)the risk phrases, denoted as a series of numbers preceded by the letter R indicating the nature of the special risks, in accordance with Annex III to Directive 67/548/EEC (see Article 23(2)(d) Directive 67/548/EEC). The numbers are separated by either a dash (-) to denote separate statements concerning special risks (R), or an oblique stroke (/) to denote a combined statement, in a single sentence, of the special risks as set out in Annex III to Directive 67/548/EEC;

(iii)the safety phrases denoted as a series of numbers preceded by the letter S indicating the recommended safety precautions, in accordance with Annex IV to Directive 67/548/EEC (see Article 23(2)(e) Directive 67/548/EEC). Again the numbers are separated by either a dash or an oblique stroke; the significance of recommended safety precautions is set out in Annex IV to Directive 67/548/EEC. The safety phrases shown apply only to substances; for mixtures, phrases are selected according to the usual rules.

Note that for certain dangerous substances and mixtures sold to the general public certain S-phrases are mandatory.

S1, S2 and S45 are obligatory for all very toxic, toxic and corrosive substances and mixtures sold to the general public.

S2 and S46 are obligatory for all other dangerous substances and mixtures sold to the general public other than those that have only been classified as dangerous for the environment.

Safety phrases S1 and S2 are shown in brackets in Annex I and can only be omitted from the label when the substance or mixture is sold for industrial use only.

1.1.4.3.   Specific Concentration Limits

The concentration limits and associated classifications are necessary to classify dangerous mixtures containing the substance in accordance with Directive 1999/45/EC.

Unless otherwise shown, the concentration limits are a percentage by weight of the substance calculated with reference to the total weight of the mixture.

Where no concentration limits are given, the concentration limits to be used when applying the conventional method of assessing health hazards are those in Annex II, and when applying the conventional method of assessing environmental hazards are those in Annex III to Directive 1999/45/EC.

1.1.4.4.   Non-conformity with Table 3.1 for physical hazards

It is recommended to update the physical hazards of some entries in Table 3.2 in a forthcoming adaptation to technical progress.

Until these entries are updated, the physical hazards of the corresponding entries in both tables will not be in conformity. These entries are indicated with reference ⊗ in Table 3.2.

1.2.   Classifications and hazard statements in table 3.1 arising from translation of classifications listed in Annex i to directive 67/548/EEC

1.2.1.   Minimum classification

For certain hazard classes, including acute toxicity and STOT repeated exposure, the classification according to the criteria in Directive 67/548/EEC does not correspond directly to the classification in a hazard class and category under this Regulation. In these cases the classification in this Annex shall be considered as a minimum classification. This classification shall be applied if none of the following conditions are fulfilled:

the manufacturer or importer has access to data or other information as specified in Part 1 of Annex I that lead to classification in a more severe category compared to the minimum classification. Classification in the more severe category must then be applied;

the minimum classification can be further refined based on the translation table in Annex VII when the physical state of the substance used in the acute inhalation toxicity test is known to the manufacturer or importer. The classification as obtained from Annex VII shall then substitute the minimum classification indicated in this Annex if it differs from it.

Minimum classification for a category is indicated by the reference * in the column ‘Classification’ in Table 3.1.

The reference * can also be found in the column ‘Specific concentration Limits and M-factors’ where it indicates that the entry concerned has specific concentration limits under Directive 67/548/EEC (Table 3.2) for acute toxicity. These concentration limits cannot be ‘translated’ into concentration limits under this Regulation, especially when a minimum classification is given. However, when the reference * is shown, the classification for acute toxicity for this entry may be of special concern.

1.2.2.   Route of exposure cannot be excluded

For certain hazard classes, e.g. STOT, the route of exposure should be indicated in the hazard statement only if it is conclusively proven that no other route of exposure can cause the hazard in accordance to the criteria in Annex I. Under Directive 67/548/EEC the route of exposure is indicated for classifications with R48 when there was data justifying the classification for this route of exposure. The classification under 67/548/EEC indicating the route of exposure has been translated into the corresponding class and category according to this Regulation, but with a general hazard statement not specifying the route of exposure as the necessary information is not available.

These hazard statements are indicated by the reference ** in Table 3.1.

1.2.3.   Hazard statements for reproductive toxicity

Hazard statements H360 and H361 indicate a general concern for effects on both fertility and development: ‘May damage/Suspected of damaging fertility or the unborn child’. According to the criteria, the general hazard statement can be replaced by the hazard statement indicating only the property of concern, where either fertility or developmental effects are proven to be not relevant.

In order not to lose information from the harmonised classifications for fertility and developmental effects under Directive 67/548/EEC, the classifications have been translated only for those effects classified under that Directive.

These hazard statements are indicated by the reference *** in Table 3.1.

1.2.4.   Correct classification for physical hazards could not be established

For some entries the correct classification for physical hazards could not be established because sufficient data are not available for the application of the classification criteria in this Regulation. The entry might be assigned to a different (also higher) category or even another hazard class than indicated. The correct classification shall be confirmed by testing.

The entries with physical hazards that need to be confirmed by testing are indicated by the reference **** in Table 3.1.

2. PART 2: DOSSIERS FOR HARMONISED CLASSIFICATION AND LABELLING

This Part lays down general principles for preparing dossiers to propose and justify harmonised classification and labelling.

The relevant parts of sections 1, 2 and 3 of Annex I to Regulation (EC) No 1907/2006 shall be used for the methodology and format of any dossier.

For all dossiers any relevant information from registration dossiers shall be considered and other available information may be used. For hazard information which has not been previously submitted to the Agency, a robust study summary shall be included in the dossier.

A dossier for harmonised classification and labelling shall contain the following:

Proposal

The proposal shall include the identity of the substance or substances concerned and the harmonised classification and labelling proposed.

Justification for the proposed harmonised classification and labelling

A comparison of the available information with the criteria contained in Parts 2 to 5, taking into account the general principles in Part 1, of Annex I to this Regulation shall be completed and documented in the format set out in Part B of the Chemical Safety Report in Annex I to Regulation (EC) No 1907/2006.

Justification for other effects at Community level

For other effects than carcinogenity, mutagenicity, reprotoxicity and respiratory sensitisation a justification shall be provided that there is a need for action demonstrated at Community level. This does not apply for an active substance in the meaning of Directive 91/414/EEC or Directive 98/8/EC.

3. PART 3: HARMONISED CLASSIFICATION AND LABELLING TABLES

Table 3.1: List of harmonised classification and labelling of hazardous substances is listed in the separate Volume IIIa.

Table 3.2: The list of harmonised classification and labelling of hazardous substances from Annex I to Directive 67/548/EEC is listed in the separate Volume IIIb.

Table 3.1

List of harmonised classification and labelling of hazardous substances

Index NoInternational Chemical IdentificationEC NoCAS NoClassificationLabellingSpecific Conc. Limits, M-factorsNotes
Hazard Class and Category Code(s)Hazard statement Code(s)Pictogram, Signal Word Code(s)Hazard statement Code(s)Suppl. Hazard statement Code(s)
001-001-00-9hydrogen215-605-71333-74-0Flam. Gas 1

Press. Gas
H220GHS02

GHS04

Dgr
H220U
001-002-00-4aluminium lithium hydride240-877-916853-85-3Water-react. 1H260GHS02

Dgr
H260
001-003-00-Xsodium hydride231-587-37646-69-7Water-react. 1H260GHS02

Dgr
H260
001-004-00-5calcium hydride232-189-27789-78-8Water-react. 1H260GHS02

Dgr
H260
003-001-00-4lithium231-102-57439-93-2Water-react. 1

Skin Corr. 1B
H260

H314
GHS02

GHS05

Dgr
H260

H314
EUH014
003-002-00-Xn-hexyllithium404-950-021369-64-2Water-react. 1

Pyr. Sol. 1

Skin Corr. 1A
H260

H250

H314
GHS02

GHS05

Dgr
H260

H250

H314
EUH014
004-001-00-7beryllium231-150-77440-41-7Carc. 1B

Acute Tox. 2 *

Acute Tox. 3 *

STOT RE 1

Eye Irrit. 2

STOT SE 3

Skin Irrit. 2

Skin Sens. 1
H350i

H330

H301

H372 **

H319

H335

H315

H317
GHS06

GHS08

Dgr
H350i

H330

H301

H372 **

H319

H335

H315

H317
004-002-00-2beryllium compounds with the exception of aluminium beryllium silicates, and with those specified elsewhere in this AnnexCarc. 1B

Acute Tox. 2 *

Acute Tox. 3 *

STOT RE 1

Eye Irrit. 2

STOT SE 3

Skin Irrit. 2

Skin Sens. 1

Aquatic Chronic 2
H350i

H330

H301

H372 **

H319

H335

H315

H317

H411
GHS06

GHS08

GHS09

Dgr
H350i

H330

H301

H372 **

H319

H335

H315

H317

H411
A
004-003-00-8beryllium oxide215-133-11304-56-9Carc. 1B

Acute Tox. 2 *

Acute Tox. 3 *

STOT RE 1

Eye Irrit. 2

STOT SE 3

Skin Irrit. 2

Skin Sens. 1
H350i

H330

H301

H372 **

H319

H335

H315

H317
GHS06

GHS08

Dgr
H350i

H330

H301

H372 **

H319

H335

H315

H317
005-001-00-Xboron trifluoride231-569-57637-07-2Press. Gas

Acute Tox. 2 *

Skin Corr. 1A
H330

H314
GHS04

GHS06

GHS05

Dgr
H330

H314
EUH014U
005-002-00-5boron trichloride233-658-410294-34-5Press. Gas

Acute Tox. 2 *

Acute Tox. 2 *

Skin Corr. 1B
H330

H300

H314
GHS04

GHS06

GHS05

Dgr
H330

H300

H314
EUH014U
005-003-00-0boron tribromide233-657-910294-33-4Acute Tox. 2 *

Acute Tox. 2 *

Skin Corr. 1A
H330

H300

H314
GHS06

GHS05

Dgr
H330

H300

H314
EUH014
005-004-00-6trialkylboranes, solidPyr. Sol. 1

Skin Corr. 1B
H250

H314
GHS02

GHS05

Dgr
H250

H314
A
005-004-01-3trialkylboranes, liquidPyr. Liq. 1

Skin Corr. 1B
H250

H314
GHS02

GHS05

Dgr
H250

H314
A
005-005-00-1trimethyl borate204-468-9121-43-7Flam. Liq. 3

Acute Tox. 4 *
H226

H312
GHS02

GHS07

Wng
H226

H312
005-006-00-7dibutyltin hydrogen borate401-040-575113-37-0STOT RE 1

Acute Tox. 4 *

Acute Tox. 4 *

Eye Dam. 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H372 **

H312

H302

H318

H317

H400

H410
GHS08

GHS05

GHS07

GHS09

Dgr
H372 **

H312

H302

H318

H317

H410
005-009-00-3tetrabutylammonium butyltriphenylborate418-080-4120307-06-4Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H317

H400

H410
GHS07

GHS09

Wng
H317

H410
005-010-00-9N,N-dimethylanilinium tetrakis(pentafluorophenyl)borate422-050-6118612-00-3Carc. 2

Acute Tox. 4 *

Skin Irrit. 2

Eye Dam. 1
H351

H302

H315

H318
GHS08

GHS05

GHS07

Dgr
H351

H302

H315

H318
005-012-00-Xdiethyl{4-[1,5,5-tris(4-diethylaminophenyl)penta-2,4-dienylidene]cyclohexa-2,5-dienylidene}ammonium butyltriphenylborate418-070-1141714-54-7Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H317

H400

H410
GHS07

GHS09

Wng
H317

H410
006-001-00-2carbon monoxide211-128-3630-08-0Flam. Gas 1

Press. Gas

Repr. 1A

Acute Tox. 3 *

STOT RE 1
H220

H360D ***

H331

H372 **
GHS02

GHS04

GHS06

GHS08

Dgr
H220

H360D ***

H331

H372 **
U
006-002-00-8phosgene;

carbonyl chloride
200-870-375-44-5Press. Gas

Acute Tox. 2 *

Skin Corr. 1B
H330

H314
GHS04

GHS06

GHS05

Dgr
H330

H314
U
006-003-00-3carbon disulphide200-843-675-15-0Flam. Liq. 2

Repr. 2

STOT RE 1

Eye Irrit. 2

Skin Irrit. 2
H225

H361fd

H372 **

H319

H315
GHS02

GHS08

GHS07

Dgr
H225

H361fd

H372 **

H319

H315
Repr. 2; H361fd: C ≥ 1 %

STOT RE 1; H372: C ≥ 1 %

STOT RE 2; H373: 0,2 % ≤C < 1 %
006-004-00-9calcium carbide200-848-375-20-7Water-react. 1H260GHS02

Dgr
H260T
006-005-00-4thiram (ISO);

tetramethylthiuram disulphide
205-286-2137-26-8Acute Tox. 4 *

Acute Tox. 4 *

STOT RE 2 *

Eye Irrit. 2

Skin Irrit. 2

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H332

H302

H373 **

H319

H315

H317

H400

H410
GHS08

GHS07

GHS09

Wng
H332

H302

H373 **

H319

H315

H317

H410
M = 10
006-006-00-Xhydrogen cyanide;

hydrocyanic acid
200-821-674-90-8Flam. Liq. 1

Acute Tox. 2 *

Aquatic Acute 1

Aquatic Chronic 1
H224

H330

H400

H410
GHS02

GHS06

GHS09

Dgr
H224

H330

H410
006-006-01-7hydrogen cyanide … %;

hydrocyanic acid … %
200-821-674-90-8Acute Tox. 2 *

Acute Tox. 1

Acute Tox. 2 *

Aquatic Acute 1

Aquatic Chronic 1
H330

H310

H300

H400

H410
GHS06

GHS09

Dgr
H330

H310

H300

H410
B
006-007-00-5salts of hydrogen cyanide with the exception of complex cyanides such as ferrocyanides, ferricyanides and mercuric oxycyanideAcute Tox. 2 *

Acute Tox. 1

Acute Tox. 2 *

Aquatic Acute 1

Aquatic Chronic 1
H330

H310

H300

H400

H410
GHS06

GHS09

Dgr
H330

H310

H300

H410
EUH032A
006-008-00-0antu (ISO);

1-(1-naphthyl)-2-thiourea
201-706-386-88-4Acute Tox. 2 *

Carc. 2
H300

H351
GHS06

GHS08

Dgr
H300

H351
006-009-00-61-isopropyl-3-methylpyrazol-5-yl dimethylcarbamate;

isolan
204-318-2119-38-0Acute Tox. 1

Acute Tox. 2 *
H310

H300
GHS06

Dgr
H310

H300
006-010-00-15,5-dimethyl-3-oxocyclohex-1-enyl dimethylcarbamate 5,5-dimethyldihydroresorcinol dimethylcarbamate;

dimetan
204-525-8122-15-6Acute Tox. 3 *H301GHS06

Dgr
H301
006-011-00-7carbaryl (ISO);

1-naphthyl methylcarbamate
200-555-063-25-2Carc. 2

Acute Tox. 4 *

Aquatic Acute 1
H351

H302

H400
GHS08

GHS07

GHS09

Wng
H351

H302

H400
006-012-00-2ziram (ISO);

zinc bis dimethyldithiocarbamate
205-288-3137-30-4Acute Tox. 2 *

Acute Tox. 4 *

STOT RE 2 *

STOT SE 3

Eye Dam. 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H330

H302

H373 **

H335

H318

H317

H400

H410
GHS06

GHS08

GHS05

GHS09

Dgr
H330

H302

H373 **

H335

H318

H317

H410
M = 100
006-013-00-8metam-sodium (ISO);

sodium methyldithiocarbamate
205-293-0137-42-8Acute Tox. 4 *

Skin Corr. 1B

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H302

H314

H317

H400

H410
GHS05

GHS07

GHS09

Dgr
H302

H314

H317

H410
EUH031
006-014-00-3nabam (ISO);

disodium ethylenebis(N,N'-dithiocarbamate)
205-547-0142-59-6Acute Tox. 4 *

STOT SE 3

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H302

H335

H317

H410
GHS07

GHS09

Wng
H302

H335

H317

H410
006-015-00-9diuron (ISO);

3-(3,4-dichlorophenyl)-1,1-dimethylurea
206-354-4330-54-1Carc. 2

Acute Tox. 4 *

STOT RE 2 *

Aquatic Acute 1

Aquatic Chronic 1
H351

H302

H373 **

H400

H410
GHS08

GHS07

GHS09

Wng
H351

H302

H373 **

H410
006-016-00-4propoxur (ISO);

2-isopropyloxyphenyl N-methylcarbamate;

2-isopropoxyphenyl methylcarbamate
204-043-8114-26-1Acute Tox. 3 *

Aquatic Acute 1

Aquatic Chronic 1
H301

H400

H410
GHS06

GHS09

Dgr
H301

H410
006-017-00-Xaldicarb (ISO);

2-methyl-2-(methylthio)propanal-O-(N-methylcarbamoyl)oxime
204-123-2116-06-3Acute Tox. 2 *

Acute Tox. 2 *

Acute Tox. 3 *

Aquatic Acute 1

Aquatic Chronic 1
H330

H300

H311

H400

H410
GHS06

GHS09

Dgr
H330

H300

H311

H410
006-018-00-5aminocarb (ISO);

4-dimethylamino-3-tolyl methylcarbamate
217-990-72032-59-9Acute Tox. 3 *

Acute Tox. 3 *

Aquatic Acute 1

Aquatic Chronic 1
H311

H301

H400

H410
GHS06

GHS09

Dgr
H311

H301

H410
006-019-00-0di-allate (ISO);

S-(2,3-dichloroallyl)-N,N-diisopropylthiocarbamate
218-961-12303-16-4Carc. 2

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1
H351

H302

H400

H410
GHS08

GHS07

GHS09

Wng
H351

H302

H410
006-020-00-6barban (ISO);

4-chlorbut-2-ynyl N-(3-chlorophenyl)carbamate
202-930-4101-27-9Acute Tox. 4 *

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H302

H317

H400

H410
GHS07

GHS09

Wng
H302

H317

H410
006-021-00-1linuron (ISO);

3-(3,4-dichlorophenyl)-1-methoxy-1-methylurea
206-356-5330-55-2Repr. 1B

Carc. 2

Acute Tox. 4 *

STOT RE 2 *

Aquatic Acute 1

Aquatic Chronic 1
H360Df

H351

H302

H373 **

H400

H410
GHS08

GHS07

GHS09

Dgr
H360Df

H351

H302

H373 **

H410
006-022-00-7decarbofuran (ISO);

2,3-dihydro-2-methylbenzofuran-7-yl methylcarbamate
1563-67-3Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *
H331

H311

H301
GHS06

Dgr
H331

H311

H301
006-023-00-2mercaptodimethur (ISO);

methiocarb (ISO);

3,5-dimethyl-4-methylthiophenyl N-methylcarbamate
217-991-22032-65-7Acute Tox. 3 *

Aquatic Acute 1

Aquatic Chronic 1
H301

H400

H410
GHS06

GHS09

Dgr
H301

H410
006-024-00-8proxan-sodium (ISO);

sodium O-isopropyldithiocarbonate
205-443-5140-93-2Acute Tox. 4 *

Skin Irrit. 2

Aquatic Chronic 2
H302

H315

H411
GHS07

GHS09

Wng
H302

H315

H411
006-025-00-3allethrin;

(RS)-3-allyl-2-methyl-4-oxocyclopent-2-enyl (1RS,3RS;1RS,3SR)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate;

bioallethrin;

(RS)-3-allyl-2-methyl-4-oxocyclopent-2-enyl (1R,3R)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate; [1]

S-bioallethrin;

(S)-3-allyl-2-methyl-4-oxocyclopent-2-enyl (1R,3R)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate; [2]

esbiothrin;

(RS)-3-allyl-2-methyl-4-oxocyclopent-2-enyl (1R,3R)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate [3]
209-542-4 [1]

249-013-5 [2]-[3]
584-79-2 [1]

28434-00-6 [2]

84030-86-4 [3]
Acute Tox. 4 *

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1
H332

H302

H400

H410
GHS07

GHS09

Wng
H332

H302

H410
C
006-026-00-9carbofuran (ISO);

2,3-dihydro-2,2-dimethylbenzofuran-7-yl N-methylcarbamate
216-353-01563-66-2Acute Tox. 2 *

Acute Tox. 2 *

Aquatic Acute 1

Aquatic Chronic 1
H330

H300

H400

H410
GHS06

GHS09

Dgr
H330

H300

H410
006-028-00-Xdinobuton (ISO);

2-(1-methylpropyl)-4,6-dinitrophenyl isopropyl carbonate
213-546-1973-21-7Acute Tox. 3 *

Aquatic Acute 1

Aquatic Chronic 1
H301

H400

H410
GHS06

GHS09

Dgr
H301

H410
006-029-00-5dioxacarb (ISO);

2-(1,3-dioxolan-2-yl)phenyl N-methylcarbamate
230-253-46988-21-2Acute Tox. 3 *

Aquatic Chronic 2
H301

H411
GHS06

GHS09

Dgr
H301

H411
006-030-00-0EPTC (ISO);

S-ethyl dipropylthiocarbamate
212-073-8759-94-4Acute Tox. 4 *H302GHS07

Wng
H302
006-031-00-6formetanate (ISO);

3-[(EZ)-dimethylaminomethyleneamino]phenyl methylcarbamate
244-879-022259-30-9Acute Tox. 2 *

Acute Tox. 2 *

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H330

H300

H317

H400

H410
GHS06

GHS09

Dgr
H330

H300

H317

H410
006-032-00-1monolinuron (ISO);

3-(4-chlorophenyl)-1-methoxy-1-methylurea
217-129-51746-81-2Acute Tox. 4 *

STOT RE 2 *

Aquatic Acute 1

Aquatic Chronic 1
H302

H373 **

H400

H410
GHS08

GHS07

GHS09

Wng
H302

H373 **

H410
006-033-00-7metoxuron (ISO);

3-(3-chloro-4-methoxyphenyl)-1,1-dimethylurea
243-433-219937-59-8Aquatic Acute 1

Aquatic Chronic 1
H400

H410
GHS09

Wng
H410
006-034-00-2pebulate (ISO);

N-butyl-N-ethyl-S-propylthiocarbamate
214-215-41114-71-2Acute Tox. 4 *

Aquatic Chronic 2
H302

H411
GHS07

GHS09

Wng
H302

H411
006-035-00-8pirimicarb (ISO);

5,6-dimethyl-2-dimethylamino-pyrimidin-4-yl N,N-dimethylcarbamate
245-430-123103-98-2Acute Tox. 3 *

Aquatic Acute 1

Aquatic Chronic 1
H301

H400

H410
GHS06

GHS09

Dgr
H301

H410
006-036-00-3benzthiazuron (ISO);

1-benzothiazol-2-yl-3-methylurea
217-685-91929-88-0Acute Tox. 4 *H302GHS07

Wng
H302
006-037-00-9promecarb (ISO);

3-isopropyl-5-methylphenyl N-methylcarbamate
220-113-02631-37-0Acute Tox. 3 *

Aquatic Acute 1

Aquatic Chronic 1
H301

H400

H410
GHS06

GHS09

Dgr
H301

H410
006-038-00-4sulfallate (ISO);

2-chloroallyl N,N-dimethyldithiocarbamate
202-388-995-06-7Carc. 1B

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1
H350

H302

H400

H410
GHS08

GHS07

GHS09

Dgr
H350

H302

H410
006-039-00-Xtri-allate (ISO);

S-2,3,3-trichloroallyl diisopropylthiocarbamate
218-962-72303-17-5Acute Tox. 4 *

STOT RE 2 *

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H302

H373 **

H317

H400

H410
GHS08

GHS07

GHS09

Wng
H302

H373 **

H317

H410
006-040-00-53-methylpyrazol-5-yl-dimethylcarbamate;

monometilan
2532-43-6Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *
H331

H311

H301
GHS06

Dgr
H331

H311

H301
006-041-00-0dimethylcarbamoyl chloride201-208-679-44-7Carc. 1B

Acute Tox. 3 *

Acute Tox. 4 *

Eye Irrit. 2

STOT SE 3

Skin Irrit. 2
H350

H331

H302

H319

H335

H315
GHS06

GHS08

Dgr
H350

H331

H302

H319

H335

H315
Carc. 1B; H350: C ≥ 0,001 %
006-042-00-6monuron (ISO);

3-(4-chlorophenyl)-1,1-dimethylurea
205-766-1150-68-5Carc. 2

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1
H351

H302

H400

H410
GHS08

GHS07

GHS09

Wng
H351

H302

H410
006-043-00-13-(4-chlorophenyl)-1,1-dimethyluronium trichloroacetate;

monuron-TCA
140-41-0Carc. 2

Eye Irrit. 2

Skin Irrit. 2

Aquatic Acute 1

Aquatic Chronic 1
H351

H319

H315

H400

H410
GHS08

GHS07

GHS09

Wng
H351

H319

H315

H410
006-044-00-7isoproturon (ISO);

3-(4-isopropylphenyl)-1,1-dimethylurea
251-835-434123-59-6Carc. 2

Aquatic Acute 1

Aquatic Chronic 1
H351

H400

H410
GHS08

GHS09

Wng
H351

H410
M = 10
006-045-00-2methomyl (ISO);

1-(methylthio)ethylideneamino N-methylcarbamate
240-815-016752-77-5Acute Tox. 2 *

Aquatic Acute 1

Aquatic Chronic 1
H300

H400

H410
GHS06

GHS09

Dgr
H300

H410
006-046-00-8bendiocarb (ISO);

2,2-dimethyl-1,3-benzodioxol-4-yl N-methylcarbamate
245-216-822781-23-3Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1
H331

H301

H312

H410
GHS06

GHS09

Dgr
H331

H301

H312

H410
006-047-00-3bufencarb (ISO);

reaction mass of 3-(1-methylbutyl)phenyl N-methylcarbamate and 3-(1-ethylpropyl)phenyl N-methylcarbamate
8065-36-9Acute Tox. 3 *

Acute Tox. 3 *

Aquatic Acute 1

Aquatic Chronic 1
H311

H301

H400

H410
GHS06

GHS09

Dgr
H311

H301

H410
006-048-00-9ethiofencarb (ISO);

2-(ethylthiomethyl)phenyl N-methylcarbamate
249-981-929973-13-5Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1
H302

H400

H410
GHS07

GHS09

Wng
H302

H410
006-049-00-4dixanthogen;

O,O-diethyl dithiobis(thioformate)
207-944-4502-55-6Acute Tox. 4 *H302GHS07

Wng
H302
006-050-00-X1,1-dimethyl-3-phenyluronium trichloroacetate;

fenuron-TCA
4482-55-7Skin Irrit. 2

Aquatic Acute 1

Aquatic Chronic 1
H315

H400

H410
GHS07

GHS09

Wng
H315

H410
006-051-00-5ferbam (ISO);

iron tris(dimethyldithiocarbamate)
238-484-214484-64-1Eye Irrit. 2

STOT SE 3

Skin Irrit. 2

Aquatic Acute 1

Aquatic Chronic 1
H319

H335

H315

H400

H410
GHS07

GHS09

Wng
H319

H335

H315

H410
006-052-00-0formetanate hydrochloride;

3-(N,N-dimethylaminomethyleneamino)phenyl N-methylcarbamate
245-656-023422-53-9Acute Tox. 2 *

Acute Tox. 2 *

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H330

H300

H317

H400

H410
GHS06

GHS09

Dgr
H330

H300

H317

H410
006-053-00-6isoprocarb (ISO);

2-isopropylphenyl N-methylcarbamate
220-114-62631-40-5Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1
H302

H400

H410
GHS07

GHS09

Wng
H302

H410
006-054-00-1mexacarbate (ISO);

3,5-dimethyl-4-dimethylaminophenyl N-methylcarbamate
206-249-3315-18-4Acute Tox. 2 *

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1
H300

H312

H400

H410
GHS06

GHS09

Dgr
H300

H312

H410
006-055-00-7xylylcarb (ISO);

3,4-dimethylphenyl N-methylcarbamate;

3,4-xylyl methylcarbamate;

MPMC
219-364-92425-10-7Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1
H302

H400

H410
GHS07

GHS09

Wng
H302

H410
006-056-00-2metolcarb (ISO);

m-tolyl methylcarbamate;

MTMC
214-446-01129-41-5Acute Tox. 4 *

Aquatic Chronic 2
H302

H411
GHS07

GHS09

Wng
H302

H411
006-057-00-8nitrapyrin (ISO);

2-chloro-6-trichloromethylpyridine
217-682-21929-82-4Acute Tox. 4 *

Aquatic Chronic 2
H302

H411
GHS07

GHS09

Wng
H302

H411
006-058-00-3noruron (ISO);

1,1-dimethyl-3-(perhydro-4,7-methanoinden-5-yl)urea
2163-79-3Acute Tox. 4 *H302GHS07

Wng
H302
006-059-00-9oxamyl (ISO);

N',N'-dimethylcarbamoyl(methylthio)methylenamine N-methylcarbamate;
245-445-323135-22-0Acute Tox. 2 *

Acute Tox. 2 *

Acute Tox. 4 *

Aquatic Chronic 2
H330

H300

H312

H411
GHS06

GHS09

Dgr
H330

H300

H312

H411
006-060-00-4oxycarboxin (ISO);

2,3-dihydro-6-methyl-5-(N-phenylcarbamoyl)-1,4-oxothiine 4,4-dioxide
226-066-25259-88-1Acute Tox. 4 *

Aquatic Chronic 3
H302

H412
GHS07

Wng
H302

H412
006-061-00-XS-ethyl N-(dimethylaminopropyl)thiocarbamatehydrochloride;

prothiocarb hydrochloride
243-193-919622-19-6Acute Tox. 4 *

Aquatic Chronic 2
H302

H411
GHS07

GHS09

Wng
H302

H411
006-062-00-5methyl 3,4-dichlorophenylcarbanilate;

SWEP.
1918-18-9Acute Tox. 4 *H302GHS07

Wng
H302
006-063-00-0thiobencarb (ISO);

S-4-chlorobenzyl diethylthiocarbamate
248-924-528249-77-6Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1
H302

H400

H410
GHS07

GHS09

Wng
H302

H410
006-064-00-6thiofanox (ISO);

3,3-dimethyl-1-(methylthio)butanone-O-(N-methylcarbamoyl)oxime
254-346-439196-18-4Acute Tox. 1

Acute Tox. 2 *

Aquatic Acute 1

Aquatic Chronic 1
H310

H300

H400

H410
GHS06

GHS09

Dgr
H310

H300

H410
006-065-00-13-chloro-6-cyano-bicyclo(2,2,1)heptan-2-one-O-(N-methylcarbamoyl)oxime;

triamid
15271-41-7Acute Tox. 2 *

Acute Tox. 3 *

Aquatic Chronic 2
H300

H311

H411
GHS06

GHS09

Dgr
H300

H311

H411
006-066-00-7vernolate (ISO);

S-propyl dipropylthiocarbamate
217-681-71929-77-7Acute Tox. 4 *

Aquatic Chronic 2
H302

H411
GHS07

GHS09

Wng
H302

H411
006-067-00-2XMC;

3,5-xylyl methylcarbamate
2655-14-3Acute Tox. 4 *H302GHS07

Wng
H302
006-068-00-8diazomethane206-382-7334-88-3Carc. 1BH350GHS08

Dgr
H350
006-069-00-3thiophanate-methyl (ISO);

1,2-di-(3-methoxycarbonyl-2-thioureido)benzene
245-740-723564-05-8Muta. 2

Acute Tox. 4 *

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H341

H332

H317

H400

H410
GHS08

GHS07

GHS09

Wng
H341

H332

H317

H410
006-070-00-9furmecyclox (ISO);

N-cyclohexyl-N-methoxy-2,5-dimethyl-3-furamide
262-302-060568-05-0Carc. 2

Aquatic Acute 1

Aquatic Chronic 1
H351

H400

H410
GHS08

GHS09

Wng
H351

H410
006-071-00-4cyclooct-4-en-1-yl methyl carbonate401-620-887731-18-8Skin Sens. 1H317GHS07

Wng
H317
006-072-00-Xprosulfocarb (ISO);

S-benzyl N,N-dipropylthiocarbamate
401-730-652888-80-9Acute Tox. 4 *

Skin Sens. 1

Aquatic Chronic 2
H302

H317

H411
GHS07

GHS09

Wng
H302

H317

H411
006-073-00-53-(dimethylamino)propylurea401-950-231506-43-1Eye Dam. 1H318GHS05

Dgr
H318
006-074-00-02-(3-(prop-1-en-2-yl)phenyl)prop-2-yl isocyanate402-440-22094-99-7Acute Tox. 2 *

Skin Corr. 1B

STOT RE 2 *

Resp. Sens. 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H330

H314

H373 **

H334

H317

H400

H410
GHS06

GHS08

GHS05

GHS09

Dgr
H330

H314

H373 **

H334

H317

H410
006-076-00-1mancozeb (ISO)8018-01-7STOT SE 3

Skin Sens. 1
H335

H317
GHS07

Wng
H335

H317
006-077-00-7maneb (ISO)235-654-812427-38-2STOT SE 3

Skin Sens. 1
H335

H317
GHS07

Wng
H335

H317
006-078-00-2zineb (ISO);

zinc ethylenebis(dithiocarbamate) (polymeric)
235-180-112122-67-7STOT SE 3

Skin Sens. 1
H335

H317
GHS07

Wng
H335

H317
006-079-00-8disulfiram;

tetraethylthiuramdisulfide
202-607-897-77-8Acute Tox. 4 *

STOT RE 2 *

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H302

H373 **

H317

H400

H410
GHS08

GHS07

GHS09

Wng
H302

H373 **

H317

H410
006-080-00-3tetramethylthiuram monosulphide202-605-797-74-5Acute Tox. 4 *

Skin Sens. 1

Aquatic Chronic 2
H302

H317

H411
GHS07

GHS09

Wng
H302

H317

H411
006-081-00-9zinc bis(dibutyldithiocarbamate)205-232-8136-23-2Eye Irrit. 2

STOT SE 3

Skin Irrit. 2

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H319

H335

H315

H317

H400

H410
GHS07

GHS09

Wng
H319

H335

H315

H317

H410
006-082-00-4zinc bis(diethyldithiocarbamate)238-270-914324-55-1Acute Tox. 4 *

Eye Irrit. 2

STOT SE 3

Skin Irrit. 2

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H302

H319

H335

H315

H317

H400

H410
GHS07

GHS09

Wng
H302

H319

H335

H315

H317

H410
006-083-00-Xbutocarboxim (ISO);

3-(methylthio)-2-butanone O-[(methylamino)carbonyl]oxime
252-139-334681-10-2Flam. Liq. 3

Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *

Eye Irrit. 2

Aquatic Acute 1

Aquatic Chronic 1
H226

H331

H311

H301

H319

H400

H410
GHS02

GHS06

GHS09

Dgr
H226

H331

H311

H301

H319

H410
006-084-00-5carbosulfan (ISO);

2,3-dihydro-2,2-dimethyl-7-benzofuryl [(dibutylamino)thio]methylcarbamate
259-565-955285-14-8Acute Tox. 3 *

Acute Tox. 3 *

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H331

H301

H317

H400

H410
GHS06

GHS09

Dgr
H331

H301

H317

H410
006-085-00-0fenobucarb (ISO);

2-butylphenyl methylcarbamate
223-188-83766-81-2Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1
H302

H400

H410
GHS07

GHS09

Wng
H302

H410
006-086-00-6ethyl [2-(4-phenoxyphenoxy)ethyl]carbamate;

fenoxycarb
276-696-772490-01-8Aquatic Acute 1

Aquatic Chronic 1
H400

H410
GHS09

Wng
H410
006-087-00-12,3-dihydro-2,2-dimethyl-7-benzofuryl 2,4-dimethyl-6-oxa-5-oxo-3-thia-2,4-diazadecanoate;

furathiocarb
265-974-365907-30-4Acute Tox. 2 *

Acute Tox. 3 *

STOT RE 2 *

Eye Irrit. 2

Skin Irrit. 2

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H330

H301

H373 **

H319

H315

H317

H400

H410
GHS06

GHS08

GHS09

Dgr
H330

H301

H373 **

H319

H315

H317

H410
006-088-00-7benfuracarb;

ethyl N-[2,3-dihydro-2,2-dimethylbenzofuran-7-yloxycarbonyl(methyl)aminothio]-N-isopropyl- β-alaninate
82560-54-1Acute Tox. 3 *

Acute Tox. 3 *

Aquatic Acute 1

Aquatic Chronic 1
H331

H301

H400

H410
GHS06

GHS09

Dgr
H331

H301

H410
006-089-00-2chlorine dioxide233-162-810049-04-4Ox. Gas 1

Press. Gas

Acute Tox. 2 *

Skin Corr. 1B

Aquatic Acute 1
H270

H330

H314

H400
GHS03

GHS04

GHS06

GHS05

GHS09

Dgr
H270

H330

H314

H400
EUH006M = 1000U
006-089-01-Xchlorine dioxide . . . %233-162-810049-04-4Acute Tox. 3 *

Skin Corr. 1B

Aquatic Acute 1
H301

H314

H400
GHS06

GHS05

GHS09

Dgr
H301

H314

H400
Skin Corr. 1B; H314: C ≥ 10 %

Skin Irrit. 2; H315: 3 % ≤ C < 10 %

Eye Irrit. 2; H319: 0,3 % ≤ C < 10 %

STOT SE 3; H335: C ≥ 3 %

M = 10
B
006-090-00-82-(3-iodoprop-2-yn-1-yloxy)ethyl phenylcarbamate408-010-088558-41-2Acute Tox. 4 *

Eye Dam. 1

Aquatic Chronic 3
H332

H318

H412
GHS05

GHS07

Dgr
H332

H318

H412
007-001-00-5ammonia, anhydrous231-635-37664-41-7Flam. Gas 2

Press. Gas

Acute Tox. 3 *

Skin Corr. 1B

Aquatic Acute 1
H221

H331

H314

H400
GHS04

GHS06

GHS05

GHS09

Dgr
H221

H331

H314

H400
U
007-001-01-2ammonia ….%215-647-61336-21-6Skin Corr. 1B

Aquatic Acute 1
H314

H400
GHS05

GHS09

Dgr
H314

H400
STOT SE 3; H335: C ≥ 5 %B
007-002-00-0nitrogen dioxide; [1]

dinitrogen tetraoxide [2]
233-272-6 [1]

234-126-4 [2]
10102-44-0 [1]

10544-72-6 [2]
Press. Gas

Acute Tox. 2 *

Skin Corr. 1B
H330

H314
GHS04

GHS06

GHS05

Dgr
H330

H314
*U

5
007-003-00-6chlormequat chloride (ISO);

2-chloroethyltrimethylammonium chloride
213-666-4999-81-5Acute Tox. 4 *

Acute Tox. 4 *
H312

H302
GHS07

Wng
H312

H302
007-004-00-1nitric acid … %231-714-27697-37-2Ox. Liq. 3

Skin Corr. 1A
H272

H314
GHS03

GHS05

Dgr
H272

H314
Skin Corr. 1A; H314: C ≥ 20 %

Skin Corr. 1B; H314: 5 % ≤ C < 20 %

Ox. Liq. 3; H272: C ≥ 65 %
B
007-006-00-2ethyl nitrite203-722-6109-95-5Flam. Gas 1

Press. Gas

Acute Tox. 4 *

Acute Tox. 4 *

Acute Tox. 4 *
H220

H332

H312

H302
GHS02

GHS04

GHS07

Dgr
H220

H332

H312

H302
U
007-007-00-8ethyl nitrate210-903-3625-58-1Unst. Expl.H200GHS01

Dgr
H200
007-008-00-3hydrazine206-114-9302-01-2Flam. Liq. 3

Carc. 1B

Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *

Skin Corr. 1B

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H226

H350

H331

H311

H301

H314

H317

H400

H410
GHS02

GHS06

GHS08

GHS05

GHS09

Dgr
H226

H350

H331

H311

H301

H314

H317

H410
Skin Corr. 1B; H314: C ≥ 10 %

Skin Irrit. 2; H315: 3 % ≤ C < 10 %

Eye Irrit. 2; H319: 3 % ≤ C < 10 %
007-009-00-9dicyclohexylammonium nitrite221-515-93129-91-7Acute Tox. 4 *

Acute Tox. 4 *
H332

H302
GHS07

Wng
H332

H302
*
007-010-00-4sodium nitrite231-555-97632-00-0Ox. Sol. 3

Acute Tox. 3 *

Aquatic Acute 1
H272

H301

H400
GHS03

GHS06

GHS09

Dgr
H272

H301

H400
*
007-011-00-Xpotassium nitrite231-832-47758-09-0Ox. Sol. 2

Acute Tox. 3 *

Aquatic Acute 1
H272

H301

H400
GHS03

GHS06

GHS09

Dgr
H272

H301

H400
*
007-012-00-5N,N-dimethylhydrazine200-316-057-14-7Flam. Liq. 2

Carc. 1B

Acute Tox. 3 *

Acute Tox. 3 *

Skin Corr. 1B

Aquatic Chronic 2
H225

H350

H331

H301

H314

H411
GHS02

GHS06

GHS08

GHS05

GHS09

Dgr
H225

H350

H331

H301

H314

H411
007-013-00-01,2-dimethylhydrazine540-73-8Carc. 1B

Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *

Aquatic Chronic 2
H350

H331

H311

H301

H411
GHS06

GHS08

GHS09

Dgr
H350

H331

H311

H301

H411
Carc. 1B; H350: C ≥ 0,01 %
007-014-00-6salts of hydrazineCarc. 1B

Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H350

H331

H311

H301

H317

H400

H410
GHS06

GHS08

GHS09

Dgr
H350

H331

H311

H301

H317

H410
A
007-015-00-1O-ethylhydroxylamine402-030-3624-86-2Flam. Liq. 2

Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *

STOT RE 1

Eye Irrit. 2

Skin Sens. 1

Aquatic Acute 1
H225

H331

H311

H301

H372 **

H319

H317

H400
GHS02

GHS06

GHS08

GHS09

Dgr
H225

H331

H311

H301

H372 **

H319

H317

H400
007-016-00-7butyl nitrite208-862-1544-16-1Flam. Liq. 2

Acute Tox. 3 *

Acute Tox. 3 *
H225

H331

H301
GHS02

GHS06

Dgr
H225

H331

H301
007-017-00-2isobutyl nitrite208-819-7542-56-3Flam. Liq. 2

Carc. 1B

Muta. 2

Acute Tox. 4 *

Acute Tox. 4 *
H225

H350

H341

H332

H302
GHS02

GHS08

GHS07

Dgr
H225

H350

H341

H332

H302
007-018-00-8sec-butyl nitrite213-104-8924-43-6Flam. Liq. 2

Acute Tox. 4 *

Acute Tox. 4 *
H225

H332

H302
GHS02

GHS07

Dgr
H225

H332

H302
007-019-00-3tert-butyl nitrite208-757-0540-80-7Flam. Liq. 2

Acute Tox. 4 *

Acute Tox. 4 *
H225

H332

H302
GHS02

GHS07

Dgr
H225

H332

H302
007-020-00-9pentyl nitrite; [1]

‘amyl nitrite’, mixed isomers [2]
207-332-7 [1]

203-770-8 [2]
463-04-7 [1]

110-46-3 [2]
Flam. Liq. 2

Acute Tox. 4 *

Acute Tox. 4 *
H225

H332

H302
GHS02

GHS07

Dgr
H225

H332

H302
007-021-00-4hydrazobenzene;

1,2-diphenylhydrazine
204-563-5122-66-7Carc. 1B

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1
H350

H302

H400

H410
GHS08

GHS07

GHS09

Dgr
H350

H302

H410
007-022-00-Xhydrazine bis(3-carboxy-4-hydroxybenzensulfonate)405-030-1Carc. 1B

Acute Tox. 4 *

Skin Corr. 1B

Skin Sens. 1

Aquatic Chronic 3
H350

H302

H314

H317

H412
GHS08

GHS05

GHS07

Dgr
H350

H302

H314

H317

H412
007-023-00-5sodium 3,5-bis(3-(2,4-di-tert-pentylphenoxy)propylcarbamoyl)benzenesulfonate405-510-0Skin Irrit. 2

Skin Sens. 1
H315

H317
GHS07

Wng
H315

H317
007-024-00-02-(decylthio)ethylammonium chloride405-640-836362-09-1STOT RE 2 *

Skin Irrit. 2

Eye Dam. 1

Aquatic Acute 1

Aquatic Chronic 1
H373 **

H315

H318

H400

H410
GHS08

GHS05

GHS09

Dgr
H373 **

H315

H318

H410
007-025-00-6(4-hydrazinophenyl)-N-methylmethanesulfonamide hydrochloride406-090-181880-96-8Muta. 2

Acute Tox. 3 *

STOT RE 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H341

H301

H372 **

H317

H400

H410
GHS06

GHS08

GHS09

Dgr
H341

H301

H372 **

H317

H410
007-026-00-1oxo-((2,2,6,6-tetramethylpiperidin-4-yl)amino)carbonylacetohydrazide413-230-5122035-71-6Eye Dam. 1

Skin Sens. 1
H318

H317
GHS05

GHS07

Dgr
H318

H317
007-027-00-71,6-bis(3,3-bis((1-methylpentylidenimino)propyl)ureido)hexane420-190-2771478-66-1Acute Tox. 4 *

Acute Tox. 4 *

STOT RE 2 *

Skin Corr. 1B

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H312

H302

H373 **

H314

H317

H400

H410
GHS08

GHS05

GHS07

GHS09

Dgr
H312

H302

H373 **

H314

H317

H410
008-001-00-8oxygen231-956-97782-44-7Ox. Gas 1

Press. Gas
H270GHS03

GHS04

Dgr
H270U
008-003-00-9hydrogen peroxide solution … %231-765-07722-84-1Ox. Liq. 1

Acute Tox. 4 *

Acute Tox. 4 *

Skin Corr. 1A
H271

H332

H302

H314
GHS03

GHS05

GHS07

Dgr
H271

H332

H302

H314
Ox. Liq. 1; H271: C ≥ 70 %****

Ox. Liq. 2; H272: 50 % ≤ C < 70 % ****

*

Skin Corr. 1A; H314: C ≥ 70 %

Skin Corr. 1B; H314: 50 % ≤ C < 70 %

Skin Irrit. 2; H315: 35 % ≤ C < 50 %

Eye Dam. 1; H318: 8 % ≤ C < 50 %

Eye Irrit. 2; H319: 5 % ≤ C < 8 %

STOT SE 3; H335; C ≥ 35 %
B
009-001-00-0fluorine231-954-87782-41-4Ox. Gas 1

Press. Gas

Acute Tox. 2 *

Skin Corr. 1A
H270

H330

H314
GHS03

GHS04

GHS06

GHS05

Dgr
H270

H330

H314
U
009-002-00-6hydrogen fluoride231-634-87664-39-3Acute Tox. 2 *

Acute Tox. 1

Acute Tox. 2 *

Skin Corr. 1A
H330

H310

H300

H314
GHS06

GHS05

Dgr
H330

H310

H300

H314
009-003-00-1hydrofluoric acid … %231-634-87664-39-3Acute Tox. 2 *

Acute Tox. 1

Acute Tox. 2 *

Skin Corr. 1A
H330

H310

H300

H314
GHS06

GHS05

Dgr
H330

H310

H300

H314
Skin Corr. 1A; H314: C ≥ 7 %

Skin Corr. 1B; H314: 1 % ≤ C < 7 %

Eye Irrit. 2; H319: 0,1 % ≤ C < 1 %
B
009-004-00-7sodium fluoride231-667-87681-49-4Acute Tox. 3 *

Eye Irrit. 2

Skin Irrit. 2
H301

H319

H315
GHS06

Dgr
H301

H319

H315
EUH032
009-005-00-2potassium fluoride232-151-57789-23-3Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *
H331

H311

H301
GHS06

Dgr
H331

H311

H301
009-006-00-8ammonium fluoride235-185-912125-01-8Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *
H331

H311

H301
GHS06

Dgr
H331

H311

H301
009-007-00-3sodium bifluoride;

sodium hydrogen difluoride
215-608-31333-83-1Acute Tox. 3 *

Skin Corr. 1B
H301

H314
GHS06

GHS05

Dgr
H301

H314
*

Skin Corr. 1B; H314: C ≥ 1 %

Skin Irrit. 2; H315: 0,1 % ≤ C < 1 %

Eye Irrit. 2; H319: 0,1 % ≤ C < 1 %
009-008-00-9potassium bifluoride;

potassium hydrogen difluoride
232-156-27789-29-9Acute Tox. 3 *

Skin Corr. 1B
H301

H314
GHS06

GHS05

Dgr
H301

H314
*

Skin Corr. 1B; H314: C ≥ 1 %

Skin Irrit. 2; H315: 0,1 % ≤ C < 1 %

Eye Irrit. 2; H319: 0,1 % ≤ C < 1 %
009-009-00-4ammonium bifluoride;

ammonium hydrogen difluoride
215-676-41341-49-7Acute Tox. 3 *

Skin Corr. 1B
H301

H314
GHS06

GHS05

Dgr
H301

H314
*

Skin Corr. 1B; H314: C ≥ 1 %

Skin Irrit. 2; H315: 0,1 % ≤ C < 1 %

Eye Irrit. 2; H319: 0,1 % ≤ C < 1 %
009-010-00-Xfluoroboric acid ... %240-898-316872-11-0Skin Corr. 1BH314GHS05

Dgr
H314Skin Corr. 1B; H314: C ≥ 25 %

Skin Irrit. 2; H315: 10 % ≤ C < 25 %

Eye Irrit. 2; H319: 10 % ≤ C < 25 %
B
009-011-00-5fluorosilicic acid ... %241-034-816961-83-4Skin Corr. 1BH314GHS05

Dgr
H314B
009-012-00-0alkali fluorosilicates(Na); [1]

alkali fluorosilicates(K); [2]

alkali fluorosilicates(NH4) [3]
240-934-8 [1]

240-896-2 [2]

240-968-3 [3]
16893-85-9 [1]

16871-90-2 [2]

16919-19-0 [3]
Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *
H331

H311

H301
GHS06

Dgr
H331

H311

H301
*A
009-013-00-6fluorosilicates, with the exception of those specified elsewhere in this AnnexAcute Tox. 4 *H302GHS07

Wng
H302*A
009-014-00-1lead hexafluorosilicate247-278-125808-74-6Repr. 1A

Acute Tox. 4 *

Acute Tox. 4 *

STOT RE 2 *

Aquatic Acute 1

Aquatic Chronic 1
H360Df

H332

H302

H373 **

H400

H410
GHS08

GHS07

GHS09

Dgr
H360Df

H332

H302

H373 **

H410
1
009-015-00-7sulphuryl difluoride220-281-52699-79-8Press. Gas

Acute Tox. 3 *

STOT RE 2 *

Aquatic Acute 1
H331

H373 **

H400
GHS04

GHS06

GHS08

GHS09

Dgr
H331

H373 **

H400
U
009-016-00-2trisodium hexafluoroaluminate;

cryolite
237-410-6

239-148-8
13775-53-6

15096-52-3
STOT RE 1

Acute Tox. 4 *

Acute Tox. 4 *

Aquatic Chronic 2
H372 **

H332

H302

H411
GHS08

GHS07

GHS09

Dgr
H372 **

H332

H302

H411
C
009-017-00-8potassium mu-fluoro-bis(triethylaluminium)400-040-212091-08-6Flam. Sol. 1

Water-react. 1

Skin Corr. 1A

Acute Tox. 4 *
H228

H270

H314

H332
GHS02

GHS05

GHS07

Dgr
H228

H270

H314

H332
EUH014T
009-018-00-3magnesium hexafluorosilicate241-022-216949-65-8Acute Tox. 3 *H301GHS06

Dgr
H301*
011-001-00-0sodium231-132-97440-23-5Water-react. 1

Skin Corr. 1B
H260

H314
GHS02

GHS05

Dgr
H260

H314
EUH014
011-002-00-6sodium hydroxide;

caustic soda
215-185-51310-73-2Skin Corr. 1AH314GHS05

Dgr
H314Skin Corr. 1A; H314: C ≥ 5 %

Skin Corr. 1B; H314: 2 % ≤ C < 5 %

Skin Irrit. 2; H315: 0,5 % ≤ C < 2 %

Eye Irrit. 2; H319: 0,5 % ≤ C < 2 %
011-003-00-1sodium peroxide215-209-41313-60-6Ox. Sol. 1

Skin Corr. 1A
H271

H314
GHS03

GHS05

Dgr
H271

H314
011-004-00-7sodium azide247-852-126628-22-8Acute Tox. 2 *

Aquatic Acute 1

Aquatic Chronic 1
H300

H400

H410
GHS06

GHS09

Dgr
H300

H400

H410
EUH032
011-005-00-2sodium carbonate207-838-8497-19-8Eye Irrit. 2H319GHS07

Wng
H319
011-006-00-8sodium cyanate213-030-6917-61-3Acute Tox. 4 *

Aquatic Chronic 3
H302

H412
GHS07

Wng
H302

H412
011-007-00-3propoxycarbazone-sodium181274-15-7Aquatic Acute 1

Aquatic Chronic 1
H400

H410
GHS09

Wng
H410M = 10
012-001-00-3magnesium powder (pyrophoric)231-104-67439-95-4Water-react. 1

Pyr. Sol. 1
H260

H250
GHS02

Dgr
H260

H250
T
012-002-00-9magnesium, powder or turnings231-104-6Flam. Sol. 1

Water-react. 2

Self-heat. 1
H228

H261

H252
GHS02

Dgr
H228

H261

H252
T
012-003-00-4magnesium alkylsPyr. Liq. 1

Water-react. 1

Skin Corr. 1B
H250

H260

H314
GHS02

GHS05

Dgr
H250

H260

H314
EUH014A
013-001-00-6aluminium powder (pyrophoric)231-072-37429-90-5Water-react. 2

Pyr. Sol. 1
H261

H250
GHS02

Dgr
H261

H250
T
013-002-00-1aluminium powder (stabilised)231-072-3Water-react. 2

Flam.Sol. 3
H261

H228
GHS02

Dgr
H261

H228
T
013-003-00-7aluminium chloride, anhydrous231-208-17446-70-0Skin Corr. 1BH314GHS05

Dgr
H314
013-004-00-2aluminium alkylsPyr. Liq. 1

Water-react. 1

Skin Corr. 1B
H250

H260

H314
GHS02

GHS05

Dgr
H250

H260

H314
EUH014A
013-005-00-8diethyl(ethyldimethylsilanolato)aluminium401-160-855426-95-4Water-react. 1

Pyr. Liq. 1

Skin Corr. 1A
H260

H250

H314
GHS02

GHS05

Dgr
H260

H250

H314
EUH014
013-006-00-3(ethyl-3-oxobutanoato-O'1,O'3)(2-dimethylaminoethanolato)(1-methoxypropan-2-olato)aluminium(III), dimerised402-370-2Flam. Liq. 3

Eye Dam. 1
H226

H318
GHS02

GHS05

Dgr
H226

H318
013-007-00-9poly(oxo(2-butoxyethyl-3-oxobutanoato-O'1,O'3)aluminium)403-430-0Eye Dam. 1H318GHS05

Dgr
H318
013-008-00-4di-n-octylaluminium iodide408-190-07585-14-0Pyr. Liq. 1

Skin Corr. 1B

Aquatic Acute 1

Aquatic Chronic 1
H250

H314

H400

H410
GHS02

GHS05

GHS09

Dgr
H250

H314

H410
EUH014
013-009-00-Xsodium (n-butyl)x(ethyl)y-1,5-dihydro)aluminate x = 0,5 y = 1,5418-720-2Flam. Sol. 1

Water-react. 1

Pyr. Sol. 1

Acute Tox. 4 *

Skin Corr. 1A
H228

H260

H250

H332

H314
GHS02

GHS05

GHS07

Dgr
H228

H260

H250

H332

H314
EUH014T
014-001-00-9trichlorosilane233-042-510025-78-2Flam. Liq. 1

Pyr. Liq. 1

Acute Tox. 4 *

Acute Tox. 4 *

Skin Corr. 1A
H224

H250

H332

H302

H314
GHS02

GHS05

GHS07

Dgr
H224

H250

H332

H302

H314
EUH014

EUH029
*

STOT SE 3; H335: C ≥ 1 %
T
014-002-00-4silicon tetrachloride233-054-010026-04-7Eye Irrit. 2

STOT SE 3

Skin Irrit. 2
H319

H335

H315
GHS07

Wng
H319

H335

H315
EUH014
014-003-00-Xdimethyldichlorosilane200-901-075-78-5Flam. Liq. 2

Eye Irrit. 2

STOT SE 3

Skin Irrit. 2
H225

H319

H335

H315
GHS02

GHS07

Dgr
H225

H319

H335

H315
014-004-00-5trichloro(methyl)silane;

methyltrichlorosilane
200-902-675-79-6Flam. Liq. 2

Eye Irrit. 2

STOT SE 3

Skin Irrit. 2
H225

H319

H335

H315
GHS02

GHS07

Dgr
H225

H319

H335

H315
EUH014Skin Irrit. 2; H315: C ≥ 1 %

Eye Irrit. 2; H319: C ≥ 1 %

STOT SE 3; H335: C ≥ 1 %
014-005-00-0tetraethyl silicate;

ethyl silicate
201-083-878-10-4Flam. Liq. 3

Acute Tox. 4 *

Eye Irrit. 2

STOT SE 3
H226

H332

H319

H335
GHS02

GHS07

Wng
H226

H332

H319

H335
014-006-00-6bis(4-fluorophenyl)-methyl-(1,2,4-triazol-4-ylmethyl)silane hydrochloride401-380-4Eye Irrit. 2

Aquatic Chronic 2
H319

H411
GHS07

GHS09

Wng
H319

H411
014-007-00-1triethoxyisobutylsilane402-810-317980-47-1Skin Irrit. 2H315GHS07

Wng
H315
014-008-00-7(chloromethyl)bis(4-fluorophenyl)methylsilane401-200-485491-26-5Aquatic Chronic 2H411GHS09H411
014-009-00-2isobutylisopropyldimethoxysilane402-580-4111439-76-0Flam. Liq. 3

Acute Tox. 4 *

Skin Irrit. 2
H226

H332

H315
GHS02

GHS07

Wng
H226

H332

H315
014-010-00-8disodium metasilicate229-912-96834-92-0Skin Corr. 1B

STOT SE 3
H314

H335
GHS05

GHS07

Dgr
H314

H335
014-011-00-3cyclohexyldimethoxymethylsilane402-140-117865-32-6Skin Irrit. 2

Aquatic Chronic 2
H315

H411
GHS07

GHS09

Wng
H315

H411
014-012-00-9bis(3-(trimethoxysilyl)propyl)amine403-480-3Eye Dam. 1

Aquatic Chronic 2
H318

H411
GHS05

GHS09

Dgr
H318

H411
014-013-00-4α-hydroxypoly(methyl-(3-(2,2,6,6-tetramethylpiperidin-4-yloxy)propyl)siloxane)404-920-7Acute Tox. 4 *

Acute Tox. 4 *

Skin Corr. 1B

Aquatic Chronic 2
H312

H302

H314

H411
GHS05

GHS07

GHS09

Dgr
H312

H302

H314

H411
014-014-00-Xetacelasil (ISO);

6-(2-chloroethyl)-6-(2-methoxyethoxy)-2,5,7,10-tetraoxa-6-silaundecane
253-704-737894-46-5Repr. 1B

Acute Tox. 4 *

STOT RE 2 *
H360D ***

H302

H373 **
GHS08

GHS07

Dgr
H360D ***

H302

H373 **
014-015-00-5α-trimethylsilanyl-ω-trimethylsiloxypoly[oxy(methyl-3-(2-(2-methoxypropoxy)propoxy)propylsilanediyl]- co-oxy(dimethylsilane))406-420-469430-40-6Aquatic Chronic 4H413H413
014-016-00-0reaction mass of: 1,3-dihex-5-en-1-yl-1,1,3,3-tetramethyldisiloxane;

1,3-dihex-n-en-1-yl-1,1,3,3-tetramethyldisiloxane
406-490-6Aquatic Chronic 2H411GHS09H411
014-017-00-6flusilazole (ISO);

bis(4-fluorophenyl)(methyl)(1H-1,2,4-triazol-1-ylmethyl)silane
85509-19-9Carc. 2

Repr. 1B

Acute Tox. 4 *

Aquatic Chronic 2
H351

H360D ***

H302

H411
GHS08

GHS07

GHS09

Dgr
H351

H360D ***

H302

H411
014-018-00-1octamethylcyclotetrasiloxane209-136-7556-67-2Repr. 2

Aquatic Chronic 4
H361f ***

H413
GHS08

Wng
H361f ***

H413
014-019-00-7reaction mass of: 4-[[bis-(4-fluorophenyl)methylsilyl]methyl]-4H-1,2,4-triazole;

1-[[bis-(4-fluorophenyl)methylsilyl]methyl]-1H-1,2,4-triazole
403-250-2Carc. 2

Repr. 1B

Acute Tox. 4 *

Aquatic Chronic 2
H351

H360D ***

H302

H411
GHS08

GHS07

GHS09

Dgr
H351

H360D ***

H302

H411
014-020-00-2bis(1,1-dimethyl-2-propynyloxy)dimethylsilane414-960-753863-99-3Acute Tox. 4 *H332GHS07

Wng
H332
014-021-00-8tris(isopropenyloxy)phenyl silane411-340-852301-18-5Aquatic Acute 1

Aquatic Chronic 1
H400

H410
GHS09

Wng
H400

H410
014-022-00-3reaction product of: (2-hydroxy-4-(3-propenoxy)benzophenone and triethoxysilane) with (hydrolysis product of silica and methyltrimethoxysilane)401-530-9Flam. Sol. 1

STOT SE 1

Acute Tox. 4 *

Acute Tox. 4 *

Acute Tox. 4 *
H228

H370 **

H332

H312

H302
GHS02

GHS08

GHS07

Dgr
H228

H370 **

H332

H312

H302
T
014-023-00-9α, ω-dihydroxypoly(hex-5-en-1-ylmethylsiloxane)hoxysilane with (hydrolysis product of silica and methyltrimethoxysilane)iazole408-160-7125613-45-8Aquatic Chronic 2H411GHS09H411
014-024-00-41-((3-(3-chloro-4-fluorophenyl)propyl)dimethylsilanyl)-4-ethoxybenzene412-620-2121626-74-2Aquatic Chronic 2H411GHS09H411
014-025-00-X4-[3-(diethoxymethylsilylpropoxy)-2,2,6,6-tetramethyl]piperidine411-400-3102089-33-8Acute Tox. 4 *

STOT RE 2 *

Skin Irrit. 2

Eye Dam. 1

Aquatic Chronic 3
H302

H373 **

H315

H318

H412
GHS08

GHS05

GHS07

Dgr
H302

H373 **

H315

H318

H412
014-026-00-5dichloro-(3-(3-chloro-4-fluorophenyl)propyl)methylsilane407-180-3770722-36-6Skin Corr. 1AH314GHS05

Dgr
H314
014-027-00-0chloro(3-(3-chloro-4-fluorophenyl)propyl)dimethylsilane410-270-5770722-46-8Skin Corr. 1AH314GHS05

Dgr
H314
014-028-00-6α-[3-(1-oxoprop-2-eny)l-1-oxypropyl]dimethoxysilyloxy-ω-[3(1-oxoprop-2-enyl)-1-oxypropyl]dimethoxysilyl poly(dimethylsiloxane)415-290-8193159-06-7Skin Sens. 1H317GHS07

Wng
H317
014-029-00-1O,O'-(ethenylmethylsilylene)di[(4-methylpentan-2-one)oxime]421-870-1156145-66-3Repr. 2

Acute Tox. 4 *

STOT RE 2 *
H361f ***

H302

H373 **
GHS08

GHS07

Wng
H361f ***

H302

H373 **
014-030-00-7[(dimethylsilylene)bis((1,2,3,3a,7a-η)-1H-inden-1-ylidene)dimethyl]hafnium422-060-0137390-08-0Acute Tox. 2 *H300GHS06

Dgr
H300
014-031-00-2bis(1-methylethyl)-dimethoxysilane421-540-718230-61-0Flam. Liq. 3

Skin Irrit. 2

Skin Sens. 1

Aquatic Chronic 3
H226

H315

H317

H412
GHS02

GHS07

Wng
H226

H315

H317

H412
014-032-00-8dicyclopentyldimethoxysilane404-370-8126990-35-0Skin Irrit. 2

Eye Dam. 1

Aquatic Acute 1

Aquatic Chronic 1
H315

H318

H400

H410
GHS05

GHS09

Dgr
H315

H318

H410
015-001-00-1white phosphorus231-768-712185-10-3Pyr. Sol. 1

Acute Tox. 2 *

Acute Tox. 2 *

Skin Corr. 1A

Aquatic Acute 1
H250

H330

H300

H314

H400
GHS02

GHS06

GHS05

GHS09

Dgr
H250

H330

H300

H314

H400
015-002-00-7red phosphorus231-768-77723-14-0Flam. Sol. 1

Aquatic Chronic 3
H228

H412
GHS02

Dgr
H228

H412
015-003-00-2calcium phosphide;

tricalcium diphosphide
215-142-01305-99-3Water-react. 1

Acute Tox. 2 *

Aquatic Acute 1
H260

H300

H400
GHS02

GHS06

GHS09

Dgr
H260

H300

H400
EUH029T
015-004-00-8aluminium phosphide244-088-020859-73-8Water-react. 1

Acute Tox. 2 *

Aquatic Acute 1
H260

H300

H400
GHS02

GHS06

GHS09

Dgr
H260

H300

H400
EUH029

EUH032
T
015-005-00-3magnesium phosphide;

trimagnesium diphosphide
235-023-712057-74-8Water-react. 1

Acute Tox. 2 *

Aquatic Acute 1
H260

H300

H400
GHS02

GHS06

GHS09

Dgr
H260

H300

H400
EUH029T
015-006-00-9trizinc diphosphide;

zinc phosphide
215-244-51314-84-7Water-react. 1

Acute Tox. 2 *

Aquatic Acute 1

Aquatic Chronic 1
H260

H300

H400

H410
GHS02

GHS06

GHS09

Dgr
H260

H300

H410
EUH029

EUH032
T
015-007-00-4phosphorus trichloride231-749-37719-12-2Acute Tox. 2 *

Acute Tox. 2 *

STOT RE 2 *

Skin Corr. 1A
H330

H300

H373 **

H314
GHS06

GHS08

GHS05

Dgr
H330

H300

H373 **

H314
EUH014

EUH029
015-008-00-Xphosphorus pentachloride233-060-310026-13-8Acute Tox. 2 *

Acute Tox. 4 *

STOT RE 2 *

Skin Corr. 1B
H330

H302

H373 **

H314
GHS06

GHS08

GHS05

Dgr
H330

H302

H373 **

H314
EUH014

EUH029
015-009-00-5phosphoryl trichloride233-046-710025-87-3Acute Tox. 2 *

STOT RE 1

Acute Tox. 4 *

Skin Corr. 1A
H330

H372 **

H302

H314
GHS06

GHS08

GHS05

Dgr
H330

H372 **

H302

H314
EUH014

EUH029
015-010-00-0phosphorus pentoxide215-236-11314-56-3Skin Corr. 1AH314GHS05

Dgr
H314
015-011-00-6phosphoric acid ... %, orthophosphoric acid ... %231-633-27664-38-2Skin Corr. 1BH314GHS05

Dgr
H314Skin Corr. 1B; H314: C ≥ 25 %

Skin Irrit. 2; H315: 10 % ≤ C < 25 %

Eye Irrit. 2; H319: 10 % ≤ C < 25 %
B
015-012-00-1tetraphosphorus trisulphide;

phosphorus sesquisulphid
215-245-01314-85-8Flam. Sol. 2

Water-react. 1

Acute Tox. 4 *

Aquatic Acute 1
H228

H260

H302

H400
GHS02

GHS07

GHS09

Dgr
H228

H260

H302

H400
T
015-013-00-7triethyl phosphate201-114-578-40-0Acute Tox. 4 *H302GHS07

Wng
H302
015-014-00-2tributyl phosphate204-800-2126-73-8Carc. 2

Acute Tox. 4 *

Skin Irrit. 2
H351

H302

H315
GHS08

GHS07

Wng
H351

H302

H315
015-015-00-8tricresyl phosphate (o-o-o-, o-o-m-, o-o-p-, o-m-m-, o-m-p-, o-p-p-);

tritolyl phosphate (o-o-o-, o-o-m-, o-o-p-, o-m-m-, o-m-p-, o-p-p-);
201-103-578-30-8STOT SE 1

Aquatic Chronic 2
H370 **

H411
GHS08

GHS09

Dgr
H370 **

H411
STOT SE 1; H370: C ≥ 1 %

STOT SE 2; H371: 0,2 % ≤ C < 1 %
C
015-016-00-3tricresyl phosphate (m-m-m-, m-m-p-, m-p-p-, p-p-p-);

tritolyl phosphate (m-m-m-, m-m-p-, m-p-p-, p-p-p-);
201-105-678-32-0Acute Tox. 4 *

Acute Tox. 4 *

Aquatic Chronic 2
H312

H302

H411
GHS07

GHS09

Wng
H312

H302

H411
*C
015-019-00-Xdichlorvos (ISO);

2,2-dichlorovinyl dimethyl phosphate
200-547-762-73-7Acute Tox. 2 *

Acute Tox. 3 *

Acute Tox. 3 *

Skin Sens. 1

Aquatic Acute 1
H330

H311

H301

H317

H400
GHS06

GHS09

Dgr
H330

H311

H301

H317

H400
015-020-00-5mevinphos (ISO);

2-methoxycarbonyl-1-methylvinyl dimethyl phosphate
232-095-17786-34-7Acute Tox. 1

Acute Tox. 2 *

Aquatic Acute 1

Aquatic Chronic 1
H310

H300

H400

H410
GHS06

GHS09

Dgr
H310

H300

H410
M = 10000
015-021-00-0trichlorfon (ISO);

dimethyl 2,2,2-trichloro-1-hydroxyethylphosphonate
200-149-352-68-6Acute Tox. 4 *

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H302

H317

H400

H410
GHS07

GHS09

Wng
H302

H317

H400

H410
M = 1000
015-022-00-6phosphamidon (ISO);

2-chloro-2-diethylcarbamoyl-1-methylvinyl dimethyl phosphate
236-116-513171-21-6Muta. 2

Acute Tox. 2 *

Acute Tox. 3 *

Aquatic Acute 1

Aquatic Chronic 1
H341

H300

H311

H400

H410
GHS06

GHS08

GHS09

Dgr
H341

H300

H311

H410
015-023-00-1pyrazoxon;

diethyl 3-methylpyrazol-5-yl phosphate
108-34-9Acute Tox. 2 *

Acute Tox. 1

Acute Tox. 2 *
H330

H310

H300
GHS06

Dgr
H330

H310

H300
015-024-00-7triamiphos (ISO);

5-amino-3-phenyl-1,2,4-triazol-1-yl-N,N,N',N'-tetramethylphosphonic diamide
1031-47-6Acute Tox. 1

Acute Tox. 2 *
H310

H300
GHS06

Dgr
H310

H300
015-025-00-2TEPP (ISO);

tetraethyl pyrophosphate
203-495-3107-49-3Acute Tox. 1

Acute Tox. 2 *

Aquatic Acute 1
H310

H300

H400
GHS06

GHS09

Dgr
H310

H300

H400
015-026-00-8schradan (ISO);

octamethylpyrophosphoramide
205-801-0152-16-9Acute Tox. 1

Acute Tox. 2 *
H310

H300
GHS06

Dgr
H310

H300
015-027-00-3sulfotep (ISO);

O,O,O,O-tetraethyl dithiopyrophosphate
222-995-23689-24-5Acute Tox. 1

Acute Tox. 2 *

Aquatic Acute 1

Aquatic Chronic 1
H310

H300

H400

H410
GHS06

GHS09

Dgr
H310

H300

H410
M = 1000
015-028-00-9demeton-O (ISO);

O,O-diethyl-O-2-ethylthioethyl phosphorothioate
206-053-8298-03-3Acute Tox. 1

Acute Tox. 2 *

Aquatic Acute 1
H310

H300

H400
GHS06

GHS09

Dgr
H310

H300

H400
015-029-00-4demeton-S (ISO);

diethyl-S-2-ethylthioethyl phosphorothioate
204-801-8126-75-0Acute Tox. 1

Acute Tox. 2 *
H310

H300
GHS06

Dgr
H310

H300
015-030-00-Xdemeton-O-methyl (ISO);

O-2-ethylthioethyl O,O-dimethyl phosphorothioate
212-758-1867-27-6Acute Tox. 3 *H301GHS06

Dgr
H301
015-031-00-5demeton-S-methyl (ISO);

S-2-ethylthioethyl dimethyl phosphorothioate
213-052-6919-86-8Acute Tox. 3 *

Acute Tox. 3 *

Aquatic Chronic 2
H311

H301

H411
GHS06

GHS09

Dgr
H311

H301

H411
015-032-00-0prothoate (ISO);

O,O-diethyl isopropylcarbamoylmethyl phosphorodithioate
218-893-22275-18-5Acute Tox. 1

Acute Tox. 2 *

Aquatic Chronic 3
H310

H300

H412
GHS06

Dgr
H310

H300

H412
015-033-00-6phorate (ISO);

O,O-diethyl ethylthiomethyl phosphorodithioate
206-052-2298-02-2Acute Tox. 1

Acute Tox. 2 *

Aquatic Acute 1

Aquatic Chronic 1
H310

H300

H400

H410
GHS06

GHS09

Dgr
H310

H300

H410
M = 1000
015-034-00-1parathion (ISO);

O,O-diethyl O-4-nitrophenyl phosphorothioate
200-271-756-38-2Acute Tox. 2 *

Acute Tox. 2 *

Acute Tox. 3 *

STOT RE 1

Aquatic Acute 1

Aquatic Chronic 1
H330

H300

H311

H372 **

H400

H410
GHS06

GHS08

GHS09

Dgr
H330

H300

H311

H372 **

H410
M = 100
015-035-00-7parathion — methyl (ISO);

O,O-dimethyl O-4-nitrophenyl phosphorothioate
206-050-1298-00-0Flam. Liq. 3

Acute Tox. 2 *

Acute Tox. 2 *

Acute Tox. 3 *

STOT RE 2 *

Aquatic Acute 1

Aquatic Chronic 1
H226

H330

H300

H311

H373 **

H400

H410
GHS02

GHS06

GHS08

GHS09

Dgr
H226

H330

H300

H311

H373 **

H410
M = 100
015-036-00-2O-ethyl O-4-nitrophenyl phenylphosphonothioate;

EPN
218-276-82104-64-5Acute Tox. 1

Acute Tox. 2 *

Aquatic Acute 1

Aquatic Chronic 1
H310

H300

H400

H410
GHS06

GHS09

Dgr
H310

H300

H410
015-037-00-8phenkapton (ISO);

S-(2,5-dichlorophenylthiomethyl) O,O-diethyl phosphorodithioate
218-892-72275-14-1Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *

Aquatic Acute 1

Aquatic Chronic 1
H331

H311

H301

H400

H410
GHS06

GHS09

Dgr
H331

H311

H301

H410
015-038-00-3coumaphos (ISO);

O-3-chloro-4-methylcoumarin-7-yl O,O-diethyl phosphorothioate
200-285-356-72-4Acute Tox. 2 *

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1
H300

H312

H400

H410
GHS06

GHS09

Dgr
H300

H312

H410
015-039-00-9azinphos-methyl (ISO);

O,O-dimethyl-4-oxobenzotriazin-3-ylmethyl phosphorodithioate
201-676-186-50-0Acute Tox. 2 *

Acute Tox. 2 *

Acute Tox. 3 *

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H330

H300

H311

H317

H400

H410
GHS06

GHS09

Dgr
H330

H300

H311

H317

H410
015-040-00-4diazinon (ISO);

O,O-diethyl O-2-isopropyl-6-methylpyrimidin-4-yl phosphorothioate
206-373-8333-41-5Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1
H302

H400

H410
GHS07

GHS09

Wng
H302

H400

H410
015-041-00-Xmalathion (ISO);

1,2-bis (ethoxycarbonyl) ethyl O,O-dimethyl phosphorodithioate
204-497-7121-75-5Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1
H302

H400

H410
GHS07

GHS09

Wng
H302

H400

H410
M = 100
015-042-00-5chlorthion

O-(3-chloro-4-nitrophenyl) O,O-dimethyl phosphorothioate
207-902-5500-28-7Acute Tox. 4 *

Acute Tox. 4 *

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1
H332

H312

H302

H400

H410
GHS07

GHS09

Wng
H332

H312

H302

H410
M = 100
015-043-00-0phosnichlor (ISO);

O-4-chloro-3-nitrophenyl O,O-dimethyl phosphorothioate
5826-76-6Acute Tox. 4 *

Acute Tox. 4 *

Acute Tox. 4 *
H332

H312

H302
GHS07

Wng
H332

H312

H302
015-044-00-6carbophenothion (ISO);

4-chlorophenylthiomethyl O,O-diethyl phosphorodithioate
212-324-1786-19-6Acute Tox. 3 *

Acute Tox. 3 *

Aquatic Acute 1

Aquatic Chronic 1
H311

H301

H400

H410
GHS06

GHS09

Dgr
H311

H301

H410
015-045-00-1mecarbam (ISO);

N-ethoxycarbonyl-N-methylcarbamoylmethyl O,O-diethyl phosphorodithioate
219-993-92595-54-2Acute Tox. 3 *

Acute Tox. 3 *

Aquatic Acute 1

Aquatic Chronic 1
H311

H301

H400

H410
GHS06

GHS09

Dgr
H311

H301

H400

H410
015-046-00-7oxydemeton-methyl;

S-2-(ethylsulphinyl)ethyl O,O-dimethyl phosphorothioate
206-110-7301-12-2Acute Tox. 3 *

Acute Tox. 3 *

Aquatic Acute 1
H311

H301

H400
GHS06

GHS09

Dgr
H311

H301

H400
015-047-00-2ethion (ISO);

O,O,O',O'-tetraethyl S,S'-methylenedi (phosphorodithioate);

diethion
209-242-3563-12-2Acute Tox. 3 *

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1
H301

H312

H400

H410
GHS06

GHS09

Dgr
H301

H312

H410
M = 10000
015-048-00-8fenthion (ISO);

O,O-dimethyl-O-(4-methylthion-m-tolyl) phosphorothioate
200-231-955-38-9Muta. 2

Acute Tox. 3 *

STOT RE 1

Acute Tox. 4 *

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1
H341

H331

H372 **

H312

H302

H400

H410
GHS06

GHS08

GHS09

Dgr
H341

H331

H372 **

H312

H302

H410
015-049-00-3endothion (ISO);

S-5-methoxy-4-oxopyran-2-ylmethyl dimethyl phosphorothioate
220-472-32778-04-3Acute Tox. 3 *

Acute Tox. 3 *
H311

H301
GHS06

Dgr
H311

H301
015-050-00-9thiometon (ISO);

S-2-ethylthioethyl O,O-dimethyl phosphorodithioate
211-362-6640-15-3Acute Tox. 3 *

Acute Tox. 4 *
H301

H312
GHS06

Dgr
H301

H312
015-051-00-4dimethoate (ISO);

O,O-dimethyl methylcarbamoylmethyl phosphorodithioate
200-480-360-51-5Acute Tox. 4 *

Acute Tox. 4 *
H312

H302
GHS07

Wng
H312

H302
015-052-00-Xfenchlorphos (ISO);

O,O-dimethyl O-2,4,5-trichlorophenyl phosphorothioate
206-082-6299-84-3Acute Tox. 4 *

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1
H312

H302

H400

H410
GHS07

GHS09

Wng
H312

H302

H410
015-053-00-5menazon (ISO);

S-[(4,6-diamino-1,3,5-triazin-2-yl)methyl] O,O-dimethyl phosphorodithioate
201-123-478-57-9Acute Tox. 4 *

Aquatic Chronic 3
H302

H412
GHS07

Wng
H302

H412
015-054-00-0fenitrothion (ISO);

O,O-dimethyl O-4-nitro-m-tolyl phosphorothioate
204-524-2122-14-5Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1
H302

H400

H410
GHS07

GHS09

Wng
H302

H410
015-055-00-6naled (ISO);

1,2-dibromo-2,2-dichloroethyl dimethyl phosphate
206-098-3300-76-5Acute Tox. 4 *

Acute Tox. 4 *

Eye Irrit. 2

Skin Irrit. 2

Aquatic Acute 1
H312

H302

H319

H315

H400
GHS07

GHS09

Wng
H312

H302

H319

H315

H400
M = 1000
015-056-00-1azinphos-ethyl (ISO);

O,O-diethyl 4-oxobenzotriazin-3-ylmethyl phosphorodithioate
220-147-62642-71-9Acute Tox. 2 *

Acute Tox. 3 *

Aquatic Acute 1

Aquatic Chronic 1
H300

H311

H400

H410
GHS06

GHS09

Dgr
H300

H311

H410
015-057-00-7formothion (ISO);

N-formyl-N-methylcarbamoylmethyl O,O-dimethyl phosphorodithioate
219-818-62540-82-1Acute Tox. 4 *

Acute Tox. 4 *
H312

H302
GHS07

Wng
H312

H302
015-058-00-2morphothion (ISO);

O,O-dimethyl-S-(morpholinocarbonylmethyl) phosphorodithioate
205-628-0144-41-2Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *

Aquatic Acute 1

Aquatic Chronic 1
H331

H311

H301

H400

H410
GHS06

GHS09

Dgr
H331

H311

H301

H410
015-059-00-8vamidothion (ISO);

O,O-dimethyl S-2-(1-methylcarbamoylethylthio) ethyl phosphorothioate
218-894-82275-23-2Acute Tox. 3 *

Acute Tox. 4 *

Aquatic Acute 1
H301

H312

H400
GHS06

GHS09

Dgr
H301

H312

H400
015-060-00-3disulfoton (ISO);

O,O-diethyl 2-ethylthioethyl phosphorodithioate
206-054-3298-04-4Acute Tox. 1

Acute Tox. 2 *

Aquatic Acute 1

Aquatic Chronic 1
H310

H300

H400

H410
GHS06

GHS09

Dgr
H310

H300

H410
015-061-00-9dimefox (ISO);

tetramethylphosphorodiamidic fluoride
204-076-8115-26-4Acute Tox. 1

Acute Tox. 2 *
H310

H300
GHS06

Dgr
H310

H300
015-062-00-4mipafox (ISO);

N,N'- di-isopropylphosphorodiamidic fluoride
206-742-3371-86-8STOT SE 1H370 **GHS08

Dgr
H370 **
015-063-00-Xdioxathion (ISO);

1,4-dioxan-2,3-diyl-O,O,O',O'-tetraethyl di(phosphorodithioate)
201-107-778-34-2Acute Tox. 2 *

Acute Tox. 2 *

Acute Tox. 3 *

Aquatic Acute 1

Aquatic Chronic 1
H330

H300

H311

H400

H410
GHS06

GHS09

Dgr
H330

H300

H311

H410
M = 1000
015-064-00-5bromophos-ethyl (ISO);

O-4-bromo-2,5-dichlorophenyl O,O-diethyl phosphorothioate
225-399-04824-78-6Acute Tox. 3 *

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1
H301

H312

H400

H410
GHS06

GHS09

Dgr
H301

H312

H410
015-065-00-0S-[2-(ethylsulphinyl)ethyl] O,O-dimethyl phosphorodithioate2703-37-9Acute Tox. 2 *

Acute Tox. 1

Acute Tox. 2 *

Aquatic Chronic 2
H330

H310

H300

H411
GHS06

GHS09

Dgr
H330

H310

H300

H411
015-066-00-6omethoate (ISO);

O,O-dimethyl S-methylcarbamoylmethyl phosphorothioate
214-197-81113-02-6Acute Tox. 3 *

Acute Tox. 4 *

Aquatic Acute 1
H301

H312

H400
GHS06

GHS09

Dgr
H301

H312

H400
015-067-00-1phosalone (ISO);

S-(6-chloro-2-oxobenzoxazolin-3-ylmethyl) O,O-diethyl phosphorodithioate
218-996-22310-17-0Acute Tox. 3 *

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1
H301

H312

H400

H410
GHS06

GHS09

Dgr
H301

H312

H410
015-068-00-7dichlofenthion (ISO);

O—2,4-dichlorophenyl O,O-diethyl phosphorothioate
202-564-597-17-6Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1
H302

H400

H410
GHS07

GHS09

Wng
H302

H400

H410
015-069-00-2methidathion (ISO);

2,3-dihydro-5-methoxy-2-oxo-1,3,4-thiadiazol-3-ylmethyl-O,O-dimethylphosphorodithioate
213-449-4950-37-8Acute Tox. 2 *

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1
H300

H312

H400

H410
GHS06

GHS09

Dgr
H300

H312

H410
015-070-00-8cyanthoate (ISO);

S-(N-(1-cyano-1-methylethyl)carbamoylmethyl) O,O-diethyl phosphorothioate
223-099-43734-95-0Acute Tox. 2 *

Acute Tox. 3 *
H300

H311
GHS06

Dgr
H300

H311
015-071-00-3chlorfenvinphos (ISO);

2-chloro-1-(2,4 dichlorophenyl) vinyl diethyl phosphate
207-432-0470-90-6Acute Tox. 2 *

Acute Tox. 3 *

Aquatic Acute 1

Aquatic Chronic 1
H300

H311

H400

H410
GHS06

GHS09

Dgr
H300

H311

H410
015-072-00-9monocrotophos (ISO);

dimethyl-1-methyl-2-(methylcarbamoyl)vinyl phosphate
230-042-76923-22-4Muta. 2

Acute Tox. 2 *

Acute Tox. 2 *

Acute Tox. 3 *

Aquatic Acute 1

Aquatic Chronic 1
H341

H330

H300

H311

H400

H410
GHS06

GHS08

GHS09

Dgr
H341

H330

H300

H311

H410
015-073-00-4dicrotophos (ISO);

(Z)-2-dimethylcarbamoyl-1-methylvinyl dimethyl phosphate
205-494-3141-66-2Acute Tox. 2 *

Acute Tox. 3 *

Aquatic Acute 1

Aquatic Chronic 1
H300

H311

H400

H410
GHS06

GHS09

Dgr
H300

H311

H410
015-074-00-Xcrufomate (ISO);

4-tert-butyl-2-chlorophenyl methyl methylphosphoramidate
206-083-1299-86-5Acute Tox. 4 *

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1
H312

H302

H400

H410
GHS07

GHS09

Wng
H312

H302

H410
015-075-00-5S-[2-(isopropylsulphinyl)ethyl] O,O-dimethyl phosphorothioate2635-50-9Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *
H331

H311

H301
GHS06

Dgr
H331

H311

H301
015-076-00-0potasan;

O,O-diethyl O-(4-methylcoumarin-7-yl) phosphorothioate
299-45-6Acute Tox. 2 *

Acute Tox. 1

Acute Tox. 2 *

Aquatic Acute 1

Aquatic Chronic 1
H330

H310

H300

H400

H410
GHS06

GHS09

Dgr
H330

H310

H300

H410
M = 1000
015-077-00-62,2-dichlorovinyl 2-ethylsulphinylethyl methyl phosphate7076-53-1Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *
H331

H311

H301
GHS06

Dgr
H331

H311

H301
015-078-00-1demeton-S-methylsulphon (ISO);

S-2-ethylsulphonylethyl dimethyl phosphorothioate
241-109-517040-19-6Acute Tox. 3 *

Acute Tox. 4 *

Aquatic Chronic 2
H301

H312

H411
GHS06

GHS09

Dgr
H301

H312

H411
015-079-00-7acephate (ISO);

O,S-dimethyl acetylphosphoramidothioate
250-241-230560-19-1Acute Tox. 4 *H302GHS07

Wng
H302
015-080-00-2amidithion (ISO);

2-methoxyethylcarbamoylmethyl O,O-dimethyl phosphorodithioate
919-76-6Acute Tox. 4 *H302GHS07

Wng
H302
015-081-00-8O,O,O',O'-tetrapropyl dithiopyrophosphate221-817-03244-90-4Acute Tox. 4 *

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1
H312

H302

H400

H410
GHS07

GHS09

Wng
H312

H302

H410
015-082-00-3azothoate (ISO);

O-4-(4-chlorophenylazo)phenyl O,O-dimethyl phosphorothioate
227-419-35834-96-8Acute Tox. 4 *

Acute Tox. 4 *
H332

H302
GHS07

Wng
H332

H302
015-083-00-9bensulide (ISO);

O,O-diisopropyl 2-phenylsulphonylaminoethyl phosphorodithioate
212-010-4741-58-2Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1
H302

H400

H410
GHS07

GHS09

Wng
H302

H410
015-084-00-4chlorpyrifos (ISO);

O,O-diethyl O-3,5,6-trichloro-2-pyridyl phosphorothioate
220-864-42921-88-2Acute Tox. 3 *

Aquatic Acute 1

Aquatic Chronic 1
H301

H400

H410
GHS06

GHS09

Dgr
H301

H400

H410
M = 10000
015-085-00-Xchlorphonium chloride (ISO);

tributyl (2,4-dichlorobenzyl) phosphonium chloride
204-105-4115-78-6Acute Tox. 3 *

Acute Tox. 4 *

Eye Irrit. 2

Skin Irrit. 2
H301

H312

H319

H315
GHS06

Dgr
H301

H312

H319

H315
015-086-00-5coumithoate (ISO);

O,O-diethyl O-7,8,9,10-tetrahydro-6-oxo-benzo(c)chromen-3-yl phosphorothioate
572-48-5Acute Tox. 3 *H301GHS06

Dgr
H301
015-087-00-0cyanophos (ISO);

O-4-cyanophenyl O,O-dimethyl phosphorothioate
220-130-32636-26-2Acute Tox. 4 *

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1
H312

H302

H400

H410
GHS07

GHS09

Wng
H312

H302

H410
015-088-00-6dialifos (ISO);

2-chloro-1-phthalimidoethyl O,O-diethyl phosphorodithioate
233-689-310311-84-9Acute Tox. 2 *

Acute Tox. 3 *

Aquatic Acute 1

Aquatic Chronic 1
H300

H311

H400

H410
GHS06

GHS09

Dgr
H300

H311

H400

H410
015-089-00-1ethoate-methyl (ISO);

ethylcarbamoylmethyl O,O-dimethyl phosphorodithioate
204-121-1116-01-8Acute Tox. 4 *

Acute Tox. 4 *
H312

H302
GHS07

Wng
H312

H302
015-090-00-7fensulfothion (ISO);

O,O-diethyl O-4-methylsulfinylphenyl phosphorothioate
204-114-3115-90-2Acute Tox. 1

Acute Tox. 2 *

Aquatic Acute 1

Aquatic Chronic 1
H310

H300

H400

H410
GHS06

GHS09

Dgr
H310

H300

H410
015-091-00-2fonofos (ISO);

O-ethyl phenyl ethylphosphonodithioate
213-408-0944-22-9Acute Tox. 1

Acute Tox. 2 *

Aquatic Acute 1

Aquatic Chronic 1
H310

H300

H400

H410
GHS06

GHS09

Dgr
H310

H300

H410
015-092-00-8phosacetim (ISO);

O,O-bis(4-chlorophenyl) N-acetimidoylphosphoramidothioate
223-874-74104-14-7Acute Tox. 1

Acute Tox. 2 *

Aquatic Acute 1

Aquatic Chronic 1
H310

H300

H400

H410
GHS06

GHS09

Dgr
H310

H300

H410
015-093-00-3leptophos (ISO);

O-4-bromo-2,5-dichlorophenyl O-methyl phenylphosphorothioate
244-472-821609-90-5Acute Tox. 3 *

STOT SE 1

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1
H301

H370 **

H312

H400

H410
GHS06

GHS08

GHS09

Dgr
H301

H370 **

H312

H410
015-094-00-9mephosfolan (ISO);

diethyl 4-methyl-1,3-dithiolan-2-ylidenephosphoramidate
213-447-3950-10-7Acute Tox. 1

Acute Tox. 2 *

Aquatic Chronic 2
H310

H300

H411
GHS06

GHS09

Dgr
H310

H300

H411
015-095-00-4methamidophos (ISO);

O,S-dimethyl phosphoramidothioate
233-606-010265-92-6Acute Tox. 2 *

Acute Tox. 2 *

Acute Tox. 3 *

Aquatic Acute 1
H330

H300

H311

H400
GHS06

GHS09

Dgr
H330

H300

H311

H400
015-096-00-Xoxydisulfoton (ISO);

O,O-diethyl S-2-ethylsulphinylethyl phosphorodithioate
219-679-12497-07-6Acute Tox. 2 *

Acute Tox. 3 *

Aquatic Acute 1

Aquatic Chronic 1
H300

H311

H400

H410
GHS06

GHS09

Dgr
H300

H311

H410
M = 10
015-097-00-5phenthoate (ISO);

ethyl 2-(dimethoxyphosphinothioylthio)-2-phenylacetate
219-997-02597-03-7Acute Tox. 4 *

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1
H312

H302

H400

H410
GHS07

GHS09

Wng
H312

H302

H410
M = 100
015-098-00-0trichloronate (ISO);

O-ethyl O-2,4,5-trichlorophenyl ethylphosphonothioate
206-326-1327-98-0Acute Tox. 2 *

Acute Tox. 3 *

Aquatic Acute 1

Aquatic Chronic 1
H300

H311

H400

H410
GHS06

GHS09

Dgr
H300

H311

H410
015-099-00-6pirimiphos-ethyl (ISO);

O,O-diethyl O-2-diethylamino-6-methylpyrimidin-4-yl phosphorothioate
245-704-023505-41-1Acute Tox. 3 *

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1
H301

H312

H400

H410
GHS06

GHS09

Dgr
H301

H312

H410
015-100-00-Xphoxim (ISO);

α-(diethoxyphosphinothioylimino) phenylacetonitrile
238-887-314816-18-3Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1
H302

H400

H410
GHS07

GHS09

Wng
H302

H410
M = 1000
015-101-00-5phosmet (ISO);

O,O-dimethyl phthalimidomethyl S-phosphorodithioate
211-987-4732-11-6Acute Tox. 4 *

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1
H312

H302

H400

H410
GHS07

GHS09

Wng
H312

H302

H410
M = 100
015-102-00-0tris(2-chloroethyl) phosphate204-118-5115-96-8Carc. 2

Acute Tox. 4 *

Aquatic Chronic 2
H351

H302

H411
GHS08

GHS07

GHS09

Wng
H351

H302

H411
015-103-00-6phosphorus tribromide232-178-27789-60-8Skin Corr. 1B

STOT SE 3
H314

H335
GHS05

GHS07

Dgr
H314

H335
EUH014
015-104-00-1diphosphorus pentasulphide;

phosphorus pentasulphide
215-242-41314-80-3Flam. Sol. 1

Water-react. 1

Acute Tox. 4 *

Acute Tox. 4 *

Aquatic Acute 1
H228

H260

H332

H302

H400
GHS02

GHS07

GHS09

Dgr
H228

H260

H332

H302

H400
EUH029T
015-105-00-7triphenyl phosphite202-908-4101-02-0Eye Irrit. 2

Skin Irrit. 2

Aquatic Acute 1

Aquatic Chronic 1
H319

H315

H400

H410
GHS07

GHS09

Wng
H319

H315

H410
Skin Irrit. 2; H315: C ≥ 5 %

Eye Irrit. 2; H319: C ≥ 5 %
015-106-00-2hexamethylphosphoric triamide;

hexamethylphosphoramide
211-653-8680-31-9Carc. 1B

Muta. 1B
H350

H340
GHS08

Dgr
H350

H340
Carc. 1B; H350: C ≥ 0,01 %
015-107-00-8ethoprophos (ISO);

ethyl-S,S-dipropyl phosphorodithioate
236-152-113194-48-4Acute Tox. 2 *

Acute Tox. 1

Acute Tox. 3 *

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H330

H310

H301

H317

H400

H410
GHS06

GHS09

Dgr
H330

H310

H301

H317

H410
015-108-00-3bromophos (ISO);

O-4-bromo-2,5-dichlorophenyl O,O-dimethyl phosphorothioate
218-277-32104-96-3Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1
H302

H400

H410
GHS07

GHS09

Wng
H302

H410
M = 100
015-109-00-9crotoxyphos (ISO);

1-phenylethyl 3-(dimethoxyphosphinyloxy) isocrotonate
231-720-57700-17-6Acute Tox. 3 *

Acute Tox. 3 *

Aquatic Acute 1

Aquatic Chronic 1
H311

H301

H400

H410
GHS06

GHS09

Dgr
H311

H301

H410
M = 10
015-110-00-4cyanofenphos (ISO);

O-4-cyanophenyl O-ethyl phenylphosphonothioate
13067-93-1Acute Tox. 3 *

STOT SE 1

Acute Tox. 4 *

Eye Irrit. 2

Aquatic Chronic 2
H301

H370 **

H312

H319

H411
GHS06

GHS08

GHS09

Dgr
H301

H370 **

H312

H319

H411
015-111-00-Xphosfolan (ISO);

diethyl 1,3-dithiolan-2-ylidenephosphoramidate
213-423-2947-02-4Acute Tox. 1

Acute Tox. 2 *
H310

H300
GHS06

Dgr
H310

H300
015-112-00-5thionazin (ISO);

O,O-diethyl O-pyrazin-2-yl phosphorothioate;
206-049-6297-97-2Acute Tox. 1

Acute Tox. 2 *
H310

H300
GHS06

Dgr
H310

H300
015-114-00-6chlormephos (ISO);

S-chloromethyl O,O-diethyl phosphorodithioate
246-538-124934-91-6Acute Tox. 1

Acute Tox. 2 *

Aquatic Acute 1

Aquatic Chronic 1
H310

H300

H400

H410
GHS06

GHS09

Dgr
H310

H300

H410
015-115-00-1chlorthiophos (ISO)244-663-621923-23-9Acute Tox. 2 *

Acute Tox. 3 *

Aquatic Acute 1

Aquatic Chronic 1
H300

H311

H400

H410
GHS06

GHS09

Dgr
H300

H311

H410
015-116-00-7demephion-O (ISO);

O,O-dimethyl O-2-methylthioethyl phosphorothioate
211-666-9682-80-4Acute Tox. 2 *

Acute Tox. 3 *
H300

H311
GHS06

Dgr
H300

H311
015-117-00-2demephion-S (ISO);

O,O-dimethyl S-2-methylthioethyl phosphorothioate
219-971-92587-90-8Acute Tox. 2 *

Acute Tox. 3 *
H300

H311
GHS06

Dgr
H300

H311
015-118-00-8demeton8065-48-3Acute Tox. 1

Acute Tox. 2 *

Aquatic Acute 1
H310

H300

H400
GHS06

GHS09

Dgr
H310

H300

H400
015-119-00-3dimethyl 4-(methylthio)phenyl phosphate3254-63-5Acute Tox. 1

Acute Tox. 2 *
H310

H300
GHS06

Dgr
H310

H300
015-120-00-9ditalimfos (ISO);

O,O-diethyl phthalimidophosphonothioate
225-875-85131-24-8Skin Irrit. 2

Skin Sens. 1
H315

H317
GHS07

Wng
H315

H317
015-121-00-4edifenphos (ISO);

O-ethyl S,S-diphenyl phosphorodithioate
241-178-117109-49-8Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 4 *

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H331

H301

H312

H317

H400

H410
GHS06

GHS09

Dgr
H331

H301

H312

H317

H410
015-122-00-Xetrimfos (ISO);

O-6-ethoxy-2-ethylpyrimidin-4-yl O,O-dimethylphosphorothioate
253-855-938260-54-7Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1
H302

H400

H410
GHS07

GHS09

Wng
H302

H410
M = 10
015-123-00-5fenamiphos (ISO);

ethyl-4-methylthio-m-tolyl isopropyl phosphoramidate
244-848-122224-92-6Acute Tox. 2 *

Acute Tox. 3 *

Aquatic Acute 1

Aquatic Chronic 1
H300

H311

H400

H410
GHS06

GHS09

Dgr
H300

H311

H410
M = 100
015-124-00-0fosthietan (ISO);

diethyl 1,3-dithietan-2-ylidenephosphoramidate
244-437-721548-32-3Acute Tox. 1

Acute Tox. 2 *
H310

H300
GHS06

Dgr
H310

H300
015-125-00-6glyphosine (ISO);

N,N-bis(phosphonomethyl)glycine
219-468-42439-99-8Eye Dam. 1H318GHS05

Dgr
H318
015-126-00-1heptenophos (ISO);

7-chlorobicyclo(3.2.0)hepta-2,6-dien-6-yl dimethyl phosphate
245-737-023560-59-0Acute Tox. 3 *

Aquatic Acute 1

Aquatic Chronic 1
H301

H400

H410
GHS06

GHS09

Dgr
H301

H410
M = 100
015-127-00-7iprobenfos(ISO);

S-benzyl diisopropyl phosphorothioate
247-449-026087-47-8Acute Tox. 4 *

Aquatic Chronic 2
H302

H411
GHS07

GHS09

Wng
H302

H411
015-128-00-2IPSP;

S-ethylsulphinylmethyl O,O-diisopropylphosphorodithioate
5827-05-4Acute Tox. 1

Acute Tox. 3 *

Aquatic Acute 1

Aquatic Chronic 1
H310

H301

H400

H410
GHS06

GHS09

Dgr
H310

H301

H410
M = 100
015-129-00-8isofenphos (ISO);

O-ethyl O-2-isopropoxycarbonylphenyl-isopropylphosphoramidothioate
246-814-125311-71-1Acute Tox. 3 *

Acute Tox. 3 *

Aquatic Acute 1

Aquatic Chronic 1
H311

H301

H400

H410
GHS06

GHS09

Dgr
H311

H301

H410
M = 100
015-130-00-3isothioate (ISO);

S-2-isopropylthioethyl O,O-dimethyl phosphorodithioate;
36614-38-7Acute Tox. 3 *

Acute Tox. 3 *
H311

H301
GHS06

Dgr
H311

H301
015-131-00-9isoxathion (ISO);

O,O-diethyl O-5-phenylisoxazol-3-ylphosphorothioate
242-624-818854-01-8Acute Tox. 3 *

Acute Tox. 3 *

Aquatic Acute 1

Aquatic Chronic 1
H311

H301

H400

H410
GHS06

GHS09

Dgr
H311

H301

H410
015-132-00-4S-(chlorophenylthiomethyl) O,O-dimethylphosphorodithioate;

methylcarbophenothione
953-17-3Acute Tox. 3 *

Acute Tox. 3 *

Aquatic Acute 1

Aquatic Chronic 1
H311

H301

H400

H410
GHS06

GHS09

Dgr
H311

H301

H410
M = 1000
015-133-00-Xpiperophos (ISO);

S-2-methylpiperidinocarbonylmethyl-O,O-dipropyl phosphorodithioate
24151-93-7Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1
H302

H400

H410
GHS07

GHS09

Wng
H302

H410
M = 10
015-134-00-5pirimiphos-methyl (ISO);

O-(2-diethylamino-6-methylpyrimidin-4-yl) O,O-dimethyl phosphorothioate
249-528-529232-93-7Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1
H302

H400

H410
GHS07

GHS09

Wng
H302

H410
015-135-00-0profenofos (ISO)

O-(4-bromo-2-chlorophenyl) O-ethyl S-propyl phosphorothioate;
255-255-241198-08-7Acute Tox. 4 *

Acute Tox. 4 *

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1
H332

H312

H302

H400

H410
GHS07

GHS09

Wng
H332

H312

H302

H410
M = 1000
015-136-00-6trans-isopropyl-3-[[(ethylamino)methoxyfosfinothioyl]oxy]crotonate;

isopropyl 3-[[(ethylamino)methoxyphosphinothioyl]oxy]isocrotonate;

propetamphos (ISO)
250-517-231218-83-4Acute Tox. 3 *

Aquatic Acute 1

Aquatic Chronic 1
H301

H400

H410
GHS06

GHS09

Dgr
H301

H410
M = 100
015-137-00-1pyrazophos (ISO);

O,O-diethyl O-(6-ethoxycarbonyl-5-methylpyrazolo[2,3-a]pyrimidin-2-yl) phosphorothioate
236-656-113457-18-6Acute Tox. 4 *

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1
H332

H302

H400

H410
GHS07

GHS09

Wng
H332

H302

H410
015-138-00-7quinalphos (ISO);

O,O-diethyl-O-quinoxalin-2-yl phosphorothioate
237-031-613593-03-8Acute Tox. 3 *

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1
H301

H312

H400

H410
GHS06

GHS09

Dgr
H301

H312

H410
M = 1000
015-139-00-2terbufos (ISO);

S-tert-butylthiomethyl O,O-diethylphosphorodithioate;
235-963-813071-79-9Acute Tox. 1

Acute Tox. 2 *

Aquatic Acute 1

Aquatic Chronic 1
H310

H300

H400

H410
GHS06

GHS09

Dgr
H310

H300

H410
M = 1000
015-140-00-8triazophos (ISO);

O,O-diethyl-O-1-phenyl-1H,2,4-triazol-3-yl phosphorothioate
245-986-524017-47-8Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1
H331

H301

H312

H400

H410
GHS06

GHS09

Dgr
H331

H301

H312

H410
015-141-00-3ethylenediammonium O,O-bis(octyl) phosphorodithioate, mixed isomers400-520-1Skin Corr. 1B

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1
H314

H302

H400

H410
GHS05

GHS07

GHS09

Dgr
H314

H302

H410
015-142-00-9butyl (dialkyloxy(dibutoxyphosphoryloxy))titanium (trialkyloxy)titanium phosphate401-100-0Flam. Liq. 2

Eye Irrit. 2

Aquatic Chronic 2
H225

H319

H411
GHS02

GHS07

GHS09

Dgr
H225

H319

H411
T
015-143-00-4reaction mass of 2-chloroethyl chloropropyl 2-chloroethylphosphonate, reaction mass of isomers and 2-chloroethyl chloropropyl 2-chloropropylphosphonate,

reaction mass of isomers
401-740-0Acute Tox. 4 *H302GHS07

Wng
H302
015-144-00-Xreaction mass of pentyl methylphosphinate and 2-methylbutyl methylphosphinate402-090-087025-52-3Skin Corr. 1BH314GHS05

Dgr
H314
015-145-00-5reaction mass of copper(I) O,O-diisopropyl phosphorodithioate and copper(I) O-isopropyl O-(4-methylpent-2-yl) phosphorodithioate and copper(I) O,O-bis(4-methylpent-2-yl) phosphorodithioate401-520-4Aquatic Acute 1

Aquatic Chronic 1
H400

H410
GHS09

Wng
H410
015-146-00-0S-(tricyclo(5.2.1.02,6)deca-3-en-8(or 9)-yl O-(isopropyl or isobutyl or 2-ethylhexyl) O-(isopropyl or isobutyl or 2-ethylhexyl) phosphorodithioate401-850-9Aquatic Acute 1

Aquatic Chronic 1
H400

H410
GHS09

Wng
H410
015-147-00-6reaction mass of C12-14-tert-alkylammonium diphenyl phosphorothioate and dinonyl sulphide (or disulphide)400-930-0Skin Irrit. 2

Eye Dam. 1

Skin Sens. 1

Aquatic Chronic 2
H315

H318

H317

H411
GHS05

GHS07

GHS09

Dgr
H315

H318

H317

H411
015-148-00-12-(diphosphonomethyl)succinic acid403-070-451395-42-7Skin Corr. 1B

Skin Sens. 1
H314

H317
GHS05

GHS07

Dgr
H314

H317
015-149-00-7reaction mass of: hexyldioctylphosphineoxide;

dihexyloctylphosphineoxide;

trioctylphosphineoxide
403-470-9Skin Corr. 1B

Aquatic Acute 1

Aquatic Chronic 1
H314

H400

H410
GHS05

GHS09

Dgr
H314

H410
015-150-00-2(2-(1,3-dioxolan-2-yl)ethyl)triphenylphosphonium bromide404-940-686608-70-0Acute Tox. 4 *

Eye Dam. 1

STOT RE 2 *

Aquatic Chronic 3
H302

H318

H373 **

H412
GHS08

GHS05

GHS07

Dgr
H302

H318

H373 **

H412
015-151-00-8tris(isopropyl/tert-butylphenyl) phosphate405-010-2Aquatic Chronic 2H411GHS09H411
015-152-00-3dioxabenzofos (ISO);

2-methoxy-4H-1,3,2-benzodioxaphosphorin 2-sulphide
223-292-33811-49-2Acute Tox. 3 *

Acute Tox. 3 *

STOT SE 1

Aquatic Chronic 2
H311

H301

H370 **

H411
GHS06

GHS08

GHS09

Dgr
H311

H301

H370 **

H411
015-153-00-9isazofos (ISO);

O-(5-chloro-1-isopropyl-1,2,4-triazol-3-yl) O,O-diethyl phosphorothioate
255-863-842509-80-8Acute Tox. 2 *

Acute Tox. 3 *

Acute Tox. 3 *

STOT RE 2 *

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H330

H311

H301

H373 **

H317

H400

H410
GHS06

GHS08

GHS09

Dgr
H330

H311

H301

H373 **

H317

H410
015-154-00-42-chloroethylphosphonic acid;

ethephon
240-718-316672-87-0Acute Tox. 4 *

Acute Tox. 4 *

Skin Corr. 1B

Aquatic Chronic 3
H332

H312

H314

H412
GHS05

GHS07

Dgr
H332

H312

H314

H412
STOT SE 3; H335: C ≥ 5 %
015-155-00-Xammonium 2-amino-4-(hydroxymethylphosphinyl)butyrate;

glufosinate ammonium
278-636-577182-82-2Acute Tox. 4 *H302GHS07

Wng
H302
015-156-00-5methyl 3-[(dimethoxyphosphinothioyl)oxy]methacrylate; [1]

methacrifos (ISO);

methyl (E)-3-[(dimethoxyphosphinothioyl)oxy]methacrylate [2]
250-366-9 [1]-[2]30864-28-9 [1]

62610-77-9 [2]
Acute Tox. 4 *

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H302

H317

H400

H410
GHS07

GHS09

Wng
H302

H317

H410
015-157-00-0phosphonic acid; [1]

phosphorous acid [2]
237-066-7 [1]

233-663-1

[2]
13598-36-2 [1]

10294-56-1 [2]
Acute Tox. 4 *

Skin Corr. 1A
H302

H314
GHS05

GHS07

Dgr
H302

H314
015-158-00-6(η-cyclopentadienyl)(η-cumenyl)iron(1+)hexafluorophosphate(1-)402-340-932760-80-8Aquatic Chronic 3H412H412
015-159-00-1hydroxyphosphonoacetic acid405-710-823783-26-8Acute Tox. 4 *

STOT RE 2 *

Skin Corr. 1B

Skin Sens. 1
H302

H373 **

H314

H317
GHS08

GHS05

GHS07

Dgr
H302

H373 **

H314

H317
015-160-00-7vanadyl pyrophosphate406-260-558834-75-6Eye Irrit. 2

Skin Sens. 1

Aquatic Chronic 3
H319

H317

H412
GHS07

Wng
H319

H317

H412
015-161-00-2divanadyl pyrophosphate407-130-065232-89-5Acute Tox. 4 *

Eye Dam. 1

Skin Sens. 1

Aquatic Chronic 2
H302

H318

H317

H411
GHS05

GHS07

GHS09

Dgr
H302

H318

H317

H411
015-162-00-8vanadium(IV) oxide hydrogen phosphate hemihydrate, lithium, zinc, molybdenum, iron and chlorine-doped407-350-7Acute Tox. 4 *

STOT RE 2 *

Eye Dam. 1

Aquatic Chronic 2
H332

H373 **

H318

H411
GHS08

GHS05

GHS07

GHS09

Dgr
H332

H373 **

H318

H411
015-163-00-3bis(2,6-dimethoxybenzoyl)-2,4,4-trimethylpentylphosphinoxide412-010-6145052-34-2Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H317

H400

H410
GHS07

GHS09

Wng
H317

H410
015-164-00-9calcium P,P'-(1-hydroxyethylene)bis(hydrogen phosphonate)dihydrate400-480-536669-85-9Aquatic Chronic 3H412H412
015-165-00-4reaction mass of: thiobis(4,1-phenylene)-S,S,S',S'-tetraphenyldisulfonium bishexafluorophosphate;

diphenyl(4-phenylthiophenyl)sulfonium hexafluorophosphate
404-986-7Eye Dam. 1

Aquatic Acute 1

Aquatic Chronic 1
H318

H400

H410
GHS05

GHS09

Dgr
H318

H410
015-166-00-X3,9-bis(2,6-di-tert-butyl-4-methylphenoxy)-2,4,8,10-tetraoxa-3,9-diphosphaspiro[5.5]undecane410-290-480693-00-1Aquatic Chronic 4H413H413
015-167-00-53-(hydroxyphenylphosphinyl)propanoic acid411-200-614657-64-8Eye Dam. 1H318GHS05

Dgr
H318
015-168-00-0fosthiazate (ISO);

(RS)-S-sec-butyl-O-ethyl-2-oxo-1,3-thiazolidin-3-ylphosphonothioate
98886-44-3Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 4 *

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H331

H301

H312

H317

H400

H410
GHS06

GHS09

Dgr
H331

H301

H312

H317

H410
EUH070
015-169-00-6tributyltetradecylphosphonium tetrafluoroborate413-520-1Acute Tox. 4 *

STOT RE 2 *

Skin Corr. 1B

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H302

H373 **

H314

H317

H400

H410
GHS08

GHS05

GHS07

GHS09

Dgr
H302

H373 **

H314

H317

H410
015-170-00-1reaction mass of: di-(1-octane-N,N,N-trimethylammonium) octylphosphate;

1-octane-N,N,N-trimethylammonium di-octylphosphate;

1-octane-N,N,N-trimethylammonium octylphosphate
407-490-9Acute Tox. 4 *

Acute Tox. 4 *

Skin Corr. 1B
H312

H302

H314
GHS05

GHS07

Dgr
H312

H302

H314
015-171-00-7O,O,O-tris(2(or 4)-C9-10-isoalkylphenyl) phosphorothioate406-940-1Aquatic Chronic 2H411GHS09H411
015-172-00-2reaction mass of: bis(isotridecylammonium)mono(di-(4-methylpent-2-yloxy)thiophosphorothionylisopropyl)phosphate;

isotridecylammonium bis(di-(4-methylpent-2-yloxy)thiophosphorothionylisopropyl)phosphate
406-240-6Flam. Liq. 3

Skin Corr. 1B

Aquatic Chronic 2
H226

H314

H411
GHS02

GHS05

GHS09

Dgr
H226

H314

H411
015-173-00-8methyl [2-(1,1-dimethylethyl)-6-methoxypyrimidin-4-yl]ethylphosphonothioate414-080-3117291-73-3Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1
H302

H400

H410
GHS07

GHS09

Wng
H302

H410
015-174-00-31-chloro-N,N-diethyl-1,1-diphenyl-1-(phenylmethyl)phosphoramine411-370-182857-68-9Acute Tox. 3 *

Eye Dam. 1

Aquatic Chronic 2
H301

H318

H411
GHS06

GHS05

GHS09

Dgr
H301

H318

H411
015-175-00-9tert-butyl (triphenylphosphoranylidene) acetate412-880-735000-38-5Acute Tox. 3 *

STOT RE 2 *

Eye Irrit. 2

Skin Sens. 1

Aquatic Chronic 2
H301

H373 **

H319

H317

H411
GHS06

GHS08

GHS09

Dgr
H301

H373 **

H319

H317

H411
015-176-00-4P,P,P',P'-tetrakis-(o-methoxyphenyl)propane-1,3-diphosphine413-430-2116163-96-3Aquatic Acute 1

Aquatic Chronic 1
H400

H410
GHS09

Wng
H410
015-177-00-X((4-phenylbutyl)hydroxyphosphoryl)acetic acid412-170-783623-61-4STOT RE 2 *

Eye Dam. 1

Skin Sens. 1
H373 **

H318

H317
GHS08

GHS05

Dgr
H373 **

H318

H317
015-178-00-5(R)-α-phenylethylammonium (-)-(1R, 2S)-(1,2-epoxypropyl)phosphonate monohydrate418-570-825383-07-7Repr. 2

Aquatic Chronic 2
H361f ***

H411
GHS08

GHS09

Wng
H361f ***

H411
015-179-00-0UVCB condensation product of: tetrakis-hydroxymethylphosphonium chloride, urea and distilled hydrogenated C16-18 tallow alkylamine422-720-8166242-53-1Carc. 2

Acute Tox. 4 *

STOT RE 2 *

Skin Corr. 1B

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H351

H302

H373 **

H314

H317

H400

H410
GHS08

GHS05

GHS07

GHS09

Dgr
H351

H302

H373 **

H314

H317

H410
015-180-00-6[R-(R*,S*)]-[[2-methyl-1-(1-oxopropoxy)propoxy]-(4-phenylbutyl)phosphinyl] acetic acid, (-)-cinchonidine (1:1) salt415-820-8137590-32-0Eye Dam. 1

Skin Sens. 1

Aquatic Chronic 3
H318

H317

H412
GHS05

GHS07

Dgr
H318

H317

H412
015-181-00-1phosphine232-260-87803-51-2Flam. Gas 1

Press. Gas

Acute Tox. 2 *

Skin Corr. 1B

Aquatic Acute 1
H220

H330

H314

H400
GHS02

GHS04

GHS06

GHS05

GHS09

Dgr
H220

H330

H314

H400
U
015-184-00-8Salts of glyphosate, with the exception of those specified elsewhere in this AnnexAquatic Chronic 2H411GHS09H411A
015-186-00-9chlorpyrifos-methyl (ISO)

O,O-dimethyl O-3,5,6-trichloro-2-pyridyl phosphorothioate
227-011-55598-13-0Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H317

H400

H410
GHS07

GHS09

Wng
H317

H410
M = 10000
015-187-00-4reaction mass of: tetrasodium(((2-hydroxyethyl)imino)bis(methylene))bisphosphonate, N-oxide;

trisodium ((tetrahydro-2-hydroxy-4H-1,4,2-oxazaphosphorin-4-yl)-methyl)phosphonate, N-oxide, P-oxide
417-540-1Eye Dam. 1

Aquatic Chronic 2
H318

H411
GHS05

GHS09

Dgr
H318

H411
015-189-00-5phenyl bis(2,4,6-trimethylbenzoyl)-phosphine oxide423-340-5162881-26-7Skin Sens. 1

Aquatic Chronic 4
H317

H413
GHS07

Wng
H317

H413
016-001-00-4hydrogen sulphide231-977-37783-06-4Flam. Gas 1

Press. Gas

Acute Tox. 2 *

Aquatic Acute 1
H220

H330

H400
GHS02

GHS04

GHS06

GHS09

Dgr
H220

H330

H400
U
016-002-00-Xbarium sulphide244-214-421109-95-5Acute Tox. 4 *

Acute Tox. 4 *

Aquatic Acute 1
H332

H302

H400
GHS07

GHS09

Wng
H332

H302

H400
EUH031
016-003-00-5barium polysulphides256-814-350864-67-0Eye Irrit. 2

STOT SE 3

Skin Irrit. 2

Aquatic Acute 1
H319

H335

H315

H400
GHS07

GHS09

Wng
H319

H335

H315

H400
EUH031
016-004-00-0calcium sulphide243-873-520548-54-3Eye Irrit. 2

STOT SE 3

Skin Irrit. 2

Aquatic Acute 1
H319

H335

H315

H400
GHS07

GHS09

Wng
H319

H335

H315

H400
EUH031
016-005-00-6calcium polysulphides215-709-21344-81-6Eye Irrit. 2

STOT SE 3

Skin Irrit. 2

Aquatic Acute 1
H319

H335

H315

H400
GHS07

GHS09

Wng
H319

H335

H315

H400
EUH031
016-006-00-1dipotassium sulphide;

potassium sulphide
215-197-01312-73-8Skin Corr. 1B

Aquatic Acute 1
H314

H400
GHS05

GHS09

Dgr
H314

H400
EUH031
016-007-00-7potassium polysulphides253-390-137199-66-9Skin Corr. 1B

Aquatic Acute 1
H314

H400
GHS05

GHS09

Dgr
H314

H400
EUH031
016-008-00-2ammonium polysulphides232-989-19080-17-5Skin Corr. 1B

Aquatic Acute 1
H314

H400
GHS05

GHS09

Dgr
H314

H400
EUH031EUH031: C ≥ 1 %
016-009-00-8disodium sulphide;

sodium sulphide
215-211-51313-82-2Skin Corr. 1B

Aquatic Acute 1
H314

H400
GHS05

GHS09

Dgr
H314

H400
EUH031
016-010-00-3sodium polysulphides215-686-91344-08-7Acute Tox. 3 *

Skin Corr. 1B

Aquatic Acute 1
H301

H314

H400
GHS06

GHS05

GHS09

Dgr
H301

H314

H400
EUH031
016-011-00-9sulphur dioxide231-195-27446-09-5Press. Gas

Acute Tox. 3 *

Skin Corr. 1B
H331

H314
GHS04

GHS06

GHS05

Dgr
H331

H314
*U

5
016-012-00-4disulphur dichloride;

sulfur monochloride
233-036-210025-67-9Acute Tox. 3 *

Acute Tox. 4 *

Skin Corr. 1A

Aquatic Acute 1
H301

H332

H314

H400
GHS06

GHS05

GHS09

Dgr
H301

H332

H314

H400
EUH014

EUH029
STOT SE 3; H335: C ≥ 1 %
016-013-00-Xsulphur dichloride234-129-010545-99-0Skin Corr. 1B

STOT SE 3

Aquatic Acute 1
H314

H335

H400
GHS05

GHS07

GHS09

Dgr
H314

H335

H400
EUH014STOT SE 3; H335: C ≥ 5 %
016-014-00-5sulphur tetrachloride13451-08-6Skin Corr. 1B

Aquatic Acute 1
H314

H400
GHS05

GHS09

Dgr
H314

H400
EUH014STOT SE 3; H335: C ≥ 5 %
016-015-00-0thionyl dichloride;

thionyl chloride
231-748-87719-09-7Acute Tox. 4 *

Acute Tox. 4 *

Skin Corr. 1A
H332

H302

H314
GHS05

GHS07

Dgr
H332

H302

H314
EUH014

EUH029
STOT SE 3; H335: C ≥ 1 %
016-016-00-6sulphuryl chloride232-245-67791-25-5Skin Corr. 1B

STOT SE 3
H314

H335
GHS05

GHS07

Dgr
H314

H335
EUH014
016-017-00-1chlorosulphonic acid232-234-67790-94-5Skin Corr. 1A

STOT SE 3
H314

H335
GHS05

GHS07

Dgr
H314

H335
EUH014
016-018-00-7fluorosulphonic acid232-149-47789-21-1Acute Tox. 4 *

Skin Corr. 1A
H332

H314
GHS05

GHS07

Dgr
H332

H314
016-019-00-2oleum ... % SO3Skin Corr. 1A

STOT SE 3
H314

H335
GHS05

GHS07

Dgr
H314

H335
EUH014B
016-020-00-8sulphuric acid ... %231-639-57664-93-9Skin Corr. 1AH314GHS05

Dgr
H314Skin Corr. 1A; H314: C ≥ 15 %

Skin Irrit. 2; H315: 5 % ≤ C < 15 %

Eye Irrit. 2; H319: 5 % ≤ C < 15 %
B
016-021-00-3methanethiol;

methyl mercaptan
200-822-174-93-1Flam. Gas. 1

Press. Gas

Acute Tox. 3 *

Aquatic Acute 1

Aquatic Chronic 1
H220

H331

H400

H410
GHS02

GHS04

GHS06

GHS09

Dgr
H220

H331

H410
U
016-022-00-9ethanethiol;

ethyl mercaptan
200-837-375-08-1Flam. Liq. 2

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1
H225

H332

H400

H410
GHS02

GHS07

GHS09

Dgr
H225

H332

H410
016-023-00-4dimethyl sulphate201-058-177-78-1Carc. 1B

Muta. 2

Acute Tox. 2 *

Acute Tox. 3 *

Skin Corr. 1B

Skin Sens. 1
H350

H341

H330

H301

H314

H317
GHS06

GHS08

GHS05

Dgr
H350

H341

H330

H301

H314

H317
Carc. 1B; H350: C ≥ 0,01 %

Muta. 2; H341: C ≥ 0,01 %

STOT SE 3; H335: C ≥ 5 %
016-024-00-Xdimexano(ISO);

bis(methoxythiocarbonyl) disulphide
215-993-81468-37-7Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1
H302

H400

H410
GHS07

GHS09

Wng
H302

H410
016-025-00-5disul (ISO);

2-(2,4-dichlorophenoxy)ethyl hydrogensulphate;

2,4-DES
205-259-5149-26-8Acute Tox. 4 *

Skin Irrit. 2

Eye Dam. 1
H302

H315

H318
GHS05

GHS07

Dgr
H302

H315

H318
016-026-00-0sulphamidic acid;

sulphamic acid;

sulfamic acid
226-218-85329-14-6Eye Irrit. 2

Skin Irrit. 2

Aquatic Chronic 3
H319

H315

H412
GHS07

Wng
H319

H315

H412
016-027-00-6diethyl sulphate200-589-664-67-5Carc. 1B

Muta. 1B

Acute Tox. 4 *

Acute Tox. 4 *

Acute Tox. 4 *

Skin Corr. 1B
H350

H340

H332

H312

H302

H314
GHS05

GHS08

GHS07

Dgr
H350

H340

H332

H312

H302

H314
016-028-00-1sodium dithionite;

sodium hydrosulphite
231-890-07775-14-6Self-heat. 1

Acute Tox. 4 *
H251

H302
GHS02

GHS07

Dgr
H251

H302
EUH031
016-029-00-7p-toluenesulphonic acid, containing more than 5 % H2SO4Skin Corr. 1BH314GHS05

Dgr
H314Skin Corr. 1B; H314: C ≥ 25 %

Skin Irrit. 2; H315: 10 % ≤ C < 25 %

Eye Irrit. 2; H319: 10 % ≤ C < 25 %
016-030-00-2p-toluenesulphonic acid (containing a maximum of 5 % H2SO4)203-180-0104-15-4Eye Irrit. 2

STOT SE 3

Skin Irrit. 2
H319

H335

H315
GHS07

Wng
H319

H335

H315
STOT SE 3; H335: C ≥ 20 %
016-031-00-8tetrahydrothiophene-1,1-dioxide;

sulpholane
204-783-1126-33-0Acute Tox. 4 *H302GHS07

Wng
H302
016-032-00-31,3-propanesultone;

1,2-oxathiolane 2,2-dioxide
214-317-91120-71-4Carc. 1B

Acute Tox. 4 *

Acute Tox. 4 *
H350

H312

H302
GHS08

GHS07

Dgr
H350

H312

H302
Carc. 1B; H350: C ≥ 0,01 %
016-033-00-9dimethylsulfamoylchloride236-412-413360-57-1Carc. 1B

Acute Tox. 2 *

Acute Tox. 4 *

Acute Tox. 4 *

Skin Corr. 1B
H350

H330

H312

H302

H314
GHS06

GHS05

GHS08

Dgr
H350

H330

H312

H302

H314
016-034-00-4tetrasodium 3,3'-(piperazine-1,4-diylbis((6-chloro-1,3,5-triazine-2,4-diyl)imino(2-acetamido)-4,1-phenyleneazo))bis(naphthalene-1,5-disulphonate)400-010-981898-60-4Skin Sens. 1H317GHS07

Wng
H317
016-035-00-Xpentasodium 5-anilino-3-(4-(4-(6-chloro-4-(3-sulphonatoanilino)-1,3,5-triazin-2-ylamino)-2,5-dimethylphenylazo)-2,5-disulphonatophenylazo)-4-hydroxynaphthalene-2,7-disulphonate400-120-7Eye Irrit. 2H319GHS07

Wng
H319
016-036-00-5tetrasodium 5-(4,6-dichloro-5-cyanopyrimidin-2-ylamino)-4-hydroxy-2,3-azodinaphthalene-1,2,5,7-disulphonate400-130-1Resp. Sens. 1

Aquatic Chronic 2
H334

H411
GHS08

GHS09

Dgr
H334

H411
016-037-00-0disodium 1-amino-4-(4-benzenesulphonamido-3-sulphonatoanilino)anthraquinone-2-sulphonate400-350-885153-93-1Eye Dam. 1

Aquatic Chronic 3
H318

H412
GHS05

Dgr
H318

H412
016-038-00-6disodium 6-((4-chloro-6-(N-methyl)-2-toluidino)-1,3,5-triazin-2-ylamino)-1-hydroxy-2-(4-methoxy-2-sulphonatophenylazo)naphthalene-3-sulphonate400-380-186393-35-3Skin Sens. 1H317GHS07

Wng
H317
016-039-00-1tetrasodium 2-(6-chloro-4-(4-(2,5-dimethyl-4-(2,5-disulphonatophenylazo)phenylazo)-3-ureidoanilino)-1,3,5-triazin-2-ylamino)benzene-1,4-disulphonate400-430-2Skin Sens. 1H317GHS07

Wng
H317
016-040-00-7reaction mass of disodium 6-(2,4-dihydroxyphenylazo)-3-(4-(4-(2,4-dihydroxyphenylazo)anilino)-3-sulphonatophenylazo)-4-hydroxynaphthalene-2-sulphonate and disodium 6-(2,4-diaminophenylazo)-3-(4-(4-(2,4-diaminophenylazo)anilino)-3-sulphonatophenylazo)-4-hydroxynaphthalene-2-sulphonate and trisodium 6-(2,4-dihydroxyphenylazo)-3-(4-(4-(7-(2,4-dihydroxyphenylazo)-1-hydroxy-3-sulphonato-2-naphthylazo)anilino)-3-sulphonatophenylazo)-4-hydroxynaphthalene-2-sulphonate400-570-4Eye Irrit. 2H319GHS07

Wng
H319
016-041-00-2calcium 2,5-dichloro-4-(4-((5-chloro-4-methyl-2-sulphonatophenyl)azo)-5-hydroxy-3-methylpyrazol-1-yl)benzenesulphonate400-710-4Acute Tox. 4 *H332GHS07

Wng
H332
016-042-00-8tetrasodium 5-benzamido-3-(5-(4-fluoro-6-(1-sulphonato-2-naphthylamino)-1,3,5-triazin-2-ylamino)-2-sulphonatophenylazo)-4-hydroxynaphthalene-2,7- disulphonate400-790-085665-97-0Eye Irrit. 2

Skin Irrit. 2

Skin Sens. 1
H319

H315

H317
GHS07

Wng
H319

H315

H317
016-043-00-3dilithium 6-acetamido-4-hydroxy-3-(4-((2-sulphonatooxy)ethylsulphonyl)phenylazo)naphthalene-2-sulphonate401-010-1Skin Sens. 1H317GHS07

Wng
H317
016-044-00-9disodium S,S-hexane-1,6-diyldi(thiosulphate) dihydrate401-320-7Skin Sens. 1

Aquatic Chronic 3
H317

H412
GHS07

Wng
H317

H412
016-045-00-4lithium sodium hydrogen 4-amino-6-(5-(5-chloro-2,6-difluoropyrimidin-4-ylamino)-2-sulphonatophenylazo)-5-hydroxy-3-(4-(2-(sulphonatooxy)ethylsulphonyl)phenylazo)naphthalene-2,7-disulphonate401-560-2108624-00-6Skin Sens. 1H317GHS07

Wng
H317
016-046-00-Xsodium hydrogensulphate231-665-77681-38-1Eye Dam. 1H318GHS05

Dgr
H318
016-047-00-5hexasodium 7-(4-(4-(4-(2,5-disulphonatoanilino)-6-fluoro-1,3,5-triazin-2-ylamino)-2-methylphenylazo)-7-sulphonatonaphthylazo)naphthalene-1,3,5- trisulphonate401-650-185665-96-9Skin Sens. 1H317GHS07

Wng
H317
016-048-00-0sodium 3,5-dichloro-2-(5-cyano-2,6-bis(3-hydroxypropylamino)-4-methylpyridin-3-ylazo)benzenesulphonate401-870-8Eye Dam. 1

Aquatic Chronic 3
H318

H412
GHS05

Dgr
H318

H412
016-049-00-6calcium octadecylxylenesulphonate402-040-8Skin Corr. 1B

Aquatic Chronic 2
H314

H411
GHS05

GHS09

Dgr
H314

H411
016-050-00-1potassium sodium 5-(4-chloro-6-(N-(4-(4-chloro-6-(5-hydroxy-2,7-disulphonato-6-(2-sulphonatophenylazo)-4-naphthylamino)-1,3,5-triazin-2-ylamino) phenyl-N-methyl)amino)-1,3,5-triazin-2-ylamino)-4-hydroxy-3-(2-sulphonatophenylazo)naphthalene-2,7-disulphonat402-150-6Eye Irrit. 2

Skin Sens. 1
H319

H317
GHS07

Wng
H319

H317
016-051-00-7trisodium 7-(4-(6-fluoro-4-(2-(2-vinylsulphonylethoxy)ethylamino)-1,3,5-triazin-2-ylamino)-2-ureidophenylazo)naphthalene-1,3,6- trisulphonate402-170-5106359-91-5Skin Sens. 1H317GHS07

Wng
H317
016-052-00-2benzyltributylammonium 4-hydroxynaphthalene-1-sulphonate402-240-5102561-46-6Acute Tox. 4 *

Aquatic Chronic 2
H332

H411
GHS07

GHS09

Wng
H332

H411
016-053-00-8(C16 or C18-n-alkyl)(C16 or C18-n-alkyl)ammonium 2-((C16 or C18-n-alkyl)(C16 or C18-n-alkyl)carbamoyl)benzenesulphonate402-460-1Skin Irrit. 2

Skin Sens. 1

Aquatic Chronic 4
H315

H317

H413
GHS07

Wng
H315

H317

H413
016-054-00-3sodium 4-(2,4,4-trimethylpentylcarbonyloxy)benzenesulfonate400-030-8Acute Tox. 3 *

STOT RE 1

Acute Tox. 4 *

Eye Irrit. 2

STOT SE 3

Skin Sens. 1
H331

H372 **

H302

H319

H335

H317
GHS06

GHS08

Dgr
H331

H372 **

H302

H319

H335

H317
016-055-00-9tetrasodium 4-amino-3,6-bis(5-(6-chloro-4-(2-hydroxyethylamino)-1,3,5-triazin-2-ylamino)-2-sulfonatophenylazo)-5-hydroxynaphthalene-2,7-sulfonate (containing > 35 % sodium chloride and sodium acetate)400-510-7Eye Dam. 1

Skin Sens. 1
H318

H317
GHS05

GHS07

Dgr
H318

H317
016-056-00-4potassium hydrogensulphate231-594-17646-93-7Skin Corr. 1B

STOT SE 3
H314

H335
GHS05

GHS07

Dgr
H314

H335
016-057-00-Xstyrene-4-sulfonyl chloride404-770-22633-67-2Skin Irrit. 2

Eye Dam. 1

Skin Sens. 1
H315

H318

H317
GHS05

GHS07

Dgr
H315

H318

H317
016-058-00-5thionyl chloride, reaction products with 1,3,4-thiadiazol-2,5-dithiol, tert-nonanethiol and C12-14-tert-alkylamine404-820-3Skin Irrit. 2

Skin Sens. 1

Aquatic Chronic 3
H315

H317

H412
GHS07

Wng
H315

H317

H412
016-059-00-0N,N,N',N'-tetramethyldithiobis(ethylene)diamine dihydrochloride405-300-917339-60-5Acute Tox. 4 *

Eye Irrit. 2

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H302

H319

H317

H400

H410
GHS07

GHS09

Wng
H302

H319

H317

H410
016-060-00-6diammonium peroxodisulphate;

ammonium persulphate
231-786-57727-54-0Ox. Sol. 3

Acute Tox. 4 *

Eye Irrit. 2

STOT SE 3

Skin Irrit. 2

Resp. Sens. 1

Skin Sens. 1
H272

H302

H319

H335

H315

H334

H317
GHS03

GHS08

GHS07

Dgr
H272

H302

H319

H335

H315

H334

H317
016-061-00-1dipotassium peroxodisulphate;

potassium persulphate
231-781-87727-21-1Ox. Sol. 3

Acute Tox. 4 *

Eye Irrit. 2

STOT SE 3

Skin Irrit. 2

Resp. Sens. 1

Skin Sens. 1
H272

H302

H319

H335

H315

H334

H317
GHS03

GHS08

GHS07

Dgr
H272

H302

H319

H335

H315

H334

H317
016-062-00-7bensultap (ISO);

1,3-bis(phenylsulfonylthio)-2-(N,N-dimethylamino)propane
17606-31-4Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1
H302

H400

H410
GHS07

GHS09

Wng
H302

H410
016-063-00-2sodium metabisulphite231-673-07681-57-4Acute Tox. 4 *

Eye Dam. 1
H302

H318
GHS05

GHS07

Dgr
H302

H318
EUH031
016-064-00-8sodium hydrogensulphite . . . %;

sodium bisulphite . . . %
231-548-07631-90-5Acute Tox. 4 *H302GHS07

Wng
H302EUH031B
016-065-00-3sodium 1-amino-4-[2-methyl-5-(4-methylphenylsulfonylamino)phenylamino]anthraquinone-2-sulfonate400-100-884057-97-6Aquatic Chronic 2H411GHS09H411
016-066-00-9tetrasodium [5-((4-amino-6-chloro-1,3,5-triazin-2-yl)amino)-2-((2-hydroxy-3,5-disulfonatophenylazo)-2- sulfonatobenzylidenehydrazino)benzoate]copper(II)404-070-7116912-62-0Aquatic Chronic 3H412H412
016-067-00-4(4-methylphenyl)mesitylene sulfonate407-530-567811-06-7Aquatic Chronic 4H413H413
016-068-00-Xsodium 3,5-bis(tetradecyloxycarbonyl)benzenesulfinate407-720-8155160-86-4Skin Sens. 1

Aquatic Chronic 2
H317

H411
GHS07

GHS09

Wng
H317

H411
016-069-00-53,5-bis-(tetradecyloxycarbonyl)benzenesulfinic acid407-990-7141915-64-2Skin Sens. 1

Aquatic Chronic 2
H317

H411
GHS07

GHS09

Wng
H317

H411
016-070-00-04-benzyloxy-4'-(2,3-epoxy-2-methylprop-1-yloxy)diphenylsulfone408-220-2Aquatic Chronic 4H413H413
016-071-00-6trisodium 3-amino-6,13-dichloro-10-((3-((4-chloro-6-(2-sulfophenylamino)-1,3,5-triazin-2-yl)amino)propyl) amino)-4,11-triphenoxydioxazinedisulfonate410-130-3136248-03-8Skin Sens. 1H317GHS07

Wng
H317
016-072-00-13-amino-4-hydroxy-N-(2-methoxyethyl)-benzenesulfonamide411-520-6112195-27-4Eye Dam. 1

Skin Sens. 1

Aquatic Chronic 2
H318

H317

H411
GHS05

GHS07

GHS09

Dgr
H318

H317

H411
016-073-00-7tetrakis(phenylmethyl)thioperoxydi(carbothioamide)404-310-010591-85-2Aquatic Chronic 4H413H413
016-074-00-26-fluoro-2-methyl-3-(4-methylthiobenzyl)indene405-410-7Skin Irrit. 2

Eye Dam. 1

Skin Sens. 1

Aquatic Chronic 2
H315

H318

H317

H411
GHS05

GHS07

GHS09

Dgr
H315

H318

H317

H411
016-075-00-82,2'-diallyl-4,4'-sulfonyldiphenol411-570-941481-66-7Skin Sens. 1

Aquatic Chronic 2
H317

H411
GHS07

GHS09

Wng
H317

H411
016-076-00-32,3-bis((2-mercaptoethyl)thio)-1-propanethiol411-290-7131538-00-6Acute Tox. 4 *

STOT RE 2 *

Aquatic Acute 1

Aquatic Chronic 1
H302

H373 **

H400

H410
GHS08

GHS07

GHS09

Wng
H302

H373 **

H410
016-077-00-92-chloro-p-toluenesulfochloride412-890-142413-03-6Skin Corr. 1B

Skin Sens. 1

Aquatic Chronic 3
H314

H317

H412
GHS05

GHS07

Dgr
H314

H317

H412
016-078-00-44-methyl-N,N-bis(2-(((4-methylphenyl)sulfonyl)amino)ethyl)benzenesulfonamide413-300-556187-04-3Aquatic Chronic 4H413
016-079-00-XN,N-bis(2-(p-toluenesulfonyloxy)ethyl)-p-toluenesulfonamide412-920-316695-22-0Skin Sens. 1

Aquatic Chronic 4
H317

H413
GHS07

Wng
H317

H413
016-080-00-5sodium 2-anilino-5-(2-nitro-4-(N-phenylsulfamoyl))anilinobenzenesulfonate412-320-131361-99-6Eye Dam. 1

Aquatic Chronic 3
H318

H412
GHS05

Dgr
H318

H412
016-081-00-0hexahydrocyclopenta[c]pyrrole-1-(1H)-ammonium N-ethoxycarbonyl-N-(p-tolylsulfonyl)azanide418-350-1Muta. 2

Acute Tox. 4 *

Eye Irrit. 2

Skin Sens. 1

Aquatic Chronic 2
H341

H302

H319

H317

H411
GHS08

GHS07

GHS09

Wng
H341

H302

H319

H317

H411
016-082-00-6ethoxysulfuron (ISO);

1-(4,6-dimethoxypyrimidin-2-yl)-3-(2-ethoxyphenoxysulfonyl)urea
126801-58-9Aquatic Acute 1

Aquatic Chronic 1
H400

H410
GHS09

Wng
H410
016-083-00-1acibenzolar-S-methyl;

benzo[1,2,3]thiadiazole-7-carbothioic acid S-methyl ester
420-050-0135158-54-2Eye Irrit. 2

STOT SE 3

Skin Irrit. 2

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H319

H335

H315

H317

H400

H410
GHS07

GHS09

Wng
H319

H335

H315

H317

H410
016-084-00-7prosulfuron;

1-(4-methoxy-6-methyl-1,3,5-triazin-2-yl)-3-[2-(3,3,3-trifluoropropyl)phenylsulfonyl]urea
94125-34-5Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1
H302

H400

H410
GHS07

GHS09

Wng
H302

H410
016-085-00-2flazasulfuron (ISO);

1-(4,6-dimethoxypyrimidin-2-yl)-3-(3-trifluoromethyl-2-pyridylsulfonyl)urea
104040-78-0Aquatic Acute 1

Aquatic Chronic 1
H400

H410
GHS09

Wng
H410
016-086-00-8tetrasodium 10-amino-6,13-dichloro-3-(3-(4-(2,5-disulfonatoanilino)-6-fluoro-1,3,5-triazin-2-ylamino)prop-3-ylamino)-5,12-dioxa-7,14-diazapentacene-4,11-disulfonate402-590-9109125-56-6Eye Dam. 1H318GHS05

Dgr
H318
016-087-00-3reaction mass of: thiobis(4,1-phenylene)-S,S,S',S'-tetraphenyldisulfonium bishexafluorophosphate;

diphenyl(4-phenylthiophenyl)sulfonium hexafluorophosphate;

propylene carbonate
403-490-8104558-95-4Eye Irrit. 2

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H319

H317

H400

H410
GHS07

GHS09

Wng
H319

H317

H410
016-088-00-94-(bis(4-(diethylamino)phenyl)methyl)benzene-1,2-dimethanesulfonic acid407-280-771297-11-5Aquatic Chronic 3H412H412
016-089-00-4reaction mass of esters of 5,5',6,6',7,7'-hexahydroxy-3,3,3',3'-tetramethyl-1,1'-spirobiindan and 2-diazo-1,2-dihydro-1-oxo-5-sulfonaphthalene413-840-1Self-react. C ****

Aquatic Chronic 4
H242

H413
GHS02

Dgr
H242

H413
016-090-00-X4-methyl-N-(methylsulfonyl)benzenesulfonamide415-040-814653-91-9Acute Tox. 4 *

STOT SE 3

Eye Dam. 1
H302

H335

H318
GHS05

GHS07

Dgr
H302

H335

H318
016-091-00-5C12-14-tert-alkyl ammonium 1-amino-9,10-dihydro-9,10-dioxo-4-(2,4,6-trimethylanilino)-anthracen-2-sulfonate414-110-5Eye Dam. 1

Aquatic Acute 1

Aquatic Chronic 1
H318

H400

H410
GHS05

GHS09

Dgr
H318

H410
016-093-00-6reaction mass of: 4-(7-hydroxy-2,4,4-trimethyl-2-chromanyl)resorcinol-4-yl-tris(6-diazo-5,6-dihydro-5-oxonaphthalen-1-sulfonate);

4-(7-hydroxy-2,4,4-trimethyl-2-chromanyl)resorcinolbis(6-diazo-5,6-dihydro-5-oxonaphthalen-1-sulfonate) (2:1)
414-770-4140698-96-0Self-react. C ****

Carc. 2
H242

H351
GHS02

GHS08

Dgr
H242

H351
016-095-00-7reaction mass of: reaction product of 4,4'-methylenebis[2-(4-hydroxybenzyl)-3,6-dimethylphenol] and 6-diazo-5,6-dihydro-5-oxo-naphthalenesulfonate (1:2);

Reaction product of 4,4'-methylenebis[2-(4-hydroxybenzyl)-3,6-dimethylphenol] and 6-diazo-5,6-dihydro-5-oxo-naphthalenesulfonate (1:3)
417-980-4Self-react. C ****

Carc. 2
H242

H351
GHS02

GHS08

Dgr
H242

H351
016-096-00-2thifensulfuron-methyl (ISO);

methyl 3-(4-methoxy-6-methyl-1,3,5-triazin-2-ylcarbamoylsulfamoyl)thiophene-2-carboxylate
79277-27-3Aquatic Acute 1

Aquatic Chronic 1
H400

H410
GHS09

Wng
H410
017-001-00-7chlorine231-959-57782-50-5Ox. Gas 1

Press. Gas

Acute Tox. 3 *

Eye Irrit. 2

STOT SE 3

Skin Irrit. 2

Aquatic Acute 1
H270

H331

H319

H335

H315

H400
GHS03

GHS04

GHS06

GHS09

Dgr
H270

H331

H319

H335

H315

H400
U
017-002-00-2hydrogen chloride231-595-77647-01-0Press. Gas

Acute Tox. 3 *

Skin Corr. 1A
H331

H314
GHS04

GHS06

GHS05

Dgr
H331

H314
U

5
017-002-01-Xhydrochloric acid ... %231-595-7Skin Corr. 1B

STOT SE 3
H314

H335
GHS05

GHS07

Dgr
H314

H335
Skin Corr. 1B; H314: C ≥ 25 %

Skin Irrit. 2; H315: 10 % ≤ C < 25 %

Eye Irrit. 2; H319: 10 % ≤ C < 25 %

STOT SE 3; H335: C ≥ 10 %
B
017-003-00-8barium chlorate236-760-713477-00-4Ox. Sol. 1

Acute Tox. 4 *

Acute Tox. 4 *

Aquatic Chronic 2
H271

H332

H302

H411
GHS03

GHS07

GHS09

Dgr
H271

H332

H302

H411
017-004-00-3potassium chlorate223-289-73811-04-9Ox. Sol. 1

Acute Tox. 4 *

Acute Tox. 4 *

Aquatic Chronic 2
H271

H332

H302

H411
GHS03

GHS07

GHS09

Dgr
H271

H332

H302

H411
017-005-00-9sodium chlorate231-887-47775-09-9Ox. Sol. 1

Acute Tox. 4 *

Aquatic Chronic 2
H271

H302

H411
GHS03

GHS07

GHS09

Dgr
H271

H302

H411
017-006-00-4perchloric acid ... %231-512-47601-90-3Ox. Liq. 1

Skin Corr. 1A
H271

H314
GHS03

GHS05

Dgr
H271

H314
Skin Corr. 1A; H314: C ≥ 50 %

Skin Corr. 1B; H314: 10 % ≤ C < 50 %

Skin Irrit. 2; H315: 1 % ≤ C < 10 %

Eye Irrit. 2; H319: 1 % ≤ C < 10 %

Ox. Liq. 1; H271: C > 50 %:

Ox. Liq. 2; H272: C ≤ 50 %:
B
017-007-00-Xbarium perchlorate236-710-413465-95-7Ox. Sol. 1

Acute Tox. 4 *

Acute Tox. 4 *
H271

H332

H302
GHS03

GHS07

Dgr
H271

H332

H302
017-008-00-5potassium perchlorate231-912-97778-74-7Ox. Sol. 1

Acute Tox. 4 *
H271

H302
GHS03

GHS07

Dgr
H271

H302
017-009-00-0ammonium perchlorate232-235-17790-98-9Expl. 1.1

Ox. Sol. 1
H201

H271
GHS01

Dgr
H201

H271
EUH044T
017-010-00-6sodium perchlorate231-511-97601-89-0Ox. Sol. 1

Acute Tox. 4 *
H271

H302
GHS03

GHS07

Dgr
H271

H302
017-011-00-1sodium hypochlorite, solution ... % Cl active231-668-37681-52-9Skin Corr. 1B

Aquatic Acute 1
H314

H400
GHS05

GHS09

Dgr
H314

H400
EUH031EUH031: C ≥ 5 %B
017-012-00-7calcium hypochlorite231-908-77778-54-3Ox. Sol. 2

Acute Tox. 4 *

Skin Corr. 1B

Aquatic Acute 1
H272

H302

H314

H400
GHS03

GHS05

GHS07

GHS09

Dgr
H272

H302

H314

H400
EUH031Skin Corr. 1B; H314: C ≥ 10 %

Skin Irrit. 2; H315: 3 % ≤ C < 10 %

Eye Dam. 1; H31: 3 % ≤ C < 10 %

Eye Irrit. 2; H319: 0,5 % ≤ C < 3 %

STOT SE 3; H335: C ≥ 3 %
T
017-013-00-2calcium chloride233-140-810043-52-4Eye Irrit. 2H319GHS07

Wng
H319
017-014-00-8ammonium chloride235-186-412125-02-9Acute Tox. 4 *

Eye Irrit. 2
H302

H319
GHS07

Wng
H302

H319
017-015-00-3(2-(aminomethyl)phenyl)acetylchloride hydrochloride417-410-461807-67-8Acute Tox. 4 *

Skin Corr. 1A

Skin Sens. 1
H302

H314

H317
GHS05

GHS07

Dgr
H302

H314

H317
017-016-00-9methyltriphenylphosphonium chloride418-400-21031-15-8Acute Tox. 4 *

Acute Tox. 4 *

Skin Irrit. 2

Eye Dam. 1

Aquatic Chronic 2
H312

H302

H315

H318

H411
GHS05

GHS07

GHS09

Dgr
H312

H302

H315

H318

H411
017-017-00-4(Z)-13-docosenyl-N,N-bis(2-hydroxyethyl)-N-methyl-ammonium-chloride426-210-6120086-58-0Skin Corr. 1B

Aquatic Acute 1

Aquatic Chronic 1
H314

H400

H410
GHS05

GHS09

Dgr
H314

H410
017-018-00-XN,N,N-trimethyl-2,3-bis(stearoyloxy)propylammonium chloride405-660-7Aquatic Chronic 2H411GHS09H411
017-019-00-5(R)-1,2,3,4-tetrahydro-6,7-dimethoxy-1-veratrylisoquinoline hydrochloride415-110-854417-53-7Acute Tox. 4 *

Aquatic Chronic 3
H302

H412
GHS07

Wng
H302

H412
017-020-00-0ethyl propoxy aluminium chloride421-790-713014-29-4Water-react. 1

Skin Corr. 1A
H260

H314
GHS02

GHS05

Dgr
H260

H314
EUH014
017-021-00-6behenamidopropyl-dimethyl-(dihydroxypropyl) ammonium chloride423-420-1136920-10-0Eye Dam. 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H318

H317

H400

H410
GHS05

GHS07

GHS09

Dgr
H318

H317

H410
019-001-00-2potassium231-119-87440-09-7Water-react. 1

Skin Corr. 1B
H260

H314
GHS02

GHS05

Dgr
H260

H314
EUH014
019-002-00-8potassium hydroxide;

caustic potash
215-181-31310-58-3Acute Tox. 4 *

Skin Corr. 1A
H302

H314
GHS05

GHS07

Dgr
H302

H314
Skin Corr. 1A; H314: C ≥ 5 %

Skin Corr. 1B; H314: 2 % ≤ C < 5 %

Skin Irrit. 2; H315: 0,5 % ≤ C < 2 %

Eye Irrit. 2; H319: 0,5 % ≤ C < 2 %
020-001-00-Xcalcium231-179-57440-70-2Water-react. 2H261GHS02

Dgr
H261
020-002-00-5calcium cyanide209-740-0592-01-8Acute Tox. 2 *

Aquatic Acute 1

Aquatic Chronic 1
H300

H400

H410
GHS06

GHS09

Dgr
H300

H410
EUH032
020-003-00-0reaction mass of: dicalcium (bis(2-hydroxy-5-tetra-propenylphenylmethyl)methylamine)dihydroxide;

tri-calcium (tris(2-hydroxy-5-tetra-propenylphenylmethyl)methylamine)tri-hydroxide;

poly[calcium ((2-hydroxy-5-tetra-propenyl-phenylmethyl)methylamine)hydroxide]
420-470-4Eye Irrit. 2

Skin Irrit. 2

Skin Sens. 1
H319

H315

H317
GHS07

Wng
H319

H315

H317
022-001-00-5titanium tetrachloride231-441-97550-45-0Skin Corr. 1BH314GHS05

Dgr
H314EUH014
022-002-00-0titanium(4+) oxalate403-260-7Eye Dam. 1H318GHS05

Dgr
H318
022-003-00-6bis(η5-cyclopentadienyl)-bis(2,6-difluoro-3-[pyrrol-1-yl]-phenyl)titanium412-000-1125051-32-3Flam. Sol. 1

Repr. 2

STOT RE 2 *

Aquatic Chronic 2
H228

H361f ***

H373 **

H411
GHS02

GHS08

GHS09

Dgr
H228

H361f ***

H373 **

H411
T
023-001-00-8divanadium pentaoxide;

vanadium pentoxide
215-239-81314-62-1Muta. 2

Repr. 2

STOT RE 1

Acute Tox. 4 *

Acute Tox. 4 *

STOT SE 3

Aquatic Chronic 2
H341

H361d ***

H372 **

H332

H302

H335

H411
GHS08

GHS07

GHS09

Dgr
H341

H361d ***

H372 **

H332

H302

H335

H411
024-001-00-0chromium (VI) trioxide215-607-81333-82-0Ox. Sol. 1

Carc. 1A

Muta. 1B

Repr. 2

Acute Tox. 2 *

Acute Tox. 3 *

Acute Tox. 3 *

STOT RE 1

Skin Corr. 1A

Resp. Sens. 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H271

H350

H340

H361f ***

H330

H311

H301

H372 **

H314

H334

H317

H400

H410
GHS03

GHS06

GHS08

GHS05

GHS09

Dgr
H271

H350

H340

H361f ***

H330

H311

H301

H372 **

H314

H334

H317

H410
STOT SE 3; H335: C ≥ 1 %
024-002-00-6potassium dichromate231-906-67778-50-9Ox. Sol. 2

Carc. 1B

Muta. 1B

Repr. 1B

Acute Tox. 2 *

Acute Tox. 3 *

STOT RE 1

Acute Tox. 4 *

Skin Corr. 1B

Resp. Sens. 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H272

H350

H340

H360FD

H330

H301

H372 **

H312

H314

H334

H317

H400

H410
GHS03

GHS06

GHS08

GHS05

GHS09

Dgr
H272

H350

H340

H360FD

H330

H301

H372 **

H312

H314

H334

H317

H410
STOT SE 3; H335: C ≥ 5 %3
024-003-00-1ammonium dichromate232-143-17789-09-5Ox. Sol. 2 ****

Carc. 1B

Muta. 1B

Repr. 1B

Acute Tox. 2 *

Acute Tox. 3 *

STOT RE 1

Acute Tox. 4 *

Skin Corr. 1B

Resp. Sens. 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H272

H350

H340

H360FD

H330

H301

H372 **

H312

H314

H334

H317

H400

H410
GHS03

GHS06

GHS08

GHS05

GHS09

Dgr
H272

H350

H340

H360FD

H330

H301

H372 **

H312

H314

H334

H317

H410
STOT SE 3; H335: C ≥ 5 %

Resp. Sens.; H334: C ≥ 0,2 %

Skin Sens.; H317: C ≥ 0,2 %
G

3
024-004-00-7sodium dichromate anhydrate234-190-310588-01-9Ox. Sol. 2

Carc. 1B

Muta. 1B

Repr. 1B

Acute Tox. 2 *

Acute Tox. 3 *

STOT RE 1

Acute Tox. 4 *

Skin Corr. 1B

Resp. Sens. 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H272

H350

H340

H360FD

H330

H301

H372 **

H312

H314

H334

H317

H400

H410
GHS03

GHS06

GHS08

GHS05

GHS09

Dgr
H272

H350

H340

H360FD

H330

H301

H372 **

H312

H314

H334

H317

H410
STOT SE 3; H335: C ≥ 5 %

Resp. Sens.; H334: C ≥ 0,2 %

Skin Sens.; H317: C ≥ 0,2 %
3
024-004-01-4sodium dichromate, dihydrate234-190-37789-12-0Ox. Sol. 2

Carc. 1B

Muta. 1B

Repr. 1B

Acute Tox. 2 *

Acute Tox. 3 *

STOT RE 1

Acute Tox. 4 *

Skin Corr. 1B

Resp. Sens. 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H272

H350

H340

H360FD

H330

H301

H372 **

H312

H314

H334

H317

H400

H410
GHS03

GHS06

GHS08

GHS05

GHS09

Dgr
H272

H350

H340

H360FD

H330

H301

H372 **

H312

H314

H334

H317

H410
STOT SE 3; H335: C ≥ 5 %

Resp. Sens.; H334: C ≥ 0,2 %

Skin Sens.; H317: C ≥ 0,2 %
3
024-005-00-2chromyl dichloride;

chromic oxychloride
239-056-814977-61-8Ox. Liq. 1

Carc. 1B

Muta. 1B

Skin Corr. 1A

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H271

H350i

H340

H314

H317

H400

H410
GHS03

GHS08

GHS05

GHS07

GHS09

Dgr
H271

H350i

H340

H314

H317

H410
Skin Corr. 1A; H314: C ≥ 10 %

Skin Corr. 1B; H314: 5 % ≤ C < 10 %

Skin Irrit. 2; H315: 0,5 % ≤ C < 5 %

Eye Irrit. 2; H319: 0,5 % ≤ C < 5 %

STOT SE 3; H335: 0,5 % ≤ C < 5 %

Skin Sens. 1; H317: C ≥ 0,5 %
T

3
024-006-00-8potassium chromate232-140-57789-00-6Carc. 1B

Muta. 1B

Eye Irrit. 2

STOT SE 3

Skin Irrit. 2

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H350i

H340

H319

H335

H315

H317

H400

H410
GHS08

GHS07

GHS09

Dgr
H350i

H340

H319

H335

H315

H317

H410
Skin Sens. 1; H317: C ≥ 0,5 %3
024-007-00-3zinc chromates including zinc potassium chromateCarc. 1A

Acute Tox. 4 *

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H350

H302

H317

H400

H410
GHS08

GHS07

GHS09

Dgr
H350

H302

H317

H410
A
024-008-00-9calcium chromate237-366-813765-19-0Carc. 1B

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1
H350

H302

H400

H410
GHS08

GHS07

GHS09

Dgr
H350

H302

H410
024-009-00-4strontium chromate232-142-67789-06-2Carc. 1B

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1
H350

H302

H400

H410
GHS08

GHS07

GHS09

Dgr
H350

H302

H400

H410
024-010-00-Xdichromium tris(chromate);

chromium III chromate;

chromic chromate
246-356-224613-89-6Ox. Sol. 1

Carc. 1B

Skin Corr. 1A

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H271

H350

H314

H317

H400

H410
GHS03

GHS08

GHS05

GHS07

GHS09

Dgr
H271

H350

H314

H317

H410
T
024-011-00-5ammonium bis(1-(3,5-dinitro-2-oxidophenylazo)-3-(N-phenylcarbamoyl)-2-naphtholato)chromate(1-)400-110-2109125-51-1Self-react. C ****

Aquatic Acute 1

Aquatic Chronic 1
H242

H400

H410
GHS02

GHS09

Dgr
H242

H410
024-012-00-0trisodium bis(7-acetamido-2-(4-nitro-2-oxidophenylazo)-3-sulphonato-1-naphtholato)chromate(1-)400-810-8Muta. 2H341GHS08

Wng
H341
024-013-00-6trisodium (6-anilino-2-(5-nitro-2-oxidophenylazo)-3-sulphonato-1-naphtholato)(4-sulphonato-1,1'-azodi-2,2'naphtholato)chromate(1-)402-500-8Eye Dam. 1

Aquatic Chronic 2
H318

H411
GHS05

GHS09

Dgr
H318

H411
024-014-00-1trisodium bis(2-(5-chloro-4-nitro-2-oxidophenylazo)-5-sulphonato-1-naphtholato)chromate(1-)402-870-093952-24-0Eye Dam. 1

Aquatic Chronic 3
H318

H412
GHS05

Dgr
H318

H412
024-015-00-7disodium (3-methyl-4-(5-nitro-2-oxidophenylazo)-1-phenylpyrazololato)(1-(3-nitro-2-oxido-5-sulfonatophenylazo)-2-naphtholato)chromate(1-)404-930-1Acute Tox. 4 *

Eye Dam. 1

Aquatic Chronic 2
H332

H318

H411
GHS05

GHS07

GHS09

Dgr
H332

H318

H411
024-016-00-2tetradecylammonium bis(1-(5-chloro-2-oxidophenylazo)-2-naphtholato)chromate(1-)405-110-688377-66-6STOT RE 2 *

Aquatic Chronic 4
H373 **

H413
GHS08

Wng
H373 **

H413
024-017-00-8Chromium (VI) compounds, with the exception of barium chromate and of compounds specified elsewhere in this AnnexCarc. 1B

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H350i

H317

H400

H410
GHS08

GHS07

GHS09

Dgr
H350i

H317

H410
A
024-018-00-3sodium chromate231-889-57775-11-3Carc. 1B

Muta. 1B

Repr. 1B

Acute Tox. 2 *

Acute Tox. 3 *

STOT RE 1

Acute Tox. 4 *

Skin Corr. 1B

Resp. Sens. 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H350

H340

H360FD

H330

H301

H372 **

H312

H314

H334

H317

H400

H410
GHS06

GHS08

GHS05

GHS09

Dgr
H350

H340

H360FD

H330

H301

H372 **

H312

H314

H334

H317

H410
Resp. Sens.; H334: C ≥ 0,2 %

Skin Sens.; H317: C ≥ 0,2 %
3
024-019-00-9Main component: acetoacetic acid anilide/3-amino-1-hydroxybenzene (ATAN-MAP): trisodium {6-[(2 or 3 or 4)-amino-(4 or 5 or 6)-hydroxyphenylazo]-5'-(phenylsulfamoyl)-3-sulfonatonaphthalene-2-azobenzene-1,2'-diolato}-{6''-[1-(phenylcarbamoyl)ethylazo]-5'''-(phenylsulfamoyl)-3''-sulfonatonaphthalene-2''-azobenzene-1'',2'''-diolato}chromate (III);

by-product 1: acetoacetic acid anilide/acetoacetic acid anilide (ATAN-ATAN): trisodium bis{6-[1-(phenylcarbamoyl)ethylazo]-5'-(phenylsulfonyl)-3-sulfonatonaphthalene-2-azobenzene-1,2'-diolato}chromate (III);

by-product 2: 3-amino-1-hydroxybenzene/3-amino-1-hydroxybenzene (MAP-MAP): trisodium bis{6-[(2 or 3 or 4)-amino-(4 or 5 or 6)-hydroxyphenylazo]-5'-(phenylsulfamoyl)-3-sulfonatonaphthalene-2-azobenzene-1,2'-diolato} chromate (III)
419-230-1Skin Sens. 1

Aquatic Chronic 3
H317

H412
GHS07

Wng
H317

H412
024-020-00-4trisodium bis[(3'-nitro-5'-sulfonato(6-amino-2-[4-(2-hydroxy-1-naphtylazo)phenylsulfonylamino]pyrimidin-5-azo)benzene-2',4-diolato)]chromate(III)418-220-4Skin Sens. 1

Aquatic Chronic 3
H317

H412
GHS07

Wng
H317

H412
025-001-00-3manganese dioxide215-202-61313-13-9Acute Tox. 4 *

Acute Tox. 4 *
H332

H302
GHS07

Wng
H332

H302
025-002-00-9potassium permanganate231-760-37722-64-7Ox. Sol. 2

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1
H272

H302

H400

H410
GHS03

GHS07

GHS09

Dgr
H272

H302

H410
025-003-00-4manganese sulphate232-089-97785-87-7STOT RE 2 *

Aquatic Chronic 2
H373 **

H411
GHS08

GHS09

Wng
H373 **

H411
025-004-00-Xbis(N,N',N''-trimethyl-1,4,7-triazacyclononane)-trioxo-dimanganese (IV) di(hexafluorophosphate) monohydrate411-760-1116633-53-5Aquatic Chronic 2H411GHS09H411
025-005-00-5reaction mass of: tri-sodium [29H, 31H-phthalocyanine-C,C,C-trisulfonato (6-)-N29,N30,N31,N32] manganate (3-);

tetrasodium [29H,31H-phthalocyanine-C,C,C,C-tetrasulfonato (6-)-N29,N30,N31,N32], manganate (3-);

pentasodium [29H,31H-phthalocyanine-C,C,C,C,C-pentasulfonato (6-)-N29,N30,N31,N32] manganate (3-)
417-660-4Aquatic Acute 1

Aquatic Chronic 1
H400

H410
GHS09

Wng
H410
026-001-00-6(η-cumene)-(η-cyclopentadienyl)iron(II) hexafluoroantimonate407-840-0100011-37-8Acute Tox. 4 *

Eye Dam. 1

Aquatic Chronic 3
H302

H318

H412
GHS05

GHS07

Dgr
H302

H318

H412
026-002-00-1(η-cumene)-(η-cyclopentadienyl)iron(II) trifluoromethane-sulfonate407-880-9117549-13-0Acute Tox. 4 *

Aquatic Chronic 3
H302

H412
GHS07

Wng
H302

H412
027-001-00-9cobalt231-158-07440-48-4Resp. Sens. 1

Skin Sens. 1

Aquatic Chronic 4
H334

H317

H413
GHS08

Dgr
H334

H317

H413
027-002-00-4cobalt oxide215-154-61307-96-6Acute Tox. 4 *

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H302

H317

H400

H410
GHS07

GHS09

Wng
H302

H317

H410
027-003-00-Xcobalt sulphide215-273-31317-42-6Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H317

H400

H410
GHS07

GHS09

Wng
H317

H410
027-004-00-5cobalt dichloride231-589-47646-79-9Carc. 1B

Acute Tox. 4 *

Resp. Sens. 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H350i

H302

H334

H317

H400

H410
GHS08

GHS07

GHS09

Dgr
H350i

H302

H334

H317

H410
Carc. 1B; H350i: C ≥ 0,01 %

*
1
027-005-00-0cobalt sulphate233-334-210124-43-3Carc. 1B

Acute Tox. 4 *

Resp. Sens. 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H350i

H302

H334

H317

H400

H410
GHS08

GHS07

GHS09

Dgr
H350i

H302

H334

H317

H410
Carc. 1B; H350i: C ≥ 0,01 %1
028-001-00-1tetracarbonylnickel;

nickel tetracarbonyl
236-669-213463-39-3Flam. Liq. 2

Carc. 2

Repr. 1B

Acute Tox. 2 *

Aquatic Acute 1

Aquatic Chronic 1
H225

H351

H360D ***

H330

H400

H410
GHS02

GHS06

GHS08

GHS09

Dgr
H225

H351

H360D ***

H330

H410
028-002-00-7nickel231-111-47440-02-0Carc. 2

Skin Sens. 1
H351

H317
GHS08

GHS07

Wng
H351

H317
028-003-00-2nickel monoxide215-215-71313-99-1Carc. 1Ai

Skin Sens. 1

Aquatic Chronic 4
H350i

H317

H413
GHS08

GHS07

Dgr
H350i

H317

H413
028-004-00-8nickel dioxide234-823-312035-36-8Carc. 1Ai

Skin Sens. 1

Aquatic Chronic 4
H350i

H317

H413
GHS08

GHS07

Dgr
H350i

H317

H413
028-005-00-3dinickel trioxide215-217-81314-06-3Carc. 1Ai

Skin Sens. 1

Aquatic Chronic 4
H350i

H317

H413
GHS08

GHS07

Dgr
H350i

H317

H413
028-006-00-9nickel sulphide240-841-216812-54-7Carc. 1Ai

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H350i

H317

H400

H410
GHS08

GHS07

GHS07

GHS09

Dgr
H350i

H317

H410
028-007-00-4nickel subsulphide;

trinickel disulphide
234-829-612035-72-2Carc. 1Ai

Skin Sens. 1

Aquatic Chronic 2
H350i

H317

H411
GHS08

GHS07

GHS09

Dgr
H350i

H317

H411
028-008-00-Xnickel dihydroxide235-008-512054-48-7Carc. 2

Acute Tox. 4 *

Acute Tox. 4 *

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H351

H332

H302

H317

H400

H410
GHS08

GHS07

GHS09

Wng
H351

H332

H302

H317

H410
028-009-00-5nickel sulphate232-104-97786-81-4Carc. 2

Acute Tox. 4 *

Resp. Sens. 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H351

H302

H334

H317

H400

H410
GHS08

GHS07

GHS09

Dgr
H351

H302

H334

H317

H410
028-010-00-0nickel carbonate222-068-23333-67-3Carc. 2

Acute Tox. 4 *

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H351

H302

H317

H400

H410
GHS08

GHS07

GHS09

Wng
H351

H302

H317

H410
029-001-00-4copper chloride;

copper (I) chloride;

cuprous chloride
231-842-97758-89-6Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1
H302

H400

H410
GHS07

GHS09

Wng
H302

H400

H410
029-002-00-Xdicopper oxide;

copper (I) oxide
215-270-71317-39-1Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1
H302

H400

H410
GHS07

GHS09

Wng
H302

H410
029-003-00-5Naphthenic acids, copper salts;

copper naphthenate
215-657-01338-02-9Flam. Liq. 3

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1
H226

H302

H400

H410
GHS02

GHS07

GHS09

Wng
H226

H302

H410
029-004-00-0copper sulphate231-847-67758-98-7Acute Tox. 4 *

Eye Irrit. 2

Skin Irrit. 2

Aquatic Acute 1

Aquatic Chronic 1
H302

H319

H315

H400

H410
GHS07

GHS09

Wng
H302

H319

H315

H410
029-005-00-6(tris(chloromethyl)phthalocyaninato)copper(II), reaction products with N-methylpiperazine and methoxyacetic acid401-260-1Eye Irrit. 2H319GHS07

Wng
H319
029-006-00-1tris(octadec-9-enylammonium) (trisulfonatophthalocyaninato)copper(II)403-210-4Eye Dam. 1

Aquatic Chronic 2
H318

H411
GHS05

GHS09

Dgr
H318

H411
029-007-00-7(trisodium (2-((3-(6-(2-chloro-5-sulfonato)anilino)-4-(3-carboxypyridinio)-1,3,5-triazin-2-ylamino)-2-oxido-5-sulfonatophenylazo)phenylmethylazo)-4-sulfonatobenzoato)copper(3-)) hydroxide404-670-989797-01-3Skin Sens. 1H317GHS07

Wng
H317G
029-008-00-2copper(II) methanesulfonate405-400-254253-62-2Acute Tox. 4 *

Eye Dam. 1

Aquatic Acute 1

Aquatic Chronic 1
H302

H318

H400

H410
GHS05

GHS07

GHS09

Dgr
H302

H318

H410
029-009-00-8phthalocyanine-N-[3-(diethylamino)propyl]sulfonamide copper complex413-650-993971-95-0Aquatic Chronic 3H412H412
029-010-00-3reaction mass of compounds from (dodecakis(p-tolylthio)phthalocyaninato)copper(II) to (hexadecakis(p-tolylthio)phthalocyaninato)copper(II)407-700-9101408-30-4Skin Sens. 1H317GHS07

Wng
H317
029-011-00-9sodium [29H,31H-phthalocyaninato-(2-)-N29,N30,N31,N32]-((3-(N-methyl-N-(2-hydroxyethyl)amino)propyl)amino)sulfonyl-sulfonato, copper complex412-730-0150522-10-4Skin Corr. 1BH314GHS05

Dgr
H314
029-012-00-4sodium ((N-(3-trimethylammoniopropyl)sulfamoyl)methylsulfonatophthalocyaninato)copper(II)407-340-2124719-24-0Eye Dam. 1H318GHS05

Dgr
H318
029-013-00-Xtrisodium(2-(α-(3-(4-chloro-6-(2-(2-(vinylsulfonyl)ethoxy)ethylamino)-1,3,5-triazin-2-ylamino)-2-oxido-5-sulfonatophenylazo)benzylidenehydrazino)-4-sulfonatobenzoato)copper(II)407-580-8130201-51-3Eye Dam. 1

Aquatic Chronic 3
H318

H412
GHS05

Dgr
H318

H412
030-001-00-1zinc powder — zinc dust (pyrophoric)231-175-37440-66-6Water-react. 1

Pyr. Sol. 1

Aquatic Acute 1

Aquatic Chronic 1
H260

H250

H400

H410
GHS02

GHS09

Dgr
H260

H250

H410
T
030-001-01-9zinc powder — zinc dust (stabilised)231-175-37440-66-6Aquatic Acute 1

Aquatic Chronic 1
H400

H410
GHS09

Wng
H410
030-003-00-2zinc chloride231-592-07646-85-7Acute Tox. 4 *

Skin Corr. 1B

Aquatic Acute 1

Aquatic Chronic 1
H302

H314

H400

H410
GHS05

GHS07

GHS09

Dgr
H302

H314

H410
STOT SE 3; H335: C ≥ 5 %
030-004-00-8dimethylzinc; [1]

diethylzinc [2]
208-884-1 [1]

209-161-3 [2]
544-97-8 [1]

557-20-0 [2]
Pyr. Liq. 1

Water-react. 1

Skin Corr. 1B

Aquatic Acute 1

Aquatic Chronic 1
H250

H260

H314

H400

H410
GHS02

GHS05

GHS09

Dgr
H250

H260

H314

H410
EUH014
030-005-00-3diamminediisocyanatozinc401-610-3Acute Tox. 4 *

Eye Dam. 1

Resp. Sens. 1

Skin Sens. 1

Aquatic Acute 1
H302

H318

H334

H317

H400
GHS05

GHS08

GHS07

GHS09

Dgr
H302

H318

H334

H317

H400
030-006-00-9zinc sulphate (hydrous) (mono-, hexa- and hepta hydrate); [1]

zinc sulphate (anhydrous) [2]
231-793-3 [1]

231-793-3 [2]
7446-19-7 [1]

7733-02-0 [2]
Acute Tox. 4 *

Eye Dam. 1

Aquatic Acute 1

Aquatic Chronic 1
H302

H318

H400

H410
GHS05

GHS07

GHS09

Dgr
H302

H318

H410
030-007-00-4bis(3,5-di-tert-butylsalicylato-O 1,O 2)zinc403-360-042405-40-3Flam. Sol. 1

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1
H228

H302

H400

H410
GHS02

GHS07

GHS09

Dgr
H228

H302

H410
T
030-008-00-Xhydroxo(2-(benzenesulfonamido)benzoato)zinc(II)403-750-0113036-91-2Acute Tox. 4 *

Aquatic Chronic 2
H332

H411
GHS07

GHS09

Wng
H332

H411
030-011-00-6trizinc bis(orthophosphate)231-944-37779-90-0Aquatic Acute 1

Aquatic Chronic 1
H400

H410
GHS09

Wng
H410
030-013-00-7zinc oxide215-222-51314-13-2Aquatic Acute 1

Aquatic Chronic 1
H400

H410
GHS09

Wng
H410
033-001-00-Xarsenic231-148-67440-38-2Acute Tox. 3 *

Acute Tox. 3 *

Aquatic Acute 1

Aquatic Chronic 1
H331

H301

H400

H410
GHS06

GHS09

Dgr
H331

H301

H410
033-002-00-5arsenic compounds, with the exception of those specified elsewhere in this AnnexAcute Tox. 3 *

Acute Tox. 3 *

Aquatic Acute 1

Aquatic Chronic 1
H331

H301

H400

H410
GHS06

GHS09

Dgr
H331

H301

H410
*A

1
033-003-00-0diarsenic trioxide;

arsenic trioxide
215-481-41327-53-3Carc. 1A

Acute Tox. 2 *

Skin Corr. 1B

Aquatic Acute 1

Aquatic Chronic 1
H350

H300

H314

H400

H410
GHS06

GHS08

GHS05

GHS09

Dgr
H350

H300

H314

H410
033-004-00-6diarsenic pentaoxide;

arsenic pentoxide;

arsenic oxide
215-116-91303-28-2Carc. 1A

Acute Tox. 3 *

Acute Tox. 3 *

Aquatic Acute 1

Aquatic Chronic 1
H350

H331

H301

H400

H410
GHS06

GHS08

GHS09

Dgr
H350

H331

H301

H410
033-005-00-1arsenic acid and its saltsCarc. 1A

Acute Tox. 3 *

Acute Tox. 3 *

Aquatic Acute 1

Aquatic Chronic 1
H350

H331

H301

H400

H410
GHS06

GHS08

GHS09

Dgr
H350

H331

H301

H410
A
033-006-00-7arsine232-066-37784-42-1Flam. Gas 1

Press. Gas

Acute Tox. 2 *

STOT RE 2 *

Aquatic Acute 1

Aquatic Chronic 1
H220

H330

H373 **

H400

H410
GHS02

GHS04

GHS06

GHS08

GHS09

Dgr
H220

H330

H373 **

H410
U
033-007-00-2tert-butylarsine423-320-64262-43-5Pyr. Liq. 1

Acute Tox. 2 *
H250

H330
GHS02

GHS06

Dgr
H250

H330
034-001-00-2selenium231-957-47782-49-2Acute Tox. 3 *

Acute Tox. 3 *

STOT RE 2 *

Aquatic Chronic 4
H331

H301

H373 **

H413
GHS06

GHS08

Dgr
H331

H301

H373 **

H413
034-002-00-8selenium compounds except cadmium sulphoselenideAcute Tox. 3 *

Acute Tox. 3 *

STOT RE 2 *

Aquatic Acute 1

Aquatic Chronic 1
H331

H301

H373 **

H400

H410
GHS06

GHS08

GHS09

Dgr
H331

H301

H373 **

H410
A
034-003-00-3sodium selenite233-267-910102-18-8Acute Tox. 2 *

Acute Tox. 3 *

Skin Sens. 1

Aquatic Chronic 2
H300

H331

H317

H411
GHS06

GHS09

Dgr
H300

H331

H317

H411
EUH031
035-001-00-5bromine231-778-17726-95-6Acute Tox. 2 *

Skin Corr. 1A

Aquatic Acute 1
H330

H314

H400
GHS06

GHS05

GHS09

Dgr
H330

H314

H400
035-002-00-0hydrogen bromide233-113-010035-10-6Press. Gas

Skin Corr. 1A

STOT SE 3
H314

H335
GHS04

GHS05

GHS07

Dgr
H314

H335
U
035-002-01-8hydrobromic acid ... %Skin Corr. 1B

STOT SE 3
H314

H335
GHS05

GHS07

Dgr
H314

H335
Skin Corr. 1B; H314: C ≥ 40 %

Skin Irrit. 2; H315: 10 % ≤ C < 40 %

Eye Irrit. 2; H319: 10 % ≤ C < 40 %

STOT SE 3; H335: C ≥ 10 %
B
035-003-00-6potassium bromate231-829-87758-01-2Ox. Sol. 1

Carc. 1B

Acute Tox. 3 *
H271

H350

H301
GHS03

GHS06

GHS08

Dgr
H271

H350

H301
035-004-00-12-hydroxyethylammonium perbromide407-440-6Ox. Sol. 2 ****

Acute Tox. 4 *

Skin Corr. 1A

Skin Sens. 1

Aquatic Acute 1
H272

H302

H314

H317

H400
GHS03

GHS05

GHS07

GHS09

Dgr
H272

H302

H314

H317

H400
040-001-00-3zirconium powder (pyrophoric)231-176-97440-67-7Water-react. 1

Pyr. Sol. 1
H260

H250
GHS02

Dgr
H260

H250
T
040-002-00-9zirconium powder, dry (non pyrophoric)Self-heat. 1H251GHS02

Dgr
H251T
042-001-00-9molybdenum trioxide215-204-71313-27-5STOT RE 2 *

Eye Irrit. 2

STOT SE 3
H373 **

H319

H335
GHS08

GHS07

Wng
H373 **

H319

H335
042-002-00-4tetrakis(dimethylditetradecylammonium) hexa-μ-oxotetra-μ3-oxodi-μ5-oxotetradecaoxooctamolybdate(4-)404-760-8117342-25-3Acute Tox. 3 *

Eye Dam. 1

Aquatic Chronic 4
H331

H318

H413
GHS06

GHS05

Dgr
H331

H318

H413
042-003-00-Xtetrakis(trimethylhexadecylammonium) hexa-mu-oxotetra-mu3-oxodi-mu5-oxotetradecaoxooctamolybdate(4-)404-860-1116810-46-9Flam. Sol. 1

Eye Dam. 1

Aquatic Acute 1

Aquatic Chronic 1
H228

H318

H400

H410
GHS02

GHS05

GHS09

Dgr
H228

H318

H410
T
042-004-00-5Reaction product of ammonium molybdate and C12-C24-diethoxylated alkylamine (1:5-1:3)412-780-3Skin Irrit. 2

Skin Sens. 1

Aquatic Chronic 2
H315

H317

H411
GHS07

GHS09

Wng
H315

H317

H411
047-001-00-2silver nitrate231-853-97761-88-8Skin Corr. 1B

Aquatic Acute 1

Aquatic Chronic 1
H314

H400

H410
GHS05

GHS09

Dgr
H314

H410
048-001-00-5cadmium compounds, with the exception of cadmium sulphoselenide (xCdS.yCdSe),

reaction mass of cadmium sulphide with zinc sulphide (xCdS.yZnS), reaction mass of cadmium sulphide with mercury sulphide (xCdS.yHgS), and those specified elsewhere in this Annex
Acute Tox. 4 *

Acute Tox. 4 *

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1
H332

H312

H302

H400

H410
GHS07

GHS09

Wng
H332

H312

H302

H410
*A

1
048-002-00-0cadmium (non-pyrophoric); [1]

cadmium oxide (non-pyrophoric) [2]
231-152-8 [1]

215-146-2 [2]
7440-43-9 [1]

1306-19-0 [2]
Carc. 1B

Muta. 2

Repr. 2

Acute Tox. 2 *

STOT RE 1

Aquatic Acute 1

Aquatic Chronic 1
H350

H341

H361fd

H330

H372 **

H400

H410
GHS06

GHS08

GHS09

Dgr
H350

H341

H361fd

H330

H372 **

H410
048-003-00-6cadmium diformate;

cadmiumformate
224-729-04464-23-7Acute Tox. 3 *

Acute Tox. 3 *

Carc. 2

STOT RE 2 *

Aquatic Acute 1

Aquatic Chronic 1
H331

H301

H351

H373 **

H400

H410
GHS06

GHS08

GHS09

Dgr
H331

H301

H351

H373 **

H410
*

STOT RE 2; H373: C ≥ 0,25 %
048-004-00-1cadmium cyanide208-829-1542-83-6Acute Tox. 2 *

Acute Tox. 1

Acute Tox. 2 *

Carc. 2

STOT RE 2 *

Aquatic Acute 1

Aquatic Chronic 1
H330

H310

H300

H351

H373 **

H400

H410
GHS06

GHS08

GHS09

Dgr
H330

H310

H300

H351

H373 **

H410
EUH032STOT RE 2; H373: C ≥ 0,1 %

EUH032: C ≥ 1 %
048-005-00-7cadmiumhexafluorosilicate(2-);

cadmium fluorosilica
241-084-017010-21-8Acute Tox. 3 *

Acute Tox. 3 *

Carc. 2

STOT RE 2 *

Aquatic Acute 1

Aquatic Chronic 1
H331

H301

H351

H373 **

H400

H410
GHS06

GHS08

GHS09

Dgr
H331

H301

H351

H373 **

H410
*

STOT RE 2; H373: C ≥ 0,1 %
048-006-00-2cadmium fluoride232-222-07790-79-6Carc. 1B

Muta. 1B

Repr. 1B

Acute Tox. 2 *

Acute Tox. 3 *

STOT RE 1

Aquatic Acute 1

Aquatic Chronic 1
H350

H340

H360FD

H330

H301

H372 **

H400

H410
GHS06

GHS08

GHS09

Dgr
H350

H340

H360FD

H330

H301

H372 **

H410
Carc. 1B; H350: C ≥ 0,01 %

* oral

STOT RE 1; H372: C ≥ 7 %

STOT RE 2: 0,1 % ≤ C < 7 %
048-007-00-8cadmium iodide232-223-67790-80-9Acute Tox. 3 *

Acute Tox. 3 *

Carc. 2

STOT RE 2 *

Aquatic Acute 1

Aquatic Chronic 1
H331

H301

H351

H373 **

H400

H410
GHS06

GHS08

GHS09

Dgr
H331

H301

H351

H373 **

H410
*

STOT RE 2; H373: C ≥ 0,1 %
048-008-00-3cadmium chloride233-296-710108-64-2Carc. 1B

Muta. 1B

Repr. 1B

Acute Tox. 2 *

Acute Tox. 3 *

STOT RE 1

Aquatic Acute 1

Aquatic Chronic 1
H350

H340

H360FD

H330

H301

H372 **

H400

H410
GHS06

GHS08

GHS09

Dgr
H350

H340

H360FD

H330

H301

H372 **

H410
Carc. 1B; H350: C ≥ 0,01 %

* oral

STOT RE 1; H372: C ≥ 7 %

STOT RE 2; H373: 0,1 % ≤ C < 7 %
048-009-00-9cadmium sulphate233-331-610124-36-4Carc. 1B

Muta. 1B

Repr. 1B

Acute Tox. 2 *

Acute Tox. 3 *

STOT RE 1

Aquatic Acute 1

Aquatic Chronic 1
H350

H340

H360FD

H330

H301

H372 **

H400

H410
GHS06

GHS08

GHS09

Dgr
H350

H340

H360FD

H330

H301

H372 **

H410
Carc. 1B; H350: C ≥ 0,01 %

* oral

STOT RE 1; H372: C ≥ 7 %

STOT RE 2; H373: 0,1 % ≤ C < 7 %
048-010-00-4cadmium sulphide215-147-81306-23-6Carc. 1B

Muta. 2

Repr. 2

STOT RE 1

Acute Tox. 4 *

Aquatic Chronic 4
H350

H341

H361fd

H372 **

H302

H413
GHS08

GHS07

Dgr
H350

H341

H361fd

H372 **

H302

H413
*

STOT RE 1; H372: C ≥ 10 %

STOT RE 2; H373: 0,1 % ≤ C < 10 %
1
048-011-00-Xcadmium (pyrophoric)231-152-87440-43-9Pyr. Sol. 1

Carc. 1B

Muta. 2

Repr. 2

Acute Tox. 2 *

STOT RE 1

Aquatic Acute 1

Aquatic Chronic 1
H250

H350

H341

H361fd

H330

H372 **

H400

H410
GHS02

GHS06

GHS08

GHS09

Dgr
H250

H350

H341

H361fd

H330

H372 **

H410
050-001-00-5tin tetrachloride;

stannic chloride
231-588-97646-78-8Skin Corr. 1B

Aquatic Chronic 3
H314

H412
GHS05

Dgr
H314

H412
STOT SE 3; H335: C ≥ 5 %
050-002-00-0cyhexatin (ISO);

hydroxytricyclohexylstannane;

tri(cyclohexyl)tin hydroxide
236-049-113121-70-5Acute Tox. 4 *

Acute Tox. 4 *

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1
H332

H312

H302

H400

H410
GHS07

GHS09

Wng
H332

H312

H302

H410
050-003-00-6fentin acetate (ISO);

triphenyltin acetate
212-984-0900-95-8Carc. 2

Repr. 2

Acute Tox. 2 *

Acute Tox. 3 *

Acute Tox. 3 *

STOT RE 1

STOT SE 3

Skin Irrit. 2

Eye Dam. 1

Aquatic Acute 1

Aquatic Chronic 1
H351

H361d ***

H330

H311

H301

H372 **

H335

H315

H318

H400

H410
GHS06

GHS08

GHS05

GHS09

Dgr
H351

H361d ***

H330

H311

H301

H372 **

H335

H315

H318

H410
050-004-00-1fentin hydroxide (ISO);

triphenyltin hydroxide
200-990-676-87-9Carc. 2

Repr. 2

Acute Tox. 2 *

Acute Tox. 3 *

Acute Tox. 3 *

STOT RE 1

STOT SE 3

Skin Irrit. 2

Eye Dam. 1

Aquatic Acute 1

Aquatic Chronic 1
H351

H361d ***

H330

H311

H301

H372 **

H335

H315

H318

H400

H410
GHS06

GHS08

GHS05

GHS09

Dgr
H351

H361d ***

H330

H311

H301

H372 **

H335

H315

H318

H410
050-005-00-7trimethyltin compounds, with the exception of those specified elsewhere in this AnnexAcute Tox. 2 *

Acute Tox. 1

Acute Tox. 2 *

Aquatic Acute 1

Aquatic Chronic 1
H330

H310

H300

H400

H410
GHS06

GHS09

Dgr
H330

H310

H300

H410
*A

1
050-006-00-2triethyltin compounds, with the exception of those specified elsewhere in this AnnexAcute Tox. 2 *

Acute Tox. 1

Acute Tox. 2 *

Aquatic Acute 1

Aquatic Chronic 1
H330

H310

H300

H400

H410
GHS06

GHS09

Dgr
H330

H310

H300

H410
*A

1
050-007-00-8tripropyltin compounds, with the exception of those specified elsewhere in this AnnexAcute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *

Aquatic Acute 1

Aquatic Chronic 1
H331

H311

H301

H400

H410
GHS06

GHS09

Dgr
H331

H311

H301

H410
*A

1
050-008-00-3tributyltin compounds, with the exception of those specified elsewhere in this AnnexAcute Tox. 3 *

STOT RE 1

Acute Tox. 4 *

Eye Irrit. 2

Skin Irrit. 2

Aquatic Acute 1

Aquatic Chronic 1
H301

H372 **

H312

H319

H315

H400

H410
GHS06

GHS08

GHS09

Dgr
H301

H372 **

H312

H319

H315

H410
* oral

STOT RE 1; H372: C ≥ 1 %

STOT RE 2; H373: 0,25 % ≤ C < 1 %

* dermal

Eye Irrit. 2; H319: C ≥ 1 %

Skin Irrit. 2; H315: C ≥ 1 %
A

1
050-009-00-9fluorotripentylstannane; [1]

hexapentyldistannoxane [2]
243-546-7 [1]

247-143-7 [2]
20153-49-5 [1]

25637-27-8 [2]
Acute Tox. 4 *

Acute Tox. 4 *

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1
H332

H312

H302

H400

H410
GHS07

GHS09

Wng
H332

H312

H302

H410
*1
050-010-00-4fluorotrihexylstannane243-547-220153-50-8Acute Tox. 4 *

Acute Tox. 4 *

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1
H332

H312

H302

H400

H410
GHS07

GHS09

Wng
H332

H312

H302

H410
*1
050-011-00-Xtriphenyltin compounds, with the exception of those specified elsewhere in this AnnexAcute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *

Aquatic Acute 1

Aquatic Chronic 1
H331

H311

H301

H400

H410
GHS06

GHS09

Dgr
H331

H311

H301

H410
*A

1
050-012-00-5tetracyclohexylstannane; [1]

chlorotricyclohexylstannane; [2]

butyltricyclohexylstannane [3]
215-910-5 [1]

221-437-5 [2]

230-358-5 [3]
1449-55-4 [1]

3091-32-5 [2]

7067-44-9 [3]
Acute Tox. 4 *

Acute Tox. 4 *

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1
H332

H312

H302

H400

H410
GHS07

GHS09

Wng
H332

H312

H302

H410
*A

1
050-013-00-0trioctyltin compounds, with the exception of those specified elsewhere in this AnnexEye Irrit. 2

STOT SE 3

Skin Irrit. 2

Aquatic Chronic 4
H319

H335

H315

H413
GHS07

Wng
H319

H335

H315

H413
Skin Irrit. 2; H315: C ≥ 1 %

Eye Irrit. 2; H319: C ≥ 1 %

STOT SE 3; H335: C ≥ 1 %
A

1
050-017-00-2fenbutatin oxide (ISO);

bis(tris(2-methyl-2-phenylpropyl)tin)oxide
236-407-713356-08-6Acute Tox. 2 *

Eye Irrit. 2

Skin Irrit. 2

Aquatic Acute 1

Aquatic Chronic 1
H330

H319

H315

H400

H410
GHS06

GHS09

Dgr
H330

H319

H315

H410
050-018-00-8tin(II) methanesulphonate401-640-753408-94-9Skin Corr. 1B

Acute Tox. 4 *

Skin Sens. 1
H314

H302

H317
GHS05

GHS07

Dgr
H314

H302

H317
050-019-00-3azocyclotin (ISO);

1-(tricyclohexylstannyl)-1H-1,2,4-triazole
255-209-141083-11-8Acute Tox. 2 *

Acute Tox. 3 *

STOT SE 3

Skin Irrit. 2

Eye Dam. 1

Aquatic Acute 1

Aquatic Chronic 1
H330

H301

H335

H315

H318

H400

H410
GHS06

GHS05

GHS09

Dgr
H330

H301

H335

H315

H318

H410
050-020-00-9trioctylstannane413-320-4869-59-0STOT RE 1

Skin Irrit. 2

Aquatic Chronic 4
H372 **

H315

H413
GHS08

GHS07

Dgr
H372 **

H315

H413
051-001-00-8antimony trichloride233-047-210025-91-9Skin Corr. 1B

Aquatic Chronic 2
H314

H411
GHS05

GHS09

Dgr
H314

H411
STOT SE 3; H335: C ≥ 5 %
051-002-00-3antimony pentachloride231-601-87647-18-9Skin Corr. 1B

Aquatic Chronic 2
H314

H411
GHS05

GHS09

Dgr
H314

H411
STOT SE 3; H335: C ≥ 5 %
051-003-00-9antimony compounds, with the exception of the tetroxide (Sb2O4), pentoxide (Sb2O5), trisulphide (Sb2S3), pentasulphide (Sb2S5) and those specified elsewhere in this AnnexAcute Tox. 4 *

Acute Tox. 4 *

Aquatic Chronic 2
H332

H302

H411
GHS07

GHS09

Wng
H332

H302

H411
*A

1
051-004-00-4antimony trifluoride232-009-27783-56-4Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *

Aquatic Chronic 2
H331

H311

H301

H411
GHS06

GHS09

Dgr
H331

H311

H301

H411
051-005-00-Xantimony trioxide215-175-01309-64-4Carc. 2H351GHS08

Wng
H351
051-006-00-5diphenyl(4-phenylthiophenyl)sulfonium hexafluoroantimonate403-500-0Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H317

H400

H410
GHS07

GHS09

Wng
H317

H410
051-007-00-0bis(4-dodecylphenyl)iodonium hexafluoroantimonate404-420-971786-70-4Skin Sens. 1

Aquatic Chronic 3
H317

H412
GHS07

Wng
H317

H412
053-001-00-3iodine231-442-47553-56-2Acute Tox. 4 *

Acute Tox. 4 *

Aquatic Acute 1
H332

H312

H400
GHS07

GHS09

Wng
H332

H312

H400
053-002-00-9hydrogen iodide233-109-910034-85-2Press. Gas

Skin Corr. 1A
H314GHS04

GHS05

Dgr
H314Skin Corr. 1A; H314: C ≥ 10 %

Skin Corr. 1B; H314: 0,2 % ≤ C < 10 %

Skin Irrit. 2; H315: 0,02 % ≤ C < 0,2 %

Eye Irrit. 2; H319: 0,02 % ≤ C < 0,2 %

STOT SE 3; H335: C ≥ 0,02 %
U

5
053-002-01-6hydriodic acid ... %Skin Corr. 1BH314GHS05

Dgr
Skin Corr. 1B; H314: C ≥ 25 %

Skin Irrit. 2; H315: 10 % ≤ C < 25 %

Eye Irrit. 2; H319: 10 % ≤ C < 25 %
B
053-005-00-5(4-(1-methylethyl)phenyl)-(4-methylphenyl)iodonium tetrakis(pentafluorophenyl)borate (1-)422-960-3178233-72-2Acute Tox. 4 *

Acute Tox. 4 *

STOT RE 2 *

Aquatic Acute 1

Aquatic Chronic 1
H312

H302

H373 **

H400

H410
GHS08

GHS07

GHS09

Wng
H312

H302

H373 **

H410
056-001-00-1barium peroxide215-128-41304-29-6Ox. Sol. 2

Acute Tox. 4 *

Acute Tox. 4 *
H272

H332

H302
GHS03

GHS07

Dgr
H272

H332

H302
056-002-00-7barium salts, with the exception of barium sulphate, salts of 1-azo-2-hydroxynaphthalenyl aryl sulphonic acid, and of salts specified elsewhere in this AnnexAcute Tox. 4 *

Acute Tox. 4 *
H332

H302
GHS07

Wng
H332

H302
*A

1
056-003-00-2barium carbonate208-167-3513-77-9Acute Tox. 4 *H302GHS07

Wng
H302
056-004-00-8barium chloride233-788-110361-37-2Acute Tox. 3 *

Acute Tox. 4 *
H301

H332
GHS06

Dgr
H301

H332
072-001-00-4hafnium tetra-n-butoxide411-740-222411-22-9Eye Dam. 1

Skin Sens. 1
H318

H317
GHS05

GHS07

Dgr
H318

H317
074-001-00-Xhexasodium tungstate hydrate412-770-912141-67-2Acute Tox. 4 *

Eye Dam. 1

Aquatic Chronic 3
H302

H318

H412
GHS05

GHS07

Dgr
H302

H318

H412
074-002-00-5Reaction products of tungsten hexachloride with 2-methylpropan-2-ol, nonylphenol and pentane-2,4-dione408-250-6Flam. Liq. 2

Acute Tox. 4 *

Skin Corr. 1B

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H225

H332

H314

H317

H400

H410
GHS02

GHS05

GHS07

GHS09

Dgr
H225

H332

H314

H317

H410
076-001-00-5osmium tetraoxide;

osmic acid
244-058-720816-12-0Acute Tox. 2 *

Acute Tox. 1

Acute Tox. 2 *

Skin Corr. 1B
H330

H310

H300

H314
GHS06

GHS05

Dgr
H330

H310

H300

H314
078-001-00-0tetrachloroplatinates with the exception of those specified elsewhere in this AnnexAcute Tox. 3 *

Eye Dam. 1

Resp. Sens. 1

Skin Sens. 1
H301

H318

H334

H317
GHS06

GHS05

GHS08

Dgr
H301

H318

H334

H317
A
078-002-00-6diammonium tetrachloroplatinate237-499-113820-41-2Acute Tox. 3 *

Skin Irrit. 2

Eye Dam. 1

Resp. Sens. 1

Skin Sens. 1
H301

H315

H318

H334

H317
GHS06

GHS05

GHS08

Dgr
H301

H315

H318

H334

H317
078-003-00-1disodium tetrachloroplatinate233-051-410026-00-3Acute Tox. 3 *

Skin Irrit. 2

Eye Dam. 1

Resp. Sens. 1

Skin Sens. 1
H301

H315

H318

H334

H317
GHS06

GHS05

GHS08

Dgr
H301

H315

H318

H334

H317
078-004-00-7dipotassium tetrachloroplatinate233-050-910025-99-7Acute Tox. 3 *

Skin Irrit. 2

Eye Dam. 1

Resp. Sens. 1

Skin Sens. 1
H301

H315

H318

H334

H317
GHS06

GHS05

GHS08

Dgr
H301

H315

H318

H334

H317
078-005-00-2hexachloroplatinates with the exception of those specified elsewhere in this AnnexAcute Tox. 3 *

Eye Dam. 1

Resp. Sens. 1

Skin Sens. 1
H301

H318

H334

H317
GHS06

GHS05

GHS08

Dgr
H301

H318

H334

H317
A
078-006-00-8disodium hexachloroplatinate240-983-516923-58-3Acute Tox. 3 *

Eye Dam. 1

Resp. Sens. 1

Skin Sens. 1
H301

H318

H334

H317
GHS06

GHS05

GHS08

Dgr
H301

H318

H334

H317
078-007-00-3dipotassium hexachloroplatinate240-979-316921-30-5Acute Tox. 3 *

Eye Dam. 1

Resp. Sens. 1

Skin Sens. 1
H301

H318

H334

H317
GHS06

GHS05

GHS08

Dgr
H301

H318

H334

H317
078-008-00-9diammonium hexachloroplatinate240-973-016919-58-7Acute Tox. 3 *

Eye Dam. 1

Resp. Sens. 1

Skin Sens. 1
H301

H318

H334

H317
GHS06

GHS05

GHS08

Dgr
H301

H318

H334

H317
078-009-00-4hexachloroplatinic acid241-010-716941-12-1Acute Tox. 3 *

Skin Corr. 1B

Resp. Sens. 1

Skin Sens. 1
H301

H314

H334

H317
GHS06

GHS05

GHS08

Dgr
H301

H314

H334

H317
080-001-00-0mercury231-106-77439-97-6Acute Tox. 3 *

STOT RE 2 *

Aquatic Acute 1

Aquatic Chronic 1
H331

H373 **

H400

H410
GHS06

GHS08

GHS09

Dgr
H331

H373 **

H410
080-002-00-6inorganic compounds of mercury with the exception of mercuric sulphide and those specified elsewhere in this AnnexAcute Tox. 2 *

Acute Tox. 1

Acute Tox. 2 *

STOT RE 2 *

Aquatic Acute 1

Aquatic Chronic 1
H330

H310

H300

H373 **

H400

H410
GHS06

GHS08

GHS09

Dgr
H330

H310

H300

H373 **

H410
*

STOT RE 2; H373: C ≥ 0,1 %
A

1
080-003-00-1dimercury dichloride;

mercurous chloride;

calomel
233-307-510112-91-1Acute Tox. 4 *

Eye Irrit. 2

STOT SE 3

Skin Irrit. 2

Aquatic Acute 1

Aquatic Chronic 1
H302

H319

H335

H315

H400

H410
GHS07

GHS09

Wng
H302

H319

H335

H315

H410
080-004-00-7organic compounds of mercury with the exception of those specified elsewhere in this AnnexAcute Tox. 2 *

Acute Tox. 1

Acute Tox. 2 *

STOT RE 2 *

Aquatic Acute 1

Aquatic Chronic 1
H330

H310

H300

H373 **

H400

H410
GHS06

GHS08

GHS09

Dgr
H330

H310

H300

H373 **

H410
*

STOT RE 2; H373: C ≥ 0,1 %
A

1
080-005-00-2mercury difulminate;

mercuric fulminate;

fulminate of mercury
211-057-8628-86-4Unst. Expl.

Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *

STOT RE 2 *

Aquatic Acute 1

Aquatic Chronic 1
H200

H331

H311

H301

H373 **

H400

H410
GHS01

GHS06

GHS08

GHS09

Dgr
H200

H331

H311

H301

H373 **

H400

H410
080-005-01-Xmercury difulminate;

mercuric fulminate;

fulminate of mercury [≥ 20 % phlegmatiser]
211-057-8628-86-4Expl. 1.1

Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *

STOT RE 2 *

Aquatic Acute 1

Aquatic Chronic 1
H201

H331

H311

H301

H373 **

H400

H410
GHS01

GHS06

GHS08

GHS09

Dgr
H201

H331

H311

H301

H373 **

H400

H410
080-006-00-8dimercury dicyanide oxide;

mercuric oxycyanide
215-629-81335-31-5Expl. 1.1

Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *

STOT RE 2 *

Aquatic Acute 1

Aquatic Chronic 1
H201

H331

H311

H301

H373 **

H400

H410
GHS01

GHS06

GHS08

GHS09

Dgr
H201

H331

H311

H301

H373 **

H410
T
080-007-00-3dimethylmercury; [1]

diethylmercury [2]
209-805-3 [1]

211-000-7 [2]
593-74-8 [1]

627-44-1 [2]
Acute Tox. 2 *

Acute Tox. 1

Acute Tox. 2 *

STOT RE 2 *

Aquatic Acute 1

Aquatic Chronic 1
H330

H310

H300

H373 **

H400

H410
GHS06

GHS08

GHS09

Dgr
H330

H310

H300

H373 **

H410
*

STOT RE 2; H373: C ≥ 0,05 %
1
080-008-00-9phenylmercury nitrate; [1]

phenylmercury hydroxide; [2]

basic phenylmercury nitrate [3]
200-242-9 [1]

202-866-7 [2]

-[3]
55-68-5 [1]

100-57-2 [2]

8003-05-2 [3]
Acute Tox. 3 *

STOT RE 1

Skin Corr. 1B

Aquatic Acute 1

Aquatic Chronic 1
H301

H372 **

H314

H400

H410
GHS06

GHS08

GHS05

GHS09

Dgr
H301

H372 **

H314

H410
080-009-00-42-methoxyethylmercury chloride204-659-7123-88-6Acute Tox. 3 *

STOT RE 1

Skin Corr. 1B

Aquatic Acute 1

Aquatic Chronic 1
H301

H372 **

H314

H400

H410
GHS06

GHS08

GHS05

GHS09

Dgr
H301

H372 **

H314

H410
080-010-00-Xmercury dichloride;

mercuric chloride
231-299-87487-94-7Acute Tox. 2 *

STOT RE 1

Skin Corr. 1B

Aquatic Acute 1

Aquatic Chronic 1
H300

H372 **

H314

H400

H410
GHS06

GHS08

GHS05

GHS09

Dgr
H300

H372 **

H314

H410
080-011-00-5phenylmercury acetate200-532-562-38-4Acute Tox. 3 *

STOT RE 1

Skin Corr. 1B

Aquatic Acute 1

Aquatic Chronic 1
H301

H372 **

H314

H400

H410
GHS06

GHS08

GHS05

GHS09

Dgr
H301

H372 **

H314

H410
081-001-00-3thallium231-138-17440-28-0Acute Tox. 2 *

Acute Tox. 2 *

STOT RE 2 *

Aquatic Chronic 4
H330

H300

H373 **

H413
GHS06

GHS08

Dgr
H330

H300

H373 **

H413
081-002-00-9thallium compounds, with the exception of those specified elsewhere in this AnnexAcute Tox. 2 *

Acute Tox. 2 *

STOT RE 2 *

Aquatic Chronic 2
H330

H300

H373 **

H411
GHS06

GHS08

GHS09

Dgr
H330

H300

H373 **

H411
A
081-003-00-4dithallium sulphate;

thallic sulphate
231-201-37446-18-6Acute Tox. 2 *

STOT RE 1

Skin Irrit. 2

Aquatic Chronic 2
H300

H372 **

H315

H411
GHS06

GHS08

GHS09

Dgr
H300

H372 **

H315

H411
082-001-00-6lead compounds with the exception of those specified elsewhere in this AnnexRepr. 1A

Acute Tox. 4 *

Acute Tox. 4 *

STOT RE 2 *

Aquatic Acute 1

Aquatic Chronic 1
H360Df

H332

H302

H373 **

H400

H410
GHS08

GHS07

GHS09

Dgr
H360Df

H332

H302

H373 **

H410
Repr. 2; H361f: C ≥ 2,5 %

*

STOT RE 2; H373: C ≥ 0,5 %
A

1
082-002-00-1lead alkylsRepr. 1A

Acute Tox. 2 *

Acute Tox. 1

Acute Tox. 2 *

STOT RE 2 *

Aquatic Acute 1

Aquatic Chronic 1
H360Df

H330

H310

H300

H373 **

H400

H410
GHS06

GHS08

GHS09

Dgr
H360Df

H330

H310

H300

H373 **

H410
Repr. 1A; H360D: C ≥ 0,1 %

*

STOT RE 2; H373: C ≥ 0,05 %
A

1
082-003-00-7lead diazide;

lead azide
236-542-113424-46-9Unst. Expl.

Repr. 1A

Acute Tox. 4 *

Acute Tox. 4 *

STOT RE 2 *

Aquatic Acute 1

Aquatic Chronic 1
H200

H360Df

H332

H302

H373 **

H400

H410
GHS01

GHS08

GHS07

GHS09

Dgr
H200

H360Df

H332

H302

H373 **

H410
1
082-003-01-4lead diazide;

lead azide [≥ 20 % phlegmatiser]
236-542-113424-46-9Expl. 1.1

Repr. 1A

Acute Tox. 4 *

Acute Tox. 4 *

STOT RE 2 *

Aquatic Acute 1

Aquatic Chronic 1
H201

H360Df

H332

H302

H373 **

H400

H410
GHS01

GHS08

GHS07

GHS09

Dgr
H201

H360Df

H332

H302

H373 **

H410
1
082-004-00-2lead chromate231-846-07758-97-6Carc. 2

Repr. 1A

STOT RE 2 *

Aquatic Acute 1

Aquatic Chronic 1
H351

H360Df

H373 **

H400

H410
GHS08

GHS09

Dgr
H351

H360Df

H373 **

H410
1
082-005-00-8lead di(acetate)206-104-4301-04-2Repr. 1A

STOT RE 2 *

Aquatic Acute 1

Aquatic Chronic 1
H360Df

H373 **

H400

H410
GHS08

GHS09

Dgr
H360Df

H373 **

H410
1
082-006-00-3trilead bis(orthophosphate)231-205-57446-27-7Repr. 1A

STOT RE 2 *

Aquatic Acute 1

Aquatic Chronic 1
H360Df

H373 **

H400

H410
GHS08

GHS09

Dgr
H360Df

H373 **

H410
1
082-007-00-9lead acetate, basic215-630-31335-32-6Carc. 2

Repr. 1A

STOT RE 2 *

Aquatic Acute 1

Aquatic Chronic 1
H351

H360Df

H373 **

H400

H410
GHS08

GHS09

Dgr
H351

H360Df

H373 **

H410
1
082-008-00-4lead(II) methanesulphonate401-750-517570-76-2Repr. 1A

Acute Tox. 4 *

Acute Tox. 4 *

STOT RE 2 *

Skin Irrit. 2

Eye Dam. 1
H360Df

H332

H302

H373 **

H315

H318
GHS08

GHS05

GHS07

Dgr
H360Df

H332

H302

H373 **

H315

H318
1
082-009-00-XLead sulfochromate yellow;

C.I. Pigment Yellow 34;

[This substance is identified in the Colour Index by Colour Index Constitution Number, C.I. 77603.]
215-693-71344-37-2Carc. 2

Repr. 1A

STOT RE 2 *

Aquatic Acute 1

Aquatic Chronic 1
H351

H360Df

H373 **

H400

H410
GHS08

GHS09

Dgr
H351

H360Df

H373 **

H410
1
082-010-00-5Lead chromate molybdate sulfate red;

C.I. Pigment Red 104;

[This substance is identified in the Colour Index by Colour Index Constitution Number, C.I. 77605.]
235-759-912656-85-8Carc. 2

Repr. 1A

STOT RE 2 *

Aquatic Acute 1

Aquatic Chronic 1
H351

H360Df

H373 **

H400

H410
GHS08

GHS09

Dgr
H351

H360Df

H373 **

H410
1
082-011-00-0lead hydrogen arsenate232-064-27784-40-9Carc. 1A

Repr. 1A

Acute Tox. 3 *

Acute Tox. 3 *

STOT RE 2 *

Aquatic Acute 1

Aquatic Chronic 1
H350

H360Df

H331

H301

H373 **

H400

H410
GHS06

GHS08

GHS09

Dgr
H350

H360Df

H331

H301

H373 **

H410
1
092-001-00-8uranium231-170-67440-61-1Acute Tox. 2 *

Acute Tox. 2 *

STOT RE 2 *

Aquatic Chronic 4
H330

H300

H373 **

H413
GHS06

GHS08

Dgr
H330

H300

H373 **

H413
092-002-00-3uranium compoundsAcute Tox. 2 *

Acute Tox. 2 *

STOT RE 2 *

Aquatic Chronic 2
H330

H300

H373 **

H411
GHS06

GHS08

GHS09

Dgr
H330

H300

H373 **

H411
A
601-001-00-4methane200-812-774-82-8Flam. Gas 1

Press. Gas
H220GHS02

GHS04

Dgr
H220U
601-002-00-Xethane200-814-874-84-0Flam. Gas 1

Press. Gas
H220GHS02

GHS04

Dgr
H220U
601-003-00-5propane200-827-974-98-6Flam. Gas 1

Press. Gas
H220GHS02

GHS04

Dgr
H220U
601-004-00-0butane; [1]

and isobutane [2]
203-448-7 [1]

200-857-2 [2]
106-97-8 [1]

75-28-5 [2]
Flam. Gas 1

Press. Gas
H220GHS02

GHS04

Dgr
H220C U
601-004-01-8butane (containing ≥ 0,1 % butadiene (203-450-8)); [1]

isobutane (containing ≥ 0,1 % butadiene (203-450-8)) [2]
203-448-7 [1]

200-857-2 [2]
106-97-8 [1]

75-28-5 [2]
Flam. Gas 1

Press. Gas

Carc. 1A

Muta. 1B
H220

H350

H340
GHS02

GHS04

GHS08

Dgr
H220

H350

H340
C S U
601-005-00-62,2-dimethylpropane;

neopentane
207-343-7463-82-1Flam. Gas 1

Press. Gas

Aquatic Chronic 2
H220

H411
GHS02

GHS04

GHS09

Dgr
H220

H411
U
601-006-00-1pentane203-692-4109-66-0Flam. Liq. 2

Asp. Tox. 1

STOT SE 3

Aquatic Chronic 2
H225

H304

H336

H411
GHS02

GHS08

GHS07

GHS09

Dgr
H225

H304

H336

H411
EUH066C
601-007-00-7hexane, reaction mass of isomers (containing < 5 % n-hexane (203-777-6))Flam. Liq. 2

Asp. Tox. 1

Skin Irrit. 2

STOT SE 3

Aquatic Chronic 2
H225

H304

H315

H336

H411
GHS02

GHS08

GHS07

GHS09

Dgr
H225

H304

H315

H336

H411
C
601-008-00-2heptane [and isomers] [1]205-563-8 [1]

203-548-0 [2]

207-346-3 [3]

209-230-8 [4]

209-280-0 [5]

209-643-3 [6]

209-680-5 [7]

209-730-6 [8]

210-529-0 [9]

250-610-8 [10]
142-82-5 [1]

108-08-7 [2]

464-06-2 [3]

562-49-2 [4]

565-59-3 [5]

589-34-4 [6]

590-35-2 [7]

591-76-4 [8]

617-78-7 [9]

31394-54-4 [10]
Flam. Liq. 2

Asp. Tox. 1

Skin Irrit. 2

STOT SE 3

Aquatic Acute 1

Aquatic Chronic 1
H225

H304

H315

H336

H400

H410
GHS02

GHS08

GHS07

GHS09

Dgr
H225

H304

H315

H336

H410
C
601-009-00-8octane [and isomers] [1]203-892-1 [1]

208-759-1 [2]

209-207-2 [3]

209-243-9 [4]

209-266-4 [5]

209-292-6 [6]

209-504-7 [7]

209-547-1 [8]

209-649-6 [9]

209-650-1 [10]

209-660-6 [11]

209-689-4 [12]

209-745-8 [13]

209-747-9 [14]

209-855-6 [15]

210-187-2 [16]

210-621-0 [17]

213-923-0 [18]

247-861-0 [19]
111-65-9 [1]

540-84-1 [2]

560-21-4 [3]

563-16-6 [4]

564-02-3 [5]

565-75-3 [6]

583-48-2 [7]

584-94-1 [8]

589-43-5 [9]

589-53-7 [10]

589-81-1 [11]

590-73-8 [12]

592-13-2 [13]

592-27-8 [14]

594-82-1 [15]

609-26-7 [16]

619-99-8 [17]

1067-08-9 [18]

26635-64-3 [19]
Flam. Liq. 2

Asp. Tox. 1

Skin Irrit. 2

STOT SE 3

Aquatic Acute 1

Aquatic Chronic 1
H225

H304

H315

H336

H400

H410
GHS02

GHS08

GHS07

GHS09

Dgr
H225

H304

H315

H336

H410
C
601-010-00-3ethylene200-815-374-85-1Flam. Gas 1

Press. Gas

STOT SE 3
H220

H336
GHS02

GHS04

GHS07

Dgr
H220

H336
U
601-011-00-9propene;

propylene
204-062-1115-07-1Flam. Gas 1

Press. Gas
H220GHS02

GHS04

Dgr
H220U
601-012-00-4but-1-ene; [1]

butene, mixed-1-and-2-isomers; [2]

2-methylpropene; [3]

(Z)-but-2-ene; [4]

(E)-but-2-ene [5]
203-449-2 [1]

203-452-9 [2]

204-066-3 [3]

209-673-7 [4]

210-855-3 [5]
106-98-9 [1]

107-01-7 [2]

115-11-7 [3]

590-18-1 [4]

624-64-6 [5]
Flam. Gas 1

Press. Gas
H220GHS02

GHS04

Dgr
H220C U
601-013-00-X1,3-butadiene;

buta-1,3-diene
203-450-8106-99-0Flam. Gas 1

Press. Gas

Carc. 1A

Muta. 1B
H220

H350

H340
GHS02

GHS04

GHS08

Dgr
H220

H350

H340
D U
601-014-00-5isoprene (stabilised)

2-methyl-1,3-butadiene
201-143-378-79-5Flam. Liq. 1

Carc. 1B

Muta. 2

Aquatic Chronic 3
H224

H350

H341

H412
GHS02

GHS08

Dgr
H224

H350

H341

H412
D
601-015-00-0acetylene;

ethyne
200-816-974-86-2Flam. Gas 1

Press. Gas
H220GHS02

GHS04

Dgr
H220EUH006U
601-016-00-6cyclopropane200-847-875-19-4Flam. Gas 1

Press. Gas
H220GHS02

GHS04

Dgr
H220U
601-017-00-1cyclohexane203-806-2110-82-7Flam. Liq. 2

Asp. Tox. 1

Skin Irrit. 2

STOT SE 3

Aquatic Acute 1

Aquatic Chronic 1
H225

H304

H315

H336

H400

H410
GHS02

GHS08

GHS07

GHS09

Dgr
H225

H304

H315

H336

H410
601-018-00-7methylcyclohexane203-624-3108-87-2Flam. Liq. 2

Asp. Tox. 1

Skin Irrit. 2

STOT SE 3

Aquatic Chronic 2
H225

H304

H315

H336

H411
GHS02

GHS08

GHS07

GHS09

Dgr
H225

H304

H315

H336

H411
601-019-00-21,4-dimethylcyclohexane209-663-2589-90-2Flam. Liq. 2

Asp. Tox. 1

Skin Irrit. 2

STOT SE 3

Aquatic Chronic 2
H225

H304

H315

H336

H411
GHS02

GHS08

GHS07

GHS09

Dgr
H225

H304

H315

H336

H411
601-020-00-8benzene200-753-771-43-2Flam. Liq. 2

Carc. 1A

Muta. 1B

STOT RE 1

Asp. Tox. 1

Eye Irrit. 2

Skin Irrit. 2
H225

H350

H340

H372 **

H304

H319

H315
GHS02

GHS08

GHS07

Dgr
H225

H350

H340

H372 **

H304

H319

H315
E
601-021-00-3toluene203-625-9108-88-3Flam. Liq. 2

Repr. 2

Asp. Tox. 1

STOT RE 2 *

Skin Irrit. 2

STOT SE 3
H225

H361d ***

H304

H373 **

H315

H336
GHS02

GHS08

GHS07

Dgr
H225

H361d ***

H304

H373 **

H315

H336
601-022-00-9o-xylene; [1]

p-xylene; [2]

m-xylene; [3]

xylene [4]
202-422-2 [1]

203-396-5 [2]

203-576-3 [3]

215-535-7 [4]
95-47-6 [1]

106-42-3 [2]

108-38-3 [3]

1330-20-7 [4]
Flam. Liq. 3

Acute Tox. 4 *

Acute Tox. 4 *

Skin Irrit. 2
H226

H332

H312

H315
GHS02

GHS07

Wng
H226

H332

H312

H315
*C
601-023-00-4ethylbenzene202-849-4100-41-4Flam. Liq. 2

Acute Tox. 4 *
H225

H332
GHS02

GHS07

Dgr
H225

H332
601-024-00-Xcumene; [1]

propylbenzene [2]
202-704-5 [1]

203-132-9 [2]
98-82-8 [1]

103-65-1 [2]
Flam. Liq. 3

Asp. Tox. 1

STOT SE 3

Aquatic Chronic 2
H226

H304

H335

H411
GHS02

GHS08

GHS07

GHS09

Dgr
H226

H304

H335

H411
C
601-025-00-5mesitylene;

1,3,5-trimethylbenzene
203-604-4108-67-8Flam. Liq. 3

STOT SE 3

Aquatic Chronic 2
H226

H335

H411
GHS02

GHS07

GHS09

Wng
H226

H335

H411
STOT SE 3; H335: C ≥ 25 %
601-026-00-0styrene202-851-5100-42-5Flam. Liq. 3

Acute Tox. 4 *

Eye Irrit. 2

Skin Irrit. 2
H226

H332

H319

H315
GHS02

GHS07

Wng
H226

H332

H319

H315
*D
601-027-00-62-phenylpropene;

α-methylstyrene
202-705-098-83-9Flam. Liq. 3

Eye Irrit. 2

STOT SE 3

Aquatic Chronic 2
H226

H319

H335

H411
GHS02

GHS07

GHS09

Wng
H226

H319

H335

H411
STOT SE 3; H335: C ≥ 25 %
601-028-00-12-methylstyrene;

2-vinyltoluene
210-256-7611-15-4Acute Tox. 4 *

Aquatic Chronic 2
H332

H411
GHS07

GHS09

Wng
H332

H411
601-029-00-7dipentene;

limonene; [1]

(R)-p-mentha-1,8-diene;

d-limonene; [2]

(S)-p-mentha-1,8-diene;

l-limonene; [3]

trans-1-methyl-4-(1-methylvinyl)cyclohexene; [4]

(±)-1-methyl-4-(1-methylvinyl)cyclohexene [5]
205-341-0 [1]

227-813-5 [2]

227-815-6 [3]

229-977-3 [4]

231-732-0 [5]
138-86-3 [1]

5989-27-5 [2]

5989-54-8 [3]

6876-12-6 [4]

7705-14-8 [5]
Flam. Liq. 3

Skin Irrit. 2

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H226

H315

H317

H400

H410
GHS02

GHS07

GHS09

Wng
H226

H315

H317

H410
C
601-030-00-2cyclopentane206-016-6287-92-3Flam. Liq. 2

Aquatic Chronic 3
H225

H412
GHS02

Dgr
H225

H412
601-031-00-82,4,4-trimethylpent-1-ene203-486-4107-39-1Flam. Liq. 2

Aquatic Chronic 2
H225

H411
GHS02

GHS09

Dgr
H225

H411
601-032-00-3benzo[a]pyrene;

benzo[def]chrysene
200-028-550-32-8Carc. 1B

Muta. 1B

Repr. 1B

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H350

H340

H360FD

H317

H400

H410
GHS08

GHS07

GHS09

Dgr
H350

H340

H360FD

H317

H410
Carc. 1B; H350: C ≥ 0,01 %
601-033-00-9benz[a]anthracene200-280-656-55-3Carc. 1B

Aquatic Acute 1

Aquatic Chronic 1
H350

H400

H410
GHS08

GHS09

Dgr
H350

H410
601-034-00-4benz[e]acephenanthrylene205-911-9205-99-2Carc. 1B

Aquatic Acute 1

Aquatic Chronic 1
H350

H400

H410
GHS08

GHS09

Dgr
H350

H410
601-035-00-Xbenzo[j]fluoranthene205-910-3205-82-3Carc. 1B

Aquatic Acute 1

Aquatic Chronic 1
H350

H400

H410
GHS08

GHS09

Dgr
H350

H410
601-036-00-5benzo[k]fluoranthene205-916-6207-08-9Carc. 1B

Aquatic Acute 1

Aquatic Chronic 1
H350

H400

H410
GHS08

GHS09

Dgr
H350

H410
601-037-00-0n-hexane203-777-6110-54-3Flam. Liq. 2

Repr. 2

Asp. Tox. 1

STOT RE 2 *

Skin Irrit. 2

STOT SE 3

Aquatic Chronic 2
H225

H361f ***

H304

H373 **

H315

H336

H411
GHS02

GHS08

GHS07

GHS09

Dgr
H225

H361f ***

H304

H373 **

H315

H336

H411
STOT RE 2; H373: C ≥ 5 %
601-041-00-2dibenz[a,h]anthracene200-181-853-70-3Carc. 1B

Aquatic Acute 1

Aquatic Chronic 1
H350

H400

H410
GHS08

GHS09

Dgr
H350

H410
Carc. 1B; H350: C ≥ 0,01 %
601-042-00-8biphenyl;

diphenyl
202-163-592-52-4Eye Irrit. 2

STOT SE 3

Skin Irrit. 2

Aquatic Acute 1

Aquatic Chronic 1
H319

H335

H315

H400

H410
GHS07

GHS09

Wng
H319

H335

H315

H410
601-043-00-31,2,4-trimethylbenzene202-436-995-63-6Flam. Liq. 3

Acute Tox. 4 *

Eye Irrit. 2

STOT SE 3

Skin Irrit. 2

Aquatic Chronic 2
H226

H332

H319

H335

H315

H411
GHS02

GHS07

GHS09

Wng
H226

H332

H319

H335

H315

H411
601-044-00-93a,4,7,7a-tetrahydro-4,7-methanoindene201-052-977-73-6Flam. Liq. 2

Acute Tox. 4 *

Acute Tox. 4 *

Eye Irrit. 2

STOT SE 3

Skin Irrit. 2

Aquatic Chronic 2
H225

H332

H302

H319

H335

H315

H411
GHS02

GHS07

GHS09

Dgr
H225

H332

H302

H319

H335

H315

H411
601-045-00-41,2,3,4-tetrahydronaphthalene204-340-2119-64-2Eye Irrit. 2

Skin Irrit. 2

Aquatic Chronic 2
H319

H315

H411
GHS07

GHS09

Wng
H319

H315

H411
EUH019
601-046-00-X7-methylocta-1,6-diene404-210-742152-47-6Flam. Liq. 3

Aquatic Acute 1

Aquatic Chronic 1
H226

H400

H410
GHS02

GHS09

Wng
H226

H410
601-047-00-5m-mentha-1,3(8)-diene404-150-117092-80-7Skin Irrit. 2

Aquatic Chronic 2
H315

H411
GHS07

GHS09

Wng
H315

H411
601-048-00-0chrysene205-923-4218-01-9Carc. 1B

Muta. 2

Aquatic Acute 1

Aquatic Chronic 1
H350

H341

H400

H410
GHS08

GHS09

Dgr
H350

H341

H410
601-049-00-6benzo[e]pyrene205-892-7192-97-2Carc. 1B

Aquatic Acute 1

Aquatic Chronic 1
H350

H400

H410
GHS08

GHS09

Dgr
H350

H410
601-051-00-74-phenylbut-1-ene405-980-7768-56-9Skin Irrit. 2

Aquatic Chronic 2
H315

H411
GHS07

GHS09

Wng
H315

H411
601-052-00-2naphthalene202-049-591-20-3Carc. 2

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1
H351

H302

H400

H410
GHS07

GHS08

GHS09

Wng
H351

H302

H410
601-053-00-8nonylphenol; [1]

4-nonylphenol, branched [2]
246-672-0 [1]

284-325-5 [2]
25154-52-3 [1]

84852-15-3 [2]
Repr. 2

Acute Tox. 4 *

Skin Corr. 1B

Aquatic Acute 1

Aquatic Chronic 1
H361fd

H302

H314

H400

H410
GHS08

GHS05

GHS07

GHS09

Dgr
H361fd

H302

H314

H410
601-054-00-3reaction mass of isomers of: dibenzylbenzene;

dibenzyl(methyl)benzene;

dibenzyl(dimethyl)benzene;

dibenzyl(trimethyl)benzene
405-570-8Aquatic Acute 1

Aquatic Chronic 1
H400

H410
GHS09

Wng
H410
601-055-00-9reaction mass of isomers of: mono-(2-tetradecyl)naphthalenes;

di-(2-tetradecyl)naphthalenes;

tri-(2-tetradecyl)naphthalenes
410-190-0132983-41-6Eye Irrit. 2

Aquatic Chronic 4
H319

H413
GHS07

Wng
H319

H413
601-056-00-4reaction mass of isomers of: methyldiphenylmethane;

dimethyldiphenylmethane
405-470-473807-39-3Skin Irrit. 2

Aquatic Acute 1

Aquatic Chronic 1
H315

H400

H410
GHS07

GHS09

Wng
H315

H410
601-057-00-XN-dodecyl-[3-(4-(dimethylamino)benzamido)-propyl]dimethylammonium tosylate421-130-8156679-41-3Eye Dam. 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H318

H317

H400

H410
GHS05

GHS07

GHS09

Dgr
H318

H317

H410
601-058-00-5di-L-para-menthene417-870-683648-84-4Skin Irrit. 2

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H315

H317

H400

H410
GHS07

GHS09

Wng
H315

H317

H410
601-059-00-0methyl 2-benzylidene-3-oxobutyrate420-940-915768-07-7Eye Irrit. 2

Skin Irrit. 2

Aquatic Chronic 2
H319

H315

H411
GHS07

GHS09

Wng
H319

H315

H411
601-060-00-61,2-bis[4-fluoro-6-{4-sulfo-5-(2-(4-sulfonaphtalene-3-ylazo)-1-hydroxy-3,6-disulfo-8-aminonaphthalene-7-ylazo)phenylamino}-1,3,5-triazin-2ylamino]ethane; x-sodium, y-potassium salts x = 7,755 y = 0,245417-610-1155522-09-1Skin Sens. 1H317GHS07

Wng
H317
601-061-00-1(ethyl-1,2-ethanediyl)[-2-[[[(2-hydroxyethyl)methylamino]acetyl]-propyl]ω-(nonylphenoxy)poly]oxy-(methyl-1,2-ethanediyl)418-960-8Skin Corr. 1B

Skin Sens. 1

Aquatic Chronic 2
H314

H317

H411
GHS05

GHS07

GHS09

Dgr
H314

H317

H411
601-062-00-7reaction mass of: branched triacontane;

branched dotriacontane;

branched tetratriacontane;

branched hexatriacontane
417-030-9151006-59-6Aquatic Chronic 4H413H413
601-063-00-2reaction mass of isomers of branched tetracosane417-060-2151006-61-0Acute Tox. 4 *

Aquatic Chronic 4
H332

H413
GHS07

Wng
H332

H413
601-064-00-8branched hexatriacontane417-070-7151006-62-1Aquatic Chronic 4H413H413
601-065-00-3reaction mass of: (1'-α,3'-α,6'-α-2,2,3',7',7'-pentamethylspiro(1,3-dioxane-5,2'-norcarane);

(1'α,3'β,6'α)-2,2,3',7',7'-pentamethylspiro(1,3-dioxane-5,2'-norcarane)
416-930-9STOT RE 2 *

Eye Dam. 1

Aquatic Chronic 2
H373 **

H318

H411
GHS08

GHS05

GHS09

Dgr
H373 **

H318

H411
601-066-00-91-(4-(trans-4-heptylcyclohexyl)phenyl) ethanone426-820-278531-60-9Skin Sens. 1

Aquatic Chronic 4
H317

H413
GHS07

Wng
H317

H413
601-067-00-4triethyl arsenate427-700-215606-95-8Carc. 1A

Acute Tox. 3 *

Acute Tox. 3 *

Aquatic Acute 1

Aquatic Chronic 1
H350

H331

H301

H400

H410
GHS06

GHS08

GHS09

Dgr
H350

H331

H301

H410
601-068-00-X1,2-diacetoxybut-3-ene421-720-518085-02-4Acute Tox. 4 *H302GHS07

Wng
H302
601-069-00-52-ethyl-1-(2-(1,3-dioxanyl)ethyl)-pyridinium bromide422-680-1287933-44-2Aquatic Chronic 3H412H412
601-071-00-61-dimethoxymethyl-2-nitro-benzene423-830-920627-73-0Skin Sens. 1

Aquatic Chronic 2
H317

H411
GHS07

GHS09

Wng
H317

H411
601-073-00-71-bromo-3,5-difluorobenzene416-710-2461-96-1Flam. Liq. 3

Acute Tox. 4 *

STOT RE 2 *

Skin Irrit. 2

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H226

H302

H373 **

H315

H317

H400

H410
GHS02

GHS08

GHS07

GHS09

Wng
H226

H302

H373 **

H315

H317

H410
601-074-00-2reaction mass of: 4-(2,2,3-trimethylcyclopent-3-en-1-yl)-1-methyl-2-oxabicyclo[2.2.2]octane;

1-(2,2,3-trimethylcyclopent-3-en-1-yl)-5-methyl-6-oxabicyclo[3.2.1]octane;

spiro[cyclohex-3-en-1-yl-[(4,5,6,6a-tetrahydro-3,6',6',6'a-tetramethyl)-1,3'(3'aH)-[2H]cyclopenta[b]furan];

spiro[cyclohex-3-en-1-yl-[4,5,6,6a-tetrahydro-4,6',6',6'a-tetramethyl)-1,3'(3'aH)-[2H]cyclopenta[b]]furan]
422-040-1Eye Irrit. 2

Skin Irrit. 2

Aquatic Chronic 2
H319

H315

H411
GHS07

GHS09

Wng
H319

H315

H411
601-085-00-2isopentane;

2-methylbutane
201-142-878-78-4Flam. Liq. 1

Asp. Tox. 1

STOT SE 3

Aquatic Chronic 2
H224

H304

H336

H411
GHS02

GHS08

GHS07

GHS09

Dgr
H224

H304

H336

H411
EUH066
602-001-00-7chloromethane;

methyl chloride
200-817-474-87-3Flam. Gas 1

Press. Gas

Carc. 2

STOT RE 2 *
H220

H351

H373 **
GHS02

GHS04

GHS08

Dgr
H220

H351

H373 **
U
602-002-00-2bromomethane;

methylbromide
200-813-274-83-9Press. Gas

Muta. 2

Acute Tox. 3 *

Acute Tox. 3 *

STOT RE 2 *

Eye Irrit. 2

STOT SE 3

Skin Irrit. 2

Aquatic Acute 1

Ozone
H341

H331

H301

H373 **

H319

H335

H315

H400

EUH059
GHS04

GHS06

GHS08

GHS09

Dgr
H341

H331

H301

H373 **

H319

H335

H315

H400
EUH059U
602-003-00-8dibromomethane200-824-274-95-3Acute Tox. 4 *

Aquatic Chronic 3
H332

H412
GHS07

Wng
H332

H412
*
602-004-00-3dichloromethane;

methylene chloride
200-838-975-09-2Carc. 2H351GHS08

Wng
H351
602-005-00-9methyl iodide;

iodomethane
200-819-574-88-4Carc. 2

Acute Tox. 4 *

Acute Tox. 3 *

Acute Tox. 3 *

STOT SE 3

Skin Irrit. 2
H351

H312

H331

H301

H335

H315
GHS06

GHS08

Dgr
H351

H312

H331

H301

H335

H315
602-006-00-4trichloromethane;

chloroform
200-663-867-66-3Carc. 2

Acute Tox. 4 *

STOT RE 2 *

STOT RE 2 *

Skin Irrit. 2
H351

H302

H373 **

H373 **

H315
GHS07

GHS08

Wng
H351

H302

H373 **

H373 **

H315
*

STOT RE 2; H373: C ≥ 5 %
602-007-00-Xbromoform;

tribromomethane
200-854-675-25-2Acute Tox. 3 *

Eye Irrit. 2

Skin Irrit. 2

Aquatic Chronic 2
H331

H319

H315

H411
GHS06

GHS09

Dgr
H331

H319

H315

H411
602-008-00-5carbon tetrachloride;

tetrachloromethane
200-262-856-23-5Carc. 2

Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *

STOT RE 1

Aquatic Chronic 3

Ozone
H351

H331

H311

H301

H372 **

H412

EUH059
GHS06

GHS08

Dgr
H351

H331

H311

H301

H372 **

H412
EUH059*

STOT RE 1; H372: C ≥ 1 %

STOT RE 2; H373: 0,2 % ≤ C < 1 %
602-009-00-0chloroethane200-830-575-00-3Flam. Gas 1

Press. Gas

Carc. 2

Aquatic Chronic 3
H220

H351

H412
GHS02

GHS04

GHS08

Dgr
H220

H351

H412
U
602-010-00-61,2-dibromoethane203-444-5106-93-4Carc. 1B

Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *

Eye Irrit. 2

STOT SE 3

Skin Irrit. 2

Aquatic Chronic 2
H350

H331

H311

H301

H319

H335

H315

H411
GHS06

GHS08

GHS09

Dgr
H350

H331

H311

H301

H319

H335

H315

H411
*
602-011-00-11,1-dichloroethane200-863-575-34-3Flam. Liq. 2

Acute Tox. 4 *

Eye Irrit. 2

STOT SE 3

Aquatic Chronic 3
H225

H302

H319

H335

H412
GHS02

GHS07

Dgr
H225

H302

H319

H335

H412
*
602-012-00-71,2-dichloroethane;

ethylene dichloride
203-458-1107-06-2Flam. Liq. 2

Carc. 1B

Acute Tox. 4 *

Eye Irrit. 2

STOT SE 3

Skin Irrit. 2
H225

H350

H302

H319

H335

H315
GHS02

GHS08

GHS07

Dgr
H225

H350

H302

H319

H335

H315
602-013-00-21,1,1-trichloroethane;

methyl chloroform
200-756-371-55-6Acute Tox. 4 *

Ozone
H332

EUH059
GHS07

Wng
H332EUH059F
602-014-00-81,1,2-trichloroethane201-166-979-00-5Carc. 2

Acute Tox. 4 *

Acute Tox. 4 *

Acute Tox. 4 *
H351

H332

H312

H302
GHS08

GHS07

Wng
H351

H332

H312

H302
EUH066*
602-015-00-31,1,2,2-tetrachloroethane201-197-879-34-5Acute Tox. 2 *

Acute Tox. 1

Aquatic Chronic 2
H330

H310

H411
GHS06

GHS09

Dgr
H330

H310

H411
602-016-00-91,1,2,2-tetrabromoethane201-191-579-27-6Acute Tox. 2 *

Eye Irrit. 2

Aquatic Chronic 3
H330

H319

H412
GHS06

Dgr
H330

H319

H412
602-017-00-4pentachloroethane200-925-176-01-7Carc. 2

STOT RE 1

Aquatic Chronic 2
H351

H372 **

H411
GHS08

GHS09

Dgr
H351

H372 **

H411
STOT RE 1; H372: C ≥ 1 %

STOT RE 2; H373: 0,2 % ≤ C < 1 %
602-018-00-X1-chloropropane; [1]

2-chloropropane [2]
208-749-7 [1]

200-858-8 [2]
540-54-5 [1]

75-29-6 [2]
Flam. Liq. 2

Acute Tox. 4 *

Acute Tox. 4 *

Acute Tox. 4 *
H225

H332

H312

H302
GHS02

GHS07

Dgr
H225

H332

H312

H302
C
602-019-00-51-bromopropane;

n-propyl bromide
203-445-0106-94-5Flam. Liq. 2

Repr. 1B

STOT RE 2 *

Eye Irrit. 2

STOT SE 3

Skin Irrit. 2

STOT SE 3
H225

H360FD

H373 **

H319

H335

H315

H336
GHS02

GHS08

GHS07

Dgr
H225

H360FD

H373 **

H319

H335

H315

H336
602-020-00-01,2-dichloropropane;

propylene dichloride
201-152-278-87-5Flam. Liq. 2

Acute Tox. 4 *

Acute Tox. 4 *
H225

H332

H302
GHS02

GHS07

Dgr
H225

H332

H302
602-021-00-61,2-dibromo-3-chloropropane202-479-396-12-8Carc. 1B

Muta. 1B

Repr. 1A

Acute Tox. 3 *

STOT RE 2 *

Aquatic Chronic 3
H350

H340

H360F ***

H301

H373 **

H412
GHS06

GHS08

Dgr
H350

H340

H360F ***

H301

H373 **

H412
602-022-00-11-chloropentane; [1]

2-chloropentane; [2]

3-chloropentane [3]
208-846-4 [1]

210-885-7 [2]

210-467-4 [3]
543-59-9 [1]

625-29-6 [2]

616-20-6 [3]
Flam. Liq. 2

Acute Tox. 4 *

Acute Tox. 4 *

Acute Tox. 4 *
H225

H332

H312

H302
GHS02

GHS07

Dgr
H225

H332

H312

H302
C
602-023-00-7vinyl chloride;

chloroethylene
200-831-075-01-4Press. Gas

Flam. Gas 1

Carc. 1A
H220

H350
GHS02

GHS08

Dgr
H220

H350
D U
602-024-00-2bromoethylene209-800-6593-60-2Press. Gas

Flam. Gas 1

Carc. 1B
H220

H350
GHS02

GHS08

Dgr
H220

H350
U
602-025-00-81,1-dichloroethylene;

vinylidene chloride
200-864-075-35-4Flam. Liq. 1

Carc. 2

Acute Tox. 4 *
H224

H351

H332
GHS02

GHS08

GHS07

Dgr
H224

H351

H332
*D
602-026-00-31,2-dichloroethylene; [1]

cis-dichloroethylene; [2]

trans-dichloroethylene [3]
208-750-2 [1]

205-859-7 [2]

205-860-2 [3]
540-59-0 [1]

156-59-2 [2]

156-60-5 [3]
Flam. Liq. 2

Acute Tox. 4 *

Aquatic Chronic 3
H225

H332

H412
GHS02

GHS07

Dgr
H225

H332

H412
*C
602-027-00-9trichloroethylene;

trichloroethene
201-167-479-01-6Carc. 1B

Muta. 2

Eye Irrit. 2

Skin Irrit. 2

STOT SE 3

Aquatic Chronic 3
H350

H341

H319

H315

H336

H412
GHS08

GHS07

Dgr
H350

H341

H319

H315

H336

H412
602-028-00-4tetrachloroethylene204-825-9127-18-4Carc. 2

Aquatic Chronic 2
H351

H411
GHS08

GHS09

Wng
H351

H411
602-029-00-X3-chloropropene;

allyl chloride
203-457-6107-05-1Flam. Liq. 2

Carc. 2

Muta. 2

Acute Tox. 4 *

Acute Tox. 4 *

Acute Tox. 4 *

STOT RE 2 *

Eye Irrit. 2

STOT SE 3

Skin Irrit. 2

Aquatic Acute 1
H225

H351

H341

H332

H312

H302

H373 **

H319

H335

H315

H400
GHS02

GHS08

GHS07

GHS09

Dgr
H225

H351

H341

H332

H312

H302

H373 **

H319

H335

H315

H400
D
602-030-00-51,3-dichloropropene; [1]

(Z)-1,3-dichloropropene [2]
208-826-5 [1]

233-195-8 [2]
542-75-6 [1]

10061-01-5 [2]
Flam. Liq. 3

Acute Tox. 3 *

Acute Tox. 4 *

Acute Tox. 4 *

Eye Irrit. 2

STOT SE 3

Skin Irrit. 2

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H226

H301

H332

H312

H319

H335

H315

H317

H400

H410
GHS02

GHS06

GHS09

Dgr
H226

H301

H332

H312

H319

H335

H315

H317

H410
C D
602-031-00-01,1-dichloropropene209-253-3563-58-6Flam. Liq. 2

Acute Tox. 3 *

Aquatic Chronic 3
H225

H301

H412
GHS02

GHS06

Dgr
H225

H301

H412
602-032-00-63-chloro-2-methylpropene209-251-2563-47-3Flam. Liq. 2

Acute Tox. 4 *

Acute Tox. 4 *

Skin Corr. 1B

Skin Sens. 1

Aquatic Chronic 2
H225

H332

H302

H314

H317

H411
GHS02

GHS05

GHS07

GHS09

Dgr
H225

H332

H302

H314

H317

H411
602-033-00-1chlorobenzene203-628-5108-90-7Flam. Liq. 3

Acute Tox. 4 *

Aquatic Chronic 2
H226

H332

H411
GHS02

GHS07

GHS09

Wng
H226

H332

H411
*
602-034-00-71,2-dichlorobenzene;

o-dichlorobenzene
202-425-995-50-1Acute Tox. 4 *

Eye Irrit. 2

STOT SE 3

Skin Irrit. 2

Aquatic Acute 1

Aquatic Chronic 1
H302

H319

H335

H315

H400

H410
GHS07

GHS09

Wng
H302

H319

H335

H315

H410
*
602-035-00-21,4-dichlorobenzene;

p-dichlorobenzene
203-400-5106-46-7Carc. 2

Eye Irrit. 2

Aquatic Acute 1

Aquatic Chronic 1
H351

H319

H400

H410
GHS08

GHS09

Wng
H351

H319

H410
602-036-00-8chloroprene (stabilised);

2-chlorobuta-1,3-diene (stabilised)
204-818-0126-99-8Flam. Liq. 2

Carc. 1B

Acute Tox. 4 *

Acute Tox. 4 *

STOT RE 2 *

Eye Irrit. 2

STOT SE 3

Skin Irrit. 2
H225

H350

H332

H302

H373 **

H319

H335

H315
GHS02

GHS08

GHS07

Dgr
H225

H350

H332

H302

H373 **

H319

H335

H315
D
602-037-00-3α-chlorotoluene;

benzyl chloride
202-853-6100-44-7Carc. 1B

Acute Tox. 3 *

Acute Tox. 4 *

STOT RE 2 *

STOT SE 3

Skin Irrit. 2

Eye Dam. 1
H350

H331

H302

H373 **

H335

H315

H318
GHS06

GHS08

GHS05

Dgr
H350

H331

H302

H373 **

H335

H315

H318
602-038-00-9α, α,α-trichlorotoluene;

benzotrichloride
202-634-598-07-7Carc. 1B

Acute Tox. 3 *

Acute Tox. 4 *

STOT SE 3

Skin Irrit. 2

Eye Dam. 1
H350

H331

H302

H335

H315

H318
GHS06

GHS08

GHS05

Dgr
H350

H331

H302

H335

H315

H318
602-039-00-4polychlorobiphenyls;

PCB
215-648-11336-36-3STOT RE 2 *

Aquatic Acute 1

Aquatic Chronic 1
H373 **

H400

H410
GHS08

GHS09

Wng
H373 **

H410
STOT RE 2; H373: C ≥ 0,005 %C
602-040-00-X2-chlorotoluene; [1]

3-chlorotoluene; [2]

4-chlorotoluene; [3]

chlorotoluene [4]
202-424-3 [1]

203-580-5 [2]

203-397-0 [3]

246-698-2 [4]
95-49-8 [1]

108-41-8 [2]

106-43-4 [3]

25168-05-2 [4]
Acute Tox. 4 *

Aquatic Chronic 2
H332

H411
GHS07

GHS09

Wng
H332

H411
C
602-041-00-5penthachloronaphthalene215-320-81321-64-8Acute Tox. 4 *

Acute Tox. 4 *

Eye Irrit. 2

Skin Irrit. 2

Aquatic Acute 1

Aquatic Chronic 1
H312

H302

H319

H315

H400

H410
GHS07

GHS09

Wng
H312

H302

H319

H315

H410
C
602-042-00-01,2,3,4,5,6-hexachlorcyclohexanes with the exception of those specified elsewhere in this AnnexCarc. 2

Acute Tox. 3 *

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1
H351

H301

H312

H400

H410
GHS06

GHS08

GHS09

Dgr
H351

H301

H312

H410
A C
602-043-00-6lindane (ISO);

γ-HCH or γ-BHC;

γ-1,2,3,4,5,6-hexachlorocyclohexane
200-401-258-89-9Acute Tox. 3 *

Acute Tox. 4 *

Acute Tox. 4 *

STOT RE 2 *

Lact.

Aquatic Acute 1

Aquatic Chronic 1
H301

H332

H312

H373 **

H362

H400

H410
GHS06

GHS08

GHS09

Dgr
H301

H332

H312

H373 **

H362

H410
M=10
602-044-00-1camphechlor (ISO);

toxaphene;
232-283-38001-35-2Carc. 2

Acute Tox. 3 *

Acute Tox. 4 *

STOT SE 3

Skin Irrit. 2

Aquatic Acute 1

Aquatic Chronic 1
H351

H301

H312

H335

H315

H400

H410
GHS06

GHS08

GHS09

Dgr
H351

H301

H312

H335

H315

H410
602-045-00-7DDT (ISO);

clofenotane (INN);

dicophane;

1,1,1-trichloro-2,2-bis(4-chlorophenyl)ethane;

dichlorodiphenyltrichloroethane
200-024-350-29-3Carc. 2

Acute Tox. 3 *

STOT RE 1

Aquatic Acute 1

Aquatic Chronic 1
H351

H301

H372 **

H400

H410
GHS06

GHS08

GHS09

Dgr
H351

H301

H372 **

H410
602-046-00-2heptachlor (ISO);

1,4,5,6,7,8,8-heptachloro-3a,4,7,7a-tetrahydro-4,7-methanoindene
200-962-376-44-8Carc. 2

Acute Tox. 3 *

Acute Tox. 3 *

STOT RE 2 *

Aquatic Acute 1

Aquatic Chronic 1
H351

H311

H301

H373 **

H400

H410
GHS06

GHS08

GHS09

Dgr
H351

H311

H301

H373 **

H410
602-047-00-8chlordane (ISO);

1,2,4,5,6,7,8,8-octachloro-3a,4,7,7a-tetrahydro-4,7-methanoindan
200-349-057-74-9Carc. 2

Acute Tox. 4 *

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1
H351

H312

H302

H400

H410
GHS08

GHS07

GHS09

Wng
H351

H312

H302

H410
602-048-00-3aldrin (ISO)206-215-8309-00-2Carc. 2

Acute Tox. 3 *

Acute Tox. 3 *

STOT RE 1

Aquatic Acute 1

Aquatic Chronic 1
H351

H311

H301

H372 **

H400

H410
GHS06

GHS08

GHS09

Dgr
H351

H311

H301

H372 **

H410
602-049-00-9dieldrin (ISO)200-484-560-57-1Carc. 2

Acute Tox. 1

Acute Tox. 3 *

STOT RE 1

Aquatic Acute 1

Aquatic Chronic 1
H351

H310

H301

H372 **

H400

H410
GHS06

GHS08

GHS09

Dgr
H351

H310

H301

H372 **

H410
602-050-00-4(1α,4α,4aβ,5β,8β,8aβ)-1,2,3,4,10,10-hexachloro-1,4,4a,5,8,8a-hexahydro-1,4:5,8-dimethanonaphfthalene;

isodrin
207-366-2465-73-6Acute Tox. 2 *

Acute Tox. 1

Acute Tox. 2 *

Aquatic Acute 1

Aquatic Chronic 1
H330

H310

H300

H400

H410
GHS06

GHS09

Dgr
H330

H310

H300

H410
602-051-00-Xendrin (ISO);

1,2,3,4,10,10-hexachloro-6,7-epoxy-1,4,4a,5,6,7,8,8a-octahydro-1,4:5,8-dimethanonaphthalene
200-775-772-20-8Acute Tox. 2 *

Acute Tox. 3 *

Aquatic Acute 1

Aquatic Chronic 1
H300

H311

H400

H410
GHS06

GHS09

Dgr
H300

H311

H410
602-052-00-5endosulfan (ISO);

1,2,3,4,7,7-hexachloro-8,9,10-trinorborn-2-en-5,6-ylenedimethyl sulphite
204-079-4115-29-7Acute Tox. 3 *

Acute Tox. 3 *

Eye Irrit. 2

Aquatic Acute 1

Aquatic Chronic 1
H311

H301

H319

H400

H410
GHS06

GHS09

Dgr
H311

H301

H319

H410
602-053-00-0isobenzan (ISO);

1,3,4,5,6,7,8,8-octachloro-1,3,3a,4,7,7a-hexahydro-4,7-methanoisobenzofuran
206-045-4297-78-9Acute Tox. 1

Acute Tox. 2 *

Aquatic Acute 1
H310

H300

H400
GHS06

GHS09

Dgr
H310

H300

H400
602-054-00-63-iodpropene;

allyl iodide
209-130-4556-56-9Flam. Liq. 2

Skin Corr. 1B
H226

H314
GHS02

GHS05

Dgr
H226

H314
602-055-00-1bromoethane;

ethyl bromide
200-825-874-96-4Flam. Liq. 2

Carc. 2

Acute Tox. 4 *

Acute Tox. 4 *
H225

H351

H332

H302
GHS02

GHS08

GHS07

Dgr
H225

H351

H332

H302
602-056-00-7α, α,α-trifluorotoluene;

benzotrifluoride
202-635-098-08-8Flam. Liq. 2

Aquatic Chronic 2
H225

H411
GHS02

GHS09

Dgr
H225

H411
602-057-00-2α-bromotoluene;

benzyl bromide
202-847-3100-39-0Eye Irrit. 2

STOT SE 3

Skin Irrit. 2
H319

H335

H315
GHS07

Wng
H319

H335

H315
602-058-00-8α, α-dichlorotoluene;

benzylidene chloride;

benzal chloride
202-709-298-87-3Carc. 2

Acute Tox. 3 *

Acute Tox. 4 *

STOT SE 3

Skin Irrit. 2

Eye Dam. 1
H351

H331

H302

H335

H315

H318
GHS06

GHS08

GHS05

Dgr
H351

H331

H302

H335

H315

H318
602-059-00-31-chlorobutane;

butyl chloride
203-696-6109-69-3Flam. Liq. 2H225GHS02

Dgr
H225
602-060-00-9bromobenzene203-623-8108-86-1Flam. Liq. 3

Skin Irrit. 2

Aquatic Chronic 2
H226

H315

H411
GHS02

GHS07

GHS09

Wng
H226

H315

H411
602-061-00-4hexafluoropropene;

hexafluoropropylene
204-127-4116-15-4Press. Gas

Acute Tox. 4 *

STOT SE 3
H332

H335
GHS07

Wng
H332

H335
U
602-062-00-X1,2,3-trichloropropane202-486-196-18-4Carc. 1B

Repr. 1B

Acute Tox. 4 *

Acute Tox. 4 *

Acute Tox. 4 *
H350

H360F ***

H332

H312

H302
GHS08

GHS07

Dgr
H350

H360F ***

H332

H312

H302
D
602-063-00-5heptachlor epoxide;

2,3-epoxy-1,4,5,6,7,8,8-heptachloro-3a,4,7,7a-tetrahydro-4,7-methanoindane
213-831-01024-57-3Carc. 2

Acute Tox. 3 *

STOT RE 2 *

Aquatic Acute 1

Aquatic Chronic 1
H351

H301

H373 **

H400

H410
GHS06

GHS08

GHS09

Dgr
H351

H301

H373 **

H410
602-064-00-01,3-dichloro-2-propanol202-491-996-23-1Carc. 1B

Acute Tox. 3 *

Acute Tox. 4 *
H350

H301

H312
GHS06

GHS08

Dgr
H350

H301

H312
602-065-00-6hexachlorobenzene204-273-9118-74-1Carc. 1B

STOT RE 1

Aquatic Acute 1

Aquatic Chronic 1
H350

H372 **

H400

H410
GHS08

GHS09

Dgr
H350

H372 **

H410
602-066-00-1tetrachloro-p-benzoquinone204-274-4118-75-2Eye Irrit. 2

Skin Irrit. 2

Aquatic Acute 1

Aquatic Chronic 1
H319

H315

H400

H410
GHS07

GHS09

Wng
H319

H315

H410
602-067-00-71,3-dichlorbenzene208-792-1541-73-1Acute Tox. 4 *

Aquatic Chronic 2
H302

H411
GHS07

GHS09

Wng
H302

H411
602-068-00-2ethylene bis(trichloroacetate)219-732-92514-53-6Skin Irrit. 2H315GHS07

Wng
H315
602-069-00-8dichloroacetylene7572-29-4Unst. Expl.

Carc. 2

STOT RE 2 *
H200

H351

H373 **
GHS01

GHS08

Wng
H200

H351

H373 **
602-070-00-33-chloro-4,5,α, α,α-pentafluorotoluene401-930-377227-99-7Flam. Liq. 3

Acute Tox. 4 *

Acute Tox. 4 *

Aquatic Acute 1
H226

H332

H302

H400
GHS02

GHS07

GHS09

Wng
H226

H332

H302

H400
602-071-00-9bromobenzylbromotoluene, reaction mass of isomers402-210-199688-47-8STOT RE 2 *

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H373 **

H317

H400

H410
GHS08

GHS07

GHS09

Wng
H373 **

H317

H410
602-072-00-4dichloro [(dichlorophenyl)methyl]methylbenzene, reaction mass of isomers;

(dichlorophenyl)(dichlorotolyl)methane, reaction mass of isomers (IUPAC)
278-404-376253-60-6Aquatic Acute 1

Aquatic Chronic 1
H400

H410
GHS09

Wng
H410
602-073-00-X1,4-dichlorobut-2-ene212-121-8764-41-0Carc. 1B

Acute Tox. 2 *

Acute Tox. 3 *

Acute Tox. 3 *

Skin Corr. 1B

Aquatic Acute 1

Aquatic Chronic 1
H350

H330

H311

H301

H314

H400

H410
GHS06

GHS08

GHS05

GHS09

Dgr
H350

H330

H311

H301

H314

H410
Carc. 1B; H350: C ≥ 0,01 %

STOT SE 3; H335: C ≥ 5 %
602-074-00-5pentachlorobenzene210-172-0608-93-5Flam. Sol. 1

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1
H228

H302

H400

H410
GHS02

GHS07

GHS09

Dgr
H228

H302

H410
T
602-075-00-04,4,5,5-tetrachloro-1,3-dioxolan-2-one404-060-222432-68-4Acute Tox. 2 *

Acute Tox. 4 *

Skin Corr. 1B
H330

H302

H314
GHS06

GHS05

Dgr
H330

H302

H314
602-076-00-62,3,4-trichlorobut-1-ene219-397-92431-50-7Carc. 2

Acute Tox. 3 *

Acute Tox. 4 *

Eye Irrit. 2

STOT SE 3

Skin Irrit. 2

Aquatic Acute 1

Aquatic Chronic 1
H351

H331

H302

H319

H335

H315

H400

H410
GHS06

GHS08

GHS09

Dgr
H351

H331

H302

H319

H335

H315

H410
Carc. 2; H351: C ≥ 0,1 %
602-077-00-1dodecachloropentacyclo[5.2.1.02,6.03,9.05,8]decane;

mirex
219-196-62385-85-5Carc. 2

Repr. 2

Lact.

Acute Tox. 4 *

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1
H351

H361fd

H362

H312

H302

H400

H410
GHS08

GHS07

GHS09

Wng
H351

H361fd

H362

H312

H302

H410
602-078-00-7hexachlorocyclopentadiene201-029-377-47-4Acute Tox. 2 *

Acute Tox. 3 *

Acute Tox. 4 *

Skin Corr. 1B

Aquatic Acute 1

Aquatic Chronic 1
H330

H311

H302

H314

H400

H410
GHS06

GHS05

GHS09

Dgr
H330

H311

H302

H314

H410
602-079-00-22,3-dichloropropene;

2,3-dichloropropylene
201-153-878-88-6Flam. Liq. 2

Muta. 2

Acute Tox. 4 *

Acute Tox. 4 *

Acute Tox. 4 *

STOT SE 3

Skin Irrit. 2

Eye Dam. 1

Aquatic Chronic 3
H225

H341

H332

H312

H302

H335

H315

H318

H412
GHS02

GHS08

GHS05

GHS07

Dgr
H225

H341

H332

H312

H302

H335

H315

H318

H412
602-080-00-8alkanes, C10-13, chloro287-476-585535-84-8Carc. 2

Aquatic Acute 1

Aquatic Chronic 1
H351

H400

H410
GHS08

GHS09

Wng
H351

H410
602-081-00-32-chloro-4,5-difluorobenzoic acid405-380-5Acute Tox. 4 *

Acute Tox. 4 *

Eye Dam. 1

Skin Sens. 1
H312

H302

H318

H317
GHS05

GHS07

Dgr
H312

H302

H318

H317
602-082-00-92,2,6,6-tetrakis(bromomethyl)-4-oxaheptane-1,7-diol408-020-5109678-33-3Skin Sens. 1

Aquatic Chronic 2
H317

H411
GHS07

GHS09

Wng
H317

H411
602-083-00-4diphenyl ether, pentabromo derivative pentabromodiphenyl ether251-084-232534-81-9STOT RE 2 *

Lact.

Aquatic Acute 1

Aquatic Chronic 1
H373 **

H362

H400

H410
GHS08

GHS09

Wng
H373 **

H362

H410
602-084-00-X1,1-dichloro-1-fluoroethane404-080-11717-00-6Aquatic Chronic 3

Ozone
H412

EUH059
H412EUH059
602-085-00-52-bromopropane200-855-175-26-3Flam. Liq. 2

Repr. 1A

STOT RE 2 *
H225

H360F ***

H373 **
GHS02

GHS08

Dgr
H225

H360F ***

H373 **
EUH066
602-086-00-0trifluoroiodomethane;

trifluoromethyl iodide
219-014-52314-97-8Muta. 2H341GHS08

Wng
H341
602-087-00-61,2,4-trichlorobenzene204-428-0120-82-1Acute Tox. 4 *

Skin Irrit. 2

Aquatic Acute 1

Aquatic Chronic 1
H302

H315

H400

H410
GHS07

GHS09

Wng
H302

H315

H410
602-088-00-12,3-dibromopropan-1-ol;

2,3-dibromo-1-propanol
202-480-996-13-9Carc. 1B

Repr. 2

Acute Tox. 3 *

Acute Tox. 4 *

Acute Tox. 4 *

Aquatic Chronic 3
H350

H361f ***

H311

H332

H302

H412
GHS08

GHS07

Dgr
H350

H361f ***

H311

H332

H302

H412
602-089-00-74-bromo-2-chlorofluorobenzene405-580-260811-21-4Acute Tox. 4 *

Skin Irrit. 2

Aquatic Acute 1

Aquatic Chronic 1
H302

H315

H400

H410
GHS07

GHS09

Wng
H302

H315

H410
602-090-00-21-allyl-3-chloro-4-fluorobenzene406-630-6121626-73-1Skin Irrit. 2

Aquatic Chronic 2
H315

H411
GHS07

GHS09

Wng
H315

H411
602-091-00-81,3-dichloro-4-fluorobenzene406-160-11435-48-9Acute Tox. 4 *

STOT RE 2 *

Skin Irrit. 2
H302

H373 **

H315

H411
GHS08

GHS07

Wng
H302

H373 **

H315

H411
602-092-00-31-bromo-3,4,5-trifluorobenzene418-480-9138526-69-9Flam. Liq. 3

Carc. 2

Skin Irrit. 2

Eye Dam. 1

Aquatic Chronic 2
H226

H351

H315

H318

H411
GHS02

GHS08

GHS05

GHS09

Dgr
H226

H351

H315

H318

H411
602-093-00-9α, α,α,4-tetrachlorotoluene;

p-chlorobenzotrichloride
226-009-15216-25-1Carc. 1B

Repr. 2

STOT RE 1

Acute Tox. 4 *

Acute Tox. 4 *

STOT SE 3

Skin Irrit. 2
H350

H361f ***

H372 **

H312

H302

H335

H315
GHS08

GHS07

Dgr
H350

H361f ***

H372 **

H312

H302

H335

H315
602-094-00-4diphenylether; octabromo derivate251-087-932536-52-0Repr. 1BH360DfGHS08

Dgr
H360Df
602-096-00-5malachite green hydrochloride; [1]

malachite green oxalate [2]
209-322-8 [1]

219-441-7 [2]
569-64-2 [1]

2437-29-8 [2]
Repr. 2

Acute Tox. 4 *

Eye Dam. 1

Aquatic Acute 1

Aquatic Chronic 1
H361d ***

H302

H318

H400

H410
GHS08

GHS05

GHS07

GHS09

Dgr
H361d ***

H302

H318

H410
602-097-00-01-bromo-9-(4,4,5,5,5-pentafluoropentylthio)nonane422-850-5148757-89-5Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H317

H400

H410
GHS07

GHS09

Wng
H317

H410
603-001-00-Xmethanol200-659-667-56-1Flam. Liq. 2

Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *

STOT SE 1
H225

H331

H311

H301

H370 **
GHS02

GHS06

GHS08

Dgr
H225

H331

H311

H301

H370 **
*

STOT SE 1; H370: C ≥ 10 %

STOT SE 2; H371: 3 % ≤ C < 10 %
603-002-00-5ethanol;

ethyl alcohol
200-578-664-17-5Flam. Liq. 2H225GHS02

Dgr
H225
603-003-00-0propan-1-ol;

n-propanol
200-746-971-23-8Flam. Liq. 2

Eye Dam. 1

STOT SE 3
H225

H318

H336
GHS02

GHS05

GHS07

Dgr
H225

H318

H336
603-004-00-6butan-1-ol;

n-butanol
200-751-671-36-3Flam. Liq. 3

Acute Tox. 4 *

STOT SE 3

Skin Irrit. 2

Eye Dam. 1

STOT SE 3
H226

H302

H335

H315

H318

H336
GHS02

GHS05

GHS07

Dgr
H226

H302

H335

H315

H318

H336
603-005-00-12-methylpropan-2-ol;

tert-butyl alcohol
200-889-775-65-0Flam. Liq. 2

Acute Tox. 4 *
H225

H332
GHS02

GHS07

Dgr
H225

H332
603-006-00-7pentanol isomers, with the exception fo those specified elsewhere in this Annex250-378-8Flam. Liq. 3

Acute Tox. 4 *

STOT SE 3
H226

H332

H335
GHS02

GHS07

Wng
H226

H332

H335
EUH066C
603-007-00-22-methylbutan-2-ol;

tert-pentanol
200-908-975-85-4Flam. Liq. 2

Acute Tox. 4 *

STOT SE 3

Skin Irrit. 2
H225

H332

H335

H315
GHS02

GHS07

Dgr
H225

H332

H335

H315
603-008-00-84-methylpentan-2-ol;

methyl isobutyl carbinol
203-551-7108-11-2Flam. Liq. 3

STOT SE 3
H226

H335
GHS02

GHS07

Wng
H226

H335
STOT SE 3; H335: C ≥ 25 %
603-009-00-3cyclohexanol203-630-6108-93-0Acute Tox. 4 *

Acute Tox. 4 *

STOT SE 3

Skin Irrit. 2
H332

H302

H335

H315
GHS07

Wng
H332

H302

H335

H315
603-010-00-92-methylcyclohexanol, mixed isomers; [1]

cis-2-methylcyclohexanol; [2]

trans-2-methylcyclohexanol [3]
209-512-0 [1]

231-187-9 [2]

231-186-3 [3]
583-59-5 [1]

7443-70-1 [2]

7443-52-9 [3]
Acute Tox. 4 *H332GHS07

Wng
H332C
603-011-00-42-methoxyethanol;

ethylene glycol monomethyl ether
203-713-7109-86-4Flam. Liq. 3

Repr. 1B

Acute Tox. 4 *

Acute Tox. 4 *

Acute Tox. 4 *
H226

H360FD

H332

H312

H302
GHS02

GHS08

GHS07

Dgr
H226

H360FD

H332

H312

H302
603-012-00-X2-ethoxyethanol;

ethylene glycol monoethyl ether
203-804-1110-80-5Flam. Liq. 3

Repr. 1B

Acute Tox. 4 *

Acute Tox. 4 *

Acute Tox. 4 *
H226

H360FD

H332

H312

H302
GHS02

GHS08

GHS07

Dgr
H226

H360FD

H332

H312

H302
603-013-00-52-isopropoxyethanol;

ethylene glycol monoisopropyl ether
203-685-6109-59-1Acute Tox. 4 *

Acute Tox. 4 *

Eye Irrit. 2
H332

H312

H319
GHS07

Wng
H332

H312

H319
603-014-00-02-butoxyethanol;

ethylene glycol monobutyl ether;

butyl cellosolve
203-905-0111-76-2Acute Tox. 4 *

Acute Tox. 4 *

Acute Tox. 4 *

Eye Irrit. 2

Skin Irrit. 2
H332

H312

H302

H319

H315
GHS07

Wng
H332

H312

H302

H319

H315
603-015-00-6allyl alcohol203-470-7107-18-6Flam. Liq. 2

Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *

Eye Irrit. 2

STOT SE 3

Skin Irrit. 2

Aquatic Acute 1
H225

H331

H311

H301

H319

H335

H315

H400
GHS02

GHS06

GHS09

Dgr
H225

H331

H311

H301

H319

H335

H315

H400
603-016-00-14-hydroxy-4-methylpentan-2-one;

diacetone alcohol
204-626-7123-42-2Eye Irrit. 2H319GHS07

Wng
H319Eye Irrit. 2; H319: C ≥ 10 %
603-018-00-2furfuryl alcohol202-626-198-00-0Acute Tox. 4 *

Acute Tox. 4 *

Acute Tox. 4 *
H332

H312

H302
GHS07

Wng
H332

H312

H302
*
603-019-00-8dimethyl ether204-065-8115-10-6Flam. Gas 1

Press. Gas
H220GHS02

GHS04

Dgr
H220U
603-020-00-3ethyl methyl ether540-67-0Flam. Gas 1

Press. Gas
H220GHS02

GHS04

Dgr
H220U
603-021-00-9methyl vinyl ether203-475-4107-25-5Flam. Gas 1

Press. Gas
H220GHS02

GHS04

Dgr
H220D U
603-022-00-4diethyl ether;

ether
200-467-260-29-7Flam. Liq. 1

Acute Tox. 4 *

STOT SE 3
H224

H302

H336
GHS02

GHS07

Dgr
H224

H302

H336
EUH019

EUH066
603-023-00-Xethylene oxide;

oxirane
200-849-975-21-8Flam. Gas 1

Press. Gas

Carc. 1B

Muta. 1B

Acute Tox. 3 *

Eye Irrit. 2

STOT SE 3

Skin Irrit. 2
H220

H350

H340

H331

H319

H335

H315
GHS02

GHS04

GHS06

GHS08

Dgr
H220

H350

H340

H331

H319

H335

H315
U
603-024-00-51,4-dioxane204-661-8123-91-1Flam. Liq. 2

Carc. 2

Eye Irrit. 2

STOT SE 3
H225

H351

H319

H335
GHS02

GHS08

GHS07

Dgr
H225

H351

H319

H335
EUH019

EUH066
D
603-025-00-0tetrahydrofuran203-726-8109-99-9Flam. Liq. 2

Eye Irrit. 2

STOT SE 3
H225

H319

H335
GHS02

GHS07

Dgr
H225

H319

H335
EUH019Eye Irrit. 2; H319: C ≥ 25 %

STOT SE 3; H335: C ≥ 25 %
603-026-00-61-chloro-2,3-epoxypropane;

epichlorhydrin
203-439-8106-89-8Flam. Liq. 3

Carc. 1B

Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *

Skin Corr. 1B

Skin Sens. 1
H226

H350

H331

H311

H301

H314

H317
GHS02

GHS06

GHS08

GHS05

Dgr
H226

H350

H331

H311

H301

H314

H317
*
603-027-00-1ethanediol;

ethylene glycol
203-473-3107-21-1Acute Tox. 4 *H302GHS07

Wng
H302
603-028-00-72-chloroethanol;

ethylene chlorohydrin
203-459-7107-07-3Acute Tox. 2 *

Acute Tox. 1

Acute Tox. 2 *
H330

H310

H300
GHS06

Dgr
H330

H310

H300
603-029-00-2bis(2-chloroethyl) ether203-870-1111-44-4Carc. 2

Acute Tox. 2 *

Acute Tox. 1

Acute Tox. 2 *
H351

H330

H310

H300
GHS06

GHS08

Dgr
H351

H330

H310

H300
603-030-00-82-aminoethanol;

ethanolamine
205-483-3141-43-5Acute Tox. 4 *

Acute Tox. 4 *

Acute Tox. 4 *

Skin Corr. 1B
H332

H312

H302

H314
GHS05

GHS07

Dgr
H332

H312

H302

H314
STOT SE 3; H335: C ≥ 5 %
603-031-00-31,2-dimethoxyethane;

ethylene glycol dimethyl ether;

EGDME
203-794-9110-71-4Flam. Liq. 2

Repr. 1B

Acute Tox. 4 *
H225

H360FD

H332
GHS02

GHS08

GHS07

Dgr
H225

H360FD

H332
EUH019
603-032-00-9ethylene dinitrate;

ethylene glycol dinitrate
211-063-0628-96-6Unst. Expl.

Acute Tox. 2 *

Acute Tox. 1

Acute Tox. 2 *

STOT RE 2 *
H200

H330

H310

H300

H373 **
GHS01

GHS06

GHS08

Dgr
H200

H330

H310

H300

H373 **
603-033-00-4oxydiethylene dinitrate;

diethylene glycol dinitrate;

digol dinitrate
211-745-8693-21-0Unst. Expl

Acute Tox. 2 *

Acute Tox. 1

Acute Tox. 2 *

STOT RE 2 *

Aquatic Chronic 3
H200

H330

H310

H300

H373 **

H412
GHS01

GHS06

GHS08

Dgr
H200

H330

H310

H300

H373 **

H412
603-033-01-1oxydiethylene dinitrate;

diethylene glycol dinitrate;

digol dinitrate;

[>25 % phlegmatiser]
211-745-8693-21-0Expl. 1.1

Acute Tox. 2 *

Acute Tox. 1

Acute Tox. 2 *

STOT RE 2 *

Aquatic Chronic 3
H201

H330

H310

H300

H373 **

H412
GHS01

GHS06

GHS08

Dgr
H201

H330

H310

H300

H373 **

H412
603-034-00-Xglycerol trinitrate;

nitroglycerine
200-240-855-63-0Unst. Expl.

Acute Tox. 2 *

Acute Tox. 1

Acute Tox. 2 *

STOT RE 2 *

Aquatic Chronic 2
H200

H330

H310

H300

H373 **

H411
GHS01

GHS06

GHS08

GHS09

Dgr
H200

H330

H310

H300

H373 **

H411
603-034-01-7glycerol trinitrate;

nitroglycerine;

[>40 % phlegmatiser]
200-240-855-63-0Expl. 1.1

Acute Tox. 2 *

Acute Tox. 1

Acute Tox. 2 *

STOT RE 2 *

Aquatic Chronic 2
H201

H330

H310

H300

H373 **

H411
GHS01

GHS06

GHS08

GHS09

Dgr
H201

H330

H310

H300

H373 **

H411
603-035-00-5pentaerythritol tetranitrate; pentaerythrite tetranitrate;

P.E.T.N.
201-084-378-11-5Unst. Expl.H200GHS01

Dgr
H200
603-035-01-2pentaerythritol tetranitrate; pentaerythrite tetranitrate;

P.E.T.N.;

[>20 % phlegmatiser]
201-084-378-11-5Expl. 1.1H201GHS01

Dgr
H201T
603-036-00-0mannitol hexanitrate;

nitromannite
239-924-615825-70-4Unst. Expl.H200GHS01

Dgr
H200
603-036-01-8mannitol hexanitrate;

nitromannite;

[>40 % phlegmatiser]
239-924-615825-70-4Expl. 1.1H201GHS01

Dgr
H201
603-037-00-6cellulose nitrate;Expl. 1.1H201GHS01

Dgr
H201EUH001T
603-038-00-1allyl glycidyl ether;

allyl 2,3-epoxypropyl ether;

prop-2-en-1-yl 2,3-epoxypropyl ether
203-442-4106-92-3Flam. Liq. 3

Carc. 2

Muta. 2

Repr. 2

Acute Tox. 4 *

Acute Tox. 4 *

STOT SE 3

Skin Irrit. 2

Eye Dam. 1

Skin Sens. 1

Aquatic Chronic 3
H226

H351

H341

H361f ***

H332

H302

H335

H315

H318

H317

H412
GHS02

GHS08

GHS05

GHS07

Dgr
H226

H351

H341

H361f ***

H332

H302

H335

H315

H318

H317

H412
603-039-00-7butyl glycidyl ether;

butyl 2,3-epoxypropyl ether
219-376-42426-08-6Flam. Liq. 3

Carc. 2

Muta. 2

Acute Tox. 4 *

Acute Tox. 4 *

STOT SE 3

Skin Sens. 1

Aquatic Chronic 3
H226

H351

H341

H332

H302

H335

H317

H412
GHS02

GHS08

GHS07

Wng
H226

H351

H341

H332

H302

H335

H317

H412
603-040-00-2sodium methanolate;

sodium methoxide; [1]

potassium methanolate;

potassium methoxide; [2]

lithium methanolate;

lithium methoxide [3]
204-699-5 [1]

212-736-1 [2]

212-737-7 [3]
124-41-4 [1]

865-33-8 [2]

865-34-9 [3]
Self-heat 1

Skin Corr. 1B
H251

H314
GHS02

GHS05

Dgr
H251

H314
EUH014T
603-041-00-8potassium ethanolate;

potassium ethoxide; [1]

sodium ethanolate;

sodium ethoxide [2]
213-029-0 [1]

205-487-5 [2]
917-58-8 [1]

141-52-6 [2]
Self-heat 1

Skin Corr. 1B
H251

H314
GHS02

GHS05

Dgr
H251

H314
EUH014T
603-042-00-3aluminium-tri-isopropoxide209-090-8555-31-7Flam. Sol. 1H228GHS02

Dgr
H228T
603-043-00-9triarimol (ISO);

2,4-dichloro-α-(pyrimidin-5-yl) benzhydryl alcohol
26766-27-8Acute Tox. 4 *H302GHS07

Wng
H302
603-044-00-4dicofol (ISO);

2,2,2-trichloro-1,1-bis(4-chlorophenyl)ethanol
204-082-0115-32-2Acute Tox. 4 *

Acute Tox. 4 *

Skin Irrit. 2

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H312

H302

H315

H317

H400

H410
GHS07

GHS09

Wng
H312

H302

H315

H317

H410
603-045-00-Xdiisopropyl ether; [1]

dipropyl ether [2]
203-560-6 [1]

203-869-6 [2]
108-20-3 [1]

111-43-3 [2]
Flam. Liq. 2

STOT SE 3
H225

H336
GHS02

GHS07

Dgr
H225

H336
EUH019

EUH066
C
603-046-00-5bis (chloromethyl) ether;

oxybis(chloromethane)
208-832-8542-88-1Flam. Liq. 2

Carc. 1A

Acute Tox. 2 *

Acute Tox. 3 *

Acute Tox. 4 *
H225

H350

H330

H311

H302
GHS02

GHS06

GHS08

Dgr
H225

H350

H330

H311

H302
Carc. 1A; H350: C ≥ 0,001 %
603-047-00-02-dimethylaminoethanol;

N,N-dimethylethanolamine
203-542-8108-01-0Flam. Liq. 3

Acute Tox. 4 *

Acute Tox. 4 *

Acute Tox. 4 *

Skin Corr. 1B
H226

H332

H312

H302

H314
GHS02

GHS05

GHS07

Dgr
H226

H332

H312

H302

H314
STOT SE 3; H335: C ≥ 5 %
603-048-00-62-diethylaminoethanol;

N,N-diethylethanolamine
202-845-2100-37-8Flam. Liq. 3

Acute Tox. 4 *

Acute Tox. 4 *

Acute Tox. 4 *

Skin Corr. 1B
H226

H332

H312

H302

H314
GHS02

GHS05

GHS07 GHS09

Dgr
H226

H332

H312

H302

H314
STOT SE 3; H335: C ≥ 5 %
603-049-00-1chlorfenethol (ISO);

1,1-bis (4-chlorophenyl) ethanol
201-246-380-06-8Acute Tox. 4 *

Aquatic Chronic 2
H302

H411
GHS07

GHS09

Wng
H302

H411
603-050-00-71-(2-butoxypropoxy)propan-2-ol246-011-624083-03-2Acute Tox. 4 *

Acute Tox. 4 *
H312

H302
GHS07

Wng
H312

H302
603-051-00-22-ethylbutan-1-ol202-621-497-95-0Acute Tox. 4 *

Acute Tox. 4 *
H312

H302
GHS07

Wng
H312

H302
603-052-00-83-butoxypropan-2-ol;

propylene glycol monobutyl ether
225-878-45131-66-8Eye Irrit. 2

Skin Irrit. 2
H319

H315
GHS07

Wng
H319

H315
603-053-00-32-methylpentane-2,4-diol203-489-0107-41-5Eye Irrit. 2

Skin Irrit. 2
H319

H315
GHS07

Wng
H319

H315
603-054-00-9di-n-butyl ether;

dibutyl ether
205-575-3142-96-1Flam. Liq. 3

Eye Irrit. 2

STOT SE 3

Skin Irrit. 2

Aquatic Chronic 3
H226

H319

H335

H315

H412
GHS02

GHS07

Wng
H226

H319

H335

H315

H412
STOT SE 3; H335: C ≥ 10 %
603-055-00-4propylene oxide;

1,2-epoxypropane;

methyloxirane
200-879-275-56-9Flam. Liq. 1

Carc. 1B

Muta. 1B

Acute Tox. 4 *

Acute Tox. 4 *

Acute Tox. 4 *

Eye Irrit. 2

STOT SE 3

Skin Irrit. 2
H224

H350

H340

H332

H312

H302

H319

H335

H315
GHS02

GHS08

GHS07

Dgr
H224

H350

H340

H332

H312

H302

H319

H335

H315
603-056-00-X[(p-tolyloxy)methyl]oxirane; [1]

[(m-tolyloxy)methyl]oxirane; [2]

2,3-epoxypropyl o-tolyl ether; [3]

[(tolyloxy)methyl]oxirane;

cresyl glycidyl ether [4]
218-574-8 [1]

218-575-3 [2]

218-645-3 [3]

247-711-4 [4]
2186-24-5 [1]

2186-25-6 [2]

2210-79-9 [3]

26447-14-3 [4]
Muta. 2

Skin Irrit. 2

Skin Sens. 1

Aquatic Chronic 2
H341

H315

H317

H411
GHS08

GHS07

GHS09

Wng
H341

H315

H317

H411
C
603-057-00-5benzyl alcohol202-859-9100-51-6Acute Tox. 4 *

Acute Tox. 4 *
H332

H302
GHS07

Wng
H332

H302
603-058-00-01,3-propylene oxide207-964-3503-30-0Flam. Liq. 2

Acute Tox. 4 *

Acute Tox. 4 *

Acute Tox. 4 *
H225

H332

H312

H302
GHS02

GHS07

Dgr
H225

H332

H312

H302
603-059-00-6hexan-1-ol203-852-3111-27-3Acute Tox. 4 *H302GHS07

Wng
H302
603-060-00-12,2'-bioxirane;

1,2:3,4-diepoxybutane
215-979-11464-53-5Carc. 1B

Muta. 1B

Acute Tox. 2 *

Acute Tox. 3 *

Acute Tox. 3 *

Skin Corr. 1B
H350

H340

H330

H311

H301

H314
GHS06

GHS08

GHS05

Dgr
H350

H340

H330

H311

H301

H314
603-061-00-7tetrahydro-2-furylmethanol;

tetrahydrofurfuryl alcohol
202-625-697-99-4Eye Irrit. 2H319GHS07

Wng
H319
603-062-00-2tetrahydrofuran-2,5-diyldimethanol203-239-0104-80-3Eye Irrit. 2

STOT SE 3

Skin Irrit. 2
H319

H335

H315
GHS07

Wng
H319

H335

H315
STOT SE 3; H335: C ≥ 10 %
603-063-00-82,3-epoxypropan-1-ol;

glycidol;

oxiranemethanol
209-128-3556-52-5Carc. 1B

Muta. 2

Repr. 1B

Acute Tox. 3 *

Acute Tox. 4 *

Acute Tox. 4 *

Eye Irrit. 2

STOT SE 3

Skin Irrit. 2
H350

H341

H360F ***

H331

H312

H302

H319

H335

H315
GHS06

GHS08

Dgr
H350

H341

H360F ***

H331

H312

H302

H319

H335

H315
603-064-00-31-methoxy-2-propanol;

monopropylene glycol methyl ether
203-539-1107-98-2Flam. Liq. 3H226GHS02

Wng
H226
603-065-00-9resorcinol diglycidyl ether;

1,3-bis(2,3-epoxypropoxy)benzene
202-987-5101-90-6Carc. 2

Muta. 2

Acute Tox. 4 *

Acute Tox. 4 *

Eye Irrit. 2

Skin Irrit. 2

Skin Sens. 1

Aquatic Chronic 3
H351

H341

H312

H302

H319

H315

H317

H412
GHS08

GHS07

Wng
H351

H341

H312

H302

H319

H315

H317

H412
603-066-00-41,2-epoxy-4-epoxyethylcyclohexane;

vinylcyclohexane diepoxide
203-437-7106-87-6Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *

Carc. 2
H331

H311

H301

H351
GHS06

GHS08

Dgr
H331

H311

H301

H351
*
603-067-00-Xphenyl glycidyl ether;

2,3-epoxypropyl phenyl ether;

1,2-epoxy-3-phenoxypropane
204-557-2122-60-1Carc. 1B

Muta. 2

Acute Tox. 4 *

STOT SE 3

Skin Irrit. 2

Skin Sens. 1

Aquatic Chronic 3
H350

H341

H332

H335

H315

H317

H412
GHS08

GHS07

Dgr
H350

H341

H332

H335

H315

H317

H412
603-068-00-52,3-epoxypropyl-2-ethylcyclohexyl ether;

ethylcyclohexylglycidyl ether
130014-35-6Eye Irrit. 2

Skin Irrit. 2

Skin Sens. 1
H319

H315

H317
GHS07

Wng
H319

H315

H317
603-069-00-02,4,6-tris(dimethylaminomethyl)phenol202-013-990-72-2Acute Tox. 4 *

Eye Irrit. 2

Skin Irrit. 2
H302

H319

H315
GHS07

Wng
H302

H319

H315
603-070-00-62-amino-2-methylpropanol204-709-8124-68-5Eye Irrit. 2

Skin Irrit. 2

Aquatic Chronic 3
H319

H315

H412
GHS07

Wng
H319

H315

H412
603-071-00-12,2'-iminodiethanol;

diethanolamine
203-868-0111-42-2Acute Tox. 4 *

STOT RE 2 *

Skin Irrit. 2

Eye Dam. 1
H302

H373 **

H315

H318
GHS08

GHS05

GHS07

Dgr
H302

H373 **

H315

H318
603-072-00-71,4-bis(2,3 epoxypropoxy)butane;

butanedioldiglycidyl ether
219-371-72425-79-8Acute Tox. 4 *

Acute Tox. 4 *

Eye Irrit. 2

Skin Irrit. 2

Skin Sens. 1
H332

H312

H319

H315

H317
GHS07

Wng
H332

H312

H319

H315

H317
603-073-00-2bis-[4-(2,3-epoxipropoxi)phenyl]propane216-823-51675-54-3Eye Irrit. 2

Skin Irrit. 2

Skin Sens. 1
H319

H315

H317
GHS07

Wng
H319

H315

H317
Eye Irrit. 2; H319: C ≥ 5 %

Skin Irrit. 2; H315: C ≥ 5 %
603-074-00-8reaction product: bisphenol-A-(epichlorhydrin);

epoxy resin (number average molecular weight ≤ 700)
500-033-525068-38-6Eye Irrit. 2

Skin Irrit. 2

Skin Sens. 1

Aquatic Chronic 2
H319

H315

H317

H411
GHS07

GHS09

Wng
H319

H315

H317

H411
Eye Irrit. 2; H319: C ≥ 5 %

Skin Irrit. 2; H315: C ≥ 5 %
603-075-00-3chlormethyl methyl ether;

chlorodimethyl ether
203-480-1107-30-2Flam. Liq. 2

Carc. 1A

Acute Tox. 4 *

Acute Tox. 4 *

Acute Tox. 4 *
H225

H350

H332

H312

H302
GHS02

GHS08

GHS07

Dgr
H225

H350

H332

H312

H302
603-076-00-9but-2-yne-1,4-diol;

2-butyne-1,4-diol
203-788-6110-65-6Skin Corr. 1B

Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 4 *

STOT RE 2 *

Skin Sens. 1
H314

H331

H301

H312

H373 **

H317
GHS06

GHS05

GHS08

Dgr
H314

H331

H301

H312

H373 **

H317
Skin Corr. 1B; H314: C ≥ 50 %

Skin Irrit. 2; H315: 25 % ≤ C < 50 %

Eye Irrit. 2; H319: 25 % ≤ C < 50 %
D
603-077-00-41-dimethylaminopropan-2-ol;

dimepranol (INN)
203-556-4108-16-7Flam. Liq. 3

Acute Tox. 4 *

Skin Corr. 1B
H226

H302

H314
GHS02

GHS05

GHS07

Dgr
H226

H302

H314
603-078-00-Xprop-2-yn-1-ol;

propargyl alcohol
203-471-2107-19-7Flam. Liq. 3

Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *

Skin Corr. 1B

Aquatic Chronic 2
H226

H331

H311

H301

H314

H411
GHS02

GHS06

GHS05

GHS09

Dgr
H226

H331

H311

H301

H314

H411
603-079-00-52,2'-(methylimino)diethanol;

N-methyldiethanolamine
203-312-7105-59-9Eye Irrit. 2H319GHS07

Wng
H319
603-080-00-02-methylaminoethanol;

N-methylethanolamine;

N-methyl-2-ethanolamine;

N-methyl-2-amino ethanol;

2-(methylamino)ethanol
203-710-0109-83-1Acute Tox. 4 *

Acute Tox. 4 *

Skin Corr. 1B
H312

H302

H314
GHS05 GHS07

Dgr
H312

H302

H314
STOT SE 3; H335: C ≥ 5 %
603-081-00-62,2'-thiodiethanol;

thiodiglycol
203-874-3111-48-8Eye Irrit. 2H319GHS07

Wng
H319
603-082-00-11-aminopropan-2-ol;

isopropanolamine
201-162-778-96-6Skin Corr. 1BH314GHS05

Dgr
H314
603-083-00-71,1'-iminodipropan-2-ol;

di-isopropanolamine
203-820-9110-97-4Eye Irrit. 2H319GHS07

Wng
H319
603-084-00-2styrene oxide;

(epoxyethyl)benzene;

phenyloxirane
202-476-796-09-3Carc. 1B

Acute Tox. 4 *

Eye Irrit. 2
H350

H312

H319
GHS08

GHS07

Dgr
H350

H312

H319
603-085-00-8bronopol (INN);

2-bromo-2-nitropropane-1,3-diol
200-143-052-51-7Acute Tox. 4 *

Acute Tox. 4 *

STOT SE 3

Skin Irrit. 2

Eye Dam. 1

Aquatic Acute 1
H312

H302

H335

H315

H318

H400
GHS05

GHS07

GHS09

Dgr
H312

H302

H335

H315

H318

H400
603-086-00-3ethirimol (ISO);

5-butyl-2-ethylamino-6-methylpyrimidin-4-ol
245-949-323947-60-6Acute Tox. 4 *H312GHS07

Wng
H312
603-087-00-92-ethylhexane-1,3-diol;

octylene glycol;

ethoexadiol
202-377-994-96-2Eye Dam. 1H318GHS05

Dgr
H318
603-088-00-42-(octylthio)ethanol;

2-hydroxyethyl octyl sulphide
222-598-43547-33-9Eye Dam. 1H318GHS05

Dgr
H318
603-089-00-X7,7-dimethyl-3-oxa-6-azaoctan-1-ol400-390-6Skin Corr. 1A

Acute Tox. 4 *
H314

H302
GHS05

GHS07

Dgr
H314

H302
603-090-00-52-(2-bromoethoxy)anisole402-010-44463-59-6Acute Tox. 4 *

Aquatic Chronic 3
H302

H412
GHS07

Wng
H302

H412
603-091-00-0exo-1-methyl-4-(1-methylethyl)-7-oxabicyclo[2.2.1]heptan-2-ol402-470-687172-89-2Acute Tox. 4 *

Eye Dam. 1
H302

H318
GHS05

GHS07

Dgr
H302

H318
603-092-00-62-methyl-4-phenylpentanol402-770-792585-24-5Skin Sens. 1

Aquatic Chronic 2
H317

H411
GHS07

GHS09

Wng
H317

H411
603-093-00-1cinmethylin (ISO);

exo-(±)-1-methyl-2-(2-methylbenzyloxy)-4-isopropyl-7-oxabicyclo(2.2.1)heptane
402-410-987818-31-3Acute Tox. 4 *

Aquatic Chronic 2
H332

H411
GHS07

GHS09

Dgr
H332

H411
603-094-00-71,3-bis(2,3-epoxypropoxy)-2,2-dimethylpropane241-536-717557-23-2Skin Irrit. 2

Skin Sens. 1
H315

H317
GHS07

Wng
H315

H317
603-095-00-22-(propyloxy)ethanol;

EGPE
220-548-62807-30-9Acute Tox. 4 *

Eye Irrit. 2
H312

H319
GHS07

Wng
H312

H319
603-096-00-82-(2-butoxyethoxy)ethanol;

diethylene glycol monobutyl ether
203-961-6112-34-5Eye Irrit. 2H319GHS07

Wng
H319
603-097-00-31,1',1''-nitrilotripropan-2-ol;

triisopropanolamine
204-528-4122-20-3Eye Irrit. 2

Aquatic Chronic 3
H319

H412
GHS07

Wng
H319

H412
603-098-00-92-phenoxyethanol204-589-7122-99-6Acute Tox. 4 *

Eye Irrit. 2
H302

H319
GHS07

Wng
H302

H319
603-099-00-43-(N-methyl-N-(4-methylamino-3-nitrophenyl)amino)propane-1,2-diol hydrochloride403-440-593633-79-5Acute Tox. 4 *

Aquatic Chronic 3
H302

H412
GHS07

Wng
H302

H412
603-100-00-81,2-dimethoxypropane404-630-07778-85-0Flam. Liq. 2H225GHS02

Dgr
H225EUH019
603-101-00-3tetrahydro-2-isobutyl-4-methylpyran-4-ol, mixed isomers (cis and trans)405-040-6Eye Irrit. 2H319GHS07

Wng
H319
603-102-00-91,2-epoxybutane203-438-2106-88-7Flam. Liq. 2

Carc. 2

Acute Tox. 4 *

Acute Tox. 4 *

Acute Tox. 4 *

Eye Irrit. 2

STOT SE 3

Skin Irrit. 2

Aquatic Chronic 3
H225

H351

H332

H312

H302

H319

H335

H315

H412
GHS02

GHS08

GHS07

Dgr
H225

H351

H332

H312

H302

H319

H335

H315

H412
603-103-00-4oxirane, mono[(C12-14-alkyloxy)methyl] derivs.271-846-868609-97-2Skin Irrit. 2

Skin Sens. 1
H315

H317
GHS07

Wng
H315

H317
603-104-00-Xfenarimol (ISO);

2,4'-dichloro-α-(pyrimidin-5-yl)benzhydryl alcohol
262-095-760168-88-9Repr. 2

Lact.

Aquatic Chronic 2
H361fd

H362

H411
GHS08 GHS09

Wng
H361fd

H362

H411
603-105-00-5furan203-727-3110-00-9Flam. Liq. 1

Carc. 1B

Muta. 2

Acute Tox. 4 *

Acute Tox. 4 *

STOT RE 2 *

Skin Irrit. 2

Aquatic Chronic 3
H224

H350

H341

H332

H302

H373 **

H315

H412
GHS02

GHS08

GHS07

Dgr
H224

H350

H341

H332

H302

H373 **

H315

H412
EUH019
603-106-00-02-methoxypropanol216-455-51589-47-5Flam. Liq. 3

Repr. 1B

STOT SE 3

Skin Irrit. 2

Eye Dam. 1
H226

H360D ***

H335

H315

H318
GHS02

GHS08

GHS05

GHS07

Dgr
H226

H360D ***

H335

H315

H318
603-107-00-62-(2-methoxyethoxy)ethanol;

diethylene glycol monomethyl ether
203-906-6111-77-3Repr. 2H361d ***GHS08

Wng
H361d ***
603-108-00-12-methylpropan-1-ol;

iso-butanol
201-148-078-83-1Flam. Liq. 3

STOT SE 3

Skin Irrit. 2

Eye Dam. 1

STOT SE 3
H226

H335

H315

H318

H336
GHS02

GHS05

GHS07

Dgr
H226

H335

H315

H318

H336
603-117-00-0propan-2-ol;

isopropyl alcohol;

isopropanol
200-661-767-63-0Flam. Liq. 2

Eye Irrit. 2

STOT SE 3
H225

H319

H336
GHS02

GHS07

Dgr
H225

H319

H336
603-118-00-66-dimethylaminohexan-1-ol404-680-31862-07-3Acute Tox. 4 *

Skin Corr. 1B

Aquatic Chronic 3
H302

H314

H412
GHS05

GHS07

Dgr
H302

H314

H412
603-119-00-11,1'-(1,3-phenylenedioxy)bis(3-(2-(prop-2-enyl)phenoxy)propan-2-ol)405-840-5Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H317

H400

H410
GHS07

GHS09

Wng
H317

H410
603-120-00-72-methyl-5-phenylpentanol405-890-825634-93-9Eye Irrit. 2

Skin Irrit. 2
H319

H315
GHS07

Wng
H319

H315
603-121-00-24-[4-(1,3-dihydroxyprop-2-yl)phenylamino]-1,8-dihydroxy-5-nitroanthraquinone406-057-1114565-66-1Carc. 2

Skin Sens. 1

Aquatic Chronic 4
H351

H317

H413
GHS08

GHS07

Wng
H351

H317

H413
603-122-00-8sodium 2-ethylhexanolate406-150-738411-13-1Flam. Sol. 1

Skin Corr. 1B

Aquatic Chronic 3
H228

H314

H412
GHS02

GHS05

Dgr
H228

H314

H412
T
603-123-00-34-methyl-8-methylenetricyclo[3.3.1.13,7]decan-2-ol406-330-5122760-84-3Skin Irrit. 2

Skin Sens. 1

Aquatic Chronic 2
H315

H317

H411
GHS07

GHS09

Wng
H315

H317

H411
603-124-00-91,4-bis[2-(vinyloxy)ethoxy]benzene406-900-384563-49-5Aquatic Acute 1

Aquatic Chronic 1
H400

H410
GHS09

Wng
H410
603-125-00-42-(2,4-dichlorophenyl)-1-(1H—1,2,4-triazol-1-yl)pent-4-en-2-ol407-850-589544-40-1Acute Tox. 4 *

Eye Dam. 1

Aquatic Chronic 2
H302

H318

H411
GHS05

GHS07

GHS09

Dgr
H302

H318

H411
603-126-00-X2-((4-methyl-2-nitrophenyl)amino)ethanol408-090-7100418-33-5Acute Tox. 4 *

Skin Sens. 1

Aquatic Chronic 3
H302

H317

H412
GHS07

Wng
H302

H317

H412
603-127-00-5butan-2-ol; [1]

(S)-butan-2-ol; [2]

(R)-butan-2-ol; [3]

(±)-butan-2-ol [4]
201-158-5 [1]

224-168-1 [2]

238-967-8 [3]

240-029-8 [4]
78-92-2 [1]

4221-99-2 [2]

14898-79-4 [3]

15892-23-6 [4]
Flam. Liq. 3

Eye Irrit. 2

STOT SE 3

STOT SE 3
H226

H319

H335

H336
GHS02

GHS07

Wng
H226

H319

H335

H336
C
603-128-00-02-(phenylmethoxy)naphthalene405-490-3613-62-7Aquatic Chronic 4H413H413
603-129-00-61-tert-butoxypropan-2-ol406-180-057018-52-7Flam. Liq. 3

Eye Dam. 1
H226

H318
GHS02

GHS05

Dgr
H226

H318
603-130-00-1reaction mass of isomers of: α-((dimethyl)biphenyl)-ω-hydroxypoly(oxyethylene)406-325-8Acute Tox. 4 *

Aquatic Chronic 3
H302

H412
GHS07

Wng
H302

H412
603-131-00-7reaction mass of: 1-deoxy-1-[methyl-(1-oxododecyl)amino]-D-glucitol;

1-deoxy-1-[methyl-(1-oxotetradecyl)amino]-D-glucitol (3:1)
407-290-1Eye Dam. 1H318GHS05

Dgr
H318
603-132-00-22-hydroxymethyl-9-methyl-6-(1-methylethyl)-1,4-dioxaspiro[4.5]decane408-200-363187-91-7Skin Irrit. 2

Eye Dam. 1

Aquatic Chronic 3
H315

H318

H412
GHS05

Dgr
H315

H318

H412
603-133-00-8reaction mass of: 3-[(4-amino-2-chloro-5-nitrophenyl)amino]-propane-1,2-diol;

3,3'-(2-chloro-5-nitro-1,4-phenylenediimino)bis(propan-1,2-diol)
408-240-1Acute Tox. 4 *

Aquatic Chronic 3
H302

H412
GHS07

Wng
H302

H412
603-134-00-3reaction mass of substituted dodecyl and/or tetradecyl, diphenyl ethers. The substance is produced by the Friedel Crafts reaction. The catalyst is removed from the reaction product. Diphenyl ether is substituted by C1-C10 alkyl groups. The alkyl groups are bonded randomly between C1 and C6. Linear C12 and C14, 50/50 used.410-450-3Aquatic Chronic 4H413H413
603-135-00-9bis[[2,2',2''-nitrilotris-[ethanolato]]-1-N,O]-bis[2-(2-methoxyethoxy)ethoxy]-titanium410-500-4Eye Dam. 1

Aquatic Chronic 2
H318

H411
GHS05

GHS09

Dgr
H318

H411
603-136-00-43-((4-(bis(2-hydroxyethyl)amino)-2-nitrophenyl)amino)-1-propanol410-910-3104226-19-9Skin Sens. 1

Aquatic Chronic 3
H317

H412
GHS07

Wng
H317

H412
603-137-00-Xreaction mass of: 1-deoxy-1-[methyl-(1-oxohexadecyl)amino]-D-glucitol;

1-deoxy-1-[methyl-(1-oxooctadecyl)amino]-D-glucitol
411-130-6Eye Dam. 1H318GHS05

Dgr
H318
603-138-00-53-(2,2-dimethyl-3-hydroxypropyl)toluene;

(alt.): 2,2-dimethyl-3-(3-methylphenyl)propanol
403-140-4103694-68-4Aquatic Chronic 3H412H412
603-139-00-0bis(2-methoxyethyl) ether203-924-4111-96-6Flam. Liq. 3

Repr. 1B
H226

H360FD
GHS02

GHS08

Dgr
H226

H360FD
EUH019
603-140-00-62,2' -oxybisethanol;

diethylene glycol
203-872-2111-46-6Acute Tox. 4 *H302GHS07

Wng
H302
603-141-00-1reaction mass of: dodecyloxy-1-methyl-1-[oxy-poly-(2-hydroxymethylethanoxy)]pentadecane;

dodecyloxy-1-methyl-1-[oxy-poly-(2-hydroxymethylethanoxy)]heptadecane
413-780-6Aquatic Chronic 3H412H412
603-142-00-72-(2-(2-hydroxyethoxy)ethyl)-2-aza-bicyclo[2.2.1]heptane407-360-1116230-20-7Acute Tox. 4 *

Acute Tox. 4 *

STOT RE 2 *

Skin Irrit. 2

Eye Dam. 1
H312

H302

H373 **

H315

H318
GHS06

GHS08

GHS05

Dgr
H312

H302

H373 **

H315

H318
603-143-00-2R—2,3-epoxy-1-propanol404-660-457044-25-4Self-react. C ****

Carc. 1B

Muta. 2

Repr. 1B

Acute Tox. 3 *

Acute Tox. 4 *

Acute Tox. 4 *

Skin Corr. 1B
H242

H350

H341

H360F ***

H331

H312

H302

H314
GHS02

GHS06

GHS08

GHS05

Dgr
H242

H350

H341

H360F ***

H331

H312

H302

H314
603-144-00-8reaction mass of: 2,6,9-trimethyl-2,5,9-cyclododecatrien-1-ol;

6,9-dimethyl-2-methylen-5,9-cyclododecadien-1-ol
413-530-6111850-00-1Aquatic Chronic 2H411GHS09H411
603-145-00-32-isopropyl-2-(1-methylbutyl)-1,3-dimethoxypropane406-970-5129228-11-1Skin Irrit. 2

Aquatic Chronic 2
H315

H411
GHS07

GHS09

Wng
H315

H411
603-146-00-92-[(2-[2-(dimethylamino)ethoxy]ethyl)methylamino]ethanol406-080-783016-70-0Acute Tox. 4 *

Skin Corr. 1B

Aquatic Chronic 3
H302

H314

H412
GHS05

GHS07

Dgr
H302

H314

H412
603-147-00-4(-)-trans-4-(4'-fluorophenyl)-3-hydroxymethyl-N-methylpiperidine406-030-4105812-81-5Acute Tox. 4 *

Eye Dam. 1

Aquatic Chronic 2
H302

H318

H411
GHS05

GHS07

GHS09

Dgr
H302

H318

H411
603-148-00-X1,4-bis[(vinyloxy)methyl]cyclohexane413-370-717351-75-6Skin Sens. 1

Aquatic Chronic 2
H317

H411
GHS07 GHS09

Wng
H317

H411
603-149-00-5reaction mass of diastereoisomers of 1-(1-hydroxyethyl)-4-(1-methylethyl)cyclohexane407-640-363767-86-2Eye Irrit. 2

Skin Irrit. 2

Aquatic Chronic 2
H319

H315

H411
GHS07 GHS09

Wng
H319

H315

H411
603-150-00-0(±) trans—3,3-dimethyl-5-(2,2,3-trimethyl-cyclopent-3-en-1-yl)-pent-4-en-2-ol411-580-3107898-54-4Skin Irrit. 2

Aquatic Acute 1

Aquatic Chronic 1
H315

H400

H410
GHS07

GHS09

Wng
H315

H410
603-151-00-6(±)-2-(2,4-dichlorophenyl)-3-(1H-1,2,4-triazol-1-yl)propan-1-ol413-570-4Aquatic Chronic 3H412H412
603-152-00-12-(4-tert-butylphenyl)ethanol410-020-55406-86-0Repr. 2

STOT RE 2 *

Eye Dam. 1

Aquatic Chronic 2
H361f ***

H373 **

H318

H411
GHS08

GHS05

GHS09

Dgr
H361f ***

H373 **

H318

H411
603-153-00-73-((2-nitro-4-(trifluoromethyl)phenyl)amino)propane-1,2-diol410-010-0104333-00-8Acute Tox. 4 *

Aquatic Chronic 3
H302

H412
GHS07

Wng
H302

H412
603-154-00-21-[(2-tert-butyl)cyclohexyloxy]-2-butanol412-300-2139504-68-0Aquatic Chronic 2H411GHS09H411
603-155-00-8Reaction products of 2-(4,6-bis(2,4-dimethylphenyl)-1,3,5-triazin-2-yl)-5-hydroxyphenol with ((C10-16, rich in C12-13 alkyloxy)methyl)oxyrane410-560-1Aquatic Acute 1

Aquatic Chronic 1
H400

H410
GHS09

Wng
H410
603-156-00-32-(2,4-dichlorophenyl)-2-(2-propenyl)oxirane411-210-089544-48-9Skin Irrit. 2

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H315

H317

H400

H410
GHS07

GHS09

Wng
H315

H317

H410
603-157-00-96,9-bis(hexadecyloxymethyl)-4,7-dioxanonane-1,2,9-triol411-450-6143747-72-2Aquatic Chronic 4H413H413
603-158-00-4reaction mass of 4 diastereoisomers of 2,7-dimethyl-10-(1-methylethyl)-1-oxaspiro[4.5]deca-3,6-diene412-460-3Skin Irrit. 2

Aquatic Chronic 2
H315

H411
GHS07 GHS09

Wng
H315

H411
603-159-00-X2-cyclododecylpropan-1-ol411-410-8118562-73-5Aquatic Acute 1

Aquatic Chronic 1
H400

H410
GHS09

Wng
H410
603-160-00-51,2-diethoxypropane412-180-110221-57-5Flam. Liq. 2H225GHS02

Dgr
H225EUH019
603-161-00-01,3-diethoxypropane413-140-63459-83-4Flam. Liq. 3H226GHS02

Wng
H226
603-162-00-6α[2-[[[(2-hydroxyethyl)methylamino]acetyl]amino]propyl]- ω nonylphenoxy)poly[oxo(methyl-1,2-ethanediyl)]413-420-8144736-29-8Skin Corr. 1B

Skin Sens. 1

Aquatic Chronic 2
H314

H317

H411
GHS05

GHS07

GHS09

Dgr
H314

H317

H411
603-163-00-12-phenyl-1,3-propanediol411-810-21570-95-2Eye Dam. 1H318GHS05

Dgr
H318
603-164-00-72-butyl-4-chloro-4,5-dihydro-5-hydroxymethyl-1-[2'-(2-triphenylmethyl-1,2,3,4-2H-tetrazol-5-yl)-1,1'-biphenyl-4-methyl]-1H-imidazole412-420-5133909-99-6Aquatic Chronic 4H413H413
603-165-00-2reaction mass of: 4-allyl-2,6-bis(2,3-epoxypropyl)phenol;

4-allyl-6-[3-[6-[3-[6-[3-(4-allyl-2,6-bis(2,3-epoxypropyl)phenoxy)-2-hydroxypropyl]-4-allyl-2-(2,3-epoxypropyl)phenoxy]-2-hydroxypropyl]-4-allyl-2-(2,3-epoxypropyl)phenoxy]-2-hydroxypropyl]-2-(2,3-epoxypropyl)phenol;

4-allyl-6-[3-(4-allyl-2,6-bis(2,3-epoxypropyl)phenoxy)-2-hydroxypropyl]-2-(2,3-epoxypropyl)phenol;

4-allyl-6-[3-[6-[3-(4-allyl-2,6-bis(2,3-epoxypropyl)phenoxy)-2-hydroxypropyl]-4-allyl-2-(2,3-epoxypropyl)phenoxy]-2-hydroxypropyl]-2-(2,3-epoxypropyl)phenol
417-470-1Muta. 2

Skin Sens. 1
H341

H317
GHS08

GHS07

Wng
H341

H317
603-166-00-8R-1-chloro-2,3-epoxypropane424-280-251594-55-9Flam. Liq. 3

Carc. 1B

Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *

Skin Corr. 1B

Skin Sens. 1
H226

H350

H331

H311

H301

H314

H317
GHS02

GHS06

GHS08

GHS05

Dgr
H226

H350

H331

H311

H301

H314

H317
603-167-00-33,3',5,5'-tetra-tert-butylbiphenyl-2,2'-diol407-920-56390-69-8Aquatic Chronic 4H413GHS05

Dgr
H413
603-168-00-93-(2-ethylhexyloxy)propane-1,2-diol408-080-270445-33-9Eye Dam. 1

Aquatic Chronic 3
H318

H412
GHS05

Dgr
H318

H412
603-169-00-4(±)-trans-4-(4-fluorophenyl)-3-hydroxymethyl-N-methylpiperidine415-550-0109887-53-8Acute Tox. 4 *

Eye Dam. 1

Aquatic Chronic 2
H302

H318

H411
GHS05

GHS07

GHS09

Dgr
H302

H318

H411
603-170-00-Xreaction mass of: 2-methyl-1-(6-methylbicyclo[2.2.1]hept-5-en-2-yl)pent-1-en-3-ol;

2-methyl-1-(1-methylbicyclo[2.2.1]hept-5-en-2-yl)-pent-1-en-3-ol;

2-methyl-1-(5-methylbicyclo[2.2.1]hept-5-en-2-yl)pent-1-en-3-ol
415-990-367739-11-1Eye Irrit. 2

Aquatic Chronic 2
H319

H411
GHS07

GHS09

Wng
H319

H411
603-171-00-55-thiazolylmethanol414-780-938585-74-9Eye Dam. 1

Aquatic Chronic 3
H318

H412
GHS05

Dgr
H318

H412
603-172-00-0mono-2-[2-(4-dibenzo[b,f][1,4]thiazepin-11-yl)piperazinium-1-yl]ethoxy)ethanol trans-butenedioate415-180-1773058-82-5Acute Tox. 4 *

Eye Dam. 1

Aquatic Chronic 2
H302

H318

H411
GHS05

GHS07

GHS09

Dgr
H302

H318

H411
603-173-00-64,4-dimethyl-3,5,8-trioxabicyclo[5.1.0]octane421-750-957280-22-5Eye Irrit. 2

Skin Sens. 1
H319

H317
GHS07

Wng
H319

H317
603-174-00-14-cyclohexyl-2-methyl-2-butanol420-630-383926-73-2Eye Dam. 1

Aquatic Chronic 2
H318

H411
GHS05

GHS09

Dgr
H318

H411
603-175-00-72-(2-hexyloxyethoxy)ethanol;

DEGHE;

diethylene glycol monohexyl ether;

3,6-dioxa-1-dodecanol;

hexyl carbitol;

3,6-dioxadodecan-1-ol
203-988-3112-59-4Acute Tox. 4 *

Eye Dam. 1
H312

H318
GHS05

GHS07

Dgr
H312

H318
603-176-00-21,2-bis(2-methoxyethoxy)ethane;

TEGDME;

triethylene glycol dimethyl ether;

triglyme
203-977-3112-49-2Repr. 1BH360DfGHS08

Dgr
H360DfEUH019
603-177-00-81-ethoxypropan-2-ol;

2PG1EE;

1-ethoxy-2-propanol;

propylene glycol monoethyl ether; [1]

2-ethoxy-1-methylethyl acetate;

2PG1EEA [2]
216-374-5 [1]

259-370-9 [2]
1569-02-4 [1]

54839-24-6 [2]
Flam. Liq. 3

STOT SE 3
H226

H336
GHS02

GHS07

Wng
H226

H336
603-178-00-32-hexyloxyethanol;

ethylene glycol monohexyl ether;

n-hexylglycol
203-951-1112-25-4Acute Tox. 4 *

Acute Tox. 4 *

Skin Corr. 1B
H312

H302

H314
GHS05

GHS07

Dgr
H312

H302

H314
603-179-00-9ergocalciferol (ISO);

Vitamin D2
200-014-950-14-6Acute Tox. 2 *

Acute Tox. 3 *

Acute Tox. 3 *

STOT RE 1
H330

H311

H301

H372 **
GHS06

GHS08

Dgr
H330

H311

H301

H372 **
603-180-00-4colecalciferol;

Vitamin D3
200-673-267-97-0Acute Tox. 2 *

Acute Tox. 3 *

Acute Tox. 3 *

STOT RE 1
H330

H311

H301

H372 **
GHS06

GHS08

Dgr
H330

H311

H301

H372 **
603-181-00-Xtert-butyl methyl ether;

MTBE;

2-methoxy-2-methylpropane
216-653-11634-04-4Flam. Liq. 2

Skin Irrit. 2
H225

H315
GHS02

GHS07

Dgr
H225

H315
603-183-00-02-[2-(2-butoxyethoxy)ethoxy]ethanol;

TEGBE;

triethylene glycol monobutyl ether;

butoxytriethylene glycol
205-592-6143-22-6Eye Dam. 1H318GHS05

Dgr
H318Eye Dam. 1; H318: C ≥ 30 %

Eye Irrit. 2; H319: 20 % ≤ C < 30 %
603-184-00-62-(hydroxymethyl)-2-[[2-hydroxy-3-(isooctadecyloxy)propoxy]methyl]-1,3-propanediol416-380-1146925-83-9Aquatic Acute 1

Aquatic Chronic 1
H400

H410
GHS09

Wng
H410
603-185-00-12,4-dichloro-3-ethyl-6-nitrophenol420-740-199817-36-4Acute Tox. 3 *

Eye Dam. 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H301

H318

H317

H400

H410
GHS06

GHS05

GHS09

Dgr
H301

H318

H317

H410
603-186-00-7trans-(5RS,6SR)-6-amino-2,2-dimethyl-1,3-dioxepan-5-ol419-050-379944-37-9Skin Sens. 1H317GHS07

Wng
H317
603-187-00-22-((4,6-bis(4-(2-(1-methylpyridinium-4-yl)vinyl)phenylamino)-1,3,5-triazin-2-yl)(2-hydroxyethyl)amino)ethanol dichloride419-360-9163661-77-6Aquatic Acute 1

Aquatic Chronic 1
H400

H410
GHS09

Wng
H410
603-189-00-3reaction mass of complexes of: titanium, 2,2'-oxydiethanol, ammonium lactate, nitrilotris(2-propanol) and ethylene glycol405-250-8Aquatic Chronic 2H411GHS09H411
603-191-00-42-(4,6-bis(2,4-dimethylphenyl)-1,3,5-triazin-2-yl)-5-(3-((2-ethylhexyl)oxy)-2-hydroxypropoxy)phenol419-740-4137658-79-8Aquatic Chronic 4H413H413
603-195-00-62-[4-(4-methoxyphenyl)-6-phenyl-1,3,5-triazin-2-yl]-phenol430-810-3154825-62-4Aquatic Chronic 3H412H412
603-196-00-12-(7-ethyl-1H-indol-3-yl)ethanol431-020-141340-36-7Acute Tox. 4 *

STOT RE 2 *

Aquatic Chronic 2
H302

H373 **

H411
GHS08

GHS07

GHS09

Wng
H302

H373 **

H411
603-197-00-7tebuconazole (ISO);

1-(4-chlorophenyl)-4,4-dimethyl-3-(1,2,4-triazol-1-ylmethyl)pentan-3-ol
403-640-2107534-96-3Repr. 2

Acute Tox. 4 *

Aquatic Chronic 2
H361d ***

H302

H411
GHS08

GHS07

GHS09

Wng
H361d ***

H302

H411
603-199-00-8etoxazol (ISO);

(RS)-5-tert-butyl-2-[2-(2,6-difluorophenyl)-4,5-dihydro-1,3-oxazol-4-yl]phenetole
153233-91-1Aquatic Acute 1

Aquatic Chronic 1
H400

H410
GHS09

Wng
H410M = 100
604-001-00-2phenol;

carbolic acid;

monohydroxybenzene;

phenylalcohol
203-632-7108-95-2Muta. 2

Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *

STOT RE 2 *

Skin Corr. 1B
H341

H331

H311

H301

H373 **

H314
GHS06

GHS08 GHS05

Dgr
H341

H331

H311

H301

H373 **

H314
*

Skin Corr. 1B; H314: C ≥ 3 %

Skin Irrit. 2; H315: 1 % ≤ C < 3 %

Eye Irrit. 2; H319: 1 % ≤ C < 3 %
604-002-00-8pentachlorophenol201-778-687-86-5Carc. 2

Acute Tox. 2 *

Acute Tox. 3 *

Acute Tox. 3 *

Eye Irrit. 2

STOT SE 3

Skin Irrit. 2

Aquatic Acute 1

Aquatic Chronic 1
H351

H330

H311

H301

H319

H335

H315

H400

H410
GHS06

GHS08

GHS09

Dgr
H351

H330

H311

H301

H319

H335

H315

H410
604-003-00-3sodium pentachlorophenolate; [1]

potassium pentachlorophenolate [2]
205-025-2 [1]

231-911-3 [2]
131-52-2 [1]

7778-73-6 [2]
Carc. 2

Acute Tox. 2 *

Acute Tox. 3 *

Acute Tox. 3 *

Eye Irrit. 2

STOT SE 3

Skin Irrit. 2

Aquatic Acute 1

Aquatic Chronic 1
H351

H330

H311

H301

H319

H335

H315

H400

H410
GHS06

GHS08

GHS09

Dgr
H351

H330

H311

H301

H319

H335

H315

H410
604-004-00-9m-cresol; [1]

o-cresol; [2]

p-cresol; [3]

mix-cresol [4]
203-577-9 [1]

202-423-8 [2]

203-398-6 [3]

215-293-2 [4]
108-39-4 [1]

95-48-7 [2]

106-44-5 [3]

1319-77-3 [4]
Acute Tox. 3 *

Acute Tox. 3 *

Skin Corr. 1B
H311

H301

H314
GHS06

GHS05

Dgr
H311

H301

H314
*C
604-005-00-41,4-dihydroxybenzene;

hydroquinone;

quinol
204-617-8123-31-9Carc. 2

Muta. 2

Acute Tox. 4 *

Eye Dam. 1

Skin Sens. 1

Aquatic Acute 1
H351

H341

H302

H318

H317

H400
GHS08

GHS05

GHS07

GHS09

Dgr
H351

H341

H302

H318

H317

H400
604-006-00-X3,4-xylenol; [1]

2,5-xylenol; [2]

2,4-xylenol; [3]

2,3-xylenol; [4]

2,6-xylenol; [5]

xylenol; [6]

2,4(or 2,5)-xylenol [7]
202-439-5 [1]

202-461-5 [2]

203-321-6 [3]

208-395-3 [4]

209-400-1 [5]

215-089-3 [6]

276-245-4 [7]
95-65-8 [1]

95-87-4 [2]

105-67-9 [3]

526-75-0 [4]

576-26-1 [5]

1300-71-6 [6]

71975-58-1 [7]
Acute Tox. 3 *

Acute Tox. 3 *

Skin Corr. 1B

Aquatic Chronic 2
H311

H301

H314

H411
GHS06

GHS05

GHS09

Dgr
H311

H301

H314

H411
C
604-007-00-52-naphthol205-182-7135-19-3Acute Tox. 4 *

Acute Tox. 4 *

Aquatic Acute 1
H332

H302

H400
GHS07

GHS09

Wng
H332

H302

H400
604-008-00-02-chlorophenol; [1]

4-chlorophenol; [2]

3-chlorophenol; [3]

chlorophenol [4]
202-433-2 [1]

203-402-6 [2]

203-582-6 [3]

246-691-4 [4]
95-57-8 [1]

106-48-9 [2]

108-43-0 [3]

25167-80-0 [4]
Acute Tox. 4 *

Acute Tox. 4 *

Acute Tox. 4 *

Aquatic Chronic 2
H332

H312

H302

H411
GHS07 GHS09

Wng
H332

H312

H302

H411
C
604-009-00-6pyrogallol;

1,2,3-trihydroxybenzene
201-762-987-66-1Muta. 2

Acute Tox. 4 *

Acute Tox. 4 *

Acute Tox. 4 *

Aquatic Chronic 3
H341

H332

H312

H302

H412
GHS08

GHS07

Wng
H341

H332

H312

H302

H412
*
604-010-00-1resorcinol;

1,3-benzenediol
203-585-2108-46-3Acute Tox. 4 *

Eye Irrit. 2

Skin Irrit. 2

Aquatic Acute 1
H302

H319

H315

H400
GHS07

GHS09

Wng
H302

H319

H315

H400
*
604-011-00-72,4-dichlorophenol204-429-6120-83-2Acute Tox. 3 *

Acute Tox. 4 *

Skin Corr. 1B

Aquatic Chronic 2
H311

H302

H314

H411
GHS06

GHS05

GHS09

Dgr
H311

H302

H314

H411
604-012-00-24-chloro-o-cresol;

4-chloro-2-methyl phenol
216-381-31570-64-5Acute Tox. 3 *

Skin Corr. 1A

Aquatic Acute 1
H331

H314

H400
GHS06

GHS05

GHS09

Dgr
H331

H314

H400
STOT SE 3; H335: C ≥ 1 %
604-013-00-82,3,4,6-tetrachlorophenol200-402-858-90-2Acute Tox. 3 *

Eye Irrit. 2

Skin Irrit. 2

Aquatic Acute 1

Aquatic Chronic 1
H301

H319

H315

H400

H410
GHS06

GHS09

Dgr
H301

H319

H315

H410
*

Eye Irrit. 2; H319: C ≥ 5 %

Skin Irrit. 2; H315: C ≥ 5 %
604-014-00-3chlorocresol;

4-chloro-m-cresol;

4-chloro-3-methylphenol
200-431-659-50-7Acute Tox. 4 *

Acute Tox. 4 *

Eye Dam. 1

Skin Sens. 1

Aquatic Acute 1
H312

H302

H318

H317

H400
GHS05

GHS07

GHS09

Dgr
H312

H302

H318

H317

H400
*
604-015-00-92,2'-methylenebis-(3,4,6-trichlorophenol);

hexachlorophene
200-733-870-30-4Acute Tox. 3 *

Acute Tox. 3 *

Aquatic Acute 1

Aquatic Chronic 1
H311

H301

H400

H410
GHS06

GHS09

Dgr
H311

H301

H410
*
604-016-00-41,2-dihydroxybenzene;

pyrocatechol
204-427-5120-80-9Acute Tox. 4 *

Acute Tox. 4 *

Eye Irrit. 2

Skin Irrit. 2
H312

H302

H319

H315
GHS07

Wng
H312

H302

H319

H315
604-017-00-X2,4,5-trichlorophenol202-467-895-95-4Acute Tox. 4 *

Eye Irrit. 2

Skin Irrit. 2

Aquatic Acute 1

Aquatic Chronic 1
H302

H319

H315

H400

H410
GHS07

GHS09

Wng
H302

H319

H315

H410
*

Eye Irrit. 2; H319: C ≥ 5 %

Skin Irrit. 2; H315: C ≥ 5 %
604-018-00-52,4,6-trichlorophenol201-795-988-06-2Carc. 2

Acute Tox. 4 *

Eye Irrit. 2

Skin Irrit. 2

Aquatic Acute 1

Aquatic Chronic 1
H351

H302

H319

H315

H400

H410
GHS08

GHS07

GHS09

Wng
H351

H302

H319

H315

H410
604-019-00-0dichlorophen (ISO)202-567-197-23-4Acute Tox. 4 *

Eye Irrit. 2

Aquatic Acute 1

Aquatic Chronic 1
H302

H319

H400

H410
GHS07

GHS09

Wng
H302

H319

H410
604-020-00-62-phenylphenol (ISO)

biphenyl-2-ol;

2-hydroxybiphenyl;
201-993-590-43-7Eye Irrit. 2

STOT SE 3

Skin Irrit. 2

Aquatic Acute 1
H319

H335

H315

H400
GHS07

GHS09

Wng
H319

H335

H315

H400
604-021-00-1sodium 2-biphenylate;

2-phenylphenol, sodium salt
205-055-6132-27-4Acute Tox. 4 *

STOT SE 3

Skin Irrit. 2

Eye Dam. 1

Aquatic Acute 1
H302

H335

H315

H318

H400
GHS05

GHS07

GHS09

Wng
H302

H335

H315

H318

H400
604-022-00-72,2-dimethyl-1,3-benzodioxol-4-ol400-900-722961-82-6Eye Dam. 1H318GHS05

Dgr
H318
604-023-00-22,4-dichloro-3-ethylphenol401-060-4Skin Corr. 1B

Aquatic Acute 1

Aquatic Chronic 1
H314

H400

H410
GHS05

GHS09

Dgr
H314

H410
604-024-00-84,4-isobutylethylidenediphenol401-720-16807-17-6Repr. 1B

Eye Irrit. 2

Aquatic Acute 1

Aquatic Chronic 1
H360F ***

H319

H400

H410
GHS08

GHS09

Dgr
H360F ***

H319

H410
604-025-00-32,5-bis(1,1-dimethylbutyl)hydroquinone400-220-0Aquatic Chronic 2H411GHS09H411
604-026-00-92,2-spirobi(6-hydroxy-4,4,7-trimethylchromane)400-270-3Aquatic Chronic 2H411GHS09H411
604-027-00-42-methyl-5-(1,1,3,3-tetramethylbutyl)hydroquinone400-530-6Eye Dam. 1

Skin Sens. 1

Aquatic Chronic 2
H318

H317

H411
GHS05

GHS07

GHS09

Dgr
H318

H317

H411
604-028-00-X4-amino-3-fluorophenol402-230-0399-95-1Carc. 1B

Acute Tox. 4 *

Skin Sens. 1

Aquatic Chronic 2
H350

H302

H317

H411
GHS08

GHS07

GHS09

Dgr
H350

H302

H317

H411
604-029-00-51-naphtol201-969-490-15-3Acute Tox. 4 *

Acute Tox. 4 *

STOT SE 3

Skin Irrit. 2

Eye Dam. 1
H312

H302

H335

H315

H318
GHS05

GHS07

Dgr
H312

H302

H335

H315

H318
604-030-00-0bisphenol A;

4,4'-isopropylidenediphenol
201-245-880-05-7Repr. 2

STOT SE 3

Eye Dam. 1

Skin Sens. 1
H361f ***

H335

H318

H317
GHS08

GHS05 GHS07

Dgr
H361f ***

H335

H318

H317
604-031-00-6guaiacol201-964-790-05-1Acute Tox. 4 *

Eye Irrit. 2

Skin Irrit. 2
H302

H319

H315
GHS07

Wng
H302

H319

H315
604-032-00-1thymol201-944-889-83-8Acute Tox. 4 *

Skin Corr. 1B

Aquatic Chronic 2
H302

H314

H411
GHS05

GHS07

GHS09

Dgr
H302

H314

H411
604-033-00-7isobutyl but-3-enoate401-170-224342-03-8Flam. Liq. 3H226GHS02

Wng
H226
604-034-00-24,4'-thiodi-o-cresol403-330-724197-34-0Eye Dam. 1

Aquatic Acute 1

Aquatic Chronic 1
H318

H400

H410
GHS05

GHS09

Dgr
H318

H410
604-035-00-84-nonylphenol, reaction products with formaldehyde and dodecane-1-thiol404-160-6Skin Sens. 1

Aquatic Chronic 4
H317

H413
GHS07

Wng
H317

H413
604-036-00-34,4'-oxybis(ethylenethio)diphenol404-590-490884-29-0Skin Sens. 1

Aquatic Chronic 2
H317

H411
GHS07

GHS09

Wng
H317

H411
604-037-00-93,5-xylenol;

3,5-dimethylphenol
203-606-5108-68-9Acute Tox. 3 *

Acute Tox. 3 *

Skin Corr. 1B
H311

H301

H314
GHS06

GHS05

Dgr
H311

H301

H314
604-038-00-44-chloro-3,5-dimethylphenol; [1]

chloroxylenol [2]
201-793-8 [1]

215-316-6 [2]
88-04-0 [1]

1321-23-9 [2]
Acute Tox. 4 *

Eye Irrit. 2

Skin Irrit. 2

Skin Sens. 1
H302

H319

H315

H317
GHS07

Wng
H302

H319

H315

H317
604-039-00-Xethyl 2-[4-[(6-chlorobenzoxazol-2-yl)oxy]phenoxy]propionate;

fenoxaprop-ethyl
266-362-966441-23-4Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H317

H400

H410
GHS07

GHS09

Wng
H317

H410
604-040-00-5fomesafen (ISO);

5-[2-chloro-4-(trifluoromethyl)phenoxy]-N-(methylsulphonyl)-2-nitrobenzamide
276-439-972178-02-0Acute Tox. 4 *H302GHS07

Wng
H302
604-041-00-0acifluorfen (ISO);

5-[2-chloro-4-(trifluoromethyl)phenoxy]-2-nitrobenzoic acid [1]

sodium 5-[2-chloro-4-(trifluoromethyl) phenoxy]-2-nitrobenzoate;

acifluorfen-sodium [2]
256-634-5 [1]

263-560-7 [2]
50594-66-6 [1]

62476-59-9 [2]
Acute Tox. 4 *

Skin Irrit. 2

Eye Dam. 1

Aquatic Acute 1

Aquatic Chronic 1
H302

H315

H318

H400

H410
GHS05

GHS07

GHS09

Dgr
H302

H315

H318

H410
604-042-00-64-nitrosophenol203-251-6104-91-6Muta. 2

Acute Tox. 4 *

Eye Dam. 1

Aquatic Chronic 2
H341

H302

H318

H411
GHS08

GHS05

GHS07

GHS09

Dgr
H341

H302

H318

H411
604-043-00-1monobenzone;

4-hydroxyphenyl benzyl ether;

hydroquinone monobenzyl ether
203-083-3103-16-2Eye Irrit. 2

Skin Sens. 1
H319

H317
GHS07

Wng
H319

H317
604-044-00-7mequinol;

4-methoxyphenol;

hydroquinone monomethyl ether
205-769-8150-76-5Acute Tox. 4 *

Eye Irrit. 2

Skin Sens. 1
H302

H319

H317
GHS07

Wng
H302

H319

H317
604-045-00-22,3,5-trimethylhydroquinone211-838-3700-13-0Acute Tox. 4 *

STOT SE 3

Skin Irrit. 2

Eye Dam. 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H332

H335

H315

H318

H317

H400

H410
GHS05

GHS07

GHS09

Dgr
H332

H335

H315

H318

H317

H410
604-046-00-84-(4-isopropoxyphenylsulfonyl)phenol405-520-595235-30-6Aquatic Chronic 2H411GHS09H411
604-047-00-34-(4-tolyloxy)biphenyl405-730-751601-57-1STOT RE 2 *

Aquatic Chronic 4
H373 **

H413
GHS08

Wng
H373 **

H413
604-048-00-94,4',4''-(ethan-1,1,1-triyl)triphenol405-800-727955-94-8Aquatic Chronic 2H411GHS09H411
604-049-00-44-4'-methylenebis(oxyethylenethio)diphenol407-480-493589-69-6Aquatic Chronic 2H411GHS09H411
604-051-00-53,5-bis((3,5-di-tert-butyl-4-hydroxy)benzyl)-2,4,6-trimethylphenol401-110-587113-78-8Aquatic Chronic 3H412H412
604-052-00-02,2'-methylenebis(6-(2H-benzotriazol-2-yl)-4-(1,1,3,3-tetramethylbutyl)phenol)403-800-1103597-45-1Aquatic Chronic 4H413H413
604-053-00-62-methyl-4-(1,1-dimethylethyl)-6-(1-methyl-pentadecyl)-phenol410-760-9157661-93-3Skin Irrit. 2

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H315

H317

H400

H410
GHS07

GHS09

Wng
H315

H317

H410
604-054-00-1reaction mass of: 2-methoxy-4-(tetrahydro-4-methylene-2H-pyran-2-yl)-phenol;

4-(3,6-dihydro-4-methyl-2H-pyran-2-yl)-2-methoxyphenol
412-020-0Skin Sens. 1

Aquatic Chronic 3
H317

H412
GHS07

Wng
H317

H412
604-055-00-72,2'-((3,3',5,5'-tetramethyl-(1,1'-biphenyl)-4,4'-diyl)-bis(oxymethylene))-bis-oxirane413-900-785954-11-6Muta. 2H341GHS08

Wng
H341
604-056-00-22-(2-hydroxy-3,5-dinitroanilino)ethanol412-520-999610-72-7Flam. Sol. 2

Repr. 2

Acute Tox. 4 *
H228

H361f ***

H302
GHS02

GHS07

GHS08

Dgr
H228

H361f ***

H302
604-057-00-8reaction mass of: isomers of 2-(2H-benzotriazol-2-yl)-4-methyl-(n)-dodecylphenol;

isomers of 2-(2H-benzotriazol-2-yl)-4-methyl-(n)-tetracosylphenol;

isomers of 2-(2H-benzotriazol-2-yl)-4-methyl-5,6-didodecyl-phenol. n = 5 or 6
401-680-5Aquatic Chronic 2H411GHS09H411
604-058-00-31,2-bis(3-methylphenoxy)ethane402-730-954914-85-1Aquatic Acute 1

Aquatic Chronic 1
H400

H410
GHS09

Wng
H410
604-059-00-92-n-hexadecylhydroquinone406-400-5STOT RE 2 *

Skin Irrit. 2

Skin Sens. 1

Aquatic Chronic 4
H373 **

H315

H317

H413
GHS08

GHS07

Wng
H373 **

H315

H317

H413
604-060-00-49,9-bis(4-hydroxyphenyl)fluorene406-950-63236-71-3Eye Irrit. 2

Skin Irrit. 2

Aquatic Acute 1

Aquatic Chronic 1
H319

H315

H400

H410
GHS07

GHS09

Wng
H319

H315

H410
604-061-00-Xreaction mass of: 2-chloro-5-sec-tetradecylhydroquinones where sec-tetradecyl = 1-methyltridecyl;

1-ethyldodecyl;

1-propylundecyl;

1-butyldecyl;

1-pentylnonyl;

1-hexyloctyl
407-740-7Skin Irrit. 2

Skin Sens. 1

Aquatic Chronic 3
H315

H317

H412
GHS07

Wng
H315

H317

H412
604-062-00-52,4-dimethyl-6-(1-methyl-pentadecyl)phenol411-220-5Skin Irrit. 2

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H315

H317

H400

H410
GHS07

GHS09

Wng
H315

H317

H410
604-063-00-05,6-dihydroxyindole412-130-93131-52-0Acute Tox. 4 *

Eye Dam. 1

Aquatic Chronic 2
H302

H318

H411
GHS05 GHS07

GHS09

Dgr
H302

H318

H411
604-064-00-62-(4,6-diphenyl-1,3,5-triazin-2-yl)-5-((hexyl)oxy)-phenol411-380-6147315-50-2Aquatic Chronic 4H413H413
604-065-00-14,4',4''-(1-methylpropan-1-yl-3-ylidene)tris(2-cyclohexyl-5-methylphenol)407-460-5111850-25-0Aquatic Chronic 2H411GHS09H411
604-066-00-7reaction mass of: phenol, 6-(1,1-dimethylethyl)-4-tetrapropyl-2-[(2-hydroxy-5-tetra-propylphenyl)methyl (C41-compound) and methane, 2,2'-bis[6-(1,1-dimethyl-ethyl)-1-hydroxy-4-tetrapropyl-phenyl)]- (C45-compound);

2,6-bis(1,1-dimethylethyl)-4-tetra-propyl-phenol and 2-(1,1-dimethylethyl)-4-tetrapropyl-phenol;

2,6-bis[(6-(1,1-dimethylethyl)-1-hydroxy-4-tetrapropylphenyl)methyl]-4-(tetrapropyl)phenol and 2-[(6-(1,1-dimethylethyl)-1-hydroxy-4-tetrapropylphenylmethyl]-6-[1-hydroxy-4-tetrapropylphenyl)methyl]-4-(tetrapropyl)phenol
414-550-8Aquatic Acute 1

Aquatic Chronic 1
H400

H410
GHS09

Wng
H410
604-067-00-2reaction mass of: 2,2'-[[(2-hydroxyethyl)imino]bis(methylene)bis[4-dodecylphenol];

formaldehyde, oligomer with 4-dodecyl phenol and 2-aminoethanol(n = 2);

formaldehyde, oligomer with 4-dodecyl phenol and 2-aminoethanol(n = 3, 4 and higher)
414-520-4Skin Irrit. 2

Eye Dam. 1

Aquatic Acute 1

Aquatic Chronic 1
H315

H318

H400

H410
GHS05

GHS09

Dgr
H315

H318

H410
604-068-00-8(±)-4-[2-[[3-(4-hydroxyphenyl)-1-methylpropyl]amino]-1-hydroxyethyl]phenol hydrochloride415-170-590274-24-1Acute Tox. 4 *

Acute Tox. 4 *

Skin Sens. 1
H332

H302

H317
GHS07

Wng
H332

H302

H317
604-069-00-32-(1-methylpropyl)-4-tert-butylphenol421-740-451390-14-8Skin Corr. 1B

Aquatic Chronic 2
H314

H411
GHS05

GHS09

Dgr
H314

H411
604-070-00-9triclosan;

2,4,4'-trichloro-2'-hydroxy-diphenyl-ether;

5-chloro-2-(2,4-dichlorophenoxy)phenol
222-182-23380-34-5Eye Irrit. 2

Skin Irrit. 2

Aquatic Acute 1

Aquatic Chronic 1
H319

H315

H400

H410
GHS07

GHS09

Wng
H319

H315

H410
M = 100
605-001-00-5formaldehyde ...%200-001-850-00-0Carc. 2

Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *

Skin Corr. 1B

Skin Sens. 1
H351

H331

H311

H301

H314

H317
GHS06

GHS08

GHS05

Dgr
H351

H331

H311

H301

H314

H317
*

Skin Corr. 1B; H314: C ≥25 %

Skin Irrit. 2; H315: 5 % ≤ C < 25 %

Eye Irrit. 2; H319: 5 % ≤ C < 25 %

STOT SE 3; H335: C ≥ 5 %

Skin Sens. 1; H317: C ≥ 0,2 %
B D
605-002-00-01,3,5-trioxan;

trioxymethylene
203-812-5110-88-3Flam. Sol. 1

Repr. 2

STOT SE 3
H228

H361d ***

H335
GHS02

GHS08

GHS07

Dgr
H228

H361d ***

H335
T
605-003-00-6acetaldehyde;

ethanal
200-836-875-07-0Flam. Liq. 1

Carc. 2

Eye Irrit. 2

STOT SE 3
H224

H351

H319

H335
GHS02

GHS08

GHS07

Dgr
H224

H351

H319

H335
605-004-00-12,4,6-trimethyl-1,3,5-trioxan;

paraldehyde
204-639-8123-63-7Flam. Liq. 3H226GHS02

Dgr
H226
605-005-00-72,4,6,8-tetramethyl-1,3,5,7-tetraoxacyclooctane;

metaldehyde
203-600-2108-62-3Flam. Sol. 2

Acute Tox. 4 *
H228

H302
GHS02

GHS07

Wng
H228

H302
605-006-00-2butyraldehyde204-646-6123-72-8Flam. Liq. 2H225GHS02

Dgr
H225
605-007-00-81,1-dimethoxyethane;

dimethyl acetal
208-589-8534-15-6Flam. Liq. 2H225GHS02

Dgr
H225
605-008-00-3acrylaldehyde;

acrolein;

prop-2-enal
203-453-4107-02-8Flam. Liq. 2

Acute Tox. 2 *

Acute Tox. 3 *

Acute Tox. 3 *

Skin Corr. 1B

Aquatic Acute 1
H225

H330

H311

H301

H314

H400
GHS02

GHS06

GHS05

GHS09

Dgr
H225

H330

H311

H301

H314

H400
D
605-009-00-9crotonaldehyde;

2-butenal; [1]

(E)-2-butenal;

(E)-crotonaldehyde [2]
224-030-0 [1]

204-647-1 [2]
4170-30-3 [1]

123-73-9 [2]
Flam. Liq. 2

Muta. 2

Acute Tox. 2 *

Acute Tox. 3 *

Acute Tox. 3 *

STOT RE 2 *

STOT SE 3

Skin Irrit. 2

Eye Dam. 1

Aquatic Acute 1
H225

H341

H330

H311

H301

H373 **

H335

H315

H318

H400
GHS02

GHS06

GHS08

GHS05

GHS09

Dgr
H225

H341

H330

H311

H301

H373 **

H335

H315

H318

H400
605-010-00-42-furaldehyde202-627-798-01-1Carc. 2

Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 4 *

Eye Irrit. 2

STOT SE 3
H351

H331

H301

H312

H319

H335
GHS06

GHS08

Dgr
H351

H331

H301

H312

H319

H335
*
605-011-00-X2-chlorobenzaldehyde;

o-chlorobenzaldehyde
201-956-389-98-5Skin Corr. 1BH314GHS05

Dgr
H314
605-012-00-5benzaldehyde202-860-4100-52-7Acute Tox. 4 *H302GHS07

Wng
H302
605-013-00-0chloralose (INN);

(R)-1,2-O-(2,2,2-trichloroethylidene)-α-D-glucofuranose;

glucochloralose;

anhydroglucochloral
240-016-715879-93-3Acute Tox. 4 *

Acute Tox. 4 *
H332

H302
GHS07

Wng
H332

H302
605-014-00-6chloral hydrate;

2,2,2-trichloroethane-1,1-diol
206-117-5302-17-0Acute Tox. 3 *

Eye Irrit. 2

Skin Irrit. 2
H301

H319

H315
GHS06

Dgr
H301

H319

H315
605-015-00-11,1-diethoxyethane;

acetal
203-310-6105-57-7Flam. Liq. 2

Eye Irrit. 2

Skin Irrit. 2
H225

H319

H315
GHS02

GHS07

Dgr
H225

H319

H315
605-016-00-7glyoxal...%;

ethandial...%
203-474-9107-22-2Muta. 2

Acute Tox. 4 *

Eye Irrit. 2

Skin Irrit. 2

Skin Sens. 1
H341

H332

H319

H315

H317
GHS07

GHS08

Wng
H341

H332

H319

H315

H317
*B
605-017-00-21,3-dioxolane211-463-5646-06-0Flam. Liq. 2H225GHS02

Dgr
H225
605-018-00-8propanal;

propionaldehyde
204-623-0123-38-6Flam. Liq. 2

Eye Irrit. 2

STOT SE 3

Skin Irrit. 2
H225

H319

H335

H315
GHS02

GHS07

Dgr
H225

H319

H335

H315
605-019-00-3citral226-394-65392-40-5Skin Irrit. 2

Skin Sens. 1
H315

H317
GHS07

Wng
H315

H317
605-020-00-9safrole;

5-allyl-1,3-benzodioxole
202-345-494-59-7Carc. 1B

Muta. 2

Acute Tox. 4 *
H350

H341

H302
GHS08

GHS07

Dgr
H350

H341

H302
605-021-00-4formaldehyde, reaction products with butylphenol294-145-991673-30-2Skin Sens. 1H317GHS07

Wng
H317
605-022-00-Xglutaral;

glutaraldehyde;

1,5-pentanedial
203-856-5111-30-8Acute Tox. 3 *

Acute Tox. 3 *

Skin Corr. 1B

Resp. Sens. 1

Skin Sens. 1

Aquatic Acute 1
H331

H301

H314

H334

H317

H400
GHS06

GHS08

GHS05

GHS09

Dgr
H331

H301

H314

H334

H317

H400
*

Skin Corr. 1B; H314: C ≥ 10 %

Skin Irrit. 2; H315: 0,5 % ≤ C < 10 %

Eye Dam. ; H318: 2 % ≤ C < 10 %

Eye Irrit. 2; H319: 0,5 % ≤ C < 2 %

STOT SE; H335: C ≥ 0,5 %

Skin Sens. 1; H317: C ≥ 0,5 %
605-025-00-6chloroacetaldehyde203-472-8107-20-0Carc. 2

Acute Tox. 2 *

Acute Tox. 3 *

Acute Tox. 3 *

Skin Corr. 1B

Aquatic Acute 1
H351

H330

H311

H301

H314

H400
GHS06

GHS08

GHS05

GHS09

Dgr
H351

H330

H311

H301

H314

H400
STOT SE 3; H335: C ≥ 5 %
605-026-00-12,5,7,7-tetramethyloctanal405-690-0114119-97-0Skin Irrit. 2

Skin Sens. 1

Aquatic Chronic 2
H315

H317

H411
GHS07 GHS09

Wng
H315

H317

H411
605-027-00-7reaction mass of: 3a,4,5,6,7,7a-hexahydro-4,7-methano-1H-indene-6-carboxaldehyde;

3a,4,5,6,7,7a-hexahydro-4,7-methano-1H-indene-5-carboxaldehyde
410-480-7Skin Sens. 1

Aquatic Chronic 2
H317

H411
GHS07

GHS09

Wng
H317

H411
605-028-00-2β-methyl-3-(1-methylethyl)-benzenepropanal412-050-4125109-85-5Aquatic Chronic 2H411GHS09H411
605-029-00-82-cyclohexylpropanal412-270-02109-22-0Skin Sens. 1

Aquatic Chronic 2
H317

H411
GHS07

GHS09

Wng
H317

H411
605-030-00-31-(p-methoxyphenyl)acetaldehyde oxime411-510-13353-51-3Skin Sens. 1H317GHS07

Wng
H317
605-031-00-9reaction mass of: 2,2-dimethoxyethanal [this component is considered to be anhydrous in terms of identity, structure and composition. However, 2,2-dimethoxyethanal will exist in a hydrated form. 60 % anhydrous is equivalent to 70,4 % hydrate;

water(Including free water and water in hydrated 2,2-dimethoxyethanal)]
421-890-0Skin Sens. 1H317GHS07

Wng
H317
606-001-00-8acetone;

propan-2-one;

propanone
200-662-267-64-1Flam. Liq. 2

Eye Irrit. 2

STOT SE 3
H225

H319

H336
GHS02

GHS07

Dgr
H225

H319

H336
EUH066
606-002-00-3butanone;

ethyl methyl ketone
201-159-078-93-3Flam. Liq. 2

Eye Irrit. 2

STOT SE 3
H225

H319

H336
GHS02

GHS07

Dgr
H225

H319

H336
EUH066
606-003-00-9heptan-3-one;

butyl ethyl ketone
203-388-1106-35-4Flam. Liq. 3

Acute Tox. 4 *

Eye Irrit. 2
H226

H332

H319
GHS02

GHS07

Wng
H226

H332

H319
606-004-00-44-methylpentan-2-one;

isobutyl methyl ketone
203-550-1108-10-1Flam. Liq. 2

Acute Tox. 4 *

Eye Irrit. 2

STOT SE 3
H225

H332

H319

H335
GHS02

GHS07

Dgr
H225

H332

H319

H335
EUH066
606-005-00-X2,6-dimethylheptan-4-one;

di-isobutyl ketone
203-620-1108-83-8Flam. Liq. 3

STOT SE 3
H226

H335
GHS02

GHS07

Wng
H226

H335
STOT SE 3; H335: C ≥ 10 %
606-006-00-5pentan-3-one;

diethyl ketone
202-490-396-22-0Flam. Liq. 2

STOT SE 3

STOT SE 3
H225

H335

H336
GHS02

GHS07

Dgr
H225

H335

H336
EUH066
606-007-00-03-methylbutan-2-one;

methyl isopropyl ketone
209-264-3563-80-4Flam. Liq. 2H225GHS02

Dgr
H225
606-009-00-14-methylpent-3-en-2-one;

mesityl oxide
205-502-5141-79-7Flam. Liq. 3

Acute Tox. 4 *

Acute Tox. 4 *

Acute Tox. 4 *
H226

H332

H312

H302
GHS02

GHS07

Wng
H226

H332

H312

H302
*
606-010-00-7cyclohexanone203-631-1108-94-1Flam. Liq. 3

Acute Tox. 4 *
H226

H332
GHS02

GHS07

Wng
H226

H332
606-011-00-22-methylcyclohexanone209-513-6583-60-8Flam. Liq. 3

Acute Tox. 4 *
H226

H332
GHS02

GHS07

Wng
H226

H332
606-012-00-83,5,5-trimethylcyclohex-2-enone;

isophorone
201-126-078-59-1Carc. 2

Acute Tox. 4 *

Acute Tox. 4 *

Eye Irrit. 2

STOT SE 3
H351

H312

H302

H319

H335
GHS08

GHS07

Wng
H351

H312

H302

H319

H335
STOT SE 3; H335: C ≥ 10 %
606-013-00-3p-benzoquinone;

quinone
203-405-2106-51-4Acute Tox. 3 *

Acute Tox. 3 *

Eye Irrit. 2

STOT SE 3

Skin Irrit. 2

Aquatic Acute 1
H331

H301

H319

H335

H315

H400
GHS06

GHS09

Dgr
H331

H301

H319

H335

H315

H400
606-014-00-9chlorophacinone (ISO);

2-(2-(4-chlorophenyl)phenylacetyl)indan-1,3-dione
223-003-03691-35-8Acute Tox. 1

Acute Tox. 2 *

Acute Tox. 3 *

STOT RE 1

Aquatic Acute 1

Aquatic Chronic 1
H310

H300

H331

H372 **

H400

H410
GHS06

GHS08

GHS09

Dgr
H310

H300

H331

H372 **

H410
606-016-00-Xpindone (ISO);

2-pivaloylindan-1,3-dione
201-462-883-26-1Acute Tox. 3 *

STOT RE 1

Aquatic Acute 1

Aquatic Chronic 1
H301

H372 **

H400

H410
GHS06

GHS08

GHS09

Dgr
H301

H372 **

H410
606-017-00-5diketene;

diketen
211-617-1674-82-8Flam. Liq. 3

Acute Tox. 4 *
H226

H332
GHS02

GHS07

Wng
H226

H332
D
606-018-00-0dichlone (ISO);

2,3-dichloro-1,4-naphthoquinone
204-210-5117-80-6Acute Tox. 4 *

Eye Irrit. 2

Skin Irrit. 2

Aquatic Acute 1

Aquatic Chronic 1
H302

H319

H315

H400

H410
GHS07

GHS09

Wng
H302

H319

H315

H410
606-019-00-6chlordecone (ISO);

perchloropentacyclo[5,3,0,02,6,03,9,04,8]decan-5-one;

decachloropentacyclo[5,2,1,02,6,03,9,05,8]decan-4-one
205-601-3143-50-0Carc. 2

Acute Tox. 3 *

Acute Tox. 3 *

Aquatic Acute 1

Aquatic Chronic 1
H351

H311

H301

H400

H410
GHS06

GHS08

GHS09

Dgr
H351

H311

H301

H410
606-020-00-15-methylheptan-3-one208-793-7541-85-5Flam. Liq. 3

Eye Irrit. 2

STOT SE 3
H226

H319

H335
GHS02

GHS07

Wng
H226

H319

H335
STOT SE 3; H335: C ≥ 10 %
606-021-00-7N-methyl-2-pyrrolidone212-828-1872-50-4Eye Irrit. 2

Skin Irrit. 2
H319

H315
GHS07

Wng
H319

H315
606-022-00-21-phenyl-3-pyrazolidone202-155-192-43-3Acute Tox. 4 *

Aquatic Chronic 2
H302

H411
GHS07

GHS09

Wng
H302

H411
606-023-00-84-methoxy-4-methylpentan-2-one203-512-4107-70-0Flam. Liq. 3

Acute Tox. 4 *
H226

H332
GHS02

GHS07

Wng
H226

H332
606-024-00-3heptan-2-one;

methyl amyl ketone
203-767-1110-43-0Flam. Liq. 3

Acute Tox. 4 *

Acute Tox. 4 *
H226

H332

H302
GHS02

GHS07

Wng
H226

H332

H302
606-025-00-9cyclopentanone204-435-9120-92-3Flam. Liq. 3

Eye Irrit. 2

Skin Irrit. 2
H226

H319

H315
GHS02

GHS07

Wng
H226

H319

H315
606-026-00-45-methylhexan-2-one;

isoamyl methyl ketone
203-737-8110-12-3Flam. Liq. 3

Acute Tox. 4 *
H226

H332
GHS02

GHS07

Wng
H226

H332
606-027-00-Xheptan-4-one;

di-n-propyl ketone
204-608-9123-19-3Flam. Liq. 3

Acute Tox. 4 *
H226

H332
GHS02

GHS07

Wng
H226

H332
606-028-00-52,4-dimethylpentan-3-one;

di-isopropyl ketone
209-294-7565-80-0Flam. Liq. 2

Acute Tox. 4 *
H225

H332
GHS02

GHS07

Dgr
H225

H332
606-029-00-0pentane-2,4-dione;

acetylacetone
204-634-0123-54-6Flam. Liq. 3

Acute Tox. 4 *
H226

H302
GHS02

GHS07

Wng
H226

H302
606-030-00-6hexan-2-one;

methyl butyl ketone;

butyl methyl ketone;

methyl-n-butyl ketone
209-731-1591-78-6Flam. Liq. 3

Repr. 2

STOT RE 1

STOT SE 3
H226

H361f ***

H372 **

H336
GHS02

GHS08

GHS07

Dgr
H226

H361f ***

H372 **

H336
606-031-00-13-propanolide;

1,3-propiolactone
200-340-157-57-8Carc. 1B

Acute Tox. 2 *

Eye Irrit. 2

Skin Irrit. 2
H350

H330

H319

H315
GHS06

GHS08

Dgr
H350

H330

H319

H315
606-032-00-7hexachloroacetone204-129-5116-16-5Acute Tox. 4 *

Aquatic Chronic 2
H302

H411
GHS07

GHS09

Wng
H302

H411
606-033-00-22-(3,4-dichlorophenyl)-4-methyl-1,2,4-oxadiazolidinedione;

methazole
243-761-620354-26-1Acute Tox. 4 *

Acute Tox. 4 *

Eye Irrit. 2

Skin Irrit. 2

Aquatic Chronic 2
H312

H302

H319

H315

H411
GHS07

GHS09

Wng
H312

H302

H319

H315

H411
606-034-00-8metribuzin (ISO);

4-amino-6-tert-butyl-3-methylthio-1,2,4-triazin-5(4H)-one;

4-amino-4,5-dihydro-6-(1,1-dimethylethyl)-3-methylthio-1,2,4-triazin-5-one
244-209-721087-64-9Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1
H302

H400

H410
GHS07

GHS09

Wng
H302

H410
606-035-00-3chloridazon (ISO);

5-amino-4-chloro-2-phenylpyridazine-3-(2H)-one;

pyrazon
216-920-21698-60-8Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H317

H400

H410
GHS07

GHS09

Wng
H317

H410
606-036-00-9quinomethionate;

chinomethionat (ISO);

6-methyl-1,3-dithiolo(4,5-b)quinoxalin-2-one
219-455-32439-01-2Repr. 2

Acute Tox. 4 *

Acute Tox. 4 *

Acute Tox. 4 *

STOT RE 2 *

Eye Irrit. 2

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H361f ***

H332

H312

H302

H373 **

H319

H317

H400

H410
GHS08

GHS07

GHS09

Wng
H361f ***

H332

H312

H302

H373 **

H319

H317

H410
606-037-00-4triadimefon (ISO);

1-(4-chlorophenoxy)-3,3-dimethyl-1-(1,2,4-triazol-1-yl)butanone
256-103-843121-43-3Acute Tox. 4 *

Skin Sens. 1

Aquatic Chronic 2
H302

H317

H411
GHS07

GHS09

Wng
H302

H317

H411
606-038-00-Xdiphacinone (ISO);

2-diphenylacetylindan-1,3-dione
201-434-582-66-6Acute Tox. 2 *

STOT RE 1
H300

H372 **
GHS06

GHS08

Dgr
H300

H372 **
606-039-00-55(or 6)-tert-butyl-2'-chloro-6'-ethylamino-3',7'-dimethylspiro(isobenzofuran-1(1H),9'-xanthene)-3-one400-680-2Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1
H332

H400

H410
GHS07

GHS09

Wng
H332

H410
606-040-00-0(N-benzyl-N-ethyl)amino-3-hydroxyacetophenone hydrochloride401-840-455845-90-4Eye Dam. 1

Aquatic Chronic 2
H318

H411
GHS05

GHS09

Dgr
H318

H411
606-041-00-62-methyl-1-(4-methylthiophenyl)-2-morpholinopropan-1-one400-600-671868-10-5Acute Tox. 4 *

Aquatic Chronic 2
H302

H411
GHS07

GHS09

Wng
H302

H411
606-042-00-1acetophenone202-708-798-86-2Acute Tox. 4 *

Eye Irrit. 2
H302

H319
GHS07

Wng
H302

H319
606-043-00-72,4-di-tert-butylcyclohexanone405-340-713019-04-0Skin Irrit. 2

Aquatic Chronic 2
H315

H411
GHS07

GHS09

Wng
H315

H411
606-044-00-22,4,6-trimethylbenzophenone403-150-9954-16-5Acute Tox. 4 *

Eye Irrit. 2

Aquatic Acute 1

Aquatic Chronic 1
H302

H319

H400

H410
GHS07

GHS09

Wng
H302

H319

H410
606-045-00-8oxadiazon (ISO);

3-[2,4-dichloro-5-(1-methylethoxy)phenyl]-5-(1,1-dimethylethyl)-1,3,4-oxadiazol-2(3H)-one
243-215-719666-30-9Aquatic Acute 1

Aquatic Chronic 1
H400

H410
GHS09

Wng
H410
606-046-00-3reaction mass of cis- and trans-cyclohexadec-8-en-1-one401-700-23100-36-5Aquatic Acute 1

Aquatic Chronic 1
H400

H410
GHS09

Wng
H410
606-047-00-92-benzyl-2-dimethylamino-4-morpholinobutyrophenone404-360-3119313-12-1Aquatic Acute 1

Aquatic Chronic 1
H400

H410
GHS09

Wng
H410
606-048-00-42'-anilino-3'-methyl-6'-dipentylaminospiro(isobenzofuran-1(1H),9'-xanthen)-3-one406-480-1Aquatic Chronic 4H413H413
606-049-00-X4-(trans-4-propylcyclohexyl)acetophenone406-700-678531-61-0Skin Sens. 1

Aquatic Chronic 4
H317

H413
GHS07

Wng
H317

H413
606-050-00-56-anilino-1-benzoyl-4-(4-tert-pentylphenoxy)naphto[1,2,3-de]quinoline-2,7-(3H)-dione412-480-272453-58-8Aquatic Chronic 2H411GHS09H411
606-051-00-04-pentylcyclohexanone406-670-461203-83-6Aquatic Chronic 2H411GHS09H411
606-052-00-64-(N,N-dibutylamino)-2-hydroxy-2'-carboxybenzophenone410-410-554574-82-2Aquatic Chronic 3H412H412
606-053-00-1flurtamone (ISO);

(RS)-5-methylamino-2-phenyl-4-(α,α,α-trifluoro-m-tolyl)furan-3(2H)-one
96525-23-4Aquatic Acute 1

Aquatic Chronic 1
H400

H410
GHS09

Wng
H410
606-054-00-7isoxaflutole (ISO);

5-cyclopropyl-1,2-oxazol-4-yl α,α,α-trifluoro-2-mesyl-p-tolyl ketone
141112-29-0Repr. 2

Aquatic Acute 1

Aquatic Chronic 1
H361d ***

H400

H410
GHS08

GHS09

Wng
H361d ***

H410
606-055-00-21-(2,3-dihydro-1,3,3,6-tetramethyl-1-(1-methylethyl)-1H-inden-5-yl)ethanone411-180-992836-10-7Acute Tox. 4 *

STOT RE 2 *

Aquatic Chronic 2
H302

H373 **

H411
GHS08

GHS07

GHS09

Wng
H302

H373 **

H411
606-056-00-84-chloro-3',4'-dimethoxybenzophenone404-610-1116412-83-0Aquatic Acute 1

Aquatic Chronic 1
H400

H410
GHS09

Wng
H410
606-057-00-34-propylcyclohexanone406-810-440649-36-3Skin Irrit. 2

Aquatic Chronic 3
H315

H412
GHS07

Wng
H315

H412
606-058-00-94'-fluoro-2,2-dimethoxyacetophenone407-500-121983-80-2Skin Sens. 1

Aquatic Chronic 3
H317

H412
GHS07

Wng
H317

H412
606-059-00-42,4-difluoro-α-(1H-1,2,4-triazol-1-yl)acetophenone hydrochloride412-390-386386-75-6Acute Tox. 4 *

Eye Dam. 1

Skin Sens. 1
H302

H318

H317
GHS05

GHS07

Dgr
H302

H318

H317
606-060-00-Xreaction mass of: trans-2,4-dimethyl-2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-naphthalene-2-yl)-1,3-dioxolane;

cis-2,4-dimethyl-2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-naphthalene-2-yl)-1,3-dioxolane
412-950-7Aquatic Acute 1

Aquatic Chronic 1
H400

H410
GHS09

Wng
H410
606-061-00-5(3-chlorophenyl)-(4-methoxy-3-nitrophenyl)methanone423-290-466938-41-8Muta. 2

Aquatic Acute 1

Aquatic Chronic 1
H341

H400

H410
GHS08

GHS09

Wng
H341

H410
606-062-00-0tetrahydrothiopyran-3-carboxaldehyde407-330-861571-06-0Repr. 1B

Eye Dam. 1

Aquatic Chronic 3
H360D ***

H318

H412
GHS08

GHS05

Dgr
H360D ***

H318

H412
606-063-00-6(E)-3-(2-chlorophenyl)-2-(4-fluorophenyl)propenal410-980-5112704-51-5Eye Irrit. 2

Skin Sens. 1
H319

H317
GHS07

Wng
H319

H317
606-064-00-1pregn-5-ene-3,20-dione bis(ethylene ketal)407-450-07093-55-2Aquatic Chronic 4H413H413
606-065-00-71-(4-morpholinophenyl)butan-1-one413-790-0Aquatic Chronic 2H411GHS09H411
606-066-00-2(E)-5[(4-chlorophenyl)methylene]-2,2-dimethylcyclopentanone410-440-9164058-20-2Aquatic Chronic 2H411GHS09H411
606-067-00-8reaction mass of: 1-(2,3,6,7,8,9-hexahydro-1,1-dimethyl-1H-benz(g)inden-4-yl)ethanone;

1-(2,3,5,6,7,8-hexahydro-1,1-dimethyl-1H-benz(f)inden-4-yl)ethanone;

1-(2,3,6,7,8,9-hexahydro-1,1-dimethyl-1H-benz(g)inden-5-yl)ethanone;

1-(2,3,6,7,8,9-hexahydro-3,3-dimethyl-1H-benz(g)inden-5-yl)ethanone
414-870-896792-67-5Aquatic Acute 1

Aquatic Chronic 1
H400

H410
GHS09

Wng
H410
606-068-00-32,7,11-trimethyl-13-(2,6,6-trimethylcyclohex-1-en-1-yl)tridecahexaen-2,4,6,8,10,12-al415-770-71638-05-7STOT RE 2 *

Skin Sens. 1

Aquatic Chronic 3
H373 **

H317

H412
GHS08

GHS07

Wng
H373 **

H317

H412
606-069-00-9spiro[1,3-dioxolane-2,5'-(4',4',8',8'-tetramethyl-hexahydro-3',9'-methanonaphthalene)]415-460-1154171-76-3Aquatic Chronic 2H411GHS09H411
606-070-00-4butroxydim (ISO);

5-(3-butyryl-2,4,6-trimethylphenyl)-2-[1-(ethoxyimino)propyl]-3-hydroxycyclohex-2-en-1-one
414-790-3138164-12-2Repr. 2

Acute Tox. 4 *

Skin Irrit. 2

Aquatic Acute 1

Aquatic Chronic 1
H361fd

H302

H315

H400

H410
GHS08

GHS07

GHS09

Wng
H361fd

H302

H315

H410
606-071-00-X17-spiro(5,5-dimethyl-1,3-dioxan-2-yl)androsta-1,4-diene-3-one421-050-313258-43-0Aquatic Acute 1

Aquatic Chronic 1
H400

H410
GHS09

Wng
H410
606-072-00-53-acetyl-1-phenyl-pyrrolidine-2,4-dione421-600-2719-86-8STOT RE 2 *

Aquatic Chronic 2
H373 **

H411
GHS08

GHS09

Wng
H373 **

H411
606-073-00-04,4'-bis(dimethylamino)benzophenone;

Michler's ketone
202-027-590-94-8Carc. 1B

Muta. 2

Eye Dam. 1
H350

H341

H318
GHS08

GHS05

Dgr
H350

H341

H318
606-075-00-11-benzyl-5-ethoxyimidazolidine-2,4-dione417-340-465855-02-9Acute Tox. 4 *H302GHS07

Wng
H302
606-076-00-71-((2-quinolinyl-carbonyl)oxy)-2,5-pyrrolidinedione418-630-3136465-99-1Eye Dam. 1

Skin Sens. 1
H318

H317
GHS05

GHS07

Dgr
H318

H317
606-077-00-2(3S,4S)-3-hexyl-4-[(R)-2-hydroxytridecyl]-2-oxetanone418-650-2104872-06-2Aquatic Acute 1

Aquatic Chronic 1
H400

H410
GHS09

Wng
H410
606-078-00-81-octylazepin-2-one420-040-659227-88-2Skin Corr. 1B

Skin Sens. 1

Aquatic Chronic 2
H314

H317

H411
GHS05

GHS07

GHS09

Dgr
H314

H317

H411
606-079-00-32-n-butyl-benzo[d]isothiazol-3-one420-590-74299-07-4Skin Corr. 1B

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H314

H317

H400

H410
GHS05

GHS07

GHS09

Dgr
H314

H317

H410
606-080-00-9Reaction product of: 3-hydroxy-5,7-di-tert-butylbenzofuran-2-one with o-xylene417-100-9Aquatic Chronic 4H413H413
606-081-00-4(3β, 5α, 6β)-3-(acetyloxy)-5-bromo-6-hydroxy-androstan-17-one419-790-74229-69-0Skin Sens. 1

Aquatic Chronic 3
H317

H412
GHS07

Wng
H317

H412
606-082-00-Xreaction mass of: butan-2-one oxime;

syn-O,O'-di(butan-2-one oxime)diethoxysilane
406-930-7STOT RE 1

Skin Sens. 1

Aquatic Chronic 3
H372 **

H317

H412
GHS08

GHS07

Dgr
H372 **

H317

H412
606-083-00-52-chloro-5-sec-hexadecylhydroquinone407-750-1137193-60-3Eye Irrit. 2

Skin Irrit. 2

Skin Sens. 1

Aquatic Chronic 3
H319

H315

H317

H412
GHS07

Wng
H319

H315

H317

H412
606-084-00-01-(4-methoxy-5-benzofuranyl)-3-phenyl-1,3-propanedione414-540-3484-33-3Aquatic Acute 1

Aquatic Chronic 1
H400

H410
GHS09

Wng
H410
606-085-00-6(1R,4S)-2-azabicyclo[2.2.1]hept-5-en-3-one418-530-179200-56-9Acute Tox. 4 *

Eye Dam. 1

Skin Sens. 1
H302

H318

H317
GHS05

GHS07

Dgr
H302

H318

H317
606-086-00-11-(3,3-dimethylcyclohexyl)pent-4-en-1-one422-330-856973-87-6Aquatic Chronic 2H411GHS09H411
606-087-00-76-ethyl-5-fluoro-4(3H)-pyrimidone422-460-5137234-87-8Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1
H302

H400

H410
GHS07

GHS09

Wng
H302

H410
606-088-00-22,4,4,7-tetramethyl-6-octen-3-one422-520-074338-72-0Skin Irrit. 2

Aquatic Chronic 2
H315

H411
GHS07

GHS09

Wng
H315

H411
606-089-00-8reaction mass of: 1,4-diamino-2-chloro-3-phenoxyanthraquinone;

1,4-diamino-2,3-bis-phenoxyanthraquinone
423-220-212223-77-7Aquatic Chronic 4H413H413
606-091-00-96-chloro-5-(2-chloroethyl)-1,3-dihydroindol-2-one421-320-0118289-55-7Aquatic Acute 1

Aquatic Chronic 1
H400

H410
GHS09

Wng
H410
606-092-00-4reaction mass of: (E)-oxacyclohexadec-12-en-2-one;

(E)-oxacyclohexadec-13-en-2-one;

a) (Z)-oxacyclohexadec-(12)-en-2-one and b) (Z)-oxacyclohexadec-(13)-en-2-one
422-320-3Aquatic Acute 1

Aquatic Chronic 1
H400

H410
GHS09

Wng
H410
607-001-00-0formic acid ... %200-579-164-18-6Skin Corr. 1AH314GHS05

Dgr
H314Skin Corr. 1A; H314: C ≥ 90 %

Skin Corr. 1B; H314: 10 % ≤ C < 90 %

Skin Irrit. 2; H315: 2 % ≤ C < 10 %

Eye Irrit. 2; H319: 2 % ≤ C < 10 %
B
607-002-00-6acetic acid ... %200-580-764-19-7Flam. Liq. 3

Skin Corr. 1A
H226

H314
GHS02

GHS05

Dgr
H226

H314
Skin Corr. 1A; H314: C ≥ 90 %

Skin Corr. 1B; H314: 25 % ≤ C < 90 %

Skin Irrit. 2; H315: 10 % ≤ C < 25 %

Eye Irrit. 2; H319: 10 % ≤ C < 25 %
B
607-003-00-1chloroacetic acid201-178-479-11-8Acute Tox. 3 *

Skin Corr. 1B

Aquatic Acute 1
H301

H314

H400
GHS06

GHS05

GHS09

Dgr
H301

H314

H400
607-004-00-7TCA (ISO);

trichloroacetic acid
200-927-276-03-9Skin Corr. 1A

Aquatic Acute 1

Aquatic Chronic 1
H314

H400

H410
GHS05

GHS09

Dgr
H314

H410
STOT SE 3; H335: C ≥ 1 %
607-005-00-2TCA-sodium (ISO);

sodium trichloroacetate
211-479-2650-51-1STOT SE 3

Aquatic Acute 1

Aquatic Chronic 1
H335

H400

H410
GHS07

GHS09

Wng
H335

H410
607-006-00-8oxalic acid205-634-3144-62-7Acute Tox. 4 *

Acute Tox. 4 *
H312

H302
GHS07

Wng
H312

H302
*
607-007-00-3salts of oxalic acidAcute Tox. 4 *

Acute Tox. 4 *
H312

H302
GHS07

Wng
H312

H302
*A
607-008-00-9acetic anhydride203-564-8108-24-7Flam. Liq. 3

Acute Tox. 4 *

Acute Tox. 4 *

Skin Corr. 1B
H226

H332

H302

H314
GHS02

GHS05

GHS07

Dgr
H226

H332

H302

H314
Skin Corr. 1B; H314: C ≥ 25 %

Skin Irrit. 2; H315: 5 % ≤ C < 25 %

Eye Dam. 1; H318: 5 % ≤ C < 25 %

Eye Irrit. 2; H319: 1 % ≤ C < 5 %

STOT SE 3; H335: C ≥ 5 %
607-009-00-4phthalic anhydride201-607-585-44-9Acute Tox. 4 *

STOT SE 3

Skin Irrit. 2

Eye Dam. 1

Resp. Sens. 1

Skin Sens. 1
H302

H335

H315

H318

H334

H317
GHS08

GHS05

GHS07

Dgr
H302

H335

H315

H318

H334

H317
607-010-00-Xpropionic anhydride204-638-2123-62-6Skin Corr. 1BH314GHS05

Dgr
H314Skin Corr. 1B; H314: C ≥ 25 %

Skin Irrit. 2; H315: 10 % ≤ C < 25 %

Eye Irrit. 2; H319: 10 % ≤ C < 25 %
607-011-00-5acetyl chloride200-865-675-36-5Flam. Liq. 2

Skin Corr. 1B
H225

H314
GHS02

GHS05

Dgr
H225

H314
EUH014
607-012-00-0benzoyl chloride202-710-898-88-4Skin Corr. 1BH314GHS05

Dgr
H314
607-013-00-6dimethyl carbonate210-478-4616-38-6Flam. Liq. 2H225GHS02

Dgr
H225
607-014-00-1methyl formate203-481-7107-31-3Flam. Liq. 1

Acute Tox. 4 *

Acute Tox. 4 *

Eye Irrit. 2

STOT SE 3
H224

H332

H302

H319

H335
GHS02

GHS07

Dgr
H224

H332

H302

H319

H335
607-015-00-7ethyl formate203-721-0109-94-4Flam. Liq. 2

Acute Tox. 4 *

Acute Tox. 4 *

Eye Irrit. 2

STOT SE 3
H225

H332

H302

H319

H335
GHS02

GHS07

Dgr
H225

H332

H302

H319

H335
607-016-00-2propyl formate; [1]

isopropyl formate [2]
203-798-0 [1]

210-901-2 [2]
110-74-7 [1]

625-55-8 [2]
Flam. Liq. 2

Eye Irrit. 2

STOT SE 3

STOT SE 3
H225

H319

H335

H336
GHS02

GHS07

Dgr
H225

H319

H335

H336
C
607-017-00-8butyl formate; [1]

tert-butyl formate; [2]

isobutyl formate [3]
209-772-5 [1]

212-105-0 [2]

208-818-1 [3]
592-84-7 [1]

762-75-4 [2]

542-55-2 [3]
Flam. Liq. 2

Eye Irrit. 2

STOT SE 3
H225

H319

H335
GHS02

GHS07

Dgr
H225

H319

H335
C
607-018-00-3isopentyl formate; [1]

2-methylbutyl formate [2]
203-769-2 [1]

252-343-2 [2]
110-45-2 [1]

35073-27-9 [2]
Flam. Liq. 2

Eye Irrit. 2

STOT SE 3
H225

H319

H335
GHS02

GHS07

Dgr
H225

H319

H335
C
607-019-00-9methyl chloroformate201-187-379-22-1Flam. Liq. 2

Acute Tox. 2 *

Acute Tox. 4 *

Acute Tox. 4 *

Skin Corr. 1B
H225

H330

H312

H302

H314
GHS02

GHS06

GHS05

Dgr
H225

H330

H312

H302

H314
607-020-00-4ethyl chloroformate208-778-5541-41-3Flam. Liq. 2

Acute Tox. 2 *

Acute Tox. 4 *

Skin Corr. 1B
H225

H330

H302

H314
GHS02

GHS06

GHS05

Dgr
H225

H330

H302

H314
607-021-00-Xmethyl acetate201-185-279-20-9Flam. Liq. 2

Eye Irrit. 2

STOT SE 3
H225

H319

H336
GHS02

GHS07

Dgr
H225

H319

H336
EUH066
607-022-00-5ethyl acetate205-500-4141-78-6Flam. Liq. 2

Eye Irrit. 2

STOT SE 3
H225

H319

H336
GHS02

GHS07

Dgr
H225

H319

H336
EUH066
607-023-00-0vinyl acetate203-545-4108-05-4Flam. Liq. 2H225GHS02

Dgr
H225D
607-024-00-6propyl acetate; [1]

isopropyl acetate [2]
203-686-1 [1]

203-561-1 [2]
109-60-4 [1]

108-21-4 [2]
Flam. Liq. 2

Eye Irrit. 2

STOT SE 3
H225

H319

H336
GHS02

GHS07

Dgr
H225

H319

H336
EUH066C
607-025-00-1n-butyl acetate204-658-1123-86-4Flam. Liq. 3

STOT SE 3
H226

H336
GHS02

GHS07

Wng
H226

H336
EUH066
607-026-00-7sec-butyl acetate; [1]

isobutyl acetate; [2]

tert-butyl acetate [3]
203-300-1 [1]

203-745-1 [2]

208-760-7 [3]
105-46-4 [1]

110-19-0 [2]

540-88-5 [3]
Flam. Liq. 2H225GHS02

Dgr
H225EUH066C
607-027-00-2methyl propionate209-060-4554-12-1Flam. Liq. 2

Acute Tox. 4 *
H225

H332
GHS02

GHS07

Dgr
H225

H332
607-028-00-8ethyl propionate203-291-4105-37-3Flam. Liq. 2H225GHS02

Dgr
H225
607-029-00-3n-butyl propionate; [1]

sec-butyl propionate; [2]

iso-butyl propionate [3]
209-669-5 [1]

- [2]

208-746-0 [3]
590-01-2 [1]

591-34-4 [2]

540-42-1 [3]
Flam. Liq. 3H226GHS02

Wng
H226C
607-030-00-9propyl propionate203-389-7106-36-5Flam. Liq. 3

Acute Tox. 4 *
H226

H332
GHS02

GHS07

Wng
H226

H332
607-031-00-4butyl butyrate203-656-8109-21-7Flam. Liq. 3H226GHS02

Wng
H226C
607-032-00-Xethyl acrylate205-438-8140-88-5Flam. Liq. 2

Acute Tox. 4 *

Acute Tox. 4 *

Acute Tox. 4 *

Eye Irrit. 2

STOT SE 3

Skin Irrit. 2

Skin Sens. 1
H225

H332

H312

H302

H319

H335

H315

H317
GHS02

GHS07

Dgr
H225

H332

H312

H302

H319

H335

H315

H317
Skin Irrit. 2; H315: C ≥ 5 %

Eye Irrit. 2; H319: C ≥ 5 %

STOT SE 3; H335: C ≥ 5 %
D
607-033-00-5n-butyl methacrylate202-615-197-88-1Flam. Liq. 3

Eye Irrit. 2

STOT SE 3

Skin Irrit. 2

Skin Sens. 1
H226

H319

H335

H315

H317
GHS02

GHS07

Wng
H226

H319

H335

H315

H317
D
607-034-00-0methyl acrylate;

methyl propenoate
202-500-696-33-3Flam. Liq. 2

Acute Tox. 4 *

Acute Tox. 4 *

Acute Tox. 4 *

Eye Irrit. 2

STOT SE 3

Skin Irrit. 2

Skin Sens. 1
H225

H332

H312

H302

H319

H335

H315

H317
GHS02

GHS07

Dgr
H225

H332

H312

H302

H319

H335

H315

H317
D
607-035-00-6methyl methacrylate;

methyl 2-methylprop-2-enoate;

methyl 2-methylpropenoate
201-297-180-62-6Flam. Liq. 2

STOT SE 3

Skin Irrit. 2

Skin Sens. 1
H225

H335

H315

H317
GHS02

GHS07

Dgr
H225

H335

H315

H317
D
607-036-00-12-methoxyethyl acetate;

methylglycol acetate
203-772-9110-49-6Repr. 1B

Acute Tox. 4 *

Acute Tox. 4 *

Acute Tox. 4 *
H360FD

H332

H312

H302
GHS08

GHS07

Dgr
H360FD

H332

H312

H302
607-037-00-72-ethoxyethyl acetate;

ethylglycol acetate
203-839-2111-15-9Repr. 1B

Acute Tox. 4 *

Acute Tox. 4 *

Acute Tox. 4 *
H360FD

H332

H312

H302
GHS08

GHS07

Dgr
H360FD

H332

H312

H302
607-038-00-22-butoxyethyl acetate;

butylglycol acetate
203-933-3112-07-2Acute Tox. 4 *

Acute Tox. 4 *
H332

H312
GHS07

Wng
H332

H312
607-039-00-82,4-D (ISO);

2,4-dichlorophenoxyacetic acid
202-361-194-75-7Acute Tox. 4 *

STOT SE 3

Eye Dam. 1

Skin Sens. 1

Aquatic Chronic 3
H302

H335

H318

H317

H412
GHS05

GHS07

Dgr
H302

H335

H318

H317

H412
607-040-00-3salts of 2,4-DAcute Tox. 4 *

Eye Dam. 1

Skin Sens. 1

Aquatic Chronic 2
H302

H318

H317

H411
GHS05

GHS07

GHS09

Dgr
H302

H318

H317

H411
A
607-041-00-92,4,5-T (ISO);

2,4,5-trichlorophenoxy acetic acid
202-273-393-76-5Acute Tox. 4 *

Eye Irrit. 2

STOT SE 3

Skin Irrit. 2

Aquatic Acute 1

Aquatic Chronic 1
H302

H319

H335

H315

H400

H410
GHS07

GHS09

Wng
H302

H319

H335

H315

H410
607-042-00-4salts and esters of 2,4,5-T;

salts and esters of 2,4,5-trichlorophenoxy acetic acid
Acute Tox. 4 *

Eye Irrit. 2

STOT SE 3

Skin Irrit. 2

Aquatic Acute 1

Aquatic Chronic 1
H302

H319

H335

H315

H400

H410
GHS07

GHS09

Wng
H302

H319

H335

H315

H410
A
607-043-00-Xdicamba (ISO);

2,5-dichloro-6-methoxybenzoic acid;

3,6-dichloro-2-methoxybenzoic acid
217-635-61918-00-9Acute Tox. 4 *

Eye Dam. 1

Aquatic Chronic 3
H302

H318

H412
GHS05

GHS07

Dgr
H302

H318

H412
607-044-00-53,6-dichloro-o-anisic acid, compound with dimethylamine (1:1); [1]

potassium 3,6-dichloro-o-anisate [2]
218-951-7 [1]

233-002-7 [2]
2300-66-5 [1]

10007-85-9 [2]
Eye Irrit. 2

Aquatic Chronic 3
H319

H412
GHS07

Wng
H319

H412
607-045-00-0dichlorprop (ISO);

2-(2,4-dichlorophenoxy) propionic acid
204-390-5120-36-5Acute Tox. 4 *

Acute Tox. 4 *

Skin Irrit. 2

Eye Dam. 1
H312

H302

H315

H318
GHS05

GHS07

Dgr
H312

H302

H315

H318
607-046-00-6salts of dichlorpropAcute Tox. 4 *

Acute Tox. 4 *

Acute Tox. 4 *
H332

H312

H302
GHS07

Wng
H332

H312

H302
A
607-047-00-1fenoprop (ISO);

2-(2,4,5-trichlorophenoxy)propionic acid
202-271-293-72-1Acute Tox. 4 *

Skin Irrit. 2

Aquatic Acute 1

Aquatic Chronic 1
H302

H315

H400

H410
GHS07

GHS09

Wng
H302

H315

H410
607-048-00-7salts of fenoprop;

salts of 2-(2,4,5-trichlorophenoxy)propionic acid
Acute Tox. 4 *

Acute Tox. 4 *

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1
H332

H312

H302

H400

H410
GHS07

GHS09

Wng
H332

H312

H302

H410
A
607-049-00-2mecoprop (ISO);

2-(4-chloro-o-tolyloxy) propionic acid;

(RS)-2-(4-chloro-o-tolyloxy)propionic acid; [1]

2-(4-chloro-2-methylphenoxy)propionic acid [2]
230-386-8 [1]

202-264-4 [2]
7085-19-0 [1]

708519-0 [2]
Acute Tox. 4 *

Skin Irrit. 2

Eye Dam. 1

Aquatic Acute 1

Aquatic Chronic 1
H302

H315

H318

H400

H410
GHS05

GHS07

GHS09

Dgr
H302

H315

H318

H410
M=100
607-050-00-8salts of mecopropAcute Tox. 4 *

Skin Irrit. 2

Eye Dam. 1

Aquatic Acute 1

Aquatic Chronic 1
H302

H315

H318

H400

H410
GHS05

GHS07

GHS09

Dgr
H302

H315

H318

H410
A
607-051-00-3MCPA (ISO);

4-chloro-o-tolyloxyacetic acid
202-360-694-74-6Acute Tox. 4 *

Skin Irrit. 2

Eye Dam. 1
H302

H315

H318
GHS05

GHS07

Dgr
H302

H315

H318
607-052-00-9salts and esters of MCPAAcute Tox. 4 *

Acute Tox. 4 *

Acute Tox. 4 *
H332

H312

H302
GHS07

Wng
H332

H312

H302
A
607-053-00-4MCPB (ISO);

4-(4-chloro-o-tolyloxy) butyric acid
202-365-394-81-5Aquatic Acute 1

Aquatic Chronic 1
H400

H410
GHS09

Wng
H410
607-054-00-Xsalts and esters of MCPBAcute Tox. 4 *H302GHS07

Wng
H302A
607-055-00-5endothal-sodium (ISO);

disodium 7-oxabicyclo(2,2,1)heptane-2,3-dicarboxylate
204-959-8129-67-9Acute Tox. 3 *

Acute Tox. 4 *

Eye Irrit. 2

STOT SE 3

Skin Irrit. 2
H301

H312

H319

H335

H315
GHS06

Dgr
H301

H312

H319

H335

H315
607-056-00-0warfarin (ISO); [1]

(S)-4-hydroxy-3-(3-oxo-1-phenylbutyl)-2-benzopyrone; [2]

(R)-4-hydroxy-3-(3-oxo-1-phenylbutyl)-2-benzopyrone [3]
201-377-6 [1]

226-907-3 [2]

226-908-9 [3]
81-81-2 [1]

5543-57-7 [2]

5543-58-8 [3]
Repr. 1A

STOT RE 1

Aquatic Chronic 3
H360D ***

H372 **

H412
GHS08

Dgr
H360D ***

H372 **

H412
607-057-00-6coumachlor (ISO);

3-[1-(4-chlorophenyl)-3-oxobutyl]-4-hydroxycoumarin
201-378-181-82-3STOT RE 2 *

Aquatic Chronic 3
H373 **

H412
GHS08

Wng
H373 **

H412
607-058-00-1coumafuryl (ISO);

fumarin;

(RS)-3-(1-(2-furyl)-3-oxobutyl)4-hydroxycoumarin;

4-hydroxy-3-[3-oxo-1-(2-furyl) butyl]coumarin
204-195-5117-52-2Acute Tox. 3 *

STOT RE 1

Aquatic Chronic 3
H301

H372 **

H412
GHS06

GHS08

Dgr
H301

H372 **

H412
607-059-00-7coumatetralyl;

4-hydroxy-3-(1,2,3,4-tetrahydro-1-naphthyl)coumarin
227-424-05836-29-3Acute Tox. 1

Acute Tox. 2 *

STOT RE 1

Aquatic Chronic 3
H310

H300

H372 **

H412
GHS06

GHS08

Dgr
H310

H300

H372 **

H412
607-060-00-2dicoumarol;

4,4'-dihydroxy-3,3'-methylenebis(2H-chromen-2-one)
200-632-966-76-2STOT RE 1

Acute Tox. 4 *

Aquatic Chronic 2
H372 **

H302

H411
GHS08

GHS07

GHS09

Dgr
H372 **

H302

H411
607-061-00-8acrylic acid;

prop-2-enoic acid
201-177-979-10-7Flam. Liq. 3

Acute Tox. 4 *

Acute Tox. 4 *

Acute Tox. 4 *

Skin Corr. 1A

Aquatic Acute 1
H226

H332

H312

H302

H314

H400
GHS02

GHS05

GHS07

GHS09

Dgr
H226

H332

H312

H302

H314

H400
STOT SE 3; H335: C ≥ 1 %D
607-062-00-3n-butyl acrylate205-480-7141-32-2Flam. Liq. 3

Eye Irrit. 2

STOT SE 3

Skin Irrit. 2

Skin Sens. 1
H226

H319

H335

H315

H317
GHS02

GHS07

Wng
H226

H319

H335

H315

H317
D
607-063-00-9isobutyric acid201-195-779-31-2Acute Tox. 4 *

Acute Tox. 4 *
H312

H302
GHS07

Wng
H312

H302
607-064-00-4benzyl chloroformate207-925-0501-53-1Skin Corr. 1B

Aquatic Acute 1

Aquatic Chronic 1
H314

H400

H410
GHS05

GHS09

Dgr
H314

H410
STOT SE 3; H335: C ≥ 5 %
607-065-00-Xbromoacetic acid201-175-879-08-3Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *

Skin Corr. 1A

Aquatic Acute 1
H331

H311

H301

H314

H400
GHS06

GHS05

GHS09

Dgr
H331

H311

H301

H314

H400
607-066-00-5dichloroacetic acid201-207-079-43-6Skin Corr. 1A

Aquatic Acute 1
H314

H400
GHS05

GHS09

Dgr
H314

H400
607-067-00-0dichloroacetyl chloride201-199-979-36-7Skin Corr. 1A

Aquatic Acute 1
H314

H400
GHS05

GHS09

Dgr
H314

H400
607-068-00-6iodoacetic acid200-590-164-69-7Acute Tox. 3 *

Skin Corr. 1A
H301

H314
GHS06

GHS05

Dgr
H301

H314
607-069-00-1ethyl bromoacetate203-290-9105-36-2Acute Tox. 2 *

Acute Tox. 1

Acute Tox. 2 *
H330

H310

H300
GHS06

Dgr
H330

H310

H300
607-070-00-7ethyl chloroacetate203-294-0105-39-5Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *

Aquatic Acute 1
H331

H311

H301

H400
GHS06

GHS09

Dgr
H331

H311

H301

H400
607-071-00-2ethyl methacrylate202-597-597-63-2Flam. Liq. 2

Eye Irrit. 2

STOT SE 3

Skin Irrit. 2

Skin Sens. 1
H225

H319

H335

H315

H317
GHS02

GHS07

Dgr
H225

H319

H335

H315

H317
D
607-072-00-82-hydroxyethyl acrylate212-454-9818-61-1Acute Tox. 3 *

Skin Corr. 1B

Skin Sens. 1

Aquatic Acute 1
H311

H314

H317

H400
GHS06

GHS05

GHS09

Dgr
H311

H314

H317

H400
*

Skin Sens. 1; H317: C ≥ 0,2 %
D
607-073-00-34-CPA (ISO);

4-chlorophenoxyacetic acid
204-581-3122-88-3Acute Tox. 4 *H302GHS07

Wng
H302
607-074-00-9chlorfenac(ISO);

2,3,6-trichlorophenylacetic acid
201-599-385-34-7Acute Tox. 4 *

Aquatic Chronic 2
H302

H411
GHS07

GHS09

Wng
H302

H411
607-075-00-4chlorfenprop-methyl;

methyl 2-chloro-3-(4-chlorophenyl)propionate
238-413-514437-17-3Acute Tox. 4 *

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1
H312

H302

H400

H410
GHS07

GHS09

Wng
H312

H302

H410
607-076-00-Xdodine(ISO);

dodecylguanidinium acetate
219-459-52439-10-3Acute Tox. 4 *

Eye Irrit. 2

Skin Irrit. 2

Aquatic Acute 1

Aquatic Chronic 1
H302

H319

H315

H400

H410
GHS07

GHS09

Wng
H302

H319

H315

H410
607-077-00-5erbon (ISO);

2-(2,4,5-trichlorophenoxy)ethyl 2,2-dichloropropionate
136-25-4Acute Tox. 4 *

Aquatic Chronic 2
H302

H411
GHS07

GHS09

Wng
H302

H411
607-078-00-0fluenetil (ISO);

2-fluoroethyl biphenyl-4-ylacetate
4301-50-2Acute Tox. 1

Acute Tox. 2 *
H310

H300
GHS06

Dgr
H310

H300
607-079-00-6kelevan (ISO);

ethyl 5-(perchloro-5-hydroxypentacyclo[5,3,0,02,6,03,9,04,8]decan-5-yl)-4-oxopentanoate;

ethyl 5-(1,2,3,5,6,7,8,9,10,10-decachloro-4-hydroxypentacyclo(5,2,1,02,6,03,9,05,8)dec-4-yl)-4-oxovalerate
4234-79-1Acute Tox. 3 *

Acute Tox. 4 *

Aquatic Chronic 2
H311

H302

H411
GHS06

GHS09

Dgr
H311

H302

H411
607-080-00-1chloroacetyl chloride201-171-679-04-9Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *

STOT RE 1

Skin Corr. 1A

Aquatic Acute 1
H331

H311

H301

H372 **

H314

H400
GHS06

GHS08

GHS05

GHS09

Dgr
H331

H311

H301

H372 **

H314

H400
EUH014

EUH029
607-081-00-7fluoroacetic acid205-631-7144-49-0Acute Tox. 2 *

Aquatic Acute 1
H300

H400
GHS06

GHS09

Dgr
H300

H400
607-082-00-2fluoroacetates, solubleAcute Tox. 2 *

Aquatic Acute 1
H300

H400
GHS06

GHS09

Dgr
H300

H400
A
607-083-00-82,4-DB (ISO);

4-(2,4-dichlorophenoxy)butyric acid
202-366-994-82-6Acute Tox. 4 *

Aquatic Chronic 2
H302

H411
GHS07

GHS09

Wng
H302

H411
607-084-00-3salts of 2,4-DBAcute Tox. 4 *

Eye Dam. 1

Aquatic Chronic 2
H302

H318

H411
GHS05

GHS07

GHS09

Dgr
H302

H318

H411
A
607-085-00-9benzyl benzoate204-402-9120-51-4Acute Tox. 4 *H302GHS07

Wng
H302
607-086-00-4diallyl phthalate205-016-3131-17-9Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1
H302

H400

H410
GHS07

GHS09

Wng
H302

H410
607-088-00-5methacrylic acid;

2-methylpropenoic acid
201-204-479-41-4Acute Tox. 4 *

Acute Tox. 4 *

Skin Corr. 1A
H312

H302

H314
GHS05

GHS07

Dgr
H312

H302

H314
STOT SE 3; H335: C ≥ 1 %D
607-089-00-0propionic acid ... %201-176-379-09-4Skin Corr. 1BH314GHS05

Dgr
H314Skin Corr. 1B; H314: C ≥ 25 %

Skin Irrit. 2; H319: 10 % ≤ C < 25 %

Eye Irrit. 2; H319: 10 % ≤ C < 25 %

STOT SE 3; H335: C ≥ 10 %
B
607-090-00-6thioglycolic acid200-677-468-11-1Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *

Skin Corr. 1B
H331

H311

H301

H314
GHS06

GHS05

Dgr
H331

H311

H301

H314
*
607-091-00-1trifluoroacetic acid . . . %200-929-376-05-1Acute Tox. 4 *H332GHS05H332*B
Skin Corr. 1A

Aquatic Chronic 3
H314

H412
GHS07

Dgr
H314

H412
607-092-00-7methyl lactate; [1]

methyl (±)-lactate; [2]

methyl (R)-lactate; [3]

methyl (S)-(-)-lactate [4]
208-930-0 [1]

218-449-8 [2]

241-420-6 [3]

248-704-9 [4]
547-64-8 [1]

2155-30-8 [2]

17392-83-5 [3]

27871-49-4 [4]
Flam. Liq. 3

Eye Irrit. 2

STOT SE 3
H226

H319

H335
GHS02

GHS07

Wng
H226

H319

H335
C
607-093-00-2propionyl chloride201-170-079-03-8Flam. Liq. 2

Skin Corr. 1B
H225

H314
GHS02

GHS05

Dgr
H225

H314
EUH014B D
607-094-00-8peracetic acid . . . %201-186-879-21-0Flam. Liq. 3

Org. Perox. D ****

Acute Tox. 4 *

Acute Tox. 4 *

Acute Tox. 4 *

Skin Corr. 1A

Aquatic Acute 1
H226

H242

H332

H312

H302

H314

H400
GHS02

GHS05

GHS07

GHS09

Dgr
H226

H242

H332

H312

H302

H314

H400
*

STOT SE 3; H335: C ≥ 1 %
B D
607-095-00-3maleic acid203-742-5110-16-7Acute Tox. 4 *

Eye Irrit. 2

STOT SE 3

Skin Irrit. 2
H302

H319

H335

H315
GHS07

Wng
H302

H319

H335

H315
607-096-00-9maleic anhydride203-571-6108-31-6Acute Tox. 4 *

Skin Corr. 1B

Resp. Sens. 1

Skin Sens. 1
H302

H314

H334

H317
GHS08

GHS05

GHS07

Dgr
H302

H314

H334

H317
607-097-00-4benzene-1,2,4-tricarboxylic acid 1,2-anhydride;

trimellitic anhydride
209-008-0552-30-7STOT SE 3

Eye Dam. 1

Resp. Sens. 1

Skin Sens. 1
H335

H318

H334

H317
GHS08

GHS05

GHS07

Dgr
H335

H318

H334

H317
607-098-00-Xbenzene-1,2:4,5-tetracarboxylic dianhydride;

benzene-1,2:4,5-tetracarboxylic dianhydride;

pyromellitic dianhydride
201-898-989-32-7Eye Dam. 1

Resp. Sens. 1

Skin Sens. 1
H318

H334

H317
GHS08

GHS05

Dgr
H318

H334

H317
607-099-00-51,2,3,6-tetrahydrophthalic anhydride; [1]

cis-1,2,3,6-tetrahydrophthalic anhydride; [2]

3,4,5,6-tetrahydrophthalic anhydride; [3]

tetrahydrophthalic anhydride [4]
201-605-4 [1]

213-308-7 [2]

219-374-3 [3]

247-570-9 [4]
85-43-8 [1]

935-79-5 [2]

2426-02-0 [3]

26266-63-7 [4]
Eye Dam. 1

Resp. Sens. 1

Skin Sens. 1

Aquatic Chronic 3
H318

H334

H317

H412
GHS08

GHS05

Dgr
H318

H334

H317

H412
C
607-100-00-9benzophenone-3,3',4,4'-tetracarboxylic dianhydride;

4,4'-carbonyldi(phthalic anhydride)
219-348-12421-28-5Eye Irrit. 2

STOT SE 3
H319

H335
GHS07

Wng
H319

H335
Eye Irrit. 2; H319: C ≥ 1 %

STOT SE 3; H335: C ≥ 1 %
607-101-00-41,4,5,6,7,7-hexachlorobicyclo [2,2,1]hept-5-ene-2,3-dicarboxylic anhydride chlorendic anhydride204-077-3115-27-5Eye Irrit. 2

STOT SE 3

Skin Irrit. 2
H319

H335

H315
GHS07

Wng
H319

H335

H315
Skin Irrit. 2; H315: C ≥ 1 %

Eye Irrit. 2; H319: C ≥ 1 %

STOT SE 3; H335: C ≥ 1 %
607-102-00-Xcyclohexane-1,2-dicarboxylic anhydride; [1]

cis-cyclohexane-1,2-dicarboxylic anhydride; [2]

trans-cyclohexane-1,2-dicarboxylic anhydride [3]
201-604-9 [1]

236-086-3 [2]

238-009-9 [3]
85-42-7 [1]

13149-00-3 [2]

14166-21-3 [3]
Eye Dam. 1

Resp. Sens. 1

Skin Sens. 1
H318

H334

H317
GHS08

GHS05

Dgr
H318

H334

H317
C
607-103-00-5succinic anhydride203-570-0108-30-5Eye Irrit. 2

STOT SE 3
H319

H335
GHS07

Wng
H319

H335
Eye Irrit. 2; H319: C ≥ 1 %

STOT SE 3; H335: C ≥ 1 %
607-104-00-0cyclopentane-1,2,3,4-tetracarboxylic dianhydride227-964-76053-68-5Eye Irrit. 2

STOT SE 3
H319

H335
GHS07

Wng
H319

H335
Eye Irrit. 2; H319: C ≥ 1 %

STOT SE 3; H335: C ≥ 1 %
607-105-00-68,9,10-trinorborn-5-ene-2,3-dicarboxylic anhydride; [1]

1,2,3,6-tetrahydro-3,6-methanophthalic anhydride; [2]

(1α,2α,3β,6β)-1,2,3,6-tetrahydro-3,6-methanophthalic anhydride [3]
204-957-7 [1]

212-557-9 [2]

220-384-5 [3]
129-64-6 [1]

826-62-0 [2]

2746-19-2 [3]
Eye Dam. 1

Resp. Sens. 1

Skin Sens. 1
H318

H334

H317
GHS08

GHS05

Dgr
H318

H334

H317
C
607-106-00-18,9-dinorborn-5-ene-2,3-dicarboxylic anhydride123748-85-6Acute Tox. 4 *

Eye Irrit. 2

STOT SE 3

Skin Irrit. 2

Resp. Sens. 1
H302

H319

H335

H315

H334
GHS08

GHS07

Dgr
H302

H319

H335

H315

H334
STOT SE 3; H335: C ≥ 10 %C
607-107-00-72-ethylhexyl acrylate203-080-7103-11-7STOT SE 3

Skin Irrit. 2

Skin Sens. 1
H335

H315

H317
GHS07

Wng
H335

H315

H317
D
607-108-00-22-hydroxy-1-methylethylacrylate; [1]

2-hydroxypropylacrylate; [2]

acrylic acid, monoester with propane-1,2-diol [3]
220-852-9 [1]

213-663-8 [2]

247-118-0 [3]
2918-23-2 [1]

999-61-1 [2]

25584-83-2 [3]
Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *

Skin Corr. 1B

Skin Sens. 1
H331

H311

H301

H314

H317
GHS06

GHS05

Dgr
H331

H311

H301

H314

H317
*

Skin Sens. 1; H317: C ≥ 0,2 %
C D
607-109-00-8hexamethylene diacrylate;

hexane-1,6-diol diacrylate
235-921-913048-33-4Eye Irrit. 2

Skin Irrit. 2

Skin Sens. 1
H319

H315

H317
GHS07

Wng
H319

H315

H317
D
607-110-00-3pentaerythritol triacrylate222-540-83524-68-3Eye Irrit. 2

Skin Irrit. 2

Skin Sens. 1
H319

H315

H317
GHS07

Wng
H319

H315

H317
D
607-111-00-92,2-bis(acryloyloxymethyl)butyl acrylate;

trimethylolpropane triacrylate
239-701-315625-89-5Eye Irrit. 2

Skin Irrit. 2

Skin Sens. 1
H319

H315

H317
GHS07

Wng
H319

H315

H317
D
607-112-00-42,2-dimethyltrimethylene diacrylate;

neopentyl glycol diacrylate
218-741-52223-82-7Acute Tox. 3 *

Eye Irrit. 2

Skin Irrit. 2

Skin Sens. 1
H311

H319

H315

H317
GHS06

Dgr
H311

H319

H315

H317
*D
607-113-00-Xisobutyl methacrylate202-613-097-86-9Flam. Liq. 3

Eye Irrit. 2

STOT SE 3

Skin Irrit. 2

Skin Sens. 1

Aquatic Acute 1
H226

H319

H335

H315

H317

H400
GHS02

GHS07

GHS09

Wng
H226

H319

H335

H315

H317

H400
D
607-114-00-5ethylene dimethacrylate202-617-297-90-5STOT SE 3

Skin Sens. 1
H335

H317
GHS07

Wng
H335

H317
STOT SE 3; H335: C ≥ 10 %D
607-115-00-0isobutyl acrylate203-417-8106-63-8Flam. Liq. 3

Acute Tox. 4 *

Acute Tox. 4 *

Skin Irrit. 2

Skin Sens. 1
H226

H332

H312

H315

H317
GHS02

GHS07

Wng
H226

H332

H312

H315

H317
D
607-116-00-6cyclohexyl acrylate221-319-33066-71-5STOT SE 3

Skin Irrit. 2

Aquatic Chronic 2
H335

H315

H411
GHS07

GHS09

Wng
H335

H315

H411
STOT SE 3; H335: C ≥ 10 %D
607-117-00-12,3-epoxypropyl acrylate;

glycidyl acrylate
203-440-3106-90-1Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *

Skin Corr. 1B

Skin Sens. 1
H331

H311

H301

H314

H317
GHS06

GHS05

Dgr
H331

H311

H301

H314

H317
*

Skin Sens. 1; H317: C ≥ 0,2 %
D
607-118-00-71-methyltrimethylene diacrylate;

1,3-butylene glycol diacrylate
243-105-919485-03-1Acute Tox. 4 *

Skin Corr. 1B

Skin Sens. 1
H312

H314

H317
GHS05

GHS07

Dgr
H312

H314

H317
D
607-119-00-2tetramethylene diacrylate;

1,4-butyleneglycol diacrylate
213-979-61070-70-8Acute Tox. 4 *

Skin Corr. 1B

Skin Sens. 1
H312

H314

H317
GHS05

GHS07

Dgr
H312

H314

H317
D
607-120-00-82,2'-oxydiethyl diacrylate;

diethylene glycol diacrylate
223-791-64074-88-8Acute Tox. 3 *

Eye Irrit. 2

Skin Irrit. 2

Skin Sens. 1
H311

H319

H315

H317
GHS06

Dgr
H311

H319

H315

H317
*

Skin Sens. 1; H317: C ≥ 0,2 %
D
607-121-00-38,9,10-trinorborn-2-yl acrylate10027-06-2Acute Tox. 4 *

Skin Irrit. 2

Skin Sens. 1
H312

H315

H317
GHS07

Wng
H312

H315

H317
D
607-122-00-9pentaerythritol tetraacrylate225-644-14986-89-4Eye Irrit. 2

Skin Irrit. 2

Skin Sens. 1
H319

H315

H317
GHS07

Wng
H319

H315

H317
D
607-123-00-42,3-epoxypropyl methacrylate;

glycidyl methacrylate
203-441-9106-91-2Acute Tox. 4 *

Acute Tox. 4 *

Acute Tox. 4 *

Eye Irrit. 2

Skin Irrit. 2

Skin Sens. 1
H332

H312

H302

H319

H315

H317
GHS07

Wng
H332

H312

H302

H319

H315

H317
D
607-124-00-X2-hydroxyethyl methacrylate212-782-2868-77-9Eye Irrit. 2

Skin Irrit. 2

Skin Sens. 1
H319

H315

H317
GHS07

Wng
H319

H315

H317
D
607-125-00-52-hydroxypropyl methacrylate; [1]

3-hydroxypropyl methacrylate [2]
213-090-3 [1]

220-426-2 [2]
923-26-2 [1]

2761-09-3 [2]
Eye Irrit. 2

Skin Sens. 1
H319

H317
GHS07

Wng
H319

H317
C D
607-126-00-02,2'-(ethylenedioxy)diethyl diacrylate;

triethylene glycol diacrylate
216-853-91680-21-3Eye Irrit. 2

Skin Irrit. 2

Skin Sens. 1
H319

H315

H317
GHS07

Wng
H319

H315

H317
D
607-127-00-62-diethylaminoethyl methacrylate203-275-7105-16-8Acute Tox. 4 *

Eye Irrit. 2

Skin Irrit. 2

Skin Sens. 1
H332

H319

H315

H317
GHS07

Wng
H332

H319

H315

H317
D
607-128-00-12-tert-butylaminoethyl methacrylate223-228-43775-90-4Eye Irrit. 2

Skin Irrit. 2

Skin Sens. 1
H319

H315

H317
GHS07

Wng
H319

H315

H317
D
607-129-00-7ethyl lactate;

ethyl DL-lactate; [1]

ethyl (S)-2-hydroxypropionate;

ethyl L-lactate;

ethyl-(S)-lactate [2]
202-598-0 [1]

211-694-1 [2]
97-64-3 [1]

687-47-8 [2]
Flam. Liq. 3

STOT SE 3

Eye Dam. 1
H226

H335

H318
GHS02

GHS05

GHS07

Dgr
H226

H335

H318
C
607-130-00-2pentyl acetate; [1]

isopentyl acetate; [2]

1-methylbutyl acetate; [3]

2-methylbutyl acetat; [4]

2(or 3)-methylbutyl acetate [5]
211-047-3 [1]

204-662-3 [2]

210-946-8 [3]

210-843-8 [4]

282-263-3 [5]
628-63-7 [1]

123-92-2 [2]

626-38-0 [3]

624-41-9 [4]

84145-37-9 [5]
Flam. Liq. 3H226GHS02

Wng
H226EUH066C
607-131-00-8isopentyl propionate; [1]

pentyl propionate; [2]

2-methylbutyl propionate [3]
203-322-1 [1]

210-852-7 [2]

219-449-0 [3]
105-68-0 [1]

624-54-4 [2]

2438-20-2 [3]
Flam. Liq. 3H226GHS02

Wng
H226C
607-132-00-32-dimethylaminoethyl methacrylate220-688-82867-47-2Acute Tox. 4 *

Acute Tox. 4 *

Eye Irrit. 2

Skin Irrit. 2

Skin Sens. 1
H312

H302

H319

H315

H317
GHS07

Wng
H312

H302

H319

H315

H317
D
607-133-00-9monoalkyl or monoaryl or monoalkylaryl esters of acrylic acid with the exception of those specified elsewhere in this AnnexEye Irrit. 2

STOT SE 3

Skin Irrit. 2

Aquatic Chronic 2
H319

H335

H315

H411
GHS07

GHS09

Wng
H319

H335

H315

H411
STOT SE 3; H335: C ≥ 10 %A
607-134-00-4monoalkyl or monoaryl or monoalkyaryl esters of methacrylic acid with the exception of those specified elsewhere in this AnnexEye Irrit. 2

STOT SE 3

Skin Irrit. 2
H319

H335

H315
GHS07

Wng
H319

H335

H315
STOT SE 3; H335: C ≥ 10 %A
607-135-00-Xbutyric acid203-532-3107-92-6Skin Corr. 1BH314GHS05

Dgr
H314
607-136-00-5butyryl chloride205-498-5141-75-3Flam. Liq. 2

Skin Corr. 1B
H225

H314
GHS02

GHS05

Dgr
H225

H314
607-137-00-0methyl acetoacetate203-299-8105-45-3Eye Irrit. 2H319GHS07

Wng
H319
607-138-00-6butyl chloroformate;

chloroformic acid butyl ester
209-750-5592-34-7Flam. Liq. 3

Acute Tox. 3 *

Skin Corr. 1B
H226

H331

H314
GHS02

GHS06

GHS05

Dgr
H226

H331

H314
607-139-00-12-chloropropionic acid209-952-3598-78-7Acute Tox. 4 *

Skin Corr. 1A
H302

H314
GHS05

GHS07

Dgr
H302

H314
607-140-00-7isobutyryl chloride201-194-179-30-1Flam. Liq. 2

Skin Corr. 1A
H225

H314
GHS02

GHS05

Dgr
H225

H314
607-141-00-2oxydiethylene bis(chloroformate)203-430-9106-75-2Acute Tox. 4 *

Skin Irrit. 2

Eye Dam. 1

Aquatic Chronic 2
H302

H315

H318

H411
GHS05

GHS07

GHS09

Dgr
H302

H315

H318

H411
607-142-00-8propyl chloroformate;

chloroformic acid propylester;

n-propyl chloroformate
203-687-7109-61-5Flam. Liq. 2

Acute Tox. 3 *

Skin Corr. 1B
H225

H331

H314
GHS02

GHS06

GHS05

Dgr
H225

H331

H314
607-143-00-3valeric acid203-677-2109-52-4Skin Corr. 1B

Aquatic Chronic 3
H314

H412
GHS05

Dgr
H314

H412
607-144-00-9adipic acid204-673-3124-04-9Eye Irrit. 2H319GHS07

Wng
H319
607-145-00-4methanesulphonic acid200-898-675-75-2Skin Corr. 1BH314GHS05

Dgr
H314
607-146-00-Xfumaric acid203-743-0110-17-8Eye Irrit. 2H319GHS07

Wng
H319
607-147-00-5oxalic acid diethylester;

diethyl oxalate
202-464-195-92-1Acute Tox. 4 *

Eye Irrit. 2
H302

H319
GHS07

Wng
H302

H319
607-148-00-0guanidinium chloride;

guanadine hydrochloride
200-002-350-01-1Acute Tox. 4 *

Eye Irrit. 2

Skin Irrit. 2
H302

H319

H315
GHS07

Wng
H302

H319

H315
607-149-00-6urethane (INN);

ethyl carbamate
200-123-151-79-6Carc. 1BH350GHS08

Dgr
H350
607-150-00-1endothal (ISO);

7-oxabicyclo(2,2,1)heptane-2,3-dicarboxylic acid
205-660-5145-73-3Acute Tox. 3 *

Acute Tox. 4 *

Eye Irrit. 2

STOT SE 3

Skin Irrit. 2
H301

H312

H319

H335

H315
GHS06

Dgr
H301

H312

H319

H335

H315
607-151-00-7propargite (ISO);

2-(4-tert-butylphenoxy) cyclohexyl prop-2-ynyl sulphite
219-006-12312-35-8Carc. 2

Acute Tox. 3 *

Skin Irrit. 2

Eye Dam. 1

Aquatic Acute 1

Aquatic Chronic 1
H351

H331

H315

H318

H400

H410
GHS06

GHS08

GHS05

GHS09

Dgr
H351

H331

H315

H318

H410
M = 10
607-152-00-22,3,6-TBA (ISO);

2,3,6-trichlorobenzoic acid
200-026-450-31-7Acute Tox. 4 *

Aquatic Chronic 2
H302

H411
GHS07

GHS09

Wng
H302

H411
607-153-00-8benazolin (ISO);

4-chloro-2,3-dihydro-2-oxo-1,3-benzothiazol-3-ylacetic acid
223-297-03813-05-6Eye Irrit. 2

Skin Irrit. 2

Aquatic Chronic 3
H319

H315

H412
GHS07

Wng
H319

H315

H412
607-154-00-3ethyl N-benzoyl-N-(3,4-dichlorophenyl)-DL-alaninate;

benzoylprop-ethyl (ISO)
244-845-522212-55-1Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1
H302

H400

H410
GHS07

GHS09

Wng
H302

H410
607-155-00-93-(3-amino-5-(1-methylguanidino)-1-oxopentylamino-6-(4-amino-2-oxo-2,3-dihydro-pyrimidin-1-yl)-2,3-dihydro-(6H)-pyran-2-carboxylic acid;

blasticidin-s
2079-00-7Acute Tox. 2 *H300GHS06

Dgr
H300
607-156-00-4chlorfenson (ISO);

4-chlorophenyl 4-chlorobenzenesulfonate
201-270-480-33-1Acute Tox. 4 *

Skin Irrit. 2

Aquatic Acute 1

Aquatic Chronic 1
H302

H315

H400

H410
GHS07

GHS09

Wng
H302

H315

H410
607-157-00-X3-(3-biphenyl-4-yl-1,2,3,4-tetrahydro-1-naphthyl)-4-hydroxycoumarin;

difenacoum
259-978-456073-07-5Acute Tox. 2 *

STOT RE 1

Aquatic Acute 1

Aquatic Chronic 1
H300

H372 **

H400

H410
GHS06

GHS08

GHS09

Dgr
H300

H372 **

H410
607-158-00-5sodium salt of chloroacetic acid;

sodium chloroacetate
223-498-33926-62-3Acute Tox. 3 *

Skin Irrit. 2

Aquatic Acute 1
H301

H315

H400
GHS06

GHS09

Dgr
H301

H315

H400
607-159-00-0chlorobenzilate (ISO);

ethyl 2,2-di(4-chlorophenyl)-2-hydroxyacetate;

ethyl 4,4'-dichlorobenzilate
208-110-2510-15-6Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1
H302

H400

H410
GHS07

GHS09

Wng
H302

H410
607-160-00-6isobutyl 2-(4-(4-chlorophenoxy)phenoxy)propionate;

clofop-isobutyl (ISO)
51337-71-4Acute Tox. 4 *H302GHS07

Wng
H302
607-161-00-1diethanolamine salt of 4-CPAAcute Tox. 4 *H302GHS07

Wng
H302
607-162-00-72,2-dichloropropionic acid;

dalapon
200-923-075-99-0Acute Tox. 4 *

Skin Irrit. 2

Eye Dam. 1

Aquatic Chronic 3
H302

H315

H318

H412
GHS05

GHS07

Dgr
H302

H315

H318

H412
607-163-00-23-acetyl-6-methyl-2H-pyran-2,4(3H)-dione;

dehydracetic acid
208-293-9520-45-6Acute Tox. 4 *H302GHS07

Wng
H302
607-164-00-8sodium 1-(3,4-dihydro-6-methyl-2,4-dioxo-2H-pyran-3-ylidene)ethonolate;

sodium dehydracetate
224-580-14418-26-2Acute Tox. 4 *H302GHS07

Wng
H302
607-165-00-3diclofop-methyl (ISO)

methyl 2-(4-(2,4-dichlorophenoxy)phenoxy)propionate;

methyl (RS)-2-[4-(2,4-dichlorophenoxy)phenoxy]propionate;
257-141-851338-27-3Acute Tox. 4 *

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H302

H317

H400

H410
GHS07

GHS09

Wng
H302

H317

H410
607-166-00-9medinoterb acetate (ISO);

6-tert-butyl-3-methyl-2,4-dinitrophenyl acetate
219-634-62487-01-6Acute Tox. 3 *

Acute Tox. 4 *
H301

H312
GHS06

Dgr
H301

H312
607-167-00-4sodium 3-chloroacrylate4312-97-4Acute Tox. 4 *

Acute Tox. 4 *
H312

H302
GHS07

Wng
H312

H302
607-168-00-Xdipropyl 6,7-methylenedioxy-1,2,3,4-tetrahydro-3-methylnaphthalene-1,2-dicarboxylate;

propylisome
83-59-0Acute Tox. 3 *

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1
H311

H302

H400

H410
GHS06

GHS09

Dgr
H311

H302

H410
607-169-00-5sodium fluoroacetate200-548-262-74-8Acute Tox. 2 *

Acute Tox. 1

Acute Tox. 2 *

Aquatic Acute 1
H330

H310

H300

H400
GHS06

GHS09

Dgr
H330

H310

H300

H400
607-170-00-0bis(1,2,3-trithiacyclohexyldimethylammonium) oxalate;

thiocyclam-oxalate
250-859-231895-22-4Acute Tox. 4 *

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1
H312

H302

H400

H410
GHS07

GHS09

Wng
H312

H302

H410
607-172-00-14-hydroxy-3-(3-(4'-bromo-4-biphenylyl)-1,2,3,4-tetrahydro-1-naphthyl)coumarin;

brodifacoum
259-980-556073-10-0Acute Tox. 1

Acute Tox. 2 *

STOT RE 1

Aquatic Acute 1

Aquatic Chronic 1
H310

H300

H372 **

H400

H410
GHS06

GHS08

GHS09

Dgr
H310

H300

H372 **

H410
607-173-00-7dimethyl (3-methyl-4-(5-nitro-3-ethoxycarbonyl-2-thienyl)azo)phenylnitrilodipropionate400-460-6Skin Sens. 1

Aquatic Chronic 3
H317

H412
GHS07

Wng
H317

H412
607-174-00-2reaction mass of dodecyl 3-(2,2,4,4-tetramethyl-21-oxo-7-oxa-3,20-diazadispiro(5,1,11,2)henicosan-20-yl)propionate and tetradecyl 3-(2,2,4,4-tetramethyl-21-oxo-7-oxa-3,20-diazadispiro(5,1,11,2)henicosan-20-yl)propionate400-580-9Skin Irrit. 2

Aquatic Chronic 2
H315

H411
GHS07

GHS09

Wng
H315

H411
607-175-00-8methyl 2-(2-nitrobenzylidene)acetoacetate400-650-939562-27-1Skin Sens. 1

Aquatic Chronic 2
H317

H411
GHS07

GHS09

Wng
H317

H411
607-176-00-3reaction mass of α-3-(3-(2H-benzotriazol-2-yl)-5-tert-butyl-4-hydroxyphenyl)propionyl-ω-hydroxypoly(oxyethylene) and α-3-(3-(2H-benzotriazol-2-yl)-5-tert-butyl-4-hydroxyphenyl)propionyl-ω-3-(3-(2H-benzotriazol-2-yl)-5-tert-butyl-4-hydroxyphenyl)propionyloxypoly(oxyethylene)400-830-7Skin Sens. 1

Aquatic Chronic 2
H317

H411
GHS07

GHS09

Wng
H317

H411
607-177-00-9methyl 2-(3-(4-methoxy-6-methyl-1,3,5-triazin-2-yl)3-methylureidosulphonyl)benzoate401-190-1101200-48-0Skin Sens. 1H317GHS07

Wng
H317
607-178-00-4methyl α-((4,6-dimethoxypyrimidin-2-yl)ureidosulphonyl)-o-toluate401-340-683055-99-6Skin Sens. 1

Aquatic Chronic 2
H317

H411
GHS07

GHS09

Wng
H317

H411
607-179-00-X(benzothiazol-2-ylthio)succinic acid401-450-495154-01-1Skin Sens. 1H317GHS07

Wng
H317
607-180-00-5potassium 2-hydroxycarbazole-1-carboxylate401-630-296566-70-0Acute Tox. 4 *

Eye Irrit. 2

STOT SE 3

Aquatic Chronic 3
H302

H319

H335

H412
GHS07

Wng
H302

H319

H335

H412
607-181-00-03,5-dichloro-2,4-difluorobenzoyl fluoride401-800-6101513-70-6Acute Tox. 3 *

Skin Corr. 1B

Acute Tox. 4 *

Skin Sens. 1

Aquatic Chronic 3
H331

H314

H302

H317

H412
GHS06

GHS05

Dgr
H331

H314

H302

H317

H412
EUH029
607-182-00-6methyl 3-sulphamoyl-2-thenoate402-050-2Skin Sens. 1H317GHS07

Wng
H317
607-183-00-1zinc 2-hydroxy-5-C13-18alkylbenzoate402-280-3Eye Irrit. 2

Skin Irrit. 2

Aquatic Chronic 2
H319

H315

H411
GHS07

GHS09

Wng
H319

H315

H411
607-184-00-7S-(3-trimethoxysilyl)propyl 19-isocyanato-11-(6-isocyanatohexyl)-10,12-dioxo-2,9,11,13-tetraazanonadecanethioate402-290-885702-90-5Flam. Liq. 3

Resp. Sens. 1

Skin Sens. 1
H226

H334

H317
GHS02

GHS08

Dgr
H226

H334

H317
607-185-00-2ethyl trans-3-dimethylaminoacrylate402-650-41117-37-9Skin Sens. 1H317GHS07

Wng
H317
607-186-00-8quinclorac (ISO);

3,7-dichloroquinoline-8-carboxylic acid
402-780-184087-01-4Skin Sens. 1H317GHS07

Wng
H317
607-187-00-3bis(2,2,6,6-tetramethyl-4-piperidyl) succinate402-940-062782-03-0Eye Irrit. 2

Aquatic Chronic 3
H319

H412
GHS07

Wng
H319

H412
607-188-00-9hydrogen sodium N-carboxylatoethyl-N-octadec-9-enylmaleamate402-970-4Skin Sens. 1

Aquatic Chronic 2
H317

H411
GHS07

GHS09

Wng
H317

H411
607-189-00-4trimethylenediaminetetraacetic acid400-400-91939-36-2Acute Tox. 4 *

Eye Dam. 1

Aquatic Acute 1

Aquatic Chronic 1
H302

H318

H400

H410
GHS05

GHS07

GHS09

Dgr
H302

H318

H410
607-190-00-Xmethyl acrylamidomethoxyacetate (containing ≥ 0,1 % acrylamid)401-890-777402-03-0Carc. 1B

Muta. 1B

Acute Tox. 4 *

Eye Irrit. 2
H350

H340

H302

H319
GHS08

GHS07

Dgr
H350

H340

H302

H319
607-191-00-5isobutyl 3,4-epoxybutyrate401-920-9100181-71-3Skin Irrit. 2

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H315

H317

H400

H410
GHS07

GHS09

Wng
H315

H317

H410
607-192-00-0disodium N-carboxymethyl-N-(2-(2-hydroxyethoxy)ethyl)glycinate402-360-892511-22-3Eye Dam. 1H318GHS05

Dgr
H318
607-194-00-1propylene carbonate203-572-1108-32-7Eye Irrit. 2H319GHS07

Wng
H319
607-195-00-72-methoxy-1-methylethyl acetate203-603-9108-65-6Flam. Liq. 3

Eye Irrit. 2
H226

H319
GHS02

GHS07

Wng
H226

H319
607-196-00-2heptanoic acid203-838-7111-14-8Skin Corr. 1BH314GHS05

Dgr
H314
607-197-00-8nonanoic acid203-931-2112-05-0Skin Corr. 1BH314GHS05

Dgr
H314
607-198-00-3propyl 3,4,5-trihydroxybenzoate204-498-2121-79-9Acute Tox. 4 *

Skin Sens. 1
H302

H317
GHS07

Wng
H302

H317
607-199-00-9octyl 3,4,5-trihydroxybenzoate213-853-01034-01-1Acute Tox. 4 *

Skin Sens. 1
H302

H317
GHS07

Wng
H302

H317
607-200-00-2dodecyl 3,4,5-trihydroxybenzoate214-620-61166-52-5Skin Sens. 1H317GHS07

Wng
H317
607-201-00-8thiocarbonyl chloride207-341-6463-71-8Acute Tox. 3 *

Acute Tox. 4 *

Eye Irrit. 2

STOT SE 3

Skin Irrit. 2
H331

H302

H319

H335

H315
GHS06

Dgr
H331

H302

H319

H335

H315
607-203-00-92-ethylhexyl[[[3,5-bis(1,1-dimethylethyl)-4-hydroxyphenyl]methyl]thio]acetate279-452-880387-97-9Repr. 1B

Skin Sens. 1

Aquatic Chronic 3
H360D ***

H317

H412
GHS08

GHS07

Dgr
H360D ***

H317

H412
607-204-00-4(chlorophenyl)(chlorotolyl)methane, mixed isomers400-140-6Aquatic Acute 1

Aquatic Chronic 1
H400

H410
GHS09

Wng
H410
607-205-00-Xmethyl chloroacetate202-501-196-34-4Flam. Liq. 3

Acute Tox. 3 *

Acute Tox. 3 *

STOT SE 3

Skin Irrit. 2

Eye Dam. 1
H226

H331

H301

H335

H315

H318
GHS02

GHS06

GHS05

Dgr
H226

H331

H301

H335

H315

H318
607-206-00-5isopropyl chloroacetate203-301-7105-48-6Flam. Liq. 3

Acute Tox. 3 *

Eye Irrit. 2

STOT SE 3

Skin Irrit. 2
H226

H301

H319

H335

H315
GHS02

GHS06

Dgr
H226

H301

H319

H335

H315
607-207-00-0haloxyfop-etotyl (ISO);

2-ethoxyethyl 2-(4-(3-chloro-5-trifluoromethyl-2-pyridyloxy)phenoxy)propionate;

haloxyfop-(2-ethoxyethyl)
402-560-587237-48-7Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1
H302

H400

H410
GHS07

GHS09

Wng
H302

H410
607-208-00-64,8,12-trimethyltrideca-3,7,11-trienoic acid, mixed isomers403-000-291853-67-7Skin Irrit. 2

Aquatic Acute 1

Aquatic Chronic 1
H315

H400

H410
GHS07

GHS09

Wng
H315

H410
607-209-00-1reaction mass of O,O'-diisopropyl (pentathio)dithioformate and O,O'-diisopropyl (trithio)dithioformate and O,O'-diisopropyl (tetrathio)dithioformate403-030-6Acute Tox. 4 *

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H302

H317

H400

H410
GHS07

GHS09

Wng
H302

H317

H410
607-210-00-7methyl acrylamidoglycolate (containing ≥ 0,1 % acrylamide)403-230-377402-05-2Carc. 1B

Muta. 1B

Skin Corr. 1B

Skin Sens. 1
H350

H340

H314

H317
GHS08

GHS05

GHS07

Dgr
H350

H340

H314

H317
607-211-00-2methyl 3-(3-tert-butyl-4-hydroxy-5-methylphenyl)propionate403-270-16386-39-6Acute Tox. 4 *

Aquatic Chronic 2
H302

H411
GHS07

GHS09

Wng
H302

H411
607-212-00-8poly(oxypropylenecarbonyl-co-oxy(ethylethylene)carbonyl), containing 27 % hydroxyvalerate403-300-3Skin Sens. 1H317GHS07

Wng
H317
607-213-00-3ethyl 3,3-bis(tert-pentylperoxy)butyrate403-320-267567-23-1Org. Perox. D ****

Flam. Liq. 3

Aquatic Chronic 2
H242

H226

H411
GHS02

GHS09

Dgr
H242

H226

H411
607-214-00-9N,N-hydrazinodiacetic acid403-510-519247-05-3Acute Tox. 3 *

STOT RE 2 *

Skin Sens. 1

Aquatic Chronic 3
H301

H373 **

H317

H412
GHS06

GHS08

Dgr
H301

H373 **

H317

H412
607-215-00-43-(3-tert-butyl-4-hydroxyphenyl)propionic acid403-920-4107551-67-7Acute Tox. 4 *

Eye Irrit. 2
H302

H319
GHS07

Wng
H302

H319
607-216-00-Xglutamic acid, reaction products with N-(C12-14alkyl)propylenediamine403-950-8Acute Tox. 2 *

Acute Tox. 4 *

Skin Corr. 1B

Aquatic Acute 1

Aquatic Chronic 1
H330

H302

H314

H400

H410
GHS06

GHS05

GHS09

Dgr
H330

H302

H314

H410
607-217-00-52-ethoxyethyl 2-(4-(2,6-dihydro-2,6-dioxo-7-phenyl-1,5-dioxaindacen-3-yl)phenoxy)acetate403-960-2Skin Sens. 1

Aquatic Chronic 4
H317

H413
GHS07

Wng
H317

H413
607-218-00-0dichlorprop-P (ISO);

(+)-R-2-(2,4-dichlorophenoxy)propionic acid
403-980-115165-67-0Acute Tox. 4 *

Skin Irrit. 2

Eye Dam. 1

Skin Sens. 1
H302

H315

H318

H317
GHS05

GHS07

Dgr
H302

H315

H318

H317
607-219-00-6bis(2-ethylhexyl) dithiodiacetate404-510-862268-47-7Acute Tox. 4 *

Skin Sens. 1

Aquatic Chronic 2
H302

H317

H411
GHS07

GHS09

Wng
H302

H317

H411
607-221-00-76-docosyloxy-1-hydroxy-4-(1-(4-hydroxy-3-methylphenanthren-1-yl)-3-oxo-2-oxaphenalen-1-yl)naphthalene-2-carboxylic acid404-550-6Skin Sens. 1

Aquatic Chronic 4
H317

H413
GHS07

Wng
H317

H413
607-222-00-26-(2,3-dimethylmaleimido)hexyl methacrylate404-870-663740-41-0Skin Sens. 1

Aquatic Chronic 2
H317

H411
GHS07

GHS09

Wng
H317

H411
607-223-00-8transfluthrin (ISO);

2,3,5,6-tetrafluorobenzyl trans-2-(2,2-dichlorovinyl)-3,3-dimethylcyclopropanecarboxylate
405-060-5118712-89-3Skin Irrit. 2

Aquatic Acute 1

Aquatic Chronic 1
H315

H400

H410
GHS07

GHS09

Wng
H315

H410
607-224-00-3methyl 2-(3-nitrobenzylidene)acetoacetate405-270-739562-17-9Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H317

H400

H410
GHS07

GHS09

Wng
H317

H410
607-225-00-93-azidosulfonylbenzoic acid405-310-315980-11-7Self-React. C ****

STOT RE 2 *

Eye Dam. 1

Skin Sens. 1
H241

H373 **

H318

H317
GHS02

GHS08

GHS05

GHS07

Dgr
H241

H373 **

H318

H317
607-226-00-4reaction mass of 2-acryloyloxyethyl hydrogen cyclohexane-1,2-dicarboxylate and 2-methacryloyloxyethyl hydrogen cyclohexane-1,2-dicarboxylate405-360-6Skin Irrit. 2

Eye Dam. 1

Skin Sens. 1

Aquatic Chronic 3
H315

H318

H317

H412
GHS05

GHS07

Dgr
H315

H318

H317

H412
607-227-00-Xpotassium 2-amino-2-methylpropionate octahydrate405-560-3120447-91-8Acute Tox. 4 *

Skin Corr. 1A
H302

H314
GHS05

GHS07

Dgr
H302

H314
607-228-00-5bis(2-methoxyethyl) phthalate204-212-6117-82-8Repr. 1BH360DfGHS08

Dgr
H360Df
607-229-00-0diethylcarbamoyl chloride201-798-588-10-8Carc. 2

Acute Tox. 4 *

Acute Tox. 4 *

Eye Irrit. 2

STOT SE 3

Skin Irrit. 2
H351

H332

H302

H319

H335

H315
GHS08

GHS07

Wng
H351

H332

H302

H319

H335

H315
607-230-00-62-ethylhexanoic acid205-743-6149-57-5Repr. 2H361d ***GHS08

Wng
H361d ***
607-231-00-13,6-dichloropyridine-2-carboxylic acid;

clopyralid
216-935-41702-17-6Eye Dam. 1

Aquatic Chronic 2
H318

H411
GHS05

GHS09

Dgr
H318

H411
607-232-00-7pyridate (ISO);

O-(6-chloro-3-phenylpyridazin-4-yl) S-octyl thiocarbonate
259-686-755512-33-9Skin Irrit. 2

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H315

H317

H400

H410
GHS07

GHS09

Wng
H315

H317

H410
607-233-00-2hexyl acrylate219-698-52499-95-8Eye Irrit. 2

STOT SE 3

Skin Irrit. 2

Skin Sens. 1

Aquatic Chronic 2
H319

H335

H315

H317

H411
GHS07

GHS09

Wng
H319

H335

H315

H317

H411
607-234-00-8flurenol (ISO);

9-hydroxy-9H-fluorene-9-carboxylic acid
207-397-1467-69-6Aquatic Chronic 2H411GHS09H411
607-235-00-3mecrilate;

methyl 2-cyanoacrylate
205-275-2137-05-3Eye Irrit. 2

STOT SE 3

Skin Irrit. 2
H319

H335

H315
GHS07

Wng
H319

H335

H315
STOT SE 3; H335: C ≥ 10 %
607-236-00-9ethyl 2-cyanoacrylate230-391-57085-85-0Eye Irrit. 2

STOT SE 3

Skin Irrit. 2
H319

H335

H315
GHS07

Wng
H319

H335

H315
STOT SE 3; H335: C ≥ 10 %
607-237-00-4benzyl 2-chloro-4-(trifluoromethyl)thiazole-5-carboxylate;

flurazole
276-942-372850-64-7Aquatic Chronic 2H411GHS09H411
607-238-00-Xtau-fluvalinate (ISO);

cyano-(3-phenoxyphenyl)methyl N-[2-chloro-4-(trifluoromethyl)phenyl]-D-valinate
102851-06-9Acute Tox. 4 *

Skin Irrit. 2

Aquatic Acute 1

Aquatic Chronic 1
H302

H315

H400

H410
GHS07

GHS09

Wng
H302

H315

H410
607-239-00-5fenpropathrin (ISO);

α-cyano-3-phenoxybenzyl 2,2,3,3-tetramethylcyclopropanecarboxylate
254-485-039515-41-8Acute Tox. 2 *

Acute Tox. 3 *

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1
H330

H301

H312

H400

H410
GHS06

GHS09

Dgr
H330

H301

H312

H410
607-240-00-0cis-1,2,3,6-tetrahydro-4-methylphthalic anhydride; [1]

1,2,3,6-tetrahydro-4-methylphthalic anhydride; [2]

1,2,3,6-tetrahydro-3-methylphthalic anhydride; [3]

tetrahydromethylphthalic anhydride; [4]

1,2,3,6-tetrahydromethylphthalic anhydride; [5]

tetrahydro-4-methylphthalic anhydride; [6]

2,3,5,6-tetrahydro-2-methylphthalic anhydride [7]
216-906-6 [1]

222-323-8 [2]

226-247-6 [3]

234-290-7 [4]

247-830-1 [5]

251-823-9 [6]

255-853-3 [7]
1694-82-2 [1]

3425-89-6 [2]

5333-84-6 [3]

11070-44-3 [4]

26590-20-5 [5]

34090-76-1 [6]

42498-58-8 [7]
Eye Dam. 1

Resp. Sens. 1

Skin Sens. 1
H318

H334

H317
GHS08

GHS05

Dgr
H318

H334

H317
C
607-241-00-6hexahydro-4-methylphthalic anhydride; [1]

hexahydromethylphthalic anhydride; [2]

hexahydro-1-methylphthalic anhydride; [3]

hexahydro-3-methylphthalic anhydride [4]
243-072-0 [1]

247-094-1 [2]

256-356-4 [3]

260-566-1 [4]
19438-60-9 [1]

25550-51-0 [2]

48122-14-1 [3]

57110-29-9 [4]
Eye Dam. 1

Resp. Sens. 1

Skin Sens. 1
H318

H334

H317
GHS08

GHS05

Dgr
H318

H334

H317
C
607-242-00-1tetrachlorophthalic anhydride204-171-4117-08-8Eye Dam. 1

Resp. Sens. 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H318

H334

H317

H400

H410
GHS08

GHS05

GHS09

Dgr
H318

H334

H317

H410
607-243-00-7sodium 3,6-dichloro-o-anisate; [1]

3,6-dichloro-o-anisic acid, compound with 2,2'-iminodiethanol (1:1); [2]

3,6-dichloro-o-anisic acid, compound with 2-aminoethanol (1:1) [3]
217-846-3 [1]

246-590-5 [2]

258-527-9 [3]
1982-69-0 [1]

25059-78-3 [2]

53404-28-7 [3]
Aquatic Chronic 3H412H412
607-244-00-2isooctyl acrylate249-707-829590-42-9Eye Irrit. 2

STOT SE 3

Skin Irrit. 2

Aquatic Acute 1

Aquatic Chronic 1
H319

H335

H315

H400

H410
GHS07

GHS09

Wng
H319

H335

H315

H410
STOT SE 3; H335: C ≥ 10 %
607-245-00-8tert-butyl acrylate216-768-71663-39-4Flam. Liq. 2

Acute Tox. 4 *

Acute Tox. 4 *

Acute Tox. 4 *

STOT SE 3

Skin Irrit. 2

Skin Sens. 1

Aquatic Chronic 3
H225

H332

H312

H302

H335

H315

H317

H412
GHS02

GHS07

Dgr
H225

H332

H312

H302

H335

H315

H317

H412
D
607-246-00-3allyl methacrylate;

2-methyl-2-propenoic acid 2-propenyl ester
202-473-096-05-9Flam. Liq. 3

Acute Tox. 3 *

Acute Tox. 4 *

Acute Tox. 4 *

Aquatic Acute 1
H226

H331

H312

H302

H400
GHS02

GHS06

GHS09

Dgr
H226

H331

H312

H302

H400
607-247-00-9dodecyl methacrylate205-570-6142-90-5Eye Irrit. 2

STOT SE 3

Skin Irrit. 2

Aquatic Acute 1

Aquatic Chronic 1
H319

H335

H315

H400

H410
GHS07

GHS09

Wng
H319

H335

H315

H410
STOT SE 3; H335: C ≥ 10 %
607-248-00-4naptalam-sodium (ISO);

sodium N-naphth-1-ylphthalamate
205-073-4132-67-2Acute Tox. 4 *H302GHS07

Wng
H302
607-249-00-X(1-methyl-1,2-ethanediyl)bis[oxy(methyl-2,1-ethanediyl)] diacrylate256-032-242978-66-5Eye Irrit. 2

STOT SE 3

Skin Irrit. 2

Skin Sens. 1

Aquatic Chronic 2
H319

H335

H315

H317

H411
GHS07

GHS09

Wng
H319

H335

H315

H317

H411
STOT SE 3; H335: C ≥ 10 %
607-250-00-54H-3,1-benzoxazine-2,4(1H)-dione204-255-0118-48-9Eye Irrit. 2

Skin Sens. 1
H319

H317
GHS07

Wng
H319

H317
607-251-00-02-methoxypropyl acetate274-724-270657-70-4Flam. Liq. 3

Repr. 1B

STOT SE 3
H226

H360D ***

H335
GHS02

GHS08

GHS07

Dgr
H226

H360D ***

H335
607-252-00-6lambda-cyhalothrin (ISO);

reaction mass of (S)-α-cyano-3-phenoxybenzyl(Z)-(1R)-cis-3-(2-chloro-3,3,3-trifluoropropenyl)-2,2-dimethylcyclopropanecarboxylate and (R)-α-cyano-3-phenoxybenzyl (Z)-(1S)-cis-3-(2-chloro-3,3,3-trifluoropropenyl)-2,2-dimethylcyclopropanecarboxylate (1:1)
415-130-791465-08-6Acute Tox. 2 *

Acute Tox. 3 *

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1
H330

H301

H312

H400

H410
GHS06

GHS09

Dgr
H330

H301

H312

H410
607-253-00-1α-cyano-4-fluoro-3-phenoxybenzyl-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate;

cyfluthrin
269-855-768359-37-5Acute Tox. 2 *

Acute Tox. 3 *

Aquatic Acute 1

Aquatic Chronic 1
H300

H331

H400

H410
GHS06

GHS09

Dgr
H300

H331

H410
607-254-00-7α-cyano-4-fluoro-3-phenoxybenzyl-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate;

beta-cyfluthrin
269-855-768359-37-5Acute Tox. 2 *

Acute Tox. 2 *

Aquatic Acute 1

Aquatic Chronic 1
H330

H300

H400

H410
GHS06

GHS09

Dgr
H330

H300

H410
607-255-00-2fluroxypyr (ISO);

4-amino-3,5-dichloro-6-fluoro-2-pyridyloxyacetic acid
69377-81-7Aquatic Chronic 3H412H412
607-256-00-8azoxystrobin (ISO);

methyl (E)-2-{2-[6-(2-cyanophenoxy)pyrimidin-4-yloxy]phenyl}-3-methoxyacrylate
131860-33-8Acute Tox. 3 *

Aquatic Acute 1

Aquatic Chronic 1
H331

H400

H410
GHS06

GHS09

Dgr
H331

H410
607-257-00-3isopropyl propionate211-300-8637-78-5Flam. Liq. 2H225GHS02

Dgr
H225
607-258-00-9dodecyl 3-(2-(3-benzyl-4-ethoxy-2,5-dioxoimidazolidin-1-yl)-3-(4-methoxybenzoyl)acetamido)-4-chlorobenzoate403-990-670950-45-7Aquatic Chronic 4H413H413
607-259-00-4methyl 2R,3S-(-)-3-(4-methoxyphenyl)oxiranecarboxylate404-130-2105560-93-8Eye Dam. 1

Skin Sens. 1

Aquatic Chronic 3
H318

H317

H412
GHS05

GHS07

Dgr
H318

H317

H412
607-260-00-Xethyl 2-(3-nitrobenzylidene)acetoacetate404-490-039562-16-8Eye Dam. 1

Skin Sens. 1

Aquatic Chronic 3
H318

H317

H412
GHS05

GHS07

Dgr
H318

H317

H412
607-261-00-5iso(C10-C14)alkyl (3,5-di-tert-butyl-4-hydroxyphenyl)methylthioacetate404-800-4118832-72-7Aquatic Acute 1

Aquatic Chronic 1
H400

H410
GHS09

Wng
H410
607-262-00-07-chloro-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid405-050-086393-33-1Acute Tox. 4 *

Aquatic Chronic 3
H302

H412
GHS07

Wng
H302

H412
607-263-00-6potassium iron(III) 1,3-propanediamine-N,N,N',N'-tetraacetate hemihydrate405-680-6Self-heat. 2 ****

Aquatic Chronic 2
H252

H411
GHS02

GHS09

Wng
H252

H411
607-264-00-12-chloro-4-(methylsulfonyl)benzoic acid406-520-853250-83-2Eye Dam. 1H318GHS05

Dgr
H318
607-265-00-7ethyl-2-chloro-2,2-diphenylacetate406-580-552460-86-3Skin Irrit. 2

Aquatic Chronic 3
H315

H412
GHS07

Wng
H315

H412
607-266-00-2reaction mass of: hydroxyaluminium bis[2-hydroxy-3,5-di-tert-butylbenzoate];

3,5-di-tert-butyl-salicylic acid
406-890-0130296-87-6Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1
H302

H400

H410
GHS07

GHS09

Wng
H302

H410
607-267-00-8tert-butyl (5S,6R,7R)-3-bromomethyl-5,8-dioxo-7-(2-(2-phenylacetamido)-5-thia-1-azabicyclo[4.2.0] oct-2-ene-2-carboxylate407-620-433610-13-8Resp. Sens. 1

Skin Sens. 1

Aquatic Chronic 3
H334

H317

H412
GHS08

Dgr
H334

H317

H412
607-268-00-32-methylpropyl (R)-2-hydroxypropanoate407-770-061597-96-4Eye Irrit. 2H319GHS07

Wng
H319
607-269-00-9(R)-2-(4-hydroxyphenoxy)propanoic acid407-960-394050-90-5Eye Dam. 1H318GHS05

Dgr
H318
607-270-00-43,9-bis(2-(3-(3-tert-butyl-4-hydroxy-5-methylphenyl)propionyloxy-1,1-dimethylethyl)-2,4,8,10- tetraoxaspiro[5.5]undecane410-730-590498-90-1Acute Tox. 4 *H312GHS07

Wng
H312
607-271-00-X2-isopropyl-5-methylcyclohexyloxycarbonyloxy-2-hydroxypropane417-420-9156324-82-2Eye Irrit. 2

Aquatic Chronic 2
H319

H411
GHS07

GHS09

Wng
H319

H411
607-272-00-5fluroxypyr-meptyl (ISO);

methylheptyl, O-(4-amino-3,5-dichloro-6-fluoro-2-pyridyloxy) acetate; [1]

fluroxypyr-butometyl (ISO);

2-butoxy-1-methylethyl, O-(4-amino-3,5-dichloro-6-fluoro-2-pyridyloxy) acetate [2]
279-752-9 [1]

- [2]
81406-37-3 [1]

154486-27-8 [2]
Aquatic Acute 1

Aquatic Chronic 1
H400

H410
GHS09

Wng
H410
607-273-00-0ammonium 7-(2,6-dimethyl-8-(2,2-dimethylbutyryloxy)-1,2,6,7,8,8a-hexahydro-1-naphthyl)-3,5-dihydroxyheptanoate404-520-2Aquatic Chronic 3H412H412
607-274-00-62-(N-benzyl-N-methylamino)ethyl 3-amino-2-butenoate405-350-154527-73-0Skin Sens. 1

Aquatic Chronic 2
H317

H411
GHS07

GHS09

Wng
H317

H411
607-275-00-1sodium benzoyloxybenzene-4-sulfonate405-450-566531-87-1Skin Sens. 1H317GHS07

Wng
H317
607-276-00-7bis[(1-methylimidazol)-(2-ethyl-hexanoate)], zinc complex405-635-0Skin Irrit. 2

Eye Dam. 1

Aquatic Acute 1

Aquatic Chronic 1
H315

H318

H400

H410
GHS05

GHS09

Dgr
H315

H318

H410
607-277-00-2reaction mass of: 2-(hexylthio)ethylamine hydrochloride;

sodium propionate
405-720-2Acute Tox. 4 *

Eye Dam. 1

Skin Sens. 1

Aquatic Chronic 2
H302

H318

H317

H411
GHS05

GHS07

GHS09

Dgr
H302

H318

H317

H411
607-278-00-8reaction mass of isomers of: sodium phenethylnaphthalenesulfonate;

sodium naphthylethylbenzenesulfonate
405-760-0Eye Dam. 1

Skin Sens. 1

Aquatic Chronic 3
H318

H317

H412
GHS05

GHS07

Dgr
H318

H317

H412
607-279-00-3reaction mass of n-octadecylaminodiethyl bis(hydrogen maleate);

n-octadecylaminodiethyl hydrogen maleate hydrogenphthalate
405-960-8Skin Sens. 1

Aquatic Chronic 2
H317

H411
GHS07

GHS09

Wng
H317

H411
607-280-00-9sodium 4-chloro-1-hydroxybutane-1-sulfonate406-190-554322-20-2Acute Tox. 4 *

Eye Irrit. 2

Skin Sens. 1
H302

H319

H317
GHS07

Wng
H302

H319

H317
607-281-00-4reaction mass of branched and linear C7-C9 alkyl 3-[3-(2H-benzotriazol-2-yl)-5-(1,1-dimethylethyl)-4-hydroxyphenyl]propionates407-000-3127519-17-9Aquatic Chronic 2H411GHS09H411
607-282-00-X2-acetoxymethyl-4-benzyloxybut-1-yl acetate407-140-5131266-10-9Aquatic Chronic 3H412H412
607-283-00-5E-ethyl-4-oxo-4-phenylcrotonate408-040-415121-89-8Acute Tox. 4 *

Acute Tox. 4 *

Skin Irrit. 2

Eye Dam. 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H312

H302

H315

H318

H317

H400

H410
GHS05

GHS07

GHS09

Dgr
H312

H302

H315

H318

H317

H410
607-284-00-0reaction mass of: sodium 3,3'-(1,4-phenylenebis(carbonylimino-3,1-propanediylimino))bis(10-amino-6,13-dichloro-4,11-triphenodioxazinedisulfonate);

lithium 3,3'-(1,4-phenylenebis-(carbonylimino-3,1-propanediyl-imino))bis(10-amino-6,13-dichloro)-4,11-triphenodioxazinedisulfonate (9:1)
410-040-4136213-76-8Aquatic Chronic 2H411GHS09H411
607-285-00-6reaction mass of: 7-(((3-aminophenyl)sulfonyl)amino)-naphthalene-1,3-disulfonic acid;

sodium 7-(((3-aminophenyl)sulfonyl)amino)-naphthalene-1,3-disulfonate;

potassium 7-(((3-aminophenyl)sulfonyl)amino)-naphthalene-1,3-disulfonate
410-065-0Skin Sens. 1H317GHS07

Wng
607-286-00-1reaction mass of: sodium/potassium 7-[[[3-[[4-((2-hydroxy-naphthyl)azo)phenyl]azo]phenyl]sulfonyl]amino]-naphthalene-1,3-disulfonate410-070-8141880-36-6Skin Sens. 1

Aquatic Chronic 3
H317

H412
GHS07

Wng
H317

H412
607-287-00-7O'-methyl O-(1-methyl-2-methacryloyloxy-ethyl)-1,2,3,6-tetrahydrophthalate410-140-8Aquatic Chronic 3H412H412
607-288-00-2tetrasodium (c-(3-(1-(3-(e-6-dichloro-5-cyanopyrimidin-f-yl(methyl)amino)propyl)-1,6-dihydro-2-hydroxy-4-methyl-6-oxo-3-pyridylazo)-4-sulfonatophenylsulfamoyl)phthalocyanine-a,b,d-trisulfonato(6-))nickelato II, where a is 1 or 2 or 3 or 4,b is 8 or 9 or 10 or 11,c is 15 or 16 or 17 or 18, d is 22 or 23 or 24 or 25 and where e and f together are 2 and 4 or 4 and 2 respectively410-160-7148732-74-5Eye Irrit. 2

Skin Sens. 1

Aquatic Chronic 3
H319

H317

H412
GHS07

Wng
H319

H317

H412
607-289-00-83-(3-(4-(2,4-bis(1,1-dimethylpropyl)phenoxy)butylaminocarbonyl-4-hydroxy-1-naphthalenyl)thio)propanoic acid410-370-9105488-33-3Aquatic Chronic 4H413H413
607-290-00-3reaction mass (ratio not known) of: ammonium 1-C14-C18-alkyloxycarbonyl-2-(3-allyloxy-2-hydroxypropoxycarbonyl)ethane-1-sulfonate;

ammonium 2-C14-C18-alkyloxycarbonyl-1-(3-allyloxy-2-hydroxypropoxycarbonyl)ethane-1-sulfonate
410-540-2Skin Irrit. 2

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H315

H317

H400

H410
GHS07

GHS09

Wng
H315

H317

H410
607-291-00-9dodecyl-ω-(C5/C6-cycloalkyl)alkyl carboxylate410-630-1104051-92-5Aquatic Chronic 4H413H413
607-292-00-4reaction mass of: [1-(methoxymethyl)-2-(C12-alkoxy)-ethoxy]acetic acid;

[1-(methoxymethyl)-2-(C14-alkoxy)-ethoxy]acetic acid
410-640-6Skin Irrit. 2

Eye Dam. 1

Aquatic Acute 1

Aquatic Chronic 1
H315

H318

H400

H410
GHS05

GHS09

Dgr
H315

H318

H410
607-293-00-Xreaction mass of: N-aminoethylpiperazonium mono-2,4,6-trimethylnonyldiphenyl ether di-sulfonate;

N-aminoethylpiperazonium di-2,4,6-trimethylnonyldiphenyl ether di-sulfonate
410-650-0Eye Dam. 1

Skin Sens. 1

Aquatic Chronic 2
H318

H317

H411
GHS05

GHS07

GHS09

Dgr
H318

H317

H411
607-294-00-5sodium 2-benzoyloxy-1-hydroxyethane-sulfonate410-680-4Skin Sens. 1H317GHS07

Wng
H317
607-295-00-0reaction mass of: tetrasodium phosphonoethane-1,2-dicarboxylate;

hexasodium phosphonobutane-1,2,3,4-tetracarboxylate
410-800-5Skin Sens. 1

Aquatic Chronic 2
H317

H411
GHS07

GHS09

Wng
H317

H411
607-296-00-6reaction mass of: pentaerythriol tetraesters with heptanoic acid and 2-ethylhexanoic acid410-830-9Aquatic Chronic 4H413H413
607-297-00-1(E-E )-3,3'-(1,4-phenylenedimethylidene)bis(2-oxobornane-10-sulfonic acid)410-960-692761-26-7Eye Dam. 1H318GHS05

Dgr
H318
607-298-00-72-(trimethylammonium)ethoxycarboxybenzene-4-sulfonate411-010-3Skin Sens. 1H317GHS07

Wng
H317
607-299-00-2methyl 3-(acetylthio)-2-methyl-propanoate411-040-797101-46-7Acute Tox. 4 *

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H302

H317

H400

H410
GHS07

GHS09

Wng
H302

H317

H410
607-300-00-6trisodium [2-(5-chloro-2,6-difluoropyrimidin-4-ylamino)-5-(b-sulfamoyl-c,d-sulfonatophthalocyanin-a-yl-K4,N29,N30,N31,N32-sulfonylamino)benzoato(5-)]cuprate(II) where a=1,2,3,4 b=8,9,10,11 c=15,16,17,18 d=22,23,24,25411-430-7Eye Dam. 1

Skin Sens. 1
H318

H317
GHS05

GHS07

Dgr
H318

H317
607-301-00-1reaction mass of: dodecanoic acid;

poly(1-7)lactate esters of dodecanoic acid
411-860-5Skin Sens. 1

Aquatic Chronic 2
H317

H411
GHS07

GHS09

Wng
H317

H411
607-302-00-7reaction mass of: tetradecanoic acid;

poly(1-7)lactate esters of tetradecanoic acid
411-910-6Skin Irrit. 2

Eye Dam. 1

Skin Sens. 1

Aquatic Chronic 2
H315

H318

H317

H411
GHS05

GHS07

GHS09

Dgr
H315

H318

H317

H411
607-303-00-21-cyclopropyl-6,7-difluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid413-760-793107-30-3Repr. 2

Aquatic Chronic 3
H361f ***

H412
GHS08

Wng
H361f ***

H412
607-304-00-8fluazifop-butyl (ISO);

butyl (RS)-2-[4-(5-trifluoromethyl-2-pyridyloxy)phenoxy]propionate
274-125-669806-50-4Repr. 1B

Aquatic Acute 1

Aquatic Chronic 1
H360D ***

H400

H410
GHS08

GHS09

Dgr
H360D ***

H410
607-305-00-3fluazifop-P-butyl (ISO);

butyl (R)-2-[4-(5-trifluoromethyl-2-pyridyloxy)phenoxy]propionate
79241-46-6Repr. 2

Aquatic Acute 1

Aquatic Chronic 1
H361d ***

H400

H410
GHS08

GHS09

Wng
H361d ***

H410
607-306-00-9chlozolinate (ISO);

ethyl (RS)-3-(3,5-dichlorophenyl)-5-methyl-2,4-dioxo-oxazolidine-5-carboxylate
282-714-484332-86-5Carc. 2

Aquatic Chronic 2
H351

H411
GHS08

GHS09

Wng
H351

H411
607-307-00-4vinclozolin (ISO);

N-3,5-dichlorophenyl-5-methyl-5-vinyl-1,3-oxazolidine-2,4-dione
256-599-650471-44-8Carc. 2

Repr. 1B

Skin Sens. 1

Aquatic Chronic 2
H351

H360FD

H317

H411
GHS08

GHS07

GHS09

Dgr
H351

H360FD

H317

H411
607-308-00-Xesters of 2,4-DAcute Tox. 4 *

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H302

H317

H400

H410
GHS07

GHS09

Wng
H302

H317

H410
A
607-309-00-5carfentrazone-ethyl (ISO);

ethyl (RS)-2-chloro-3-[2-chloro-4-fluoro-5-[4-difluoromethyl-4,5-dihydro-3-methyl-5-oxo-1H-1,2,4-triazol-1-yl]phenyl]propionate
128639-02-1Aquatic Acute 1

Aquatic Chronic 1
H400

H410
GHS09

Wng
H410
607-310-00-0kresoxim-methyl (ISO);

methyl (E)-2-methoxyimino-[2-(o-tolyloxymethyl)phenyl]acetate
143390-89-0Carc. 2

Aquatic Acute 1

Aquatic Chronic 1
H351

H400

H410
GHS08

GHS09

Wng
H351

H410
607-311-00-6benazolin-ethyl;

ethyl 4-chloro-2-oxo-2H-benzothiazole-3-acetate
246-591-025059-80-7Aquatic Chronic 2H411GHS09H411
607-312-00-1methoxyacetic acid210-894-6625-45-6Repr. 1B

Acute Tox. 4 *

Skin Corr. 1B
H360FD

H302

H314
GHS08

GHS05

GHS07

Dgr
H360FD

H302

H314
STOT SE 3; H335: C ≥ 5 %
607-313-00-7neodecanoyl chloride254-875-040292-82-8Acute Tox. 2 *

Acute Tox. 4 *

Skin Corr. 1B
H330

H302

H314
GHS06

GHS06

Dgr
H330

H302

H314
STOT SE 3; H335: C ≥ 5 %
607-314-00-2ethofumesate (ISO);

(±)-2-ethoxy-2,3-dihydro-3,3-dimethylbenzofuran-5-yl methanesulfonate
247-525-326225-79-6Aquatic Chronic 2H411GHS09H411
607-315-00-8glyphosate (ISO);

N-(phosphonomethyl)glycine
213-997-41071-83-6Eye Dam. 1

Aquatic Chronic 2
H318

H411
GHS05

GHS09

Dgr
H318

H411
607-316-00-3glyphosate-trimesium;

glyphosate-trimethylsulfonium
81591-81-3Acute Tox. 4 *

Aquatic Chronic 2
H302

H411
GHS07 GHS09

Wng
H302

H411
607-317-00-9bis(2-ethylhexyl) phthalate;

di-(2-ethylhexyl) phthalate;

DEHP
204-211-0117-81-7Repr. 1BH360FDGHS08

Dgr
H360FD
607-318-00-4dibutyl phthalate;

DBP
201-557-484-74-2Repr. 1B

Aquatic Acute 1
H360Df

H400
GHS08

GHS09

Dgr
H360Df

H400
607-319-00-Xdeltamethrin (ISO);

(S)-α-cyano-3-phenoxybenzyl (1R, 3R)-3-(2,2-dibromovinyl)-2,2-dimethylcyclopropanecarboxylate
258-256-652918-63-5Acute Tox. 3 *

Acute Tox. 3 *

Aquatic Acute 1

Aquatic Chronic 1
H331

H301

H400

H410
GHS06

GHS09

Dgr
H331

H301

H410
607-320-00-5bis[4-(ethenyloxy)butyl] 1,3-benzenedicarboxylate413-930-0130066-57-8Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H317

H400

H410
GHS07

GHS09

Wng
H317

H410
607-321-00-0(S)-methyl-2-chloropropionate412-470-873246-45-4Flam. Liq. 3

STOT RE 2 *

Eye Irrit. 2
H226

H373 **

H319
GHS02

GHS08

Wng
H226

H373 **

H319
607-322-00-64-(4,4-dimethyl-3-oxo-pyrazolidin-1-yl)-benzoic acid413-120-7107144-30-9Acute Tox. 4 *

Aquatic Chronic 2
H302

H411
GHS07

GHS09

Wng
H302

H411
607-323-00-12-(1-(2-hydroxy-3,5-di-tert-pentyl-phenyl)ethyl)-4,6-di-tert-pentylphenyl acrylate413-850-6123968-25-2Aquatic Chronic 4H413H413
607-324-00-7reaction mass of: N,N-di(hydrogenated alkyl C14-C18)phtalamic acid;

dihydrogenated alkyl (C14-C18)amine
413-800-3Aquatic Chronic 4H413H413
607-325-00-2(S)-2-chloropropionic acid411-150-529617-66-1Acute Tox. 4 *

Acute Tox. 4 *

Skin Corr. 1A
H312

H302

H314
GHS05

GHS07

Dgr
H312

H302

H314
607-326-00-8reaction mass of: isobutyl hydrogen 2-(α-2,4,6-trimethylnon-2-enyl)succinate;

isobutyl hydrogen 2-(ß-2,4,6-trimetyhylnon-2-enyl)succinate
410-720-0141847-13-4Eye Dam. 1

Aquatic Chronic 2
H318

H411
GHS05

GHS09

Dgr
H318

H411
607-327-00-32-(2-iodoethyl)-1,3-propanediol diacetate411-780-0127047-77-2Acute Tox. 4 *

Aquatic Chronic 2
H302

H411
GHS07

GHS09

Wng
H302

H411
607-328-00-9methyl 4-bromomethyl-3-methoxybenzoate410-310-170264-94-7Skin Irrit. 2

Eye Dam. 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H315

H318

H317

H400

H410
GHS05

GHS07

GHS09

Dgr
H315

H318

H317

H410
607-329-00-4reaction mass of: sodium 2-(C12-18-n-alkyl)amino-1,4-butandioate;

sodium 2-octadecenyl-amino-1,4-butandioate
411-250-9Skin Sens. 1H317GHS07

Wng
H317
607-330-00-X(S)-2,3-dihydro-1H-indole-2-carboxylic acid410-860-279815-20-6Repr. 2

STOT RE 2 *

Skin Sens. 1
H361f ***

H373 **

H317
GHS08

GHS07

Wng
H361f ***

H373 **

H317
607-331-00-5reaction mass of: bis(2,2,6,6-tetramethyl-1-octyloxypiperidin-4-yl)-1,10-decanedioate;

1,8-bis[(2,2,6,6-tetramethyl-4-((2,2,6,6-tetramethyl-1-octyloxypiperidin-4-yl)-decan-1,10-dioyl)piperidin-1-yl)oxy]octane
406-750-9Aquatic Chronic 4H413H413
607-332-00-0cyclopentyl chloroformate411-460-050715-28-1Flam. Liq. 3

Acute Tox. 3 *

Acute Tox. 4 *

STOT RE 2 *

Eye Dam. 1

Skin Sens. 1
H226

H331

H302

H373 **

H318

H317
GHS02

GHS06

GHS08

GHS05

Dgr
H226

H331

H302

H373 **

H318

H317
607-333-00-6reaction mass of: dodecyl N-(2,2,6,6-tetramethylpiperidin-4-yl)-β-alaninate;

tetradecyl N-(2,2,6,6-tetramethylpiperidin-4-yl)-β-alaninate
405-670-1Acute Tox. 4 *

STOT RE 2 *

Skin Corr. 1B

Aquatic Acute 1

Aquatic Chronic 1
H302

H373 **

H314

H400

H410
GHS08

GHS05

GHS07

GHS09

Dgr
H302

H373 **

H314

H410
607-334-00-1ethyl 1-ethyl-6,7,8-trifluoro-1,4-dihydro-4-oxoquinoline-3-carboxylate405-880-3100501-62-0Skin Sens. 1

Aquatic Chronic 3
H317

H412
GHS07

Wng
H317

H412
607-335-00-7methyl (R)-2-(4-(3-chloro-5-trifluoromethyl-2-pyridyloxy)phenoxy)propionate406-250-072619-32-0Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1
H302

H400

H410
GHS07

GHS09

Wng
H302

H410
607-336-00-24-methyl-8-methylenetricyclo[3.3.1.13,7]dec-2-yl acetate406-560-6122760-85-4Skin Irrit. 2

Skin Sens. 1

Aquatic Chronic 2
H315

H317

H411
GHS07

GHS09

Wng
H315

H317

H411
607-337-00-8di-tert-(C12-14)-alkylammonium 2-benzothiazolylthiosuccinate406-052-4125078-60-6Flam. Liq. 3

Acute Tox. 4 *

Skin Irrit. 2

Eye Dam. 1

Aquatic Chronic 2
H226

H302

H315

H318

H411
GHS02

GHS05

GHS07

GHS09

Dgr
H226

H302

H315

H318

H411
607-338-00-32-methylpropyl 2-hydroxy-2-methylbut-3-enoate406-235-972531-53-4Eye Irrit. 2

Skin Irrit. 2
H319

H315
GHS07

Wng
H319

H315
607-339-00-92,3,4,5-tetrachlorobenzoylchloride406-760-342221-52-3Acute Tox. 4 *

Skin Corr. 1B

Skin Sens. 1
H302

H314

H317
GHS05

GHS07

Dgr
H302

H314

H317
607-340-00-41,3-bis(4-benzoyl-3-hydroxyphenoxy)prop-2-yl acetate406-990-4Aquatic Chronic 2H411GHS09H411
607-341-00-X(9S)-9-amino-9-deoxyerythromycin406-790-726116-56-3Eye Dam. 1

Aquatic Acute 1

Aquatic Chronic 1
H318

H400

H410
GHS05

GHS09

Dgr
H318

H410
607-342-00-54-chlorobutyl veratrate410-950-169788-75-6Skin Sens. 1

Aquatic Chronic 2
H317

H411
GHS07

GHS09

Wng
H317

H411
607-343-00-04,7-methanooctahydro-1H-indene-diyldimethyl bis(2-carboxybenzoate)407-410-2Aquatic Chronic 4H413H413
607-344-00-6reaction mass of: 3-(N-(3-dimethylaminopropyl)-(C4-8)perfluoroalkylsulfonamido)propionic acid;

N-[dimethyl-3-(C4-8-perfluoroalkylsulfonamido)propylammonium propionate;

3-(N-(3-dimethyl-propylammonium)-(C4-8)perfluoroalkylsulfonamido)propionic acid propionate
407-810-7STOT RE 2 *H373 **GHS08

Wng
H373 **
607-345-00-1potassium 2-(2,4-dichlorophenoxy)-(R)-propionate413-580-9113963-87-4Acute Tox. 4 *

Skin Irrit. 2

Eye Dam. 1

Skin Sens. 1
H302

H315

H318

H317
GHS05

GHS07

Dgr
H302

H315

H318

H317
607-346-00-73-icosyl-4-henicosylidene-2-oxetanone401-210-983708-14-9Aquatic Chronic 4H413H413
607-347-00-2sodium (R)-2-(2,4-dichlorophenoxy)propionate413-340-3119299-10-4Acute Tox. 4 *

Skin Irrit. 2

Eye Dam. 1

Skin Sens. 1
H302

H315

H318

H317
GHS05

GHS07

Dgr
H302

H315

H318

H317
607-348-00-8magnesium bis((R)-2-(2,4-dichlorophenoxy)propionate)413-360-2Acute Tox. 4 *

Skin Irrit. 2

Eye Dam. 1

Skin Sens. 1
H302

H315

H318

H317
GHS05

GHS07

Dgr
H302

H315

H318

H317
607-349-00-3mono-(tetrapropylammonium) hydrogen 2,2'-dithiobisbenzoate411-270-8Aquatic Chronic 3H412H412
607-350-00-9bis(4-(1,2-bis(ethoxycarbonyl)ethylamino)-3-methylcyclohexyl)methane412-060-9136210-32-7Skin Sens. 1

Aquatic Chronic 3
H317

H412
GHS07

Wng
H317

H412
607-351-00-4methyl O-(4-amino-3,5-dichloro-6-fluoropyridin-2-yloxy)acetate407-550-469184-17-4Aquatic Chronic 2H411GHS09H411
607-352-00-X4,4'-oxydiphthalic anhydride412-830-41823-59-2Aquatic Chronic 3H412H412
607-353-00-5reaction mass of: ethyl exo-tricyclo[5.2.1.02,6]decane-endo-2-carboxylate;

ethyl endo-tricyclo[5.2.1.02,6]decane-exo-2-carboxylate
407-520-080657-64-3Skin Irrit. 2

Aquatic Chronic 2
H315

H411
GHS07

GHS09

Wng
H315

H411
607-354-00-0ethyl 2-cyclohexylpropionate412-280-52511-00-4Aquatic Chronic 2H411GHS09H411
607-355-00-6p-tolyl 4-chlorobenzoate411-530-015024-10-9Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H317

H400

H410
GHS07

GHS09

Wng
H317

H410
607-356-00-1ethyl trans-2,2,6-trimethylcyclohexanecarboxylate412-540-8Skin Irrit. 2

Aquatic Chronic 2
H315

H411
GHS07

GHS09

Wng
H315

H411
607-357-00-7reaction mass of: trans-4-acetoxy-4-methyl-2-propyl-tetrahydro-2H-pyran;

cis-4-acetoxy-4-methyl-2-propyl-tetrahydro-2H-pyran
412-450-9131766-73-9Skin Sens. 1H317GHS07

Wng
H317
607-358-00-2(1S,3S,5R,6R)-(4-nitrophenylmethyl)-1-dioxo-6-phenylacetamido-penam-3-carboxylate412-670-554275-93-3Resp. Sens. 1H334GHS08

Dgr
H334
607-359-00-8(1S,4R,6R,7R)-(4-nitrophenylmethyl)3-methylene-1-oxo-7-phenylacetamido-cepham-4-carboxylateido-penam-3-carboxylate412-800-076109-32-5Resp. Sens. 1H334GHS08

Dgr
H334
607-360-00-3sodium 3-acetoacetylamino-4-methoxytolyl-6-sulfonate411-680-7133167-77-8Skin Sens. 1H317GHS07

Wng
H317
607-361-00-9methyl (R)-2-(4-hydroxyphenoxy)propionate411-950-496562-58-2Eye Dam. 1

Aquatic Chronic 3
H318

H412
GHS05

Dgr
H318

H412
607-362-00-4reaction mass of: (3-methoxy)propylammonium/[tris-(2-hydroxyethyl)]ammonium 2-(2-(bis(2-hydroxyethyl)amino)ethoxycarbonylmethyl)hexadec-4-enoate;

(3-methoxy)propylammonium/[tris-(2-hydroxyethyl)]ammonium 2-(2-(bis(2-hydroxyethyl)amino)ethoxycarbonylmethyl)tetradec-4-enoate;

(3-methoxy)propylammonium/[tris-(2-hydroxyethyl)]ammonium 2-(3-methoxypropylcarbamoylmethyl)hexadec-4-enoate;

(3-methoxy)propylammonium/[tris-(2-hydroxyethyl)]ammonium 2-(3-methoxypropylcarbamoylmethyl)tetradec-4-enoate
413-500-2Skin Irrit. 2

Eye Dam. 1

Aquatic Chronic 2
H315

H318

H411
GHS05

GHS09

Dgr
H315

H318

H411
607-363-00-Xmethyl-3-methoxyacrylate412-900-45788-17-0Skin Sens. 1H317GHS07

Wng
H317
607-364-00-53-phenyl-7-[4-(tetrahydrofurfuryloxy)phenyl]-1,5-dioxa-s-indacen-2,6-dione413-330-9134724-55-3Aquatic Chronic 4H413H413
607-365-00-02-(2-amino-1,3-thiazol-4-yl)-(Z)-2-methoxyiminoacetyl chloride hydrochloride410-620-7119154-86-8Acute Tox. 4 *

Skin Corr. 1B

Skin Sens. 1
H302

H314

H317
GHS05

GHS07

Dgr
H302

H314

H317
607-366-00-63,5-dimethylbenzoyl chloride413-010-96613-44-1Skin Corr. 1B

Skin Sens. 1
H314

H317
GHS05

GHS07

Dgr
H314

H317
607-367-00-1potassium bis(N-carboxymethyl)-N-methyl-glycinato-(2-)N,O,O,N)-ferrate-(1-) monohydrate411-640-9153352-59-1Acute Tox. 4 *H302GHS07

Wng
H302
607-368-00-71-(N,N-dimethylcarbamoyl)-3-tert-butyl-5-carbethoxymethylthio-1H-1,2,4-triazole411-650-3110895-43-7Acute Tox. 3 *

Acute Tox. 3 *

Aquatic Acute 1

Aquatic Chronic 1
H331

H301

H400

H410
GHS06

GHS09

Dgr
H331

H301

H410
607-369-00-2reaction mass of: trans-(2R)-5-acetoxy-1,3-oxathiolane-2-carboxylic acid;

cis-(2R)-5-acetoxy-1,3-oxathiolane-2-carboxylic acid
411-660-8147027-04-1Acute Tox. 4 *

Skin Irrit. 2

Eye Dam. 1

Skin Sens. 1
H302

H315

H318

H317
GHS05

GHS07

Dgr
H302

H315

H318

H317
607-370-00-82-[[2-(acetyloxy)-3-(1,1-dimethyl-ethyl)-5-methylphenyl]methyl]-6-(1,1-dimethylethyl)-4-methylphenol412-210-341620-33-1Aquatic Acute 1

Aquatic Chronic 1
H400

H410
GHS09

Wng
H410
607-371-00-33-ethyl 5-methyl 4-(2-chlorophenyl)-1,4-dihydro-2-[2-(1,3-dihydro-1,3-dioxo-(2H)isoindol-2-yl)-ethoxymethyl]-6-methyl-3,5-pyridinedicarboxylate413-410-388150-62-3Aquatic Chronic 4H413H413
607-372-00-9ethoxylated bis phenol A di-(norbornene carboxylate)412-410-0Aquatic Chronic 3H412H412
607-373-00-4(±) tetrahydrofurfuryl (R)-2-[4-(6-chloroquinoxalin-2-yloxy)phenyloxy]propionate414-200-4119738-06-6Muta. 2

Repr. 1B

Acute Tox. 4 *

STOT RE 2 *

Aquatic Acute 1

Aquatic Chronic 1
H341

H360Df

H302

H373 **

H400

H410
GHS08

GHS07

GHS09

Dgr
H341

H360Df

H302

H373 **

H410
607-374-00-X5-amino-2,4,6-triiodo-1,3-benzenedicarbonyldichloride417-220-137441-29-5Skin Sens. 1

Aquatic Chronic 2
H317

H411
GHS07

GHS09

Wng
H317

H411
607-375-00-5reaction mass of: cis-4-hydroxy-3-(1,2,3,4-tetrahydro-3-(4-(4-trifluoromethylbenzyloxy)phenyl)-1-naphthyl)coumarin;

trans-4-hydroxy-3-(1,2,3,4-tetrahydro-3-(4-(4-trifluoromethylbenzyloxy)phenyl)-1-naphthyl)coumarin
421-960-090035-08-8Acute Tox. 2 *

Acute Tox. 1

Acute Tox. 2 *

STOT RE 1

Aquatic Acute 1

Aquatic Chronic 1
H330

H310

H300

H372 **

H400

H410
GHS06

GHS08

GHS09

Dgr
H330

H310

H300

H372 **

H410
607-376-00-0benzyl 2,4-dibromobutanoate420-710-823085-60-1Repr. 2

Skin Irrit. 2

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H361f ***

H315

H317

H400

H410
GHS08

GHS07

GHS09

Wng
H361f ***

H315

H317

H410
607-377-00-6trans-4-cyclohexyl-L-proline monohydrochloride419-160-190657-55-9Repr. 2

Acute Tox. 4 *

Skin Irrit. 2

Eye Dam. 1

Skin Sens. 1
H361f ***

H302

H315

H318

H317
GHS08

GHS05

GHS07

Dgr
H361f ***

H302

H315

H318

H317
607-378-00-1ammonium (Z)-α-methoxyimino-2-furylacetate405-990-197148-39-5Flam. Sol. 2H228GHS02

Dgr
H228T
607-379-00-7reaction mass of: 2-[N-(2-hydroxyethyl)stearamido]ethyl stearate;

sodium [bis[2-(stearoyloxy)ethyl]amino]methylsulfonate;

sodium [bis(2-hydroxyethyl)amino]methylsulfonate;

N,N-bis(2-hydroxyethyl)stearamide
401-230-8Aquatic Chronic 3H412H412
607-380-00-2reaction mass of: ammonium-1,2-bis(hexyloxycarbonyl)ethanesulfonate;

ammonium-1-hexyloxycarbonyl-2-octyloxycarbonylethanesulfonate;

ammonium-2-hexyloxycarbonyl-1-octyloxycarbonylethanesulfonate
407-320-3Skin Irrit. 2

Eye Dam. 1

Aquatic Chronic 3
H315

H318

H412
GHS05

Dgr
H315

H318

H412
607-381-00-8reaction mass of triesters of 2,2-bis(hydroxymethyl)butanol with C7-alkanoic acids and 2-ethylhexanoic acid413-710-4Aquatic Chronic 4H413H413
607-382-00-32-((4-amino-2-nitrophenyl)amino)benzoic acid411-260-3117907-43-4Eye Dam. 1

Skin Sens. 1

Aquatic Chronic 3
H318

H317

H412
GHS05

GHS07

Dgr
H318

H317

H412
607-383-00-9reaction mass of: 2,2,6,6-tetramethylpiperidin-4-yl-hexadecanoate;

2,2,6,6-tetramethylpiperidin-4-yl-octadecanoate
415-430-886403-32-9Eye Dam. 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H318

H317

H400

H410
GHS05

GHS07

GHS09

Dgr
H318

H317

H410
607-384-00-4reaction mass of: esters of C14-C15 branched alcohols with 3,5-di-t-butyl-4-hydroxyphenyl propionic acid;

C15 branched and linear alkyl 3,5-bis(1,1-dimethylethyl)-4-hydroxybenzenepropanoate;

C13 branched and linear alkyl 3,5-bis(1,1-dimethylethyl)-4-hydroxybenzenepropanoate
413-750-2171090-93-0Aquatic Chronic 4H413H413
607-385-00-XCopolymer of vinyl-alcohol and vinyl acetate partially acetilized with 4-(2-(4-formylphenyl)ethenyl)-1-methylpyridinium methylsulfate414-590-6125229-74-5Aquatic Chronic 2H411GHS09H411
607-386-00-5reaction mass of: tetradecanoic acid (42,5-47,5 %);

poly(1-7)lactate esters of tetradecanoic acid (52,5-57,5 %)
412-580-6174591-51-6Skin Irrit. 2

Eye Dam. 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H315

H318

H317

H400

H410
GHS05

GHS07

GHS09

Dgr
H315

H318

H317

H410
607-387-00-0reaction mass of: dodecanoic acid (35-40 %);

poly(1-7)lactate esters of dodecanoic acid (60-65 %)
412-590-058856-63-6Skin Irrit. 2

Eye Dam. 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H315

H318

H317

H400

H410
GHS05

GHS07

GHS09

Dgr
H315

H318

H317

H410
607-388-00-64-ethylamino-3-nitrobenzoic acid412-090-22788-74-1Acute Tox. 4 *

Skin Sens. 1

Aquatic Chronic 3
H302

H317

H412
GHS07

Wng
H302

H317

H412
607-389-00-1trisodium N,N-bis(carboxymethyl)-3-amino-2-hydroxypropionate414-130-4119710-96-2Acute Tox. 4 *H302GHS07

Wng
H302
607-390-00-71,2,3,4-tetrahydro-6-nitro-quinoxaline414-270-641959-35-7Acute Tox. 4 *

Aquatic Chronic 2
H302

H411
GHS07

GHS09

Wng
H302

H411
607-391-00-2dimethylcyclopropane-1,1-dicarboxylate414-240-26914-71-2Aquatic Chronic 3H412H412
607-392-00-82-phenoxyethyl 4-((5-cyano-1,6-dihydro-2-hydroxy-1,4-dimethyl-6-oxo-3-pyridinyl)azo)benzoate414-260-188938-37-8Aquatic Chronic 4H413H413
607-393-00-33-(cis-1-propenyl)-7-amino-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid415-750-8106447-44-3Skin Sens. 1H317GHS07

Wng
H317
607-394-00-95-methylpyrazine-2-carboxylic acid413-260-95521-55-1Eye Dam. 1H318GHS05

Dgr
H318
607-395-00-4reaction mass of: sodium 1-tridecyl-4-allyl-(2 or 3)-sulfobutanedioate;

sodium 1-dodecyl-4-allyl-(2 or 3)-sulfobutanedioate
410-230-7Skin Corr. 1B

Skin Sens. 1

Aquatic Chronic 2
H314

H317

H411
GHS05

GHS07

GHS09

Dgr
H314

H317

H411
607-396-00-Xbis(1,2,2,6,6-pentamethyl-4-piperidinyl) 2-(4-methoxybenzylidene)malonate414-840-4147783-69-5Aquatic Acute 1

Aquatic Chronic 1
H400

H410
GHS09

Wng
H410
607-397-00-5reaction mass of: Ca salicylates (branched C10-14 and C18-30 alkylated);

Ca phenates (branched C10-14 and C18-30 alkylated);

Ca sulfurized phenates (branched C10-14 and C18-30 alkylated)
415-930-6Skin Sens. 1H317GHS07

Wng
H317
607-398-00-0ethyl N-(5-chloro-3-(4-(diethylamino)-2-methylphenylimino)-4-methyl-6-oxo-1,4-cyclohexadienyl)carbamate414-820-5125630-94-6Aquatic Acute 1

Aquatic Chronic 1
H400

H410
GHS09

Wng
H410
607-399-00-62,2-dimethyl 3-methyl-3-butenyl propanoate415-610-6104468-21-5Skin Irrit. 2

Aquatic Chronic 3
H315

H412
GHS07

Wng
H315

H412
607-400-00-Xmethyl 3-[[(dibutylamino)thioxomethyl]thio]propanoate414-400-132750-89-3Aquatic Acute 1

Aquatic Chronic 1
H400

H410
GHS09

Wng
H410
607-401-00-5ethyl 3-hydroxy-5-oxo-3-cyclohexene-1-carboxylate414-450-488805-65-6Skin Irrit. 2

Eye Dam. 1

Skin Sens. 1
H315

H318

H317
GHS05

GHS07

Dgr
H315

H318

H317
607-402-00-0methyl N-(phenoxycarbonyl)-L-valinate414-500-5153441-77-1Aquatic Chronic 3H412H412
607-403-00-6reaction mass of: bis(1S,2S,4S)-(1-benzyl-4-tert-butoxycarboxamido-2-hydroxy-5-phenyl)pentylammonium succinate;

isopropyl alcohol
414-810-0STOT RE 2 *

Eye Dam. 1

Aquatic Acute 1

Aquatic Chronic 1
H373 **

H318

H400

H410
GHS08

GHS05

GHS09

Dgr
H373 **

H318

H410
607-404-00-1reaction mass of: ((Z)-3,7-dimethyl-2,6-octadienyl)oxycarbonylpropanoic acid;

di-((E)-3,7-dimethyl-2,6-octadienyl) butandioate;

di-((Z)-3,7-dimethyl-2,6-octadienyl) butandioate;

(Z)-3,7-dimethyl-2,6-octadienyl butandioate;

((E)-3,7-dimethyl-2,6-octadienyl)oxycarbonylpropanoic acid
415-190-4Skin Sens. 1H317GHS07

Wng
H317
607-405-00-72-hexyldecyl-p-hydroxybenzoate415-380-7148348-12-3Aquatic Chronic 2H411GHS09H411
607-406-00-2potassium 2,5-dichlorobenzoate415-700-5184637-62-5Acute Tox. 4 *

Eye Dam. 1
H302

H318
GHS05

GHS07

Dgr
H302

H318
607-407-00-8ethyl 2-carboxy-3-(2-thienyl)propionate415-680-8143468-96-6Skin Irrit. 2

Eye Dam. 1

Skin Sens. 1
H315

H318

H317
GHS05

GHS07

Dgr
H315

H318

H317
607-408-00-3potassium N-(4-fluorophenyl)glycinate415-710-1184637-63-6STOT RE 2 *

Eye Dam. 1

Skin Sens. 1

Aquatic Chronic 3
H373 **

H318

H317

H412
GHS08

GHS05

GHS07

Dgr
H373 **

H318

H317

H412
607-409-00-9reaction mass of: (3R)-[1S-(1α, 2α, 6β-((2S)-2-methyl-1-oxo-butoxy)-8aγ)hexahydro-2,6-dimethyl-1-naphthalene]-3,5-dihydroxyheptanoic acid;

inert biomass from Aspergillus terreus
415-840-7Skin Sens. 1

Aquatic Chronic 3
H317

H412
GHS07

Wng
H317

H412
607-410-00-4mono[2-(dimethylamino)ethyl]monohydrogen-2-(hexadec-2-enyl)butanedioate and/or mono[2-(dimethylamino)ethyl]monohydrogen-3-(hexadec-2-enyl)butanedioate415-880-5779343-34-9Skin Irrit. 2

Eye Dam. 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H315

H318

H317

H400

H410
GHS05

GHS07

GHS09

Dgr
H315

H318

H317

H410
607-411-00-Xoxiranemethanol, 4-methylbenzene-sulfonate, (S)-417-210-770987-78-9Carc. 1B

Muta. 2

Eye Dam. 1

Skin Sens. 1

Aquatic Chronic 2
H350

H341

H318

H317

H411
GHS08

GHS05

GHS07

GHS09

Dgr
H350

H341

H318

H317

H411
607-412-00-5ethyl 2-(1-cyanocyclohexyl)acetate415-970-4133481-10-4Acute Tox. 4 *

STOT RE 2 *

Aquatic Chronic 3
H302

H373 **

H412
GHS08

GHS07

Wng
H302

H373 **

H412
607-413-00-0trans-4-phenyl-L-proline416-020-196314-26-0Repr. 2

Skin Sens. 1
H361f ***

H317
GHS08

GHS07

Wng
H361f ***

H317
607-414-00-6tris(2-ethylhexyl)-4,4',4''-(1,3,5-triazine-2,4,6-triyltriimino)tribenzoate402-070-188122-99-0Aquatic Chronic 4H413H413
607-415-00-1poly-(methyl methacrylate)-co-(butylmethacrylate)-co-(4-acryloxybutyl-isopropenyl-α,α-dimethylbenzyl carbamate)-co-(maleicanhydride)419-590-1Flam. Sol. 1

Skin Sens. 1
H228

H317
GHS02

GHS07

Dgr
H228

H317
T
607-416-00-74-(2-carboxymethylthio)ethoxy-1-hydroxy-5-isobutyloxycarbonylamino-N-(3-dodecyloxypropyl)-2-naphthamide420-730-7Aquatic Acute 1

Aquatic Chronic 1
H400

H410
GHS09

Wng
H410
607-418-00-82-ethylhexyl 4-aminobenzoate420-170-326218-04-2Aquatic Acute 1

Aquatic Chronic 1
H400

H410
GHS09

Wng
H410
607-419-00-3(3'-carboxymethyl-5-(2-(3-ethyl-3H-benzothiazol-2-ylidene)-1-methyl-ethylidene)-4,4'-dioxo-2'-thioxo-(2,5')bithiazolidinyliden-3-yl)-acetic acid422-240-9166596-68-5Eye Dam. 1

Skin Sens. 1
H318

H317
GHS05

GHS07

Dgr
H318

H317
607-420-00-92,2-bis(hydroxymethyl)butanoic acid424-090-110097-02-6Eye Dam. 1

Aquatic Chronic 3
H318

H412
GHS05

Dgr
H318

H412
607-421-00-4cypermethrin cis/trans +/- 40/60;

(RS)-α-cyano-3-phenoxybenzyl (1RS,3RS;1RS,3SR)-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate
257-842-952315-07-8Acute Tox. 4 *

Acute Tox. 4 *

STOT SE 3

Aquatic Acute 1

Aquatic Chronic 1
H332

H302

H335

H400

H410
GHS07

GHS09

Wng
H332

H302

H335

H410
607-422-00-Xα-cypermethrin257-842-967375-30-8Acute Tox. 3 *

STOT RE 2 *

STOT SE 3

Aquatic Acute 1

Aquatic Chronic 1
H301

H373 **

H335

H400

H410
GHS06

GHS08

GHS09

Dgr
H301

H373 **

H335

H410
607-423-00-5esters of mecoprop and of mecoprop-PAcute Tox. 4 *

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H302

H317

H400

H410
GHS07

GHS09

Wng
H302

H317

H410
A
607-424-00-0trifloxystrobin (ISO);

(E,E)-α-methoxyimino-{2-[[[[1-[3-(trifluoromethyl)phenyl]ethylidene]amino]oxy]methyl]benzeneacetic acid methyl ester
141517-21-7Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H317

H400

H410
GHS07

GHS09

Wng
H317

H410
607-425-00-6metalaxyl (ISO);

methyl-N-(2,6-dimethylphenyl)-N-(methoxyacetyl)-DL-alaninate
260-979-757837-19-1Acute Tox. 4 *

Skin Sens. 1

Aquatic Chronic 3
H302

H317

H412
GHS07

Wng
H302

H317

H412
607-426-00-11,2-benzenedicarboxylic acid, dipentylester, branched and linear; [1]

n-pentyl-isopentylphthalate; [2]

di-n-pentyl phthalate; [3]

diisopentylphthalate [4]
284-032-2 [1]

- [2]

205-017-9 [3]

210-088-4 [4]
84777-06-0 [1]

- [2]

131-18-0 [3]

605-50-5 [4]
Repr. 1B

Aquatic Acute 1
H360FD

H400
GHS08

GHS09

Dgr
H360FD

H400
607-427-00-7bromoxynil heptanoate (ISO);

2,6-dibromo-4-cyanophenyl heptanoate
260-300-456634-95-8Repr. 2

Acute Tox. 4 *

Acute Tox. 4 *

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H361d ***

H332

H302

H317

H400

H410
GHS08

GHS07

GHS09

Wng
H361d ***

H332

H302

H317

H410
607-430-00-3BBP;

benzyl butyl phthalate e
201-622-785-68-7Repr. 1B

Aquatic Acute 1

Aquatic Chronic 1
H360Df

H400

H410
GHS08

GHS09

Dgr
H360Df

H410
607-431-00-9prallethrin (ISO);

ETOC;

2-methyl-4-oxo-3-(prop-2-ynyl)cyclopent-2-en-1-yl 2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate
245-387-923031-36-9Acute Tox. 3 *

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1
H331

H302

H400

H410
GHS06

GHS09

Dgr
H331

H302

H410
607-432-00-4S-metolachlor;

reaction mass of (S)-2-chloro-N-(2-ethyl-6-methyl-phenyl)-N-(2-methoxy-1-methyl-ethyl)-acetamide (80-100 %); [1] (R)-2-chloro-N-(2-ethyl-6-methyl-phenyl)-N-(2-methoxy-1-methyl-ethyl)-acetamide (0-20 %) [2]
- [1]

- [2]
87392-12-9 [1]

178961-20-1 [2]
Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H317

H400

H410
GHS07

GHS09

Wng
H317

H410
607-433-00-Xcypermethrin cis/trans +/- 80/20;

(RS)-α-cyano-3-phenoxybenzyl (1RS; 3RS; 1RS, 3SR)-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate
257-842-952315-07-8Acute Tox. 4 *

STOT SE 3

Skin Irrit. 2

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H302

H335

H315

H317

H400

H410
GHS07

GHS09

Wng
H302

H335

H315

H317

H410
607-434-00-5mecoprop-P [1] and its salts;

(R)-2-(4-chloro-2-methylphenoxy)propionic acid
240-539-016484-77-8Acute Tox. 4 *

Eye Dam. 1

Aquatic Chronic 2
H302

H318

H411
GHS05

GHS07

GHS09

Dgr
H302

H318

H411
607-435-00-02S-isopropyl-5R-methyl-1R-cyclohexyl 2,2-dihydroxyacetate416-810-6111969-64-3STOT RE 2 *

Eye Dam. 1

Aquatic Chronic 2
H373 **

H318

H411
GHS08

GHS05

GHS09

Dgr
H373 **

H318

H411
607-436-00-62-hydroxy-3-(2-ethyl-4-methylimidazoyl)propyl neodecanoate417-350-9Skin Irrit. 2

Eye Dam. 1

Aquatic Acute 1

Aquatic Chronic 1
H315

H318

H400

H410
GHS05

GHS09

Dgr
H315

H318

H410
607-437-00-13-(4-aminophenyl)-2-cyano-2-propenoic acid417-480-6252977-62-1Skin Sens. 1H317GHS07

Wng
H317
607-438-00-7methyl-2-[(aminosulfonyl)methyl]benzoate419-010-5112941-26-1Acute Tox. 4 *

Eye Irrit. 2
H302

H319
GHS07

Wng
H302

H319
607-439-00-2methyl tetrahydro-2-furancarboxylate420-670-137443-42-8Eye Dam. 1H318GHS05

Dgr
H318
607-440-00-8methyl 2-aminosulfonyl-6-(trifluoromethyl)pyridine-3-c arboxylate421-220-7144740-59-0Skin Sens. 1

Aquatic Chronic 2
H317

H411
GHS07

GHS09

Wng
H317

H411
607-441-00-33-[3-(2-dodecyloxy-5-methylphenylcarbamoyl)-4-hydroxy-1-naphthylthio]propionic acid421-490-6167684-63-1Aquatic Chronic 4H413H413
607-442-00-9benzyl [hydroxy-(4-phenylbutyl)phosphinyl] acetate416-050-587460-09-1Eye Dam. 1H318GHS05

Dgr
H318
607-443-00-4bis(2,4-di-tert-butyl-6-methylphenyl)ethyl phosphate416-140-4145650-60-8Aquatic Chronic 4H413H413
607-444-00-Xreaction mass of: cis-1,4-dimethylcyclohexyl dibenzoate;

trans-1,4-dimethylcyclohexyl dibenzoate
416-230-335541-81-2Aquatic Chronic 4H413H413
607-445-00-5Iron (III) tris(4-methylbenzenesulfonate)420-960-877214-82-5Eye Dam. 1H318GHS05

Dgr
H318
607-446-00-0methyl 2-[4-(2-chloro-4-nitrophenylazo)-3-(1-oxopropyl)amino]phenylaminopropionate416-240-8155522-12-6Skin Sens. 1

Aquatic Chronic 4
H317

H413
GHS07

Wng
H317

H413
607-447-00-6sodium 4-[4-(4-hydroxyphenylazo)phenylamino]-3-nitrobenzenesulfonate416-370-5156738-27-1Skin Sens. 1

Aquatic Chronic 3
H317

H412
GHS07

Wng
H317

H412
607-448-00-12,3,5,6-tetrafluorobenzoic acid416-800-1652-18-6Skin Irrit. 2

Eye Dam. 1
H315

H318
GHS05

Dgr
H315

H318
607-449-00-7reaction mass of: 4,4',4''-[(2,4,6-trioxo-1,3,5(2H,4H,6H)-triazine-1,3,5-triyl)tris[methylene(3,5,5-trimethyl-3,1-cyclohexanediyl)iminocarbonyloxy-2,1-ethanediyl(ethyl)amino]]trisbenzenediazoniumtri[bis(2-methylpropyl)naphthalenesulfonate];

4,4',4'',4'''-[[5,5'-[carbonylbis[imino(1,5,5-trimethyl-3,1-cyclohexanediyl)methylene]]-2,4,6-trioxo-1,3,5(2H,4H,6H)-triazine-1,1',3,3'-tetrayl]tetrakis[methylene(3,5,5-trimethyl-3,1-cyclohexanediyl)iminocarbonyloxy-2,1-ethanediyl(ethyl)amino]]tetrakisbenzenediazoniumtetra[bis(2-methylpropyl)naphthalenesulfonate]
417-080-1Self-react. D ****

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H242

H317

H400

H410
GHS02

GHS07

GHS09

Dgr
H242

H317

H410
607-450-00-22-mercaptobenzothiazolyl-(Z)-(2-aminothiazol-4-yl)-2-(tert-butoxycarbonyl) isopropoxyiminoacetate419-040-989604-92-2Aquatic Chronic 4H413H413
607-451-00-84-[4-amino-5-hydroxy-3-(4-(2-sulfoxyethylsulfonyl)phenylazo)-2,7-disulfonapht-6-ylazo]-6-[3-(4-amino-5-hydroxy-3-(4-(2-sulfoxyethylsulfonyl)phenylazo)-2,7-disulfonapht-6-ylazo]phenylcarbonylamino]benzenesulfonic acid, sodium salt417-640-5161935-19-9Eye Dam. 1

Skin Sens. 1
H318

H317
GHS05

GHS07

Dgr
H318

H317
607-453-00-94-benzyl-2,6-dihydroxy-4-aza-heptylene bis(2,2-dimethyloctanoate)418-100-1172964-15-7Skin Sens. 1

Aquatic Chronic 4
H317

H413
GHS07

Wng
H317

H413
607-454-00-4reaction mass of: trans-2-(1-methylethyl)-1,3-dioxane-5-carboxylic acid;

cis-2-(1-methylethyl)-1,3-dioxane-5-carboxylic acid
418-170-3116193-72-7Eye Dam. 1

Aquatic Chronic 3
H318

H412
GHS05

Dgr
H318

H412
607-455-00-X1-amino-4-(3-[4-chloro-6-(2,5-di-sulfophenylamino)-1,3,5-triazin-2-ylamino]-2,2-dimethyl-propylamino)-anthraquinone-2-sulfonic acid, sodium/lithium salt419-520-8172890-93-6Skin Sens. 1H317GHS07

Wng
H317
607-456-00-53-amino-4-chlorobenzoic acid, hexadecyl ester419-700-6143269-74-3Aquatic Chronic 2H411GHS09H411
607-457-00-0tetrasodium dihydrogen 1,1''-dihydroxy-8,8''-[p-phenylbis(imino-{6-[4-(2-aminoethyl)piperazin-1-yl]}-1,3,5-triazine-4,2-diyl-imino)]bis(2,2'-azonaphthalene-1',3,6-trisulfonate)420-350-1172277-97-3Eye Dam. 1

Aquatic Chronic 2
H318

H411
GHS05

GHS09

Dgr
H318

H411
607-458-00-6reaction mass of: 2-ethyl-[2,6-dibromo-4-[1-[3,5-dibromo-4-(2-hydroxyethoxy)phenyl]-1-methylethyl]phenoxy]propenoate;

2,2'-diethyl-[4,4'-bis(2,6-dibromophenoxy)-1-methylethylidene] dipropenoate;

2,2'-[(1-methylethylidene)bis[[2,6-dibromo-4,1-phenylene)oxy]ethanol]]
420-850-1Aquatic Chronic 2H411GHS09H411
607-459-00-1isopentyl 4-{2-[5-cyano-1,2,3,6-tetrahydro-1-(2-isopropoxyethoxy-carbonylmethyl)-4-methyl-2,6-dioxo-3-pyridylidene]hydrazino}benzoate418-930-4Aquatic Chronic 4H413H413
607-460-00-73-tridecyloxy-propyl-ammonium 9-octadecenoate418-990-1778577-53-0STOT RE 2 *

Eye Irrit. 2

Skin Irrit. 2

Aquatic Acute 1

Aquatic Chronic 1
H373 **

H319

H315

H400

H410
GHS08

GHS07

GHS09

Wng
H373 **

H319

H315

H410
607-461-00-2reaction mass of: pentasodium 2-{4-{3-methyl-4-[6-sulfonato-4-(2-sulfonato-phenylazo)-naphthalen-1-ylazo]-phenylamino}-6-[3-(2-sulfato-ethanesulfonyl)-phenylamino]-1,3,5-triazin-2-ylamino}-benzene-1,4-disulfonate;

pentasodium 2-{4-{3-methyl-4-[7-sulfonato-4-(2-sulfonato-phenylazo)-naphthalen-1-ylazo]-phenylamino}-6-[3-(2-sulfato-ethanesulfonyl)-phenylamino]-1,3,5-triazin-2-ylamino}-benzene-1,4-disulfonate
421-160-1Aquatic Chronic 3H412H412
607-462-00-8reaction mass of: 1-hexyl acetate;

2-methyl-1-pentyl acetate;

3-methyl-1-pentyl acetate;

4-methyl-1-pentyl acetate;

other mixed linear and branched C6-alkyl acetates
421-230-188230-35-7Aquatic Chronic 2H411GHS09H411
607-463-00-33-(phenothiazin-10-yl)propionic acid421-260-5362-03-8Aquatic Chronic 2H411GHS09H411
607-464-00-9reaction mass of: 7-chloro-1-ethyl-6-fluoro-1,4-dihydro-4-oxo-quinoline-3-carboxylic acid;

5-chloro-1-ethyl-6-fluoro-1,4-dihydro-4-oxo-quinoline-3-carboxylic acid
421-280-4Aquatic Chronic 3H412H412
607-465-00-4tris(2-hydroxyethyl)ammonium 7-{4-[4-(2-cyanoamino-4-hydroxy-6-oxidopyrimidin-5-ylazo)benzamido]-2-ethoxy-phenylazo}naphthalene-1,3-disulfonate421-440-3778583-04-3Aquatic Chronic 3H412H412
607-466-00-Xreaction mass of: phenyl 1-(1-[2-chloro-5-(hexadecyloxycarbonyl)phenylcarbamoyl]-3,3-dimethyl-2-oxobutyl)-1H-2,3,3a,7a-tetrahydrobenzotriazole-5-carboxylate;

phenyl 2-(1-(2-chloro-5-(hexadecyloxycarbonyl)phenylcarbamoyl)-3,3-dimethyl-2-oxobutyl)-1H-2,3,3a,7a-tetrahydrobenzotriazole-5-carboxylate;

phenyl 3-(1-(2-chloro-5-(hexadecyloxycarbonyl)phenylcarbamoyl)-3,3-dimethyl-2-oxobutyl)-1H-2,3,3a,7a-tetrahydrobenzotriazole-5-carboxylate
421-480-1Aquatic Chronic 2H411GHS09H411
607-467-00-51,1,3,3-tetrabutyl-1,3-ditinoxydicaprylate419-430-956533-00-7Acute Tox. 4 *

Acute Tox. 4 *

STOT RE 2 *

Skin Corr. 1B

Aquatic Acute 1

Aquatic Chronic 1
H312

H302

H373 **

H314

H400

H410
GHS08

GHS05

GHS07

GHS09

Dgr
H312

H302

H373 **

H314

H410
607-468-00-0reaction mass of: monosodium 4-((4-(5-sulfonato-2-methoxyphenylamino)-6-chloro-1,3,5-triazine-2-yl)amino)-2-((1,4-dimethyl-6-oxido-2-oxo-5-sulfonatomethyl-1,2-dihydropyridine-3-yl)azo)benzenesulfonate;

disodium 4-((4-(5-sulfonato-2-methoxyphenylamino)-6-chloro-1,3,5-triazine-2-yl)amino)-2-((1,4-dimethyl-6-oxido-2-oxo-5-sulfonatomethyl-1,2-dihydropyridine-3-yl)azo)benzenesulfonate;

trisodium 4-((4-(5-sulfonato-2-methoxyphenylamino)-6-chloro-1,3,5-triazine-2-yl)amino)-2-((1,4-dimethyl-6-oxido-2-oxo-5-sulfonatomethyl-1,2-dihydropyridine-3-yl)azo)benzenesulfonate;

tetrasodium 4-((4-(5-sulfonato-2-methoxyphenylamino)-6-chloro-1,3,5-triazine-2-yl)amino)-2-((1,4-dimethyl-6-oxido-2-oxo-5-sulfonatomethyl-1,2-dihydropyridine-3-yl)azo)benzenesulfonate
419-450-8Skin Sens. 1H317GHS07

Wng
H317
607-469-00-6disodium 7-((4,6-bis(3-diethylaminopropylamino)-1,3,5-triazine-2-yl)amino)-4-hydroxy-3-(4-(4-sulfonatophenylazo)phenylazo)-2-naphthalene sulfonate419-460-2120029-06-3Aquatic Chronic 3H412H412
607-470-00-1potassium sodium 6,13-dichloro-3,10-bis{2-[4-[3-(2-hydroxysulphonyloxyethanesulfonyl)phenylamino]-6-(2,5-disulfonatophenylamino)-1,3,5-triazin-2-ylamino]ethylamino}benzo[5,6][1,4]oxazino[2,3-b]phenoxazine-4,11-disulfonate414-100-0154336-20-6Eye Dam. 1

Aquatic Chronic 3
H318

H412
GHS05

Dgr
H318

H412
607-472-00-2ammonium iron(III) trimethylenediaminetetraacetate hemihydrate400-660-3111687-36-6Aquatic Chronic 2H411GHS09H411
607-474-00-3(4-(4-(4-dimethylaminobenzyliden-1-yl)-3-methyl-5-oxo-2-pyrazolin-1-yl)benzoic acid410-430-4117573-89-4Aquatic Chronic 4H413H413
607-475-00-9reaction mass of: tetrasodium 7-(4-[4-chloro-6-[methyl-(3-sulfonatophenyl)amino]-1,3,5-triazin-2-ylamino]-2-ureidophenylazo)naphthalene-1,3,6-trisulfonate;

tetrasodium 7-(4-[4-chloro-6-[methyl-(4-sulfonatophenyl)amino]-1,3,5-triazin-2-ylamino]-2-ureidophenylazo)naphthalene-1,3,6-trisulfonate (1:1)
412-940-2148878-18-6Skin Sens. 1H317GHS07

Wng
H317
607-476-00-4trisodium N,N-bis(carboxymethyl)-β-alanine414-070-9129050-62-0Skin Corr. 1B

Aquatic Chronic 3
H314

H412
GHS05

Dgr
H314

H412
607-478-00-5tetramethylammonium hydrogen phthalate416-900-579723-02-7Acute Tox. 3 *

STOT RE 2 *

Aquatic Acute 1
H301

H373 **

H400
GHS06

GHS08

GHS09

Dgr
H301

H373 **

H400
607-479-00-0hexadecyl 4-chloro-3-[2-(5,5-dimethyl-2,4-dioxo-1,3-oxazolidin-3-yl)-4,4-dimethyl-3-oxopentamido]benzoate418-550-9168689-49-4Aquatic Chronic 4H413H413
607-480-00-61,2-benzenedicarboxylic acid;

di-C7-11-branched and linear alkylesters
271-084-668515-42-4Repr. 1BH360DfGHS08

Dgr
H360Df
607-487-00-4reaction mass of: disodium 4-(3-ethoxycarbonyl-4-(5-(3-ethoxycarbonyl-5-hydroxy-1-(4-sulfonatophenyl)pyrazol-4-yl)penta-2,4-dienylidene)-4,5-dihydro-5-oxopyrazol-1-yl)benzenesulfonate;

trisodium 4-(3-ethoxycarbonyl-4-(5-(3-ethoxycarbonyl-5-oxido-1-(4-sulfonatophenyl)pyrazol-4-yl)penta-2,4-dienylidene)-4,5-dihydro-5-oxopyrazol-1-yl)benzenesulfonate
402-660-9Repr. 1B

Aquatic Chronic 3
H360D ***

H412
GHS08

Dgr
H360D ***

H412
607-488-00-Xethyl (2-acetylamino-5-fluoro-4-isothiocyanatophenoxy)acetate414-210-9147379-38-2Aquatic Acute 1

Aquatic Chronic 1
H400

H410
GHS09

Wng
H410
607-489-00-5reaction mass of: 2-ethylhexyl linolenate, linoleate and oleate;

2-ethylhexyl epoxyoleate;

2-ethylhexyl diepoxylinoleate;

2-ethylhexyl triepoxylinolenate
414-890-771302-79-9Skin Sens. 1H317GHS07

Wng
H317
607-490-00-0N-[2-hydroxy-3-(C12-16-alkyloxy)propyl]-N-methyl glycinate415-060-7Eye Dam. 1

Skin Sens. 1
H318

H317
GHS05

GHS07

Dgr
H318

H317
607-492-00-12-(1-(3',3'-dimethyl-1'-cyclohexyl)ethoxy)-2-methyl propyl propanoate415-490-5141773-73-1Aquatic Chronic 2H411GHS09H411
607-493-00-7methyl (3aR,4R,7aR)-2-methyl-4-(1S,2R,3-triacetoxypropyl)-3a,7a-dihydro-4H-pyrano[3,4-d]oxazole-6-carboxylate415-670-378850-37-0Eye Dam. 1H318GHS05

Dgr
H318
607-494-00-2bis(2-ethylhexyl)octylphosphonate417-170-052894-02-7Aquatic Acute 1

Aquatic Chronic 1
H400

H410
GHS09

Wng
H410
607-495-00-8sodium 4-sulfophenyl-6-((1-oxononyl)amino)hexanoate417-550-6168151-92-6Skin Sens. 1H317GHS07

Wng
H317
607-496-00-32,2'-methylenebis(4,6-di-tert-butyl-phenyl)-2-ethylhexyl phosphite418-310-3126050-54-2Aquatic Chronic 4H413H413
607-497-00-9cerium oxide isostearate419-760-3Aquatic Chronic 4H413H413
607-498-00-4(E)-3,7-dimethyl-2,6-octadienylhexadecanoate421-370-33681-73-0Skin Irrit. 2

Aquatic Chronic 4
H315

H413
GHS07

Wng
H315

H413
607-499-00-Xbis(dimethyl-(2-hydroxyethyl)ammonium) 1,2-ethanediyl-bis(2-hexadecenylsuccinate)421-660-1Eye Dam. 1

Skin Sens. 1

Aquatic Chronic 2
H318

H317

H411
GHS05

GHS07

GHS09

Dgr
H318

H317

H411
607-500-00-3calcium 2,2,bis[(5-tetrapropylene-2-hydroxy)phenyl]ethanoate421-670-4Skin Irrit. 2

Aquatic Acute 1

Aquatic Chronic 1
H315

H400

H410
GHS07

GHS09

Wng
H315

H410
607-501-00-9reaction mass of: triphenylthiophosphate and tertiary butylated phenyl derivatives421-820-9192268-65-8Aquatic Chronic 4H413H413
607-502-00-4(N-benzyl-N,N,N-tributyl)ammonium 4-dodecylbenzenesulfonate422-200-0178277-55-9Skin Corr. 1B

Acute Tox. 4 *

Aquatic Chronic 2
H314

H302

H411
GHS05

GHS07

GHS09

Dgr
H314

H302

H411
607-503-00-X2,4,6-tri-n-propyl-2,4,6-trioxo-1,3,5,2,4,6-trioxatriphosphorinane422-210-568957-94-8Skin Corr. 1BH314GHS05

Dgr
H314
607-505-00-0pentasodium 7-(4-(4-(5-amino-4-sulfonato-2-(4-((2-(sulfonato-ethoxy)sulfonyl)phenylazo)phenylamino)-6-chloro-1,3,5-triazin-2-yl)amino-2-ureidophenylazo)naphtalene-1,3,6-trisulfonate422-930-1Aquatic Chronic 3H412H412
607-506-00-6reaction mass of: strontium (4-chloro-2-((4,5-dihydro-3-methyl-5-oxo-1-(3-sulfonatophenyl)-1H-pyrazol-4-yl)azo)-5-methyl)benzenesulfonate;

disodium (4-chloro-2-((4,5-dihydro-3-methyl-5-oxo-1-(3-sulfonatophenyl)-1H-pyrazol-4-yl)azo)-5-methyl)benzenesulfonate
422-970-8Aquatic Chronic 2H411GHS09H411
607-507-00-1potassium,sodium 2,4-diamino-3-[4-(2-sulfonatoethoxysulfonyl)phenylazo]-5-[4-(2-sulfonatoethoxysulfonyl)-2-sulfonatophenylazo]-benzenesulfonate422-980-2187026-95-5Eye Dam. 1H318GHS05

Dgr
H318
607-508-00-7disodium 3,3'-[iminobis[sulfonyl-4,1-phenylene-(5-hydroxy-3-methylpyrazole-1,4-diyl)azo-4,1-phenylenesulfonylimino-(4-amino-6-hydroxypyrimidine-2,5-diyl)azo-4,1-phenylenesulfonylimino(4-amino-6-hydroxypyrimidine-2,5-diyl)azo]bis(benzenesulfonate)]423-110-4Eye Dam. 1H318GHS05

Dgr
H318
607-512-00-9trisodium 2,4-diamino-3,5-bis-[4-(2-sulfonatoethoxy)sulfonyl)phenylazo]benzenesulfonate423-970-0182926-43-8Aquatic Chronic 3H412H412
607-513-00-4reaction mass of: trisodium 4-benzoylamino-6-(6-ethenesulfonyl-1-sulfato-naphthalen-2-ylazo)-5-hydroxynaphthalene-2,7-disulfonate;

5-(benzoylamino)-4-hydroxy-3-((1-sulfo-6-((2-(sulfooxy)ethyl)sulfonyl)-2-naphthyl)azo)naphthalene-2,7-disulfonic acid sodium salt;

5-(benzoylamino)-4-hydroxy-3-((1-sulfo-6-((2-(sulfooxy)ethyl)sulfonyl)-2-naphthyl)azo)naphthalene-2,7-disulfonic acid
423-200-3Eye Dam. 1

Skin Sens. 1

Aquatic Chronic 3
H318

H317

H412
GHS05

GHS07

Dgr
H318

H317

H412
607-515-00-5reaction mass of: disodium hexyldiphenyl ether disulphonate;

disodium dihexyldiphenyl ether disulphonate
429-650-7147732-60-3Eye Irrit. 2

Aquatic Chronic 2
H319

H411
GHS07

GHS09

Wng
H319

H411
607-516-00-0N,N'-bis(trifluoroacetyl)-S,S'-bis-L-homocysteine429-670-6105996-54-1Eye Dam. 1

Skin Sens. 1
H318

H317
GHS05

GHS07

Dgr
H318

H317
607-517-00-6(S)-α-(acetylthio)benzenepropanoic acid430-300-076932-17-7Acute Tox. 4 *

Eye Dam. 1

Skin Sens. 1
H302

H318

H317
GHS05

GHS07

Dgr
H302

H318

H317
607-526-00-5cartap (ISO);

1,3-bis(carbamoylthio)-2-(dimethylamino)propane
15263-53-3Aquatic Acute 1

Aquatic Chronic 1
H400

H410
GHS09

Wng
H410
607-527-00-0reaction mass of: 1-(1'H,1'H,2'H,2'H-tridecafluorooctyl)-12-(1''H,1''H,2''H,2''H-tridecafluorooctyl)dodecanedioate;

1-(1'H,1'H,2'H,2'H-tridecafluorooctyl)-12-(1''H,1''H,2''H,2''H-heptdecafluorodecyl)dodecanedioate;

1-(1'H,1'H,2'H,2'H-tridecafluorooctyl)-12-(1''H,1''H,2''H,2''H-heneicosafluorododecyl)dodecanedioate;

1-(1'H,1'H,2'H,2'H-tridecafluorooctyl)-12-(1''H,1''H,2''H,2''H-pentacosafluorotetradecyl)dodecanedioate;

1-(1'H,1'H,2'H,2'H-heptadecafluorodecyl)-12-(1''H,1''H,2''H,2''H-heptadecafluorodecyl)dodecanedioate;

1-(1'H,1'H,2'H,2'H-heptadecafluorodecyl)-12-(1''H,1''H,2''H,2''H-heneicosafluorododecyl)dodecanedioate
423-180-6STOT RE 2 *H373 **GHS08

Wng
H373 **
607-696-00-0pentyl formate211-340-6638-49-3Flam. Liq. 3

Eye Irrit. 2

STOT SE 3
H226

H319

H335
GHS02

GHS07

Dgr
H226

H319

H335
C
607-697-00-6tert-butyl propionate20487-40-5Flam. Liq. 2H225GHS02

Dgr
H225C
608-001-00-3acetonitrile;

cyanomethane
200-835-275-05-8Flam. Liq. 2

Acute Tox. 4 *

Acute Tox. 4 *

Acute Tox. 4 *

Eye Irrit. 2
H225

H332

H312

H302

H319
GHS02

GHS07

Dgr
H225

H332

H312

H302

H319
608-002-00-9trichloroacetonitrile208-885-7545-06-2Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *

Aquatic Chronic 2
H331

H311

H301

H411
GHS06

GHS09

Dgr
H331

H311

H301

H411
608-003-00-4acrylonitrile203-466-5107-13-1Flam. Liq. 2

Carc. 1B

Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *

STOT SE 3

Skin Irrit. 2

Eye Dam. 1

Skin Sens. 1

Aquatic Chronic 2
H225

H350

H331

H311

H301

H335

H315

H318

H317

H411
GHS02

GHS06

GHS08

GHS05

GHS09

Dgr
H225

H350

H331

H311

H301

H335

H315

H318

H317

H411
*D
608-004-00-X2-hydroxy-2-methylpropionitrile;

2-cyanopropan-2-ol;

acetone cyanohydrin
200-909-475-86-5Acute Tox. 2 *

Acute Tox. 1

Acute Tox. 2 *

Aquatic Acute 1

Aquatic Chronic 1
H330

H310

H300

H400

H410
GHS06

GHS09

Dgr
H330

H310

H300

H410
608-005-00-5n-butyronitrile203-700-6109-74-0Flam. Liq. 2

Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *
H225

H331

H311

H301
GHS02

GHS06

Dgr
H225

H331

H311

H301
608-006-00-0bromoxynil (ISO)

3,5-dibromo-4-hydroxybenzonitrile;

bromoxynil phenol
216-882-71689-84-5Repr. 2

Acute Tox. 2 *

Acute Tox. 3 *

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H361d ***

H330

H301

H317

H400

H410
GHS06

GHS08

GHS09

Dgr
H361d ***

H330

H301

H317

H410
M = 10
608-007-00-6ioxynil (ISO)

4-hydroxy-3,5-diiodobenzonitrile
216-881-11689-83-4Repr. 2

Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 4 *

STOT RE 2 *

Eye Irrit. 2

Aquatic Acute 1

Aquatic Chronic 1
H361d ***

H331

H301

H312

H373 **

H319

H400

H410
GHS06

GHS08

GHS09

Dgr
H361d ***

H331

H301

H312

H373 **

H319

H410
M = 10
608-008-00-1chloroacetonitrile203-467-0107-14-2Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *

Aquatic Chronic 2
H331

H311

H301

H411
GHS06

GHS09

Dgr
H331

H311

H301

H411
608-009-00-7malononitrile203-703-2109-77-3Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *

Aquatic Acute 1

Aquatic Chronic 1
H331

H311

H301

H400

H410
GHS06

GHS09

Dgr
H331

H311

H301

H410
608-010-00-2methacrylonitrile;

2-methyl-2-propene nitrile
204-817-5126-98-7Flam. Liq. 2

Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *

Skin Sens. 1
H225

H331

H311

H301

H317
GHS02

GHS06

Dgr
H225

H331

H311

H301

H317
*

Skin Sens. 1; H317: C ≥ 0,2 %
D
608-011-00-8oxalonitrile;

cyanogen
207-306-5460-19-5Flam. Gas 1

Press. Gas

Acute Tox. 3 *

Aquatic Acute 1

Aquatic Chronic 1
H220

H331

H400

H410
GHS02

GHS04

GHS06

GHS09

Dgr
H220

H331

H410
U
608-012-00-3benzonitrile202-855-7100-47-0Acute Tox. 4 *

Acute Tox. 4 *
H312

H302
GHS07

Wng
H312

H302
608-013-00-92-chlorobenzonitrile212-836-5873-32-5Acute Tox. 4 *

Acute Tox. 4 *

Eye Irrit. 2
H312

H302

H319
GHS07

Wng
H312

H302

H319
608-014-00-4chlorothalonil (ISO);

tetrachloroisophthalonitrile
217-588-11897-45-6Carc. 2

Acute Tox. 2 *

Eye Dam. 1

STOT SE 3

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H351

H330

H318

H335

H317

H400

H410
GHS06

GHS08

GHS05

GHS09

Dgr
H351

H330

H318

H335

H317

H410
M = 10
608-015-00-Xdichlobenil (ISO);

2,6-dichlorobenzonitrile
214-787-51194-65-6Acute Tox. 4 *

Aquatic Chronic 2
H312

H411
GHS07

GHS09

Wng
H312

H411
608-016-00-51,4-Dicyano-2,3,5,6-tetra-chloro-benzene401-550-81897-41-2Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H317

H400

H410
GHS07

GHS09

Wng
H317

H410
608-017-00-0bromoxynil octanoate (ISO);

2,6-dibromo-4-cyanophenyl octanoate
216-885-31689-99-2Repr. 2

Acute Tox. 3 *

Acute Tox. 4 *

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H361d ***

H331

H302

H317

H400

H410
GHS06

GHS08

GHS09

Dgr
H361d ***

H331

H302

H317

H410
M = 10
608-018-00-6ioxynil octanoate (ISO);

4-cyano-2,6-diiodophenyl octanoate
223-375-43861-47-0Repr. 2

Acute Tox. 3 *

Eye Irrit. 2

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H361d ***

H301

H319

H317

H400

H410
GHS06

GHS08

GHS09

Dgr
H361d ***

H301

H319

H317

H410
M = 10
608-019-00-12,2'-dimethyl-2,2'-azodipropiononitrile;

ADZN
201-132-378-67-1Self-react. C

Acute Tox. 4 *

Acute Tox. 4 *

Aquatic Chronic 3
H242

H332

H302

H412
GHS02

GHS07

Dgr
H242

H332

H302

H412
T
608-021-00-23-(2-(diaminomethyleneamino)thiazol-4-ylmethylthio)propionitrile403-710-276823-93-3Acute Tox. 4 *

Skin Sens. 1
H302

H317
GHS07

Wng
H302

H317
608-022-00-83,7-dimethyloctanenitrile403-620-340188-41-8Skin Irrit. 2

Skin Sens. 1

Aquatic Chronic 2
H315

H317

H411
GHS07

GHS09

Wng
H315

H317

H411
608-023-00-3fenbuconazole (ISO);

4-(4-chlorophenyl)-2-phenyl-2-[(1H-1,2,4-triazol-1-yl)methyl]butanenitrile
406-140-2114369-43-6Aquatic Acute 1

Aquatic Chronic 1
H400

H410
GHS09

Wng
H410
608-024-00-92-(4-(N-butyl-N-phenethylamino)phenyl)ethylene-1,1,2-tricarbonitrile407-650-897460-76-9Aquatic Chronic 4H413H413
608-025-00-42-nitro-4,5-bis(benzyloxy)phenylacetonitrile410-970-0117568-27-1Aquatic Chronic 4H413H413
608-026-00-X3-cyano-3,5,5-trimethylcyclohexanone411-490-47027-11-4Acute Tox. 4 *

STOT RE 2 *

Skin Sens. 1

Aquatic Chronic 3
H302

H373 **

H317

H412
GHS08

GHS07

Wng
H302

H373 **

H317

H412
608-027-00-5reaction mass of: 3-(4-ethylphenyl)-2,2-dimethylpropanenitrile;

3-(2-ethylphenyl)-2,2-dimethylpropanenitrile;

3-(3-ethylphenyl)-2,2-dimethylpropanenitrile
412-660-0Aquatic Chronic 2H411GHS09H411
608-028-00-04-(2-cyano-3-phenylamino acryloyloxymethyl)-cyclohexyl-methyl 2-cyano-3-phenylamino)-acrylate413-510-7147374-67-2STOT RE 2 *

Skin Sens. 1

Aquatic Chronic 2
H373 **

H317

H411
GHS08

GHS09

Wng
H373 **

H317

H411
608-029-00-61,2-dihydro-6-hydroxy-4-methyl-1-[3-(1-methylethoxy)propyl]-2-oxo-3-pyridinecarbonitrile411-990-268612-94-2Skin Sens. 1H317GHS07

Wng
H317
608-030-00-1N-acetyl-N-[5-cyano-3-(2-dibutylamino-4-phenylthyazol-5-yl-methylene)-4-methyl-2,6-dioxo-1,2,3,6-tetrahydropyridin-1-yl]benzamide412-340-0147741-93-3Aquatic Acute 1

Aquatic Chronic 1
H400

H410
GHS09

Wng
H410
608-031-00-72-benzyl-2-methyl-3-butenitrile407-870-497384-48-0Acute Tox. 4 *

Aquatic Chronic 3
H302

H412
GHS07

Wng
H302

H412
608-033-00-8N-butyl-3-(2-chloro-4-nitrophenylhydrazono)-1-cyano-2-methylprop-1-ene-1,3-dicarboximide407-970-875511-91-0Skin Sens. 1

Aquatic Chronic 3
H317

H412
GHS07

Wng
H317

H412
608-034-00-3chlorfenapyr;

4-bromo-2-(4-chlorophenyl)-1-ethoxymethyl-5-trifluoromethylpyrrole-3-carbonitrile
122453-73-0Acute Tox. 3 *

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1
H331

H302

H400

H410
GHS06

GHS09

Dgr
H331

H302

H410
608-035-00-9(±)-α-[(2-acetyl-5-methylphenyl)-amino]-2,6-dichlorobenzene-aceto-nitrile419-290-9Skin Sens. 1

Aquatic Chronic 4
H317

H413
GHS07

Wng
H317

H413
608-036-00-43-(2-{4-[2-(4-cyanophenyl)vinyl]phenyl}vinyl)benzonitrile419-060-879026-02-1Aquatic Chronic 4H413H413
608-037-00-Xreaction mass of: (E)-2,12-tridecadiennitrile;

(E)-3,12-tridecadiennitrile;

(Z)-3,12-tridecadiennitrile
422-190-8Aquatic Acute 1

Aquatic Chronic 1
H400

H410
GHS09

Wng
H410
608-038-00-52,2,4-trimethyl-4-phenyl-butane-nitrile422-580-875490-39-0Acute Tox. 4 *

Aquatic Chronic 2
H302

H411
GHS07

GHS09

Wng
H302

H411
608-039-00-02-phenylhexanenitrile423-460-83508-98-3Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1
H302

H400

H410
GHS07

GHS09

Wng
H302

H410
608-040-00-64,4'-dithiobis(5-amino-1-(2,6-dichloro-4-(trifluoromethyl)phenyl)-1H-pyrazole-3-carbonitrile)423-490-1130755-46-3Aquatic Acute 1

Aquatic Chronic 1
H400

H410
GHS09

Wng
H410
608-041-00-14'-((2-butyl-4-oxo-1,3-diazaspiro[4.4]non-1-ene-3-yl)methyl)(1,1'-biphenyl)-2-carbonitrile423-500-4138401-24-8Aquatic Acute 1

Aquatic Chronic 1
H400

H410
GHS09

Wng
H410
608-043-00-23-(cis-3-hexenyloxy)propanenitril415-220-6142653-61-0Acute Tox. 3 *

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1
H331

H302

H400

H410
GHS06

GHS09

Dgr
H331

H302

H410
608-065-00-2salts of bromoxynil with the exception of those specified elsewhere in this AnnexRepr. 2

Acute Tox. 2 *

Acute Tox. 3 *

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H361d ***

H330

H301

H317

H400

H410
GHS06

GHS08

GHS09

Dgr
H361d ***

H330

H301

H317

H410
M = 10A
608-066-00-8salts of ioxynil with the exception of those specified elsewhere in this AnnexRepr. 2

Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 4 *

STOT RE 2 *

Eye Irrit. 2

Aquatic Acute 1

Aquatic Chronic 1
H361d ***

H331

H301

H312

H373 **

H319

H400

H410
GHS06

GHS08

GHS09

Dgr
H361d ***

H331

H301

H312

H373 **

H319

H410
M = 10A
609-001-00-61-nitropropane203-544-9108-03-2Flam. Liq. 3

Acute Tox. 4 *

Acute Tox. 4 *

Acute Tox. 4 *
H226

H332

H312

H302
GHS02

GHS07

Wng
H226

H332

H312

H302
*
609-002-00-12-nitropropane201-209-179-46-9Flam. Liq. 3

Carc. 1B

Acute Tox. 4 *

Acute Tox. 4 *
H226

H350

H332

H302
GHS02

GHS08

GHS07

Dgr
H226

H350

H332

H302
609-003-00-7nitrobenzene202-716-098-95-3Carc. 2

Repr. 2

Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *

STOT RE 1

Aquatic Chronic 2
H351

H361f ***

H331

H311

H301

H372 **

H411
GHS06

GHS08

GHS09

Dgr
H351

H361f ***

H331

H311

H301

H372 **

H411
609-004-00-2dinitrobenzene; [1]

1,4-dinitrobenzene; [2]

1,3-dinitrobenzene; [3]

1,2-dinitrobenzene [4]
246-673-6 [1]

202-833-7 [2]

202-776-8 [3]

208-431-8 [4]
25154-54-5 [1]

100-25-4 [2]

99-65-0 [3]

528-29-0 [4]
Acute Tox. 2 *

Acute Tox. 1

Acute Tox. 2 *

STOT RE 2 *

Aquatic Acute 1

Aquatic Chronic 1
H330

H310

H300

H373 **

H400

H410
GHS06

GHS08

GHS09

Dgr
H330

H310

H300

H373 **

H410
609-005-00-81,3,5-trinitrobenzene202-752-799-35-4Expl. 1.1

Acute Tox. 2 *

Acute Tox. 1

Acute Tox. 2 *

STOT RE 2 *

Aquatic Acute 1

Aquatic Chronic 1
H201

H330

H310

H300

H373 **

H400

H410
GHS01

GHS06

GHS08

GHS09

Dgr
H201

H330

H310

H300

H373 **

H410
609-006-00-34-nitrotoluene202-808-099-99-0Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *

STOT RE 2 *

Aquatic Chronic 2
H331

H311

H301

H373 **

H411
GHS06

GHS08

GHS09

Dgr
H331

H311

H301

H373 **

H411
609-007-00-92,4-dinitrotoluene;

dinitrotoluene, technical grade; [1]

dinitrotoluene [2]
204-450-0 [1]

246-836-1 [2]
121-14-2 [1]

25321-14-6 [2]
Carc. 1B

Muta. 2

Repr. 2

Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *

STOT RE 2 *

Aquatic Chronic 2
H350

H341

H361f ***

H331

H311

H301

H373 **

H411
GHS06

GHS08

GHS09

Dgr
H350

H341

H361f ***

H331

H311

H301

H373 **

H411
609-008-00-42,4,6-trinitrotoluene;

TNT
204-289-6118-96-7Expl. 1.1

Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *

STOT RE 2 *

Aquatic Chronic 2
H201

H331

H311

H301

H373 **

H411
GHS01

GHS06

GHS08

GHS09

Dgr
H201

H331

H311

H301

H373 **

H411
609-009-00-X2,4,6-trinitrophenol;

picric acid
201-865-988-89-1Expl. 1.1

Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *
H201

H331

H311

H301
GHS01

GHS06

Dgr
H201

H331

H311

H301
609-010-00-5salts of picric acidUnst. Expl

Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *
H201

H331

H311

H301
GHS01

GHS06

Dgr
H201

H331

H311

H301
T
609-011-00-02,4,6-trinitroanisole606-35-9Expl. 1.1

Acute Tox. 4 *

Acute Tox. 4 *

Acute Tox. 4 *

Aquatic Chronic 2
H201

H332

H312

H302

H411
GHS01

GHS07

GHS09

Wng
H201

H332

H312

H302

H411
609-012-00-62,4,6-trinitro-m-cresol210-027-1602-99-3Expl. 1.1

Acute Tox. 4 *

Acute Tox. 4 *

Acute Tox. 4 *
H201

H332

H312

H302
GHS01

GHS07

Wng
H201

H332

H312

H302
609-013-00-12,4,6-trinitro-m-xylene211-187-5632-92-8Expl. 1.1

Acute Tox. 4 *

Acute Tox. 4 *

Acute Tox. 4 *

STOT RE 2 *
H201

H332

H312

H302

H373 **
GHS01

GHS08

GHS07

Wng
H201

H332

H312

H302

H373 **
609-015-00-24-nitrophenol;

p-nitrophenol
202-811-7100-02-7Acute Tox. 4 *

Acute Tox. 4 *

Acute Tox. 4 *

STOT RE 2 *
H332

H312

H302

H373 **
GHS08

GHS07

Wng
H332

H312

H302

H373 **
609-016-00-8dinitrophenol (reaction mass of isomers); [1]

2,4(or 2,6)-dinitrophenol [2]
247-096-2 [1]

275-732-9 [2]
25550-58-7 [1]

71629-74-8 [2]
Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *

STOT RE 2 *

Aquatic Acute 1

Aquatic Chronic 1
H331

H311

H301

H373 **

H400

H410
GHS06

GHS08

GHS09

Dgr
H331

H311

H301

H373 **

H410
609-018-00-92,4,6-trinitroresorcinol;

styphnic acid
201-436-682-71-3Expl. 1.1

Acute Tox. 4 *

Acute Tox. 4 *

Acute Tox. 4 *
H201

H332

H312

H302
GHS01

GHS07

Wng
H201

H332

H312

H302
T
609-019-00-4lead 2,4,6-trinitro-m-phenylene dioxide;

lead 2,4,6-trinitroresorcinoxide;

lead styphnate
239-290-015245-44-0Unst. Expl

Repr. 1A

Acute Tox. 4 *

Acute Tox. 4 *

STOT RE 2 *

Aquatic Acute 1

Aquatic Chronic 1
H200

H360Df

H332

H302

H373 **

H400

H410
GHS01

GHS08

GHS07

GHS09

Dgr
H200

H360Df

H332

H302

H373 **

H410
1
609-019-01-1lead 2,4,6-trinitro-m-phenylene dioxide;

lead 2,4,6-trinitroresorcinoxide;

lead styphnate (≥ 20 % phlegmatiser)
239-290-015245-44-0Expl. 1.1

Repr. 1A

Acute Tox. 4 *

Acute Tox. 4 *

STOT RE 2 *

Aquatic Acute 1

Aquatic Chronic 1
H201

H360Df

H332

H302

H373 **

H400

H410
GHS01

GHS08

GHS07

GHS09

Dgr
H201

H360Df

H332

H302

H373 **

H410
1
609-020-00-XDNOC (ISO);

4,6-dinitro-o-cresol
208-601-1534-52-1Muta. 2

Acute Tox. 2 *

Acute Tox. 1

Acute Tox. 2 *

Skin Irrit. 2

Eye Dam. 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H341

H330

H310

H300

H315

H318

H317

H400

H410
GHS06

GHS08

GHS05

GHS07

GHS09

Dgr
H341

H330

H310

H300

H315

H318

H317

H410
EUH044
609-021-00-5sodium salt of DNOC;

sodium 4,6-dinitro-o-cresolate; [1]

potassium salt of DNOC;

potassium 4,6-dinitro-o-cresolate [2]
219-007-7 [1]

- [2]
2312-76-7 [1]

5787-96-2 [2]
Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *

STOT RE 2 *

Aquatic Acute 1

Aquatic Chronic 1
H331

H311

H301

H373 **

H400

H410
GHS06

GHS08

GHS09

Dgr
H331

H311

H301

H373 **

H410
609-022-00-0ammonium salt of DNOC;

ammonium 4,6-dinitro-o-tolyl oxide
221-037-02980-64-5Acute Tox. 2 *

Acute Tox. 1

Acute Tox. 2 *

STOT RE 2 *

Aquatic Acute 1

Aquatic Chronic 1
H330

H310

H300

H373 **

H400

H410
GHS06

GHS08

GHS09

Dgr
H330

H310

H300

H373 **

H410
609-023-00-6dinocap (ISO)254-408-039300-45-3Repr. 1B

Acute Tox. 4 *

STOT RE 2 *

Skin Irrit. 2

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H360D ***

H332

H373 **

H315

H317

H400

H410
GHS08

GHS07

GHS09

Dgr
H360D ***

H332

H373 **

H315

H317

H410
609-024-00-1binapacryl (ISO);

2-sec-butyl-4,6-dinitrophenyl-3-methylcrotonate
207-612-9485-31-4Repr. 1B

Acute Tox. 4 *

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1
H360D ***

H312

H302

H400

H410
GHS08

GHS07

GHS09

Dgr
H360D ***

H312

H302

H410
609-025-00-7dinoseb(ISO);

6-sec-butyl-2,4-dinitrophenol
201-861-788-85-7Repr. 1B

Acute Tox. 3 *

Acute Tox. 3 *

Eye Irrit. 2

Aquatic Acute 1

Aquatic Chronic 1
H360Df

H311

H301

H319

H400

H410
GHS06

GHS08

GHS09

Dgr
H360Df

H311

H301

H319

H410
EUH044
609-026-00-2salts and esters of dinoseb, with the exception of those specified elsewhere in this AnnexRepr. 1B

Acute Tox. 3 *

Acute Tox. 3 *

Eye Irrit. 2

Aquatic Acute 1

Aquatic Chronic 1
H360Df

H311

H301

H319

H400

H410
GHS06

GHS08

GHS09

Dgr
H360Df

H311

H301

H319

H410
EUH044A
609-027-00-8dinocton;

reaction mass of isomers: methyl 2-octyl-4,6-dinitrophenyl carbonate, methyl 4-octyl-2,6-dinitrophenyl carbonate
63919-26-6Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1
H302

H400

H410
GHS07

GHS09

Wng
H302

H410
609-028-00-3dinex (ISO);

2-cyclohexyl-4,6-dinitrophenol
205-042-5131-89-5Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *

Aquatic Acute 1

Aquatic Chronic 1
H331

H311

H301

H400

H410
GHS06

GHS09

Dgr
H331

H311

H301

H410
609-029-00-9salts and esters of dinexAcute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *

Aquatic Acute 1

Aquatic Chronic 1
H331

H311

H301

H400

H410
GHS06

GHS09

Dgr
H331

H311

H301

H410
A
609-030-00-4dinoterb (ISO);

2-tert-butyl-4,6-dinitrophenol
215-813-81420-07-1Repr. 1B

Acute Tox. 2 *

Acute Tox. 3 *

Aquatic Acute 1

Aquatic Chronic 1
H360D ***

H300

H311

H400

H410
GHS06

GHS08

GHS09

Dgr
H360D ***

H300

H311

H410
EUH044
609-031-00-Xsalts and esters of dinoterbRepr. 1B

Acute Tox. 2 *

Acute Tox. 3 *

Aquatic Acute 1

Aquatic Chronic 1
H360D ***

H300

H311

H400

H410
GHS06

GHS08

GHS09

Dgr
H360D ***

H300

H311

H410
A
609-032-00-5bromofenoxim (ISO);

3,5-dibromo-4-hydroxybenzaldehyde-O-(2,4-dinitrophenyl)-oxime
236-129-613181-17-4Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1
H302

H400

H410
GHS07

GHS09

Wng
H302

H410
609-033-00-0dinosam (ISO);

2-(1-methylbutyl)-4,6-dinitrophenol
4097-36-3Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *

Aquatic Acute 1

Aquatic Chronic 1
H331

H311

H301

H400

H410
GHS06

GHS09

Dgr
H331

H311

H301

H410
609-034-00-6salts and esters of dinosamAcute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *

Aquatic Acute 1

Aquatic Chronic 1
H331

H311

H301

H400

H410
GHS06

GHS09

Dgr
H331

H311

H301

H410
A
609-035-00-1nitroethane201-188-979-24-3Flam. Liq. 3

Acute Tox. 4 *

Acute Tox. 4 *
H226

H332

H302
GHS02

GHS07

Wng
H226

H332

H302
*
609-036-00-7nitromethane200-876-675-52-5Flam. Liq. 3

Acute Tox. 4 *
H226

H302
GHS02

GHS07

Wng
H226

H302
*
609-037-00-25-nitroacenaphthene210-025-0602-87-9Carc. 1BH350GHS08

Dgr
H350
609-038-00-82-nitronaphthalene209-474-5581-89-5Carc. 1B

Aquatic Chronic 2
H350

H411
GHS08

GHS09

Dgr
H350

H411
609-039-00-34-nitrobiphenyl202-204-792-93-3Carc. 1B

Aquatic Chronic 2
H350

H411
GHS08

GHS09

Dgr
H350

H411
609-040-00-9nitrofen (ISO);

2,4-dichlorophenyl 4-nitrophenyl ether
217-406-01836-75-5Carc. 1B

Repr. 1B

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1
H350

H360D ***

H302

H400

H410
GHS08

GHS07

GHS09

Dgr
H350

H360D ***

H302

H410
609-041-00-42,4-dinitrophenol200-087-751-28-5Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *

STOT RE 2 *

Aquatic Acute 1
H331

H311

H301

H373 **

H400
GHS06

GHS08

GHS09

Dgr
H331

H311

H301

H373 **

H400
609-042-00-Xpendimethalin (ISO);

N-(1-ethylpropyl)-2,6-dinitro-3,4-xylidine
254-938-240487-42-1Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H317

H400

H410
GHS07

GHS09

Wng
H317

H410
609-043-00-5quintozene (ISO);

pentachloronitrobenzene
201-435-082-68-8Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H317

H400

H410
GHS07

GHS09

Wng
H317

H410
609-044-00-0tecnazene (ISO);

1,2,4,5-tetrachloro-3-nitrobenzene
204-178-2117-18-0Acute Tox. 4 *

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H302

H317

H400

H410
GHS07

GHS09

Wng
H302

H317

H410
609-045-00-6reaction mass of: 4,6-dinitro-2-(3-octyl)phenyl methyl carbonate and 4,6-dinitro-2-(4-octyl)phenyl methyl carbonate;

dinocton-6
8069-76-9Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1
H302

H400

H410
GHS07

GHS09

Wng
H302

H410
609-046-00-1trifluralin (ISO) (containing < 0.5 ppm NPDA);

α,α,α-trifluoro-2,6-dinitro-N,N-dipropyl-p-toluidine (containing < 0.5 ppm NPDA);

2,6-dinitro-N,N-dipropyl-4-trifluoromethylaniline (containing < 0.5 ppm NPDA);

N,N-dipropyl-2,6-dinitro-4-trifluoromethylaniline (containing < 0.5 ppm NPDA)
216-428-81582-09-8Eye Irrit. 2

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H319

H317

H400

H410
GHS07

GHS09

Wng
H319

H317

H410
609-047-00-72-nitroanisole202-052-191-23-6Carc. 1B

Acute Tox. 4 *
H350

H302
GHS08

GHS07

Dgr
H350

H302
609-048-00-2sodium 3-nitrobenzenesulphonate204-857-3127-68-4Eye Irrit. 2

Skin Sens. 1
H319

H317
GHS07

Wng
H319

H317
609-049-00-82,6-dinitrotoluene210-106-0606-20-2Carc. 1B

Muta. 2

Repr. 2

Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *

STOT RE 2 *

Aquatic Chronic 3
H350

H341

H361f ***

H331

H311

H301

H373 **

H412
GHS06

GHS08

Dgr
H350

H341

H361f ***

H331

H311

H301

H373 **

H412
609-050-00-32,3-dinitrotoluene210-013-5602-01-7Carc. 1B

Muta. 2

Repr. 2

Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *

STOT RE 2 *

Aquatic Acute 1

Aquatic Chronic 1
H350

H341

H361f ***

H331

H311

H301

H373 **

H400

H410
GHS06

GHS08

GHS09

Dgr
H350

H341

H361f ***

H331

H311

H301

H373 **

H410
609-051-00-93,4-dinitrotoluene210-222-1610-39-9Carc. 1B

Muta. 2

Repr. 2

Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *

STOT RE 2 *

Aquatic Chronic 2
H350

H341

H361f ***

H331

H311

H301

H373 **

H411
GHS06

GHS08

GHS09

Dgr
H350

H341

H361f ***

H331

H311

H301

H373 **

H411
609-052-00-43,5-dinitrotoluene210-566-2618-85-9Carc. 1B

Muta. 2

Repr. 2

Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *

STOT RE 2 *

Aquatic Chronic 3
H350

H341

H361f ***

H331

H311

H301

H373 **

H412
GHS06

GHS08

Dgr
H350

H341

H361f ***

H331

H311

H301

H373 **

H412
609-053-00-Xhydrazine-trinitromethane414-850-9Expl. 1.1 ****

Self-react. A

Carc. 1B

Acute Tox. 3 *

Acute Tox. 3 *

Skin Sens. 1
H201

H240

H350

H331

H301

H317
GHS01

GHS06

GHS08

Dgr
H201

H240

H350

H331

H301

H317
609-054-00-52,3-dinitrophenol; [1]

2,5-dinitrophenol; [2]

2,6-dinitrophenol; [3]

3,4-dinitrophenol; [4]

salts of dinitrophenol [5]
200-628-7 [1]

206-348-1 [2]

209-357-9 [3]

209-415-3 [4]

- [5]
66-56-8 [1]

329-71-5 [2]

573-56-8 [3]

577-71-9 [4]

- [5]
Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *

STOT RE 2 *

Aquatic Chronic 2
H331

H311

H301

H373 **

H411
GHS06

GHS08

GHS09

Dgr
H331

H311

H301

H373 **

H411
609-055-00-02,5-dinitrotoluene210-581-4619-15-8Carc. 1B

Muta. 2

Repr. 2

Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *

STOT RE 2 *

Aquatic Chronic 2
H350

H341

H361f ***

H331

H311

H301

H373 **

H411
GHS06

GHS08

GHS09

Dgr
H350

H341

H361f ***

H331

H311

H301

H373 **

H411
609-056-00-62,2-dibromo-2-nitroethanol412-380-969094-18-4Expl. 1.1

Carc. 2

Acute Tox. 4 *

STOT RE 2 *

Skin Corr. 1A

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H201

H351

H302

H373 **

H314

H317

H400

H410
GHS01

GHS08

GHS05

GHS07

GHS09

Dgr
H201

H351

H302

H373 **

H314

H317

H410
*

STOT SE 3; H335: C ≥ 1 %
T
609-057-00-13-chloro-2,4-difluoronitrobenzene411-980-83847-58-3Acute Tox. 4 *

Skin Corr. 1B

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H302

H314

H317

H400

H410
GHS05

GHS07

GHS09

Dgr
H302

H314

H317

H410
609-058-00-72-nitro-2-phenyl-1,3-propanediol410-360-45428-02-4STOT RE 1

Acute Tox. 4 *

Acute Tox. 4 *

Skin Sens. 1

Aquatic Chronic 2
H372 **

H312

H302

H317

H411
GHS08

GHS07

GHS09

Dgr
H372 **

H312

H302

H317

H411
EUH070
609-059-00-22-chloro-6-(ethylamino)-4-nitrophenol411-440-1131657-78-8Acute Tox. 4 *

Skin Sens. 1

Aquatic Chronic 2
H302

H317

H411
GHS07

GHS09

Wng
H302

H317

H411
609-060-00-84-[(3-hydroxypropyl)amino]-3-nitrophenol406-305-992952-81-3Skin Irrit. 2

Aquatic Chronic 2
H315

H411
GHS07

GHS09

Wng
H315

H411
609-061-00-3(E,Z)-4-chlorophenyl(cyclopropyl)ketone O-(4-nitrophenylmethyl)oxime406-100-494097-88-8Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H317

H400

H410
GHS07

GHS09

Wng
H317

H410
609-062-00-92-bromo-2-nitropropanol407-030-724403-04-1Acute Tox. 3 *

Acute Tox. 4 *

STOT RE 2 *

Skin Corr. 1B

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H311

H302

H373 **

H314

H317

H400

H410
GHS06

GHS08

GHS05

GHS09

Dgr
H311

H302

H373 **

H314

H317

H410
609-063-00-42-[(4-chloro-2-nitrophenyl)amino]ethanol413-280-859320-13-7Acute Tox. 4 *

Aquatic Chronic 2
H302

H411
GHS07

GHS09

Wng
H302

H411
609-064-00-Xmesotrione(ISO);

2-[4-(methylsulfonyl)-2-nitrobenzoyl]-1,3-cyclohexanedione
104206-82-8Aquatic Acute 1

Aquatic Chronic 1
H400

H410
GHS09

Wng
H410
609-065-00-52-nitrotoluene201-853-388-72-2Carc. 1B

Muta. 1B

Repr. 2

Acute Tox. 4 *

Aquatic Chronic 2
H350

H340

H361f ***

H302

H411
GHS08

GHS07

GHS09

Dgr
H350

H340

H361f ***

H302

H411
609-066-00-0lithium sodium 3-amino-10-{4-(10-amino-6,13-dichloro-4,11-disulfonatobenzo[5,6][1,4]oxazino[2,3-b]phenoxazine-3-ylamino)-6-[methyl(2-sulfonato-ethyl)amino]-1,3,5-triazin-2-ylamino}-6,13-dichlorobenzo[5,6][1,4]oxazino[2,3-b]phenoxazine-4,11-disulfonate418-870-9154212-58-5Acute Tox. 4 *

Acute Tox. 4 *

Acute Tox. 4 *

STOT SE 2 **
H332

H312

H302

H371 **
GHS08

GHS07

Dgr
H332

H312

H302

H371 **
609-067-00-6sodium and potassium 4-(3-aminopropylamino)-2,6-bis[3-(4-methoxy-2-sulfophenylazo)-4-hydroxy-2-sulfo-7-naphthylamino]-1,3,5-triazine416-280-6156769-97-0Skin Sens. 1H317GHS07

Wng
H317
609-068-00-1musk xylene;

5-tert-butyl-2,4,6-trinitro-m-xylene
201-329-481-15-2Expl. 1.1

Carc. 2

Aquatic Acute 1

Aquatic Chronic 1
H201

H351

H400

H410
GHS01

GHS08

GHS09

Wng
H201

H351

H410
T
609-070-00-21,4-dichloro-2-(1,1,2,3,3,3-hexafluoropropoxy)-5-nitrobenzene415-580-4130841-23-5Acute Tox. 4 *

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H302

H317

H400

H410
GHS07

GHS09

Wng
H302

H317

H410
609-071-00-8reaction mass of: 2-methylsulfanyl-4,6-bis-(2-hydroxy-4-methoxy-phenyl)-1,3,5-triazine;

2-(4,6-bis-methylsulfanyl-1,3,5-triazin-2-yl)-5-methoxy-phenol
423-520-3156137-33-6Skin Sens. 1H317GHS07

Wng
H317
610-001-00-3trichloronitromethane;

chloropicrin
200-930-976-06-2Acute Tox. 2 *

Acute Tox. 4 *

Eye Irrit. 2

STOT SE 3

Skin Irrit. 2
H330

H302

H319

H335

H315
GHS06

Dgr
H330

H302

H319

H335

H315
610-002-00-91,1-dichloro-1-nitroethane209-854-0594-72-9Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *
H331

H311

H301
GHS06

Dgr
H331

H311

H301
610-003-00-4chlorodinitrobenzeneAcute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *

STOT RE 2 *

Aquatic Acute 1

Aquatic Chronic 1
H331

H311

H301

H373 **

H400

H410
GHS06

GHS08

GHS09

Dgr
H331

H311

H301

H373 **

H410
C
610-004-00-X2-chloro-1,3,5-trinitrobenzene201-864-388-88-0Expl. 1.1

Acute Tox. 2 *

Acute Tox. 1

Acute Tox. 2 *

Aquatic Acute 1

Aquatic Chronic 1
H201

H330

H310

H300

H400

H410
GHS01

GHS06

GHS09

Dgr
H201

H330

H310

H300

H410
610-005-00-51-chloro-4-nitrobenzene202-809-6100-00-5Carc. 2

Muta. 2

Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *

STOT RE 2 *

Aquatic Chronic 2
H351

H341

H331

H311

H301

H373 **

H411
GHS06

GHS08

GHS09

Dgr
H351

H341

H331

H311

H301

H373 **

H411
610-006-00-0chloronitroanilines with the exception of those specified elsewhere in this AnnexAcute Tox. 2 *

Acute Tox. 1

Acute Tox. 2 *

STOT RE 2 *

Aquatic Chronic 2
H330

H310

H300

H373 **

H411
GHS06

GHS08

GHS09

Dgr
H330

H310

H300

H373 **

H411
A C
610-007-00-61-chloro-1-nitropropane209-990-0600-25-9Acute Tox. 4 *

Acute Tox. 4 *
H332

H302
GHS07

Wng
H332

H302
*
610-008-00-12,6-dichloro-4-nitroanisole403-350-617742-69-7Acute Tox. 3 *

Aquatic Chronic 2
H301

H411
GHS06

GHS09

Dgr
H301

H411
610-009-00-72-chloro-4-nitroaniline204-502-2121-87-9Acute Tox. 4 *

Aquatic Chronic 2
H302

H411
GHS07

GHS09

Wng
H302

H411
610-010-00-22-bromo-1-(2-furyl)-2-nitroethylene406-110-935950-52-8Acute Tox. 4 *

STOT RE 2 *

Skin Corr. 1B

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H302

H373 **

H314

H317

H400

H410
GHS08

GHS05

GHS07

GHS09

Dgr
H302

H373 **

H314

H317

H410
611-001-00-6azobenzene203-102-5103-33-3Carc. 1B

Muta. 2

Acute Tox. 4 *

Acute Tox. 4 *

STOT RE 2 *

Aquatic Acute 1

Aquatic Chronic 1
H350

H341

H332

H302

H373 **

H400

H410
GHS08

GHS07

GHS09

Dgr
H350

H341

H332

H302

H373 **

H410
611-002-00-1azoxybenzene207-802-1495-48-7Acute Tox. 4 *

Acute Tox. 4 *
H332

H302
GHS07

Wng
H332

H302
611-003-00-7fenaminosulf (ISO);

sodium 4-dimethylaminobenzenediazosulphonate
205-419-4140-56-7Acute Tox. 3 *

Acute Tox. 4 *

Aquatic Chronic 3
H301

H312

H412
GHS06

Dgr
H301

H312

H412
611-004-00-2methyl-ONN-azoxymethyl acetate;

methyl azoxy methyl acetate
209-765-7592-62-1Carc. 1B

Repr. 1B
H350

H360D ***
GHS08

Dgr
H350

H360D ***
611-005-00-8disodium {5-[(4'-((2,6-hydroxy-3-((2-hydroxy-5-sulphophenyl)azo)phenyl)azo)(1,1'-biphenyl)-4-yl)azo]salicylato(4-)}cuprate(2-);

CI Direct Brown 95
240-221-116071-86-6Carc. 1BH350GHS08

Dgr
H350
611-006-00-34-o-tolylazo-o-toluidine;

4-amino-2',3-dimethylazobenzene;

fast garnet GBC base;

AAT;

o-aminoazotoluene
202-591-297-56-3Carc. 1B

Skin Sens. 1
H350

H317
GHS08

Dgr
H350

H317
611-007-00-9tricyclazole (ISO);

5-methyl-1,2,4-triazolo(3,4-b)benzo-1,3-thiazole;
255-559-541814-78-2Acute Tox. 4 *H302GHS07

Wng
H302
611-008-00-44-aminoazobenzene;

4-phenylazoaniline
200-453-660-09-3Carc. 1B

Aquatic Acute 1

Aquatic Chronic 1
H350

H400

H410
GHS08

GHS09

Dgr
H350

H410
611-009-00-Xsodium (1-(5-(4-(4-anilino-3-sulphophenylazo)-2-methyl-5-methylsulphonamidophenylazo)-4-hydroxy-2-oxido-3-(phenylazo)phenylazo)-5-nitro-4-sulphonato-2-naphtholato)iron(II)401-220-3Acute Tox. 4 *

Aquatic Chronic 3
H332

H412
GHS07

Wng
H332

H412
611-010-00-52'-(2-cyano-4,6-dinitrophenylazo)-5'-(N,N-dipropylamino)propionanilide403-010-7106359-94-8Skin Sens. 1

Aquatic Chronic 3
H317

H412
GHS07

Wng
H317

H412
611-011-00-0N,N,N',N'-tetramethyl-3,3'-(propylenebis(iminocarbonyl-4,1-phenylenazo(1,6-dihydro-2-hydroxy-4-methyl-6-oxopyridine-3,1-diyl)))di(propylammonium) dilactate403-340-1Eye Dam. 1

Aquatic Chronic 2
H318

H411
GHS05

GHS09

Dg
H318

H411
611-012-00-6reaction mass of 2,2-iminodiethanol 6-methyl-2-(4-(2,4,6-triaminopyrimidin-5-ylazo)phenyl)benzothiazole-7-sulfonate and 2-methylaminoethanol 6-methyl-2-(4-(2,4,6-triaminopyrimidin-5-ylazo)phenyl)benzothiazole-7-sulfonate and N,N-diethylpropane-1,3-diamine 6-methyl-2-(4-(2,4,6-triaminopyrimidin-5-ylazo)phenyl)benzothiazole-7-sulfonate403-410-1114565-65-0Skin Sens. 1H317GHS07

Wng
H317
611-013-00-1trilithium-1-hydroxy-7-(3-sulfonatoanilino)-2-(3-methyl-4-(2-methoxy-4-(3-sulfonatophenylazo)phenylazo)phenylazo)naphthalene-3-sulfonate403-650-7117409-78-6Expl. 1.3 ****

Aquatic Chronic 2
H203

H411
GHS01

GHS09

Dgr
H203

H411
611-014-00-7(tetrasodium 1-(4-(3-acetamido-4-(4'-nitro-2,2'-disulfonatostilben-4-ylazo)anilino)-6-(2,5-disulfonatoanilino)-1,3,5-triazin-2-yl)-3-carboxypyridinium) hydroxide404-250-5115099-55-3Skin Sens. 1H317GHS07

Wng
H317
611-015-00-2tetrasodium 4-amino-5-hydroxy-6-(4-(2-(2-(sulfonatooxy)ethylsulfonyl)ethylcarbamoyl)phenylazo)-3-(4-(2-(sulfonatooxy)ethylsulfonyl)phenylazo)naphthalene-2,7-disulfonate404-320-5116889-78-2Skin Sens. 1H317GHS07

Wng
H317
611-016-00-8reaction mass of 1,1'-((dihydroxyphenylene)bis(azo-3,1-phenylenazo(1-(3-dimethylaminopropyl)-1,2-dihydro-6-hydroxy-4-methyl-2-oxopyridine-5,3-diyl)))dipyridinium dichloride dihydrochloride, mixed isomers and 1-(1-(3-dimethylaminopropyl)-5-(3-((4-(1-(3-dimethylaminopropyl)-1,6-dihydro-2-hydroxy-4-methyl-6-oxo-5-pyridinio-3-pyridylazo)phenylazo)-2,4(or2,6 or3,5)-dihydroxyphenylazo)phenylazo)-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-3-pyridyl)pyridinium dichloride404-540-1Skin Sens. 1H317GHS07

Wng
H317
611-017-00-32-(4-(diethylaminopropylcarbamoyl)phenylazo)-3-oxo-N-(2,3-dihydro-2-oxobenzimidazol-5-yl)butyramide404-910-2Skin Sens. 1

Aquatic Chronic 2
H317

H411
GHS07

GHS09

Wng
H317

H411
611-018-00-9tetraammonium 5-(4-(7-amino-1-hydroxy-3-sulfonato-2-naphthylazo)-6-sulfonato-1-naphthylazo)isophthalate405-130-5Skin Sens. 1H317GHS07

Wng
H317
611-019-00-4tetralithium 6-amino-4-hydroxy-3-(7-sulfonato-4-(4-sulfonatophenylazo)-1-naphthylazo)naphthalene-2,7-disulfonate405-150-4106028-58-4Skin Sens. 1H317GHS07

Wng
H317
611-020-00-Xtetrakis(tetramethylammonium) 6-amino-4-hydroxy-3-(7-sulfonato-4-(4-sulfonatophenylazo)-1-naphthylazo)naphthalene-2,7-disulfonate405-170-3116340-05-7Acute Tox. 3 *

Skin Sens. 1

Aquatic Chronic 3
H301

H317

H412
GHS06

Dgr
H301

H317

H412
611-021-00-52-(4-(4-cyano-3-methylisothiazol-5-ylazo)-N-ethyl-3-methylanilino)ethyl acetate405-480-9Acute Tox. 4 *

STOT RE 2 *

Skin Irrit. 2

Aquatic Chronic 4
H302

H373 **

H315

H413
GHS08

GHS07

Wng
H302

H373 **

H315

H413
611-022-00-04-dimethylaminobenzenediazonium 3-carboxy-4-hydroxybenzenesulfonate404-980-4Self-react. C

Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 4 *

STOT RE 2 *

Eye Dam. 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H242

H331

H301

H312

H373 **

H318

H317

H400

H410
GHS02

GHS06

GHS08

GHS05

GHS09

Dgr
H242

H331

H301

H312

H373 **

H318

H317

H410
T
611-023-00-6disodium 7-(4,6-dichloro-1,3,5-triazin-2-ylamino)-4-hydroxy-3-(4-(2-(sulfonatooxy)ethylsulfonyl)phenylazo) naphthalene-2-sulfonate404-600-7Skin Sens. 1H317GHS07

Wng
H317
611-024-00-1Benzidine based azo dyes;

4,4'-diarylazobiphenyl dyes, with the exception of those specified elsewhere in this Annex
Carc. 1BH350GHS08

Dgr
H350A
611-025-00-7disodium 4-amino-3-[[4'-[(2,4-diaminophenyl)azo][1,1'-biphenyl]-4-yl]azo]-5-hydroxy-6-(phenylazo)naphtalene-2,7-disulphonate;

C.I. Direct Black 38
217-710-31937-37-7Carc. 1B

Repr. 2
H350

H361d ***
GHS08

Dgr
H350

H361d ***
611-026-00-2tetrasodium 3,3'-[[1,1'-biphenyl]-4,4'-diylbis(azo)]bis[5-amino-4-hydroxynaphthalene-2,7-disulphonate];

C.I. Direct Blue 6
220-012-12602-46-2Carc. 1B

Repr. 2
H350

H361d ***
GHS08

Dgr
H350

H361d ***
611-027-00-8disodium 3,3'-[[1,1'-biphenyl]-4,4'-diylbis(azo)]bis(4-aminonaphthalene-1-sulphonate);

C.I. Direct Red 28
209-358-4573-58-0Carc. 1B

Repr. 2
H350

H361d ***
GHS08

Dgr
H350

H361d ***
611-028-00-3C,C'-azodi(formamide)204-650-8123-77-3Resp. Sens. 1H334GHS08

Dgr
H334G
611-029-00-9o-dianisidine based azo dyes;

4,4'-diarylazo-3,3'-dimethoxybiphenyl dyes with the exception of those mentioned elsewhere in this Annex
Carc. 1BH350GHS08

Dgr
H350A H
611-030-00-4o-tolidine based dyes;

4,4'-diarylazo-3,3'-dimethylbiphenyl dyes, with the exception of those mentioned elsewhere in this Annex
Carc. 1BH350GHS08

Dgr
H350A H
611-031-00-X4,4'-(4-iminocyclohexa-2,5-dienylidenemethylene)dianiline hydrochloride;

C.I. Basic Red 9
209-321-2569-61-9Carc. 1BH350GHS08

Dgr
H350
611-032-00-51,4,5,8-tetraaminoanthraquinone;

C.I. Disperse Blue 1
219-603-72475-45-8Carc. 1B

Skin Irrit. 2

Eye Dam. 1

Skin Sens. 1
H350

H315

H318

H317
GHS08

GHS05

GHS07

Dgr
H350

H315

H318

H317
611-033-00-0hexasodium [4,4''-azoxybis(2,2'-disulfonatostilbene-4,4'-diylazo)]-bis[5'-sulfonatobenzene-2,2'- diolato-O(2),O(2),N(1)]-copper(II)400-020-382027-60-9Aquatic Chronic 2H411GHS09H411
611-034-00-6N-(5-(bis(2-methoxyethyl)amino)-2-((5-nitro-2,1-benzisothiazol-3-yl)azo)phenylacetamide402-430-8105076-77-5Aquatic Chronic 4H413H413
611-035-00-1tetralithium 6-amino-4-hydroxy-3-[7-sulfonato-4-(5-sulfonato-2-naphthylazo)-1-naphthylazo]naphthalene-2,7-disulfonate403-660-1107246-80-0Skin Sens. 1

Aquatic Chronic 2
H317

H411
GHS07

GHS09

Wng
H317

H411
611-036-00-72-(4-(5,6(or 6,7)-dichloro-1,3-benzothiazol-2-ylazo)-N-methyl-m-toluidino)ethyl acetate405-440-0Skin Sens. 1H317GHS07

Wng
H317
611-037-00-23(or 5)-(4-(N-benzyl-N-ethylamino)-2-methylphenylazo)-1,4-dimethyl-1,2,4-triazolium methylsulphate406-055-0124584-00-5Acute Tox. 4 *

Eye Dam. 1

Skin Sens. 1

Aquatic Chronic 2
H302

H318

H317

H411
GHS05

GHS07

GHS09

Dgr
H302

H318

H317

H411
611-038-00-8trisodium 1-hydroxynaphthalene-2-azo-4'(5',5''-dimethylbiphenyl)-4''-azo(4''-phenylsulfonyloxybenzene)- 2',2'',4-trisulfonate406-820-9Eye Irrit. 2H319GHS07

Wng
H319
611-039-00-37-[((4,6-dichloro-1,3,5-triazin-2-yl)amino)-4-hydroxy-3-(4-((2-sulfoxy)ethyl)sulfonyl)phenylazo]naphthalene-2-sulfonic acid407-050-6117715-57-8Skin Sens. 1H317GHS07

Wng
H317
611-040-00-93-(5-acetylamino-4-(4-[4,6-bis(3-diethylaminopropylamino)-1,3,5-triazin-2-ylamino]phenylazo)-2-(2-methoxyethoxy)phenylazo)-6-amino-4-hydroxy-2-naphthalenesulfonic acid407-670-7115099-58-6Aquatic Acute 1

Aquatic Chronic 1
H400

H410
GHS09

Wng
H410
611-041-00-42-[[4[[4,6-bis[[3-(diethylamino)propyl]amino]-1,3,5-triazine-2-yl]amino]phenyl]azo]-N-(2,3-dihydro-2-oxo-1H-benzimidazol-5-yl)-3-oxobutanamide407-680-198809-11-1Eye Dam. 1

Skin Sens. 1

Aquatic Chronic 2
H318

H317

H411
GHS05

GHS07

GHS09

Dgr
H318

H317

H411
611-042-00-Xtrisodium 5-amino-3-[5-(2-bromoacryloylamino)-2-sulfonatophenylazo]-4-hydroxy-6-(4-vinylsulfonylphenylazo)naphthalene-2,7-disulfonate411-770-6136213-71-3Aquatic Chronic 3H412H412
611-043-00-5reaction mass of: trisodium N(1')-N(2):N(1''')-N(2'')-η-6-[2-amino-4-(or 6)-hydroxy-(or 4-amino-2-hydroxy)phenylazo]-6''-(1-carbaniloyl-2-hydroxyprop-1-enylazo)-5',5'''-disulfamoyl-3,3''-disulfonatobis(naphthalene-2,1'-azobenzene-1,2'-diolato-O(1),O(2'))-chromate;

trisodium N(1')-N(2):N(1''')-N(2'')-η-6,6''-bis(1-carbaniloyl-2-hydroxyprop-1-enylazo)-5',5'''-disulfamoyl-3,3''-disulfonatobis(naphthalene-2,1'azobenzene-1,2'-diolato-O(1),O(2'))-chromate;

trisodium N(1')-N(2):N(1''')-N(2'')-η-6,6''-bis[2-amino-4-(or 6)-hydroxy-(or 4-amino-2-hydroxy)phenylazo]5',5'''-disulfamoyl-3,3''-disulfonatobis(naphthalene-2,1'azobenzene-1,2'-diolato-O(1),O(2'))-chromate (2:1:1)
402-850-1Eye Dam. 1

Aquatic Chronic 3
H318

H412
GHS05

Dgr
H318

H412
611-044-00-0reaction mass of: tert-alkyl(C12-C14)ammonium bis[1-[(2-hydroxy-5-nitrophenyl)azo]-2-naphthalenolato(2-)]-chromate(1-);

tert-alkyl(C12-C14)ammonium bis[1-[(2-hydroxy-4-nitrophenyl)azo]-2-naphthalenolato(2-)]-chromate(1-);

tert-alkyl(C12-C14)ammonium bis[1-[[5-(1,1-dimethylpropyl)-2-hydroxy-3-nitrophenyl]azo]-2-naphthalenolato(2-)]-chromate(1-);

tert-alkyl(C12-C14)ammonium [[1-[(2-hydroxy-5-nitrophenyl)azo]-2-naphthalenolato(2-)]-[1-[(2-hydroxy-5-nitrophenyl)azo]-2-naphthalenolato(2-)]]-chromate(1-);

tert-alkyl(C12-C14)ammonium [[1-[[5-(1,1-dimethylpropyl)-2-hydroxy-3-nitrophenyl]azo]-2-naphthalenolato(2-)]-[1-[(2-hydroxy-5-nitrophenyl)azo]-2-naphthalenolato(2-)]]-chromate(1-);

tert-alkyl(C12-C14)ammonium ((1-(4(or 5)-nitro-2-oxidophenylazo)-2-naphtholato)(1-(3-nitro-2-oxido-5-pentylphenylazo)-2-naphtholato))chromate(1-)
403-720-7117527-94-3Aquatic Chronic 2H411GHS09H411
611-045-00-62-[4-[N-(4-acetoxybutyl)-N-ethyl]amino-2-methylphenylazo]-3-acetyl-5-nitrothiophene404-830-8Aquatic Chronic 4H413H413
611-046-00-14,4'-diamino-2-methylazobenzene407-590-243151-99-1Acute Tox. 3 *

STOT RE 2 *

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H301

H373 **

H317

H400

H410
GHS06

GHS08

GHS09

Dgr
H301

H373 **

H317

H410
611-047-00-7reaction mass of: 2-[[4-[N-ethyl-N-(2-acetoxyethyl)amino]phenyl]azo]-5,6-dichlorobenzothiazole;

2-[[4-[N-ethyl-N-(2-acetoxyethyl)amino]phenyl]azo]-6,7-dichlorobenzothiazole (1:1)
407-890-3111381-11-4Aquatic Chronic 4H413H413
611-048-00-2reaction mass of: 2-[[4-[bis(2-acetoxyethyl)amino]phenyl]azo]-5,6-dichlorobenzothiazole;

2-[[4-[bis(2-acetoxyethyl)amino]phenyl]azo]-6,7-dichlorobenzothiazole (1:1)
407-900-6111381-12-5Aquatic Chronic 4H413H413
611-049-00-8reaction mass of 7-[4-(3-diethylaminopropylamino)-6-(3-diethylammoniopropylamino)-1,3,5-triazin-2-ylamino]-4-hydroxy-3-(4-phenylazophenylazo)-naphthalene-2-sulfonate, acetic acid, lactic acid (2:1:1)408-000-6118658-98-3STOT RE 2 *

Skin Sens. 1

Aquatic Chronic 3
H373 **

H317

H412
GHS08

Wng
H373 **

H317

H412
611-051-00-92-(4-(N-ethyl-N-(2-hydroxy)ethyl)amino-2-methylphenyl)azo-6-methoxy-3-methyl-benzothiazolium chloride411-110-7136213-74-6Aquatic Acute 1

Aquatic Chronic 1
H400

H410
GHS09

Wng
H410
611-052-00-4monosodium aqua-[5-[[2,4-dihydroxy-5-[(2-hydroxy-3,5-dinitrophenyl)azo]phenyl]azo]-2-naphthalensulfonate], iron complex400-720-9Aquatic Chronic 3H412H412
611-053-00-X2,2'-azobis[2-methylpropionamidine] dihydrochloride221-070-02997-92-4Acute Tox. 4 *

Skin Sens. 1
H302

H317
GHS07

Wng
H302

H317
611-055-00-0C.I. Disperse Yellow 3;

N-[4-[(2-hydroxy-5-methylphenyl)azo]phenyl]acetamide
220-600-82832-40-8Carc. 2

Skin Sens. 1
H351

H317
GHS08

GHS07

Wng
H351

H317
611-056-00-6C.I. Solvent Yellow 14;

1-phenylazo-2-naphthol
212-668-2842-07-9Carc. 2

Muta. 2

Skin Sens. 1

Aquatic Chronic 4
H351

H341

H317

H413
GHS08

GHS07

Wng
H351

H341

H317

H413
611-057-00-16-hydroxy-1-(3-isopropoxypropyl)-4-methyl-2-oxo-5-[4-(phenylazo)phenylazo]-1,2-dihydro-3-pyridinecarbonitrile400-340-385136-74-9Carc. 1B

Aquatic Chronic 4
H350

H413
GHS08

Wng
H350

H413
611-058-00-7(6-(4-hydroxy-3-(2-methoxyphenylazo)-2-sulfonato-7-naphthylamino)-1,3,5-triazin-2,4-diyl)bis[(amino-1-methylethyl)ammonium] formate402-060-7108225-03-2Carc. 1B

Eye Dam. 1

Aquatic Chronic 2
H350

H318

H411
GHS08

GHS05

GHS09

Dgr
H350

H318

H411
611-059-00-2octasodium 2-(6-(4-chloro-6-(3-(N-methyl-N-(4-chloro-6-(3,5-disulfonato-2-naphthylazo)-1-hydroxy-6-naphthylamino)-1,3,5-triazin-2-yl)aminomethyl)phenylamino)-1,3,5-triazin-2-ylamino)-3,5-disulfonato-1-hydroxy-2-naphthylazo)naphthalene-1,5-disulfonate412-960-1148878-21-1Eye Dam. 1

Skin Sens. 1

Aquatic Chronic 3
H318

H317

H412
GHS05

GHS07

Dgr
H318

H317

H412
611-060-00-8reaction mass of: sodium 5-[8-[4-[4-[4-[7-(3,5-dicarboxylatophenylazo)-8-hydroxy-3,6-disulfonatonaphthalen-1-ylamino]-6-hydroxy-1,3,5-triazin-2-yl]-2,5-dimethylpiperazin-1-yl]-6-hydroxy-1,3,5-triazin-2-ylamino]-1-hydroxy-3,6-disulfonatonaphthalen-2-ylazo]-isophthalate;

ammonium 5-[8-[4-[4-[4-[7-(3,5-dicarboxylatophenylazo)-8-hydroxy-3,6-disulfonatonaphthalen-1-ylamino]-6-hydroxy-1,3,5-triazin-2-yl]-2,5-dimethylpiperazin-1-yl]-6-hydroxy-1,3,5-triazin-2-ylamino]-1-hydroxy-3,6-disulfonatonaphthalen-2-ylazo]-isophthalate;

5-[8-[4-[4-[4-[7-(3,5-dicarboxylatophenylazo)-8-hydroxy-3,6-disulfonatonaphthalen-1-ylamino]-6-hydroxy-1,3,5-triazin-2-yl]-2,5-dimethylpiperazin-1-yl]-6-hydroxy-1,3,5-triazin-2-ylamino]-1-hydroxy-3,6-disulfonaphthalen-2-ylazo]-isophthalic acid
413-180-4187285-15-0Eye Dam. 1H318GHS05

Dgr
H318
611-061-00-3disodium 5-[5-[4-(5-chloro-2,6-difluoropyrimidin-4-ylamino)benzamido]-2-sulfonatophenylazo]-1-ethyl-6-hydroxy-4-methyl-2-oxo-3-pyridylmethylsulfonate412-530-3Eye Dam. 1

Skin Sens. 1
H318

H317
GHS05

GHS07

Dgr
H318

H317
611-062-00-9octasodium 2-(8-(4-chloro-6-(3-((4-chloro-6-(3,6-disulfonato-2-(1,5-disulfonatonaphthalen-2-ylazo)-1-hydroxynaphthalen-8-ylamino)-1,3,5-triazin-2-yl)aminomethyl)phenylamino)-1,3,5-triazin-2-ylamino)-3,6-disulfonato-1-hydroxynaphthalen-2-ylazo)naphthalene-1,5-disulfonate413-550-5Skin Irrit. 2

Eye Dam. 1
H315

H318
GHS05

Dgr
H315

H318
611-063-00-4trisodium [4'-(8-acetylamino-3,6-disulfonato-2-naphthylazo)-4''-(6-benzoylamino-3-sulfonato-2-naphthylazo)-biphenyl-1,3',3'',1'''-tetraolato-O,O',O'',O''']copper(II)413-590-3164058-22-4Carc. 1BH350GHS08

Dgr
H350
611-064-00-X4-(3,4-dichlorophenylazo)-2,6-di-sec-butyl-phenol410-600-8124719-26-2STOT RE 2 *

Skin Irrit. 2

Aquatic Acute 1

Aquatic Chronic 1
H373 **

H315

H400

H410
GHS08

GHS07

GHS09

Wng
H373 **

H315

H410
611-065-00-54-(4-nitrophenylazo)-2,6-di-sec-butyl-phenol410-610-2111850-24-9STOT RE 2 *

Eye Irrit. 2

Skin Irrit. 2

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H373 **

H319

H315

H317

H400

H410
GHS08

GHS07

GHS09

Wng
H373 **

H319

H315

H317

H410
611-066-00-0tetrasodium 5-[4-chloro-6-(N-ethyl-anilino)-1,3,5-triazin-2-ylamino]-4-hydroxy-3-(1,5-disulfonatonaphthalen-2-ylazo)-naphthalene-2,7-disulfonate411-540-5130201-57-9Eye Dam. 1

Skin Sens. 1

Aquatic Chronic 2
H318

H317

H411
GHS05

GHS07

GHS09

Dgr
H318

H317

H411
611-067-00-6reaction mass of: bis(tris(2-(2-hydroxy(1-methyl)ethoxy)ethyl)ammonium) 7-anilino-4-hydroxy-3-(2-methoxy-5-methyl-4-(4-sulfonatophenylazo)phenylazo)naphthalene-2-sulfonate;

bis(tris(2-(2-hydroxy(2-methyl)ethoxy)ethyl)ammonium) 7-anilino-4-hydroxy-3-(2-methoxy-5-methyl-4-(4-sulfonatophenylazo)phenylazo)naphthalene-2-sulfonate
406-910-8Acute Tox. 4 *

Eye Dam. 1

Aquatic Chronic 3
H302

H318

H412
GHS05

GHS07

Dgr
H302

H318

H412
611-068-00-1tetrasodium 4-amino-3,6-bis(5-[4-chloro-6-(2-hydroxyethylamino)-1,3,5-triazin-2-ylamino]-2-sulfonatophenylazo)-5-hydroxynaphthalene-2,7-disulfonate400-690-785665-98-1Aquatic Chronic 2H411GHS09H411
611-069-00-7N,N-di-[poly(oxyethylene)-co-poly(oxypropylene)]-4-[(3,5-dicyano-4-methyl-2-thienyl)azo)]-3-methylaniline413-380-1Aquatic Chronic 2H411GHS09H411
611-070-00-2reaction mass of: disodium (6-(4-anisidino)-3-sulfonato-2-(3,5-dinitro-2-oxidophenylazo)-1-naphtholato)(1-(5-chloro-2-oxidophenylazo)-2-naphtholato)chromate(1-);

trisodium bis(5-(4-anisidino)-3-sulfonato-2-(3,5-dinitro-2-oxidophenylazo)-1-naphtholato)chromate(1-)
405-665-4Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H317

H400

H410
GHS07

GHS09

Wng
H317

H410
611-071-00-8tris(tetramethylammonium) 5-hydroxy-1-(4-sulphonatophenyl)-4-(4-sulphonatophenylazo)pyrazole-3-carboxylate406-073-9131013-81-5Acute Tox. 3 *

Aquatic Chronic 3
H301

H412
GHS06

Dgr
H301

H412
611-072-00-32,4-bis[2,2'-[2-(N,N-dimethylamino)ethyloxycarbonyl]phenylazo]-1,3-dihydroxybenzene, dihydrochloride407-010-8118208-02-9Acute Tox. 4 *

Eye Dam. 1

Aquatic Chronic 2
H302

H318

H411
GHS05

GHS07

GHS09

Dgr
H302

H318

H411
611-073-00-9dimethyl 3,3'-(N-(4-(4-bromo-2,6-dicyanophenylazo)-3-hydroxyphenyl)imino)dipropionate407-310-9122630-55-1Aquatic Chronic 4H413H413
611-074-00-4reaction mass of: sodium/potassium (3-(4-(5-(5-chloro-2,6-difluoropyrimidin-4-ylamino)-2-methoxy-3-sulfonatophenylazo)-2-oxidophenylazo)-2,5,7-trisulfonato-4-naphtholato)copper(II);

sodium/potassium (3-(4-(5-(5-chloro-4,6-difluoropyrimidin-2-ylamino)-2-methoxy-3-sulfonatophenylazo)-2-oxidophenylazo)-2,5,7-trisulfonato-4-naphtholato)copper(II)
407-100-7Skin Sens. 1H317GHS07

Wng
H317
611-075-00-Xreaction mass of: tris(3,5,5-trimethylhexylammonium) 4-amino-3-(4-(4-(2-amino-4-hydroxyphenylazo)anilino)-3-sulfonatophenylazo)-5,6-dihydro-5-oxo-6-phenylhydrazononaphthalene-2,7-disulfonate;

tris(3,5,5-trimethylhexylammonium) 4-amino-3-(4-(4-(4-amino-2-hydroxyphenylazo)anilino)-3-sulfonatophenylazo)-5,6-dihydro-5-oxo-6-phenylhydrazononaphthalene-2,7-disulfonate (2:1)
406-000-0Eye Dam. 1

Aquatic Chronic 2
H318

H411
GHS05

GHS09

Dgr
H318

H411
611-076-00-53-(2,6-dichloro-4-nitrophenylazo)-1-methyl-2-phenylindole406-280-4117584-16-4Aquatic Acute 1

Aquatic Chronic 1
H400

H410
GHS09

Wng
H410
611-077-00-0dilithium disodium (5,5'-diamino-(μ-4,4'-dihydroxy-1:2-κ-2,O4,O4',-3,3'-[3,3'-dihydroxy-1:2-κ-2-O3,O3'-biphenyl-4,4'-ylenebisazo-1:2-(N3,N4-η:N3',N4'-η)]-dinaphthalene-2,7-disulfonato(8)))dicuprate(2-)407-230-4126637-70-5Acute Tox. 4 *

Skin Sens. 1
H302

H317
GHS07

Wng
H302

H317
611-078-00-6(2,2'-(3,3'-dioxidobiphenyl-4,4'-diyldiazo)bis(6-(4-(3-(diethylamino)propylamino)-6-(3-(diethylammonio)propylamino)-1,3,5-triazin-2-ylamino)-3-sulfonato-1-naphtholato))dicopper(II) acetate lactate407-240-9159604-94-1Skin Sens. 1

Aquatic Chronic 2
H317

H411
GHS07

GHS09

Wng
H317

H411
611-079-00-1disodium 7-[4-chloro-6-(N-ethyl-o-toluidino)-1,3,5-triazin-2-ylamino]-4-hydroxy-3-(4-methoxy-2-sulfonatophenylazo)-2-naphthalenesulfonate410-390-8147703-64-8Eye Dam. 1H318GHS05

Dgr
H318
611-080-00-7sodium 3-(2-acetamido-4-(4-(2-hydroxybutoxy)phenylazo)phenylazo)benzenesulfonate410-150-2147703-65-9Skin Sens. 1H317GHS07

Wng
H317
611-081-00-2tetrasodium [7-(2,5-dihydroxy-KO2-7-sulfonato-6-[4-(2,5,6-trichloro-pyrimidin-4-ylamino)phenylazo]-(N1,N7-N)-1-naphthylazo)-8-hydroxy-KO8-naphthalene-1,3,5-trisulfonato(6-)]cuprate(II)411-470-5141048-13-7Skin Sens. 1

Aquatic Chronic 3
H317

H412
GHS07

Wng
H317

H412
611-082-00-8reaction mass of: pentasodium bis(1-(3(or 5)-(4-anilino-3-sulfonatophenylazo)-4-hydroxy-2-oxidophenylazo)-6-nitro-4-sulfonato-2-naphtholato)ferrate(1-);

pentasodium [(1-(3-(4-anilino-3-sulfonatophenylazo)-4-hydroxy-2-oxidophenylazo)-6-nitro-4-sulfonato-2-naphtholato)-(5-(4-anilino-3-sulfonatophenylazo)-4-hydroxy-2-oxidophenylazo)-6-nitro-4-sulfonato-2-naphtholato]ferrate(1-)
407-570-3Aquatic Chronic 2H411GHS09H411
611-083-00-3reaction mass of: 2-[N-ethyl-4-[(5,6-dichlorobenzothiazol-2-yl)azo]-m-toludino]ethyl acetate;

2-[N-ethyl-4-[(6,7-dichlorobenzothiazol-2-yl)azo]-m-toludino]ethyl acetate (1:1)
411-560-4STOT RE 1

Skin Sens. 1

Aquatic Chronic 2
H372 **

H317

H411
GHS08

GHS07

GHS09

Dgr
H372 **

H317

H411
611-084-00-9reaction mass of: N-(4-chlorophenyl)-4-(2,5-dichloro-4-(dimethylsulfamoyl)phenylazo)-3-hydroxy-2-naphthalenecarboxamide;

N-(4-chlorophenyl)-4-(2,5-dichloro-4-(methylsulfamoyl)phenylazo)-3-hydroxy-2-naphthalenecarboxamide
412-550-2Aquatic Chronic 4H413H413
611-085-00-4reaction mass of: 3-cyano-5-(2-cyano-4-nitro-phenylazo)-2-(2-hydroxy-ethylamino)-4-methyl-6-[3-(2-phenoxyethoxy)propylamino]pyridine;

3-cyano-5-(2-cyano-4-nitro-phenylazo)-6-(2-hydroxy-ethylamino)-4-methyl-2-[3-(2-phenoxyethoxy)propylamino]pyridine;

3-cyano-5-(2-cyano-4-nitro-phenylazo)-2-amino-4-methyl-6-[3-(3-hydroxypropoxy)propylamino]pyridine;

3-cyano-5-(2-cyano-4-nitro-phenylazo)-6-amino-4-methyl-2-[3-(3-methoxypropoxy)propylamino]pyridine
411-880-4Skin Sens. 1

Aquatic Chronic 2
H317

H411
GHS07

GHS09

Wng
H317

H411
611-086-00-Xmonolithium 5-[[2,4-dihydroxy-5-[(2-hydroxy-3,5-dinitrophenyl)azo]phenyl]azo]-2-naphthalenesulfonate], iron complex, monohydrate411-360-7Aquatic Chronic 3H412H412
611-087-00-5reaction mass of: 3-((5-cyano-1,6-dihydro-1,4-dimethyl-2-hydroxyl-6-oxo-3-pyridinyl)azo)-benzoyloxy-2-phenoxyethane;

3-((5-cyano-1,6-dihydro-1,4-dimethyl-2-hydroxy-6-oxo-3-pyridinyl)azo)-benzoyloxy-2-ethyloxy-2-(ethylphenol)
411-710-9Aquatic Chronic 4H413H413
611-088-00-0reaction mass of: trilithium 4-amino-3-((4-((4-((2-amino-4-hydroxyphenyl)azo)phenyl)amino)-3-sulfophenyl)azo)-5-hydroxy-6-(phenylazo)naphthalene-2,7-disulfonate;

trilithium 4-amino-3-((4-((4-((4-amino-2-hydroxyphenyl)azo)phenyl)amino)-3-sulfophenyl)azo)-5-hydroxy-6-(phenylazo)naphthalene-2,7-disulfonate
411-890-9Acute Tox. 4 *

Eye Dam. 1

Aquatic Chronic 3
H302

H318

H412
GHS05

GHS07

Dgr
H302

H318

H412
611-089-00-62-((4-(ethyl-(2-hydroxyethyl)amino)-2-methylphenyl)azo)-6-methoxy-3-methyl-benzothiazolium methylsulfate411-100-2136213-73-5STOT RE 2 *

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H373 **

H317

H400

H410
GHS08

GHS07

GHS09

Wng
H373 **

H317

H410
611-090-00-12,5-dibutoxy-4-(morpholin-4-yl)benzenediazonium 4-methylbenzenesulfonate413-290-293672-52-7Self-react. C

Acute Tox. 4 *

Eye Dam. 1

Skin Sens. 1

Aquatic Chronic 3
H242

H302

H318

H317

H412
GHS02

GHS05

GHS07

Dgr
H242

H302

H318

H317

H412
T
611-091-00-7sodium (1,0-1,95)/lithium (0,05-1) 5-((5-((5-chloro-6-fluoro-pyrimidin-4-yl)amino)-2-sulfonatophenyl)azo)-1,2-dihydro-6-hydroxy-1,4-dimethyl-2-oxo-3-pyridinemethylsulfonate413-470-0134595-59-8Skin Sens. 1H317GHS07

Wng
H317
611-092-00-2tert-(dodecyl/tetradecyl)-ammonium bis(3-(4-((5-(1,1-dimethyl-propyl)-2-hydroxy-3-nitrophenyl)azo)-3-methyl-5-hydroxy-(1H)pyrazol-1-yl)benzenesulfonamidato)chromate413-210-6Aquatic Chronic 2H411GHS09H411
611-093-00-8sodium 2-(4-(4-fluoro-6-(2-sulfo-ethylamino)-[1,3,5]triazin-2-ylamino)-2-ureido-phenylazo)-5-(4-sulfophenylazo)benzene-1-sulfonate410-770-3146177-84-6Skin Sens. 1H317GHS07

Wng
H317
611-094-00-3reaction mass of: 2-[2-acetylamino-4-[N,N-bis[2-ethoxy-carbonyloxy)ethyl]amino]phenylazo]-5,6-dichloro-1,3-benzothiazole;

2-[2-acetylamino-4-[N,N-bis[2-ethoxy-carbonyloxy)ethyl]amino]phenylazo]-6,7-dichloro-1,3-benzotriazole (1:1)
411-600-0143145-93-1Aquatic Chronic 4H413H413
611-095-00-9hexasodium 1,1'-[(1-amino-8-hydroxy-3,6-disulfonate-2,7-naphthalenediyl)bis(azo(4-sulfonate-1,3-phenyl)imino[6-[(4-chloro-3-sulfonatophenyl)amino]-1,3,5-triazin-2,4-diyl]]]bis[3-carboxypyridinium] dihydroxide412-240-789797-03-5Aquatic Chronic 2H411GHS09H411
611-096-00-4methyl N-[3-acetylamino)-4-(2-cyano-4-nitrophenylazo)phenyl]-N-[(1-methoxy)acetyl]glycinate413-040-2149850-30-6Skin Sens. 1H317GHS07

Wng
H317
611-097-00-Xreaction mass of iron complexes of: 1,3-dihydroxy-4-[(5-phenylaminosulfonyl)-2-hydroxyphenylazo]-n-(5-amino-sulfonyl-2-hydroxyphenylazo)benzene and: 1,3-dihydroxy-4-[(5-phenylaminosulfonyl)-2-hydroxyphenylazo]-n-[4-(4-nitro-2-sulfophenylamino)phenylazo]benzene (n=2,5,6)414-150-3Skin Sens. 1

Aquatic Chronic 2
H317

H411
GHS07

GHS09

Wng
H317

H411
611-098-00-5tetrakis(tetramethylammonium)3,3'-(6-(2-hydroxyethylamino)1,3,5-triazine-2,4-diylbisimino(2-methyl-4,1-phenyleneazo))bisnaphthalene-1,5-disulfonate405-950-3131013-83-7Acute Tox. 3 *

Aquatic Chronic 3
H301

H412
GHS06

Dgr
H301

H412
611-099-00-0(methylenebis(4,1-phenylenazo(1-(3-(dimethylamino)propyl)-1,2-dihydro-6-hydroxy-4-methyl-2-oxopyridine-5,3-diyl)))-1,1'-dipyridinium dichloride dihydrochloride401-500-5118658-99-4Carc. 1B

Aquatic Chronic 2
H350

H411
GHS08

GHS09

Dgr
H350

H411
611-100-00-4potassium sodium 3,3'-(3(or4)-methyl-1,2-phenylenebis(imino(6-chloro)-1,3,5-triazine-4,2-diylimino(2-acetamido-5-methoxy)-4,1-phenylenazo)dinaphthalene-1,5-disulfonate403-810-6140876-13-7Eye Dam. 1H318GHS05

Dgr
H318
611-101-00-X2'-(4-chloro-3-cyano-5-formyl-2-thienyl)azo-5'-diethylaminoacetanilide405-200-5104366-25-8Skin Sens. 1H317GHS07

Wng
H317
611-103-00-0trisodium (1-(3-carboxylato-2-oxido-5-sulfonatophenylazo)-5-hydroxy-7-sulfonatonaphthalen-2-amido)nickel(II)407-110-1Eye Dam. 1

Skin Sens. 1

Aquatic Chronic 2
H318

H317

H411
GHS05

GHS07

GHS09

Dgr
H318

H317

H411
611-104-00-6reaction mass of: trisodium (2,4(or 2,6 or 4,6)-bis(3,5-dinitro-2-oxidophenylazo)-5-hydroxyphenolato)(2(or 4or 6)-(3,5-dinitro-2-oxidophenylazo)-5-hydroxy-4(or 2or 6)-(4-(4-nitro-2-sulfonatoanilino)phenylazo)phenolato)ferrate(1-);

trisodium bis(2,4(or 2,6 or 4,6)-bis(3,5-dinitro-2-oxidophenylazo)-5-hydroxyphenolato)ferrate(1-);

trisodium (2,4(or 2,6 or 4,6)-bis(3,5-dinitro-2-oxidophenylazo)-5-hydroxyphenolato)(2(or 4 or 6)-(3,5-dinitro-2-oxidophenylazo)-5-hydroxy-4(or 2 or 6)-(4-nitro-2-sulfonatophenylazo)phenolato)ferrate(1-);

trisodium (2,4(or 2,6 or 4,6)-bis(3,5-dinitro-2-oxidophenylazo)-5-hydroxyphenolato)(2(or 4 or 6)-(3,5-dinitro-2-oxidophenylazo)-5-hydroxy-4(or 2 or 6)-(3-sulfonatophenylazo)phenolato)ferrate(1-);

disodium 3,3'-(2,4-dihydroxy-1,3(or 1,5 or 3,5)-phenylenediazo)dibenzenesulfonate
406-870-1Skin Sens. 1

Aquatic Chronic 2
H317

H411
GHS07

GHS09

Wng
H317

H411
611-105-00-1sodium 4-(4-chloro-6-(N-ethylanilino)-1,3,5-triazin-2-ylamino)-2-(1-(2-chlorophenyl)-5-hydroxy-3-methyl-1H-pyrazol-4-ylazo)benzenesulfonate407-800-2136213-75-7Skin Sens. 1

Aquatic Chronic 2
H317

H411
GHS07

GHS09

Wng
H317

H411
611-106-00-7hexasodium 4,4'-dihydroxy-3,3'-bis[2-sulfonato-4-(4-sulfonatophenylazo)phenylazo]-7,7'[p-phenylenebis[imino(6-chloro-1,3,5-triazine-4,2-diyl)imino]]dinaphthalene-2-sulfonate410-180-6157627-99-1Eye Dam. 1H318GHS05

Dgr
H318
611-107-00-2potassium sodium 4-(4-chloro-6-(3,6-disulfonato-7-(5,8-disulfonato-naphthalen-2-ylazo)-8-hydroxy-naphthalen-1-ylamino)-1,3,5-triazin-2-ylamino)-5-hydroxy-6-(4-(2-sulfatoethanesulfonyl)-phenylazo)-naphthalene-1,7-disulfonate412-490-7Skin Sens. 1H317GHS07

Wng
H317
611-108-00-8disodium 5-((4-((4-chloro-3-sulfonatophenyl)azo)-1-naphthyl)azo)-8-(phenylamino)-1-naphthalenesulfonate413-600-66527-62-4Aquatic Chronic 3H412H412
611-109-00-3reaction products of: copper(II) sulfate and tetrasodium 2,4-bis[6-(2-methoxy-5-sulfonatophenylazo)-5-hydroxy-7-sulfonato-2-naphthylamino]-6-(2-hydroxyethylamino)-1,3,5-triazine (2:1)407-710-3Aquatic Chronic 2H411GHS09H411
611-110-00-9tetra-sodium/lithium 4,4'-bis-(8-amino-3,6-disulfonato-1-naphthol-2-ylazo)-3-methylazobenzene408-210-8124605-82-9Skin Sens. 1

Aquatic Chronic 2
H317

H411
GHS07

GHS09

Wng
H317

H411
611-111-00-4disodium 2-[[4-(2-chloroethylsulfonyl)phenyl]-[(2-hydroxy-5-sulfo-3-[3-[2-(2-(sulfooxy)ethylsulfonyl)ethylazo]-4-sulfobenzoato(3-)cuprate(1-)414-230-8Skin Sens. 1H317GHS07

Wng
H317
611-112-00-Xtetrasodium 4-hydroxy-5-[4-[3-(2-sulfatoethanesulfonyl)phenylamino]-6-morpholin-4-yl-1,3,5-triazin-2-ylamino]-3-(1-sulfonatonaphthalen-2-ylazo)naphthalene-2,7-disulfonate413-070-6Skin Sens. 1H317GHS07

Wng
H317
611-113-00-5lithium sodium (2-(((5-((2,5-dichlorophenyl)azo)-2-hydroxyphenyl)methylene)amino)benzoato(2-))(2-((4,5-dihydro-3-methyl-5-oxo-1-phenyl-1H-pyrazol-4-yl)azo)-5-sulfobenzoato(3-)) chromate(2-)414-280-0149626-00-6Aquatic Chronic 2H411GHS09H411
611-114-00-0lithium sodium (4-((5-chloro-2-hydroxyphenyl)azo)-2,4-dihydro-5-methyl-3H-pyrazol-3-onato(2-))(3-((4,5-dihydro-3-methyl-1-(4-methylphenyl)-5-oxo-1H-pyrazol-4-yl)azo)-4-hydroxy-5-nitrobenzenesulfonato(3-)) chromate(2-)414-250-7149564-66-9Acute Tox. 4 *

Eye Dam. 1

Aquatic Chronic 3
H302

H318

H412
GHS05

GHS07

Dgr
H302

H318

H412
611-115-00-6trilithium bis(4-((4-(diethylamino)-2-hydroxyphenyl)azo)-3-hydroxy-1-naphthalenesulfonato(3-))chromate(3-)414-290-5149564-65-8Acute Tox. 4 *

Aquatic Chronic 3
H302

H412
GHS07

Wng
H302

H412
611-116-00-1reaction mass of: trisodium 5-{4-chloro-6-[2-(2,6-dichloro-5-cyanopyrimidin-4-ylamino)-propylamino]-1,3,5-triazin-2-ylamino}-4-hydroxy-3-(1-sulfonatonaphthalene-2-ylazo)-naphthalene-2,7-disulfonate;

trisodium 5-{4-chloro-6-[2-(2,6-dichloro-5-cyanopyrimidin-4-ylamino)-1-methyl-ethylamino]-1,3,5-triazin-2-ylamino}-4-hydroxy-3-(1-sulfonatonaphthalene-2-ylazo)-naphthalene-2,7-disulfonate;

trisodium 5-{4-chloro-6-[2-(4,6-dichloro-5-cyanopyrimidin-2-ylamino)-propylamino]-1,3,5-triazin-2-ylamino}-4-hydroxy-3-(1-sulfonatonaphthalen-2-ylazo)-naphthalene-2,7-disulfonate;

trisodium 5-{4-chloro-6-[2-(4,6-dichloro-5-cyanopyrimidin-2-ylamino)-1-methyl-ethylamino]-1,3,5-triazin-2-ylamino}-4-hydroxy-3-(1-sulfonatonaphthalen-2-ylazo)-naphthalene-2,7-disulfonate
414-620-8Eye Dam. 1

Skin Sens. 1
H318

H317
GHS05

GHS07

Dgr
H318

H317
611-117-00-71,3-bis{6-fluoro-4-[1,5-disulfo-4-(3-aminocarbonyl-1-ethyl-6-hydroxy-4-methyl-pyrid-2-on-5-ylazo)-phenyl-2-ylamino]-1,3,5-triazin-2-ylamino}propane lithium-, sodium salt415-100-3149850-29-3Skin Sens. 1H317GHS07

Wng
H317
611-118-00-2sodium 1,2-bis[4-[4-{4-(4-sulfophenylazo)-2-sulfophenylazo}-2-ureido-phenyl-amino]-6-fluoro-1,3,5-triazin-2-ylamino]-propane, sodium salt413-990-8Skin Sens. 1H317GHS07

Wng
H317
611-119-00-8tetrasodium 4-[4-chloro-6-(4-methyl-2-sulfophenylamino)-1,3,5-triazin-2-ylamino]-6-(4,5-dimethyl-2-sulfophenylazo)-5-hydroxynaphthalene-2,7-disulfonate415-400-4148878-22-2Eye Dam. 1

Skin Sens. 1
H318

H317
GHS05

GHS07

Dgr
H318

H317
611-120-00-35-{4-[5-amino-2-[4-(2-sulfoxyethylsulfonyl)phenylazo]-4-sulfo-phenylamino]-6-chloro-1,3,5-triazin-2-ylamino}-4-hydroxy-3-(1-sulfo-naphthalen-2-ylazo)-naphthalene-2,7-disulfonicacid sodium salt418-340-7157707-94-3Eye Dam. 1

Aquatic Chronic 3
H318

H412
GHS05

Dgr
H318

H412
611-121-00-9main component 6 (isomer): asym. 1:2 Cr(III)-complex of: A: 3-hydroxy-4-(2-hydroxy-naphthalene-1-ylazo)naphthalene-1-sulfonic acid, Na-salt and B: 1-[2-hydroxy-5-(4-methoxy-phenylazo)phenylazo]naphthalene-2-ol;

main component 8 (isomer): asym. 1:2 Cr-complex of: A: 3-hydroxy-4-(2-hydroxy-naphthalene-1-ylazo)-naphthalene-1-sulfonic acid, Na-salt and B: 1-[2-hydroxy-5-(4-methoxy-phenylazo)-phenylazo]-naphthalene-2-ol
417-280-930785-74-1Eye Dam. 1

Aquatic Acute 1

Aquatic Chronic 1
H318

H400

H410
GHS05

GHS09

Dgr
H318

H410
611-122-00-4hexasodium (di[N-(3-(4-[5-(5-amino-3-methyl-1-phenylpyrazol-4-yl-azo)-2,4-disulfo-anilino]-6-chloro-1,3,5-triazin-2-ylamino)phenyl)-sulfamoyl](di-sulfo)-phthalocyaninato)nickel417-250-5151436-99-6Eye Dam. 1

Skin Sens. 1
H318

H317
GHS05

GHS07

Dgr
H318

H317
611-123-00-X3-(2,4-bis(4-((5-(4,6-bis(2-aminopropylamino)-1,3,5-triazin-2-ylamino)-4-hydroxy-2,7-disulfonaphthalen-3-yl)azo)phenylamino)-1,3,5-triazin-6-ylamino)propyldiethylammonium lactate424-310-4178452-66-9Eye Dam. 1H318GHS05

Dgr
H318
611-124-00-5reaction mass of: pentasodium 5-amino-3-(5-{4-chloro-6-[4-(2-sulfoxyethoxysulfonato)phenylamino]-1,3,5-triazin-2-ylamino}-2-sulfonatophenylazo)-6-[5-(2,3-dibromopropionylamino)-2-sulfonatophenylazo]-4-hydroxynaphthalene-2,7-disulfonate;

pentasodium 5-amino-6-[5-(2-bromoacryloylamino)-2-sulfonatophenylazo]-3-(5-{4-chloro-6-[4-(2-sulfoxyethoxysulfonato)phenylamino]-1,3,5-triazin-2-ylamino}-2-sulfonatophenylazo)-4-hydroxynaphthalene-2,7-disulfonate;

tetrasodium 5-amino-3-[5-{4-chloro-6-[4-(vinylsulfonyl)phenylamino]-1,3,5-triazin-2-ylamino}-2-sulfonatophenylazo]-6-[5-(2,3-dibromopropionylamino)-2-sulfonatophenylazo]-4-hydroxynaphthalene-2,7-disulfonate
424-320-9Eye Dam. 1

Aquatic Chronic 2
H318

H411
GHS05

GHS09

Dgr
H318

H411
611-125-00-0reaction mass of: Disodium 6-[3-carboxy-4,5-dihydro-5-oxo-4-sulfonatophenyl)pyrazolin-4-yl-azo]-3-[2-oxido-4-(ethensulfonyl)-5-methoxyphenylazo]-4-oxidonaphthalene-2-sulfonate copper (II) complex;

Disodium 6-[3-carboxy-4,5-dihydro-5-oxo-4-sulfonatophenyl)pyrazolin-4-yl-azo]-3-[2-oxido-4-(2-hydroxyethylsulfonyl)-5-methoxyphenylazo]-4-oxidonaphthalene-2-sulfonate copper (II) complex
423-940-7Eye Dam. 1

Aquatic Chronic 2
H318

H411
GHS05

GHS09

Dgr
H318

H411
611-126-00-62,6-bis-(2-(4-(4-amino-phenylamino)-phenylazo)-1,3-dimethyl-3H-imidazolium)-4-dimethylamino-1,3,5-triazine, dichloride424-120-1174514-06-8Eye Dam. 1

Aquatic Acute 1

Aquatic Chronic 1
H318

H400

H410
GHS05

GHS09

Dgr
H318

H410
611-127-00-1pentasodium 4-amino-6-(5-(4-(2-ethyl-phenylamino)-6-(2-sulfatoethanesulfonyl)-1,3,5-triazin-2-ylamino)-2-sulfonatophenylazo)-5-hydroxy-3-(4-(2-sulfatoethanesulfonyl)phenylazo)naphthalene-2,7-disulfonate423-790-2Eye Dam. 1

Skin Sens. 1

Aquatic Chronic 3
H318

H317

H412
GHS05

GHS07

Dgr
H318

H317

H412
G
611-128-00-7N,N'-bis{6-chloro-4-[6-(4-vinylsulfonylphenylazo)-2,7-disulfonicacid-5-hydroxynapht-4-ylamino]-1,3,5-triazin-2-yl}-N-(2-hydroxyethyl)ethane-1,2-diamine, sodium salt419-500-9171599-85-2Eye Dam. 1

Skin Sens. 1
H318

H317
GHS05

GHS07

Dgr
H318

H317
611-129-00-2reaction mass of: 5-[(4-[(7-amino-1-hydroxy-3-sulfo-2-naphthyl)azo]-2,5-diethoxyphenyl)azo]-2-[(3-phosphonophenyl)azo]benzoic acid;

5-[(4-[(7-amino-1-hydroxy-3-sulfo-2-naphthyl)azo]-2,5-diethoxyphenyl)azo]-3-[(3-phosphonophenyl)azo]benzoic acid
418-230-9163879-69-4Expl. 1.3 ****

Repr. 2

STOT RE 2 *

Skin Sens. 1

Aquatic Chronic 2
H203

H361f ***

H373 **

H317

H411
GHS01

GHS08

GHS07

GHS09

Dgr
H203

H361f ***

H373 **

H317

H411
611-130-00-8tetra-ammonium 2-[6-[7-(2-carboxylato-phenylazo)-8-hydroxy-3,6-disulfonato-1-naphthylamino]-4-hydroxy-1,3,5-triazin-2-ylamino]benzoate418-520-5183130-96-3Eye Irrit. 2

Aquatic Acute 1

Aquatic Chronic 1
H319

H400

H410
GHS07

GHS09

Wng
H319

H410
611-131-00-32-[2-hydroxy-3-(2-chlorophenyl)carbamoyl-1-naphthylazo]-7-[2-hydroxy-3-(3-methylphenyl)carbamoyl-1-naphthylazo]fluoren-9-one420-580-2151798-26-4Repr. 1B

Aquatic Chronic 4
H360D ***

H413
GHS08

Dgr
H360D ***

H413
611-132-00-9pentasodium bis{7-[4-(1-butyl-5-cyano-1,2-dihydro-2-hydroxy-4-methyl-6-oxo-3-pyridylazo)phenylsulfonylamino]-5'-nitro-3,3'-disulfonatonaphthalene-2-azobenzene-1,2'-diolato} chromate (III)419-210-2178452-71-6Eye Dam. 1

Aquatic Chronic 3
H318

H412
GHS05

Dgr
H318

H412
611-133-00-4Product by process iron complex of azo dyestuffs obtained by coupling a mixture of diazotized 2-amino-1-hydroxybenzene-4-sulfanilide and 2-amino-1-hydroxybenzene-4-sulfonamide with resorcin, the obtained mixture being subsequently submitted to a second coupling reaction with a mixture of diazotized 3-aminobenzene-1-sulfonic acid (metanilic acid) and 4'-amino-4-nitro-1,1'-diphenylamine-2-sulfonic acid and metallization with ferric chloride, sodium salt419-260-5Eye Dam. 1

Aquatic Chronic 2
H318

H411
GHS05

GHS09

Dgr
H318

H411
611-134-00-Xtrisodium 2-{α[2-hydroxy-3-[4-chloro-6-[4-(2,3-dibromopropionylamino)-2-sulfonatophenylamino]-1,3,5-triazin-2-ylamino]-5-sulfonatophenylazo]-benzylidenehydrazino}-4-sulfonatobenzoate, copper complex423-770-3Eye Dam. 1

Aquatic Chronic 2
H318

H411
GHS05

GHS09

Dgr
H318

H411
611-135-00-5reaction product of: 2-[[4-amino-2-ureidophenylazo]-5-[(2-(sulfooxy)ethyl)sulfonyl]]benzenesulfonic acid with 2,4,6-trifluoropyrimidine and partial hydrolysis to the corresponding vinylsulfonyl derivative, mixed potassium/sodium salt424-250-9Eye Dam. 1

Aquatic Chronic 3
H318

H412
GHS05

Dgr
H318

H412
611-136-00-02-{4-(2-ammoniopropylamino)-6-[4-hydroxy-3-(5-methyl-2-methoxy-4-sulfamoylphenylazo)-2-sulfonatonaphth-7-ylamino]-1,3,5-triazin-2-ylamino}-2-aminopropyl formate424-260-3Repr. 2

Eye Dam. 1

Aquatic Chronic 2
H361f ***

H318

H411
GHS05

GHS08

GHS09

Dgr
H361f ***

H318

H411
611-137-00-66-tert-butyl-7-chloro-3-tridecyl-7,7a-dihydro-1H-pyrazolo[5,1-c]-1,2,4-triazole419-870-1159038-16-1Aquatic Chronic 4H413H413
611-138-00-12-(4-aminophenyl)-6-tert-butyl-1H-pyrazolo[1,5-b][1,2,4]triazole415-910-7152828-25-6Skin Sens. 1

Aquatic Chronic 2
H317

H411
GHS07

GHS09

Wng
H317

H411
611-140-00-2azafenidin (ISO);

2-(2,4-dichloro-5-prop-2-ynyloxyphenyl)-5,6,7,8-tetrahydro-1,2,4-triazolo[4,3-a]pyridin-3(2H)-one
68049-83-2Repr. 1B

STOT RE 2 *

Aquatic Acute 1

Aquatic Chronic 1
H360Df

H373 **

H400

H410
GHS08

GHS09

Dgr
H360Df

H373 **

H410
M = 1 000
612-001-00-9mono-methylamine; [1]

di-methylamine; [2]

tri-methylamine [3]
200-820-0 [1]

204-697-4 [2]

200-875-0 [3]
74-89-5 [1]

124-40-3 [2]

75-50-3 [3]
Flam. Gas 1

Press. Gas

Acute Tox. 4 *

STOT SE 3

Skin Irrit. 2

Eye Dam. 1
H220

H332

H335

H315

H318
GHS02

GHS04

GHS05

GHS07

Dgr
H220

H332

H335

H315

H318
*

Skin Irrit. 2; H315: C ≥ 5 %

Eye Dam. 1; H318: C ≥ 5 %

Eye Irrit. 2; H319: 0,5 % ≤ C < 5 %

STOT SE 3; H335: C ≥ 5 %
U

5
612-001-01-6mono-methylamine ... %; [1]

di-methylamine ... %; [2]

tri-methylamine ... % [3]
200-820-0 [1]

204-697-4 [2]

200-875-0 [3]
74-89-5 [1]

124-40-3 [2]

75-50-3 [3]
Flam. Liq. 1

Acute Tox. 4 *

Acute Tox. 4 *

Skin Corr. 1B
H224

H332

H302

H314
GHS02

GHS05

GHS07

Dgr
H224

H332

H302

H314
*

STOT SE 3; H335: C ≥ 5 %
B
612-002-00-4ethylamine200-834-775-04-7Flam. Gas 1

Press. Gas

Eye Irrit. 2

STOT SE 3
H220

H319

H335
GHS02

GHS04

GHS07

Dgr
H220

H319

H335
U
612-003-00-Xdiethylamine203-716-3109-89-7Flam. Liq. 2

Acute Tox. 4 *

Acute Tox. 4 *

Acute Tox. 4 *

Skin Corr. 1A
H225

H332

H312

H302

H314
GHS02

GHS05

GHS07

Dgr
H225

H332

H312

H302

H314
STOT SE 3; H335: C ≥ 1 %
612-004-00-5triethylamine204-469-4121-44-8Flam. Liq. 2

Acute Tox. 4 *

Acute Tox. 4 *

Acute Tox. 4 *

Skin Corr. 1A
H225

H332

H312

H302

H314
GHS02

GHS05

GHS07

Dgr
H225

H332

H312

H302

H314
STOT SE 3; H335: C ≥ 1 %
612-005-00-0butylamine203-699-2109-73-9Flam. Liq. 2

Acute Tox. 4 *

Acute Tox. 4 *

Acute Tox. 4 *

Skin Corr. 1A
H225

H332

H312

H302

H314
GHS02

GHS05

GHS07

Dgr
H225

H332

H312

H302

H314
STOT SE 3; H335: C ≥ 1 %
612-006-00-6ethylenediamine;

1,2-diaminoethane
203-468-6107-15-3Flam. Liq. 3

Acute Tox. 4 *

Acute Tox. 4 *

Skin Corr. 1B

Resp. Sens. 1

Skin Sens. 1
H226

H312

H302

H314

H334

H317
GHS02

GHS08

GHS05

GHS07

Dgr
H226

H312

H302

H314

H334

H317
612-007-00-12-aminopropane;

isopropylamine
200-860-975-31-0Flam. Liq. 1

Eye Irrit. 2

STOT SE 3

Skin Irrit. 2
H224

H319

H335

H315
GHS02

GHS07

Dgr
H224

H319

H335

H315
612-008-00-7aniline200-539-362-53-3Carc. 2

Muta. 2

Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *

STOT RE 1

Eye Dam. 1

Skin Sens. 1

Aquatic Acute 1
H351

H341

H331

H311

H301

H372 **

H318

H317

H400
GHS06

GHS08

GHS05

GHS09

Dgr
H351

H341

H331

H311

H301

H372 **

H318

H317

H400
*

STOT RE 1; H372: C ≥ 1 %

STOT RE 2; H373: 0,2 % ≤ C < 1 %
612-009-00-2salts of anilineCarc. 2

Muta. 2

Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *

STOT RE 1

Eye Dam. 1

Skin Sens. 1

Aquatic Acute 1
H351

H341

H331

H311

H301

H372 **

H318

H317

H400
GHS06

GHS08

GHS05

GHS09

Dgr
H351

H341

H331

H311

H301

H372 **

H318

H317

H400
*

STOT RE 1; H372: C ≥ 1 %

STOT RE 2; H373: 0,2 % ≤ C < 1 %
A
612-010-00-8chloroanilines (with exception of those specified elsewhere in this Annex)Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *

STOT RE 2 *

Aquatic Acute 1

Aquatic Chronic 1
H331

H311

H301

H373 **

H400

H410
GHS06

GHS08

GHS09

Dgr
H331

H311

H301

H373 **

H410
C
612-011-00-34-nitrosoaniline211-535-6659-49-4Acute Tox. 4 *

Acute Tox. 4 *

Acute Tox. 4 *
H332

H312

H302
GHS07

Wng
H332

H312

H302
612-012-00-9o-nitroaniline; [1]

m-nitroaniline; [2]

p-nitroaniline [3]
201-855-4 [1]

202-729-1 [2]

202-810-1 [3]
88-74-4 [1]

99-09-2 [2]

100-01-6 [3]
Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *

STOT RE 2 *

Aquatic Chronic 3
H331

H311

H301

H373 **

H412
GHS06

GHS08

Dgr
H331

H311

H301

H373 **

H412
C
612-013-00-43-aminobenzene sulphonic acid;

metanilic acid
204-473-6121-47-1Acute Tox. 4 *

Acute Tox. 4 *

Acute Tox. 4 *
H332

H312

H302
GHS07

Wng
H332

H312

H302
612-014-00-Xsulphanilic acid;

4-aminobenzenesulphonic acid
204-482-5121-57-3Eye Irrit. 2

Skin Irrit. 2

Skin Sens. 1
H319

H315

H317
GHS07

Wng
H319

H315

H317
612-015-00-5N-methylaniline202-870-9100-61-8Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *

STOT RE 2 *

Aquatic Acute 1

Aquatic Chronic 1
H331

H311

H301

H373 **

H400

H410
GHS06

GHS08

GHS09

Dgr
H331

H311

H301

H373 **

H410
612-016-00-0N,N-dimethylaniline204-493-5121-69-7Carc. 2

Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *

Aquatic Chronic 2
H351

H331

H311

H301

H411
GHS06

GHS08

GHS09

Dgr
H351

H331

H311

H301

H411
612-017-00-6N-methyl-N,2,4,6-tetranitroaniline;

tetryl
207-531-9479-45-8Expl. 1.1

Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *

STOT RE 2 *
H201

H331

H311

H301

H373 **
GHS01

GHS06

GHS08

Dgr
H201

H331

H311

H301

H373 **
612-018-00-1bis(2,4,6-trinitrophenyl)amine;

hexyl
205-037-8131-73-7Expl. 1.1

Acute Tox. 2 *

Acute Tox. 1

Acute Tox. 2 *

STOT RE 2 *

Aquatic Chronic 2
H201

H330

H310

H300

H373 **

H411
GHS01

GHS06

GHS08

GHS09

Dgr
H201

H330

H310

H300

H373 **

H411
612-019-00-7dipicrylamine, ammonium salt220-639-02844-92-0Expl. 1.1

Acute Tox. 2 *

Acute Tox. 1

Acute Tox. 2 *

STOT RE 2 *

Aquatic Chronic 2
H201

H330

H310

H300

H373 **

H411
GHS01

GHS06

GHS08

GHS09

Dgr
H201

H330

H310

H300

H373 **

H411
EUH001
612-020-00-21-naphthylamine205-138-7134-32-7Acute Tox. 4 *

Aquatic Chronic 2
H302

H411
GHS07

GHS09

Wng
H302

H411
612-022-00-32-naphthylamine202-080-491-59-8Carc. 1A

Acute Tox. 4 *

Aquatic Chronic 2
H350

H302

H411
GHS08

GHS07

GHS09

Dgr
H350

H302

H411
Carc. 1A; H350: C ≥ 0,01 %
612-023-00-9phenylhydrazine; [1]

phenylhydrazinium chloride; [2]

phenylhydrazine hydrochloride; [3]

phenylhydrazinium sulphate (2:1) [4]
202-873-5 [1]

200-444-7 [2]

248-259-0 [3]

257-622-2 [4]
100-63-0 [1]

59-88-1 [2]

27140-08-5 [3]

52033-74-6 [4]
Carc. 1B

Muta. 2

Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *

STOT RE 1

Eye Irrit. 2

Skin Irrit. 2

Skin Sens. 1

Aquatic Acute 1
H350

H341

H331

H311

H301

H372 **

H319

H315

H317

H400
GHS06

GHS08

GHS09

Dgr
H350

H341

H331

H311

H301

H372 **

H319

H315

H317

H400
612-024-00-4m-toluidine;

3-aminotoluene
203-583-1108-44-1Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *

STOT RE 2 *

Aquatic Acute 1
H331

H311

H301

H373 **

H400
GHS06

GHS08

GHS09

Dgr
H331

H311

H301

H373 **

H400
612-025-00-Xnitrotoluidines, with the exception of those specified elsewhere in this AnnexAcute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *

STOT RE 2 *

Aquatic Chronic 2
H331

H311

H301

H373 **

H411
GHS06

GHS08

GHS09

Dgr
H331

H311

H301

H373 **

H411
C
612-026-00-5diphenylamine204-539-4122-39-4Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *

STOT RE 2 *

Aquatic Acute 1

Aquatic Chronic 1
H331

H311

H301

H373 **

H400

H410
GHS06

GHS08

GHS09

Dgr
H331

H311

H301

H373 **

H410
612-027-00-0xylidines with the exception of those specified elsewhere in this Annex;

dimethyl anilines with the exception of those specified elsewhere in this Annex
Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *

STOT RE 2 *

Aquatic Chronic 2
H331

H311

H301

H373 **

H411
GHS06

GHS08

GHS09

Dgr
H331

H311

H301

H373 **

H411
C
612-028-00-6p-phenylenediamine203-404-7106-50-3Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *

Eye Irrit. 2

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H331

H311

H301

H319

H317

H400

H410
GHS06

GHS09

Dgr
H331

H311

H301

H319

H317

H410
612-029-00-1benzene-1,4-diamine dihydrochloride;

p-phenylenediamine dihydrochloride
210-834-9624-18-0Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *

Eye Irrit. 2

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H331

H311

H301

H319

H317

H400

H410
GHS06

GHS09

Dgr
H331

H311

H301

H319

H317

H410
612-030-00-72-methyl-p-phenylenediamine sulphate [1]210-431-8 [1]

228-871-4 [2]
615-50-9 [1]

6369-59-1 [2]
Acute Tox. 3 *

Acute Tox. 4 *

Acute Tox. 4 *

Skin Sens. 1

Aquatic Chronic 2
H301

H332

H312

H317

H411
GHS06

GHS09

Dgr
H301

H332

H312

H317

H411
612-031-00-2N,N-dimethylbenzene-1,3-diamine; [1]

4-amino-N,N-dimethylaniline;

3-amino-N,N'-dimethylaniline [2]
220-623-3 [1]

202-807-5 [2]
2836-04-6 [1]

99-98-9 [2]
Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *
H331

H311

H301
GHS06

Dgr
H331

H311

H301
C
612-032-00-8N,N,N',N'-tetramethyl-p-phenylenediamine202-831-6100-22-1Acute Tox. 4 *

Acute Tox. 4 *

Acute Tox. 4 *
H332

H312

H302
GHS07

Wng
H332

H312

H302
612-033-00-32-aminophenol202-431-195-55-6Muta. 2

Acute Tox. 4 *

Acute Tox. 4 *
H341

H332

H302
GHS08

GHS07

Wng
H341

H332

H302
612-034-00-92-amino-4,6-dinitrophenol;

picramic acid (< 20 % water)
202-544-696-91-3Expl. 1.1

Acute Tox. 4 *

Acute Tox. 4 *

Acute Tox. 4 *

Aquatic Chronic 3
H201

H332

H312

H302

H412
GHS01

GHS07

Wng
H201

H332

H312

H302

H412
T
612-034-01-62-amino-4,6-dinitrophenol;

picramic acid;

[≥ 20 % water]
202-544-696-91-3Acute Tox. 4 *

Acute Tox. 4 *

Acute Tox. 4 *

Aquatic Chronic 3
H332

H312

H302

H412
GHS07

Wng
H332

H312

H302

H412
G
612-035-00-42-methoxyaniline;

o-anisidine
201-963-190-04-0Carc. 1B

Muta. 2

Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *
H350

H341

H331

H311

H301
GHS06

GHS08

Dgr
H350

H341

H331

H311

H301
612-036-00-X3,3'-dimethoxybenzidine;

o-dianisidine
204-355-4119-90-4Carc. 1B

Acute Tox. 4 *
H350

H302
GHS08

GHS07

Dgr
H350

H302
612-037-00-5salts of 3,3'-dimethoxybenzidine;

salts of o-dianisidine
Carc. 1B

Acute Tox. 4 *
H350

H302
GHS08

GHS07

Dgr
H350

H302
A
612-038-00-02-nitro-p-anisidine;

4-methoxy-2-nitroaniline
202-547-296-96-8Acute Tox. 2 *

Acute Tox. 1

Acute Tox. 2 *

STOT RE 2 *

Aquatic Chronic 3
H330

H310

H300

H373 **

H412
GHS06

GHS08

Dgr
H330

H310

H300

H373 **

H412
612-039-00-62-ethoxyaniline;

o-phenetidine
202-356-494-70-2Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *

STOT RE 2 *
H331

H311

H301

H373 **
GHS06

GHS08

Dgr
H331

H311

H301

H373 **
612-040-00-12,4-dinitroaniline202-553-597-02-9Acute Tox. 2 *

Acute Tox. 1

Acute Tox. 2 *

STOT RE 2 *

Aquatic Chronic 2
H330

H310

H300

H373 **

H411
GHS06

GHS08

GHS09

Dgr
H330

H310

H300

H373 **

H411
612-041-00-74,4'-bi-o-toluidine204-358-0119-93-7Carc. 1B

Acute Tox. 4 *

Aquatic Chronic 2
H350

H302

H411
GHS08

GHS07

GHS09

Dgr
H350

H302

H411
612-042-00-2benzidine;

1,1'-biphenyl-4,4'-diamine;

4,4'-diaminobiphenyl;

biphenyl-4,4'-ylenediamine
202-199-192-87-5Carc. 1A

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1
H350

H302

H400

H410
GHS08

GHS07

GHS09

Dgr
H350

H302

H410
Carc. 1A; H350: C ≥ 0,01 %
612-043-00-8N,N'-dimethylbenzidine2810-74-4Acute Tox. 4 *

Acute Tox. 4 *

Acute Tox. 4 *
H332

H312

H302
GHS07

Wng
H332

H312

H302
612-044-00-3N,N'-diacetylbenzidine210-338-2613-35-4Acute Tox. 4 *

Acute Tox. 4 *

Acute Tox. 4 *
H332

H312

H302
GHS07

Wng
H332

H312

H302
612-046-00-4allylamine203-463-9107-11-9Flam. Liq. 2

Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *

Aquatic Chronic 2
H225

H331

H311

H301

H411
GHS02

GHS06

GHS09

Dgr
H225

H331

H311

H301

H411
612-047-00-Xbenzylamine202-854-1100-46-9Acute Tox. 4 *

Acute Tox. 4 *

Skin Corr. 1B
H312

H302

H314
GHS05

GHS07

Dgr
H312

H302

H314
612-048-00-5dipropylamine205-565-9142-84-7Flam. Liq. 2

Acute Tox. 4 *

Acute Tox. 4 *

Acute Tox. 4 *

Skin Corr. 1A
H225

H332

H312

H302

H314
GHS02

GHS05

GHS07

Dgr
H225

H332

H312

H302

H314
STOT SE 3; H335: C ≥ 1 %
612-049-00-0di-n-butylamine; [1]

di-sec-butylamine [2]
203-921-8 [1]

210-937-9 [2]
111-92-2 [1]

626-23-3 [2]
Flam. Liq. 3

Acute Tox. 4 *

Acute Tox. 4 *

Acute Tox. 4 *
H226

H332

H312

H302
GHS02

GHS07

Wng
H226

H332

H312

H302
612-050-00-6cyclohexylamine203-629-0108-91-8Flam. Liq. 3

Acute Tox. 4 *

Acute Tox. 4 *

Skin Corr. 1B
H226

H312

H302

H314
GHS02

GHS05

GHS07

Dgr
H226

H312

H302

H314
612-051-00-14,4'-diaminodiphenylmethane;

4,4'-methylenedianiline
202-974-4101-77-9Carc. 1B

Muta. 2

STOT SE 1

STOT RE 2 *

Skin Sens. 1

Aquatic Chronic 2
H350

H341

H370 **

H373 **

H317

H411
GHS08

GHS07

GHS09

Dgr
H350

H341

H370 **

H373 **

H317

H411
612-052-00-7(S)-sec-butylamine;

(S)-2-aminobutane; [1]

(R)-sec-butylamine;

(R)-2-aminobutane; [2]

sec-butylamine;

2-aminobutane [3]
208-164-7 [1]

236-232-6 [2]

237-732-7 [3]
513-49-5 [1]

13250-12-9 [2]

13952-84-6 [3]
Flam. Liq. 2

Acute Tox. 4 *

Acute Tox. 4 *

Skin Corr. 1A

Aquatic Acute 1
H225

H332

H302

H314

H400
GHS02

GHS05

GHS07

GHS09

Dgr
H225

H332

H302

H314

H400
C
612-053-00-2N-ethylaniline203-135-5103-69-5Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *

STOT RE 2 *
H331

H311

H301

H373 **
GHS06

GHS08

Dgr
H331

H311

H301

H373 **
612-054-00-8N,N-diethylaniline202-088-891-66-7Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *

STOT RE 2 *

Aquatic Chronic 2
H331

H311

H301

H373 **

H411
GHS06

GHS08

GHS09

Dgr
H331

H311

H301

H373 **

H411
*
612-055-00-3N-methyl-o-toluidine; [1]

N-methyl-m-toluidine; [2]

N-methyl-p-toluidine [3]
210-260-9 [1]

211-795-0 [2]

210-769-6 [3]
611-21-2 [1]

696-44-6 [2]

623-08-5 [3]
Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *

STOT RE 2 *

Aquatic Chronic 3
H331

H311

H301

H373 **

H412
GHS06

GHS08

Dgr
H331

H311

H301

H373 **

H412
C
612-056-00-9N,N-dimethyl-p-toluidine; [1]

N,N-dimethyl-m-toluidine; [2]

N,N-dimethyl-o-toluidine [3]
202-805-4 [1]

204-495-6 [2]

210-199-8 [3]
99-97-8 [1]

121-72-2 [2]

609-72-3 [3]
Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *

STOT RE 2 *

Aquatic Chronic 3
H331

H311

H301

H373 **

H412
GHS06

GHS08

Dgr
H331

H311

H301

H373 **

H412
*C
612-057-00-4piperazine203-808-3110-85-0Skin Corr. 1B

Resp. Sens. 1

Skin Sens. 1

Aquatic Chronic 3
H314

H334

H317

H412
GHS08

GHS05

Dgr
H314

H334

H317

H412
612-058-00-X2,2'-iminodiethylamine;

diethylenetriamine
203-865-4111-40-0Acute Tox. 4 *

Acute Tox. 4 *

Skin Corr. 1B

Skin Sens. 1
H312

H302

H314

H317
GHS05

GHS07

Dgr
H312

H302

H314

H317
612-059-00-53,6-diazaoctanethylenediamin;

triethylenetetramine
203-950-6112-24-3Acute Tox. 4 *

Skin Corr. 1B

Skin Sens. 1

Aquatic Chronic 3
H312

H314

H317

H412
GHS05

GHS07

Dgr
H312

H314

H317

H412
612-060-00-03,6,9-triazaundecamethylenediamine;

tetraethylenepentamine
203-986-2112-57-2Acute Tox. 4 *

Acute Tox. 4 *

Skin Corr. 1B

Skin Sens. 1

Aquatic Chronic 2
H312

H302

H314

H317

H411
GHS05

GHS07

GHS09

Dgr
H312

H302

H314

H317

H411
612-061-00-63-aminopropyldimethylamine;

N,N-dimethyl-1,3-diaminopropane
203-680-9109-55-7Flam. Liq. 3

Acute Tox. 4 *

Skin Corr. 1B

Skin Sens. 1
H226

H302

H314

H317
GHS02

GHS05

GHS07

Dgr
H226

H302

H314

H317
612-062-00-13-aminopropyldiethylamine;

N,N-diethyl-1,3-diaminopropane
203-236-4104-78-9Flam. Liq. 3

Acute Tox. 4 *

Acute Tox. 4 *

Skin Corr. 1B

Skin Sens. 1
H226

H312

H302

H314

H317
GHS02

GHS05

GHS07

Dgr
H226

H312

H302

H314

H317
612-063-00-73,3'-iminodi(propylamine);

dipropylenetriamine
200-261-256-18-8Acute Tox. 2 *

Acute Tox. 3 *

Acute Tox. 4 *

Skin Corr. 1A

Skin Sens. 1
H330

H311

H302

H314

H317
GHS06

GHS05

Dgr
H330

H311

H302

H314

H317
612-064-00-23,6,9,12-tetra-azatetradecamethylenediamine;

pentacthylenehexamine
223-775-94067-16-7Skin Corr. 1B

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H314

H317

H400

H410
GHS05

GHS07

GHS09

Dgr
H314

H317

H410
612-065-00-8polyethlyenepolyamines with the exception of those specified elsewhere in this AnnexAcute Tox. 4 *

Acute Tox. 4 *

Skin Corr. 1B

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H312

H302

H314

H317

H400

H410
GHS05

GHS07

GHS09

Dgr
H312

H302

H314

H317

H410
612-066-00-3dicyclohexylamine202-980-7101-83-7Acute Tox. 4 *

Skin Corr. 1B

Aquatic Acute 1

Aquatic Chronic 1
H302

H314

H400

H410
GHS05

GHS07

GHS09

Dgr
H302

H314

H410
612-067-00-93-aminomethyl-3,5,5-trimethylcyclohexylamine220-666-82855-13-2Acute Tox. 4 *

Acute Tox. 4 *

Skin Corr. 1B

Skin Sens. 1

Aquatic Chronic 3
H312

H302

H314

H317

H412
GHS05

GHS07

Dgr
H312

H302

H314

H317

H412
612-068-00-43,3'-dichlorobenzidine;

3,3'-dichlorobiphenyl-4,4'-ylenediamine
202-109-091-94-1Carc. 1B

Acute Tox. 4 *

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H350

H312

H317

H400

H410
GHS08

GHS07

GHS09

Dgr
H350

H312

H317

H410
612-069-00-Xsalts of 3,3'-dichlorobenzidine;

salts of 3,3'-dichlorobiphenyl-4,4'-ylenediamine
Carc. 1B

Acute Tox. 4 *

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H350

H312

H317

H400

H410
GHS08

GHS07

GHS09

Dgr
H350

H312

H317

H410
A
612-070-00-5salts of benzidine208-519-6

208-520-1

244-236-4

252-984-8
531-85-1

531-86-2

21136-70-9

36341-27-2
Carc. 1A

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1
H350

H302

H400

H410
GHS08

GHS07

GHS09

Dgr
H350

H302

H410
A
612-071-00-0salts of 2-naphthylamine209-030-0

210-313-6
553-00-4

612-52-2
Carc. 1A

Acute Tox. 4 *

Aquatic Chronic 2
H350

H302

H411
GHS08

GHS07

GHS09

Dgr
H350

H302

H411
A
612-072-00-6biphenyl-4-ylamine;

xenylamine;

4-aminobiphenyl
202-177-192-67-1Carc. 1A

Acute Tox. 4 *
H350

H302
GHS08

GHS07

Dgr
H350

H302
612-073-00-1salts of biphenyl-4-ylamine;

salts of xenylamine;

salts of 4-aminobiphenyl
Carc. 1A

Acute Tox. 4 *
H350

H302
GHS08

GHS07

Dgr
H350

H302
A
612-074-00-7benzyldimethylamine203-149-1103-83-3Flam. Liq. 3

Acute Tox. 4 *

Acute Tox. 4 *

Acute Tox. 4 *

Skin Corr. 1B

Aquatic Chronic 3
H226

H332

H312

H302

H314

H412
GHS02

GHS05

GHS07

Dgr
H226

H332

H312

H302

H314

H412
612-075-00-22-aminoethyldimethylamine;

2-dimethylaminoethylamine
203-541-2108-00-9Flam. Liq. 2

Acute Tox. 4 *

Acute Tox. 4 *

Skin Corr. 1A
H225

H312

H302

H314
GHS02

GHS05

GHS07

Dgr
H225

H312

H302

H314
612-076-00-8ethyldimethylamine209-940-8598-56-1Flam. Liq. 2

Acute Tox. 4 *

Acute Tox. 4 *

Skin Corr. 1B
H225

H332

H302

H314
GHS02

GHS05

GHS07

Dgr
H225

H332

H302

H314
612-077-00-3dimethylnitrosoamine;

N-nitrosodimethylamine
200-549-862-75-9Carc. 1B

Acute Tox. 2 *

Acute Tox. 3 *

STOT RE 1

Aquatic Chronic 2
H350

H330

H301

H372 **

H411
GHS06

GHS08

GHS09

Dgr
H350

H330

H301

H372 **

H411
Carc. 1B; H350: C ≥ 0,001 %
612-078-00-92,2'-dichloro-4,4'-methylenedianiline;

4,4'-methylene bis(2-chloroaniline)
202-918-9101-14-4Carc. 1B

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1
H350

H302

H400

H410
GHS08

GHS07

GHS09

Dgr
H350

H302

H410
612-079-00-4salts of 2,2'-dichloro-4,4'-methylenedianiline;

salts of 4,4'-methylenebis(2-chloroaniline)
Carc. 1B

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1
H350

H302

H400

H410
GHS08

GHS07

GHS09

Dgr
H350

H302

H410
A
612-080-00-X4-amino-N,N-diethylaniline;

N,N-diethyl-p-phenylendiamine
202-214-193-05-0Acute Tox. 3 *

Skin Corr. 1B
H301

H314
GHS06

GHS05

Dgr
H301

H314
612-081-00-5salts of 4,4'-bi-o-toluidine;

salts of 3,3'-dimethylbenzidine;

salts of o-tolidine
210-322-5

265-294-7

277-985-0
612-82-8

64969-36-4

74753-18-7
Carc. 1B

Acute Tox. 4 *

Aquatic Chronic 2
H350

H302

H411
GHS08

GHS07

GHS09

Dgr
H350

H302

H411
A
612-082-00-0thiourea;

thiocarbamide
200-543-562-56-6Carc. 2

Repr. 2

Acute Tox. 4 *

Aquatic Chronic 2
H351

H361d ***

H302

H411
GHS08

GHS07

GHS09

Wng
H351

H361d ***

H302

H411
612-083-00-61-methyl-3-nitro-1-nitrosoguanidine200-730-170-25-7Carc. 1B

Acute Tox. 4 *

Eye Irrit. 2

Skin Irrit. 2

Aquatic Chronic 2
H350

H332

H319

H315

H411
GHS08

GHS07

GHS09

Dgr
H350

H332

H319

H315

H411
Carc. 1B; H350: C ≥ 0,01 %
612-084-00-1dapsone;

4,4'-diamino diphenyl sulfone
201-248-480-08-0Acute Tox. 4 *H302GHS07

Wng
H302
612-085-00-74,4'-methylenedi-o-toluidine212-658-8838-88-0Carc. 1B

Acute Tox. 4 *

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H350

H302

H317

H400

H410
GHS08

GHS07

GHS09

Dgr
H350

H302

H317

H410
612-086-00-2amitraz (ISO);

N,N-bis(2,4-xylyliminomethyl) methylamine
251-375-433089-61-1Acute Tox. 4 *

STOT RE 2 *

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H302

H373 **

H317

H400

H410
GHS08

GHS07

GHS09

Wng
H302

H373 **

H317

H410
M = 10
612-087-00-8guazatine (ISO)108173-90-6Acute Tox. 2 *

Acute Tox. 4 *

Acute Tox. 4 *

STOT SE 3

Skin Irrit. 2

Eye Dam. 1

Aquatic Acute 1

Aquatic Chronic 1
H330

H312

H302

H335

H315

H318

H400

H410
GHS06

GHS05

GHS09

Dgr
H330

H312

H302

H335

H315

H318

H410
612-088-00-3simazine (ISO);

6-chloro-N,N'-diethyl-1,3,5-triazine-2,4-diamine
204-535-2122-34-9Carc. 2

Aquatic Acute 1

Aquatic Chronic 1
H351

H400

H410
GHS08

GHS09

Wng
H351

H410
612-089-00-91,5-naphthylenediamine218-817-82243-62-1Carc. 2

Aquatic Acute 1

Aquatic Chronic 1
H351

H400

H410
GHS08

GHS09

Wng
H351

H410
612-090-00-42,2'-(nitrosoimino)bisethanol214-237-41116-54-7Carc. 1BH350GHS08

Dgr
H350
612-091-00-Xo-toluidine;

2-aminotoluene
202-429-095-53-4Carc. 1B

Acute Tox. 3 *

Acute Tox. 3 *

Eye Irrit. 2

Aquatic Acute 1
H350

H331

H301

H319

H400
GHS06

GHS08

GHS09

Dgr
H350

H331

H301

H319

H400
612-092-00-5N,N'-(2,2-dimethylpropylidene)hexamethylenediamine401-660-61000-78-8Skin Irrit. 2

Skin Sens. 1
H315

H317
GHS07

Wng
H315

H317
612-093-00-03,5-dichloro-4-(1,1,2,2-tetrafluoroethoxy)aniline401-790-3104147-32-2Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1
H302

H400

H410
GHS07

GHS09

Wng
H302

H410
612-094-00-64-(2-chloro-4-trifluoromethyl)phenoxy-2-fluoroaniline hydrochloride402-190-4STOT RE 1

Acute Tox. 4 *

Eye Dam. 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H372 **

H302

H318

H317

H400

H410
GHS08

GHS05

GHS07

GHS09

Dgr
H372 **

H302

H318

H317

H410
612-095-00-1benzyl-2-hydroxydodecyldimethylammonium benzoate402-610-6113694-52-3Skin Corr. 1B

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1
H314

H302

H400

H410
GHS05

GHS07

GHS09

Dgr
H314

H302

H410
612-096-00-74,4'-carbonimidoylbis[N,N-dimethylaniline]207-762-5492-80-8Carc. 2

Acute Tox. 4 *

Eye Irrit. 2

Aquatic Chronic 2
H351

H302

H319

H411
GHS08

GHS07

GHS09

Wng
H351

H302

H319

H411
612-097-00-2salts of 4,4'-carbonimidoylbis[N,N-dimethylaniline]Carc. 2

Acute Tox. 4 *

Eye Irrit. 2

Aquatic Chronic 2
H351

H302

H319

H411
GHS08

GHS07

GHS09

Wng
H351

H302

H319

H411
A
612-098-00-8nitrosodipropylamine210-698-0621-64-7Carc. 1B

Acute Tox. 4 *

Aquatic Chronic 2
H350

H302

H411
GHS08

GHS07

GHS09

Dgr
H350

H302

H411
Carc. 1B; H350: C ≥ 0,001 %
612-099-00-34-methyl-m-phenylenediamine;

2,4-toluenediamine
202-453-195-80-7Carc. 1B

Acute Tox. 3 *

Acute Tox. 4 *

Eye Irrit. 2

Skin Sens. 1

Aquatic Chronic 2
H350

H301

H312

H319

H317

H411
GHS06

GHS08

GHS09

Dgr
H350

H301

H312

H319

H317

H411
612-100-00-7propylenediamine201-155-978-90-0Flam. Liq. 3

Acute Tox. 4 *

Acute Tox. 4 *

Skin Corr. 1A
H226

H312

H302

H314
GHS02

GHS05

GHS07

Dgr
H226

H312

H302

H314
612-101-00-2methenamine;

hexamethylenetetramine
202-905-8100-97-0Flam. Sol. 2

Resp. Sens. 1

Skin Sens. 1
H228

H334

H317
GHS02

GHS08

Dgr
H228

H334

H317
612-102-00-8N,N-bis(3-aminopropyl)methylamine203-336-8105-83-9Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 4 *

Skin Corr. 1B
H331

H311

H302

H314
GHS06

GHS05

Dgr
H331

H311

H302

H314
612-103-00-3N,N,N',N'-tetramethylethylenediamine203-744-6110-18-9Flam. Liq. 2

Acute Tox. 4 *

Acute Tox. 4 *

Skin Corr. 1B
H225

H332

H302

H314
GHS02

GHS05

GHS07

Dgr
H225

H332

H302

H314
612-104-00-9hexamethylenediamine204-679-6124-09-4Acute Tox. 4 *

Acute Tox. 4 *

STOT SE 3

Skin Corr. 1B
H312

H302

H335

H314
GHS05

GHS07

Dgr
H312

H302

H335

H314
612-105-00-42-piperazin-1-ylethylamine205-411-0140-31-8Acute Tox. 4 *

Acute Tox. 4 *

Skin Corr. 1B

Skin Sens. 1

Aquatic Chronic 3
H312

H302

H314

H317

H412
GHS05

GHS07

Dgr
H312

H302

H314

H317

H412
612-106-00-X2,6-diethylaniline209-445-7579-66-8Acute Tox. 4 *H302H302
612-107-00-51-phenylethylamine; [1]

DL-α-methylbenzylamine [2]
202-706-6 [1]

210-545-8 [2]
98-84-0 [1]

618-36-0 [2]
Acute Tox. 4 *

Acute Tox. 4 *

Skin Corr. 1B
H312

H302

H314
GHS05

GHS07

Dgr
H312

H302

H314
612-108-00-03-aminopropyltriethoxysilane213-048-4919-30-2Acute Tox. 4 *

Skin Corr. 1B
H302

H314
GHS05

GHS07

Dgr
H302

H314
612-109-00-6bis(2-dimethylaminoethyl)(methyl)amine221-201-13030-47-5Acute Tox. 3 *

Acute Tox. 4 *

Skin Corr. 1B
H311

H302

H314
GHS06

GHS05

Dgr
H311

H302

H314
612-110-00-12,2'-dimethyl-4,4'-methylenebis(cyclohexylamine)229-962-16864-37-5Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 4 *

Skin Corr. 1A

Aquatic Chronic 2
H331

H311

H302

H314

H411
GHS06

GHS05

GHS09

Dgr
H331

H311

H302

H314

H411
612-111-00-72-methyl-m-phenylenediamine;

2,6-toluenediamine
212-513-9823-40-5Muta. 2

Acute Tox. 4 *

Acute Tox. 4 *

Skin Sens. 1

Aquatic Chronic 2
H341

H312

H302

H317

H411
GHS08

GHS07

GHS09

Wng
H341

H312

H302

H317

H411
612-112-00-2p-anisidine;

4-methoxyaniline
203-254-2104-94-9Acute Tox. 2 *

Acute Tox. 1

Acute Tox. 2 *

STOT RE 2 *

Aquatic Acute 1
H330

H310

H300

H373 **

H400
GHS06

GHS08

GHS09

Dgr
H330

H310

H300

H373 **

H400
612-113-00-86-methyl-2,4-bis(methylthio)phenylene-1,3-diamine403-240-8106264-79-3Acute Tox. 4 *

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H302

H317

H400

H410
GHS07

GHS09

Wng
H302

H317

H410
612-114-00-3R,R-2-hydroxy-5-(1-hydroxy-2-(4-phenylbut-2-ylamino)ethyl)benzamide hydrogen 2,3-bis(benzoyloxy)succinate404-390-7Flam. Sol. 1

Skin Sens. 1

Aquatic Chronic 3
H228

H317

H412
GHS02

GHS07

Wng
H228

H317

H412
612-115-00-9dimethyldioctadecylammonium hydrogen sulfate404-050-8123312-54-9Eye Irrit. 2

Aquatic Chronic 4
H319

H413
GHS07

Wng
H319

H413
612-116-00-4C8-18alkylbis(2-hydroxyethyl)ammonium bis(2-ethylhexyl)phosphate404-690-868132-19-4Acute Tox. 3 *

Skin Corr. 1B

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H331

H314

H317

H400

H410
GHS06

GHS05

GHS09

Dgr
H331

H314

H317

H410
612-117-00-XC12-14-tert-alkylamine, methylphosphonic acid salt404-750-3119415-07-5Acute Tox. 4 *

Skin Corr. 1B

Aquatic Chronic 2
H302

H314

H411
GHS05

GHS07

GHS09

Dgr
H302

H314

H411
612-118-00-5A reaction mass of: (1,3-dioxo-2H-benz(de)isoquinolin-2-ylpropyl)hexadecyldimethylammonium 4-toluenesulfonate;

(1,3-dioxo-2H-benz(de)isoquinolin-2-ylpropyl)hexadecyldimethylammonium bromide
405-080-4Eye Dam. 1

Aquatic Acute 1

Aquatic Chronic 1
H318

H400

H410
GHS05

GHS09

Dgr
H318

H410
612-119-00-0benzyldimethyloctadecylammonium 3-nitrobenzenesulfonate405-330-2Skin Irrit. 2

Eye Dam. 1

Aquatic Acute 1

Aquatic Chronic 1
H315

H318

H400

H410
GHS05

GHS09

Dgr
H315

H318

H410
612-120-00-6aclonifen (ISO);

2-chloro-6-nitro-3-phenoxyaniline
277-704-174070-46-5Aquatic Acute 1

Aquatic Chronic 1
H400

H410
GHS09

Wng
H410
612-121-00-1amines, polyethylenepoly-;

HEPA
268-626-968131-73-7Acute Tox. 4 *

Acute Tox. 4 *

Skin Corr. 1B

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H312

H302

H314

H317

H400

H410
GHS05

GHS07

GHS09

Dgr
H312

H302

H314

H317

H410
612-122-00-7hydroxylamine232-259-27803-49-8Unst. Expl.

Met. Corr. 1

Acute Tox. 4 *

STOT RE 2 *

STOT SE 3

Skin Irrit. 2

Eye Dam. 1

Skin Sens. 1

Aquatic Acute 1
H200

H290

H302

H373 **

H335

H315

H318

H317

H400
GHS01

GHS08

GHS05

GHS07

GHS09

Dgr
H200

H290

H302

H373 **

H335

H315

H318

H317

H400
T
612-123-00-2hydroxylammonium chloride;

hydroxylamine hydrochloride; [1]

bis(hydroxylammonium) sulphate;

hydroxylamine sulphate (2:1); [2]

hydroxylammonium hydrogensulphate;

hydroxylamine sulphate (1:1) [3]
226-798-2 [1]

233-118-8 [2]

233-154-4 [3]
5470-11-1 [1]

10039-54-0 [2]

10046-00-1 [3]
Met. Corr. 1

Acute Tox. 4 *

STOT RE 2 *

Eye Irrit. 2

Skin Irrit. 2

Skin Sens. 1

Aquatic Acute 1
H290

H302

H373 **

H319

H315

H317

H400
GHS08

GHS05

GHS07

GHS09

Wng
H290

H302

H373 **

H319

H315

H317

H400
G T
612-124-00-8N,N,N-trimethylanilinium chloride205-319-0138-24-9Acute Tox. 3 *

Acute Tox. 3 *
H311

H301
GHS06

Dgr
H311

H301
612-125-00-32-methyl-p-phenylenediamine;

2,5-toluenediamine
202-442-195-70-5Acute Tox. 3 *

Acute Tox. 4 *

Acute Tox. 4 *

Skin Sens. 1

Aquatic Chronic 2
H301

H332

H312

H317

H411
GHS06

GHS09

Dgr
H301

H332

H312

H317

H411
612-126-00-9toluene-2,4-diammonium sulphate;

4-methyl-m-phenylenediamine sulfate
265-697-865321-67-7Carc. 1B

Acute Tox. 3 *

Acute Tox. 4 *

Eye Irrit. 2

Skin Sens. 1

Aquatic Chronic 2
H350

H301

H312

H319

H317

H411
GHS06

GHS08

GHS09

Dgr
H350

H301

H312

H319

H317

H411
612-127-00-43-aminophenol209-711-2591-27-5Acute Tox. 4 *

Acute Tox. 4 *

Aquatic Chronic 2
H332

H302

H411
GHS07

GHS09

Wng
H332

H302

H411
612-128-00-X4-aminophenol204-616-2123-30-8Muta. 2

Acute Tox. 4 *

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1
H341

H332

H302

H400

H410
GHS08

GHS07

GHS09

Wng
H341

H332

H302

H410
612-129-00-5diisopropylamine203-558-5108-18-9Flam. Liq. 2

Acute Tox. 4 *

Acute Tox. 4 *

Skin Corr. 1B
H225

H332

H302

H314
GHS02

GHS05

GHS07

Dgr
H225

H332

H302

H314
STOT SE 3; H335: C ≥ 5 %
612-130-00-02,6-diamino-3,5-diethyltoluene;

4,6-diethyl-2-methyl-1,3-benzenediamine; [1]

2,4-diamino-3,5-diethyltoluene;

2,4-diethyl-6-methyl-1,3-benzenediamine; [2]

diethylmethylbenzenediamine [3]
218-255-3 [1]

218-256-9 [2]

270-877-4 [3]
2095-01-4 [1]

2095-02-5 [2]

68479-98-1 [3]
Acute Tox. 4 *

Acute Tox. 4 *

STOT RE 2 *

Eye Irrit. 2

Aquatic Acute 1

Aquatic Chronic 1
H312

H302

H373 **

H319

H400

H410
GHS08

GHS07

GHS09

Wng
H312

H302

H373 **

H319

H410
C
612-131-00-6didecyldimethylammonium chloride230-525-27173-51-5Acute Tox. 4 *

Skin Corr. 1B
H302

H314
GHS05

GHS07

Dgr
H302

H314
612-132-00-1N,N'-diphenyl-p-phenylenediamine;

N,N'-diphenyl-1,4-benzenediamine
200-806-474-31-7Skin Sens. 1

Aquatic Chronic 3
H317

H412
GHS07

Wng
H317

H412
612-133-00-7(4-ammonio-m-tolyl)ethyl(2-hydroxyethyl)ammonium sulphate;

4-(N-ethyl-N-2-hydroxyethyl)-2-methylphenylenediamine sulphate
247-162-025646-77-9Acute Tox. 3 *

STOT RE 2 *

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H301

H373 **

H317

H400

H410
GHS06

GHS08

GHS09

Dgr
H301

H373 **

H317

H410
612-134-00-2N-(2-(4-amino-N-ethyl-m-toluidino)ethyl)methanesulphonamide sesquisulphate;

4-(N-ethyl-N-2-methanesulphonylaminoethyl)-2-methylphenylenediamine sesquisulphate monohydrate
247-161-525646-71-3Acute Tox. 4 *

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H302

H317

H400

H410
GHS07

GHS09

Wng
H302

H317

H410
612-135-00-8N-2-naphthylaniline;

N-phenyl-2-naphthylamine
205-223-9135-88-6Carc. 2

Eye Irrit. 2

Skin Irrit. 2

Skin Sens. 1

Aquatic Chronic 2
H351

H319

H315

H317

H411
GHS08

GHS07

GHS09

Wng
H351

H319

H315

H317

H411
612-136-00-3N-isopropyl-N'-phenyl-p-phenylenediamine202-969-7101-72-4Acute Tox. 4 *

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H302

H317

H400

H410
GHS07

GHS09

Wng
H302

H317

H410
Skin Sens. 1; H317: C ≥ 0,1 %
612-137-00-94-chloroaniline203-401-0106-47-8Carc. 1B

Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H350

H331

H311

H301

H317

H400

H410
GHS06

GHS08

GHS09

Dgr
H350

H331

H311

H301

H317

H410
612-138-00-4furalaxyl (ISO);

methyl N-(2,6-dimethylphenyl)-N-(2-furylcarbonyl)-DL-alaninate
260-875-157646-30-7Acute Tox. 4 *

Aquatic Chronic 3
H302

H412
GHS07

Wng
H302

H412
612-139-00-Xmefenacet (ISO);

2-(benzothiazol-2-yloxy)-N-methyl-N-phenylacetamide
277-328-873250-68-7Aquatic Chronic 2H411GHS09H411
612-140-00-5quaternary ammonium compounds, benzyl-C8-18-alkyldimethyl, chlorides264-151-663449-41-2Acute Tox. 4 *

Acute Tox. 4 *

Skin Corr. 1B

Aquatic Acute 1
H312

H302

H314

H400
GHS05

GHS07

GHS09

Dgr
H312

H302

H314

H400
612-141-00-04,4'-methylenebis(2-ethylaniline);

4,4'-methylenebis(2-ethylbenzeneamine)
243-420-119900-65-3Carc. 2

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1
H351

H302

H400

H410
GHS08

GHS07

GHS09

Wng
H351

H302

H410
612-142-00-6biphenyl-2-ylamine201-990-990-41-5Carc. 2

Acute Tox. 4 *

Aquatic Chronic 3
H351

H302

H412
GHS08

GHS07

Wng
H351

H302

H412
612-143-00-1N5,N5-diethyltoluene-2,5-diamine monohydrochloride;

4-diethylamino-2-methylaniline monohydrochloride
218-130-32051-79-8Acute Tox. 3 *

Eye Irrit. 2

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H301

H319

H317

H400

H410
GHS06

GHS09

Dgr
H301

H319

H317

H410
612-144-00-7flumetralin (ISO);

N-(2-chloro-6-fluorobenzyl)-N-ethyl-α,α,α-trifluoro-2,6-dinitro-p-toluidine
62924-70-3Eye Irrit. 2

Skin Irrit. 2

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H319

H315

H317

H400

H410
GHS07

GHS09

Wng
H319

H315

H317

H410
612-145-00-2o-phenylenediamine202-430-695-54-5Carc. 2

Muta. 2

Acute Tox. 3 *

Acute Tox. 4 *

Acute Tox. 4 *

Eye Irrit. 2

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H351

H341

H301

H332

H312

H319

H317

H400

H410
GHS06

GHS08

GHS09

Dgr
H351

H341

H301

H332

H312

H319

H317

H410
612-146-00-8o-phenylenediamine dihydrochloride210-418-7615-28-1Carc. 2

Muta. 2

Acute Tox. 3 *

Acute Tox. 4 *

Acute Tox. 4 *

Eye Irrit. 2

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H351

H341

H301

H332

H312

H319

H317

H400

H410
GHS06

GHS08

GHS09

Dgr
H351

H341

H301

H332

H312

H319

H317

H410
612-147-00-3m-phenylenediamine203-584-7108-45-2Muta. 2

Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *

Eye Irrit. 2

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H341

H331

H311

H301

H319

H317

H400

H410
GHS06

GHS08

GHS09

Dgr
H341

H331

H311

H301

H319

H317

H410
612-148-00-9m-phenylenediamine dihydrochloride208-790-0541-69-5Muta. 2

Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *

Eye Irrit. 2

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H341

H331

H311

H301

H319

H317

H400

H410
GHS06

GHS08

GHS09

Dgr
H341

H331

H311

H301

H319

H317

H410
612-149-00-41,3-diphenylguanidine203-002-1102-06-7Repr. 2

Acute Tox. 4 *

Eye Irrit. 2

STOT SE 3

Skin Irrit. 2

Aquatic Chronic 2
H361f ***

H302

H319

H335

H315

H411
GHS08

GHS07

GHS09

Wng
H361f ***

H302

H319

H335

H315

H411
612-150-00-Xspiroxamine (ISO);

8-tert-butyl-1,4-dioxaspiro[4.5]decan-2-ylmethyl(ethyl)(propyl)amine
118134-30-8Acute Tox. 4 *

Acute Tox. 4 *

Acute Tox. 4 *

Skin Irrit. 2

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H332

H312

H302

H315

H317

H400

H410
GHS07

GHS09

Wng
H332

H312

H302

H315

H317

H410
612-151-00-5diaminotoluene, technical product - reaction mass of [2] and [3];

methyl-phenylenediamine; [1]

4-methyl-m-phenylene diamine; [2]

2-methyl-m-phenylene diamine [3]
246-910-3 [1]

202-453-1 [2]

212-513-9 [3]
25376-45-8 [1]

95-80-7 [2]

823-40-5 [3]
Carc. 1B

Acute Tox. 3 *

Acute Tox. 4 *

Acute Tox. 4 *

Eye Irrit. 2

Skin Sens. 1

Aquatic Chronic 2
H350

H301

H332

H312

H319

H317

H411
GHS06

GHS08

GHS09

Dgr
H350

H301

H332

H312

H319

H317

H411
612-152-00-0N,N-diethyl-N',N'-dimethylpropan-1,3-diyl-diamine406-610-762478-82-4Flam. Liq. 3

Acute Tox. 4 *

Acute Tox. 4 *

STOT RE 2 *

Skin Corr. 1A

Aquatic Chronic 3
H226

H332

H302

H373 **

H314

H412
GHS02

GHS08

GHS05

GHS07

Dgr
H226

H332

H302

H373 **

H314

H412
612-153-00-64-[N-ethyl-N-(2-hydroxyethyl)amino]-1-(2-hydroxyethyl)amino-2-nitrobenzene, monohydrochloride407-020-2132885-85-9Acute Tox. 4 *

Skin Sens. 1

Aquatic Chronic 3
H302

H317

H412
GHS07

Wng
H302

H317

H412
612-154-00-16'-(isobutylethylamino)-3'-methyl-2'-phenylamino-spiro[isobenzo-2-oxofuran-7,9'-[9H]-xanthene]410-890-695235-29-3Aquatic Chronic 4H413H413
612-155-00-72'-anilino-6'-((3-ethoxypropyl)ethylamino)-3'-methylspiro(isobenzo-3-oxofuran)-1-(1H)-9'-xanthene411-730-893071-94-4Aquatic Chronic 4H413H413
612-156-00-2reaction mass of: trihexadecylmethylammonium chloride;

dihexadecyldimethylammonium chloride
405-620-9Eye Dam. 1

Aquatic Acute 1

Aquatic Chronic 1
H318

H400

H410
GHS05

GHS09

Dgr
H318

H410
612-157-00-8(Z)-1-benzo[b]thien-2-ylethanone oxime hydrochloride410-780-8Acute Tox. 4 *

STOT RE 2 *

Eye Dam. 1

Skin Sens. 1

Aquatic Chronic 2
H302

H373 **

H318

H317

H411
GHS08

GHS05

GHS07

GHS09

Dgr
H302

H373 **

H318

H317

H411
612-158-00-3reaction mass of: bis(5-dodecyl-2-hydroxybenzald-oximate) copper (II) C12-alkyl group is branched;

4-dodecylsalicylaldoxime
410-820-4Aquatic Chronic 4H413H413
612-159-00-9Reaction products of: trimethylhexamethylene diamine (a mixture of 2,2,4-trimethyl-1,6-hexanediamine and 2,4,4-trimethyl-1,6-hexanediamine, EINECS listed), Epoxide 8 (mono[(C10-C16-alkyloxy)methyl]oxirane derivatives) and p-toluene-sulfonic acid410-880-1Acute Tox. 4 *

Skin Corr. 1B

Aquatic Acute 1

Aquatic Chronic 1
H302

H314

H400

H410
GHS05

GHS07

GHS09

Dgr
H302

H314

H410
612-160-00-4p-toluidine;

4-aminotoluene; [1]

toluidinium chloride; [2]

toluidine sulphate (1:1) [3]
203-403-1 [1]

208-740-8 [2]

208-741-3 [3]
106-49-0 [1]

540-23-8 [2]

540-25-0 [3]
Carc. 2

Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *

Eye Irrit. 2

Skin Sens. 1

Aquatic Acute 1
H351

H331

H311

H301

H319

H317

H400
GHS06

GHS08

GHS09

Dgr
H351

H331

H311

H301

H319

H317

H400
612-161-00-X2,6-xylidine;

2,6-dimethylaniline
201-758-787-62-7Carc. 2

Acute Tox. 4 *

Acute Tox. 4 *

Acute Tox. 4 *

STOT SE 3

Skin Irrit. 2

Aquatic Chronic 2
H351

H332

H312

H302

H335

H315

H411
GHS08

GHS07

GHS09

Wng
H351

H332

H312

H302

H335

H315

H411
612-162-00-5dimethyldioctadecylammonium chloride;

DODMAC
203-508-2107-64-2Eye Dam. 1

Aquatic Acute 1

Aquatic Chronic 1
H318

H400

H410
GHS05

GHS09

Dgr
H318

H410
612-163-00-0metalaxyl-M (ISO);

mefenoxam;

(R)-2-[(2,6-dimethylphenyl)-methoxyacetylamino]propionic acid methyl ester
70630-17-0Acute Tox. 4 *

Eye Dam. 1
H302

H318
GHS05

GHS07

Dgr
H302

H318
612-164-00-62-butyl-2-ethyl-1,5-diaminopentane412-700-7137605-95-9Acute Tox. 4 *

Acute Tox. 4 *

STOT RE 2 *

Skin Corr. 1B

Skin Sens. 1

Aquatic Chronic 3
H312

H302

H373 **

H314

H317

H412
GHS08

GHS05

GHS07

Dgr
H312

H302

H373 **

H314

H317

H412
612-165-00-1N,N'-diphenyl-N,N'-bis(3-methylphenyl)-(1,1'-diphenyl)-4,4'-diamine413-810-865181-78-4Aquatic Chronic 2H411GHS09H411
612-166-00-7reaction mass of: cis-(5-ammonium-1,3,3-trimethyl)-cyclohexanemethylammonium phosphate (1:1);

trans-(5-ammonium-1,3,3-trimethyl)-cyclohexanemethylammonium phosphate (1:1)
411-830-1114765-88-7Eye Dam. 1

Skin Sens. 1

Aquatic Chronic 3
H318

H317

H412
GHS05

GHS07

Dgr
H318

H317

H412
612-167-00-25-acetyl-3-amino-10,11-dihydro-5H-dibenz[b,f]azepine-hydrochloride410-490-1Acute Tox. 4 *

STOT RE 2 *

Eye Dam. 1

Skin Sens. 1

Aquatic Chronic 2
H302

H373 **

H318

H317

H411
GHS08

GHS05

GHS07

GHS09

Dgr
H302

H373 **

H318

H317

H411
612-168-00-83,5-dichloro-2,6-difluoropyrdine-4-amine220-630-12840-00-8Acute Tox. 4 *

Acute Tox. 4 *

Aquatic Chronic 2
H312

H302

H411
GHS07

GHS09

Wng
H312

H302

H411
612-170-00-94-chlorophenyl cyclopropyl ketone O-(4-aminobenzyl)oxime405-260-2Acute Tox. 4 *

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H302

H317

H400

H410
GHS07

GHS09

Wng
H302

H317

H410
612-171-00-4N,N,N',N'-tetraglycidyl-4,4'-diamino-3,3'-diethyldiphenylmethane410-060-3130728-76-6Muta. 2

Skin Sens. 1

Aquatic Chronic 2
H341

H317

H411
GHS08

GHS09

Wng
H341

H317

H411
612-172-00-X4,4'-methylenebis(N,N'-dimethylcyclohexanamine412-840-913474-64-1Acute Tox. 4 *

STOT RE 2 *

Skin Corr. 1A

Aquatic Chronic 3
H302

H373 **

H314

H412
GHS08

GHS05

GHS07

Dgr
H302

H373 **

H314

H412
612-173-00-5lithium 1-amino-4-(4-tert-butylanilino)anthraquinone-2-sulfonate411-140-0125328-86-1Eye Dam. 1

Skin Sens. 1

Aquatic Chronic 2
H318

H317

H411
GHS05

GHS07

GHS09

Dgr
H318

H317

H411
612-174-00-04,4-dimethoxybutylamine407-690-619060-15-2Acute Tox. 4 *

Skin Corr. 1B

Skin Sens. 1

Aquatic Chronic 3
H302

H314

H317

H412
GHS05

GHS07

Dgr
H302

H314

H317

H412
612-175-00-62-(O-aminooxy)ethylamine dihydrochloride412-310-737866-45-8Skin Sens. 1

Aquatic Chronic 3
H317

H412
GHS07

Wng
H317

H412
612-176-00-1polymer of 1,3-dibromopropane and N,N-diethyl-N',N'-dimethyl-1,3-propanediamine410-570-6143747-73-3Aquatic Acute 1

Aquatic Chronic 1
H400

H410
GHS09

Wng
H410
612-177-00-72-naphthylamino-6-sulfomethylamide412-120-4104295-55-8STOT RE 2 *

Skin Sens. 1

Aquatic Chronic 2
H373 **

H317

H411
GHS08

GHS09

Wng
H373 **

H317

H411
612-178-00-21,4,7,10-tetraazacyclododecane disulfate412-080-8112193-77-8Acute Tox. 4 *

STOT SE 3

Eye Dam. 1

Aquatic Chronic 3
H302

H335

H318

H412
GHS05

GHS07

Dgr
H302

H335

H318

H412
612-179-00-81-(2-propenyl)pyridinium chloride412-740-525965-81-5Acute Tox. 4 *

Skin Sens. 1
H302

H317
GHS07

Wng
H302

H317
612-180-00-33-aminobenzylamine412-230-24403-70-7Acute Tox. 4 *

Skin Corr. 1B

Aquatic Chronic 2
H302

H314

H411
GHS05

GHS07

GHS09

Dgr
H302

H314

H411
612-181-00-92-phenylthioaniline413-030-81134-94-7Skin Sens. 1

Aquatic Chronic 2
H317

H411
GHS07

GHS09

Wng
H317

H411
612-182-00-41-ethyl-1-methylmorpholinium bromide418-210-165756-41-4Muta. 2H341GHS08

Wng
H341
612-183-00-X1-ethyl-1-methylpyrrolidinium bromide418-200-569227-51-6Muta. 2H341GHS08

Wng
H341
612-184-00-56'-(dibutylamino)-3'-methyl-2'-(phenylamino)spiro[isobenzofuran-1(3H),9-(9H)-xanthen]-3-one403-830-589331-94-2Aquatic Chronic 3H412H412
612-185-00-01-[3-[4-((heptadecafluorononyl)oxy)-benzamido]propyl]-N,N,N-trimethylammonium iodide407-400-859493-72-0Eye Dam. 1

Aquatic Acute 1

Aquatic Chronic 1
H318

H400

H410
GHS05

GHS09

Dgr
H318

H410
612-186-00-6bis(N-(7-hydroxy-8-methyl-5-phenylphenazin-3-ylidene)dimethylammonium) sulfate406-770-8149057-64-7STOT RE 2 *

Eye Dam. 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H373 **

H318

H317

H400

H410
GHS08

GHS05

GHS07

GHS09

Dgr
H373 **

H318

H317

H410
612-187-00-12,3,4-trifluoroaniline407-170-93862-73-5Acute Tox. 4 *

Acute Tox. 4 *

STOT RE 2 *

Skin Irrit. 2

Eye Dam. 1

Aquatic Chronic 2
H312

H302

H373 **

H315

H318

H411
GHS08

GHS05

GHS07

GHS09

Dgr
H312

H302

H373 **

H315

H318

H411
612-188-00-74,4'-(9H-fluoren-9-ylidene)bis(2-chloroaniline)407-560-9107934-68-9Aquatic Chronic 2H411GHS09H411
612-189-00-24-amino-2-(aminomethyl)phenol dihydrochloride412-510-4135043-64-0Acute Tox. 4 *

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H302

H317

H400

H410
GHS07

GHS09

Wng
H302

H317

H410
612-190-00-84,4'-methylenebis(2-isopropyl-6-methylaniline)415-150-616298-38-7STOT RE 2 *

Aquatic Chronic 2
H373 **

H411
GHS08

GHS09

Wng
H373 **

H411
612-191-00-3polymer of allylamine hydrochloride415-050-271550-12-4Acute Tox. 4 *

Skin Sens. 1
H302

H317
GHS07

Wng
H302

H317
612-192-00-92-isopropyl-4-(N-methyl)aminomethylthiazole414-800-6154212-60-9Acute Tox. 4 *

Acute Tox. 4 *

Skin Irrit. 2

Eye Dam. 1

Aquatic Chronic 2
H312

H302

H315

H318

H411
GHS05

GHS07

GHS09

Dgr
H312

H302

H315

H318

H411
612-193-00-43-methylaminomethylphenylamine414-570-718759-96-1Acute Tox. 4 *

Acute Tox. 4 *

Skin Corr. 1B

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H312

H302

H314

H317

H400

H410
GHS05

GHS07

GHS09

Dgr
H312

H302

H314

H317

H410
612-194-00-X2-hydroxy-3-[(2-hydroxyethyl)-[2-(1-oxotetradecyl)amino]ethyl]amino]-N,N,N-trimethyl-1-propanammonium chloride414-670-0141890-30-4Acute Tox. 4 *

Eye Dam. 1

Aquatic Acute 1

Aquatic Chronic 1
H302

H318

H400

H410
GHS05

GHS07

GHS09

Dgr
H302

H318

H410
612-195-00-5bis[tributyl 4-(methylbenzyl)ammonium] 1,5-naphthalenedisulfonate415-210-1160236-81-7Acute Tox. 4 *

Acute Tox. 4 *

Eye Dam. 1

Aquatic Acute 1

Aquatic Chronic 1
H332

H302

H318

H400

H410
GHS05

GHS07

GHS09

Dgr
H332

H302

H318

H410
612-196-00-04-chloro-o-toluidine; [1]

4-chloro-o-toluidine hydrochloride [2]
202-441-6 [1]

221-627-8 [2]
95-69-2 [1]

3165-93-3 [2]
Carc. 1B

Muta. 2

Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *

Aquatic Acute 1

Aquatic Chronic 1
H350

H341

H331

H311

H301

H400

H410
GHS06

GHS08

GHS09

Dgr
H350

H341

H331

H311

H301

H410
612-197-00-62,4,5-trimethylaniline; [1]

2,4,5-trimethylaniline hydrochloride [2]
205-282-0 [1] - [2]137-17-7 [1]

21436-97-5 [2]
Carc. 1B

Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *

Aquatic Chronic 2
H350

H331

H311

H301

H411
GHS06

GHS08

GHS09

Dgr
H350

H331

H311

H301

H411
612-198-00-14,4'-thiodianiline and its salts205-370-9139-65-1Carc. 1B

Acute Tox. 4 *

Aquatic Chronic 2
H350

H302

H411
GHS08

GHS07

GHS09

Dgr
H350

H302

H411
612-199-00-74,4'-oxydianiline and its salts;

p-aminophenyl ether
202-977-0101-80-4Carc. 1B

Muta. 1B

Repr. 2

Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *

Aquatic Chronic 2
H350

H340

H361f ***

H331

H311

H301

H411
GHS06

GHS08

GHS09

Dgr
H350

H340

H361f ***

H331

H311

H301

H411
612-200-00-02,4-diaminoanisole;

4-methoxy-m-phenylenediamine; [1]

2,4-diaminoanisole sulphate [2]
210-406-1 [1]

254-323-9 [2]
615-05-4 [1]

39156-41-7 [2]
Carc. 1B

Muta. 2

Acute Tox. 4 *

Aquatic Chronic 2
H350

H341

H302

H411
GHS08

GHS07

GHS09

Dgr
H350

H341

H302

H411
612-201-00-6N,N,N',N'-tetramethyl-4,4'-methylendianiline202-959-2101-61-1Carc. 1B

Aquatic Acute 1

Aquatic Chronic 1
H350

H400

H410
GHS08

GHS09

Dgr
H350

H410
612-202-00-13,4-dichloroaniline202-448-495-76-1Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *

Eye Dam. 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H331

H311

H301

H318

H317

H400

H410
GHS06

GHS05

GHS09

Dgr
H331

H311

H301

H318

H317

H410
612-204-00-2C.I. Basic Violet 3;

4-[4,4'-bis(dimethylamino) benzhydrylidene]cyclohexa-2,5-dien-1-ylidene]dimethylammonium chloride
208-953-6548-62-9Carc. 2

Acute Tox. 4 *

Eye Dam. 1

Aquatic Acute 1

Aquatic Chronic 1
H351

H302

H318

H400

H410
GHS08

GHS05

GHS07

GHS09

Dgr
H351

H302

H318

H410
612-205-00-8C.I. Basic Violet 3 with ≥ 0,1 % of Michler's ketone (EC no. 202-027-5)208-953-6548-62-9Carc. 1B

Acute Tox. 4 *

Eye Dam. 1

Aquatic Acute 1

Aquatic Chronic 1
H350

H302

H318

H400

H410
GHS08

GHS05

GHS07

GHS09

Dgr
H350

H302

H318

H410
612-206-00-3famoxadone (ISO);

3-anilino-5-methyl-5-(4-phenoxyphenyl)-1,3-oxazolidine-2,4-dione
131807-57-3STOT RE 2 *

Aquatic Acute 1

Aquatic Chronic 1
H373 **

H400

H410
GHS08

GHS09

Wng
H373 **

H410
612-207-00-94-ethoxyaniline;

p-phenetidine
205-855-5156-43-4Muta. 2

Acute Tox. 4 *

Acute Tox. 4 *

Acute Tox. 4 *

Eye Irrit. 2

Skin Sens. 1
H341

H332

H312

H302

H319

H317
GHS08

GHS07

Wng
H341

H332

H312

H302

H319

H317
612-209-00-X6-methoxy-m-toluidine;

p-cresidine
204-419-1120-71-8Carc. 1B

Acute Tox. 4 *
H350

H302
GHS08

GHS07

Dgr
H350

H302
612-210-00-55-nitro-o-toluidine; [1]

5-nitro-o-toluidine hydrochloride [2]
202-765-8 [1]

256-960-8 [2]
99-55-8 [1]

51085-52-0 [2]
Carc. 2

Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *

Aquatic Chronic 3
H351

H331

H311

H301

H412
GHS06

GHS08

Dgr
H351

H331

H311

H301

H412
612-211-00-0N-[(benzotriazole-1-yl)methyl)]-4-carboxybenzenesulfonamide416-470-9170292-97-4Eye Irrit. 2

Aquatic Chronic 2
H319

H411
GHS07

GHS09

Wng
H319

H411
612-212-00-62,6-dichloro-4-trifluoromethylaniline416-430-024279-39-8Acute Tox. 4 *

Acute Tox. 4 *

Skin Irrit. 2

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H332

H302

H315

H317

H400

H410
GHS07

GHS09

Wng
H332

H302

H315

H317

H410
612-213-00-1isobutylidene-(2-(2-isopropyl-4,4-dimethyloxazolidine-3-yl)-1,1-dimethylethyl)amine419-850-2148348-13-4Skin Corr. 1B

Aquatic Chronic 3
H314

H412
GHS05

Dgr
H314

H412
612-214-00-74-(2,2-diphenylethenyl)-N,N-di-phenylbenzenamine421-390-289114-90-9Aquatic Chronic 4H413H413
612-215-00-23-chloro-2-(isopropylthio)aniline421-700-6179104-32-6Skin Irrit. 2

Aquatic Chronic 2
H315

H411
GHS07

GHS09

Wng
H315

H411
612-217-00-31-methoxy-2-propylamine422-550-437143-54-7Flam. Liq. 2

Skin Corr. 1B

Acute Tox. 4 *

Aquatic Chronic 3
H225

H314

H302

H412
GHS02

GHS05

GHS07

Dgr
H225

H314

H302

H412
613-001-00-1ethyleneimine;

aziridine
205-793-9151-56-4Flam. Liq. 2

Carc. 1B

Muta. 1B

Acute Tox. 2 *

Acute Tox. 1

Acute Tox. 2 *

Skin Corr. 1B

Aquatic Chronic 2
H225

H350

H340

H330

H310

H300

H314

H411
GHS02

GHS06

GHS08

GHS05

GHS09

Dgr
H225

H350

H340

H330

H310

H300

H314

H411
D
613-002-00-7pyridine203-809-9110-86-1Flam. Liq. 2

Acute Tox. 4 *

Acute Tox. 4 *

Acute Tox. 4 *
H225

H332

H312

H302
GHS02

GHS07

Dgr
H225

H332

H312

H302
*
613-003-00-21,2,3,4-tetranitrocarbazole6202-15-9Expl. 1.1

Acute Tox. 4 *

Acute Tox. 4 *

Acute Tox. 4 *
H201

H332

H312

H302
GHS01

GHS07

Wng
H201

H332

H312

H302
613-004-00-8crimidine (ISO);

2-chloro-6-methylpyrimidin-4-yldimethylamine
208-622-6535-89-7Acute Tox. 2 *H300GHS06

Dgr
H300
613-007-00-4desmetryne (ISO);

6-isopropylamino-2-methylamino-4-methylthio-1,3,5-triazine
213-800-11014-69-3Acute Tox. 4 *

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1
H312

H302

H400

H410
GHS07

GHS09

Wng
H312

H302

H410
613-008-00-Xdazomet (ISO);

tetrahydro-3,5-dimethyl-1,3,5-thiadiazine-2-thione
208-576-7533-74-4Acute Tox. 4 *

Eye Irrit. 2

Aquatic Acute 1

Aquatic Chronic 1
H302

H319

H400

H410
GHS07

GHS09

Wng
H302

H319

H410
613-009-00-52,4,6-trichloro-1,3,5-triazine;

cyanuric chloride
203-614-9108-77-0Acute Tox. 2 *

Acute Tox. 4 *

Skin Corr. 1B

Skin Sens. 1
H330

H302

H314

H317
GHS06

GHS05

Dgr
H330

H302

H314

H317
EUH014STOT SE 3; H335: C ≥ 5 %
613-010-00-0ametryn (ISO);

2-ethylamino-4-isopropylamino-6-methylthio-1,3,5-triazine
212-634-7834-12-8Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1
H302

H400

H410
GHS07

GHS09

Wng
H302

H410
613-011-00-6amitrole (ISO);

1,2,4-triazol-3-ylamine
200-521-561-82-5Repr. 2

STOT RE 2 *

Aquatic Chronic 2
H361d ***

H373 **

H411
GHS08

GHS09

Wng
H361d ***

H373 **

H411
613-012-00-1bentazone (ISO);

3-isopropyl-2,1,3-benzothiadiazine-4-one-2,2-dioxide
246-585-825057-89-0Acute Tox. 4 *

Eye Irrit. 2

Skin Sens. 1

Aquatic Chronic 3
H302

H319

H317

H412
GHS07

Wng
H302

H319

H317

H412
613-013-00-7cyanazine (ISO);

2-(4-chloro-6-ethylamino-1,3,5-triazine-2-ylamino)-2-methylpropionitrile
244-544-921725-46-2Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1
H302

H400

H410
GHS07

GHS09

Wng
H302

H410
613-014-00-2ethoxyquin(ISO);

6-ethoxy-1,2-dihydro-2,2,4-trimethylquinoline
202-075-791-53-2Acute Tox. 4 *H302GHS07

Wng
H302
613-015-00-8fenazaflor (ISO);

phenyl 5,6-dichloro-2-trifluoromethylbenzimidazole-1-carboxylate
238-134-914255-88-0Acute Tox. 4 *

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1
H312

H302

H400

H410
GHS07

GHS09

Wng
H312

H302

H410
613-016-00-3fuberidazole(ISO);

2-(2-furyl)benzimidazole
223-404-03878-19-1Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1
H302

H400

H410
GHS07

GHS09

Wng
H302

H410
613-017-00-9bis (8-hydroxyquinolinium) sulphate205-137-1134-31-6Acute Tox. 4 *H302GHS07

Wng
H302
613-018-00-4morfamquat (ISO);

1,1'-bis(3,5-dimethylmorpholinocarbonylmethyl)-4,4'-bipyridilium ion
7411-47-4Acute Tox. 4 *

Eye Irrit. 2

STOT SE 3

Skin Irrit. 2

Aquatic Chronic 3
H302

H319

H335

H315

H412
GHS07

Wng
H302

H319

H335

H315

H412
613-019-00-Xthioquinox(ISO);

2-thio-1,3-dithiolo(4,5,b)quinoxaline
202-272-893-75-4Acute Tox. 4 *H302GHS07

Wng
H302
613-020-00-5tridemorph (ISO);

2,6-dimethyl-4-tridecylmorpholine
246-347-324602-86-6Repr. 1B

Acute Tox. 4 *

Acute Tox. 4 *

Skin Irrit. 2

Aquatic Acute 1

Aquatic Chronic 1
H360D ***

H332

H302

H315

H400

H410
GHS08

GHS07

GHS09

Dgr
H360D ***

H332

H302

H315

H410
613-021-00-0dithianon (ISO);

5,10-dihydro-5,10-dioxonaphtho(2,3-b)(1,4)dithiazine-2,3-dicarbonitrile
222-098-63347-22-6Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1
H302

H400

H410
GHS07

GHS09

Wng
H302

H410
613-022-00-6pyrethrins including cinerins, with the exception of those specified elsewhere in this AnnexAcute Tox. 4 *

Acute Tox. 4 *

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1
H332

H312

H302

H400

H410
GHS07

GHS09

Wng
H332

H312

H302

H410
A
613-023-00-12-methyl-4-oxo-3-(penta-2,4-dienyl)cyclopent-2-enyl [1R-[1α[S*(Z)],3β]]-chrysanthemate;

pyrethrin I
204-455-8121-21-1Acute Tox. 4 *

Acute Tox. 4 *

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1
H332

H312

H302

H400

H410
GHS07

GHS09

Wng
H332

H312

H302

H410
613-024-00-72-methyl-4-oxo-3-(penta-2,4-dienyl)cyclopent-2-enyl[1R-[1α[S*(Z)](3β)]]-3-(3-methoxy-2-methyl-3-oxoprop-1-enyl)-2,2-dimethylcyclopropanecarboxylate;

pyrethrin II
204-462-6121-29-9Acute Tox. 4 *

Acute Tox. 4 *

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1
H332

H312

H302

H400

H410
GHS07

GHS09

Wng
H332

H312

H302

H410
613-025-00-2cinerin I;

3-(but-2-enyl)-2-methyl-4-oxocyclopent-2-enyl 2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate
246-948-025402-06-6Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1
H302

H400

H410
GHS07

GHS09

Wng
H302

H410
613-026-00-8cinerin II;

3-(but-2-enyl)-2-methyl-4-oxocyclopent-2-enyl 2,2-dimethyl-3-(3-methoxy-2-methyl-3-oxoprop-1-enyl)cyclopropanecarboxylate
204-454-2121-20-0Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1
H302

H400

H410
GHS07

GHS09

Wng
H302

H410
613-027-00-3piperidine203-813-0110-89-4Flam. Liq. 2

Acute Tox. 3 *

Acute Tox. 3 *

Skin Corr. 1B
H225

H331

H311

H314
GHS02

GHS06

GHS05

Dgr
H225

H331

H311

H314
*
613-028-00-9morpholine203-815-1110-91-8Flam. Liq. 3

Acute Tox. 4 *

Acute Tox. 4 *

Acute Tox. 4 *

Skin Corr. 1B
H226

H332

H312

H302

H314
GHS02

GHS05

GHS07

Dg
H226

H332

H312

H302

H314
613-029-00-4dichloro-1,3,5-triazinetrione;

dichloroisocyanuric acid
220-487-52782-57-2Ox. Sol. 2

Acute Tox. 4 *

Eye Irrit. 2

STOT SE 3

Aquatic Acute 1

Aquatic Chronic 1
H272

H302

H319

H335

H400

H410
GHS03

GHS07

GHS09

Dgr
H272

H302

H319

H335

H410
EUH031T
613-030-00-Xtroclosene potassium; [1]

troclosene sodium [2]
218-828-8 [1]

220-767-7 [2]
2244-21-5 [1]

2893-78-9 [2]
Ox. Sol. 2

Acute Tox. 4 *

Eye Irrit. 2

STOT SE 3

Aquatic Acute 1

Aquatic Chronic 1
H272

H302

H319

H335

H400

H410
GHS03

GHS07

GHS09

Dgr
H272

H302

H319

H335

H410
EUH031*

STOT SE 3; H335: C ≥ 10 %

EUH031: C ≥ 10 %
613-030-01-7troclosene sodium, dihydrate220-767-751580-86-0Acute Tox. 4 *

Eye Irrit. 2

STOT SE 3

Aquatic Acute 1

Aquatic Chronic 1
H302

H319

H335

H400

H410
GHS07

GHS09

Wng
H302

H319

H335

H410
EUH031
613-031-00-5symclosene;

trichloroisocyanuric acid;

trichloro-1,3,5-triazinetrion
201-782-887-90-1Ox. Sol. 2

Acute Tox. 4 *

Eye Irrit. 2

STOT SE 3

Aquatic Acute 1

Aquatic Chronic 1
H272

H302

H319

H335

H400

H410
GHS03

GHS07

GHS09

Dgr
H272

H302

H319

H335

H410
EUH031
613-032-00-0methyl-2,3,5,6-tetrachloro-4-pyridylsulphone;

2,3,5,6-tetrachloro-4-(methylsulphonyl)pyridine
236-035-513108-52-6Acute Tox. 4 *

Acute Tox. 4 *

Eye Irrit. 2

Skin Sens. 1
H312

H302

H319

H317
GHS07

Wng
H312

H302

H319

H317
613-033-00-62-methylaziridine;

propyleneimine
200-878-775-55-8Flam. Liq. 2

Carc. 1B

Acute Tox. 2 *

Acute Tox. 1

Acute Tox. 2 *

Eye Dam. 1

Aquatic Chronic 2
H225

H350

H330

H310

H300

H318

H411
GHS02

GHS06

GHS08

GHS05

GHS09

Dgr
H225

H350

H330

H310

H300

H318

H411
Carc. 1B; H350: C ≥ 0,01 %
613-034-00-11,2-dimethylimidazole217-101-21739-84-0Acute Tox. 4 *

Skin Irrit. 2

Eye Dam. 1
H302

H315

H318
GHS05

GHS07

Dgr
H302

H315

H318
613-035-00-71-methylimidazole210-484-7616-47-7Acute Tox. 4 *

Acute Tox. 4 *

Skin Corr. 1B
H312

H302

H314
GHS05

GHS07

Dgr
H312

H302

H314
613-036-00-22-methylpyridine;

2-picoline
203-643-7109-06-8Flam. Liq. 3

Acute Tox. 4 *

Acute Tox. 4 *

Acute Tox. 4 *

Eye Irrit. 2

STOT SE 3
H226

H332

H312

H302

H319

H335
GHS02

GHS07

Wng
H226

H332

H312

H302

H319

H335
613-037-00-84-methylpyridine;

4-picoline
203-626-4108-89-4Flam. Liq. 3

Acute Tox. 3 *

Acute Tox. 4 *

Acute Tox. 4 *

Eye Irrit. 2

STOT SE 3

Skin Irrit. 2
H226

H311

H332

H302

H319

H335

H315
GHS02

GHS06

Dgr
H226

H311

H332

H302

H319

H335

H315
613-038-00-36-phenyl-1,3,5-triazine-2,4-diyldiamine;

6-phenyl-1,3,5-triazine-2,4-diamine;

benzoguanamine
202-095-691-76-9Acute Tox. 4 *

Aquatic Chronic 3
H302

H412
GHS07

Wng
H302

H412
613-039-00-9ethylene thiourea;

imidazolidine-2-thione;

2-imidazoline-2-thiol
202-506-996-45-7Repr. 1B

Acute Tox. 4 *
H360D ***

H302
GHS08

GHS07

Dgr
H360D ***

H302
613-040-00-4azaconazole (ISO);

1-{[2-(2,4-dichlorophenyl)-1,3-dioxolan-2-yl]methyl}-1H-1,2.4-triazole
262-102-360207-31-0Acute Tox. 4 *H302GHS07

Wng
H302
613-041-00-Xmorpholine-4-carbonyl chloride239-213-015159-40-7Carc. 2

Eye Irrit. 2

Skin Irrit. 2
H351

H319

H315
GHS08

Wng
H351

H319

H315
EUH014
613-042-00-5imazalil (ISO);

1-[2-(allyloxy)-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole
252-615-035554-44-0Acute Tox. 4 *

Acute Tox. 4 *

Eye Dam. 1

Aquatic Acute 1

Aquatic Chronic 1
H332

H302

H318

H400

H410
GHS05

GHS07

GHS09

Dgr
H332

H302

H318

H410
613-043-00-0imazalil sulphate (ISO) powder;

1- [2-(allyloxy)ethyl-2-(2,4-dichlorophenyl)]-1H-imidazolium hydrogen sulphate; [1]

(±)-1- [2-(allyloxy)ethyl-2-(2,4-dichlorophenyl)]-1H-imidazolium hydrogen sulphate [2]
261-351-5 [1]

281-291-3 [2]
58594-72-2 [1]

83918-57-4 [2]
Acute Tox. 4 *

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H302

H317

H400

H410
GHS07

GHS09

Wng
H302

H317

H410
613-043-01-8imazalil sulphate (ISO), aqueous solution;

1- [2-(allyloxy)ethyl-2-(2,4-dichlorophenyl)]-1H-imidazolium hydrogen sulphate; [1]

(±)-1- [2-(allyloxy)ethyl-2-(2,4-dichlorophenyl)]-1H-imidazolium hydrogen sulphate [2]
261-351-5 [1]

281-291-3 [2]
58594-72-2 [1]

83918-57-4 [2]
Acute Tox. 4 *

Skin Corr. 1B

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H302

H314

H317

H400

H410
GHS05

GHS07

GHS09

Wng
H302

H314

H317

H410
Skin Corr. 1B; H314: C ≥ 50 %

Skin Irrit. 2; H315: 30 % ≤ C < 50 %

Eye Dam. 1; H318: 15 % ≤ C < 50 %

Eye Irrit. 2; H319: 5 % ≤ C < 15 %
613-044-00-6captan (ISO);

1,2,3,6-tetrahydro-N-(trichloromethylthio)phthalimide
205-087-0133-06-2Carc. 2

Acute Tox. 3 *

Eye Dam. 1

Skin Sens. 1

Aquatic Acute 1
H351

H331

H318

H317

H400
GHS06

GHS08

GHS05

GHS09

Dgr
H351

H331

H318

H317

H400
613-045-00-1folpet (ISO);

N-(trichloromethylthio)phthalimide
205-088-6133-07-3Carc. 2

Acute Tox. 4 *

Eye Irrit. 2

Skin Sens. 1

Aquatic Acute 1
H351

H332

H319

H317

H400
GHS08

GHS07

GHS09

Wng
H351

H332

H319

H317

H400
613-046-00-7captafol (ISO);

1,2,3,6-tetrahydro-N-(1,1,2,2-tetrachloroethylthio)phthalimide
219-363-32425-06-1Carc. 1B

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H350

H317

H400

H410
GHS08

GHS09

Dgr
H350

H317

H410
613-047-00-21-dimethylcarbamoyl-5-methylpyrazol-3-yl dimethylcarbamate;

dimetilan (ISO)
211-420-0644-64-4Acute Tox. 3 *

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1
H301

H312

H400

H410
GHS06

GHS09

Dgr
H301

H312

H410
613-048-00-8carbendazim (ISO);

methyl benzimidazol-2-ylcarbamate
234-232-010605-21-7Muta. 1B

Repr. 1B

Aquatic Acute 1

Aquatic Chronic 1
H340

H360FD

H400

H410
GHS08

GHS09

Dgr
H340

H360FD

H410
613-049-00-3benomyl (ISO);

methyl 1-(butylcarbamoyl)benzimidazol-2-ylcarbamate
241-775-717804-35-2Muta. 1B

Repr. 1B

STOT SE 3

Skin Irrit. 2

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H340

H360FD

H335

H315

H317

H400

H410
GHS08

GHS07

GHS09

Dgr
H340

H360FD

H335

H315

H317

H410
M = 10
613-050-00-9carbadox (INN);

methyl 3-(quinoxalin-2-ylmethylene)carbazate 1,4-dioxide;

2-(methoxycarbonylhydrazonomethyl)quinoxaline 1,4-dioxide
229-879-06804-07-5Flam. Sol. 1

Carc. 1B

Acute Tox. 4 *
H228

H350

H302
GHS02

GHS08

GHS07

Dgr
H228

H350

H302
T
613-051-00-4molinate (ISO);

S-ethyl 1-perhydroazepinecarbothioate;

S-ethyl perhydroazepine-1-carbothioate
218-661-02212-67-1Carc. 2

Repr. 2

Acute Tox. 4 *

Acute Tox. 4 *

STOT RE 2 *

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H351

H361f ***

H332

H302

H373 **

H317

H400

H410
GHS08

GHS07

GHS09

Wng
H351

H361f ***

H332

H302

H373 **

H317

H410
M = 100
613-052-00-Xtrifenmorph (ISO);

4-tritylmorpholine
215-812-21420-06-0Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1
H302

H400

H410
GHS07

GHS09

Wng
H302

H410
613-053-00-5anilazine (ISO);

2-chloro-N-(4,6-dichloro-1,3,5-triazin-2-yl)aniline
202-910-5101-05-3Eye Irrit. 2

Skin Irrit. 2

Aquatic Acute 1

Aquatic Chronic 1
H319

H315

H400

H410
GHS07

GHS09

Wng
H319

H315

H410
613-054-00-0thiabendazol (ISO);

2-(thiazole-4-yl)benzimidazole
205-725-8148-79-8Aquatic Acute 1

Aquatic Chronic 1
H400

H410
GHS09

Wng
H410
613-056-00-11,2-dimethyl-3,5-diphenylpyrazolium methylsulphate;

difenzoquat methyl sulfate
256-152-543222-48-6Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1
H302

H400

H410
GHS09

Wng
H302

H410
613-057-00-7dodemorph (ISO);

4-cyclododecyl-2,6-dimethylmorpholine
216-474-91593-77-7Eye Irrit. 2

STOT SE 3

Skin Irrit. 2

Aquatic Chronic 2
H319

H335

H315

H411
GHS07

GHS09

Wng
H319

H335

H315

H411
613-058-00-2permethrin (ISO);

m-phenoxybenzyl 3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate
258-067-952645-53-1Acute Tox. 4 *

Acute Tox. 4 *

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H332

H302

H317

H400

H410
GHS07

GHS09

Wng
H332

H302

H317

H410
M = 1 000
613-059-00-8profluralin (ISO);

N-(cyclopropylmethyl)-α,α,α-trifluoro-2,6-dinitro-N-propyl-p-toluidine
247-656-626399-36-0Eye Irrit. 2

Aquatic Acute 1

Aquatic Chronic 1
H319

H400

H410
GHS07

GHS09

Wng
H319

H410
613-060-00-3resmethrin (ISO);

5-benzyl-3-furylmethyl (±)-cis-trans-chrysanthemate
233-940-710453-86-8Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1
H302

H400

H410
GHS07

GHS09

Wng
H302

H410
613-061-00-96-(1α,5aβ,8aβ,9-pentahydroxy-7β-isopropyl-2β,5β,8β-trimethylperhydro-8bα,9-epoxy-5,8-ethanocyclopenta[1,2-b]indenyl) pyrrole-2-carboxylate;

ryania
239-732-215662-33-6Acute Tox. 4 *

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1
H312

H302

H400

H410
GHS07

GHS09

Wng
H312

H302

H410
613-062-00-4sabadilla (ISO);

veratrine
8051-02-3Eye Irrit. 2

STOT SE 3

Skin Irrit. 2
H319

H335

H315
GHS07

Wng
H319

H335

H315
613-063-00-Xsecbumeton (ISO);

2-sec-butylamino-4-ethylamino-6-methoxy-1,3,5-triazine
247-554-126259-45-0Acute Tox. 4 *

Eye Irrit. 2

Aquatic Acute 1

Aquatic Chronic 1
H302

H319

H400

H410
GHS07

GHS09

Wng
H302

H319

H410
613-064-00-55-(3,6,9-trioxa-2-undecyloxy)benzo(d)-1,3-dioxolane;

sesamex
51-14-9Acute Tox. 4 *H302GHS07

Wng
H302
613-065-00-0simetryn (ISO);

2,4-bis(ethylamino)-6-methylthio-1,3,5-triazine
213-801-71014-70-6Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1
H302

H400

H410
GHS07

GHS09

Wng
H302

H410
613-066-00-6terbumeton (ISO);

2-tert-butylamino-4-ethylamino-6-methoxy-1,3,5-triazine
251-637-833693-04-8Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1
H302

H400

H410
GHS07

GHS09

Wng
H302

H410
613-067-00-1propazine(ISO);

2-chloro-4,6-bis(isopropylamino)-1,3,5-triazine
205-359-9139-40-2Carc. 2

Aquatic Acute 1

Aquatic Chronic 1
H351

H400

H410
GHS08

GHS09

Wng
H351

H410
613-068-00-7atrazine (ISO);

2-chloro-4-ethylamine-6-isopropylamine-1,3,5-triazine
217-617-81912-24-9STOT RE 2 *

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H373 **

H317

H400

H410
GHS08

GHS09

Wng
H373 **

H317

H410
613-069-00-2ε-caprolactam203-313-2105-60-2Acute Tox. 4 *

Acute Tox. 4 *

Eye Irrit. 2

STOT SE 3

Skin Irrit. 2
H332

H302

H319

H335

H315
GHS07

Wng
H332

H302

H319

H335

H315
613-070-00-8propylenethiourea2122-19-2Repr. 2

Acute Tox. 4 *

Aquatic Chronic 3
H361d ***

H302

H412
GHS08

GHS07

Wng
H361d ***

H302

H412
613-071-00-32-fluoro-5-trifluoromethylpyridine400-290-269045-82-5Flam. Liq. 3

Skin Sens. 1

Aquatic Chronic 3
H226

H317

H412
GHS02

GHS07

Wng
H226

H317

H412
613-072-00-9N,N-bis(2-ethylhexyl)-((1,2,4-triazol-1-yl)methyl)amine401-280-091273-04-0Skin Corr. 1B

Skin Sens. 1

Aquatic Chronic 2
H314

H317

H411
GHS05

GHS07

GHS09

Dgr
H314

H317

H411
613-073-00-4N,N-dimethyl-2-(3-(4-chlorophenyl)-4,5-dihydropyrazol-1-ylphenylsulphonyl)ethylamine401-410-610357-99-0STOT RE 2 *

Skin Sens. 1

Aquatic Chronic 2
H373 **

H317

H411
GHS08

GHS09

Wng
H373 **

H317

H411
613-074-00-X3-(3-methylpent-3-yl)isoxazol-5-ylamine401-460-982560-06-3Acute Tox. 3 *

Acute Tox. 3 *

Eye Dam. 1

Aquatic Chronic 3
H331

H301

H318

H412
GHS06

GHS05

Dgr
H331

H301

H318

H412
613-075-00-51,3-dichloro-5-ethyl-5-methylimidazolidine-2,4-dione401-570-789415-87-2Ox. Sol. 1 ****

Acute Tox. 3 *

Skin Corr. 1B

Acute Tox. 4 *

Skin Sens. 1

Aquatic Acute 1
H271

H331

H314

H302

H317

H400
GHS03

GHS06

GHS05

GHS09

Dgr
H271

H331

H314

H302

H317

H400
613-076-00-03-chloro-5-trifluoromethyl-2-pyridylamine401-670-079456-26-1Acute Tox. 4 *

Aquatic Chronic 3
H302

H412
GHS07

Wng
H302

H412
613-077-00-6reaction mass of 5-heptyl-1,2,4-triazol-3-ylamine and 5-nonyl-1,2,4-triazol-3-ylamine401-940-8Acute Tox. 4 *

Eye Irrit. 2

Aquatic Chronic 2
H302

H319

H411
GHS07

GHS09

Wng
H302

H319

H411
613-078-00-1N,N,N,N-tetrakis(4,6-bis(butyl-(N-methyl-2,2,6,6-tetramethylpiperidin-4-yl)amino)triazin-2-yl)-4,7-diazadecane-1,10-diamine401-990-0106990-43-6Skin Sens. 1

Aquatic Chronic 2
H317

H411
GHS07

GHS09

Wng
H317

H411
613-079-00-74-(1(or 4 or 5 or 6)-methyl-8,9,10-trinorborn-5-en-2-yl)pyridine, reaction mass of isomers402-520-7Acute Tox. 4 *

Acute Tox. 4 *

Skin Irrit. 2

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H312

H302

H315

H317

H400

H410
GHS07

GHS09

Wng
H312

H302

H315

H317

H410
613-080-00-23-(bis(2-ethylhexyl)aminomethyl)benzothiazole-2(3H)-thione402-540-6105254-85-1Skin Corr. 1B

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H314

H317

H400

H410
GHS05

GHS07

GHS09

Dgr
H314

H317

H410
613-081-00-81-butyl-2-methylpyridinium bromide402-680-826576-84-1Acute Tox. 4 *

Aquatic Chronic 3
H302

H412
GHS07

Wng
H302

H412
613-082-00-32-methyl-1-pentylpyridinium bromide402-690-2Acute Tox. 4 *

Acute Tox. 4 *

Aquatic Chronic 3
H312

H302

H412
GHS07

Wng
H312

H302

H412
613-083-00-92-(4-(3-(4-chlorophenyl)-2-pyrazolin-1-yl)phenylsulfonyl)ethyldimethylammonium formate402-120-2Skin Corr. 1B

STOT RE 2 *

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H314

H373 **

H317

H400

H410
GHS08

GHS05

GHS07

GHS09

Dgr
H314

H373 **

H317

H410
613-084-00-42-(4-(3-(4-chlorophenyl)-4,5-dihydropyrazolyl)phenylsulphonyl)ethyldimethylammonium hydrogen phosphonate402-490-5106359-93-7Eye Irrit. 2

Aquatic Acute 1

Aquatic Chronic 1
H319

H400

H410
GHS07

GHS09

Wng
H319

H410
613-085-00-Xreaction mass of 1,1'-(methylenebis(4,1-phenylene))dipyrrole-2,5-dione and N-(4-(4-(2,5-dioxopyrrol-1-yl)benzyl)phenyl)acetamide and 1-(4-(4-(5-oxo-2H-2-furylidenamino)benzyl)phenyl)pyrrole-2,5-dione401-970-1Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H317

H400

H410
GHS07

GHS09

Wng
H317

H410
613-086-00-5caffeine200-362-158-08-2Acute Tox. 4 *H302GHS07

Wng
H302
613-087-00-0tetrahydrothiophene203-728-9110-01-0Flam. Liq. 2

Acute Tox. 4 *

Acute Tox. 4 *

Acute Tox. 4 *

Eye Irrit. 2

Skin Irrit. 2

Aquatic Chronic 3
H225

H332

H312

H302

H319

H315

H412
GHS02

GHS07

Dgr
H225

H332

H312

H302

H319

H315

H412
613-088-00-61,2-benzisothiazol-3(2H)-one;

1,2-benzisothiazolin-3-one
220-120-92634-33-5Acute Tox. 4 *

Skin Irrit. 2

Eye Dam. 1

Skin Sens. 1

Aquatic Acute 1
H302

H315

H318

H317

H400
GHS05

GHS07

GHS09

Dgr
H302

H315

H318

H317

H400
Skin Sens. 1; H317: C ≥ 0,05 %
613-089-00-1diquat dibromide; [1]

diquat dichloride; [2]

6,7-dihydrodipyrido[1,2-α:2',1'-c]pyrazinediylium dihydroxide [3]
201-579-4 [1]

223-714-6 [2]

301-467-6 [3]
85-00-7 [1]

4032-26-2 [2]

94021-76-8 [3]
Acute Tox. 2 *

STOT RE 1

Acute Tox. 4 *

Eye Irrit. 2

STOT SE 3

Skin Irrit. 2

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H330

H372 **

H302

H319

H335

H315

H317

H400

H410
GHS06

GHS08

GHS09

Dgr
H330

H372 **

H302

H319

H335

H315

H317

H410
613-090-00-7paraquat dichloride;

1,1-dimethyl-4,4'-bipyridinium dichloride; [1]

paraquat dimethylsulfate;

1,1-dimethyl-4,4'-bipyridinium dimethyl sulphate [2]
217-615-7 [1]

218-196-3 [2]
1910-42-5 [1]

2074-50-2 [2]
Acute Tox. 2 *

Acute Tox. 3 *

Acute Tox. 3 *

STOT RE 1

Eye Irrit. 2

STOT SE 3

Skin Irrit. 2

Aquatic Acute 1

Aquatic Chronic 1
H330

H311

H301

H372 **

H319

H335

H315

H400

H410
GHS06

GHS08

GHS09

Dgr
H330

H311

H301

H372 **

H319

H335

H315

H410
613-091-00-2morfamquat dichloride; [1]

morfamquat sulfate [2]
225-062-8 [1]

[2]
4636-83-3 [1]

29873-36-7 [2]
Acute Tox. 4 *

Eye Irrit. 2

STOT SE 3

Skin Irrit. 2

Aquatic Chronic 3
H302

H319

H335

H315

H412
GHS07

Wng
H302

H319

H335

H315

H412
613-092-00-81,10-phenanthroline200-629-266-71-7Acute Tox. 3 *

Aquatic Acute 1

Aquatic Chronic 1
H301

H400

H410
GHS06

GHS09

Dgr
H301

H410
613-093-00-3hexasodium 6,13-dichloro-3,10-bis((4-(2,5-disulfonatoanilino)-6-fluoro-1,3,5-triazin-2-ylamino)prop-3-ylamino)-5,12-dioxa-7,14-diazapentacene-4,11-disulfonate400-050-785153-92-0Resp. Sens. 1

Skin Sens. 1
H334

H317
GHS08

Dgr
H334

H317
613-094-00-94-methoxy-N,6-dimethyl-1,3,5-triazin-2-ylamine401-360-55248-39-5Acute Tox. 4 *

STOT RE 2 *
H302

H373 **
GHS08

GHS07

Wng
H302

H373 **
613-095-00-4sodium 3-(2H-benzotriazol-2-yl)-5-sec-butyl-4-hydroxybenzenesulfonate403-080-992484-48-5Eye Dam. 1H318GHS05

Dgr
H318
613-096-00-X2-amino-6-ethoxy-4-methylamino-1,3,5-triazine403-580-762096-63-3Acute Tox. 4 *H302GHS07

Wng
H302
613-097-00-57-amino-3-((5-carboxymethyl-4-methyl-1,3-thiazol-2-ylthio)methyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid403-690-5111298-82-9Resp. Sens. 1

Skin Sens. 1

Aquatic Chronic 3
H334

H317

H412
GHS08

Dgr
H334

H317

H412
613-098-00-0N-(n-octyl)-2-pyrrolidone403-700-82687-94-7Skin Corr. 1B

Aquatic Chronic 2
H314

H411
GHS05

GHS09

Dgr
H314

H411
613-099-00-61-dodecyl-2-pyrrolidone403-730-12687-96-9Skin Corr. 1B

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H314

H317

H400

H410
GHS05

GHS07

GHS09

Dgr
H314

H317

H410
613-100-00-X2,9-bis(3-(diethylamino)propylsulfamoyl)quino(2,3-b)acridine-7,14-dione404-230-6Skin Sens. 1

Aquatic Chronic 4
H317

H413
GHS07

Wng
H317

H413
613-101-00-5N—tert-pentyl-2-benzothiazolesulfenamide404-380-2110799-28-5Skin Sens. 1

Aquatic Chronic 3
H317

H412
GHS07

Wng
H317

H412
613-102-00-0dimethomorph (ISO);

4-(3-(4-chlorophenyl)-3-(3,4-dimethoxyphenyl)acryloyl)morpholine
404-200-2110488-70-5Aquatic Chronic 2H411GHS09H411
613-103-00-6sodium 5-n-butylbenzotriazole404-450-2118685-34-0Acute Tox. 4 *

Skin Corr. 1B

Skin Sens. 1

Aquatic Chronic 2
H302

H314

H317

H411
GHS05

GHS07

GHS09

Dgr
H302

H314

H317

H411
613-104-00-15-tert-butyl-3-isoxazolylamine hydrochloride404-840-2Acute Tox. 4 *

STOT RE 2 *

Eye Dam. 1

Aquatic Chronic 3
H302

H373 **

H318

H412
GHS08

GHS05

GHS07

Dgr
H302

H373 **

H318

H412
613-105-00-7hexakis(tetramethylammonium) 4,4'-vinylenebis((3-sulfonato-4,1-phenylene)imino(6-morpholino-1,3,5-triazine-4,2-diyl)imino)bis(5-hydroxy-6-phenylazonaphthalene-2,7-disulfonate)405-160-9124537-30-0Acute Tox. 3 *

Skin Sens. 1

Aquatic Chronic 3
H301

H317

H412
GHS06

Dgr
H301

H317

H412
613-106-00-2tetrapotassium 2-(4-(5-(1-(2,5-disulfonatophenyl)-3-ethoxycarbonyl-5-hydroxypyrazol-4-yl)penta-2,4-dienylidene)-3-ethoxycarbonyl-5-oxo-2-pyrazolin-1-yl)benzene-1,4-disulfonate405-240-3Skin Sens. 1H317GHS07

Wng
H317
613-107-00-8hexasodium 2,2'-vinylenebis((3-sulfonato-4,1-phenylene)imino(6-(N-cyanoethyl-N-(2-hydroxypropyl)amino)-1,3,5-triazine-4,2-diyl)imino)dibenzene-1,4-disulfonate405-280-176508-02-6Eye Irrit. 2H319GHS07

Wng
H319
613-108-00-3benzothiazole-2-thiol205-736-8149-30-4Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H317

H400

H410
GHS07

GHS09

Wng
H317

H410
613-109-00-9bis(piperidinothiocarbonyl) disulphide202-328-194-37-1Eye Irrit. 2

STOT SE 3

Skin Irrit. 2

Skin Sens. 1
H319

H335

H315

H317
GHS07

Wng
H319

H335

H315

H317
613-110-00-4dimepiperate (ISO);

S-(1-methyl-1-phenylethyl) piperidine-1-carbothioate
262-784-261432-55-1Acute Tox. 4 *

Aquatic Chronic 2
H302

H411
GHS07

GHS09

Wng
H302

H411
613-111-00-X1,2,4-triazole206-022-9288-88-0Repr. 2

Acute Tox. 4 *

Eye Irrit. 2
H361d ***

H302

H319
GHS08

GHS07

Wng
H361d ***

H302

H319
613-112-00-5octhilinone (ISO);

2-octyl-2H-isothiazol-3-one
247-761-726530-20-1Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 4 *

Skin Corr. 1B

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H331

H311

H302

H314

H317

H400

H410
GHS06

GHS05

GHS09

Dgr
H331

H311

H302

H314

H317

H410
Skin Sens. 1; H317: C ≥ 0,05 %
613-113-00-02-(morpholinothio)benzothiazole203-052-4102-77-2Eye Irrit. 2

Skin Irrit. 2

Skin Sens. 1

Aquatic Chronic 2
H319

H315

H317

H411
GHS07

GHS09

Wng
H319

H315

H317

H411
613-114-00-62,2',2"-(hexahydro-1,3,5-triazine-1,3,5-triyl)triethanol;

1,3,5-tris(2-hydroxyethyl)hexahydro-1,3,5-triazine
225-208-04719-04-4Acute Tox. 4 *

Skin Sens. 1
H302

H317
GHS07

Wng
H302

H317
Skin Sens. 1; H317: C ≥ 0,1 %
613-115-00-1hymexazol (ISO);

3-hydroxy-5-methylisoxazole
233-000-610004-44-1Acute Tox. 4 *

Eye Dam. 1

Aquatic Chronic 3
H302

H318

H412
GHS05

GHS07

Dgr
H302

H318

H412
613-116-00-7tolylfluanid (ISO);

dichloro-N-[(dimethylamino)sulphonyl]fluoro-N-(p-tolyl)methanesulphenamide
211-986-9731-27-1Acute Tox. 3 *

STOT RE 2 *

Eye Irrit. 2

STOT SE 3

Skin Irrit. 2

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H331

H373 **

H319

H335

H315

H317

H400

H410
GHS06

GHS08

GHS09

Dgr
H331

H373 **

H319

H335

H315

H317

H410
613-117-00-2diniconazole (ISO);

(E)-β-[(2,4-dichlorophenyl)methylene]-α-(1,1-dimethylethyl)-1H—1,2,4-triazol-1-ethanol;

(E)-(RS)-1-(2,4-dichlorophenyl)-4,4-dimethyl-2-(1H—1,2,4-triazol-1-yl)pent-1-en-3-ol
76714-88-0Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1
H302

H400

H410
GHS07

GHS09

Wng
H302

H410
613-118-00-8flubenzimine (ISO);

N-[3-phenyl-4,5-bis[(trifluoromethyl)imino]thiazolidin-2-ylidene]aniline
253-703-137893-02-0Eye Irrit. 2

Aquatic Acute 1

Aquatic Chronic 1
H319

H400

H410
GHS07

GHS09

Wng
H319

H410
613-119-00-3(benzothiazol-2-ylthio)methyl thiocyanate;

TCMTB
244-445-021564-17-0Acute Tox. 2 *

Acute Tox. 4 *

Eye Irrit. 2

Skin Irrit. 2

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H330

H302

H319

H315

H317

H400

H410
GHS06

GHS09

Dgr
H330

H302

H319

H315

H317

H410
613-120-00-9bioresmethrin;

(5-bezylfur-3-yl)methyl(1R)-trans-2,2-dimethyl-3-(2-methylpropenyl)cyclopropanecarboylate
249-014-028434-01-7Aquatic Acute 1

Aquatic Chronic 1
H400

H410
GHS09

Wng
H410
613-121-00-4chlorsulfuron (ISO);

2-chloro-N-[[(4-methoxy-6-methyl-1,3,5-triazin-2-yl)amino]carbonyl]benzenesulphonamide
265-268-564902-72-3Aquatic Acute 1

Aquatic Chronic 1
H400

H410
GHS09

Wng
H410
613-122-00-Xdiclobutrazole (ISO);

(R*, R*)-(±)-β-[(2,4-dichlorophenyl)methyl]-α-(1,1-dimethylethyl)-1H-1,2,4-triazole-1-ethanol;

(2RS, 3RS)-1-(2,4-dichlorophenyl)-4,4-dimethyl-2-(1H—1,2,4-triazol-1yl)pentan-3-ol
75736-33-3Eye Irrit. 2

Aquatic Chronic 2
H319

H411
GHS07

GHS09

Wng
H319

H411
613-123-00-55,6-dihydro-3H-imidazo[2,1-c]-1,2,4-dithiazole-3-thione;

etem
251-684-433813-20-6Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1
H302

H400

H410
GHS07

GHS09

Wng
H302

H410
613-124-00-0fenpropimorph (ISO);

cis-4-[3-(p-tert-butylphenyl)-2-methylpropyl]-2,6-dimethylmorpholine
266-719-967564-91-4Repr. 2

Acute Tox. 4 *

Skin Irrit. 2

Aquatic Chronic 2
H361d ***

H302

H315

H411
GHS08

GHS07

GHS09

Wng
H361d ***

H302

H315

H411
613-125-00-6hexythiazox(ISO);

trans-5-(4-chlorophenyl)-N-cyclohexyl-4-methyl-2-oxo-3-thiazolidine-carboxamide
78587-05-0Aquatic Acute 1

Aquatic Chronic 1
H400

H410
GHS09

Wng
H410
613-126-00-1imazapyr (ISO);

2-[4,5-dihydro-4-methyl-4-(1-methylethyl)-5-oxo-1H-imidazol-2-yl]-3-pyridine carboxylate
81334-34-1Eye Irrit. 2

Aquatic Chronic 3
H319

H412
GHS07

Wng
H319

H412
613-127-00-71,1-dimethylpiperidinium chloride;

mepiquat chloride
246-147-624307-26-4Acute Tox. 4 *

Aquatic Chronic 3
H302

H412
GHS07

Wng
H302

H412
613-128-00-2prochloraz (ISO);

N-propyl-N-[2-(2,4,6-trichlorophenoxy)ethyl]-1H-imidazole-1-carboxamide
266-994-567747-09-5Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1
H302

H400

H410
GHS07

GHS09

Wng
H302

H410
613-129-00-8metamitron (ISO);

4-amino-3-methyl-6-phenyl-1,2,4-triazin-5-one
255-349-341394-05-2Acute Tox. 4 *

Aquatic Acute 1
H302

H400
GHS07

GHS09

Wng
H302

H400
613-131-00-9pyroquilon (ISO);

1,2,5,6-tetrahydropyrrolo[3,2,1-ij]quinolin-4-one
57369-32-1Acute Tox. 4 *

Aquatic Chronic 3
H302

H412
GHS07

Wng
H302

H412
613-132-00-4hexazinone (ISO);

3-cyclohexyl-6-dimethylamino-1-methyl-1,2,3,4-tetrahydro-1,3,5-triazine-2,4-dione
257-074-451235-04-2Acute Tox. 4 *

Eye Irrit. 2

Aquatic Acute 1

Aquatic Chronic 1
H302

H319

H400

H410
GHS07

GHS09

Wng
H302

H319

H410
613-133-00-Xetridiazole (ISO);

5-ethoxy-3-trichloromethyl-1,2,4-thiadiazole
219-991-82593-15-9Carc. 2

Acute Tox. 3 *

Acute Tox. 4 *

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1
H351

H331

H312

H302

H400

H410
GHS06

GHS08

GHS09

Dgr
H351

H331

H312

H302

H410
613-134-00-5myclobutanil(ISO);

2-(4-chlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)hexanenitrile
88671-89-0Repr. 2

Acute Tox. 4 *

Eye Irrit. 2

Aquatic Chronic 2
H361d ***

H302

H319

H411
GHS08

GHS07

GHS09

Wng
H361d ***

H302

H319

H411
613-135-00-0di(benzothiazol-2-yl) disulphide204-424-9120-78-5Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H317

H400

H410
GHS07

GHS09

Wng
H317

H410
EUH031
613-136-00-6N-cyclohexylbenzothiazole-2-sulphenamide202-411-295-33-0Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H317

H400

H410
GHS07

GHS09

Wng
H317

H410
613-137-00-1methabenzthiazuron (ISO);

1-(1,3-benzothiazol-2-yl)1,3-dimethylurea
242-505-018691-97-9Aquatic Acute 1

Aquatic Chronic 1
H400

H410
GHS09

Wng
H410
613-138-00-7quinoxyfen (ISO);

5,7-dichloro-4-(4-fluorophenoxy)quinoline
124495-18-7Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H317

H400

H410
GHS07

GHS09

Wng
H317

H410
613-139-00-2metsulfuron-methyl;

2-(4-methoxy-6-methyl-1,3,5-triazin-2-ylcarbamoylsulfamoyl) benzoic acid
74223-64-6Aquatic Acute 1

Aquatic Chronic 1
H400

H410
GHS09

Wng
H410
613-140-00-8cycloheximide (ISO);

4-{(2R)-2-[(1S,3S,5S)-3,5-dimethyl-2-oxocyclohexyl]-2-hydroxyethyl}piperidine-2,6-dione
200-636-066-81-9Muta. 2

Repr. 1B

Acute Tox. 2 *

Aquatic Chronic 2
H341

H360D ***

H300

H411
GHS06

GHS08

GHS09

Dgr
H341

H360D ***

H300

H411
613-141-00-31,4-diamino-2-(2-butyltetrazol-5-yl)-3-cyanoanthraquinone401-470-393686-63-6Aquatic Chronic 4H413H413
613-142-00-9trans—N-methyl-2-styryl-[4'-aminomethine-(1-acetyl-1-(2-methoxyphenyl)acetamido)]pyridinium acetate405-860-4Skin Sens. 1

Aquatic Chronic 2
H317

H411
GHS07

GHS09

Wng
H317

H411
613-143-00-41-(3-phenylpropyl)-2-methylpyridinium bromide405-930-410551-42-5Acute Tox. 4 *

Eye Irrit. 2

Aquatic Chronic 3
H302

H319

H412
GHS07

Wng
H302

H319

H412
613-144-00-Xreaction products of: poly(vinyl acetate), partially hydrolyzed, with (E)-2-(4-formylstyryl)-3,4-dimethylthiazoliummethyl sulfate406-460-2125139-08-4Aquatic Chronic 3H412H412
613-145-00-5(S)-3-benzyloxycarbonyl-1,2,3,4-tetrahydro-isoquinolinium 4-methylbenzenesulfonate406-960-077497-97-3Aquatic Chronic 2H411GHS09H411
613-146-00-0N-ethyl-N-methylpiperidinium iodide407-780-54186-71-4Acute Tox. 4 *

Aquatic Chronic 2
H302

H411
GHS07

GHS09

Wng
H302

H411
613-147-00-64-[2-(1-methyl-2-(4-morpholinyl)ethoxy)ethyl]morpholine407-940-4111681-72-2Eye Dam. 1H318GHS05

Dgr
H318
613-148-00-1tetrasodium 1,2-bis(4-fluoro-6-[5-(1-amino-2-sulfonatoanthrachinon-4-ylamino)-2,4,6-trimethyl-3-sulfonatophenylamino]-1,3,5-triazin-2-ylamino)ethane411-240-4143683-23-2Skin Sens. 1

Aquatic Chronic 3
H317

H412
GHS07

Wng
H317

H412
613-149-00-7pyridaben (ISO);

2-tert-butyl-5-(4-tert-butylbenzylthio)-4-chloropyridazin-3(2H)-one
405-700-396489-71-3Acute Tox. 3 *

Acute Tox. 3 *

Aquatic Acute 1

Aquatic Chronic 1
H331

H301

H400

H410
GHS06

GHS09

Dgr
H331

H301

H410
613-150-00-22,2'-[3,3'-(piperazine-1,4-diyl)dipropyl]bis(1H-benzimidazo[2,1—b]benzo[l,m,n][3,8]phenanthroline-1,3,6-trione406-295-6Aquatic Chronic 4H413H413
613-151-00-81-(3-mesyloxy-5-trityloxymethyl-2-D-threofuryl)thymine406-360-9104218-44-2Aquatic Chronic 4H413H413
613-152-00-3phenyl N-(4,6-dimethoxypyrimidin-2-yl)carbamate406-600-289392-03-0Skin Sens. 1

Aquatic Chronic 2
H317

H411
GHS07

GHS09

Wng
H317

H411
613-153-00-92,3,5-trichloropyridine407-270-216063-70-0Aquatic Chronic 3H412H412
613-154-00-42-amino-4-chloro-6-methoxypyrimidine410-050-95734-64-5Acute Tox. 4 *H302GHS07

Wng
H302
613-155-00-X5-chloro-2,3-difluoropyridine410-090-789402-43-7Flam. Liq. 3

Acute Tox. 4 *

Aquatic Chronic 3
H226

H302

H412
GHS02

GHS07

Wng
H226

H302

H412
613-156-00-52-butyl-4-chloro-5-formylimidazole410-260-083857-96-9Skin Sens. 1

Aquatic Chronic 2
H317

H411
GHS07

GHS09

Wng
H317

H411
613-157-00-02,4-diamino-5-methoxymethylpyrimidine410-330-054236-98-5Acute Tox. 4 *

STOT RE 2 *

Eye Irrit. 2
H302

H373 **

H319
GHS08

GHS07

Wng
H302

H373 **

H319
613-158-00-62,3-dichloro-5-trifluoromethyl-pyridine410-340-569045-84-7Acute Tox. 4 *

Acute Tox. 4 *

Eye Dam. 1

Skin Sens. 1

Aquatic Chronic 2
H332

H302

H318

H317

H411
GHS05

GHS07

GHS09

Dgr
H332

H302

H318

H317

H411
613-159-00-1fenazaquin (ISO);

4-[2-[4-(1,1-dimethylethyl)phenyl]-ethoxy]quinazoline
410-580-0120928-09-8Acute Tox. 3 *

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1
H301

H332

H400

H410
GHS06

GHS09

Dgr
H301

H332

H410
613-160-00-7(1S)-2-methyl-2,5-diazobicyclo[2.2.1]heptane dihydrobromide411-000-9125224-62-6Skin Sens. 1H317GHS07

Wng
H317
613-163-00-3azimsulfuron (ISO);

1-(4,6-dimethoxypyrimidin-2-yl)-3-[1-methyl-4-(2-methyl-2H-tetrazol-5-yl)pyrazol-5-ylsulfonyl]urea
120162-55-2Aquatic Acute 1

Aquatic Chronic 1
H400

H410
GHS09

Wng
H410
613-164-00-9flufenacet (ISO);

N-(4-fluorophenyl)-N-isopropyl-2-(5-trifluoromethyl-[1,3,4]thiadiazol-2-yloxy)acetamide
142459-58-3Acute Tox. 4 *

STOT RE 2 *

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H302

H373 **

H317

H400

H410
GHS08

GHS07

GHS09

Wng
H302

H373 **

H317

H410
613-165-00-4flupyrsulfuron-methyl-sodium (ISO);

methyl 2-[[(4,6-dimethoxypyrimidin-2-ylcarbamoyl)sulfamoyl]-6-trifluoromethyl]nicotinate, monosodium salt
144740-54-5Aquatic Acute 1

Aquatic Chronic 1
H400

H410
GHS09

Wng
H410
613-166-00-Xflumioxazin (ISO);

N-(7-fluoro-3,4-dihydro-3-oxo-4-prop-2-ynyl-2H—1,4-benzoxazin-6-yl)cyclohex-1-ene-1,2-dicarboxamide
103361-09-7Repr. 1B

Aquatic Acute 1

Aquatic Chronic 1
H360D ***

H400

H410
GHS08

GHS09

Dgr
H360D ***

H410
613-167-00-5reaction mass of: 5-chloro-2-methyl-4-isothiazolin-3-one [EC no. 247-500-7]

and 2-methyl-2H -isothiazol-3-one [EC no. 220-239-6] (3:1);

reaction mass of: 5-chloro-2-methyl-4-isothiazolin-3-one [EC no. 247-500-7]

and 2-methyl-4-isothiazolin-3-one [EC no. 220-239-6] (3:1)
55965-84-9Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *

Skin Corr. 1B

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H331

H311

H301

H314

H317

H400

H410
GHS06

GHS05

GHS09

Dgr
H331

H311

H301

H314

H317

H410
Skin Corr. 1B; H314: C ≥ 0,6 %

Skin Irrit. 2; H315: 0,06 % ≤ C < 0,6 %

Eye Irrit. 2; H319: 0,06 % ≤ C < 0,6 %

Skin Sens. 1; H317: C ≥ 0,0015 %
613-168-00-01-vinyl-2-pyrrolidone201-800-488-12-0Carc. 2

Acute Tox. 4 *

Acute Tox. 4 *

Acute Tox. 4 *

STOT RE 2 *

STOT SE 3

Eye Dam. 1
H351

H332

H312

H302

H373 **

H335

H318
GHS06

GHS05

GHS09

Dgr
H351

H332

H312

H302

H373 **

H335

H318
D
613-169-00-69-vinylcarbazole216-055-01484-13-5Muta. 2

Acute Tox. 4 *

Acute Tox. 4 *

Skin Irrit. 2

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H341

H312

H302

H315

H317

H400

H410
GHS08

GHS07

GHS09

Wng
H341

H312

H302

H315

H317

H410
613-170-00-12,2-ethylmethylthiazolidine404-500-3694-64-4Acute Tox. 4 *

Eye Dam. 1

Skin Sens. 1

Aquatic Chronic 2
H302

H318

H317

H411
GHS05

GHS07

GHS09

Dgr
H302

H318

H317

H411
613-171-00-7hexaconazole (ISO);

(RS)-2-(2,4-dichlorophenyl)-1-(1H-1,2,4-triazol-1-yl)hexan-2-ol
413-050-779983-71-4Acute Tox. 4 *

Skin Sens. 1

Aquatic Chronic 2
H302

H317

H411
GHS07

GHS09

Wng
H302

H317

H411
613-172-00-25-chloro-1,3-dihydro-2H-indol-2-one412-200-917630-75-0Repr. 2

Acute Tox. 4 *

Skin Sens. 1

Aquatic Chronic 3
H361f ***

H302

H317

H412
GHS08

GHS07

Wng
H361f ***

H302

H317

H412
613-173-00-8fluquinconazole (ISO);

3-(2,4-dichlorophenyl)-6-fluoro-2-(1H-1,2,4-triazol-1-yl)quinazolin-4-(3H)-one
411-960-9136426-54-5Acute Tox. 3 *

Acute Tox. 3 *

STOT RE 1

Acute Tox. 4 *

Skin Irrit. 2

Aquatic Acute 1

Aquatic Chronic 1
H331

H301

H372 **

H312

H315

H400

H410
GHS06

GHS08

GHS09

Dgr
H331

H301

H372 **

H312

H315

H410
613-174-00-3(±) 2-(2,4-dichlorophenyl)-3-(1H-1,2,4-triazol-1-yl)propyl-1,1,2,2-tetrafluoroethylether407-760-6112281-77-3Carc. 2

Acute Tox. 4 *

Acute Tox. 4 *

Aquatic Chronic 2
H351

H332

H302

H411
GHS08

GHS07

GHS09

Wng
H351

H332

H302

H411
613-175-00-9epoxiconazole(ISO);

(2RS,3SR)-3-(2-chlorophenyl)-2-(4-fluorophenyl)-[(1H-1,2,4-triazol-1-yl)methyl]oxirane
406-850-2133855-98-8Carc. 2

Repr. 2

Aquatic Chronic 2
H351

H361fd

H411
GHS08

GHS09

Wng
H351

H361fd

H411
613-176-00-42-methyl-2-azabicyclo[2.2.1]heptane404-810-94524-95-2Flam. Liq. 3

Acute Tox. 4 *

Acute Tox. 4 *

STOT RE 2 *

Skin Corr. 1B
H226

H312

H302

H373 **

H314
GHS02

GHS08

GHS05

GHS07

Dgr
H226

H312

H302

H373 **

H314
613-177-00-X8-amino-7-methylquinoline412-760-45470-82-6Acute Tox. 4 *

Acute Tox. 4 *

Skin Sens. 1

Aquatic Chronic 2
H312

H302

H317

H411
GHS07

GHS09

Wng
H312

H302

H317

H411
613-178-00-54-ethyl-2-methyl-2-isopentyl-1,3-oxazolidine410-470-2137796-06-6Skin Corr. 1B

Skin Sens. 1
H314

H317
GHS05

GHS07

Dgr
H314

H317
STOT SE 3; H335: C ≥ 5 %
613-179-00-0lithium 3-oxo-1,2(2H)-benzisothiazol-2-ide411-690-1111337-53-2Acute Tox. 4 *

Skin Corr. 1B

Skin Sens. 1

Aquatic Chronic 2
H302

H314

H317

H411
GHS05

GHS07

Dgr
H302

H314

H317

H411
613-180-00-6N-(1,1-dimethylethyl)bis(2-benzothiazolesulfen)amide407-430-13741-80-8Aquatic Acute 1

Aquatic Chronic 1
H400

H410
GHS09

Wng
H410
613-181-00-15,5-dimethyl-perhydro-pyrimidin-2-one α-(4-trifluoromethylstyryl)-α-(4-trifluoromethyl)cinnamylidenehydrazone405-090-967485-29-4STOT RE 1

Acute Tox. 4 *

Eye Irrit. 2

Aquatic Acute 1

Aquatic Chronic 1
H372 **

H302

H319

H400

H410
GHS08

GHS07

GHS09

Dgr
H372 **

H302

H319

H410
613-182-00-71-(1-naphthylmethyl)quinolinium chloride406-220-765322-65-8Carc. 2

Muta. 2

Acute Tox. 4 *

Skin Irrit. 2

Eye Dam. 1

Aquatic Chronic 3
H351

H341

H302

H315

H318

H412
GHS08

GHS05

GHS07

Dgr
H351

H341

H302

H315

H318

H412
613-183-00-2reaction mass of: 5-(N-methylperfluorooctylsulfonamido)methyl-3-octadecyl-1,3-oxazolidin-2-one;

5-(N-methylperfluoroheptylsulfonamido)methyl-3-octadecyl-1,3-oxazolidin-2-one
413-640-4STOT RE 2 *

Aquatic Acute 1

Aquatic Chronic 1
H373 **

H400

H410
GHS08

GHS09

Wng
H373 **

H410
613-184-00-8nitrilotriethyleneammoniopropane-2-ol 2-ethylhexanoate413-670-8Eye Irrit. 2

Skin Sens. 1
H319

H317
GHS07

Wng
H319

H317
613-185-00-32,3,5,6-tetrahydro-2-methyl-2H-cyclopenta[d]-1,2-thiazol-3-one407-630-982633-79-2Acute Tox. 3 *

Eye Dam. 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H301

H318

H317

H400

H410
GHS06

GHS05

GHS09

Dgr
H301

H318

H317

H410
613-186-00-9(2R,3R)-3-((R)-1-(tert-butyldimethylsiloxy)ethyl)-4-oxoazetidin-2-yl acetate408-050-976855-69-1Eye Irrit. 2

Skin Sens. 1

Aquatic Chronic 2
H319

H317

H411
GHS07

GHS09

Wng
H319

H317

H411
613-188-00-X1-(3-(4-fluorophenoxy)propyl)-3-methoxy-4-piperidinone411-500-7116256-11-2Acute Tox. 4 *

Eye Dam. 1

Skin Sens. 1

Aquatic Chronic 2
H302

H318

H317

H411
GHS05

GHS07

GHS09

Dgr
H302

H318

H317

H411
613-189-00-51,4,7,10-tetrakis(p-toluensulfonyl)-1,4,7,10-tetraazacyclododecane414-030-052667-88-6Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H317

H400

H410
GHS07

GHS09

Wng
H317

H410
613-190-00-0disodium 1-amino-4-(2-(5-chloro-6-fluoro-pyrimidin-4-ylamino-methyl)-4-methyl-6-sulfo-phenylamino)-9,10-dioxo-9,10-dihydro-anthracene-2-sulfonate414-040-5149530-93-8Acute Tox. 4 *

Skin Sens. 1
H302

H317
GHS07

Wng
H302

H317
613-191-00-63-ethyl-2-methyl-2-(3-methylbutyl)-1,3-oxazolidine421-150-7143860-04-2Repr. 1B

Skin Corr. 1B

Aquatic Acute 1

Aquatic Chronic 1
H360F ***

H314

H400

H410
GHS08

GHS05

GHS09

Dgr
H360F ***

H314

H410
613-193-00-7pentakis[3-(dimethylammonio)propylsulfamoyl]-[(6-hydroxy-4,4,8,8-tetramethyl-4,8-diazoniaundecane-1,11-diyldisulfamoyl)di[phthalocyaninecopper(II)]] heptalactate414-930-3Aquatic Chronic 2H411GHS09H411
613-194-00-26,13-dichloro-3,10-bis{2-[4-fluoro-6-(2-sulfophenylamino)-1,3,5-triazin-2-ylamino]propylamino}benzo[5,6][1,4]oxazino[2,3-.b.]phenoxazine-4,11-disulphonic acid, lithium-, sodium salt418-000-8163062-28-0Eye Dam. 1H318GHS05

Dgr
H318
613-195-00-82,2-(1,4-phenylene)bis((4H—3,1-benzoxazine-4-one)418-280-118600-59-4Skin Sens. 1

Aquatic Chronic 4
H317

H413
GHS07

Wng
H317

H413
613-196-00-35-[[4-chloro-6-[[2-[[4-fluoro-6-[[5-hydroxy-6-[(4-methoxy-2-sulfophenyl)azo]-7-sulfo-2-naphthalenyl]amino]-1,3,5-triazin-2-yl]amino]-1-methylethyl]amino]-1,3,5-triazin-2-yl]amino]-3-[[4-(ethenylsulfonyl)phenyl]azo]-4-hydroxy-naphtalene-2,7-disulfonic acid, sodium salt418-380-5168113-78-8Eye Dam. 1H318GHS05

Dgr
H318
613-197-00-9reaction mass of: 2,4,6-tri(butylcarbamoyl)-1,3,5-triazine;

2,4,6-tri(methylcarbamoyl)-1,3,5-triazine;

[(2-butyl-4,6-dimethyl)tricarbamoyl]-1,3,5-triazine;

[(2,4-dibutyl-6-methyl)tricarbamoyl]-1,3,5-triazine
420-390-1187547-46-2Skin Sens. 1

Aquatic Chronic 2
H317

H411
GHS07

GHS09

Wng
H317

H411
613-199-00-Xreaction mass of: 1,3,5-tris(3-aminomethylphenyl)-1,3,5-(1H,3H,5H)-triazine-2,4,6-trione;

reaction mass of oligomers of 3,5-bis(3-aminomethylphenyl)-1-poly[3,5-bis(3-aminomethylphenyl)-2,4,6-trioxo-1,3,5-(1H,3H,5H)-triazin-1-yl]-1,3,5-(1H,3H,5H)-triazine-2,4,6-trione
421-550-1Carc. 1B

Repr. 1B

Skin Sens. 1

Aquatic Chronic 3
H350

H360D ***

H317

H412
GHS08

Dgr
H350

H360D ***

H317

H412
613-200-00-3Reaction product of: copper, (29H,31H-phthalocyaninato(2-)-N29,N30,N31,N32)-, chlorosulfuric acid and 3-(2-sulfooxyethylsulfonyl)aniline, sodium salts420-980-7Eye Dam. 1H318GHS05

Dgr
H318
613-201-00-9(R)-5-bromo-3-(1-methyl-2-pyrrolidinyl methyl)-1H-indole422-390-5143322-57-0Repr. 2

STOT RE 1

Acute Tox. 4 *

Acute Tox. 4 *

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H361f ***

H372 **

H332

H302

H317

H400

H410
GHS08

GHS07

GHS09

Dgr
H361f ***

H372 **

H332

H302

H317

H410
EUH070
613-202-00-4pymetrozine (ISO);

(E)-4,5-dihydro-6-methyl-4-(3-pyridylmethyleneamino)-1,2,4-triazin-3(2H)-one
123312-89-0Carc. 2

Aquatic Chronic 3
H351

H412
GHS08

Wng
H351

H412
613-203-00-Xpyraflufen-ethyl; [1]

pyraflufen [2]
-[1]

-[2]
129630-19-9 [1]

129630-17-7 [2]
Aquatic Acute 1

Aquatic Chronic 1
H400

H410
GHS09

Wng
H410
613-204-00-5oxadiargyl (ISO);

3-[2,4-dichloro-5-(2-propynyloxy)phenyl]-5-(1,1-dimethylethyl)-1,3,4-oxadiazol-2(3H)-one;

5-tert-butyl-3-[2,4-dichloro-5-(prop-2-ynyloxy)phenyl]-1,3,4-oxadiazol-2(3H)-one
254-637-639807-15-3Repr. 2

STOT RE 2 *

Aquatic Acute 1

Aquatic Chronic 1
H361d ***

H373 **

H400

H410
GHS08

GHS09

Wng
H361d ***

H373 **

H410
613-205-00-0propiconazole(ISO);

(±) 1-[2-(2,4-dichlorophenyl)-4-propyl-1,3-dioxolan-2-ylmethyl]-1H—1,2,4-triazole
262-104-460207-90-1Acute Tox. 4 *

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H302

H317

H400

H410
GHS07

GHS09

Wng
H302

H317

H410
613-206-00-6fenamidone (ISO);

(S)-5-methyl-2-methylthio-5-phenyl-3-phenylamino-3,5-dihydroimidazol-4-one
161326-34-7Aquatic Acute 1

Aquatic Chronic 1
H400

H410
GHS09

Wng
H410
613-208-00-7imazamox (ISO);

(RS)-2-(4-isopropyl-4-methyl-5-oxo-2-imidazolin-2-yl)-5-methoxymethylnicotinic acid
114311-32-9Aquatic Acute 1

Aquatic Chronic 1
H400

H410
GHS09

Wng
H410
613-209-00-2cis-1-(3-chloropropyl)-2,6-dimethyl-piperidin hydrochloride417-430-363645-17-0Acute Tox. 3 *

STOT RE 2 *

Skin Sens. 1

Aquatic Chronic 2
H301

H373 **

H317

H411
GHS06

GHS08

GHS09

Dgr
H301

H373 **

H317

H411
613-210-00-82-(3-chloropropyl)-2,5,5-trimethyl-1,3-dioxane417-650-188128-57-8STOT RE 2 *

Aquatic Chronic 3
H373 **

H412
GHS08

Wng
H373 **

H412
613-211-00-3N-methyl-4-(p-formylstyryl)pyridinium methylsulfate418-240-374401-04-0Skin Sens. 1

Aquatic Chronic 3
H317

H412
GHS07

Wng
H317

H412
613-212-00-94-[4-(2-ethylhexyloxy)phenyl](1,4-thiazinane-1,1-dioxide)418-320-8133467-41-1Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1
H302

H400

H410
GHS07

GHS09

Wng
H302

H410
613-213-00-4cis-1-benzoyl-4-[(4-methylsulfonyl)oxy]-L-proline416-040-0120807-02-5Aquatic Chronic 3H412H412
613-214-00-XN,N-di-n-butyl-2-(1,2-dihydro-3-hydroxy-6-isopropyl-2-quinolylidene)-1,3-dioxoindan-5-carboxamide416-260-7147613-95-4Aquatic Chronic 4H413H413
613-215-00-52-chloromethyl-3,4-dimethoxypyridinium chloride416-440-572830-09-2Acute Tox. 4 *

Acute Tox. 4 *

STOT RE 2 *

Skin Irrit. 2

Eye Dam. 1

Skin Sens. 1

Aquatic Chronic 2
H312

H302

H373 **

H315

H318

H317

H411
GHS08

GHS05

GHS07

GHS09

Dgr
H312

H302

H373 **

H315

H318

H317

H411
613-216-00-06-tert-butyl-7-(6-diethylamino-2-methyl-3-pyridylimino)-3-(3-methylphenyl)pyrazolo[3,2-c][1,2,4]triazole416-490-8162208-01-7Aquatic Acute 1

Aquatic Chronic 1
H400

H410
GHS09

Wng
H410
613-217-00-64-[3-(3,5-di-tert-butyl-4-hydroxyphenyl)propionyloxy]-1-[2-[3-(3,5-di-tert-butyl-4-hydrophenyl)propionyloxy]ethyl]-2,2,6,6-tetramethylpiperidine416-770-173754-27-5Aquatic Chronic 4H413H413
613-218-00-16-hydroxyindole417-020-42380-86-1Acute Tox. 4 *

Eye Dam. 1

Skin Sens. 1

Aquatic Chronic 2
H302

H318

H317

H411
GHS05

GHS07

GHS09

Dgr
H302

H318

H317

H411
613-219-00-77a-ethyl-3,5-bis(1-methylethyl)-2,3,4,5-tetrahydrooxazolo[3,4-c]-2,3,4,5-tetrahydrooxazole417-140-779185-77-6Skin Irrit. 2

Aquatic Chronic 2
H315

H411
GHS07

GHS09

Wng
H315

H411
613-220-00-2trans-(4S,6S)-5,6-dihydro-6-methyl-4H-thieno[2,3-b]thiopyran-4-ol, 7,7-dioxide417-290-3147086-81-5Acute Tox. 4 *H302GHS07

Wng
H302
613-221-00-82-chloro-5-methyl-pyridine418-050-018368-64-4Acute Tox. 4 *

Acute Tox. 4 *

Skin Irrit. 2

Aquatic Chronic 3
H312

H302

H315

H412
GHS07

Wng
H312

H302

H315

H412
613-222-00-34-(1-oxo-2-propenyl)-morpholine418-140-15117-12-4Acute Tox. 4 *

STOT RE 2 *

Eye Dam. 1

Skin Sens. 1
H302

H373 **

H318

H317
GHS08

GHS05

GHS07

Dgr
H302

H373 **

H318

H317
613-223-00-9N-isopropyl-3-(4-fluorophenyl)-1H-indole418-790-493957-49-4Aquatic Chronic 4H413H413
613-224-00-42,5-dimercaptomethyl-1,4-dithiane419-770-8136122-15-1Acute Tox. 4 *

Skin Corr. 1B

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H302

H314

H317

H400

H410
GHS05

GHS07

GHS09

Dgr
H302

H314

H317

H410
613-225-00-Xreaction mass of:[2-(anthraquinon-1-ylamino)-6-[(5-benzoylamino)-anthraquinone-1-ylamino]-4-phenyl]-1,3,5-triazine;

2,6-bis-[(5-benzoylamino)-anthraquinon-1-ylamino]-4-phenyl-1,3,5-triazine.
421-290-9STOT RE 2 *

Aquatic Chronic 4
H373 **

H413
GHS08

Wng
H373 **

H413
613-226-00-51-(2-(ethyl(4-(4-(4-(4-(ethyl(2-pyridinoethyl)amino)-2-methylphenylazo)benzoylamino)-phenylazo)-3-methylphenyl)amino)ethyl)-pyridinium dichloride420-950-3163831-67-2Eye Dam. 1

Aquatic Acute 1

Aquatic Chronic 1
H318

H400

H410
GHS05

GHS09

Dgr
H318

H410
613-227-00-0(±)-[(R*,R*) and (R*,S*)]-6-fluoro-3,4-dihydro-2-oxiranyl-2H-1-benzopyran419-600-299199-90-3Skin Sens. 1

Aquatic Chronic 2
H317

H411
GHS07

GHS09

Wng
H317

H411
613-228-00-6(±)-(R*,S*)-6-fluoro-3,4-dihydro-2-oxiranyl-2H-1-benzopyran419-630-6793669-26-8Aquatic Chronic 2H411GHS09H411
613-230-00-7florasulam (ISO);

2',6',8-trifluoro-5-methoxy-5-triazolo[1,5-c];

pyrimidine-2-sulfonanilide
145701-23-1Aquatic Acute 1

Aquatic Chronic 1
H400

H410
GHS09

Wng
H410
613-233-00-34,4'-(oxy-(bismethylene))-bis-1,3-dioxolane423-230-756552-15-9Eye Dam. 1H318GHS05

Dgr
H318
614-001-00-4nicotine (ISO);

3-(N-methyl-2-pyrrolidinyl)pyridine
200-193-354-11-5Acute Tox. 1

Acute Tox. 3 *

Aquatic Chronic 2
H310

H301

H411
GHS06

GHS09

Dgr
H310

H301

H411
614-002-00-Xsalts of nicotineAcute Tox. 2 *

Acute Tox. 1

Acute Tox. 2 *

Aquatic Chronic 2
H330

H310

H300

H411
GHS06

GHS09

Dgr
H330

H310

H300

H411
A
614-003-00-5strychnine200-319-757-24-9Acute Tox. 1

Acute Tox. 2 *

Aquatic Acute 1

Aquatic Chronic 1
H310

H300

H400

H410
GHS06

GHS09

Dgr
H310

H300

H410
614-004-00-0salts of strychnineAcute Tox. 2 *

Acute Tox. 2 *

Aquatic Acute 1

Aquatic Chronic 1
H330

H300

H400

H410
GHS06

GHS09

Dgr
H330

H300

H410
A
614-005-00-6colchicine200-598-564-86-8Acute Tox. 2 *

Acute Tox. 2 *
H330

H300
GHS06

Dgr
H330

H300
614-006-00-1brucine;

2,3-dimethoxystrychnine
206-614-7357-57-3Acute Tox. 2 *

Acute Tox. 2 *

Aquatic Chronic 3
H330

H300

H412
GHS06

Dgr
H330

H300

H412
614-007-00-7brucine sulphate; [1]

brucine nitrate; [2]

strychnidin-10-one, 2,3-dimethoxy-, mono[(R)-1-methylheptyl 1,2-benzenedicarboxylate]; [3]

strychnidin-10-one, 2,3-dimethoxy-, compd. with (S)mono(1-methylheptyl)-1,2-benzenedicarboxylate (1:1) [4]
225-432-9 [1]

227-317-9 [2]

269-439-5 [3]

269-710-8 [4]
4845-99-2 [1]

5786-97-0 [2]

68239-26-9 [3]

68310-42-9 [4]
Acute Tox. 2 *

Acute Tox. 2 *

Aquatic Chronic 3
H330

H300

H412
GHS06

Dgr
H330

H300

H412
A
614-008-00-2aconitine206-121-7302-27-2Acute Tox. 2 *

Acute Tox. 2 *
H330

H300
GHS06

Dgr
H330

H300
614-009-00-8salts of aconitineAcute Tox. 2 *

Acute Tox. 2 *
H330

H300
GHS06

Dgr
H330

H300
A
614-010-00-3atropine200-104-851-55-8Acute Tox. 2 *

Acute Tox. 2 *
H330

H300
GHS06

Dgr
H330

H300
614-011-00-9salts of atropineAcute Tox. 2 *

Acute Tox. 2 *
H330

H300
GHS06

Dgr
H330

H300
A
614-012-00-4hyoscyamine202-933-0101-31-5Acute Tox. 2 *

Acute Tox. 2 *
H330

H300
GHS06

Dgr
H330

H300
614-013-00-Xsalts of hyoscyamineAcute Tox. 2 *

Acute Tox. 2 *
H330

H300
GHS06

Dgr
H330

H300
A
614-014-00-5hyoscine200-090-351-34-3Acute Tox. 2 *

Acute Tox. 1

Acute Tox. 2 *
H330

H310

H300
GHS06

Dgr
H330

H310

H300
614-015-00-0salts of hyoscineAcute Tox. 2 *

Acute Tox. 1

Acute Tox. 2 *
H330

H310

H300
GHS06

Dgr
H330

H310

H300
A
614-016-00-6pilocarpine202-128-492-13-7Acute Tox. 2 *

Acute Tox. 2 *
H330

H300
GHS06

Dgr
H330

H300
614-017-00-1salts of pilocarpineAcute Tox. 2 *

Acute Tox. 2 *
H330

H300
GHS06

Dgr
H330

H300
A
614-018-00-7papaverine200-397-258-74-2Acute Tox. 4 *H302GHS07

Wng
H302
614-019-00-2salts of papaverineAcute Tox. 4 *H302GHS07

Wng
H302A
614-020-00-8physostigmine200-332-857-47-6Acute Tox. 2 *

Acute Tox. 2 *
H330

H300
GHS06

Dgr
H330

H300
614-021-00-3salts of physostigmineAcute Tox. 2 *

Acute Tox. 2 *
H330

H300
GHS06

Dgr
H330

H300
A
614-022-00-9digitoxin200-760-571-63-6Acute Tox. 3 *

Acute Tox. 3 *

STOT RE 2 *
H331

H301

H373 **
GHS06

GHS08

Dgr
H331

H301

H373 **
614-023-00-4ephedrine206-080-5299-42-3Acute Tox. 4 *H302GHS07

Wng
H302
614-024-00-Xsalts of ephedrineAcute Tox. 4 *H302GHS07

Wng
H302A
614-025-00-5ouabain211-139-3630-60-4Acute Tox. 3 *

Acute Tox. 3 *

STOT RE 2 *
H331

H301

H373 **
GHS06

GHS08

Dgr
H331

H301

H373 **
614-026-00-0strophantin-K234-239-911005-63-3Acute Tox. 3 *

Acute Tox. 3 *

STOT RE 2 *
H331

H301

H373 **
GHS06

GHS08

Dgr
H331

H301

H373 **
614-027-00-6bufa-4,20,22-trienolide, 6-(acetyloxy)-3-(β-D-glucopyranosyloxy)-8,14-dihydroxy-, (3β, 6β)-;

red squill;

scilliroside
208-077-4507-60-8Acute Tox. 2 *H300GHS06

Dgr
H300
614-028-00-1reaction mass of: 2-ethylhexyl mono-D-glucopyranoside;

2-ethylhexyl di-D-glucopyranoside
414-420-0Eye Dam. 1H318GHS05

Dgr
H318
614-029-00-7constitutional isomers of penta-O-allyl-β-D-fructofuranosyl-α-D-glucopyranoside;

constitutional isomers of hexa-O-allyl-β-D-fructofuranosyl-α-D-glucopyranoside;

constitutional isomers of hepta-O-allyl-β-D-fructofuransoyl-α-D-glucopyranoside
419-640-068784-14-5Acute Tox. 4 *H302GHS07

Wng
H302
615-001-00-7methyl isocyanate210-866-3624-83-9Flam. Liq. 2

Repr. 2

Acute Tox. 2 *

Acute Tox. 3 *

Acute Tox. 3 *

STOT SE 3

Skin Irrit. 2

Eye Dam. 1

Resp. Sens. 1

Skin Sens. 1
H225

H361d ***

H330

H311

H301

H335

H315

H318

H334

H317
GHS02

GHS06

GHS06

GHS08

GHS05

Dgr
H225

H361d ***

H330

H311

H301

H335

H315

H318

H334

H317
615-002-00-2methyl isothiocyanate209-132-5556-61-6Acute Tox. 3 *

Acute Tox. 3 *

Skin Corr. 1B

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H331

H301

H314

H317

H400

H410
GHS06

GHS05

GHS09

Dgr
H331

H301

H314

H317

H410
615-003-00-8thiocyanic acid207-337-4463-56-9Acute Tox. 4 *

Acute Tox. 4 *

Acute Tox. 4 *

Aquatic Chronic 3
H332

H312

H302

H412
GHS07

Wng
H332

H312

H302

H412
EUH032
615-004-00-3salts of thiocyanic acidAcute Tox. 4 *

Acute Tox. 4 *

Acute Tox. 4 *

Aquatic Chronic 3
H332

H312

H302

H412
GHS07

Wng
H332

H312

H302

H412
EUH032A
615-005-00-94,4'-methylenediphenyl diisocyanate;

diphenylmethane-4,4'-diisocyanate; [1]

2,2'-methylenediphenyl diisocyanate;

diphenylmethane-2,2'-diisocyanate; [2]

o-(p-isocyanatobenzyl)phenyl isocyanate;

diphenylmethane-2,4'-diisocyanate; [3]

methylenediphenyl diisocyanate [4]
202-966-0 [1]

219-799-4 [2]

227-534-9 [3]

247-714-0 [4]
101-68-8 [1]

2536-05-2 [2]

5873-54-1 [3]

26447-40-5 [4]
Acute Tox. 4 *

Eye Irrit. 2

STOT SE 3

Skin Irrit. 2

Resp. Sens. 1

Skin Sens. 1
H332

H319

H335

H315

H334

H317
GHS08

GHS07

Dgr
H332

H319

H335

H315

H334

H317
Eye Irrit.; H319: C ≥ 5 %

STOT SE 3; H335: C ≥ 5 %

Skin Irrit. 2; H315: C ≥ 5 %

Resp. Sens. 1; H334: C ≥ 0,1 %
C

2
615-006-00-42-methyl-m-phenylene diisocyanate;

toluene-2,4-di-isocyanate; [1]

4-methyl-m-phenylene diisocyanate;

toluene-2,6-di-isocyanate; [2]

m-tolylidene diisocyanate;

toluene-diisocyanate [3]
202-039-0 [1]

209-544-5 [2]

247-722-4 [3]
91-08-7 [1]

584-84-9 [2]

26471-62-5 [3]
Carc. 2

Acute Tox. 2 *

Eye Irrit. 2

STOT SE 3

Skin Irrit. 2

Resp. Sens. 1

Skin Sens. 1

Aquatic Chronic 3
H351

H330

H319

H335

H315

H334

H317

H412
GHS06

GHS08

Dgr
H351

H330

H319

H335

H315

H334

H317

H412
Resp. Sens. 1; H334: C ≥ 0,1 %C
615-007-00-X1,5-naphthylene diisocyanate221-641-43173-72-6Acute Tox. 4 *

Eye Irrit. 2

STOT SE 3

Skin Irrit. 2

Resp. Sens. 1

Aquatic Chronic 3
H332

H319

H335

H315

H334

H412
GHS08

GHS07

Dgr
H332

H319

H335

H315

H334

H412
615-008-00-53-isocyanatomethyl-3,5,5-trimethylcyclohexyl isocyanate;

isophorone di-isocyanate
223-861-64098-71-9Acute Tox. 3 *

Eye Irrit. 2

STOT SE 3

Skin Irrit. 2

Resp. Sens. 1

Skin Sens. 1

Aquatic Chronic 2
H331

H319

H335

H315

H334

H317

H411
GHS06

GHS08

GHS09

Dgr
H331

H319

H335

H315

H334

H317

H411
*

Resp. Sens. 1; H334: C ≥ 0,5 %

Skin Sens.1; H317: C ≥ 0,5 %
2
615-009-00-04,4'-methylenedi(cyclohexyl isocyanate);

dicyclohexylmethane-4,4'-di-isocyanate
225-863-25124-30-1Acute Tox. 3 *

Eye Irrit. 2

STOT SE 3

Skin Irrit. 2

Resp. Sens. 1

Skin Sens. 1
H331

H319

H335

H315

H334

H317
GHS06

GHS08

Dgr
H331

H319

H335

H315

H334

H317
*

Resp. Sens. 1; H334: C ≥ 0,5 %

Skin Sens. 1; H317: C ≥ 0,5 %
2
615-010-00-62,2,4-trimethylhexamethylene-1,6-di-isocyanate; [1]

2,4,4-trimethylhexamethylene-1,6-di-isocyanate [2]
241-001-8 [1]

239-714-4 [2]
16938-22-0 [1]

15646-96-5 [2]
Acute Tox. 3 *

Eye Irrit. 2

STOT SE 3

Skin Irrit. 2

Resp. Sens. 1
H331

H319

H335

H315

H334
GHS06

GHS08

Dgr
H331

H319

H335

H315

H334
*

Resp. Sens. 1; H334: C ≥ 0,5 %

Skin Sens. 1; H317: C ≥ 0,5 %
C

2
615-011-00-1hexamethylene-di-isocyanate212-485-8822-06-0Acute Tox. 3 *

Eye Irrit. 2

STOT SE 3

Skin Irrit. 2

Resp. Sens. 1

Skin Sens. 1
H331

H319

H335

H315

H334

H317
GHS06

GHS08

Dgr
H331

H319

H335

H315

H334

H317
*

Resp. Sens. 1; H334: C ≥ 0,5 %

Skin Sens. 1; H317: C ≥ 0,5 %
2
615-012-00-74-isocyanatosulphonyltoluene;

tosyl isocyanate
223-810-84083-64-1Eye Irrit. 2

STOT SE 3

Skin Irrit. 2

Resp. Sens. 1
H319

H335

H315

H334
GHS08

GHS07

Dgr
H319

H335

H315

H334
EUH014Eye Irrit.; H319: C ≥ 5 %

STOT SE 3; H335: C ≥ 5 %

Skin Irrit. 2; H315: C ≥ 5 %
615-013-00-2cyanamide;

carbanonitril
206-992-3420-04-2Acute Tox. 3 *

Acute Tox. 4 *

Eye Irrit. 2

Skin Irrit. 2

Skin Sens. 1
H301

H312

H319

H315

H317
GHS06

Dgr
H301

H312

H319

H315

H317
615-014-00-8tris(1-dodecyl-3-methyl-2-phenylbenzimidazolium)hexacyanoferrate7276-58-6Acute Tox. 4 *H302GHS07

Wng
H302
615-015-00-31,7,7-trimethylbicyclo(2,2,1)hept-2-yl thiocyanatoacetate;

isobornyl thiocyanoacetate
204-081-5115-31-1Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1
H302

H400

H410
GHS07

GHS09

Wng
H302

H410
615-016-00-9potassium cyanate209-676-3590-28-3Acute Tox. 4 *H302GHS07

Wng
H302
615-017-00-4calcium cyanamide205-861-8156-62-7Acute Tox. 4 *

STOT SE 3

Eye Dam. 1
H302

H335

H318
GHS05

GHS07

Dgr
H302

H335

H318
615-018-00-X2-(2-butoxyethoxy)ethyl thiocyanate203-985-7112-56-1Flam. Liq. 3

Acute Tox. 3 *

Acute Tox. 3 *
H226

H311

H301
GHS02

GHS06

Dgr
H226

H311

H301
615-019-00-5dicyclohexylcarbodiimide208-704-1538-75-0Acute Tox. 3 *

Acute Tox. 4 *

Eye Dam. 1

Skin Sens. 1
H311

H302

H318

H317
GHS06

GHS05

Dgr
H311

H302

H318

H317
615-020-00-0methylene dithiocyanate228-652-36317-18-6Acute Tox. 2 *

Acute Tox. 3 *

Skin Corr. 1B

Skin Sens. 1

Aquatic Acute 1
H330

H301

H314

H317

H400
GHS06

GHS05

GHS09

Dgr
H330

H301

H314

H317

H400
615-021-00-61,3,5-tris(oxiranylmethyl)-1,3,5-triazine-2,4,6(1H,3H,5H)-trione;

TGIC
219-514-32451-62-9Muta. 1B

Acute Tox. 3 *

Acute Tox. 3 *

STOT RE 2 *

Eye Dam. 1

Skin Sens. 1

Aquatic Chronic 3
H340

H331

H301

H373 **

H318

H317

H412
GHS06

GHS08

GHS05

Dgr
H340

H331

H301

H373 **

H318

H317

H412
615-022-00-1methyl 3-isocyanatosulfonyl-2-thiophene-carboxylate410-550-779277-18-2STOT RE 2 *

Resp. Sens. 1

Skin Sens. 1
H373 **

H334

H317
GHS08

Dgr
E; R2

H373 **

H334

H317
EUH014
615-023-00-72-(isocyanatosulfonylmethyl)benzoic acid methyl ester;

(alt.):methyl 2-(isocyanatosulfonylmethyl)benzoate
410-900-983056-32-0Flam. Liq. 3

Muta. 2

Acute Tox. 4 *

STOT RE 2 *

Eye Dam. 1

Resp. Sens. 1
H226

H341

H332

H373 **

H318

H334
GHS02

GHS08

GHS05

GHS07

Dgr
H226

H341

H332

H373 **

H318

H334
EUH014
615-024-00-22-phenylethylisocyanate413-080-01943-82-4Acute Tox. 3 *

Acute Tox. 4 *

Skin Corr. 1A

Resp. Sens. 1

Skin Sens. 1

Aquatic Chronic 2
H331

H302

H314

H334

H317

H411
GHS06

GHS08

GHS05

GHS09

Dgr
H331

H302

H314

H334

H317

H411
615-025-00-84,4'-ethylidenediphenyl dicyanate405-740-147073-92-7Acute Tox. 4 *

Acute Tox. 4 *

STOT RE 2 *

Eye Dam. 1

Aquatic Acute 1

Aquatic Chronic 1
H332

H302

H373 **

H318

H400

H410
GHS08

GHS05

GHS07

GHS09

Dgr
H332

H302

H373 **

H318

H410
615-026-00-34,4'-methylenebis(2,6-dimethylphenyl cyanate)405-790-4101657-77-6Skin Sens. 1

Aquatic Chronic 3
H317

H412
GHS07

Wng
H317

H412
615-028-00-4ethyl 2-(isocyanatosulfonyl)benzoate410-220-277375-79-2****

Acute Tox. 4 *

STOT RE 2 *

Eye Dam. 1

Resp. Sens. 1

Skin Sens. 1
H302

H373 **

H318

H334

H317
GHS08

GHS05

GHS07

Dgr
E; R2

H302

H373 **

H318

H334

H317
EUH014
615-029-00-X2,5-bis-isocyanatomethyl-bicyclo[2.2.1]heptane411-280-2Acute Tox. 2 *

Acute Tox. 4 *

Skin Corr. 1B

Resp. Sens. 1

Skin Sens. 1

Aquatic Chronic 3
H330

H302

H314

H334

H317

H412
GHS06

GHS08

GHS05

Dgr
H330

H302

H314

H334

H317

H412
615-030-00-5alkali salts, alkali earth salts and other salts of thiocyanic acid not mentioned elsewhere in this AnnexAcute Tox. 4 *

Acute Tox. 4 *

Acute Tox. 4 *

Aquatic Chronic 3
H332

H312

H302

H412
GHS07

Wng
H332

H312

H302

H412
EUH032A
615-031-00-0thallium salt of thiocyanic acid222-571-73535-84-0Acute Tox. 4 *

Acute Tox. 4 *

Acute Tox. 4 *

Aquatic Chronic 2
H332

H312

H302

H411
GHS07

GHS09

Wng
H332

H312

H302

H411
EUH032A
615-032-00-6metal salts of thiocyanic acid not mentioned elsewhere in this AnnexAcute Tox. 4 *

Acute Tox. 4 *

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1
H332

H312

H302

H400

H410
GHS07

GHS09

Wng
H332

H312

H302

H410
EUH032A
616-001-00-XN,N-dimethylformamide;

dimethyl formamide
200-679-568-12-2Repr. 1B

Acute Tox. 4 *

Acute Tox. 4 *

Eye Irrit. 2
H360D ***

H332

H312

H319
GHS08

GHS07

Dgr
H360D ***

H332

H312

H319
616-002-00-52-fluoroacetamide211-363-1640-19-7Acute Tox. 2 *

Acute Tox. 3 *
H300

H311
GHS06

Dgr
H300

H311
616-003-00-0acrylamide;

prop-2-enamide
201-173-779-06-1Carc. 1B

Muta. 1B

Repr. 2

Acute Tox. 3 *

STOT RE 1

Acute Tox. 4 *

Acute Tox. 4 *

Eye Irrit. 2

Skin Irrit. 2

Skin Sens. 1
H350

H340

H361f ***

H301

H372 **

H332

H312

H319

H315

H317
GHS06

GHS08

Dgr
H350

H340

H361f ***

H301

H372 **

H332

H312

H319

H315

H317
D
616-004-00-6allidochlor (ISO);

N,N-diallylchloroacetamide
202-270-793-71-0Acute Tox. 4 *

Acute Tox. 4 *

Eye Irrit. 2

Skin Irrit. 2

Aquatic Chronic 2
H312

H302

H319

H315

H411
GHS07

GHS09

Wng
H312

H302

H319

H315

H411
616-005-00-1chlorthiamid (ISO);

2,6-dichloro (thiobenzamide)
217-637-71918-13-4Acute Tox. 4 *H302GHS07

Wng
H302
616-006-00-7dichlofluanid (ISO);

N-dichlorofluoromethylthio-N',N'-dimethyl-N-phenylsulphamide
214-118-71085-98-9Acute Tox. 4 *

Eye Irrit. 2

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H332

H319

H317

H400

H410
GHS07

GHS09

Wng
H332

H319

H317

H410
616-007-00-2diphenamid (ISO);

N,N-dimethyl-2,2-diphenylacetamide
213-482-4957-51-7Acute Tox. 4 *

Aquatic Chronic 3
H302

H412
GHS07

Wng
H302

H412
616-008-00-8propachlor (ISO);

2-chloro-N-isopropylacetanilide;

α-chloro-N-isopropylacetanilide
217-638-21918-16-7Acute Tox. 4 *

Eye Irrit. 2

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H302

H319

H317

H400

H410
GHS07

GHS09

Wng
H302

H319

H317

H410
616-009-00-3propanil (ISO);

3',4'-dichloropropionanilide
211-914-6709-98-8Acute Tox. 4 *

Aquatic Acute 1
H302

H400
GHS07

GHS09

Wng
H302

H400
616-010-00-9tosylchloramide sodium204-854-7127-65-1Acute Tox. 4 *

Skin Corr. 1B

Resp. Sens. 1
H302

H314

H334
GHS08

GHS05

GHS07

Dg
H302

H314

H334
EUH031
616-011-00-4N,N-dimethylacetamide204-826-4127-19-5Repr. 1B

Acute Tox. 4 *

Acute Tox. 4 *
H360D ***

H332

H312
GHS08

GHS07

Dgr
H360D ***

H332

H312
Repr. 1B; H360D: C ≥ 5 %
616-012-00-XN-(dichlorofluoromethylthio)phthalimide;

N-(fluorodichloromethylthio)phthalimide
211-952-3719-96-0Skin Irrit. 2H315GHS07

Wng
H315
616-013-00-5butyraldehyde oxime203-792-8110-69-0Acute Tox. 3 *

Acute Tox. 4 *

Eye Irrit. 2
H311

H302

H319
GHS06

Dgr
H311

H302

H319
616-014-00-02-butanone oxime;

ethyl methyl ketoxime;

ethyl methyl ketone oxime
202-496-696-29-7Carc. 2

Acute Tox. 4 *

Eye Dam. 1

Skin Sens. 1
H351

H312

H318

H317
GHS08

GHS05

GHS07

Dgr
H351

H312

H318

H317
616-015-00-6alachlor (ISO);

2-chloro-2',6'-diethyl-N-(methoxymethyl)acetanilide
240-110-815972-60-8Carc. 2

Acute Tox. 4 *

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H351

H302

H317

H400

H410
GHS08

GHS07

GHS09

Wng
H351

H302

H317

H410
M=10
616-016-00-11-(3,4-dichlorophenylimino) thiosemicarbazide5836-73-7Acute Tox. 2 *H300GHS06

Dgr
H300
616-017-00-7cartap hydrochloride239-309-215263-52-2Acute Tox. 4 *

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1
H312

H302

H400

H410
GHS07

GHS09

Wng
H312

H302

H410
616-018-00-2N,N-diethyl-m-toluamide;

deet
205-149-7134-62-3Acute Tox. 4 *

Eye Irrit. 2

Skin Irrit. 2

Aquatic Chronic 3
H302

H319

H315

H412
GHS07

Wng
H302

H319

H315

H412
616-019-00-8perfluidone (ISO);

1,1,1-trifluoro-N-(4-phenylsulphonyl-o-tolyl)methanesulphonamide;
253-718-337924-13-3Acute Tox. 4 *

Eye Irrit. 2
H302

H319
GHS07

Wng
H302

H319
616-020-00-3tebuthiuron (ISO);

1-(5-tert-butyl-1,3,4-thiadiazol-2-yl)-1,3-dimethylurea
251-793-734014-18-1Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1
H302

H400

H410
GHS07

GHS09

Wng
H302

H410
616-021-00-9thiazafluron (ISO);

1,3-dimethyl-1-(5-trifluoromethyl-1,3,4-thiadiazol-2-yl)urea
246-901-425366-23-8Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1
H302

H400

H410
GHS07

GHS09

Wng
H302

H410
616-022-00-4acetamide200-473-560-35-5Carc. 2H351GHS08

Wng
H351
616-023-00-XN-hexadecyl(or octadecyl)-N-hexadecyl(or octadecyl)benzamide401-980-6Skin Irrit. 2

Skin Sens. 1
H315

H317
GHS07

Wng
H315

H317
616-024-00-52-(4,4-dimethyl-2,5-dioxooxazolidin-1-yl)-2-chloro-5-(2-(2,4-di-tert-pentylphenoxy)butyramido)-4,4-dimethyl-3-oxovaleranilide402-260-454942-74-4Aquatic Chronic 4H413H413
616-025-00-0valinamide402-840-720108-78-5Repr. 2

Eye Irrit. 2

Skin Sens. 1
H361f ***

H319

H317
GHS08

Wng
H361f ***

H319

H317
616-026-00-6thioacetamide200-541-462-55-5Carc. 1B

Acute Tox. 4 *

Eye Irrit. 2

Skin Irrit. 2

Aquatic Chronic 3
H350

H302

H319

H315

H412
GHS08

GHS07

Dgr
H350

H302

H319

H315

H412
616-027-00-1tris(2-(2-hydroxyethoxy)ethyl)ammonium 3-acetoacetamido-4-methoxybenzenesulfonate403-760-5Skin Sens. 1H317GHS07

Wng
H317
616-028-00-7N-(4-(3-(4-cyanophenyl)ureido)-3-hydroxyphenyl)-2-(2,4-di-tert-pentylphenoxy)octanamide403-790-9108673-51-4Skin Sens. 1

Aquatic Chronic 4
H317

H413
GHS07

Wng
H317

H413
616-029-00-2N,N'-ethylenebis(vinylsulfonylacetamide)404-790-166710-66-5Eye Dam. 1

Skin Sens. 1
H318

H317
GHS05

GHS07

Dgr
H318

H317
616-030-00-8ethidimuron (ISO);

1-(5-ethylsulphonyl-1,3,4-thiadiazol-2-yl)-1,3-dimethylurea
250-010-630043-49-3Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H317

H400

H410
GHS07

GHS09

Wng
H317

H410
616-031-00-3dimethachlor (ISO);

2-chloro-N-(2,6-dimethylphenyl)-N-(2-methoxyethyl)acetamide;
256-625-650563-36-5Acute Tox. 4 *

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H302

H317

H400

H410
GHS07

GHS09

Wng
H302

H317

H410
616-032-00-9diflufenican (ISO);

N-(2,4-difluorophenyl)-2-[3-(trifluoromethyl)phenoxy]-3-pyridinecarboxamide
83164-33-4Aquatic Chronic 3H412H412
616-033-00-4cyprofuram (ISO);

N-(3-chlorophenyl)-N-(tetrahydro-2-oxo-3-furyl)cyclopropanecarboxamide
274-050-969581-33-5Acute Tox. 3 *

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1
H301

H312

H400

H410
GHS06

GHS09

Dgr
H301

H312

H410
616-034-00-Xpyracarbolid; (ISO);

3,4-dihydro-6-methyl-2H-pyran-5-carboxanilide
246-419-424691-76-7Aquatic Chronic 3H412H412
616-035-00-5cymoxanil (ISO);

2-cyano-N-[(ethylamino)carbonyl]-2-(methoxyimino)acetamide
261-043-057966-95-7Acute Tox. 4 *

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H302

H317

H400

H410
GHS07

GHS09

Wng
H302

H317

H410
616-036-00-02-chloracetamide201-174-279-07-2Repr. 2

Acute Tox. 3 *

Skin Sens. 1
H361f ***

H301

H317
GHS06

GHS08

Dgr
H361f ***

H301

H317
Skin Sens. 1; H317: C ≥ 0,1 %
616-037-00-6acetochlor (ISO);

2-chloro-N-(ethoxymethyl)-N-(2-ethyl-6-methylphenyl)acetamide
251-899-334256-82-1Acute Tox. 4 *

STOT SE 3

Skin Irrit. 2

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H332

H335

H315

H317

H400

H410
GHS07

GHS09

Wng
H332

H335

H315

H317

H410
616-038-00-1(4-aminophenyl)-N-methylmethylensulfonamide hydrochloride406-010-588918-84-7Eye Dam. 1

Skin Sens. 1

Aquatic Chronic 2
H318

H317

H411
GHS05

GHS07

GHS09

Dgr
H318

H317

H411
616-039-00-73',5'-dichloro-4'-ethyl-2'-hydroxypalmitanilide406-200-8117827-06-2Skin Sens. 1H317GHS07

Wng
H317
616-040-00-2potassium N-(4-toluenesulfonyl)-4-toluenesulfonamide406-650-597888-41-0Eye Dam. 1H318GHS05

Dgr
H318
616-041-00-83',5'-dichloro-2-(2,4-di-tert-pentylphenoxy)-4'-ethyl-2'-hydroxyhexananilide406-840-8101664-25-9Aquatic Chronic 4H413H413
616-042-00-3N-(2-(6-ethyl-7-(4-methylphenoxy)-1H-pyrazolo[1,5-b][1,2,4]triazol-2-yl)propyl)-2-octadecyloxybenzamide407-070-5142859-67-4Skin Sens. 1

Aquatic Chronic 4
H317

H413
GHS07

Wng
H317

H413
616-043-00-9isoxaben (ISO);

N-[3-(1-ethyl-1-methylpropyl)-1,2-oxazol-5-yl]-2,6-dimethoxybenzamide
407-190-882558-50-7Aquatic Chronic 4H413H413
616-044-00-4N-(3,5-dichloro-4-ethyl-2-hydroxyphenyl)-2-(3-pentadecylphenoxy)-butanamide402-510-2Aquatic Chronic 2H411GHS09H411
616-045-00-X2'-(4-chloro-3-cyano-5-formyl-2-thienylazo)-5'-diethylamino-2-methoxyacetanilide405-190-2122371-93-1Skin Sens. 1

Aquatic Chronic 4
H317

H413
GHS07

Wng
H317

H413
616-046-00-5N-(2-(6-chloro-7-methylpyrazolo(1,5-b)-1,2,4-triazol-4-yl)propyl)-2-(2,4-di-tert-pentylphenoxy)octanamide406-390-2Aquatic Acute 1

Aquatic Chronic 1
H400

H410
GHS09

Wng
H410
616-047-00-0reaction mass of: 2,2',2'',2'''-(ethylenedinitrilotetrakis-N,N-di(C16)alkylacetamide;

2,2',2'',2'''-(ethylenedinitrilotetrakis-N,N-di(C18)alkylacetamide
406-640-0Skin Sens. 1H317GHS07

Wng
H317
616-048-00-63'-trifluoromethylisobutyranilide406-740-41939-27-1STOT RE 2 *

Aquatic Chronic 2
H373 **

H411
GHS08

GHS09

Wng
H373 **

H411
616-049-00-12-(2,4-bis(1,1-dimethylethyl)phenoxy)-N-(3,5-dichloro-4-ethyl-2-hydroxyphenyl)-hexanamide408-150-299141-89-6Aquatic Chronic 4H413H413
616-050-00-7lufenuron (ISO);

N-[2,5-dichloro-4-(1,1,2,3,3,3-hexafluoropropoxy)-phenyl-aminocarbonyl]-2,6-difluorobenzamide
410-690-9103055-07-8Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H317

H400

H410
GHS07

GHS09

Wng
H317

H410
616-051-00-2reaction mass of: 2,4 -bis(N'-(4-methylphenyl)-ureido)-toluene;

2,6 -bis(N'-(4-methylphenyl)-ureido)-toluene
411-070-0Aquatic Chronic 4H413H413
616-052-00-8formamide200-842-075-12-7Repr. 1BH360D ***GHS08

Dgr
H360D ***
616-053-00-3N-methylacetamide201-182-679-16-3Repr. 1BH360D ***GHS08

Dgr
H360D ***
616-054-00-9iprodione (ISO);

3-(3,5-dichlorophenyl)-2,4-dioxo-N-isopropylimidazolidine-1-carboxamide
253-178-936734-19-7Carc. 2

Aquatic Acute 1

Aquatic Chronic 1
H351

H400

H410
GHS08

GHS09

Wng
H351

H410
616-055-00-4propyzamide (ISO);

3,5-dichloro-N-(1,1-dimethylprop-2-ynyl)benzamide
245-951-423950-58-5Carc. 2

Aquatic Acute 1

Aquatic Chronic 1
H351

H400

H410
GHS08

GHS09

Wng
H351

H410
616-056-00-XN-methylformamide204-624-6123-39-7Repr. 1B

Acute Tox. 4 *
H360D ***

H312
GHS08

GHS07

Dg
H360D ***

H312
616-057-00-5reaction mass of: N-[3-hydroxy-2-(2-methylacryloylaminomethoxy)propoxymethyl]-2-methylacrylamide;

N-[2,3-bis-(2-methylacryloylaminomethoxy)propoxymethyl]-2-methylacrylamide;

methacrylamide;

2-methyl-N-(2-methylacryloylaminomethoxymethyl)-acrylamide;

N-(2,3-dihydroxypropoxymethyl)-2-methylacrylamide
412-790-8Carc. 1B

Muta. 2

STOT RE 2 *
H350

H341

H373 **
GHS08

Dgr
H350

H341

H373 **
616-058-00-01,3-bis(3-methyl-2,5-dioxo-1H-pyrrolinylmethyl)benzene412-570-1119462-56-5STOT RE 2 *

Eye Dam. 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H373 **

H318

H317

H400

H410
GHS08

GHS05

GHS07

GHS09

Dgr
H373 **

H318

H317

H410
616-059-00-64-((4-(diethylamino)-2-ethoxyphenyl)imino)-1,4-dihydro-1-oxo-N-propyl-2-naphthalenecarboxamide412-650-6121487-83-0Aquatic Chronic 4H413H413
616-060-00-1Condensation product of: 3-(7-carboxyhept-1-yl)-6-hexyl-4-cyclohexene-1,2-dicarboxylic acid with polyamines (primarily amino-ethyl-piperazine and triethylenetetramine)413-770-1Acute Tox. 4 *

Skin Corr. 1B

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H302

H314

H317

H400

H410
GHS05

GHS07

GHS09

Dgr
H302

H314

H317

H410
616-061-00-7N,N'—1,6-hexanediylbis(N-(2,2,6,6-tetramethyl-piperidin-4-yl)-formamide413-610-0124172-53-8Eye Irrit. 2

Aquatic Chronic 3
H319

H412
GHS07

Wng
H319

H412
616-062-00-2N-[3-[(2-acetyloxy)ethyl](phenyl-methyl)amino]-4-methoxyphenylacetamide411-590-870693-57-1Skin Corr. 1B

Aquatic Chronic 3
H314

H412
GHS05

Dgr
H314

H412
616-063-00-83-dodecyl-(1-(1,2,2,6,6-pentamethyl-4-piperidin)-yl)-2,5-pyrrolidindione411-920-0106917-30-0Acute Tox. 3 *

Acute Tox. 4 *

STOT RE 2 *

Skin Corr. 1A

Aquatic Acute 1

Aquatic Chronic 1
H331

H302

H373 **

H314

H400

H410
GHS06

GHS08

GHS05

GHS09

Dgr
H331

H302

H373 **

H314

H410
616-064-00-3N—tert-butyl-3-methylpicolinamide406-720-532998-95-1Aquatic Chronic 3H412H412
616-065-00-93'-(3-acetyl-4-hydroxyphenyl)-1,1-diethylurea411-970-379881-89-3Acute Tox. 4 *

STOT RE 2 *
H302

H373 **
GHS08

GHS07

Wng
H302

H373 **
616-066-00-45,6,12,13-tetrachloroanthra(2,1,9-def:6,5,10-d'e'f')diisoquinoline-1,3,8,10(2H,9H)-tetrone405-100-1115662-06-1Repr. 2H361f ***GHS08

Wng
H361f ***
616-067-00-Xdodecyl 3-(2-(3-benzyl-4-ethoxy-2,5-dioxoimidazolidin-1-yl)-4,4-dimethyl-3-oxovaleramido)-4-chlorobenzoate407-300-492683-20-0Aquatic Chronic 4H413H413
616-068-00-5potassium 4-(11-methacrylamidoundecanamido)benzenesulfonate406-500-9174393-75-0Skin Sens. 1H317GHS07

Wng
H317
616-069-00-01-hydroxy-5-(2-methylpropyloxycarbonylamino)-N-(3-dodecyloxypropyl)-2-naphthoamide406-210-2110560-22-0Aquatic Chronic 4H413H413
616-070-00-6reaction mass of: 3,3'-dicyclohexyl-1,1'-methylenebis(4,1-phenylene)diurea;

3-cyclohexyl-1-(4-(4-(3-octadecylureido)benzyl)phenyl)urea;

3,3'-dioctadecyl-1,1'-methylenebis(4,1-phenylene)diurea
406-530-2Aquatic Chronic 4H413H413
616-071-00-1reaction mass of: bis(N-cyclohexyl-N'-phenyleneureido)methylene;

bis(N-octadecyl-N'-phenyleneureido)methylene;

bis(N-dicyclohexyl-N'-phenyleneureido)methylene (1:2:1)
406-550-1Skin Sens. 1

Aquatic Chronic 4
H317

H413
GHS07

Wng
H317

H413
616-072-00-71-(2-deoxy-5-O-trityl-β-D-threopentofuranosyl)thymine407-120-655612-11-8Aquatic Chronic 4H413H413
616-073-00-24'-ethoxy-2-benzimidazoleanilide407-600-5120187-29-3Muta. 2

Aquatic Chronic 4
H341

H413
GHS08

Wng
H341

H413
616-074-00-8N-butyl-2-(4-morpholinylcarbonyl)benzamide407-730-2104958-67-0Eye Irrit. 2

Skin Sens. 1

Aquatic Chronic 3
H319

H317

H412
GHS07

Wng
H319

H317

H412
616-075-00-3D, L-(N,N-diethyl-2-hydroxy-2-phenylacetamide)408-120-965197-96-8Acute Tox. 4 *

Eye Dam. 1
H302

H318
GHS05

GHS07

Dgr
H302

H318
616-076-00-9tebufenozide (ISO);

N-tert-butyl-N'-(4-ethylbenzoyl)-3,5-dimethylbenzohydrazide
412-850-3112410-23-8Aquatic Chronic 2H411GHS09H411
616-077-00-4reaction mass of: 2-(9-methyl-1,3,8,10-tetraoxo-2,3,9,10-tetrahydro-(1H,8H)-anthra[2,1,9-def: 6,5,10-d'e'f']diisoquinolin-2-ylethansulfonic acid;

potassium 2-(9-methyl-1,3,8,10-tetraoxo-2,3,9,10-tetrahydro-(1H,8H)-anthra[2,1,9-def: 6,5,10-d'e'f']diisoquinolin-2-ylethansulfate
411-310-4Eye Dam. 1H318GHS05

Dgr
H318
616-078-00-X2-[2,4-bis(1,1-dimethyl-ethyl)phenoxy]-N-(2-hydroxy-5-methyl-phenyl)hexanamide411-330-3104541-33-5Aquatic Chronic 4H413H413
616-079-00-51,6-hexanediyl-bis(2-(2-(1-ethylpentyl)-3-oxazolidinyl)ethyl)carbamate411-700-4140921-24-0Skin Sens. 1H317GHS07

Wng
H317
616-080-00-04-(2-((3-ethyl-4-methyl-2-oxo-pyrrolin-1-yl)carboxamido)ethyl)benzenesulfonamide)411-850-0119018-29-0Aquatic Chronic 3H412H412
616-081-00-65-bromo-8-naphtholactam413-480-524856-00-6Acute Tox. 4 *

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H302

H317

H400

H410
GHS07

GHS09

Wng
H302

H317

H410
616-082-00-1N-(5-chloro-3-((4-(diethylamino)-2-methylphenyl)imino-4-methyl-6-oxo-1,4-cyclohexadien-1-yl)benzamide413-200-1129604-78-0Skin Sens. 1H317GHS07

Wng
H317
616-083-00-7[2-[(4-nitrophenyl)amino]ethyl]urea410-700-127080-42-8Skin Sens. 1

Aquatic Chronic 3
H317

H412
GHS07

Wng
H317

H412
616-084-00-22,4-bis[N'-(4-methylphenyl)ureido]toluene411-790-5Aquatic Acute 1

Aquatic Chronic 1
H400

H410
GHS09

Wng
H410
616-085-00-83-(2,4-dichlorophenyl)-6-fluoro-quinazoline-2,4(1H,3H)-dione412-190-6168900-02-5Aquatic Acute 1

Aquatic Chronic 1
H400

H410
GHS09

Wng
H410
616-086-00-32-acetylamino-6-chloro-4-[(4-diethylamino)2-methylphenyl-imino]-5-methyl-1-oxo-2,5-cyclohexadiene412-250-1102387-48-4Aquatic Chronic 4H413H413
616-087-00-9reaction mass of: 7,9,9-trimethyl-3,14-dioxa-4,13-dioxo-5,12-diazahexadecane-1,16-diyl-prop-2-enoate;

7,7,9-trimethyl-3,14-dioxa-4,13-dioxo-5,12-diazahexadecan-1,16-diyl-prop-2-enoate
412-260-652658-19-2Eye Irrit. 2

Skin Sens. 1

Aquatic Chronic 2
H319

H317

H411
GHS07

GHS09

Wng
H319

H317

H411
616-088-00-42-aminosulfonyl-N,N-dimethylnicotinamide413-440-7112006-75-4Skin Sens. 1

Aquatic Chronic 3
H317

H412
GHS07

Wng
H317

H412
616-089-00-X5-(2,4-dioxo-1,2,3,4-tetrahydropyrimidine)-3-fluoro-2-hydroxymethyltetrahydrofuran415-360-841107-56-6Muta. 2H341GHS08

Wng
H341
616-090-00-51-(1,4-benzodioxan-2-ylcarbonyl)piperazine hydrochloride415-660-970918-74-0Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *

STOT RE 2 *

Aquatic Chronic 2
H331

H311

H301

H373 **

H411
GHS06

GHS08

GHS09

Dgr
H331

H311

H301

H373 **

H411
616-091-00-01,3,5-tris-[(2S and 2R)-2,3-epoxypropyl]-1,3,5-triazine-2,4,6-(1H,3H,5H)-trione423-400-059653-74-6Muta. 1B

Acute Tox. 3 *

Acute Tox. 4 *

STOT RE 2 *

Eye Dam. 1

Skin Sens. 1
H340

H331

H302

H373 **

H318

H317
GHS06

GHS08

GHS05

Dgr
H340

H331

H302

H373 **

H318

H317
616-092-00-6Polymeric reaction product of bicyclo[2.2.1]hepta-2,5-diene, ethene, 1,4-hexadiene, 1-propene with N,N-di-2-propenylformamide404-035-6Skin Sens. 1

Aquatic Chronic 4
H317

H413
GHS07

Wng
H317

H413
616-093-00-1Reaction products of: aniline-terephthalaldehyde-o-toluidine condensate with maleic anhydride406-620-1129217-90-9Skin Sens. 1

Aquatic Chronic 2
H317

H411
GHS07

GHS09

Wng
H317

H411
616-094-00-73,3'-dicyclohexyl-1,1'-methylenebis(4,1-phenylene)diurea406-370-358890-25-8Skin Sens. 1

Aquatic Chronic 4
H317

H413
GHS07

Wng
H317

H413
616-095-00-23,3'-dioctadecyl-1,1'-methylenebis(4,1-phenylene)diurea406-690-343136-14-7Aquatic Chronic 4H413H413
616-096-00-8N-(3-hexadecyloxy-2-hydroxyprop-1-yl)-N-(2-hydroxyethyl)palmitamide408-110-4110483-07-3Aquatic Chronic 4H413H413
616-097-00-3N,N'-1,4-phenylenebis(2-((2-methoxy-4-nitrophenyl)azo)-3-oxobutanamide411-840-683372-55-8Aquatic Chronic 4H413H413
616-098-00-91-[4-chloro-3-((2,2,3,3,3-pentafluoropropoxy)methyl)phenyl]-5-phenyl-1H-1,2,4-triazole-3-carboxamide411-750-7119126-15-7Aquatic Chronic 2H411GHS09H411
616-099-00-42-[4-[(4-hydroxyphenyl)sulfonyl]phenoxy]-4,4-dimethyl-N-[5-[(methylsulfonyl)amino]-2-[4-(1,1,3,3-tetramethylbutyl)phenoxy]phenyl]-3-oxopentanamide414-170-2135937-20-1Aquatic Chronic 4H413H413
616-100-00-81,3-dimethyl-1,3-bis(trimethylsilyl)urea414-180-710218-17-4Acute Tox. 4 *

Skin Irrit. 2
H302

H315
GHS07

Wng
H302

H315
616-101-00-3(S)-N-tert-butyl-1,2,3,4-tetrahydro-3-isoquinolinecarboxamide414-600-9149182-72-9Acute Tox. 4 *

Aquatic Chronic 3
H302

H412
GHS07

Wng
H302

H412
616-102-00-9reaction mass of: α-[3-(3-mercaptopropanoxycarbonylamino)methylphenylaminocarbonyl]-ω-[3-(3-mercaptopropanoxycarbonylamino)methylphenylaminocarbonyloxy]-poly-(oxyethylene-co-oxypropylene);

1,2-(or 1,3-)bis[α-(3-mercaptopropanoxycarbonylamino)methylphenylaminocarbonyl)-ω-oxy-poly(oxyethylene-co-oxypropylene)]-3-(or 2-)propanol;

1,2,3-tris[α-(3-mercaptopropanoxycarbonyl-amino)methylphenylaminocarbonyl)-ω-oxy-poly-(oxyethylene-co-oxypropylene)]propane]
415-870-0Skin Sens. 1

Aquatic Chronic 2
H317

H411
GHS07

GHS09

Wng
H317

H411
616-103-00-4(S,S)-trans-4-(acetylamino)-5,6-dihydro-6-methyl-7,7-dioxo-4H-thieno[2,3-b]thiopyran-2-sulfonamide415-030-3120298-38-6Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H317

H400

H410
GHS07

GHS09

Wng
H317

H410
616-104-00-Xbenalaxyl (ISO);

methyl N-(2,6-dimethylphenyl)-N-(phenylacetyl)-DL-alaninate
275-728-771626-11-4Aquatic Acute 1

Aquatic Chronic 1
H400

H410
GHS09

Wng
H410
616-105-00-5chlorotoluron (ISO);

3-(3-chloro-p-tolyl)-1,1-dimethylurea
239-592-215545-48-9Carc. 2

Repr. 2

Aquatic Acute 1

Aquatic Chronic 1
H351

H361d ***

H400

H410
GHS08

GHS09

Wng
H351

H361d ***

H410
616-106-00-0phenmedipham (ISO);

methyl 3-(3-methylcarbaniloyloxy)carbanilate
237-199-013684-63-4Aquatic Acute 1

Aquatic Chronic 1
H400

H410
GHS09

Wng
H410
616-108-00-1iodosulfuron-methyl-sodium;

sodium ({[5-iodo-2-(methoxycarbonyl)phenyl]sulfonyl}carbamoyl)(4-methoxy-6-methyl-1,3,5-triazin-2-yl)azanide
144550-36-7Aquatic Acute 1

Aquatic Chronic 1
H400

H410
GHS09

Wng
H410
616-109-00-7sulfosulfuron (ISO);

1-(4,6-dimethoxypyrimidin-2-yl)-3-(2-ethylsulfonylimidazo[1,2-a]pyridin-3-yl)sulfonylurea
141776-32-1Aquatic Acute 1

Aquatic Chronic 1
H400

H410
GHS09

Wng
H410
616-110-00-2cyclanilide (ISO);

1-(2,4-dichloroanilinocarbonyl)cyclopropanecarboxylic acid
419-150-7113136-77-9Acute Tox. 4 *

Aquatic Chronic 2
H302

H411
GHS07

GHS09

Wng
H302

H411
616-111-00-8fenhexamid (ISO);

N-(2,3-dichlor-4-hydroxyphenyl)-1-methylcyclohexancarboxamid
422-530-5126833-17-8Aquatic Chronic 2H411GHS09H411
616-112-00-3oxasulfuron (ISO);

oxetan-3-yl 2-[(4,6-dimethylpyrimidin-2-yl)-carbamoylsulfamoyl]benzoate
144651-06-9STOT RE 2 *

Aquatic Acute 1

Aquatic Chronic 1
H373 **

H400

H410
GHS08

GHS09

Wng
H373 **

H410
616-113-00-9desmedipham (ISO);

ethyl 3-phenylcarbamoyloxyphenylcarbamate
237-198-513684-56-5Aquatic Acute 1

Aquatic Chronic 1
H400

H410
GHS09

Wng
H410M=10
616-114-00-4dodecanamide, N,N'-(9,9',10,10'-tetrahydro-9,9',10,10'-tetraoxo(1,1'-bianthracene)-4,4'-diyl)bis-418-010-2136897-58-0Aquatic Chronic 4H413H413
616-115-00-XN-(3-acetyl-2-hydroxyphenyl)-4-(4-phenylbutoxy)benzamide416-150-9136450-06-1Aquatic Chronic 4H413H413
616-116-00-5N-(4-dimethylaminopyridinium)-3-methoxy-4-(1-methyl-5-nitroindol-3-ylmethyl)-N-(o-tolylsulfonyl)benzamidate416-790-9143052-96-4Aquatic Chronic 4H413H413
616-117-00-0N-[2-(3-acetyl-5-nitrothiophen-2-ylazo)-5-diethylaminophenyl]acetamide416-860-9777891-21-1Repr. 2

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H361f ***

H317

H400

H410
GHS08

GHS09

Wng
H361f ***

H317

H410
616-118-00-6N-(2',6'-dimethylphenyl)-2-piperidinecarboxamide hydrochloride417-950-065797-42-4Acute Tox. 4 *

Aquatic Chronic 3
H302

H412
GHS07

Wng
H302

H412
616-119-00-12-(1-butyl-3,5-dioxo-2-phenyl-(1,2,4)-triazolidin-4-yl)-4,4-dimethyl-3-oxo-N-(2-methoxy-5-(2-(dodecyl-1-sulfonyl))propionylamino)-phenyl)-pentanamide418-060-5118020-93-2Aquatic Chronic 4H413H413
616-120-00-7reaction mass of: N-(3-dimethylamino-4-methyl-phenyl)-benzamide;

N-(3-dimethylamino-2-methyl-phenyl)-benzamide;

N-(3-dimethylamino-3-methyl-phenyl)-benzamide
420-600-1STOT RE 2 *

Aquatic Chronic 2
H373 **

H411
GHS08

GHS09

Wng
H373 **

H411
616-121-00-22,4-dihydroxy-N-(2-methoxyphenyl)benzamide419-090-1129205-19-2Skin Sens. 1

Aquatic Chronic 2
H317

H411
GHS07

GHS09

Wng
H317

H411
616-123-00-3N-[3-[[4-(diethylamino)-2-methylphenyl]imino]-6-oxo-1,4-cyclohexadienyl]acetamide414-740-096141-86-5Aquatic Acute 1

Aquatic Chronic 1
H400

H410
GHS09

Wng
H410
616-124-00-9lithium bis(trifluoromethylsulfonyl)imide415-300-090076-65-6Acute Tox. 3 *

Acute Tox. 3 *

Skin Corr. 1B

Aquatic Chronic 3
H311

H301

H314

H412
GHS06

GHS05

Dgr
H311

H301

H314

H412
616-125-00-43-cyano-N-(1,1-dimethylethyl)androsta-3,5-diene-17-β-carboxamide415-730-9151338-11-3Aquatic Acute 1

Aquatic Chronic 1
H400

H410
GHS09

Wng
410
616-127-00-5reaction mass of: N,N'-Ethane-1,2-diylbis(decanamide);

12-Hydroxy-N-[2-[1-oxydecyl)amino]ethyl]octadecanamide;

N,N'-Ethane-1,2-diylbis(12-hydroxyoctadecanamide)
430-050-2Skin Sens. 1

Aquatic Chronic 2
H317

H411
GHS07

GHS09

Wng
H317

H411
616-128-00-0N-(2-(1-allyl-4,5-dicyanoimidazol-2-ylazo)-5-(dipropylamino)phenyl)-acetamide417-530-7123590-00-1Aquatic Chronic 4H413H413
616-129-00-6N,N'-bis(2,2,6,6-tetramethyl-4-piperidyl)isophthalamide419-710-042774-15-2Acute Tox. 4 *

Eye Irrit. 2
H302

H319
GHS07

Wng
H302

H319
616-130-00-1N-(3-(2-(4,4-dimethyl-2,5-dioxo-imidazolin-1-yl)-4,4-dimethyl-3-oxo-pentanoylamino)-4-methoxy-phenyl)-octadecanamide421-780-2150919-56-5Aquatic Chronic 4H413H413
616-132-00-2N-[4-(4-cyano-2-furfurylidene-2,5-dihydro-5-oxo-3-furyl)phenyl]butane-1-sulfonamide423-250-6130016-98-7Aquatic Acute 1

Aquatic Chronic 1
H400

H410
GHS09

Wng
H410
616-133-00-8N-cyclohexyl-S,S-dioxobenzo[b]tiophene-2-carboxamide423-990-1149118-66-1Acute Tox. 4 *

Eye Dam. 1

Aquatic Acute 1

Aquatic Chronic 1
H302

H318

H400

H410
GHS05

GHS07

GHS09

Dgr
H302

H318

H410
616-134-00-33,3'-bis(dioctyloxyphosphinothioylthio)-N,N'-oxybis(methylene)dipropionamide401-820-5793710-14-2Aquatic Chronic 3H412H412
616-135-00-9(3S,4aS,8aS)-2-[(2R,3S)-3-amino-2-hydroxy-4-phenylbutyl]-N-tert-butyldecahydroisoquinoline-3-carboxamide430-230-0136522-17-3Acute Tox. 4 *

Aquatic Chronic 3
H302

H412
GHS07

Wng
H302

H412
616-142-00-71,3-Bis(vinylsulfonylacetamido)propane428-350-393629-90-4Muta. 2

Eye Dam. 1

Skin Sens. 1

Aquatic Chronic 3
H341

H318

H317

H412
GHS08

GHS05

GHS07

Dgr
H341

H318

H317

H412
616-143-00-2N,N'-dihexadecyl-N,N'-bis(2-hydroxyethyl)propanediamide422-560-9149591-38-8Repr. 2

Eye Irrit. 2

Aquatic Chronic 4
H361f ***

H319

H413
GHS08

Wng
H361f ***

H319

H413
617-001-00-2di-tert-butyl peroxide203-733-6110-05-4Org. Perox. E

Flam. Liq. 2
H242

H225
GHS02

Dgr
H242

H225
617-002-00-8α, α-dimethylbenzyl hydroperoxide;

cumene hydroperoxide
201-254-780-15-9Org. Perox. E

Acute Tox. 3 *

Acute Tox. 4 *

Acute Tox. 4 *

STOT RE 2 *

Skin Corr. 1B

Aquatic Chronic 2
H242

H331

H312

H302

H373 **

H314

H411
GHS02

GHS06

GHS08

GHS05

GHS09

Dgr
H242

H331

H312

H302

H373 **

H314

H411
Skin Corr. 1B; H314: C ≥ 10 %

Skin Irrit. 2; H315: 3 % ≤ C < 10 %

Eye Dam. 1; H318: 3 % ≤ C < 10 %

Eye Irrit. 2; H319: 1 % ≤ C < 3 %

STOT SE 3; H335: C < 10 %
617-003-00-3dilauroyl peroxide203-326-3105-74-8Org. Perox. DH242GHS02

Dgr
H242
617-004-00-91,2,3,4-tetrahydro-1-naphthyl hydroperoxide212-230-0771-29-9Org. Perox. D

Acute Tox. 4 *

Skin Corr. 1B

Aquatic Acute 1

Aquatic Chronic 1
H242

H302

H314

H400

H410
GHS02

GHS05

GHS07

GHS09

Dgr
H242

H302

H314

H410
STOT SE 3; H335: C ≥ 5 %
617-006-00-Xbis(α, α-dimethylbenzyl) peroxide201-279-380-43-3Org. Perox. F

Eye Irrit. 2

Skin Irrit. 2

Aquatic Chronic 2
H242

H319

H315

H411
GHS02

GHS07

GHS09

Wng
H242

H319

H315

H411
617-007-00-5tert-butyl α, α-dimethylbenzyl peroxide222-389-83457-61-2Org. Perox. E Skin Irrit. 2

Aquatic Chronic 2
H242

H315

H411
GHS02

GHS07

GHS09

Wng
H242

H315

H411
617-008-00-0dibenzoyl peroxide;

benzoyl peroxide
202-327-694-36-0Org. Perox. B

Eye Irrit. 2

Skin Sens. 1
H241

H319

H317
GHS01

GHS02

GHS07

Wng
H241

H319

H317
T
617-010-00-11-hydroperoxycyclohexyl 1-hydroxycyclohexyl peroxide; [1]

1,1'-dioxybiscyclohexan-1-ol; [2]

cyclohexylidene hydroperoxide; [3]

cyclohexanone, peroxide [4]

[> 91 % solution]
201-091-1 [1]

219-306-2 [2]

220-279-4 [3]

235-527-7 [4]
78-18-2 [1]

2407-94-5 [2]

2699-11-8 [3]

12262-58-7 [4]
Org. Perox. A

Acute Tox. 4 *

Skin Corr. 1B
H240

H302

H314
GHS01

GHS05

GHS07

Dgr
H240

H302

H314
STOT SE 3; H335: C ≥ 5 %C T
617-010-01-91-hydroperoxycyclohexyl 1-hydroxycyclohexyl peroxide; [1]

1,1'-dioxybiscyclohexan-1-ol; [2]

cyclohexylidene hydroperoxide; [3]

cyclohexanone, peroxide [4]

[≤ 91 % solution]
201-091-1 [1]

219-306-2 [2]

220-279-4 [3]

235-527-7 [4]
78-18-2 [1]

2407-94-5 [2]

2699-11-8 [3]

12262-58-7 [4]
Org. Perox. C

Acute Tox. 4 *

Skin Corr. 1B
H242

H302

H314
GHS02

GHS05

GHS07

Dgr
H242

H302

H314
STOT SE 3; H335: C ≥ 5 %C T
617-012-00-28-p-menthyl hydroperoxide;

p-menthane hydroperoxide
201-281-480-47-7Org. Perox. D

Skin Corr. 1B

Acute Tox. 4 *
H242

H314

H332
GHS02

GHS05

GHS07

Dgr
H242

H314

H332
STOT SE 3; H335: C ≥ 5 %
617-013-00-8O,O-tert-butyl O-docosyl monoperoxyoxalate404-300-6116753-76-5Org. Perox. C ****

Aquatic Acute 1

Aquatic Chronic 1
H242

H400

H410
GHS02

GHS09

Dgr
H242

H410
617-014-00-36-(nonylamino)-6-oxo-peroxyhexanoic acid406-680-9104788-63-8Org. Perox. C ****

Eye Dam. 1

Skin Sens. 1

Aquatic Acute 1
H242

H318

H317

H400
GHS02

GHS05

GHS07

GHS09

Dgr
H242

H318

H317

H400
617-015-00-9bis(4-methylbenzoyl)peroxide407-950-9895-85-2Org. Perox. B ****

Aquatic Acute 1

Aquatic Chronic 1
H241

H400

H410
GHS01

GHS02

GHS09

Dgr
H241

H410
617-016-00-43-hydroxy-1,1-dimethylbutyl 2-ethyl-2-methylheptaneperoxoate413-910-1Org. Perox. C ****

Flam. Liq. 3

Skin Irrit. 2

Aquatic Acute 1

Aquatic Chronic 1
H242

H226

H315

H400

H410
GHS02

GHS07

GHS09

Dgr
H242

H226

H315

H410
617-017-00-Xreaction mass of: 2,2'-bis(tert-pentylperoxy)-p-diisopropylbenzene;

2,2'-bis(tert-pentylperoxy)-m-diisopropylbenzene
412-140-332144-25-5Org. Perox. D ****

Aquatic Chronic 4
H242

H413
GHS02

Dgr
H242

H413
T
617-018-00-5reaction mass of: 1-methyl-1-(3-(1-methylethyl)phenyl)ethyl-1-methyl-1-phenylethylperoxide, 63 % by weight;

1-methyl-1-(4-(1-methylethyl)phenyl)ethyl-1-methyl-1-phenylethylperoxide, 31 % by weight
410-840-371566-50-2Org. Perox. C ****

Aquatic Chronic 2
H242

H411
GHS02

GHS09

Dgr
H242

H411
T
617-019-00-06-(phthalimido)peroxyhexanoic acid410-850-8128275-31-0Org. Perox. D

Eye Dam. 1

Aquatic Acute 1
H242

H318

H400
GHS02

GHS05

GHS09

DgDgr
H242

H318

H400
T
617-020-00-61,3-di(prop-2,2-diyl)benzene bis(neodecanoylperoxide)420-060-5117663-11-3Flam. Liq. 3

Org. Perox. D ****

Aquatic Chronic 2
H226

H242

H411
GHS02

GHS09

Dgr
H226

H242

H411
647-001-00-8glucosidase, β-232-589-79001-22-3Resp. Sens. 1H334GHS08

Dgr
H334
647-002-00-3cellulase232-734-49012-54-8Resp. Sens. 1H334GHS08

Dgr
H334
647-003-00-9cellobiohydrolase, exo-253-465-937329-65-0Resp. Sens. 1H334GHS08

Dgr
H334
647-004-00-4cellulases with the exception of those specified elsewhere in this AnnexResp. Sens. 1H334GHS08

Dgr
H334A
647-005-00-Xbromelain, juice232-572-49001-00-7Eye Irrit. 2

STOT SE 3

Skin Irrit. 2

Resp. Sens. 1
H319

H335

H315

H334
GHS08

GHS07

Dgr
H319

H335

H315

H334
647-006-00-5ficin232-599-19001-33-6Eye Irrit. 2

STOT SE 3

Skin Irrit. 2

Resp. Sens. 1
H319

H335

H315

H334
GHS08

GHS07

Dgr
H319

H335

H315

H334
647-007-00-0papain232-627-29001-73-4Eye Irrit. 2

STOT SE 3

Skin Irrit. 2

Resp. Sens. 1
H319

H335

H315

H334
GHS08

GHS07

Dgr
H319

H335

H315

H334
647-008-00-6pepsin A232-629-39001-75-6Eye Irrit. 2

STOT SE 3

Skin Irrit. 2

Resp. Sens. 1
H319

H335

H315

H334
GHS08

GHS07

Dgr
H319

H335

H315

H334
647-009-00-1rennin232-645-09001-98-3Eye Irrit. 2

STOT SE 3

Skin Irrit. 2

Resp. Sens. 1
H319

H335

H315

H334
GHS08

GHS07

Dgr
H319

H335

H315

H334
647-010-00-7trypsin232-650-89002-07-7Eye Irrit. 2

STOT SE 3

Skin Irrit. 2

Resp. Sens. 1
H319

H335

H315

H334
GHS08

GHS07

Dgr
H319

H335

H315

H334
647-011-00-2chymotrypsin232-671-29004-07-3Eye Irrit. 2

STOT SE 3

Skin Irrit. 2

Resp. Sens. 1
H319

H335

H315

H334
GHS08

GHS07

Dgr
H319

H335

H315

H334
647-012-00-8subtilisin232-752-29014-01-1STOT SE 3

Skin Irrit. 2

Eye Dam. 1

Resp. Sens. 1
H335

H315

H318

H334
GHS08

GHS05 GHS07

Dgr
H335

H315

H318

H334
647-013-00-3proteinase, microbial neutral232-966-69068-59-1Eye Irrit. 2

STOT SE 3

Skin Irrit. 2

Resp. Sens. 1
H319

H335

H315

H334
GHS08

GHS07

Dgr
H319

H335

H315

H334
647-014-00-9proteases with the exception of those specified elsewhere in this AnnexEye Irrit. 2

STOT SE 3

Skin Irrit. 2

Resp. Sens. 1
H319

H335

H315

H334
GHS08

GHS07

Dgr
H319

H335

H315

H334
647-015-00-4amylase, α-232-565-69000-90-2Resp. Sens. 1H334GHS08

Dgr
H334
647-016-00-Xamylases with the exception of those specified elsewhere in this AnnexResp. Sens. 1H334GHS08

Dgr
H334
648-001-00-0Distillates (coal tar), benzole fraction;

Light Oil;

[A complex combination of hydrocarbons obtained by the distillation of coal tar. It consists of hydrocarbons having carbon numbers primarily in the range of C4 to C10 and distilling in the approximate range of 80 oC to 160 oC (175 oF to 320 oF).]
283-482-784650-02-2Carc. 1BH350GHS08

Dgr
H350H
648-002-00-6Tar oils, brown-coal;

Light Oil;

[The distillate from lignite tar boiling in the range of approximately 80 oC to 250 oC (176 oF to 482 oF). Composed primarily of aliphatic and aromatic hydrocarbons and monobasic phenols.]
302-674-494114-40-6Carc. 1BH350GHS08

Dgr
H350H J
648-003-00-1Benzol forerunnings (coal);

Light Oil Redistillate, low boiling;

[The distillate from coke oven light oil having an approximate distillation range below 100 oC (212 oF). Composed primarily of C4 to C6 aliphatic hydrocarbons.]
266-023-565996-88-5Carc. 1BH350GHS08

Dgr
H350H J
648-004-00-7Distillates (coal tar), benzole fraction, BTX-rich;

Light Oil Redistillate, low boiling;

[A residue from the distillation of crude benzole to remove benzole fronts. Composed primarily of benzene, toluene and xylenes boiling in the range of approximately 75 oC to 200 oC (167 oF to 392 oF).]
309-984-9101896-26-8Carc. 1BH350GHS08

Dgr
H350H J
648-005-00-2Aromatic hydrocarbons, C6-10, C8-rich;

Light Oil Redistillate, low boiling
292-697-590989-41-6Carc. 1BH350GHS08

Dgr
H350H J
648-006-00-8Solvent naphtha (coal), light;

Light Oil Redistillate, low boiling
287-498-585536-17-0Carc. 1BH350GHS08

Dgr
H350H J
648-007-00-3Solvent naphtha (coal), xylene-styrene cut;

Light Oil Redistillate, intermediate boiling
287-502-585536-20-5Carc. 1BH350GHS08

Dgr
H350H J
648-008-00-9Solvent naphtha (coal), coumarone-styrene contg.;

Light Oil Redistillate, intermediate boiling
287-500-485536-19-2Carc. 1BH350GHS08

Dgr
H350H J
648-009-00-4Naphtha (coal), distn. residues;

Light Oil Redistillate, high boiling;

[The residue remaining from the distillation of recovered naphtha. Composed primarily of naphthalene and condensation products of indene and styrene.]
292-636-290641-12-6Carc. 1BH350GHS08

Dgr
H350H J
648-010-00-XAromatic hydrocarbons, C8;

Light Oil Redistillate, high boiling
292-694-990989-38-1Carc. 1BH350GHS08

Dgr
H350H J
648-012-00-0Aromatic hydrocarbons, C8-9, hydrocarbon resin polymn. by-product;

Light Oil Redistillate, high boiling;

[A complex combination of hydrocarbons obtained from the evaporation of solvent under vacuum from polymerized hydrocarbon resin. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C8 through C9 and boiling in the range of approximately 120 oC to 215 oC (248 oF to 419 oF).]
295-281-191995-20-9Carc. 1BH350GHS08

Dgr
H350H J
648-013-00-6Aromatic hydrocarbons, C9-12, benzene distn.;

Light Oil Redistillate, high boiling
295-551-992062-36-7Carc. 1BH350GHS08

Dgr
H350H J
648-014-00-1Extract residues (coal), benzole fraction alk., acid ext.;

Light Oil Extract Residues, low boiling;

[The redistillate from the distillate, freed of tar acids and tar bases, from bituminous coal high temperature tar boiling in the approximate range of 90 oC to 160 oC (194 oF to 320 oF). It consists predominantly of benzene, toluene and xylenes.]
295-323-991995-61-8Carc. 1BH350GHS08

Dgr
H350H J
648-015-00-7Extract residues (coal tar), benzole fraction alk., acid ext.;

Light Oil Extract Residues, low boiling;

[A complex combination of hydrocarbons obtained by the redistillation of the distillate of high temperature coal tar (tar acid and tar base free). It consists predominantly of unsubstituted and substituted mononuclear aromatic hydrocarbons boiling in the range of 85 oC-195 oC (185 oF-383 oF).]
309-868-8101316-63-6Carc. 1BH350GHS08

Dgr
H350H J
648-016-00-2Extract residues (coal), benzole fraction acid;

Light Oil Extract Residues, low boiling;

[An acid sludge by-product of the sulphuric acid refining of crude high temperature coal. Composed primarily of sulfuric acid and organic compounds.]
298-725-293821-38-6Carc. 1BH350GHS08

Dgr
H350H J
648-017-00-8Extract residues (coal), light oil alk., distn. overheads;

Light Oil Extract Residues, low boiling;

[The first fraction from the distillation of aromatic hydrocarbons, coumarone, naphthalene and indene rich prefactionator bottoms or washed carbolic oil boiling substantially below 145 oC (293 oF). Composed primarily of C7 and C8 aliphatic and aromatic hydrocarbons.]
292-625-290641-02-4Carc. 1BH350GHS08

Dgr
H350H J
648-018-00-3Extract residues (coal), light oil alk., acid ext., indene fraction;

Light Oil Extract Residues, intermediate boiling
309-867-2101316-62-5Carc. 1BH350GHS08

Dgr
H350H J
648-019-00-9Extract residues (coal), light oil alk., indene naphtha fraction;

Light Oil Extract Residues, high boiling;

[The distillate from aromatic hydrocarbons, coumarone, naphthalene and indene rich prefractionator bottoms or washed carbolic oils, having an approximate boiling range of 155 oC to 180 oC (311 oF to 356 oF). Composed primarily of indene, indan and trimethylbenzenes.]
292-626-890641-03-5Carc. 1BH350GHS08

Dgr
H350H J
648-020-00-4Solvent naphtha (coal);

Light Oil Extract Residues, high boiling;

[The distillate from either high temperature coal tar, coke oven light oil, or coal tar oil alkaline extract residue having an approximate distillation range of 130 oC to 210 oC (266 oF to 410 oF) Composed primarily of indene and other polycyclic ring systems containing a single aromatic ring. May contain phenolic compounds and aromatic nitrogen bases.]
266-013-065996-79-4Carc. 1BH350GHS08

Dgr
H350H J
648-021-00-XDistillates (coal tar), light oils, neutral fraction;

Light Oil Extract Residues, high boiling;

[A distillate from the fractional distillation of high temperature coal tar. Composed primarily of alkyl-substituted one ring aromatic hydrocarbons boiling in the range of approximately 135 oC to 210 oC (275 oF to 410 oF). May also include unsaturated hydrocarbons such as indene and coumarone.]
309-971-8101794-90-5Carc. 1BH350GHS08

Dgr
H350H J
648-022-00-5Distillates (coal tar), light oils, acid exts.;

Light Oil Extract Residues, high boiling;

[This oil is a complex mixture of aromatic hydrocarbons, primarily indene, naphthalene, coumarone, phenol, and o-, m- and p-cresol and boiling in the range of 140 oC to 215 oC (284 oF to 419 oF).]
292-609-590640-87-2Carc. 1BH350GHS08

Dgr
H350H J
648-023-00-0Distillates (coal tar), light oils;

Carbolic Oil;

[A complex combination of hydrocarbons obtained by distillation of coal tar. It consists of aromatic and other hydrocarbons, phenolic compounds and aromatic nitrogen compounds and distills at the approximate range of 150 oC to 210 oC (302 oF to 410 oF).]
283-483-284650-03-3Carc. 1BH350GHS08

Dgr
H350H J
648-024-00-6Tar oils, coal;

Carbolic Oil;

[The distillate from high temperature coal tar having an approximate distillation range of 130 oC to 250 oC (266 oF to 410 oF). Composed primarily of naphthalene, alkylnaphthalenes, phenolic compounds, and aromatic nitrogen bases.]
266-016-765996-82-9Carc. 1BH350GHS08

Dgr
H350H J
648-026-00-7Extract residues (coal), light oil alk., acid ext.;

Carbolic Oil Extract Residue;

[The oil resulting from the acid washing of alkali-washed carbolic oil to remove the minor amounts of basic compounds (tar bases). Composed primarily of indene, indan and alkylbenzenes.]
292-624-790641-01-3Carc. 1BH350GHS08

Dgr
H350H J
648-027-00-2Extract residues (coal), tar oil alk.;

Carbolic Oil Extract Residue;

[The residue obtained from coal tar oil by an alkaline wash such as aqueous sodium hydroxide after the removal of crude coal tar acids. Composed primarily of naphthalenes and aromatic nitrogen bases.]
266-021-465996-87-4Carc. 1BH350GHS08

Dgr
H350H J
648-028-00-8Extract oils (coal), light oil;

Acid Extract;

[The aqueous extract produced by an acidic wash of alkali-washed carbolic oil. Composed primarily of acid salts of various aromatic nitrogen bases including pyridine, quinoline and their alkyl derivatives.]
292-622-690640-99-6Carc. 1BH350GHS08

Dgr
H350H J
648-029-00-3Pyridine, alkyl derivs.;

Crude Tar Bases;

[The complex combination of polyalkylated pyridines derived from coal tar distillation or as high-boiling distillates approximately above 150 oC (302 oF) from the reaction of ammonia with acetaldehyde, formaldehyde or paraformaldehyde.]
269-929-968391-11-7Carc. 1BH350GHS08

Dgr
H350H J
648-030-00-9Tar bases, coal, picoline fraction;

Distillate Bases;

[Pyridine bases boiling in the range of approximately 125 oC to 160 oC (257 oF 320 oF) obtained by distillation of neutralized acid extract of the base-containing tar fraction obtained by the distillation of bituminous coal tars. Composed chiefly of lutidines and picolines.]
295-548-292062-33-4Carc. 1BH350GHS08

Dgr
H350H J
648-031-00-4Tar bases, coal, lutidine fraction;

Distillate Bases
293-766-291082-52-9Carc. 1BH350GHS08

Dgr
H350H J
648-032-00-XExtract oils (coal), tar base, collidine fraction;

Distillate Bases;

[The extract produced by the acidic extraction of bases from crude coal tar aromatic oils, neutralization, and distillation of the bases. Composed primarily of collidines, aniline, toluidines, lutidines, xylidines.]
273-077-368937-63-3Carc. 1BH350GHS08

Dgr
H350H J
648-033-00-5Tar bases, coal, collidine fraction;

Distillate Bases;

[The distillation fraction boiling in the range of approximately 181 oC to 186 oC (356 oF to 367 oF) from the crude bases obtained from the neutralized, acid-extracted base-containing tar fractions obtained by the distillation of bituminous coal tar. It contains chiefly aniline and collidines.]
295-543-592062-28-7Carc. 1BH350GHS08

Dgr
H350H J
648-034-00-0Tar bases, coal, aniline fraction;

Distillate Bases;

[The distillation fraction boiling in the range of approximately 180 oC to 200 oC (356 oF to 392 oF) from the crude bases obtained by dephenolating and debasing the carbolated oil from the distillation of coal tar. It contains chiefly aniline, collidines, lutidines and toluidines.]
295-541-492062-27-6Carc. 1BH350GHS08

Dgr
H350H J
648-035-00-6Tar bases, coal, toluidine fraction;

Distillate Bases
293-767-891082-53-0Carc. 1BH350GHS08

Dgr
H350H J
648-036-00-1Distillates (petroleum), alkene-alkyne manuf. pyrolysis oil, mixed with high-temp. coal tar, indene fraction;

Redistillates;

[A complex combination of hydrocarbons obtained as a redistillate from the fractional distillation of bituminous coal high temperature tar and residual oils that are obtained by the pyrolytic production of alkenes and alkynes from petroleum products or natural gas. It consists predominantly of indene and boils in a range of approximately 160 oC to 190 oC (320 oF to 374 oF).]
295-292-191995-31-2Carc. 1BH350GHS08

Dgr
H350H J
648-037-00-7Distillates (coal), coal tar-residual pyrolysis oils, naphthalene oils;

Redistillates;

[The redistillate obtained from the fractional distillation of bituminous coal high temperature tar and pyrolysis residual oils and boiling in the range of approximately 190 oC to 270 oC (374 oF to 518 oF). Composed primarily of substituted dinuclear aromatics.]
295-295-891995-35-6Carc. 1BH350GHS08

Dgr
H350H J
648-038-00-2Extract oils (coal), coal tar-residual pyrolysis oils, naphthalene oil, redistillate;

Redistillates;

[The redistillate from the fractional distillation of dephenolated and debased methylnaphthalene oil obtained from bituminous coal high temperature tar and pyrolysis residual oils boiling in the approximate range of 220 oC to 230 oC (428 oF to 446 oF). It consists predominantly of unsubstituted and substituted dinuclear aromatic hydrocarbons.]
295-329-191995-66-3Carc. 1BH350GHS08

Dgr
H350H J
648-039-00-8Extract oils (coal), coal tar-residual pyrolysis oils, naphthalene oils;

Redistillates;

[A neutral oil obtained by debasing and dephenolating the oil obtained from the distillation of high temperature tar and pyrolysis residuel oils which has a boiling range of 225 oC to 255 oC (437 oF to 491 oF). Composed primarily of substituted dinuclear aromatic hydrocarbons.]
310-170-0122070-79-5Carc. 1BH350GHS08

Dgr
H350H J
648-040-00-3Extract oils (coal), coal tar residual pyrolysis oils, naphthalene oil, distn. residues;

Redistillates;

[Residue from the distillation of dephenolated and debased methylnaphthalene oil (from bituminous coal tar and pyrolysis residual oils) with a boiling range of 240 oC to 260 oC (464 oF to 500 oF). Composed primarily of substituted dinuclear aromatic and heterocyclic hydrocarbons.]
310-171-6122070-80-8Carc. 1BH350GHS08

Dgr
H350H J
648-041-00-9Absorption oils, bicyclo arom. and heterocyclic hydrocarbon fraction;

Wash Oil Redistillate;

[A complex combination of hydrocarbons obtained as a redistillate from the distillation of wash oil. It consists predominantly of 2-ringed aromatic and heterocyclic hydrocarbons boiling in the range of approximately 260 oC to 290 oC (500 oF to 554 oF).]
309-851-5101316-45-4Carc. 1BH350GHS08

Dgr
H350H M
648-042-00-4Distillates (coal tar), upper, fluorene-rich;

Wash Oil Redistillate;

[A complex combination of hydrocarbons obtained by the crystallization of tar oil. It consists af aromatic and polycyclic hydrocarbons primarily fluorene and some acenaphthene.]
284-900-084989-11-7Carc. 1BH350GHS08

Dgr
H350H M
648-043-00-XCreosote oil, acenaphthene fraction, acenaphthene-free;

Wash Oil Redistillate;

[The oil remaining after removal by a crystallization process of acenaphthene from acenaphthene oil from coal tar. Composed primarily of naphthalene and alkylnaphthalenes.]
292-606-990640-85-0Carc. 1BH350GHS08

Dgr
H350H
648-044-00-5Distillates (coal tar), heavy oils;

Heavy Anthracene Oil;

[Distillate from the fractional distillation of coal tar of bituminous coal, with boiling range of 240 oC to 400 oC (464 oF to 752 oF). Composed primarily of tri- and polynuclear hydrocarbons and heterocyclic compounds.]
292-607-490640-86-1Carc. 1BH350GHS08

Dgr
H350H
648-045-00-0Distillates (coal tar), upper;

Heavy Anthracene Oil;

[The distillate from coal tar having an approximate distillation range of 220 oC to 450 oC (428 oF to 842 oF). Composed primarily of three to four membered condensed ring aromatic hydrocarbons and other hydrocarbons.]
266-026-165996-91-0Carc. 1BH350GHS08

Dgr
H350H M
648-046-00-6Anthracene oil, acid ext.;

Anthracene Oil Extract Residue;

[A complex combination of hydrocarbons from the base-freed fraction obtained from the distillation of coal tar and boiling in the range of approximately 325 oC to 365 oC (617 oF to 689 oF). It contains predominantly anthracene and phenanthrene and their alkyl derivatives.]
295-274-391995-14-1Carc. 1BH350GHS08

Dgr
H350H M
648-047-00-1Distillates (coal tar);

Heavy Anthracene Oil;

[The distillate from coal tar having an approximate distillation range of 100 oC to 450 oC (212 oF to 842 oF). Composed primarily of two to four membered condensed ring aromatic hydrocarbons, phenolic compounds, and aromatic nitrogen bases.]
266-027-765996-92-1Carc. 1BH350GHS08

Dgr
H350H M
648-048-00-7Distillates (coal tar), pitch, heavy oils;

Heavy Anthracene Oil;

[The distillate from the distillation of the pitch obtained from bituminous high temperature tar. Composed primarily of tri- and polynuclear aromatic hydrocarbons and boiling in the range of approximately 300 oC to 470 oC (572 oF to 878 oF). The product may also contain heteroatoms.]
295-312-991995-51-6Carc. 1BH350GHS08

Dgr
H350H M
648-049-00-2Distillates (coal tar), pitch;

Heavy Anthracene Oil;

[The oil obtained from condensation of the vapors from the heat treatment of pitch. Composed primarily of two- to four-ring aromatic compounds boiling in the range of 200 oC to greater than 400 oC (392 oF to greater than 752 oF).]
309-855-7101316-49-8Carc. 1BH350GHS08

Dgr
H350H M
648-050-00-8Distillates (coal tar), heavy oils, pyrene fraction;

Heavy Anthracene Oil Redistillate;

[The redistillate obtained from the fractional distillation of pitch distillate boiling in the range of approximately 350 oC to 400 oC (662 oF to 752 oF). Consists predominantly of tri- and polynuclear aromatics and heterocyclic hydrocarbons.]
295-304-591995-42-5Carc. 1BH350GHS08

Dgr
H350H M
648-051-00-3Distillates (coal tar), pitch, pyrene fraction;

Heavy Anthracene Oil Redistillate;

[The redistillate obtained from the fractional distillation of pitch distillate and boiling in the range of approximately 380 oC to 410 oC (7160 to 770 oF). Composed primarily of tri- and polynuclear aromatic hydrocarbons and heterocyclic compounds.]
295-313-491995-52-7Carc. 1BH350GHS08

Dgr
H350H M
648-052-00-9Paraffin waxes (coal), brown-coal high-temp. tar, carbon-treated;

Coal Tar Extract;

[A complet combination of hydrocarbons obtained by the treatment of lignite carbonization tar with activated carbon for removal of trace constituents and impurities. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C12.]
308-296-697926-76-6Carc. 1BH350GHS08

Dgr
H350H M
648-053-00-4Paraffin waxes (coal), brown-coal high-temp tar, clay-treated;

Coal Tar Extract;

[A complex combination of hydrocarbons obtained by the treatment of lignite carbonization tar with bentonite for removal of trace constituents and impurities. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C12.]
308-297-197926-77-7Carc. 1BH350GHS08

Dgr
H350H M
648-054-00-XPitch;

Pitch
263-072-461789-60-4Carc. 1BH350GHS08

Dgr
H350H M
648-055-00-5Pitch, coal tar, high-temp.;

Pitch;

[The residue from the distillation of high temperature coal tar. A black solid with an approximate softening point from 30 oC to 180 oC (86 oF to 356 oF). Composed primarily of a complex mixture of three or more membered condensed ring aromatic hydrocarbons.]
266-028-265996-93-2Carc. 1BH350GHS08

Dgr
H350H
648-056-00-0Pitch, coal tar, high-temp., heat-treated;

Pitch;

[The heat treated residue from the distillation of high temperature coal tar. A black solid with an approximate softening point from 80 oC to 180 oC (176 oF to 356 oF). Composed primarily of a complex mixture of three or more membered condensed ring aromatic hydrocarbons.]
310-162-7121575-60-8Carc. 1BH350GHS08

Dgr
H350H M
648-057-00-6Pitch, coal tar, high-temp., secondary;

Pitch Redistillate;

[The residue obtained during the distillation of high boiling fractions from bituminous coal high temperature tar and/or pitch coke oil, with a softening point of 140 oC to 170 oC (284 oF to 392 oF) according to DIN 52025. Composed primarily of tri- and polynuclear aromatic compounds which also contain heteroatoms.]
302-650-394114-13-3Carc. 1BH350GHS08

Dgr
H350H M
648-058-00-1Residues (coal tar), pitch distn.;

Pitch Redistillate;

[Residue from the fractional distillation of pitch distillate boiling in the range of approximately 400 oC to 470 oC (752 oF to 846 oF). Composed primarily of polynuclear aromatic hydrocarbons, and heterocyclic compounds.]
295-507-992061-94-4Carc. 1BH350GHS08

Dgr
H350H M
648-059-00-7Tar, coal, high-temp., distn. and storage residues;

Coal Tar Solids Residue;

[Coke- and ash-containing solid residues that separate on distillation and thermal treatment of bituminous coal high temperature tar in distillation installations and storage vessels. Consists predominantly of carbon and contains a small quantity of hetero compounds as well as ash components.]
295-535-192062-20-9Carc. 1BH350GHS08

Dgr
H350H M
648-060-00-2Tar, coal, storage residues;

Coal Tar Solids Residue;

[The deposit removed from crude coal tar storages. Composed primarily of coal tar and carbonaceous particulate matter.]
293-764-191082-50-7Carc. 1BH350GHS08

Dgr
H350H M
648-061-00-8Tar, coal, high-temp., residues;

Coal Tar Solids Residue;

[Solids formed during the coking of bituminous coal to produce crude bituminous coal high temperature tar. Composed primarily of coke and coal particles, highly aromatized compounds and mineral substances.]
309-726-5100684-51-3Carc. 1BH350GHS08

Dgr
H350H M
648-062-00-3Tar, coal, high-temp., high-solids;

Coal Tar Solids Residue;

[The condensation product obtained by cooling, to approximately ambient temperature, the gas evolved in the high temperature (greater than 700 oC (1292 oF)) destructive distillation of coal. Composed primarily of a complex mixture of condensed ring aromatic hydrocarbons with a high solid content of coal-type materials.]
273-615-768990-61-4Carc. 1BH350GHS08

Dgr
H350H M
648-063-00-9Waste solids, coal-tar pitch coking;

Coal Tar Solids Residue;

[The combination of wastes formed by the coking of bituminous coal tar pitch. It consists predominantly of carbon.]
295-549-892062-34-5Carc. 1BH350GHS08

Dgr
H350H M
648-064-00-4Extract residues (coal), brown;

Coal Tar Extract;

[The residue from extraction of dried coal.]
294-285-091697-23-3Carc. 1BH350GHS08

Dgr
H350H M
648-065-00-XParaffin waxes (coal), brown-coal-high-temp. tar;

Coal Tar Extract;

[A complex combination of hydrocarbons obtained from lignite carbonization tar by solvent crystallisation (solvent deoiling), by sweating or an adducting process. It consists predominantly of straight and branched chain saturated hydrocarbons having carbon numbers predominantly greater than C12.]
295-454-192045-71-1Carc. 1BH350GHS08

Dgr
H350H M
648-066-00-5Paraffin waxes (coal), brown-coal-high-temp. tar, hydrotreated;

Coal Tar Extract;

[A complex combination of hydrocarbons obtained from lignite carbonization tar by solvent crystallisation (solvent deoiling), by sweating or an adducting process treated with hydrogen in the presence of a catalyst. It consists predominantly of straight and branched chain saturated hydrocarbons having carbon numbers predominantly greater than C12.]
295-455-792045-72-2Carc. 1BH350GHS08

Dgr
H350H M
648-067-00-0Paraffin waxes (coal), brown-coal high-temp tar, silicic acid-treated;

Coal Tar Extract;

[A complex combination of hydrocarbons obtained by the treatment of lignite carbonization tar with silicic acid for removal of trace constituents and impurities. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C12.]
308-298-797926-78-8Carc. 1BH350GHS08

Dgr
H350H M
648-068-00-6Tar, coal, low-temp., distn. residues;

Tar Oil, intermediate boiling;

[Residues from fractional distillation of low temperature coal tar to remove oils that boil in a range up to approximately 300 oC (572 oF). Composed primarily of aromatic compounds.]
309-887-1101316-85-2Carc. 1BH350GHS08

Dgr
H350H M
648-069-00-1Pitch, coal tar, low-temp;

Pitch Residue;

[A complex black solid or semi-solid obtained from the distillation of a low temperature coal tar. It has a softening point within the approximate range of 40 oC to 180 oC (104 oF to 356 oF). Composed primarily of a complex mixture of hydrocarbons.]
292-651-490669-57-1Carc. 1BH350GHS08

Dgr
H350H M
648-070-00-7Pitch, coal tar, low-temp., oxidized;

Pitch Residue, oxidised;

[The product obtained by air-blowing, at elevated temperature, low-temperature coal tar pitch. It has a softening-point within the approximate range of 70 oC to 180 oC (158 oF to 356 oF). Composed primarily of a complex mixture of hydrocarbons.]
292-654-090669-59-3Carc. 1BH350GHS08

Dgr
H350H M
648-071-00-2Pitch, coal tar, low-temp., heat-treated;

Pitch Residue, oxidised;

Pitch Residue, heat-treated;

[A complex black solid obtained by the heat treatment of low temperature coal tar pitch. It has a softening point within the approximate range of 50 oC to 140 oC (122 oF to 284 oF). Composed primarily of a complex mixture of aromatic compounds.]
292-653-590669-58-2Carc. 1BH350GHS08

Dgr
H350H M
648-072-00-8Distillates (coal-petroleum), condensed-ring arom;

Distillates;

[The distillate from a mixture of coal and tar and aromatic petroleum streams having an approximate distillation range of 220 oC to 450 oC (428 oF to 842 oF). Composed primarily of 3- to 4-membered condensed ring aromatic hydrocarbons.]
269-159-368188-48-7Carc. 1BH350GHS08

Dgr
H350H M
648-073-00-3Aromatic hydrocarbons, C20-28, polycyclic, mixed coal-tar pitch-polyethylene-polypropylene pyrolysis-derived;

Pyrolysis Products;

[A complex combination hydrocarbons obtained from mixed coal tar pitch-polyethylene-polypropylene pyrolysis. Composed primarily of polycyclic aromatic hydrocarbons having carbon numbers predominantly in the range of C20 through C28 and having a softening point of 100 oC to 220 oC (212 oF to 428 oF) according to DIN 52025.]
309-956-6101794-74-5Carc. 1BH350GHS08

Dgr
H350H M
648-074-00-9Aromatic hydrocarbons, C20-28, polycyclic, mixed coal-tar pitch-polyethylene pyrolysis-derived;

Pyrolysis Products;

[A complex combination of hydrocarbons obtained from mixed coal tar pitch-polyethylene pyrolysis. Composed primarily of polycyclic aromatic hydrocarbons having carbon numbers predominantly in the range of C20 through C28 and having a softening point of 100 oC to 220 oC (212 oF to 428 oF) according to DIN 52025.]
309-957-1101794-75-6Carc. 1BH350GHS08

Dgr
H350H M
648-075-00-4Aromatic hydrocarbons, C20-28, polycyclic, mixed coal-tar pitch-polystyrene pyrolysis-derived;

Pyrolysis Products;

[A complex combination of hydrocarbons obtained from mixed coal tar pitch-polystyrene pyrolysis. Composed primarily of polycyclic aromatic hydrocarbons having carbon numbers predominantly in the range of C20 through C28 and having a softening point of 100 oC to 220 oC (212 oF to 428 oF) according to DIN 52025.]
309-958-7101794-76-7Carc. 1BH350GHS08

Dgr
H350H M
648-076-00-XPitch, coal tar-petroleum;

Pitch Residues;

[The residue from the distillation of a mixture of coal tar and aromatic petroleum streams. A solid with a softening point from 40 oC to 180 oC (140 oF to 356 oF). Composed primarily of a complex combination of three or more membered condensed ring aromatic hydrocarbons.]
269-109-068187-57-5Carc. 1BH350GHS08

Dgr
H350H M
648-077-00-5Phenanthrene, distn. residues;

Heavy Anthracene Oil Redistillate;

[Residue from the distillation of crude phenanthrene boiling in the approximate range of 340 oC to 420 oC (644 oF to 788 oF). It consists predominantly of phenanthrene, anthracene and carbazole.]
310-169-5122070-78-4Carc. 1BH350GHS08

Dgr
H350H M
648-078-00-0Distillates (coal tar), upper, fluorene-free;

Wash Oil Redistillate;

[A complex combination of hydrocarbons obtained by the crystallization of tar oil. It consists of aromatic polycyclic hydrocarbons, primarily diphenyl, dibenzofuran and acenaphthene.]
284-899-784989-10-6Carc. 1BH350GHS08

Dgr
H350H M
648-079-00-6Anthracene oil;

Anthracene oil;

[A complex combination of polycyclic aromatic hydrocarbons obtained from coal tar having an approximate distillation range of 300 oC ot 400 oC (572 oF to 752 oF). Composed primarily of phenanthrene, anthracene and carbazole.]
292-602-790640-80-5Carc. 1BH350GHS08

Dgr
H350H M
648-080-00-1Residues (coal tar), creosote oil distn.;

Wash Oil Redistillate;

[The residue from the fractional distillation of wash oil boiling in the approximate range of 270 oC to 330 oC (518 oF to 626 oF). It consists predominantly of dinuclear aromatic and heterocyclic hydrocarbons.]
295-506-392061-93-3Carc. 1BH350GHS08

Dgr
H350H
648-081-00-7Tar, coal;

Coal tar;

[The by-product from the destructive distillation of coal. Almost black semisolid. A complex combination of aromatic hydro-carbons, phenolic compounds, nitrogen bases and thiophene.]
232-361-78007-45-2Carc. 1AH350GHS08

Dgr
H350H
648-082-00-2Tar, coal, high-temp.;

Coal tar;

[The condensation product obtained by cooling, to approximately ambient temperature, the gas evolved in the high temperature (greater than 700 oC (1292 oF)) destructive distillation of coal. A black viscous liquid denser than water. Composed primarily of a complex mixture of condensed ring aromatic hydrocarbons. May contain minor amounts of phenolic compounds and aromatic nitrogen bases.]
266-024-065996-89-6Carc. 1AH350GHS08

Dgr
H350H
648-083-00-8Tar, coal, low-temp.;

Coal oil;

[The condensation product obtained by cooling, to approximately ambient temperature, the gas evolved in low temperature (less than 700 oC (1292 oF)) destructive distillation of coal. A black viscous liquid denser than water. Composed primarily of condensed ring aromatic hydrocarbons, phenolic compounds, aromatic nitrogen bases, and their alkyl derivatives.]
266-025-665996-90-9Carc. 1AH350GHS08

Dgr
H350H
648-084-00-3Distillates (coal), coke-oven light oil, naphthalene cut;

Naphthalene Oil;

[The complex combination of hydrocarbons obtained from prefractionation (continuous distillation) of coke oven light oil. It consists predominantly of naphthalene, coumarone and indene and boils above 148 oC (298 oF).]
285-076-585029-51-2Carc. 1BH350GHS08

Dgr
H350HJM
648-085-00-9Distillates (coal tar), naphthalene oils;

Naphthalene Oil;

[A complex combination of hydrocarbons obtained by the distillation of coal tar. It consists primarily of aromatic and other hydrocarbons, phenolic compounds and aromatic nitrogen compounds and distills in the approximate range of 200 oC to 250 oC (392 oF to 482 oF).]
283-484-884650-04-4Carc. 1BH350GHS08

Dgr
H350HJM
648-086-00-4Distillates (coal tar), naphthalene oils, naphthalene-low;

Naphthalene Oil Redistillate;

[A complex combination of hydrocarbons obtained by crystallization of naphthalene oil. Composed primarily of naphthalene, alkyl naphthalenes and phenolic compounds.]
284-898-184989-09-3Carc. 1BH350GHS08

Dgr
H350HJM
648-087-00-XDistillates (coal tar), naphthalene oil crystn. mother liquor;

Naphthalene Oil Redistillate;

[A complex combination of organic compounds obtained as a filtrate from the crystallization of the naphthalene fraction from coal tar and boiling in the range of approximately 200 oC to 230 oC (392 oF to 446 oF). Contains chiefly naphthalene, thionaphthene and alkylnaphthalenes.]
295-310-891995-49-2Carc. 1BH350GHS08

Dgr
H350HJM
648-088-00-5Extract residues (coal), naphthalene oil, alk.;

Naphthalene Oil Extract Residue;

[A complex combination of hydrocarbons obtained from the alkali washing of naphthalene oil to remove phenolic compounds (tar acids). It is composed of naphthalene and alkyl naphthalenes.]
310-166-9121620-47-1Carc. 1BH350GHS08

Dgr
H350HJM
648-089-00-0Extract residues (coal), naphthalene oil, alk., naphthalene-low;

Naphthalene Oil Extract Residue;

[A complex combination of hydrocarbons remaining after the removal of naphthalene from alkali-washed naphthalene oil by a crystallization process. It is composed primarily of naphthalene and alkyl naphthalenes.]
310-167-4121620-48-2Carc. 1BH350GHS08

Dgr
H350HJM
648-090-00-6Distillates (coal tar), naphthalene oils, naphthalene-free, alk. exts.;

Naphthalene Oil Extract Residue;

[The oil remaining after the removal of phenolic compounds (tar acids) from drained naphthalene oil by an alkali wash. Composed primarily of naphthalene and alkyl naphthalenes.]
292-612-190640-90-7Carc. 1BH350GHS08

Dgr
H350HJM
648-091-00-1Extract residues (coal), naphthalene oil alk., distn. overheads;

Naphthalene Oil Extract Residue;

[The distillation from alkali-washed naphthalene oil having an approximate distillation range of 180 oC to 220 oC (356 oF to 428 oF). Composed primarily of naphthalene, alkylbenzenes, indene and indan.]
292-627-390641-04-6Carc. 1BH350GHS08

Dgr
H350HJM
648-092-00-7Distillates (coal tar), naphthalene oils, methylnaphthalene fraction;

Methylnaphthalene Oil;

[A distillate from the fractional distillation of high temperature coal tar. Composed primarily of substituted two ring aromatic hydrocarbons and aromatic nitrogen bases boiling in the range of approximately 225 oC to 255 oC (437 oF to 491 oF).]
309-985-4101896-27-9Carc. 1BH350GHS08

Dgr
H350HJM
648-093-00-2Distillates (coal tar), naphthalene oils, indole-methylnaphthalene fraction;

Methylnaphthalene Oil;

[A distillate from the fractional distillation of high temperature coal tar. Composed primarily of indole and methylnaphthalene boiling in the range of approximately 235 oC to 255 oC (455 oF to 491 oF).]
309-972-3101794-91-6Carc. 1BH350GHS08

Dgr
H350HJM
648-094-00-8Distillates (coal tar), naphthalene oils, acid exts.;

Methylnaphthalene Oil Extract Residue;

[A complex combination of hydrocarbons obtained by debasing the methylnaphthalene fraction obtained by the distillation of coal tar and boiling in the range of approximately 230 oC to 255 oC (446 oF to 491 oF). Contains chiefly 1(2)-methylnaphthalene, naphthalene, dimethylnaphthalene and biphenyl.]
295-309-291995-48-1Carc. 1BH350GHS08

Dgr
H350HJM
648-095-00-3Extract residues (coal), naphthalene oil alk., distn. residues;

Methylnaphthalene Oil Extract Residue;

[The residue from the distillation of alkali-washed naphthalene oil having an approximate distillation range of 220 oC to 300 oC (428 oF to 572 oF). Composed primarily of naphthalene, alkylnaphthalenes and aromatic nitrogen bases.]
292-628-990641-05-7Carc. 1BH350GHS08

Dgr
H350HJM
648-096-00-9Extract oils (coal), acidic, tar-base free;

Methylnaphthalene Oil Extract Residue;

[The extract oil boiling in the range of approximately 220 oC to 265 oC (428 oF to 509 oF) from coal tar alkaline extract residue produced by an acidic wash such as aqueous sulfuric acid after distillation to remove tar bases. Composed primarily of alkylnaphthalenes.]
284-901-684989-12-8Carc. 1BH350GHS08

Dgr
H350HJM
648-097-00-4Distillates (coal tar), benzole fraction, distn. residues;

Wash Oil;

[A complex combination of hydrocarbons obtained from the distillation of crude benzole (high temperature coal tar). It may be a liquid with the approximate distillation range of 150 oC to 300 oC (302 oF to 572 oF) or a semi-solid or solid with a melting point up to 70 oC (158 oF). It is composed primarily of naphthalene and alkyl naphthalenes.]
310-165-3121620-46-0Carc. 1BH350GHS08

Dgr
H350HJM
648-098-00-XCreosote oil, acenaphthene fraction;

Wash Oil;

[A complex combination of hydrocarbons produced by the distillation of coal tar and boiling in the range of approximately 240 oC to 280 oC (464 oF to 536 oF). Composed primarily of acenaphthene, naphthalene and alkyl naphthalene.]
292-605-390640-84-9Carc. 1BH350GHS08

Dgr
H350H
648-099-00-5Creosote oil;

[A complex combination of hydrocarbons obtained by the distillation of coal tar. It consists primarily of aromatic hydrocarbons and may contain appreciable quantities of tar acids and tar bases. It distills at the approximate range of 200 oC to 325 oC (392 oF to 617 oF).]
263-047-861789-28-4Carc. 1BH350GHS08

Dgr
H350H
648-100-00-9Creosote oil, high-boiling distillate;

Wash Oil;

[The high-boiling distillation fraction obtained from the high temperature carbonization of bituminous coal which is further refined to remove excess crystalline salts. It consists primarily of creosote oil with some of the normal polynuclear aromatic salts, which are components of coal tar distillates, removed. It is crystal free at approximately 5 oC (41 oF).]
274-565-970321-79-8Carc. 1BH350GHS08

Dgr
H350H
648-101-00-4Creosote;

[The distillate of coal tar produced by the high temperature carbonization of bituminous coal. It consists primarily of aromatic hydrocarbons, tar acids and tar bases.]
232-287-58001-58-9Carc. 1BH350GHS08

Dgr
H350H
648-102-00-XExtract residues (coal), creosote oil acid;

Wash Oil Extract Residue;

[A complex combination of hydrocarbons from the base-freed fraction from the distillation of coal tar, boiling in the range of approximately 250 oC to 280 oC (482 oF to 536 oF). It consists predominantly of biphenyl and isomeric diphenylnaphthalenes.]
310-189-4122384-77-4Carc. 1BH350GHS08

Dgr
H350H
648-103-00-5Anthracene oil, anthracene paste;

Anthracene Oil Fraction;

[The anthracene-rich solid obtained by the crystallization and centrifuging of anthracene oil. It is composed primarily of anthracene, carbazole and phenanthrene.]
292-603-290640-81-6Carc. 1BH350GHS08

Dgr
H350HJM
648-104-00-0Anthracene oil, anthracene-low;

Anthracene Oil Fraction;

[The oil remaining after the removal, by a crystallization process, of an anthracene-rich solid (anthracene paste) from anthracene oil. It is composed primarily of two, three and four membered aromatic compounds.]
292-604-890640-82-7Carc. 1BH350GHS08

Dgr
H350HJM
648-105-00-6Residues (coal tar), anthracene oil distn.;

Anthracene Oil Fraction;

[The residue from the fraction distillation of crude anthracene boiling in the approximate range of 340 oC to 400 oC (644 oF to 752 oF). It consists predominantly of tri- and polynuclear aromatic and heterocyclic hydrocarbons.]
295-505-892061-92-2Carc. 1BH350GHS08

Dgr
H350HJM
648-106-00-1Anthracene oil, anthracene paste, anthracene fraction;

Anthracene Oil Fraction;

[A complex combination of hydrocarbons from the distillation of anthracene obtained by the crystallization of anthracene oil from bituminous high temperature tar and boiling in the range of 330 oC to 350 oC (626 oF to 662 oF). It contains chiefly anthracene, carbazole and phenanthrene.]
295-275-991995-15-2Carc. 1BH350GHS08

Dgr
H350HJM
648-107-00-7Anthracene oil, anthracene paste, carbazole fraction;

Anthracene Oil Fraction;

[A complex combination of hydrocarbons from the distillation of anthracene obtained by crystallization of anthrancene oil from bituminous coal high temperature tar and boiling in the approximate range of 350 oC to 360 oC (662 oF to 680 oF). It contains chiefly anthacene, carbazole and phenanthrene.]
295-276-491995-16-3Carc. 1BH350GHS08

Dgr
H350HJM
648-108-00-2Anthracene oil, anthracene paste, distn. lights;

Anthracene Oil Fraction;

[A complex combination of hydrocarbons from the distillation of anthracene obtained by crystallization of anthracene oil from bituminous light temperature tar and boiling in the range of approximately 290 oC to 340 oC (554 oF to 644 oF). It contains chiefly trinuclear aromatics and their dihydro derivatives.]
295-278-591995-17-4Carc. 1BH350GHS08

Dgr
H350HJM
648-109-00-8Tar oils, coal, low-temp.;

Tar Oil, high boiling;

[A distillate from low-temperature coal tar. Composed primarily of hydrocarbons, phenolic compounds and aromatic nitrogen bases boiling in the range of approximately 160 oC to 340 oC (320 oF to 644 oF).]
309-889-2101316-87-4Carc. 1BH350GHS08

Dgr
H350HJM
648-110-00-3Extract residues (coal), low temp. coal atar alk.;

[The residue from low temperature coal tar oils after an alkaline wash, such as aqueous sodium hydroxide, to remove crude coal tar acids. Composed primarily of hydrocarbons and aromatic nitrogen bases.]
310-191-5122384-78-5Carc. 1BH350GHS08

Dgr
H350HJM
648-111-00-9Phenols, ammonia liquor ext.;

Alkaline Extract;

[The combination of phenols extracted, using isobutyl acetate, from the ammonia liquor condensed from the gas evolved in low-temperature (less than 700 oC (1292 oF)) destructive distillation of coal. It consists predominantly of a mixture of monohydric and dihydric phenols.]
284-881-984988-93-2Carc. 1BH350GHS08

Dgr
H350HJM
648-112-00-4Distillates (coal tar), light oils, alk. exts.;

Alkaline Extract;

[The aqueous extract from carbolic oil produced by an alkaline wash such as aqueous sodium hydroxide. Composed primarily of the alkali salts of various phenolic compounds.]
292-610-090640-88-3Carc. 1BH350GHS08

Dgr
H350HJM
648-113-00-XExtracts, coal tar oil alk.;

Alkaline Extract;

[The extract from coal tar oil produced by an alkaline wash such as aqueous sodium hydroxide. Composed primarily of the alkali salts of various phenolic compounds.]
266-017-265996-83-0Carc. 1BH350GHS08

Dgr
H350HJM
648-114-00-5Distillates (coal tar), naphthalene oils, alk. exts.;

Alkaline Extract;

[The aqueous extract from naphthalene oil produced by an alkaline wash such as aqueous sodium hydroxid. Composed primarily of the alkali salts of various phenolic compounds.]
292-611-690640-89-4Carc. 1BH350GHS08

Dgr
H350HJM
648-115-00-0Extract residues (coal), tar oil alk., carbonated, limed;

Crude Phenols;

[The product obtained by treatment of coal tar oil alkaline extract with CO2 and CaO. Composed primarily of CaCO3, Ca(OH)2, Na2CO3 and other organic and inorganic impurities.]
292-629-490641-06-8Carc. 1BH350GHS08

Dgr
H350HJM
648-116-00-6Tar acids, coal, crude;

Crude Phenols;

[The reaction product obtained by neutralizing coal tar oil alkaline extract with an acidic solution, such as aqueous sulfuric acid, or gaseous carbon dioxide, to obtain the free acids. Composed primarily of tar acids such as phenol, cresols, and xylenols.]
266-019-365996-85-2Carc. 1BH350GHS08

Dgr
H350HJM
648-117-00-1Tar acids, brown-coal, crude;

Crude Phenols;

[An acidified alkaline extract of brown coal tar distillate. Composed primarily of phenol and phenol homologs.]
309-888-7101316-86-3Carc. 1BH350GHS08

Dgr
H350HJM
648-118-00-7Tar acids, brown-coal gasification;

Crude Phenols;

[A complex combination of organic compounds obtained from brown coal gasification. Composed primarily of C6-10 hydroxy aromatic phenols and their homologs.]
295-536-792062-22-1Carc. 1BH350GHS08

Dgr
H350HJM
648-119-00-2Tar acids, distn. residues;

Distillate Phenols;

[A residue from the distillation of crude phenol from coal. It consists predominantly of phenols having carbon numbers in the range of C8 through C10 with a softening point of 60 oC to 80 oC (140 oF to 176 oF).]
306-251-596690-55-0Carc. 1BH350GHS08

Dgr
H350HJM
648-120-00-8Tar acids, methylphenol fraction;

Distillate Phenols;

[The fraction of tar acid rich in 3- and 4-methylphenol, recovered by distillation of low-temperature coal tar crude tar acids.]
284-892-984989-04-8Carc. 1BH350GHS08

Dgr
H350HJM
648-121-00-3Tar acids, polyalkylphenol fraction;

Distillate Phenols;

[The fraction of tar aicds, recovered by distillation of low-temperature coal tar crude tar acids, having an approximate boiling range of 225 oC to 320 oC (437 oF to 608 oF). Composed primarily of polyalkylphenols.]
284-893-484989-05-9Carc. 1BH350GHS08

Dgr
H350HJM
648-122-00-9Tar acids, xylenol fraction;

Distillate Phenols;

[The fraction of tar acids, rich in 2,4- and 2,5-dimethylphenol, recovered by distillation of low-temperature coal tar crude tar acids.]
284-895-584989-06-0Carc. 1BH350GHS08

Dgr
H350HJM
648-123-00-4Tar acids, ethylphenol fraction;

Distillate Phenols;

[The fraction of tar acids, rich in 3- and 4-ethylphenol, recovered by distillation of low-temperature coal tar crude tar acids.]
284-891-384989-03-7Carc. 1BH350GHS08

Dgr
H350HJM
648-124-00-XTar acids, 3,5-xylenol fraction;

Distillate Phenols;

[The fraction of tar acids, rich in 3,5-dimethylphenol, recovered by distillation of low-temperature coal tar acids.]
284-896-084989-07-1Carc. 1BH350GHS08

Dgr
H350HJM
648-125-00-5Tar acids, residues, distillates, first-cut;

Distillate Phenols;

[The residue from the distillation in the range of 235 oC to 355 oC (481 oF to 697 oF) of light carbolic oil.]
270-713-168477-23-6Carc. 1BH350GHS08

Dgr
H350HJM
648-126-00-0Tar acids, cresylic, residues;

Distillate Phenols;

[The residue from crude coal tar acids after removal of phenol, cresols, xylenols and any higher boiling phenols. A black solid with a melting point approximately 80 oC (176 oF). Composed primarily of polyalkyphenols, resin gums, and inorganic salts.]
271-418-068555-24-8Carc. 1BH350GHS08

Dgr
H350HJM
648-127-00-6Phenols, C9-11;

Distillate Phenols
293-435-291079-47-9Carc. 1BH350GHS08

Dgr
H350HJM
648-128-00-1Tar acids, cresylic;

Distillate Phenols;

[A complex combination of organic compounds obtained from brown coal and boiling in the range of approximately 200 oC to 230 oC (392 oF to 446 oF). It contains chiefly phenols and pyridine bases.]
295-540-992062-26-5Carc. 1BH350GHS08

Dgr
H350HJM
648-129-00-7Tar acids, brown-coal, C2-alkylphenol fraction;

Distillate Phenols;

[The distillate from the acidification of alkaline washed lignite tar distillate boiling in the range of approximately 200 oC to 230 oC (392 oF to 446 oF). Composed primarily of m- and p-ethylphenol as well as cresols and xylenols.]
302-662-994114-29-1Carc. 1BH350GHS08

Dgr
H350HJM
648-130-00-2Extract oils (coal), naphthalene oils;

Acid Extract;

[The aqueous extract produced by an acidic wash of alkali-washed napthalene oil. Composed primarily of acid salts of various aromatic nitrogen bases including pyridine, quinoline and their alkyl derivatives.]
292-623-190641-00-2Carc. 1BH350GHS08

Dgr
H350HJM
648-131-00-8Tar bases, quinoline derivs.;

Distillate Bases
271-020-768513-87-1Carc. 1BH350GHS08

Dgr
H350HJM
648-132-00-3Tar bases, coal, quinoline derivs. fraction;

Distillate Bases
274-560-170321-67-4Carc. 1BH350GHS08

Dgr
H350HJM
648-133-00-9Tar bases, coal, distn. residues;

Distillate Bases;

[The distillation residue remaining after the distillation of the neutralized, acid-extracted base-containing tar fractions obtained by the distillation of coal tars. It contains chiefly aniline, collidines, quinoline and quinoline derivatives and toluidines.]
295-544-092062-29-8Carc. 1BH350GHS08

Dgr
H350HJM
648-134-00-4Hydrocarbon oils, arom., mixed with polyethylene and polypropylene, pyrolyzed, light oil fraction;

Heat Treatment Products;

[The oil obtained from the heat treatment of a polyethylene/polypropylene mixture with coal tar pitch or aromatic oils. It consists predominantly of benzene and its homologs boiling in a range of approximately 70 oC to 120 oC (158 oF to 248 oF).]
309-745-9100801-63-6Carc. 1BH350GHS08

Dgr
H350HJM
648-135-00-XHydrocarbon oils, arom., mixed with polyethylene, pyrolyzed, light oil fraction;

Heat Treatment Products;

[The oil obtained from the heat treatment of polyethylene with coal tar pitch or aromatic oils. It consists predominantly of benzene and its homologs boiling in a range of 70 oC to 120 oC (158 oF to 248 oF).]
309-748-5100801-65-8Carc. 1BH350GHS08

Dgr
H350HJM
648-136-00-5Hydrocarbon oils, arom., mixed with polystyrene, pyrolyzed, light oil fraction;

Heat Treatment Products;

[The oil obtained from the heat treatment of polystyrene with coal tar pitch or aromatic oils. It consists predominantly of benzene and its homologs boiling in a range of approximately 70 oC to 210 oC (158 oF to 410 oF).]
309-749-0100801-66-9Carc. 1BH350GHS08

Dgr
H350HJM
648-137-00-0Extract residues (coal), tar oil alk., naphthalene distn. residues;

Naphthalene Oil Extract Residue;

[The residue obtained from chemical oil extracted after the removal of naphthalene by distillation composed primarily of two to four membered condensed ring aromatic hydrocarbons and aromatic nitrogen bases.]
277-567-873665-18-6Carc. 1BH350GHS08

Dgr
H350HJM
648-138-00-6Creosote oil, low-boiling distillate;

Wash Oil;

[The low-boiling distillation fraction obtained from the high temperature carbonization of bituminous coal, which is further refined to remove excess crystalline salts. It consists primarily of creosote oil with some of the normal polynuclear aromatic salts, which are components of coal tar distillate, removed. It is crystal free at approximately 38 oC (100 oF).]
274-566-470321-80-1Carc. 1BH350GHS08

Dgr
H350H
648-139-00-1Tar acids, cresylic, sodium salts, caustic solns.;

Alkaline Extract
272-361-468815-21-4Carc. 1BH350GHS08

Dgr
H350HJM
648-140-00-7Extract oils (coal), tar base;

Acid Extract;

[The extract from coal tar oil alkaline extract residue produced by an acidic wash such as aqueous sulfuric acid after distillatin to remove naphthalene. Composed primarily of the acid salts of various aromatic nitrogen bases including pyridine, quinoline, and their alkyl derivatives.]
266-020-965996-86-3Carc. 1BH350GHS08

Dgr
H350HJM
648-141-00-2Tar bases, coal, crude;

Crude Tar Bases;

[The reaction product obtained by neutralizing coal tar base extract oil with an alkaline solution, such as aqueous sodium hydroxide, to obtain the free bases. Composed primarily of such organic bases as acridine, phenanthridine, pyridine, quinoline and their alkyl derivatives.]
266-018-865996-84-1Carc. 1BH350GHS08

Dgr
H350HJM
648-142-00-8Residues (coal), liq. solvent extn.;

[A cohesive powder composed of coal mineral matter and undissolved coal remaining after extraction of coal by a liquid solvent.]
302-681-294114-46-2Carc. 1BH350GHS08

Dgr
H350H M
648-143-00-3Coal liquids, liq. solvent extn. soln.;

[The product obtained by filtration of coal mineral matter and undissolved coal from coal extract solution produced by digesting coal in a liquid solvent. A black, viscous, highly complex liquid combination composed primarily of aromatic and partly hydro-genated aromatic hydrocarbons, aromatic nitrogen compounds, aromatic sulfur compounds, phenolic and other aromatic oxygen compounds and their alkyl derivatives.]
302-682-894114-47-3Carc. 1BH350GHS08

Dgr
H350H M
648-144-00-9Coal liquids, liq. solvent extn.;

[The substantially solvent-free product obtained by the distillation of the solvent from filtered coal extract solution produced by digesting coal in a liquid solvent. A black semi-solid, composed primarily of a complex combination of condensed-ring aromatic hydrocarbons, aromatic nitrogen compounds, aromatic sulfur compounds, phenolic compounds and other aromatic oxygen compounds, and their alkyl derivatives.]
302-683-394114-48-4Carc. 1BH350GHS08

Dgr
H350H M
648-145-00-4Tar brown-coal;

[An oil distilled from brown-coal tar. Composed primarily of aliphatic, naphthenic and one- to three-ring aromatic hydrocarbons, their alkyl derivates, heteroaromatics and one- and two-ring phenols boiling in the range of approximately 150 oC to 360 oC (302 oF to 680 oF).]
309-885-0101316-83-0Carc. 1AH350GHS08

Dgr
H350H
648-146-00-XTar, brown-coal, low-temp.;

[A tar obtained from low temperature carbonization and low temperature gasification of brown coal. Composed primarily of aliphatic, naphthenic and cyclic aromatic hydrocarbons, heteroaromatic hydrocarbons and cyclic phenols.]
309-886-6101316-84-1Carc. 1AH350GHS08

Dgr
H350H
648-147-00-5Light oil (coal), coke-oven;

Crude benzole;

[The volatile organic liquid extracted from the gas evolved in the high temperature (greater than 700 oC (1292 oF)) destructive distillation of coal. Composed primarily of benzene, toluene, and xylenes. May contain other minor hydrocarbon constituents.]
266-012-565996-78-3Carc. 1BH350GHS08

Dgr
H350H J
648-148-00-0Distillates (coal), liq. solvent extn., primary;

[The liquid product of condensation of vapors emitted during the digestion of coal in a liquid solvent and boiling in the range of approximately 30 oC to 300 oC (86 oF to 572 oF). Composed primarily of partly hydrogenated condensed-ring aromatic hydrocarbons, aromatic compounds containing nitrogen, oxygen and sulfur, and their alkyl derivatives having carbon numbers predominantly in the range of C4 through C14.]
302-688-094114-52-0Carc. 1BH350GHS08

Dgr
H350H J
648-149-00-6Distillates (coal), solvent extn., hydrocracked;

[Distillate obtained by hydrocracking of coal extract or solution produced by the liquid solvent extraction or supercritical gas extraction process and boiling in the range of approximately 30 oC to 300 oC (86 oF to 572 oF). Composed primarily of aromatic, hydrogenated aromatic and naphthenic compounds, their alkyl derivatives and alkanes with carbon numbers predominantly in the range of C4 through C14. Nitrogen, sulfur and oxygen-containing aromatic and hydrogenated aromatic compounds are also present.]
302-689-694114-53-1Carc. 1BH350GHS08

Dgr
H350H J
648-150-00-1Naphtha (coal), solvent extn., hydrocracked;

[Fraction of the distillate obtained by hydrocracking of coal extract or solution produced by the liquid solvent extraction or supercritical gas extraction processes and boiling in the range of approximately 30 oC to 180 oC (86 oF to 356 oF). Composed primarily of aromatic, hydrogenated aromatic and naphthenic compounds, their alkyl derivatives and alkanes with carbon numbers predominantly in the range of C4 to C9. Nitrogen, sulfur and oxygen-containing aromatic and hydrogenated aromatic compounds are also present.]
302-690-194114-54-2Carc. 1BH350GHS08

Dgr
H350H J
648-151-00-7Gasoline, coal solvent extn., hydrocracked naphtha;

[Motor fuel produced by the reforming of the refined naphtha fraction of the products of hydrocracking of coal extract or solution produced by the liquid solvent extraction or supercritical gas extraction processes and boiling in the range of approximately 30 oC to 180 oC (86 oF to 356 oF). Composed primarily of aromatic and naphthenic hydrocarbons, their alkyl derivatives and alkyl hydrocarbons having carbon numbers in the range of C4 through C9.]
302-691-794114-55-3Carc. 1BH350GHS08

Dgr
H350H
648-152-00-2Distillates (coal), solvent extn., hydrocracked middle;

[Distillate obtained from the hydrocracking of coal extract or solution produced by the liquid solvent extraction or supercritical gas extraction processes and boiling in the range of approximately 180 oC to 300 oC (356 oF to 572 oF). Composed primarily of two-ring aromatic, hydrogenated aromatic and naphthenic compounds, their alkyl derivatives and alkanes having carbon numbers predominantly in the range of C9 through C14. Nitrogen, sulfur and oxygen-containing compounds are also present.]
302-692-294114-56-4Carc. 1BH350GHS08

Dgr
H350H J
648-153-00-8Distillates (coal), solvent extn., hydrocracked hydrogenated middle;

[Distillate from the hydrogenation of hydrocracked middle distillate from coal extract or solution produced by the liquid solvent extraction or supercritical gas extraction processes and boiling in the range of approximately 180 oC to 280 oC (356 oF to 536 oF). Composed primarily of hydrogenated two- ring carbon compounds and their alkyl derivatives having carbon numbers predominantly in the range of C9 through C14.]
302-693-894114-57-5Carc. 1BH350GHS08

Dgr
H350H J
648-154-00-3Fuels, jet aircraft, coal solvent extn., hydrocracked hydrogenated;

[Jet engine fuel produced by hydrogenation of the middle distillate fraction of the products of hydrocracking of coal extract or solution produced by the liquid solvent extraction or supercritical gas extraction processes and boiling in the range of approximately 180 oC to 225 oC (356 oF to 473 oF). Composed primarily of hydrogenated two-ring hydrocarbons and their alkyl derivatives having carbon numbers predominantly in the range of C10 through C12.]
302-694-394114-58-6Carc. 2H351GHS08

Wng
H350H
648-155-00-9Fuels, diesel, coal solvent extn., hydrocracked hydrogenated;

[Diesel engine fuel produced by the hydrogenation of the middle distillate fraction of the products of hydrocracking of coal extract or solution produced by the liquid solvent extraction or supercritical gas extraction processes and boiling in the range of approximately 200 oC to 280 oC (392 oF to 536 oF). Composed primarily of hydrogenated two-ring hydrocarbons and their alkyl derivatives having carbon numbers predominantly in the range of C11 through C14.]
302-695-994114-59-7Carc. 2H351GHS08

Wng
H350H
648-156-00-4Light oil (coal), semi-coking process;

Fresh oil;

[The volatile organic liquid condensed from the gas evolved in the low temperature (less than 700 oC (1292 oF) destructive distillation of coal. Composed primarily of C6-10 hydrocarbons.]
292-635-790641-11-5Carc. 1BH350GHS08

Dgr
H350H J
649-001-00-3Extracts (petroleum), light naphthenic distillate solvent265-102-164742-03-6Carc. 1BH350GHS08

Dgr
H350H
649-002-00-9Extracts (petroleum), heavy paraffinic distillate solvent265-103-764742-04-7Carc. 1BH350GHS08

Dgr
H350H
649-003-00-4Extracts (petroleum), light paraffinic distillate solvent265-104-264742-05-8Carc. 1BH350GHS08

Dgr
H350H
649-004-00-XExtracts (petroleum), heavy naphthenic distillate solvent265-111-064742-11-6Carc. 1BH350GHS08

Dgr
H350H
649-005-00-5Extracts (petroleum), light vacuum gas oil solvent295-341-791995-78-7Carc. 1BH350GHS08

Dgr
H350H
649-006-00-0hydrocarbons C26-55, arom-rich307-753-797722-04-8Carc. 1BH350GHS08

Dgr
H350H
649-007-00-6fatty acids, tall-oil, reaction products with iminodiethanol and boric acid400-160-5Skin Irrit. 2

Aquatic Chronic 2
H315

H411
GHS07

GHS09

Wng
H315

H411
649-008-00-1Residues (petroleum), atm. tower;

Heavy Fuel oil;

[A complex residuum from the atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly greater than C20 and boiling above approximately 350 oC (662 oF). This stream is likely to contain 5 wt. % or more of 4- to 6-membered condensed ring aromatic hydrocarbons.]
265-045-264741-45-3Carc. 1BH350GHS08

Dgr
H350H
649-009-00-7Gas oils (petroleum), heavy vacuum;

Heavy Fuel oil;

[A complex combination of hydrocarbons produced by the vacuum distillation of the residuum from atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and boiling in the range of approximately 350 oC to 600 oC (662 oF to 1112 oF). This stream is likely to contain 5 wt. % or more of 4-to 6-membered condensed ring aromatic hydrocarbons.]
265-058-364741-57-7Carc. 1BH350GHS08

Dgr
H350H
649-010-00-2Distillates (petroleum), heavy catalytic cracked;

Heavy Fuel oil;

[A complex combination of hydrocarbons produced by the distillation of products from a catalytic cracking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C35 and boiling in the range of approximately 260 oC to 500 oC (500 oF to 932 oF). This stream is likely to contain 5 wt. % or more of 4- to 6-membered condensed ring aromatic hydrocarbons.]
265-063-064741-61-3Carc. 1BH350GHS08

Dgr
H350H
649-011-00-8Clarified oils (petroleum), catalytic cracked;

Heavy Fuel oil;

[A complex combination of hydrocarbons produced as the residual fraction from distillation of the products from a catalytic cracking process. It consists of hydrocarbons having carbon numbers predominantly greater than C20 and boiling above approximately 350 oC (662 oF). This stream is likely to contain 5 wt. % or more of 4- to 6-membered condensed ring aromatic hydrocarbons.]
265-064-664741-62-4Carc. 1BH350GHS08

Dgr
H350H
649-012-00-3Residues (petroleum), hydrocracked;

Heavy Fuel oil;

[A complex combination of hydrocarbons produced as the residual fraction from distillation of the products of a hydrocracking process. It consists of hydrocarbons having carbon numbers predominantly greater than C20 and boiling above approximately 350 oC (662 oF).]
265-076-164741-75-9Carc. 1BH350GHS08

Dgr
H350H
649-013-00-9Residues (petroleum), thermal cracked;

Heavy Fuel oil;

[A complex combination of hydrocarbons produced as the residual fraction from distillation of the product from a thermal cracking process. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly greater than C20 and boiling above approximately 350 oC (662 oF). This stream is likely to contain 5 wt. % or more of 4- to 6-membered condensed ring aromatic hydrocarbons.]
265-081-964741-80-6Carc. 1BH350GHS08

Dgr
H350H
649-014-00-4Distillates (petroleum), heavy thermal cracked;

Heavy Fuel oil;

[A complex combination of hydrocarbons from the distillation of the products from a thermal cracking process. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C15 through C36 and boiling in the range of approximately 260 oC to 480 oC (500 oF to 896 oF). This stream is likely to contain 5 wt. % or more of 4- to 6-membered condensed ring aromatic hydrocarbons.]
265-082-464741-81-7Carc. 1BH350GHS08

Dgr
H350H
649-015-00-XGas oils (petroleum), hydrotreated vacuum;

Heavy Fuel oil;

[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly in the range of C13 through C50 and boiling in the range of approximately 230 oC to 600 oC (446 oF to 1112 oF). This stream is likely to contain 5 wt.% or more of 4- to 6-membered condensed ring aromatic hydrocarbons.]
265-162-964742-59-2Carc. 1BH350GHS08

Dgr
H350H
649-016-00-5Residues (petroleum), hydrodesulfurized atmospheric tower;

Heavy Fuel oil;

[A complex combination of hydrocarbons obtained by treating an atmospheric tower residuum with hydrogen in the presence of a catalyst under conditions primarily to remove organic sulfur compounds. It consists of hydrocarbons having carbon numbers predominantly greater than C20 and boiling above approximately 350 oC (662 oF). This stream is likely to contain 5 wt. % or more of 4- to 6-membered condensed ring aromatic hydrocarbons.]
265-181-264742-78-5Carc. 1BH350GHS08

Dgr
H350H
649-017-00-0Gas oils (petroleum), hydrodesulfurized heavy vacuum;

Heavy Fuel oil;

[A complex combination of hydrocarbons obtained from a catalytic hydrodesulfurization process. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and boiling in the range of approximately 350 oC to 600 oC (662 oF to 1112 oC). This stream is likely to contain 5 wt. % or more of 4- to 6-membered condensed ring aromatic hydrocarbons.]
265-189-664742-86-5Carc. 1BH350GHS08

Dgr
H350H
649-018-00-6Residues (petroleum), steam-cracked;

Heavy Fuel oil;

[A complex combination of hydrocarbons obtained as the residual fraction from the distillation of the products of a steam cracking process (including steam cracking to produce ethylene). It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly greater than C14 and boiling above approximately 260 oC (500 oF). This stream is likely to contain 5 wt. % or more of 4- to 6-membered condensed ring aromatic hydrocarbons.]
265-193-864742-90-1Carc. 1BH350GHS08

Dgr
H350H
649-019-00-1Residues (petroleum), atmospheric;

Heavy Fuel oil;

[A complex residuum from atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly greater than C11 and boiling above approximately 200 oC (392 oF). This stream is likely to contain 5 wt. % or more of 4-to 6-membered condensed ring aromatic hydrocarbons.]
269-777-368333-22-2Carc. 1BH350GHS08

Dgr
H350H
649-020-00-7Clarified oils (petroleum), hydrodesulfurized catalytic cracked;

Heavy Fuel oil;

[A complex combination of hydrocarbons obtained by treating catalytic cracked clarified oil with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists of hydrocarbons having carbon numbers predominantly greater than C20 and boiling above approximately 350 oC (662 oF). This stream is likely to contain 5 wt. % or more of 4-to 6-membered condensed ring aromatic hydrocarbons.]
269-782-068333-26-6Carc. 1BH350GHS08

Dgr
H350H
649-021-00-2Distillates (petroleum), hydrodesulfurized intermediate catalytic cracked;

Heavy Fuel oil;

[A complex combination of hydrocarbons obtained by treating intermediate catalytic cracked distillates with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists of hydrocarbons having carbon numbers predominantly in the range of C11 through C30 and boiling in the range of approximately 205 oC to 450 oC (401 oF to 842 oF). It contains a relatively large proportion of tricyclic aromatic hydrocarbons.]
269-783-668333-27-7Carc. 1BH350GHS08

Dgr
H350H
649-022-00-8Distillates (petroleum), hydrodesulfurized heavy catalytic cracked;

Heavy Fuel oil;

[A complex combination of hydrocarbons obtained by treatment of heavy catalytic cracked distillates with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C35 and boiling in the range of approximately 260 oC to 500 oC (500 oF to 932 oF). This stream is likely to contain 5 wt. % or more of 4- to 6-membered condensed ring aromatic hydrocarbons.]
269-784-168333-28-8Carc. 1BH350GHS08

Dgr
H350H
649-023-00-3Fuel oil, residues-straight-run gas oils, high-sulfur;

Heavy Fuel oil
270-674-068476-32-4Carc. 1BH350GHS08

Dgr
H350H
649-024-00-9Fuel oil, residual;

Heavy Fuel oil;

[The liquid product from various refinery streams, usually residues. The composition is complex and varies with the source of the crude oil.]
270-675-668476-33-5Carc. 1BH350GHS08

Dgr
H350H
649-025-00-4Residues (petroleum), catalytic reformer fractionator residue distn.;

Heavy Fuel oil;

[A complex residuum from the distillation of catalytic reformer fractionator residue. It boils approximately above 399 oC (750 oF).]
270-792-268478-13-7Carc. 1BH350GHS08

Dgr
H350H
649-026-00-XResidues (petroleum), heavy coker gas oil and vacuum gas oil;

Heavy Fuel oil;

[A complex combination of hydrocarbons produced as the residual fraction from the distillation of heavy coker gas oil and vacuum gas oil. It predominantly consists of hydrocarbons having carbon numbers predominantly greater than C13 and boiling above approximately 230 oC (446 oF).]
270-796-468478-17-1Carc. 1BH350GHS08

Dgr
H350H
649-027-00-5Residues (petroleum), heavy coker and light vacuum;

Heavy Fuel oil;

[A complex combination of hydrocarbons produced as the residual fraction from the distillation of heavy coker gas oil and light vacuum gas oil. It consists predominantly of hydrocarbons having carbon numbers predominantly greater than C13 and boiling above approximately 230 oC (446 oF).]
270-983-068512-61-8Carc. 1BH350GHS08

Dgr
H350H
649-028-00-0Residues (petroleum), light vacuum;

Heavy Fuel oil;

[A complex residuum from the vacuum distillation of the residuum from the atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly greater than C13 and boiling above approximately 230 oC (446 oF).]
270-984-668512-62-9Carc. 1BH350GHS08

Dgr
H350H
649-029-00-6Residues (petroleum), steam-cracked light;

Heavy Fuel oil;

[A complex residuum from the distillation of the products from a steam-cracking process. It consists predominantly of aromatic and unsaturated hydrocarbons having carbon numbers greater than C7 and boiling in the range of approximately 101 oC to 555 oC (214 oF to 1030 oF).]
271-013-968513-69-9Carc. 1BH350GHS08

Dgr
H350H
649-030-00-1Fuel oil, No 6;

Heavy Fuel oil;

[A distillate oil having a minimum viscosity of 900 SUS at 37.7 oC (100 oF) to a maximum of 9000 SUS at 37.7 oC (100 oF).]
271-384-768553-00-4Carc. 1BH350GHS08

Dgr
H350H
649-031-00-7Residues (petroleum), topping plant, low-sulfur;

Heavy Fuel oil;

[A low-sulfur complex combination of hydrocarbons produced as the residual fraction from the topping plant distillation of crude oil. It is the residuum after the straight-run gasoline cut, kerosene cut and gas oil cut have been removed.]
271-763-768607-30-7Carc. 1BH350GHS08

Dgr
H350H
649-032-00-2Gas oils (petroleum), heavy atmospheric;

Heavy Fuel oil;

[A complex combination of hydrocarbons obtained by the distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C7 through C35 and boiling in the range of approximately 121 oC to 510 oC (250 oF to 950 oF).]
272-184-268783-08-4Carc. 1BH350GHS08

Dgr
H350H
649-033-00-8Residues (petroleum), coker scrubber, Condensed-ring-arom.-contg.;

Heavy Fuel oil;

[A very complex combination of hydrocarbons produced as the residual fraction from the distillation of vaccum residuum and the products from a thermal cracking process. It consists predominantly of hydrocarbons having carbon numbers predominantly greater than C20 and boiling above approximately 350 oC (662 oF). This stream is likely to contain 5 wt.% or more of 4- to 6-membered condensed rind aromatic hydrocarbons.]
272-187-968783-13-1Carc. 1BH350GHS08

Dgr
H350H
649-034-00-3Distillates (petroleum), petroleum residues vacuum;

Heavy Fuel oil;

[A complex combination of hydrocarbons produced by the vacuum distillation of the residuum from the atmospheric distillation of crude oil.]
273-263-468955-27-1Carc. 1BH350GHS08

Dgr
H350H
649-035-00-9Residues (petroleum), steam-cracked, resinous;

Heavy Fuel oil;

[A complex residuum from the distillation of steam-cracked petroleum residues.]
273-272-368955-36-2Carc. 1BH350GHS08

Dgr
H350H
649-036-00-4Distillates (petroleum), intermediate vacuum;

Heavy Fuel oil;

[A complex combination of hydrocarbons produced by the vacuum, distillation of the residuum from atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C14 through C42 and boiling in the range of approximately 250 oC to 545 oC (482 oF to 1013 oF). This stream is likely to contain 5 wt. % or more of 4- to 6-membered condensed ring aromatic hydrocarbons.]
274-683-070592-76-6Carc. 1BH350GHS08

Dgr
H350H
649-037-00-XDistillates (petroleum), light vacuum;

Heavy Fuel oil;

[A complex combination of hydrocarbons produced by the vacuum distillation of the residuum from atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C11 through C35 and boiling in the range of approximately 250 oC to 545 oC (482 oF to 1013 oF).]
274-684-670592-77-7Carc. 1BH350GHS08

Dgr
H350H
649-038-00-5Distillates (petroleum), vacuum;

Heavy Fuel oil;

[A complex combination of hydrocarbons produced by the vacuum distillation of the residuum from atmospheric distillation of crude oil. It consists of hydrocarbons having numbers predominantly in the range of C15 through C50 and boiling in the range of approximately 270 oC to 600 oC (518 oF to 1112 oF). This stream is likely to contain 5 wt.% or more of 4- to 6-membered condensed ring aromatic hydrocarbons.]
274-685-170592-78-8Carc. 1BH350GHS08

Dgr
H350H
649-039-00-0Gas oils (petroleum), hydrodesulfurized coker heavy vacuum;

Heavy Fuel oil;

[A complex combination of hydrocarbons obtained by hydrodesulfurization of heavy coker distillate stocks, It consists predominantly of hydrocarbons having carbon numbers predominantly in the range C18 to C44 and boiling in the range of approximately 304 oC to 548 oC (579 oF to 1018 oF). Likely to contain 5 % or more of 4- to 6-membered condensed ring aromatic hydrocarbons.]
285-555-985117-03-9Carc. 1BH350GHS08

Dgr
H350H
649-040-00-6Residues (petroleum), steam-cracked, distillates;

Heavy Fuel oil;

[A complex combination of hydrocarbons obtained during the production of refined petroleum tar by the distillation of steam cracked tar. It consists predominantly of aromatic and other hydrocarbons and organic sulfur compounds.]
292-657-790669-75-3Carc. 1BH350GHS08

Dgr
H350H
649-041-00-1Residues (petroleum), vacuum, light;

Heavy Fuel oil;

[A complex residuum from the vacuum distillation of the residuum from atmospheric distillation of crude oil. It consists predominantly of hydrocarbons having carbon numbers predominantly greater than C24 and boiling above approximately 390 oC (734 oF).]
292-658-290669-76-4Carc. 1BH350GHS08

Dgr
H350H
649-042-00-7Fuel oil, heavy, high-sulfur;

Heavy Fuel oil;

[A complex combination of hydrocarbons obtained by the distillation of crude petroleum. It consists predominantly of aliphatic, aromatic and cycloaliphatic hydrocarbons having carbon numbers predominantly higher than C25 and boiling above approximately 400 oC (752 oF).]
295-396-792045-14-2Carc. 1BH350GHS08

Dgr
H350H
649-043-00-2Residues (petroleum), catalytic cracking;

Heavy Fuel oil;

[A complex combination of hydrocarbons produced as the residual fraction from the distillation of the products from a catalytic cracking process. It consists predominantly of hydrocarbons having carbon numbers predominantly greater than C11 and boiling above approximately 200 oC (392 oF).]
295-511-092061-97-7Carc. 1BH350GHS08

Dgr
H350H
649-044-00-8Distillates (petroleum), intermediate catalytic cracked, thermally degraded;

Heavy Fuel oil;

[A complex combination of hydrocarbons produced by the distillation of products from a catalytic cracking process which has been used as a heat transfer fluid. It consists predominantly of hydrocarbons boiling in the range of approximately 220 oC to 450 oC (428 oF to 842 oF). This stream is likely to contain organic sulfur compounds.]
295-990-692201-59-7Carc. 1BH350GHS08

Dgr
H350H
649-045-00-3Residual oils (petroleum);

Heavy Fuel oil;

[A complex combination of hydrocarbons, sulfur compounds and metal-containing organic compounds obtained as the residue from refinery fractionation cracking processes. It produces a finished oil with a viscosity above 2cSt. at 100 oC.]
298-754-093821-66-0Carc. 1BH350GHS08

Dgr
H350H
649-046-00-9Residues, steam cracked, thermally treated;

Heavy Fuel oil;

[A complex combination of hydrocarbons obtained by the treatment and distillation of raw steam-cracked naphtha. It consists predominantly of unsaturated hydrocarbons boiling in the range above approximately 180 oC (356 oF).]
308-733-098219-64-8Carc. 1BH350GHS08

Dgr
H350H
649-047-00-4Distillates (petroleum), hydrodesulfurized full-range middle;

Heavy Fuel oil;

[A complex combination of hydrocarbons obtained by treating a petroleum stock with hydrogen. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C9 through C25 and boiling in the range of approximately 150 oC to 400 oC (302 oF to 752 oF).]
309-863-0101316-57-8Carc. 1BH350GHS08

Dgr
H350H
649-048-00-XResidues (petroleum), catalytic reformer fractionator;

Heavy Fuel oil;

[A complex combination of hydrocarbons produced as the residual fraction from distillation of the product from a catalytic reforming process. It consists of predominantly aromatic hydrocarbons having carbon numbers predominantly in the range of C10 through C25 and boiling in the range of approximately 160 oC to 400 oC (320 oF to 725 oF). This stream is likely to contain 5 wt. % or more of 4- or 6-membered condensed ring aromatic hydrocarbons.]
265-069-364741-67-9Carc. 1BH350GHS08

Dgr
H350H
649-049-00-5Petroleum;

Crude oil;

[A complex combination of hydrocarbons, It consists predominantly of aliphatic, alicyclic and aromatic hydrocarbons. It may also contain small amounts of nitrogen, oxygen and sulfur compounds. This category encompasses light, medium, and heavy petroleums, as well as the oils extended from tar sands. Hydrocarbonaceous materials requiring major chemical changes for their recovery or conversion to petroleum refinery feedstocks such as crude shale oils; upgraded shale oils and liquid coal fuels are not included in this definition.]
232-298-58002-05-9Carc. 1BH350GHS08

Dgr
H350H
649-050-00-0Distillates (petroleum), light paraffinic;

Unrefined or mildly refined baseoil;

[A complex combination of hydrocarbons produced by vacuum distillation of the residuum from atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC). It contains a relatively large proportion of saturated aliphatic hydrocarbons normally present in this distillation range of crude oil.]
265-051-564741-50-0Carc. 1AH350GHS08

Dgr
H350H
649-051-00-6Distillates (petroleum), heavy paraffinic;

Unrefined or mildly refined baseoil;

[A complex combination of hydrocarbons produced by vacuum distillation of the residuum from atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100 oF (19cSt at 40 oC). It contains a relatively large proportion of saturated aliphatic hydrocarbons.]
265-052-064741-51-1Carc. 1AH350GHS08

Dgr
H350H
649-052-00-1Distillates (petroleum), light naphthenic;

Unrefined or mildly refined baseoil;

[A complex combination of hydrocarbons produced by vacuum distillation of the residuum from atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.]
265-053-664741-52-2Carc. 1AH350GHS08

Dgr
H350H
649-053-00-7Distillates (petroleum), heavy naphthenic;

Unrefined or mildly refined baseoil;

[A complex combination of hydrocarbons produced by vacuum distillation of the residuum from atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.]
265-054-164741-53-3Carc. 1AH350GHS08

Dgr
H350H
649-054-00-2Distillates (petroleum), acid-treated heavy naphthenic;

Unrefined or mildly refined baseoil;

[A complex combination of hydrocarbons obtained as a raffinate from a sulfuric acid treating process. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.]
265-117-364742-18-3Carc. 1AH350GHS08

Dgr
H350H
649-055-00-8Distillates (petroleum), acid-treated light naphthenic;

Unrefined or mildly refined baseoil;

[A complex combination of hydrocarbons obtained as a raffinate from a sulfuric acid treating process. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.]
265-118-964742-19-4Carc. 1AH350GHS08

Dgr
H350H
649-056-00-3Distillates (petroleum), acid-treated heavy paraffinic;

Unrefined or mildly refined baseoil;

[A complex combination of hydrocarbons obtained as a raffinate from a sulfuric acid process. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil having a viscosity of a least 100 SUS at 100 oF (19cSt at 40 oC).]
265-119-464742-20-7Carc. 1AH350GHS08

Dgr
H350H
649-057-00-9Distillates (petroleum), acid-treated light paraffinic;

Unrefined or mildly refined baseoil;

[A complex combination of hydrocarbons obtained as a raffinate from a sulfuric acid treating process. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil having a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC).]
265-121-564742-21-8Carc. 1AH350GHS08

Dgr
H350H
649-058-00-4Distillates (petroleum), chemically neutralized heavy paraffinic;

Unrefined or mildly refined baseoil;

[A complex combination of hydrocarbons obtained from a treating process to remove acidic materials. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100 oF (19cSt at 40 oC). It contains a relatively large proportion of aliphatic hydrocarbons.]
265-127-864742-27-4Carc. 1AH350GHS08

Dgr
H350H
649-059-00-XDistillates (petroleum), chemically neutralized light paraffinic;

Unrefined or mildly refined baseoil;

[A complex combination of hydrocarbons produced by a treating process to remove acidic materials. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity less than 100 SUS at 100 oF (19cSt at 40 oC).]
265-128-364742-28-5Carc. 1AH350GHS08

Dgr
H350H
649-060-00-5Distillates (petroleum), chemically neutralized heavy naphthenic;

Unrefined or mildly refined baseoil;

[A complex combination of hydrocarbons produced by a treating process to remove acidic materials. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.]
265-135-164742-34-3Carc. 1AH350GHS08

Dgr
H350H
649-061-00-0Distillates (petroleum), chemically neutralized light naphthenic;

Unrefined or mildly refined baseoil;

[A complex combination of hydrocarbons produced by a treating process to remove acidic materials. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS a 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.]
265-136-764742-35-4Carc. 1AH350GHS08

Dgr
H350H
649-062-00-6Gases (petroleum), catalytic cracked naphtha depropanizer overhead, C3-rich acid-free;

Petroleum gas;

[A complex combination of hydrocarbons obtained from fractionation of catalytic cracked hydrocarbons and treated to remove acidic impurities. It consists of hydrocarbons having carbon numbers in the range of C2 through C4, predominantly C3.]
270-755-068477-73-6Flam. Gas 1

Press. Gas

Carc. 1A

Muta. 1B
H220

H350

H340
GHS02

GHS04

GHS08

Dgr
H220

H350

H340
H K U
649-063-00-1Gases (petroleum), catalytic cracker;

Petroleum gas;

[A complex combination of hydrocarbons produced by the distillation of the products from a catalytic cracking process. It consists predominantly of aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]
270-756-668477-74-7Flam. Gas 1

Press. Gas

Carc. 1A

Muta. 1B
H220

H350

H340
GHS02

GHS04

GHS08

Dgr
H220

H350

H340
H K U
649-064-00-7Gases (petroleum), catalytic cracker, C1-5-rich;

Petroleum gas;

[A complex combination of hydrocarbons produced by the distillation of products from a catalytic cracking process. It consists of aliphatic hydrocarbons having carbon numbers in the range of C1 through C6, predominantly C1 through C5.]
270-757-168477-75-8Flam. Gas 1

Press. Gas

Carc. 1A

Muta. 1B
H220

H350

H340
GHS02

GHS04

GHS08

Dgr
H220

H350

H340
H K U
649-065-00-2Gases (petroleum), catalytic polymd. naphtha stabilizer overhead, C2-4-rich;

Petroleum gas;

[A complex combination of hydrocarbons obtained from the fractionation stabilization of catalytic polymerized naphtha. It consists of aliphatic hydrocarbons having carbon numbers in the range of C2 through C6, predominantly C2 through C4.]
270-758-768477-76-9Flam. Gas 1

Press. Gas

Carc. 1A

Muta. 1B
H220

H350

H340
GHS02

GHS04

GHS08

Dgr
H220

H350

H340
H K U
649-066-00-8Gases (petroleum), catalytic reformer, C1-4-rich;

Petroleum gas;

[A complex combination of hydrocarbons produced by distillation of products from a catalytic reforming process. It consists of hydrocarbons having carbon numbers in the range of C1 through C6, predominantly C1 through C4.]
270-760-868477-79-2Flam. Gas 1

Press. Gas

Carc. 1A

Muta. 1B
H220

H350

H340
GHS02

GHS04

GHS08

Dgr
H220

H350

H340
H K U
649-067-00-3Gases (petroleum), C3-5 olefinic-paraffinic alkylation feed;

Petroleum gas;

[A complex combination of olefinic and paraffinic hydrocarbons having carbon numbers in the range of C3 through C5 which are used as alkylation feed. Ambient temperatures normally exceed the critical temperature of these combinations.]
270-765-568477-83-8Flam. Gas 1

Press. Gas

Carc. 1A

Muta. 1B
H220

H350

H340
GHS02

GHS04

GHS08

Dgr
H220

H350

H340
H K U
649-068-00-9Gases (petroleum), C4-rich;

Petroleum gas;

[A complex combination of hydrocarbons produced by distillation of products from a catalytic fractionation process. It consists of aliphatic hydrocarbons having carbon numbers in the range of C3 through C5, predominantly C4.]
270-767-668477-85-0Flam. Gas 1

Press. Gas

Carc. 1A

Muta. 1B
H220

H350

H340
GHS02

GHS04

GHS08

Dgr
H220

H350

H340
H K U
649-069-00-4Gases (petroleum), deethanizer overheads;

Petroleum gas;

[A complex combination of hydrocarbons produced from distillation of the gas and gasoline fractions from the catalytic cracking process. It contains predominantly ethane and ethylene.]
270-768-168477-86-1Flam. Gas 1

Press. Gas

Carc. 1A

Muta. 1B
H220

H350

H340
GHS02

GHS04

GHS08

Dgr
H220

H350

H340
H K U
649-070-00-XGases (petroleum), deisobutanizer tower overheads;

Petroleum gas;

[A complex combination of hydrocarbons produced by the atmospheric distillation of a butane-butylene stream. It consists of aliphatic hydrocarbons having carbon numbers predominantly in the range of C3 through C4.]
270-769-768477-87-2Flam. Gas 1

Press. Gas

Carc. 1A

Muta. 1B
H220

H350

H340
GHS02

GHS04

GHS08

Dgr
H220

H350

H340
H K U
649-071-00-5Gases (petroleum), depropanizer dry, propene-rich;

Petroleum gas;

[A complex combination of hydrocarbons produced by the distillation of products from the gas and gasoline fractions of a catalytic cracking process. It consists predominantly of propylene with some ethane and propane.]
270-772-368477-90-7Flam. Gas 1

Press. Gas

Carc. 1A

Muta. 1B
H220

H350

H340
GHS02

GHS04

GHS08

Dgr
H220

H350

H340
H K U
649-072-00-0Gases (petroleum), depropanizer overheads;

Petroleum gas;

[A complex combination of hydrocarbons produced by distillation of products from the gas and gasoline fractions of a catalytic cracking process. It consists of aliphatic hydrocarbons having carbon numbers predominantly in the range of C2 through C4.]
270-773-968477-91-8Flam. Gas 1

Press. Gas

Carc. 1A

Muta. 1B
H220

H350

H340
GHS02

GHS04

GHS08

Dgr
H220

H350

H340
H K U
649-073-00-6Gases (petroleum), gas recovery plant depropanizer overheads;

Petroleum gas;

[A complex combination of hydrocarbons obtained by fractionation of miscellaneous hydrocarbon streams. It consists predominantly of hydrocarbons having carbon numbers in the range of C1 through C4, predominantly propane.]
270-777-068477-94-1Flam. Gas 1

Press. Gas

Carc. 1A

Muta. 1B
H220

H350

H340
GHS02

GHS04

GHS08

Dgr
H220

H350

H340
H K U
649-074-00-1Gases (petroleum), Girbatol unit feed;

Petroleum gas;

[A complex combination of hydrocarbons that is used as the feed into the Girbatol unit to remove hydrogen sulfide. It consists of aliphatic hydrocarbons having carbon numbers predominantly in the range of C2 through C4.]
270-778-668477-95-2Flam. Gas 1

Press. Gas

Carc. 1A

Muta. 1B
H220

H350

H340
GHS02

GHS04

GHS08

Dgr
H220

H350

H340
H K U
649-075-00-7Gases (petroleum), isomerized naphtha fractionator, C4-rich, hydrogen sulfide-free;

Petroleum gas
270-782-868477-99-6Flam. Gas 1

Press. Gas

Carc. 1A

Muta. 1B
H220

H350

H340
GHS02

GHS04

GHS08

Dgr
H220

H350

H340
H K U
649-076-00-2Tail gas (petroleum), catalytic cracked clarified oil and thermal cracked vacuum residue fractionation reflux drum;

Petroleum gas;

[A complex combination of hydrocarbons obtained from fractionation of catalytic cracked clarified oil and thermal cracked vacuum residue. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]
270-802-568478-21-7Flam. Gas 1

Press. Gas

Carc. 1A

Muta. 1B
H220

H350

H340
GHS02

GHS04

GHS08

Dgr
H220

H350

H340
H K U
649-077-00-8Tail gas (petroleum), catalytic cracked naphtha stabilization absorber;

Petroleum gas;

[A complex combination of hydrocarbons obtained from the stabilization of catalytic cracked naphtha. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]
270-803-068478-22-8Flam. Gas 1

Press. Gas

Carc. 1A

Muta. 1B
H220

H350

H340
GHS02

GHS04

GHS08

Dgr
H220

H350

H340
H K U
649-078-00-3Tail gas (petroleum), catalytic cracker, catalytic reformer and hydrodesulfurizer combined fractionater;

Petroleum gas;

[A complex combination of hydrocarbons obtained from the fractionation of products from catalytic cracking, catalytic reforming and hydrodesulfurizing processes treated to remove acidic impurities. It consists predominantly of hydrocarbons having cabon numbers predominantly in the range of C1 through C5.]
270-804-668478-24-0Flam. Gas 1

Press. Gas

Carc. 1A

Muta. 1B
H220

H350

H340
GHS02

GHS04

GHS08

Dgr
H220

H350

H340
H K U
649-079-00-9Tail gas (petroleum), catalytic reformed naphtha fractionation stabilizer;

Petroleum gas;

[A complex combination of hydrocarbons obtained from the fractionation stabilization of catalytic reformed naphtha. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]
270-806-768478-26-2Flam. Gas 1

Press. Gas

Carc. 1A

Muta. 1B
H220

H350

H340
GHS02

GHS04

GHS08

Dgr
H220

H350

H340
H K U
649-080-00-4Tail gas (petroleum), saturate gas plant mixed stream, C4-rich;

Petroleum gas;

[A complex combination of hydrocarbons obtained from the fractionation stabilization of straight-run naphtha, distillation tail gas and catalytic reformed naphtha stabilizer tail gas. It consists of hydrocarbons having carbon numbers in the range of C3 through C6, predominantly butane and isobutane.]
270-813-568478-32-0Flam. Gas 1

Press. Gas

Carc. 1A

Muta. 1B
H220

H350

H340
GHS02

GHS04

GHS08

Dgr
H220

H350

H340
H K U
649-081-00-XTail gas (petroleum), saturate gas recovery plant, C1-2-rich;

Petroleum gas;

[A complex combination of hydrocarbons obtained from fractionation of distillate tail gas, straight-run naphtha, catalytic reformed naphtha stabilizer tail gas. It consists predominantly of hydrocarbons having carbon numbers in the range of C1through C5, predominantly methane and ethane.]
270-814-068478-33-1Flam. Gas 1

Press. Gas

Carc. 1A

Muta. 1B
H220

H350

H340
GHS02

GHS04

GHS08

Dgr
H220

H350

H340
H K U
649-082-00-5Tail gas (petroleum), vacuum residues thermal cracker;

Petroleum gas;

[A complex combination of hydrocarbons obtained from the thermal cracking of vacuum residues. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]
270-815-668478-34-2Flam. Gas 1

Press. Gas

Carc. 1A

Muta. 1B
H220

H350

H340
GHS02

GHS04

GHS08

Dgr
H220

H350

H340
H K U
649-083-00-0Hydrocarbons, C3-4-rich, petroleum distillate;

Petroleum gas;

[A complex combination of hydrocarbons produced by distillation and condensation of crude oil. It consists of hydrocarbons having carbon numbers in the range of C3 through C5, predominantly C3 through C4.]
270-990-968512-91-4Flam. Gas 1

Press. Gas

Carc. 1A

Muta. 1B
H220

H350

H340
GHS02

GHS04

GHS08

Dgr
H220

H350

H340
H K U
649-084-00-6Gases (petroleum), full-range straight-run naphtha dehexanizer off;

petroleum gas;

[A complex combination of hydrocarbons obtained by the fractionation of the full-range straight-run naphtha. It consists of hydrocarbons having carbon numbers predominantly in the range of C2 through C6.]
271-000-868513-15-5Flam. Gas 1

Press. Gas

Carc. 1A

Muta. 1B
H220

H350

H340
GHS02

GHS04

GHS08

Dgr
H220

H350

H340
H K U
649-085-00-1Gases (petroleum), hydrocracking depropanizer off, hydrocarbon-rich;

Petroleum gas;

[A complex combination of hydrocarbon produced by the distillation of products from a hydrocracking process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C4. It may also contain small amounts of hydrogen and hydrogen sulfide.]
271-001-368513-16-6Flam. Gas 1

Press. Gas

Carc. 1A

Muta. 1B
H220

H350

H340
GHS02

GHS04

GHS08

Dgr
H220

H350

H340
H K U
649-086-00-7Gases (petroleum), light straight-run naphtha stabilizer off;

Petroleum gas;

[A complex combination of hydrocarbons obtained by the stabilization of light straight-run naphtha. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C2 through C6.]
271-002-968513-17-7Flam. Gas 1

Press. Gas

Carc. 1A

Muta. 1B
H220

H350

H340
GHS02

GHS04

GHS08

Dgr
H220

H350

H340
H K U
649-087-00-2Residues (petroleum), alkylation splitter, C4-rich;

Petroleum gas;

[A complex residuum from the distillation of streams various refinery operations. It consists of hydrocarbons having carbon numbers in the range of C4 through C5, predominantly butane and boiling in the range of approximately - 11.7 oC to 27.8 oC (11 oF to 82 oF).]
271-010-268513-66-6Flam. Gas 1

Press. Gas

Carc. 1A

Muta. 1B
H220

H350

H340
GHS02

GHS04

GHS08

Dgr
H220

H350

H340
H K U
649-088-00-8Hydrocarbons, C1-4;

Petroleum gas;

[A complex combination of hydrocarbons provided by thermal cracking and absorber operations and by distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C4 and boiling in the range of approximately minus 164 oC to minus 0.5 oC (- 263 oF to 31 oF).]
271-032-268514-31-8Flam. Gas 1

Press. Gas

Carc. 1A

Muta. 1B
H220

H350

H340
GHS02

GHS04

GHS08

Dgr
H220

H350

H340
H K U
649-089-00-3Hydrocarbons, C1-4, sweetened;

Petroleum gas;

[A complex combination of hydrocarbons obtained by subjecting hydrocarbon gases to a sweetening process to convert mercaptans or to remove acidic impurities. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C4 and boiling in the range of approximately - 164 oC to - 0.5 oC (-263 oF to 31 oF).]
271-038-568514-36-3Flam. Gas 1

Press. Gas

Carc. 1A

Muta. 1B
H220

H350

H340
GHS02

GHS04

GHS08

Dgr
H220

H350

H340
H K U
649-090-00-9Hydrocarbons, C1-3;

Petroleum gas;

[A complex combination of hydrocarbons having carbon numbers predominantly in the range of C1 through C3 and boiling in the range of approximately minus 164 oC to minus 42 oC (- 263 oF to - 44 oF).]
271-259-768527-16-2Flam. Gas 1

Press. Gas

Carc. 1A

Muta. 1B
H220

H350

H340
GHS02

GHS04

GHS08

Dgr
H220

H350

H340
H K U
649-091-00-4Hydrocarbons, C1-4, debutanizer fraction;

Petroleum gas
271-261-868527-19-5Flam. Gas 1

Press. Gas

Carc. 1A

Muta. 1B
H220

H350

H340
GHS02

GHS04

GHS08

Dgr
H220

H350

H340
H K U
649-092-00-XGases (petroleum), C1-5, wet;

Petroleum gas;

[A complex combination of hydrocarbons produced by the distillation of crude oil and/or the cracking of tower gas oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]
271-624-068602-83-5Flam. Gas 1

Press. Gas

Carc. 1A

Muta. 1B
H220

H350

H340
GHS02

GHS04

GHS08

Dgr
H220

H350

H340
H K U
649-093-00-5Hydrocarbons, C2-4;

Petroleum gas
271-734-968606-25-7Flam. Gas 1

Press. Gas

Carc. 1A

Muta. 1B
H220

H350

H340
GHS02

GHS04

GHS08

Dgr
H220

H350

H340
H K U
649-094-00-0Hydrocarbons, C3;

Petroleum gas
271-735-468606-26-8Flam. Gas 1

Press. Gas

Carc. 1A

Muta. 1B
H220

H350

H340
GHS02

GHS04

GHS08

Dgr
H220

H350

H340
H K U
649-095-00-6Gases (petroleum), alkylation feed;

Petroleum gas;

[A complex combination of hydrocarbons produced by the catalytic cracking of gas oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C3 through C4.]
271-737-568606-27-9Flam. Gas 1

Press. Gas

Carc. 1A

Muta. 1B
H220

H350

H340
GHS02

GHS04

GHS08

Dgr
H220

H350

H340
H K U
649-096-00-1Gases (petroleum), depropanizer bottoms fractionation off;

Petroleum gas;

[A complex combination of hydrocarbons obtained from the fractionation of depropanizer bottoms. It consists predominantly of butane, isobutane and butadiene.]
271-742-268606-34-8Flam. Gas 1

Press. Gas

Carc. 1A

Muta. 1B
H220

H350

H340
GHS02

GHS04

GHS08

Dgr
H220

H350

H340
H K U
649-097-00-7Gases (petroleum), refinery blend;

Petroleum gas;

[A complex combination obtained from various processes. It consists of hydrogen, hydrogen sulfide and hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]
272-183-768783-07-3Flam. Gas 1

Press. Gas

Carc. 1A

Muta. 1B
H220

H350

H340
GHS02

GHS04

GHS08

Dgr
H220

H350

H340
H K U
649-098-00-2Gases (petroleum), catalytic cracking;

Petroleum gas;

[A complex combination of hydrocarbons produced by the distillation of the products from a catalytic cracking process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C3 through C5.]
272-203-468783-64-2Flam. Gas 1

Press. Gas

Carc. 1A

Muta. 1B
H220

H350

H340
GHS02

GHS04

GHS08

Dgr
H220

H350

H340
H K U
649-099-00-8Gases (petroleum), C2-4, sweetened;

Petroleum gas;

[A complex combination of hydrocarbons obtained by subjecting a petroleum distillate to a sweetening process to convert mercaptans or to remove acidic impurities. It consists predominantly of saturated and unsaturated hydrocarbons having carbon numbers predominantly in the range of C2 through C4 and boiling in the range of approximately - 51 oC to - 34 oC (-60 oF to - 30 oF).]
272-205-568783-65-3Flam. Gas 1

Press. Gas

Carc. 1A

Muta. 1B
H220

H350

H340
GHS02

GHS04

GHS08

Dgr
H220

H350

H340
H K U
649-100-00-1Gases (petroleum), crude oil fractionation off;

Petroleum gas;

[A complex combination of hydrocarbons produced by the fractionation of crude oil. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]
272-871-768918-99-0Flam. Gas 1

Press. Gas

Carc. 1A

Muta. 1B
H220

H350

H340
GHS02

GHS04

GHS08

Dgr
H220

H350

H340
H K U
649-101-00-7Gases (petroleum), dehexanizer off;

Petroleum gas;

[A complex combination of hydrocarbons obtained by the fractionation of combined naphtha streams. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]
272-872-268919-00-6Flam. Gas 1

Press. Gas

Carc. 1A

Muta. 1B
H220

H350

H340
GHS02

GHS04

GHS08

Dgr
H220

H350

H340
H K U
649-102-00-2Gases (petroleum), light straight run gasoline fractionation stabilizer off;

Petroleum gas;

[A complex combination of hydrocarbons obtained by the fractionation of light straight-run gasoline. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]
272-878-568919-05-1Flam. Gas 1

Press. Gas

Carc. 1A

Muta. 1B
H220

H350

H340
GHS02

GHS04

GHS08

Dgr
H220

H350

H340
H K U
649-103-00-8Gases (petroleum), naphtha unifiner desulfurization stripper off;

Petroleum gas;

[A complex combination of hydrocarbons produced by a naphtha unifiner desulfurization process and stripped from the naphtha product. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]
272-879-068919-06-2Flam. Gas 1

Press. Gas

Carc. 1A

Muta. 1B
H220

H350

H340
GHS02

GHS04

GHS08

Dgr
H220

H350

H340
H K U
649-104-00-3Gases (petroleum), straight-run naphtha catalytic reforming off;

Petroleum gas;

[A complex combination of hydrocarbons obtained by the catalytic reforming of straight-run naphtha and fractionation of the total effluent. It consists of methane, ethane, and propane.]
272-882-768919-09-5Flam. Gas 1

Press. Gas

Carc. 1A

Muta. 1B
H220

H350

H340
GHS02

GHS04

GHS08

Dgr
H220

H350

H340
H K U
649-105-00-9Gases (petroleum), fluidized catalytic cracker splitter overheads;

Petroleum gas;

[A complex combination of hydrocarbons produced by the fractionation of the charge to the C3 -C4 splitter. It consists predominantly of C3 hydrocarbons.]
272-893-768919-20-0Flam. Gas 1

Press. Gas

Carc. 1A

Muta. 1B
H220

H350

H340
GHS02

GHS04

GHS08

Dgr
H220

H350

H340
H K U
649-106-00-4Gases (petroleum), straight-run stabilizer off;

Petroleum gas;

[A complex combination of hydrocarbons obtained from the fractionation of the liquid from the first tower used in the distillation of crude oil. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]
272-883-268919-10-8Flam. Gas 1

Press. Gas

Carc. 1A

Muta. 1B
H220

H350

H340
GHS02

GHS04

GHS08

Dgr
H220

H350

H340
H K U
649-107-00-XGases (petroleum), catalytic cracked naphtha debutanizer;

Petroleum gas;

[A complex combination of hydrocarbons obtained from fractionation of catalytic cracked naphtha. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]
273-169-368952-76-1Flam. Gas 1

Press. Gas

Carc. 1A

Muta. 1B
H220

H350

H340
GHS02

GHS04

GHS08

Dgr
H220

H350

H340
H K U
649-108-00-5Tail gas (petroleum), catalytic cracked distillate and naphtha stabilizer;

Petroleum gas;

[A complex combination of hydrocarbons obtained by the fractionation of catalytic cracked naphtha and distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]
273-170-968952-77-2Flam. Gas 1

Press. Gas

Carc. 1A

Muta. 1B
H220

H350

H340
GHS02

GHS04

GHS08

Dgr
H220

H350

H340
H K U
649-109-00-0Tail gas (petroleum), thermal-cracked distillate, gas oil and naphtha absorber;

petroleum gas;

[A complex combination of hydrocarbons obtained from the separation of thermal-cracked distillates, naphtha and gas oil. It consists pedrominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]
273-175-668952-81-8Flam. Gas 1

Press. Gas

Carc. 1A

Muta. 1B
H220

H350

H340
GHS02

GHS04

GHS08

Dgr
H220

H350

H340
H K U
649-110-00-6Tail gas (petroleum), thermal cracked hydrocarbon fractionation stabilizer, petroleum coking;

Petroleum gas;

[A complex combination of hydrocarbons obtained from the fractionation stabilization of thermal cracked hydrocarbons from petroleum coking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]
273-176-168952-82-9Flam. Gas 1

Press. Gas

Carc. 1A

Muta. 1B
H220

H350

H340
GHS02

GHS04

GHS08

Dgr
H220

H350

H340
H K U
649-111-00-1Gases (petroleum, light steam-cracked, butadiene conc.;

Petroleum gas;

[A complex combination of hydrocarbons produced by the distillation of products from a thermal cracking process, It consists of hydrocarbons having a carbon number predominantly of C4.]
273-265-568955-28-2Flam. Gas 1

Press. Gas

Carc. 1A

Muta. 1B
H220

H350

H340
GHS02

GHS04

GHS08

Dgr
H220

H350

H340
H K U
649-112-00-7Gases (petroleum), straight-run naphtha catalytic reformer stabilizer overhead;

Petroleum gas;

[A complex combination of hydrocarbons obtained by the catalytic reforming of straight-run naphtha and the fractionation of the total effluent. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C2 through C4.]
273-270-268955-34-0Flam. Gas 1

Press. Gas

Carc. 1A

Muta. 1B
H220

H350

H340
GHS02

GHS04

GHS08

Dgr
H220

H350

H340
H K U
649-113-00-2Hydrocarbons, C4;

Petroleum gas
289-339-587741-01-3Flam. Gas 1

Press. Gas

Carc. 1A

Muta. 1B
H220

H350

H340
GHS02

GHS04

GHS08

Dgr
H220

H350

H340
H K U
649-114-00-8Alkanes, C1-4, C3-rich;

Petroleum gas
292-456-490622-55-2Flam. Gas 1

Press. Gas

Carc. 1A

Muta. 1B
H220

H350

H340
GHS02

GHS04

GHS08

Dgr
H220

H350

H340
H K U
649-115-00-3Gases (petroleum), steam-cracker C3-rich;

Petroleum gas;

[A complex combination of hydrocarbons produced by the distillation of products from a steam cracking process. It consists predominantly of propylene with some propane and boils in the range of approximately - 70 oC to 0 oC (- 94 oF to 32 oF).]
295-404-992045-22-2Flam. Gas 1

Press. Gas

Carc. 1A

Muta. 1B
H220

H350

H340
GHS02

GHS04

GHS08

Dgr
H220

H350

H340
H K U
649-116-00-9Hydrocarbons, C4, steam-cracker distillate;

Petroleum gas;

[A complex combination of hydrocarbons produced by the distillation of the products of a steam cracking process. It consists predominantly of hydrocarbons having a carbon number of C4, predominantly 1-butene and 2-butene, containing also butane and isobutene and boiling in the range of approximately minus 12 oC to 5 oC (10.4 oF to 41 oF).]
295-405-492045-23-3Flam. Gas 1

Press. Gas

Carc. 1A

Muta. 1B
H220

H350

H340
GHS02

GHS04

GHS08

Dgr
H220

H350

H340
H K U
649-117-00-4Petroleum gases, liquefied, sweetened, C4 fraction;

Petroleum gas;

[A complex combination of hydrocarbons obtained by subjecting a liquified petroleum gas mix to a sweetening process to oxidize mercaptans or to remove acidic impurities. It consists predominantly of C4 saturated and unsaturated hydrocarbons.]
295-463-092045-80-2Flam. Gas 1

Press. Gas

Carc. 1A

Muta. 1B
H220

H350

H340
GHS02

GHS04

GHS08

Dgr
H220

H350

H340
HKSU
649-118-00-XHydrocarbons, C4, 1,3-butadiene- and isobutene-free;

Petroleum gas
306-004-195465-89-7Flam. Gas 1

Press. Gas

Carc. 1B
H220

H350
GHS02

GHS04

GHS08

Dgr
H220

H350
H K U
649-119-00-5Raffinates (petroleum), steam-cracked C4 fraction cuprous ammonium acetate extn., C3-5 and C3-5 unsatd., butadiene-free;

Petroleum gas
307-769-497722-19-5Flam. Gas 1

Press. Gas

Carc. 1A

Muta. 1B
H220

H350

H340
GHS02

GHS04

GHS08

Dgr
H220

H350

H340
H K U
649-120-00-0Gases (petroleum), amine system feed;

Refinery gas;

[The feed gas to the amine system for removal of hydrogen sulfide. It consists of hydrogen. Carbon monoxide, carbon dioxide, hydrogen sulfide and aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5 may also be present.]
270-746-168477-65-6Flam. Gas 1

Press. Gas

Carc. 1A

Muta. 1B
H220

H350

H340
GHS02

GHS04

GHS08

Dgr
H220

H350

H340
H K U
649-121-00-6Gases (petroleum), benzene unit hydrodesulfurizer off;

Refinery gas;

[Off gases produced by the benzene unit. It consists primarily of hydrogen. Carbon monoxide and hydrocarbons having carbon numbers predominantly in the range of C1 through C6, including benzene, may also be present.]
270-747-768477-66-7Flam. Gas 1

Press. Gas

Carc. 1A

Muta. 1B
H220

H350

H340
GHS02

GHS04

GHS08

Dgr
H220

H350

H340
H K U
649-122-00-1Gases (petroleum), benzene unit recycle, hydrogen-rich;

Refinery gas;

[A complex combination of hydrocarbons obtained by recycling the gases of the benzene unit. It consists primarily of hydrogen with various small amounts of carbon monoxide and hydrocarbons having carbon numbers in the range of C1 through C6.]
270-748-268477-67-8Flam. Gas 1

Press. Gas

Carc. 1A

Muta. 1B
H220

H350

H340
GHS02

GHS04

GHS08

Dgr
H220

H350

H340
H K U
649-123-00-7Gases (petroleum), blend oil, hydrogen-nitrogen-rich;

Refinery gas;

[A complex combination of hydrocarbons obtained by distillation of a blend oil. It consists primarily of hydrogen and nitrogen with various small amounts of carbon monoxide, carbon dioxide, and aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]
270-749-868477-68-9Flam. Gas 1

Press. Gas

Carc. 1A

Muta. 1B
H220

H350

H340
GHS02

GHS04

GHS08

Dgr
H220

H350

H340
H K U
649-124-00-2Gases (petroleum), catalytic reformed naphtha stripper overheads;

Refinery gas;

[A complex combination of hydrocarbons obtained from stabilization of catalytic reformed naphtha. Its consists of hydrogen and saturated hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]
270-759-268477-77-0Flam. Gas 1

Press. Gas

Carc. 1A

Muta. 1B
H220

H350

H340
GHS02

GHS04

GHS08

Dgr
H220

H350

H340
H K U
649-125-00-8Gases (petroleum), C6-8 catalytic reformer recycle;

Refinery gas;

[A complex combination of hydrocarbons produced by distillation of products from catalytic reforming of C6-C8 feed and recycled to conserve hydrogen. It consists primarily of hydrogen. It may also contain various small amounts of carbon monoxide, carbon dioxide, nitrogen, and hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]
270-761-368477-80-5Flam. Gas 1

Press. Gas

Carc. 1A

Muta. 1B
H220

H350

H340
GHS02

GHS04

GHS08

Dgr
H220

H350

H340
H K U
649-126-00-3Gases (petroleum), C6-8 catalytic reformer;

Refinery gas;

[A complex combination of hydrocarbons produced by distillation of products from catalytic reforming of C6-C8feed. It consists of hydrocarbons having carbon numbers in the range of C1 through C5 and hydrogen.]
270-762-968477-81-6Flam. Gas 1

Press. Gas

Carc. 1A

Muta. 1B
H220

H350

H340
GHS02

GHS04

GHS08

Dgr
H220

H350

H340
H K U
649-127-00-9Gases (petroleum), C6-8 catalytic reformer recycle, hydrogen-rich;

Refinery gas
270-763-468477-82-7Flam. Gas 1

Press. Gas

Carc. 1A

Muta. 1B
H220

H350

H340
GHS02

GHS04

GHS08

Dgr
H220

H350

H340
H K U
649-128-00-4Gases (petroleum), C2-return stream;

Refinery gas;

[A complex combination of hydrocarbons obtained by the extraction of hydrogen from a gas stream which consists primarily of hydrogen with small amounts of nitrogen, carbon monoxide, methane, ethane, and ethylene. It contains predominantly hydrocarbons such as methane, ethane, and ethylene with small amounts of hydrogen, nitrogen and carbon monoxide.]
270-766-068477-84-9Flam. Gas 1

Press. Gas

Carc. 1A

Muta. 1B
H220

H350

H340
GHS02

GHS04

GHS08

Dgr
H220

H350

H340
H K U
649-129-00-XGases (petroleum), dry sour, gas-concn.-unit-off;

Refinery gas;

[The complex combination of dry gases from a gas concentration unit. It consists of hydrogen, hydrogen sulfide and hydrocarbons having carbon numbers predominantly in the range of C1 through C3.]
270-774-468477-92-9Flam. Gas 1

Press. Gas

Carc. 1A

Muta. 1B
H220

H350

H340
GHS02

GHS04

GHS08

Dgr
H220

H350

H340
H K U
649-130-00-5Gases (petroleum), gas concn. reabsorber distn.;

Refinery gas;

[A complex combination of hydrocarbons produced by distillation of products from combined gas streams in a gas concentration reabsorber. It consists predominantly of hydrogen, carbon monoxide, carbon dioxide, nitrogen, hydrogen sulfide and hydrocarbons having carbon numbers in the range of C1 through C3.]
270-776-568477-93-0Flam. Gas 1

Press. Gas

Carc. 1A

Muta. 1B
H220

H350

H340
GHS02

GHS04

GHS08

Dgr
H220

H350

H340
H K U
649-131-00-0Gases (petroleum), hydrogen absorber off;

Refinery gas;

[A complex combination obtained by absorbing hydrogen from a hydrogen rich stream. It consists of hydrogen, carbon monoxide, nitrogen, and methane with small amounts of C2 hydrocarbons.]
270-779-168477-96-3Flam. Gas 1

Press. Gas

Carc. 1A

Muta. 1B
H220

H350

H340
GHS02

GHS04

GHS08

Dgr
H220

H350

H340
H K U
649-132-00-6Gases (petroleum), hydrogen-rich;

Refinery gas;

[A complex combination separated as a gas from hydrocarbon gases by chilling. It consists primarily of hydrogen with various small amounts of carbon monoxide, nitrogen, methane, and C2 hydrocarbons.]
270-780-768477-97-4Flam. Gas 1

Press. Gas

Carc. 1A

Muta. 1B
H220

H350

H340
GHS02

GHS04

GHS08

Dgr
H220

H350

H340
H K U
649-133-00-1Gases (petroleum), hydrotreater blend oil recycle, hydrogen-nitrogen-rich;

Refinery gas;

[A complex combination obtained from recycled hydrotreated blend oil. It consists primarily of hydrogen and nitrogen with various small amounts of carbon monoxide, carbon dioxide and hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]
270-781-268477-98-5Flam. Gas 1

Press. Gas

Carc. 1A

Muta. 1B
H220

H350

H340
GHS02

GHS04

GHS08

Dgr
H220

H350

H340
H K U
649-134-00-7Gases (petroleum), recycle, hydrogen-rich;

Refinery gas;

[A complex combination obtained from recycled reactor gases. It consists primarily of hydrogen with various small amounts of carbon monoxide, carbon dioxide, nitrogen, hydrogen sulfide, and saturated aliphatic hydrocarbons having carbon numbers in the range of C1 through C5.]
270-783-368478-00-2Flam. Gas 1

Press. Gas

Carc. 1A

Muta. 1B
H220

H350

H340
GHS02

GHS04

GHS08

Dgr
H220

H350

H340
H K U
649-135-00-2Gases (petroleum), reformer make-up, hydrogen-rich;

Refinery gas;

[A complex combination obtained from the reformers. It consists primarily of hydrogen with various small amounts of carbon monoxide and aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]
270-784-968478-01-3Flam. Gas 1

Press. Gas

Carc. 1A

Muta. 1B
H220

H350

H340
GHS02

GHS04

GHS08

Dgr
H220

H350

H340
H K U
649-136-00-8Gases (petroleum), reforming hydrotreater;

Refinery gas;

[A complex combination obtained from the reforming hydrotreating process. It consists primarily of hydrogen, methane, and ethane with various small amounts of hydrogen sulfide and aliphatic hydrocarbons having carbon numbers predominantly in the range of C3 thorugh C5.]
270-785-468478-02-4Flam. Gas 1

Press. Gas

Carc. 1A

Muta. 1B
H220

H350

H340
GHS02

GHS04

GHS08

Dgr
H220

H350

H340
H K U
649-137-00-3Gases (petroleum), reforming hydrotreater, hydrogen-methane-rich;

Refinery gas;

[A complex combination obtained from the reforming hydrotreating process. It consists primarily of hydrogen and methane with various small amounts of carbon monoxide, carbon dioxide, nitrogen and saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C2 through C5.]
270-787-568478-03-5Flam. Gas 1

Press. Gas

Carc. 1A

Muta. 1B
H220

H350

H340
GHS02

GHS04

GHS08

Dgr
H220

H350

H340
H K U
649-138-00-9Gases (petroleum), reforming hydrotreater make-up, hydrogen-rich;

Refinery gas;

[A complex combination obtained from the reforming hydrotreating process. It consists primarily of hydrogen with various small amounts of carbon monoxide and aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]
270-788-068478-04-6Flam. Gas 1

Press. Gas

Carc. 1A

Muta. 1B
H220

H350

H340
GHS02

GHS04

GHS08

Dgr
H220

H350

H340
H K U
649-139-00-4Gases (petroleum), thermal cracking distn.;

Refinery gas;

[A complex combination produced by distillation of products from a thermal cracking process. It consists of hydrogen, hydrogen sulfide, carbon monoxide, carbon dioxide and hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]
270-789-668478-05-7Flam. Gas 1

Press. Gas

Carc. 1A

Muta. 1B
H220

H350

H340
GHS02

GHS04

GHS08

Dgr
H220

H350

H340
H K U
649-140-00-XTail gas (petroleum), catalytic cracker refractionation absorber;

Refinery gas;

[A complex combination of hydrocarbons obtained from refractionation of products from a catalytic cracking process. It consists of hydrogen and hydrocarbons having carbon numbers predominantly in the range of C1 through C3.]
270-805-168478-25-1Flam. Gas 1

Press. Gas

Carc. 1A

Muta. 1B
H220

H350

H340
GHS02

GHS04

GHS08

Dgr
H220

H350

H340
H K U
649-141-00-5Tail gas (petroleum), catalytic reformed naphtha separator;

Refinery gas;

[A complex combination of hydrocarbons obtained from the catalytic reforming of straight run naphtha. It consists of hydrogen and hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]
270-807-268478-27-3Flam. Gas 1

Press. Gas

Carc. 1A

Muta. 1B
H220

H350

H340
GHS02

GHS04

GHS08

Dgr
H220

H350

H340
H K U
649-142-00-0Tail gas (petroleum), catalytic reformed naphtha stabilizer;

Refinery gas;

[A complex combination of hydrocarbons obtained from the stabilization of catalytic reformed naphtha. It consists of hydrogen and hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]
270-808-868478-28-4Flam. Gas 1

Press. Gas

Carc. 1A

Muta. 1B
H220

H350

H340
GHS02

GHS04

GHS08

Dgr
H220

H350

H340
H K U
649-143-00-6Tail gas (petroleum), cracked distillate hydrotreater separator;

Refinery gas;

[A complex combination of hydrocarbons obtained by treating cracked distillates with hydrogen in the presence of a catalyst. It consists of hydrogen and saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]
270-809-368478-29-5Flam. Gas 1

Press. Gas

Carc. 1A

Muta. 1B
H220

H350

H340
GHS02

GHS04

GHS08

Dgr
H220

H350

H340
H K U
649-144-00-1Tail gas (petroleum), hydrodesulfurized straight-run naphtha separator;

Refinery gas;

[A complex combination of hydrocarbons obtained from hydrodesulfurization of straight-run naphtha. It consists of hydrogen and saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]
270-810-968478-30-8Flam. Gas 1

Press. Gas

Carc. 1A

Muta. 1B
H220

H350

H340
GHS02

GHS04

GHS08

Dgr
H220

H350

H340
H K U
649-145-00-7Gases (petroleum), catalytic reformed straight-run naphtha stabilizer overheads;

Refinery gas;

[A complex combination of hydrocarbons obtained from the catalytic reforming of straight-run naphtha followed by fractionation of the total effluent. It consists of hydrogen, methane, ethane and propane.]
270-999-868513-14-4Flam. Gas 1

Press. Gas

Carc. 1A

Muta. 1B
H220

H350

H340
GHS02

GHS04

GHS08

Dgr
H220

H350

H340
H K U
649-146-00-2Gases (petroleum), reformer effluent high-pressure flash drum off;

Refinery gas;

[A complex combination produced by the high-pressure flashing of the effluent from the reforming reactor. It consists primarily of hydrogen with various small amounts of methane, ethane, and propane.]
271-003-468513-18-8Flam. Gas 1

Press. Gas

Carc. 1A

Muta. 1B
H220

H350

H340
GHS02

GHS04

GHS08

Dgr
H220

H350

H340
H K U
649-147-00-8Gases (petroleum), reformer effluent low-pressure flash drum off;

Refinery gas;

[A complex combination produced by low-pressure flashing of the effluent from the reforming reactor. It consists primarily of hydrogen with various small amounts of methane, ethane, and propane.]
271-005-568513-19-9Flam. Gas 1

Press. Gas

Carc. 1A

Muta. 1B
H220

H350

H340
GHS02

GHS04

GHS08

Dgr
H220

H350

H340
H K U
649-148-00-3Gases (petroleum), oil refinery gas distn. off;

Refinery gas;

[A complex combination separated by distillation of a gas stream containing hydrogen, carbon monoxide, carbon dioxide and hydrocarbons having carbon numbers in the range of C1 through C6 or obtained by cracking ethane and propane. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C2, hydrogen, nitrogen, and carbon monoxide.]
271-258-168527-15-1Flam. Gas 1

Press. Gas

Carc. 1A

Muta. 1B
H220

H350

H340
GHS02

GHS04

GHS08

Dgr
H220

H350

H340
H K U
649-149-00-9Gases (petroleum), benzene unit hydrotreater depentanizer overheads;

Refinery gas;

[A complex combination produced by treating the feed from the benzene unit with hydrogen in the presence of a catalyst followed by depentanizing. It consists primarily of hydrogen, ethane and propane with various small amounts of nitrogen, carbon monoxide, carbon dioxide and hydrocarbons having carbon numbers predominantly in the range of C1 through C6. It may contain trace amounts of benzene.]
271-623-568602-82-4Flam. Gas 1

Press. Gas

Carc. 1A

Muta. 1B
H220

H350

H340
GHS02

GHS04

GHS08

Dgr
H220

H350

H340
H K U
649-150-00-4Gases (petroleum), secondary absorber off, fluidized catalytic cracker overheads fractionator;

Refinery gas;

[A complex combination produced by the fractionation of the overhead products from the catalytic cracking process in the fluidized catalytic cracker. It consists of hydrogen, nitrogen, and hydrocarbons having carbon numbers predominantly in the range of C1 through C3.]
271-625-668602-84-6Flam. Gas 1

Press. Gas

Carc. 1A

Muta. 1B
H220

H350

H340
GHS02

GHS04

GHS08

Dgr
H220

H350

H340
H K U
649-151-00-XPetroleum products, refinery gases;

Refinery gas;

[A complex combination which consists primarily of hydrogen with various small amounts of methane, ethane, and propane.]
271-750-668607-11-4Flam. Gas 1

Press. Gas

Carc. 1A

Muta. 1B
H220

H350

H340
GHS02

GHS04

GHS08

Dgr
H220

H350

H340
H K U
649-152-00-5Gases (petroleum), hydrocracking low-pressure separator;

Refinery gas;

[A complex combination obtained by the liquid-vapor separation of the hydrocracking process reactor effluent. It consists predominantly of hydrogen and saturated hydrocarbons having carbon numbers predominantly in the range of C1 through C3.]
272-182-168783-06-2Flam. Gas 1

Press. Gas

Carc. 1A

Muta. 1B
H220

H350

H340
GHS02

GHS04

GHS08

Dgr
H220

H350

H340
H K U
649-153-00-0Gases (petroleum), refinery;

Refinery gas;

[A complex combination obtained from various petroleum refining operations. It consists of hydrogen and hydrocarbons having carbon numbers predominantly in the range of C1 through C3.]
272-338-968814-67-5Flam. Gas 1

Press. Gas

Carc. 1A

Muta. 1B
H220

H350

H340
GHS02

GHS04

GHS08

Dgr
H220

H350

H340
H K U
649-154-00-6Gases (petroleum), platformer products separator off;

Refinery gas;

[A complex combination obtained from the chemical reforming of naphthenes to aromatics. It consists of hydrogen and saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C2 through C4.]
272-343-668814-90-4Flam. Gas 1

Press. Gas

Carc. 1A

Muta. 1B
H220

H350

H340
GHS02

GHS04

GHS08

Dgr
H220

H350

H340
H K U
649-155-00-1Gases (petroleum), hydrotreated sour kerosine depentanizer stabilizer off;

Refinery gas;

[The complex combination obtained from the depentanizer stabilization of hydrotreated kerosine. It consists primarily of hydrogen, methane, ethane, and propane with various small amounts of nitrogen, hydrogen sulfide, carbon monoxide and hydrocarbons having carbon numbers predominantly in the range of C4 through C5.]
272-775-568911-58-0Flam. Gas 1

Press. Gas

Carc. 1A

Muta. 1B
H220

H350

H340
GHS02

GHS04

GHS08

Dgr
H220

H350

H340
H K U
649-156-00-7Gases (petroleum), hydrotreated sour kerosine flash drum;

Refinery gas;

[A complex combination obtained from the flash drum of the unit treating sour kerosine with hydrogen in the presence of a catalyst. It consists primarily of hydrogen and methane with various small amounts of nitrogen, carbon monoxide, and hydro-carbons having carbon numbers predominantly in the range of C2 through C5.]
272-776-068911-59-1Flam. Gas 1

Press. Gas

Carc. 1A

Muta. 1B
H220

H350

H340
GHS02

GHS04

GHS08

Dgr
H220

H350

H340
H K U
649-157-00-2Gases (petroleum), distillate unifiner desulfurization stripper off;

Refinery gas;

[A complex combination stripped from the liquid product of the unifiner desulfurization process. It consists of hydrogen sulfide, methane, ethane, and propane.]
272-873-868919-01-7Flam. Gas 1

Press. Gas

Carc. 1A

Muta. 1B
H220

H350

H340
GHS02

GHS04

GHS08

Dgr
H220

H350

H340
H K U
649-158-00-8Gases (petroleum), fluidized catalytic cracker fractionation off;

Refinery gas;

[A complex combination produced by the fractionation of the overhead product of the fluidized catalytic cracking process. It consists of hydrogen, hydrogen sulfide, nitrogen, and hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]
272-874-368919-02-8Flam. Gas 1

Press. Gas

Carc. 1A

Muta. 1B
H220

H350

H340
GHS02

GHS04

GHS08

Dgr
H220

H350

H340
H K U
649-159-00-3Gases (petroleum), fluidized catalytic cracker scrubbing secondary absorber off;

Refinery gas;

[A complex combination produced by scrubbing the overhead gas from the fluidized catalytic cracker. It consists of hydrogen, nitrogen, methane, ethane and propane.]
272-875-968919-03-9Flam. Gas 1

Press. Gas

Carc. 1A

Muta. 1B
H220

H350

H340
GHS02

GHS04

GHS08

Dgr
H220

H350

H340
H K U
649-160-00-9Gases (petroleum), heavy distillate hydrotreater desulfurization stripper off;

Refinery gas;

[A complex combination stripped from the liquid product of the heavy distillate hydrotreater desulfurization process. It consists of hydrogen, hydrogen sulfide, and saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5].
272-876-468919-04-0Flam. Gas 1

Press. Gas

Carc. 1A

Muta. 1B
H220

H350

H340
GHS02

GHS04

GHS08

Dgr
H220

H350

H340
H K U
649-161-00-4Gases (petroleum), platformer stabilizer off, light ends fractionation;

Refinery gas;

[A complex combination obtained by the fractionation of the light ends of the platinum reactors of the plattformer unit. It consists of hydrogen, methane, ethane and propane.]
272-880-668919-07-3Flam. Gas 1

Press. Gas

Carc. 1A

Muta. 1B
H220

H350

H340
GHS02

GHS04

GHS08

Dgr
H220

H350

H340
H K U
649-162-00-XGases (petroleum), preflash tower off, crude distn.;

Refinery gas;

[A complex combination produced from the first tower used in the distillation of crude oil. It consists of nitrogen and saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]
272-881-168919-08-4Flam. Gas 1

Press. Gas

Carc. 1A

Muta. 1B
H220

H350

H340
GHS02

GHS04

GHS08

Dgr
H220

H350

H340
H K U
649-163-00-5Gases (petroleum), tar stripper off;

Refinery gas;

[A complex combination obtained by the fractionation of reduced crude oil. It consists of hydrogen and hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]
272-884-868919-11-9Flam. Gas 1

Press. Gas

Carc. 1A

Muta. 1B
H220

H350

H340
GHS02

GHS04

GHS08

Dgr
H220

H350

H340
H K U
649-164-00-0Gases (petroleum), unifiner stripper off;

Refinery gas;

[A combination of hydrogen and methane obtained by fractionation of the products from the unifiner unit.]
272-885-368919-12-0Flam. Gas 1

Press. Gas

Carc. 1A

Muta. 1B
H220

H350

H340
GHS02

GHS04

GHS08

Dgr
H220

H350

H340
H K U
649-165-00-6Tail gas (petroleum), catalytic hydrodesulfurized naphtha separator;

Refinery gas;

[A complex combination of hydrocarbons obtained from the hydrodesulfurization of naphtha. It consists of hydrogen, methane, ethane, and propane.]
273-173-568952-79-4Flam. Gas 1

Press. Gas

Carc. 1A

Muta. 1B
H220

H350

H340
GHS02

GHS04

GHS08

Dgr
H220

H350

H340
H K U
649-166-00-1Tail gas (petroleum), straight-run naphtha hydrodesulfurizer;

Refinery gas;

[A complex combination obtained from the hydrodesulfurization of straight-run naphtha. It consists of hydrogen and hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]
273-174-068952-80-7Press. Gas

Flam. Gas 1

Carc. 1A

Muta. 1B
H220

H350

H340
GHS02

GHS04

GHS08

Dgr
H220

H350

H340
H K U
649-167-00-7Gases (petroleum), sponge absorber off, fluidized catalytic cracker and gas oil desulfurizer overhead fractionation;

Refinery gas;

[A complex combination obtained by the fractionation of products from the fluidized catalytic cracker and gas oil desulfurizer. It consists of hydrogen and hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]
273-269-768955-33-9Flam. Gas 1

Press. Gas

Carc. 1A

Muta. 1B
H220

H350

H340
GHS02

GHS04

GHS08

Dgr
H220

H350

H340
H K U
649-168-00-2Gases (petroleum), crude distn. and catalytic cracking;

Refinery gas;

[A complex combination produced by crude distillation and catalytic cracking processes. It consists of hydrogen, hydrogen sulfide, nitrogen, carbon monoxide and paraffinic and olefinic hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]
273-563-568989-88-8Flam. Gas 1

Press. Gas

Carc. 1A

Muta. 1B
H220

H350

H340
GHS02

GHS04

GHS08

Dgr
H220

H350

H340
H K U
649-169-00-8Gases (petroleum), gas oil diethanolamine scrubber off;

Refinery gas;

[A complex combination produced by desulfurization of gas oils with diethanolamine. It consists predominantly of hydrogen sulfide, hydrogen and aliphatic hydrocarbons having carbon numbers in the range of C1 through C5.]
295-397-292045-15-3Flam. Gas 1

Press. Gas

Carc. 1A

Muta. 1B
H220

H350

H340
GHS02

GHS04

GHS08

Dgr
H220

H350

H340
H K U
649-170-00-3Gases (petroleum), gas oil hydrodesulfurization effluent;

Refinery gas;

[A complex combination obtained by separation of the liquid phase from the effluent from the hydrogenation reaction. It consists predominantly of hydrogen, hydrogen sulfide and aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C3.]
295-398-892045-16-4Flam. Gas 1

Press. Gas

Carc. 1A

Muta. 1B
H220

H350

H340
GHS02

GHS04

GHS08

Dgr
H220

H350

H340
H K U
649-171-00-9Gases (petroleum), gas oil hydrodesulfurization purge;

Refinery gas;

[A complex combination of gases obtained from the reformer and from the purges from the hydrogenation reactor. It consists predominantly of hydrogen and aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]
295-399-392045-17-5Flam. Gas 1

Press. Gas

Carc. 1A

Muta. 1B
H220

H350

H340
GHS02

GHS04

GHS08

Dgr
H220

H350

H340
H K U
649-172-00-4Gases (petroleum), hydrogenator effluent flash drum off;

Refinery gas;

[A complex combination of gases obtained from flash of the effluents after the hydrogenation reaction. It consists predominantly of hydrogen and aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]
295-400-792045-18-6Flam. Gas 1

Press. Gas

Carc. 1A

Muta. 1B
H220

H350

H340
GHS02

GHS04

GHS08

Dgr
H220

H350

H340
H K U
649-173-00-XGases (petroleum), naphtha steam cracking high-pressure residual;

Refinery gas;

[A complex combination obtained as a mixture of the non-condensable portions from the product of a naphtha steam cracking process as well as residual gases obtained during the preparation of subsequent products. It consists predominantly of hydrogen and paraffinic and olefinic hydrocarbons having carbon numbers predominantly in the range of C1 through C5 with which natural gas may also be mixed.]
295-401-292045-19-7Flam. Gas 1

Press. Gas

Carc. 1A

Muta. 1B
H220

H350

H340
GHS02

GHS04

GHS08

Dgr
H220

H350

H340
H K U
649-174-00-5Gases (petroleum), residue visbaking off;

Refinery gas;

[A complex combination obtained from viscosity reduction of residues in a furnace. It consists predominantly of hydrogen sulfide and paraffinic and olefinic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]
295-402-892045-20-0Flam. Gas 1

Press. Gas

Carc. 1A

Muta. 1B
H220

H350

H340
GHS02

GHS04

GHS08

Dgr
H220

H350

H340
H K U
649-175-00-0Foots oil (petroleum), acid-treated;

Foots oil;

[A complex combination of hydrocarbons obtained by treatment of Foot's oil with sulfuric acid. It consists predominantly of branched-chain hydrocarbons with carbon numbers predominantly in the range of C20 through C50.]
300-225-793924-31-3Flam. Gas 1

Press. Gas

Carc. 1B
H220

H350

H340
GHS02

GHS04

GHS08

Dgr
H220

H350

H340
H K U
649-176-00-6Foots oil (petroleum), clay-treated;

Foots oil;

[A complex combination of hydrocarbons obtained by treatment of Foot's oil with natural or modified clay in either a contacting or percolation process to remove the trace amounts of polar compounds and impurities present. It consists predominantly of branched chain hydrocarbons with carbon numbers predominantly in the range of C20 through C50.]
300-226-293924-32-4Flam. Gas 1

Press. Gas

Carc. 1B
H220

H350

H340
GHS02

GHS04

GHS08

Dgr
H220

H350

H340
H K U
649-177-00-1Gases (petroleum), C3-4;

Petroleum gas;

[A complex combination of hydrocarbons produced by distillation of products from the cracking of crude oil. It consists of hydrocarbons having carbon numbers in the range of C3 through C4, predominantly of propane and propylene, and boiling in the range of approximately - 51 oC to - 1 oC (-60oF to 30 oF.)]
268-629-568131-75-9Flam. Gas 1

Press. Gas

Carc. 1A

Muta. 1B
H220

H350

H340
GHS02

GHS04

GHS08

Dgr
H220

H350

H340
H K U
649-178-00-7Tail gas (petroleum), catalytic cracked distillate and catalytic cracked naphtha fractionation absorber;

Petroleum gas;

[The complex combination of hydrocarbons from the distillation of the products from catalytic cracked distillates and catalytic cracked naphtha. It consists predominantly of hydrocarbons having carbon numbers in the range of C1 through C4.]
269-617-268307-98-2Flam. Gas 1

Press. Gas

Carc. 1A

Muta. 1B
H220

H350

H340
GHS02

GHS04

GHS08

Dgr
H220

H350

H340
H K U
649-179-00-2Tail gas (petroleum), catalytic polymn. naphtha fractionation stabilizer;

Petroleum gas;

[A complex combination of hydrocarbons from the fractionation stabilization products from polymerization of naphtha. It consists predominantly of hydrocarbons having carbon numbers in the range of C1 through C4.]
269-618-868307-99-3Flam. Gas 1

Press. Gas

Carc. 1A

Muta. 1B
H220

H350

H340
GHS02

GHS04

GHS08

Dgr
H220

H350

H340
H K U
649-180-00-8Tail gas (petroleum), catalytic reformed naphtha fractionation stabilizer, hydrogen sulfide-free;

Petroleum gas;

[A complex combination of hydrocarbons obtained from fractionation stabilization of catalytic reformed naphtha and from which hydrogen sulfide has been removed by amine treatment. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]
269-619-368308-00-9Flam. Gas 1

Press. Gas

Carc. 1A

Muta. 1B
H220

H350

H340
GHS02

GHS04

GHS08

Dgr
H220

H350

H340
H K U
649-181-00-3Tail gas (petroleum), cracked distillate hydrotreater stripper;

Petroleum gas;

[A complex combination of hydrocarbons obtained by treating thermal cracked distillates with hydrogen in the presence of a catalyst. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]
269-620-968308-01-0Flam. Gas 1

Press. Gas

Carc. 1A

Muta. 1B
H220

H350

H340
GHS02

GHS04

GHS08

Dgr
H220

H350

H340
H K U
649-182-00-9Tail gas (petroleum), straight-run distillate hydrodesulfurizer, hydrogen sulfide-free;

Petroleum gas;

[A complex combination of hydrocarbons obtained from catalytic hydrodesulfurization of straight run distillates and from which hydrogen sulfide has been removed by amine treatment. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]
269-630-368308-10-1Flam. Gas 1

Press. Gas

Carc. 1A

Muta. 1B
H220

H350

H340
GHS02

GHS04

GHS08

Dgr
H220

H350

H340
H K U
649-183-00-4Tail gas (petroleum), gas oil catalytic cracking absorber;

Petroleum gas;

[A complex combination of hydrocarbons obtained from the distillation of products from the catalytic cracking of gas oil. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]
269-623-568308-03-2Flam. Gas 1

Press. Gas

Carc. 1A

Muta. 1B
H220

H350

H340
GHS02

GHS04

GHS08

Dgr
H220

H350

H340
H K U
649-184-00-XTail gas (petroleum), gas recovery plant;

Petroleum gas;

[A complex combination of hydrocarbons from the distillation of products from miscellaneous hydrocarbon streams. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]
269-624-068308-04-3Press. Gas

Flam. Gas 1

Carc. 1A

Muta. 1B
H220

H350

H340
GHS02

GHS04

GHS08

Dgr
H220

H350

H340
H K U
649-185-00-5Tail gas (petroleum), gas recovery plant deethanizer;

Petroleum gas;

[A complex combination of hydrocarbons from the distillation of products from miscellaneous hydrocarbon streams. It consists of hydrocarbon having carbon numbers predominantly in the range of C1 through C4.]
269-625-668308-05-4Flam. Gas 1

Press. Gas

Carc. 1A

Muta. 1B
H220

H350

H340
GHS02

GHS04

GHS08

Dgr
H220

H350

H340
H K U
649-186-00-0Tail gas (petroleum), hydrodesulfurized distillate and hydrodesulfurized naphtha fractionator, acid-free;

Petroleum gas;

[A complex combination of hydrocarbons obtained from fractionation of hydrodesulfurized naphtha and distillate hydrocarbon streams and treated to remove acidic impurities. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]
269-626-168308-06-5Flam. Gas 1

Press. Gas

Carc. 1A

Muta. 1B
H220

H350

H340
GHS02

GHS04

GHS08

Dgr
H220

H350

H340
H K U
649-187-00-6Tail gas (petroleum), hydrodesulfurized vacuum gas oil stripper, hydrogen sulfide-free;

Petroleum gas;

[A complex combination of hydrocarbons obtained from stripping stabilization of catalytic hydrodesulfurized vacuum gas oil and from which hydrogen sulfide has been removed by amine treatment. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]
269-627-768308-07-6Flam. Gas 1

Press. Gas

Carc. 1A

Muta. 1B
H220

H350

H340
GHS02

GHS04

GHS08

Dgr
H220

H350

H340
H K U
649-188-00-1Tail gas (petroleum), light straight-run naphtha stabilizer, hydrogen sulfide-free;

Petroleum gas;

[A complex combination of hydrocarbons obtained from fractionation stabilization of light straight run naphtha and from which hydrogen sulfide has been removed by amine treatment. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]
269-629-868308-09-8Flam. Gas 1

Press. Gas

Carc. 1A

Muta. 1B
H220

H350

H340
GHS02

GHS04

GHS08

Dgr
H220

H350

H340
H K U
649-189-00-7Tail gas (petroleum), propane-propylene alkylation feed prep deethanizer;

Petroleum gas;

[A complex combination of hydrocarbons obtained from the distillation of the reaction products of propane with propylene. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]
269-631-968308-11-2Flam. Gas 1

Press. Gas

Carc. 1A

Muta. 1B
H220

H350

H340
GHS02

GHS04

GHS08

Dgr
H220

H350

H340
H K U
649-190-00-2Tail gas (petroleum), vacuum gas oil hydrodesulfurizer, hydrogen sulfide-free;

Petroleum gas;

[A complex combination of hydrocarbons obtained from catalytic hydrodesulfurization of vacuum gas oil and from which hydrogen sulfide has been removed by amine treatment. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]
269-632-468308-12-3Flam. Gas 1

Press. Gas

Carc. 1A

Muta. 1B
H220

H350

H340
GHS02

GHS04

GHS08

Dgr
H220

H350

H340
H K U
649-191-00-8Gases (petroleum), catalytic cracked overheads;

Petroleum gas;

[A complex combination of hydrocarbons produced by the distillation of products from the catalytic cracking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C3 through C5 and boiling in the range of approximately - 48 oC to 32 oC (- 54 oF to 90 oF).]
270-071-268409-99-4Flam. Gas 1

Press. Gas

Carc. 1A

Muta. 1B
H220

H350

H340
GHS02

GHS04

GHS08

Dgr
H220

H350

H340
H K U
649-193-00-9Alkanes, C1-2;

Petroleum gas
270-651-568475-57-0Flam. Gas 1

Press. Gas

Carc. 1A

Muta. 1B
H220

H350

H340
GHS02

GHS04

GHS08

Dgr
H220

H350

H340
H K U
649-194-00-4Alkanes, C2-3;

Petroleum gas
270-652-068475-58-1Flam. Gas 1

Press. Gas

Carc. 1A

Muta. 1B
H220

H350

H340
GHS02

GHS04

GHS08

Dgr
H220

H350

H340
H K U
649-195-00-XAlkanes, C3-4;

Petroleum gas
270-653-668475-59-2Flam. Gas 1

Press. Gas

Carc. 1A

Muta. 1B
H220

H350

H340
GHS02

GHS04

GHS08

Dgr
H220

H350

H340
H K U
649-196-00-5Alkanes, C4-5;

Petroleum gas
270-654-168475-60-5Flam. Gas 1

Press. Gas

Carc. 1A

Muta. 1B
H220

H350

H340
GHS02

GHS04

GHS08

Dgr
H220

H350

H340
H K U
649-197-00-0Fuel gases;

Petroleum gas;

[A combination of light gases. It consists predominantly of hydrogen and/or low molecular weight hydrocarbons.]
270-667-268476-26-6Flam. Gas 1

Press. Gas

Carc. 1A

Muta. 1B
H220

H350

H340
GHS02

GHS04

GHS08

Dgr
H220

H350

H340
H K U
649-198-00-6Fuel gases, crude oil of distillates;

Petroleum gas;

[A complex combination of light gases produced by distillation of crude oil and by catalytic reforming of naphtha. It consists of hydrogen and hydrocarbons having carbon numbers predominantly in the range of C1 through C4 and boiling in the range of approximately - 217 oC to - 12 oC (- 423 oF to 10 oF).]
270-670-968476-29-9Flam. Gas 1

Press. Gas

Carc. 1A

Muta. 1B
H220

H350

H340
GHS02

GHS04

GHS08

Dgr
H220

H350

H340
H K U
649-199-00-1Hydrocarbons, C3-4;

Petroleum gas
270-681-968476-40-4Flam. Gas 1

Press. Gas

Carc. 1A

Muta. 1B
H220

H350

H340
GHS02

GHS04

GHS08

Dgr
H220

H350

H340
H K U
649-200-00-5Hydrocarbons, C4-5;

Petroleum gas
270-682-468476-42-6Flam. Gas 1

Press. Gas

Carc. 1A

Muta. 1B
H220

H350

H340
GHS02

GHS04

GHS08

Dgr
H220

H350

H340
H K U
649-201-00-0Hydrocarbons, C2-4, C3-rich;

Petroleum gas
270-689-268476-49-3Flam. Gas 1

Press. Gas

Carc. 1A

Muta. 1B
H220

H350

H340
GHS02

GHS04

GHS08

Dgr
H220

H350

H340
H K U
649-202-00-6Petroleum gases, liquefied;

Petroleum gas;

[A complex combination of hydrocarbons produced by the distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C3 through C7 and boiling in the range of approximately - 40 oC to 80 oC (- 40 oF to 176 oF).]
270-704-268476-85-7Flam. Gas 1

Press. Gas

Carc. 1A

Muta. 1B
H220

H350

H340
GHS02

GHS04

GHS08

Dgr
H220

H350

H340
HKSU
649-203-00-1Petroleum gases, liquefied, sweetened;

Petroleum gas;

[A complex combination of hydrocarbons obtained by subjecting liquefied petroleum gas mix to a sweetening process to convert mercaptans or to remove acidic impurities. It consists of hydrocarbons having carbon numbers predominantly in the range of C3 through C7 and boiling in the range of approximately - 40 oC to 80 oC (- 40 oF to 176 oF).]
270-705-868476-86-8Flam. Gas 1

Press. Gas

Carc. 1A

Muta. 1B
H220

H350

H340
GHS02

GHS04

GHS08

Dgr
H220

H350

H340
HKSU
649-204-00-7Gases (petroleum), C3-4, isobutane-rich;

Petroleum gas;

[A complex combination of hydrocarbons from the distillation of saturated and unsaturated hydrocarbons usually ranging in carbon numbers from C3 through C6, predominantly butane and isobutane. It consists of saturated and unsaturated hydrocarbons having carbon numbers in the range of C3 through C4, predominantly isobutane.]
270-724-168477-33-8Flam. Gas 1

Press. Gas

Carc. 1A

Muta. 1B
H220

H350

H340
GHS02

GHS04

GHS08

Dgr
H220

H350

H340
H K U
649-205-00-2Distillates (petroleum), C3-6, piperylene-rich;

Petroleum gas;

[A complex combination of hydrocarbons from the distillation of saturated and unsaturated aliphatic hydrocarbons usually ranging in the carbon numbers C3 through C6. It consists of saturated and unsaturated hydrocarbons having carbon numbers in the range of C3 through C6, predominantly piperylenes.]
270-726-268477-35-0Flam. Gas 1

Press. Gas

Carc. 1A

Muta. 1B
H220

H350

H340
GHS02

GHS04

GHS08

Dgr
H220

H350

H340
H K U
649-206-00-8Gases (petroleum), butane splitter overheads;

Petroleum gas;

[A complex combination of hydrocarbons obtained from the distillation of the butane stream. It consists of aliphatic hydrocarbons having carbon numbers predominantly in the range of C3 through C4.]
270-750-368477-69-0Flam. Gas 1

Press. Gas

Carc. 1A

Muta. 1B
H220

H350

H340
GHS02

GHS04

GHS08

Dgr
H220

H350

H340
H K U
649-207-00-3Gases (petroleum), C2-;

Petroleum gas;

[A complex combination of hydrocarbons produced by the distillation of products from a catalytic fractionation process. It contains predominantly ethane, ethylene, propane, and propylene.]
270-751-968477-70-3Flam. Gas 1

Press. Gas

Carc. 1A

Muta. 1B
H220

H350

H340
GHS02

GHS04

GHS08

Dgr
H220

H350

H340
H K U
649-208-00-9Gases (petroleum), catalytic-cracked gas oil depropanizer bottoms, C4-rich acid-free;

Petroleum gas;

[A complex combination of hydrocarbons obtained from fractionation of catalytic cracked gas oil hydrocarbon stream and treated to remove hydrogen sulfide and other acidic components. It consists of hydrocarbons having carbon numbers in the range of C3 through C5, predominantly C4.]
270-752-468477-71-4Flam. Gas 1

Press. Gas

Carc. 1A

Muta. 1B
H220

H350

H340
GHS02

GHS04

GHS08

Dgr
H220

H350

H340
H K U
649-209-00-4Gases (petroleum), catalytic-cracked naphtha debutanizer bottoms, C3-5-rich;

Petroleum gas;

[A complex combination of hydrocarbons obtained from the stabilization of catalytic cracked naphtha. It consists of aliphatic hydrocarbons having carbon numbers predominantly in the range of C3 through C5.]
270-754-568477-72-5Flam. Gas 1

Press. Gas

Carc. 1A

Muta. 1B
H220

H350

H340
GHS02

GHS04

GHS08

Dgr
H220

H350

H340
H K U
649-210-00-XTail gas (petroleum), isomerized naphtha fractionation stabilizer;

Petroleum gas;

[A complex combination of hydrocarbons obtained from the fractionation stabilization products from isomerized naphtha. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]
269-628-268308-08-7Flam. Gas 1

Press. Gas

Carc. 1A

Muta. 1B
H220

H350

H340
GHS02

GHS04

GHS08

Dgr
H220

H350

H340
H K U
649-211-00-5Foots oil (petroleum), carbon-treated;

Foots oil;

[A complex combination of hydrocarbons obtained by the treatment of Foots oil with activated carbon for the removal of trace constituents and impurities. It consists predominantly of saturated straight chain hydrocarbons having carbon numbers predominantly greater than C12.]
308-126-097862-76-5Carc. 1BH350GHS08

Dgr
H350H L
649-212-00-0Distillates (petroleum), sweetened middle;

Gasoil — unspecified;

[A complex combination of hydrocarbons obtained by subjecting a petroleum distillate to a sweetening process to convert mercaptans or to remove acidic impurities. It consists of hydrocarbons having carbon numbers predominantly in the range of C9 through C20 and boiling in the range of approximately 150 oC to 345 oC (302 oF to 653 oF).]
265-088-764741-86-2Carc. 1BH350GHS08

Dgr
H350H N
649-213-00-6Gas oils (petroleum), solvent-refined;

Gasoil — unspecified;

[A complex combination of hydrocarbons obtained as the raffinate from a solvent extraction process. It consists predominantly of aliphatic hydrocarbons having carbon numbers predominantly in the range of C11 through C25 and boiling in the range of approximately 205 oC to 400 oC (401 oF to 752 oF).]
265-092-964741-90-8Carc. 1BH350GHS08

Dgr
H350H N
649-214-00-1Distillates (petroleum), solvent-refined middle;

Gasoil — unspecified;

[A complex combination of hydrocarbons obtained as the raffinate from a solvent extraction process. It consists predominantly of aliphatic hydrocarbons having carbon numbers predominantly in the range of C9 through C20 and boiling in the range of approximately 150 oC to 345 oC (302 oF to 653 oF).]
265-093-464741-91-9Carc. 1BH350GHS08

Dgr
H350H N
649-215-00-7Gas oils (petroleum), acid-treated;

Gasoil — unspecified;

[A complex combination of hydrocarbons obtained as a raffinate from a sulfuric acid treating process. It consists of hydrocarbons having carbon numbers predominantly in the range of C13 through C25 and boiling in the range of approximately 230 oC to 400 oC (446 oF to 752 oF).]
265-112-664742-12-7Carc. 1BH350GHS08

Dgr
H350H N
649-216-00-2Distillates (petroleum), acid-treated middle;

Gasoil — unspecified;

[A complex combination of hydrocarbons obtained as a raffinate from a sulfuric acid treating process. It consists of hydrocarbons having carbon numbers predominantly in the range of C11 through C20 and boiling in the range of approximately 205 oC to 345 oC (401 oF to 653 oF).]
265-113-164742-13-8Carc. 1BH350GHS08

Dgr
H350H N
649-217-00-8Distillates (petroleum), acid-treated light;

Gasoil — unspecified;

[A complex combination of hydrocarbons obtained as a raffinate from a sulfuric acid treating process. It consists of hydrocarbons having carbon numbers predominantly in the range of C9 through C16 and boiling in the range of approximately 150 oC to 290 oC (302 oF to 554 oF).]
265-114-764742-14-9Carc. 1BH350GHS08

Dgr
H350H N
649-218-00-3Gas oils (petroleum), chemically neutralized;

Gasoil — unspecified;

[A complex combination of hydrocarbons produced by a treating process to remove acidic materials. It consists of hydrocarbons having carbon numbers predominantly in the range of C13 through C25 and boiling in the range of approximately 230 oC to 400 oC (446 oF to 752 oF).]
265-129-964742-29-6Carc. 1BH350GHS08

Dgr
H350H N
649-219-00-9Distillates (petroleum), chemically neutralized middle;

Gasoil — unspecified;

[A complex combination of hydrocarbons produced by a treating process to remove acidic materials. It consists of hydrocarbons having carbon numbers predominantly in the range of C11 through C20 and boiling in the range of approximately 205 oC to 345 oC (401 oF to 653 oF).]
265-130-464742-30-9Carc. 1BH350GHS08

Dgr
H350H N
649-220-00-4Distillates (petroleum), clay-treated middle;

Gasoil — unspecified;

[A complex combination of hydrocarbons resulting from treatment of a petroleum fraction with natural or modified clay, usually in a percolation process to remove the trace amounts of polar compounds and impurities present. It consists of hydrocarbons having carbon numbers predominantly in the range of C9 through C20 and boiling in the range of approximately 150 oC to 345 oC (302 oF to 653 oF).]
265-139-364742-38-7Carc. 1BH350GHS08

Dgr
H350H N
649-221-00-XDistillates (petroleum), hydrotreated middle;

Gasoil — unspecified;

[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly in the range of C11 through C25 and boiling in the range of approximately 205 oC to 400 oC (401 oF to 752 oF).]
265-148-264742-46-7Carc. 1BH350GHS08

Dgr
H350H N
649-222-00-5Gas oils (petroleum), hydrodesulfurized;

Gasoil — unspecified;

[A complex combination of hydrocarbons obtained from a petroleum stock by treating with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C13 through C25 and boiling in the range of approximately 230 oC to 400 oC (446 oF to 752 oF).]
265-182-864742-79-6Carc. 1BH350GHS08

Dgr
H350H N
649-223-00-0Distillates (petroleum), hydrodesulfurized middle;

Gasoil — unspecified;

[A complex combination of hydrocarbons obtained from a petroleum stock by treating with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists of hydrocarbons having carbon numbers predominantly in the range of C11 through C25 and boiling in the range of approximately 205 oC to 400 oC (401 oF to 752 oF).]
265-183-364742-80-9Carc. 1BH350GHS08

Dgr
H350H N
649-224-00-6Fuels, diesel;

Gasoil — unspecified;

[A complex combination of hydrocarbons produced by the distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C9 through C20 and boiling in the range of approximately 163 oC to 357 oC (325 oF to 675 oF).]
269-822-768334-30-5Carc. 2H351GHS08

Wng
H351H N
649-225-00-1Fuel oil, No 2;

Gasoil — unspecified;

[A distillate oil having a minimum viscosity of 32,6 SUS at 37,7 oC (100 oF) to a maximum of 37,9 SUS at 37,7 oC (100 oF).]
270-671-468476-30-2Carc. 2H351GHS08

Wng
H351H
649-226-00-7Fuel oil, No 4;

Gasoil — unspecified;

[A distillate oil having a minimum viscosity of 45 SUS at 37,7 oC (100 oF) to a maximum of 125 SUS at 37,7 oC (100 oF).]
270-673-568476-31-3Carc. 2H351GHS08

Wng
H351H
649-227-00-2Fuels, diesel, No 2;

Gasoil — unspecified;

[A distillate oil having a minimum viscosity of 32,6 SUS at 37,7 oC (100 oF).]
270-676-168476-34-6Carc. 2H351GHS08

Wng
H351H
649-228-00-8Distillates (petroleum), catalytic reformer fractionator residue, high-boiling;

Gasoil — unspecified;

[A complex combination of hydrocarbons from the distillation of catalytic reformer fracftionator residue. It boils in the range of approximately 343 oC to 399 oC (650 oF to 750 oF).]
270-719-468477-29-2Carc. 1BH350GHS08

Dgr
H350H N
649-229-00-3Distillates (petroleum), catalytic reformer fractionator residue, intermediate-boiling;

Gasoil — unspecified;

[A complex combination of hydrocarbons from the distillation of catalytic reformer fractionator residue. It boils in the range of approximately 288 oC to 371 oC (550 oF to 700 oF).]
270-721-568477-30-5Carc. 1BH350GHS08

Dgr
H350H N
649-230-00-9Distillates (petroleum), catalytic reformer fractionator residue, low-boiling;

Gasoil — unspecified;

[The complex combination of hydrocarbons from the distillation of catalytic reformer fractionator residue. It boils approximately below 288 oC (550 oF).]
270-722-068477-31-6Carc. 1BH350GHS08

Dgr
H350H N
649-231-00-4Distillates (petroleum), highly refined middle;

Gasoil — unspecified;

[A complex combination of hydrocarbons obtained by the subjection of a petroleum fraction to several of the following steps: filtration, centrifugation, atmospheric distillation, vacuum distillation, acidification, neutralization and clay treatment. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C10 through C20.]
292-615-890640-93-0Carc. 1BH350GHS08

Dgr
H350H N
649-232-00-XDistillates (petroleum) catalytic reformer, heavy arom. conc.;

Gasoil — unspecified;

[A complex combination of hydrocarbons obtained from the distillation of a catalytically reformed petroleum cut. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C10 through C16 and boiling in the range of approximately 200 oC to 300 oC (392 oF to 572 oF).]
295-294-291995-34-5Carc. 1BH350GHS08

Dgr
H350H N
649-233-00-5Gas oils, paraffinic;

Gasoil — unspecified;

[A distillate obtained from the redistillation of a complex combination of hydrocarbons obtained by the distillation of the effluents from a severe catalytic hydrotreatment of paraffins. It boils in the range of approximately 190 oC to 330 oC (374 oF to 594 oF).]
300-227-893924-33-5Carc. 1BH350GHS08

Dgr
H350H N
649-234-00-0Naphtha (petroleum), solvent-refined hydrodesulfurized heavy;

Gasoil — unspecified
307-035-397488-96-5Carc. 1BH350GHS08

Dgr
H350H N
649-235-00-6Hydrocarbons, C16-20, hydrotreated middle distillate, distn. lights;

Gasoil — unspecified;

[A complex combination of hydrocarbons obtained as first runnings from the vacuum distillation of effluents from the treatment of a middle distillate with hydrogen. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C16 through C20 and boiling in the range of approximately 290 oC to 350 oC (554 oF to 662 oF). It produces a finished oil having a viscosity of 2cSt at 100 oC (212 oF).]
307-659-697675-85-9Carc. 1BH350GHS08

Dgr
H350H N
649-236-00-1Hydrocarbons, C12-20, hydrotreated paraffinic, distn. lights;

Gasoil — unspecified;

[A complex combination of hydrocarbons obtained as first runnings from the vacuum distillation of effluents from the treatment of heavy paraffins with hydrogen in the presence of a catalyst. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C12 through C20 and boiling in the range of approximately 230 oC to 350 oC (446 oF to 662 oF). It produces a finished oil having a viscosity of 2cSt at 100 oC (212 oF).]
307-660-197675-86-0Carc. 1BH350GHS08

Dgr
H350H N
649-237-00-7Hydrocarbons, C11-17, solvent-extd. light naphthenic;

Gasoil — unspecified;

[A complex combination of hydrocarbons obtained by extraction of the aromatics from a light naphthenic distillate having a visciosity of 2.2 cSt at 40 oC (104 oF). It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C11 through C17 and boiling in the range of approximately 200 oC to 300 oC (392 oF to 572 oF).]
307-757-997722-08-2Carc. 1BH350GHS08

Dgr
H350H N
649-238-00-2Gas oils, hydrotreated;

Gasoil — unspecified;

[A complex combination of hydrocarbons obtained from the redistillation of the effluents from the treatment of paraffins with hydrogen in the presence of a catalyst. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C17 through C27 and boiling in the range of approximately 330 oC to 340 oC (626 oF to 644 oF).]
308-128-197862-78-7Carc. 1BH350GHS08

Dgr
H350H N
649-239-00-8Distillates (petroleum), carbon-treated light paraffinic;

Gasoil — unspecified;

[A complex combination of hydrocarbons obtained by the treatment of a petroleum oil fraction with activated charcoal for the removal of traces of polar constituents and impurities. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C12 through C28.]
309-667-5100683-97-4Carc. 1BH350GHS08

Dgr
H350H N
649-240-00-3Distillates (petroleum), intermediate paraffinic, carbon-treated;

Gasoil — unspecified;

[A complex combination of hydrocarbons obtained by the treatment of petroleum with activated charcoal for the removal of trace polar constituents and impurities. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C16 through C36.]
309-668-0100683-98-5Carc. 1BH350GHS08

Dgr
H350H N
649-241-00-9Distillates (petroleum), intermediate paraffinic, clay-treated;

Gasoil — unspecified;

[A complex combination of hydrocarbons obtained by the treatment of petroleum with bleaching earth for the removal of trace polar constituents and impurities. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C16 through C36.]
309-669-6100683-99-6Carc. 1BH350GHS08

Dgr
H350H N
649-242-00-4Alkanes, C12-26-branched and linear292-454-390622-53-0Carc. 1BH350GHS08

Dgr
H350H N
649-243-00-XLubricating greases;

Grease;

[A complex combination of hydrocarbons having carbon numbers predominantly in the range of C12 through C50. May contain organic salts of alkali metals, alkaline earth metals, and/or aluminium compounds.]
278-011-774869-21-9Carc. 1BH350GHS08

Dgr
H350H N
649-244-00-5Slack wax (petroleum);

Slack wax;

[A complex combination of hydrocarbons obtained from a petroleum fraction by solvent crystallization (solvent dewaxing) or as a distillation fraction from a very waxy crude. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C20.]
265-165-564742-61-6Carc. 1BH350GHS08

Dgr
H350H N
649-245-00-0Slack wax (petroleum), acid-treated;

Slack wax;

[A complex combination of hydrocarbons obtained as a raffinate by treatment of a petroleum slack wax fraction with sulfuric acid treating process. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C20.]
292-659-890669-77-5Carc. 1BH350GHS08

Dgr
H350H N
649-246-00-6Slack wax (petroleum), clay-treated;

Slack wax;

[A complex combination of hydrocarbons obtained by treatment of a petroleum slack wax fraction with natural or modified clay in either a contacting or percolation process. It consists predominantly of saturated straight and branched hydrocarbons having carbon numbers predominantly greater than C20.]
292-660-390669-78-6Carc. 1BH350GHS08

Dgr
H350H N
649-247-00-1Slack wax (petroleum), hydrotreated;

Slack wax;

[A complex combination of hydrocarbons obtained by treating slack wax with hydrogen in the presence of a catalyst. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C20.]
295-523-692062-09-4Carc. 1BH350GHS08

Dgr
H350H N
649-248-00-7Slack wax (petroleum), low-melting;

Slack wax;

[A complex combination of hydrocarbons obtained from a petroleum fraction by solvent deparaffination. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C12.]
295-524-192062-10-7Carc. 1BH350GHS08

Dgr
H350H N
649-249-00-2Slack wax (petroleum), low-melting, hydrotreated;

Slack wax;

[A complex combination of hydrocarbons obtained by treatment of low-melting petroleum slack wax with hydrogen in the presence of a catalyst. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C12.]
295-525-792062-11-8Carc. 1BH350GHS08

Dgr
H350H N
649-250-00-8Slack wax (petroleum), low-melting, carbon-treated;

Slack wax;

[A complex combination of hydrocarbons obtained by the treatment of low-melting slack wax with activated carbon for the removal of trace polar constituents and impurities. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C12.]
308-155-997863-04-2Carc. 1BH350GHS08

Dgr
H350H N
649-251-00-3Slack wax (petroleum), low-melting, clay-treated;

Slack wax;

[A complex combination of hydrocarbons obtained by the treatment of low-melting petroleum slack wax with bentonite for removal of trace polar constituents and impurities. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C12.]
308-156-497863-05-3Carc. 1BH350GHS08

Dgr
H350H N
649-252-00-9Slack wax (petroleum), low-melting, silicic acid-treated;

Slack wax;

[A complex combination of hydrocarbons obtained by the treatment of low-melting petroleum slack wax with silicic acid for the removal of trace polar constituents and impurities. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C12.]
308-158-597863-06-4Carc. 1BH350GHS08

Dgr
H350H N
649-253-00-4Slack wax (petroleum), carbon-treated;

Slack wax;

[A complex combination of hydrocarbons obtained by treatment of petroleum slack wax with activated charcoal for the removal of trace polar constituents and impurities.]
309-723-9100684-49-9Carc. 1BH350GHS08

Dgr
H350H N
649-254-00-XPetrolatum;

Petrolatum;

[A complex combination of hydrocarbons obtained as a semi-solid from dewaxing paraffinic residual oil. It consists predominantly of saturated crystalline and liquid hydrocarbons having carbon numbers predominantly greater than C25.]
232-373-28009-03-8Carc. 1BH350GHS08

Dgr
H350H N
649-255-00-5Petrolatum (petroleum), oxidized;

Petrolatum;

[A complex combination of organic compounds, predominantly high molecular weight carboxylic acids, obtained by the air oxidation of petrolatum.]
265-206-764743-01-7Carc. 1BH350GHS08

Dgr
H350H N
649-256-00-0Petrolatum (petroleum), alumina-treated;

Petrolatum;

[A complex combination of hydrocarbons obtained when petrolatum is treated with Al2O3 to remove polar components and impurities. It consists predominantly of saturated, crystalline, and liquid hydrocarbons having carbon numbers predominantly greater than C25.]
285-098-585029-74-9Carc. 1BH350GHS08

Dgr
H350H N
649-257-00-6Petrolatum (petroleum), hydrotreated;

Petrolatum;

[A complex combination of hydrocarbons obtained as a semi-solid from dewaxed paraffinic residual oil treated with hydrogen in the presence of a catalyst. It consists predominantly of saturated microcrystalline and liquid hydrocarbons having carbon numbers predominantly greater than C20.]
295-459-992045-77-7Carc. 1BH350GHS08

Dgr
H350H N
649-258-00-1Petrolatum (petroleum), carbon-treated;

Petrolatum;

[A complex combination of hydrocarbons obtained by the treatment of petroleum petrolatum with activated carbon for the removal of trace polar constituents and impurities. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly greater than C20.]
308-149-697862-97-0Carc. 1BH350GHS08

Dgr
H350H N
649-259-00-7Petrolatum (petroleum), silicic acid-treated;

Petrolatum;

[A complex combination of hydrocarbons obtained by the treatment of petroleum petrolatum with silicic acid for the removal of trace polar constituents and impurities. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly greater than C20.]
308-150-197862-98-1Carc. 1BH350GHS08

Dgr
H350H N
649-260-00-2Petrolatum (petroleum), clay-treated;

Petrolatum;

[A complex combination of hydrocarbons obtained by treatment of petrolatum with bleaching earth for the removal of traces of polar constituents and impurities. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of greater than C25.]
309-706-6100684-33-1Carc. 1BH350GHS08

Dgr
H350H N
649-261-00-8Gasoline, natural;

Low boiling point naphtha;

[A complex combination of hydrocarbons separated from natural gas by processes such as refrigeration or absorption. It consists predominantly of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C4 through C8 and boiling in the range of approximately minus 20 oC to 120 oC (- 4 oF to 248 oF).]
232-349-18006-61-9Carc. 1B

Asp. Tox. 1
H350

H304
GHS08

Dgr
H350

H304
H P
649-262-00-3Naphtha;

Low boiling point naphtha;

[Refined, partly refined, or unrefined petroleum products by the distillation of natural gas. It consists of hydrocarbons having carbon numbers predominantly in the range of C5 through C6 and boiling in the range of approximately 100 oC to 200 oC (212 oF to 392 oF).]]
232-443-28030-30-6Carc. 1B

Asp. Tox. 1
H350

H304
GHS08

Dgr
H350

H304
H P
649-263-00-9Ligroine;

Low boiling point naphtha;

[A complex combination of hydrocarbons obtained by the fractional distillation of petroleum. This fraction boils in a range of approximately 20 oC to 135 oC (58 oF to 275 oF).]
232-453-78032-32-4Carc. 1B

Asp. Tox. 1
H350

H304
GHS08

Dgr
H350

H304
H P
649-264-00-4Naphtha (petroleum), heavy straight-run;

Low boiling point naphtha;

[A complex combination of hydrocarbons produced by distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C6 through C12 and boiling in the range of approximately 65 oC to 230 oC (149 oF to 446 oF).]
265-041-064741-41-9Carc. 1B

Asp. Tox. 1
H350

H304
GHS08

Dgr
H350

H304
H P
649-265-00-XNaphtha (petroleum), full-range straight-run;

Low boiling point naphtha;

[A complex combination of hydrocarbons produced by distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C11 and boiling in the range of approximately minus 20 oC to 220 oC (- 4 oF to 428 oF).]
265-042-664741-42-0Carc. 1B

Asp. Tox. 1
H350

H304
GHS08

Dgr
H350

H304
H P
649-266-00-5Naphtha (petroleum), light straight-run;

Low boiling point naphtha;

[A complex combination of hydrocarbons produced by distillation of crude oil. It consists predominantly of aliphatic hydrocarbons having carbon numbers predominantly in the range of C4 through C10 and boiling in the range of approximately minus 20 oC to 180 oC (- 4 oF to 356 oF).]
265-046-864741-46-4Carc. 1B

Asp. Tox. 1
H350

H304
GHS08

Dgr
H350

H304
H P
649-267-00-0Solvent naphtha (petroleum), light aliph.;

Low boiling point naphtha;

[A complex combination of hydrocarbons obtained from the distillation of crude oil or natural gasoline. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C5 through C10 and boiling in the range of approximately 35 oC to 160 oC (95 oF to 320 oF).]
265-192-264742-89-8Carc. 1B

Asp. Tox. 1
H350

H304
GHS08

Dgr
H350

H304
H P
649-268-00-6Distillates (petroleum), straight-run light;

Low boiling point naphtha;

[A complex combination of hydrocarbons produced by the distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C2 through C7 and boiling in the range of approximately - 88 oC to 99 oC (- 127 oF to 210 oF).]
270-077-568410-05-9Carc. 1B

Asp. Tox. 1
H350

H304
GHS08

Dgr
H350

H304
H P
649-269-00-1Gasoline, vapor-recovery;

Low boiling point naphtha;

[A complex combination of hydrocarbons separated from the gases from vapor recovery systems by cooling. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C11 and boiling in the range of approximately - 20 oC to 196 oC (-4 oF to 384 oF).]
271-025-468514-15-8Carc. 1B

Asp. Tox. 1
H350

H304
GHS08

Dgr
H350

H304
H P
649-270-00-7Gasoline, straight-run, topping-plant;

Low boiling point naphtha;

[A complex combination of hydrocarbons produced from the topping plant by the distillation of crude oil. It boils in the range of approximately 36,1 oC to 193,3 oC (97 oF to 380 oF).]
271-727-068606-11-1Carc. 1B

Asp. Tox. 1
H350

H304
GHS08

Dgr
H350

H304
H P
649-271-00-2Naphtha (petroleum), unsweetened;

Low boiling point naphtha;

[A complex combination of hydrocarbons produced from the distillation of naphtha streams from various refinery processes. It consists of hydrocarbons having carbon numbers predominantly in the range of C5 through C12 and boiling in the range of approximately 0 oC to 230 oC (25 oF to 446 oF).]
272-186-368783-12-0Carc. 1B

Asp. Tox. 1
H350

H304
GHS08

Dgr
H350

H304
H P
649-272-00-8Distillates (petroleum), light straight-run gasoline fractionation stabilizer overheads;

Low boiling point naphtha;

[A complex combination of hydrocarbons having carbon numbers predominantly in the range of C3 through C6..]
272-931-268921-08-4Carc. 1B

Asp. Tox. 1
H350

H304
GHS08

Dgr
H350

H304
H P
649-273-00-3Naphtha (petroleum), heavy straight run, arom.-contg.;

Low boiling point naphtha;

[A complex combination of hydrocarbons obtained from a distillation process of crude petroleum. It consists predominantly of hydrocarbons having carbon numbers in the range of C8 through C12 and boiling in the range of approximately 130 oC to 210 oC (266 oF to 410 oF).]
309-945-6101631-20-3Carc. 1B

Asp. Tox. 1
H350

H304
GHS08

Dgr
H350

H304
H P
649-274-00-9Naphtha (petroleum), full-range alkylate;

Low boiling point modified naphtha;

[A complex combination of hydrocarbons produced by distillation of the reaction products of isobutane with monoolefinic hydrocarbons usually ranging in carbon numbers from C3 through C5. It consist of predominantly branched chain saturated hydro-carbons having carbon numbers predominantly in the range of C7 through C12 and boiling in the range of approximately 90 oC to 220 oC (194 oF to 428 oF).]
265-066-764741-64-6Carc. 1B

Asp. Tox. 1
H350

H304
GHS08

Dgr
H350

H304
H P
649-275-00-4Naphtha (petroleum), heavy alkylate;

Low boiling point modified naphtha;

[A complex combination of hydrocarbons produced by distillation of the reaction products of isobutane with monoolefinic hydrocarbons usually ranging in carbon numbers from C3 to C5. It consists of predominantly branched chain saturated hydrocarbons having carbon numbers predominantly in the range of C9 through C12 and boiling in the range of approximately 150 oC to 220 oC (302 oF to 428 oF).]
265-067-264741-65-7Carc. 1B

Asp. Tox. 1
H350

H304
GHS08

Dgr
H350

H304
H P
649-276-00-XNaphtha (petroleum), light alkylate;

Low boiling point modified naphtha;

[A complex combination of hydrocarbons produced by distillation of the reaction products of isobutane with monoolefinic hydrocarbons usually ranging in carbon numbers from C3 through C5. It consists of predominantly branched chain saturated hydro-carbons having carbon numbers predominantly in the range of C7 through C10 and boiling in the range of aproximately 90 oC to 160 oC (194 oF to 320 oF).]
265-068-864741-66-8Carc. 1B

Asp. Tox. 1
H350

H304
GHS08

Dgr
H350

H304
H P
649-277-00-5Naphtha (petroleum), isomerization;

Low boiling point modified naphtha;

[A complex combination of hydrocarbons obtained from catalytic isomerization of straight chain paraffinic C4 through C6 hydrocarbons. It consists predominantly of saturated hydrocarbons such as isobutane, isopentane, 2,2-dimethylbutane, 2-methylpentane, and 3-methylpentane.]
265-073-564741-70-4Carc. 1B

Asp. Tox. 1
H350

H304
GHS08

Dgr
H350

H304
H P
649-278-00-0Naphtha (petroleum), solvent-refined light;

Low boiling point modified naphtha;

[A complex combination of hydrocarbons obtained as the raffinate from a solvent extraction process. It consists predominantly of aliphatic hydrocarbons having carbon numbers predominantly in the range of C5 through C11 and boiling in the range of approximately 35 oC to 190 oC (95 oF to 374 oF).]
265-086-664741-84-0Carc. 1B

Asp. Tox. 1
H350

H304
GHS08

Dgr
H350

H304
H P
649-279-00-6Naphtha (petroleum), solvent-refined heavy;

Low boiling point modified naphtha;

[A complex combination of hydrocarbons obtained as the raffinate from a solvent extraction process. It consists predominantly of aliphatic hydrocarbons having carbon numbers predominantly in the range of C7 through C12 and boiling in the range of approximately 90 oC to 230 oC (194 oF to 446 oF).]
265-095-564741-92-0Carc. 1B

Asp. Tox. 1
H350

H304
GHS08

Dgr
H350

H304
H P
649-280-00-1Raffinates (petroleum), catalytic reformer ethylene glycol-water countercurrent exts.;

Low boiling point modified naphtha;

[A complex combination of hydrocarbons obtained as the raffinate from the UDEX extraction process on the catalytic reformer stream. It consists of saturated hydrocarbons having carbon numbers predominantly in the range of C6 through C9.]
270-088-568410-71-9Carc. 1B

Asp. Tox. 1
H350

H304
GHS08

Dgr
H350

H304
H P
649-281-00-7Raffinates (petroleum), reformer, Lurgi unit-sepd.;

Low boiling point modified naphtha;

[The complex combination of hydrocarbons obtained as a raffinate from a Lurgi separation unit. It consists predominantly of non-aromatic hydrocarbons with various small amounts of aromatic hydrocarbons having carbon numbers predominantly in the range of C6 through C8.]
270-349-368425-35-4Carc. 1B

Asp. Tox. 1
H350

H304
GHS08

Dgr
H350

H304
H P
649-282-00-2Naphtha (petroleum), full-range alkylate, butane-contg.;

Low boiling point modified naphta;

[A complex combination of hydrocarbons produced by the distillation of the reaction products of isobutane with monoolefinic hydrocarbons usually ranging in carbon numbers from C3 through C5. It consists of predominantly branched chain saturated hydrocarbons having carbon numbers predominantly in the range of C7 through C12 with some butanes and boiling in the range of approximately 35 oC to 200 oC (95 oF to 428 oF).]
271-267-068527-27-5Carc. 1B

Asp. Tox. 1
H350

H304
GHS08

Dgr
H350

H304
H P
649-283-00-8Distillates (petroleum), naphtha steam cracking-derived, solvent-refined light hydrotreated;

Low boiling point modified naphtha;

[A complex combination of hydrocarbons obtained as the raffinates from a solvent extraction process of hydrotreated light distillate from steam-cracked naphtha.]
295-315-591995-53-8Carc. 1B

Asp. Tox. 1
H350

H304
GHS08

Dgr
H350

H304
H P
649-284-00-3Naphtha (petroleum), C4-12 butane-alkylate, isooctane-rich;

Low boiling point modified naphtha;

[A complex combination of hydrocarbons obtained by alkylation of butanes. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C4 through C12, rich in isooctane, and boiling in the range of approximately 35 oC to 210 oC (95 oF to 410 oF).]
295-430-092045-49-3Carc. 1B

Asp. Tox. 1
H350

H304
GHS08

Dgr
H350

H304
H P
649-285-00-9Hydrocarbons, hydrotreated light naphtha distillates, solvent-refined;

Low boiling point modified naphtha;

[A combination of hydrocarbons obtained from the distillation of hydrotreated naphtha followed by a solvent extraction and distillation process. It consists predominantly of saturated hydrocarbons boiling in the range of approximately 94 oC to 99 oC (201 oF to 210 oF).]
295-436-392045-55-1Carc. 1B

Asp. Tox. 1
H350

H304
GHS08

Dgr
H350

H304
H P
649-286-00-4Naphtha (petroleum), isomerization, C6-fraction;

Low boiling point modified naphtha;

[A complex combination of hydrocarbons obtained by distillation of a gasoline which has been catalytically isomerized. It consists predominantly of hexane isomers boiling in the range of approximately 60 oC to 66 oC (140 oF to 151 oF).]
295-440-592045-58-4Carc. 1B

Asp. Tox. 1
H350

H304
GHS08

Dgr
H350

H304
H P
649-287-00-XHydrocarbons, C6-7, naphtha-cracking, solvent-refined;

Low boiling point modified naphtha;

[A complex combination of hydrocarbons obtained by the sorption of benzene from a catalytically fully hydrogenated benzene-rich hydrocarbon cut that was distillatively obtained from prehydrogenated cracked naphtha. It consists predominantly of paraffinic and naphthenic hydrocarbons having carbon numbers predominantly in the range of C6 through C7 and boiling in the range of approximately 70 oC to 100 oC (158 oF to 212 oF).]
295-446-892045-64-2Carc. 1B

Asp. Tox. 1
H350

H304
GHS08

Dgr
H350

H304
H P
649-288-00-5Hydrocarbons, C6-rich, hydrotreated light naphtha distillates, solvent-refined;

Low boiling point modified naphtha;

[A complex combination of hydrocarbons obtained by distillation of hydrotreated naphtha followed by solvent extraction. It consists predominantly of saturated hydrocarbons and boiling in the range of approximately 65 oC to 70 oC (149 oF to 158 oF).]
309-871-4101316-67-0Carc. 1B

Asp. Tox. 1
H350

H304
GHS08

Dgr
H350

H304
H P
649-289-00-0Naphtha (petroleum), heavy catalytic cracked;

Low boiling point cat-cracked naphtha;

[A complex combination of hydrocarbons produced by a distillation of products from a catalytic cracking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C6 through C12 and boiling in the range of approximately 65 oC to 230 oC (148 oF to 446 oF). It contains a relatively large proportion of unsaturated hydrocarbons.]
265-055-764741-54-4Carc. 1B

Asp. Tox. 1
H350

H304
GHS08

Dgr
H350

H304
H P
649-290-00-6Naphtha (petroleum), light catalytic cracked;

Low boiling point cat-cracked naphtha;

[A complex combination of hydrocarbons produced by the distillation of products from a catalytic cracking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C11 and boiling in the range of approximately minus 20 oC to 190 oC (- 4 oF to 374 oF). It contains a relatively large proportion of unsaturated hydrocarbons.]
265-056-264741-55-5Carc. 1B

Asp. Tox. 1
H350

H304
GHS08

Dgr
H350

H304
H P
649-291-00-1Hydrocarbons, C3-11, catalytic cracker distillates;

Low boiling point cat-cracked naphtha;

[A complex combination of hydrocarbons produced by the distillations of products from a catalytic cracking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C3 through C11 and boiling in a range approximately up to 204 oC (400 oF).]
270-686-668476-46-0Carc. 1B

Asp. Tox. 1
H350

H304
GHS08

Dgr
H350

H304
H P
649-292-00-7Naphtha (petroleum), catalytic cracked light distd.;

Low boiling point cat-cracked naphtha;

[A complex combination of hydrocarbons produced by the distillation of products from a catalytic cracking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]
272-185-868783-09-5Carc. 1B

Asp. Tox. 1
H350

H304
GHS08

Dgr
H350

H304
H P
649-293-00-2Distillates (petroleum), naphtha steam cracking-derived, hydrotreated light arom.;

Low boiling point cat-cracked naphtha.;

[A complex combination of hydrocarbons obtained by treating a light distillate from steam-cracked naphtha. It consists predom-inantly of aromatic hydrocarbons.]
295-311-391995-50-5Carc. 1B

Asp. Tox. 1
H350

H304
GHS08

Dgr
H350

H304
H P
649-294-00-8Naphtha (petroleum), heavy catalytic cracked, sweetened;

Low boiling point cat-cracked naphtha;

[A complex combination of hydrocarbons obtained by subjecting a catalytic cracked petroleum distillate to a sweetening process to convert mercaptans or to remove acidic impurities. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C6 through C12 and boiling in the range of approximately 60 oC to 200 oC (140 oF to 392 oF).]
295-431-692045-50-6Carc. 1B

Asp. Tox. 1
H350

H304
GHS08

Dgr
H350

H304
H P
649-295-00-3Naphtha (petroleum), light catalytic cracked sweetened;

Low boiling point cat-cracked naphtha;

[A complex combination of hydrocarbons obtained by subjecting naphtha from a catalytic cracking process to a sweetening process to convert mercaptans or to remove acidic impurities. It consists predominantly of hydrocarbons boiling in a range of approximately 35 oC to 210 oC (95 oF to 410 oF).]
295-441-092045-59-5Carc. 1B

Asp. Tox. 1
H350

H304
GHS08

Dgr
H350

H304
H P
649-296-00-9Hydrocarbons, C8-12, catalytic-cracking, chem. neutralized;

Low boiling point cat-cracked naphtha;

[A complex combination of hydrocarbons produced by the distillation of a cut from the catalytic cracking process, having undergone an alkaline washing. It consists predominantly of hydrocarbons having carbon numbers in the range of C8 through C12 and boiling in the range of approximately 130 oC to 210 oC (266 oF to 410 oF).]
295-794-092128-94-4Carc. 1B

Asp. Tox. 1
H350

H304
GHS08

Dgr
H350

H304
H P
649-297-00-4Hydrocarbons, C8-12, catalytic cracker distillates;

Low boiling point cat-cracked naphtha;

[A complex combination of hydrocarbons obtained by distillation of products from a catalytic cracking process. It consists pre-dominantly of hydrocarbons having carbon numbers predominantly in the range of C8 through C12 and boiling in the range of approximately 140 oC to 210 oC (284 oF to 410 oF).]
309-974-4101794-97-2Carc. 1B

Asp. Tox. 1
H350

H304
GHS08

Dgr
H350

H304
H P
649-298-00-XHydrocarbons, C8-12, catalytic cracking, chem. neutralized, sweetened;

Low boiling point cat-cracked naphtha
309-987-5101896-28-0Carc. 1B

Asp. Tox. 1
H350

H304
GHS08

Dgr
H350

H304
H P
649-299-00-5Naphtha (petroleum), light catalytic reformed;

Low boiling point cat-reformed naphtha;

[A complex combination of hydrocarbons produced from the distillation of products from a catalytic reforming process. It consists of hydrocarbons having carbon numbers predominantly in the range of C5 through C11 and boiling in the range of approximately 35 oC to 190 oC (95 oF to 374 oF). It contains a relatively large proportion of aromatic and branched chain hydrocarbons. This stream may contain 10 vol. % or more benzene.]]
265-065-164741-63-5Carc. 1B

Asp. Tox. 1
H350

H304
GHS08

Dgr
H350

H304
H P
649-300-00-9Naphtha (petroleum), heavy catalytic reformed;

Low boiling point cat-reformed naphtha;

[A complex combination of hydrocarbons produced from the distillation of products from a catalytic reforming process. It consists of predominantly aromatic hydrocarbons having numbers predominantly in the range of C7 through C12 and boiling in the range of approximately 90 oC to 230 oC (194 oF to 446 oF).]
265-070-964741-68-0Carc. 1B

Asp. Tox. 1
H350

H304
GHS08

Dgr
H350

H304
H P
649-301-00-4Distillates (petroleum), catalytic reformed depentanizer;

Low boiling point cat-reformed naphtha;

[A complex combination of hydrocarbons from the distillation of products from a catalytic reforming process. It consists predominantly of aliphatic hydrocarbons having carbon numbers predominantly in the range of C3 through C6 and boiling in the range of approximately - 49 oC to 63 oC - 57 oF to 145 oF).]
270-660-468475-79-6Carc. 1B

Asp. Tox. 1
H350

H304
GHS08

Dgr
H350

H304
H P
649-302-00-XHydrocarbons, C2-6, C6-8 catalytic reformer;

Low boiling point cat-reformed naphtha
270-687-168476-47-1Carc. 1B

Asp. Tox. 1
H350

H304
GHS08

Dgr
H350

H304
H P
649-303-00-5Residues (petroleum), C6-8 catalytic reformer;

Low boiling point cat-reformed naphtha';

[A complex residuum from the catalytic reforming of C6-8 feed. It consists of hydrocarbons having carbon numbers predominantly in the range of C2 through C6.]
270-794-368478-15-9Carc. 1B

Asp. Tox. 1
H350

H304
GHS08

Dgr
H350

H304
H P
649-304-00-0Naphtha (petroleum), light catalytic reformed, arom.-free;

Low boiling point cat-reformed naphtha;

[A complex combination of hydrocarbons obtained from distillation of products from a catalytic reforming process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C5 through C8 and boiling in the range of approximately 35 oC to 120 oC (95 oF to 248 oF). It contains a relatively large proportion of branched chain hydrocarbons with the aromatic components removed.]
270-993-568513-03-1Carc. 1B

Asp. Tox. 1
H350

H304
GHS08

Dgr
H350

H304
H P
649-305-00-6Distillates (petroleum), catalytic reformed straight-run naphtha overheads;

Low boiling point cat-reformed naphtha;

[A complex combination of hydrocarbons obtained by the catalytic reforming of straight-run naphtha followed by the fractionation of the total effluent. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C2 through C6.]
271-008-168513-63-3Carc. 1B

Asp. Tox. 1
H350

H304
GHS08

Dgr
H350

H304
H P
649-306-00-1Petroleum products, hydrofiner-powerformer reformates;

Low boiling point cat-reformed naphtha;

[The complex combination of hydrocarbons obtained in a hydrofiner-powerformer process and boiling in a range of approximately 27 oC to 210 oC (80 oF to 410 oF).]
271-058-468514-79-4Carc. 1B

Asp. Tox. 1
H350

H304
GHS08

Dgr
H350

H304
H P
649-307-00-7Naphtha (petroleum, full-range reformed;

Low boiling point cat-reformed naphtha;

[A complex combination of hydrocarbons produced by the distillation of the products from a catalytic reforming process. It consists of hydrocarbons having carbon numbers predominantly in the range of C5 through C12 and boiling in the range of approximately 35 oC to 230 oC (95 oF to 446 oF).]
272-895-868919-37-9Carc. 1B

Asp. Tox. 1
H350

H304
GHS08

Dgr
H350

H304
H P
649-308-00-2Naphtha (petroleum), catalytic reformed;

Low boiling point cat-reformed naphtha;

[A complex combination of hydrocarbons produced by the distillation of products from a catalytic reforming process. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C12 and boiling in the range of approximately 30 oC to 220 oC (90 oF to 430 oF). It contains a relatively large proportion of aromatic and branched chain hydrocarbons. This stream may contain 10 vol.% or more benzene.]
273-271-868955-35-1Carc. 1B

Asp. Tox. 1
H350

H304
GHS08

Dgr
H350

H304
H P
649-309-00-8Distillates (petroleum), catalytic reformed hydrotreated light, C8-12 arom. fraction;

Low boiling point cat-reformed naphtha;

[A complex combination of alkylbenzenes obtained by the catalytic reforming of petroleum naphtha. It consists predominantly of alkylbenzenes having carbon numbers predominantly in the range of C8 through C10 and boiling in the range of approximately 160 oC to 180 oC (320 oF to 356 oF).]
285-509-885116-58-1Carc. 1B

Asp. Tox. 1
H350

H304
GHS08

Dgr
H350

H304
H P
649-310-00-3Aromatic hydrocarbons, C8, catalytic reforming-derived;

Low boiling point cat-reformed naphtha
295-279-091995-18-5Carc. 1B

Asp. Tox. 1
H350

H304
GHS08

Dgr
H350

H304
H P
649-311-00-9Aromatic hydrocarbons, C7-12, C8-rich;

Low boiling point cat-reformed naphtha;

[A complex combination of hydrocarbons obtained by separation from the platformate-containing fraction. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C7 through C12 (primarily C8) and can contain nonaromatic hydrocarbons, both boiling in the range of approximately 130 oC to 200 oC (266 oF to 392 oF).]
297-401-893571-75-6Carc. 1B

Asp. Tox. 1
H350

H304
GHS08

Dgr
H350

H304
H P
649-312-00-4Gasoline, C5-11, high-octane stabilized reformed;

Low boiling point cat-reformed naphtha;

[A complex high octane combination of hydrocarbons obtained by the catalytic dehydrogenation of a predominantly naphthenic naphtha. It consists predominantly of aromatics and non-aromatics having carbon numbers predominantly in the range of C5 through C11 and boiling in the range of approximately 45 oC to 185 oC (113 oF to 365 oF).]
297-458-993572-29-3Carc. 1B

Asp. Tox. 1
H350

H304
GHS08

Dgr
H350

H304
H P
649-313-00-XHydrocarbons, C7-12, C >9-arom.-rich, reforming heavy fraction;

Low boiling point cat-reformed naphtha;

[A complex combination of hydrocarbons obtained by separation from the platformate-containing fraction. It consists predominantly of nonaromatic hydrocarbons having carbon numbers predominantly in the range of C7 through C12 and boiling in the range of approximately 120 oC to 210 oC (248 oF to 380 oF) and C9 and higher aromatic hydrocarbons.]
297-465-793572-35-1Carc. 1B

Asp. Tox. 1
H350

H304
GHS08

Dgr
H350

H304
H P
649-314-00-5Hydrocarbons, C5-11, nonaroms.-rich, reforming light fraction;

Low boiling point cat-reformed naphtha;

[A complex combination of hydrocarbons obtained by separation from the platformate-containing fraction. It consists predominantly of nonaromatic hydrocarbons having carbon numbers predominantly in the range of C5 to C11 and boiling in the range of approximately 35 oC to 125 oC (94 oF to 257 oF), benzene and toluene.]
297-466-293572-36-2Carc. 1B

Asp. Tox. 1
H350

H304
GHS08

Dgr
H350

H304
H P
649-315-00-0Foots oil (petroleum), silicic acid-treated;

Foots oil;

[A complex combination of hydrocarbons obtained by the treatment of Foots oil with silicic acid for removal of trace constituents and impurities. It consists predominantly of straight chain hydrocarbons having carbon numbers predominantly greater than C12.]
308-127-697862-77-6Carc. 1BH350

H304
GHS08

Dgr
H350

H304
H L
649-316-00-6Naphtha (petroleum), light thermal cracked;

Low boiling point thermally cracked naphtha;

[A complex combination of hydrocarbons from distillation of products from a thermal cracking process. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C4 through C8 and boiling in the range of approximately minus 10 oC to 130 oC (14 oF to 266 oF).]
265-075-664741-74-8Carc. 1B

Asp. Tox. 1
H350

H304
GHS08

Dgr
H350

H304
H P
649-317-00-1Naphtha (petroleum), heavy thermal cracked;

Low boiling point thermally cracked naphtha;

[A complex combination of hydrocarbons from distillation of the products from a thermal cracking process. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C6 through C12 and boiling in the range of approximately 65 oC to 220 oC (148 oF to 428 oF).]
265-085-064741-83-9Carc. 1B

Asp. Tox. 1
H350

H304
GHS08

Dgr
H350

H304
H P
649-318-00-7Distillates (petroleum), heavy arom.;

Low boiling point thermally cracked naphtha;

[The complex combination of hydrocarbons from the distillation of the products from the thermal cracking of ethane and propane. This higher boiling fraction consists predominantly of C5-C7 aromatic hydrocarbons with some unsaturated aliphatic hydrocarbons having carbon number predominantly of C5. This stream may contain benzene.]
267-563-467891-79-6Carc. 1B

Asp. Tox. 1
H350

H304
GHS08

Dgr
H350

H304
H P
649-319-00-2Distillates (petroleum), light arom.;

Low boiling point thermally cracked naphtha;

[The complex combination of hydrocarbons from the distillation of the products from the thermal cracking of ethane and propane. This lower boiling fraction consists predominantly of C5-C7 aromatic hydrocarbons with some unsaturated aliphatic hydrocarbons having a carbon number predominantly of C5. This stream may contain benzene.]
267-565-567891-80-9Carc. 1B

Asp. Tox. 1
H350

H304
GHS08

Dgr
H350

H304
H P
649-320-00-8Distillates (petroleum), naphtha-raffinate pyrolyzate-derived, gasoline-blending;

Low boiling point thermally cracked naphtha;

[The complex combination of hydrocarbons obtained by the pyrolysis fractionation at 816 oC (1500 oF) of naphtha and raffinate. It consists predominantly of hydrocarbons having a carbon number of C9 and boiling at approximately 204 oC (400 oF).]
270-344-668425-29-6Carc. 1B

Asp. Tox. 1
H350

H304
GHS08

Dgr
H350

H304
H P
649-321-00-3Aromatic hydrocarbons, C6-8, naphtha-raffinate pyrolyzate-derived;

Low boiling point thermally cracked naphtha;

A complex combination of hydrocarbons obtained by the fractionation pyrolysis at 816 oC (1500 oF) of naphtha and raffinate. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C6 through C8, including benzene.]
270-658-368475-70-7Carc. 1B

Asp. Tox. 1
H350

H304
GHS08

Dgr
H350

H304
H P
649-322-00-9Distillates (petroleum), thermal cracked naphtha and gas oil;

Low boiling point thermally cracked naphtha;

[A complex combination of hydrocarbons produced by distillation of thermally cracked naphtha and/or gas oil. It consists predominantly of olefinic hydrocarbons having a carbon number of C5 and boiling in the range of approximately 33 oC to 60 oC (91 oF to 140 oF).]
271-631-968603-00-9Carc. 1B

Asp. Tox. 1
H350

H304
GHS08

Dgr
H350

H304
H P
649-323-00-4Distillates (petroleum), thermal cracked naphtha and gas oil, C5-dimer-contg.;

Low boiling point thermally cracked naphtha;

[A complex combination of hydrocarbons produced by the extractive distillation of thermal cracked naphtha and/or gas oil. It consists predominantly of hydrocarbons having a carbon number of C5 with some dimerized C5 olefins and boiling in the range of approximately 33 oC to 184 oC (91 oF to 363 oF).]
271-632-468603-01-0Carc. 1B

Asp. Tox. 1
H350

H304
GHS08

Dgr
H350

H304
H P
649-324-00-XDistillates (petroleum), thermal cracked naphtha and gas oil, extractive;

Low boiling point thermally cracked naphtha;

[A complex combination of hydrocarbons produced by the extractive distillation of thermal cracked naphtha and/or gas oil. It consists of paraffinic and olefinic hydrocarbons, predominantly isoamylenes such as 2-methyl-1-butene and 2-methyl-2-butene and boiling in the range of approximately 31 oC to 40 oC (88 oF to 104 oF).]
271-634-568603-03-2Carc. 1B

Asp. Tox. 1
H350

H304
GHS08

Dgr
H350

H304
H P
649-325-00-5Distillates (petroleum), light thermal cracked, debutanized arom.;

Low boiling point thermally cracked naphtha;

[A complex combination of hydrocarbons produced by the distillation of products from a thermal cracking process. It consists predominantly of aromatic hydrocarbons, primarily benzene.]
273-266-068955-29-3Carc. 1B

Asp. Tox. 1
H350

H304
GHS08

Dgr
H350

H304
H P
649-326-00-0Naphtha (petroleum), light thermal cracked, sweetened;

Low boiling point thermally cracked naphtha;

[A complex combination of hydrocarbons obtained by subjecting a petroleum distillate from the high temperature thermal cracking of heavy oil fractions to a sweetening process to convert mercaptans. It consists predominantly of aromatics, olefins and saturated hydrocarbons boiling in the range of approximately 20 oC to 100 oC (68 oF to 212 oF).]
295-447-392045-65-3Carc. 1B

Asp. Tox. 1
H350

H304
GHS08

Dgr
H350

H304
H P
649-327-00-6Naphtha (petroleum), hydrotreated heavy;

Low boiling point hydrogen treated naphtha;

[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly in the range of C6 through C13 and boiling in the range of approximately 65 oC to 230 oC (149 oF to 446 oF).]
265-150-364742-48-9Carc. 1B

Asp. Tox. 1
H350

H304
GHS08

Dgr
H350

H304
H P
649-328-00-1Naphtha (petroleum), hydrotreated light;

Low boiling point hydrogen treated naphtha;

[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C11 and boiling in the range of approximately minus 20 oC to 190 oC (- 4 oF to 374 oF).]
265-151-964742-49-0Carc. 1B

Asp. Tox. 1
H350

H304
GHS08

Dgr
H350

H304
H P
649-329-00-7Naphtha (petroleum), hydrodesulfurized light;

Low boiling point hydrogen treated naphtha;

[A complex combination of hydrocarbons obtained from a catalytic hydrodesulfurization process. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C11 and boiling in the range of approximately minus 20 oC to 190 oC (- 4 oF to 374 oF).]
265-178-664742-73-0Carc. 1B

Asp. Tox. 1
H350

H304
GHS08

Dgr
H350

H304
H P
649-330-00-2Naphtha (petroleum), hydrodesulfurized heavy;

Low boiling point hydrogen treated naphtha;

[A complex combination of hydrocarbons obtained from a catalytic hydrodesulfurization process. It consists of hydrocarbons having carbon numbers predominantly in the range of C7 through C12 and boiling in the range of approximately 90 oC to 230 oC (194 oF to 446 oF).]
265-185-464742-82-1Carc. 1B

Asp. Tox. 1
H350

H304
GHS08

Dgr
H350

H304
H P
649-331-00-8Distillates (petroleum), hydrotreated middle, intermediate boiling;

Low boiling point hydrogen treated naphtha;

[A complex combination of hydrocarbons obtained by the distillation of products from a middle distillate hydrotreating process. It consists of hydrocarbons having carbon numbers predominantly in the range of C5 through C10 and boiling in the range of approximately 127 oC to 188 oC (262 oF to 370 oF).]
270-092-768410-96-8Carc. 1B

Asp. Tox. 1
H350

H304
GHS08

Dgr
H350

H304
H P
649-332-00-3Distillates (petroleum), light distillate hydrotreating process, low-boiling;

Low boiling point hydrogen treated naphtha;

[A complex combination of hydrocarbons obtained by the distillation of products from the light distillate hydrotreating process. It consists of hydrocarbons having carbon numbers predominantly in the range of C6 through C9 and boiling in the range of approximately 3 oC to 194 oC (37 oF to 382 oF).]
270-093-268410-97-9Carc. 1B

Asp. Tox. 1
H350

H304
GHS08

Dgr
H350

H304
H P
649-333-00-9Distillates (petroleum), hydrotreated heavy naphtha, deisohexanizer overheads;

Low boiling point hydrogen treated naphtha;

[A complex combination of hydrocarbons obtained by distillation of the products from a heavy naphtha hydrotreating process. It consists of hydrocarbons having carbon numbers predominantly in the range of C3 through C6 and boiling in the range of approximately - 49 oC to 68 oC (- 57 oF to 155 oF).]
270-094-868410-98-0Carc. 1B

Asp. Tox. 1
H350

H304
GHS08

Dgr
H350

H304
H P
649-334-00-4Solvent naphtha (petroleum), light arom., hydrotreated;

Low boiling point hydrogen treated naphtha;

[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C8 through C10 and boiling in the range of approximately 135 oC to 210 oC (275 oF to 410 oF).]
270-988-868512-78-7Carc. 1B

Asp. Tox. 1
H350

H304
GHS08

Dgr
H350

H304
H P
649-335-00-XNaphtha (petroleum), hydrodesulfurized thermal cracked light;

Low boiling point hydrogen treated naphtha;

[A complex combination of hydrocarbons obtained by fractionation of hydrodesulfurized thermal cracker distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C5 to C11 and boiling in the range of approximately 23 oC to 195 oC (73 oF to 383 oF).]
285-511-985116-60-5Carc. 1B

Asp. Tox. 1
H350

H304
GHS08

Dgr
H350

H304
H P
649-336-00-5Naphtha (petroleum), hydrotreated light, cycloalkane-contg.;

Low boiling point hydrogen treated naphtha;

[A complex combination of hydrocarbons obtained from the distillation of a petroleum fraction. It consists predominantly of alkanes and cycloalkanes boiling in the range of approximately minus 20 oC to 190 oC (- 4 oF to 374 oF).]
285-512-485116-61-6Carc. 1B

Asp. Tox. 1
H350

H304
GHS08

Dgr
H350

H304
H P
649-337-00-0Naphtha (petroleum), heavy steam-cracked, hydrogenated;

Low boiling point hydrogen treated naphtha
295-432-192045-51-7Carc. 1B

Asp. Tox. 1
H350

H304
GHS08

Dgr
H350

H304
H P
649-338-00-6Naphtha (petroleum), hydrodesulfurized full-range;

Low boiling point hydrogen treated naphtha;

[A complex combination of hydrocarbons obtained from a catalytic hydrodesulfurization process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C4 through C11 and boiling in the range of approximately 30 oC to 250 oC (86 oF to 482 oF).]
295-433-792045-52-8Carc. 1B

Asp. Tox. 1
H350

H304
GHS08

Dgr
H350

H304
H P
649-339-00-1Naphtha (petroleum), hydrotreated light steam-cracked;

Low boiling point hydrogen treated naphtha;

[A complex combination of hydrocarbons obtained by treating a petroleum fraction, derived from a pyrolysis process, with hydrogen in the presence of a catalyst. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C5 through C11 and boiling in the range of approximately 35 oC to 190 oC (95 oF to 374 oF).]
295-438-492045-57-3Carc. 1B

Asp. Tox. 1
H350

H304
GHS08

Dgr
H350

H304
H P
649-340-00-7Hydrocarbons, C4-12, naphtha-cracking, hydrotreated;

Low boiling point hydrogen treated naphtha;

[A complex combination of hydrocarbons obtained by distillation from the product of a naphtha steam cracking process and subsequent catalytic selective hydrogenation of gum formers. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C12 and boiling in the range of approximately 30 oC to 230 oC (86 oF to 446 oF).]
295-443-192045-61-9Carc. 1B

Asp. Tox. 1
H350

H304
GHS08

Dgr
H350

H304
H P
649-341-00-2Solvent naphtha (petroleum), hydrotreated light naphthenic;

Low boiling point hydrogen treated naphtha;

[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists predominantly of cycloparaffinic hydrocarbons having carbon numbers predominantly in the range of C6 through C7 and boiling in the range of approximately 73 oC to 85 oC (163 oF to 185 oF).]
295-529-992062-15-2Carc. 1B

Asp. Tox. 1
H350

H304
GHS08

Dgr
H350

H304
H P
649-342-00-8Naphtha (petroleum), light steam-cracked, hydrogenated;

Low boiling point hydrogen treated naphtha;

[A complex comination of hydrocarbons produced from the separation and subsequent hydrogenation of the products of a steam-cracking process to produce ethylene. It consists predominantly of saturated and unsaturated paraffins, cyclic paraffins and cyclic aromatic hydrocarbons having carbon numbers predominantly in the range of C4 through C10 and boiling in the range of approximately 50 oC to 200 oC (122 oF to 392 oF). The proportion of benzene hydrocarbons may vary up to 30 wt. % and the stream may also contain small amounts of sulphur and oxygenated compounds.]
296-942-793165-55-0Carc. 1B

Asp. Tox. 1
H350

H304
GHS08

Dgr
H350

H304
H P
649-343-00-3Hydrocarbons, C6-11, hydrotreated, dearomatized;

Low boiling point hydrogen treated naphtha;

[A complex combination of hydrocarbons obtained as solvents which have been subjected to hydrotreatment in order to convert aromatics to naphthenes by catalytic hydrogenation.]
297-852-093763-33-8Carc. 1B

Asp. Tox. 1
H350

H304
GHS08

Dgr
H350

H304
H P
649-344-00-9Hydrocarbons, C9-12, hydrotreated, dearomatized;

Low boiling point hydrogen treated naphtha;

[A complex combination of hydrocarbons obtained as solvents which have been subjected to hydrotreatment in order to convert aromatics to naphthenes by catalytic hydrogenation.]
297-853-693763-34-9Carc. 1B

Asp. Tox. 1
H350

H304
GHS08

Dgr
H350

H304
H P
649-345-00-4Stoddard solvent;

Low boiling point naphtha — unspecified;

[A colourless, refined petroleum distillate that is free from rancid or objectionable odors and that boils in a range of approximately 300 oF to 400 oF.]
232-489-38052-41-3Carc. 1B

Asp. Tox. 1
H350

H304
GHS08

Dgr
H350

H304
H P
649-346-00-XNatural gas condensates (petroleum);

Low boiling point naphtha — unspecified;

[A complex combination of hydrocarbons separated as a liquid from natural gas in a surface separator by retrograde condensation. It consists mainly of hydrocarbons having carbon numbers predominantly in the range of C2 to C20. It is a liquid at atmospheric temperature and pressure.]
265-047-364741-47-5Carc. 1B

Asp. Tox. 1
H350

H304
GHS08

Dgr
H350

H304
H P
649-347-00-5Natural gas (petroleum), raw liq. mix;

Low boiling point naphtha — unspecified;

[A complex combination of hydrocarbons separated as a liquid from natural gas in a gas recycling plant by processes such as refrigeration or absorption. It consists mainly of saturated aliphatic hydrocarbons having carbon numbers in the range of C2 through C8.]
265-048-964741-48-6Carc. 1B

Asp. Tox. 1
H350

H304
GHS08

Dgr
H350

H304
H P
649-348-00-0Naphtha (petroleum), light hydrocracked;

Low boiling naphtha — unspecified;

[A complex combination of hydrocarbons from distillation of the products from a hydrocracking process. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C4 through C10, and boiling in the range of approximately minus 20 oC to 180 oC (- 4 oF to 356 oF).]
265-071-464741-69-1Carc. 1B

Asp. Tox. 1
H350

H304
GHS08

Dgr
H350

H304
H P
649-349-00-6Naphtha (petroleum), heavy hydrocracked;

Low boiling point naphtha — unspecified;

[A complex combination of hydrocarbons from distillation of the products from a hydrocracking process. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C6 through C12, and boiling in the range of approximately 65 oC to 230 oC (148 oF to 446 oF).]
265-079-864741-78-2Carc. 1B

Asp. Tox. 1
H350

H304
GHS08

Dgr
H350

H304
H P
649-350-00-1Naphtha (petroleum), sweetened;

Low boiling point naphtha — unspecified;

[A complex combination of hydrocarbons obtained by subjecting a petroleum naphtha to a sweetening process to convert mercaptans or to remove acidic impurities. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C12 and boiling in the range of approximately minus 10 oC to 230 oC (14 oF to 446 oF).]
265-089-264741-87-3Carc. 1B

Asp. Tox. 1
H350

H304
GHS08

Dgr
H350

H304
H P
649-351-00-7Naphtha (petroleum), acid-treated;

Low boiling point naphtha — unspecified;

[A complex combination of hydrocarbons obtained as a raffinate from a sulfuric acid treating process. It consists of hydrocarbons having carbon numbers predominantly in the range of C7 through C12 and boiling in the range of approximately 90 oC to 230 oC (194 oF to 446 oF).]
265-115-264742-15-0Carc. 1B

Asp. Tox. 1
H350

H304
GHS08

Dgr
H350

H304
H P
649-352-00-2Naphtha (petroleum), chemically neutralized heavy;

Low boiling point naphtha — unspecified;

[A complex combination of hydrocarbons produced by a treating process to remove acidic materials. It consists of hydrocarbons having carbon numbers predominantly in the range of C6 through C12 and boiling in the range of approximately 65 oC to 230 oC (149 oF to 446 oF).]
265-122-064742-22-9Carc. 1B

Asp. Tox. 1
H350

H304
GHS08

Dgr
H350

H304
H P
649-353-00-8Naphtha (petroleum), chemically neutralized light;

Low boiling point naphtha — unspecified;

[A complex combination of hydrocarbons produced by a treating process to remove acidic materials. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C11 and boiling in the range of approximately minus 20 oC to 190 oC (- 4 oF to 374 oF).]
265-123-664742-23-0Carc. 1B

Asp. Tox. 1
H350

H304
GHS08

Dgr
H350

H304
H P
649-354-00-3Naphtha (petroleum), catalytic dewaxed;

Low boiling point naphtha — unspecified;

[A complex combination of hydrocarbons obtained from the catalytic dewaxing of a petroleum fraction. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C5 through C12 and boiling in the range of approximately 35 oC to 230 oC (95 oF to 446 oF).]
265-170-264742-66-1Carc. 1B

Asp. Tox. 1
H350

H304
GHS08

Dgr
H350

H304
H P
649-355-00-9Naphtha (petroleum), light steam-cracked;

Low boiling point naphtha — unspecified;

[A complex combination of hydrocarbons obtained by the distillation of the products from a steam cracking process. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C4 through C11 and boiling in the range of approximately minus 20 oC to 190 oC (- 4 oF to 374 oF). This stream is likely to contain 10 vol.% or more benzene.]
265-187-564742-83-2Carc. 1B

Asp. Tox. 1
H350

H304
GHS08

Dgr
H350

H304
H P
649-356-00-4Solvent naphtha (petroleum), light arom.;

Low boiling point naphtha — unspecified;

[A complex combination of hydrocarbons obtained from distillation of aromatic streams. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C8 through C10 and boiling in the range of approximately 135 oC to 210 oC (275 oF to 410 oF).]
265-199-064742-95-6Carc. 1B

Asp. Tox. 1
H350

H304
GHS08

Dgr
H350

H304
H P
649-357-00-XAromatic hydrocarbons, C6-10, acid-treated, neutralized;

Low boiling point naphtha — unspecified
268-618-568131-49-7Carc. 1B

Asp. Tox. 1
H350

H304
GHS08

Dgr
H350

H304
H P
649-358-00-5Distillates (petroleum), C3-5, 2-methyl-2-butene-rich;

Low boiling point naphtha — unspecified;

[A complex combination of hydrocarbons from the distillation of hydrocarbons usually ranging in carbon numbers from C3 through C5, predominantly isopentane and 3-methyl-1-butene. It consists of saturated and unsaturated hydrocarbons having carbon numbers in the range of C3 through C5, predominantly 2-methyl-2-butene.]
270-725-768477-34-9Carc. 1B

Asp. Tox. 1
H350

H304
GHS08

Dgr
H350

H304
H P
649-359-00-0Distillates (petroleum), polymd. steam-cracked petroleum distillates, C5-12 fraction;

Low boiling point naphtha — unspecified;

[A complex combination of hydrocarbons obtained from the distillation of polymerized steam-cracked petroleum distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C5 through C12.]]
270-735-168477-50-9Carc. 1B

Asp. Tox. 1
H350

H304
GHS08

Dgr
H350

H304
H P
649-360-00-6Distillates (petroleum), steam-cracked, C5-12 fraction;

Low boiling point naphtha — unspecified;

[A complex combination of organic compounds obtained by the distillation of products from a steam cracking process. It consists of unsaturated hydrocarbons having carbon numbers predominantly in the range of C5 through C12.]
270-736-768477-53-2Carc. 1B

Asp. Tox. 1
H350

H304
GHS08

Dgr
H350

H304
H P
649-361-00-1Distillates (petroleum), steam-cracked, C5-10 fraction, mixed with light steam-cracked petroleum naphtha C5 fraction;

Low boiling point naphtha — unspecified
270-738-868477-55-4Carc. 1B

Asp. Tox. 1
H350

H304
GHS08

Dgr
H350

H304
H P
649-362-00-7Extracts (petroleum), cold-acid, C4-6;

Low boiling point naphtha — unspecified;

[A complex combination of organic compounds produced by cold acid unit extraction of saturated and unsaturated aliphatic hydrocarbons usually ranging in carbon numbers from C3 through C6, predominantly pentanes and amylenes. It consists predominantly of saturated and unsaturated hydrocarbons having carbon numbers in the range of C4 through C6, predominantly C5.]
270-741-468477-61-2Carc. 1B

Asp. Tox. 1
H350

H304
GHS08

Dgr
H350

H304
H P
649-363-00-2Distillates (petroleum), depentanizer overheads;

Low boiling point naphtha — unspecified;

[A complex combination of hydrocarbons obtained from a catalytic cracked gas stream. It consists of aliphatic hydrocarbons having carbon numbers predominantly in the range of C4 through C6.]
270-771-868477-89-4Carc. 1B

Asp. Tox. 1
H350

H304
GHS08

Dgr
H350

H304
H P
649-364-00-8Residues (petroleum), butane splitter bottoms;

Low boiling point naphtha — unspecified;

[A complex residuum from the distillation of butane stream. It consists of aliphatic hydrocarbons having carbon numbers predominantly in the range of C4 through C6.]
270-791-768478-12-6Carc. 1B

Asp. Tox. 1
H350

H304
GHS08

Dgr
H350

H304
H P
649-365-00-3Residual oils (petroleum), deisobutanizer tower;

Low boiling point naphtha — unspecified;

[A complex residuum from the atmospheric distillation of the butane-butylene stream. It consists of aliphatic hydrocarbons having carbon numbers predominantly in the range of C4 through C6.]
270-795-968478-16-0Carc. 1B

Asp. Tox. 1
H350

H304
GHS08

Dgr
H350

H304
H P
649-366-00-9Naphtha (petroleum), full-range coker;

Low boiling point naphtha — unspecified;

[A complex combination of hydrocarbons produced by the distillation of products from a fluid coker. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C4 through C15 and boiling in the range of approximately 43 oC to 250 oC (110 oF to 500 oF).]
270-991-468513-02-0Carc. 1B

Asp. Tox. 1
H350

H304
GHS08

Dgr
H350

H304
H P
649-367-00-4Naphtha (petroleum), steam-cracked middle arom.;

Low boiling point naphtha — unspecified;

[A complex combination of hydrocarbons produced by the distillation of products from a steam-cracking process. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C7 through C12 and boiling in the range of approximately 130 oC to 220 oC (266 oF to 428 oF).]]
271-138-968516-20-1Carc. 1B

Asp. Tox. 1
H350

H304
GHS08

Dgr
H350

H304
H P
649-368-00-XNaphtha (petroleum), clay-treated full-range straight-run;

Low boiling point naphtha — unspecified;

[A complex combination of hydrocarbons resulting from treatment of full-range straight-run naphtha with natural or modified clay, usually in a percolation process to remove the trace amounts of polar compounds and impurities present. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C11 and boiling in the range of approximately - 20 oC to 220 oC (- 4 oF to 429 oF).]
271-262-368527-21-9Carc. 1B

Asp. Tox. 1
H350

H304
GHS08

Dgr
H350

H304
H P
649-369-00-5Naphtha (petroleum), clay-treated light straight-run;

Low boiling point naphtha — unspecified;

[A complex combination of hydrocarbons resulting from treatment of light straight-run naphtha with a natural or modified clay, usually in a percolation process to remove the trace amounts of polar compounds and impurities, present. It consists of hydro-carbons having carbon numbers predominantly in the range of C7 through C10 and boiling in the range of approximately 93 oC to 180 oC (200 oF to 356 oF.]
271-263-968527-22-0Carc. 1B

Asp. Tox. 1
H350

H304
GHS08

Dgr
H350

H304
H P
649-370-00-0Naphtha (petroleum), light steam-cracked arom.;

Low boiling point naphtha — unspecified;

[A complex combination of hydrocarbons produced by distillation of products from a steam-cracking process. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C7 through C9 and boiling in the range of approximately 110 oC to 165 oC (230 oF to 329 oF).]
271-264-468527-23-1Carc. 1B

Asp. Tox. 1
H350

H304
GHS08

Dgr
H350

H304
H P
649-371-00-6Naphtha (petroleum), light steam-cracked, debenzenized;

Low boiling point naphtha — unspecified;

[A complex combination of hydrocarbons produced by distillation of products from a steam-cracking process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C4 through C12 and boiling in the range of approximately 80 oC to 218 oC (176 oF to 424 oF).]
271-266-568527-26-4Carc. 1B

Asp. Tox. 1
H350

H304
GHS08

Dgr
H350

H304
H P
649-372-00-1Naphtha (petroleum), arom.-contg.;

Low boiling point naphtha — unspecified
271-635-068603-08-7Carc. 1B

Asp. Tox. 1
H350

H304
GHS08

Dgr
H350

H304
H P
649-373-00-7Gasoline, pyrolysis, debutanizer bottoms;

Low boiling point naphtha — unspecified;

[A complex combination of hydrocarbons obtained from the fractionation of depropanizer bottoms. It consists of hydrocarbons having carbon numbers predominantly greater than C5.]
271-726-568606-10-0Carc. 1B

Asp. Tox. 1
H350

H304
GHS08

Dgr
H350

H304
H P
649-374-00-2Naphtha (petroleum), light, sweetened;

Low boiling point naphtha — unspecified;

[A complex combination of hydrocarbons obtained by subjecting a petroleum distillate to a sweetening process to convert mercaptans or to remove acidic impurities. It consists predominantly of saturated and unsaturated hydrocarbons having carbon numbers predominantly in the range of C3 through C6 and boiling in the range of approximately - 20 oC to 100 oC (- 4 oF to 212 oF).]
272-206-068783-66-4Carc. 1B

Asp. Tox. 1
H350

H304
GHS08

Dgr
H350

H304
H P
649-375-00-8Natural gas condensates;

Low boiling point naphtha — unspecified;

[A complex combination of hydrocarbons separated and/or condensed from natural gas during transportation and collected at the wellhead and/or from the production, gathering, transmission, and distribution pipelines in deeps, scrubbers, etc. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C2 through C8.]
272-896-368919-39-1Carc. 1B

Asp. Tox. 1
H350

H304
GHS08

Dgr
H350

H304
H J
649-376-00-3Distillates (petroleum), naphtha unifiner stripper;

Low boiling point naphtha — unspecified;

[A complex combination of hydrocarbons produced by stripping the products from the naphtha unifiner. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C2 through C6.]
272-932-868921-09-5Carc. 1B

Asp. Tox. 1
H350

H304
GHS08

Dgr
H350

H304
H P
649-377-00-9Naphtha (petroleum), catalytic reformed light, arom.-free fraction;

Low boiling point naphtha — unspecified;

[A complex combination of hydrocarbons remaining after removal of aromatic compounds from catalytic reformed light naphtha in a selective absorption process. It consists predominantly of paraffinic and cyclic compounds having carbon numbers predominantly in the range of C5 to C8 and boiling in the range of approximately 66 oC to 121 oC (151 oF to 250 oF).]
285-510-385116-59-2Carc. 1B

Asp. Tox. 1
H350

H304
GHS08

Dgr
H350

H304
H P
649-378-00-4Gasoline;

Low boiling point naphtha — unspecified;

[A complex combination of hydrocarbons consisting primarily of paraffins, cycloparaffins, aromatic and olefinic hydrocarbons having carbon numbers predominantly greater than C3 and boiling in the range of 30 oC to 260 oC (86 oF to 500 oF).]
289-220-886290-81-5Carc. 1B

Asp. Tox. 1
H350

H304
GHS08

Dgr
H350

H304
H P
649-379-00-XAromatic hydrocarbons, C7-8, dealkylation products, distn. residues;

Low boiling point naphtha — unspecified
292-698-090989-42-7Carc. 1B

Asp. Tox. 1
H350

H304
GHS08

Dgr
H350

H304
H P
649-380-00-5Hydrocarbons, C4-6, depentanizer lights, arom. hydrotreater;

Low boiling point naphtha — unspecified;

[A complex combination of hydrocarbons obtained as first runnings from the depentanizer column before hydrotreatment of the aromatic charges. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C4 through C6, predominantly pentanes and pentenes, and boiling in the range of approximately 25 oC to 40 oC (77 oF to 104 oF).]
295-298-491995-38-9Carc. 1B

Asp. Tox. 1
H350

H304
GHS08

Dgr
H350

H304
H P
649-381-00-0Distillates (petroleum), heat-soaked steam-cracked naphtha, C5-rich;

Low boiling point naphtha — unspecified;

[A complex combination of hydrocarbons obtained by distillation of heat-soaked steam-cracked naphtha. It consists predominantly of hydrocarbons having carbon numbers in the range of C4 through C6, predominantly C5.]
295-302-491995-41-4Carc. 1B

Asp. Tox. 1
H350

H304
GHS08

Dgr
H350

H304
H P
649-382-00-6Extracts (petroleum), catalytic reformed light naphtha solvent;

Low boiling point naphtha — unspecified;

[A complex combination of hydrocarbons obtained as the extract from the solvent extraction of a catalytically reformed petroleum cut. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C7 through C8 and boiling in the range of approximately 100 oC to 200 oC (212 oF to 392 oF).]
295-331-291995-68-5Carc. 1B

Asp. Tox. 1
H350

H304
GHS08

Dgr
H350

H304
H P
649-383-00-1Naphtha (petroleum), hydrodesulfurized light, dearomatized;

Low boiling point naphtha — unspecified;

[A complex combination of hydrocarbons obtained by distillation of hydrodesulfurized and dearomatized light petroleum fractions. It consists predominantly of C7 paraffins and cycloparaffins boiling in a range of approximately 90 oC to 100 oC (194 oF to 212 oF).]
295-434-292045-53-9Carc. 1B

Asp. Tox. 1
H350

H304
GHS08

Dgr
H350

H304
H P
649-384-00-7Naphtha (petroleum), light, C5-rich, sweetened;

Low boiling point naphtha — unspecified;

[A complex combination of hydrocarbons obtained by subjecting a petroleum naphtha to a sweetening process to convert mercaptans or to remove acidic impurities. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C5, predominantly C5, and boiling in the range of approximately minus 10 oC to 35 oC (14 oF to 95 oF).]
295-442-692045-60-8Carc. 1B

Asp. Tox. 1
H350

H304
GHS08

Dgr
H350

H304
H P
649-385-00-2Hydrocarbons, C8-11, naphtha-cracking, toluene cut;

Low boiling point naphtha — unspecified;

[A complex combination of hydrocarbons obtained by distillation from prehydrogenated cracked naphtha. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C8 through C11 and boiling in the range of approximately 130 oC to 205 oC (266 oF to 401 oF).]
295-444-792045-62-0Carc. 1B

Asp. Tox. 1
H350

H304
GHS08

Dgr
H350

H304
H P
649-386-00-8Hydrocarbons, C4-11, naphtha-cracking, arom.-free;

Low boiling point naphtha — unspecified;

[A complex combination of hydrocarbons obtained from prehydrogenated cracked naphtha after distillative separation of benzene- and toluene-containing hydrocarbon cuts and a higher boiling fraction. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range C4 through C11 and boiling in the range of approximately 30 oC to 205 oC (86 oF to 401 oF).]
295-445-292045-63-1Carc. 1B

Asp. Tox. 1
H350

H304
GHS08

Dgr
H350

H304
H P
649-387-00-3Naphtha (petroleum), light heat-soaked, steam-cracked;

Low boiling point naphtha — unspecified;

[A complex combination of hydrocarbons obtained by the fractionation of steam cracked naphtha after recovery from a heat soaking process. It consists predominantly of hydrocarbons having a carbon numbers predominantly in the range of C4 through C6 and boiling in the range of approximately 0 oC to 80 oC (32 oF to 176 oF.]
296-028-892201-97-3Carc. 1B

Asp. Tox. 1
H350

H304
GHS08

Dgr
H350

H304
H P
649-388-00-9Distillates (petroleum), C6-rich;

Low boiling point naphtha — unspecified;

[A complex combination of hydrocarbons obtained from the distillation of a petroleum feedstock. It consists predominantly of hydrocarbons having carbon numbers of C5 through C7, rich in C6, and boiling in the range of approximately 60 oC to 70 oC (140 oF to 158 oF).]
296-903-493165-19-6Carc. 1B

Asp. Tox. 1
H350

H304
GHS08

Dgr
H350

H304
H P
649-389-00-4Gasoline, pyrolysis, hydrogenated;

Low boiling point naphtha — unspecified;

[A distillation fraction from the hydrogenation of pyrolysis gasoline boiling in the range of approximately 20 oC to 200 oC (68 oF to 392 oF).]
302-639-394114-03-1Carc. 1B

Asp. Tox. 1
H350

H304
GHS08

Dgr
H350

H304
H P
649-390-00-XDistillates (petroleum), steam-cracked, C8-12 fraction, polymd., distn. lights;

Low boiling point naphtha — unspecified;

[A complex combination of hydrocarbons obtained by distillation of the polymerized C8 through C12 fraction from steam-cracked petroleum distillates. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C8 through C12.]
305-750-595009-23-7Carc. 1B

Asp. Tox. 1
H350

H304
GHS08

Dgr
H350

H304
H P
649-391-00-5Extracts (petroleum) heavy naphtha solvent, clay-treated;

Low boiling point naphtha — unspecified;

[A complex combination of hydrocarbons obtained by the treatment of heavy naphthic solvent petroleum extract with bleaching earth. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C6 through C18 and boiling in the range of approximately 80 oC to 180 oC (175 oF to 356 oF).]
308-261-597926-43-7Carc. 1B

Asp. Tox. 1
H350

H304
GHS08

Dgr
H350

H304
H P
649-392-00-0Naphtha (petroleum), light steam-cracked, debenzenized, thermally treated;

Low boiling point naphtha — unspecified;

[A complex combination of hydrocarbons obtained by the treatment and distillation of debenzenized light steam-cracked petroleum naphtha. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C7 through C12 and boiling in the range of approximately 95 oC to 200 oC (203 oF to 392 oF).]
308-713-198219-46-6Carc. 1B

Asp. Tox. 1
H350

H304
GHS08

Dgr
H350

H304
H P
649-393-00-6Naphtha (petroleum), light steam-cracked, thermally treated;

Low boiling point naphtha — unspecified;

[A complex combination of hydrocarbons obtained by the treatment and distillation of light steam-cracked petroleum naphtha. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C5 through C6 and boiling in the range of approximately 35 oC to 80 oC (95 oF to 176 oF).]
308-714-798219-47-7Carc. 1B

Asp. Tox. 1
H350

H304
GHS08

Dgr
H350

H304
H P
649-394-00-1Distillates (petroleum), C7-9, C8-rich, hydrodesulfurized dearomatized;

Low boiling point naphtha — unspecified;

[A complex combination of hydrocarbons obtained by the distillation of petroleum light fraction, hydrodesulfurized and dearomatized. It consists predominantly of hydrocarbons having carbon numbers in the range of C7 through C9, predominantly C8 paraffins and cycloparaffins, boiling in the range of approximately 120 oC to 130 oC (248 oF to 266 oF).]
309-862-5101316-56-7Carc. 1B

Asp. Tox. 1
H350

H304
GHS08

Dgr
H350

H304
H P
649-395-00-7Hydrocarbons, C6-8, hydrogenated sorption-dearomatized, toluene raffination;

Low boiling point naphtha — unspecified;

[A complex combination of hydrocarbons obtained during the sorptions of toluene from a hydrocarbon fraction from cracked gasoline treated with hydrogen in the presence of a catalyst. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C6 through C8 and boiling in the range of approximately 80 oC to 135 oC (176 oF to 275 oF).]
309-870-9101316-66-9Carc. 1B

Asp. Tox. 1
H350

H304
GHS08

Dgr
H350

H304
H P
649-396-00-2Naphtha (petroleum), hydrodesulfurized full-range coker;

Low boiling point naphtha — unspecified;

[A complex combination of hydrocarbons obtained by fractionation from hydrodesulfurized coker distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C5 to C11 and boiling in the range of approximately 23 oC to 196 oC (73 oF to 385 oF).]
309-879-8101316-76-1Carc. 1B

Asp. Tox. 1
H350

H304
GHS08

Dgr
H350

H304
H P
649-397-00-8Naphtha (petroleum), sweetened light;

Low boiling point naphtha — unspecified;

[A complex combination of hydrocarbons obtained by subjecting a petroleum naphtha to a sweetening process to convert mercaptans or to remove acidic impurities. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C5 through C8 and boiling in the range of approximately 20 oC to 130 oC (68 oF to 266 oF).]
309-976-5101795-01-1Carc. 1B

Asp. Tox. 1
H350

H304
GHS08

Dgr
H350

H304
H P
649-398-00-3Hydrocarbons, C3-6, C5-rich, steam-cracked naphtha;

Low boiling point naphtha — unspecified;

[A complex combination of hydrocarbons obtained by distillation of steam-cracked naphtha. It consists predominantly of hydrocarbons having carbon numbers in the range of C3 through C6, predominantly C5.]
310-012-0102110-14-5Carc. 1B

Asp. Tox. 1
H350

H304
GHS08

Dgr
H350

H304
H P
649-399-00-9Hydrocarbons, C5-rich, dicyclopentadiene-contg.;

Low boiling point naphtha — unspecified;

[A complex combination of hydrocarbons obtained by distillation of the products from a stream-cracking process. It consists predominantly of hydrocarbons having carbon numbers of C5 and dicyclopentadiene and boiling in the range of approximately 30 oC to 170 oC (86 oF to 338 oF).]
310-013-6102110-15-6Carc. 1B

Asp. Tox. 1
H350

H304
GHS08

Dgr
H350

H304
H P
649-400-00-2Residues (petroleum), steam-cracked light, arom.;

Low boiling point naphtha — unspecified;

[A complex combination of hydrocarbons obtained by the distillation of the products of steam cracking or similar processes after taking off the very light products resulting in a residue starting with hydrocarbons having carbon numbers greater than C5. It consists predominantly of aromatic hydrocarbons having carbon numbers greater than C5 and boiling above approximately 40 oC (104 oF).]
310-057-6102110-55-4Carc. 1B

Asp. Tox. 1
H350

H304
GHS08

Dgr
H350

H304
H P
649-401-00-8Hydrocarbons, C≥ 5, C5-6-rich;

Low boiling point naphtha — unspecified
270-690-868476-50-6Carc. 1B

Asp. Tox. 1
H350

H304
GHS08

Dgr
H350

H304
H P
649-402-00-3Hydrocarbons, C5-rich;

Low boiling point naphtha — unspecified
270-695-568476-55-1Carc. 1B

Asp. Tox. 1
H350

H304
GHS08

Dgr
H350

H304
H P
649-403-00-9Aromatic hydrocarbons, C8-10;

Low boiling point naphtha — unspecified
292-695-490989-39-2Carc. 1B

Asp. Tox. 1
H350

H304
GHS08

Dgr
H350

H304
H P
649-404-00-4Kerosine (petroleum);

Straight run kerosine;

[A complex combination of hydrocarbons produced by the distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C9 through C16 and boiling in the range of approximately 150 oC to 290 oC (320 oF to 554 oF).]
232-366-48008-20-6Asp. Tox. 1H304GHS08

Dgr
H304H
649-405-00-XSolvent naphtha (petroleum), medium aliph.;

Straight run kerosine;

[A complex combination of hydrocarbons obtained from the distillation of crude oil or natural gasoline. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C9 through C12 and boiling in the range of approximately 140 oC to 220 oC (284 oF to 428 oF).]
265-191-764742-88-7Asp. Tox. 1H304GHS08

Dgr
H304H
649-406-00-5Solvent naphtha (petroleum) heavy aliph.;

Straight run kerosine;

[A complex combination of hydrocarbons obtained from the distillation of crude oil or natural gasoline. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C11 through C16 and boiling in the range of approximately 190 oC to 290 oC (374 oF to 554 oF).]
265-200-464742-96-7Asp. Tox. 1H304GHS08

Dgr
H304H
649-407-00-0Kerosine (petroleum), straight-run wide-cut;

Straight run kerosine;

[A complex combination of hydrocarbons obtained as a wide cut hydrocarbon fuel cut from atmospheric distillation and boiling in the range of approximately 70 oC to 220 oC (158 oF to 428 oF).]
295-418-592045-37-9Asp. Tox. 1H304GHS08

Dgr
H304H
649-408-00-6Distillates (petroleum), steam-cracked;

Cracked kerosine;

[A complex combination of hydrocarbons obtained by the distillation of the products from a steam cracking process. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C7 through C16 and boiling in the range of approximately 90 oC to 290 oC (190 oF to 554 oF).]
265-194-364742-91-2Asp. Tox. 1H304GHS08

Dgr
H304H
649-409-00-1Distillates (petroleum), cracked stripped steam-cracked petroleum distillates, C8-10 fraction;

Cracked kerosine;

[A complex combination of hydrocarbons obtained by distilling cracked stripped steam-cracked distillates. It consists of hydro-carbons having carbon numbers in the range of C8 through C10 and boiling in the range of approximately 129 oC to 194 oC (264 oF to 382 oF).]
270-728-368477-39-4Asp. Tox. 1H304GHS08

Dgr
H304H
649-410-00-7Distillates (petroleum), cracked stripped steam-cracked petroleum distillates, C10-12 fraction;

Cracked kerosine;

[A complex combination of hydrocarbons obtained by distilling cracked stripped steam-cracked distillates. It consists predominantly of aromatic hydrocarbons having carbon numbers in the range of C10 through C12.]
270-729-968477-40-7Asp. Tox. 1H304GHS08

Dgr
H304H
649-411-00-2Distillates (petroleum), steam-cracked, C8-12 fraction;

Cracked kerosine;

[A complex combination of organic compounds obtained by the distillation of products from a steam cracking process. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C8 through C12.]
270-737-268477-54-3Asp. Tox. 1H304GHS08

Dgr
H304H
649-412-00-8Kerosine (petroleum), hydrodesulfurized thermal cracked;

Cracked kerosine;

[A complex combination of hydrocarbons obtained by fractionation from hydrodesulfurized thermal cracker distillate. It consists predominantly of hydrocarbons predominantly in the range of C8 to C16 and boiling in the range of approximately 120 oC to 283 oC (284 oF to 541 oF).]
285-507-785116-55-8Asp. Tox. 1H304GHS08

Dgr
H304H
649-413-00-3Aromtic hydrocarbons, C≥10, steam-cracking, hydrotreated;

Cracked kerosine;

[A complex combination of hydrocarbons produced by the distillation of the products from a steam cracking process treated with hydrogen in the presence of a catalyst. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly greater than C10 and boiling in the range of approximately 150 oC to 320 oC (302 oF to 608 oF).]
292-621-090640-98-5Asp. Tox. 1H304GHS08

Dgr
H304H
649-414-00-9Naphtha (petroleum), steam-cracked, hydrotreated, C9-10-arom.-rich;

Cracked kerosine;

[A complex combination of hydrocarbons produced by the distillation of the products from a steam cracking process thereafter treated with hydrogen in the presence of a catalyst. It consists predominantly of aromatic hydrocarbons having carbon numbers in the range of C9 through C10 and boiling in the range of approximately 140 oC to 200 oC (284 oF to 392 oF).]
292-637-890641-13-7Asp. Tox. 1H304GHS08

Dgr
H304H
649-415-00-4Distillates (petroleum), thermal-cracked, alkylarom. hydrocarbon-rich;

Cracked kerosine;

[A complex combination of hydrocarbons obtained by distillation of thermal-cracking heavy tars. It consists predominantly of highly alkylated aromatic hydrocarbons boiling in the range of approximately 100 oC to 250 oC (212 oF to 482 oF.]
309-866-7101316-61-4Asp. Tox. 1H304GHS08

Dgr
H304H
649-416-00-XDistillates (petroleum), catalytic cracked heavy tar light;

Cracked kerosine;

[A complex combination of hydrocarbons obtained by distillation of catalytic cracking heavy tars. It consists predominantly of highly alkylated aromatic hydrocarbons boiling in the range of approximately 100 oC to 250 oC (212 oF to 482 oF).]
309-938-8101631-13-4Asp. Tox. 1H304GHS08

Dgr
H304H
649-417-00-5Solvent naphtha (petroleum), hydrocracked heavy arom.;

Cracked kerosine;

[A complex combination of hydrocarbons obtained by the distillation of hydrocracked petroleum distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C9 through C16 and boiling in the range of approximately 235 oC to 290 oC (455 oF to 554 oF).]
309-881-9101316-80-7Asp. Tox. 1H304GHS08

Dgr
H304H
649-418-00-0Distillates (petroleum), steam-cracked heavy tar light;

Cracked kerosine;

[A complex combination of hydrocarbons obtained by distillation of steam cracking heavy tars. It consists predominantly of highly alkylated aromatic hydrocarbons boiling in the range of approximately 100 oC to 250 oC (212 oF to 482 oF).]
309-940-9101631-15-6Asp. Tox. 1H304GHS08

Dgr
H304H
649-419-00-6Distillates (petroleum), alkylate;

Kerosine — unspecified;

[A complex combination of hydrocarbons produced by distillation of the reaction products of isobutane with monoolefinic hydrocarbons usually ranging in carbon numbers from C3 through C5. It consists of predominantly branched chain saturated hydro-carbons having carbon numbers predominantly in the range of C11 through C17 and boiling in the range of approximately 205 oC to 320 oC (401 oF to 608 oF).]
265-074-064741-73-7Asp. Tox. 1H304GHS08

Dgr
H304H
649-420-00-1Extracts (petroleum), heavy naphtha solvent;

Kerosine — unspecified;

[A complex combination of hydrocarbons obtained as the extract from a solvent extraction process. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C7 through C12 and boiling in the range of approximately 90 oC to 220 oC (194 oF to 428 oF).]
265-099-764741-98-6Asp. Tox. 1H304GHS08

Dgr
H304H
649-421-00-7Distillates (petroleum), chemically neutralized light;

Kerosine — unspecified;

[A complex combination of hydrocarbons produced by a treating process to remove acidic materials. It consists of hydrocarbons having carbon numbers predominantly in the range of C9 through C16 and boiling in the range of approximately 150 oC to 290 oC (302 oF to 554 oF).]
265-132-564742-31-0Asp. Tox. 1H304GHS08

Dgr
H304H
649-422-00-2Distillates (petroleum), hydrotreated light;

Kerosine — unspecified;

[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly in the range of C9 through C16 and boiling in the range of approximately 150 oC to 290 oC (302 oF to 554 oF).]
265-149-864742-47-8Asp. Tox. 1H304GHS08

Dgr
H304H
649-423-00-8Kerosine (petroleum), hydrodesulfurized;

Kerosine — unspecified;

[A complex combination of hydrocarbons obtained from a petroleum stock by treating with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists of hydrocarbons having carbon numbers predominantly in the range of C9 through C16 and boiling in the range of approximately 150 oC to 290 oC (302 oF to 554 oF).]
265-184-964742-81-0Asp. Tox. 1H304GHS08

Dgr
H304H
649-424-00-3Solvent naphtha (petroleum), heavy arom.;

Kerosine — unspecified;

[A complex combination of hydrocarbons obtained from distillation of aromatic streams. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C9 through C16 and boiling in the range of approximately 165 oC to 290 oC (330 oF to 554 oF).]
265-198-564742-94-5Asp. Tox. 1H304GHS08

Dgr
H304H
649-425-00-9Naphtha (petroleum), heavy coker;

Kerosine — unspecified;

[A complex combination of hydrocarbons from the distillation of products from a fluid coker. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C6 through C15 and boiling in the range of approximately 157 oC to 288 oC (315 oF to 550 oF).]
269-778-968333-23-3Asp. Tox. 1H304GHS08

Dgr
H304H
649-426-00-4Naphtha (petroleum), catalytic reformed hydrodesulfurized heavy, arom. fraction;

Kerosine — unspecified;

[A complex combination of hydrocarbons produced by fractionation from catalytically reformed hydrodesulfurized naphtha. It consists predominantly of aromatic hydrocarbons having carbon numbers predominently in the range of C7 to C 13 and boiling in the range of approximately 98 oC to 218 oC (208 oF to 424 oF).]
285-508-285116-57-0Asp. Tox. 1H304GHS08

Dgr
H304H
649-427-00-XKerosine (petroleum), sweetened;

Kerosine — unspecified;

[A complex combination of hydrocarbons obtained by subjecting a petroleum distillate to a sweetening process to convert mercaptans or to remove acidic impurities. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C9 through C16 and boiling in the range of 130 oC to 290 oC (266 oF to 554 oF).]
294-799-591770-15-9Asp. Tox. 1H304GHS08

Dgr
H304H
649-428-00-5Kerosine (petroleum), solvent-refined sweetened;

Kerosine — unspecified;

[A complex combination of hydrocarbons obtained from a petroleum stock by solvent refining and sweetening and boiling in the range of approximately 150 oC to 260 oC (302 oF to 500 oF).]
295-416-492045-36-8Asp. Tox. 1H304GHS08

Dgr
H304H
649-429-00-0Hydrocarbons, C9-16, hydrotreated, dearomatized;

Kerosine — unspecified;

[A complex combination of hydrocarbons obtained as solvents which have been subjected to hydrotreatment in order to convert aromatics to naphthenes by catalytic hydrogenation.]
297-854-193763-35-0Asp. Tox. 1H304GHS08

Dgr
H304H
649-430-00-6Kerosine (petroleum), solvent-refined hydrodesulfurized;

Kerosine — unspecified
307-033-297488-94-3Asp. Tox. 1H304GHS08

Dgr
H304H
649-431-00-1Distillates (petroleum), hydrodesulfurized full-range middle coker;

Kerosine — unspecified;

[A complex combination of hydrocarbons obtained by fractionation from hydrodesulfurized coker distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C8 through C16 and boiling in the range of approximately 120 oC to 283 oC (248 oF to 541 oF).]
309-864-6101316-58-9Asp. Tox. 1H304GHS08

Dgr
H304H
649-432-00-7Solvent naphtha (petroleum), hydrodesulfurized heavy arom.;

Kerosine — unspecified;

[A complex combination of hydrocarbons obtained by the catalytic hydrodesulfurization of a petroleum fraction. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C10 through C13 and boiling in the range of approximately 180 oC to 240 oC (356 oF to 464 oF).]
309-882-4101316-81-8Asp. Tox. 1H304GHS08

Dgr
H304H
649-433-00-2Solvent naphtha (petroleum), hydrodesulfurized medium;

Kerosine — unspecified;

[A complex combination of hydrocarbons obtained by the catalytic hydrodesulfurization of a petroleum fraction. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C10 through C13 and boiling in the range of approximately 175 oC to 220 oC (347 oF to 428 oF).]
309-884-5101316-82-9Asp. Tox. 1H304GHS08

Dgr
H304H
649-434-00-8Kerosine (petroleum), hydrotreated;

Kerosine — unspecified;

[A complex combination of hydrocarbons obtained from the distillation of petroleum and subsequent hydrotreatment. It consists predominantly of alkanes, cycloalkanes and alkylbenzenes having carbon numbers predominantly in the range of C12 through C16 and boiling in the range of approximately 230 oC to 270 oC (446 oF to 518 oF).]
309-944-0101631-19-0Asp. Tox. 1H304GHS08

Dgr
H304H
649-435-00-3Distillates (petroleum), light catalytic cracked;

Cracked gasoil;

[A complex combination of hydrocarbons produced by the distillation of products from a catalytic cracking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C9 through C25 and boiling in the range of approximately 150 oC to 400 oC (302 oF to 752 oF). It contains a relatively large proportion of bicyclic aromatic hydrocarbons.]
265-060-464741-59-9Carc. 1BH350GHS08

Dgr
H350H
649-436-00-9Distillates (petroleum), intermediate catalytic cracked;

Cracked gasoil;

[A complex combination of hydrocarbons produced by the distillation of products from a catalytic cracking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C11 through C30 and boiling in the range of approximately 205 oC to 450 oC (401 oF to 842 oF). It contains a relatively large proportion of tricyclic aromatic hydrocarbons.]
265-062-564741-60-2Carc. 1BH350GHS08

Dgr
H350H
649-437-00-4Distillates (petroleum), light hydrocracked;

Cracked gasoil;

[A complex combination of hydrocarbons from distillation of the products from a hydrocracking process. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C10 through C18 and boiling in the range of approximately 160 oC to 320 oC (320 oF to 608 oF).]
265-078-264741-77-1Carc. 2H351GHS08

Wng
H351H
649-438-00-XDistillates (petroleum), light thermal cracked;

Cracked gasoil;

[A complex combination of hydrocarbons from the distillation of the products from a thermal cracking process. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C10 through C22 and boiling in the range of approximately 160 oC to 370 oC (320 oF to 698 oF).]
265-084-564741-82-8Carc. 1BH350GHS08

Dgr
H350H
649-439-00-5Distillates (petroleum), hydrodesulfurized light catalytic cracked;

Cracked gasoil;

[A complex combination of hydrocarbons obtained by treating light catalytic cracked distillates with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists of hydrocarbons having carbon numbers predominantly in the range of C9 through C25 and boiling in the range of approximately 150 oC to 400 oC (302 oF to 752 oF). It contains a relatively large proportion of bicyclic aromatic hydrocarbons.]
269-781-568333-25-5Carc. 1BH350GHS08

Dgr
H350H
649-440-00-0Distillates (petroleum), light steam-cracked naphtha;

Cracked gasoil;

[A complex combination of hydrocarbons from the multiple distillation of products from a steam cracking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C10 through C18.]
270-662-568475-80-9Carc. 1BH350GHS08

Dgr
H350H
649-441-00-6Distillates (petroleum), cracked steam-cracked petroleum distillates;

Cracked gasoil;

[A complex combination of hydrocarbons produced by distilling cracked steam cracked distillate and/or its fractionation products. It consists of hydrocarbons having carbon numbers predominently in the range of C10 to low molecular weight polymers.]
270-727-868477-38-3Carc. 1BH350GHS08

Dgr
H350H
649-442-00-1Gas oils (petroleum), steam-cracked;

Cracked gasoil;

[A complex combination of hydrocarbons produced by distillation of the products from a steam cracking process. It consists of hydrocarbons having carbon numbers predominantly greater than C9 and boiling in the range of from approximately 205 oC to 400 oC (400 oF to 752 oF).]
271-260-268527-18-4Carc. 1BH350GHS08

Dgr
H350H
649-443-00-7Distillates (petroleum), hydrodesulfurized thermal cracked middle;

Cracked gasoil;

[A complex combination of hydrocarbons obtained by fractionation from hydrodesulfurized themal cracker distillate stocks. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C11 to C25 and boiling in the range of approximately 205 oC to 400 oC (401 oF to 752 oF).]
285-505-685116-53-6Carc. 1BH350GHS08

Dgr
H350H
649-444-00-2Gas oils (petroleum), thermal-cracked, hydrodesulfurized;

Cracked gasoil
295-411-792045-29-9Carc. 1BH350GHS08

Dgr
H350H
649-445-00-8Residues (petroleum), hydrogenated steam-cracked naphtha;

Cracked gasoil;

[A complex combination of hydrocarbons obtained as a residual fraction from the distillation of hydrotreated steam-cracked naphtha. It consists predominantly of hydrocarbons boiling in the range of approximately 200 oC to 350 oC (32 oF to 662 oF).]
295-514-792062-00-5Carc. 1BH350GHS08

Dgr
H350H
649-446-00-3Residues (petroleum), steam-cracked naphtha distn.;

Cracked gasoil;

[A complex combination of hydrocarbons obtained as a column bottom from the separation of effluents from steam cracking naphtha at a high temperature. It boils in the range of approximately 147 oC to 300 oC (297 oF to 572 oF) and produces a finished oil having a viscosity of 18cSt at 50 oC.]
295-517-392062-04-9Carc. 1BH350GHS08

Dgr
H350H
649-447-00-9Distillates (petroleum), light catalytic cracked, thermally degraded;

Cracked gasoil;

[A complex combination of hydrocarbons produced by the distillation of products from a catalytic cracking process which has been used as a heat transfer fluid. It consists predominantly of hydrocarbons boiling in the range of approximately 190 oC to 340 oC (374 oF to 644 oF). This stream is likely to contain organic sulfur compounds.]
295-991-192201-60-0Carc. 1BH350GHS08

Dgr
H350H
649-448-00-4Residues (petroleum), steam-cracked heat-soaked naphtha;

Cracked gasoil;

[A complex combination of hydrocarbons obtained as residue from the distillation of steam cracked heat soaked naphtha and boiling in the range of approximately 150 oC to 350 oC (302 oF to 662 oF).]
297-905-893763-85-0Carc. 1BH350GHS08

Dgr
H350H
649-449-00-XHydrocarbons, C16-20, solvent-dewaxed hydrocracked paraffinic distn. residue;

Cracked gasoil;

[A complex combination of hydrocarbons obtained by solvent dewaxing of a distillation residue from a hydrocracked paraffinic distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C16 through C20 and boiling in the range of approximately 360 oC to 500 oC (680 oF to 932 oF). It produces a finished oil having a viscosity of 4,5 cSt at approximately 100 oC (212 oF).]
307-662-297675-88-2Carc. 2H351GHS08

Wng
H351H
649-450-00-5Gas oils (petroleum), light vacuum, thermal-cracked hydrodesulfurized;

Cracked gasoil;

[A complex combination of hydrocarbons obtained by catalytic dehydrosulfurization of thermal-cracked light vacuum petroleum. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C14 through C20 and boiling in the range of approximately 270 oC to 370 oC (518 oF to 698 oF).]
308-278-897926-59-5Carc. 1BH350GHS08

Dgr
H350H
649-451-00-0Distillates (petroleum), hydrodesulfurized middle coker;

Cracked gasoil;

[A complex combination of hydrocarbons by fractionation from hydrodesulfurised coker distillate stocks. Is consists of hydro-carbons having carbon numbers predominantly in the range of C12 through C21 and boiling in the range of approximately 200 oC to 360 oC (392 oF to 680 oF).]
309-865-1101316-59-0Carc. 1BH350GHS08

Dgr
H350H
649-452-00-6Distillates (petroleum), heavy steam-cracked;

Cracked gasoil;

[A complex combination of hydrocarbons obtained by distillation of steam cracking heavy residues. It consists predominantly of highly alkylated heavy aromatic hydrocarbons boiling in the range of approximately 250 oC to 400 oC (482 oF to 752 oF).]
309-939-3101631-14-5Carc. 1BH350GHS08

Dgr
H350H
649-453-00-1Distillates (petroleum), heavy hydrocracked;

Baseoil — unspecified;

[A complex combination of hydrocarbons from the distillation of the products from a hydrocracking process. It consists predominantly of saturated hydrocarbons having carbon numbers in the range of C15-C39 and boiling in the range of approximately 260 oC to 600 oC (500 oF to 1112 oF).]
265-077-764741-76-0Carc. 1BH350GHS08

Dgr
H350H L
649-454-00-7Distillates (petroleum), solvent-refined heavy paraffinic;

Baseoil — unspecified;

[A complex combination of hydrocarbons obtained as the raffinate from a solvent extraction process. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100 oF (19cSt at 40 oC).]
265-090-864741-88-4Carc. 1BH350GHS08

Dgr
H350H L
649-455-00-2Distillates (petroleum), solvent-refined light paraffinic;

Baseoil — unspecified;

[A complex combination of hydrocarbons obtained as the raffinate from a solvent extraction process. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC).]
265-091-364741-89-5Carc. 1BH350GHS08

Dgr
H350H L
649-456-00-8Residual oils (petroleum), solvent deasphalted;

Baseoil — unspecified;

[A complex combination of hydrocarbons obtained as the solvent soluble fraction from C3-C4 solvent deasphalting of a residuum. It consists of hydrocarbons having carbon numbers predominantly higher than C25 and boiling above approximately 400 oC (752 oF).]
265-096-064741-95-3Carc. 1BH350GHS08

Dgr
H350H L
649-457-00-3Distillates (petroleum), solvent-refined heavy naphthenic;

Baseoil — unspecified;

[A complex combination of hydrocarbons obtained as the raffinate from a solvent extraction process. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100 oF (19cSt a 40 oC). It contains relatively few normal paraffins.]
265-097-664741-96-4Carc. 1BH350GHS08

Dgr
H350H L
649-458-00-9Distillates (petroleum), solvent-refined light naphthenic;

Baseoil — unspecified;

[A complex combination of hydrocarbons obtained as the raffinate from a solvent extraction process. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.]
265-098-164741-97-5Carc. 1BH350GHS08

Dgr
H350H L
649-459-00-4Residual oils (petroleum,) solvent-refined;

Baseoil — unspecified;

[A complex combination by hydrocarbons obtained as the solvent insoluble fraction from solvent refining of a residuum using a polar organic solvent such as phenol or furfural. It consists of hydrocarbons having carbon numbers predominantly higher than C25 and boiling above approximately 400 oC (752 oF).]
265-101-664742-01-4Carc. 1BH350GHS08

Dgr
H350H L
649-460-00-XDistillates (petroleum), clay-treated paraffinic;

Baseoil — unspecified;

[A complex combination of hydrocarbons resulting from treatment of a petroleum fraction with natural or modified clay in either a contacting or percolation process to remove the trace amounts of polar compounds and impurities present. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100 oF (19cSt at 40 oC). It contains a relatively large proportion of saturated hydrocarbons.]
265-137-264742-36-5Carc. 1BH350GHS08

Dgr
H350H L
649-461-00-5Distillates (petroleum), clay-treated light paraffinic;

Baseoil — unspecified;

[A complex combination of hydrocarbons resulting from treatment of a petroleum fraction with natural or modified clay in either a contacting or percolation process to remove the trace amounts of polar compounds and impurities present. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC). It contains a relatively large proportion of saturated hydrocarbons.]
265-138-864742-37-6Carc. 1BH350GHS08

Dgr
H350H L
649-462-00-0Residual oils (petroleum), clay-treated;

Baseoil — unspecified;

[A complex combination of hydrocarbons obtained by treatment of a residual oil with a natural or modified clay in either a contacting or percolation process to remove the trace amounts of polar compounds and impurities present. It consists of hydro-carbons having carbon numbers predominantly higher than C25 and boiling above approximately 400 oC (752 oF).]
265-143-564742-41-2Carc. 1BH350GHS08

Dgr
H350H L
649-463-00-6Distillates (petroleum), clay-treated heavy naphthenic;

Baseoil — unspecified;

[A complex combination of hydrocarbons resulting from treatment of a petroleum fraction with natural or modified clay in either a contacting or percolation process to remove the trace amounts of polar compounds and impurities present. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.]
265-146-164742-44-5Carc. 1BH350GHS08

Dgr
H350H L
649-464-00-1Distillates (petroleum), clay-treated light naphthenic;

Baseoil — unspecified;

[A complex combination of hydrocarbons resulting from treatment of a petroleum fraction with natural or modified clay in either a contacting or percolation process to remove the trace amounts of polar compounds and impurities present. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.]
265-147-764742-45-6Carc. 1BH350GHS08

Dgr
H350H L
649-465-00-7Distillates (petroleum), hydrotreated heavy naphthenic;

Baseoil — unspecified;

[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil of at least 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.]
265-155-064742-52-5Carc. 1BH350GHS08

Dgr
H350H L
649-466-00-2Distillates (petroleum), hydrotreated light naphthenic;

Baseoil — unspecified;

[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.]
265-156-664742-53-6Carc. 1BH350GHS08

Dgr
H350H L
649-467-00-8Distillates (petroleum), hydrotreated heavy paraffinic;

Baseoil — unspecified;

[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil of at least 100 SUS at 100 oF (19cSt at 40 oC). It contains a relatively large proportion of saturated hydrocarbons.]
265-157-164742-54-7Carc. 1BH350GHS08

Dgr
H350H L
649-468-00-3Distillates (petroleum), hydrotreated light paraffinic;

Baseoil — unspecified;

[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC). It contains a relatively large proportion of saturated hydrocarbons.]
265-158-764742-55-8Carc. 1BH350GHS08

Dgr
H350H L
649-469-00-9Distillates (petroleum), solvent-dewaxed light paraffinic;

Baseoil — unspecified;

[A complex comination of hydrocarbons obtained by removal of normal paraffins from a petroleum fraction by solvent crystallization. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC).]
265-159-264742-56-9Carc. 1BH350GHS08

Dgr
H350H L
649-470-00-4Residual oils (petroleum), hydrotreated;

Baseoil — unspecified;

[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly greater than C25 and boiling above approximately 400 oC (752 oF).]
265-160-864742-57-0Carc. 1BH350GHS08

Dgr
H350H L
649-471-00-XResidual oils (petroleum), solvent-dewaxed;

Baseoil — unspecified;

[A complex combination of hydrocarbons obtained by removal of long, branched chain hydrocarbons from a residual oil by solvent crystallization. It consists of hydrocarbons having carbon numbers predominantly greater than C25 and boiling above approximately 400 oC (752 oF).]
265-166-064742-62-7Carc. 1BH350GHS08

Dgr
H350H L
649-472-00-5Distillates (petroleum), solvent-dewaxed heavy naphthenic;

Baseoil — unspecified;

[A complex combination of hydrocarbons obtained by removal of normal paraffins from a petroleum fraction by solvent crystallization. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 . through C50 and produces a finished oil of not less than 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.]
265-167-664742-63-8Carc. 1BH350GHS08

Dgr
H350H L
649-473-00-0Distillates (petroleum), solvent-dewaxed light naphthenic;

Baseoil — unspecified;

[A complex combination of hydrocarbons obtained by removal of normal paraffins from a petroleum fraction by solvent crystallization. It consists of hydrocarbons having carbon numbers predominantly in the range C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.]
265-168-164742-64-9Carc. 1BH350GHS08

Dgr
H350H L
649-474-00-6Distillates (petroleum), solvent-dewaxed heavy paraffinic;

Baseoil — unspecified;

[A complex combination of hydrocarbons obtained by removal of normal paraffins from a petroleum fraction by solvent crystallization. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity not less than 100 SUS at 100 oF (19cSt at 40 oC).]
265-169-764742-65-0Carc. 1BH350GHS08

Dgr
H350H L
649-475-00-1Naphthenic oils (petroleum), catalytic dewaxed heavy;

Baseoil — unspecified;

[A complex combination of hydrocarbons obtained from a catalytic dewaxing process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.]
265-172-364742-68-3Carc. 1BH350GHS08

Dgr
H350H L
649-476-00-7Naphthenic oils (petroleum), catalytic dewaxed light;

Baseoil — unspecified;

[A complex combination of hydrocarbons obtained from a catalytic dewaxing process. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity less than 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.]
265-173-964742-69-4Carc. 1BH350GHS08

Dgr
H350H L
649-477-00-2Paraffin oils (petroleum), catalytic dewaxed heavy;

Baseoil — unspecified;

[A complex combination of hydrocarbons obtained from a catalytic dewaxing process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100 oF (19cSt at 40 oC).]
265-174-464742-70-7Carc. 1BH350GHS08

Dgr
H350H L
649-478-00-8Paraffin oils (petroleum), catalytic dewaxed light;

Baseoil — unspecified;

[A complex combination of hydrocarbons obtained from a catalytic dewxing process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC).]
265-176-564742-71-8Carc. 1BH350GHS08

Dgr
H350H L
649-479-00-3Naphthenic oils (petroleum), complex dewaxed heavy;

Baseoil — unspecified;

[A complex combination of hydrocarbons obtained by removing straight chain paraffin hydrocarbons as a solid by treatment with an agent such as urea. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil having a viscosity of at least 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.]
265-179-164742-75-2Carc. 1BH350GHS08

Dgr
H350H L
649-480-00-9Naphthenic oils (petroleum), complex dewaxed light;

Baseoil — unspecified;

[A complex combination of hydrocarbons obtained from a catalytic dewaxing process. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil having a viscosity less than 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.]
265-180-764742-76-3Carc. 1BH350GHS08

Dgr
H350H L
649-481-00-4Lubricating oils (petroleum), C20-50, hydrotreated neutral oil-based, high-viscosity;

Baseoil — unspecified;

[A complex combination of hydrocarbons obtained by treating light vacuum gas oil, heavy vacuum gas oil, and solvent deasphalted residual oil with hydrogen in the presence of a catalyst in a two stage process with dewaxing being carried out between the two stages. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil having a viscosity of approximately 112cSt at 40 oC. It contains a relatively large proportion of saturated hydrocarbons.]
276-736-372623-85-9Carc. 1BH350GHS08

Dgr
H350H L
649-482-00-XLubricating oils (petroleum), C15-30, hydrotreated neutral oil-based;

Baseoil — unspecified;

[A complex combination of hydrocarbons obtained by treating light vacuum gas oil and heavy vacuum gas oil with hydrogen in the presence of a catalyst in a two stage process with dewaxing being carried out between the two stages. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil having a viscosity of approximately 15cSt at 40 oC. It contains a relatively large proportion of saturated hydrocabons.]
276-737-972623-86-0Carc. 1BH350GHS08

Dgr
H350H L
649-483-00-5Lubricating oils (petroleum), C20-50, hydrotreated neutral oil-based;

Baseoil — unspecified;

[A complex combination of hydrocarbons obtained by treating light vacuum gas oil, heavy vacuum gas oil and solvent deasphalted residual oil with hydrogen in the presence of a catalyst in a two stage process with dewaxing being carried out between the two stages. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of approximately 32cSt at 40 oC. It contains a relatively large proportion of saturated hydrocarbons.]
276-738-472623-87-1Carc. 1BH350GHS08

Dgr
H350H L
649-484-00-0Lubricating oils;

Baseoil — unspecified;

[A complex combination of hydrocarbons obtained from solvent extraction and dewaxing processes. It consists predominantly of saturated hydrocarbons having carbon numbers in the range C15 through C50.]
278-012-274869-22-0Carc. 1BH350GHS08

Dgr
H350H L
649-485-00-6Distillates (petroleum), complex dewaxed heavy paraffinci;

Baseoil — unspecified;

[A complex combination of hydrocarbons obtained by dewaxing heavy paraffinic distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of equal to or greater than 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.]
292-613-790640-91-8Carc. 1BH350GHS08

Dgr
H350H L
649-486-00-1Distillates (petroleum), complex dewaxed light paraffinic;

Baseoil — unspecified;

[A complex combination of hydrocarbons obtained by dewaxing light paraffinic distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C12 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.]
292-614-290640-92-9Carc. 1BH350GHS08

Dgr
H350H L
649-487-00-7Distillates (petroleum), solvent dewaxed heavy paraffinic, clay-treated;

Baseoil — unspecified;

[A complex combination of hydrocarbons obtained by treating dewaxed heavy paraffinic distillate with neutral or modified clay in either a contacting or percolation process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C50.]
292-616-390640-94-1Carc. 1BH350GHS08

Dgr
H350H L
649-488-00-2Hydrocarbons, C20-50, solvent dewaxed heavy paraffinic, hydrotreated;

Baseoil — unspecified;

[A complex combination of hydrocarbons produced by treating dewaxed heavy paraffinic distillate with hydrogen in the presence of a catalyst. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C50.]
292-617-990640-95-2Carc. 1BH350GHS08

Dgr
H350H L
649-489-00-8Distillates (petroleum), solvent dewaxed light paraffinic, clay-treated;

Baseoil — unspecified;

[A complex combination of hydrocarbons resulting from treatment of dewaxed light paraffinic distillate with natural or modified clay in either a contacting or percolation process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C15 through C30.]
292-618-490640-96-3Carc. 1BH350GHS08

Dgr
H350H L
649-490-00-3Distillates (petroleum), solvent dewaxed light paraffinic, hydrotreated;

Baseoil — unspecified;

[A complex combination of hydrocarbons produced by treating a dewaxed light paraffinic distillate with hydrogen in the presence of a catalyst. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C15 through C30.]
292-620-590640-97-4Carc. 1BH350GHS08

Dgr
H350H L
649-491-00-9Residual oils (petroleum), hydrotreated solvent dewaxed;

Baseoil — unspecified
292-656-190669-74-2Carc. 1BH350GHS08

Dgr
H350H L
649-492-00-4Residual oils (petroleum), catalytic dewaxed;

Baseoil — unspecified
294-843-391770-57-9Carc. 1BH350GHS08

Dgr
H350H L
649-493-00-XDistillates (petroleum), dewaxed heavy paraffinic, hydrotreated;

Baseoil — unspecified;

[A complex combination of hydrocarbons obtained from an intensive treatment of dewaxed distillate by hydrogenation in the presence of a catalyst. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C25 through C39 and produces a finished oil with a viscosity of approximately 44 cSt at 50 oC.]
295-300-391995-39-0Carc. 1BH350GHS08

Dgr
H350H L
649-494-00-5Distillates (petroleum), dewaxed light paraffinic, hydrotreated;

Baseoil — unspecified;

[A complex combination of hydrocarbons obtained from an intensive treatment of dewaxed distillate by hydrogenation in the presence of a catalyst. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C21 through C29 and produces a finished oil with a viscosity of approximately 13 cSt at 50 oC.]
295-301-991995-40-3Carc. 1BH350GHS08

Dgr
H350H L
649-495-00-0Distillates (petroleum), hydrocracked solvent-refined, dewaxed;

Baseoil — unspecified;

[A complex combination of liquid hydrocarbons obtained by recrystallization of dewaxed hydrocracked solvent-refined petroleum distillates.]
295-306-691995-45-8Carc. 1BH350GHS08

Dgr
H350H L
649-496-00-6Distillates (petroleum), solvent-refined light naphthenic, hydrotreated;

Baseoil — unspecified;

[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst and removing the aromatic hydrocarbons by solvent extraction. It consists predominantly of naphthenic hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of between 13-15cSt at 40 oC.]
295-316-091995-54-9Carc. 1BH350GHS08

Dgr
H350H L
649-497-00-1Lubricating oils (petroleum), C17-35, solvent-extd., dewaxed, hydrotreated;

Baseoil — unspecified
295-423-292045-42-6Carc. 1BH350GHS08

Dgr
H350H L
649-498-00-7Lubricating oils (petroleum), hydrocracked nonarom. solvent-deparaffined;

Baseoil — unspecified
295-424-892045-43-7Carc. 1BH350GHS08

Dgr
H350H L
649-499-00-2Residual oils (petroleum), hydrocracked acid-treated solvent-dewaxed;

Baseoil — unspecified;

[A complex combination of hydrocarbons produced by solvent removal of paraffins from the residue of the distillation of acid-treated, hydrocracked heavy paraffins and boiling approximately above 380 oC (716 oF).]
295-499-792061-86-4Carc. 1BH350GHS08

Dgr
H350H L
649-500-00-6Paraffin oils (petroleum), solvent-refined dewaxed heavy;

Baseoil — unspecified;

[A complex combination of hydrocarbons obtained from sulfur-containing paraffinic crude oil. It consists predominantly of a solvent refined deparaffinated lubricating oil with a viscosity of 65cSt at 50 oC.]
295-810-692129-09-4Carc. 1BH350GHS08

Dgr
H350H L
649-501-00-1Lubricating oils (petroleum), base oils, paraffinic;

Baseoil — unspecified;

[A complex combination of hydrocarbons obtained by refining of crude oil. It consists predominantly of aromatics, naphthenics and paraffinics and produces a finished oil with a viscosity of 120 SUS at 100 oF (23cSt at 40 oC).]
297-474-693572-43-1Carc. 1BH350GHS08

Dgr
H350H L
649-502-00-7Hydrocarbons, hydrocracked paraffinic distn. residues, solvent-dewaxed;

Baseoil — unspecified
297-857-893763-38-3Carc. 1BH350GHS08

Dgr
H350H L
649-503-00-2Hydrocarbons, C20-50, residual oil hydrogenation vacuum distillate;

Baseoil — unspecified
300-257-193924-61-9Carc. 1BH350GHS08

Dgr
H350H L
649-504-00-8Distillates (petroleum), solvent-refined hydrotreated heavy;

hydrogenated;

Baseoil — unspecified
305-588-594733-08-1Carc. 1BH350GHS08

Dgr
H350H L
649-505-00-3Distillates (petroleum), solvent-refined hydrocracked light;

Baseoil — unspecified;

[A complex combination of hydrocarbons obtained by solvent dearomatization of the residue of hydrocracked petroleum. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C18 through C27 and boiling in the range of approximately 370 oC to 450 oC (698 oF to 842 oF).]
305-589-094733-09-2Carc. 1BH350GHS08

Dgr
H350H L
649-506-00-9Lubricating oils (petroleum), C18-40, solvent-dewaxed hydrocracked distillate-based;

Baseoil — unspecified;

[A complex combination of hydrocarbons obtained by solvent deparaffination of the distillation residue from hydrocracked petroleum. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C18 through C40 and boiling in the range of approximately 370 oC to 550 oC (698 oF to 1022 oF).]
305-594-894733-15-0Carc. 1BH350GHS08

Dgr
H350H L
649-507-00-4Lubricating oils (petroleum), C18-40, solvent-dewaxed hydrogenated raffinate-based;

Baseoil — unspecified;

[A complex combination of hydrocarbons obtained by solvent deparaffination of the hydrogenated raffinate obtained by solvent extraction of a hydrotreated petroleum distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C18 through C40 and boiling in the range of approximately 370 oC to 550 oC (698 oF to 1022 oF).]
305-595-394733-16-1Carc. 1BH350GHS08

Dgr
H350H L
649-508-00-XHydrocarbons, C13-30, arom.-rich, solvent-extd. naphthenic distillate;

Baseoil — unspecified
305-971-795371-04-3Carc. 1BH350GHS08

Dgr
H350H L
649-509-00-5Hydrocarbons, C16-32, arom. rich, solvent-extd. naphthenic distillate;

Baseoil — unspecified
305-972-295371-05-4Carc. 1BH350GHS08

Dgr
H350H L
649-510-00-0Hydrocarbons, C37-68, dewaxed deasphalted hydrotreated vacuum distn. residues;

Baseoil — unspecified
305-974-395371-07-6Carc. 1BH350GHS08

Dgr
H350H L
649-511-00-6Hydrocarbons, C37-65, hydrotreated deasphalted vacuum distn. residues;

Baseoil — unspecified
305-975-995371-08-7Carc. 1BH350GHS08

Dgr
H350H L
649-512-00-1Distillates (petroleum), hydrocracked solvent-refined light;

Baseoil — unspecified;

[A complex combination of hydrocarbons obtained by the solvent treatment of a distillate from hydrocracked petroleum distillates. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C18 through C27 and boiling in the range of approximately 370 oC to 450 oC (698 oF to 842 oF.]
307-010-797488-73-8Carc. 1BH350GHS08

Dgr
H350H L
649-513-00-7Distillates (petroleum), solvent-refined hydrogenated heavy;

Baseoil — unspecified;

[A complex combination of hydrocarbons, obtained by the treatment of a hydrogenated petroleum distillate with a solvent. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C19 through C40 and boiling in the range of approximately 390 oC to 550 oC (734 oF to 1022 oF).]
307-011-297488-74-9Carc. 1BH350GHS08

Dgr
H350H L
649-514-00-2Lubricating oils (petroleum), C18-27, hydrocracked solvent-dewaxed;

Baseoil — unspecified
307-034-897488-95-4Carc. 1BH350GHS08

Dgr
H350H L
649-515-00-8Hydrocarbons, C17-30, hydrotreated solvent-deasphalted atm. distn. residue, distn. lights;

Baseoil — unspecified;

[A complex combination of hydrocarbons obtained as first runnings from the vacuum distillation of effluents from the treatment of a solvent deasphalted short residue with hydrogen in the presence of a catalyst. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C17 through C30 and boiling in the range of approximately 300 oC to 400 oC (572 oF to 752 oF). It produces a finished oil having a viscosity of 4cSt at approximately 100 oC (212 oF).]
307-661-797675-87-1Carc. 1BH350GHS08

Dgr
H350H L
649-516-00-3Hydrocarbons, C17-40, hydrotreated solvent-deasphalted distn. residue, vacuum distn. lights;

Baseoil — unspecified;

[A complex combination of hydrocarbons obtained as first runnings from the vacuum distillation of effluents from the catalytic hydrotreatment of a solvent deasphalted short residue having a viscosity of 8cSt at approximately 100 oC (212 oF). It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C17 through C40 and boiling in the range of approximately 300 oC to 500 oC (592 oF to 932 oF).]
307-755-897722-06-0Carc. 1BH350GHS08

Dgr
H350H L
649-517-00-9Hydrocarbons, C13-27, solvent-extd. light naphthenic;

Baseoil — unspecified;

[A complex combination of hydrocarbons obtained by extraction of the aromatics from a light naphthenic distillate having a viscosity of 9.5cSt at 40 oC (104 oF). It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C13 through C27 and boiling in the range of approximately 240 oC to 400 oC (464 oF to 752 oF).]
307-758-497722-09-3Carc. 1BH350GHS08

Dgr
H350H L
649-518-00-4Hydrocarbons, C14-29, solvent-extd. light naphthenic;

Baseoil — unspecified;

[A complex combination of hydrocarbons obtained by extraction of the aromatics from a light naphthenic distillate having a viscosity of 16cSt at 40 oC (104 oF). It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C14 through C29 and boiling in the range of approximately 250 oC to 425 oC (482 oF to 797 oF).]
307-760-597722-10-6Carc. 1BH350GHS08

Dgr
H350H L
649-519-00-XHydrocarbons, C27-42, dearomatized;

Baseoil — unspecified
308-131-897862-81-2Carc. 1BH350GHS08

Dgr
H350H L
649-520-00-5Hydrocarbons, C17-30, hydrotreated distillates, distn. lights;

Baseoil — unspecified
308-132-397862-82-3Carc. 1BH350GHS08

Dgr
H350H L
649-521-00-0Hydrocarbons, C27-45, naphthenic vacuum distn.;

Baseoil — unspecified
308-133-997862-83-4Carc. 1BH350GHS08

Dgr
H350H L
649-522-00-6Hydrocarbons, C27-45, dearomatized;

Baseoil — unspecified
308-287-797926-68-6Carc. 1BH350GHS08

Dgr
H350H L
649-523-00-1Hydrocarbons, C20-58, hydrotreated;

Baseoil — unspecified
308-289-897926-70-0Carc. 1BH350GHS08

Dgr
H350H L
649-524-00-7Hydrocarbons, C27-42, naphthenic;

Baseoil — unspecified
308-290-397926-71-1Carc. 1BH350GHS08

Dgr
H350H L
649-525-00-2Residual oils (petroleum), carbon-treated solvent-dewaxed;

Baseoil — unspecified;

[A complex combination of hydrocarbons obtained by the treatment of solvent-dewaxed petroleum residual oils with activated charcoal for the removal of trace polar constituents and impurities.]
309-710-8100684-37-5Carc. 1BH350GHS08

Dgr
H350H L
649-526-00-8Residual oils (petroleum), clay-treated solvent-dewaxed;

Baseoil — unspecified;

[A complex combination of hydrocarbons obtained by treatment of solvent-dewaxed petroleum residual oils with bleaching earth for the removal of trace polar constituents and impurities.]
309-711-3100684-38-6Carc. 1BH350GHS08

Dgr
H350H L
649-527-00-3Lubricating oils (petroleum), C>25, solvent-extd., deasphalted, dewaxed, hydrogenated;

Baseoil — unspecified;

[A complex combination of hydrocarbons obtained by solvent extraction and hydrogenation of vacuum distillation residues. It consists predominantly of hydrocarbons having carbon numbers predominantly greater than C25 and produces a finished oil with a viscosity in the order of 32cSt to 37cSt at 100 oC (212 oF).]
309-874-0101316-69-2Carc. 1BH350GHS08

Dgr
H350H L
649-528-00-9Lubricating oils (petroleum), C17-32, solvent-extd., dewaxed, hydrogenated;

Baseoil — unspecified;

[A complex combination of hydrocarbons obtained by solvent extraction and hydrogenation of atmospheric distillation residues. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C17 through C32 and produced a finished oil with a viscosity in the order of 17cSt to 23cSt at 40 oC (104 oF.]
309-875-6101316-70-5Carc. 1BH350GHS08

Dgr
H350H L
649-529-00-4Lubricating oils (petroleum), C20-35, solvent-extd., dewaxed, hydrogenated;

Baseoil — unspecified;

[A complex combination of hydrocarbons obtained by solvent extraction and hydrogenation of atmospheric distillation residues. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C35 and produces a finished oil with a viscosity in the order of 37cSt to 44cSt at 40 oC (104 oF).]
309-876-1101316-71-6Carc. 1BH350GHS08

Dgr
H350H L
649-530-00-XLubricating oils (petroleum), C24-50, solvent-extd., dewaxed, hydrogenated;

Baseoil — unspecified;

[A complex combination of hydrocarbons obtained by solvent extraction and hydrogenation of atmospheric distillation residues. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C24 through C50 and produces a finished oil with a viscosity in the order of 16cSt to 75cSt at 40 oC (104 oF).]
309-877-7101316-72-7Carc. 1BH350GHS08

Dgr
H350H L
649-531-00-5Extracts (petroleum), heavy naphthenic distillate solvent, arom. conc.;

Distillate aromatic extract (treated);

[An aromatic concentrate produced by adding water to heavy naphthenic distillate solvent extract and extraction solvent.]
272-175-368783-00-6Carc. 1BH350GHS08

Dgr
H350H L
649-532-00-0Extracts (petroleum), solvent-refined heavy paraffinic distillate solvent;

Distillate aromatic extract (treated);

[A complex combination of hydrocarbons obtained as the extract from the re-extraction of solvent-refined heavy paraffinic distillate. It consists of saturated and aromatic hydrocarbons having carbon numbers predominantly in the range of C20 through C50.]
272-180-068783-04-0Carc. 1BH350GHS08

Dgr
H350H L
649-533-00-6Extracts (petroleum), heavy paraffinic distillates, solvent-deasphalted;

Distillate aromatic extract (treated);

[A complex combination of hydrocarbons obtained as the extract from a solvent extraction of heavy paraffinic distillate.]
272-342-068814-89-1Carc. 1BH350GHS08

Dgr
H350H L
649-534-00-1Extracts (petroleum), heavy naphthenic distillate solvent, hydrotreated;

Distillate aromatic extract (treated);

[A complex combination of hydrocarbons obtained by treating a heavy naphthenic distillate solvent extract with hydrogen in the presence of a catalyst. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil of at least 19cSt at 40 oC (100 SUS at 100 oF).]
292-631-590641-07-9Carc. 1BH350GHS08

Dgr
H350H L
649-535-00-7Extracts (petroleum), heavy paraffinic distillate solvent, hydrotreated;

Distillate aromatic extract (treated);

[A complex combination of hydrocarbons produced by treating a heavy paraffinic distillate solvent extract with hydrogen in the presence of a catalyst. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C21 through C33 and boiling in the range of approximately 350 oC to 480 oC (662 oF to 896 oF).
292-632-090641-08-0Carc. 1BH350GHS08

Dgr
H350H L
649-536-00-2Extracts (petroleum), light paraffinic distillate solvent, hydrotreated;

Distillate aromatic extract (treated);

[A complex combination of hydrocarbons produced by treating a light paraffinic distillate solvent extract with hydrogen in the presence of a catalyst. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C17 through C26 and boiling in the range of approximately 280 oC to 400 oC (536 oF to 752 oF).]
292-633-690641-09-1Carc. 1BH350GHS08

Dgr
H350H L
649-537-00-8Extracts (petroleum), hydrotreated light paraffinic distillate solvent;

Distillate aromatic extract (treated);

[A complex combination of hydrocarbons obtained as the extract from solvent extraction of intermediate paraffinic top solvent distillate that is treated with hydrogen in the presence of a catalyst. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C16 through C36.]
295-335-491995-73-2Carc. 1BH350GHS08

Dgr
H350H L
649-538-00-3Extracts (petroleum), light naphthenic distillate solvent, hydrodesulfurized;

Distillate aromatic extract (treated);

[A complex combination of hydrocarbons obtained by treating the extract, obtained from a solvent extraction process, with hydrogen in the presence of a catalyst under conditions primarily to remove sulfur compounds. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C15 through C30. This stream is likely to contain 5 wt.% or more of 4- to 6-membered condensed ring aromatic hydrocarbons.]
295-338-091995-75-4Carc. 1BH350GHS08

Dgr
H350H L
649-539-00-9Extracts (petroleum), light paraffinic distillate solvent, acid-treated;

Distillate aromatic extract (treated);

[A complex combination of hydrocarbons obtained as a fraction of the distillation of an extract from the solvent extraction of light paraffinic top petroleum distillates that is subjected to a sulfuric acid refining. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C16 through C32.]
295-339-691995-76-5Carc. 1BH350GHS08

Dgr
H350H L
649-540-00-4Extracts (petroleum), light paraffinic distillate solvent, hydrodesulfurized;

Distillate aromatic extract (treated);

[A complex combination of hydrocarbons obtained by solvent extraction of a light paraffin distillate and treated with hydrogen to convert the organic sulfur to hydrogen sulfide which is eliminated. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C15 through C40 and produces a finished oil with a viscosity of greater than 10cSt at 40 oC.]
295-340-191995-77-6Carc. 1BH350GHS08

Dgr
H350H L
649-541-00-XExtracts (petroleum), light vacuum gas oil solvent, hydrotreated;

Distillate aromatic extract (treated);

[A complex combination of hydrocarbons, obtained by solvent extraction from light vacuum petroleum gas oils and treated with hydrogen in the presence of a catalyst. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C13 through C30.]
295-342-291995-79-8Carc. 1BH350GHS08

Dgr
H350H L
649-542-00-5Extracts (petroleum), heavy paraffinic distillate solvent, clay-treated;

Distillate aromatic extract (treated);

[A complex combination of hydrocarbons resulting from treatment of a petroleum fraction with natural or modified clay in either a contact or percolation process to remove the trace amounts of polar compounds and impurities present. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C20 through C50. This stream is likely to contain 5 wt.% or more 4-6 membered ring aromatic hydrocarbons.]
296-437-192704-08-0Carc. 1BH350GHS08

Dgr
H350H L
649-543-00-0Extracts (petroleum), heavy naphthenic distillate solvent, hydrodesulfurized;

Distillate aromatic extract (treated);

[A complex combination of hydrocarbons obtained from a petroleum stock by treating with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C15 through C50 and produces a finished oil with a viscosity of greater than 19cSt at 40 oC.]
297-827-493763-10-1Carc. 1BH350GHS08

Dgr
H350H L
649-544-00-6Extracts (petroleum), solvent-dewaxed heavy paraffinic distillate solvent, hydrodesulfurized;

Distillate aromatic extract (treated);

[A complex combination of hydrocarbons obtained from a solvent dewaxed petroleum stock by treating with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C15 through C50 and produces a finished oil with a viscosity of greater than 19cSt at 40 oC.]
297-829-593763-11-2Carc. 1BH350GHS08

Dgr
H350H L
649-545-00-1Extracts (petroleum), light paraffinic distillate solvent, carbon-treated;

Distillate aromatic extract (treated);

[A complex combination of hydrocarbons obtained as a fraction from distillation of an extract recovered by solvent extraction of light paraffinic top petroleum distillate treated with activated charcoal to remove traces of polar constituents and impurities. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C16 through C32.]
309-672-2100684-02-4Carc. 1BH350GHS08

Dgr
H350H L
649-546-00-7Extracts (petroleum), light paraffinic distillate solvent, clay-treated;

Distillate aromatic extract (treated);

[A complex combination of hydrocarbons obtained as a fraction from distillation of an extract recovered by solvent extraction of light paraffinic top petroleum distillates treated with bleaching earth to remove traces of polar constituents and impurities. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C16 through C32.]
309-673-8100684-03-5Carc. 1BH350GHS08

Dgr
H350H L
649-547-00-2Extracts (petroleum), light vacuum, gas oil solvent, carbon-treated;

Distillate aromatic extract (treated);

[A complex combination of hydrocarbons obtained by solvent extraction of light vacuum petroleum gas oil treated with activated charcoal for the removal of trace polar constituents and impurities. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C13 through C30.]
309-674-3100684-04-6Carc. 1BH350GHS08

Dgr
H350H L
649-548-00-8Extracts (petroleum), light vacuum gas oil solvent, clay-treated;

Distillate aromatic extract (treated);

[A complex combination of hydrocarbons obtained by solvent extraction of light vacuum petroleum gas oils treated with bleaching earth for removal of trace polar constituents and impurities. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C13 through C30.]
309-675-9100684-05-7Carc. 1BH350GHS08

Dgr
H350H L
649-549-00-3Foots oil (petroleum);

Foots oil;

[A complex combination of hydrocarbons obtained as the oil fraction from a solvent deoiling or a wax sweating process. It consists predominantly of branched chain hydrocarbons having carbon numbers predominantly in the range of C20 through C50.]
265-171-864742-67-2Carc. 1BH350GHS08

Dgr
H350H L
649-550-00-9Foots oil (petroleum), hydrotreated;

Foots oil
295-394-692045-12-0Carc. 1BH350GHS08

Dgr
H350H L
650-002-00-6turpentine, oil232-350-78006-64-2Flam. Liq. 3

Acute Tox. 4 *

Acute Tox. 4 *

Acute Tox. 4 *

Asp. Tox. 1

Eye Irrit. 2

Skin Irrit. 2

Skin Sens. 1

Aquatic Chronic 2
H226

H332

H312

H302

H304

H319

H315

H317

H411
GHS02

GHS08

GHS07

GHS09

Dgr
H226

H332

H312

H302

H304

H319

H315

H317

H411
650-003-00-1fenson (ISO);

4-chlorophenyl benzenesulphonate;
201-274-680-38-6Acute Tox. 4 *

Eye Irrit. 2

Aquatic Chronic 2
H302

H319

H411
GHS07

GHS09

Wng
H302

H319

H411
650-004-00-7norbormide (ISO);

5-(α-hydroxy-α-2-pyridylbenzyl)-7-(α-2-pyridylbenzylidene)bicyclo [2.2.1] hept-5-ene-2,3-dicarboximide
213-589-6991-42-4Acute Tox. 4 *H302GHS07

Wng
H302
650-005-00-2(2R,6aS,12aS)-1,2,6,6a,12,12a-hexahydro-2-isopropenyl-8,9-dimethoxychromeno[3,4-b]furo[2,3-h]chromen-6-one, rotenone201-501-983-79-4Acute Tox. 3 *

Eye Irrit. 2

STOT SE 3

Skin Irrit. 2

Aquatic Acute 1

Aquatic Chronic 1
H301

H319

H335

H315

H400

H410
GHS06

GHS09

Dgr
H301

H319

H335

H315

H410
650-006-00-8benquinox (ISO);

p-benzoquinone 1-benzoylhydrazone 4-oxime
207-807-9495-73-8Acute Tox. 3 *

Acute Tox. 4 *
H301

H312
GHS06

Dgr
H301

H312
650-007-00-3chlordimeform (ISO);

N 2-(4-chloro-o-tolyl)-N 1,N 1-dimethylformamidine
228-200-56164-98-3Carc. 2

Acute Tox. 4 *

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1
H351

H312

H302

H400

H410
GHS08

GHS07

GHS09

Wng
H351

H312

H302

H410
650-008-00-9drazoxolon (ISO);

4-(2-chlorophenylhydrazone)-3-methyl-5-isoxazolone
227-197-85707-69-7Acute Tox. 3 *

Aquatic Acute 1

Aquatic Chronic 1
H301

H400

H410
GHS06

GHS09

Dgr
H301

H410
650-009-00-4chlordimeform hydrochloride;

N'-(4-chloro-o-tolyl)-N,N-dimethylformamidine monohydrochloride;

N 2-(4-chloro-o-tolyl)-N 1,N 1-dimethylformamidine hydorchloride
243-269-119750-95-9Carc. 2

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1
H351

H302

H400

H410
GHS08

GHS07

GHS09

Wng
H351

H302

H410
650-010-00-Xbenzyl violet 4B;

α-[4-(4-dimethylamino-α-{4-[ethyl(3-sodiosulphonatobenzyl)amino] phenyl}benzylidene)cyclohexa-2,5-dienylidene(ethyl)ammonio]toluene-3-sulphonate
216-901-91694-09-3Carc. 2H351GHS08

Wng
H351
650-012-00-0erionite12510-42-8Carc. 1AH350GHS08

Dgr
H350
650-013-00-6asbestos












12001-28-4

132207-32-0

12172-73-5

77536-66-4

77536-68-6

77536-67-5

12001-29-5
Carc. 1A

STOT RE 1
H350

H372 **
GHS08

Dgr
H350

H372 **
650-014-00-1diethyl 2,4-dihydroxycyclodisiloxane-2,4-diylbis(trimethylene)diphosphonate, tetrasodium salt, reaction products with disodium metasilicate401-770-4Skin Corr. 1B

Acute Tox. 4 *
H314

H302
GHS05

GHS07

Dgr
H314

H302
650-015-00-7rosin;

colophony
232-475-7

232-484-6

277-299-1
8050-09-7

8052-10-6

73138-82-6
Skin Sens. 1H317GHS07

Wng
H317
650-016-00-2Mineral wool, with the exception of those specified elsewhere in this Annex;

[Man-made vitreous (silicate) fibres with random orientation with alkaline oxide and alkali earth oxide (Na2O+K2O+CaO+MgO+BaO) content greater than 18 % by weight]
Carc. 2

Skin Irrit. 2
H351

H315
GHS08

GHS07

Wng
H351

H315
AQR
650-017-00-8Refractory Ceramic Fibres;

Special Purpose Fibres, with the exception of those specified elsewhere in this Annex;

[Man-made vitreous (silicate) fibres with random orientation with alkaline oxide and alkali earth oxide (Na2O+K2O+CaO+ MgO+BaO) content less or equal to 18 % by weight]
Carc. 1B

Skin Irrit. 2
H350i

H315
GHS08

GHS07

Dgr
H350i

H315
A R
650-018-00-3Reaction product of: acetophenone, formaldehyde, cyclohexylamine, methanol and acetic acid406-230-1Flam. Liq. 3

Carc. 2

Skin Corr. 1B

Acute Tox. 4 *

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H226

H351

H314

H332

H317

H400

H410
GHS02

GHS08

GHS05 GHS07

GHS09

Dgr
H226

H351

H314

H332

H317

H410
650-031-00-4bis(4-hydroxy-N-methylanilinium) sulphate200-237-155-55-0Acute Tox. 4 *

STOT RE 2 *

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H302

H373 **

H317

H400

H410
GHS08

GHS07

GHS09

Wng
H302

H373 **

H317

H410
650-032-00-Xcyproconazole (ISO);

(2RS,3RS;2RS,3SR)-2-(4-chlorophenyl)-3-cyclopropyl-1-(1H—1,2,4-triazol-1-yl)butan-2-ol
94361-06-5Repr. 2

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1
H361d ***

H302

H400

H410
GHS08

GHS07 GHS09

Wng
H361d ***

H302

H410
650-033-00-5(S)-α-cyano-3-phenoxybenzyl-(S)-2-(4-chlorophenyl)-3-methylbutyrate;

esfenvalerate
66230-04-4Acute Tox. 3 *

Acute Tox. 3 *

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H331

H301

H317

H400

H410
GHS06

GHS09

Dgr
H331

H301

H317

H410
650-041-00-9triasulfuron (ISO);

1-[2-(2-chloroethoxy)phenylsulfonyl]-3-(4-methoxy-6-methyl-1,3,5-triazin-2-yl)urea
82097-50-5Aquatic Acute 1

Aquatic Chronic 1
H400

H410
GHS09

Wng
H410
650-042-00-4reaction product of: polyethylene-polyamine-(C16-C18)-alkylamides with monothio-(C2)-alkyl phosphonates417-450-2Eye Irrit. 2

Skin Irrit. 2

Skin Sens. 1

Aquatic Chronic 3
H319

H315

H317

H412
GHS07

Wng
H319

H315

H317

H412
650-043-00-Xreaction product of: 3,5-bis-tert-butylsalicylic acid and aluminiumsulfate420-310-3Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1
H302

H400

H410
GHS07

GHS09

Wng
H302

H410
650-044-00-5mixed linear and branched C14-15 alcohols ethoxylated, reaction product with epichlorohydrin420-480-9158570-99-1Skin Irrit. 2

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H315

H317

H400

H410
GHS07

GHS09

Wng
H315

H317

H410
650-045-00-0reaction product of: 1,2,3-propanetricarboxylic acid, 2-hydroxy, diethyl ester, 1-propanol and zirconium tetra-n-propanolate417-110-3Flam. Liq. 2

Skin Irrit. 2

Eye Dam. 1

Aquatic Chronic 2
H225

H315

H318

H411
GHS02

GHS05

GHS09

Dgr
H225

H315

H318

H411
650-046-00-6di(tetramethylammonium)(29H,31H-phthalocyanin-N29,N30,N31,N32)disulfonamide disulfonate, cuprate(2-)complex, derivates416-180-212222-04-7Acute Tox. 4 *

STOT RE 2 *

Aquatic Chronic 2
H302

H373 **

H411
GHS08

GHS07

GHS09

Wng
H302

H373 **

H411
650-047-00-1dibenzylphenylsulfonium hexafluoroantimonate417-760-8134164-24-2STOT RE 1

Acute Tox. 4 *

Eye Dam. 1

Skin Sens. 1

Aquatic Chronic 2
H372 **

H302

H318

H317

H411
GHS08

GHS05 GHS07

GHS09

Dgr
H372 **

H302

H318

H317

H411
650-048-00-7reaction product of: borax, hydrogen peroxide, acetic acid anhydride and acetic acid420-070-1Org. Perox. D ****

Acute Tox. 4 *

Acute Tox. 4 *

Acute Tox. 4 *

Skin Corr. 1A

Aquatic Acute 1
H242

H332

H312

H302

H314

H400
GHS02

GHS05 GHS07

GHS09

Dgr
H242

H332

H312

H302

H314

H400
650-049-00-22-alkoyloxyethyl hydrogen maleate, where alkoyl represents (by weight) 70 to 85 % unsaturated octadecoyl, 0.5 to 10 % saturated octadecoyl, and 2 to 18 % saturated hexadecoyl417-960-5Skin Irrit. 2

Eye Dam. 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1
H315

H318

H317

H400

H410
GHS05 GHS07

GHS09

Dgr
H315

H318

H317

H410
650-050-00-8reaction mass of: 1-methyl-3-hydroxypropyl 3,5-[1,1-dimethylethyl]-4-hydroxydihydro-cinnamate and/or 3-hydroxybutyl 3,5-[1,1-dimethylethyl]-4-hydroxydihydrocinnamate;

1,3-butanediol bis[3-(3'-(1,1-dimethylethyl)4'-hydroxy-phenyl)propionate] isomers;

1,3-butanediol bis[3-(3',5'-(1,1-dimethylethyl)-4'-hydroxyphenyl)propionate] isomers
423-600-8Aquatic Chronic 2H411GHS09H411
650-055-00-5silver sodium zirconium hydrogenphosphate422-570-3155925-27-2Aquatic Acute 1

Aquatic Chronic 1
H400

H410
GHS09

Wng
H410


Table 3.2

The list of harmonised classification and labelling of hazardous substances from Annex I to Directive 67/548/EEC

Index NoInternational Chemical IdentificationEC NoCAS NoClassificationLabellingConcentration LimitsNotes
001-001-00-9hydrogen215-605-71333-74-0F+; R12F+

R: 12

S: (2-)9-16-33
001-002-00-4aluminium lithium hydride240-877-916853-85-3F; R15F

R: 15

S: (2-)7/8-24/25-43
001-003-00-Xsodium hydride231-587-37646-69-7F; R15F

R: 15

S: (2-)7/8-24/25-43
001-004-00-5calcium hydride232-189-27789-78-8F; R15F

R: 15

S: (2-)7/8-24/25-43
003-001-00-4lithium231-102-57439-93-2F; R15

R14

C; R34
F; C

R: 14/15-34

S: (1/2-)8-43-45
003-002-00-Xn-hexyllithium404-950-021369-64-2F; R15-17

R14

C; R35
F; C

R: 14/15-17-35

S: (1/2-)6-16-26-30-36/37/39-43-45
004-001-00-7beryllium231-150-77440-41-7Carc. Cat. 2; R49

T+; R26

T; R25-48/23

Xi; R36/37/38

R43
T+

R: 49-25-26-36/37/38-43-48/23

S: 53-45
E
004-002-00-2beryllium compounds with the exception of aluminium beryllium silicates, and with those specified elsewhere in this AnnexCarc. Cat. 2; R49

T+; R26

T; R25-48/23

Xi; R36/37/38

R43

N; R51-53
T+; N

R: 49-25-26-36/37/38-43-48/23-51/53

S: 53-45-61
AE
004-003-00-8beryllium oxide215-133-11304-56-9Carc. Cat. 2; R49

T+; R26

T; R25-48/23

Xi; R36/37/38

R43
T+

R: 49-25-26-36/37/38-43-48/23

S: 53-45
E
005-001-00-Xboron trifluoride231-569-57637-07-2R14

T+; R26

C; R35
T+; C

R: 14-26-35

S: (1/2-)9-26-28-36/37/39-45
005-002-00-5boron trichloride233-658-410294-34-5R14

T+; R26/28

C; R34
T+

R: 14-26/28-34

S: (1/2-)9-26-28-36/37/39-45
005-003-00-0boron tribromide233-657-910294-33-4R14

T+; R26/28

C; R35
T+; C

R: 14-26/28-35

S: (1/2-)9-26-28-36/37/39-45
005-004-00-6trialkylboranesF; R17

C; R34
F; C

R: 17-34

S: (1/2-)7-23-26-36/37/39-43-45
A
005-005-00-1trimethyl borate204-468-9121-43-7R10

Xn; R21
Xn

R: 10-21

S: (2-)23-25
005-006-00-7dibutyltin hydrogen borate401-040-575113-37-0T; R48/25

Xn; R21/22

Xi; R41

R43

N; R50-53
T; N

R: 21/22-41-43-48/25-50/53

S: (1/2-)22-26-36/37-45-60-61
005-009-00-3tetrabutylammonium butyltriphenylborate418-080-4120307-06-4R43

N; R50-53
Xi; N

R: 43-50/53

S: (2-)24-37-56-61
005-010-00-9N,N-dimethylanilinium tetrakis(pentafluorophenyl)borate422-050-6118612-00-3Carc. Cat. 3; R40

Xn; R22

Xi; R38-41
Xn

R: 22-38-40-41

S: (2-)22-26-36/37/39
005-012-00-Xdiethyl{4-[1,5,5-tris(4-diethylaminophenyl)penta-2,4-dienylidene]cyclohexa-2,5-dienylidene}ammonium butyltriphenylborate418-070-1141714-54-7R43

N; R50-53
Xi; N

R: 43-50/53

S: (2-)24-37-60-61
006-001-00-2carbon monoxide211-128-3630-08-0F+; R12

Repr. Cat. 1; R61

T; R23-48/23
F+; T

R: 61-12-23-48/23

S: 53-45
E
006-002-00-8phosgene;

carbonyl chloride
200-870-375-44-5T+; R26

C; R34
T+

R: 26-34

S: (1/2-)9-26-36/37/39-45
006-003-00-3carbon disulphide200-843-675-15-0F; R11

Repr. Cat. 3; R62-63

T; R48/23

Xi; R36/38
F; T

R: 11-36/38-48/23-62-63

S: (1/2-)16-33-36/37-45
Repr. Cat. 3; R62-63: C ≥ 1 %

T; R48/23: C ≥ 1 %

Xn; R48/20: 0,2 % ≤ C < 1 %
006-004-00-9calcium carbide200-848-375-20-7F; R15F

R: 15

S: (2-)8-43
006-005-00-4thiram (ISO);

tetramethylthiuram disulphide
205-286-2137-26-8Xn; R20/22-48/22

Xi; R36/38

R43

N; R50-53
Xn; N

R: 20/22-36/38-43-48/22-50/53

S: (2-)26-36/37-60-61
N; R50-53: C ≥ 2,5 %

N; R51-53: 0,25 % ≤ C < 2,5 %

R52-53: 0,025 % ≤ C < 0,25 %
006-006-00-Xhydrogen cyanide;

hydrocyanic acid
200-821-674-90-8F+; R12

T+; R26

N; R50-53
F+; T+; N

R: 12-26-50/53

S: (1/2-)7/9-16-36/37-38-45-60-61
006-006-01-7hydrogen cyanide ...%;

hydrocyanic acid ...%
200-821-674-90-8T+; R26/27/28

N; R50-53
T+; N

R: 26/27/28-50/53

S: (1/2-)7/9-36/37-38-45-60-61
B
006-007-00-5salts of hydrogen cyanide with the exception of complex cyanides such as ferrocyanides, ferricyanides and mercuric oxycyanideT+; R26/27/28

R32

N; R50-53
T+; N

R: 26/27/28-32-50/53

S: (1/2-)7-28-29-45-60-61
A
006-008-00-0antu (ISO);

1-(1-naphthyl)-2-thiourea
201-706-386-88-4T+; R28

Carc. Cat. 3; R40
T+

R: 28-40

S: (1/2-)25-36/37-45
006-009-00-61-isopropyl-3-methylpyrazol-5-yl dimethylcarbamate;

isolan
204-318-2119-38-0T+; R27/28T+

R: 27/28

S: (1/2-)28-36/37/39-45
006-010-00-15,5-dimethyl-3-oxocyclohex-1-enyl dimethylcarbamate 5,5-dimethyldihydroresorcinol dimethylcarbamate;

dimetan
204-525-8122-15-6T; R25T

R: 25

S: (1/2-)36/37-45
006-011-00-7carbaryl (ISO);

1-naphthyl methylcarbamate
200-555-063-25-2Carc. Cat. 3; R40

Xn; R22

N; R50
Xn; N

R: 22-40-50

S: (2-)22-24-36/37-46-61
006-012-00-2ziram (ISO);

zinc bis dimethyldithiocarbamate
205-288-3137-30-4T+; R26

Xn; R22-48/22

Xi; R37-41

R43

N; R50-53
T+; N

R: 22-26-37-41-43-48/22-50/53

S: (1/2-)22-26-28-36/37/39-45-60-61
N; R50-53: C ≥ 0,25 %

N; R51-53: 0,025 % ≤ C < 0,25 %

R52-53: 0,0025 % ≤ C < 0,025 %
006-013-00-8metam-sodium (ISO);

sodium methyldithiocarbamate
205-293-0137-42-8Xn; R22

R31

C; R34

R43

N; R50-53
C; N

R: 22-31-34-43-50/53

S: (1/2-)26-36/37/39-45-60-61
006-014-00-3nabam (ISO);

disodium ethylenebis(N,N'-dithiocarbamate)
205-547-0142-59-6Xn; R22

Xi; R37

R43

N; R50-53
Xn; N

R: 22-37-43-50/53

S: (2-)8-24/25-46-60-61
006-015-00-9diuron (ISO);

3-(3,4-dichlorophenyl)-1,1-dimethylurea
206-354-4330-54-1Carc. Cat. 3; R40

Xn; R22-48/22

N; R50-53
Xn; N

R: 22-40-48/22-50/53

S: (2-)13-22-23-37-46-60-61
006-016-00-4propoxur (ISO);

2-isopropyloxyphenyl N-methylcarbamate;

2-isopropoxyphenyl methylcarbamate
204-043-8114-26-1T; R25

N; R50-53
T; N

R: 25-50/53

S: (1/2-)37-45-60-61
006-017-00-Xaldicarb (ISO);

2-methyl-2-(methylthio)propanal-O-(N-methylcarbamoyl)oxime
204-123-2116-06-3T+; R26/28

T; R24

N; R50-53
T+; N

R: 24-26/28-50/53

S: (1/2-)22-36/37-45-60-61
006-018-00-5aminocarb (ISO);

4-dimethylamino-3-tolyl methylcarbamate
217-990-72032-59-9T; R24/25

N; R50-53
T; N

R: 24/25-50/53

S: (1/2-)28-36/37-45-60-61
006-019-00-0di-allate (ISO);

S-(2,3-dichloroallyl)-N,N-diisopropylthiocarbamate
218-961-12303-16-4Carc. Cat. 3; R40

Xn; R22

N; R50-53
Xn; N

R: 22-40-50/53

S: (2-)25-36/37-60-61
006-020-00-6barban (ISO);

4-chlorbut-2-ynyl N-(3-chlorophenyl)carbamate
202-930-4101-27-9Xn; R22

R43

N; R50-53
Xn; N

R: 22-43-50/53

S: (2-)24-36/37-60-61
006-021-00-1linuron (ISO);

3-(3,4-dichlorophenyl)-1-methoxy-1-methylurea
206-356-5330-55-2Repr. Cat. 2; R61

Repr. Cat. 3; R62

Carc. Cat. 3; R40

Xn; R22-48/22

N; R50-53
T; N

R: 61-22-40-48/22-62-50/53

S: 53-45-60-61
E
006-022-00-7decarbofuran (ISO);

2,3-dihydro-2-methylbenzofuran-7-yl methylcarbamate
1563-67-3T; R23/24/25T

R: 23/24/25

S: (1/2-)13-36/37-45
006-023-00-2mercaptodimethur (ISO);

methiocarb (ISO);

3,5-dimethyl-4-methylthiophenyl N-methylcarbamate
217-991-22032-65-7T; R25

N; R50-53
T; N

R: 25-50/53

S: (1/2-)22-37-45-60-61
006-024-00-8proxan-sodium (ISO);

sodium O-isopropyldithiocarbonate
205-443-5140-93-2Xn; R22

Xi; R38

N; R51-53
Xn; N

R: 22-38-51/53

S: (2-)13-61
006-025-00-3allethrin;

(RS)-3-allyl-2-methyl-4-oxocyclopent-2-enyl (1RS,3RS;1RS,3SR)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate;

bioallethrin;

(RS)-3-allyl-2-methyl-4-oxocyclopent-2-enyl (1R,3R)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate; [1]

S-bioallethrin;

(S)-3-allyl-2-methyl-4-oxocyclopent-2-enyl (1R,3R)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate; [2]

esbiothrin;

(RS)-3-allyl-2-methyl-4-oxocyclopent-2-enyl (1R,3R)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate [3]
209-542-4 [1]

249-013-5 [2]

- [3]
584-79-2 [1]

28434-00-6 [2]

84030-86-4 [3]
Xn; R20/22

N; R50-53
Xn; N

R: 20/22-50/53

S: (2-)36-60-61
C
006-026-00-9carbofuran (ISO);

2,3-dihydro-2,2-dimethylbenzofuran-7-yl N-methylcarbamate
216-353-01563-66-2T+; R26/28

N; R50-53
T+; N

R: 26/28-50/53

S: (1/2-)36/37-45-60-61
006-028-00-Xdinobuton (ISO);

2-(1-methylpropyl)-4,6-dinitrophenyl isopropyl carbonate
213-546-1973-21-7T; R25

N; R50-53
T; N

R: 25-50/53

S: (1/2-)37-45-60-61
006-029-00-5dioxacarb (ISO);

2-(1,3-dioxolan-2-yl)phenyl N-methylcarbamate
230-253-46988-21-2T; R25

N; R51-53
T; N

R: 25-51/53

S: (1/2-)37-45-61
006-030-00-0EPTC (ISO);

S-ethyl dipropylthiocarbamate
212-073-8759-94-4Xn; R22Xn

R: 22

S: (2-)23
006-031-00-6formetanate (ISO);

3-[(EZ)-dimethylaminomethyleneamino]phenyl methylcarbamate
244-879-022259-30-9T+; R26/28

R43

N; R50-53
T+; N

R: 26/28-43-50/53

S: (1/2-)24-28-37/39-45-60-61
006-032-00-1monolinuron (ISO);

3-(4-chlorophenyl)-1-methoxy-1-methylurea
217-129-51746-81-2Xn; R22-48/22

N; R50-53
Xn; N

R: 22-48/22-50/53

S: (2-)22-60-61
006-033-00-7metoxuron (ISO);

3-(3-chloro-4-methoxyphenyl)-1,1-dimethylurea
243-433-219937-59-8N; R50-53N

R: 50/53

S: 60-61
006-034-00-2pebulate (ISO);

N-butyl-N-ethyl-S-propylthiocarbamate
214-215-41114-71-2Xn; R22

N; R51-53
Xn; N

R: 22-51/53

S: (2-)23-61
006-035-00-8pirimicarb (ISO);

5,6-dimethyl-2-dimethylamino-pyrimidin-4-yl N,N-dimethylcarbamate
245-430-123103-98-2T; R25

N; R50-53
T; N

R: 25-50/53

S: (1/2-)22-37-45-60-61
006-036-00-3benzthiazuron (ISO);

1-benzothiazol-2-yl-3-methylurea
217-685-91929-88-0Xn; R22Xn

R: 22

S: (2-)24/25
006-037-00-9promecarb (ISO);

3-isopropyl-5-methylphenyl N-methylcarbamate
220-113-02631-37-0T; R25

N; R50-53
T; N

R: 25-50/53

S: (1/2-)24-37-45-60-61
006-038-00-4sulfallate (ISO);

2-chloroallyl N,N-dimethyldithiocarbamate
202-388-995-06-7Carc. Cat. 2; R45

Xn; R22

N; R50-53
T; N

R: 45-22-50/53

S: 53-45-60-61
E
006-039-00-Xtri-allate (ISO);

S-2,3,3-trichloroallyl diisopropylthiocarbamate
218-962-72303-17-5Xn; R22-48/22

R43

N; R50-53
Xn; N

R: 22-43-48/22-50/53

S: (2-)24-37-60-61
006-040-00-53-methylpyrazol-5-yl-dimethylcarbamate;

monometilan
2532-43-6T; R23/24/25T

R: 23/24/25

S: (1/2-)13-45
006-041-00-0dimethylcarbamoyl chloride201-208-679-44-7Carc. Cat. 2; R45

T; R23

Xn; R22

Xi; R36/37/38
T

R: 45-22-23-36/37/38

S: 53-45
Carc. Cat. 2; R45: C ≥ 0,001 %E
006-042-00-6monuron (ISO);

3-(4-chlorophenyl)-1,1-dimethylurea
205-766-1150-68-5Carc. Cat. 3; R40

Xn; R22

N; R50-53
Xn; N

R: 22-40-50/53

S: (2-)36/37-60-61
006-043-00-13-(4-chlorophenyl)-1,1-dimethyluronium trichloroacetate;

monuron-TCA
140-41-0Xi; R36/38

Carc. Cat. 3; R40

N; R50-53
Xn; N

R: 36/38-40-50/53

S: (2-)36/37-60-61
006-044-00-7isoproturon (ISO);

3-(4-isopropylphenyl)-1,1-dimethylurea
251-835-434123-59-6Carc. Cat. 3; R40

N; R50-53
Xn; N

R: 40-50/53

S: (2-)36/37-60-61
N; R50-53: C ≥ 2,5 %

N; R51-53: 0,25 % ≤ C < 2,5 %

R52-53: 0,025 % ≤ C < 0,25 %
006-045-00-2methomyl (ISO);

1-(methylthio)ethylideneamino N-methylcarbamate
240-815-016752-77-5T+;R28

N; R50-53
T+; N

R: 28-50/53

S: (1/2-)22-36/37-45-60-61
006-046-00-8bendiocarb (ISO);

2,2-dimethyl-1,3-benzodioxol-4-yl N-methylcarbamate
245-216-822781-23-3T; R23/25

Xn; R21

N; R50-53
T; N

R: 21-23/25-50/53

S: (1/2-)22-36/37-45-60-61
006-047-00-3bufencarb (ISO);

reaction mass of 3-(1-methylbutyl)phenyl N-methylcarbamate and 3-(1-ethylpropyl)phenyl N-methylcarbamate
8065-36-9T; R24/25

N; R50-53
T; N

R: 24/25-50/53

S: (1/2-)28-36/37-45-60-61
006-048-00-9ethiofencarb (ISO);

2-(ethylthiomethyl)phenyl N-methylcarbamate
249-981-929973-13-5Xn; R22

N; R50-53
Xn; N

R: 22-50/53

S: (2-)60-61
006-049-00-4dixanthogen;

O,O-diethyl dithiobis(thioformate)
207-944-4502-55-6Xn; R22Xn

R: 22

S: (2-)24
006-050-00-X1,1-dimethyl-3-phenyluronium trichloroacetate;

fenuron-TCA
4482-55-7Xi; R38

N; R50-53
Xi; N

R: 38-50/53

S: (2-)60-61
006-051-00-5ferbam (ISO);

iron tris(dimethyldithiocarbamate)
238-484-214484-64-1Xi; R36/37/38

N; R50-53
Xi; N

R: 36/37/38-50/53

S: (2-)60-61
006-052-00-0formetanate hydrochloride;

3-(N,N-dimethylaminomethyleneamino)phenyl N-methylcarbamate
245-656-023422-53-9T+; R26/28

R43

N; R50-53
T+; N

R: 26/28-43-50/53

S: (1/2-)24-28-37/39-45-60-61
006-053-00-6isoprocarb (ISO);

2-isopropylphenyl N-methylcarbamate
220-114-62631-40-5Xn; R22

N; R50-53
Xn; N

R: 22-50/53

S: (2-)60-61
006-054-00-1mexacarbate (ISO);

3,5-dimethyl-4-dimethylaminophenyl N-methylcarbamate
206-249-3315-18-4T+; R28

Xn; R21

N; R50-53
T+; N

R: 21-28-50/53

S: (1/2-)36/37-45-60-61
006-055-00-7xylylcarb (ISO);

3,4-dimethylphenyl N-methylcarbamate;

3,4-xylyl methylcarbamate;

MPMC
219-364-92425-10-7Xn; R22

N; R50-53
Xn; N

R: 22-50/53

S: (2-)60-61
006-056-00-2metolcarb (ISO);

m-tolyl methylcarbamate;

MTMC
214-446-01129-41-5Xn; R22

N; R51-53
Xn; N

R: 22-51/53

S: (2-)61
006-057-00-8nitrapyrin (ISO);

2-chloro-6-trichloromethylpyridine
217-682-21929-82-4Xn; R22

N; R51-53
Xn; N

R: 22-51/53

S: (2-)24-61
006-058-00-3noruron (ISO);

1,1-dimethyl-3-(perhydro-4,7-methanoinden-5-yl)urea
2163-79-3Xn; R22Xn

R: 22

S: (2-)
006-059-00-9oxamyl (ISO);

N',N'-dimethylcarbamoyl(methylthio)methylenamine N-methylcarbamate;
245-445-323135-22-0T+; R26/28

Xn; R21

N; R51-53
T+; N

R: 21-26/28-51/53

S: (1/2-)36/37-45-61
006-060-00-4oxycarboxin (ISO);

2,3-dihydro-6-methyl-5-(N-phenylcarbamoyl)-1,4-oxothiine 4,4-dioxide
226-066-25259-88-1Xn; R22

R52-53
Xn

R: 22-52/53

S: (2-)61
006-061-00-XS-ethyl N-(dimethylaminopropyl)thiocarbamatehydrochloride;

prothiocarb hydrochloride
243-193-919622-19-6Xn; R22

N; R51-53
Xn; N

R: 22-51/53

S: (2-)61
006-062-00-5methyl 3,4-dichlorophenylcarbanilate;

SWEP.
1918-18-9Xn; R22Xn

R: 22

S: (2-)
006-063-00-0thiobencarb (ISO);

S-4-chlorobenzyl diethylthiocarbamate;
248-924-528249-77-6Xn; R22

N; R50-53
Xn; N

R: 22-50/53

S: (2-)60-61
006-064-00-6thiofanox (ISO);

3,3-dimethyl-1-(methylthio)butanone-O-(N-methylcarbamoyl)oxime;
254-346-439196-18-4T+; R27/28

N; R50-53
T+; N

R: 27/28-50/53

S: (1/2-)27-36/37-45-60-61
006-065-00-13-chloro-6-cyano-bicyclo(2,2,1)heptan-2-one-O-(N-methylcarbamoyl)oxime;

triamid
15271-41-7T+; R28

T; R24

N; R51-53
T+; N

R: 24-28-51/53

S: (1/2-)28-36/37-45-61
006-066-00-7vernolate (ISO);

S-propyl dipropylthiocarbamate;
217-681-71929-77-7Xn; R22

N; R51-53
Xn; N

R: 22-51/53

S: (2-)61
006-067-00-2XMC;

3,5-xylyl methylcarbamate
2655-14-3Xn; R22Xn

R: 22

S: (2-)
006-068-00-8diazomethane206-382-7334-88-3Carc. Cat. 2; R45T

R: 45

S: 53-45
006-069-00-3thiophanate-methyl (ISO);

1,2-di-(3-methoxycarbonyl-2-thioureido)benzene
245-740-723564-05-8Muta. Cat. 3; R68

Xn; R20

R43

N; R50-53
Xn; N

R: 20-43-50/53-68

S: (2-)36/37-46-60-61
006-070-00-9furmecyclox (ISO);

N-cyclohexyl-N-methoxy-2,5-dimethyl-3-furamide;
262-302-060568-05-0Carc. Cat. 3; R40

N; R50-53
Xn; N

R: 40-50/53

S: (2-)36/37-60-61
006-071-00-4cyclooct-4-en-1-yl methyl carbonate401-620-887731-18-8R43Xi

R: 43

S: (2-)24-37
006-072-00-Xprosulfocarb(ISO);

S-benzyl N,N-dipropylthiocarbamate;
401-730-652888-80-9Xn; R22

R43

N; R51-53
Xn; N

R: 22-43-51/53

S: (2-)24-37-61
006-073-00-53-(dimethylamino)propylurea401-950-231506-43-1Xi; R41Xi

R: 41

S: (2-)26-39
006-074-00-02-(3-(prop-1-en-2-yl)phenyl)prop-2-yl isocyanate402-440-22094-99-7T+; R26

C; R34

Xn; R48/20

R42/43

N; R50-53
T+; N

R: 26-34-42/43-48/20-50/53

S: (1/2-)7-15-28-36/37/39-38-45-60-61
006-076-00-1mancozeb (ISO)8018-01-7Xi; R37

R43
Xi

R: 37-43

S: (2-)8-24/25-46
006-077-00-7maneb (ISO)235-654-812427-38-2Xi; R37

R43
Xi

R: 37-43

S: (2-)8-24/25-46
006-078-00-2zineb (ISO);

zinc ethylenebis(dithiocarbamate) (polymeric)
235-180-112122-67-7Xi; R37

R43
Xi

R: 37-43

S: (2-)8-24/25-46
006-079-00-8disulfiram;

tetraethylthiuramdisulfide
202-607-897-77-8Xn; R22-48/22

R43

N; R50-53
Xn; N

R: 22-43-48/22-50/53

S: (2-)24-37-60-61
006-080-00-3tetramethylthiuram monosulphide202-605-797-74-5Xn; R22

R43

N; R51-53
Xn; N

R: 22-43-51/53

S: (2-)24-26-37-61
006-081-00-9zinc bis(dibutyldithiocarbamate)205-232-8136-23-2Xi; R36/37/38

R43

N; R50-53
Xi; N

R: 36/37/38-43-50/53

S: (2-)24-37-60-61
006-082-00-4zinc bis(diethyldithiocarbamate)238-270-914324-55-1Xn; R22

Xi; R36/37/38

R43

N; R50-53
Xn; N

R: 22-36/37/38-43-50/53

S: (2-)24-37-60-61
006-083-00-Xbutocarboxim (ISO);

3-(methylthio)-2-butanone O-[(methylamino)carbonyl]oxime
252-139-334681-10-2R10

T; R23/24/25

Xi; R36

N; R50-53
T; N

R: 10-23/24/25-36-50/53

S: (1/2-)36/37-45-60-61
006-084-00-5carbosulfan (ISO);

2,3-dihydro-2,2-dimethyl-7-benzofuryl [(dibutylamino)thio]methylcarbamate;
259-565-955285-14-8T; R23/25

R43

N; R50-53
T; N

R: 23/25-43-50/53

S: (1/2-)24-37-38-45-60-61
006-085-00-0fenobucarb (ISO);

2-butylphenyl methylcarbamate;
223-188-83766-81-2Xn; R22

N; R50-53
Xn; N

R: 22-50/53

S: (2-)60-61
006-086-00-6ethyl [2-(4-phenoxyphenoxy)ethyl]carbamate;

fenoxycarb
276-696-772490-01-8N; R50-53N

R: 50/53

S: 60-61
006-087-00-12,3-dihydro-2,2-dimethyl-7-benzofuryl 2,4-dimethyl-6-oxa-5-oxo-3-thia-2,4-diazadecanoate;

furathiocarb
265-974-365907-30-4T+; R26

T; R25

Xn; R48/22

Xi; R36/38

R43

N; R50-53
T+; N

R: 25-26-36/38-43-48/22-50/53

S: (1/2-)28-36/37-38-45-60-61
006-088-00-7benfuracarb;

ethyl N-[2,3-dihydro-2,2-dimethylbenzofuran-7-yloxycarbonyl(methyl)aminothio]-N-isopropyl- β-alaninate
82560-54-1T; R23/25

N; R50-53
T; N

R: 23/25-50/53

S: (1/2-)36/37-45-60-61
006-089-00-2chlorine dioxide233-162-810049-04-4O; R8

R6

T+; R26

C; R34

N; R50
O; T+; N

R: 6-8-26-34-50

S: (1/2-)23-26-28-36/37/39-38-45-61
N; R50: C ≥ 0,02 %5
006-089-01-Xchlorine dioxide … %233-162-810049-04-4T; R25

C; R34

N; R50
T; N

R: 25-34-50

S: (1/2-)23-26-28-36/37/39-45-61
C; R34: C ≥ 10 %

Xi; R36/37/38: 3 % ≤ C < 10 %

Xi; R36: 0,3 % ≤ C < 3 %

N; R50: C ≥ 3 %
B
006-090-00-82-(3-iodoprop-2-yn-1-yloxy)ethyl phenylcarbamate408-010-088558-41-2Xn; R20

Xi; R41

R52-53
Xn

R: 20-41-52/53

S: (2-)22-26-39-61
007-001-00-5ammonia, anhydrous231-635-37664-41-7R10 ⊗

T; R23

C; R34

N; R50
T; N

R: 10-23-34-50

S: (1/2-)9-16-26-36/37/39-45-61
007-001-01-2ammonia ....%215-647-61336-21-6C; R34

N; R50
C; N

R: 34-50

S: (1/2-)26-36/37/39-45-61
C; R34: C ≥ 10 %

Xi; R36/37/38: 5 % ≤ C < 10 %
B
007-002-00-0nitrogen dioxide; [1]

dinitrogen tetraoxide [2]
233-272-6 [1]

234-126-4 [2]
10102-44-0 [1]

10544-72-6 [2]
T+; R26

C; R34
T+

R: 26-34

S: (1/2-)9-26-28-36/37/39-45
T+; R26: C ≥ 10 %

T; R23: 1 % ≤ C < 10 %

Xn; R20: 0,1 % ≤ C < 1 %
5
007-003-00-6chlormequat chloride (ISO);

2-chloroethyltrimethylammonium chloride
213-666-4999-81-5Xn; R21/22Xn

R: 21/22

S: (2-)36/37
007-004-00-1nitric acid ... %231-714-27697-37-2O; R8

C; R35
O; C

R: 8-35

S: (1/2-)23-26-36-45
C; R35: C ≥ 20 %

C; R34: 5 % ≤ C < 20 %

Footnote:

O; R8: C ≥ 70 %
B
007-006-00-2ethyl nitrite203-722-6109-95-5E; R2

Xn; R20/21/22
E; Xn

R: 2-20/21/22

S: (2-)
007-007-00-8ethyl nitrate210-903-3625-58-1E; R2 ⊗E

R: 2

S: (2-)23-24/25
007-008-00-3hydrazine206-114-9302-01-2R10

Carc. Cat. 2; R45

T; R23/24/25

C; R34

R43

N; R50-53
T; N

R: 45-10-23/24/25-34-43-50/53

S: 53-45-60-61
C; R34: C ≥ 10 %

Xi; R36/38: 3 % ≤ C < 10 %
E
007-009-00-9dicyclohexylammonium nitrite221-515-93129-91-7Xn; R20/22Xn

R: 20/22

S: (2-)15-41
Xn; R20/22: C ≥ 10 %
007-010-00-4sodium nitrite231-555-97632-00-0O; R8

T; R25

N; R50
O; T; N

R: 8-25-50

S: (1/2-)45-61
T; R25: C ≥ 5 %

Xn; R22: 1 % ≤ C < 5 %
007-011-00-Xpotassium nitrite231-832-47758-09-0O; R8

T; R25

N; R50
O; T; N

R: 8-25-50

S: (1/2-)45-61
T; R25: C ≥ 5 %

Xn; R22: 1 % ≤ C < 5 %
007-012-00-5N,N-dimethylhydrazine200-316-057-14-7F; R11

Carc. Cat. 2; R45

T; R23/25

C; R34

N; R51-53
F; T; N

R: 45-11-23/25-34-51/53

S: 53-45-61
E
007-013-00-01,2-dimethylhydrazine540-73-8Carc. Cat. 2; R45

T; R23/24/25

N; R51-53
T; N

R: 45-23/24/25-51/53

S: 53-45-61
Carc. Cat. 2; R45: C ≥ 0,01 %E
007-014-00-6salts of hydrazineCarc. Cat. 2; R45

T; R23/24/25

R43

N; R50-53
T; N

R: 45-23/24/25-43-50/53

S: 53-45-60-61
AE
007-015-00-1O-ethylhydroxylamine402-030-3624-86-2F; R11

T; R23/24/25-48/23

Xi; R36

R43

N; R50
F; T; N

R: 11-23/24/25-36-43-48/23-50

S: (1/2-)16-26-36/37/39-45-60-61
007-016-00-7butyl nitrite208-862-1544-16-1F; R11

T; R23/25
F; T

R: 11-23/25

S: (1/2-)16-24-45
007-017-00-2isobutyl nitrite208-819-7542-56-3F; R11

Carc. Cat. 2; R45

Muta. Cat. 3; R68

Xn; R20/22
F; T

R: 11-20/22-45-68

S: 53-45
E
007-018-00-8sec-butyl nitrite213-104-8924-43-6F; R11

Xn; R20/22
F; Xn

R: 11-20/22

S: (2-)16-24-46
007-019-00-3tert-butyl nitrite208-757-0540-80-7F; R11

Xn; R20/22
F; Xn

R: 11-20/22

S: (2-)16-24-46
007-020-00-9pentyl nitrite; [1]

‘amyl nitrite’, mixed isomers [2]
207-332-7 [1]

203-770-8 [2]
463-04-7 [1]

110-46-3 [2]
F; R11

Xn; R20/22
F; Xn

R: 11-20/22

S: (2-)16-24-46
007-021-00-4hydrazobenzene;

1,2-diphenylhydrazine
204-563-5122-66-7Carc. Cat. 2; R45

Xn; R22

N; R50-53
T; N

R: 45-22-50/53

S: 53-45-60-61
E
007-022-00-Xhydrazine bis(3-carboxy-4-hydroxybenzensulfonate)405-030-1Carc. Cat. 2; R45

Xn; R22

C; R34

R43

R52-53
T

R: 45-22-34-43-52/53

S: 53-45-61
E
007-023-00-5sodium 3,5-bis(3-(2,4-di-tert-pentylphenoxy)propylcarbamoyl)benzenesulfonate405-510-0Xi; R38

R43
Xi

R: 38-43

S: (2-)24-37
007-024-00-02-(decylthio)ethylammonium chloride405-640-836362-09-1Xn; R48/22

Xi; R38-41

N; R50-53
Xn; N

R: 38-41-48/22-50/53

S: (2-)26-36/37/39-60-61
007-025-00-6(4-hydrazinophenyl)-N-methylmethanesulfonamide hydrochloride406-090-181880-96-8Muta. Cat. 3; R68

T; R25-48/25

R43

N; R50-53
T; N

R: 25-43-48/25-68-50/53

S: (1/2-)22-36/37/39-45-60-61
007-026-00-1oxo-((2,2,6,6-tetramethylpiperidin-4-yl)amino)carbonylacetohydrazide413-230-5122035-71-6Xi; R41

R43
Xi

R: 41-43

S: (2-)8-22-24-26-30-37/39
007-027-00-71,6-bis(3,3-bis((1-methylpentylidenimino)propyl)ureido)hexane420-190-2771478-66-1C; R34

Xn; R21/22-48/21

R43

N; R50-53
C; N

R: 21/22-34-43-48/21-50/53

S: (1/2-)7-26-36/37/39-45-60-61
008-001-00-8oxygen231-956-97782-44-7O; R8O

R: 8

S: (2-)17
008-003-00-9hydrogen peroxide solution ... %231-765-07722-84-1R5

O; R8

C; R35

Xn; R20/22
O; C

R: 5-8-20/22-35

S: (1/2-)17-26-28-36/37/39-45
Xn; R20: C ≥ 50 %

Xn; R22: C ≥ 8 %

C; R35: C ≥ 70 %

C; R34: 50 % ≤ C < 70 %

Xi; R37/38: 35 % ≤ C < 50 %

Xi; R41: 8 % ≤ C < 50 %

Xi; R36: 5 % ≤ C < 8 %

Footnote:

O; R8: C ≥ 50 %

R5: C ≥ 70 %
B
009-001-00-0fluorine231-954-87782-41-4R7 ⊗

T+; R26

C; R35
T+; C

R: 7-26-35

S: (1/2-)9-26-36/37/39-45
009-002-00-6hydrogen fluoride231-634-87664-39-3T+; R26/27/28

C; R35
T+; C

R: 26/27/28-35

S: (1/2-)7/9-26-36/37/39-45
009-003-00-1hydrofluoric acid ... %231-634-87664-39-3T+; R26/27/28

C; R35
T+; C

R: 26/27/28-35

S: (1/2-)7/9-26-36/37-45
C; R35: C ≥ 7 %

C; R34: 1 % ≤ C < 7 %

Xi; R36: 0,1 % ≤ C < 1 %
B
009-004-00-7sodium fluoride231-667-87681-49-4T; R25

Xi; R36/38

R32
T

R: 25-32-36/38

S: (1/2-)22-36-45
009-005-00-2potassium fluoride232-151-57789-23-3T; R23/24/25T

R: 23/24/25

S: (1/2-)26-45
009-006-00-8ammonium fluoride235-185-912125-01-8T; R23/24/25T

R: 23/24/25

S: (1/2-)26-45
009-007-00-3sodium bifluoride;

sodium hydrogen difluoride
215-608-31333-83-1T; R25

C; R34
T; C

R: 25-34

S: (1/2-)22-26-37-45
T; R25: C ≥ 10 %

Xn; R22: 1 % ≤ C < 10 %

C; R34: C ≥ 1 %

Xi; R36/38: 0,1 % ≤ C < 1 %
009-008-00-9potassium bifluoride;

potassium hydrogen difluoride
232-156-27789-29-9T; R25

C; R34
T; C

R: 25-34

S: (1/2-)22-26-37-45
T; R25: C ≥ 10 %

Xn; R22: 1 % ≤ C < 10 %

C; R34: C ≥ 1 %

Xi; R36/38: 0,1 % ≤ C < 1 %
009-009-00-4ammonium bifluoride;

ammonium hydrogen difluoride
215-676-41341-49-7T; R25

C; R34
T; C

R: 25-34

S: (1/2-)22-26-37-45
T; R25: C ≥ 10 %

Xn; R22: 1 % ≤ C < 10 %

C; R34: C ≥ 1 %

Xi; R36/38: 0,1 % ≤ C < 1 %
009-010-00-Xfluoroboric acid ... %240-898-316872-11-0C; R34C

R: 34

S: (1/2-)26-27-45
C; R34: C ≥ 25 %

Xi; R36/38: 10 % ≤ C < 25 %
B
009-011-00-5fluorosilicic acid ... %241-034-816961-83-4C; R34C

R: 34

S: (1/2-)26-27-45
B
009-012-00-0alkali fluorosilicates(Na); [1]

alkali fluorosilicates(K); [2]

alkali fluorosilicates(NH4) [3]
240-934-8 [1]

240-896-2 [2]

240-968-3 [3]
16893-85-9 [1]

16871-90-2 [2]

16919-19-0 [3]
T; R23/24/25T

R: 23/24/25

S: (1/2-)26-45
T; R23/24/25: C ≥ 10 %

Xn; R20/21/22: 1 % ≤ C < 10 %
A
009-013-00-6fluorosilicates, with the exception of those specified elsewhere in this annexXn; R22Xn

R: 22

S: (2-)13-24/25
Xn; R22: C ≥ 10 %A
009-014-00-1lead hexafluorosilicate247-278-125808-74-6Repr. Cat. 1; R61

Repr. Cat. 3; R62

Xn; R20/22

R33

N; R50-53
T; N

R: 61-62-20/22-33-50/53

S: 53-45-60-61
E

1
009-015-00-7sulphuryl difluoride220-281-52699-79-8T; R23

Xn; R48/20

N; R50
T; N

R: 23-48/20-50

S: (1/2-)45-63-60-61
009-016-00-2trisodium hexafluoroaluminate;

cryolite
237-410-6

239-148-8
13775-53-6

15096-52-3
T; R48/23/25

Xn; R20/22

N; R51-53
T; N

R: 20/22-48/23/25-51/53

S: (1/2-)22-37-45-61
C
009-017-00-8potassium mu-fluoro-bis(triethylaluminium)400-040-212091-08-6F; R11-14/15

C; R35

Xn; R20
F; C

R: 11-14/15-20-35

S: (1/2-)16-30-36/39-43-45
009-018-00-3magnesium hexafluorosilicate241-022-216949-65-8T; R25T

R: 25

S: (1/2-)24/25-45
T; R25: C ≥ 10 %

Xn; R22: 1 % ≤ C < 10 %
011-001-00-0sodium231-132-97440-23-5F; 15

R14

C; R34
F; C

R: 14/15-34

S: (1/2-)5-8-43-45
011-002-00-6sodium hydroxide;

caustic soda
215-185-51310-73-2C; R35C

R: 35

S: (1/2-)26-37/39-45
C; R35: C ≥ 5 %

C; R34: 2 % ≤ C < 5 %

Xi; R36/38: 0,5 % ≤ C < 2 %
011-003-00-1sodium peroxide215-209-41313-60-6O; R8

C; R35
O; C

R: 8-35

S: (1/2-)8-27-39-45
011-004-00-7sodium azide247-852-126628-22-8T+; R28

R32

N; R50-53
T+; N

R: 28-32-50/53

S: (1/2-)28-45-60-61
011-005-00-2sodium carbonate207-838-8497-19-8Xi; R36Xi

R: 36

S: (2-)22-26
011-006-00-8sodium cyanate213-030-6917-61-3Xn; R22

R52-53
Xn

R: 22-52/53

S: (2-)24/25-61
011-007-00-3propoxycarbazone-sodium181274-15-7N; R50-53N

R: 50/53

S: 60-61
N; R50-53: C ≥ 2,5 %

N; R51-53: 0,25 % ≤ C < 2,5 %

R52-53: 0,025 % ≤ C < 0,25 %
012-001-00-3magnesium powder (pyrophoric)231-104-67439-95-4F; R15-17F

R: 15-17

S: (2-)7/8-43
012-002-00-9magnesium, powder or turnings231-104-6F; R11-15F

R: 11-15

S: (2-)7/8-43
012-003-00-4magnesium alkylsR14

F; R17

C; R34
F; C

R: 14-17-34

S: (1/2-)16-43-45
A
013-001-00-6aluminium powder (pyrophoric)231-072-37429-90-5F; R15-17F

R: 15-17

S: (2-)7/8-43
013-002-00-1aluminium powder (stabilised)231-072-3F; R15

R10 ⊗
F

R: 10-15

S: (2-)7/8-43
013-003-00-7aluminium chloride, anhydrous231-208-17446-70-0C; R34C

R: 34

S: (1/2-)7/8-28-45
013-004-00-2aluminium alkylsR14

F; R17

C; R34
F; C

R: 14-17-34

S: (1/2-)16-43-45
A
013-005-00-8diethyl(ethyldimethylsilanolato)aluminium401-160-855426-95-4F; R 15-17

R14

C; R35
F; C

R: 14/15-17-35

S: (1/2-)6-16-30-36/39-43-45
013-006-00-3(ethyl-3-oxobutanoato-O'1,O'3)(2-dimethylaminoethanolato)(1-methoxypropan-2-olato)aluminium(III), dimerised402-370-2R10

Xi; R41
Xi

R: 10-41

S: (2-)26-39
013-007-00-9poly(oxo(2-butoxyethyl-3-oxobutanoato-O'1,O'3)aluminium)403-430-0Xi; R41Xi

R: 41

S: (2-)26-39
013-008-00-4di-n-octylaluminium iodide408-190-07585-14-0R14

F; R17

C; R34

N; R50-53
F; C; N

R: 14-17-34-50/53

S: (1/2-)6-16-26-36/37/39-43-45-60-61
013-009-00-Xsodium((n-butyl)x(ethyl)y-1,5-dihydro)aluminate) x = 0,5, y = 1,5418-720-2F; R11-15-17

R14

Xn; R20

C; R35
F; C

R: 11-14/15-17-20-35

S: (1/2-)6-16-26-30-36/37/39-43-45
014-001-00-9trichlorosilane233-042-510025-78-2F+; R12

R14

F; R17

Xn; R20/22

R29

C; R35
F+; C

R: 12-14-17-20/22-29-35

S: (2-)7/9-16-26-36/37/39-43-45
Xn; R20/22: C ≥ 10 %

C; R35: C ≥ 10 %

C; R34: 5 % ≤ C < 10 %

Xi; R36/37/38: 1 % ≤ C < 5 %
014-002-00-4silicon tetrachloride233-054-010026-04-7R14

Xi; R36/37/38
Xi

R: 14-36/37/38

S: (2-)7/8-26
014-003-00-Xdimethyldichlorosilane200-901-075-78-5F; R11

Xi; R36/37/38
F; Xi

R: 11-36/37/38

S: (2-)
014-004-00-5trichloro(methyl)silane;

methyltrichlorosilane
200-902-675-79-6R14

F; R11

Xi; R36/37/38
F; Xi

R: 11-14-36/37/38

S: (2-)26-39
Xi; R36/37/38: C ≥ 1 %
014-005-00-0tetraethyl silicate;

ethyl silicate
201-083-878-10-4R10

Xn; R20

Xi; R36/37
Xn

R: 10-20-36/37

S: (2-)
014-006-00-6bis(4-fluorophenyl)-methyl-(1,2,4-triazol-4-ylmethyl)silane hydrochloride401-380-4Xi; R36

N; R51-53
Xi; N

R: 36-51/53

S: (2-)26-61
014-007-00-1triethoxyisobutylsilane402-810-317980-47-1Xi; R38Xi

R: 38

S: (2-)24
014-008-00-7(chloromethyl)bis(4-fluorophenyl)methylsilane401-200-485491-26-5N; R51-53N

R: 51/53

S: 61
014-009-00-2isobutylisopropyldimethoxysilane402-580-4111439-76-0R10

Xn; R20

Xi; R38
Xn

R: 10-20-38

S: (2-)25-26-36/37
014-010-00-8disodium metasilicate229-912-96834-92-0C; R34

Xi; R37
C

R: 34-37

S: (1/2-)13-24/25-36/37/39-45
014-011-00-3cyclohexyldimethoxymethylsilane402-140-117865-32-6Xi; R38

N; R51-53
Xi; N

R: 38-51/53

S: (2-)24-61
014-012-00-9bis(3-(trimethoxysilyl)propyl)amine403-480-3Xi; R41

N; R51-53
Xi; N

R: 41-51/53

S: (2-)24-26-39-61
014-013-00-4α-hydroxypoly(methyl-(3-(2,2,6,6-tetramethylpiperidin-4-yloxy)propyl)siloxane)404-920-7Xn; R21/22

C; R34

N; R51-53
C; N

R: 21/22-34-51/53

S: (1/2-)26-36/37/39-45-61
014-014-00-Xetacelasil (ISO);

6-(2-chloroethyl)-6-(2-methoxyethoxy)-2,5,7,10-tetraoxa-6-silaundecane;
253-704-737894-46-5Repr. Cat. 2; R61

Xn; R22-48/22
T

R: 61-22-48/22

S: 53-45
E
014-015-00-5α-trimethylsilanyl-ω-trimethylsiloxypoly[oxy(methyl-3-(2-(2-methoxypropoxy)propoxy)propylsilanediyl]-co-oxy(dimethylsilane))406-420-469430-40-6R53R: 53

S: 61
014-016-00-0reaction mass of: 1,3-dihex-5-en-1-yl-1,1,3,3-tetramethyldisiloxane;

1,3-dihex-n-en-1-yl-1,1,3,3-tetramethyldisiloxane
406-490-6N; R51-53N

R: 51/53

S: 61
014-017-00-6flusilazole (ISO);

bis(4-fluorophenyl)(methyl)(1H-1,2,4-triazol-1-ylmethyl)silane
85509-19-9Carc. Cat. 3; R40

Repr. Cat. 2; R61

Xn; R22

N; R51-53
T; N

R: 61-22-40-51/53

S: 53-45-61
E
014-018-00-1octamethylcyclotetrasiloxane209-136-7556-67-2Repr. Cat. 3; R62

R53
Xn

R: 53-62

S: (2-)36/37-46-51-61
014-019-00-7reaction mass of: 4-[[bis-(4-fluorophenyl)methylsilyl]methyl]-4H-1,2,4-triazole;

1-[[bis-(4-fluorophenyl)methylsilyl]methyl]-1H-1,2,4-triazole
403-250-2Carc. Cat. 3; R40

Repr. Cat. 2; R61

Xn; R22

N; R51-53
T; N

R: 61-22-40-51/53

S: 53-45-61
E
014-020-00-2bis(1,1-dimethyl-2-propynyloxy)dimethylsilane414-960-753863-99-3Xn; R20Xn

R: 20

S: (2)
014-021-00-8tris(isopropenyloxy)phenyl silane411-340-852301-18-5N; R50-53N

R: 50/53

S: 60-61
014-022-00-3reaction product of: (2-hydroxy-4-(3-propenoxy)benzophenone and triethoxysilane) with (hydrolysis product of silica and methyltrimethoxysilane)401-530-9F; R11

T; R39/23/24/25

Xn; R20/21/22
F; T

R: 11-20/21/22-39/23/24/25

S: (1/2-)16-29-36/37-45
014-023-00-9α, ω-dihydroxypoly(hex-5-en-1-ylmethylsiloxane)hoxysilane with (hydrolysis product of silica and methyltrimethoxysilane)iazole408-160-7125613-45-8N; R51-53N

R: 51/53

S: 61
014-024-00-41-((3-(3-chloro-4-fluorophenyl)propyl)dimethylsilanyl)-4-ethoxybenzene412-620-2121626-74-2N; R51-53N

R: 51/53

S: 61
014-025-00-X4-[3-(diethoxymethylsilylpropoxy)-2,2,6,6-tetramethyl]piperidine411-400-3102089-33-8Xn; R22-48/21

Xi; R38-41

R52-53
Xn

R: 22-38-41-48/21-52/53

S: (2-)26-36/37/39-61
014-026-00-5dichloro-(3-(3-chloro-4-fluorophenyl)propyl)methylsilane407-180-3770722-36-6C; R35C

R: 35

S: (1/2-)26-36/37/39-45
014-027-00-0chloro(3-(3-chloro-4-fluorophenyl)propyl)dimethylsilane410-270-5770722-46-8C; R35C

R: 35

S: (1/2-)8-26-28-36/37/39-45
014-028-00-6α-[3-(1-oxoprop-2-eny)l-1-oxypropyl]dimethoxysilyloxy-ω-[3(1-oxoprop-2-enyl)-1-oxypropyl]dimethoxysilyl poly(dimethylsiloxane)415-290-8193159-06-7R43Xi

R: 43

S: (2-)24-37
014-029-00-1O,O'-(ethenylmethylsilylene)di[(4-methylpentan-2-one)oxime]421-870-1156145-66-3Repr. Cat. 3; R62

Xn; R22-48/22
Xn

R: 22-48/22-62

S: (2-)36/37
014-030-00-7[(dimethylsilylene)bis((1,2,3,3a,7a-η)-1H-inden-1-ylidene)dimethyl]hafnium422-060-0137390-08-0T+; R28T+

R: 28

S: (1/2-)6-22-28-36/37-45
014-031-00-2bis(1-methylethyl)-dimethoxysilane421-540-718230-61-0R10

Xi; R38

R43

R52-53
Xi

R: 10-38-43-52/53

S: (2-)24-37-61
014-032-00-8dicyclopentyldimethoxysilane404-370-8126990-35-0Xi; R38-41

N; R50-53
Xi; N

R: 38-41-50/53

S: (2-)26-37/39-60-61
015-001-00-1white phosphorus231-768-712185-10-3F; R17

T+; R26/28

C; R35

N; R50
F; T+; C; N

R: 17-26/28-35-50

S: (1/2-)5-26-38-45-61
015-002-00-7red phosphorus231-768-77723-14-0F; R11

R16

R52-53
F

R: 11-16-52/53

S: (2-)7-43-61
015-003-00-2calcium phosphide;

tricalcium diphosphide
215-142-01305-99-3F; R15/29

T+; R28

N; R50
F; T+; N

R: 15/29-28-50

S: (1/2-)22-43-45-61
015-004-00-8aluminium phosphide244-088-020859-73-8F; R15/29

T+; R28

R32

N; R50
F; T+; N

R: 15/29-28-32-50

S: (1/2-)3/9/14-30-36/37-45-61
015-005-00-3magnesium phosphide;

trimagnesium diphosphide
235-023-712057-74-8F; R15/29

T+; R28

N; R50
F; T+; N

R: 15/29-28-50

S: (1/2-)22-43-45-61
015-006-00-9trizinc diphosphide;

zinc phosphide
215-244-51314-84-7F; R15/29

T+; R28

R32

N; R50-53
F; T+; N

R: 15/29-28-32-50/53

S: (1/2-)3/9/14-30-36/37-45-60-61
015-007-00-4phosphorus trichloride231-749-37719-12-2R14

T+; R26/28

Xn; R48/20

C; R35

R29
T+; C

R: 14-26/28-35-48/20

S: (1/2-)7/8-26-36/37/39-45
015-008-00-Xphosphorus pentachloride233-060-310026-13-8R14

T+; R26

Xn; R22-48/20

C; R34

R29
T+

R: 14-22-26-34-48/20

S: (1/2-)7/8-26-36/37/39-45
015-009-00-5phosphoryl trichloride233-046-710025-87-3R14

T+; R26

T; R48/23

Xn; R22

C; R35

R29
T+; C

R: 14-22-26-35-48/23

S: (1/2-)7/8-26-36/37/39-45
015-010-00-0phosphorus pentoxide215-236-11314-56-3C; R35C

R: 35

S: (1/2-)22-26-45
015-011-00-6phosphoric acid ... %, orthophosphoric acid ... %231-633-27664-38-2C; R34C

R: 34

S: (1/2-)26-45
C; R34: C ≥ 25 %

Xi; R36/38: 10 % ≤ C < 25 %
B
015-012-00-1tetraphosphorus trisulphide;

phosphorus sesquisulphid
215-245-01314-85-8F; R11

Xn; R22

N; R50
F; Xn; N

R: 11-22-50

S: (2-)7-16-24/25-61
015-013-00-7triethyl phosphate201-114-578-40-0Xn; R22Xn

R: 22

S: (2-)25
015-014-00-2tributyl phosphate204-800-2126-73-8Carc. Cat. 3; R40

Xn; R22

Xi; R38
Xn

R: 22-38-40

S: (2-)36/37-46
015-015-00-8tricresyl phosphate (o-o-o-, o-o-m-, o-o-p-, o-m-m-, o-m-p-, o-p-p-);

tritolyl phosphate (o-o-o-, o-o-m-, o-o-p-, o-m-m-, o-m-p-, o-p-p-);
201-103-578-30-8T; R39/23/24/25

N; R51-53
T; N

R: 39/23/24/25-51/53

S: (1/2-)20/21-28-45-61
T; R39/23/24/25: C ≥ 1 %

Xn; R68/20/21/22: 0,2 % ≤ C < 1 %
C
015-016-00-3tricresyl phosphate (m-m-m-, m-m-p-, m-p-p-, p-p-p-);

tritolyl phosphate (m-m-m-, m-m-p-, m-p-p-, p-p-p-);
201-105-678-32-0Xn; R21/22

N; R51-53
Xn; N

R: 21/22-51/53

S: (2-)28-61
Xn; R21/22: C ≥ 5 %C
015-019-00-Xdichlorvos (ISO);

2,2-dichlorovinyl dimethyl phosphate
200-547-762-73-7T+; R26

T; R24/25

R43

N; R50
T+; N

R: 24/25-26-43-50

S: (1/2-)28-36/37-45-61
015-020-00-5mevinphos (ISO);

2-methoxycarbonyl-1-methylvinyl dimethyl phosphate
232-095-17786-34-7T+; R27/28

N; R50-53
T+; N

R: 27/28-50/53

S: (1/2-)23-28-36/37-45-60-61
N; R50-53: C ≥ 0,0025 %

N; R51-53: 0,00025 % ≤ C < 0,0025 %

R52-53: 0,000025 % ≤ C < 0,00025 %
015-021-00-0trichlorfon (ISO);

dimethyl 2,2,2-trichloro-1-hydroxyethylphosphonate
200-149-352-68-6Xn; R22

R43

N; R50-53
Xn; N

R: 22-43-50/53

S: (2-)24-37-60-61
N; R50-53: C ≥ 0,025 %

N; R51-53: 0,0025 % ≤ C < 0,025 %

R52-53: 0,00025 % ≤ C < 0,0025 %
015-022-00-6phosphamidon (ISO);

2-chloro-2-diethylcarbamoyl-1-methylvinyl dimethyl phosphate
236-116-513171-21-6T+; R28

T; R24

Muta. Cat. 3; R68

N; R50-53
T+; N

R: 24-28-50/53-68

S: (1/2-)23-36/37-45-60-61
015-023-00-1pyrazoxon;

diethyl 3-methylpyrazol-5-yl phosphate
108-34-9T+; R26/27/28T+

R: 26/27/28

S: (1/2-)13-28-45
015-024-00-7triamiphos (ISO);

5-amino-3-phenyl-1,2,4-triazol-1-yl-N,N,N',N'-tetramethylphosphonic diamide
1031-47-6T+; R27/28T+

R: 27/28

S: (1/2-)22-28-36/37-45
015-025-00-2TEPP (ISO);

tetraethyl pyrophosphate
203-495-3107-49-3T+; R27/28

N; R50
T+; N

R: 27/28-50

S: (1/2-)36/37/39-38-45-61
015-026-00-8schradan (ISO);

octamethylpyrophosphoramide
205-801-0152-16-9T+; R27/28T+

R: 27/28

S: (1/2-)36/37-38-45
015-027-00-3sulfotep (ISO);

O,O,O,O-tetraethyl dithiopyrophosphate
222-995-23689-24-5T+; R27/28

N; R50-53
T+; N

R: 27/28-50/53

S: (1/2-)23-28-36/37-45-60-61
N; R50-53: C ≥ 0,025 %

N; R51-53: 0,0025 % ≤ C < 0,025 %

R52-53: 0,00025 % ≤ C < 0,0025 %
015-028-00-9demeton-O (ISO);

O,O-diethyl-O-2-ethylthioethyl phosphorothioate
206-053-8298-03-3T+; R27/28

N; R50
T+; N

R: 27/28-50

S: (1/2-)28-36/37-45-61
015-029-00-4demeton-S (ISO);

diethyl-S-2-ethylthioethyl phosphorothioate
204-801-8126-75-0T+; R27/28T+

R: 27/28

S: (1/2-)28-36/37-45
015-030-00-Xdemeton-O-methyl (ISO);

O-2-ethylthioethyl O,O-dimethyl phosphorothioate
212-758-1867-27-6T; R25T

R: 25

S: (1/2-)24-36/37-45
015-031-00-5demeton-S-methyl (ISO);

S-2-ethylthioethyl dimethyl phosphorothioate
213-052-6919-86-8T; R24/25

N; R51-53
T; N

R: 24/25-51/53

S: (1/2-)28-36/37-45-61
015-032-00-0prothoate (ISO);

O,O-diethyl isopropylcarbamoylmethyl phosphorodithioate
218-893-22275-18-5T+; R27/28

R52-53
T+

R: 27/28-52/53

S: (1/2-)28-36/37-45-61
015-033-00-6phorate (ISO);

O,O-diethyl ethylthiomethyl phosphorodithioate
206-052-2298-02-2T+; R27/28

N; R50-53
T+; N

R: 27/28-50/53

S: (1/2-)28-36/37-45-60-61
N; R50-53: C ≥ 0,025 %

N; R51-53: 0,0025 % ≤ C < 0,025 %

R52-53: 0,00025 % ≤ C < 0,0025 %
015-034-00-1parathion (ISO);

O,O-diethyl O-4-nitrophenyl phosphorothioate
200-271-756-38-2T+; R26/28

T; R24-48/25

N; R50-53
T+; N

R: 24-26/28-48/25-50/53

S: (1/2-)28-36/37-45-60-61
N; R50-53: C ≥ 0,25 %

N; R51-53: 0,025 % ≤ C < 0,25 %

R52-53: 0,0025 % ≤ C < 0,025 %
015-035-00-7parathion — methyl (ISO);

O,O-dimethyl O-4-nitrophenyl phosphorothioate
206-050-1298-00-0R5

R10

T+; R26/28

T; R24

Xn; R48/22

N; R50-53
T+; N

R: 5-10-24-26/28-48/22-50/53

S: (1/2-)28-36/37-45-60-61
N; R50-53: C ≥ 0,25 %

N; R51-53: 0,025 % ≤ C < 0,25 %

R52-53: 0,0025 % ≤ C < 0,025 %
015-036-00-2O-ethyl O-4-nitrophenyl phenylphosphonothioate;

EPN
218-276-82104-64-5T+; R27/28

N; R50-53
T+; N

R: 27/28-50/53

S: (1/2-)22-36/37-45-60-61
015-037-00-8phenkapton (ISO);

S-(2,5-dichlorophenylthiomethyl) O,O-diethyl phosphorodithioate
218-892-72275-14-1T; R23/24/25

N; R50-53
T; N

R: 23/24/25-50/53

S: (1/2-)13-45-60-61
015-038-00-3coumaphos (ISO);

O-3-chloro-4-methylcoumarin-7-yl O,O-diethyl phosphorothioate
200-285-356-72-4T+; R28

Xn; R21

N; R50-53
T+; N

R: 21-28-50/53

S: (1/2-)28-36/37-45-60-61
015-039-00-9azinphos-methyl (ISO);

O,O-dimethyl-4-oxobenzotriazin-3-ylmethyl phosphorodithioate
201-676-186-50-0T+; R26/28

T; R24

R43

N; R50-53
T+; N

R: 24-26/28-43-50/53

S: (1/2-)28-36/37-45-60-61
015-040-00-4diazinon (ISO);

O,O-diethyl O-2-isopropyl-6-methylpyrimidin-4-yl phosphorothioate
206-373-8333-41-5Xn; R22

N; R50-53
Xn; N

R: 22-50/53

S: (2-)24/25-60-61
015-041-00-Xmalathion (ISO);

1,2-bis (ethoxycarbonyl) ethyl O,O-dimethyl phosphorodithioate
204-497-7121-75-5Xn; R22

N; R50-53
Xn; N

R: 22-50/53

S: (2-)24-60-61
N; R50-53: C ≥ 0,25 %

N; R51-53: 0,025 % ≤ C < 0,25 %

R52-53: 0,0025 % ≤ C < 0,025 %
015-042-00-5chlorthion

O-(3-chloro-4-nitrophenyl) O,O-dimethyl phosphorothioate
207-902-5500-28-7Xn; R20/21/22

N; R50-53
Xn; N

R: 20/21/22-50/53

S: (2-)13-60-61
N; R50-53: C ≥ 0,25 %

N; R51-53: 0,025 % ≤ C < 0,25 %

R52-53: 0,0025 % ≤ C < 0,025 %
015-043-00-0phosnichlor (ISO);

O-4-chloro-3-nitrophenyl O,O-dimethyl phosphorothioate
5826-76-6Xn; R20/21/22Xn

R: 20/21/22

S: (2-)13
015-044-00-6carbophenothion (ISO);

4-chlorophenylthiomethyl O,O-diethyl phosphorodithioate
212-324-1786-19-6T; R24/25

N; R50-53
T; N

R: 24/25-50/53

S: (1/2-)28-36/37-45-60-61
015-045-00-1mecarbam (ISO);

N-ethoxycarbonyl-N-methylcarbamoylmethyl O,O-diethyl phosphorodithioate
219-993-92595-54-2T; R24/25

N; R50-53
T; N

R: 24/25-50/53

S: (1/2-)36/37-45-60-61
015-046-00-7oxydemeton-methyl;

S-2-(ethylsulphinyl)ethyl O,O-dimethyl phosphorothioate
206-110-7301-12-2T; R24/25

N; R50
T; N

R: 24/25-50

S: (1/2-)23-36/37-45-61
015-047-00-2ethion (ISO);

O,O,O',O'-tetraethyl S,S'-methylenedi (phosphorodithioate);

diethion
209-242-3563-12-2T; R25

Xn; R21

N; R50-53
T; N

R: 21-25-50/53

S: (1/2-)25-36/37-45-60-61
N; R50-53: C ≥ 0,0025 %

N; R51-53: 0,00025 % ≤ C < 0,0025 %

R52-53: 0,000025 % ≤ C < 0,00025 %
015-048-00-8fenthion (ISO);

O,O-dimethyl-O-(4-methylthion-m-tolyl) phosphorothioate
200-231-955-38-9Muta. Cat. 3; R68

T; R23-48/25

Xn; R21/22

N; R50-53
T; N

R: 21/22-23-48/25-50/53-68

S: (1/2-)36/37-45-60-61
015-049-00-3endothion (ISO);

S-5-methoxy-4-oxopyran-2-ylmethyl dimethyl phosphorothioate
220-472-32778-04-3T; R24/25T

R: 24/25

S: (1/2-)36/37-45
015-050-00-9thiometon (ISO);

S-2-ethylthioethyl O,O-dimethyl phosphorodithioate
211-362-6640-15-3T; R25

Xn; R21
T

R: 21-25

S: (1/2-)36/37-45
015-051-00-4dimethoate (ISO);

O,O-dimethyl methylcarbamoylmethyl phosphorodithioate
200-480-360-51-5Xn; R21/22Xn

R: 21/22

S: (2-)36/37
015-052-00-Xfenchlorphos (ISO);

O,O-dimethyl O-2,4,5-trichlorophenyl phosphorothioate
206-082-6299-84-3Xn; R21/22

N; R50-53
Xn; N

R: 21/22-50/53

S: (2-)25-36/37-60-61
015-053-00-5menazon (ISO);

S-[(4,6-diamino-1,3,5-triazin-2-yl)methyl] O,O-dimethyl phosphorodithioate
201-123-478-57-9Xn; R22

R52-53
Xn

R: 22-52/53

S: (2-)61
015-054-00-0fenitrothion (ISO);

O,O-dimethyl O-4-nitro-m-tolyl phosphorothioate
204-524-2122-14-5Xn; R22

N; R50-53
Xn; N

R: 22-50/53

S: (2-)60-61
015-055-00-6naled (ISO);

1,2-dibromo-2,2-dichloroethyl dimethyl phosphate
206-098-3300-76-5Xn; R21/22

Xi; R36/38

N; R50
Xn; N

R: 21/22-36/38-50

S: (2-)36/37-61
N; R50: C ≥ 0,025 %
015-056-00-1azinphos-ethyl (ISO);

O,O-diethyl 4-oxobenzotriazin-3-ylmethyl phosphorodithioate
220-147-62642-71-9T+; R28

T; R24

N; R50-53
T+; N

R: 24-28-50/53

S: (1/2-)28-36/37-45-60-61
015-057-00-7formothion (ISO);

N-formyl-N-methylcarbamoylmethyl O,O-dimethyl phosphorodithioate
219-818-62540-82-1Xn; R21/22Xn

R: 21/22

S: (2-)36/37
015-058-00-2morphothion (ISO);

O,O-dimethyl-S-(morpholinocarbonylmethyl) phosphorodithioate
205-628-0144-41-2T; R23/24/25

N; R50-53
T; N

R: 23/24/25-50/53

S: (1/2-)13-45-60-61
015-059-00-8vamidothion (ISO);

O,O-dimethyl S-2-(1-methylcarbamoylethylthio) ethyl phosphorothioate
218-894-82275-23-2T; R25

Xn; R21

N; R50
T; N

R: 21-25-50

S: (1/2-)36/37-45-61
015-060-00-3disulfoton (ISO);

O,O-diethyl 2-ethylthioethyl phosphorodithioate
206-054-3298-04-4T+; R27/28

N; R50-53
T+; N

R: 27/28-50/53

S: (1/2-)28-36/37-45-60-61
015-061-00-9dimefox (ISO);

tetramethylphosphorodiamidic fluoride
204-076-8115-26-4T+; R27/28T+

R: 27/28

S: (1/2-)23-28-36/37-38-45
015-062-00-4mipafox (ISO);

N,N'- di-isopropylphosphorodiamidic fluoride
206-742-3371-86-8T+; R39/26/27/28T+

R: 39/26/27/28

S: (1/2-)13-45
015-063-00-Xdioxathion (ISO);

1,4-dioxan-2,3-diyl-O,O,O',O'-tetraethyl di(phosphorodithioate)
201-107-778-34-2T+; R26/28

T; R24

N; R50-53
T+; N

R: 24-26/28-50/53

S: (1/2-)28-36/37-45-60-61
N; R50-53: C ≥ 0,025 %

N; R51-53: 0,0025 % ≤ C < 0,025 %

R52-53: 0,00025 % ≤ C < 0,0025 %
015-064-00-5bromophos-ethyl (ISO);

O-4-bromo-2,5-dichlorophenyl O,O-diethyl phosphorothioate
225-399-04824-78-6T; R25

Xn; R21

N; R50-53
T; N

R: 21-25-50/53

S: (1/2-)28-36/37-45-60-61
015-065-00-0S-[2-(ethylsulphinyl)ethyl] O,O-dimethyl phosphorodithioate2703-37-9T+; R26/27/28

N; R51-53
T+; N

R: 26/27/28-51/53

S: (1/2-)13-28-45-61
015-066-00-6omethoate (ISO);

O,O-dimethyl S-methylcarbamoylmethyl phosphorothioate
214-197-81113-02-6T; R25

Xn; R21

N; R50
T; N

R: 21-25-50

S: (1/2-)23-36/37-45-61
015-067-00-1phosalone (ISO);

S-(6-chloro-2-oxobenzoxazolin-3-ylmethyl) O,O-diethyl phosphorodithioate
218-996-22310-17-0T; R25

Xn; R21

N; R50-53
T; N

R: 21-25-50/53

S: (1/2-)36/37-45-60-61
015-068-00-7dichlofenthion (ISO);

O-,4-dichlorophenyl O,O-diethyl phosphorothioate
202-564-597-17-6Xn; R22

N; R50-53
Xn; N

R: 22-50/53

S: (2-)60-61
015-069-00-2methidathion (ISO);

2,3-dihydro-5-methoxy-2-oxo-1,3,4-thiadiazol-3-ylmethyl-O,O-dimethylphosphorodithioate
213-449-4950-37-8T+; R28

Xn; R21

N; R50-53
T+; N

R: 21-28-50/53

S: (1/2-)22-28-36/37-45-60-61
015-070-00-8cyanthoate (ISO);

S-(N-(1-cyano-1-methylethyl)carbamoylmethyl) O,O-diethyl phosphorothioate
223-099-43734-95-0T+; R28

T; R24
T+

R: 24-28

S: (1/2-)36/37-45
015-071-00-3chlorfenvinphos (ISO);

2-chloro-1-(2,4 dichlorophenyl) vinyl diethyl phosphate
207-432-0470-90-6T+; R28

T; R24

N; R50-53
T+; N

R: 24-28-50/53

S: (1/2-)28-36/37-45-60-61
015-072-00-9monocrotophos (ISO);

dimethyl-1-methyl-2-(methylcarbamoyl)vinyl phosphate
230-042-76923-22-4Muta. Cat. 3; R68

T+; R26/28

T; R24

N; R50-53
T+; N

R: 24-26/28-50/53-68

S: (1/2-)36/37-45-60-61
015-073-00-4dicrotophos (ISO);

(Z)-2-dimethylcarbamoyl-1-methylvinyl dimethyl phosphate
205-494-3141-66-2T+; R28

T; R24

N; R50-53
T+; N

R: 24-28-50/53

S: (1/2-)28-36/37-45-60-61
015-074-00-Xcrufomate (ISO);

4-tert-butyl-2-chlorophenyl methyl methylphosphoramidate
206-083-1299-86-5Xn; R21/22

N; R50-53
Xn; N

R: 21/22-50/53

S: (2-)36/37-60-61
015-075-00-5S-[2-(isopropylsulphinyl)ethyl] O,O-dimethyl phosphorothioate2635-50-9T; R23/24/25T

R: 23/24/25

S: (1/2-)13-45
015-076-00-0potasan;

O,O-diethyl O-(4-methylcoumarin-7-yl) phosphorothioate
299-45-6T+; R26/27/28

N; R50-53
T+; N

R: 26/27/28-50/53

S: (1/2-)13-28-45-60-61
N; R50-53: C ≥ 0,025 %

N; R51-53: 0,0025 % ≤ C < 0,025 %

R52-53: 0,00025 % ≤ C < 0,0025 %
015-077-00-62,2-dichlorovinyl 2-ethylsulphinylethyl methyl phosphate7076-53-1T; R23/24/25T

R: 23/24/25

S: (1/2-)13-45
015-078-00-1demeton-S-methylsulphon (ISO);

S-2-ethylsulphonylethyl dimethyl phosphorothioate
241-109-517040-19-6T; R25

Xn; R21

N; R51-53
T; N

R: 21-25-51/53

S: (1/2-)22-28-36/37-45-61
015-079-00-7acephate (ISO);

O,S-dimethyl acetylphosphoramidothioate
250-241-230560-19-1Xn; R22Xn

R: 22

S: (2-)36
015-080-00-2amidithion (ISO);

2-methoxyethylcarbamoylmethyl O,O-dimethyl phosphorodithioate
919-76-6Xn; R22Xn

R: 22

S: (2-)24-36
015-081-00-8O,O,O',O'-tetrapropyl dithiopyrophosphate221-817-03244-90-4Xn; R21/22

N; R50-53
Xn; N

R: 21/22-50/53

S: (2-)36/37-60-61
015-082-00-3azothoate (ISO);

O-4-(4-chlorophenylazo)phenyl O,O-dimethyl phosphorothioate
227-419-35834-96-8Xn; R20/22Xn

R: 20/22

S: (2-)13
015-083-00-9bensulide (ISO);

O,O-diisopropyl 2-phenylsulphonylaminoethyl phosphorodithioate
212-010-4741-58-2Xn; R22

N; R50-53
Xn; N

R: 22-50/53

S: (2-)24-36-60-61
015-084-00-4chlorpyrifos (ISO);

O,O-diethyl O-3,5,6-trichloro-2-pyridyl phosphorothioate
220-864-42921-88-2T; R25

N; R50-53
T; N

R: 25-50/53

S: (1/2-)45-60-61
N; R50-53: C ≥ 0,0025 %

N; R51-53: 0,00025 % ≤ C < 0,0025 %

R52-53: 0,000025 % ≤ C < 0,00025 %
015-085-00-Xchlorphonium chloride (ISO);

tributyl (2,4-dichlorobenzyl) phosphonium chloride
204-105-4115-78-6T; R25

Xn; R21

Xi; R36/38
T

R: 21-25-36/38

S: (1/2-)36/37/39-45
015-086-00-5coumithoate (ISO);

O,O-diethyl O-,8,9,10-tetrahydro-6-oxo-benzo(c)chromen-3-yl phosphorothioate
572-48-5T; R25T

R: 25

S: (1/2-)28-36/37-45
015-087-00-0cyanophos (ISO);

O-4-cyanophenyl O,O-dimethyl phosphorothioate
220-130-32636-26-2Xn; R21/22

N; R50-53
Xn; N

R: 21/22-50/53

S: (2-)36/37-60-61
015-088-00-6dialifos (ISO);

2-chloro-1-phthalimidoethyl O,O-diethyl phosphorodithioate
233-689-310311-84-9T+; R28

T; R24

N; R50-53
T+; N

R: 24-28-50/53

S: (1/2-)28-36/37-45-60-61
015-089-00-1ethoate-methyl (ISO);

ethylcarbamoylmethyl O,O-dimethyl phosphorodithioate
204-121-1116-01-8Xn; R21/22Xn

R: 21/22

S: (2-)36/37
015-090-00-7fensulfothion (ISO);

O,O-diethyl O-4-methylsulfinylphenyl phosphorothioate
204-114-3115-90-2T+; R27/28

N; R50-53
T+; N

R: 27/28-50/53

S: (1/2-)23-28-36/37-45-60-61
015-091-00-2fonofos (ISO);

O-ethyl phenyl ethylphosphonodithioate
213-408-0944-22-9T+; R27/28

N; R50-53
T+; N

R: 27/28-50/53

S: (1/2-)28-36/37-45-60-61
015-092-00-8phosacetim (ISO);

O,O-bis(4-chlorophenyl) N-acetimidoylphosphoramidothioate
223-874-74104-14-7T+; R27/28

N; R50-53
T+; N

R: 27/28-50/53

S: (1/2-)28-36/37-45-60-61
015-093-00-3leptophos (ISO);

O-4-bromo-2,5-dichlorophenyl O-methyl phenylphosphorothioate
244-472-821609-90-5T; R25-39/25

Xn; R21

N; R50-53
T; N

R: 21-25-39/25-50/53

S: (1/2-)25-36/37/39-45-60-61
015-094-00-9mephosfolan (ISO);

diethyl 4-methyl-1,3-dithiolan-2-ylidenephosphoramidate
213-447-3950-10-7T+; R27/28

N; R51-53
T+; N

R: 27/28-51/53

S: (1/2-)36/37/39-45-61
015-095-00-4methamidophos (ISO);

O,S-dimethyl phosphoramidothioate
233-606-010265-92-6T+; R26/28

T; R24

N; R50
T+; N

R: 24-26/28-50

S: (1/2-)28-36/37-45-61
015-096-00-Xoxydisulfoton (ISO);

O, O-diethyl S-2-ethylsulphinylethyl phosphorodithioate
219-679-12497-07-6T+; R28

T; R24

N; R50-53
T+; N

R: 24-28-50/53

S: (1/2-)28-36/37-45-60-61
N; R50-53: C ≥ 2,5 %

N; R51-53: 0,25 % ≤ C < 2,5 %

R52-53: 0,025 % ≤ C < 0,25 %
015-097-00-5phenthoate (ISO);

ethyl 2-(dimethoxyphosphinothioylthio)-2-phenylacetate
219-997-02597-03-7Xn; R21/22

N; R50-53
Xn; N

R: 21/22-50/53

S: (2-)22-36/37-60-61
N; R50-53: C ≥ 0,25 %

N; R51-53: 0,025 % ≤ C < 0,25 %

R52-53: 0,0025 % ≤ C < 0,025 %
015-098-00-0trichloronate (ISO);

O-ethyl O-2,4,5-trichlorophenyl ethylphosphonothioate
206-326-1327-98-0T+; R28

T; R24

N; R50-53
T+; N

R: 24-28-50/53

S: (1/2-)23-28-36/37-45-60-61
015-099-00-6pirimiphos-ethyl (ISO);

O,O-diethyl O-2-diethylamino-6-methylpyrimidin-4-yl phosphorothioate
245-704-023505-41-1T; R25

Xn; R21

N; R50-53
T; N

R: 21-25-50/53

S: (1/2-)23-36/37-45-60-61
015-100-00-Xphoxim (ISO);

α-(diethoxyphosphinothioylimino) phenylacetonitrile
238-887-314816-18-3Xn; R22

N; R50-53
Xn; N

R: 22-50/53

S: (2-)36-60-61
N; R50-53: C ≥ 0,025 %

N; R51-53: 0,0025 % ≤ C < 0,025 %

R52-53: 0,00025 % ≤ C < 0,0025 %
015-101-00-5phosmet (ISO);

O,O-dimethyl phthalimidomethyl S-phosphorodithioate
211-987-4732-11-6Xn; R21/22

N; R50-53
Xn; N

R: 21/22-50/53

S: (2-)22-36/37-60-61
N; R50-53: C ≥ 0,25 %

N; R51-53: 0,025 % ≤ C < 0,25 %

R52-53: 0,0025 % ≤ C < 0,025 %
015-102-00-0tris(2-chloroethyl) phosphate204-118-5115-96-8Carc. Cat. 3; R40

Xn; R22

N; R51-53
Xn; N

R: 22-40-51/53

S: (2-)36/37-61
015-103-00-6phosphorus tribromide232-178-27789-60-8R14

C; R34

Xi; R37
C

R: 14-34-37

S: (1/2-)26-45
015-104-00-1diphosphorus pentasulphide;

phosphorus pentasulphide
215-242-41314-80-3F; R11

R29

Xn; R20/22

N; R50
F; Xn; N

R: 11-20/22-29-50

S: (2-)61
015-105-00-7triphenyl phosphite202-908-4101-02-0Xi; R36/38

N; R50-53
Xi; N

R: 36/38-50/53

S: (2-)28-60-61
Xi; R36/38: C ≥ 5 %
015-106-00-2hexamethylphosphoric triamide;

hexamethylphosphoramide
211-653-8680-31-9Carc. Cat. 2; R45

Muta. Cat. 2; R46
T

R: 45-46

S: 53-45
Carc. Cat. 2; R45: C ≥ 0,01 %
015-107-00-8ethoprophos (ISO);

ethyl-S,S-dipropyl phosphorodithioate
236-152-113194-48-4T+; R26/27

T; R25

R43

N; R50-53
T+; N

R: 25-26/27-43-50/53

S: (1/2-)27/28-36/37/39-45-60-61
015-108-00-3bromophos (ISO);

O-4-bromo-2,5-dichlorophenyl O,O-dimethyl phosphorothioate
218-277-32104-96-3Xn; R22

N; R50-53
Xn; N

R: 22-50/53

S: (2-) 46-60-61
N; R50-53: C ≥ 0,25 %

N; R51-53: 0,025 % ≤ C < 0,25 %

R52-53: 0,0025 % ≤ C < 0,025 %
015-109-00-9crotoxyphos (ISO);

1-phenylethyl 3-(dimethoxyphosphinyloxy) isocrotonate
231-720-57700-17-6T; R24/25

N; R50-53
T; N

R: 24/25-50/53

S: (1/2-)28-36/37-45-60-61
N; R50-53: C ≥ 2,5 %

N; R51-53: 0,25 % ≤ C < 2,5 %

R52-53: 0,025 % ≤ C < 0,25 %
015-110-00-4cyanofenphos (ISO);

O-4-cyanophenyl O-ethyl phenylphosphonothioate
13067-93-1T; R25-39/25

Xn; R21

Xi; R36

N; R51-53
T; N

R: 21-25-36-39/25-51/53

S: (1/2-)36/37-45-61
015-111-00-Xphosfolan (ISO);

diethyl 1,3-dithiolan-2-ylidenephosphoramidate
213-423-2947-02-4T+; R27/28T+

R: 27/28

S: (1/2-)28-36/37-45
015-112-00-5thionazin (ISO);

O,O-diethyl O-pyrazin-2-yl phosphorothioate;
206-049-6297-97-2T+; R27/28T+

R: 27/28

S: (1/2-)36/37/39-38-45
015-114-00-6chlormephos (ISO);

S-chloromethyl O,O-diethyl phosphorodithioate
246-538-124934-91-6T+; R27/28

N; R50-53
T+; N

R: 27/28-50/53

S: (1/2-)28-36/37-45-60-61
015-115-00-1chlorthiophos (ISO)244-663-621923-23-9T+; R28

T; R24

N; R50-53
T+; N

R: 24-28-50/53

S: (1/2-)28-36/37-45-60-61
015-116-00-7demephion-O (ISO);

O,O-dimethyl O-2-methylthioethyl phosphorothioate
211-666-9682-80-4T+; R28

T; R24
T+

R: 24-28

S: (1/2-)28-36/37-45
015-117-00-2demephion-S (ISO);

O,O-dimethyl S-2-methylthioethyl phosphorothioate
219-971-92587-90-8T+; R28

T; R24
T+

R: 24-28

S: (1/2-)28-36/37-45
015-118-00-8demeton8065-48-3T+; R27/28

N; R50
T+; N

R: 27/28-50

S: (1/2-)28-36/37-45-61
015-119-00-3dimethyl 4-(methylthio)phenyl phosphate3254-63-5T+; R27/28T+

R: 27/28

S: (1/2-)28-36/37-45
015-120-00-9ditalimfos (ISO);

O,O-diethyl phthalimidophosphonothioate;
225-875-85131-24-8Xi; R38

R43
Xi

R: 38-43

S: (2-)36/37
015-121-00-4edifenphos (ISO);

O-ethyl S,S-diphenyl phosphorodithioate
241-178-117109-49-8T; R23/25

Xn; R21

R43

N; R50-53
T; N

R: 21-23/25-43-50/53

S: (1/2-)36/37-45-60-61
015-122-00-Xetrimfos (ISO);

O-6-ethoxy-2-ethylpyrimidin-4-yl O,O-dimethylphosphorothioate;
253-855-938260-54-7Xn; R22

N; R50-53
Xn; N

R: 22-50/53

S: (2-)60-61
N; R50-53: C ≥ 2,5 %

N; R51-53: 0,25 % ≤ C < 2,5 %

R52-53: 0,025 % ≤ C < 0,25 %
015-123-00-5fenamiphos (ISO);

ethyl-4-methylthio-m-tolyl isopropyl phosphoramidate
244-848-122224-92-6T+; R28

T; R24

N; R50-53
T+; N

R: 24-28-50/53

S: (1/2-)23-28-36/37-45-60-61
N; R50-53: C ≥ 0,25 %

N; R51-53: 0,025 % ≤ C < 0,25 %

R52-53: 0,0025 % ≤ C < 0,025 %
015-124-00-0fosthietan (ISO);

diethyl 1,3-dithietan-2-ylidenephosphoramidate;
244-437-721548-32-3T+; R27/28T+

R: 27/28

S: (1/2-)36/37-45
015-125-00-6glyphosine (ISO);

N,N-bis(phosphonomethyl)glycine
219-468-42439-99-8Xi; R41Xi

R: 41

S: (2-)26
015-126-00-1heptenophos (ISO);

7-chlorobicyclo(3.2.0)hepta-2,6-dien-6-yl dimethyl phosphate
245-737-023560-59-0T; R25

N; R50-53
T; N

R: 25-50/53

S: (1/2-)23-28-37-45-60-61
N; R50-53: C ≥ 0,25 %

N; R51-53: 0,025 % ≤ C < 0,25 %

R52-53: 0,0025 % ≤ C < 0,025 %
015-127-00-7iprobenfos (ISO);

S-benzyl diisopropyl phosphorothioate
247-449-026087-47-8Xn; R22

N; R51-53
Xn; N

R: 22-51/53

S: (2-)61
015-128-00-2IPSP;

S-ethylsulphinylmethyl O,O-diisopropylphosphorodithioate
5827-05-4T+; R27

T; R25

N; R50-53
T+; N

R: 25-27-50/53

S: (1/2-)28-36/37-45-60-61
N; R50-53: C ≥ 0,25 %

N; R51-53: 0,025 % ≤ C < 0,25 %

R52-53: 0,0025 % ≤ C < 0,025 %
015-129-00-8isofenphos (ISO);

O-ethyl O-2-isopropoxycarbonylphenyl-isopropylphosphoramidothioate
246-814-125311-71-1T; R24/25

N; R50-53
T; N

R: 24/25-50/53

S: (1/2-)36/37-45-60-61
N; R50-53: C ≥ 0,25 %

N; R51-53: 0,025 % ≤ C < 0,25 %

R52-53: 0,0025 % ≤ C < 0,025 %
015-130-00-3isothioate (ISO)

S-2-isopropylthioethyl O,O-dimethyl phosphorodithioate;
36614-38-7T; R24/25T

R: 24/25

S: (1/2-)28-36/37-45
015-131-00-9isoxathion (ISO);

O,O-diethyl O-5-phenylisoxazol-3-ylphosphorothioate
242-624-818854-01-8T; R24/25

N; R50-53
T; N

R: 24/25-50/53

S: (1/2-)28-36/37-45-60-61
015-132-00-4S-(chlorophenylthiomethyl) O,O-dimethylphosphorodithioate;

methylcarbophenothione
953-17-3T; R24/25

N; R50-53
T; N

R: 24/25-50/53

S: (1/2-)28-36/37-45-60-61
N; R50-53: C ≥ 0,025 %

N; R51-53: 0,0025 % ≤ C < 0,025 %

R52-53: 0,00025 % ≤ C < 0,0025 %
015-133-00-Xpiperophos (ISO);

S-2-methylpiperidinocarbonylmethyl-O,O-dipropyl phosphorodithioate
24151-93-7Xn; R22

N; R50-53
Xn; N

R: 22-50/53

S: (2-)60-61
N; R50-53: C ≥ 2,5 %

N; R51-53: 0,25 % ≤ C < 2,5 %

R52-53: 0,025 % ≤ C < 0,25 %
015-134-00-5pirimiphos-methyl (ISO);

O-(2-diethylamino-6-methylpyrimidin-4-yl) O,O-dimethyl phosphorothioate
249-528-529232-93-7Xn; R22

N; R50-53
Xn; N

R: 22-50/53

S: (2-)60-61
015-135-00-0profenofos (ISO);

O-(4-bromo-2-chlorophenyl) O-ethyl S-propyl phosphorothioate
255-255-241198-08-7Xn; R20/21/22

N; R50-53
Xn; N

R: 20/21/22-50/53

S: (2-)36/37-60-61
N; R50-53: C ≥ 0,025 %

N; R51-53: 0,0025 % ≤ C < 0,025 %

R52-53: 0,00025 % ≤ C < 0,0025 %
015-136-00-6trans-isopropyl-3-[[(ethylamino)methoxyfosfinothioyl]oxy]crotonate;

isopropyl 3-[[(ethylamino)methoxyphosphinothioyl]oxy]isocrotonate;

propetamphos (ISO)
250-517-231218-83-4T; R25

N; R50-53
T; N

R: 25-50/53

S: (1/2-)37-45-60-61
N; R50-53: C ≥ 0,25 %

N; R51-53: 0,025 % ≤ C < 0,25 %

R52-53: 0,0025 % ≤ C < 0,025 %
015-137-00-1pyrazophos (ISO);

O,O-diethyl O-(6-ethoxycarbonyl-5-methylpyrazolo[2,3-a]pyrimidin-2-yl) phosphorothioate
236-656-113457-18-6Xn; R20/22

N; R50-53
Xn; N

R: 20/22-50/53

S: (2-)36/37-46-60-61
015-138-00-7quinalphos (ISO);

O,O-diethyl-O-quinoxalin-2-yl phosphorothioate
237-031-613593-03-8T; R25

Xn; R21

N; R50-53
T; N

R: 21-25-50/53

S: (1/2-)22-36/37-45-60-61
N; R50-53: C ≥ 0,025 %

N; R51-53: 0,0025 % ≤ C < 0,025 %

R52-53: 0,00025 % ≤ C < 0,0025 %
015-139-00-2terbufos (ISO)

S-tert-butylthiomethyl O,O-diethylphosphorodithioate;
235-963-813071-79-9T+; R27/28

N; R50-53
T+; N

R: 27/28-50/53

S: (1/2-)36/37-45-60-61
N; R50-53: C ≥ 0,025 %

N; R51-53: 0,0025 % ≤ C < 0,025 %

R52-53: 0,00025 % ≤ C < 0,0025 %
015-140-00-8triazophos (ISO);

O,O-diethyl-O-1-phenyl-1H,2,4-triazol-3-yl phosphorothioate
245-986-524017-47-8T; R23/25

Xn; R21

N; R50-53
T; N

R: 21-23/25-50/53

S: (1/2-)36/37-45-60-61
015-141-00-3ethylenediammonium O,O-bis(octyl) phosphorodithioate, mixed isomers400-520-1C; R34

Xn; R22

N; R50-53
C; N

R: 22-34-50/53

S: (1/2-)24/25-26-28-39-45-60-61
015-142-00-9butyl (dialkyloxy(dibutoxyphosphoryloxy))titanium (trialkyloxy)titanium phosphate401-100-0F; R11

Xi; R36

N; R51-53
F; Xi; N

R: 11-36-51/53

S: (2-)7/9-16-26-43-61
015-143-00-4reaction mass of 2-chloroethyl chloropropyl 2-chloroethylphosphonate, mixture reaction mass of isomers and 2-chloroethyl chloropropyl 2-chloropropylphosphonate, reaction mass of isomers401-740-0Xn; R22Xn

R: 22

S: (2-)
015-144-00-Xreaction mass of pentyl methylphosphinate and 2-methylbutyl methylphosphinate402-090-087025-52-3C; R34C

R: 34

S: (1/2-)26-36/37/39-45
015-145-00-5reaction mass of copper(I) O,O-diisopropyl phosphorodithioate and copper(I) O-isopropyl O-(4-methylpent-2-yl) phosphorodithioate and copper(I) O,O-bis(4-methylpent-2-yl) phosphorodithioate401-520-4N; R50-53N

R: 50/53

S: 60-61
015-146-00-0S-(tricyclo(5.2.1.02,6)deca-3-en-8(or 9)-yl O-(isopropyl or isobutyl or 2-ethylhexyl) O-(isopropyl or isobutyl or 2-ethylhexyl) phosphorodithioate401-850-9N; R50-53N

R: 50/53

S: 60-61
015-147-00-6reaction mass of C12-14-tert-alkylammonium diphenyl phosphorothioate and dinonyl sulphide (or disulphide)400-930-0Xi; R38-41

N; R51-53

R43
Xi; N

R: 38-41-43-51/53

S: (2-)24-26-37/39-61
015-148-00-12-(diphosphonomethyl)succinic acid403-070-451395-42-7C; R34

R43
C

R: 34-43

S: (1/2-)26-36/37/39-45
015-149-00-7reaction mass of: hexyldioctylphosphineoxide;

dihexyloctylphosphineoxide;

trioctylphosphineoxide
403-470-9C; R34

N; R50-53
C; N

R: 34-50/53

S: (1/2-)26-36/37/39-45-60-61
015-150-00-2(2-(1,3-dioxolan-2-yl)ethyl)triphenylphosphonium bromide404-940-686608-70-0Xn; R22

Xi; R41

R33

R52-53
Xn

R: 22-33-41-52/53

S: (2-)22-26-39-61
015-151-00-8tris(isopropyl/tert-butylphenyl) phosphate405-010-2N; R51-53N

R: 51/53

S: 61
015-152-00-3dioxabenzofos (ISO);

2-methoxy-4H-1,3,2-benzodioxaphosphorin 2-sulphide;
223-292-33811-49-2T; R24/25-39/25

N; R51-53
T; N

R: 24/25-39/25-51/53

S: (1/2-)36/37-38-45-61
015-153-00-9isazofos (ISO);

O-(5-chloro-1-isopropyl-1,2,4-triazol-3-yl) O,O-diethyl phosphorothioate;
255-863-842509-80-8T+; R26

T; R24/25

Xn; R48/20

R43

N; R50-53
T+; N

R: 24/25-26-43-48/20-50/53

S: (1/2-)28-36/37-38-45-59-61
015-154-00-42-chloroethylphosphonic acid;

ethephon
240-718-316672-87-0Xn; R20/21

C; R34

R52-53
C

R: 20/21-34-52/53

S: (1/2-)26-28-36/37/39-45-61
C; R34: C ≥ 10 %

Xi; R36/37/38: 5 % ≤ C < 10 %
015-155-00-Xammonium 2-amino-4-(hydroxymethylphosphinyl)butyrate;

glufosinate ammonium
278-636-577182-82-2Xn; R22Xn

R: 22

S: (2-)
015-156-00-5methyl 3-[(dimethoxyphosphinothioyl)oxy]methacrylate; [1]

methacrifos (ISO);

methyl (E)-3-[(dimethoxyphosphinothioyl)oxy]methacrylate [2]
250-366-9 [1]

- [2]
30864-28-9 [1]

62610-77-9 [2]
Xn; R22

R43

N; R50-53
Xn; N

R: 22-43-50/53

S: (2-)36/37-60-61
015-157-00-0phosphonic acid; [1]

phosphorous acid [2]
237-066-7 [1]

233-663-1 [2]
13598-36-2 [1]

10294-56-1 [2]
Xn; R22

C; R35
C

R: 22-35

S: (1/2-)26-36/37/39-45
015-158-00-6(η-cyclopentadienyl)(η-cumenyl)iron(1+)hexafluorophosphate(1-)402-340-932760-80-8R52-53R: 52/53

S: 61
015-159-00-1hydroxyphosphonoacetic acid405-710-823783-26-8Xn; R22-48/22

C; R34

R43
C

R: 22-34-43-48/22

S: (1/2-)22-26-36/37/39-45
015-160-00-7vanadyl pyrophosphate406-260-558834-75-6Xi; R36

R43

R52-53
Xi

R: 36-43-52/53

S: (2-)24-26-37-61
015-161-00-2divanadyl pyrophosphate407-130-065232-89-5Xn; R22

Xi; R41

R43

N; R51-53
Xn; N

R: 22-41-43-51/53

S: (2-)24-26-37/39-61
015-162-00-8vanadium(IV) oxide hydrogen phosphate hemihydrate, lithium, zinc, molybdenum, iron and chlorine-doped407-350-7Xn; R20-48/22

Xi; R41

N; R51-53
Xn; N

R: 20-41-48/22-51/53

S: (2-)22-26-36/39-61
015-163-00-3bis(2,6-dimethoxybenzoyl)-2,4,4-trimethylpentylphosphinoxide412-010-6145052-34-2R43

N; R50-53
Xi; N

R: 43-50/53

S: (2-)24-37-60-61
015-164-00-9calcium P,P'-(1-hydroxyethylene)bis(hydrogen phosphonate)dihydrate400-480-536669-85-9R52-53R: 52/53

S: 61
015-165-00-4reaction mass of: thiobis(4,1-phenylene)-S,S,S',S'-tetraphenyldisulfonium bishexafluorophosphate;

diphenyl(4-phenylthiophenyl)sulfonium hexafluorophosphate
404-986-7Xi; R41

N; R50-53
Xi; N

R: 41-50/53

S: (2-)15-26-39-60-61
015-166-00-X3,9-bis(2,6-di-tert-butyl-4-methylphenoxy)-2,4,8,10-tetraoxa-3,9-diphosphaspiro[5.5]undecane410-290-480693-00-1R53R: 53

S: 61
015-167-00-53-(hydroxyphenylphosphinyl)propanoic acid411-200-614657-64-8Xi; R41Xi

R: 41

S: (2-)26-39
015-168-00-0fosthiazate (ISO);

(RS)-S-sec-butyl-O-ethyl-2-oxo-1,3-thiazolidin-3-ylphosphonothioate
98886-44-3T; R23/25-39

Xn; R21

Xi; R41

R43

N; R50-53
T; N

R: 21-23/25-39-41-43-50/53

S: (1/2-)53-45-25-26-39-60-61
015-169-00-6tributyltetradecylphosphonium tetrafluoroborate413-520-1Xn; R22-48/22

C; R34

R43

N; R50-53
C; N

R: 22-34-43-48/22-50/53

S: (1/2-)26-28-36/37/39-45-60-61
015-170-00-1reaction mass of: di-(1-octane-N,N,N-trimethylammonium) octylphosphate;

1-octane-N,N,N-trimethylammonium di-octylphosphate;

1-octane-N,N,N-trimethylammonium octylphosphate
407-490-9Xn; R21/22

C; R34
C

R: 21/22-34

S: (1/2-)26-36/37/39-45
015-171-00-7O,O,O-tris(2(or 4)-C9-10-isoalkylphenyl) phosphorothioate406-940-1N; R51-53N

R: 51/53

S: 61
015-172-00-2reaction mass of: bis(isotridecylammonium)mono(di-(4-methylpent-2-yloxy)thiophosphorothionylisopropyl)phosphate;

isotridecylammonium bis(di-(4-methylpent-2-yloxy)thiophosphorothionylisopropyl)phosphate
406-240-6R10

C; R34

N; R51-53
C; N

R: 10-34-51/53

S: (1/2-)23-26-28-36/37/39-45-61
015-173-00-8methyl [2-(1,1-dimethylethyl)-6-methoxypyrimidin-4-yl]ethylphosphonothioate414-080-3117291-73-3Xn; R22

N; R50-53
Xn; N

R: 22-50/53

S: (2-)23-36-60-61
015-174-00-31-chloro-N,N-diethyl-1,1-diphenyl-1-(phenylmethyl)phosphoramine411-370-182857-68-9T; R25

Xi; R41

N; R51-53
T; N

R: 25-41-51/53

S: (1/2-)26-37/39-41-45-61
015-175-00-9tert-butyl (triphenylphosphoranylidene) acetate412-880-735000-38-5T; R25

Xn; R48/22

Xi; R36

R43

N; R51-53
T; N

R: 25-36-43-48/22-51/53

S: (1/2-)26-36/37/39-45-61
015-176-00-4P,P,P',P'-tetrakis-(o-methoxyphenyl)propane-1,3-diphosphine413-430-2116163-96-3N; R50-53N

R: 50/53

S: 60-61
015-177-00-X((4-phenylbutyl)hydroxyphosphoryl)acetic acid412-170-783623-61-4Xn; R48/22

Xi; R41

R43
Xn

R: 41-43-48/22

S: (2-)22-26-36/37/39
015-178-00-5(R)-α-phenylethylammonium (-)-(1R, 2S)-(1,2-epoxypropyl)phosphonate monohydrate418-570-825383-07-7Repr. Cat. 3; R62

N; R51-53
Xn; N

R: 62-51/53

S: (2-)22-36/37-61
015-179-00-0UVCB condensation product of: tetrakis-hydroxymethylphosphonium chloride, urea and distilled hydrogenated C16-18 tallow alkylamine422-720-8166242-53-1Carc. Cat. 3; R40

Xn; R22-48/22

C; R34

R43

N; R50-53
C; N

R: 22-34-40-43-48/22-50/53

S: (1/2-)26-36/37/39-45-60-61
015-180-00-6[R-(R*,S*)]-[[2-methyl-1-(1-oxopropoxy)propoxy]-(4-phenylbutyl)phosphinyl] acetic acid, (-)-cinchonidine (1:1) salt415-820-8137590-32-0Xi; R41

R43

R52-53
Xi

R: 41-43-52/53

S: (2-)24-26-37/39-61
015-181-00-1phosphine232-260-87803-51-2F+; R12

R17

T+; R26

C; R34

N; R50
F+; T+; N

R: 12-17-26-34-50

S: (1/2-)28-36/37-45-61-63
015-184-00-8Salts of glyphosate, with the exception of those specified elsewhere in this AnnexN; R51-53N

R: 51/53

S: 61
A
015-186-00-9chlorpyrifos-methyl (ISO),

O, O-dimethyl O-3,5,6-trichloro-2-pyridyl phosphorothioate
227-011-55598-13-0R43

N; R50-53
Xi; N

R: 43-50/53

S: (2-)36/37-60-61
N; R50-53: C ≥ 0,0025 %

N; R51-53: 0,00025 % ≤ C < 0,0025 %

R52-53: 0,000025 % ≤ C < 0,00025 %
015-187-00-4reaction mass of: tetrasodium(((2-hydroxyethyl)imino)bis(methylene))bisphosphonate, N-oxide;

trisodium ((tetrahydro-2-hydroxy-4H-1,4,2-oxazaphosphorin-4-yl)-methyl)phosphonate, N-oxide, P-oxide
417-540-1Xi; R41

N; R51-53
Xi; N

R: 41-51/53

S: (2-)26-39-61
015-189-00-5phenyl bis(2,4,6-trimethylbenzoyl)-phosphine oxide423-340-5162881-26-7R43

R53
Xi

R: 43-53

S: (2-)22-24-37-61
016-001-00-4hydrogen sulphide231-977-37783-06-4F+; R12

T+; R26

N; R50
F+; T+; N

R: 12-26-50

S: (1/2-)9-16-36-38-45-61
016-002-00-Xbarium sulphide244-214-421109-95-5R31

Xn; R20/22

N; R50
Xn; N

R: 20/22-31-50

S: (2-)28-61
016-003-00-5barium polysulphides256-814-350864-67-0R31

Xi; R36/37/38

N; R50
Xi; N

R: 31-36/37/38-50

S: (2-)28-61
016-004-00-0calcium sulphide243-873-520548-54-3R31

Xi; R36/37/38

N; R50
Xi; N

R: 31-36/37/38-50

S: (2-)28-61
016-005-00-6calcium polysulphides215-709-21344-81-6R31

Xi; R36/37/38

N; R50
Xi; N

R: 31-36/37/38-50

S: (2-)28-61
016-006-00-1dipotassium sulphide;

potassium sulphide
215-197-01312-73-8R31

C; R34

N; R50
C; N

R: 31-34-50

S: (1/2-)26-45-61
016-007-00-7potassium polysulphides253-390-137199-66-9R31

C; R34

N; R50
C; N

R: 31-34-50

S: (1/2-)26-45-61
016-008-00-2ammonium polysulphides232-989-19080-17-5R31

C; R34

N; R50
C; N

R: 31-34-50

S: (1/2-)26-45-61
C; R34: C ≥ 5 %

Xi; R36/38: 1 % ≤ C < 5 %

R31: C ≥ 1 %
016-009-00-8disodium sulphide;

sodium sulphide
215-211-51313-82-2R31

C; R34

N; R50
C; N

R: 31-34-50

S: (1/2-)26-45-61
016-010-00-3sodium polysulphides215-686-91344-08-7T; R25

R31

C; R34

N; R50
T; N

R: 25-31-34-50

S: (1/2-)26-36/37/39-45-61
016-011-00-9sulphur dioxide231-195-27446-09-5T; R23

C; R34
T

R: 23-34

S: (1/2-)9-26-36/37/39-45
T; R23: C ≥ 20 %

Xn; R20: 5 % ≤ C < 20 %
5
016-012-00-4disulphur dichloride;

sulfur monochloride
233-036-210025-67-9R14

T; R25

Xn; R20

R29

C; R35

N; R50
T; C; N

R: 14-20-25-29-35-50

S: (1/2-)26-36/37/39-45-61
C; R35: C ≥ 10 %

C; R34: 5 % ≤ C < 10 %

Xi; R36/37/38: 1 % ≤ C < 5 %
016-013-00-Xsulphur dichloride234-129-010545-99-0R14

C; R34

Xi; R37

N; R50
C; N

R: 14-34-37-50

S: (1/2-)26-45-61
016-014-00-5sulphur tetrachloride13451-08-6R14

C; R34

N; R50
C; N

R: 14-34-50

S: (1/2-)26-45-61
C; R34: C ≥ 10 %

Xi; R36/37/38: 5 % ≤ C < 10 %
016-015-00-0thionyl dichloride;

thionyl chloride
231-748-87719-09-7R14

Xn; R20/22

R29

C; R35
C

R: 14-20/22-29-35

S: (1/2-)26-36/37/39-45
C; R35: C ≥ 10 %

C; R34: 5 % ≤ C < 10 %

Xi; R36/37/38: 1 % ≤ C < 5 %
016-016-00-6sulphuryl chloride232-245-67791-25-5R14

C; R34

Xi; R37
C

R: 14-34-37

S: (1/2-)26-45
016-017-00-1chlorosulphonic acid232-234-67790-94-5R14

C; R35

Xi; R37
C

R: 14-35-37

S: (1/2-)26-45
016-018-00-7fluorosulphonic acid232-149-47789-21-1Xn; R20

C; R35
C

R: 20-35

S: (1/2-)26-45
016-019-00-2oleum ... % SO3R14

C; R35

Xi; R37
C

R: 14-35-37

S: (1/2-)26-30-45
B
016-020-00-8sulphuric acid ... %231-639-57664-93-9C; R35C

R: 35

S: (1/2-)26-30-45
C; R35: C ≥ 15 %

Xi; R36/38: 5 % ≤ C < 15 %
B
016-021-00-3methanethiol;

methyl mercaptan
200-822-174-93-1F+; R12

T; R23

N; R50-53
F+; T; N

R: 12-23-50/53

S: (2-)16-25-60-61
016-022-00-9ethanethiol;

ethyl mercaptan
200-837-375-08-1F; R11

Xn; R20

N; R50-53
F; Xn; N

R: 11-20-50/53

S: (2-)16-25-60-61
016-023-00-4dimethyl sulphate201-058-177-78-1Carc. Cat. 2; R45

Muta. Cat. 3; R68

T+; R26

T; R25

C; R34

R43
T+

R: 45-25-26-34-43-68

S: 53-45
Car. Cat. 2; R45: C ≥ 0,01 %

Muta. Cat. 3, R68: C ≥ 0,01 %

C; R34: C ≥ 10 %

Xi; R36/37/38: 5 % ≤ C < 10 %
E
016-024-00-Xdimexano (ISO);

bis(methoxythiocarbonyl) disulphide
215-993-81468-37-7Xn; R22

N; R50-53
Xn; N

R: 22-50/53

S: (2-)60-61
016-025-00-5disul (ISO);

2-(2,4-dichlorophenoxy)ethyl hydrogensulphate;

2,4-DES
205-259-5149-26-8Xn; R22

Xi; R38-41
Xn

R: 22-38-41

S: (2-)26
016-026-00-0sulphamidic acid;

sulphamic acid;

sulfamic acid
226-218-85329-14-6Xi; R36/38

R52-53
Xi

R: 36/38-52/53

S: (2-)26-28-61
016-027-00-6diethyl sulphate200-589-664-67-5Carc. Cat. 2; R45

Muta. Cat. 2; R46

Xn; R20/21/22

C; R34
T

R: 45-46-20/21/22-34

S: 53-45
E
016-028-00-1sodium dithionite;

sodium hydrosulphite
231-890-07775-14-6R7

R31

Xn; R22
Xn

R: 7-22-31

S: (2-)7/8-26-28-43
016-029-00-7p-toluenesulphonic acid, containing more than 5 % H2SO4C; R34C

R: 34

S: (1/2-)26-37/39-45
C; R34: C ≥ 25 %

Xi; R36/38: 10 % ≤ C < 25 %
016-030-00-2p-toluenesulphonic acid (containing a maximum of 5 % H2SO4)203-180-0104-15-4Xi; R36/37/38Xi

R: 36/37/38

S: (2-)26-37
016-031-00-8tetrahydrothiophene-1,1-dioxide;

sulpholane
204-783-1126-33-0Xn; R22Xn

R: 22

S: (2-)25
016-032-00-31,3-propanesultone;

1,2-oxathiolane 2,2-dioxide
214-317-91120-71-4Carc. Cat. 2; R45

Xn; R21/22
T

R: 45-21/22

S: 53-45
Carc. Cat. 2; R45: C ≥ 0,01 %E
016-033-00-9dimethylsulfamoylchloride236-412-413360-57-1Carc. Cat. 2; R45

T+; R26

Xn; R21/22

C; R34
T+

R: 45-21/22-26-34

S: 53-45
E
016-034-00-4tetrasodium 3,3'-(piperazine-1,4-diylbis((6-chloro-1,3,5-triazine-2,4-diyl)imino(2-acetamido)-4,1-phenyleneazo))bis(naphthalene-1,5-disulphonate)400-010-981898-60-4R43Xi

R: 43

S: (2-)22-24-37
016-035-00-Xpentasodium 5-anilino-3-(4-(4-(6-chloro-4-(3-sulphonatoanilino)-1,3,5-triazin-2-ylamino)-2,5-dimethylphenylazo)-2,5-disulphonatophenylazo)-4-hydroxynaphthalene-2,7-disulphonate400-120-7Xi; R36Xi

R: 36

S: (2-)22-26
016-036-00-5tetrasodium 5-(4,6-dichloro-5-cyanopyrimidin-2-ylamino)-4-hydroxy-2,3-azodinaphthalene-1,2,5,7-disulphonate400-130-1R42

N; R51-53
Xn; N

R: 42-51/53

S: (2-)22-61
016-037-00-0disodium 1-amino-4-(4-benzenesulphonamido-3-sulphonatoanilino)anthraquinone-2-sulphonate400-350-885153-93-1Xi; R41

R52-53
Xi

R: 41-52/53

S: (2-)26-39-61
016-038-00-6disodium 6-((4-chloro-6-(N-methyl)-2-toluidino)-1,3,5-triazin-2-ylamino)-1-hydroxy-2-(4-methoxy-2-sulphonatophenylazo)naphthalene-3-sulphonate400-380-186393-35-3R43Xi

R: 43

S: (2-)22-24-37
016-039-00-1tetrasodium 2-(6-chloro-4-(4-(2,5-dimethyl-4-(2,5-disulphonatophenylazo)phenylazo)-3-ureidoanilino)-1,3,5-triazin-2-ylamino)benzene-1,4-disulphonate400-430-2R43Xi

R: 43

S: (2-)22-24-37
016-040-00-7reaction mass of disodium 6-(2,4-dihydroxyphenylazo)-3-(4-(4-(2,4-dihydroxyphenylazo)anilino)-3-sulphonatophenylazo)-4-hydroxynaphthalene-2-sulphonate and disodium 6-(2,4-diaminophenylazo)-3-(4-(4-(2,4-diaminophenylazo)anilino)-3-sulphonatophenylazo)-4-hydroxynaphthalene-2-sulphonate and trisodium 6-(2,4-dihydroxyphenylazo)-3-(4-(4-(7-(2,4-dihydroxyphenylazo)-1-hydroxy-3-sulphonato-2-naphthylazo)anilino)-3-sulphonatophenylazo)-4-hydroxynaphthalene-2-sulphonate400-570-4Xi; R36Xi

R: 36

S: (2-)26
016-041-00-2calcium 2,5-dichloro-4-(4-((5-chloro-4-methyl-2-sulphonatophenyl)azo)-5-hydroxy-3-methylpyrazol-1-yl)benzenesulphonate400-710-4Xn; R20Xn

R: 20

S: (2-)
016-042-00-8tetrasodium 5-benzamido-3-(5-(4-fluoro-6-(1-sulphonato-2-naphthylamino)-1,3,5-triazin-2-ylamino)-2-sulphonatophenylazo)-4-hydroxynaphthalene-2,7- disulphonate400-790-085665-97-0Xi; R36/38

R43
Xi

R: 36/38-43

S: (2-)22-24/25-37
016-043-00-3dilithium 6-acetamido-4-hydroxy-3-(4-((2-sulphonatooxy)ethylsulphonyl)phenylazo)naphthalene-2-sulphonate401-010-1R43Xi

R: 43

S: (2-)24-37
016-044-00-9disodium S,S-hexane-1,6-diyldi(thiosulphate) dihydrate401-320-7R43

R52-53
Xi

R: 43-52/53

S: (2-)22-24-37-61
016-045-00-4lithium sodium hydrogen 4-amino-6-(5-(5-chloro-2,6-difluoropyrimidin-4-ylamino)-2-sulphonatophenylazo)-5-hydroxy-3-(4-(2-(sulphonatooxy)ethylsulphonyl)phenylazo)naphthalene-2,7-disulphonate401-560-2108624-00-6R43Xi

R: 43

S: (2-)22-24-37
016-046-00-Xsodium hydrogensulphate231-665-77681-38-1Xi; R41Xi

R: 41

S: (2-)24-26
016-047-00-5hexasodium 7-(4-(4-(4-(2,5-disulphonatoanilino)-6-fluoro-1,3,5-triazin-2-ylamino)-2-methylphenylazo)-7-sulphonatonaphthylazo)naphthalene-1,3,5- trisulphonate401-650-185665-96-9R43Xi

R: 43

S: (2-)22-24-37
016-048-00-0sodium 3,5-dichloro-2-(5-cyano-2,6-bis(3-hydroxypropylamino)-4-methylpyridin-3-ylazo)benzenesulphonate401-870-8Xi; R41

R52-53
Xi

R: 41-52/53

S: (2-)26-61
016-049-00-6calcium octadecylxylenesulphonate402-040-8C; R34

N; R51-53
C; N

R: 34-51/53

S: (1/2-)26-28-36/37/39-45-61
016-050-00-1potassium sodium 5-(4-chloro-6-(N-(4-(4-chloro-6-(5-hydroxy-2,7-disulphonato-6-(2-sulphonatophenylazo)-4-naphthylamino)-1,3,5-triazin-2-ylamino) phenyl-N-methyl)amino)-1,3,5-triazin-2-ylamino)-4-hydroxy-3-(2-sulphonatophenylazo)naphthalene-2,7-disulphonat402-150-6Xi; R36

R43
Xi

R: 36-43

S: (2-)22-24-26-37
016-051-00-7trisodium 7-(4-(6-fluoro-4-(2-(2-vinylsulphonylethoxy)ethylamino)-1,3,5-triazin-2-ylamino)-2-ureidophenylazo)naphthalene-1,3,6- trisulphonate402-170-5106359-91-5R43Xi

R: 43

S: (2-)22-24-37
016-052-00-2benzyltributylammonium 4-hydroxynaphthalene-1-sulphonate402-240-5102561-46-6Xn; R20

N; R51-53
Xn; N

R: 20-51/53

S: (2-)22-61
016-053-00-8(C16 or C18-n-alkyl)(C16 or C18-n-alkyl)ammonium 2-((C16 or C18-n-alkyl)(C16 or C18-n-alkyl)carbamoyl)benzenesulphonate402-460-1Xi; R38

R43

R53
Xi

R: 38-43-53

S: (2-)24-37-61
016-054-00-3sodium 4-(2,4,4-trimethylpentylcarbonyloxy)benzenesulfonate400-030-8T; R23-48/23

Xn; R22

Xi; R36/37

R43
T

R: 22-23-36/37-43-48/23

S: (1/2-)22-24-36-45
016-055-00-9tetrasodium 4-amino-3,6-bis(5-(6-chloro-4-(2-hydroxyethylamino)-1,3,5-triazin-2-ylamino)-2-sulfonatophenylazo)-5-hydroxynaphthalene-2,7-sulfonate (containing > 35 % sodium chloride and sodium acetate)400-510-7Xi; R41

R43
Xi

R: 41-43

S: (2-)22-24-26-37/39
016-056-00-4potassium hydrogensulphate231-594-17646-93-7C; R34

Xi; R37
C

R: 34-37

S: (1/2-)26-36/37/39-45
016-057-00-Xstyrene-4-sulfonyl chloride404-770-22633-67-2Xi; R38-41

R43
Xi

R: 38-41-43

S: (2-)24-26-37/39
016-058-00-5thionyl chloride, reaction products with 1,3,4-thiadiazol-2,5-dithiol, tert-nonanethiol and C12-14-tert-alkylamine404-820-3Xi; R38

R43

R52-53
Xi

R: 38-43-52/53

S: (2-)36/37-61
016-059-00-0N,N,N',N'-tetramethyldithiobis(ethylene)diamine dihydrochloride405-300-917339-60-5Xn; R22

Xi; R36

R43

N; R50-53
Xn; N

R: 22-36-43-50/53

S: (2-)26-36/37-60-61
016-060-00-6diammonium peroxodisulphate;

ammonium persulphate
231-786-57727-54-0O; R8

Xn; R22

Xi; R36/37/38

R42/43
O; Xn

R: 8-22-36/37/38-42/43

S: (2-)22-24-26-37
016-061-00-1dipotassium peroxodisulphate;

potassium persulphate
231-781-87727-21-1O; R8

Xn; R22

Xi; R36/37/38

R42/43
O; Xn

R: 8-22-36/37/38-42/43

S: (2-)22-24-26-37
016-062-00-7bensultap (ISO);

1,3-bis(phenylsulfonylthio)-2-(N,N-dimethylamino)propane
17606-31-4Xn; R22

N; R50-53
Xn; N

R: 22-50/53

S: (2-)60-61
016-063-00-2sodium metabisulphite231-673-07681-57-4Xn; R22

Xi; R41

R31
Xn

R: 22-31-41

S: (2-)26-39-46
016-064-00-8sodium hydrogensulphite … %;

sodium bisulphite … %
231-548-07631-90-5Xn; R22

R31
Xn

R: 22-31

S: (2-)25-46
B
016-065-00-3sodium 1-amino-4-[2-methyl-5-(4-methylphenylsulfonylamino)phenylamino]anthraquinone-2-sulfonate400-100-884057-97-6N; R51-53N

R: 51/53

S: 61
016-066-00-9tetrasodium [5-((4-amino-6-chloro-1,3,5-triazin-2-yl)amino)-2-((2-hydroxy-3,5-disulfonatophenylazo)-2- sulfonatobenzylidenehydrazino)benzoate]copper(II)404-070-7116912-62-0R52-53R: 52/53

S: 61
016-067-00-4(4-methylphenyl)mesitylene sulfonate407-530-567811-06-7R53R: 53

S: 61
016-068-00-Xsodium 3,5-bis(tetradecyloxycarbonyl)benzenesulfinate407-720-8155160-86-4R43

N; R51-53
Xi; N

R: 43-51/53

S: (2-)24-37-61
016-069-00-53,5-bis-(tetradecyloxycarbonyl)benzenesulfinic acid407-990-7141915-64-2R43

N; R51-53
Xi; N

R: 43-51/53

S: (2-)24-37-61
016-070-00-04-benzyloxy-4'-(2,3-epoxy-2-methylprop-1-yloxy)diphenylsulfone408-220-2R53R: 53

S: 61
016-071-00-6trisodium 3-amino-6,13-dichloro-10-((3-((4-chloro-6-(2-sulfophenylamino)-1,3,5-triazin-2-yl)amino)propyl) amino)-4,11-triphenoxydioxazinedisulfonate410-130-3136248-03-8R43Xi

R: - 43

S: (2-)22-24-37
016-072-00-13-amino-4-hydroxy-N-(2-methoxyethyl)-benzenesulfonamide411-520-6112195-27-4Xi; R41

R43

N; R51-53
Xi; N

R: 41-43-51/53

S: (2-)24-26-37/39-61
016-073-00-7tetrakis(phenylmethyl)thioperoxydi(carbothioamide)404-310-010591-85-2R53R: 53

S: 61
016-074-00-26-fluoro-2-methyl-3-(4-methylthiobenzyl)indene405-410-7Xi; R38-41

R43

N; R51-53
Xi; N

R: 38-41-43-51/53

S: (2-)26-36/37/39-61
016-075-00-82,2'-diallyl-4,4'-sulfonyldiphenol411-570-941481-66-7R43

N; R51-53
Xi; N

R: 43-51/53

S: (2-)24-37-61
016-076-00-32,3-bis((2-mercaptoethyl)thio)-1-propanethiol411-290-7131538-00-6Xn; R22-48/22

N; R50-53
Xn; N

R: 22-48/22-50/53

S: (2-)23-24/25-36-60-61
016-077-00-92-chloro-p-toluenesulfochloride412-890-142413-03-6C; R34

R43

R52-53
C

R: 34-43-52/53

S: (1/2-)23-26-36/37/39-45-61
016-078-00-44-methyl-N,N-bis(2-(((4-methylphenyl)sulfonyl)amino)ethyl)benzenesulfonamide413-300-556187-04-3R53R: 53

S: 61
016-079-00-XN,N-bis(2-(p-toluenesulfonyloxy)ethyl)-p-toluenesulfonamide412-920-316695-22-0R43

R53
Xi

R: 43-53

S: (2-)24-37-61
016-080-00-5sodium 2-anilino-5-(2-nitro-4-(N-phenylsulfamoyl))anilinobenzenesulfonate412-320-131361-99-6Xi; R41

R52-53
Xi

R: 41-52/53

S: (2-)26-39-61
016-081-00-0hexahydrocyclopenta[c]pyrrole-1-(1H)-ammonium N-ethoxycarbonyl-N-(p-tolylsulfonyl)azanide418-350-1Muta. Cat. 3; R68

Xn; R22

Xi; R36

R43

N; R51-53
Xn; N

R: 22-36-43-68-51/53

S: (2-)26-36/37-61
016-082-00-6ethoxysulfuron (ISO);

1-(4,6-dimethoxypyrimidin-2-yl)-3-(2-ethoxyphenoxysulfonyl)urea
126801-58-9N; R50-53N

R: 50/53

S: 60-61
016-083-00-1acibenzolar-S-methyl;

benzo[1,2,3]thiadiazole-7-carbothioic acid S-methyl ester
420-050-0135158-54-2Xi; R36/37/38

R43

N; R50-53
Xi; N

R: 36/37/38-43-50/53

S: (2-)24/25-37-46-59-60-61
016-084-00-7prosulfuron;

1-(4-methoxy-6-methyl-1,3,5-triazin-2-yl)-3-[2-(3,3,3-trifluoropropyl)phenylsulfonyl]urea
94125-34-5Xn; R22

N; R50-53
Xn; N

R: 22-50/53

S: (2-)60-61
016-085-00-2flazasulfuron (ISO);

1-(4,6-dimethoxypyrimidin-2-yl)-3-(3-trifluoromethyl-2-pyridylsulfonyl)urea
104040-78-0N; R50-53N

R: 50/53

S: 60-61
016-086-00-8tetrasodium 10-amino-6,13-dichloro-3-(3-(4-(2,5-disulfonatoanilino)-6-fluoro-1,3,5-triazin-2-ylamino)prop-3-ylamino)-5,12-dioxa-7,14-diazapentacene-4,11-disulfonate402-590-9109125-56-6Xi; R41Xi

R: 41

S: (2-)22-26-39
016-087-00-3reaction mass of: thiobis(4,1-phenylene)-S,S,S',S'-tetraphenyldisulfonium bishexafluorophosphate;

diphenyl(4-phenylthiophenyl)sulfonium hexafluorophosphate;

propylene carbonate
403-490-8104558-95-4Xi; R36

R43

N; R50-53
Xi; N

R: 36-43-50/53

S: (2-)24-26-37-60-61
016-088-00-94-(bis(4-(diethylamino)phenyl)methyl)benzene-1,2-dimethanesulfonic acid407-280-771297-11-5R52-53R: 52/53

S: 61
016-089-00-4reaction mass of esters of 5,5',6,6',7,7'-hexahydroxy-3,3,3',3'-tetramethyl-1,1'-spirobiindan and 2-diazo-1,2-dihydro-1-oxo-5-sulfonaphthalene413-840-1E; R2

F; R11

R53
E

R: 2-11-53

S: (2-)33-35-40-61
016-090-00-X4-methyl-N-(methylsulfonyl)benzenesulfonamide415-040-814653-91-9Xn; R22

Xi; R37-41
Xn

R: 22-37-41

S: (2-)26-39
016-091-00-5C12-14-tert-alkyl ammonium 1-amino-9,10-dihydro-9,10-dioxo-4-(2,4,6-trimethylanilino)-anthracen-2-sulfonate414-110-5Xi; R41

N; R50-53
Xi; N

R: 41-50/53

S: (2-)26-39-60-61
016-093-00-6reaction mass of: 4-(7-hydroxy-2,4,4-trimethyl-2-chromanyl)resorcinol-4-yl-tris(6-diazo-5,6-dihydro-5-oxonaphthalen-1-sulfonate);

4-(7-hydroxy-2,4,4-trimethyl-2-chromanyl)resorcinolbis(6-diazo-5,6-dihydro-5-oxonaphthalen-1-sulfonate) (2:1)
414-770-4140698-96-0F; R11

Carc. Cat. 3; R40
F; Xn

R: 11-40

S: (2-)7-36/37
016-095-00-7reaction mass of: reaction product of 4,4'-methylenebis[2-(4-hydroxybenzyl)-3,6-dimethylphenol] and 6-diazo-5,6-dihydro-5-oxo-naphthalenesulfonate (1:2);

Reaction product of 4,4'-methylenebis[2-(4-hydroxybenzyl)-3,6-dimethylphenol] and 6-diazo-5,6-dihydro-5-oxo-naphthalenesulfonate (1:3)
417-980-4F; R11

Carc. Cat. 3; R40
F; Xn

R: 11-40

S: (2-)7-36/37
016-096-00-2thifensulfuron-methyl (ISO);

methyl 3-(4-methoxy-6-methyl-1,3,5-triazin-2-ylcarbamoylsulfamoyl)thiophene-2-carboxylate
79277-27-3N; R50-53N

R: 50/53

S: 60-61
017-001-00-7chlorine231-959-57782-50-5T; R23

Xi; R36/37/38

N; R50
T; N

R: 23-36/37/38-50

S: (1/2-)9-45-61
017-002-00-2hydrogen chloride231-595-77647-01-0T; R23

C; R35
T; C

R: 23-35

S: (1/2-)9-26-36/37/39-45
5
017-002-01-Xhydrochloric acid ... %231-595-7C; R34

Xi; R37
C

R: 34-37

S: (1/2-)26-45
C; R34-37: C ≥ 25 %

Xi; R36/37/38: 10 % ≤ C < 25 %
B
017-003-00-8barium chlorate236-760-713477-00-4O; R9

Xn; R20/22

N; R51-53
O; Xn; N

R: 9-20/22-51/53

S: (2-)13-27-61
017-004-00-3potassium chlorate223-289-73811-04-9O; R9

Xn; R20/22

N; R51-53
O; Xn; N

R: 9-20/22-51/53

S: (2-)13-16-27-61
017-005-00-9sodium chlorate231-887-47775-09-9O; R9

Xn; R22

N; R51-53
O; Xn; N

R: 9-22-51/53

S: (2-)13-17-46-61
017-006-00-4perchloric acid ... %231-512-47601-90-3R5

O; R8

C; R35
O; C

R: 5-8-35

S: (1/2-)23-26-36-45
C; R35: C ≥ 50 %

C; R34: 10 % ≤ C < 50 %

Xi; R36/38: 1 % ≤ C < 10 %

Footnote

O; R5-8: C > 50 %
B
017-007-00-Xbarium perchlorate236-710-413465-95-7O; R9

Xn; R20/22
O; Xn

R: 9-20/22

S: (2-)27
017-008-00-5potassium perchlorate231-912-97778-74-7O; R9

Xn; R22
O; Xn

R: 9-22

S: (2-)13-22-27
017-009-00-0ammonium perchlorate232-235-17790-98-9O; R9

R44 ⊗
O

R: 9-44

S: (2-)14-16-27-36/37
G
017-010-00-6sodium perchlorate231-511-97601-89-0O; R9

Xn; R22
O; Xn

R: 9-22

S: (2-)13-22-27
017-011-00-1sodium hypochlorite, solution ... % Cl active231-668-37681-52-9C; R34

R31

N; R50
C; N

R: 31-34-50

S: (1/2-)28-45-50-61
R31: C ≥ 5 %B
017-012-00-7calcium hypochlorite231-908-77778-54-3O; R8 ⊗

Xn; R22

R31

C; R34

N; R50
O; C; N

R: 8-22-31-34-50

S: (1/2-)26-36/37/39-45-61
C; R34: C ≥ 10 %

Xi; R37/38-41: 3 % ≤ C < 10 %

Xi; R36: 0,5 % ≤ C < 3 %
017-013-00-2calcium chloride233-140-810043-52-4Xi; R36Xi

R: 36

S: (2-)22-24
017-014-00-8ammonium chloride235-186-412125-02-9Xn; R22

Xi; R36
Xn

R: 22-36

S: (2-)22
017-015-00-3(2-(aminomethyl)phenyl)acetylchloride hydrochloride417-410-461807-67-8Xn; R22

C; R35

R43
C

R: 22-35-43

S: (1/2-)26-36/37/39-45
017-016-00-9methyltriphenylphosphonium chloride418-400-21031-15-8Xn; R21/22

Xi; R38-41

N; R51-53
Xn; N

R: 21/22-38-41-51/53

S: (2-)22-26-36/37/39-61
017-017-00-4(Z)-13-docosenyl-N,N-bis(2-hydroxyethyl)-N-methyl-ammonium-chloride426-210-6120086-58-0C; R34

N; R50-53
C; N

R: 34-50/53

S: (2-)26-36/37/39-45-60-61
017-018-00-XN,N,N-trimethyl-2,3-bis(stearoyloxy)propylammonium chloride405-660-7N; R51-53N

R: 51/53

S: 61
017-019-00-5(R)-1,2,3,4-tetrahydro-6,7-dimethoxy-1-veratrylisoquinoline hydrochloride415-110-854417-53-7Xn; R22

R52-53
Xn

R: 22-52/53

S: (2-)22-61
017-020-00-0ethyl propoxy aluminium chloride421-790-713014-29-4F; R15

R 14

C; R35
F; C

R: 14/15-35

S: (1/2-)16-23-26-30-36/37/39-43-45
017-021-00-6behenamidopropyl-dimethyl-(dihydroxypropyl) ammonium chloride423-420-1136920-10-0Xi; R41

R43

N; R50-53
Xi; N

R: 41-43-50/53

S: (2-)26-36/37/39-60-61
019-001-00-2potassium231-119-87440-09-7F; R15

R14

C; R34
F; C

R: 14/15-34

S: (1/2-)5-8-45
019-002-00-8potassium hydroxide;

caustic potash
215-181-31310-58-3Xn; R22

C; R35
C

R: 22-35

S: (1/2-)26-36/37/39-45
C; R35: C ≥ 5 %

C; R34: 2 % ≤ C < 5 %

Xi; R36/38: 0.5 % ≤ C < 2 %
020-001-00-Xcalcium231-179-57440-70-2F; R15F

R: 15

S: (2-)8-24/25-43
020-002-00-5calcium cyanide209-740-0592-01-8T+; R28

R32

N; R50-53
T+; N

R: 28-32-50/53

S: (1/2-)7/8-23-36/37-45-60-61
020-003-00-0reaction mass of: dicalcium (bis(2-hydroxy-5-tetra-propenylphenylmethyl)methylamine)dihydroxide;

tri-calcium (tris(2-hydroxy-5-tetra-propenylphenylmethyl)methylamine)tri-hydroxide;

poly[calcium ((2-hydroxy-5-tetra-propenyl-phenylmethyl)methylamine)hydroxide]
420-470-4Xi; R36/38

R43
Xi

R: 36/38-43

S: (2-)24-26-37
022-001-00-5titanium tetrachloride231-441-97550-45-0R14

C; R34
C

R: 14-34

S: (1/2-)7/8-26-36/37/39-45
022-002-00-0titanium(4+) oxalate403-260-7Xi; R41Xi

R: 41

S: (2-)26-39
022-003-00-6bis(η5-cyclopentadienyl)-bis(2,6-difluoro-3-[pyrrol-1-yl]-phenyl)titanium412-000-1125051-32-3F; R11

Repr. Cat. 3; R62

Xn; R48/22

N; R51-53
F; Xn; N

R: 11-48/22-62-51/53

S: (2-)7-22-33-36/37-61
023-001-00-8divanadium pentaoxide;

vanadium pentoxide
215-239-81314-62-1Muta. Cat. 3; R68

Repr. Cat. 3; R63

T; R48/23

Xn; R20/22

Xi; R37

N; R51-53
T; N

R: 20/22-37-48/23-51/53-63-68

S: (1/2-)36/37-38-45-61
024-001-00-0chromium (VI) trioxide215-607-81333-82-0O; R9

Carc. Cat. 1; R45

Muta. Cat. 2; R46

Repr. Cat. 3; R62

T+; R26

T; R24/25-48/23

C; R35

R42/43

N; R50-53
O; T+; N

R: 45-46-9-24/25-26-35-42/43-48/23-62-50/53

S: 53-45-60-61
C: R35: C ≥ 10 %

C; R34: 5 % ≤ C < 10 %

Xi; R36/37/38: 1 % ≤ C < 5 %
E
024-002-00-6potassium dichromate231-906-67778-50-9O; R8

Carc. Cat. 2; R45

Muta. Cat. 2; R46

Repr. Cat. 2; R60-61

T+; R26

T; R25-48/23

Xn; R21

C; R34

R42/43

N; R50-53
T+; N; O

R: 45-46-60-61-8-21-25-26-34-42/43-48/23-50/53

S: 53-45-60-61
C; R34: C ≥ 10 %:

Xi; R36/37/38: 5 % ≤ C < 10 %
E

3
024-003-00-1ammonium dichromate232-143-17789-09-5E; R2

O; R8

Carc. Cat. 2; R45

Muta. Cat. 2; R46

Repr. Cat. 2; R60-61

T+; R26

T; R25-48/23

Xn; R21

C; R34

R42/43

N; R50-53
E; T+; N

R: 45-46-60-61-2-8-21-25-26-34-42/43-48/23-50/53

S: 53-45-60-61
C; R34: C ≥ 10 %

Xi; R36/37/38: 5 % ≤ C < 10 %

R42/43: C ≥ 0,2 %
E

3
024-004-00-7sodium dichromate anhydrate234-190-310588-01-9O; R8

Carc. Cat. 2; R45

Muta. Cat. 2; R46

Repr. Cat. 2; R60-61

T+; R26

T; R25-48/23

Xn; R21

C; R34

R42/43

N; 50-53
T+; N; O

R: 45-46-60-61-8-21-25-26-34-42/43-48/23-50/53

S: 53-45-60-61
C; R34: C ≥ 10 %

Xi; R36/37/38: 5 % ≤ C < 10 %

R42/43: C ≥ 0,2 %
E

3
024-004-01-4sodium dichromate, dihydrate234-190-37789-12-0O; R8

Carc. Cat. 2; R45

Muta. Cat. 2; R46

Repr. Cat. 2; R60-61

T+; R26

T; R25-48/23

Xn; R21

C; R34

R42/43

N; R50-53
T+; N; O

R: 45-46-60-61-8-21-25-26-34-42/43-48/23-50/53

S: 53-45-60-61
C; R34: C ≥ 10 %

Xi; R36/37/38: 5 % ≤ C < 10 %

R42/43: C ≥ 0,2 %
E

3
024-005-00-2chromyl dichloride;

chromic oxychloride
239-056-814977-61-8O; R8

Carc. Cat. 2; R49

Muta. Cat. 2; R46

C; R35

R43

N; R50-53
O; T; C; N

R: 49-46-8-35-43-50/53

S: 53-45-60-61
C; R35: C ≥ 10 %

C; R34: 5 % ≤ C < 10 %

Xi; R36/37/38: 0,5 % ≤ C < 5 %

R43: C ≥ 0,5 %
3
024-006-00-8potassium chromate232-140-57789-00-6Carc. Cat. 2; R49

Muta. Cat. 2; R46

Xi; R36/37/38

R43

N; R50-53
T; N

R: 49-46-36/37/38-43-50/53

S: 53-45-60-61
R43: C ≥ 0,5 %3
024-007-00-3zinc chromates including zinc potassium chromateCarc. Cat. 1; R45

Xn; R22

R43

N; R50-53
T; N

R: 45-22-43-50/53

S: 53-45-60-61
AE
024-008-00-9calcium chromate237-366-813765-19-0Carc. Cat. 2; R45

Xn; R22

N; R50-53
T; N

R: 45-22-50/53

S: 53-45-60-61
E
024-009-00-4strontium chromate232-142-67789-06-2Carc. Cat. 2; R45

Xn; R22

N; R50-53
T; N

R: 45-22-50/53

S: 53-45-60-61
E
024-010-00-Xdichromium tris(chromate);

chromium III chromate;

chromic chromate
246-356-224613-89-6O; R8

Carc. Cat. 2; R45

C; R35

R43

N; R50-53
O; T; C; N

R: 45-8-35-43-50/53

S: 53-45-60-61
024-011-00-5ammonium bis(1-(3,5-dinitro-2-oxidophenylazo)-3-(N-phenylcarbamoyl)-2-naphtholato)chromate(1-)400-110-2109125-51-1F; R11

N; R50-53
F; N

R: 11-50/53

S: (2-)33-60-61
024-012-00-0trisodium bis(7-acetamido-2-(4-nitro-2-oxidophenylazo)-3-sulphonato-1-naphtholato)chromate(1-)400-810-8Muta. Cat. 3; R68Xn

R: 68

S: (2-)22-36/37
024-013-00-6trisodium (6-anilino-2-(5-nitro-2-oxidophenylazo)-3-sulphonato-1-naphtholato)(4-sulphonato-1,1'-azodi-2,2'naphtholato)chromate(1-)402-500-8Xi; R41

N; R51-53
Xi; N

R: 41-51/53

S: (2-)26-39-61
024-014-00-1trisodium bis(2-(5-chloro-4-nitro-2-oxidophenylazo)-5-sulphonato-1-naphtholato)chromate(1-)402-870-093952-24-0Xi; R41

R52-53
Xi

R: 41-52/53

S: (2-)26-39-61
024-015-00-7disodium (3-methyl-4-(5-nitro-2-oxidophenylazo)-1-phenylpyrazololato)(1-(3-nitro-2-oxido-5-sulfonatophenylazo)-2-naphtholato)chromate(1-)404-930-1Xn; R20

Xi; R41

N; R51-53
Xn; N

R: 20-41-51/53

S: (2-)26-39-61
024-016-00-2tetradecylammonium bis(1-(5-chloro-2-oxidophenylazo)-2-naphtholato)chromate(1-)405-110-688377-66-6Xn; R48/22

R53
Xn

R: 48/22-53

S: (2-)22-36-61
024-017-00-8Chromium (VI) compounds, with the exception of barium chromate and of compounds specified elsewhere in this AnnexCarc. Cat. 2; R49

R43

N; R50-53
T; N

R: 49-43-50/53

S: 53-45-60-61
A
024-018-00-3sodium chromate231-889-57775-11-3Carc. Cat. 2; R45

Muta. Cat. 2; R46

Repr. Cat. 2; R60-61

T+; R26

T; R25-48/23

Xn; R21

C; R34

R42/43

N; R50-53
T+; N

R: 45-46-60-61-21-25-26-34-42/43-48/23-50/53

S: 53-45-60-61
R42/43: C ≥ 0,2 %E

3
024-019-00-9Main component: acetoacetic acid anilide/3-amino-1-hydroxybenzene (ATAN-MAP): trisodium {6-[(2 or 3 or 4)-amino-(4 or 5 or 6)-hydroxyphenylazo]-5'-(phenylsulfamoyl)-3-sulfonatonaphthalene-2-azobenzene-1,2'-diolato}-{6''-[1-(phenylcarbamoyl)ethylazo]-5'''-(phenylsulfamoyl)-3''-sulfonatonaphthalene-2''-azobenzene-1'',2'''-diolato}chromate (III);

by-product 1: acetoacetic acid anilide/acetoacetic acid anilide (ATAN-ATAN): trisodium bis{6-[1-(phenylcarbamoyl)ethylazo]-5'-(phenylsulfonyl)-3-sulfonatonaphthalene-2-azobenzene-1,2'-diolato}chromate (III);

by-product 2: 3-amino-1-hydroxybenzene/3-amino-1-hydroxybenzene (MAP-MAP): trisodium bis{6-[(2 or 3 or 4)-amino-(4 or 5 or 6)-hydroxyphenylazo]-5'-(phenylsulfamoyl)-3-sulfonatonaphthalene-2-azobenzene-1,2'-diolato} chromate (III)
419-230-1R43

R52-53
Xi

R: 43-52/53

S: (2-)22-24-37-61
024-020-00-4trisodium bis[(3'-nitro-5'-sulfonato(6-amino-2-[4-(2-hydroxy-1-naphtylazo)phenylsulfonylamino]pyrimidin-5-azo)benzene-2',4-diolato)]chromate (III)418-220-4R43

R52-53
Xi

R: 43-52/53

S: (2-)22-24-37-61
025-001-00-3manganese dioxide215-202-61313-13-9Xn; R20/22Xn

R: 20/22

S: (2-)25
025-002-00-9potassium permanganate231-760-37722-64-7O; R8

Xn; R22

N; R50-53
O; Xn; N

R: 8-22-50/53

S: (2-)60-61
025-003-00-4manganese sulphate232-089-97785-87-7Xn; R48/20/22

N; R51-53
Xn; N

R: 48/20/22-51/53

S: (2-)22-61
025-004-00-Xbis(N,N',N''-trimethyl-1,4,7-triazacyclononane)-trioxo-dimanganese (IV) di(hexafluorophosphate) monohydrate411-760-1116633-53-5N; R51-53N

R: 51/53

S: 61
025-005-00-5reaction mass of: tri-sodium [29H, 31H-phthalocyanine-C,C,C-trisulfonato (6-)-N29,N30,N31,N32] manganate (3-);

tetrasodium [29H,31H-phthalocyanine-C,C,C,C-tetrasulfonato (6-)-N29,N30,N31,N32], manganate (3-);

pentasodium [29H,31H-phthalocyanine-C,C,C,C,C-pentasulfonato (6-)-N29,N30,N31,N32] manganate (3-)
417-660-4N; R50-53N

R: 50/53

S: 60-61
026-001-00-6(η-cumene)-(η-cyclopentadienyl)iron(II) hexafluoroantimonate407-840-0100011-37-8Xn; R22

Xi; R41

R52-53
Xn

R: 22-41-52/53

S: (2-)22-26-39-61
026-002-00-1(η-cumene)-(η-cyclopentadienyl)iron(II) trifluoromethane-sulfonate407-880-9117549-13-0Xn; R22

R52-53
Xn

R: 22-52/53

S: (2-)26-61
027-001-00-9cobalt231-158-07440-48-4R42/43

R53
Xn

R: 42/43-53

S: (2-)22-24-37-61
027-002-00-4cobalt oxide215-154-61307-96-6Xn; R22

R43

N; R50-53
Xn; N

R: 22-43-50/53

S: (2-)24-37-60-61
027-003-00-Xcobalt sulphide215-273-31317-42-6R43

N; R50-53
Xi; N

R: 43-50/53

S: (2-)24-37-60-61
027-004-00-5cobalt dichloride231-589-47646-79-9Carc. Cat. 2; R49

Xn; R22

R42/43

N; R50-53
T; N

R: 49-22-42/43-50/53

S: (2-)22-53-45-60-61
Carc. Cat. 2; R49: C ≥ 0,01 %

Xn; R22: C ≥ 2,5 %
E

1
027-005-00-0cobalt sulphate233-334-210124-43-3Carc. Cat. 2; R49

Xn; R22

R42/43

N; R50-53
T; N

R: 49-22-42/43-50/53

S: (2-)22-53-45-60-61
Carc. Cat. 2; R49: C ≥ 0,01 %E

1
028-001-00-1tetracarbonylnickel;

nickel tetracarbonyl
236-669-213463-39-3F; R11

Carc. Cat. 3; R40

Repr. Cat. 2; R61

T+; R26

N; R50-53
F; T+; N

R: 61-11-26-40-50/53

S: 53-45-60-61
E
028-002-00-7nickel231-111-47440-02-0Carc. Cat. 3; R40

R43
Xn

R: 40-43

S: (2-)22-36
028-003-00-2nickel monoxide215-215-71313-99-1Carc. Cat. 1; R49

R43

R53
T

R: 49-43-53

S: 53-45-61
028-004-00-8nickel dioxide234-823-312035-36-8Carc. Cat. 1; R49

R43

R53
T

R: 49-43-53

S: 53-45-61
028-005-00-3dinickel trioxide215-217-81314-06-3Carc. Cat. 1; R49

R43

R53
T

R: 49-43-53

S: 53-45-61
028-006-00-9nickel sulphide240-841-216812-54-7Carc. Cat. 1; R49

R43

N; R50-53
T; N

R: 49-43-50/53

S: 53-45-60-61
028-007-00-4nickel subsulphide;

trinickel disulphide
234-829-612035-72-2Carc. Cat. 1; R49

R43

N; R51-53
T; N

R: 49-43-51/53

S: 53-45-61
028-008-00-Xnickel dihydroxide235-008-512054-48-7Carc. Cat. 3; R40

Xn; R20/22

R43

N; R50-53
Xn; N

R: 20/22-40-43-50/53

S: (2-)22-36-60-61
028-009-00-5nickel sulphate232-104-97786-81-4Carc. Cat. 3; R40

Xn; R22

R42/43

N; R50-53
Xn; N

R: 22-40-42/43-50/53

S: (2-)22-36/37-60-61
028-010-00-0nickel carbonate222-068-23333-67-3Carc. Cat. 3; R40

Xn; R22

R43

N; R50-53
Xn; N

R: 22-40-43-50/53

S: (2-)22-36/37-60-61
029-001-00-4copper chloride;

copper (I) chloride;

cuprous chloride
231-842-97758-89-6Xn; R22

N; R50-53
Xn; N

R: 22-50/53

S: (2-)22-60-61
029-002-00-Xdicopper oxide;

copper (I) oxide
215-270-71317-39-1Xn; R22

N; R50-53
Xn; N

R: 22-50/53

S: (2-)22-60-61
029-003-00-5Naphthenic acids, copper salts;

copper naphthenate
215-657-01338-02-9R10

Xn; R22

N; R50-53
Xn; N

R: 10-22-50/53

S: (2-)60-61
029-004-00-0copper sulphate231-847-67758-98-7Xn; R22

Xi; R36/38

N; R50-53
Xn; N

R: 22-36/38-50/53

S: (2-)22-60-61
029-005-00-6(tris(chloromethyl)phthalocyaninato)copper(II), reaction products with N-methylpiperazine and methoxyacetic acid401-260-1Xi; R36Xi

R: 36

S: (2-)26
029-006-00-1tris(octadec-9-enylammonium) (trisulfonatophthalocyaninato)copper(II)403-210-4Xi; R41

N; R51-53
Xi; N

R: 41-51/53

S: (2-)22-26-39-61
029-007-00-7(trisodium (2-((3-(6-(2-chloro-5-sulfonato)anilino)-4-(3-carboxypyridinio)-1,3,5-triazin-2-ylamino)-2-oxido-5-sulfonatophenylazo)phenylmethylazo)-4-sulfonatobenzoato)copper(3-)) hydroxide404-670-989797-01-3E; R2

R43
E; Xi

R: 2-43

S: (2-)22-24-35-37
029-008-00-2copper(II) methanesulfonate405-400-254253-62-2Xn; R22

Xi; R41

N; R50-53
Xn; N

R: 22-41-50/53

S: (2-)26-36/37/39-60-61
029-009-00-8phthalocyanine-N-[3-(diethylamino)propyl]sulfonamide copper complex413-650-993971-95-0R52-53R: 52/53

S: 61
029-010-00-3reaction mass of compounds from (dodecakis(p-tolylthio)phthalocyaninato)copper(II) to (hexadecakis(p-tolylthio)phthalocyaninato)copper(II)407-700-9101408-30-4R43Xi

R: 43

S: (2-)24-37
029-011-00-9sodium [29H,31H-phthalocyaninato-(2-)-N29,N30,N31,N32]-((3-(N-methyl-N-(2-hydroxyethyl)amino)propyl)amino)sulfonyl-sulfonato, copper complex412-730-0150522-10-4C; R34C

R: 34

S: (1/2-)22-26-36/37/39-45
029-012-00-4sodium ((N-(3-trimethylammoniopropyl)sulfamoyl)methylsulfonatophthalocyaninato)copper(II)407-340-2124719-24-0Xi; R41Xi

R: 41

S: (2-)26-39
029-013-00-Xtrisodium(2-(α-(3-(4-chloro-6-(2-(2-(vinylsulfonyl)ethoxy)ethylamino)-1,3,5-triazin-2-ylamino)-2-oxido-5-sulfonatophenylazo)benzylidenehydrazino)-4-sulfonatobenzoato)copper(II)407-580-8130201-51-3Xi; R41

R52-53
Xi

R: 41-52/53

S: (2-)24-37-61
030-001-00-1zinc powder — zinc dust (pyrophoric)231-175-37440-66-6F; R15-17

N; R50-53
F; N

R: 15-17-50/53

S: (2-)43-46-60-61
030-001-01-9zinc powder — zinc dust (stabilised)231-175-37440-66-6N; R50-53N

R: 50/53

S: 60-61
030-003-00-2zinc chloride231-592-07646-85-7C; R34

Xn; R22

N; R50-53
C; N

R: 22-34-50/53

S: (1/2-)26-36/37/39-45-60-61
C; R34: C ≥ 10 %

Xi; R36/37/38: 5 % ≤ C < 10 %
030-004-00-8dimethylzinc; [1]

diethylzinc [2]
208-884-1 [1]

209-161-3 [2]
544-97-8 [1]

557-20-0 [2]
F; R17

R14

C; R34

N; R50-53
F; C; N

R: 14-17-34-50/53

S: (1/2-)16-43-45-60-61
030-005-00-3diamminediisocyanatozinc401-610-3Xn; R22

Xi; R41

R42/43

N; R50
Xn; N

R: 22-41-42/43-50

S: (2-)22-26-36/37/39-41-61
030-006-00-9zinc sulphate (hydrous) (mono-, hexa- and hepta hydrate); [1]

zinc sulphate (anhydrous) [2]
231-793-3 [1]

231-793-3 [2]
7446-19-7 [1]

7733-02-0 [2]
Xn; R22

Xi; R41

N; R50-53
Xn; N

R: 22-41-50/53

S: (2-)22-26-39-46-60-61
030-007-00-4bis(3,5-di-tert-butylsalicylato-O 1,O 2)zinc403-360-042405-40-3F; R11

Xn; R22

N; R50-53
F; Xn; N

R: 11-22-50/53

S: (2-)7-22-60-61
030-008-00-Xhydroxo(2-(benzenesulfonamido)benzoato)zinc(II)403-750-0113036-91-2Xn; R20

N; R51-53
Xn; N

R: 20-51/53

S: (2-)22-57-61
030-011-00-6trizinc bis(orthophosphate)231-944-37779-90-0N; R50-53N

R: 50/53

S: 60-61
030-013-00-7zinc oxide215-222-51314-13-2N; R50-53N

R: 50/53

S: 60-61
033-001-00-Xarsenic231-148-67440-38-2T; R23/25

N; R50-53
T; N

R: 23/25-50/53

S: (1/2-)20/21-28-45-60-61
033-002-00-5arsenic compounds, with the exception of those specified elsewhere in this AnnexT; R23/25

N; R50-53
T; N

R: 23/25-50/53

S: (1/2-)20/21-28-45-60-61
T; R23/25: C ≥ 0,2 %

Xn; R20/22: 0,1 % ≤ C < 0,2 %
A

1
033-003-00-0diarsenic trioxide;

arsenic trioxide
215-481-41327-53-3Carc. Cat. 1; R45

T+; R28

C; R34

N; R50-53
T+; N

R: 45-28-34-50/53

S: 53-45-60-61
E
033-004-00-6diarsenic pentaoxide;

arsenic pentoxide;

arsenic oxide
215-116-91303-28-2Carc. Cat. 1; R45

T; R23/25

N; R50-53
T; N

R: 45-23/25-50/53

S: 53-45-60-61
E
033-005-00-1arsenic acid and its saltsCarc. Cat. 1; R45

T; R23/25

N; R50-53
T; N

R: 45-23/25-50/53

S: 53-45-60-61
AE
033-006-00-7arsine232-066-37784-42-1F+; R12

T+; R26

Xn; R48/20

N; R50-53
F+; T+; N

R: 12-26-48/20-50/53

S: (1/2-)9-16-28-33-36/37-45-60-61
033-007-00-2tert-butylarsine423-320-64262-43-5F; R17

T+; R26
F; T+

R: 17-26

S: (1/2-)9-28-36/37-43-45
034-001-00-2selenium231-957-47782-49-2T; R23/25

R33

R53
T

R: 23/25-33-53

S: (1/2-)20/21-28-45-61
034-002-00-8selenium compounds except cadmium sulphoselenideT; R23/25

R33

N; R50-53
T; N

R: 23/25-33-50/53

S: (1/2-)20/21-28-45-60-61
A
034-003-00-3sodium selenite233-267-910102-18-8T+; R28

T; R23

R31

R43

N; R51-53
T+; N

R: 23-28-31-43-51/53

S: (1/2-)28-36/37-45-61
035-001-00-5bromine231-778-17726-95-6T+; R26

C; R35

N; R50
T+; C; N

R: 26-35-50

S: (1/2-)7/9-26-45-61
035-002-00-0hydrogen bromide233-113-010035-10-6C; R35

Xi; R37
C

R: 35-37

S: (1/2-)7/9-26-45
035-002-01-8hydrobromic acid ... %C; R34

Xi; R37
C

R: 34-37

S: (1/2-)7/9-26-45
C; R34: C ≥ 40 %

Xi; R36/38: 10 % ≤ C < 40 %

Xi; R37: C ≥ 10 %
B
035-003-00-6potassium bromate231-829-87758-01-2O; R9

Carc. Cat. 2; R45

T; R25
T; O

R: 45-9-25

S: 53-45
E
035-004-00-12-hydroxyethylammonium perbromide407-440-6O; R8

Xn; R22

C; R35

R43

N; R50
O; C; N

R: 8-22-35-43-50

S: (1/2-)3/7-14-26-36/37/39-45-60-61
040-001-00-3zirconium powder (pyrophoric)231-176-97440-67-7F; R15-17F

R: 15-17

S: (2-)7/8-43
040-002-00-9zirconium powder (non pyrophoric)F; R15F

R: 15

S: (2-)7/8-43
042-001-00-9molybdenum trioxide215-204-71313-27-5Xn; R48/20/22

Xi; R36/37
Xn

R: 36/37-48/20/22

S: (2-)22-25
042-002-00-4tetrakis(dimethylditetradecylammonium) hexa-μ-oxotetra-μ3-oxodi-μ5-oxotetradecaoxooctamolybdate(4-)404-760-8117342-25-3T; R23

Xi; R41

R53
T

R: 23-41-53

S: (1/2-)26-37/39-45-61
042-003-00-Xtetrakis(trimethylhexadecylammonium) hexa-mu-oxotetra-mu3-oxodi-mu5-oxotetradecaoxooctamolybdate(4-)404-860-1116810-46-9F; R11

Xi; R41

N; R50-53
F; Xi; N

R: 11-41-50/53

S: (2-)26-39-60-61
042-004-00-5Reaction product of ammonium molybdate and C12-C24-diethoxylated alkylamine (1:5-1:3)412-780-3Xi; R38

R43

N; R51-53
Xi; N

R: 38-43-51/53

S: 24/25-37-61
047-001-00-2silver nitrate231-853-97761-88-8⊗ C; R34

N; R50-53
C; N

R: 34-50/53

S: (1/2-)26-45-60-61
048-001-00-5cadmium compounds, with the exception of cadmium sulphoselenide (xCdS.yCdSe), reaction mass of cadmium sulphide with zinc sulphide (xCdS.yZnS), reaction mass of cadmium sulphide with mercury sulphide (xCdS.yHgS), and those specified elsewhere in this AnnexXn; R20/21/22

N; R50-53
Xn; N

R: 20/21/22-50/53

S: (2-)60-61
Xn; R20/21/22: C ≥ 0,1 %A

1
048-002-00-0cadmium (non-pyrophoric); [1]

cadmium oxide (non-pyrophoric) [2]
231-152-8 [1]

215-146-2 [2]
7440-43-9 [1]

1306-19-0 [2]
Carc. Cat. 2; R45

Muta. Cat. 3; R68

Repr. Cat. 3; R62-63

T+; R26

T; R48/23/25

N; R50-53
T+; N

R: 45-26-48/23/25-62-63-68-50/53

S: 53-45-60-61
E
048-003-00-6cadmium diformate;

cadmiumformate
224-729-04464-23-7T; R23/25

R33

Xn; R68

N; R50-53
T; N

R: 23/25-33-68-50/53

S: (1/2-)22-45-60-61
T; R23/25: C ≥ 10 %

Xn; R20/22: 0,25 % ≤ C < 10 %

R33: C ≥ 0,25 %
048-004-00-1cadmium cyanide208-829-1542-83-6T+; R26/27/28

R32

R33

Xn; R68

N; R50-53
T+; N

R: 26/27/28-32-33-68-50/53

S: (1/2-)7-28-29-45-60-61
R32: C ≥ 1 %

R33: C ≥ 0,1 %
048-005-00-7cadmiumhexafluorosilicate(2-);

cadmium fluorosilica
241-084-017010-21-8T; R23/25

R33

Xn; R68

N; R50-53
T; N

R: 23/25-33-68-50/53

S: (1/2-)22-45-60-61
T; R23/25: C ≥ 10 %

Xn; R20/22: 0,1 % ≤ C < 10 %

R33: C ≥ 0,1 %
048-006-00-2cadmium fluoride232-222-07790-79-6Carc. Cat. 2; R45

Muta. Cat. 2; R46

Repr. Cat. 2; R60-61

T+; R26

T; R25-48/23/25

N; R50-53
T+; N

R: 45-46-60-61-25-26-48/23/25-50/53

S: 53-45-60-61
Carc. Cat. 2; R45: C ≥ 0,01 %

T; R25: C ≥ 10 %

Xn; R22: 0,1 % ≤ C < 10 %

T; R48/23/25: C ≥ 7 %

Xn; R48/20/22: 0,1 % ≤ C < 7 %
E
048-007-00-8cadmium iodide232-223-67790-80-9T; R23/25

R33

Xn; R68

N; R50-53
T; N

R: 23/25-33-68-50/53

S: (1/2-)22-45-60-61
T; R23/25: C ≥ 10 %

Xn; R20/22: 0,1 % ≤ C < 10 %

R33: C ≥ 0,1 %
048-008-00-3cadmium chloride233-296-710108-64-2Carc. Cat. 2; R45

Muta. Cat. 2; R46

Repr. Cat. 2; R60-61

T+; R26

T; R25-48/23/25

N; R50-53
T+; N

R: 45-46-60-61-25-26-48/23/25-50/53

S: 53-45-60-61
Carc. Cat. 2; R45: C ≥ 0,01 %

T; R25: C ≥ 10 %

Xn; R22: 0,1 % ≤ C < 10 %

T; R48/23/25: C ≥ 7 %

Xn; R48/20/22: 0,1 % ≤ C < 7 %
E
048-009-00-9cadmium sulphate233-331-610124-36-4Carc. Cat. 2; R45

Muta. Cat. 2; R46

Repr. Cat. 2; R60-61

T+; R26

T; R25-48/23/25

N; R50-53
T+; N

R: 45-46-60-61-25-26-48/23/25-50/53

S: 53-45-60-61
Carc. Cat. 2; R45: C ≥ 0,01 %

T; R25: C ≥ 10 %

Xn; R22: 0,1 % ≤ C < 10 %

T; R48/23/25: C ≥ 7 %

Xn; R48/20/22: 0,1 % ≤ C < 7 %
E
048-010-00-4cadmium sulphide215-147-81306-23-6Carc. Cat. 2; R45

Muta. Cat. 3; R68

Repr. Cat. 3; R62-63

T; R48/23/25

Xn; R22

R53
T;

R: 45-22-48/23/25-62-63-68-53

S: 53-45-61
Xn; R22: C ≥ 10 %

T; R48/23/25: C ≥ 10 %

Xn; R48/20/22: 0,1 % ≤ C < 10 %
E

1
048-011-00-Xcadmium (pyrophoric)231-152-87440-43-9F; R17

Carc. Cat. 2; R45

Muta. Cat. 3; R68

Repr. Cat. 3; R62-63

T+; R26

T; R48/23/25

N; R50-53
F; T+; N

R: 45-17-26-48/23/25-62-63-68-50/53

S: 53-45-7/8-43-60-61
E
050-001-00-5tin tetrachloride;

stannic chloride
231-588-97646-78-8C; R34

R52-53
C

R: 34-52/53

S: (1/2-)7/8-26-45-61
C; R34: C ≥ 10 %

Xi; R36/37/38: 5 % ≤ C < 10 %
050-002-00-0cyhexatin (ISO);

hydroxytricyclohexylstannane;

tri(cyclohexyl)tin hydroxide
236-049-113121-70-5Xn; R20/21/22

N; R50-53
Xn; N

R: 20/21/22-50/53

S: (2-)13-60-61
050-003-00-6fentin acetate (ISO);

triphenyltin acetate
212-984-0900-95-8Carc. Cat. 3; R40

Repr. Cat. 3; R63

T+; R26

T; R24/25-48/23

Xi; R37/38-41

N; R50-53
T+; N

R: 24/25-26-37/38-40-41-48/23-50/53-63

S: (1/2-)26-28-36/37/39-45-60-61
050-004-00-1fentin hydroxide (ISO);

triphenyltin hydroxide
200-990-676-87-9Carc. Cat. 3; R40

Repr. Cat. 3; R63

T+; R26

T; R24/25-48/23

Xi; R37/38-41

N; R50-53
T+; N

R: 24/25-26-37/38-40-41-48/23-50/53-63

S: (1/2-)26-28-36/37/39-45-60-61
050-005-00-7trimethyltin compounds, with the exception of those specified elsewhere in this AnnexT+; R26/27/28

N; R50-53
T+; N

R: 26/27/28-50/53

S: (1/2-)26-27-28-45-60-61
T+; R26/27/28: C ≥ 0,5 %

T; R23/24/25: 0,1 % ≤ C < 0,5 %

Xn; R20/21/22: 0,05 % ≤ C < 0,1 %
A

1
050-006-00-2triethyltin compounds, with the exception of those specified elsewhere in this AnnexT+; R26/27/28

N; R50-53
T+; N

R: 26/27/28-50/53

S: (1/2-)26-27-28-45-60-61
T+; R26/27/28: C ≥ 0,5 %

T; R23/24/25: 0,1 % ≤ C < 0,5 %

Xn; R20/21/22: 0,05 % ≤ C < 0,1 %
A

1
050-007-00-8tripropyltin compounds, with the exception of those specified elsewhere in this AnnexT; R23/24/25

N; R50-53
T; N

R: 23/24/25-50/53

S: (1/2-)26-27-28-45-60-61
T; R23/24/25: C ≥ 0,5 %

Xn; R20/21/22: 0,1 % ≤ C < 0,5 %
A

1
050-008-00-3tributyltin compounds, with the exception of those specified elsewhere in this AnnexT; R25-48/23/25

Xn; R21

Xi; R36/38

N; R50-53
T; N

R: 21-25-36/38-48/23/25-50/53

S: (1/2-)35-36/37/39-45-60-61
T; R25: C ≥ 1 %

Xn; R22: 0,25 % ≤ C < 1 %

T; R48/23/25: C ≥ 1 %

Xn; R48/20/22: 0,25 % ≤ C < 1 %

Xn; R21: C ≥ 1 %

Xi; R36/38: C ≥ 1 %
A

1
050-009-00-9fluorotripentylstannane; [1]

hexapentyldistannoxane [2]
243-546-7 [1]

247-143-7 [2]
20153-49-5 [1]

25637-27-8 [2]
Xn; R20/21/22

N; R50-53
Xn; N

R: 20/21/22-50/53

S: (2-)26-28-60-61
Xn; R20/21/22: C ≥ 1 %1
050-010-00-4fluorotrihexylstannane243-547-220153-50-8Xn; R20/21/22

N; R50-53
Xn; N

R: 20/21/22-50/53

S: (2-)26-28-60-61
Xn; R20/21/22: C ≥ 1 %1
050-011-00-Xtriphenyltin compounds, with the exception of those specified elsewhere in this AnnexT; R23/24/25

N; R50-53
T; N

R: 23/24/25-50/53

S: (1/2-)26-27-28-45-60-61
T; R23/24/25: C ≥ 1 %

Xn; R20/21/22: 0,25 % ≤ C < 1 %
A

1
050-012-00-5tetracyclohexylstannane; [1]

chlorotricyclohexylstannane; [2]

butyltricyclohexylstannane [3]
215-910-5 [1]

221-437-5 [2]

230-358-5 [3]
1449-55-4 [1]

3091-32-5 [2]

7067-44-9 [3]
Xn; R20/21/22

N; R50-53
Xn; N

R: 20/21/22-50/53

S: (2-)26-28-60-61
Xn; R20/21/22: C ≥ 1 %A

1
050-013-00-0trioctyltin compounds, with the exception of those specified elsewhere in this AnnexXi; R36/37/38

R53
Xi

R: 36/37/38-53

S: (2-)61
Xi; R36/37/38: C ≥ 1 %A

1
050-017-00-2fenbutatin oxide (ISO);

bis(tris(2-methyl-2-phenylpropyl)tin)oxide
236-407-713356-08-6T+; R26

Xi; R36/38

N; R50-53
T+; N

R: 26-36/38-50/53

S: (1/2-)28-36/37-45-60-61
050-018-00-8tin(II) methanesulphonate401-640-753408-94-9C; R34

Xn; R22

R43
C

R: 22-34-43

S: (1/2-)22-26-36/37/39-45
050-019-00-3azocyclotin (ISO);

1-(tricyclohexylstannyl)-1H-1,2,4-triazole;
255-209-141083-11-8T+; R26

T; R25

Xi; R37/38-41

N; R50-53
T+; N

R: 25-26-37/38-41-50/53

S: (1/2-)26-28-36/37/39-38-45-60-61
050-020-00-9trioctylstannane413-320-4869-59-0T; R48/25

Xi; R38

R53
T

R: 38-48/25-53

S: (1/2-)23-36/37-45-61
051-001-00-8antimony trichloride233-047-210025-91-9C; R34

N; R51-53
C; N

R: 34-51/53

S: (1/2-)26-45-61
C; R34: C ≥ 10 %

Xi; R36/37/38: 5 % ≤ C < 10 %
051-002-00-3antimony pentachloride231-601-87647-18-9C; R34

N; R51-53
C; N

R: 34-51/53

S: (1/2-)26-45-61
C; R34: C ≥ 10 %

Xi; R36/37/38: 5 % ≤ C < 10 %
051-003-00-9antimony compounds, with the exception of the tetroxide (Sb2O4), pentoxide (Sb2O5), trisulphide (Sb2S3), pentasulphide (Sb2S5) and those specified elsewhere in this AnnexXn; R20/22

N; R51-53
Xn; N

R: 20/22-51/53

S: (2-)61
Xn; R20/22: C ≥ 0,25 %A

1
051-004-00-4antimony trifluoride232-009-27783-56-4T; R23/24/25

N; R51-53
T; N

R: 23/24/25-51/53

S: (1/2-)7-26-45-61
051-005-00-Xantimony trioxide215-175-01309-64-4Carc. Cat. 3; R40Xn

R: 40

S: (2-)22-36/37
051-006-00-5diphenyl(4-phenylthiophenyl)sulfonium hexafluoroantimonate403-500-0R43

N; R50-53
Xi; N

R: 43-50/53

S: (2-)24-37-60-61
051-007-00-0bis(4-dodecylphenyl)iodonium hexafluoroantimonate404-420-971786-70-4R43

R52-53
Xi

R: 43-52/53

S: (2-)24-37-61
053-001-00-3iodine231-442-47553-56-2Xn; R20/21

N; R50
Xn; N

R: 20/21-50

S: (2-)23-25-61
053-002-00-9hydrogen iodide233-109-910034-85-2C; R35C

R: 35

S: (1/2-)9-26-36/37/39-45
C; R35: C ≥ 10 %

C; R34: 0,2 % ≤ C < 10 %

Xi; R36/37/38: 0,02 % ≤ C < 0,2 %
5
053-002-01-6hydriodic acid ... %C; R34C

R: 34

S: (1/2-)26-45
C; R34: C ≥ 25 %

Xi; R36/38: 10 % ≤ C < 25 %
B
053-003-00-4iodoxybenzene696-33-3E; R1 ⊗E

R: 1

S: (2-)35
053-004-00-Xcalcium iodoxybenzoateE; R1 ⊗E

R: 1

S: (2-)35
C
053-005-00-5(4-(1-methylethyl)phenyl)-(4-methylphenyl)iodonium tetrakis(pentafluorophenyl)borate (1-)422-960-3178233-72-2Xn; R21/22-48/22

N; R50-53
Xn; N

R: 21/22-48/22-50/53

S: (2-)22-36/37-60-61
056-001-00-1barium peroxide215-128-41304-29-6O; R8

Xn; R20/22
O; Xn

R: 8-20/22

S: (2-)13-27
056-002-00-7barium salts, with the exception of barium sulphate, salts of 1-azo-2-hydroxynaphthalenyl aryl sulphonic acid, and of salts specified elsewhere in this AnnexXn; R20/22Xn

R: 20/22

S: (2-)28
Xn; R20/22: C ≥ 1 %A

1
056-003-00-2barium carbonate208-167-3513-77-9Xn; R22Xn

R: 22

S: (2-)24/25
056-004-00-8barium chloride233-788-110361-37-2T; R25

Xn; R20
T

R: 20-25

S: (1/2-)45
072-001-00-4hafnium tetra-n-butoxide411-740-222411-22-9Xi; R41

R43
Xi

R: 41-43

S: (2-)24/25-26-37/39
074-001-00-Xhexasodium tungstate hydrate412-770-912141-67-2Xn; R22

Xi; R41

R52-53
Xn

R: 22-41-52/53

S: (2-)22-26-39-61
074-002-00-5Reaction products of tungsten hexachloride with 2-methylpropan-2-ol, nonylphenol and pentane-2,4-dione408-250-6F; R11

Xn; R20

C; R34

R43

N; R50-53
F; C; N

R: 11-20-34-43-50/53

S: (1/2-)16-26-29-33-36/37/39-45-60-61
076-001-00-5osmium tetraoxide;

osmic acid
244-058-720816-12-0T+; R26/27/28

C; R34
T+

R: 26/27/28-34

S: (1/2-)7/9-26-45
078-001-00-0tetrachloroplatinates with the exception of those specified elsewhere in this AnnexT; R25

Xi; R41

R42/43
T

R: 25-41-42/43

S: (2-)22-26-36/37/39-45
A
078-002-00-6diammonium tetrachloroplatinate237-499-113820-41-2T; R25

Xi; R38-41

R42/43
T

R: 25-38-41-42/43

S: (2-)22-26-36/37/39-45
078-003-00-1disodium tetrachloroplatinate233-051-410026-00-3T; R25

Xi; R38-41

R42/43
T

R: 25-38-41-42/43

S: (2-)22-26-36/37/39-45
078-004-00-7dipotassium tetrachloroplatinate233-050-910025-99-7T; R25

Xi; R38-41

R42/43
T

R: 25-38-41-42/43

S: (2-)22-26-36/37/39-45
078-005-00-2hexachloroplatinates with the exception of those specified elsewhere in this AnnexT; R25

Xi; R41

R42/43
T

R: 25-41-42/43

S: (1/2-)22-26-36/37/39-45
A
078-006-00-8disodium hexachloroplatinate240-983-516923-58-3T; R25

Xi; R41

R42/43
T

R: 25-41-42/43

S: (1/2-)22-26-36/37/39-45
078-007-00-3dipotassium hexachloroplatinate240-979-316921-30-5T; R25

Xi; R41

R42/43
T

R: 25-41-42/43

S: (1/2-)22-26-36/37/39-45
078-008-00-9diammonium hexachloroplatinate240-973-016919-58-7T; R25

Xi; R41

R42/43
T

R: 25-41-42/43

S: (1/2-)22-26-36/37/39-45
078-009-00-4hexachloroplatinic acid241-010-716941-12-1T; R25

C; R34

R42/43
T

R: 25-34-42/43

S: (1/2-)22-26-36/37/39-45
080-001-00-0mercury231-106-77439-97-6T; R23

R33

N; R50-53
T; N

R: 23-33-50/53

S: (1/2-)7-45-60-61
080-002-00-6inorganic compounds of mercury with the exception of mercuric sulphide and those specified elsewhere in this AnnexT+; R26/27/28

R33

N; R50-53
T+; N

R: 26/27/28-33-50/53

S: (1/2-)13-28-45-60-61
T+; R26/27/28: C ≥ 2 %

T; R23/24/25: 0,5 % ≤ C < 2 %

Xn; R20/21/22: 0,1 % ≤ C < 0,5 %

R33: C ≥ 0,1 %
A

1
080-003-00-1dimercury dichloride;

mercurous chloride;

calomel
233-307-510112-91-1Xn; R22

Xi; R36/37/38

N; R50-53
Xn; N

R: 22-36/37/38-50/53

S: (2-)13-24/25-46-60-61
080-004-00-7organic compounds of mercury with the exception of those specified elsewhere in this AnnexT+; R26/27/28

R33

N; R50-53
T+; N

R: 26/27/28-33-50/53

S: (1/2-)13-28-36-45-60-61
T+; R26/27/28: C ≥ 2 %

T; R23/24/25: 0,5 % ≤ C < 2 %

Xn; R20/21/22: 0,05 % ≤ C < 0,5 %

R33: C ≥ 0,05 %
A

1
080-005-00-2mercury difulminate;

mercuric fulminate;

fulminate of mercury
211-057-8628-86-4E; R3

T; R23/24/25

R33

N; R50-53
E; T; N

R: 3-23/24/25-33-50/53

S: (1/2-)3-45-60-61
080-006-00-8dimercury dicyanide oxide;

mercuric oxycyanide
215-629-81335-31-5E; R3 ⊗

T; R23/24/25

R33

N; R50-53
E; T; N

R: 3-23/24/25-33-50/53

S: (1/2-)28-35-45-60-61
080-007-00-3dimethylmercury; [1]

diethylmercury [2]
209-805-3 [1]

211-000-7 [2]
593-74-8 [1]

627-44-1 [2]
T+; R26/27/28

R33

N; R50-53
T+; N

R: 26/27/28-33-50/53

S: (1/2-)13-28-36-45-60-61
T+; R26/27/28: C ≥ 0,5 %

T; R23/24/25: 0,1 % ≤ C < 0,5 %

Xn; R20/21/22: 0,05 % ≤ C < 0,1 %

R33: C ≥ 0,05 %
1
080-008-00-9phenylmercury nitrate; [1]

phenylmercury hydroxide; [2]

basic phenylmercury nitrate [3]
200-242-9 [1]

202-866-7 [2]

- [3]
55-68-5 [1]

100-57-2 [2]

8003-05-2 [3]
T; R25-48/24/25

C; R34

N; R50-53
T; N

R: 25-34-48/24/25-50/53

S: (1/2-)23-24/25-37-45-60-61
080-009-00-42-methoxyethylmercury chloride204-659-7123-88-6T; R25-48/25

C; R34

N; R50-53
T; N

R: 25-34-48/25-50/53

S: (1/2-)36/37/39-45-60-61
080-010-00-Xmercury dichloride;

mercuric chloride
231-299-87487-94-7T+; R28

T; R48/24/25

C; R34

N; R50-53
T+; N

R: 28-34-48/24/25-50/53

S: (1/2-)36/37/39-45-60-61
080-011-00-5phenylmercury acetate200-532-562-38-4T; R25-48/24/25

C; R34

N; R50-53
T; N

R: 25-34-48/24/25-50/53

S: (1/2-)23-24/25-37-45-60-61
081-001-00-3thallium231-138-17440-28-0T+; R26/28

R33

R53
T+

R: 26/28-33-53

S: (1/2-)13-28-45-61
081-002-00-9thallium compounds, with the exception of those specified elsewhere in this AnnexT+; R26/28

R33

N; R51-53
T+; N

R: 26/28-33-51/53

S: (1/2-)13-28-45-61
A
081-003-00-4dithallium sulphate;

thallic sulphate
231-201-37446-18-6T+; R28

T; R48/25

Xi; R38

N; R51-53
T+; N

R: 28-38-48/25-51/53

S: (1/2-)13-36/37-45-61
082-001-00-6lead compounds with the exception of those specified elsewhere in this AnnexRepr. Cat. 1; R61

Repr. Cat. 3; R62

Xn; R20/22

R33

N; R50-53
T; N

R: 61-20/22-33-62-50/53

S: 53-45-60-61
Repr. Cat. 3; R62: C ≥ 2,5 %

Xn; R20/22: C ≥ 1 %

R33: C ≥ 0,5 %
AE

1
082-002-00-1lead alkylsRepr. Cat. 1; R61

Repr. Cat. 3; R62

T+; R26/27/28

R33

N; R50-53
T+; N

R: 61-26/27/28-33-62-50/53

S: 53-45-60-61
Repr. Cat. 1; R61: C ≥ 0,1 %

T+; R26/27/28: C ≥ 0,25 %

T; R23/24/25: 0,1 % ≤ C < 0,25 %

Xn; R20/21/22: 0,05 % ≤ C < 0,1 %

R33: C ≥ 0,05 %
AE

1
082-003-00-7lead diazide;

lead azide
236-542-113424-46-9E; R3

Repr. Cat. 1; R61

Repr. Cat. 3; R62

Xn; R20/22

R33

N; R50-53
E; T; N

R: 61-3-20/22-33-50/53-62

S: 53-45-60-61
E

1
082-004-00-2lead chromate231-846-07758-97-6Carc. Cat. 3; R40

Repr. Cat. 1; R61

Repr. Cat. 3; R62

R33

N; R50-53
T; N

R: 61-33-40-50/53-62

S: 53-45-60-61
1
082-005-00-8lead di(acetate)206-104-4301-04-2Repr. Cat. 1; R61

Repr. Cat. 3; R62

Xn; R48/22

R33

N; R50-53
T; N

R: 61-33-48/22-50/53-62

S: 53-45-60-61
E

1
082-006-00-3trilead bis(orthophosphate)231-205-57446-27-7Repr. Cat. 1; R61

Repr. Cat. 3; R62

Xn; R48/22

R33

N; R50-53
T; N

R: 61-33-48/22-50/53-62

S: 53-45-60-61
E

1
082-007-00-9lead acetate, basic;215-630-31335-32-6Carc. Cat. 3; R40

Repr. Cat. 1; R61

Repr. Cat. 3; R62

Xn; R48/22

R33

N; R50-53
T; N

R: 61-33-40-48/22-50/53-62

S: 53-45-60-61
E

1
082-008-00-4lead(II) methanesulphonate401-750-517570-76-2Repr. Cat. 1; R61

Repr. Cat. 3; R62

Xn; R20/22-48/20/22

Xi; R38-41

N; R58

R33
T; N

R: 61-62-20/22-33-38-41-48/20/22-58

S: 53-45-57-61
E

1
082-009-00-XLead sulfochromate yellow;

C.I. Pigment Yellow 34;

[This substance is identified in the Colour Index by Colour Index Constitution Number, C.I. 77603.]
215-693-71344-37-2Carc. Cat. 3; R40

Repr. Cat. 1; R61

Repr. Cat. 3; R62

R33

N; R50-53
T; N

R: 61-33-40-50/53-62

S: 53-45-60-61
1
082-010-00-5Lead chromate molybdate sulfate red;

C.I. Pigment Red 104;

[This substance is identified in the Colour Index by Colour Index Constitution Number, C.I. 77605.]
235-759-912656-85-8Carc. Cat. 3; R40

Repr. Cat. 1; R61

Repr. Cat. 3; R62

R33

N; R50-53
T; N

R: 61-33-40-50/53-62

S: 53-45-60-61
1
082-011-00-0lead hydrogen arsenate232-064-27784-40-9Carc. Cat. 1; R45

Repr. Cat. 1; R61

Repr. Cat. 3; R62

T; R23/25

R33

N; R50-53
T; N

R: 45-61-23/25-33-50/53-62

S: 53-45-60-61
E

1
092-001-00-8uranium231-170-67440-61-1T+; R26/28

R33

R53
T+

R: 26/28-33-53

S: (1/2-)20/21-45-61
092-002-00-3uranium compoundsT+; R26/28

R33

N; R51-53
T+; N

R: 26/28-33-51/53

S: (1/2-)20/21-45-61
A
601-001-00-4methane200-812-774-82-8F+; R12F+

R: 12

S: (2-)9-16-33
601-002-00-Xethane200-814-874-84-0F+; R12F+

R: 12

S: (2-)9-16-33
601-003-00-5propane200-827-974-98-6F+; R12F+

R: 12

S: (2-)9-16
601-004-00-0butane; [1]

and isobutane [2]
203-448-7 [1]

200-857-2 [2]
106-97-8 [1]

75-28-5 [2]
F+; R12F+

R: 12

S: (2-)9-16
C
601-004-01-8butane (containing ≥ 0,1 % butadiene (203-450-8)); [1]

isobutane (containing ≥ 0,1 % butadiene (203-450-8)) [2]
203-448-7 [1]

200-857-2 [2]
106-97-8 [1]

75-28-5 [2]
F+; R12

Carc. Cat. 1; R45

Muta. Cat. 2; R46
F+; T

R: 45-46-12

S: 53-45
CS
601-005-00-62,2-dimethylpropane;

neopentane
207-343-7463-82-1F+; R12

N; R51-53
F+; N

R: 12-51/53

S: (2-)9-16-33-61
601-006-00-1pentane; [1]

isopentane;

2-methylbutane [2]
203-692-4 [1]

201-142-8 [2]
109-66-0 [1]

78-78-4 [2]
F+; R12

Xn; R65

R66

R67

N; R51-53
F+; Xn; N

R: 12-51/53-65-66-67

S: (2-)9-16-29-33-61-62
C
601-007-00-7hexane, reaction mass of isomers (containing < 5 % n-hexane (203-777-6))F; R11

Xn; R65

Xi; R38

R67

N; R51-53
F; Xn; N

R: 11-38-51/53-65-67

S: (2-)9-16-29-33-61-62
C
601-008-00-2heptane [and isomers] [1]205-563-8 [1]

203-548-0 [2]

207-346-3 [3]

209-230-8 [4]

209-280-0 [5]

209-643-3 [6]

209-680-5 [7]

209-730-6 [8]

210-529-0 [9]

250-610-8 [10]
142-82-5 [1]

108-08-7 [2]

464-06-2 [3]

562-49-2 [4]

565-59-3 [5]

589-34-4 [6]

590-35-2 [7]

591-76-4 [8]

617-78-7 [9]

31394-54-4 [10]
F; R11

Xn; R65

Xi; R38

R67

N; R50-53
F; Xn; N

R: 11-38-50/53-65-67

S: (2-)9-16-29-33-60-61-62
C
601-009-00-8octane [and isomers] [1]203-892-1 [1]

208-759-1 [2]

209-207-2 [3]

209-243-9 [4]

209-266-4 [5]

209-292-6 [6]

209-504-7 [7]

209-547-1 [8]

209-649-6 [9]

209-650-1 [10]

209-660-6 [11]

209-689-4 [12]
111-65-9 [1]

540-84-1 [2]

560-21-4 [3]

563-16-6 [4]

564-02-3 [5]

565-75-3 [6]

583-48-2 [7]

584-94-1 [8]

589-43-5 [9]

589-53-7 [10]

589-81-1 [11]

590-73-8 [12]

592-13-2 [13]

592-27-8 [14]

594-82-1 [15]

609-26-7 [16]

619-99-8 [17]

1067-08-9 [18]

26635-64-3 [19]
F; R11

Xn; R65

Xi; R38

R67

N; R50-53
F; Xn; N

R: 11-38-50/53-65-67

S: (2-)9-16-29-33-60-61-62
C
209-745-8 [13]

209-747-9 [14]

209-855-6 [15]

210-187-2 [16]

210-621-0 [17]

213-923-0 [18]

247-861-0 [19]
601-010-00-3ethylene200-815-374-85-1F+; R12

R67
F+

R: 12-67

S: (2-)9-16-33-45
601-011-00-9propene;

propylene
204-062-1115-07-1F+; R12F+

R: 12

S: (2-)9-16-33
601-012-00-4but-1-ene; [1]

butene, mixed-1-and-2-isomers; [2]

2-methylpropene; [3]

(Z)-but-2-ene; [4]

(E)-but-2-ene [5]
203-449-2 [1]

203-452-9 [2]

204-066-3 [3]

209-673-7 [4]

210-855-3 [5]
106-98-9 [1]

107-01-7 [2]

115-11-7 [3]

590-18-1 [4]

624-64-6 [5]
F+; R12F+

R: 12

S: (2-)9-16-33
C
601-013-00-X1,3-butadiene;

buta-1,3-diene
203-450-8106-99-0F+; R12

Carc. Cat. 1; R45

Muta. Cat. 2; R46
F+; T

R: 45-46-12

S: 53-45
D
601-014-00-5isoprene (stabilised)

2-methyl-1,3-butadiene
201-143-378-79-5F+; R12

Carc. Cat. 2; R45

Muta. Cat. 3; R68

R52-53
F+; T

R: 45-12-68-52/53

S: 53-45-61
D
601-015-00-0acetylene;

ethyne
200-816-974-86-2R5

R6

F+; R12
F+

R: 5-6-12

S: (2-)9-16-33
601-016-00-6cyclopropane200-847-875-19-4F+; R12F+

R: 12

S: (2-)9-16-33
601-017-00-1cyclohexane203-806-2110-82-7F; R11

Xn; R65

Xi; R38

R67

N; R50-53
F; Xn; N

R: 11-38-65-67-50/53

S: (2-)9-16-25-33-60-61-62
601-018-00-7methylcyclohexane203-624-3108-87-2F; R11

Xn; R65

Xi; R38

R67

N; R51-53
F; Xn; N

R: 11-38-51/53-65-67

S: (2-)9-16-33-61-62
601-019-00-21,4-dimethylcyclohexane209-663-2589-90-2F; R11

Xn; R65

Xi; R38

R67

N; R51-53
F; Xn; N

R: 11-38-51/53-65-67

S: (2-)9-16-33-61-62
601-020-00-8benzene200-753-771-43-2F; R11

Carc. Cat. 1; R45

Muta. Cat. 2; R46

T; R48/23/24/25

Xn; R65

Xi; R36/38
F; T

R: 45-46-11-36/38-48/23/24/25-65

S: 53-45
E
601-021-00-3toluene203-625-9108-88-3F; R11

Repr. Cat. 3; R63

Xn; R48/20-65

Xi; R38

R67
F; Xn

R: 11-38-48/20-63-65-67

S: (2-)36/37-46-62
601-022-00-9o-xylene; [1]

p-xylene; [2]

m-xylene; [3]

xylene [4]
202-422-2 [1]

203-396-5 [2]

203-576-3 [3]

215-535-7 [4]
95-47-6 [1]

106-42-3 [2]

108-38-3 [3]

1330-20-7 [4]
R10

Xn; R20/21

Xi; R38
Xn

R: 10-20/21-38

S: (2-)25
Xn; R20/21: C ≥ 12,5 %C
601-023-00-4ethylbenzene202-849-4100-41-4F; R11

Xn; R20
F; Xn

R: 11-20

S: (2-)16-24/25-29
601-024-00-Xcumene; [1]

propylbenzene [2]
202-704-5 [1]

203-132-9 [2]
98-82-8 [1]

103-65-1 [2]
R10

Xn; R65

Xi; R37

N; R51-53
Xn; N

R: 10-37-51/53-65

S: (2-)24-37-61-62
C
601-025-00-5mesitylene;

1,3,5-trimethylbenzene
203-604-4108-67-8R10

Xi; R37

N; R51-53
Xi; N

R: 10-37-51/53

S: (2-)61
Xi; R37: C ≥ 25 %
601-026-00-0styrene202-851-5100-42-5R10

Xn; R20

Xi; R36/38
Xn

R: 10-20-36/38

S: (2-)23
Xn; R20: C ≥ 12,5 %

Xi; R36/38: C ≥ 12,5 %
D
601-027-00-62-phenylpropene;

α-methylstyrene
202-705-098-83-9R10

Xi; R36/37

N; R51-53
Xi; N

R: 10-36/37-51/53

S: (2-)61
Xi; R36/37: C ≥ 25 %
601-028-00-12-methylstyrene;

2-vinyltoluene
210-256-7611-15-4Xn; R20

N; R51-53
Xn; N

R: 20-51/53

S: (2-)24-61
601-029-00-7dipentene;

limonene; [1]

(R)-p-mentha-1,8-diene;

d-limonene; [2]

(S)-p-mentha-1,8-diene;

l-limonene; [3]

trans-1-methyl-4-(1-methylvinyl)cyclohexene; [4]

(±)-1-methyl-4-(1-methylvinyl)cyclohexene [5]
205-341-0 [1]

227-813-5 [2]

227-815-6 [3]

229-977-3 [4]

231-732-0 [5]
138-86-3 [1]

5989-27-5 [2]

5989-54-8 [3]

6876-12-6 [4]

7705-14-8 [5]
R10

Xi; R38

R43

N; R50-53
Xi; N

R: 10-38-43-50/53

S: (2-)24-37-60-61
C
601-030-00-2cyclopentane206-016-6287-92-3F; R11

R52-53
F

R: 11-52/53

S: (2-)9-16-29-33-61
601-031-00-82,4,4-trimethylpent-1-ene203-486-4107-39-1F; R11

N; R51-53
F; N

R: 11-51/53

S: (2-)9-16-29-33-61
601-032-00-3benzo[a]pyrene;

benzo[def]chrysene
200-028-550-32-8Carc. Cat. 2; R45

Muta. Cat. 2; R46

Repr. Cat. 2; R60-61

R43

N; R50-53
T; N

R: 45-46-60-61-43-50/53

S: 53-45-60-61
Carc. Cat. 2; R45: C ≥ 0,01 %
601-033-00-9benz[a]anthracene200-280-656-55-3Carc. Cat. 2; R45

N; R50-53
T; N

R: 45-50/53

S: 53-45-60-61
601-034-00-4benz[e]acephenanthrylene205-911-9205-99-2Carc. Cat. 2; R45

N; R50-53
T; N

R: 45-50/53

S: 53-45-60-61
601-035-00-Xbenzo[j]fluoranthene205-910-3205-82-3Carc. Cat. 2; R45

N; R50-53
T; N

R: 45-50/53

S: 53-45-60-61
601-036-00-5benzo[k]fluoranthene205-916-6207-08-9Carc. Cat. 2; R45

N; R50-53
T; N

R: 45-50/53

S: 53-45-60-61
601-037-00-0n-hexane203-777-6110-54-3F; R11

Repr. Cat. 3; R62

Xn; R65-48/20

Xi; R38

R67

N; R51-53
F; Xn; N

R: 11-38-48/20-62-65-67-51/53

S: (2-)9-16-29-33-36/37-61-62
Xn; R48/20: C ≥ 5 %
601-041-00-2dibenz[a,h]anthracene200-181-853-70-3Carc. Cat. 2; R45

N; R50-53
T; N

R: 45-50/53

S: 53-45-60-61
Carc. Cat. 2; R45: C ≥ 0,01 %
601-042-00-8biphenyl;

diphenyl
202-163-592-52-4Xi; R36/37/38

N; R50-53
Xi; N

R: 36/37/38-50/53

S: (2-)23-60-61
601-043-00-31,2,4-trimethylbenzene202-436-995-63-6R10

Xn; R20

Xi; R36/37/38

N; R51-53
Xn; N

R: 10-20-36/37/38-51/53

S: (2-)26-61
601-044-00-93a,4,7,7a-tetrahydro-4,7-methanoindene201-052-977-73-6F; R11

Xn; R20/22

Xi; R36/37/38

N; R51-53
F; Xn; N

R: 11-20/22-36/37/38-51/53

S: (2-)36/37-61
601-045-00-41,2,3,4-tetrahydronaphthalene204-340-2119-64-2R19

Xi; R36/38

N; R51-53
Xi; N

R: 19-36/38-51/53

S: (2-)26-28-61
601-046-00-X7-methylocta-1,6-diene404-210-742152-47-6R10

N; R50-53
N

R: 10-50/53

S: (2-)60-61
601-047-00-5m-mentha-1,3(8)-diene404-150-117092-80-7Xi; R38

N; R51-53
Xi; N

R: 38-51/53

S: (2-)37-61
601-048-00-0chrysene205-923-4218-01-9Carc. Cat. 2; R45

Muta. Cat. 3; R68

N; R50-53
T; N

R: 45-68-50/53

S: 53-45-60-61
601-049-00-6benzo[e]pyrene205-892-7192-97-2Carc. Cat. 2; R45

N; R50-53
T; N

R: 45-50/53

S: 53-45-60-61
601-051-00-74-phenylbut-1-ene405-980-7768-56-9Xi; R38

N; R51-53
Xi; N

R: 38-51/53

S: (2-)37-61
601-052-00-2naphthalene202-049-591-20-3Carc. Cat. 3; R40

Xn; R22

N; R50-53
Xn; N

R: 22-40-50/53

S: (2-)36/37-46-60-61
601-053-00-8nonylphenol; [1]

4-nonylphenol, branched [2]
246-672-0 [1]

284-325-5 [2]
25154-52-3 [1]

84852-15-3 [2]
Repr. Cat. 3; R62-63

Xn; R22

C; R34

N; R50-53
C; N

R: 22-34-62-63-50/53

S: (1/2-)26-36/37/39-45-46-60-61
601-054-00-3reaction mass of isomers of: dibenzylbenzene;

dibenzyl(methyl)benzene;

dibenzyl(dimethyl)benzene;

dibenzyl(trimethyl)benzene
405-570-8N; R50-53N

R: 50/53

S: 60-61
601-055-00-9reaction mass of isomers of: mono-(2-tetradecyl)naphthalenes;

di-(2-tetradecyl)naphthalenes;

tri-(2-tetradecyl)naphthalenes
410-190-0132983-41-6Xi; R36

R53
Xi

R: 36-53

S: (2-)26-61
601-056-00-4reaction mass of isomers of: methyldiphenylmethane;

dimethyldiphenylmethane
405-470-473807-39-3Xi; R38

N; R50-53
Xi; N

R: 38-50/53

S: (2-)37-60-61
601-057-00-XN-dodecyl-[3-(4-(dimethylamino)benzamido)-propyl]dimethylammonium tosylate421-130-8156679-41-3Xi; R41

R43

N; R50-53
Xi; N

R: 41-43-50/53

S: (2-)24-26-37/39-60-61
601-058-00-5di-L-para-menthene417-870-683648-84-4Xi; R38

R43

N; R50-53
Xi; N

R: 38-43-50/53

S: (2-)23-24-37-60-61
601-059-00-0methyl 2-benzylidene-3-oxobutyrate420-940-915768-07-7Xi; R36/38

N; R51-53
Xi; N

R: 36/38-51/53

S: (2-)26-37/39-61
601-060-00-61,2-bis[4-fluoro-6-{4-sulfo-5-(2-(4-sulfonaphtalene-3-ylazo)-1-hydroxy-3,6-disulfo-8-aminonaphthalene-7-ylazo)phenylamino}-1,3,5-triazin-2ylamino]ethane; x-sodium, y-potassium salts x = 7,755 y = 0,245417-610-1155522-09-1R43Xi

R: 43

S: (2-)22-24-37
601-061-00-1(ethyl-1,2-ethanediyl)[-2-[[[(2-hydroxyethyl)methylamino]acetyl]-propyl]ω-(nonylphenoxy)poly]oxy-(methyl-1,2-ethanediyl)418-960-8C; R34

R43

N; R51-53
C; N

R: 34-43-51/53

S: (1/2-)26-28-36/37/39-45-61
601-062-00-7reaction mass of: branched triacontane;

branched dotriacontane;

branched tetratriacontane;

branched hexatriacontane
417-030-9151006-59-6R53R: 53

S: 61
601-063-00-2reaction mass of isomers of branched tetracosane417-060-2151006-61-0Xn; R20

R53
Xn

R: 20-53

S: (2-)61
601-064-00-8branched hexatriacontane417-070-7151006-62-1R53R: 53

S: 61
601-065-00-3reaction mass of: (1'-α,3'-α,6'-α-2,2,3',7',7'-pentamethylspiro(1,3-dioxane-5,2'-norcarane);

(1'α,3'β,6'α)-2,2,3',7',7'-pentamethylspiro(1,3-dioxane-5,2'-norcarane)
416-930-9Xn; R48/22

Xi; R41

N; R51-53
Xn; N

R: 41-48/22-51/53

S: (2-)22-26-37/39-61
601-066-00-91-(4-(trans-4-heptylcyclohexyl)phenyl)ethanone426-820-278531-60-9R43

R53
Xi

R: 43-53

S: (2-)24-37-61
601-067-00-4triethyl arsenate427-700-215606-95-8Carc. Cat. 1; R45

T; R23/25

N; R50-53
T; N

R: 45-23/25-50/53

S: 53-45-60-61
E
601-068-00-X1,2-diacetoxybut-3-ene421-720-518085-02-4Xn; R22Xn

R: 22

S: (2-)
601-069-00-52-ethyl-1-(2-(1,3-dioxanyl)ethyl)-pyridinium bromide422-680-1287933-44-2R52-53R: 52/53

S: 61
601-071-00-61-dimethoxymethyl-2-nitro-benzene423-830-920627-73-0R43

N; R51-53
Xi; N

R: 43-51/53

S: (2-)24-37-61
601-073-00-71-bromo-3,5-difluorobenzene416-710-2461-96-1R10

Xn; R22-48/22

Xi; R38

R43

N; R50-53
Xn; N

R: 10-22-38-43-48/22-50/53

S: (2-)24-36/37-60-61
601-074-00-2reaction mass of: 4-(2,2,3-trimethylcyclopent-3-en-1-yl)-1-methyl-2-oxabicyclo[2.2.2]octane;

1-(2,2,3-trimethylcyclopent-3-en-1-yl)-5-methyl-6-oxabicyclo[3.2.1]octane;

spiro[cyclohex-3-en-1-yl-[(4,5,6,6a-tetrahydro-3,6',6',6'a-tetramethyl)-1,3'(3'aH)-[2H]cyclopenta[b]furan];

spiro[cyclohex-3-en-1-yl-[4,5,6,6a-tetrahydro-4,6',6',6'a-tetramethyl)-1,3'(3'aH)-[2H]cyclopenta[b]]furan]
422-040-1Xi; R36/38

N; R51-53
Xi; N

R: 36/38-51/53

S: (2-)26-37-61
602-001-00-7chloromethane;

methyl chloride
200-817-474-87-3F+; R12

Carc. Cat. 3; R40

Xn; R48/20
F+; Xn

R: 12-40-48/20

S: (2-)9-16-33
602-002-00-2bromomethane;

methylbromide
200-813-274-83-9Muta. Cat. 3; R68

T; R23/25

Xn; R48/20

Xi; R36/37/38

N; R50

N; R59
T; N

R: 23/25-36/37/38-48/20-50-59-68

S: (1/2-)15-27-36/39-38-45-59-61
602-003-00-8dibromomethane200-824-274-95-3Xn; R20

R52-53
Xn

R: 20-52/53

S: (2-)24-61
Xn; R20: C ≥ 12,5 %
602-004-00-3dichloromethane;

methylene chloride
200-838-975-09-2Carc. Cat. 3; R40Xn

R: 40

S: (2-)23-24/25-36/37
602-005-00-9methyl iodide;

iodomethane
200-819-574-88-4Carc. Cat. 3; R40

Xn; R21

T; R23/25

Xi; R37/38
T

R: 21-23/25-37/38-40

S: (1/2-)36/37-38-45
602-006-00-4trichloromethane;

chloroform
200-663-867-66-3Xn; R22-48/20/22

Xi; R38

Carc. Cat. 3; R40
Xn

R: 22-38-40-48/20/22

S: (2-)36/37
Xn; R22: C ≥ 5 %

Xn; R48/20/22: C ≥ 5 %
602-007-00-Xbromoform;

tribromomethane
200-854-675-25-2T; R23

Xi; R36/38

N; R51-53
T; N

R: 23-36/38-51/53

S: (1/2-)28-45-61
602-008-00-5carbon tetrachloride;

tetrachloromethane
200-262-856-23-5Carc. Cat. 3; R40

T; R23/24/25-48/23

N; R59

R52-53
T; N

R: 23/24/25-40-48/23-59-52/53

S: (1/2-)23-36/37-45-59-61
T; R23/24/25: C ≥ 1 %

Xn; R20/21/22: 0,2 % ≤ C < 1 %

T; R48/23: C ≥ 1 %

Xn; R48/20: 0,2 % ≤ C < 1 %
602-009-00-0chloroethane200-830-575-00-3F+; R12

Carc. Cat. 3; R40

R52-53
F+; Xn

R: 12-40-52/53

S: (2-)9-16-33-36/37-61
602-010-00-61,2-dibromoethane203-444-5106-93-4Carc. Cat. 2; R45

T; R23/24/25

Xi; R36/37/38

N; R51-53
T; N

R: 45-23/24/25-36/37/38-51/53

S: 53-45-61
T; R23/24/25: C ≥ 1 %

Xn; R20/21/22: 0,1 % ≤ C < 1 %
E
602-011-00-11,1-dichloroethane200-863-575-34-3F; R11

Xn; R22

Xi; R36/37

R52-53
F; Xn

R: 11-22-36/37-52/53

S: (2-)16-23-61
Xn; R22: C ≥ 12,5 %
602-012-00-71,2-dichloroethane;

ethylene dichloride
203-458-1107-06-2F; R11

Carc. Cat. 2; R45

Xn; R22

Xi; R36/37/38
F; T

R: 45-11-22-36/37/38

S: 53-45
E
602-013-00-21,1,1-trichloroethane;

methyl chloroform
200-756-371-55-6Xn; R20

N; R59
Xn; N

R: 20-59

S: (2-)24/25-59-61
F
602-014-00-81,1,2-trichloroethane201-166-979-00-5Carc. Cat. 3; R40

Xn; R20/21/22

R66
Xn

R: 20/21/22-40-66

S: (2-)9-36/37-46
Xn; R20/21/22: C ≥ 5 %
602-015-00-31,1,2,2-tetrachloroethane201-197-879-34-5T+; R26/27

N; R51-53
T+; N

R: 26/27-51/53

S: (1/2-)38-45-61
602-016-00-91,1,2,2-tetrabromoethane201-191-579-27-6T+; R26

Xi; R36

R52-53
T+

R: 26-36-52/53

S: (1/2-)24-27-45-61
602-017-00-4pentachloroethane200-925-176-01-7Carc. Cat. 3; R40

T; R48/23

N; R51-53
T; N

R: 40-48/23-51/53

S: (1/2-)23-36/37-45-61
T; R48/23: C ≥ 1 %

Xn; R48/20: 0,2 % ≤ C < 1 %
602-018-00-X1-chloropropane; [1]

2-chloropropane [2]
208-749-7 [1]

200-858-8 [2]
540-54-5 [1]

75-29-6 [2]
F; R11

Xn; R20/21/22
F; Xn

R: 11-20/21/22

S: (2-)9-29
C
602-019-00-51-bromopropane;

n-propyl bromide
203-445-0106-94-5F; R11

Repr. Cat. 2; R60

Repr. Cat. 3; R63

Xn; R48/20

Xi; R36/37/38

R67
F; T

R: 60-11-36/37/38-48/20-63-67

S: 53-45
E
602-020-00-01,2-dichloropropane;

propylene dichloride
201-152-278-87-5F; R11

Xn; R20/22
F; Xn

R: 11-20/22

S: (2-)16-24
602-021-00-61,2-dibromo-3-chloropropane202-479-396-12-8Carc. Cat. 2; R45

Muta. Cat. 2; R46

Repr. Cat. 1; R60

T; R25

Xn; R48/20/22

R52-53
T

R: 45-46-60-25-48/20/22-52/53

S: 53-45-61
E
602-022-00-11-chloropentane; [1]

2-chloropentane; [2]

3-chloropentane [3]
208-846-4 [1]

210-885-7 [2]

210-467-4 [3]
543-59-9 [1]

625-29-6 [2]

616-20-6 [3]
F; R11

Xn; R20/21/22
F; Xn

R: 11-20/21/22

S: (2-)9-29
C
602-023-00-7vinyl chloride;

chloroethylene
200-831-075-01-4F+; R12

Carc. Cat. 1; R45
F+; T

R: 45-12

S: 53-45
D
602-024-00-2bromoethylene209-800-6593-60-2F+; R12

Carc. Cat. 2; R45
F+; T

R: 45-12

S: 53-45
602-025-00-81,1-dichloroethylene;

vinylidene chloride
200-864-075-35-4F+; R12

Carc. Cat. 3; R40

Xn; R20
F+; Xn

R: 12-20-40

S: (2-)7-16-29-36/37-46
Xn; R20: C ≥ 12,5 %D
602-026-00-31,2-dichloroethylene; [1]

cis-dichloroethylene; [2]

trans-dichloroethylene [3]
208-750-2 [1]

205-859-7 [2]

205-860-2 [3]
540-59-0 [1]

156-59-2 [2]

156-60-5 [3]
F; R11

Xn; R20

R52-53
F; Xn

R: 11-20-52/53

S: (2-)7-16-29-61
Xn; R20: C ≥ 12,5 %C
602-027-00-9trichloroethylene;

trichloroethene
201-167-479-01-6Carc. Cat. 2; R45

Muta. Cat. 3; R68

R67

Xi; R36/38

R52-53
T

R: 45-36/38-52/53-67

S: 53-45-61
602-028-00-4tetrachloroethylene204-825-9127-18-4Carc. Cat. 3; R40

N; R51-53
Xn; N

R: 40-51/53

S: (2-)23-36/37-61
602-029-00-X3-chloropropene;

allyl chloride
203-457-6107-05-1F; R11

Carc. Cat. 3; R40

Muta. Cat. 3; R68

Xn; R20/21/22-48/20

Xi; R36/37/38

N; R50
F; Xn; N

R: 11-20/21/22-36/37/38-40-48/20-68-50

S: (2-)16-25-26-36/37-46-61
D
602-030-00-51,3-dichloropropene; [1]

(Z)-1,3-dichloropropene [2]
208-826-5 [1]

233-195-8 [2]
542-75-6 [1]

10061-01-5 [2]
R10

T; R25

Xn; R20/21

Xi; R36/37/38

R43

N; R50-53
T; N

R: 10-20/21-25-36/37/38-43-50/53

S: (1/2-)36/37-45-60-61
DC
602-031-00-01,1-dichloropropene209-253-3563-58-6F; R11

T; R25

R52-53
F; T

R: 11-25-52/53

S: (1/2-)16-29-33-45-61
602-032-00-63-chloro-2-methylpropene209-251-2563-47-3F; R11

Xn; R20/22

C; R34

R43

N; R51-53
F; C; N

R: 11-20/22-34-43-51/53

S: (2-)9-16-26-29-36/37/39-45-61
602-033-00-1chlorobenzene203-628-5108-90-7R10

Xn; R20

N; R51-53
Xn; N

R: 10-20-51/53

S: (2-)24/25-61
Xn; R20: C ≥ 5 %
602-034-00-71,2-dichlorobenzene;

o-dichlorobenzene
202-425-995-50-1Xn; R22

Xi; R36/37/38

N; R50-53
Xn; N

R: 22-36/37/38-50/53

S: (2-)23-60-61
Xn; R22: C ≥ 5 %
602-035-00-21,4-dichlorobenzene;

p-dichlorobenzene
203-400-5106-46-7Carc. Cat. 3; R40

Xi; R36

N; R50-53
Xn; N

R: 36-40-50/53

S: (2-)36/37-46-60-61
602-036-00-8chloroprene (stabilised);

2-chlorobuta-1,3-diene (stabilised)
204-818-0126-99-8F; R11

Carc. Cat. 2; R45

Xn; R20/22-48/20

Xi; R36/37/38
F; T

R: 45-11-20/22-36/37/38-48/20

S: 53-45
D E
602-037-00-3α-chlorotoluene;

benzyl chloride
202-853-6100-44-7Carc. Cat. 2; R45

T; R23

Xn; R22-48/22

Xi; R37/38-41
T

R: 45-22-23-37/38-41-48/22

S: 53-45
E
602-038-00-9α,α,α-trichlorotoluene;

benzotrichloride
202-634-598-07-7Carc. Cat. 2; R45

T; R23

Xn; R22

Xi; R37/38-41
T

R: 45-22-23-37/38-41

S: 53-45
E
602-039-00-4polychlorobiphenyls;

PCB
215-648-11336-36-3R33

N; R50-53
N

R: 33-50/53

S: (2-)-60-61
R33: C ≥ 0,005 %C
602-040-00-X2-chlorotoluene; [1]

3-chlorotoluene; [2]

4-chlorotoluene; [3]

chlorotoluene [4]
202-424-3 [1]

203-580-5 [2]

203-397-0 [3]

246-698-2 [4]
95-49-8 [1]

108-41-8 [2]

106-43-4 [3]

25168-05-2 [4]
Xn; R20

N; R51-53
Xn; N

R: 20-51/53

S: (2-)24/25-61
C
602-041-00-5penthachloronaphthalene215-320-81321-64-8Xn; R21/22

Xi; R36/38

N; R50-53
Xn; N

R: 21/22-36/38-50/53

S: (2-)-60-61
C
602-042-00-01,2,3,4,5,6-hexachlorcyclohexanes with the exception of those specified elsewhere in this AnnexCarc. Cat. 3; R40

T; R25

Xn; R21

N; R50-53
T; N

R: 21-25-40-50/53

S: (1/2-)22-36/37-45-60-61
A C
602-043-00-6lindane (ISO)

γ-HCH or γ-BHC;

γ-1,2,3,4,5,6-hexachlorocyclohexane;
200-401-258-89-9T; R25

Xn; R20/21-48/22

R64

N; R50-53
T; N

R: 20/21-25-48/22-64-50/53

S: (1/2-)36/37-45-60-61
N; R50-53: C ≥ 2,5 %

N; R51-53: 0,25 % ≤ C < 2,5 %

R52-53: 0,025 % ≤ C < 0,25 %
602-044-00-1camphechlor (ISO)

toxaphene;
232-283-38001-35-2Carc. Cat. 3; R40

T; R25

Xn; R21

Xi; R37/38

N; R50-53
T; N

R: 21-25-37/38-40-50/53

S: (1/2-)36/37-45-60-61
602-045-00-7DDT (ISO);

clofenotane (INN);

dicophane;

1,1,1-trichloro-2,2-bis(4-chlorophenyl)ethane;

dichlorodiphenyltrichloroethane
200-024-350-29-3T; R25-48/25

Carc. Cat. 3; R40

N; R50-53
T; N

R: 25-40-48/25-50/53

S: (1/2-)22-36/37-45-60-61
602-046-00-2heptachlor (ISO);

1,4,5,6,7,8,8-heptachloro-3a,4,7,7a-tetrahydro-4,7-methanoindene
200-962-376-44-8T; R24/25

Carc. Cat. 3; R40

R33

N; R50-53
T; N

R: 24/25-33-40-50/53

S: (1/2-)36/37-45-60-61
602-047-00-8chlordane (ISO);

1,2,4,5,6,7,8,8-octachloro-3a,4,7,7a-tetrahydro-4,7-methanoindan
200-349-057-74-9Carc. Cat. 3; R40

Xn; R21/22

N; R50-53
Xn; N

R: 21/22-40-50/53

S: (2-)36/37-60-61
602-048-00-3aldrin (ISO)206-215-8309-00-2T; R24/25-48/24/25

Carc. Cat. 3; R40

N; R50-53
T; N

R: 24/25-40-48/24/25-50/53

S: (1/2-)22-36/37-45-60-61
602-049-00-9dieldrin (ISO)200-484-560-57-1T+; R27

T; R25-48/25

Carc. Cat. 3; R40

N; R50-53
T+; N

R: 25-27-40-48/25-50/53

S: (1/2-)22-36/37-45-60-61
602-050-00-4(1α,4α,4aβ,5β,8β,8aβ)-1,2,3,4,10,10-hexachloro-1,4,4a,5,8,8a-hexahydro-1,4:5,8-dimethanonaphfthalene;

isodrin
207-366-2465-73-6T+; R26/27/28

N; R50-53
T+; N

R: 26/27/28-50/53

S: (1/2-)13-28-45-60-61
602-051-00-Xendrin (ISO);

1,2,3,4,10,10-hexachloro-6,7-epoxy-1,4,4a,5,6,7,8,8a-octahydro-1,4:5,8-dimethanonaphthalene
200-775-772-20-8T+; R28

T; R24

N; R50-53
T+; N

R: 24-28-50/53

S: (1/2-)22-36/37-45-60-61
602-052-00-5endosulfan (ISO);

1,2,3,4,7,7-hexachloro-8,9,10-trinorborn-2-en-5,6-ylenedimethyl sulphite
204-079-4115-29-7T; R24/25

Xi; R36

N; R50-53
T; N

R: 24/25-36-50/53

S: (1/2-)28-36/37-45-60-61
602-053-00-0isobenzan (ISO);

1,3,4,5,6,7,8,8-octachloro-1,3,3a,4,7,7a-hexahydro-4,7-methanoisobenzofuran
206-045-4297-78-9T+; R27/28

N; R50
T+; N

R: 27/28-50

S: (1/2-)28-36/37-45-61
602-054-00-63-iodpropene;

allyl iodide
209-130-4556-56-9R10

C; R34
C

R: 10-34

S: (1/2-)7-26-45
602-055-00-1bromoethane;

ethyl bromide
200-825-874-96-4F; R11

Carc. Cat. 3; R40

Xn; R20/22
F; Xn

R: 11-20/22-40

S: (2-)36/37
602-056-00-7α,α,α-trifluorotoluene;

benzotrifluoride
202-635-098-08-8F; R11

N; R51-53
F; N

R: 11-51/53

S: (2-)16-23-61
602-057-00-2α-bromotoluene;

benzyl bromide
202-847-3100-39-0Xi; R36/37/38Xi

R: 36/37/38

S: (2-)39
602-058-00-8α,α-dichlorotoluene;

benzylidene chloride;

benzal chloride
202-709-298-87-3Carc. Cat. 3; R40

T; R23

Xn; R22

Xi; R37/38-41
T

R: 22-23-37/38-40-41

S: (1/2-)36/37-38-45
602-059-00-31-chlorobutane;

butyl chloride
203-696-6109-69-3F; R11F

R: 11

S: (2-)9-16-29
602-060-00-9bromobenzene203-623-8108-86-1R10

Xi; R38

N; R51-53
Xi; N

R: 10-38-51/53

S: (2-)61
602-061-00-4hexafluoropropene;

hexafluoropropylene
204-127-4116-15-4Xn; R20

Xi; R37
Xn

R: 20-37

S: (2-)41
602-062-00-X1,2,3-trichloropropane202-486-196-18-4Carc. Cat. 2; R45

Repr. Cat. 2; R60

Xn; R20/21/22
T

R: 45-60-20/21/22

S: 53-45
E D
602-063-00-5heptachlor epoxide;

2,3-epoxy-1,4,5,6,7,8,8-heptachloro-3a,4,7,7a-tetrahydro-4,7-methanoindane
213-831-01024-57-3T; R25

Carc. Cat. 3; R40

R33

N; R50-53
T; N

R: 25-33-40-50/53

S: (1/2-)36/37-45-60-61
602-064-00-01,3-dichloro-2-propanol202-491-996-23-1Carc. Cat. 2; R45

T; R25

Xn; R21
T

R: 45-21-25

S: 53-45
E
602-065-00-6hexachlorobenzene204-273-9118-74-1Carc. Cat. 2; R45

T; R48/25

N; R50-53
T; N

R: 45-48/25-50/53

S: 53-45-60-61
E
602-066-00-1tetrachloro-p-benzoquinone204-274-4118-75-2Xi; R36/38

N; R50-53
Xi; N

R: 36/38-50/53

S: (2-)37-60-61
602-067-00-71,3-dichlorbenzene208-792-1541-73-1Xn; R22

N; R51-53
Xn; N

R: 22-51/53

S: (2-)61
602-068-00-2ethylene bis(trichloroacetate)219-732-92514-53-6Xi; R38Xi

R: 38

S: (2-)
602-069-00-8dichloroacetylene7572-29-4E; R2

Carc. Cat. 3; R40

Xn; R48/20
E; Xn

R: 2-40-48/20

S: (2-)36/37
602-070-00-33-chloro-4,5,α, α,α-pentafluorotoluene401-930-377227-99-7R10

Xn; R20/22

N; R50-58
Xn; N

R: 10-20/22-50-58

S: (2-)51-60-61
602-071-00-9bromobenzylbromotoluene, reaction mass of isomers402-210-199688-47-8Xn; R48/22

R43

N; R50-53
Xn; N

R: 43-48/22-50/53

S: (2-)24-37-41-60-61
602-072-00-4dichloro [(dichlorophenyl)methyl]methylbenzene, reaction mass of isomers;

(dichlorophenyl)(dichlorotolyl)methane, reaction mass of isomers (IUPAC)
278-404-376253-60-6N; R50-53N

R: 50/53

S: 60-61
602-073-00-X1,4-dichlorobut-2-ene212-121-8764-41-0Carc. Cat. 2; R45

T+; R26

T; R24/25

C; R34

N; R50-53
T+; N

R: 45-24/25-26-34-50/53

S: 53-45-60-61
Carc. Cat. 2; R45: C ≥ 0,01 %

C; R34: C ≥ 10 %

Xi; R36/37/38: 5 % ≤ C < 10 %
E
602-074-00-5pentachlorobenzene210-172-0608-93-5F; R11

Xn; R22

N; R50-53
F; Xn; N

R: 11-22-50/53

S: (2-)41-46-50-60-61
602-075-00-04,4,5,5-tetrachloro-1,3-dioxolan-2-one404-060-222432-68-4T+; R26

Xn; R22

C; R34
T+

R: 22-26-34

S: (1/2-)9-26-28-36/37/39-45
602-076-00-62,3,4-trichlorobut-1-ene219-397-92431-50-7Carc. Cat. 3; R40

T; R23

Xn; R22

Xi; R36/37/38

N; R50-53
T; N

R: 22-23-36/37/38-40-50/53

S: (1/2-)36/37-45-60-61
Carc. Cat. 3; R40: C ≥ 0,1 %
602-077-00-1dodecachloropentacyclo[5.2.1.02,6.03,9.05,8]decane;

mirex
219-196-62385-85-5Carc. Cat. 3; R40

Repr. Cat. 3; R62-63

R64

Xn; R21/22

N; R50/53
Xn; N

R: 21/22-40-50/53-62-63-64

S: (2-)13-36/37-46-60-61
602-078-00-7hexachlorocyclopentadiene201-029-377-47-4T+; R26

T; R24

Xn; R22

C; R34

N; R50-53
T+; N

R: 22-24-26-34-50/53

S: (1/2-)25-39-45-53-60-61
602-079-00-22,3-dichloropropene;

2,3-dichloropropylene
201-153-878-88-6F; R11

Muta. Cat. 3; R68

Xn; R20/21/22

Xi; R37/38-41

R52-53
F; Xn

R: 11-20/21/22-37/38-41-52/53-68

S: (2-)9-16-23-26-36/37/39-61
602-080-00-8alkanes, C10-13, chloro287-476-585535-84-8Carc. Cat. 3; R40

N; R50-53
Xn; N

R: 40-50/53

S: (2-)24-36/37-60-61
602-081-00-32-chloro-4,5-difluorobenzoic acid405-380-5Xn; R21/22

Xi; R41

R43
Xn

R: 21/22-41-43

S: (2-)26-36/37/39
602-082-00-92,2,6,6-tetrakis(bromomethyl)-4-oxaheptane-1,7-diol408-020-5109678-33-3R43

N; R51-53
Xi; N

R: 43-51/53

S: (2-)22-24-37-41-61
602-083-00-4diphenyl ether, pentabromo derivative pentabromodiphenyl ether251-084-232534-81-9Xn; R48/21/22

R64

N; R50-53
Xn; N

R: 48/21/22-50/53-64

S: (1/2-)36/37-45-60-61
602-084-00-X1,1-dichloro-1-fluoroethane404-080-11717-00-6R52-53

N; R59
N

R: 52/53-59

S: 59-61
602-085-00-52-bromopropane200-855-175-26-3F; R11

Repr. Cat. 1; R60

Xn; R48/20

R66
F; T

R: 60-11-48/20-66

S: 53-45
E
602-086-00-0trifluoroiodomethane;

trifluoromethyl iodide
219-014-52314-97-8Muta. Cat. 3; R68Xn

R: 68

S: (2-)36/37
602-087-00-61,2,4-trichlorobenzene204-428-0120-82-1Xn; R22

Xi; R38

N; R50-53
Xn; N

R: 22-38-50/53

S: (2-)23-37/39-60-61
602-088-00-12,3-dibromopropan-1-ol;

2,3-dibromo-1-propanol
202-480-996-13-9Carc. Cat. 2; R45

Repr. Cat. 3; R62

T; R24

Xn; R20/22

R52-53
T

R: 45-20/22-24-52/53-62

S: 53-45-61
E
602-089-00-74-bromo-2-chlorofluorobenzene405-580-260811-21-4Xn; R22

Xi; R38

N; R50-53
Xn; N

R: 22-38-50/53

S: (2-)26-36/37-60-61
602-090-00-21-allyl-3-chloro-4-fluorobenzene406-630-6121626-73-1Xi; R38

N; R51-53
Xi; N

R: 38-51/53

S: (2-)23-37-61
602-091-00-81,3-dichloro-4-fluorobenzene406-160-11435-48-9Xn; R22-48/20/22

Xi; R38

N; R51-53
Xn; N

R: 22-38-48/20/22-51/53

S: (2-)36/37-61
602-092-00-31-bromo-3,4,5-trifluorobenzene418-480-9138526-69-9R10

Carc. Cat. 3; R40

Xi; R38-41

N; R51-53
Xn; N

R: 10-38-40-41-51/53

S: (2-)23-26-36/37/39-61
602-093-00-9α, α,α,4-tetrachlorotoluene;

p-chlorobenzotrichloride
226-009-15216-25-1Carc. Cat. 2; R45

Repr. Cat. 3; R62

T; R48/23

Xn; R21/22

Xi; R37/38
T

R: 45-21/22-37/38-48/23-62

S: 53-45
E
602-094-00-4diphenylether; octabromo derivate251-087-932536-52-0Repr. Cat. 2; R61

Repr. Cat. 3; R62
T

R: 61-62

S: 53-45
602-096-00-5malachite green hydrochloride; [1]

malachite green oxalate [2]
209-322-8 [1]

219-441-7 [2]
569-64-2 [1]

2437-29-8 [2]
Repr. Cat. 3; R63

Xn; R22

Xi; R41

N; R50-53
Xn; N

R: 22-41-63-50/53

S: (2-)26-36/37-39-46-60-61
602-097-00-01-bromo-9-(4,4,5,5,5-pentafluoropentylthio)nonane422-850-5148757-89-5R43

N; R50-53
Xi; N

R: 43-50/53

S: (2-)24-37-60-61
603-001-00-Xmethanol200-659-667-56-1F; R11

T; R23/24/25-39/23/24/25
F; T

R: 11-23/24/25-39/23/24/25

S: (1/2-)7-16-36/37-45
T; R23/24/25: C ≥ 20 %

Xn; R20/21/22: 3 % ≤ C < 20 %

T; R39/23/24/25: C ≥ 10 %

Xn; R68/20/21/22: 3 % ≤ C < 10 %
603-002-00-5ethanol;

ethyl alcohol
200-578-664-17-5F; R11F

R: 11

S: (2-)7-16
603-003-00-0propan-1-ol;

n-propanol
200-746-971-23-8F; R11

Xi; R41

R67
F; Xi

R: 11-41-67

S: (2-)7-16-24-26-39
603-004-00-6butan-1-ol;

n-butanol
200-751-671-36-3R10

Xn; R22

Xi; R37/38-41

R67
Xn

R: 10-22-37/38-41-67

S: (2-)7/9-13-26-37/39-46
603-005-00-12-methylpropan-2-ol;

tert-butyl alcohol
200-889-775-65-0F; R11

Xn; R20
F; Xn

R: 11-20

S: (2-)9-16
603-006-00-7pentanol isomers, with the exception fo those specified elsewhere in this Annex250-378-8R10

Xn; R20

Xi; R37

R66
Xn

R: 10-20-37-66

S: (2-)46
C
603-007-00-22-methylbutan-2-ol;

tert-pentanol
200-908-975-85-4F; R11

Xn; R20

Xi; R37/38
F; Xn

R: 11-20-37/38

S: (2-)46
603-008-00-84-methylpentan-2-ol;

methyl isobutyl carbinol
203-551-7108-11-2R10

Xi; R37
Xi

R: 10-37

S: (2-)24/25
Xi; R37: C ≥ 25 %
603-009-00-3cyclohexanol203-630-6108-93-0Xn; R20/22

Xi; R37/38
Xn

R: 20/22-37/38

S: (2-)24/25
603-010-00-92-methylcyclohexanol, mixed isomers; [1]

cis-2-methylcyclohexanol; [2]

trans-2-methylcyclohexanol [3]
209-512-0 [1]

231-187-9 [2]

231-186-3 [3]
583-59-5 [1]

7443-70-1 [2]

7443-52-9 [3]
Xn; R20Xn

R: 20

S: (2-)24/25
C
603-011-00-42-methoxyethanol;

ethylene glycol monomethyl ether
203-713-7109-86-4R10

Repr. Cat. 2; R60-61

Xn; R20/21/22
T

R: 60-61-10-20/21/22

S: 53-45
E
603-012-00-X2-ethoxyethanol;

ethylene glycol monoethyl ether
203-804-1110-80-5R10

Repr. Cat. 2; R60-61

Xn; R20/21/22
T

R: 60-61-10-20/21/22

S: 53-45
E
603-013-00-52-isopropoxyethanol;

ethylene glycol monoisopropyl ether
203-685-6109-59-1Xn; R20/21

Xi; R36
Xn

R: 20/21-36

S: (2-)24/25
603-014-00-02-butoxyethanol;

ethylene glycol monobutyl ether;

butyl cellosolve
203-905-0111-76-2Xn; R20/21/22

Xi; R36/38
Xn

R: 20/21/22-36/38

S: (2-)36/37-46
603-015-00-6allyl alcohol203-470-7107-18-6R10

T; R23/24/25

Xi; R36/37/38

N; R50
T; N

R: 10-23/24/25-36/37/38-50

S: (1/2-)36/37/39-38-45-61
603-016-00-14-hydroxy-4-methylpentan-2-one;

diacetone alcohol
204-626-7123-42-2Xi; R36Xi

R: 36

S: (2-)24/25
Xi; R36: C ≥ 10 %
603-018-00-2furfuryl alcohol202-626-198-00-0Xn; R20/21/22Xn

R: 20/21/22

S: (2-)
Xn; R20/21/22: C ≥ 5 %
603-019-00-8dimethyl ether204-065-8115-10-6F+; R12F+

R: 12

S: (2-)9-16-33
603-020-00-3ethyl methyl ether540-67-0F+; R12F+

R: 12

S: (2-)9-16-33
603-021-00-9methyl vinyl ether203-475-4107-25-5F+; R12F+

R: 12

S: (2-)9-16-33
D
603-022-00-4diethyl ether;

ether
200-467-260-29-7F+; R12

R19

Xn; R22

R66

R67
F+; Xn

R: 12-19-22-66-67

S: (2-)9-16-29-33
603-023-00-Xethylene oxide;

oxirane
200-849-975-21-8F+; R12 ⊗

Carc. Cat. 2; R45

Muta. Cat. 2; R46

T; R23

Xi; R36/37/38
F+; T

R: 45-46-12-23-36/37/38

S: 53-45
E
603-024-00-51,4-dioxane204-661-8123-91-1F; R11-19

Carc. Cat. 3; R40

Xi; R36/37

R66
F; Xn

R: 11-19-36/37-40-66

S: (2-)9-16-36/37-46
D
603-025-00-0tetrahydrofuran203-726-8109-99-9F; R11-19

Xi; R36/37
F; Xi

R: 11-19-36/37

S: (2-)16-29-33
Xi; R36/37: C ≥ 25 %
603-026-00-61-chloro-2,3-epoxypropane;

epichlorhydrin
203-439-8106-89-8R10

Carc. Cat. 2; R45

T; R23/24/25

C; R34

R43
T

R: 45-10-23/24/25-34-43

S: 53-45
T; R23/24/25: C ≥ 1 %

Xn; R20/21/22: 0,1 % ≤ C < 1 %
E
603-027-00-1ethanediol;

ethylene glycol
203-473-3107-21-1Xn; R22Xn

R: 22

S: (2-)
603-028-00-72-chloroethanol;

ethylene chlorohydrin
203-459-7107-07-3T+; R26/27/28T+

R: 26/27/28

S: (1/2-)7/9-28-45
603-029-00-2bis(2-chloroethyl) ether203-870-1111-44-4R10 ⊗

Carc. Cat. 3; R40

T+; R26/27/28
T+

R: 10-26/27/28-40

S: (1/2-)7/9-27-28-36/37-45
603-030-00-82-aminoethanol;

ethanolamine
205-483-3141-43-5Xn; R20/21/22

C; R34
C

R: 20/21/22-34

S: (1/2-)26-36/37/39-45
C; R34: C ≥ 10 %

Xi; R36/37/38: 5 % ≤ C < 10 %
603-031-00-31,2-dimethoxyethane;

ethylene glycol dimethyl ether;

EGDME
203-794-9110-71-4F; R11

R19

Repr. Cat. 2; R60

Repr. Cat. 2; R61

Xn; R20
F; T

R: 60-61-11-19-20

S: 53-45
E
603-032-00-9ethylene dinitrate;

ethylene glycol dinitrate
211-063-0628-96-6E; R2 $

T+; R26/27/28

R33
E; T+

R: 2-26/27/28-33

S: (1/2-)33-35-36/37-45
603-033-00-4oxydiethylene dinitrate;

diethylene glycol dinitrate;

digol dinitrate
211-745-8693-21-0E; R3

T+; R26/27/28

R33

R52-53
E; T+

R: 3-26/27/28-33-52/53

S: (1/2-)33-35-36/37-45-61
603-034-00-Xglycerol trinitrate;

nitroglycerine
200-240-855-63-0E; R3

T+; R26/27/28

R33

N; R51-53
E; T+; N

R: 3-26/27/28-33-51/53

S: (1/2-)33-35-36/37-45-61
603-035-00-5pentaerythritol tetranitrate;

P.E.T.N.
201-084-378-11-5E; R3E

R: 3

S: (2-)35
603-036-00-0mannitol hexanitrate;

nitromannite
239-924-615825-70-4E; R3E

R: 3

S: (2-)35
603-037-00-6cellulose nitrate;

nitrocellulose, containing more than 12,6 % nitrogen
E; R3 $

R1
E

R: 1-3

S: (2-)35
603-037-01-3cellulose nitrate;

nitrocellulose, containing a maximum of 12,6 % nitrogen
F; R11 $F

R: 11

S: (2-)16-33-37/39
603-038-00-1allyl glycidyl ether;

allyl 2,3-epoxypropyl ether;

prop-2-en-1-yl 2,3-epoxypropyl ether
203-442-4106-92-3R10

Carc. Cat. 3; R40

Muta. Cat. 3; R68

Repr. Cat. 3; R62

Xn; R20/22

Xi; R37/38-41

R43

R52-53
Xn

R: 10-20/22-37/38-40-41-43-52/53-62-68

S: (2-)24/25-26-36/37/39-61
603-039-00-7butyl glycidyl ether;

butyl 2,3-epoxypropyl ether
219-376-42426-08-6R10

Carc. Cat. 3; R40

Muta. Cat. 3; R68

Xn; R20/22

Xi; R37

R43

R52-53
Xn

R: 10-20/22-37-40-43-52/53-68

S: (2-)24/25-36/37-61
603-040-00-2sodium methanolate;

sodium methoxide; [1]

potassium methanolate;

potassium methoxide; [2]

lithium methanolate;

lithium methoxide [3]
204-699-5 [1]

212-736-1 [2]

212-737-7 [3]
124-41-4 [1]

865-33-8 [2]

865-34-9 [3]
F; R11

C; R34

R14
F; C

R: 11-14-34

S: (1/2-)8-16-26-43-45
603-041-00-8potassium ethanolate;

potassium ethoxide; [1]

sodium ethanolate;

sodium ethoxide [2]
213-029-0 [1]

205-487-5 [2]
917-58-8 [1]

141-52-6 [2]
F; R11

C; R34

R14
F; C

R: 11-14-34

S: (1/2-)8-16-26-43-45
603-042-00-3aluminium-tri-isopropoxide209-090-8555-31-7F; R11F

R: 11

S: (2-)8-16
603-043-00-9triarimol (ISO);

2,4-dichloro-α-(pyrimidin-5-yl) benzhydryl alcohol
26766-27-8Xn; R22Xn

R: 22

S: (2-)
603-044-00-4dicofol (ISO);

2,2,2-trichloro-1,1-bis(4-chlorophenyl)ethanol
204-082-0115-32-2Xn; R21/22

Xi; R38

R43

N; R50-53
Xn; N

R: 21/22-38-43-50/53

S: (2-)36/37-60-61
603-045-00-Xdiisopropyl ether; [1]

dipropyl ether [2]
203-560-6 [1]

203-869-6 [2]
108-20-3 [1]

111-43-3 [2]
F; R11

R19

R66

R67
F

R: 11-19-66-67

S: (2-)9-16-29-33
C
603-046-00-5bis (chloromethyl) ether;

oxybis(chloromethane)
208-832-8542-88-1R10 $

Carc. Cat. 1; R45

T+; R26

T; R24

Xn; R22
T+

R: 45-10-22-24-26

S: 53-45
Carc. Cat. 1; R45: C ≥ 0,001 %E
603-047-00-02-dimethylaminoethanol;

N,N-dimethylethanolamine
203-542-8108-01-0R10

Xn; R20/21/22

C; R34
C

R: 10-20/21/22-34

S: (1/2-)25-26-36/37/39-45
C; R34: C ≥ 10 %

Xi; R36/37/38: 5 % ≤ C < 10 %
603-048-00-62-diethylaminoethanol;

N,N-diethylethanolamine
202-845-2100-37-8R10

Xn; R20/21/22

C; R34
C

R: 10-20/21/22-34

S: (1/2-)25-26-36/37/39-45
C; R34: C ≥ 10 %

Xi; R36/37/38: 5 % ≤ C < 10 %
603-049-00-1chlorfenethol (ISO);

1,1-bis (4-chlorophenyl) ethanol
201-246-380-06-8Xn; R22

N; R51-53
Xn; N

R: 22-51/53

S: (2-)36-61
603-050-00-71-(2-Butoxypropoxy)propan-2-ol246-011-624083-03-2Xn; R21/22Xn

R: 21/22

S: (2-)
603-051-00-22-ethylbutan-1-ol202-621-497-95-0Xn; R21/22Xn

R: 21/22

S: (2-)
603-052-00-83-butoxypropan-2-ol;

propylene glycol monobutyl ether
225-878-45131-66-8Xi; R36/38Xi

R: 36/38

S: (2-)
603-053-00-32-methylpentane-2,4-diol203-489-0107-41-5Xi; R36/38Xi

R: 36/38

S: (2-)
Xi; R36/38: C ≥ 10 %
603-054-00-9di-n-butyl ether;

dibutyl ether
205-575-3142-96-1R10

Xi; R36/37/38

R52-53
Xi

R: 10-36/37/38-52/53

S: (2-)61
Xi; R36/37/38: C ≥ 10 %
603-055-00-4propylene oxide;

1,2-epoxypropane;

methyloxirane
200-879-275-56-9F+; R12

Carc. Cat. 2; R45

Muta. Cat. 2; R46

Xn; R20/21/22

Xi; R36/37/38
F+; T

R: 45-46-12-20/21/22-36/37/38

S: 53-45
E
603-056-00-X[(p-tolyloxy)methyl]oxirane; [1]

[(m-tolyloxy)methyl]oxirane; [2]

2,3-epoxypropyl o-tolyl ether; [3]

[(tolyloxy)methyl]oxirane;

cresyl glycidyl ether [4]
218-574-8 [1]

218-575-3 [2]

218-645-3 [3]

247-711-4 [4]
2186-24-5 [1]

2186-25-6 [2]

2210-79-9 [3]

26447-14-3 [4]
Muta. Cat. 3; R68

Xi; R38

R43

N; R51-53
Xn; N

R: 38-43-51/53-68

S: (2-)36/37-61
C
603-057-00-5benzyl alcohol202-859-9100-51-6Xn; R20/22Xn

R: 20/22

S: (2-)26
603-058-00-01,3-propylene oxide207-964-3503-30-0F; R11

Xn; R20/21/22
F; Xn

R: 11-20/21/22

S: (2-)9-16-26-29
603-059-00-6hexan-1-ol203-852-3111-27-3Xn; R22Xn

R: 22

S: (2-)24/25
603-060-00-12,2'-bioxirane;

1,2:3,4-diepoxybutane
215-979-11464-53-5Carc. Cat. 2; R45

Muta. Cat. 2; R46

T+; R26

T; R24/25

C; R34
T+

R: 45-46-24/25-26-34

S: 53-45
E
603-061-00-7tetrahydro-2-furylmethanol;

tetrahydrofurfuryl alcohol
202-625-697-99-4Xi; R36Xi

R: 36

S: (2-)39
Xi; R36: C ≥ 10 %
603-062-00-2tetrahydrofuran-2,5-diyldimethanol203-239-0104-80-3Xi; R36/37/38Xi

R: 36/37/38

S: (2-)39
Xi; R36/37/38: C ≥ 10 %
603-063-00-82,3-epoxypropan-1-ol;

glycidol;

oxiranemethanol
209-128-3556-52-5Carc. Cat. 2; R45

Muta. Cat. 3; R68

Repr. Cat. 2; R60

T; R23

Xn; R21/22

Xi; R36/37/38
T

R: 45-60-21/22-23-36/37/38-68

S: 53-45
E
603-064-00-31-methoxy-2-propanol;

monopropylene glycol methyl ether
203-539-1107-98-2R10R: 10

S: (2-)24
603-065-00-9resorcinol diglycidyl ether;

1,3-bis(2,3-epoxypropoxy)benzene
202-987-5101-90-6Carc. Cat. 3; R40

Muta. Cat. 3; R68

Xn; R21/22

Xi; R36/38

R43

R52-53
Xn

R: 21/22-36/38-40-43-52/53-68

S: (2-)23-36/37-61
603-066-00-41,2-epoxy-4-epoxyethylcyclohexane;

vinylcyclohexane diepoxide
203-437-7106-87-6T; R23/24/25

Xn; R68
T

R: 23/24/25-68

S: (1/2-)23-24-45
T; R23/24/25: C ≥ 1 %:

Xn; R20/21/22: 0,1 % ≤ C < 1 %
603-067-00-Xphenyl glycidyl ether;

2,3-epoxypropyl phenyl ether;

1,2-epoxy-3-phenoxypropane
204-557-2122-60-1Carc. Cat. 2; R45

Muta. Cat. 3; R68

Xn; R20

Xi; R37/38

R43

R52-53
T

R: 45-20-37/38-43-68-52/53

S: 53-45-61
E
603-068-00-52,3-epoxypropyl-2-ethylcyclohexyl ether;

ethylcyclohexylglycidyl ether
130014-35-6Xi; R36/38

R43
Xi

R: 36/38-43

S: (2-)26-28-37/39
603-069-00-02,4,6-tris(dimethylaminomethyl)phenol202-013-990-72-2Xn; R22

Xi; R36/38
Xn

R: 22-36/38

S: (2-)26-28
603-070-00-62-amino-2-methylpropanol204-709-8124-68-5Xi; R36/38

R52-53
Xi

R: 36/38-52/53

S: (2-)61
Xi; R36/38: C ≥ 10 %
603-071-00-12,2'-iminodiethanol;

diethanolamine
203-868-0111-42-2Xn; R22-48/22

Xi; R38-41
Xn

R: 22-38-41-48/22

S: (2-)26-36/37/39-46
603-072-00-71,4-bis(2,3 epoxypropoxy)butane;

butanedioldiglycidyl ether
219-371-72425-79-8Xn; R20/21

Xi; R36/38

R43
Xn

R: 20/21-36/38-43

S: (2-)26-28-37/39
603-073-00-2bis-[4-(2,3-epoxipropoxi)phenyl]propane216-823-51675-54-3Xi; R36/38

R43
Xi

R: 36/38-43

S: (2-)28-37/39
Xi; R36/38: C ≥ 5 %
603-074-00-8reaction product: bisphenol-A-(epichlorhydrin);

epoxy resin (number average molecular weight ≤ 700)
500-033-525068-38-6Xi; R36/38

R43

N; R51-53
Xi; N

R: 36/38-43-51/53

S: (2-)28-37/39-61
Xi; R36/38: C ≥ 5 %
603-075-00-3chlormethyl methyl ether;

chlorodimethyl ether
203-480-1107-30-2F; R11

Carc. Cat. 1; R45

Xn; R20/21/22
F; T

R: 45-11-20/21/22

S: 53-45
E
603-076-00-9but-2-yne-1,4-diol;

2-butyne-1,4-diol
203-788-6110-65-6C; R34

T; R23/25

Xn; R21-48/22

R43
C; T

R: 21-23/25-34-43-48/22

S: (1/2-)25-26-36/37/39-45-46
C; R34: C ≥ 50 %

Xi; R36/38: 25 % ≤ C < 50 %
D
603-077-00-41-dimethylaminopropan-2-ol;

dimepranol (INN)
203-556-4108-16-7R10

Xn; R22

C; R34
C

R: 10-22-34

S: (1/2-)23-26-36-45
603-078-00-Xprop-2-yn-1-ol;

propargyl alcohol
203-471-2107-19-7R10

T; R23/24/25

C; R34

N; R51-53
T; N

R: 10-23/24/25-34-51/53

S: (1/2-)26-28-36-45-61
603-079-00-52,2'-(methylimino)diethanol;

N-methyldiethanolamine
203-312-7105-59-9Xi; R36Xi

R: 36

S: (2-)24
603-080-00-02-methylaminoethanol;

N-methylethanolamine;

N-methyl-2-ethanolamine;

N-methyl-2-amino ethanol;

2-(methylamino)ethanol
203-710-0109-83-1Xn; R21/22

C; R34
C

R: 21/22-34

S: (1/2-)26-36/37/39-45
C; R34: C ≥ 10 %

Xi; R36/37/38: 5 % ≤ C < 10 %
603-081-00-62,2'-thiodiethanol;

thiodiglycol
203-874-3111-48-8Xi; R36Xi

R: 36

S: (2-)
603-082-00-11-aminopropan-2-ol;

isopropanolamine
201-162-778-96-6C; R34C

R: 34

S: (1/2-)23-26-36-45
603-083-00-71,1'-iminodipropan-2-ol;

di-isopropanolamine
203-820-9110-97-4Xi; R36Xi

R: 36

S: (2-)26
603-084-00-2styrene oxide;

(epoxyethyl)benzene;

phenyloxirane
202-476-796-09-3Carc. Cat. 2; R45

Xn; R21

Xi; R36
T

R: 45-21-36

S: 53-45
E
603-085-00-8bronopol (INN);

2-bromo-2-nitropropane-1,3-diol
200-143-052-51-7Xn; R21/22

Xi; R37/38-41

N; R50
Xn; N

R: 21/22-37/38-41-50

S: (2-)26-37/39-61
603-086-00-3ethirimol (ISO);

5-butyl-2-ethylamino-6-methylpyrimidin-4-ol
245-949-323947-60-6Xn; R21Xn

R: 21

S: (2-)36/37
603-087-00-92-ethylhexane-1,3-diol;

octylene glycol;

ethoexadiol
202-377-994-96-2Xi; R41Xi

R: 41

S: (2-)25-26-39-46
603-088-00-42-(octylthio)ethanol;

2-hydroxyethyl octyl sulphide
222-598-43547-33-9Xi; R41Xi

R: 41

S: (2-)26
603-089-00-X7,7-dimethyl-3-oxa-6-azaoctan-1-ol400-390-6C; R35

Xn; R22
C

R: 22-35

S: (1/2-)26-28-36/37/39-45
603-090-00-52-(2-bromoethoxy)anisole402-010-44463-59-6Xn; R22

R52-53
Xn

R: 22-52/53

S: (2-)22-61
603-091-00-0exo-1-methyl-4-(1-methylethyl)-7-oxabicyclo[2.2.1]heptan-2-ol402-470-687172-89-2Xn; R22

Xi; R41
Xn

R: 22-41

S: (2-)26-39
603-092-00-62-methyl-4-phenylpentanol402-770-792585-24-5R43

N; R51-53
Xi; N

R: 43-51/53

S: (2-)24-37-61
603-093-00-1cinmethylin (ISO)

exo-(±)-1-methyl-2-(2-methylbenzyloxy)-4-isopropyl-7-oxabicyclo(2.2.1)heptane
402-410-987818-31-3Xn; R20

N; R51-53
Xn; N

R: 20-51/53

S: (2-)23-61
603-094-00-71,3-bis(2,3-epoxypropoxy)-2,2-dimethylpropane241-536-717557-23-2Xi; R38

R43
Xi

R: 38-43

S: (2-)24-37
603-095-00-22-(propyloxy)ethanol;

EGPE
220-548-62807-30-9Xn; R21

Xi; R36
Xn

R: 21-36

S: (2-)26-36/37-46
603-096-00-82-(2-butoxyethoxy)ethanol;

diethylene glycol monobutyl ether
203-961-6112-34-5Xi; R36Xi

R: 36

S: (2-)24-26
603-097-00-31,1',1''-nitrilotripropan-2-ol;

triisopropanolamine
204-528-4122-20-3Xi; R36

R52-53
Xi

R: 36-52/53

S: (2-)26-61
603-098-00-92-phenoxyethanol204-589-7122-99-6Xn; R22

Xi; R36
Xn

R: 22-36

S: (2-)26
603-099-00-43-(N-methyl-N-(4-methylamino-3-nitrophenyl)amino)propane-1,2-diol hydrochloride403-440-593633-79-5Xn; R22

R52-53
Xn

R: 22-52/53

S: (2-)61
603-100-00-81,2-dimethoxypropane404-630-07778-85-0F; R11-19F

R: 11-19

S: (2-)9-16-24/25-33
603-101-00-3tetrahydro-2-isobutyl-4-methylpyran-4-ol, mixed isomers (cis and trans)405-040-6Xi; R36Xi

R: 36

S: (2-)25-26
603-102-00-91,2-epoxybutane203-438-2106-88-7F; R11

Carc. Cat. 3; R40

Xn; R20/21/22

Xi; R36/37/38

R52-53
F; Xn

R: 11-20/21/22-36/37/38-40-52/53

S: (2-)9-16-29-36/37-61
603-103-00-4oxirane, mono[(C12-14-alkyloxy)methyl] derivs.271-846-868609-97-2Xi; R38

R43
Xi

R: 38-43

S: (2-)24-37
603-104-00-Xfenarimol (ISO);

2,4'-dichloro-α-(pyrimidin-5-yl)benzhydryl alcohol
262-095-760168-88-9Repr. Cat. 3; R62-63

R64

N; R51-53
Xn; N

R: 51/53-62-63-64

S: (2-)36/37-61
603-105-00-5furan203-727-3110-00-9F+; R12

R19

Carc. Cat. 2; R45

Muta. Cat. 3; R68

Xn; R20/22-48/22

Xi; R38

R52-53
F+; T

R: 45-12-19-20/22-38-48/22-68-52/53

S: 53-45-61
E
603-106-00-02-methoxypropanol216-455-51589-47-5R10

Repr. Cat. 2; R61

Xi; R37/38-41
T

R: 61-10-37/38-41

S: 53-45
603-107-00-62-(2-methoxyethoxy)ethanol;

diethylene glycol monomethyl ether
203-906-6111-77-3Repr. Cat. 3; R63Xn

R: 63

S: (2-)36/37
603-108-00-12-methylpropan-1-ol;

iso-butanol
201-148-078-83-1R10

Xi; R37/38-41

R67
Xi

R: 10-37/38-41-67

S: (2-)7/9-13-26-37/39-46
603-117-00-0propan-2-ol;

isopropyl alcohol;

isopropanol
200-661-767-63-0F; R11

Xi; R36

R67
F; Xi

R: 11-36-67

S: (2-)7-16-24/25-26
603-118-00-66-dimethylaminohexan-1-ol404-680-31862-07-3Xn; R22

C; R34

R52-53
C

R: 22-34-52/53

S: (1/2-)26-36/37/39-45-61
603-119-00-11,1'-(1,3-phenylenedioxy)bis(3-(2-(prop-2-enyl)phenoxy)propan-2-ol)405-840-5R43

N; R50-53
Xi; N

R: 43-50/53

S: (2-)24-37-60-61
603-120-00-72-methyl-5-phenylpentanol405-890-825634-93-9Xi; R36/38Xi

R: 36/38

S: (2-)26-37
603-121-00-24-[4-(1,3-dihydroxyprop-2-yl)phenylamino]-1,8-dihydroxy-5-nitroanthraquinone406-057-1114565-66-1Carc. Cat. 3; R40

R43

R53
Xn

R: 40-43-53

S: (2-)36/37-61
603-122-00-8sodium 2-ethylhexanolate406-150-738411-13-1F; R11

C; R34

R52-53
F; C

R: 11-34-52/53

S: (1/2-)7-26-36/37/39-45-61
603-123-00-34-methyl-8-methylenetricyclo[3.3.1.13,7]decan-2-ol406-330-5122760-84-3Xi; R38

R43

N; R51-53
Xi; N

R: 38-43-51/53

S: (2-)24-37-61
603-124-00-91,4-bis[2-(vinyloxy)ethoxy]benzene406-900-384563-49-5N; R50-53N

R: 50/53

S: 60-61
603-125-00-42-(2,4-dichlorophenyl)-1-(1H-1,2,4-triazol-1-yl)pent-4-en-2-ol407-850-589544-40-1Xn; R22

Xi; R41

N; R51-53
Xn; N

R: 22-41-51/53

S: (2-)26-39-61
603-126-00-X2-((4-methyl-2-nitrophenyl)amino)ethanol408-090-7100418-33-5Xn; R22

R43

R52-53
Xn

R: 22-43-52/53

S: (2-)36/37-61
603-127-00-5butan-2-ol; [1]

(S)-butan-2-ol; [2]

(R)-butan-2-ol; [3]

(±)-butan-2-ol [4]
201-158-5 [1]

224-168-1 [2]

238-967-8 [3]

240-029-8 [4]
78-92-2 [1]

4221-99-2 [2]

14898-79-4 [3]

15892-23-6 [4]
R10

Xi; R36/37

R67
Xi

R: 10-36/37-67

S: (2-)7/9-13-24/25-26-46
C
603-128-00-02-(phenylmethoxy)naphthalene405-490-3613-62-7R53R: 53

S: 61
603-129-00-61-tert-butoxypropan-2-ol406-180-057018-52-7R10

Xi; R41
Xi

R: 10-41

S: (2-)26-39
603-130-00-1reaction mass of isomers of: α-((dimethyl)biphenyl)-ω-hydroxypoly(oxyethylene)406-325-8Xn; R22

R52-53
Xn

R: 22-52/53

S: (2-)39-61
603-131-00-7reaction mass of: 1-deoxy-1-[methyl-(1-oxododecyl)amino]-D-glucitol;

1-deoxy-1-[methyl-(1-oxotetradecyl)amino]-D-glucitol (3:1)
407-290-1Xi; R41Xi

R: 41

S: (2-)26-39
603-132-00-22-hydroxymethyl-9-methyl-6-(1-methylethyl)-1,4-dioxaspiro[4.5]decane408-200-363187-91-7Xi; R38-41

R52-53
Xi

R: 38-41-52/53

S: (2-)26-37/39-61
603-133-00-8reaction mass of: 3-[(4-amino-2-chloro-5-nitrophenyl)amino]-propane-1,2-diol;

3,3'-(2-chloro-5-nitro-1,4-phenylenediimino)bis(propan-1,2-diol)
408-240-1Xn; R22

R52-53
Xn

R: 22-52/53

S: (2-)22-36-61
603-134-00-3reaction mass of substituted dodecyl and/or tetradecyl, diphenyl ethers. The substance is produced by the Friedel Crafts reaction. The catalyst is removed from the reaction product. Diphenyl ether is substituted by C1-C10 alkyl groups. The alkyl groups are bonded randomly between C1 and C6. Linear C12 and C14, 50/50 used.410-450-3R53R: 53

S: 61
603-135-00-9bis[[2,2',2''-nitrilotris-[ethanolato]]-1-N,O]-bis[2-(2-methoxyethoxy)ethoxy]-titanium410-500-4Xi; R41

N; R51-53
Xi; N

R: 41-51/53

S: (2-)26-39-61
603-136-00-43-((4-(bis(2-hydroxyethyl)amino)-2-nitrophenyl)amino)-1-propanol410-910-3104226-19-9R43

R52-53
Xi

R: 43-52/53

S: (2-)24-37-61
603-137-00-Xreaction mass of: 1-deoxy-1-[methyl-(1-oxohexadecyl)amino]-D-glucitol;

1-deoxy-1-[methyl-(1-oxooctadecyl)amino]-D-glucitol
411-130-6Xi; R41Xi

R: 41

S: (2-)26-39
603-138-00-53-(2,2-dimethyl-3-hydroxypropyl)toluene;

(alt.): 2,2-dimethyl-3-(3-methylphenyl)propanol
403-140-4103694-68-4R52-53R: 52/53

S: 61
603-139-00-0bis(2-methoxyethyl) ether203-924-4111-96-6R10

R19

Repr. Cat. 2; R60-61
T

R: 60-61-10-19

S: 53-45
603-140-00-62,2' -oxybisethanol;

diethylene glycol
203-872-2111-46-6Xn; R22Xn

R: 22

S: (2-)46
603-141-00-1reaction mass of: dodecyloxy-1-methyl-1-[oxy-poly-(2-hydroxymethylethanoxy)]pentadecane;

dodecyloxy-1-methyl-1-[oxy-poly-(2-hydroxymethylethanoxy)]heptadecane
413-780-6R52-53R: 52/53

S: 61
603-142-00-72-(2-(2-hydroxyethoxy)ethyl)-2-aza-bicyclo[2.2.1]heptane407-360-1116230-20-7Xn; R21/22-48/20

Xi; R38-41
Xn

R: 21/22-38-41-48/20

S: (2-)26-36/37/39
603-143-00-2R-2,3-epoxy-1-propanol404-660-457044-25-4E; R2

Carc. Cat. 2; R45

Muta. Cat. 3; R68

Repr. Cat. 2; R60

T; R23

Xn; R21/22

C; R34
E; T

R: 45-60-2-21/22-23-34-68

S: 53-45
E
603-144-00-8reaction mass of: 2,6,9-trimethyl-2,5,9-cyclododecatrien-1-ol;

6,9-dimethyl-2-methylen-5,9-cyclododecadien-1-ol
413-530-6111850-00-1N; R51-53N

R: 51/53

S: 61
603-145-00-32-isopropyl-2-(1-methylbutyl)-1,3-dimethoxypropane406-970-5129228-11-1Xi; R38

N; R51-53
Xi; N

R: 38-51/53

S: (2-)36/37-61
603-146-00-92-[(2-[2-(dimethylamino)ethoxy]ethyl)methylamino]ethanol406-080-783016-70-0Xn; R22

C; R34

R52-53
C

R: 22-34-52/53

S: (1/2-)23-26-36/37/39-45-61
603-147-00-4(-)-trans-4-(4'-fluorophenyl)-3-hydroxymethyl-N-methylpiperidine406-030-4105812-81-5Xn; R22

Xi; R41

N; R51-53
Xn; N

R: 22-41-51/53

S: (2-)22-24-26-37/39-61
603-148-00-X1,4-bis[(vinyloxy)methyl]cyclohexane413-370-717351-75-6R43

N; R51-53
Xi; N

R: 43-51/53

S: (2-)24-37-61
603-149-00-5reaction mass of diastereoisomers of 1-(1-hydroxyethyl)-4-(1-methylethyl)cyclohexane407-640-363767-86-2Xi; R36/38

N; R51-53
Xi; N

R: 36/38-51/53

S: (2-)26-37-61
603-150-00-0(±) trans-3,3-dimethyl-5-(2,2,3-trimethyl-cyclopent-3-en-1-yl)-pent-4-en-2-ol411-580-3107898-54-4Xi; R38

N; R50-53
Xi; N

R: 38-50/53

S: (2-)24/25-37-60-61
603-151-00-6(±)-2-(2,4-dichlorophenyl)-3-(1H-1,2,4-triazol-1-yl)propan-1-ol413-570-4R52-53R: 52/53

S: 61
603-152-00-12-(4-tert-butylphenyl)ethanol410-020-55406-86-0Repr. Cat. 3; R62

Xn; R48/22

Xi; R41

N; R51-53
Xn; N

R: 41-48/22-62-51/53

S: (2-)26-36/37/39-61
603-153-00-73-((2-nitro-4-(trifluoromethyl)phenyl)amino)propane-1,2-diol410-010-0104333-00-8Xn; R22

R52-53
Xn

R: 22-52/53

S: (2-)22-61
603-154-00-21-[(2-tert-butyl)cyclohexyloxy]-2-butanol412-300-2139504-68-0N; R51-53N

R: 51/53

S: 61
603-155-00-8Reaction products of 2-(4,6-bis(2,4-dimethylphenyl)-1,3,5-triazin-2-yl)-5-hydroxyphenol with ((C10-16, rich in C12-13 alkyloxy)methyl)oxyrane410-560-1N; R50-53N

R: 50/53

S: 60-61
603-156-00-32-(2,4-dichlorophenyl)-2-(2-propenyl)oxirane411-210-089544-48-9Xi; R38

R43

N; R50-53
Xi; N

R: 38-43-50/53

S: (2-)24-37-60-61
603-157-00-96,9-bis(hexadecyloxymethyl)-4,7-dioxanonane-1,2,9-triol411-450-6143747-72-2R53R: 53

S: 61
603-158-00-4reaction mass of 4 diastereoisomers of 2,7-dimethyl-10-(1-methylethyl)-1-oxaspiro[4.5]deca-3,6-diene412-460-3Xi; R38

N; R51-53
Xi; N

R: 38-51/53

S: (2-)37-61
603-159-00-X2-cyclododecylpropan-1-ol411-410-8118562-73-5N; R50-53N

R: 50/53

S: 60-61
603-160-00-51,2-diethoxypropane412-180-110221-57-5F; R11

R19
F

R: 11-19

S: (2-)9-16-24-33
603-161-00-01,3-diethoxypropane413-140-63459-83-4R10R: 10

S: (2-)9-24
603-162-00-6α[2-[[[(2-hydroxyethyl)methylamino]acetyl]amino]propyl]-ω-(nonylphenoxy)poly[oxo(methyl-1,2-ethanediyl)]413-420-8144736-29-8C; R34

R43

N; R51-53
C; N

R: 34-43-51/53

S: (1/2-)26-28-36/37/39-45-61
603-163-00-12-phenyl-1,3-propanediol411-810-21570-95-2Xi; R41Xi

R: 41

S: (2-)26-39
603-164-00-72-butyl-4-chloro-4,5-dihydro-5-hydroxymethyl-1-[2'-(2-triphenylmethyl-1,2,3,4-2H-tetrazol-5-yl)-1,1'-biphenyl-4-methyl]-1H-imidazole412-420-5133909-99-6R53R: 53

S: 61
603-165-00-2reaction mass of: 4-allyl-2,6-bis(2,3-epoxypropyl)phenol;

4-allyl-6-[3-[6-[3-[6-[3-(4-allyl-2,6-bis(2,3-epoxypropyl)phenoxy)-2-hydroxypropyl]-4-allyl-2-(2,3-epoxypropyl)phenoxy]-2-hydroxypropyl]-4-allyl-2-(2,3-epoxypropyl)phenoxy]-2-hydroxypropyl]-2-(2,3-epoxypropyl)phenol;

4-allyl-6-[3-(4-allyl-2,6-bis(2,3-epoxypropyl)phenoxy)-2-hydroxypropyl]-2-(2,3-epoxypropyl)phenol;

4-allyl-6-[3-[6-[3-(4-allyl-2,6-bis(2,3-epoxypropyl)phenoxy)-2-hydroxypropyl]-4-allyl-2-(2,3-epoxypropyl)phenoxy]-2-hydroxypropyl]-2-(2,3-epoxypropyl)phenol
417-470-1Muta. Cat. 3; R68

R43
Xn

R: 43-68

S: (2-)36/37
603-166-00-8R-1-chloro-2,3-epoxypropane424-280-251594-55-9R10

Carc. Cat. 2; R45

T; R23/24/25

C; R34

R43
T

R: 45-10-23/24/25-34-43

S: 53-45
E
603-167-00-33,3',5,5'-tetra-tert-butylbiphenyl-2,2'-diol407-920-56390-69-8R53R: 53

S: 61
603-168-00-93-(2-ethylhexyloxy)propane-1,2-diol408-080-270445-33-9Xi; R41

R52-53
Xi

R: 41-52/53

S: (2-)26-39-61
603-169-00-4(±)-trans-4-(4-fluorophenyl)-3-hydroxymethyl-N-methylpiperidine415-550-0109887-53-8Xn; R22

Xi; R41

N; R51-53
Xn; N

R: 22-41-51/53

S: (2-)22-26-39-61
603-170-00-Xreaction mass of: 2-methyl-1-(6-methylbicyclo[2.2.1]hept-5-en-2-yl)pent-1-en-3-ol;

2-methyl-1-(1-methylbicyclo[2.2.1]hept-5-en-2-yl)-pent-1-en-3-ol;

2-methyl-1-(5-methylbicyclo[2.2.1]hept-5-en-2-yl)pent-1-en-3-ol
415-990-367739-11-1Xi; R36

N; R51-53
Xi; N

R: 36-51/53

S: (2-)26-61
603-171-00-55-thiazolylmethanol414-780-938585-74-9Xi; R41

R52-53
Xi

R: 41-52/53

S: (2-)26-39-61
603-172-00-0mono-2-[2-(4-dibenzo[b,f][1,4]thiazepin-11-yl)piperazinium-1-yl]ethoxy)ethanol trans-butenedioate415-180-1773058-82-5Xn; R22

Xi; R41

N; R51-53
Xn; N

R: 22-41-51/53

S: (2-)22-26-39-61
603-173-00-64,4-dimethyl-3,5,8-trioxabicyclo[5.1.0]octane421-750-957280-22-5Xi; R36

R43
Xi

R: 36-43

S: (2-)26-36/37
603-174-00-14-cyclohexyl-2-methyl-2-butanol420-630-383926-73-2Xi; R41

N; R51-53
Xi; N

R: 41-51/53

S: (2-)26-39-61
603-175-00-72-(2-hexyloxyethoxy)ethanol;

DEGHE;

diethylene glycol monohexyl ether;

3,6-dioxa-1-dodecanol;

hexyl carbitol;

3,6-dioxadodecan-1-ol
203-988-3112-59-4Xn; R21

Xi; R41
Xn

R: 21-41

S: (2-)26-36/37/39-46
603-176-00-21,2-bis(2-methoxyethoxy)ethane;

TEGDME;

triethylene glycol dimethyl ether;

triglyme
203-977-3112-49-2R19

Repr. Cat. 2; R61

Repr. Cat. 3; R62
T

R: 61-19-62

S: 53-45
603-177-00-81-ethoxypropan-2-ol;

2PG1EE;

1-ethoxy-2-propanol;

propylene glycol monoethyl ether; [1]

2-ethoxy-1-methylethyl acetate;

2PG1EEA [2]
216-374-5 [1]

259-370-9 [2]
1569-02-4 [1]

54839-24-6 [2]
R10

R67
R: 10-67

S: (2-)24
603-178-00-32-hexyloxyethanol;

ethylene glycol monohexyl ether;

n-hexylglycol
203-951-1112-25-4Xn; R21/22

C; R34
C

R: 21/22-34

S: (1/2-)26-36/37/39-45
603-179-00-9ergocalciferol (ISO);

Vitamin D2
200-014-950-14-6T+; R26

T; R24/25-48/25
T+

R: 24/25-26-48/25

S: (1/2-)28-36/37-45
603-180-00-4colecalciferol;

Vitamin D3
200-673-267-97-0T+; R26

T; R24/25-48/25
T+

R: 24/25-26-48/25

S: (1/2-)28-36/37-45
603-181-00-Xtert-butyl methyl ether;

MTBE;

2-methoxy-2-methylpropane
216-653-11634-04-4F; R11

Xi; R38
F; Xi

R: 11-38

S: (2-)9-16-24
603-183-00-02-[2-(2-butoxyethoxy)ethoxy]ethanol;

TEGBE;

triethylene glycol monobutyl ether;

butoxytriethylene glycol
205-592-6143-22-6Xi; R41Xi

R: 41

S: (2-)26-39-46
Xi; R41: C ≥ 30 %

Xi; R36: 20 % ≤ C < 30 %
603-184-00-62-(hydroxymethyl)-2-[[2-hydroxy-3-(isooctadecyloxy)propoxy]methyl]-1,3-propanediol416-380-1146925-83-9N; R50-53N

R: 50/53

S: 60-61
603-185-00-12,4-dichloro-3-ethyl-6-nitrophenol420-740-199817-36-4T; R25

Xi; R41

R43

N; R50-53
T; N

R: 25-41-43-50/53

S: (1/2-)26-36/37/39-45-60-61
603-186-00-7trans-(5RS,6SR)-6-amino-2,2-dimethyl-1,3-dioxepan-5-ol419-050-379944-37-9R43Xi

R: 43

S: (2-)22-24/25-26-37
603-187-00-22-((4,6-bis(4-(2-(1-methylpyridinium-4-yl)vinyl)phenylamino)-1,3,5-triazin-2-yl)(2-hydroxyethyl)amino)ethanol dichloride419-360-9163661-77-6N; R50-53N

R: 50/53

S: 60-61
603-189-00-3reaction mass of complexes of: titanium, 2,2'-oxydiethanol, ammonium lactate, nitrilotris(2-propanol) and ethylene glycol405-250-8N; R51-53N

R: 51/53

S: 61
603-191-00-42-(4,6-bis(2,4-dimethylphenyl)-1,3,5-triazin-2-yl)-5-(3-((2-ethylhexyl)oxy)-2-hydroxypropoxy)phenol419-740-4137658-79-8R53R: 53

S: 61
603-195-00-62-[4-(4-methoxyphenyl)-6-phenyl-1,3,5-triazin-2-yl]-phenol430-810-3154825-62-4R52-53R: 52/53

S: 61
603-196-00-12-(7-ethyl-1H-indol-3-yl)ethanol431-020-141340-36-7Xn; 22-48/22

N; R51-53
Xn; N

R: 22-48/22-51/53

S: (2-)36/37/39-61
603-197-00-7tebuconazole (ISO);

1-(4-chlorophenyl)-4,4-dimethyl-3-(1,2,4-triazol-1-ylmethyl)pentan-3-ol
403-640-2107534-96-3Repr. Cat. 3; R63

Xn; R22

N; R51-53
Xn; N

R: 22-51/53-63

S: (2-)22-36/37-61
603-199-00-8etoxazol (ISO);

(RS)-5-tert-butyl-2-[2-(2,6-difluorophenyl)-4,5-dihydro-1,3-oxazol-4-yl]phenetole
153233-91-1N; R50-53N

R: 50/53

S: 60-61
N; R50-53: C ≥ 0,25 %

N; R51-53: 0,025 % ≤ C < 0,25 %

R52-53: 0,0025 % ≤ C < 0,025 %
604-001-00-2phenol;

carbolic acid;

monohydroxybenzene;

phenylalcohol
203-632-7108-95-2Muta. Cat. 3; R68

T; R23/24/25

Xn; R48/20/21/22

C; R34
T;

R: 23/24/25-34-48/20/21/22-68

S: (1/2-)24/25-26-28-36/37/39-45
T; R23/24/25: C ≥ 10 %

Xn; R20/21/22: 3 % ≤ C < 10 %

C; R34: C ≥ 3 %

Xi; R36/38: 1 % ≤ C < 3 %
604-002-00-8pentachlorophenol201-778-687-86-5Carc. Cat. 3; R40

T+; R26

T; R24/25

Xi; R36/37/38

N; R50-53
T+; N

R: 24/25-26-36/37/38-40-50/53

S: (1/2-)22-36/37-45-52-60-61
604-003-00-3sodium pentachlorophenolate; [1]

potassium pentachlorophenolate [2]
205-025-2 [1]

231-911-3 [2]
131-52-2 [1]

7778-73-6 [2]
Carc. Cat. 3; R40

T+; R26

T; R24/25

Xi; R36/37/38

N; R50-53
T+; N

R: 24/25-26-36/37/38-40-50/53

S: (1/2-)22-28-36/37-45-52-60-61
604-004-00-9m-cresol; [1]

o-cresol; [2]

p-cresol; [3]

mix-cresol [4]
203-577-9 [1]

202-423-8 [2]

203-398-6 [3]

215-293-2 [4]
108-39-4 [1]

95-48-7 [2]

106-44-5 [3]

1319-77-3 [4]
T; R24/25

C; R34
T

R: 24/25-34

S: (1/2-)36/37/39-45
T; R24/25: C ≥ 5 %

Xn; R21/22: 1 % ≤ C < 5 %

C; R34: C ≥ 5 %

Xi; R36/38: 1 % ≤ C < 5 %
C
604-005-00-41,4-dihydroxybenzene;

hydroquinone;

quinol
204-617-8123-31-9Carc. Cat. 3; R40

Muta. Cat. 3; R68

Xn; R22

Xi; R41

R43

N; R50
Xn; N

R: 22-40-41-43-50-68

S: (2-)26-36/37/39-61
604-006-00-X3,4-xylenol; [1]

2,5-xylenol; [2]

2,4-xylenol; [3]

2,3-xylenol; [4]

2,6-xylenol; [5]

xylenol; [6]

2,4(or 2,5)-xylenol [7]
202-439-5 [1]

202-461-5 [2]

203-321-6 [3]

208-395-3 [4]

209-400-1 [5]

215-089-3 [6]

276-245-4 [7]
95-65-8 [1]

95-87-4 [2]

105-67-9 [3]

526-75-0 [4]

576-26-1 [5]

1300-71-6 [6]

71975-58-1 [7]
T; R24/25

C; R34

N; R51-53
T; N

R: 24/25-34-51/53

S: (1/2-)26-36/37/39-45-61
C
604-007-00-52-naphthol205-182-7135-19-3Xn; R20/22

N; R50
Xn; N

R: 20/22-50

S: (2-)24/25-61
604-008-00-02-chlorophenol; [1]

4-chlorophenol; [2]

3-chlorophenol; [3]

chlorophenol [4]
202-433-2 [1]

203-402-6 [2]

203-582-6 [3]

246-691-4 [4]
95-57-8 [1]

106-48-9 [2]

108-43-0 [3]

25167-80-0 [4]
Xn; R20/21/22

N; R51-53
Xn; N

R: 20/21/22-51/53

S: (2-)28-61
C
604-009-00-6pyrogallol;

1,2,3-trihydroxybenzene
201-762-987-66-1Muta. Cat. 3; R68

Xn; R20/21/22

R52-53
Xn

R: 20/21/22-68-52/53

S: (2-)36/37-61
Xn; R20/21/22: C ≥ 10 %
604-010-00-1resorcinol;

1,3-benzenediol
203-585-2108-46-3Xn; R22

Xi; R36/38

N; R50
Xn; N

R: 22-36/38-50

S: (2-)26-61
Xn; R22: C ≥ 10 %
604-011-00-72,4-dichlorophenol204-429-6120-83-2T; R24

Xn; R22

C; R34

N; R51-53
T; N

R: 22-24-34-51/53

S: (1/2-)26-36/37/39-45-61
604-012-00-24-chloro-o-cresol;

4-chloro-2-methyl phenol
216-381-31570-64-5T; R23

C; R35

N; R50
T; C; N

R: 23-35-50

S: (1/2-)26-36/37/39-45-61
C; R35: C ≥ 10 %

C; R34: 5 % ≤ C < 10 %

Xi; R36/37/38: 1 % ≤ C < 5 %
604-013-00-82,3,4,6-tetrachlorophenol200-402-858-90-2T; R25

Xi; R36/38

N; R50-53
T; N

R: 25-36/38-50/53

S: (1/2-)26-28-37-45-60-61
T; R25: C ≥ 5 %

Xn; R22: 0,5 % ≤ C < 5 %

Xi; R36/38: C ≥ 5 %
604-014-00-3chlorocresol;

4-chloro-m-cresol;

4-chloro-3-methylphenol
200-431-659-50-7Xn; R21/22

Xi; R41

R43

N; R50
Xn; N

R: 21/22-41-43-50

S: (2-)26-36/37/39-61
Xn; R21/22: C ≥ 10 %
604-015-00-92,2'-methylenebis-(3,4,6-trichlorophenol);

hexachlorophene
200-733-870-30-4T; R24/25

N; R50-53
T; N

R: 24/25-50/53

S: (1/2-)20-37-45-60-61
T; R24/25: C ≥ 2 %

Xn; R21/22: 0,2 % ≤ C < 2 %
604-016-00-41,2-dihydroxybenzene;

pyrocatechol
204-427-5120-80-9Xn; R21/22

Xi; R36/38
Xn

R: 21/22-36/38

S: (2-)22-26-37
604-017-00-X2,4,5-trichlorophenol202-467-895-95-4Xn; R22

Xi; R36/38

N; R50-53
Xn; N

R: 22-36/38-50/53

S: (2-)26-28-60-61
Xn; R22: C ≥ 20 %

Xi; R36/38: C ≥ 5 %
604-018-00-52,4,6-trichlorophenol201-795-988-06-2Carc. Cat. 3; R40

Xn; R22

Xi; R36/38

N; R50-53
Xn; N

R: 22-36/38-40-50/53

S: (2-)36/37-60-61
604-019-00-0dichlorophen (ISO)202-567-197-23-4Xn; R22

Xi; R36

N; R50-53
Xn; N

R: 22-36-50/53

S: (2-)26-60-61
604-020-00-62-phenylphenol (ISO);

biphenyl-2-ol;

2-hydroxybiphenyl;
201-993-590-43-7Xi; R36/37/38

N; R50
Xi; N

R: 36/37/38-50

S: (2-)22-61
604-021-00-1sodium 2-biphenylate;

2-phenylphenol, sodium salt
205-055-6132-27-4Xn; R22

Xi; R37/38-41

N; R50
Xn; N

R: 22-37/38-41-50

S: (2-)22-26-61
604-022-00-72,2-dimethyl-1,3-benzodioxol-4-ol400-900-722961-82-6Xi; R41Xi

R: 41

S: (2-)24-26-39
604-023-00-22,4-dichloro-3-ethylphenol401-060-4C; R34

N; R50-53
C; N

R: 34-50/53

S: (1/2-)26-36/39-45-60-61
604-024-00-84,4-isobutylethylidenediphenol401-720-16807-17-6Repr. Cat. 2; R60

Xi; R36

N; R50-53
T; N

R: 60-36-50/53

S: 53-45-60-61
604-025-00-32,5-bis(1,1-dimethylbutyl)hydroquinone400-220-0N; R51-53N

R: 51/53

S: 61
604-026-00-92,2-spirobi(6-hydroxy-4,4,7-trimethylchromane)400-270-3N; R51-53N

R: 51/53

S: 61
604-027-00-42-methyl-5-(1,1,3,3-tetramethylbutyl)hydroquinone400-530-6Xi; R41

R43

N; R51-53
Xi; N

R: 41-43-51/53

S: (2-)24/25-26-37-61
604-028-00-X4-amino-3-fluorophenol402-230-0399-95-1Carc. Cat. 2; R45

Xn; R22

R43

N; R51-53
T; N

R: 45-22-43-51/53

S: 53-45-61
E
604-029-00-51-naphtol201-969-490-15-3Xn; R21/22

Xi; R37/38-41
Xn

R: 21/22-37/38-41

S: (2-)22-26-37/39
604-030-00-0bisphenol A;

4,4'-isopropylidenediphenol
201-245-880-05-7Repr. Cat. 3; R62

Xi; R37-41

R43
Xn

R: 37-41-43-62

S: (2-)26-36/37-39-46
604-031-00-6guaiacol201-964-790-05-1Xn; R22

Xi; R36/38
Xn

R: 22-36/38

S: (2-)26
604-032-00-1thymol201-944-889-83-8Xn; R22

C; R34

N; R51-53
C; N

R: 22-34-51/53

S: (1/2-)26-28-36/37/39-45-61
604-033-00-7isobutyl but-3-enoate401-170-224342-03-8R10R: 10

S: (2-)
604-034-00-24,4'-thiodi-o-cresol403-330-724197-34-0Xi; R41

N; R50-53
Xi; N

R: 41-50/53

S: (2-)26-39-60-61
604-035-00-84-nonylphenol, reaction products with formaldehyde and dodecane-1-thiol404-160-6R43

R53
X

R: 43-53

S: (2-)24-37-61
604-036-00-34,4'-oxybis(ethylenethio)diphenol404-590-490884-29-0R43

N; R51-53
Xi; N

R: 43-51/53

S: (2-)24-37-61
604-037-00-93,5-xylenol;

3,5-dimethylphenol
203-606-5108-68-9T; R24/25

C; R34
T

R: 24/25-34

S: (1/2-)26-28-36/37/39-45
604-038-00-44-chloro-3,5-dimethylphenol; [1]

chloroxylenol [2]
201-793-8 [1]

215-316-6 [2]
88-04-0 [1]

1321-23-9 [2]
Xn; R22

Xi; R36/38

R43
Xn

R: 22-36/38-43

S: (2-)24-37
604-039-00-Xethyl 2-[4-[(6-chlorobenzoxazol-2-yl)oxy]phenoxy]propionate;

fenoxaprop-ethyl
266-362-966441-23-4R43

N; R50-53
Xi; N

R: 43-50/53

S: (2-)24-37-60-61
604-040-00-5fomesafen (ISO);

5-[2-chloro-4-(trifluoromethyl)phenoxy]-N-(methylsulphonyl)-2-nitrobenzamide
276-439-972178-02-0Xn; R22Xn

R: 22

S: (2-)
604-041-00-0acifluorfen (ISO);

5-[2-chloro-4-(trifluoromethyl)phenoxy]-2-nitrobenzoic acid [1]

sodium 5-[2-chloro-4-(trifluoromethyl) phenoxy]-2-nitrobenzoate;

acifluorfen-sodium [2]
256-634-5 [1]

263-560-7 [2]
50594-66-6 [1]

62476-59-9 [2]
Xn; R22

Xi; R38-41

N; R50-53
Xn; N

R: 22-38-41-50/53

S: (2-)24-39-60-61
604-042-00-64-nitrosophenol203-251-6104-91-6Muta. Cat. 3; R68

Xn; R22

Xi; R41

N; R51-53
Xn; N

R: 22-41-51/53-68

S: (2-)26-36/37/39-47-49-61
604-043-00-1monobenzone;

4-hydroxyphenyl benzyl ether;

hydroquinone monobenzyl ether
203-083-3103-16-2Xi; R36

R43
Xi

R: 36-43

S: (2-)24/25-26-37
604-044-00-7mequinol;

4-methoxyphenol;

hydroquinone monomethyl ether
205-769-8150-76-5Xn; R22

Xi; R36

R43
Xn

R: 22-36-43

S: (2-)24/25-26-37/39-46
604-045-00-22,3,5-trimethylhydroquinone211-838-3700-13-0Xn; R20

Xi; R37/38-41

R43

N; R50-53
Xn; N

R: 20-37/38-41-43-50/53

S: (2-)24-26-37/39-60-61
604-046-00-84-(4-isopropoxyphenylsulfonyl)phenol405-520-595235-30-6N; R51-53N

R: 51/53

S: 61
604-047-00-34-(4-tolyloxy)biphenyl405-730-751601-57-1Xn; R48/22

R53
Xn

R: 48/22-53

S: (2-)22-36-61
604-048-00-94,4',4''-(ethan-1,1,1-triyl)triphenol405-800-727955-94-8N; R51-53N

R: 51/53

S: 61
604-049-00-44-4'-methylenebis(oxyethylenethio)diphenol407-480-493589-69-6N; R51-53N

R: 51/53

S: 61
604-051-00-53,5-bis((3,5-di-tert-butyl-4-hydroxy)benzyl)-2,4,6-trimethylphenol401-110-587113-78-8R52-53R: 52/53

S: 61
604-052-00-02,2'-methylenebis(6-(2H-benzotriazol-2-yl)-4-(1,1,3,3-tetramethylbutyl)phenol)403-800-1103597-45-1R53R: 53

S: 61
604-053-00-62-methyl-4-(1,1-dimethylethyl)-6-(1-methyl-pentadecyl)-phenol410-760-9157661-93-3Xi; R38

R43

N; R50-53
Xi; N

R: 38-43-50/53

S: (2-)24-37-60-61
604-054-00-1reaction mass of: 2-methoxy-4-(tetrahydro-4-methylene-2H-pyran-2-yl)-phenol;

4-(3,6-dihydro-4-methyl-2H-pyran-2-yl)-2-methoxyphenol
412-020-0R43

R52-53
Xi

R: 43-52/53

S: (2-)24-37-61
604-055-00-72,2'-((3,3',5,5'-tetramethyl-(1,1'-biphenyl)-4,4'-diyl)-bis(oxymethylene))-bis-oxirane413-900-785954-11-6Muta. Cat. 3; R68Xn

R: 68

S: (2-)22-36-37
604-056-00-22-(2-hydroxy-3,5-dinitroanilino)ethanol412-520-999610-72-7F; R11

Repr. Cat. 3; R62

Xn; R22
F; Xn

R: 11-22-62

S: (2-)22-33-36/37
604-057-00-8reaction mass of: isomers of 2-(2H-benzotriazol-2-yl)-4-methyl-(n)-dodecylphenol;

isomers of 2-(2H-benzotriazol-2-yl)-4-methyl-(n)-tetracosylphenol;

isomers of 2-(2H-benzotriazol-2-yl)-4-methyl-5,6-didodecyl-phenol. n = 5 or 6
401-680-5N; R51-53N

R: 51/53

S: 61
604-058-00-31,2-bis(3-methylphenoxy)ethane402-730-954914-85-1N; R50-53N

R: 50/53

S: 60-61
604-059-00-92-n-hexadecylhydroquinone406-400-5Xn; R48/22

Xi; R38

R43

R53
Xn

R: 38-43-48/22-53

S: (2-)22-36/37-61
604-060-00-49,9-bis(4-hydroxyphenyl)fluorene406-950-63236-71-3Xi; R36-38

N; R50-53
Xi; N

R: 36/38-50/53

S: (2-)26-37-60-61
604-061-00-Xreaction mass of: 2-chloro-5-sec-tetradecylhydroquinones where sec-tetradecyl = 1-methyltridecyl;

1-ethyldodecyl;

1-propylundecyl;

1-butyldecyl;

1-pentylnonyl;

1-hexyloctyl
407-740-7Xi; R38

R43

R52-53
Xi

R: 38-43-52/53

S: (2-)24-37-61
604-062-00-52,4-dimethyl-6-(1-methyl-pentadecyl)phenol411-220-5Xi; R38

R43

N; R50-53
Xi; N

R: 38-43-50/53

S: (2-)24-37-60-61
604-063-00-05,6-dihydroxyindole412-130-93131-52-0Xn; R22

Xi; R41

N; R51-53
Xn; N

R: 22-41-51/53

S: (2-)22-26-36/37/39-61
604-064-00-62-(4,6-diphenyl-1,3,5-triazin-2-yl)-5-((hexyl)oxy)-phenol411-380-6147315-50-2R53R: 53

S: 61
604-065-00-14,4',4''-(1-methylpropan-1-yl-3-ylidene)tris(2-cyclohexyl-5-methylphenol)407-460-5111850-25-0N; R51-53N

R: 51/53

S: 61
604-066-00-7reaction mass of: phenol, 6-(1,1-dimethylethyl)-4-tetrapropyl-2-[(2-hydroxy-5-tetra-propylphenyl)methyl (C41-compound) and methane, 2,2'-bis[6-(1,1-dimethyl-ethyl)-1-hydroxy-4-tetrapropyl-phenyl)]- (C45-compound);

2,6-bis(1,1-dimethylethyl)-4-tetra-propyl-phenol and 2-(1,1-dimethylethyl)-4-tetrapropyl-phenol;

2,6-bis[(6-(1,1-dimethylethyl)-1-hydroxy-4-tetrapropylphenyl)methyl]-4-(tetrapropyl)phenol and 2-[(6-(1,1-dimethylethyl)-1-hydroxy-4-tetrapropylphenylmethyl]-6-[1-hydroxy-4-tetrapropylphenyl)methyl]-4-(tetrapropyl)phenol
414-550-8N; R50-53N

R: 50/53

S: 60-61
604-067-00-2reaction mass of: 2,2'-[[(2-hydroxyethyl)imino]bis(methylene)bis[4-dodecylphenol];

formaldehyde, oligomer with 4-dodecyl phenol and 2-aminoethanol(n = 2);

formaldehyde, oligomer with 4-dodecyl phenol and 2-aminoethanol(n = 3, 4 and higher)
414-520-4Xi; R38-41

N; R50-53
Xi; N

R: 38-41-50/53

S: (2-)26-37/39-60-61
604-068-00-8(±)-4-[2-[[3-(4-hydroxyphenyl)-1-methylpropyl]amino]-1-hydroxyethyl]phenol hydrochloride415-170-590274-24-1Xn; R20/22

R43
Xn

R: 20/22-43

S: (2-)24-26-37
604-069-00-32-(1-methylpropyl)-4-tert-butylphenol421-740-451390-14-8C; R34

N; R51-53
C; N

R: 34-51/53

S: (1/2-)26-36/37/39-45-61
604-070-00-9triclosan;

2,4,4'-trichloro-2'-hydroxy-diphenyl-ether;

5-chloro-2-(2,4-dichlorophenoxy)phenol
222-182-23380-34-5Xi; R36/38

N; R50-53
Xi; N

R: 36/38-50/53

S: 26-39-46-60-61
N; R50-53: C ≥ 0,25 %

N; R51-53: 0,025 % ≤ C < 0,25 %

R52-53: 0,0025 % ≤ C < 0,025 %
605-001-00-5formaldehyde … %200-001-850-00-0Carc. Cat. 3; R40

T; R23/24/25

C; R34

R43
T

R: 23/24/25-34-40-43

S: (1/2-)26-36/37/39-45-51
T; R23/24/25: C ≥25 %

Xn; R20/21/22: 5 % ≤ C < 25 %

C; R34: C ≥25 %

Xi; R36/37/38: 5 % ≤ C < 25 %

R43: C ≥ 0,2 %
B D
605-002-00-01,3,5-trioxan;

trioxymethylene
203-812-5110-88-3F; R11

Repr. Cat. 3; R63

Xi; R37
F; Xn

R: 11-37-63

S: (2-)36/37-46
605-003-00-6acetaldehyde;

ethanal
200-836-875-07-0F+; R12

Carc. Cat. 3; R40

Xi; R36/37
F+; Xn

R: 12-36/37-40

S: (2-)16-33-36/37
605-004-00-12,4,6-trimethyl-1,3,5-trioxan;

paraldehyde
204-639-8123-63-7F; R11 $F

R: 11

S: (2-)9-16-29-33
605-005-00-72,4,6,8-tetramethyl-1,3,5,7-tetraoxacyclooctane;

metaldehyde
203-600-2108-62-3R10 $

Xn; R22
Xn

R: 10-22

S: (2-)13-25-46
605-006-00-2butyraldehyde204-646-6123-72-8F; R11F

R: 11

S: (2-)9-29-33
605-007-00-81,1-dimethoxyethane;

dimethyl acetal
208-589-8534-15-6F; R11F

R: 11

S: (2-)9-16-33
605-008-00-3acrylaldehyde;

acrolein;

prop-2-enal
203-453-4107-02-8F; R11

T+; R26

T; R24/25

C; R34

N; R50
F; T+; N

R: 11-24/25-26-34-50

S: 23-26-28-36/37/39-45-61
D
605-009-00-9crotonaldehyde;

2-butenal; [1]

(E)-2-butenal;

(E)-crotonaldehyde [2]
224-030-0 [1]

204-647-1 [2]
4170-30-3 [1]

123-73-9 [2]
F; R11

Muta. Cat. 3; R68

T+; R26

T; R24/25

Xn; R48/22

Xi; R37/38-41

N; R50
F; T+; N

R: 11-24/25-26-37/38-41-48/22-50-68

S: (1/2-)26-28-36/37/39-45-61
605-010-00-42-furaldehyde202-627-798-01-1Carc. Cat. 3; R40

T; R23/25

Xn; R21

Xi; R36/37
T

R: 21-23/25-36/37-40

S: (1/2-)26-36/37/39-45
T; R23/25: C ≥ 5 %

Xn; R20/22: 1 % ≤ C < 5 %
605-011-00-X2-chlorobenzaldehyde;

o-chlorobenzaldehyde
201-956-389-98-5C; R34C

R: 34

S: (1/2-)26-45
605-012-00-5benzaldehyde202-860-4100-52-7Xn; R22Xn

R: 22

S: (2-)24
605-013-00-0chloralose (INN);

(R)-1,2-O-(2,2,2-trichloroethylidene)-α-D-glucofuranose;

glucochloralose;

anhydroglucochloral
240-016-715879-93-3Xn; R20/22Xn

R: 20/22

S: (2-)16-24/25-28
605-014-00-6chloral hydrate;

2,2,2-trichloroethane-1,1-diol
206-117-5302-17-0T; R25

Xi; R36/38
T

R: 25-36/38

S: (1/2-)25-45
605-015-00-11,1-diethoxyethane;

acetal
203-310-6105-57-7F; R11

Xi; R36/38
F; Xi

R: 11-36/38

S: (2-)9-16-33
Xi; R36/38: C ≥ 10 %
605-016-00-7glyoxal … %;

ethandial … %
203-474-9107-22-2Muta. Cat. 3; R68

Xn; R20

Xi; R36/38

R43
Xn

R: 20-36/38-43-68

S: (2-)36/37
Xn; R20: C ≥ 10 %

Xi; R36/38: C ≥ 10 %
B
605-017-00-21,3-dioxolane211-463-5646-06-0F; R11F

R: 11

S: (2-)16
605-018-00-8propanal;

propionaldehyde
204-623-0123-38-6F; R11

Xi; R36/37/38
F; Xi

R: 11-36/37/38

S: (2-)9-16-29
605-019-00-3citral226-394-65392-40-5Xi; R38

R43
Xi

R: 38-43

S: (2-)24/25-37
605-020-00-9safrole;

5-allyl-1,3-benzodioxole
202-345-494-59-7Carc. Cat. 2; R45

Muta. Cat. 3; R68

Xn; R22
T

R: 45-22-68

S: 53-45
E
605-021-00-4formaldehyde, reaction products with butylphenol294-145-991673-30-2R43Xi

R: 43

S: (2-)24-37
605-022-00-Xglutaral;

glutaraldehyde;

1,5-pentanedial
203-856-5111-30-8T; R23/25

C; R34

R42/43

N; R50
T; N

R: 23/25-34-42/43-50

S: (1/2-)26-36/37/39-45-61
T; R25: C ≥ 50 %

Xn; R22: 2 % ≤ C < 50 %

T; R23: C ≥ 25 %

Xn; R20: 2 % ≤ C < 25 %

C; R34: C ≥ 10 %

Xi; R37/38-41: 2 % ≤ C < 10 %

Xi; R36/37/38: 0,5 % ≤ C < 2 %

R43: C ≥ 0,5 %
605-025-00-6chloroacetaldehyde203-472-8107-20-0Carc. Cat. 3; R40

T+; R26

T; R24/25

C; R34

N; R50
T+; N

R: 24/25-26-34-40-50

S: (1/2-)26-28-36/37/39-45-61
605-026-00-12,5,7,7-tetramethyloctanal405-690-0114119-97-0Xi; R38

R43

N; R51-53
Xi; N

R: 38-43-51/53

S: (2-)24-37-61
605-027-00-7reaction mass of: 3a,4,5,6,7,7a-hexahydro-4,7-methano-1H-indene-6-carboxaldehyde;

3a,4,5,6,7,7a-hexahydro-4,7-methano-1H-indene-5-carboxaldehyde
410-480-7R43

N; R51-53
Xi; N

R: 43-51/53

S: (2-)24-37-61
605-028-00-2β-methyl-3-(1-methylethyl)-benzenepropanal412-050-4125109-85-5N; R51-53N

R: 51/53

S: 61
605-029-00-82-cyclohexylpropanal412-270-02109-22-0R43

N; R51-53
Xi; N

R: 43-51/53

S: (2-)24-37-61
605-030-00-31-(p-methoxyphenyl)acetaldehyde oxime411-510-13353-51-3R43Xi

R: 43

S: (2-)24-37
605-031-00-9reaction mass of: 2,2-dimethoxyethanal [(this component is considered to be anhydrous in terms of identity, structure and composition. However, 2,2-dimethoxyethanal will exist in a hydrated form. 60 % anhydrous is equivalent to 70.4 % hydrate;

water(Including free water and water in hydrated 2,2-dimethoxyethanal)]
421-890-0R43Xi

R: 43

S: (2-)24-37
606-001-00-8acetone;

propan-2-one;

propanone
200-662-267-64-1F; R11

Xi; R36

R66

R67
F; Xi

R: 11-36-66-67

S: (2-)9-16-26
606-002-00-3butanone;

ethyl methyl ketone
201-159-078-93-3F; R11

Xi; R36

R66

R67
F; Xi

R: 11-36-66-67

S: (2-)9-16
606-003-00-9heptan-3-one;

butyl ethyl ketone
203-388-1106-35-4R10

Xn; R20

Xi; R36
Xn

R: 10-20-36

S: (2-)24
606-004-00-44-methylpentan-2-one;

isobutyl methyl ketone
203-550-1108-10-1F; R11

Xn; R20

Xi; R36/37

R66
F; Xn

R: 11-20-36/37-66

S: (2-)9-16-29
606-005-00-X2,6-dimethylheptan-4-one;

di-isobutyl ketone
203-620-1108-83-8R10

Xi; R37
Xi

R: 10-37

S: (2-)24
Xi; R37: C ≥ 10 %
606-006-00-5pentan-3-one;

diethyl ketone
202-490-396-22-0F; R11

Xi; R37

R66

R67
F; Xi

R: 11-37-66-67

S: (2-)9-16-25-33
606-007-00-03-methylbutan-2-one;

methyl isopropyl ketone
209-264-3563-80-4F; R11F

R: 11

S: (2-)9-16-33
606-009-00-14-methylpent-3-en-2-one;

mesityl oxide
205-502-5141-79-7R10

Xn; R20/21/22
Xn

R: 10-20/21/22

S: (2-)25
Xn; R20/21/22: C ≥ 5 %
606-010-00-7cyclohexanone203-631-1108-94-1R10

Xn; R20
Xn

R: 10-20

S: (2-)25
606-011-00-22-methylcyclohexanone209-513-6583-60-8R10

Xn; R20
Xn

R: 10-20

S: (2-)25
606-012-00-83,5,5-trimethylcyclohex-2-enone;

isophorone
201-126-078-59-1Carc. Cat. 3; R40

Xn; R21/22

Xi; R36/37
Xn

R: 21/22-36/37-40

S: (2-)13-23-36/37/39-46
Xi; R36/37: C ≥ 10 %
606-013-00-3p-benzoquinone;

quinone
203-405-2106-51-4T; R23/25

Xi; R36/37/38

N; R50
T; N

R: 23/25-36/37/38-50

S: (1/2-)26-28-45-61
606-014-00-9chlorophacinone (ISO);

2-(2-(4-chlorophenyl)phenylacetyl)indan-1,3-dione
223-003-03691-35-8T+; R27/28

T; R23-48/24/25

N; R50-53
T+; N

R: 23-27/28-48/24/25-50/53

S: (1/2-)36/37-45-60-61
606-016-00-Xpindone (ISO);

2-pivaloylindan-1,3-dione
201-462-883-26-1T; R25-48/25

N; R50-53
T; N

R: 25-48/25-50/53

S: (1/2-)37-45-60-61
606-017-00-5diketene;

diketen
211-617-1674-82-8R10

Xn; R20
Xn

R: 10-20

S: (2-)3
D
606-018-00-0dichlone (ISO);

2,3-dichloro-1,4-naphthoquinone
204-210-5117-80-6Xn; R22

Xi; R36/38

N; R50-53
Xn; N

R: 22-36/38-50/53

S: (2-)26-60-61
606-019-00-6chlordecone (ISO);

perchloropentacyclo[5,3,0,02,6,03,9,04,8]decan-5-one;

decachloropentacyclo[5,2,1,02,6,03,9,05,8]decan-4-one
205-601-3143-50-0Carc. Cat. 3; R40

T; R24/25

N; R50-53
T; N

R: 24/25-40-50/53

S: (1/2-)22-36/37-45-60-61
606-020-00-15-methylheptan-3-one208-793-7541-85-5R10

Xi; R36/37
Xi

R: 10-36/37

S: (2-)23
Xi; R36/37: C ≥ 10 %
606-021-00-7N-methyl-2-pyrrolidone212-828-1872-50-4Xi; R36/38Xi

R: 36/38

S: (2-)41
Xi; R36/38: C ≥ 10 %
606-022-00-21-phenyl-3-pyrazolidone202-155-192-43-3Xn; R22

N; R51-53
Xn; N

R: 22-51/53

S: (2-)61
606-023-00-84-methoxy-4-methylpentan-2-one203-512-4107-70-0R10

Xn; R20
Xn

R: 10-20

S: (2-)23-24/25
606-024-00-3heptan-2-one;

methyl amyl ketone
203-767-1110-43-0R10

Xn; R20/22
Xn

R: 10-20/22

S: (2-)24/25
606-025-00-9cyclopentanone204-435-9120-92-3R10

Xi; R36/38
Xi

R: 10-36/38

S: (2-)23
606-026-00-45-methylhexan-2-one;

isoamyl methyl ketone
203-737-8110-12-3R10

Xn; R20
Xn

R: 10-20

S: (2-)23-24/25
606-027-00-Xheptan-4-one;

di-n-propyl ketone
204-608-9123-19-3R10

Xn; R20
Xn

R: 10-20

S: (2-)24/25
606-028-00-52,4-dimethylpentan-3-one;

di-isopropyl ketone
209-294-7565-80-0F; R11

Xn; R20
F; Xn

R: 11-20

S: (2-)9-16-24/25
606-029-00-0pentane-2,4-dione;

acetylacetone
204-634-0123-54-6R10

Xn; R22
Xn

R: 10-22

S: (2-)21-23-24/25
606-030-00-6hexan-2-one;

methyl butyl ketone;

butyl methyl ketone;

methyl-n-butyl ketone
209-731-1591-78-6R10

Repr. Cat. 3; R62

T; R48/23

R67
T

R: 10-48/23-62-67

S: (1/2-)36/37-45
606-031-00-13-propanolide;

1,3-propiolactone
200-340-157-57-8Carc. Cat. 2; R45

T+; R26

Xi; R36/38
T+

R: 45-26-36/38

S: 53-45
E
606-032-00-7hexachloroacetone204-129-5116-16-5Xn; R22

N; R51-53
Xn; N

R: 22-51/53

S: (2-)24/25-61
606-033-00-22-(3,4-dichlorophenyl)-4-methyl-1,2,4-oxadiazolidinedione;

methazole
243-761-620354-26-1Xn; R21/22

Xi; R36/38

N; R51-53
Xn; N

R: 21/22-36/38-51/53

S: (2-)36/37-61
606-034-00-8metribuzin (ISO);

4-amino-6-tert-butyl-3-methylthio-1,2,4-triazin-5(4H)-one;

4-amino-4,5-dihydro-6-(1,1-dimethylethyl)-3-methylthio-1,2,4-triazin-5-one
244-209-721087-64-9Xn; R22

N; R50-53
Xn; N

R: 22-50/53

S: (2-)60-61
606-035-00-3chloridazon (ISO);

5-amino-4-chloro-2-phenylpyridazine-3-(2H)-one;

pyrazon
216-920-21698-60-8R43

N; R50-53
Xi; N

R: 43-50/53

S: (2-)24-37-60-61
606-036-00-9quinomethionate;

chinomethionat (ISO);

6-methyl-1,3-dithiolo(4,5-b)quinoxalin-2-one
219-455-32439-01-2Repr. Cat. 3; R62

Xn; R20/21/22-48/22

Xi; R36

R43

N; R50-53
Xn; N

R: 20/21/22-36-43-48/22-50/53-62

S: (2-)24-37-60-61
606-037-00-4triadimefon (ISO);

1-(4-chlorophenoxy)-3,3-dimethyl-1-(1,2,4-triazol-1-yl)butanone
256-103-843121-43-3Xn; R22

R43

N; R51-53
Xn; N

R: 22-43-51/53

S: (2-)24-37-61
606-038-00-Xdiphacinone (ISO);

2-diphenylacetylindan-1,3-dione
201-434-582-66-6T+; R28

T; R48/23/24/25
T+

R: 28-48/23/24/25

S: (1/2-)36/37-45
606-039-00-55(or 6)-tert-butyl-2'-chloro-6'-ethylamino-3',7'-dimethylspiro(isobenzofuran-1(1H),9'-xanthene)-3-one400-680-2Xn; R20

N; R50-53
Xn; N

R: 20-50/53

S: (2-)60-61
606-040-00-0(N-benzyl-N-ethyl)amino-3-hydroxyacetophenone hydrochloride401-840-455845-90-4Xi; R41

N; R51-53
Xi; N

R: 41-51/53

S: (2-)26-39-61
606-041-00-62-methyl-1-(4-methylthiophenyl)-2-morpholinopropan-1-one400-600-671868-10-5Xn; R22

N; R51-53
Xn; N

R: 22-51/53

S: (2-)22-61
606-042-00-1acetophenone202-708-798-86-2Xn; R22

Xi; R36
Xn

R: 22-36

S: (2-)26
606-043-00-72,4-di-tert-butylcyclohexanone405-340-713019-04-0Xi; R38

N; R51-53
Xi; N

R: 38-51/53

S: (2-)37-61
606-044-00-22,4,6-trimethylbenzophenone403-150-9954-16-5Xn; R22

Xi; R36

N; R50-53
Xn; N

R: 22-36-50/53

S: (2-)26-60-61
606-045-00-8oxadiazon (ISO);

3-[2,4-dichloro-5-(1-methylethoxy)phenyl]-5-(1,1-dimethylethyl)-1,3,4-oxadiazol-2(3H)-one
243-215-719666-30-9N; R50-53N

R: 50/53

S: 60-61
606-046-00-3reaction mass of cis- and trans-cyclohexadec-8-en-1-one401-700-23100-36-5N; R50-53N

R: 50/53

S: 60-61
606-047-00-92-benzyl-2-dimethylamino-4-morpholinobutyrophenone404-360-3119313-12-1N; R50-53N

R: 50/53

S: 60-61
606-048-00-42'-anilino-3'-methyl-6'-dipentylaminospiro(isobenzofuran-1(1H),9'-xanthen)-3-one406-480-1R53R: 53

S: 61
606-049-00-X4-(trans-4-propylcyclohexyl)acetophenone406-700-678531-61-0R43

R53
Xi

R: 43-53

S: (2-)24-37-61
606-050-00-56-anilino-1-benzoyl-4-(4-tert-pentylphenoxy)naphto[1,2,3-de]quinoline-2,7-(3H)-dione412-480-272453-58-8N; R51-53N

R: 51/53

S: 61
606-051-00-04-pentylcyclohexanone406-670-461203-83-6N; R51-53N

R: 51/53

S: 61
606-052-00-64-(N,N-dibutylamino)-2-hydroxy-2'-carboxybenzophenone410-410-554574-82-2R52-53R: 52/53

S: 61
606-053-00-1flurtamone (ISO);

(RS)-5-methylamino-2-phenyl-4-(α, α,α-trifluoro-m-tolyl)furan-3(2H)-one
96525-23-4N; R50-53N

R: 50/53

S: 60-61
606-054-00-7isoxaflutole (ISO);

5-cyclopropyl-1,2-oxazol-4-yl α, α,α-trifluoro-2-mesyl-p-tolyl ketone
141112-29-0Repr. Cat. 3; R63

N; R50-53
Xn; N

R: 50/53-63

S: (2-)36/37-60-61
606-055-00-21-(2,3-dihydro-1,3,3,6-tetramethyl-1-(1-methylethyl)-1H-inden-5-yl)ethanone411-180-992836-10-7Xn; R22-48/22

N; R51-53
Xn; N

R: 22-48/22-51/53

S: (2-)24-36-61
606-056-00-84-chloro-3',4'-dimethoxybenzophenone404-610-1116412-83-0N; R50-53N

R: 50/53

S: 60-61
606-057-00-34-propylcyclohexanone406-810-440649-36-3Xi; R38

R52-53
Xi

R: 38-52/53

S: (2-)25-37-61
606-058-00-94'-fluoro-2,2-dimethoxyacetophenone407-500-121983-80-2R43

R52-53
Xi

R: 43-52/53

S: (2-)24-37-61
606-059-00-42,4-difluoro-α-(1H-1,2,4-triazol-1-yl)acetophenone hydrochloride412-390-386386-75-6Xn; R22

Xi; R41

R43
Xn

R: 22-41-43

S: (2-)22-26-36/37/39
606-060-00-Xreaction mass of: trans-2,4-dimethyl-2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-naphthalene-2-yl)-1,3-dioxolane;

cis-2,4-dimethyl-2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-naphthalene-2-yl)-1,3-dioxolane
412-950-7N; R50-53N

R: 50/53

S: 60-61
606-061-00-5(3-chlorophenyl)-(4-methoxy-3-nitrophenyl)methanone423-290-466938-41-8Muta. Cat. 3; R68

N; R50-53
Xn; N

R: 68-50/53

S: (2-)22-36/37-60-61
606-062-00-0tetrahydrothiopyran-3-carboxaldehyde407-330-861571-06-0Repr. Cat. 2; R61

Xi; R41

R52-53
T

R: 61-41-52/53

S: 53-45-61
606-063-00-6(E)-3-(2-chlorophenyl)-2-(4-fluorophenyl)propenal410-980-5112704-51-5Xi; R36

R43
Xi

R: 36-43

S: (2-)24-26-37
606-064-00-1pregn-5-ene-3,20-dione bis(ethylene ketal)407-450-07093-55-2R53R: 53

S: 61
606-065-00-71-(4-morpholinophenyl)butan-1-one413-790-0N; R51-53N

R: 51/53

S: 61
606-066-00-2(E)-5[(4-chlorophenyl)methylene]-2,2-dimethylcyclopentanone410-440-9164058-20-2N; R51-53N

R: 51/53

S: 61
606-067-00-8reaction mass of: 1-(2,3,6,7,8,9-hexahydro-1,1-dimethyl-1H-benz(g)inden-4-yl)ethanone;

1-(2,3,5,6,7,8-hexahydro-1,1-dimethyl-1H-benz(f)inden-4-yl)ethanone;

1-(2,3,6,7,8,9-hexahydro-1,1-dimethyl-1H-benz(g)inden-5-yl)ethanone;

1-(2,3,6,7,8,9-hexahydro-3,3-dimethyl-1H-benz(g)inden-5-yl)ethanone
414-870-896792-67-5N; R50-53N

R: 50/53

S: 60-61
606-068-00-32,7,11-trimethyl-13-(2,6,6-trimethylcyclohex-1-en-1-yl)tridecahexaen-2,4,6,8,10,12-al415-770-71638-05-7Xn; R48/22

R43

R52-53
Xn

R: 43-48/22-52/53

S: (2-)22-36/37-61
606-069-00-9spiro[1,3-dioxolane-2,5'-(4',4',8',8'-tetramethyl-hexahydro-3',9'-methanonaphthalene)]415-460-1154171-76-3N; R51-53N

R: 51/53

S: 24-61
606-070-00-4butroxydim (ISO);

5-(3-butyryl-2,4,6-trimethylphenyl)-2-[1-(ethoxyimino)propyl]-3-hydroxycyclohex-2-en-1-one
414-790-3138164-12-2Repr. Cat. 3; R62-63

Xn; R22

Xi; R38

N; R50-53
Xn; N

R: 22-38-62-63-50/53

S: (2-)22-36/37-60-61
606-071-00-X17-spiro(5,5-dimethyl-1,3-dioxan-2-yl)androsta-1,4-diene-3-one421-050-313258-43-0N; R50-53N

R: 50/53

S: 22-60-61
606-072-00-53-acetyl-1-phenyl-pyrrolidine-2,4-dione421-600-2719-86-8Xn; R48/22

N; R51-53
Xn; N

R: 48/22-51/53

S: (2-)22-36/37-61
606-073-00-04,4'-bis(dimethylamino)benzophenone;

Michler's ketone
202-027-590-94-8Carc. Cat. 2; R45

Muta. Cat. 3; R68

Xi; R41
T

R: 45-41-68

S: 53-45
606-075-00-11-benzyl-5-ethoxyimidazolidine-2,4-dione417-340-465855-02-9Xn; R22Xn

R: 22

S: (2-)22
606-076-00-71-((2-quinolinyl-carbonyl)oxy)-2,5-pyrrolidinedione418-630-3136465-99-1Xi; R41

R43
Xi

R: 41-43

S: (2-)24-26-37/39
606-077-00-2(3S,4S)-3-hexyl-4-[(R)-2-hydroxytridecyl]-2-oxetanone418-650-2104872-06-2N; R50-53N

R: 50/53

S: 60-61
606-078-00-81-octylazepin-2-one420-040-659227-88-2C; R34

R43

N; R51-53
C; N

R: 34-43-51/53

S: (1/2-)26-36/37/39-45-61
606-079-00-32-n-butyl-benzo[d]isothiazol-3-one420-590-74299-07-4C; R34

R43

N; R50-53
C; N

R: 34-43-50/53

S: (1/2-)26-36/37/39-45-60-61
606-080-00-9Reaction product of: 3-hydroxy-5,7-di-tert-butylbenzofuran-2-one with o-xylene417-100-9R53R: 53

S: 61
606-081-00-4(3β, 5α, 6β)-3-(acetyloxy)-5-bromo-6-hydroxy-androstan-17-one419-790-74229-69-0R43

R52-53
Xi

R: 43-52/53

S: (2-)22-36/37-61
606-082-00-Xreaction mass of: butan-2-one oxime;

syn-O,O'-di(butan-2-one oxime)diethoxysilane
406-930-7T; R48/25

R43

R52-53
T

R: 43-48/25-52/53

S: (1/2-)25-36/37-45-61
606-083-00-52-chloro-5-sec-hexadecylhydroquinone407-750-1137193-60-3Xi; R36/38

R43

R52-53
Xi

R: 36/38-43-52/53

S: (2-)24-26-37-61
606-084-00-01-(4-methoxy-5-benzofuranyl)-3-phenyl-1,3-propanedione414-540-3484-33-3N; R50-53N

R: 50/53

S: 60-61
606-085-00-6(1R,4S)-2-azabicyclo[2.2.1]hept-5-en-3-one418-530-179200-56-9Xn; R22

Xi; R41

R43
Xn

R: 22-41-43

S: (2-)24-26-37/39
606-086-00-11-(3,3-dimethylcyclohexyl)pent-4-en-1-one422-330-856973-87-6N; R51-53N

R: 51/53

S: 61
606-087-00-76-ethyl-5-fluoro-4(3H)-pyrimidone422-460-5137234-87-8Xn; R22

N; R50-53
Xn; N

R: 22-50/53

S: (2-)60-61
606-088-00-22,4,4,7-tetramethyl-6-octen-3-one422-520-074338-72-0Xi; R38

N; R51-53
Xi; N

R: 38-51/53

S: (2-)37-61
606-089-00-8reaction mass of: 1,4-diamino-2-chloro-3-phenoxyanthraquinone;

1,4-diamino-2,3-bis-phenoxyanthraquinone
423-220-212223-77-7R53R: 53

S: 61
606-091-00-96-chloro-5-(2-chloroethyl)-1,3-dihydroindol-2-one421-320-0118289-55-7N; R50-53N

R: 50/53

S: 60-61
606-092-00-4reaction mass of: (E)-oxacyclohexadec-12-en-2-one;

(E)-oxacyclohexadec-13-en-2-one;

a) (Z)-oxacyclohexadec-(12)-en-2-one and b) (Z)-oxacyclohexadec-(13)-en-2-one
422-320-3N; R50-53N

R: 50/53

S: 60-61
607-001-00-0formic acid … %200-579-164-18-6C; R35C

R: 35

S: (1/2-)23-26-45
C; R35: C ≥ 90 %

C; R34: 10 % ≤ C < 90 %

Xi; R36/38: 2 % ≤ C < 10 %
B
607-002-00-6acetic acid … %200-580-764-19-7R10

C; R35
C

R: 10-35

S: (1/2-)23-26-45
C; R35: C ≥ 90 %

C; R34: 25 % ≤ C < 90 %

Xi; R36/38: 10 % ≤ C < 25 %
B
607-003-00-1chloroacetic acid201-178-479-11-8T; R25

C; R34

N; R50
T; N

R: 25-34-50

S: (1/2-)23-37-45-61
607-004-00-7TCA (ISO);

trichloroacetic acid
200-927-276-03-9C; R35

N; R50-53
C; N

R: 35-50/53

S: (1/2-)26-36/37/39-45-60-61
C; R35: C ≥ 10 %

C; R34: 5 % ≤ C < 10 %

Xi; R36/37/38: 1 % ≤ C < 5 %
607-005-00-2TCA-sodium (ISO);

sodium trichloroacetate
211-479-2650-51-1Xi; R37

N; R50-53
Xi; N

R: 37-50/53

S: (2-)46-60-61
607-006-00-8oxalic acid205-634-3144-62-7Xn; R21/22Xn

R: 21/22

S: (2-)24/25
Xn; R21/22: C ≥ 5 %
607-007-00-3salts of oxalic acidXn; R21/22Xn

R: 21/22

S: (2-)24/25
Xn; R21/22: C ≥ 5 %A
607-008-00-9acetic anhydride203-564-8108-24-7R10

Xn; R20/22

C; R34
C

R: 10-20/22-34

S: (1/2-)26-36/37/39-45
C; R34: C ≥ 25 %

Xi; R37/38-41: 5 % ≤ C < 25 %

Xi; R36: 1 % ≤ C < 5 %
607-009-00-4phthalic anhydride201-607-585-44-9Xn; R22

Xi; R37/38-41

R42/43
Xn

R: 22-37/38-41-42/43

S: (2-)23-24/25-26-37/39-46
607-010-00-Xpropionic anhydride204-638-2123-62-6C; R34C

R: 34

S: (1/2-)26-45
C; R34: C ≥ 25 %

Xi; R36/38: 10 % ≤ C < 25 %
607-011-00-5acetyl chloride200-865-675-36-5F; R11

R14

C; R34
F; C

R: 11-14-34

S: (1/2-)9-16-26-45
607-012-00-0benzoyl chloride202-710-898-88-4C; R34C

R: 34

S: (1/2-)26-45
607-013-00-6dimethyl carbonate210-478-4616-38-6F; R11F

R: 11

S: (2-)9-16
607-014-00-1methyl formate203-481-7107-31-3F+; R12

Xn; R20/22

Xi; R36/37
F+; Xn

R: 12-20/22-36/37

S: (2-)9-16-24-26-33
607-015-00-7ethyl formate203-721-0109-94-4F; R11

Xn; R20/22

Xi; R36/37
F; Xn

R: 11-20/22-36/37

S: (2-)9-16-24-26-33
607-016-00-2propyl formate; [1]

isopropyl formate [2]
203-798-0 [1]

210-901-2 [2]
110-74-7 [1]

625-55-8 [2]
F; R11

Xi; R36/37

R67
F; Xi

R: 11-36/37-67

S: (2-)9-16-24-33
C
607-017-00-8butyl formate; [1]

tert-butyl formate; [2]

isobutyl formate [3]
209-772-5 [1]

212-105-0 [2]

208-818-1 [3]
592-84-7 [1]

762-75-4 [2]

542-55-2 [3]
F; R11

Xi; R36/37
F; Xi

R: 11-36/37

S: (2-)9-16-24-33
C
607-018-00-3isopentyl formate; [1]

pentyl formate; [2]

2-methylbutyl formate [3]
203-769-2 [1]

211-340-6 [2]

252-343-2 [3]
110-45-2 [1]

638-49-3 [2]

35073-27-9 [3]
R10

Xi; R36/37
Xi

R: 10-36/37

S: (2-)24
C
607-019-00-9methyl chloroformate201-187-379-22-1F; R11

T+; R26

Xn; R21/22

C; R34
F; T+

R: 11-21/22-26-34

S: (1/2-)14-26-28-36/37/39-45-46-63
607-020-00-4ethyl chloroformate208-778-5541-41-3F; R11

T+; R26

Xn; R22

C; R34
F; T+

R: 11-22-26-34

S: (1/2-)9-16-26-28-33-36/37/39-45
607-021-00-Xmethyl acetate201-185-279-20-9F; R11

Xi; R36

R66

R67
F; Xi

R: 11-36-66-67

S: (2-)16-26-29-33
607-022-00-5ethyl acetate205-500-4141-78-6F; R11

Xi; R36

R66

R67
F; Xi

R: 11-36-66-67

S: (2-)16-26-33
607-023-00-0vinyl acetate203-545-4108-05-4F; R11F

R: 11

S: (2-)16-23-29-33
D
607-024-00-6propyl acetate; [1]

isopropyl acetate [2]
203-686-1 [1]

203-561-1 [2]
109-60-4 [1]

108-21-4 [2]
F; R11

Xi; R36

R66

R67
F; Xi

R: 11-36-66-67

S: (2-)16-26-29-33
C
607-025-00-1n-butyl acetate204-658-1123-86-4R10

R66

R67
R: 10-66-67

S: (2-)25
607-026-00-7sec-butyl acetate; [1]

isobutyl acetate; [2]

tert-butyl acetate [3]
203-300-1 [1]

203-745-1 [2]

208-760-7 [3]
105-46-4 [1]

110-19-0 [2]

540-88-5 [3]
F; R11

R66
F

R: 11-66

S: (2-)16-23-25-29-33
C
607-027-00-2methyl propionate209-060-4554-12-1F; R11

Xn; R20
F; Xn

R: 11-20

S: (2-)16-24-29-33
607-028-00-8ethyl propionate203-291-4105-37-3F; R11F

R: 11

S: (2-)16-23-24-29-33
607-029-00-3n-butyl propionate; [1]

sec-butyl propionate; [2]

tert-butyl propionate; [3]

iso-butyl propionate [4]
209-669-5 [1]

- [2]

- [3]

208-746-0 [4]
590-01-2 [1]

591-34-4 [2]

20487-40-5 [3]

540-42-1 [4]
R10R: 10

S: (2-)
C
607-030-00-9propyl propionate203-389-7106-36-5R10

Xn; R20
Xn

R: 10-20

S: (2-)24
607-031-00-4butyl butyrate203-656-8109-21-7R10R: 10

S: (2-)
C
607-032-00-Xethyl acrylate205-438-8140-88-5F; R11

Xn; R20/21/22

Xi; R36/37/38

R43
F; Xn

R: 11-20/21/22-36/37/38-43

S: (2-)9-16-33-36/37
Xi; 36/37/38: C ≥ 5 %D
607-033-00-5n-butyl methacrylate202-615-197-88-1R10

Xi; R36/37/38

R43
Xi

R: 10-36/37/38-43

S: (2-)
D
607-034-00-0methyl acrylate;

methyl propenoate
202-500-696-33-3F; R11

Xn; R20/21/22

Xi; R36/37/38

R43
F; Xn

R: 11-20/21/22-36/37/38-43

S: (2-)9-25-26-33-36/37-43
D
607-035-00-6methyl methacrylate;

methyl 2-methylprop-2-enoate;

methyl 2-methylpropenoate
201-297-180-62-6F; R11

Xi; R37/38

R43
F; Xi

R: 11-37/38-43

S: (2-)24-37-46
D
607-036-00-12-methoxyethyl acetate;

methylglycol acetate
203-772-9110-49-6Repr. Cat. 2; R60-61

Xn; R20/21/22
T

R: 60-61-20/21/22

S: 53-45
E
607-037-00-72-ethoxyethyl acetate;

ethylglycol acetate
203-839-2111-15-9$ Repr. Cat. 2; R60-61

Xn; R20/21/22
T

R: 60-61-20/21/22

S: 53-45
E
607-038-00-22-butoxyethyl acetate;

butylglycol acetate
203-933-3112-07-2Xn; R20/21Xn

R: 20/21

S: (2-)24
607-039-00-82,4-D (ISO);

2,4-dichlorophenoxyacetic acid
202-361-194-75-7Xn; R22

Xi; R37-41

R43

R52-53
Xn

R: 22-37-41-43-52/53

S: (2-)24/25-26-36/37/39-46-61
607-040-00-3salts of 2,4-DXn; R22

Xi; R41

R43

N; R51-53
Xn; N

R: 22-41-43-51/53

S: (2-)24/25-26-36/37/39-46-61
A
607-041-00-92,4,5-T (ISO);

2,4,5-trichlorophenoxy acetic acid
202-273-393-76-5Xn; R22

Xi; R36/37/38

N; R50-53
Xn; N

R: 22-36/37/38-50/53

S: (2-)24-60-61
607-042-00-4salts and esters of 2,4,5-T;

salts and esters of 2,4,5-trichlorophenoxy acetic acid
Xn; R22

Xi; R36/37/38

N; R50-53
Xn; N

R: 22-36/37/38-50/53

S: (2-)24-60-61
A
607-043-00-Xdicamba (ISO);

2,5-dichloro-6-methoxybenzoic acid;

3,6-dichloro-2-methoxybenzoic acid
217-635-61918-00-9Xn; R22

Xi; R41

R52-53
Xn

R: 22-41-52/53

S: (2-)26-61
607-044-00-53,6-dichloro-o-anisic acid, compound with dimethylamine (1:1); [1]

potassium 3,6-dichloro-o-anisate [2]
218-951-7 [1]

233-002-7 [2]
2300-66-5 [1]

10007-85-9 [2]
Xi; R36

R52-53
Xi

R: 36-52/53

S: (2-)26-61
607-045-00-0dichlorprop (ISO);

2-(2,4-dichlorophenoxy) propionic acid
204-390-5120-36-5Xn; R21/22

Xi; R38-41
Xn

R: 21/22-38-41

S: (2-)26-36/37
607-046-00-6salts of dichlorpropXn; R20/21/22Xn

R: 20/21/22

S: (2-)13
A
607-047-00-1fenoprop (ISO);

2-(2,4,5-trichlorophenoxy)propionic acid
202-271-293-72-1Xn; R22

Xi; R38

N; R50-53
Xn; N

R: 22-38-50/53

S: (2-)37-60-61
607-048-00-7salts of fenoprop;

salts of 2-(2,4,5-trichlorophenoxy)propionic acid
Xn; R20/21/22

N; R50-53
Xn; N

R: 20/21/22-50/53

S: (2-)13-60-61
A
607-049-00-2mecoprop (ISO);

2-(4-chloro-o-tolyloxy) propionic acid;

(RS)-2-(4-chloro-o-tolyloxy)propionic acid; [1]

2-(4-chloro-2-methylphenoxy)propionic acid [2]
230-386-8 [1]

202-264-4 [2]
7085-19-0 [1]

7085-19-0 [2]
Xn; R22

Xi; R38-41

N; R50-53
Xn; N

R: 22-38-41-50/53

S: (2-)13-26-37/39-60-61
N; R50-53: C ≥ 0,25 %

N; R51-53: 0,025 % ≤ C < 0,25 %

R52-53: 0,0025 % ≤ C < 0,025 %
607-050-00-8salts of mecopropXn; R22

Xi; R38-41

N; R50-53
Xn; N

R: 22-38-41-50/53

S: (2-)13-26-37/39-60-61
N; R50-53: C ≥ 0,25 %

N; R51-53: 0,025 % ≤ C < 0,25 %

R52-53: 0,0025 % ≤ C < 0,025 %
A
607-051-00-3MCPA (ISO);

4-chloro-o-tolyloxyacetic acid
202-360-694-74-6Xn; R22

Xi; R38-41
Xn

R: 22-38-41

S: (2-)26-37-39
607-052-00-9salts and esters of MCPAXn; R20/21/22Xn

R: 20/21/22

S: (2-)13
A
607-053-00-4MCPB (ISO);

4-(4-chloro-o-tolyloxy) butyric acid
202-365-394-81-5N; R50-53N

R: 50/53

S: 60-61
607-054-00-Xsalts and esters of MCPBXn; R22Xn

R: 22

S: (2-)24/25
A
607-055-00-5endothal-sodium (ISO);

disodium 7-oxabicyclo(2,2,1)heptane-2,3-dicarboxylate
204-959-8129-67-9T; R25

Xn; R21

Xi; R36/37/38
T

R: 21-25-36/37/38

S: (1/2-)36/37/39-45
607-056-00-0warfarin (ISO); [1]

(S)-4-hydroxy-3-(3-oxo-1-phenylbutyl)-2-benzopyrone; [2]

(R)-4-hydroxy-3-(3-oxo-1-phenylbutyl)-2-benzopyrone [3]
201-377-6 [1]

226-907-3 [2]

226-908-9 [3]
81-81-2 [1]

5543-57-7 [2]

5543-58-8 [3]
Repr. Cat. 1; R61

T; R48/25

R52-53
T

R: 61-48/25-52/53

S: 53-45-61
E
607-057-00-6coumachlor (ISO);

3-[1-(4-chlorophenyl)-3-oxobutyl]-4-hydroxycoumarin
201-378-181-82-3Xn; R48/22

R52-53
Xn

R: 48/22-52/53

S: (2-)37-61
607-058-00-1coumafuryl (ISO);

fumarin;

(RS)-3-(1-(2-furyl)-3-oxobutyl)4-hydroxycoumarin;

4-hydroxy-3-[3-oxo-1-(2-furyl) butyl]coumarin
204-195-5117-52-2T; R25-48/25

R52-53
T

R: 25-48/25-52/53

S: (1/2-)37-45-61
607-059-00-7coumatetralyl;

4-hydroxy-3-(1,2,3,4-tetrahydro-1-naphthyl)coumarin
227-424-05836-29-3T+; R27/28

T; R48/24/25

R52-53
T+

R: 27/28-48/24/25-52/53

S: (1/2-)28-36/37-45-61
607-060-00-2dicoumarol;

4,4'-dihydroxy-3,3'-methylenebis(2H-chromen-2-one)
200-632-966-76-2T; R48/25

Xn; R22

N; R51-53
T; N

R: 22-48/25-51/53

S: (1/2-)37-45-61
607-061-00-8acrylic acid;

prop-2-enoic acid
201-177-979-10-7R10

Xn; R20/21/22

C; R35

N; R50
C; N

R: 10-20/21/22-35-50

S: (1/2-)26-36/37/39-45-61
C; R35: C ≥ 10 %

C; R34: 5 % ≤ C < 10 %

Xi; R36/37/38: 1 % ≤ C < 5 %
D
607-062-00-3n-butyl acrylate205-480-7141-32-2R10

Xi; R36/37/38

R43
Xi

R: 10-36/37/38-43

S: (2-)9
D
607-063-00-9isobutyric acid201-195-779-31-2Xn; R21/22Xn

R: 21/22

S: (2-)
607-064-00-4benzyl chloroformate207-925-0501-53-1C; R34

N; R50-53
C; N

R: 34-50/53

S: (1/2-)26-45-60-61
C; R34: C ≥ 10 %

Xi; R36/37/38: 5 % ≤ C < 10 %
607-065-00-Xbromoacetic acid201-175-879-08-3T; R23/24/25

C; R35

N; R50
T; C; N

R: 23/24/25-35-50

S: (1/2-)26-36/37/39-45-61
607-066-00-5dichloroacetic acid201-207-079-43-6C; R35

N; R50
C; N

R: 35-50

S: (1/2-)26-45-61
607-067-00-0dichloroacetyl chloride201-199-979-36-7C; R35

N; R50
C; N

R: 35-50

S: (1/2-)9-26-45-61
607-068-00-6iodoacetic acid200-590-164-69-7T; R25

C; R35
T; C

R: 25-35

S: (1/2-)22-36/37/39-45
607-069-00-1ethyl bromoacetate203-290-9105-36-2T+; R26/27/28T+

R: 26/27/28

S: (1/2-)7/9-26-45
607-070-00-7ethyl chloroacetate203-294-0105-39-5T; R23/24/25

N; R50
T; N

R: 23/24/25-50

S: (1/2-)7/9-45-61
607-071-00-2ethyl methacrylate202-597-597-63-2F; R11

Xi; R36/37/38

R43
F; Xi

R: 11-36/37/38-43

S: (2-)9-16-29-33
D
607-072-00-82-hydroxyethyl acrylate212-454-9818-61-1T; R24

C; R34

R43

N; R50
T; N

R: 24-34-43-50

S: (1/2-)26-36/39-45-61
T; R24: C ≥ 2 %

Xn; R21: 0,2 % ≤ C < 2 %

R43: C ≥ 0,2 %
D
607-073-00-34-CPA (ISO);

4-chlorophenoxyacetic acid
204-581-3122-88-3Xn; R22Xn

R: 22

S: (2-)
607-074-00-9chlorfenac (ISO);

2,3,6-trichlorophenylacetic acid
201-599-385-34-7Xn; R22

N; R51-53
Xn; N

R: 22-51/53

S: (2-)36-61
607-075-00-4chlorfenprop-methyl;

methyl 2-chloro-3-(4-chlorophenyl)propionate
238-413-514437-17-3Xn; R21/22

N; R50-53
Xn; N

R: 21/22-50/53

S: (2-)36/37-60-61
607-076-00-Xdodine (ISO);

dodecylguanidinium acetate
219-459-52439-10-3Xn; R22

Xi; R36/38

N; R50-53
Xn; N

R: 22-36/38-50/53

S: (2-)26-60-61
607-077-00-5erbon (ISO);

2-(2,4,5-trichlorophenoxy)ethyl 2,2-dichloropropionate
136-25-4Xn; R22

N; R51-53
Xn; N

R: 22-51/53

S: (2-)61
607-078-00-0fluenetil (ISO);

2-fluoroethyl biphenyl-4-ylacetate
4301-50-2T+; R27/28T+

R: 27/28

S: (1/2-)28-36/

37-45
607-079-00-6kelevan (ISO);

ethyl 5-(perchloro-5-hydroxypentacyclo[5,3,0,02,6,03,9,04,8]decan-5-yl)-4-oxopentanoate;

ethyl 5-(1,2,3,5,6,7,8,9,10,10-decachloro-4-hydroxypentacyclo(5,2,1,02,6,03,9,05,8)dec-4-yl)-4-oxovalerate
4234-79-1T; R24

Xn; R22

N; R51-53
T; N

R: 22-24-51/53

S: (1/2-)36/37-45-61
607-080-00-1chloroacetyl chloride201-171-679-04-9R14

R29

T; R23/24/25-48/23

C; R35

N; R50
T; C; N

R: 14-23/24/25-29-35-48/23-50

S: (1/2-)7/8-9-26-36/37/39-45-61
607-081-00-7fluoroacetic acid205-631-7144-49-0T+; R28

N; R50
T+; N

R: 28-50

S: (1/2-)20-22-26-45-61
607-082-00-2fluoroacetates, solubleT+; R28

N; R50
T+; N

R: 28-50

S: (1/2-)20-22-26-45-61
A
607-083-00-82,4-DB (ISO);

4-(2,4-dichlorophenoxy)butyric acid
202-366-994-82-6Xn; R22

N; R51-53
Xn; N

R: 22-51/53

S: (2-)25-29-46-61
607-084-00-3salts of 2,4-DBXn; R22

Xi; R41

N; R51-53
Xn; N

R: 22-41-51/53

S: (2-)26-29-39-46-61
A
607-085-00-9benzyl benzoate204-402-9120-51-4Xn; R22Xn

R: 22

S: (2-)25
607-086-00-4diallyl phthalate205-016-3131-17-9Xn; R22

N; R50-53
Xn; N

R: 22-50/53

S: (2-)24/25-60-61
607-088-00-5methacrylic acid;

2-methylpropenoic acid
201-204-479-41-4Xn; R21/22

C; R35
C

R: 21/22-35

S: (1/2-)26-36/37/39-45
C; R35: C ≥ 10 %

C; R34: 5 % ≤ C < 10 %

Xi; R36/37/38: 1 % ≤ C < 5 %
D
607-089-00-0propionic acid … %201-176-379-09-4C; R34C

R: 34

S: (1/2-)23-36-45
C; R34: C ≥ 25 %

Xi; R36/37/38: 10 % ≤ C < 25 %
B
607-090-00-6thioglycolic acid200-677-468-11-1T; R23/24/25

C; R34
T

R: 23/24/25-34

S: (1/2-)25-27-28-45
T; R23/24/25: C ≥ 2 %

Xn; R20/21/22: 0,2 % ≤ C < 2 %
607-091-00-1trifluoroacetic acid . . . %200-929-376-05-1Xn; R20

C; R35

R52-53
C

R: 20-35-52/53

S: (1/2-)9-26-27-28-45-61
Xn; R20: C ≥ 10 %B
607-092-00-7methyl lactate; [1]

methyl (±)-lactate; [2]

methyl (R)-lactate; [3]

methyl (S)-(-)-lactate [4]
208-930-0 [1]

218-449-8 [2]

241-420-6 [3]

248-704-9 [4]
547-64-8 [1]

2155-30-8 [2]

17392-83-5 [3]

27871-49-4 [4]
R10

Xi; R36/37
Xi

R: 10-36/37

S: (2-)24
C
607-093-00-2propionyl chloride201-170-079-03-8F; R11

R14

C; R34
F; C

R: 11-14-34

S: (1/2-)9-16-26-45
B D
607-094-00-8peracetic acid . . . %201-186-879-21-0R10

O; R7

Xn; R20/21/22

C; R35

N; R50
O; C; N

R: 7-10-20/21/22-35-50

S: (1/2-)3/7-14-36/37/39-45-61
Xn; R20/21/22: C ≥ 10 %

C; R35: C ≥ 10 %

C; R34: 5 % ≤ C < 10 %

Xi; R36/37/38: 1 % ≤ C < 5 %
B D
607-095-00-3maleic acid203-742-5110-16-7Xn; R22

Xi; R36/37/38
Xn

R: 22-36/37/38

S: (2-)26-28-37
607-096-00-9maleic anhydride203-571-6108-31-6Xn; R22

C; R34

R42/43
C

R: 22-34-42/43

S: (2-)22-26-36/37/39-45
607-097-00-4benzene-1,2,4-tricarboxylic acid 1,2-anhydride;

trimellitic anhydride
209-008-0552-30-7Xi; R37-41

R42/43
Xn

R: 37-41-42/43

S: (2-)22-26-36/37/39
607-098-00-Xbenzene-1,2:4,5-tetracarboxylic dianhydride;

benzene-1,2:4,5-tetracarboxylic dianhydride;

pyromellitic dianhydride
201-898-989-32-7Xi; R41

R42/43
Xn

R: 41-42/43

S: (2-)22-24-26-37/39
607-099-00-51,2,3,6-tetrahydrophthalic anhydride; [1]

cis-1,2,3,6-tetrahydrophthalic anhydride; [2]

3,4,5,6-tetrahydrophthalic anhydride; [3]

tetrahydrophthalic anhydride [4]
201-605-4 [1]

213-308-7 [2]

219-374-3 [3]

247-570-9 [4]
85-43-8 [1]

935-79-5 [2]

2426-02-0 [3]

26266-63-7 [4]
Xi; R41

R42/43

R52-53
Xn

R: 41-42/43-52/53

S: (2-)22-24-26-37/39-61
C
607-100-00-9benzophenone-3,3',4,4'-tetracarboxylic dianhydride;

4,4'-carbonyldi(phthalic anhydride)
219-348-12421-28-5Xi; R36/37Xi

R: 36/37

S: (2-)25
Xi; R36/37: C ≥ 1 %
607-101-00-41,4,5,6,7,7-hexachlorobicyclo [2,2,1]hept-5-ene-2,3-dicarboxylic anhydride chlorendic anhydride204-077-3115-27-5Xi; R36/37/38Xi

R: 36/37/38

S: (2-)25
Xi; R36/37/38: C ≥ 1 %
607-102-00-Xcyclohexane-1,2-dicarboxylic anhydride; [1]

cis-cyclohexane-1,2-dicarboxylic anhydride; [2]

trans-cyclohexane-1,2-dicarboxylic anhydride [3]
201-604-9 [1]

236-086-3 [2]

238-009-9 [3]
85-42-7 [1]

13149-00-3 [2]

14166-21-3 [3]
Xi; R41

R42/43
Xn

R: 41-42/43

S: (2-)23-24-26-37/39
C
607-103-00-5succinic anhydride203-570-0108-30-5Xi; R36/37Xi

R: 36/37

S: (2-)25
Xi; R36/37: C ≥ 1 %
607-104-00-0cyclopentane-1,2,3,4-tetracarboxylic dianhydride227-964-76053-68-5Xi; R36/37Xi

R: 36/37

S: (2-)25
Xi; R36/37: C ≥ 1 %
607-105-00-68,9,10-trinorborn-5-ene-2,3-dicarboxylic anhydride; [1]

1,2,3,6-tetrahydro-3,6-methanophthalic anhydride; [2]

(1α,2α,3β,6β)-1,2,3,6-tetrahydro-3,6-methanophthalic anhydride [3]
204-957-7 [1]

212-557-9 [2]

220-384-5 [3]
129-64-6 [1]

826-62-0 [2]

2746-19-2 [3]
Xi; R41

R42/43
Xn

R: 41-42/43

S: (2-)22-24-26-37/39
C
607-106-00-18,9-dinorborn-5-ene-2,3-dicarboxylic anhydride123748-85-6Xn; R22

Xi; R36/37/38

R42
Xn

R: 22-36/37/38-42

S: (2-)39
Xi; R36/37/38: C ≥ 10 %C
607-107-00-72-ethylhexyl acrylate203-080-7103-11-7Xi; R37/38

R43
Xi

R: 37/38-43

S: (2-)36/37-46
D
607-108-00-22-hydroxy-1-methylethylacrylate; [1]

2-hydroxypropylacrylate; [2]

acrylic acid, monoester with propane-1,2-diol [3]
220-852-9 [1]

213-663-8 [2]

247-118-0 [3]
2918-23-2 [1]

999-61-1 [2]

25584-83-2 [3]
T; R23/24/25

C; R34

R43
T

R: 23/24/25-34-43

S: (1/2-)26-36/37/39-45
T; R23/24/25: C ≥ 2 %

Xn; R20/21/22: 0,2 % ≤ C < 2 %

R43: C ≥ 0,2 %
C D
607-109-00-8hexamethylene diacrylate;

hexane-1,6-diol diacrylate
235-921-913048-33-4Xi; R36/38

R43
Xi

R: 36/38-43

S: (2-)39
D
607-110-00-3pentaerythritol triacrylate222-540-83524-68-3Xi; R36/38

R43
Xi

R: 36/38-43

S: (2-)39
D
607-111-00-92,2-bis(acryloyloxymethyl)butyl acrylate;

trimethylolpropane triacrylate
239-701-315625-89-5Xi; R36/38

R43
Xi

R: 36/38-43

S: (2-)39
D
607-112-00-42,2-dimethyltrimethylene diacrylate;

neopentyl glycol diacrylate
218-741-52223-82-7T; R24

Xi; R36/38

R43
T

R: 24-36/38-43

S: (1/2-)28-39-45
T; R24: C ≥ 5 %

Xn; R21: 0,2 % ≤ C < 5 %
D
607-113-00-Xisobutyl methacrylate202-613-097-86-9R10

Xi; R36/37/38

R43

N; R50
Xi; N

R: 10-36/37/38-43-50

S: (2-)24-37-61
D
607-114-00-5ethylene dimethacrylate202-617-297-90-5Xi; R37

R43
Xi

R: 37-43

S: (2-)24-37
Xi; R37: C ≥ 10 %D
607-115-00-0isobutyl acrylate203-417-8106-63-8R10

Xn; R20/21

Xi; R38

R43
Xn

R: 10-20/21-38-43

S: (2-)9-24-37
Xi; R38: C ≥ 10 %D
607-116-00-6cyclohexyl acrylate221-319-33066-71-5Xi; R37/38

N; R51-53
Xi; N

R: 37/38-51/53

S: (2-)61
Xi; R37/38: C ≥ 10 %D
607-117-00-12,3-epoxypropyl acrylate;

glycidyl acrylate
203-440-3106-90-1T; R23/24/25

C; R34

R43
T

R: 23/24/25-34-43

S: (1/2-)26-36/37/39-45
T; R23/24/25: C ≥ 2 %

Xn; R20/21/22: 0,2 % ≤ C < 2 %

R43: C ≥ 0,2 %
D
607-118-00-71-methyltrimethylene diacrylate;

1,3-butylene glycol diacrylate
243-105-919485-03-1Xn; R21

C; R34

R43
C

R: 21-34-43

S: (1/2-)26-36/37/39-45
D
607-119-00-2tetramethylene diacrylate;

1,4-butyleneglycol diacrylate
213-979-61070-70-8Xn; R21

C; R34

R43
C

R: 21-34-43

S: (1/2-)26-36/37/39-45
D
607-120-00-82,2'-oxydiethyl diacrylate;

diethylene glycol diacrylate
223-791-64074-88-8T; R24

Xi; R36/38

R43
T

R: 24-36/38-43

S: (1/2-)28-39-45
T; R24: C ≥ 2 %

Xn; R21: 0,2 % ≤ C < 2 %

R43: C ≥ 0,2 %
D
607-121-00-38,9,10-trinorborn-2-yl acrylate10027-06-2Xn; R21

Xi; R38

R43
Xn

R: 21-38-43

S: (2-)28
Xi; R38: C ≥ 10 %D
607-122-00-9pentaerythritol tetraacrylate225-644-14986-89-4Xi; R36/38

R43
Xi

R: 36/38-43

S: (2-)26-39
D
607-123-00-42,3-epoxypropyl methacrylate;

glycidyl methacrylate
203-441-9106-91-2Xn; R20/21/22

Xi; R36/38

R43
Xn

R: 20/21/22-36/38-43

S: (2-)26-28
Xi; R36/38: C ≥ 10 %D
607-124-00-X2-hydroxyethyl methacrylate212-782-2868-77-9Xi; R36/38

R43
Xi

R: 36/38-43

S: (2-)26-28
D
607-125-00-52-hydroxypropyl methacrylate; [1]

3-hydroxypropyl methacrylate [2]
213-090-3 [1]

220-426-2 [2]
923-26-2 [1]

2761-09-3 [2]
Xi; R36

R43
Xi

R: 36-43

S: (2-)24/25-26-37/39
C D
607-126-00-02,2'-(ethylenedioxy)diethyl diacrylate;

triethylene glycol diacrylate
216-853-91680-21-3Xi; R36/38

R43
Xi

R: 36/38-43

S: (2-)26-28
D
607-127-00-62-diethylaminoethyl methacrylate203-275-7105-16-8Xn; R20

Xi; R36/38

R43
Xn

R: 20-36/38-43

S: (2-)26
Xi; R36/38: C ≥ 10 %D
607-128-00-12-tert-butylaminoethyl methacrylate223-228-43775-90-4Xi; R36/38

R43
Xi

R: 36/38-43

S: (2-)26
D
607-129-00-7ethyl lactate;

ethyl DL-lactate; [1]

ethyl (S)-2-hydroxypropionate;

ethyl L-lactate;

ethyl-(S)-lactate [2]
202-598-0 [1]

211-694-1 [2]
97-64-3 [1]

687-47-8 [2]
R10

Xi; R37-41
Xi

R: 10-37-41

S: (2-)24-26-39
C
607-130-00-2pentyl acetate; [1]

isopentyl acetate; [2]

1-methylbutyl acetate; [3]

2-methylbutyl acetat; [4]

2(or 3)-methylbutyl acetate [5]
211-047-3 [1]

204-662-3 [2]

210-946-8 [3]

210-843-8 [4]

282-263-3 [5]
628-63-7 [1]

123-92-2 [2]

626-38-0 [3]

624-41-9 [4]

84145-37-9 [5]
R10

R66
R: 10-66

S: (2-)23-25
C
607-131-00-8isopentyl propionate; [1]

pentyl propionate; [2]

2-methylbutyl propionate [3]
203-322-1 [1]

210-852-7 [2]

219-449-0 [3]
105-68-0 [1]

624-54-4 [2]

2438-20-2 [3]
R10R: 10

S: (2-)23-24
C
607-132-00-32-dimethylaminoethyl methacrylate220-688-82867-47-2Xn; R21/22

Xi; R36/38

R43
Xn

R: 21/22-36/38-43

S: (2-)26-28
Xi; R36/38: C ≥ 10 %D
607-133-00-9monoalkyl or monoaryl or monoalkylaryl esters of acrylic acid with the exception of those specified elsewhere in this AnnexXi; R36/37/38

N; R51-53
Xi; N

R: 36/37/38-51/53

S: (2-)26-28-61
Xi; R36/37/38: C ≥ 10 %A
607-134-00-4monoalkyl or monoaryl or monoalkyaryl esters of methacrylic acid with the exception of those specified elsewhere in this AnnexXi; R36/37/38Xi

R: 36/37/38

S: (2-)26-28
Xi; R36/37/38: C ≥ 10 %A
607-135-00-Xbutyric acid203-532-3107-92-6C; R34C

R: 34

S: (1/2-)26-36-45
607-136-00-5butyryl chloride205-498-5141-75-3F; R11

C; R34
F; C

R: 11-34

S: (1/2-)16-23-26-36-45
607-137-00-0methyl acetoacetate203-299-8105-45-3Xi; R36Xi

R: 36

S: (2-)26
607-138-00-6butyl chloroformate;

chloroformic acid butyl ester
209-750-5592-34-7R10

T; R23

C; R34
T

R: 10-23-34

S: (1/2-)26-36-45
607-139-00-12-chloropropionic acid209-952-3598-78-7Xn; R22

C; R35
C

R: 22-35

S: (1/2-)23-26-28-36-45
607-140-00-7isobutyryl chloride201-194-179-30-1F; R11

C; R35
F; C

R: 11-35

S: (1/2-)16-23-26-36-45
607-141-00-2oxydiethylene bis(chloroformate)203-430-9106-75-2Xn; R22

Xi; R38-41

N; R51-53
Xn; N

R: 22-38-41-51/53

S: (2-)23-26-61
607-142-00-8propyl chloroformate;

chloroformic acid propylester;

n-propyl chloroformate
203-687-7109-61-5R10 $

T; R23

C; R34
T

R: 10-23-34

S: (1/2-)26-36-45
607-143-00-3valeric acid203-677-2109-52-4C; R34

R52-53
C

R: 34-52/53

S: (1/2-)26-36-45-61
607-144-00-9adipic acid204-673-3124-04-9Xi; R36Xi

R: 36

S: (2-)
607-145-00-4methanesulphonic acid200-898-675-75-2C; R34C

R: 34

S: (1/2-)26-36-45
607-146-00-Xfumaric acid203-743-0110-17-8Xi; R36Xi

R: 36

S: (2-)26
607-147-00-5oxalic acid diethylester;

diethyl oxalate
202-464-195-92-1Xn; R22

Xi; R36
Xn

R: 22-36

S: (2-)23
607-148-00-0guanidinium chloride;

guanadine hydrochloride
200-002-350-01-1Xn; R22

Xi; R36/38
Xn

R: 22-36/38

S: (2-)22
607-149-00-6urethane (INN);

ethyl carbamate
200-123-151-79-6Carc. Cat. 2; R45T

R: 45

S: 53-45
607-150-00-1endothal (ISO);

7-oxabicyclo(2,2,1)heptane-2,3-dicarboxylic acid
205-660-5145-73-3T; R25

Xn; R21

Xi; R36/37/38
T

R: 21-25-36/37/38

S: (1/2-)36/37/39-45
607-151-00-7propargite (ISO);

2-(4-tert-butylphenoxy) cyclohexyl prop-2-ynyl sulphite
219-006-12312-35-8Carc. Cat. 3; R40

T; R23

Xi; R38-41

N; R50-53
T; N

R: 23-38-40-41-50/53

S: (1/2-)26-36/37/39-45-60-61
N; R50-53: C ≥ 2,5 %

N; R51-53: 0,25 % ≤ C < 2,5 %

R52-53: 0,025 % ≤ C < 0,25 %
607-152-00-22,3,6-TBA (ISO);

2,3,6-trichlorobenzoic acid
200-026-450-31-7Xn; R22

N; R51-53
Xn; N

R: 22-51/53

S: (2-)61
607-153-00-8benazolin (ISO);

4-chloro-2,3-dihydro-2-oxo-1,3-benzothiazol-3-ylacetic acid
223-297-03813-05-6Xi; R36/38

R52-53
Xi

R: 36/38-52/53

S: (2-)22-61
607-154-00-3ethyl N-benzoyl-N-(3,4-dichlorophenyl)-DL-alaninate;

benzoylprop-ethyl (ISO)
244-845-522212-55-1Xn; R22

N; R50-53
Xn; N

R: 22-50/53

S: (2-)24-60-61
607-155-00-93-(3-amino-5-(1-methylguanidino)-1-oxopentylamino-6-(4-amino-2-oxo-2,3-dihydro-pyrimidin-1-yl)-2,3-dihydro-(6H)-pyran-2-carboxylic acid;

blasticidin-s
2079-00-7T+; R28T+

R: 28

S: (1/2-)24/25-36/37-45
607-156-00-4chlorfenson (ISO);

4-chlorophenyl 4-chlorobenzenesulfonate
201-270-480-33-1Xn; R22

Xi; R38

N; R50-53
Xn; N

R: 22-38-50/53

S: (2-)37-60-61
607-157-00-X3-(3-biphenyl-4-yl-1,2,3,4-tetrahydro-1-naphthyl)-4-hydroxycoumarin;

difenacoum
259-978-456073-07-5T+; R28

T; R48/25

N; R50-53
T+; N

R: 28-48/25-50/53

S: (1/2-)36/37-45-60-61
607-158-00-5sodium salt of chloroacetic acid;

sodium chloroacetate
223-498-33926-62-3T; R25

Xi; R38

N; R50
T; N

R: 25-38-50

S: (1/2-)22-37-45-61
607-159-00-0chlorobenzilate (ISO);

ethyl 2,2-di(4-chlorophenyl)-2-hydroxyacetate;

ethyl 4,4'-dichlorobenzilate
208-110-2510-15-6Xn; R22

N; R50-53
Xn; N

R: 22-50/53

S: (2-)60-61
607-160-00-6isobutyl 2-(4-(4-chlorophenoxy)phenoxy)propionate;

clofop-isobutyl (ISO)
51337-71-4Xn; R22Xn

R: 22

S: (2-)
607-161-00-1diethanolamine salt of 4-CPAXn; R22Xn

R: 22

S: (2-)
607-162-00-72,2-dichloropropionic acid;

dalapon
200-923-075-99-0Xn; R22

Xi; R38-41

R52-53
Xn

R: 22-38-41-52/53

S: (2-)26-39-61
607-163-00-23-acetyl-6-methyl-2H-pyran-2,4(3H)-dione;

dehydracetic acid
208-293-9520-45-6Xn; R22Xn

R: 22

S: (2-)
607-164-00-8sodium 1-(3,4-dihydro-6-methyl-2,4-dioxo-2H-pyran-3-ylidene)ethonolate;

sodium dehydracetate
224-580-14418-26-2Xn; R22Xn

R: 22

S: (2-)
607-165-00-3diclofop-methyl (ISO);

methyl 2-(4-(2,4-dichlorophenoxy)phenoxy)propionate;

methyl (RS)-2-[4-(2,4-dichlorophenoxy)phenoxy]propionate;
257-141-851338-27-3Xn; R22

R43

N; R50-53
Xn; N

R: 22-43-50/53

S: (2-)24-37-60-61
607-166-00-9medinoterb acetate (ISO);

6-tert-butyl-3-methyl-2,4-dinitrophenyl acetate
219-634-62487-01-6T; R25

Xn; R21
T

R: 21-25

S: (1/2-)36/37-45
607-167-00-4sodium 3-chloroacrylate4312-97-4Xn; R21/22Xn

R: 21/22

S: (2-)36/37
607-168-00-Xdipropyl 6,7-methylenedioxy-1,2,3,4-tetrahydro-3-methylnaphthalene-1,2-dicarboxylate;

propylisome
83-59-0T; R24

Xn; R22

N; R50-53
T; N

R: 22-24-50/53

S: (1/2-)36/37-45-60-61
607-169-00-5sodium fluoroacetate200-548-262-74-8T+; R26/27/28

N; R50
T+; N

R: 26/27/28-50

S: (1/2-)13-22-36/37-45-61
607-170-00-0bis(1,2,3-trithiacyclohexyldimethylammonium) oxalate;

thiocyclam-oxalate
250-859-231895-22-4Xn; R21/22

N; R50-53
Xn; N

R: 21/22-50/53

S: (2-)36/37-46-60-61
607-172-00-14-hydroxy-3-(3-(4'-bromo-4-biphenylyl)-1,2,3,4-tetrahydro-1-naphthyl)coumarin;

brodifacoum
259-980-556073-10-0T+; R27/28

T; R48/24/25

N; R50-53
T+; N

R: 27/28-48/24/25-50/53

S: (1/2-)36/37-45-60-61
607-173-00-7dimethyl (3-methyl-4-(5-nitro-3-ethoxycarbonyl-2-thienyl)azo)phenylnitrilodipropionate400-460-6R43

R52-53
Xi

R: 43-52/53

S: (2-)24-37-61
607-174-00-2reaction mass of dodecyl 3-(2,2,4,4-tetramethyl-21-oxo-7-oxa-3,20-diazadispiro(5,1,11,2)henicosan-20-yl)propionate and tetradecyl 3-(2,2,4,4-tetramethyl-21-oxo-7-oxa-3,20-diazadispiro(5,1,11,2)henicosan-20-yl)propionate400-580-9Xi; R38

N; R51-53
Xi; N

R: 38-51/53

S: (2-)28-61
607-175-00-8methyl 2-(2-nitrobenzylidene)acetoacetate400-650-939562-27-1R43

N; R51-53
Xi; N

R: 43-51/53

S: (2-)24-37-61
607-176-00-3reaction mass of α-3-(3-(2H-benzotriazol-2-yl)-5-tert-butyl-4-hydroxyphenyl)propionyl-ω-hydroxypoly(oxyethylene) and α-3-(3-(2H-benzotriazol-2-yl)-5-tert-butyl-4-hydroxyphenyl)propionyl-ω-3-(3-(2H-benzotriazol-2-yl)-5-tert-butyl-4-hydroxyphenyl)propionyloxypoly(oxyethylene)400-830-7R43

N; R51-53
Xi; N

R: 43-51/53

S: (2-)36/37-61
607-177-00-9methyl 2-(3-(4-methoxy-6-methyl-1,3,5-triazin-2-yl)3-methylureidosulphonyl)benzoate401-190-1101200-48-0R43Xi

R: 43

S: (2-)22-24-37
607-178-00-4methyl α-((4,6-dimethoxypyrimidin-2-yl)ureidosulphonyl)-o-toluate401-340-683055-99-6R43

N; R51-53
Xi; N

R: 43-51/53

S: (2-)24-37-61
607-179-00-X(benzothiazol-2-ylthio)succinic acid401-450-495154-01-1R43Xi

R: 43

S: (2-)24-37
607-180-00-5potassium 2-hydroxycarbazole-1-carboxylate401-630-296566-70-0Xn; R22

Xi; R36/37

R52-53
Xn

R: 22-36/37-52/53

S: (2-)22-26-61
607-181-00-03,5-dichloro-2,4-difluorobenzoyl fluoride401-800-6101513-70-6T; R23

C; R34

Xn; R22

R29

R43

R52-53
T; C

R: 22-23-29-34-43-52/53

S: (1/2-)26-36/37/39-45-61
607-182-00-6methyl 3-sulphamoyl-2-thenoate402-050-2R43Xi

R: 43

S: (2-)24-37
607-183-00-1zinc 2-hydroxy-5-C13-18alkylbenzoate402-280-3Xi; R36/38

N; R51-53
Xi; N

R: 36/38-51/53

S: (2-)26-61
607-184-00-7S-(3-trimethoxysilyl)propyl 19-isocyanato-11-(6-isocyanatohexyl)-10,12-dioxo-2,9,11,13-tetraazanonadecanethioate402-290-885702-90-5R10

R42/43
Xn

R: 10-42/43

S: (2-)23-24-37
607-185-00-2ethyl trans-3-dimethylaminoacrylate402-650-41117-37-9R43Xi

R: 43

S: (2-)24-37
607-186-00-8quinclorac (ISO);

3,7-dichloroquinoline-8-carboxylic acid
402-780-184087-01-4R43Xi

R: 43

S: (2-)24-37
607-187-00-3bis(2,2,6,6-tetramethyl-4-piperidyl) succinate402-940-062782-03-0Xi; R36

R52-53
Xi

R: 36-52/53

S: (2-)26-61
607-188-00-9hydrogen sodium N-carboxylatoethyl-N-octadec-9-enylmaleamate402-970-4R43

N; R51-53
Xi; N

R: 43-51/53

S: (2-)24-37-61
607-189-00-4trimethylenediaminetetraacetic acid400-400-91939-36-2Xn; R22

Xi; R41

N; R50-53
Xn; N

R: 22-41-50/53

S: (2-)22-26-39-60-61
607-190-00-Xmethyl acrylamidomethoxyacetate (containing ≥ 0,1 % acrylamid)401-890-777402-03-0Carc. Cat. 2; R45

Muta. Cat. 2; R46

Xn; R22

Xi; R36
T

R: 45-46-22-36

S: 53-45
E
607-191-00-5isobutyl 3,4-epoxybutyrate401-920-9100181-71-3Xi; R38

R43

N; R50-53
Xi; N

R: 38-43-50/53

S: (2-)24-28-36/37-60-61
607-192-00-0disodium N-carboxymethyl-N-(2-(2-hydroxyethoxy)ethyl)glycinate402-360-892511-22-3Xi; R41Xi

R: 41

S: (2-)26-39
607-194-00-1propylene carbonate203-572-1108-32-7Xi; R36Xi

R: 36

S: (2-)
607-195-00-72-methoxy-1-methylethyl acetate203-603-9108-65-6R10

Xi; R36
Xi

R: 10-36

S: (2-)25
607-196-00-2heptanoic acid203-838-7111-14-8C; R34C

R: 34

S: (1/2-)26-28-36/37/39-45
607-197-00-8nonanoic acid203-931-2112-05-0C; R34C

R: 34

S: (1/2-)26-28-36/37/39-45
607-198-00-3propyl 3,4,5-trihydroxybenzoate204-498-2121-79-9Xn; R22

R43
Xn

R: 22-43

S: (2-)24-37
607-199-00-9octyl 3,4,5-trihydroxybenzoate213-853-01034-01-1Xn; R22

R43
Xn

R: 22-43

S: (2-)24-37
607-200-00-2dodecyl 3,4,5-trihydroxybenzoate214-620-61166-52-5R43Xi

R: 43

S: (2-)24-37
607-201-00-8thiocarbonyl chloride207-341-6463-71-8T; R23

Xn; R22

Xi; R36/37/38
T

R: 22-23-36/37/38

S: (1/2-)7-9-36/37-45
607-203-00-92-ethylhexyl[[[3,5-bis(1,1-dimethylethyl)-4-hydroxyphenyl]methyl]thio]acetate279-452-880387-97-9Repr. Cat. 2; R61

R43

R52-53
T

R: 61-43-52/53

S: 53-45-61
607-204-00-4(chlorophenyl)(chlorotolyl)methane, mixed isomers400-140-6N; R50-53N

R: 50/53

S: 60-61
607-205-00-Xmethyl chloroacetate202-501-196-34-4R10

T; R23/25

Xi; R37/38-41
T

R: 10-23/25-37/38-41

S: (1/2-)26-37/39-45
607-206-00-5isopropyl chloroacetate203-301-7105-48-6R10

T; R25

Xi; R36/37/38
T

R: 10-25-36/37/38

S: (1/2-)26-37/39-45
607-207-00-0haloxyfop-etotyl (ISO)

2-ethoxyethyl 2-(4-(3-chloro-5-trifluoromethyl-2-pyridyloxy)phenoxy)propionate;

haloxyfop-(2-ethoxyethyl)
402-560-587237-48-7Xn; R22

N; R50-53
Xn; N

R: 22-50/53

S: (2-)22-36-60-61
607-208-00-64,8,12-trimethyltrideca-3,7,11-trienoic acid, mixed isomers403-000-291853-67-7Xi; R38

N; R50-53
Xi; N

R: 38-50/53

S: (2-)37/39-60-61
607-209-00-1reaction mass of O,O'-diisopropyl (pentathio)dithioformate and O,O'-diisopropyl (trithio)dithioformate and O,O'-diisopropyl (tetrathio)dithioformate403-030-6Xn; R22

R43

N; R50-53
Xn; N

R: 22-43-50/53

S: (2-)36/37-60-61
607-210-00-7methyl acrylamidoglycolate (containing ≥ 0,1 % acrylamide)403-230-377402-05-2Carc. Cat. 2; R45

Muta. Cat. 2; R46

C; R34

R43
T

R: 45-46-34-43

S: 53-45
607-211-00-2methyl 3-(3-tert-butyl-4-hydroxy-5-methylphenyl)propionate403-270-16386-39-6Xn; R22

N; R51-53
Xn; N

R: 22-51/53

S: (2-)36-61
607-212-00-8poly(oxypropylenecarbonyl-co-oxy(ethylethylene)carbonyl), containing 27 % hydroxyvalerate403-300-3R43Xi

R: 43

S: (2-)24-37
607-213-00-3ethyl 3,3-bis(tert-pentylperoxy)butyrate403-320-267567-23-1E; R2 $

O; R7

R10

N; R51-53
E; N

R: 2-7-10-51/53

S: (2-)3/7-14-33-36/37/39-61
607-214-00-9N,N-hydrazinodiacetic acid403-510-519247-05-3T; R25

Xn; R48/22

R43

R52-53
T

R: 25-43-48/22-52/53

S: (1/2-)26-36/37/39-45-61
607-215-00-43-(3-tert-butyl-4-hydroxyphenyl)propionic acid403-920-4107551-67-7Xn; R22

Xi; R36
Xn

R: 22-36

S: (2-)25-26-36
607-216-00-Xglutamic acid, reaction products with N-(C12-14alkyl)propylenediamine403-950-8T+; R26

Xn; R22

C; R34

N; R50-53
T+; N

R: 22-26-34-50/53

S: (1/2-)26-36/37/39-38-45-60-61
607-217-00-52-ethoxyethyl 2-(4-(2,6-dihydro-2,6-dioxo-7-phenyl-1,5-dioxaindacen-3-yl)phenoxy)acetate403-960-2R43

R53
Xi

R: 43-53

S: (2-)24-37-61
607-218-00-0dichlorprop-P (ISO);

(+)-R-2-(2,4-dichlorophenoxy)propionic acid
403-980-115165-67-0Xn; R22

Xi; R38-41

R43
Xn

R: 22-38-41-43

S: (2-)24-26-37/39
607-219-00-6bis(2-ethylhexyl) dithiodiacetate404-510-862268-47-7Xn; R22

R43

N; R51-53
Xn; N

R: 22-43-51/53

S: (2-)24/25-37-61
607-221-00-76-docosyloxy-1-hydroxy-4-(1-(4-hydroxy-3-methylphenanthren-1-yl)-3-oxo-2-oxaphenalen-1-yl)naphthalene-2-carboxylic acid404-550-6R43

R53
Xi

R: 43-53

S: (2-)24-37-61
607-222-00-26-(2,3-dimethylmaleimido)hexyl methacrylate404-870-663740-41-0R43

N; R51-53
Xi; N

R: 43-51/53

S: (2-)24-37-61
607-223-00-8transfluthrin (ISO);

2,3,5,6-tetrafluorobenzyl trans-2-(2,2-dichlorovinyl)-3,3-dimethylcyclopropanecarboxylate
405-060-5118712-89-3Xi; R38

N; R50-53
Xi; N

R: 38-50/53

S: (2-)36/37-60-61
607-224-00-3methyl 2-(3-nitrobenzylidene)acetoacetate405-270-739562-17-9Xi; R43

N; R50-53
Xi; N

R: 43-50/53

S: (2-)24-37-60-61
607-225-00-93-azidosulfonylbenzoic acid405-310-315980-11-7E; R2

Xn; R48/22

Xi; R41

R43
E; Xn

R: 2-41-43-48/22

S: (2-)22-26-35-36/37/39
607-226-00-4reaction mass of 2-acryloyloxyethyl hydrogen cyclohexane-1,2-dicarboxylate and 2-methacryloyloxyethyl hydrogen cyclohexane-1,2-dicarboxylate405-360-6Xi; R38-41

R43

R52-53
Xi

R: 38-41-43-52/53

S: (2-)24-26-37/39-61
607-227-00-Xpotassium 2-amino-2-methylpropionate octahydrate405-560-3120447-91-8Xn; R22

C; R35
C

R: 22-35

S: (1/2-)26-28-36/37/39-45
607-228-00-5bis(2-methoxyethyl) phthalate204-212-6117-82-8Repr. Cat. 2; R61

Repr. Cat. 3; R62
T

R: 61-62

S: 53-45
607-229-00-0diethylcarbamoyl chloride201-798-588-10-8Carc. Cat. 3; R40

Xn; R20/22

Xi; R36/37/38
Xn

R: 20/22-36/37/38-40

S: (2-)26-36/37
607-230-00-62-ethylhexanoic acid205-743-6149-57-5Repr. Cat. 3; R63Xn

R: 63

S: (2-)36/37
607-231-00-13,6-dichloropyridine-2-carboxylic acid;

clopyralid
216-935-41702-17-6Xi; R41

N; R51-53
X; N

R: 41-51/53

S: (2-)26-39-61
607-232-00-7pyridate (ISO);

O-(6-chloro-3-phenylpyridazin-4-yl) S-octyl thiocarbonate
259-686-755512-33-9Xi; R38

R43

N; R50-53
Xi; N

R: 38-43-50/53

S: (2-)24-37-60-61
607-233-00-2hexyl acrylate219-698-52499-95-8Xi; R36/37/38

R43

N; R51-53
Xi; N

R: 36/37/38-43-51/53

S: (2-)24-26-37-61
607-234-00-8flurenol (ISO);

9-hydroxy-9H-fluorene-9-carboxylic acid
207-397-1467-69-6N; R51-53N

R: 51/53

S: 61
607-235-00-3mecrilate;

methyl 2-cyanoacrylate
205-275-2137-05-3Xi; R36/37/38Xi

R: 36/37/38

S: (2-)23-24/25-26
Xi; R36/37/38: C ≥ 10 %
607-236-00-9ethyl 2-cyanoacrylate230-391-57085-85-0Xi; R36/37/38Xi

R: 36/37/38

S: (2-)23-24/25-26
Xi; R36/37/38: C ≥ 10 %
607-237-00-4benzyl 2-chloro-4-(trifluoromethyl)thiazole-5-carboxylate;

flurazole
276-942-372850-64-7N; R51-53N

R: 51/53

S: 61
607-238-00-Xtau-fluvalinate (ISO);

cyano-(3-phenoxyphenyl)methyl N-[2-chloro-4-(trifluoromethyl)phenyl]-D-valinate
102851-06-9Xn; R22

Xi; R38

N; R50-53
Xn; N

R: 22-38-50/53

S: (2-)24-59-61
607-239-00-5fenpropathrin (ISO);

α-cyano-3-phenoxybenzyl 2,2,3,3-tetramethylcyclopropanecarboxylate;
254-485-039515-41-8T+; R26

T; R25

Xn; R21

N; R50-53
T+; N

R: 21-25-26-50/53

S: (1/2-)28-36/37-38-45-60-61
607-240-00-0cis-1,2,3,6-tetrahydro-4-methylphthalic anhydride; [1]

1,2,3,6-tetrahydro-4-methylphthalic anhydride; [2]

1,2,3,6-tetrahydro-3-methylphthalic anhydride; [3]

tetrahydromethylphthalic anhydride; [4]

1,2,3,6-tetrahydromethylphthalic anhydride; [5]

tetrahydro-4-methylphthalic anhydride; [6]

2,3,5,6-tetrahydro-2-methylphthalic anhydride [7]
216-906-6 [1]

222-323-8 [2]

226-247-6 [3]

234-290-7 [4]

247-830-1 [5]

251-823-9 [6]

255-853-3 [7]
1694-82-2 [1]

3425-89-6 [2]

5333-84-6 [3]

11070-44-3 [4]

26590-20-5 [5]

34090-76-1 [6]

42498-58-8 [7]
Xi; R41

R42/43
Xn

R: 41-42/43

S: (2-)22-24-26-37/39
C
607-241-00-6hexahydro-4-methylphthalic anhydride; [1]

hexahydromethylphthalic anhydride; [2]

hexahydro-1-methylphthalic anhydride; [3]

hexahydro-3-methylphthalic anhydride [4]
243-072-0 [1]

247-094-1 [2]

256-356-4 [3]

260-566-1 [4]
19438-60-9 [1]

25550-51-0 [2]

48122-14-1 [3]

57110-29-9 [4]
Xi; R41

R42/43
Xn

R: 41-42/43

S: (2-)22-24-26-37/39
C
607-242-00-1tetrachlorophthalic anhydride204-171-4117-08-8Xi; R41

R42/43

N; R50-53
Xn; N

R: 41-42/43-50/53

S: (2-)22-24-26-37/39-60-61
607-243-00-7sodium 3,6-dichloro-o-anisate; [1]

3,6-dichloro-o-anisic acid, compound with 2,2'-iminodiethanol (1:1); [2]

3,6-dichloro-o-anisic acid, compound with 2-aminoethanol (1:1) [3]
217-846-3 [1]

246-590-5 [2]

258-527-9 [3]
1982-69-0 [1]

25059-78-3 [2]

53404-28-7 [3]
R52-53R: 52/53

S: 61
607-244-00-2isooctyl acrylate249-707-829590-42-9Xi; R36/37/38

N; R50-53
Xi; N

R: 36/37/38-50/53

S: (2-)26-28-60-61
Xi; R36/37/38: C ≥ 10 %
607-245-00-8tert-butyl acrylate216-768-71663-39-4F; R11

Xn; R20/21/22

Xi; R37/38

R43

N; R52-53
F; Xn

R: 11-20/21/22-37/38-43-52/53

S: (2-)16-25-37-61
D
607-246-00-3allyl methacrylate;

2-methyl-2-propenoic acid 2-propenyl ester
202-473-096-05-9R10

T; R23

Xn; R21/22

N; R50
T; N

R: 10-21/22-23-50

S: (1/2-)36/37-45-61
607-247-00-9dodecyl methacrylate205-570-6142-90-5Xi; 36/37/38

N; R50-53
Xi; N

R: 36/37/38-50/53

S: (2-)26-28-60-61
Xi; R36/37/38: C ≥ 10 %
607-248-00-4naptalam-sodium (ISO);

sodium N-naphth-1-ylphthalamate
205-073-4132-67-2Xn; R22Xn

R: 22

S: (2-)
607-249-00-X(1-methyl-1,2-ethanediyl)bis[oxy(methyl-2,1-ethanediyl)] diacrylate256-032-242978-66-5Xi; R36/37/38

R43

N; R51-53
Xi; N

R: 36/37/38-43-51/53

S: (2-)24-37-61
Xi; R36/37/38: C ≥ 10 %
607-250-00-54H-3,1-benzoxazine-2,4(1H)-dione204-255-0118-48-9Xi; R36

R43
Xi

R: 36-43

S: (2-)24-26-37
607-251-00-02-methoxypropyl acetate274-724-270657-70-4R10

Repr. Cat. 2; R61

Xi; R37
T

R: 61-10-37

S: 53-45
607-252-00-6lambda-cyhalothrin (ISO);

reaction mass of (S)-α-cyano-3-phenoxybenzyl(Z)-(1R)-cis-3-(2-chloro-3,3,3-trifluoropropenyl)-2,2-dimethylcyclopropanecarboxylate and (R)-α-cyano-3-phenoxybenzyl (Z)-(1S)-cis-3-(2-chloro-3,3,3-trifluoropropenyl)-2,2-dimethylcyclopropanecarboxylate (1:1)
415-130-791465-08-6T+; R26

T; R25

Xn; R21

N; R50-53
T+; N

R: 21-25-26-50/53

S: (1/2-)28-36/37/39-38-45-60-61
607-253-00-1α-cyano-4-fluoro-3-phenoxybenzyl-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate;

cyfluthrin
269-855-768359-37-5T+; R28

T; R23

N; R50-53
T+; N

R: 23-28-50/53

S: (1/2-)36/37/39-45-60-61
607-254-00-7α-cyano-4-fluoro-3-phenoxybenzyl-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate;

beta-cyfluthrin
269-855-768359-37-5T+; R26/28

N; R50-53
T+; N

R: 26/28-50/53

S: (1/2-)36/37/39-45-60-61
607-255-00-2fluroxypyr (ISO);

4-amino-3,5-dichloro-6-fluoro-2-pyridyloxyacetic acid
69377-81-7R52-53R: 52/53

S: 61
607-256-00-8azoxystrobin (ISO);

methyl (E)-2-{2-[6-(2-cyanophenoxy)pyrimidin-4-yloxy]phenyl}-3-methoxyacrylate
131860-33-8T; R23

N; 50-53
T; N

R: 23-50/53

S: (1/2-)22-45-60-61
607-257-00-3isopropyl propionate211-300-8637-78-5F; R11F

R: 11

S: (2-)16-23-24-29-33
607-258-00-9dodecyl 3-(2-(3-benzyl-4-ethoxy-2,5-dioxoimidazolidin-1-yl)-3-(4-methoxybenzoyl)acetamido)-4-chlorobenzoate403-990-670950-45-7R53R: 53

S: 61
607-259-00-4methyl 2R,3S-(-)-3-(4-methoxyphenyl)oxiranecarboxylate404-130-2105560-93-8Xi; R41

R43

R52-53
Xi

R: 41-43-52/53

S: (2-)24-26-37/39-61
607-260-00-Xethyl 2-(3-nitrobenzylidene)acetoacetate404-490-039562-16-8Xi; R41

R43

R52-53
Xi

R: 41-43-52/53

S: (2-)24-26-37/39-61
607-261-00-5iso(C10-C14)alkyl (3,5-di-tert-butyl-4-hydroxyphenyl)methylthioacetate404-800-4118832-72-7N; R50-53N

R: 50/53

S: 60-61
607-262-00-07-chloro-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid405-050-086393-33-1Xn; R22

R52-53
Xn

R: 22-52/53

S: (2-)22-61
607-263-00-6potassium iron(III) 1,3-propanediamine-N,N,N',N'-tetraacetate hemihydrate405-680-6E; R2

N; R51-53
E; N

R: 2-51/53

S: (2-)35-61
607-264-00-12-chloro-4-(methylsulfonyl)benzoic acid406-520-853250-83-2Xi; R41Xi

R: 41

S: (2-)26-39
607-265-00-7ethyl-2-chloro-2,2-diphenylacetate406-580-552460-86-3Xi; R38

R52-53
Xi

R: 38-52/53

S: (2-)37-61
607-266-00-2reaction mass of: hydroxyaluminium bis[2-hydroxy-3,5-di-tert-butylbenzoate];

3,5-di-tert-butyl-salicylic acid
406-890-0130296-87-6Xn; R22

N; R50-53
Xn; N

R: 22-50/53

S: (2-)22-60-61
607-267-00-8tert-butyl (5S,6R,7R)-3-bromomethyl-5,8-dioxo-7-(2-(2-phenylacetamido)-5-thia-1-azabicyclo[4.2.0] oct-2-ene-2-carboxylate407-620-433610-13-8R42/43

R52-53
Xn

R: 42/43-52/53

S: (2-)22-24-37-61
607-268-00-32-methylpropyl (R)-2-hydroxypropanoate407-770-061597-96-4Xi; R36Xi

R: 36

S: (2-)26
607-269-00-9(R)-2-(4-hydroxyphenoxy)propanoic acid407-960-394050-90-5Xi; R41Xi

R: 41

S: (2-)26-39
607-270-00-43,9-bis(2-(3-(3-tert-butyl-4-hydroxy-5-methylphenyl)propionyloxy-1,1-dimethylethyl)-2,4,8,10- tetraoxaspiro[5.5]undecane410-730-590498-90-1Xn; R21Xn

R: 21

S: (2-)36/37
607-271-00-X2-isopropyl-5-methylcyclohexyloxycarbonyloxy-2-hydroxypropane417-420-9156324-82-2Xi; R36

N; R51-53
Xi; N

R: 36-51/53

S: (2-)26-61
607-272-00-5fluroxypyr-meptyl (ISO);

methylheptyl, O-(4-amino-3,5-dichloro-6-fluoro-2-pyridyloxy) acetate; [1]

fluroxypyr-butometyl (ISO);

2-butoxy-1-methylethyl, O-(4-amino-3,5-dichloro-6-fluoro-2-pyridyloxy) acetate [2]
279-752-9 [1]

- [2]
81406-37-3 [1]

154486-27-8 [2]
N; R50-53N

R: 50/53

S: 60-61
607-273-00-0ammonium 7-(2,6-dimethyl-8-(2,2-dimethylbutyryloxy)-1,2,6,7,8,8a-hexahydro-1-naphthyl)-3,5-dihydroxyheptanoate404-520-2R52-53R: 52/53

S: 61
607-274-00-62-(N-benzyl-N-methylamino)ethyl 3-amino-2-butenoate405-350-154527-73-0R43

N; R51-53
Xi; N

R: 43-51/53

S: (2-)24-37-61
607-275-00-1sodium benzoyloxybenzene-4-sulfonate405-450-566531-87-1R43Xi

R: 43

S: (2-)24-37
607-276-00-7bis[(1-methylimidazol)-(2-ethyl-hexanoate)], zinc complex405-635-0Xi; R38-41

N; R50-53
Xi; N

R: 38-41-50/53

S: (2-)26-37/39-60-61
607-277-00-2reaction mass of: 2-(hexylthio)ethylamine hydrochloride;

sodium propionate
405-720-2Xn; R22

Xi; R41

R43

N; R51-53
Xn; N

R: 22-41-43-51/53

S: (2-)24-26-37/39-61
607-278-00-8reaction mass of isomers of: sodium phenethylnaphthalenesulfonate;

sodium naphthylethylbenzenesulfonate
405-760-0Xi; R41

R43

R52-53
Xi

R: 41-43-52/53

S: (2-)24-26-37/39-61
607-279-00-3reaction mass of n-octadecylaminodiethyl bis(hydrogen maleate);

n-octadecylaminodiethyl hydrogen maleate hydrogenphthalate
405-960-8R43

N; R51-53
Xi; N

R: 43-51/53

S: (2-)24-37-61
607-280-00-9sodium 4-chloro-1-hydroxybutane-1-sulfonate406-190-554322-20-2Xn; R22

Xi; R36

R43
Xn

R: 22-36-43

S: (2-)22-26-36/37
607-281-00-4reaction mass of branched and linear C7-C9 alkyl 3-[3-(2H-benzotriazol-2-yl)-5-(1,1-dimethylethyl)-4-hydroxyphenyl]propionates407-000-3127519-17-9N; R51-53N

R: 51/53

S: 61
607-282-00-X2-acetoxymethyl-4-benzyloxybut-1-yl acetate407-140-5131266-10-9R52-53R: 52/53

S: 61
607-283-00-5E-ethyl-4-oxo-4-phenylcrotonate408-040-415121-89-8Xn; R21/22

Xi; R38-41

R43

N; R50-53
Xn; N

R: 21/22-38-41-43-50/53

S: (2-)26-36/37/39-60-61
607-284-00-0reaction mass of: sodium 3,3'-(1,4-phenylenebis(carbonylimino-3,1-propanediylimino))bis(10-amino-6,13-dichloro-4,11-triphenodioxazinedisulfonate);

lithium 3,3'-(1,4-phenylenebis-(carbonylimino-3,1-propanediyl-imino))bis(10-amino-6,13-dichloro)-4,11-triphenodioxazinedisulfonate (9:1)
410-040-4136213-76-8N; R51-53N

R: 51/53

S: 61
607-285-00-6reaction mass of: 7-(((3-aminophenyl)sulfonyl)amino)-naphthalene-1,3-disulfonic acid;

sodium 7-(((3-aminophenyl)sulfonyl)amino)-naphthalene-1,3-disulfonate;

potassium 7-(((3-aminophenyl)sulfonyl)amino)-naphthalene-1,3-disulfonate
410-065-0R43Xi

R: 43

S: (2-)22-24-37
607-286-00-1reaction mass of: sodium/potassium 7-[[[3-[[4-((2-hydroxy-naphthyl)azo)phenyl]azo]phenyl]sulfonyl]amino]-naphthalene-1,3-disulfonate410-070-8141880-36-6R43

R52-53
Xi

R: 43-52/53

S: (2-)22-24-37-61
607-287-00-7O'-methyl O-(1-methyl-2-methacryloyloxy-ethyl)-1,2,3,6-tetrahydrophthalate410-140-8R52-53R: 52/53

S: 61
607-288-00-2Tetrasodium (c-(3-(1-(3-(e-6-dichloro-5-cyanopyrimidin-f-yl(methyl)amino)propyl)-1,6-dihydro-2-hydroxy-4-methyl-6-oxo-3-pyridylazo)-4-sulfonatophenylsulfamoyl)phthalocyanine-a,b,d-trisulfonato(6-))nickelato II, where a is 1 or 2 or 3 or 4,b is 8 or 9 or 10 or 11,c is 15 or 16 or 17 or 18, d is 22 or 23 or 24 or 25 and where e and f together are 2 and 4 or 4 and 2 respectively410-160-7148732-74-5Xi; R36

R43

R52-53
Xi

R: 36-43-52/53

S: (2-)22-26-36/37-61
607-289-00-83-(3-(4-(2,4-bis(1,1-dimethylpropyl)phenoxy)butylaminocarbonyl-4-hydroxy-1-naphthalenyl)thio)propanoic acid410-370-9105488-33-3R53R: 53

S: 61
607-290-00-3reaction mass (ratio not known) of: ammonium 1-C14-C18-alkyloxycarbonyl-2-(3-allyloxy-2-hydroxypropoxycarbonyl)ethane-1-sulfonate;

ammonium 2-C14-C18-alkyloxycarbonyl-1-(3-allyloxy-2-hydroxypropoxycarbonyl)ethane-1-sulfonate
410-540-2Xi; R38

R43

N; R50-53
Xi; N

R: 38-43-50/53

S: (2-)24-37-60-61
607-291-00-9dodecyl-ω-(C5/C6-cycloalkyl)alkyl carboxylate410-630-1104051-92-5R53R: 53

S: 61
607-292-00-4reaction mass of: [1-(methoxymethyl)-2-(C12-alkoxy)-ethoxy]acetic acid;

[1-(methoxymethyl)-2-(C14-alkoxy)-ethoxy]acetic acid
410-640-6Xi; R38-41

N; R50-53
Xi; N

R: 38-41-50/53

S: (2-)26-37/39-60-61
607-293-00-Xreaction mass of: N-aminoethylpiperazonium mono-2,4,6-trimethylnonyldiphenyl ether di-sulfonate;

N-aminoethylpiperazonium di-2,4,6-trimethylnonyldiphenyl ether di-sulfonate
410-650-0Xi; R41

R43

N; R51-53
Xi; N

R: 41-43-51/53

S: (2-)26-36/37/39-61
607-294-00-5sodium 2-benzoyloxy-1-hydroxyethane-sulfonate410-680-4R43Xi

R: 43

S: (2-)24-37
607-295-00-0reaction mass of: tetrasodium phosphonoethane-1,2-dicarboxylate;

hexasodium phosphonobutane-1,2,3,4-tetracarboxylate
410-800-5R43

N; R51-53
Xi; N

R: 43-51/53

S: (2-)24-37-61
607-296-00-6reaction mass of: pentaerythriol tetraesters with heptanoic acid and 2-ethylhexanoic acid410-830-9R53R: 53

S: 61
607-297-00-1(E-E)-3,3'-(1,4-phenylenedimethylidene)bis(2-oxobornane-10-sulfonic acid)410-960-692761-26-7Xi; R41Xi

R: 41

S: (2-)26-39
607-298-00-72-(trimethylammonium)ethoxycarboxybenzene-4-sulfonate411-010-3R43Xi

R: 43

S: (2-)22-36/37
607-299-00-2methyl 3-(acetylthio)-2-methyl-propanoate411-040-797101-46-7Xn; R22

R43

N; R50-53
Xn; N

R: 22-43-50/53

S: (2-)24-37-60-61
607-300-00-6trisodium [2-(5-chloro-2,6-difluoropyrimidin-4-ylamino)-5-(b-sulfamoyl-c, d-sulfonatophthalocyanin-a-yl-K4,N29,N30,N31,N32-sulfonylamino)benzoato(5-)]cuprate(II) where a = 1,2,3,4 b = 8,9,10,11 c = 15,16,17,18 d = 22,23,24,25411-430-7Xi; R41

R43
Xi

R: 41-43

S: (2-)26-36/37/39
607-301-00-1reaction mass of: dodecanoic acid;

poly(1-7)lactate esters of dodecanoic acid
411-860-5R43

N; R51-53
Xi; N

R: 38-41-43-51/53

S: (2-)24-26-37/39-61
607-302-00-7reaction mass of: tetradecanoic acid;

poly(1-7)lactate esters of tetradecanoic acid
411-910-6Xi; R38-41

R43

N; R51-53
Xi; N

R: 38-41-43-51/53

S: (2-)24-26-37/39-61
607-303-00-21-cyclopropyl-6,7-difluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid413-760-793107-30-3Repr. Cat. 3; R62

R52-53
Xn

R: 62-52/53

S: (2-)22-36/37-61
607-304-00-8fluazifop-butyl (ISO);

butyl (RS)-2-[4-(5-trifluoromethyl-2-pyridyloxy)phenoxy]propionate
274-125-669806-50-4Repr. Cat. 2; R61

N; R50-53
T; N

R: 61-50/53

S: 53-45-60-61
607-305-00-3fluazifop-P-butyl (ISO);

butyl (R)-2-[4-(5-trifluoromethyl-2-pyridyloxy)phenoxy]propionate
79241-46-6Repr. Cat. 3; R63

N; R50-53
Xn; N

R: 50/53-63

S: (2-)29-36/37-46-60-61
607-306-00-9chlozolinate (ISO);

ethyl (RS)-3-(3,5-dichlorophenyl)-5-methyl-2,4-dioxo-oxazolidine-5-carboxylate
282-714-484332-86-5Carc. Cat. 3; R40

N; R51-53
Xn; N

R: 40-51/53

S: (2-)36/37-61
607-307-00-4vinclozolin (ISO);

N-3,5-dichlorophenyl-5-methyl-5-vinyl-1,3-oxazolidine-2,4-dione
256-599-650471-44-8Carc. Cat. 3; R40

Repr. Cat. 2; R60-61

R43

N; R51-53
T; N

R: 60-61-40-43-51/53

S: 53-45-61
607-308-00-Xesters of 2,4-DXn; R22

R43

N; R50-53
Xn; N

R: 22-43-50/53

S: (2-)26-29-36/37-46-60-61
A
607-309-00-5carfentrazone-ethyl (ISO);

ethyl (RS)-2-chloro-3-[2-chloro-4-fluoro-5-[4-difluoromethyl-4,5-dihydro-3-methyl-5-oxo-1H-1,2,4-triazol-1-yl]phenyl]propionate
128639-02-1N; R50-53N

R: 50/53

S: 60-61
607-310-00-0kresoxim-methyl (ISO);

methyl (E)-2-methoxyimino-[2-(o-tolyloxymethyl)phenyl]acetate
143390-89-0Carc. Cat. 3; R40

N; R50-53
Xn; N

R: 40-50/53

S: (2-)36/37-60-61
607-311-00-6benazolin-ethyl;

ethyl 4-chloro-2-oxo-2H-benzothiazole-3-acetate
246-591-025059-80-7N; R51-53N

R: 51/53

S: 61
607-312-00-1methoxyacetic acid210-894-6625-45-6Repr. Cat. 2; R60-61

Xn; R22

C; R34
T

R: 60-61-22-34

S: 53-45
C; R34: C ≥ 10 %

Xi; R36/37/38: 5 % ≤ C < 10 %
E
607-313-00-7neodecanoyl chloride254-875-040292-82-8T+; R26

Xn; R22

C; R34
T+

R: 22-26-34

S: (1/2-)26-28-36/37/39-45
C; R34: C ≥ 10 %

Xi; R36/37/38: 5 % ≤ C < 10 %
607-314-00-2ethofumesate (ISO);

(±)-2-ethoxy-2,3-dihydro-3,3-dimethylbenzofuran-5-yl methanesulfonate
247-525-326225-79-6N; R51-53N

R: 51/53

S: 61
607-315-00-8glyphosate (ISO);

N-(phosphonomethyl)glycine
213-997-41071-83-6Xi; R41

N; R51-53
Xi; N

R: 41-51/53

S: (2-)26-39-61
607-316-00-3glyphosate-trimesium;

glyphosate-trimethylsulfonium
81591-81-3Xn; R22

N; R51-53
Xn; N

R: 22-51/53

S: (2-)36/37-46-61
607-317-00-9bis(2-ethylhexyl) phthalate;

di-(2-ethylhexyl) phthalate;

DEHP
204-211-0117-81-7Repr. Cat. 2; R60-61T

R: 60-61

S: 53-45
607-318-00-4dibutyl phthalate;

DBP
201-557-484-74-2Repr. Cat. 2; R61

Repr. Cat. 3; R62

N; R50
T; N

R: 61-50-62

S: 53-45-61
607-319-00-Xdeltamethrin (ISO);

(S)-α-cyano-3-phenoxybenzyl (1R, 3R)-3-(2,2-dibromovinyl)-2,2-dimethylcyclopropanecarboxylate
258-256-652918-63-5T; R23/25

N; R50-53
T; N

R: 23/25-50/53

S: (1/2-)24-28-36/37/39-38-45-60-61
607-320-00-5bis[4-(ethenyloxy)butyl] 1,3-benzenedicarboxylate413-930-0130066-57-8R43

N; R50-53
Xi; N

R: 43-50/53

S: (2-)24-37-60-61
607-321-00-0(S)-methyl-2-chloropropionate412-470-873246-45-4R10

Xn; R48/22

Xi; R36
Xn

R: 10-36-48/22

S: (2-)23-26-36
607-322-00-64-(4,4-dimethyl-3-oxo-pyrazolidin-1-yl)-benzoic acid413-120-7107144-30-9Xn; R22

N; R51-53
Xn; N

R: 22-51/53

S: (2-)22-61
607-323-00-12-(1-(2-hydroxy-3,5-di-tert-pentyl-phenyl)ethyl)-4,6-di-tert-pentylphenyl acrylate413-850-6123968-25-2R53R: 53

S: 61
607-324-00-7reaction mass of: N,N-di(hydrogenated alkyl C14-C18)phtalamic acid;

dihydrogenated alkyl (C14-C18)amine
413-800-3R53R: 53

S: 61
607-325-00-2(S)-2-chloropropionic acid411-150-529617-66-1Xn; R21/22

C; R35
C

R: 21/22-35

S: (1/2-)23-26-28-36/37/39-45
607-326-00-8reaction mass of: isobutyl hydrogen 2-(α-2,4,6-trimethylnon-2-enyl)succinate;

isobutyl hydrogen 2-(ß-2,4,6-trimetyhylnon-2-enyl)succinate
410-720-0141847-13-4Xi; R41

N; R51-53
Xi; N

R: 41-51/53

S: (2-)26-39-61
607-327-00-32-(2-iodoethyl)-1,3-propanediol diacetate411-780-0127047-77-2Xn; R22

N; R51-53
Xn; N

R: 22-51/53

S: (2-)36-61
607-328-00-9methyl 4-bromomethyl-3-methoxybenzoate410-310-170264-94-7Xi; R38-41

R43

N; R50-53
Xi; N

R: 38-41-43-50/53

S: (2-)26-36/37/39-60-61
607-329-00-4reaction mass of: sodium 2-(C12-18-n-alkyl)amino-1,4-butandioate;

sodium 2-octadecenyl-amino-1,4-butandioate
411-250-9R43Xi

R: 43

S: (2-)24-26-37/39
607-330-00-X(S)-2,3-dihydro-1H-indole-2-carboxylic acid410-860-279815-20-6Repr. Cat. 3; R62

Xn; R48/22

R43
Xn

R: 43-48/22-62

S: (2-)22-25-26-36/37
607-331-00-5reaction mass of: bis(2,2,6,6-tetramethyl-1-octyloxypiperidin-4-yl)-1,10-decanedioate;

1,8-bis[(2,2,6,6-tetramethyl-4-((2,2,6,6-tetramethyl-1-octyloxypiperidin-4-yl)-decan-1,10-dioyl)piperidin-1-yl)oxy]octane
406-750-9R53R: 53

S: 23-61
607-332-00-0cyclopentyl chloroformate411-460-050715-28-1R10

T; R23

Xn; R22-48/22

Xi; R41

R43
T

R: 10-22-23-41-43-48/22

S: (1/2-)26-36/37/39-45
607-333-00-6reaction mass of: dodecyl N-(2,2,6,6-tetramethylpiperidin-4-yl)-β-alaninate;

tetradecyl N-(2,2,6,6-tetramethylpiperidin-4-yl)-β-alaninate
405-670-1Xn; R22-48/22

C; R34

N; R50-53
C; N

R: 22-34-48/22-50/53

S: (1/2-)26-36/37/39-45-60-61
607-334-00-1ethyl 1-ethyl-6,7,8-trifluoro-1,4-dihydro-4-oxoquinoline-3-carboxylate405-880-3100501-62-0R43

R52-53
Xi

R: 43-52/53

S: (2-)24-37-61
607-335-00-7methyl (R)-2-(4-(3-chloro-5-trifluoromethyl-2-pyridyloxy)phenoxy)propionate406-250-072619-32-0Xn; R22

N; R50-53
Xn; N

R: 22-50/53

S: (2-)60-61
607-336-00-24-methyl-8-methylenetricyclo[3.3.1.13,7]dec-2-yl acetate406-560-6122760-85-4Xi; R38

R43

N; R51-53
Xi; N

R: 38-43-51/53

S: (2-)36/37-61
607-337-00-8di-tert-(C12-14)-alkylammonium 2-benzothiazolylthiosuccinate406-052-4125078-60-6R10

Xn; R22

Xi; R38-41

N; R51-53
Xn; N

R: 10-22-38-41-51/53

S: (2-)26-37/39-61
607-338-00-32-methylpropyl 2-hydroxy-2-methylbut-3-enoate406-235-972531-53-4Xi; R36/38Xi

R: 36/38

S: (2-)26-37
607-339-00-92,3,4,5-tetrachlorobenzoylchloride406-760-342221-52-3Xn; R22

C; R34

R43
C

R: 22-34-43

S: (1/2-)26-36/37/39-45
607-340-00-41,3-bis(4-benzoyl-3-hydroxyphenoxy)prop-2-yl acetate406-990-4N; R51-53N

R: 51/53

S: 61
607-341-00-X(9S)-9-amino-9-deoxyerythromycin406-790-726116-56-3Xi; R41

N; R50-53
Xi; N

R: 41-50/53

S: (2-)26-39-60-61
607-342-00-54-chlorobutyl veratrate410-950-169788-75-6R43

N; R51-53
Xi; N

R: 43-51/53

S: (2-)24-37-61
607-343-00-04,7-methanooctahydro-1H-indene-diyldimethyl bis(2-carboxybenzoate)407-410-2R53R: 53

S: 61
607-344-00-6reaction mass of: 3-(N-(3-dimethylaminopropyl)-(C4-8)perfluoroalkylsulfonamido)propionic acid;

N-[dimethyl-3-(C4-8-perfluoroalkylsulfonamido)propylammonium propionate;

3-(N-(3-dimethyl-propylammonium)-(C4-8)perfluoroalkylsulfonamido)propionic acid propionate
407-810-7Xn; R48/22Xn

R: 48/22

S: (2-)21-22-36/37
607-345-00-1potassium 2-(2,4-dichlorophenoxy)-(R)-propionate413-580-9113963-87-4Xn; R22

Xi; R38-41

R43
Xn

R: 22-38-41-43

S: (2-)24-26-37/39
607-346-00-73-icosyl-4-henicosylidene-2-oxetanone401-210-983708-14-9R53R: 53

S: 61
607-347-00-2sodium (R)-2-(2,4-dichlorophenoxy)propionate413-340-3119299-10-4Xn; R22

Xi; R38-41

R43
Xn

R: 22-38-41-43

S: (2-)22-26-36/37/39
607-348-00-8magnesium bis((R)-2-(2,4-dichlorophenoxy)propionate)413-360-2Xn; R22

Xi; R38-41

R43
Xn

R: 22-38-41-43

S: (2-)22-26-36/37/39
607-349-00-3mono-(tetrapropylammonium) hydrogen 2,2'-dithiobisbenzoate411-270-8R52-53R: 52/53

S: 61
607-350-00-9bis(4-(1,2-bis(ethoxycarbonyl)ethylamino)-3-methylcyclohexyl)methane412-060-9136210-32-7R43

R52-53
Xi

R: 43-52/53

S: (2-)36/37-61
607-351-00-4methyl O-(4-amino-3,5-dichloro-6-fluoropyridin-2-yloxy)acetate407-550-469184-17-4N; R51-53N

R: 51/53

S: 20/21-61
607-352-00-X4,4'-oxydiphthalic anhydride412-830-41823-59-2R52-53R: 52/53

S: 61
607-353-00-5reaction mass of: ethyl exo-tricyclo[5.2.1.02,6]decane-endo-2-carboxylate;

ethyl endo-tricyclo[5.2.1.02,6]decane-exo-2-carboxylate
407-520-080657-64-3Xi; R38

N; R51-53
Xi; N

R: 38-51/53

S: (2-)37-61
607-354-00-0ethyl 2-cyclohexylpropionate412-280-52511-00-4N; R51-53N

R: 51/53

S: 61
607-355-00-6p-tolyl 4-chlorobenzoate411-530-015024-10-9R43

N; R50-53
Xi; N

R: 43-50/53

S: (2-)24-37-60-61
607-356-00-1ethyl trans-2,2,6-trimethylcyclohexanecarboxylate412-540-8Xi; R38

N; R51-53
Xi; N

R: 38-51/53

S: (2-)37-61
607-357-00-7reaction mass of: trans-4-acetoxy-4-methyl-2-propyl-tetrahydro-2H-pyran;

cis-4-acetoxy-4-methyl-2-propyl-tetrahydro-2H-pyran
412-450-9131766-73-9R43Xi

R: 43

S: (2-)24-37
607-358-00-2(1S,3S,5R,6R)-(4-nitrophenylmethyl)-1-dioxo-6-phenylacetamido-penam-3-carboxylate412-670-554275-93-3R42Xn

R: 42

S: (2-)22
607-359-00-8(1S,4R,6R,7R)-(4-nitrophenylmethyl)3-methylene-1-oxo-7-phenylacetamido-cepham-4-carboxylateido-penam-3-carboxylate412-800-076109-32-5R42Xn

R: 42

S: (2-)22
607-360-00-3sodium 3-acetoacetylamino-4-methoxytolyl-6-sulfonate411-680-7133167-77-8R43Xi

R: 43

S: (2-)24-37
607-361-00-9methyl (R)-2-(4-hydroxyphenoxy)propionate411-950-496562-58-2Xi; R41

R52-53
Xi

R: 41-52/53

S: (2-)26-39-61
607-362-00-4reaction mass of: (3-methoxy)propylammonium/[tris-(2-hydroxyethyl)]ammonium 2-(2-(bis(2-hydroxyethyl)amino)ethoxycarbonylmethyl)hexadec-4-enoate;

(3-methoxy)propylammonium/[tris-(2-hydroxyethyl)]ammonium 2-(2-(bis(2-hydroxyethyl)amino)ethoxycarbonylmethyl)tetradec-4-enoate;

(3-methoxy)propylammonium/[tris-(2-hydroxyethyl)]ammonium 2-(3-methoxypropylcarbamoylmethyl)hexadec-4-enoate;

(3-methoxy)propylammonium/[tris-(2-hydroxyethyl)]ammonium 2-(3-methoxypropylcarbamoylmethyl)tetradec-4-enoate
413-500-2Xi; R38-41

N; R51-53
Xi; N

R: 38-41-51/53

S: (2-)26-37/39-61
607-363-00-Xmethyl-3-methoxyacrylate412-900-45788-17-0R43Xi

R: 43

S: (2-)24-37
607-364-00-53-phenyl-7-[4-(tetrahydrofurfuryloxy)phenyl]-1,5-dioxa-s-indacen-2,6-dione413-330-9134724-55-3R53R: 53

S: 61
607-365-00-02-(2-amino-1,3-thiazol-4-yl)-(Z)-2-methoxyiminoacetyl chloride hydrochloride410-620-7119154-86-8Xn; R22

C; R34

R43
C

R: 22-34-43

S: (1/2-)22-26-36/37/39-45
607-366-00-63,5-dimethylbenzoyl chloride413-010-96613-44-1C; R34

R43
C

R: 34-43

S: (1/2-)26-36/37/39-45
607-367-00-1potassium bis(N-carboxymethyl)-N-methyl-glycinato-(2-)N,O,O,N)-ferrate-(1-) monohydrate411-640-9153352-59-1Xn; R22Xn

R: 22

S: (2-)37
607-368-00-71-(N,N-dimethylcarbamoyl)-3-tert-butyl-5-carbethoxymethylthio-1H-1,2,4-triazole411-650-3110895-43-7T; R23/25

N; R50-53
T; N

R: 23/25-50/53

S: (1/2-)37-38-45-60-61
607-369-00-2reaction mass of: trans-(2R)-5-acetoxy-1,3-oxathiolane-2-carboxylic acid;

cis-(2R)-5-acetoxy-1,3-oxathiolane-2-carboxylic acid
411-660-8147027-04-1Xn; R22

Xi; R38-41

R43
Xn

R: 22-38-41-43

S: (2-)22-24-26-37/39
607-370-00-82-[[2-(acetyloxy)-3-(1,1-dimethyl-ethyl)-5-methylphenyl]methyl]-6-(1,1-dimethylethyl)-4-methylphenol412-210-341620-33-1N; R50-53N

R: 50/53

S: 60-61
607-371-00-33-ethyl 5-methyl 4-(2-chlorophenyl)-1,4-dihydro-2-[2-(1,3-dihydro-1,3-dioxo-(2H)isoindol-2-yl)-ethoxymethyl]-6-methyl-3,5-pyridinedicarboxylate413-410-388150-62-3R53R: 53

S: 61
607-372-00-9ethoxylated bis phenol A di-(norbornene carboxylate)412-410-0R52-53R: 52/53

S: 61
607-373-00-4(±) tetrahydrofurfuryl (R)-2-[4-(6-chloroquinoxalin-2-yloxy)phenyloxy]propionate414-200-4119738-06-6Muta. Cat. 3; R68

Repr. Cat. 2; R61

Repr. Cat. 3; R62

Xn; R22-48/22

N; R50-53
T; N

R: 61-22-48/22-62-68-50/53

S: 53-45-60-61
E
607-374-00-X5-amino-2,4,6-triiodo-1,3-benzenedicarbonyldichloride417-220-137441-29-5R43

N; R51-53
Xi; N

R: 43-51/53

S: (2-)22-36/37-61
607-375-00-5reaction mass of: cis-4-hydroxy-3-(1,2,3,4-tetrahydro-3-(4-(4-trifluoromethylbenzyloxy)phenyl)-1-naphthyl)coumarin;

trans-4-hydroxy-3-(1,2,3,4-tetrahydro-3-(4-(4-trifluoromethylbenzyloxy)phenyl)-1-naphthyl)coumarin
421-960-090035-08-8T+; R26/27/28

T; R48/23/24/25

N; R50-53
T+; N

R: 26/27/28-48/23/24/25-50/53

S: (1/2-)28-36/37/39-45-60-61
607-376-00-0benzyl 2,4-dibromobutanoate420-710-823085-60-1Repr. Cat. 3; R62

Xi; R38

R43

N; R50-53
Xn; N

R: 38-43-62-50/53

S: (2-)23-36/37-41-60-61
607-377-00-6trans-4-cyclohexyl-L-proline monohydrochloride419-160-190657-55-9Repr. Cat. 3; R62

Xn; R22

Xi; R38-41

R43
Xn

R: 22-38-41-43-62

S: (2-)22-26-36/37/39
607-378-00-1ammonium (Z)-α-methoxyimino-2-furylacetate405-990-197148-39-5F; R11F

R: 11

S: (2-)22-43
607-379-00-7reaction mass of: 2-[N-(2-hydroxyethyl)stearamido]ethyl stearate;

sodium [bis[2-(stearoyloxy)ethyl]amino]methylsulfonate;

sodium [bis(2-hydroxyethyl)amino]methylsulfonate;

N,N-bis(2-hydroxyethyl)stearamide
401-230-8R52-53R: 52/53

S: 61
607-380-00-2reaction mass of: ammonium-1,2-bis(hexyloxycarbonyl)ethanesulfonate;

ammonium-1-hexyloxycarbonyl-2-octyloxycarbonylethanesulfonate;

ammonium-2-hexyloxycarbonyl-1-octyloxycarbonylethanesulfonate
407-320-3Xi; R38-41

R52-53
Xi

R: 38-41-52/53

S: (2-)26-37/39-61
607-381-00-8reaction mass of triesters of 2,2-bis(hydroxymethyl)butanol with C7-alkanoic acids and 2-ethylhexanoic acid413-710-4R53R: 53

S: 61
607-382-00-32-((4-amino-2-nitrophenyl)amino)benzoic acid411-260-3117907-43-4Xi; R41

R43

R52-53
Xi

R: 41-43-52/53

S: (2-)24-26-37/39-61
607-383-00-9reaction mass of: 2,2,6,6-tetramethylpiperidin-4-yl-hexadecanoate;

2,2,6,6-tetramethylpiperidin-4-yl-octadecanoate
415-430-886403-32-9Xi; R41

R43

N; R50-53
Xi; N

R: 41-43-50/53

S: (2-)24-26-37/39-60-61
607-384-00-4reaction mass of: esters of C14-C15 branched alcohols with 3,5-di-t-butyl-4-hydroxyphenyl propionic acid;

C15 branched and linear alkyl 3,5-bis(1,1-dimethylethyl)-4-hydroxybenzenepropanoate;

C13 branched and linear alkyl 3,5-bis(1,1-dimethylethyl)-4-hydroxybenzenepropanoate
413-750-2171090-93-0R53R: 53

S: 61
607-385-00-XCopolymer of vinyl-alcohol and vinyl acetate partially acetilized with 4-(2-(4-formylphenyl)ethenyl)-1-methylpyridinium methylsulfate414-590-6125229-74-5N; R51-53N

R: 51/53

S: 61
607-386-00-5reaction mass of: tetradecanoic acid (42.5-47.5 %);

poly(1-7)lactate esters of tetradecanoic acid (52.5-57.5 %)
412-580-6174591-51-6Xi; R38-41

R43

N; R50-53
Xi; N

R: 38-41-43-50/53

S: (2-)24-26-37/39-60-61
607-387-00-0reaction mass of: dodecanoic acid (35-40 %);

poly(1-7)lactate esters of dodecanoic acid (60-65 %)
412-590-058856-63-6Xi; R38-41

R43

N; R50-53
Xi; N

R: 38-41-43-50/53

S: (2-)24-26-37/39-60-61
607-388-00-64-ethylamino-3-nitrobenzoic acid412-090-22788-74-1Xn; R22

R43

R52-53
Xn

R: 22-43-52/53

S: (2-)22-24-37-61
607-389-00-1trisodium N,N-bis(carboxymethyl)-3-amino-2-hydroxypropionate414-130-4119710-96-2Xn; R22Xn

R: 22

S: (2-)22
607-390-00-71,2,3,4-tetrahydro-6-nitro-quinoxaline414-270-641959-35-7Xn; R22

N; R51-53
Xn; N

R: 22-51/53

S: (2-)22-61
607-391-00-2dimethylcyclopropane-1,1-dicarboxylate414-240-26914-71-2R52-53R: 52/53

S: 61
607-392-00-82-phenoxyethyl 4-((5-cyano-1,6-dihydro-2-hydroxy-1,4-dimethyl-6-oxo-3-pyridinyl)azo)benzoate414-260-188938-37-8R53R: 53

S: 61
607-393-00-33-(cis-1-propenyl)-7-amino-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid415-750-8106447-44-3R43Xi

R: 43

S: (2-)22-24-37
607-394-00-95-methylpyrazine-2-carboxylic acid413-260-95521-55-1Xi; R41Xi

R: 41

S: (2-)26-39
607-395-00-4reaction mass of: sodium 1-tridecyl-4-allyl-(2 or 3)-sulfobutanedioate;

sodium 1-dodecyl-4-allyl-(2 or 3)-sulfobutanedioate
410-230-7C; R34

R43

N; R51-53
C; N

R: 34-43-51/53

S: (1/2-)26-36/37/39-45-61
607-396-00-Xbis(1,2,2,6,6-pentamethyl-4-piperidinyl) 2-(4-methoxybenzylidene)malonate414-840-4147783-69-5N; R50-53N

R: 50/53

S: 22-60-61
607-397-00-5reaction mass of: Ca salicylates (branched C10-14 and C18-30 alkylated);

Ca phenates (branched C10-14 and C18-30 alkylated);

Ca sulfurized phenates (branched C10-14 and C18-30 alkylated)
415-930-6R43Xi

R: 43

S: (2-)36/37
607-398-00-0ethyl N-(5-chloro-3-(4-(diethylamino)-2-methylphenylimino)-4-methyl-6-oxo-1,4-cyclohexadienyl)carbamate414-820-5125630-94-6N; R50-53N

R: 50/53

S: 60-61
607-399-00-62,2-dimethyl 3-methyl-3-butenyl propanoate415-610-6104468-21-5Xi; R38

R52-53
Xi

R: 38-52/53

S: (2-)37-61
607-400-00-Xmethyl 3-[[(dibutylamino)thioxomethyl]thio]propanoate414-400-132750-89-3N; R50-53N

R: 50/53

S: 60-61
607-401-00-5ethyl 3-hydroxy-5-oxo-3-cyclohexene-1-carboxylate414-450-488805-65-6Xi; R38-41

R43
Xi

R: 38-41-43

S: (2-)24-26-37/39
607-402-00-0methyl N-(phenoxycarbonyl)-L-valinate414-500-5153441-77-1R52-53R: 52/53

S: 61
607-403-00-6reaction mass of: bis(1S,2S,4S)-(1-benzyl-4-tert-butoxycarboxamido-2-hydroxy-5-phenyl)pentylammonium succinate;

isopropyl alcohol
414-810-0Xn; R48/22

Xi; R41

N; R50-53
Xn; N

R: 41-48/22-50/53

S: (2-)22-26-36/39-60-61
607-404-00-1reaction mass of: ((Z)-3,7-dimethyl-2,6-octadienyl)oxycarbonylpropanoic acid;

di-((E)-3,7-dimethyl-2,6-octadienyl) butandioate;

di-((Z)-3,7-dimethyl-2,6-octadienyl) butandioate;

(Z)-3,7-dimethyl-2,6-octadienyl butandioate;

((E)-3,7-dimethyl-2,6-octadienyl)oxycarbonylpropanoic acid
415-190-4R43Xi

R: 43

S: (2-)24-37
607-405-00-72-hexyldecyl-p-hydroxybenzoate415-380-7148348-12-3N; R51-53N

R: 51/53

S: 61
607-406-00-2potassium 2,5-dichlorobenzoate415-700-5184637-62-5Xn; R22

Xi; R41
Xn

R: 22-41

S: (2-)26-39
607-407-00-8ethyl 2-carboxy-3-(2-thienyl)propionate415-680-8143468-96-6Xi; R38-41

R43
Xi

R: 38-41-43

S: (2-)24-26-37/39
607-408-00-3potassium N-(4-fluorophenyl)glycinate415-710-1184637-63-6Xn; R48/22

Xi; R41

R43

R52-53
Xn

R: 41-43-48/22-52/53

S: (2-)22-26-36/37/39-61
607-409-00-9reaction mass of: (3R)-[1S-(1α, 2α, 6β-((2S)-2-methyl-1-oxo-butoxy)-8aγ)hexahydro-2,6-dimethyl-1-naphthalene]-3,5-dihydroxyheptanoic acid;

inert biomass from Aspergillus terreus
415-840-7R43

R52-53
Xi

R: 43-52/53

S: (2-)36/37-61
607-410-00-4mono[2-(dimethylamino)ethyl]monohydrogen-2-(hexadec-2-enyl)butanedioate and/or mono[2-(dimethylamino)ethyl]monohydrogen-3-(hexadec-2-enyl)butanedioate415-880-5779343-34-9Xi; R38-41

R43

N; R50-53
Xi; N

R: 38-41-43-50/53

S: (2-)24-26-37/39-60-61
607-411-00-Xoxiranemethanol, 4-methylbenzene-sulfonate, (S)-417-210-770987-78-9Carc. Cat. 2; R45

Muta. Cat. 3; R68

Xi; R41

R43

N; R51-53
T; N

R: 45-41-43-68-51/53

S: 53-45-61
607-412-00-5ethyl 2-(1-cyanocyclohexyl)acetate415-970-4133481-10-4Xn; R22-48/22

R52-53
Xn

R: 22-48/22-52/53

S: (2-)36/37-61
607-413-00-0trans-4-phenyl-L-proline416-020-196314-26-0Repr. Cat. 3; R62

R43
Xn

R: 43-62

S: (2-)22-36/37
607-414-00-6tris(2-ethylhexyl)-4,4',4''-(1,3,5-triazine-2,4,6-triyltriimino)tribenzoate402-070-188122-99-0R53R: 53

S: 61
607-415-00-1poly-(methyl methacrylate)-co-(butylmethacrylate)-co-(4-acryloxybutyl-isopropenyl-α, α-dimethylbenzyl carbamate)-co-(maleicanhydride)419-590-1F; R11

R43
F; Xi

R: 11-43

S: (2-)24-37-43
607-416-00-74-(2-carboxymethylthio)ethoxy-1-hydroxy-5-isobutyloxycarbonylamino-N-(3-dodecyloxypropyl)-2-naphthamide420-730-7N; R50-53N

R: 50/53

S: 60-61
607-418-00-82-ethylhexyl 4-aminobenzoate420-170-326218-04-2N; R50-53N

R: 50/53

S: 60-61
607-419-00-3(3'-carboxymethyl-5-(2-(3-ethyl-3H-benzothiazol-2-ylidene)-1-methyl-ethylidene)-4,4'-dioxo-2'-thioxo-(2,5')bithiazolidinyliden-3-yl)-acetic acid422-240-9166596-68-5Xi; R41

R43
Xi

R: 41-43

S: (2-)26-36/37/39
607-420-00-92,2-bis(hydroxymethyl)butanoic acid424-090-110097-02-6Xi; R41

R52-53
Xi

R: 41-52/53

S: (2-)26-39-61
607-421-00-4cypermethrin cis/trans +/- 40/60;

(RS)-α-cyano-3-phenoxybenzyl (1RS,3RS;1RS,3SR)-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate
257-842-952315-07-8Xn; R20/22

Xi; R37

N; R50-53
Xn; N

R: 20/22-37-50/53

S: (2-)24-36/37/39-60-61
607-422-00-Xα-cypermethrin257-842-967375-30-8T; R25

Xn; R48/22

Xi; R37

N; R50-53
T; N

R: 25-37-48/22-50/53

S: (2-)36/37/39-45-60-61
607-423-00-5esters of mecoprop and of mecoprop-PXn; R22

R43

N; R50-53
Xn; N

R: 22-43-50/53

S: (2-)13-36/37-60-61
A
607-424-00-0trifloxystrobin (ISO);

(E,E)-α-methoxyimino-{2-[[[[1-[3-(trifluoromethyl)phenyl]ethylidene]amino]oxy]methyl]benzeneacetic acid methyl ester
141517-21-7R43

N; R50-53
Xi; N

R: 43-50/53

S: (2-)24-37-46-60-61
607-425-00-6metalaxyl (ISO);

methyl-N-(2,6-dimethylphenyl)-N-(methoxyacetyl)-DL-alaninate
260-979-757837-19-1Xn; R22

R43

R52-53
Xn

R: 22-43-52/53

S: (2-)13-24-37-46-61
607-426-00-11,2-benzenedicarboxylic acid, dipentylester, branched and linear; [1]

n-pentyl-isopentylphthalate; [2]

di-n-pentyl phthalate; [3]

diisopentylphthalate [4]
284-032-2 [1]

- [2]

205-017-9 [3]

210-088-4 [4]
84777-06-0 [1]

- [2]

131-18-0 [3]

605-50-5 [4]
Repr. Cat. 2; R60-61

N; R50
T; N

R: 60-61-50

S: 53-45-61
607-427-00-7bromoxynil heptanoate (ISO);

2,6-dibromo-4-cyanophenyl heptanoate
260-300-456634-95-8Repr. Cat. 3; R63

Xn; R20/22

R43

N; R50-53
Xn; N

R: 20/22-43-63-50/53

S: (2-)36/37-46-60-61
607-430-00-3BBP;

benzyl butyl phthalate
201-622-785-68-7Repr. Cat. 2; R61

Repr. Cat. 3; R62

N; R50-53
T; N

R: 61-62-50/53

S: 53-45-60-61
607-431-00-9prallethrin (ISO);

ETOC;

2-methyl-4-oxo-3-(prop-2-ynyl)cyclopent-2-en-1-yl 2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate
245-387-923031-36-9T; R23

Xn; R22

N; R50-53
T; N

R: 22-23-50/53

S: (1/2-)45-60-61
607-432-00-4S-metolachlor;

reaction mass of (S)-2-chloro-N-(2-ethyl-6-methyl-phenyl)-N-(2-methoxy-1-methyl-ethyl)-acetamide (80-100 %); [1]

(R)-2-chloro-N-(2-ethyl-6-methyl-phenyl)-N-(2-methoxy-1-methyl-ethyl)-acetamide (0-20 %) [2]
- [1]

- [2]
87392-12-9 [1]

178961-20-1 [2]
R43

N; R50-53
Xi; N

R: 43-50/53

S: (2-)24-37-60-61
607-433-00-Xcypermethrin cis/trans +/- 80/20;

(RS)-α-cyano-3-phenoxybenzyl (1RS; 3RS; 1RS, 3SR)-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate
257-842-952315-07-8Xn; R22

Xi; R37/38

R43

N; R50-53
Xn; N

R: 22-37/38-43-50/53

S: (2-)36/37/39-60-61
607-434-00-5mecoprop-P [1] and its salts;

(R)-2-(4-chloro-2-methylphenoxy)propionic acid
240-539-016484-77-8Xn; R22

Xi; R41

N; R51-53
Xn; N

R: 22-41-51/53

S: (2-)13-26-37/39-46-61
607-435-00-02S-isopropyl-5R-methyl-1R-cyclohexyl 2,2-dihydroxyacetate416-810-6111969-64-3Xn; R48/22

Xi; R41

N; R51-53
Xn; N

R: 41-48/22-51/53

S: (2-)22-26-36/39-61
607-436-00-62-hydroxy-3-(2-ethyl-4-methylimidazoyl)propyl neodecanoate417-350-9Xi; R38-41

N; R50-53
Xi; N

R: 38-41-50/53

S: (2-)26-28-37/39-60-61
607-437-00-13-(4-aminophenyl)-2-cyano-2-propenoic acid417-480-6252977-62-1R43Xi

R: 43

S: (2-)22-24-37
607-438-00-7methyl-2-[(aminosulfonyl)methyl]benzoate419-010-5112941-26-1Xn; R22

Xi; R36
Xn

R: 22-36

S: (2-)22-26
607-439-00-2methyl tetrahydro-2-furancarboxylate420-670-137443-42-8Xi; R41Xi

R: 41

S: (2-)26-39
607-440-00-8methyl 2-aminosulfonyl-6-(trifluoromethyl)pyridine-3-c arboxylate421-220-7144740-59-0R43

N; R51-53
Xi; N

R: 43-51/53

S: (2-)22-24-37-61
607-441-00-33-[3-(2-dodecyloxy-5-methylphenylcarbamoyl)-4-hydroxy-1-naphthylthio]propionic acid421-490-6167684-63-1R53R: 53

S: 57-61
607-442-00-9benzyl [hydroxy-(4-phenylbutyl)phosphinyl] acetate416-050-587460-09-1Xi; R41Xi

R: 41

S: (2-)26-36/39
607-443-00-4bis(2,4-di-tert-butyl-6-methylphenyl)ethyl phosphate416-140-4145650-60-8R53R: 53

S: 61
607-444-00-Xreaction mass of: cis-1,4-dimethylcyclohexyl dibenzoate;

trans-1,4-dimethylcyclohexyl dibenzoate
416-230-335541-81-2R53R: 53

S: 61
607-445-00-5Iron (III) tris(4-methylbenzenesulfonate)420-960-877214-82-5Xi; R41Xi

R: 41

S: (2-)24-26-39
607-446-00-0methyl 2-[4-(2-chloro-4-nitrophenylazo)-3-(1-oxopropyl)amino]phenylaminopropionate416-240-8155522-12-6R43

R53
Xi

R: 43-53

S: (2-)22-24-37-61
607-447-00-6sodium 4-[4-(4-hydroxyphenylazo)phenylamino]-3-nitrobenzenesulfonate416-370-5156738-27-1R43

R52-53
Xi

R: 43-52/53

S: (2-)22-24-37-61
607-448-00-12,3,5,6-tetrafluorobenzoic acid416-800-1652-18-6Xi; R38-41Xi

R: 38-41

S: (2-)22-26-37/39
607-449-00-7reaction mass of: 4,4',4''-[(2,4,6-trioxo-1,3,5(2H,4H,6H)-triazine-1,3,5-triyl)tris[methylene(3,5,5-trimethyl-3,1-cyclohexanediyl)iminocarbonyloxy-2,1-ethanediyl(ethyl)amino]]trisbenzenediazoniumtri[bis(2-methylpropyl)naphthalenesulfonate];

4,4',4'',4'''-[[5,5'-[carbonylbis[imino(1,5,5-trimethyl-3,1-cyclohexanediyl)methylene]]-2,4,6-trioxo-1,3,5(2H,4H,6H)-triazine-1,1',3,3'-tetrayl]tetrakis[methylene(3,5,5-trimethyl-3,1-cyclohexanediyl)iminocarbonyloxy-2,1-ethanediyl(ethyl)amino]]tetrakisbenzenediazoniumtetra[bis(2-methylpropyl)naphthalenesulfonate]
417-080-1E; R2

R43

N; R50-53
E; Xi; N

R: 2-43-50/53

S: (2-)24-37-60-61
607-450-00-22-mercaptobenzothiazolyl-(Z)-(2-aminothiazol-4-yl)-2-(tert-butoxycarbonyl) isopropoxyiminoacetate419-040-989604-92-2R53R: 53

S: 61
607-451-00-84-[4-amino-5-hydroxy-3-(4-(2-sulfoxyethylsulfonyl)phenylazo)-2,7-disulfonapht-6-ylazo]-6-[3-(4-amino-5-hydroxy-3-(4-(2-sulfoxyethylsulfonyl)phenylazo)-2,7-disulfonapht-6-ylazo]phenylcarbonylamino]benzenesulfonic acid, sodium salt417-640-5161935-19-9Xi; R41

R43
Xi

R: 41-43

S: (2-)22-24-26-37/39
607-453-00-94-benzyl-2,6-dihydroxy-4-aza-heptylene bis(2,2-dimethyloctanoate)418-100-1172964-15-7R43

R53
Xi

R: 43-53

S: (2-)24-37-61
607-454-00-4reaction mass of: trans-2-(1-methylethyl)-1,3-dioxane-5-carboxylic acid;

cis-2-(1-methylethyl)-1,3-dioxane-5-carboxylic acid
418-170-3116193-72-7Xi; R41

R52-53
Xi

R: 41-52/53

S: (2-)25-26-39-61
607-455-00-X1-amino-4-(3-[4-chloro-6-(2,5-di-sulfophenylamino)-1,3,5-triazin-2-ylamino]-2,2-dimethyl-propylamino)-anthraquinone-2-sulfonic acid, sodium/lithiumsalt419-520-8172890-93-6R43Xi

R: 43

S: (2-)22-24-37
607-456-00-53-amino-4-chlorobenzoic acid, hexadecyl ester419-700-6143269-74-3N; R51-53N

R: 51/53

S: 61
607-457-00-0tetrasodium dihydrogen 1,1''-dihydroxy-8,8''-[p-phenylbis(imino-{6-[4-(2-aminoethyl)piperazin-1-yl]}-1,3,5-triazine-4,2-diyl-imino)]bis(2,2'-azonaphthalene-1',3,6-trisulfonate)420-350-1172277-97-3Xi; R41

N; R51-53
Xi; N

R: 41-51/53

S: (2-)26-39-61
607-458-00-6reaction mass of: 2-ethyl-[2,6-dibromo-4-[1-[3,5-dibromo-4-(2-hydroxyethoxy)phenyl]-1-methylethyl]phenoxy]propenoate;

2,2'-diethyl-[4,4'-bis(2,6-dibromophenoxy)-1-methylethylidene] dipropenoate;

2,2'-[(1-methylethylidene)bis[[2,6-dibromo-4,1-phenylene)oxy]ethanol]]
420-850-1N; R51-53N

R: 51/53

S: 61
607-459-00-1isopentyl 4-{2-[5-cyano-1,2,3,6-tetrahydro-1-(2-isopropoxyethoxy-carbonylmethyl)-4-methyl-2,6-dioxo-3-pyridylidene]hydrazino}benzoate418-930-4R53R: 53

S: 61
607-460-00-73-tridecyloxy-propyl-ammonium 9-octadecenoate418-990-1778577-53-0Xn; R48/22

Xi; R36/38

N; R50-53
Xn; N

R: 36/38-48/22-50/53

S: (2-)23-26-37/39-60-61
607-461-00-2reaction mass of: pentasodium 2-{4-{3-methyl-4-[6-sulfonato-4-(2-sulfonato-phenylazo)-naphthalen-1-ylazo]-phenylamino}-6-[3-(2-sulfato-ethanesulfonyl)-phenylamino]-1,3,5-triazin-2-ylamino}-benzene-1,4-disulfonate;

pentasodium 2-{4-{3-methyl-4-[7-sulfonato-4-(2-sulfonato-phenylazo)-naphthalen-1-ylazo]-phenylamino}-6-[3-(2-sulfato-ethanesulfonyl)-phenylamino]-1,3,5-triazin-2-ylamino}-benzene-1,4-disulfonate
421-160-1R52-53R: 52/53

S: 61
607-462-00-8reaction mass of: 1-hexyl acetate;

2-methyl-1-pentyl acetate;

3-methyl-1-pentyl acetate;

4-methyl-1-pentyl acetate;

other mixed linear and branched C6-alkyl acetates
421-230-188230-35-7N; R51-53N

R: 51/53

S: 61
607-463-00-33-(phenothiazin-10-yl)propionic acid421-260-5362-03-8N; R51-53N

R: 51/53

S: 24/25-61
607-464-00-9reaction mass of: 7-chloro-1-ethyl-6-fluoro-1,4-dihydro-4-oxo-quinoline-3-carboxylic acid;

5-chloro-1-ethyl-6-fluoro-1,4-dihydro-4-oxo-quinoline-3-carboxylic acid
421-280-4R52-53R: 52/53

S: 61
607-465-00-4tris(2-hydroxyethyl)ammonium 7-{4-[4-(2-cyanoamino-4-hydroxy-6-oxidopyrimidin-5-ylazo)benzamido]-2-ethoxy-phenylazo}naphthalene-1,3-disulfonate421-440-3778583-04-3R52-53R: 52/53

S: 61
607-466-00-Xreaction mass of: phenyl 1-(1-[2-chloro-5-(hexadecyloxycarbonyl)phenylcarbamoyl]-3,3-dimethyl-2-oxobutyl)-1H-2,3,3a,7a-tetrahydrobenzotriazole-5-carboxylate;

phenyl 2-(1-(2-chloro-5-(hexadecyloxycarbonyl)phenylcarbamoyl)-3,3-dimethyl-2-oxobutyl)-1H-2,3,3a,7a-tetrahydrobenzotriazole-5-carboxylate;

phenyl 3-(1-(2-chloro-5-(hexadecyloxycarbonyl)phenylcarbamoyl)-3,3-dimethyl-2-oxobutyl)-1H-2,3,3a,7a-tetrahydrobenzotriazole-5-carboxylate
421-480-1N; R51-53N

R: 51/53

S: 37/39-61
607-467-00-51,1,3,3-tetrabutyl-1,3-ditinoxydicaprylate419-430-956533-00-7Xn; R21/22-48/22

C; R34

N; R50-53
C; N

R: 21/22-34-48/22-50/53

S: (1/2-)26-36/37/39-45-60-61
607-468-00-0reaction mass of: monosodium 4-((4-(5-sulfonato-2-methoxyphenylamino)-6-chloro-1,3,5-triazine-2-yl)amino)-2-((1,4-dimethyl-6-oxido-2-oxo-5-sulfonatomethyl-1,2-dihydropyridine-3-yl)azo)benzenesulfonate;

disodium 4-((4-(5-sulfonato-2-methoxyphenylamino)-6-chloro-1,3,5-triazine-2-yl)amino)-2-((1,4-dimethyl-6-oxido-2-oxo-5-sulfonatomethyl-1,2-dihydropyridine-3-yl)azo)benzenesulfonate;

trisodium 4-((4-(5-sulfonato-2-methoxyphenylamino)-6-chloro-1,3,5-triazine-2-yl)amino)-2-((1,4-dimethyl-6-oxido-2-oxo-5-sulfonatomethyl-1,2-dihydropyridine-3-yl)azo)benzenesulfonate;

tetrasodium 4-((4-(5-sulfonato-2-methoxyphenylamino)-6-chloro-1,3,5-triazine-2-yl)amino)-2-((1,4-dimethyl-6-oxido-2-oxo-5-sulfonatomethyl-1,2-dihydropyridine-3-yl)azo)benzenesulfonate
419-450-8R43Xi

R: 43

S: (2-)22-24-37
607-469-00-6disodium 7-((4,6-bis(3-diethylaminopropylamino)-1,3,5-triazine-2-yl)amino)-4-hydroxy-3-(4-(4-sulfonatophenylazo)phenylazo)-2-naphthalene sulfonate419-460-2120029-06-3R52-53R: 52/53

S: 61
607-470-00-1potassium sodium 6,13-dichloro-3,10-bis{2-[4-[3-(2-hydroxysulphonyloxyethanesulfonyl)phenylamino]-6-(2,5-disulfonatophenylamino)-1,3,5-triazin-2-ylamino]ethylamino}benzo[5,6][1,4]oxazino[2,3-b]phenoxazine-4,11-disulfonate414-100-0154336-20-6Xi; R41

R52-53
Xi

R: 41-52/53

S: (2-)39-22-26-61
607-472-00-2ammonium iron(III) trimethylenediaminetetraacetate hemihydrate400-660-3111687-36-6N; R51-53N

R: 51/53

S: 61
607-474-00-3(4-(4-(4-dimethylaminobenzyliden-1-yl)-3-methyl-5-oxo-2-pyrazolin-1-yl)benzoic acid410-430-4117573-89-4R53R: 53

S: 61
607-475-00-9reaction mass of: tetrasodium 7-(4-[4-chloro-6-[methyl-(3-sulfonatophenyl)amino]-1,3,5-triazin-2-ylamino]-2-ureidophenylazo)naphthalene-1,3,6-trisulfonate;

tetrasodium 7-(4-[4-chloro-6-[methyl-(4-sulfonatophenyl)amino]-1,3,5-triazin-2-ylamino]-2-ureidophenylazo)naphthalene-1,3,6-trisulfonate (1:1)
412-940-2148878-18-6R43Xi

R: 43

S: (2-)22-24-37
607-476-00-4trisodium N,N-bis(carboxymethyl)-β-alanine414-070-9129050-62-0C; R34

R52-53
C

R: 34-52/53

S: (1/2-)26-36/37/39-45-61
607-478-00-5tetramethylammonium hydrogen phthalate416-900-579723-02-7T; R25

Xn; R48/22

N; R50
T; N

R: 25-48/22-50

S: (1/2-)25-36-45-61
607-479-00-0hexadecyl 4-chloro-3-[2-(5,5-dimethyl-2,4-dioxo-1,3-oxazolidin-3-yl)-4,4-dimethyl-3-oxopentamido]benzoate418-550-9168689-49-4R53R: 53

S: 61
607-480-00-61,2-benzenedicarboxylic acid;

di-C7-11-branched and linear alkylesters
271-084-668515-42-4Repr. Cat. 2; R61

Repr. Cat. 3; R62
T

R: 61-62

S: 53-45
607-487-00-4reaction mass of: disodium 4-(3-ethoxycarbonyl-4-(5-(3-ethoxycarbonyl-5-hydroxy-1-(4-sulfonatophenyl)pyrazol-4-yl)penta-2,4-dienylidene)-4,5-dihydro-5-oxopyrazol-1-yl)benzenesulfonate;

trisodium 4-(3-ethoxycarbonyl-4-(5-(3-ethoxycarbonyl-5-oxido-1-(4-sulfonatophenyl)pyrazol-4-yl)penta-2,4-dienylidene)-4,5-dihydro-5-oxopyrazol-1-yl)benzenesulfonate
402-660-9Repr. Cat. 2; R61

R52-53
T

R: 61-52/53

S: 53-45-61
607-488-00-Xethyl (2-acetylamino-5-fluoro-4-isothiocyanatophenoxy)acetate414-210-9147379-38-2N; R50-53N

R: 50/53

S: 60-61
607-489-00-5reaction mass of: 2-ethylhexyl linolenate, linoleate and oleate;

2-ethylhexyl epoxyoleate;

2-ethylhexyl diepoxylinoleate;

2-ethylhexyl triepoxylinolenate
414-890-771302-79-9R43Xi

R: 43

S: (2-)24-37
607-490-00-0N-[2-hydroxy-3-(C12-16-alkyloxy)propyl]-N-methyl glycinate415-060-7Xi; R41

R43
Xi

R: 41-43

S: (2-)24-26-37/39
607-492-00-12-(1-(3',3'-dimethyl-1'-cyclohexyl)ethoxy)-2-methyl propyl propanoate415-490-5141773-73-1N; R51-53N

R: 51/53

S: 61
607-493-00-7methyl (3aR,4R,7aR)-2-methyl-4-(1S,2R,3-triacetoxypropyl)-3a,7a-dihydro-4H-pyrano[3,4-d]oxazole-6-carboxylate415-670-378850-37-0Xi; R41Xi

R: 41

S: (2-)26-39
607-494-00-2bis(2-ethylhexyl)octylphosphonate417-170-052894-02-7N; R50-53N

R: 50/53

S: 60-61
607-495-00-8sodium 4-sulfophenyl-6-((1-oxononyl)amino)hexanoate417-550-6168151-92-6R43Xi

R: 43

S: (2-)24-37
607-496-00-32,2'-methylenebis(4,6-di-tert-butyl-phenyl)-2-ethylhexyl phosphite418-310-3126050-54-2R53R: 53

S: 61
607-497-00-9cerium oxide isostearate419-760-3R53R: 53

S: 61
607-498-00-4(E)-3,7-dimethyl-2,6-octadienylhexadecanoate421-370-33681-73-0Xi; R38

R53
Xi

R: 38-53

S: (2-)37-61
607-499-00-Xbis(dimethyl-(2-hydroxyethyl)ammonium) 1,2-ethanediyl-bis(2-hexadecenylsuccinate)421-660-1Xi; R41

R43

N; R51-53
Xi; N

R: 41-43-51/53

S: (2-)24-26-37/39-61
607-500-00-3calcium 2,2,bis[(5-tetrapropylene-2-hydroxy)phenyl]ethanoate421-670-4Xi; R38

N; R50-53
Xi; N

R: 38-50/53

S: (2-)37-60-61
607-501-00-9reaction mass of: triphenylthiophosphate and tertiary butylated phenyl derivatives421-820-9192268-65-8R53R: 53

S: 61
607-502-00-4(N-benzyl-N,N,N-tributyl)ammonium 4-dodecylbenzenesulfonate422-200-0178277-55-9C; R34

Xn; R22

N; R51-53
C; N

R: 22-34-51/53

S: (1/2-)26-36/37/39-45-61
607-503-00-X2,4,6-tri-n-propyl-2,4,6-trioxo-1,3,5,2,4,6-trioxatriphosphorinane422-210-568957-94-8C; R34C

R: 34

S: (1/2-)26-36/37/39-45
607-505-00-0pentasodium 7-(4-(4-(5-amino-4-sulfonato-2-(4-((2-(sulfonato-ethoxy)sulfonyl)phenylazo)phenylamino)-6-chloro-1,3,5-triazin-2-yl)amino-2-ureidophenylazo)naphtalene-1,3,6-trisulfonate422-930-1R52-53R: 52/53

S: 22-61
607-506-00-6reaction mass of: strontium (4-chloro-2-((4,5-dihydro-3-methyl-5-oxo-1-(3-sulfonatophenyl)-1H-pyrazol-4-yl)azo)-5-methyl)benzenesulfonate;

disodium (4-chloro-2-((4,5-dihydro-3-methyl-5-oxo-1-(3-sulfonatophenyl)-1H-pyrazol-4-yl)azo)-5-methyl)benzenesulfonate
422-970-8N; R51-53N

R: 51/53

S: 22-61
607-507-00-1potassium,sodium 2,4-diamino-3-[4-(2-sulfonatoethoxysulfonyl)phenylazo]-5-[4-(2-sulfonatoethoxysulfonyl)-2-sulfonatophenylazo]-benzenesulfonate422-980-2187026-95-5Xi; R41Xi

R: 41

S: (2-)22-26-39
607-508-00-7disodium 3,3'-[iminobis[sulfonyl-4,1-phenylene-(5-hydroxy-3-methylpyrazole-1,4-diyl)azo-4,1-phenylenesulfonylimino-(4-amino-6-hydroxypyrimidine-2,5-diyl)azo-4,1-phenylenesulfonylimino(4-amino-6-hydroxypyrimidine-2,5-diyl)azo]bis(benzenesulfonate)]423-110-4Xi; R41Xi

R: 41

S: (2-)22-26-39
607-512-00-9trisodium 2,4-diamino-3,5-bis-[4-(2-sulfonatoethoxy)sulfonyl)phenylazo]benzenesulfonate423-970-0182926-43-8R52-53R: 52/53

S: 22-61
607-513-00-4reaction mass of: Trisodium 4-benzoylamino-6-(6-ethenesulfonyl-1-sulfato-naphthalen-2-ylazo)-5-hydroxynaphthalene-2,7-disulfonate;

5-(benzoylamino)-4-hydroxy-3-((1-sulfo-6-((2-(sulfooxy)ethyl)sulfonyl)-2-naphthyl)azo)naphthalene-2,7-disulfonic acid sodium salt;

5-(benzoylamino)-4-hydroxy-3-((1-sulfo-6-((2-(sulfooxy)ethyl)sulfonyl)-2-naphthyl)azo)naphthalene-2,7-disulfonic acid
423-200-3Xi; R41

R43

R52-53
Xi

R: 41-43-52/53

S: (2-)22-26-36/37/39-61
607-515-00-5reaction mass of: disodium hexyldiphenyl ether disulphonate;

disodium dihexyldiphenyl ether disulphonate
429-650-7147732-60-3Xi; R36

N; R51-53
Xi; N

R: 36-51/53

S: (2-)26-61
607-516-00-0N,N'-bis(trifluoroacetyl)-S,S'-bis L-homocysteine429-670-6105996-54-1Xi; R41

R43
Xi

R: 41-43

S: (2-)24-26-37/39
607-517-00-6(S)-α-(acetylthio)benzenepropanoic acid430-300-076932-17-7Xn; R22

Xi; R41

R43
Xn

R: 22-41-43

S: (2-)22-26-36/37/39
607-526-00-5cartap (ISO);

1,3-bis(carbamoylthio)-2-(dimethylamino)propane
15263-53-3N; R50-53N

R: 50/53

S: 60-61
607-527-00-0reaction mass of: 1-(1'H,1'H,2'H,2'H-tridecafluorooctyl)-12-(1''H,1''H,2''H,2''H-tridecafluorooctyl)dodecanedioate;

1-(1'H,1'H,2'H,2'H-tridecafluorooctyl)-12-(1''H,1''H,2''H,2''H-heptdecafluorodecyl)dodecanedioate;

1-(1'H,1'H,2'H,2'H-tridecafluorooctyl)-12-(1''H,1''H,2''H,2''H-heneicosafluorododecyl)dodecanedioate;

1-(1'H,1'H,2'H,2'H-tridecafluorooctyl)-12-(1''H,1''H,2''H,2''H-pentacosafluorotetradecyl)dodecanedioate;

1-(1'H,1'H,2'H,2'H-heptadecafluorodecyl)-12-(1''H,1''H,2''H,2''H-heptadecafluorodecyl)dodecanedioate;

1-(1'H,1'H,2'H,2'H-heptadecafluorodecyl)-12-(1''H,1''H,2''H,2''H-heneicosafluorododecyl)dodecanedioate
423-180-6Xn; R48/22Xn

R: 48/22

S: (2-)36
608-001-00-3acetonitrile;

cyanomethane
200-835-275-05-8F; R11

Xn; R20/21/22

Xi; R36
F; Xn

R: 11-20/21/22-36

S: (2-)16-36/37
608-002-00-9trichloroacetonitrile208-885-7545-06-2T; R23/24/25

N; R51-53
T; N

R: 23/24/25-51/53

S: (1/2-)45-61
608-003-00-4acrylonitrile203-466-5107-13-1F; R11

Carc. Cat. 2; R45

T; R23/24/25

Xi; R37/38-41

R43

N; R51-53
F; T; N

R: 45-11-23/24/25-37/38-41-43-51/53

S: - 53-45-61
T; R23/24/25: C ≥ 1 %

Xn; R20/21/22: 0,2 % ≤ C < 1 %
D E
608-004-00-X2-hydroxy-2-methylpropionitrile;

2-cyanopropan-2-ol;

acetone cyanohydrin
200-909-475-86-5T+; R26/27/28

N; R50-53
T+; N

R: 26/27/28-50/53

S: (1/2-)7/9-27-45-60-61
608-005-00-5n-butyronitrile203-700-6109-74-0R10 ⊗

T; R23/24/25
T

R: 10-23/24/25

S: (1/2-)45
608-006-00-0bromoxynil (ISO)

3,5-dibromo-4-hydroxybenzonitrile;

bromoxynil phenol
216-882-71689-84-5Repr. Cat. 3; R63

T+; R26

T; R25

R43

N; R50-53
T+; N

R: 25-26-43-63-50/53

S: (1/2-)27/28-36/37-45-63-60-61
N; R50-53: C ≥ 2,5 %

N; R51-53: 0,25 % ≤ C < 2,5 %

R52-53: 0,025 % ≤ C < 0,25 %
608-007-00-6ioxynil (ISO)

4-hydroxy-3,5-diiodobenzonitrile
216-881-11689-83-4Repr. Cat. 3; R63

T; R23/25

Xn; R21-48/22

Xi; R36

N; R50-53
T; N

R: 21-23/25-36-48/22-63-50/53

S: (1/2-)36/37-45-60-61-63
N; R50-53: C ≥ 2,5 %

N; R51-53: 0,25 % ≤ C < 2,5 %

R52-53: 0,025 % ≤ C < 0,25 %
608-008-00-1chloroacetonitrile203-467-0107-14-2T; R23/24/25

N; R51-53
T; N

R: 23/24/25-51/53

S: (1/2-)45-61
608-009-00-7malononitrile203-703-2109-77-3T; R23/24/25

N; R50-53
T; N

R: 23/24/25-50/53

S: (1/2-)23-27-45-60-61
608-010-00-2methacrylonitrile;

2-methyl-2-propene nitrile
204-817-5126-98-7F; R11

T; R23/24/25

R43
F; T

R: 11-23/24/25-43

S: (1/2-)9-16-18-29-45
T; R23/24/25: C ≥ 1 %

Xn; R20/21/22: 0,2 % ≤ C < 1 %

R43: C ≥ 0,2 %
D
608-011-00-8oxalonitrile;

cyanogen
207-306-5460-19-5F; R11 ⊗

T; R23

N; R50-53
F; T; N

R: 11-23-50/53

S: (1/2-)23-45-60-61
608-012-00-3benzonitrile202-855-7100-47-0Xn; R21/22Xn

R: 21/22

S: (2-)23
608-013-00-92-chlorobenzonitrile212-836-5873-32-5Xn; R21/22

Xi; R36
Xn

R: 21/22-36

S: (2-)23
608-014-00-4chlorothalonil (ISO);

tetrachloroisophthalonitrile
217-588-11897-45-6Carc. Cat. 3; R40

T+; R26

Xi; R41

Xi; R37

R43

N; R50-53
T+; N

R: 26-37-40-41-43-50/53

S: (2-)28-36/37/39-45-60-61
N; R50-53: C ≥ 2,5 %

N; R51-53: 0,25 % ≤ C < 2,5 %

R52-53: 0,025 % ≤ C < 0,25 %
608-015-00-Xdichlobenil (ISO);

2,6-dichlorobenzonitrile
214-787-51194-65-6Xn; R21

N; R51-53
Xn; N

R: 21-51/53

S: (2-)36/37-61
608-016-00-51,4-Dicyano-2,3,5,6-tetra-chloro-benzene401-550-81897-41-2R43

N; R50-53
Xi; N

R: 43-50/53

S: (2-)24-37-60-61
608-017-00-0bromoxynil octanoate (ISO);

2,6-dibromo-4-cyanophenyl octanoate
216-885-31689-99-2Repr. Cat. 3; R63

T; R23

Xn; R22

R43

N; R50-53
T; N

R: 22-23-43-63-50/53

S: (1/2-)36/37-45-63-60-61
N; R50-53: C ≥ 2,5 %

N; R51-53: 0,25 % ≤ C < 2,5 %

R52-53: 0,025 % ≤ C < 0,25 %
608-018-00-6ioxynil octanoate (ISO);

4-cyano-2,6-diiodophenyl octanoate
223-375-43861-47-0Repr. Cat. 3; R63

T; R25

Xi; R36

R43

N; R50-53
T; N

R: 25-36-43-63-50/53

S: (1/2-)26-36/37-45-60-61
N; R50-53: C ≥ 2,5 %

N; R51-53: 0,25 % ≤ C < 2,5 %

R52-53: 0,025 % ≤ C < 0,25 %
608-019-00-12,2'-dimethyl-2,2'-azodipropiononitrile;

ADZN
201-132-378-67-1E; R2

F; R11

Xn; R20/22

R52-53
E; Xn

R: 2-11-20/22-52/53

S: (2-)39-41-47-61
608-021-00-23-(2-(diaminomethyleneamino)thiazol-4-ylmethylthio)propionitrile403-710-276823-93-3Xn; R22

R43
Xn

R: 22-43

S: (2-)22-24-37
608-022-00-83,7-dimethyloctanenitrile403-620-340188-41-8Xi; R38

R43

N; R51-53
Xi; N

R: 38-43-51/53

S: (2-)36/37-61
608-023-00-3fenbuconazole (ISO)

4-(4-chlorophenyl)-2-phenyl-2-[(1H-1,2,4-triazol-1-yl)methyl]butanenitrile
406-140-2114369-43-6N; R50-53N

R: 50/53

S: 60-61
608-024-00-92-(4-(N-butyl-N-phenethylamino)phenyl)ethylene-1,1,2-tricarbonitrile407-650-897460-76-9R53R: 53

S: 61
608-025-00-42-nitro-4,5-bis(benzyloxy)phenylacetonitrile410-970-0117568-27-1R53R: 53

S: 61
608-026-00-X3-cyano-3,5,5-trimethylcyclohexanone411-490-47027-11-4Xn; R22-48/22

R43

R52-53
Xn

R: 22-43-48/22-52/53

S: (2-)36/37-61
608-027-00-5reaction mass of: 3-(4-ethylphenyl)-2,2-dimethylpropanenitrile;

3-(2-ethylphenyl)-2,2-dimethylpropanenitrile;

3-(3-ethylphenyl)-2,2-dimethylpropanenitrile
412-660-0N; R51-53N

R: 51/53

S: 61
608-028-00-04-(2-cyano-3-phenylamino-acryloyloxymethyl)-cyclohexyl-methyl 2-cyano-3-phenylamino)-acrylate413-510-7147374-67-2Xn; R48/20/21

R43

N; R51-53
Xn; N

R: 43-48/20/21-51/53

S: (2-)36/37-61
608-029-00-61,2-dihydro-6-hydroxy-4-methyl-1-[3-(1-methylethoxy)propyl]-2-oxo-3-pyridinecarbonitrile411-990-268612-94-2R43Xi

R: 43

S: (2-)24-37
608-030-00-1N-acetyl-N-[5-cyano-3-(2-dibutylamino-4-phenylthyazol-5-yl-methylene)-4-methyl-2,6-dioxo-1,2,3,6-tetrahydropyridin-1-yl]benzamide412-340-0147741-93-3N; R50-53N

R: 50/53

S: 60-61
608-031-00-72-benzyl-2-methyl-3-butenitrile407-870-497384-48-0Xn; R22

R52-53
Xn

R: 22-52/53

S: (2-)61
608-033-00-8N-butyl-3-(2-chloro-4-nitrophenylhydrazono)-1-cyano-2-methylprop-1-ene-1,3-dicarboximide407-970-875511-91-0R43

R52-53
Xi

R: 43-52/53

S: (2-)24-37-61
608-034-00-3chlorfenapyr;

4-bromo-2-(4-chlorophenyl)-1-ethoxymethyl-5-trifluoromethylpyrrole-3-carbonitrile
122453-73-0T; R23

Xn; R22

N; R50-53
T; N

R: 22-23-50/53

S: (1/2-)13-36/37-45-60-61
608-035-00-9(±)-α-[(2-acetyl-5-methylphenyl)-amino]-2,6-dichlorobenzene-aceto-nitrile419-290-9R43

R53
Xi

R: 43-53

S: (2-)24-37-61
608-036-00-43-(2-{4-[2-(4-cyanophenyl)vinyl]phenyl}vinyl)benzonitrile419-060-879026-02-1R53R: 53

S: 61
608-037-00-Xreaction mass of: (E)-2,12-tridecadiennitrile;

(E)-3,12-tridecadiennitrile;

(Z)-3,12-tridecadiennitrile
422-190-8N; R50-53N

R: 50/53

S: 60-61
608-038-00-52,2,4-trimethyl-4-phenyl-butane-nitrile422-580-875490-39-0Xn; R22

N; R51-53
Xn; N

R: 22-51/53

S: (2-)61
608-039-00-02-phenylhexanenitrile423-460-83508-98-3Xn; R22

N; R50-53
Xn; N

R: 22-50/53

S: (2-)23-60-61
608-040-00-64,4'-dithiobis(5-amino-1-(2,6-dichloro-4-(trifluoromethyl)phenyl)-1H-pyrazole-3-carbonitrile)423-490-1130755-46-3N; R50-53N

R: 50/53

S: 60-61
608-041-00-14'-((2-butyl-4-oxo-1,3-diazaspiro[4.4]non-1-ene-3-yl)methyl)(1,1'-biphenyl)-2-carbonitrile423-500-4138401-24-8N; R50-53N

R: 50/53

S: 60-61
608-043-00-23-(cis-3-hexenyloxy)propanenitril415-220-6142653-61-0T; R23

Xn; R22

N; R50-53
T; N

R: 22-23-50/53

S: (1/2-)13-36/37-45-60-61
608-065-00-2salts of bromoxynil with the exception of those specified elsewhere in this AnnexRepr. Cat. 3; R63

T+; R26

T; R25

R43

N; R50-53
T+; N

R: 25-26-43-50/53

S: (1/2-)27/28-36/37-45-63-60-61
N; R50-53: C ≥ 2,5 %

N; R51-53: 0,25 % ≤ C < 2,5 %

R52-53: 0,025 % ≤ C < 0,25 %
A
608-066-00-8salts of ioxynil with the exception of those specified elsewhere in this AnnexRepr. Cat. 3; R63

T; R23/25

Xn; R21-48/22

Xi; R36

N; R50-53
T; N

R: 21-23/25-36-48/22-63-50/53

S: (1/2-)36/37-45-63-60-61
N; R50-53: C ≥ 2,5 %

N; R51-53: 0,25 % ≤ C < 2,5 %

R52-53: 0,025 % ≤ C < 0,25 %
A
609-001-00-61-nitropropane203-544-9108-03-2R10

Xn; R20/21/22
Xn

R: 10-20/21/22

S: (2-)9
Xn; R20/21/22: C ≥ 5 %
609-002-00-12-nitropropane201-209-179-46-9R10

Carc. Cat. 2; R45

Xn; R20/22
T

R: 45-10-20/22

S: 53-45
E
609-003-00-7nitrobenzene202-716-098-95-3Carc. Cat. 3; R40

Repr. Cat. 3; R62

T; R23/24/25-48/23/24

N; R51-53
T; N

R: 23/24/25-40-48/23/24-51/53-62

S: (1/2-)28-36/37-45-61
609-004-00-2dinitrobenzene; [1]

1,4-dinitrobenzene; [2]

1,3-dinitrobenzene; [3]

1,2-dinitrobenzene [4]
246-673-6 [1]

202-833-7 [2]

202-776-8 [3]

208-431-8 [4]
25154-54-5 [1]

100-25-4 [2]

99-65-0 [3]

528-29-0 [4]
T+; R26/27/28

R33

N; R50-53
T+; N

R: 26/27/28-33-50/53

S: (1/2-)28-36/37-45-60-61
609-005-00-81,3,5-trinitrobenzene202-752-799-35-4E; R2 ⊗

T+; R26/27/28

R33

N; R50-53
E; T+; N

R: 2-26/27/28-33-50/53

S: (1/2-)35-45-60-61
609-006-00-34-nitrotoluene202-808-099-99-0T; R23/24/25

R33

N; R51-53
T; N

R: 23/24/25-33-51/53

S: (1/2-)28-37-45-61
609-007-00-92,4-dinitrotoluene;

dinitrotoluene, technical grade; [1]

dinitrotoluene [2]
204-450-0 [1]

246-836-1 [2]
121-14-2 [1]

25321-14-6 [2]
Carc. Cat. 2; R45

Muta. Cat. 3; R68

Repr. Cat. 3; R62

T; R23/24/25

Xn; R48/22

N; R51-53
T; N

R: 45-23/24/25-48/22-62-68-51/53

S: 53-45-61
E
609-008-00-42,4,6-trinitrotoluene;

TNT
204-289-6118-96-7E; R2

T; R23/24/25

R33

N; R51-53
E; T; N

R: 2-23/24/25-33-51/53

S: (1/2-)35-45-61
609-009-00-X2,4,6-trinitrophenol;

picric acid
201-865-988-89-1E; R2 ⊗

R4

T; R23/24/25
E; T

R: 2-4-23/24/25

S: (1/2-)28-35-37-45
609-010-00-5salts of picric acidE; R3

T; R23/24/25
E; T

R: 3-23/24/25

S: (1/2-)28-35-37-45
A
609-011-00-02,4,6-trinitroanisole606-35-9E; R2

Xn; R20/21/22

N; R51-53
E; Xn; N

R: 2-20/21/22-51/53

S: (2-)35-61
609-012-00-62,4,6-trinitro-m-cresol210-027-1602-99-3E; R2

R4

Xn; R20/21/22
E; Xn

R: 2-4-20/21/22

S: (2-)35
609-013-00-12,4,6-trinitro-m-xylene211-187-5632-92-8E; R2

Xn; R20/21/22

R33
E; Xn

R: 2-20/21/22-33

S: (2-)35
609-015-00-24-nitrophenol;

p-nitrophenol
202-811-7100-02-7Xn; R20/21/22

R33
Xn

R: 20/21/22-33

S: (2-)28
609-016-00-8dinitrophenol (reaction mass of isomers); [1]

2,4(or 2,6)-dinitrophenol [2]
247-096-2 [1]

275-732-9 [2]
25550-58-7 [1]

71629-74-8 [2]
T; R23/24/25

R33

N; R50-53
T; N

R: 23/24/25-33-50/53

S: (1/2-)28-37-45-60-61
609-018-00-92,4,6-trinitroresorcinol;

styphnic acid
201-436-682-71-3E; R2 ⊗

R4

Xn; R20/21/22
E; Xn

R: 2-4-20/21/22

S: (2-)35
609-019-00-4lead 2,4,6-trinitro-m-phenylene dioxide;

lead 2,4,6-trinitroresorcinoxide;

lead styphnate
239-290-015245-44-0E; R3

Repr. Cat. 1; R61

Repr. Cat. 3; R62

Xn; R20/22

R33

N; R50-53
E; T; N

R: 61-3-20/22-33-50/53-62

S: 53-45-60-61
E

1
609-020-00-XDNOC (ISO);

4,6-dinitro-o-cresol
208-601-1534-52-1Muta. Cat. 3; R68

T+; R26/27/28

Xi; R38-41

R43

R44

N; R50-53
T+; N

R: 26/27/28-38-41-43-44-50/53-68

S: (1/2-)36/37-45-60-61
609-021-00-5sodium salt of DNOC;

sodium 4,6-dinitro-o-cresolate; [1]

potassium salt of DNOC;

potassium 4,6-dinitro-o-cresolate [2]
219-007-7 [1]

[2]
2312-76-7 [1]

5787-96-2 [2]
T; R23/24/25

R33

N; R50-53
T; N

R: 23/24/25-33-50/53

S: (1/2-)13-45-60-61
609-022-00-0ammonium salt of DNOC;

ammonium 4,6-dinitro-o-tolyl oxide
221-037-02980-64-5T+; R26/27/28

R33

N; R50-53
T+; N

R: 26/27/28-33-50/53

S: (1/2-)13-28-45-60-61
609-023-00-6dinocap (ISO)254-408-039300-45-3Repr. Cat. 2; R61

Xn; R20-48/22

Xi; R38

R43

N; R50-53
T; N

R: 61-20-22-38-43-48/22-50/53

S: 53-45-60-61
E
609-024-00-1binapacryl (ISO);

2-sec-butyl-4,6-dinitrophenyl-3-methylcrotonate
207-612-9485-31-4Repr. Cat. 2; R61

Xn; R21/22

N; R50-53
T; N

R: 61-21/22-50/53

S: 53-45-60-61
E
609-025-00-7dinoseb (ISO);

6-sec-butyl-2,4-dinitrophenol
201-861-788-85-7R44

T; R24/25

Repr. Cat. 2; R61

Repr. Cat. 3; R62

Xi; R36

N; R50-53
T; N

R: 61-62-24/25-36-44-50/53

S: 53-45-60-61
E
609-026-00-2salts and esters of dinoseb, with the exception of those specified elsewhere in this AnnexR44

Repr. Cat. 2; R61

Repr. Cat. 3; R62

T; R24/25

Xi; R36

N; R50-53
T; N

R: 61-62-24/25-36-44-50/53

S: 53-45-60-61
AE
609-027-00-8dinocton;

reaction mass of isomers: methyl 2-octyl-4,6-dinitrophenyl carbonate, methyl 4-octyl-2,6-dinitrophenyl carbonate
63919-26-6Xn; R22

N; R50-53
Xn; N

R: 22-50/53

S: (2-)60-61
609-028-00-3dinex (ISO);

2-cyclohexyl-4,6-dinitrophenol
205-042-5131-89-5T; R23/24/25

N; R50-53
T; N

R: 23/24/25-50/53

S: (1/2-)13-45-60-61
609-029-00-9salts and esters of dinexT; R23/24/25

N; R50-53
T; N

R: 23/24/25-50/53

S: (1/2-)13-45-60-61
A
609-030-00-4dinoterb (ISO);

2-tert-butyl-4,6-dinitrophenol
215-813-81420-07-1Repr. Cat. 2; R61

T+; R28

T; R24

R44

N; R50-53
T+; N

R: 61-24-28-44-50/53

S: 53-45-60-61
E
609-031-00-Xsalts and esters of dinoterbRepr. Cat. 2; R61

T+; R28

T; R24

N; R50-53
T+; N

R: 61-24-28-50/53

S: 45-53-60-61
AE
609-032-00-5bromofenoxim (ISO);

3,5-dibromo-4-hydroxybenzaldehyde-O-(2,4-dinitrophenyl)-oxime
236-129-613181-17-4Xn; R22

N; R50-53
Xn; N

R: 22-50/53

S: (2-)25-60-61
609-033-00-0dinosam (ISO);

2-(1-methylbutyl)-4,6-dinitrophenol
4097-36-3T; R23/24/25

N; R50-53
T; N

R: 23/24/25-50/53

S: (1/2-)13-45-60-61
609-034-00-6salts and esters of dinosamT; R23/24/25

N; R50-53
T; N

R: 23/24/25-50/53

S: (1/2-)13-45-60-61
A
609-035-00-1nitroethane201-188-979-24-3R10

Xn; R20/22
Xn

R: 10-20/22

S: (2-)9-25-41
Xn; R20/22: C ≥ 12,5 %
609-036-00-7nitromethane200-876-675-52-5R5-10

Xn; R22
Xn

R: 5-10-22

S: (2-)41
Xn; R22: C ≥ 12,5 %
609-037-00-25-nitroacenaphthene210-025-0602-87-9Carc. Cat. 2; R45T

R: 45

S: 53-45
609-038-00-82-nitronaphthalene209-474-5581-89-5Carc. Cat. 2; R45

N; R51-53
T; N

R: 45-51/53

S: 53-45-61
609-039-00-34-nitrobiphenyl202-204-792-93-3Carc. Cat. 2; R45

N; R51-53
T; N

R: 45-51/53

S: 53-45-61
609-040-00-9nitrofen (ISO);

2,4-dichlorophenyl 4-nitrophenyl ether
217-406-01836-75-5Carc. Cat. 2; R45

Repr. Cat. 2; R61

Xn; R22

N; R50-53
T; N

R: 45-61-22-50/53

S: 53-45-60-61
E
609-041-00-42,4-dinitrophenol200-087-751-28-5T; R23/24/25

R33

N; R50
T; N

R: 23/24/25-33-50

S: (1/2-)28-37-45-61
609-042-00-Xpendimethalin (ISO);

N-(1-ethylpropyl)-2,6-dinitro-3,4-xylidine
254-938-240487-42-1R43

N; R50-53
Xi; N

R: 43-50/53

S: (2-)24-29-37-60-61
609-043-00-5quintozene (ISO);

pentachloronitrobenzene
201-435-082-68-8R43

N; R50-53
Xi; N

R: 43-50/53

S: (2-)13-24-37-60-61
609-044-00-0tecnazene (ISO);

1,2,4,5-tetrachloro-3-nitrobenzene
204-178-2117-18-0Xn; R22

R43

N; R50-53
Xn; N

R: 22-43-50/53

S: (2-)24-37-60-61
609-045-00-6reaction mass of: 4,6-dinitro-2-(3-octyl)phenyl methyl carbonate and 4,6-dinitro-2-(4-octyl)phenyl methyl carbonate;

dinocton-6
8069-76-9Xn; R22

N; R50-53
Xn; N

R: 22-50/53

S: (2-)60-61
609-046-00-1trifluralin (ISO) (containing < 0.5 ppm NPDA);

α,α,α-trifluoro-2,6-dinitro-N,N-dipropyl-p-toluidine (containing < 0.5 ppm NPDA);

2,6-dinitro-N,N-dipropyl-4-trifluoromethylaniline (containing < 0.5 ppm NPDA);

N,N-dipropyl-2,6-dinitro-4-trifluoromethylaniline (containing < 0.5 ppm NPDA)
216-428-81582-09-8Xi; R36

R43

N; R50-53
Xi; N

R: 36-43-50/53

S: (2-)24-37-60-61
609-047-00-72-nitroanisole202-052-191-23-6Carc. Cat. 2; R45

Xn; R22
T

R: 45-22

S: 53-45
E
609-048-00-2sodium 3-nitrobenzenesulphonate204-857-3127-68-4Xi; R36

R43
Xi

R: 36-43

S: (2-)24-26-37
609-049-00-82,6-dinitrotoluene210-106-0606-20-2Carc. Cat. 2; R45

Muta. Cat. 3; R68

Repr. Cat. 3; R62

T; R23/24/25

Xn; R48/22

R52-53
T

R: 45-23/24/25-48/22-62-68-52/53

S: 53-45-61
E
609-050-00-32,3-dinitrotoluene210-013-5602-01-7Carc. Cat. 2; R45

Muta. Cat. 3; R68

Repr. Cat. 3; R62

T; R23/24/25

Xn; R48/22

N; R50-53
T; N

R: 45-23/24/25-48/22-62-68-50/53

S: 53-45-60-61
E
609-051-00-93,4-dinitrotoluene210-222-1610-39-9Carc. Cat. 2; R45

Muta. Cat. 3; R68

Repr. Cat. 3; R62

T; R23/24/25

Xn; R48/22

N; R51-53
T; N

R: 45-23/24/25-48/22-62-68-51/53

S: 53-45-61
E
609-052-00-43,5-dinitrotoluene210-566-2618-85-9Carc. Cat. 2; R45

Muta. Cat. 3; R68

Repr. Cat. 3; R62

T; R23/24/25

Xn; R48/22

R52-53
T

R: 45-23/24/25-48/22-62-68-52/53

S: 53-45-61
E
609-053-00-Xhydrazine-trinitromethane414-850-9E; R3

O; R8

Carc. Cat. 2; R45

T; R23/25

R43
E; T

R: 45-3-8-23/25-43

S: 53-45
E
609-054-00-52,3-dinitrophenol; [1]

2,5-dinitrophenol; [2]

2,6-dinitrophenol; [3]

3,4-dinitrophenol; [4]

salts of dinitrophenol [5]
200-628-7 [1]

206-348-1 [2]

209-357-9 [3]

209-415-3 [4]

[5]
66-56-8 [1]

329-71-5 [2]

573-56-8 [3]

577-71-9 [4]

[5]
T; R23/24/25

R33

N; R51-53
T; N

R: 23/24/25-33-51

S: (1/2-)28-37-45-61
609-055-00-02,5-dinitrotoluene210-581-4619-15-8Carc. Cat. 2; R45

Muta. Cat. 3; R68

Repr. Cat. 3; R62

T; R23/24/25

Xn; R48/22

N; R51-53
T; N

R: 45-23/24/25-48/22-62-68-51/53

S: 53-45-61
E
609-056-00-62,2-dibromo-2-nitroethanol412-380-969094-18-4E; R2

Carc. Cat. 3; R40

Xn; R22-48/22

C; R35

R43

N; R50-53
E; C; N

R: 2-22-35-40-43-48/22-50/53

S: (1/2-)23-26-36/37/39-45-60-61
Xn; R22: C ≥ 10 %

C; R35: C ≥ 10 %

C; R34: 5 % ≤ C < 10 %

Xi; R36/37/38: 1 % ≤ C < 5 %
609-057-00-13-chloro-2,4-difluoronitrobenzene411-980-83847-58-3Xn; R22

C; R34

R43

N; R50-53
C; N

R: 22-34-43-50/53

S: (1/2-)22-26-28-36/37/39-45-60-61
609-058-00-72-nitro-2-phenyl-1,3-propanediol410-360-45428-02-4T; R39-48/25

Xn; R21/22

Xi; R41

R43

N; R51-53
T; N

R: 21/22-39-41-43-48/25-51/53

S: 53-45-61
609-059-00-22-chloro-6-(ethylamino)-4-nitrophenol411-440-1131657-78-8Xn; R22

R43

N; R51-53
Xn; N

R: 22-43-51/53

S: (2-)22-24-37/39-61
609-060-00-84-[(3-hydroxypropyl)amino]-3-nitrophenol406-305-992952-81-3Xi; R38

N; R51-53
Xi; N

R: 38-51/53

S: (2-)37-61
609-061-00-3(E,Z)-4-chlorophenyl(cyclopropyl)ketone O-(4-nitrophenylmethyl)oxime406-100-494097-88-8R43

N; R50-53
Xi; N

R: 43-50/53

S: (2-)24-37-60-61
609-062-00-92-bromo-2-nitropropanol407-030-724403-04-1T; R24

Xn; R22-48/22

C; R34

R43

N; R50-53
T; N

R: 22-24-34-43-48/22-50/53

S: (1/2-)26-36/37/39-45-60-61
609-063-00-42-[(4-chloro-2-nitrophenyl)amino]ethanol413-280-859320-13-7Xn; R22

N; R51-53
Xn; N

R: 22-51/53

S: (2-)22-61
609-064-00-Xmesotrione (ISO);

2-[4-(methylsulfonyl)-2-nitrobenzoyl]-1,3-cyclohexanedione
104206-82-8N; R50-53N

R: 50/53

S: 60-61
609-065-00-52-nitrotoluene201-853-388-72-2Carc. Cat. 2; R45

Muta. Cat. 2; R46

Repr. Cat. 3; R62

Xn; R22

N; R51-53
T; N

R: 45-46-22-62-51/53

S: 53-45-61
E
609-066-00-0lithium sodium 3-amino-10-{4-(10-amino-6,13-dichloro-4,11-disulfonatobenzo[5,6][1,4]oxazino[2,3-b]phenoxazine-3-ylamino)-6-[methyl(2-sulfonato-ethyl)amino]-1,3,5-triazin-2-ylamino}-6,13-dichlorobenzo[5,6][1,4]oxazino[2,3-b]phenoxazine-4,11-disulfonate418-870-9154212-58-5Xn; R20/21/22-68/20/21/22Xn

R: 20/21/22-68/20/21/22

S: (2-)36/37
609-067-00-6sodium and potassium 4-(3-aminopropylamino)-2,6-bis[3-(4-methoxy-2-sulfophenylazo)-4-hydroxy-2-sulfo-7-naphthylamino]-1,3,5-triazine416-280-6156769-97-0R43Xi

R: 43

S: (2-)22-24-37
609-068-00-1musk xylene;

5-tert-butyl-2,4,6-trinitro-m-xylene
201-329-481-15-2E; R2

Carc. Cat. 3; R40

N; R50-53
E; Xn; N

R: 2-40-50/53

S: (2-)36/37-46-60-61
609-070-00-21,4-dichloro-2-(1,1,2,3,3,3-hexafluoropropoxy)-5-nitrobenzene415-580-4130841-23-5Xn; R22

R43

N; R50-53
Xn; N

R: 22-43-50/53

S: (2-)36/37/39-60-61
609-071-00-8reaction mass of: 2-methylsulfanyl-4,6-bis-(2-hydroxy-4-methoxy-phenyl)-1,3,5-triazine;

2-(4,6-bis-methylsulfanyl-1,3,5-triazin-2-yl)-5-methoxy-phenol
423-520-3156137-33-6R43Xi

R: 43

S: (2-)22-24-37
610-001-00-3trichloronitromethane;

chloropicrin
200-930-976-06-2Xn; R22

T+; R26

Xi; R36/37/38
T+

R: 22-26-36/37/38

S: (1/2-)36/37-38-45
610-002-00-91,1-dichloro-1-nitroethane209-854-0594-72-9T; R23/24/25T

R: 23/24/25

S: (1/2-)26-45
610-003-00-4chlorodinitrobenzeneT; R23/24/25

R33

N; R50-53
T; N

R: 23/24/25-33-50/53

S: (1/2-)28-36/37-45-60-61
C
610-004-00-X2-chloro-1,3,5-trinitrobenzene201-864-388-88-0E; R2

T+; R26/27/28

N; R50-53
E; T+; N

R: 2-26/27/28-50/53

S: (1/2-)28-36/37-45-60-61
610-005-00-51-chloro-4-nitrobenzene202-809-6100-00-5Carc. Cat. 3; R40

Muta. Cat. 3; R68

T; R23/24/25

Xn; R48/20/21/22

N; R51-53
T; N

R: 23/24/25-40-48/20/21/22-68-51/53

S: (1/2-)28-36/37-45-61
610-006-00-0chloronitroanilines with the exception of those specified elsewhere in this AnnexT+; R26/27/28

R33

N; R51-53
T+; N

R: 26/27/28-33-51/53

S: (1/2-)28-36/37-45-61
A C
610-007-00-61-chloro-1-nitropropane209-990-0600-25-9Xn; R20/22Xn

R: 20/22

S: (2-)
Xn; R20/22: C ≥ 5 %
610-008-00-12,6-dichloro-4-nitroanisole403-350-617742-69-7T; R25

N; R51-53
T; N

R: 25-51/53

S: (1/2-)36/37-45-61
610-009-00-72-chloro-4-nitroaniline204-502-2121-87-9Xn; R22

N; R51-53
Xn; N

R: 22-51/53

S: (2-)22-24-61
610-010-00-22-bromo-1-(2-furyl)-2-nitroethylene406-110-935950-52-8Xn; R22-48/22

C; R34

R43

N; R50-53
C; N

R: 22-34-43-48/22-50/53

S: (1/2-)22-26-36/37/39-45-60-61
611-001-00-6azobenzene203-102-5103-33-3Carc. Cat. 2; R45

Muta. Cat. 3; R68

Xn; R20/22-48/22

N; R50-53
T; N

R: 45-20/22-48/22-68-50/53

S: 53-45-60-61
E
611-002-00-1azoxybenzene207-802-1495-48-7Xn; R20/22Xn

R: 20/22

S: (2-)28
611-003-00-7fenaminosulf (ISO);

sodium 4-dimethylaminobenzenediazosulphonate
205-419-4140-56-7T; R25

Xn; R21

R52-53
T

R: 21-25-52/53

S: (1/2-)36/37-45-61
611-004-00-2methyl-ONN-azoxymethyl acetate;

methyl azoxy methyl acetate
209-765-7592-62-1Carc. Cat. 2; R45

Repr. Cat. 2; R61
T

R: 45-61

S: 53-45
611-005-00-8disodium {5-[(4'-((2,6-hydroxy-3-((2-hydroxy-5-sulphophenyl)azo)phenyl)azo)(1,1'-biphenyl)-4-yl)azo]salicylato(4-)}cuprate(2-);

CI Direct Brown 95
240-221-116071-86-6Carc. Cat. 2; R45T

R: 45

S: 53-45
611-006-00-34-o-tolylazo-o-toluidine;

4-amino-2',3-dimethylazobenzene;

fast garnet GBC base;

AAT;

o-aminoazotoluene
202-591-297-56-3Carc. Cat. 2; R45

R43
T

R: 45-43

S: 53-45
611-007-00-9tricyclazole (ISO);

5-methyl-1,2,4-triazolo(3,4-b)benzo-1,3-thiazole
255-559-541814-78-2Xn; R22Xn

R: 22

S: (2-)
611-008-00-44-aminoazobenzene;

4-phenylazoaniline
200-453-660-09-3Carc. Cat. 2; R45

N; R50-53
T; N

R: 45-50/53

S: 53-45-60-61
611-009-00-Xsodium (1-(5-(4-(4-anilino-3-sulphophenylazo)-2-methyl-5-methylsulphonamidophenylazo)-4-hydroxy-2-oxido-3-(phenylazo)phenylazo)-5-nitro-4-sulphonato-2-naphtholato)iron(II)401-220-3Xn; R20

R52-53
Xn

R: 20-52/53

S: (2-)61
611-010-00-52'-(2-cyano-4,6-dinitrophenylazo)-5'-(N,N-dipropylamino)propionanilide403-010-7106359-94-8R43

R52-53
Xi

R: 43-52/53

S: (2-)22-24-37-61
611-011-00-0N,N,N',N'-tetramethyl-3,3'-(propylenebis(iminocarbonyl-4,1-phenylenazo(1,6-dihydro-2-hydroxy-4-methyl-6-oxopyridine-3,1-diyl)))di(propylammonium) dilactate403-340-1Xi; R41

N; R51-53
Xi; N

R: 41-51/53

S: (2-)26-39-61
611-012-00-6reaction mass of 2,2-iminodiethanol 6-methyl-2-(4-(2,4,6-triaminopyrimidin-5-ylazo)phenyl)benzothiazole-7-sulfonate and 2-methylaminoethanol 6-methyl-2-(4-(2,4,6-triaminopyrimidin-5-ylazo)phenyl)benzothiazole-7-sulfonate and N,N-diethylpropane-1,3-diamine 6-methyl-2-(4-(2,4,6-triaminopyrimidin-5-ylazo)phenyl)benzothiazole-7-sulfonate403-410-1114565-65-0R43Xi

R: 43

S: (2-)22-24-26-37
611-013-00-1trilithium-1-hydroxy-7-(3-sulfonatoanilino)-2-(3-methyl-4-(2-methoxy-4-(3-sulfonatophenylazo)phenylazo)phenylazo)naphthalene-3-sulfonate403-650-7117409-78-6E; R2

N; R51-53
E; N

R: 2-51/53

S: (2-)35-61
611-014-00-7(tetrasodium 1-(4-(3-acetamido-4-(4'-nitro-2,2'-disulfonatostilben-4-ylazo)anilino)-6-(2,5-disulfonatoanilino)-1,3,5-triazin-2-yl)-3-carboxypyridinium) hydroxide404-250-5115099-55-3R43Xi

R: 43

S: (2-)22-24-37
611-015-00-2tetrasodium 4-amino-5-hydroxy-6-(4-(2-(2-(sulfonatooxy)ethylsulfonyl)ethylcarbamoyl)phenylazo)-3-(4-(2-(sulfonatooxy)ethylsulfonyl)phenylazo)naphthalene-2,7-disulfonate404-320-5116889-78-2R43Xi

R: 43

S: (2-)22-24-37
611-016-00-8reaction mass of 1,1'-((dihydroxyphenylene)bis(azo-3,1-phenylenazo(1-(3-dimethylaminopropyl)-1,2-dihydro-6-hydroxy-4-methyl-2-oxopyridine-5,3-diyl)))dipyridinium dichloride dihydrochloride, mixed isomers and 1-(1-(3-dimethylaminopropyl)-5-(3-((4-(1-(3-dimethylaminopropyl)-1,6-dihydro-2-hydroxy-4-methyl-6-oxo-5-pyridinio-3-pyridylazo)phenylazo)-2,4(or2,6 or3,5)-dihydroxyphenylazo)phenylazo)-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-3-pyridyl)pyridinium dichloride404-540-1R43Xi

R: 43

S: (2-)22-24-37
611-017-00-32-(4-(diethylaminopropylcarbamoyl)phenylazo)-3-oxo-N-(2,3-dihydro-2-oxobenzimidazol-5-yl)butyramide404-910-2R43

N; R51-53
Xi; N

R: 43-51/53

S: (2-)24-37-61
611-018-00-9tetraammonium 5-(4-(7-amino-1-hydroxy-3-sulfonato-2-naphthylazo)-6-sulfonato-1-naphthylazo)isophthalate405-130-5R43Xi

R: 43

S: (2-)24-37
611-019-00-4tetralithium 6-amino-4-hydroxy-3-(7-sulfonato-4-(4-sulfonatophenylazo)-1-naphthylazo)naphthalene-2,7-disulfonate405-150-4106028-58-4R43Xi

R: 43

S: (2-)24-37
611-020-00-Xtetrakis(tetramethylammonium) 6-amino-4-hydroxy-3-(7-sulfonato-4-(4-sulfonatophenylazo)-1-naphthylazo)naphthalene-2,7-disulfonate405-170-3116340-05-7T; R25

R43

R52-53
T

R: 25-43-52/53

S: (1/2-)22-24-37-45-61
611-021-00-52-(4-(4-cyano-3-methylisothiazol-5-ylazo)-N-ethyl-3-methylanilino)ethyl acetate405-480-9Xn; R22-48/22

Xi; R38

R53
Xn

R: 22-38-48/22-53

S: (2-)22-36/37-61
611-022-00-04-dimethylaminobenzenediazonium 3-carboxy-4-hydroxybenzenesulfonate404-980-4E; R2

T; R23/25

Xn; R21-48/22

Xi; R41

R43

N; R50/53
E; T; N

R: 2-21-23/25-41-43-48/22-50/53

S: (1/2-)3-12-26-35-36/37/39-45-61
611-023-00-6disodium 7-(4,6-dichloro-1,3,5-triazin-2-ylamino)-4-hydroxy-3-(4-(2-(sulfonatooxy)ethylsulfonyl)phenylazo) naphthalene-2-sulfonate404-600-7R43X

R: 43

S: (2-)22-24-37
611-024-00-1Benzidine based azo dyes;

4,4'-diarylazobiphenyl dyes, with the exception of those specified elsewhere in this Annex
Carc. Cat. 2; R45T

R: 45

S: 53-45
A
611-025-00-7disodium 4-amino-3-[[4'-[(2,4-diaminophenyl)azo][1,1'-biphenyl]-4-yl]azo]-5-hydroxy-6-(phenylazo)naphtalene-2,7-disulphonate;

C.I. Direct Black 38
217-710-31937-37-7Carc. Cat. 2; R45

Repr. Cat. 3; R63
T

R: 45-63

S: 53-45
611-026-00-2tetrasodium 3,3'-[[1,1'-biphenyl]-4,4'-diylbis(azo)]bis[5-amino-4-hydroxynaphthalene-2,7-disulphonate];

C.I. Direct Blue 6
220-012-12602-46-2Carc. Cat. 2; R45

Repr. Cat. 3; R63
T

R: 45-63

S: 53-45
611-027-00-8disodium 3,3'-[[1,1'-biphenyl]-4,4'-diylbis(azo)]bis(4-aminonaphthalene-1-sulphonate);

C.I. Direct Red 28
209-358-4573-58-0Carc. Cat. 2; R45

Repr. Cat. 3; R63
T

R: 45-63

S: 53-45
611-028-00-3C,C'-azodi(formamide)204-650-8123-77-3R42

R44 ⊗
Xn

R: 42-44

S: (2-)22-24-37
611-029-00-9o-dianisidine based azo dyes;

4,4'-diarylazo-3,3'-dimethoxybiphenyl dyes with the exception of those mentioned elsewhere in this Annex
Carc. Cat. 2; R45T

R: 45

S: 53-45
A H
611-030-00-4o-tolidine based dyes;

4,4'-diarylazo-3,3'-dimethylbiphenyl dyes, with the exception of those mentioned elsewhere in this Annex
Carc. Cat. 2; R45T

R: 45

S: 53-45
A H
611-031-00-X4,4'-(4-iminocyclohexa-2,5-dienylidenemethylene)dianiline hydrochloride;

C.I. Basic Red 9
209-321-2569-61-9Carc. Cat. 2; R45T

R: 45

S: 53-45
611-032-00-51,4,5,8-tetraaminoanthraquinone;

C.I. Disperse Blue 1
219-603-72475-45-8Carc. Cat. 2; R45

Xi; R38-41

R43
T

R: 45-38-41-43

S: 53-45
611-033-00-0hexasodium [4,4''-azoxybis(2,2'-disulfonatostilbene-4,4'-diylazo)]-bis[5'-sulfonatobenzene-2,2'- diolato-O(2),O(2),N(1)]-copper(II)400-020-382027-60-9N; R51-53N

R: 51/53

S: 61
611-034-00-6N-(5-(bis(2-methoxyethyl)amino)-2-((5-nitro-2,1-benzisothiazol-3-yl)azo)phenylacetamide402-430-8105076-77-5R53R: 53

S: 61
611-035-00-1tetralithium 6-amino-4-hydroxy-3-[7-sulfonato-4-(5-sulfonato-2-naphthylazo)-1-naphthylazo]naphthalene-2,7-disulfonate403-660-1107246-80-0R43

N; R51-53
Xi; N

R: 43-51/53

S: (2-)24-37-61
611-036-00-72-(4-(5,6(or 6,7)-dichloro-1,3-benzothiazol-2-ylazo)-N-methyl-m-toluidino)ethyl acetate405-440-0R43Xi

R: 43

S: (2-)22-24-37
611-037-00-23(or 5)-(4-(N-benzyl-N-ethylamino)-2-methylphenylazo)-1,4-dimethyl-1,2,4-triazolium methylsulphate406-055-0124584-00-5Xn; R22

Xi; R41

R43

N; R51-53
Xn; N

R: 22-41-43-51/53

S: (2-)22-24-26-37/39-61
611-038-00-8trisodium 1-hydroxynaphthalene-2-azo-4'(5',5''-dimethylbiphenyl)-4''-azo(4''-phenylsulfonyloxybenzene)- 2',2'',4-trisulfonate406-820-9Xi; R36Xi

R: 36

S: (2-)25-26
611-039-00-37-[((4,6-dichloro-1,3,5-triazin-2-yl)amino)-4-hydroxy-3-(4-((2-sulfoxy)ethyl)sulfonyl)phenylazo]naphthalene-2-sulfonic acid407-050-6117715-57-8R43Xi

R: 43

S: (2-)22-24-37
611-040-00-93-(5-acetylamino-4-(4-[4,6-bis(3-diethylaminopropylamino)-1,3,5-triazin-2-ylamino]phenylazo)-2-(2-methoxyethoxy)phenylazo)-6-amino-4-hydroxy-2-naphthalenesulfonic acid407-670-7115099-58-6N; R50-53N

R: 50/53

S: 60-61
611-041-00-42-[[4[[4,6-bis[[3-(diethylamino)propyl]amino]-1,3,5-triazine-2-yl]amino]phenyl]azo]-N-(2,3-dihydro-2-oxo-1H-benzimidazol-5-yl)-3-oxobutanamide407-680-198809-11-1Xi; R41

R43

N; R51-53
Xi; N

R: 41-43-51/53

S: (2-)24-26-37/39-61
611-042-00-Xtrisodium 5-amino-3-[5-(2-bromoacryloylamino)-2-sulfonatophenylazo]-4-hydroxy-6-(4-vinylsulfonylphenylazo)naphthalene-2,7-disulfonate411-770-6136213-71-3R52-53R: 52/53

S: 61
611-043-00-5reaction mass of: trisodium N(1')-N(2):N(1''')-N(2'')-η-6-[2-amino-4-(or 6)-hydroxy-(or 4-amino-2-hydroxy)phenylazo]-6''-(1-carbaniloyl-2-hydroxyprop-1-enylazo)-5',5'''-disulfamoyl-3,3''-disulfonatobis(naphthalene-2,1'-azobenzene-1,2'-diolato-O(1),O(2'))-chromate;

trisodium N(1')-N(2):N(1''')-N(2'')-η-6,6''-bis(1-carbaniloyl-2-hydroxyprop-1-enylazo)-5',5'''-disulfamoyl-3,3''-disulfonatobis(naphthalene-2,1'azobenzene-1,2'-diolato-O(1),O(2'))-chromate;

trisodium N(1')-N(2):N(1''')-N(2'')-η-6,6''-bis[2-amino-4-(or 6)-hydroxy-(or 4-amino-2-hydroxy)phenylazo]5',5'''-disulfamoyl-3,3''-disulfonatobis(naphthalene-2,1'azobenzene-1,2'-diolato-O(1),O(2'))-chromate (2:1:1)
402-850-1Xi; R41

R52-53
Xi

R: 41-52/53

S: (2-)26-39-61
611-044-00-0reaction mass of: tert-alkyl(C12-C14)ammonium bis[1-[(2-hydroxy-5-nitrophenyl)azo]-2-naphthalenolato(2-)]-chromate(1-);

tert-alkyl(C12-C14)ammonium bis[1-[(2-hydroxy-4-nitrophenyl)azo]-2-naphthalenolato(2-)]-chromate(1-);

tert-alkyl(C12-C14)ammonium bis[1-[[5-(1,1-dimethylpropyl)-2-hydroxy-3-nitrophenyl]azo]-2-naphthalenolato(2-)]-chromate(1-);

tert-alkyl(C12-C14)ammonium [[1-[(2-hydroxy-5-nitrophenyl)azo]-2-naphthalenolato(2-)]-[1-[(2-hydroxy-5-nitrophenyl)azo]-2-naphthalenolato(2-)]]-chromate(1-);

tert-alkyl(C12-C14)ammonium [[1-[[5-(1,1-dimethylpropyl)-2-hydroxy-3-nitrophenyl]azo]-2-naphthalenolato(2-)]-[1-[(2-hydroxy-5-nitrophenyl)azo]-2-naphthalenolato(2-)]]-chromate(1-);

tert-alkyl(C12-C14)ammonium ((1-(4(or 5)-nitro-2-oxidophenylazo)-2-naphtholato)(1-(3-nitro-2-oxido-5-pentylphenylazo)-2-naphtholato))chromate(1-)
403-720-7117527-94-3N; R51-53N

R: 51/53

S: 61
611-045-00-62-[4-[N-(4-acetoxybutyl)-N-ethyl]amino-2-methylphenylazo]-3-acetyl-5-nitrothiophene404-830-8R53R: 53

S: 61
611-046-00-14,4'-diamino-2-methylazobenzene407-590-243151-99-1T; R25

Xn; R48/22

R43

N; R50-53
T; N

R: 25-43-48/22-50/53

S: (1/2-)22-28-36/37-45-60-61
611-047-00-7reaction mass of: 2-[[4-[N-ethyl-N-(2-acetoxyethyl)amino]phenyl]azo]-5,6-dichlorobenzothiazole;

2-[[4-[N-ethyl-N-(2-acetoxyethyl)amino]phenyl]azo]-6,7-dichlorobenzothiazole (1:1)
407-890-3111381-11-4R53R: 53

S: 61
611-048-00-2reaction mass of: 2-[[4-[bis(2-acetoxyethyl)amino]phenyl]azo]-5,6-dichlorobenzothiazole;

2-[[4-[bis(2-acetoxyethyl)amino]phenyl]azo]-6,7-dichlorobenzothiazole (1:1)
407-900-6111381-12-5R53R: 53

S: 61
611-049-00-8reaction mass of 7-[4-(3-diethylaminopropylamino)-6-(3-diethylammoniopropylamino)-1,3,5-triazin-2-ylamino]-4-hydroxy-3-(4-phenylazophenylazo)-naphthalene-2-sulfonate, acetic acid, lactic acid (2:1:1)408-000-6118658-98-3Xn; R48/22

R43

R52-53
Xn

R: 43-48/22-52/53

S: (2-)22-36/37-61
611-051-00-92-(4-(N-ethyl-N-(2-hydroxy)ethyl)amino-2-methylphenyl)azo-6-methoxy-3-methyl-benzothiazolium chloride411-110-7136213-74-6N; R50-53N

R: 50/53

S: 60-61
611-052-00-4monosodium aqua-[5-[[2,4-dihydroxy-5-[(2-hydroxy-3,5-dinitrophenyl)azo]phenyl]azo]-2-naphthalensulfonate], iron complex400-720-9R52-53R: 52/53

S: 61
611-053-00-X2,2'-azobis[2-methylpropionamidine] dihydrochloride221-070-02997-92-4Xn; R22

R43
Xn

R: 22-43

S: (2-)24-37
611-055-00-0C.I. Disperse Yellow 3;

N-[4-[(2-hydroxy-5-methylphenyl)azo]phenyl]acetamide
220-600-82832-40-8Carc. Cat. 3; R40

R43
Xn

R: 40-43

S: (2-)22-36/37-46
611-056-00-6C.I. Solvent Yellow 14;

1-phenylazo-2-naphthol
212-668-2842-07-9Carc. Cat. 3; R40

Muta. Cat. 3; R68

R43

R53
Xn

R: 40-43-53-68

S: (2-)22-36/37-46-61
611-057-00-16-hydroxy-1-(3-isopropoxypropyl)-4-methyl-2-oxo-5-[4-(phenylazo)phenylazo]-1,2-dihydro-3-pyridinecarbonitrile400-340-385136-74-9Carc. Cat. 2; R45

R53
T

R: 45-53

S: 53-45-61
611-058-00-7(6-(4-hydroxy-3-(2-methoxyphenylazo)-2-sulfonato-7-naphthylamino)-1,3,5-triazin-2,4-diyl)bis[(amino-1-methylethyl)ammonium] formate402-060-7108225-03-2Carc. Cat. 2; R45

Xi; R41

N; R51-53
T; N

R: 45-41-51/53

S: 53-45-61
611-059-00-2octasodium 2-(6-(4-chloro-6-(3-(N-methyl-N-(4-chloro-6-(3,5-disulfonato-2-naphthylazo)-1-hydroxy-6-naphthylamino)-1,3,5-triazin-2-yl)aminomethyl)phenylamino)-1,3,5-triazin-2-ylamino)-3,5-disulfonato-1-hydroxy-2-naphthylazo)naphthalene-1,5-disulfonate412-960-1148878-21-1Xi; R41

R43

R52-53
Xi

R: 41-43-52/53

S: (2-)22-24-26-37/39-61
611-060-00-8reaction mass of: sodium 5-[8-[4-[4-[4-[7-(3,5-dicarboxylatophenylazo)-8-hydroxy-3,6-disulfonatonaphthalen-1-ylamino]-6-hydroxy-1,3,5-triazin-2-yl]-2,5-dimethylpiperazin-1-yl]-6-hydroxy-1,3,5-triazin-2-ylamino]-1-hydroxy-3,6-disulfonatonaphthalen-2-ylazo]-isophthalate;

ammonium 5-[8-[4-[4-[4-[7-(3,5-dicarboxylatophenylazo)-8-hydroxy-3,6-disulfonatonaphthalen-1-ylamino]-6-hydroxy-1,3,5-triazin-2-yl]-2,5-dimethylpiperazin-1-yl]-6-hydroxy-1,3,5-triazin-2-ylamino]-1-hydroxy-3,6-disulfonatonaphthalen-2-ylazo]-isophthalate;

5-[8-[4-[4-[4-[7-(3,5-dicarboxylatophenylazo)-8-hydroxy-3,6-disulfonatonaphthalen-1-ylamino]-6-hydroxy-1,3,5-triazin-2-yl]-2,5-dimethylpiperazin-1-yl]-6-hydroxy-1,3,5-triazin-2-ylamino]-1-hydroxy-3,6-disulfonaphthalen-2-ylazo]-isophthalic acid
413-180-4187285-15-0Xi; R41Xi

R: 41

S: (2-)22-26-39
611-061-00-3disodium 5-[5-[4-(5-chloro-2,6-difluoropyrimidin-4-ylamino)benzamido]-2-sulfonatophenylazo]-1-ethyl-6-hydroxy-4-methyl-2-oxo-3-pyridylmethylsulfonate412-530-3Xi; R41

R43
Xi

R: 41-43

S: (2-)22-24-26-37/39
611-062-00-9octasodium 2-(8-(4-chloro-6-(3-((4-chloro-6-(3,6-disulfonato-2-(1,5-disulfonatonaphthalen-2-ylazo)-1-hydroxynaphthalen-8-ylamino)-1,3,5-triazin-2-yl)aminomethyl)phenylamino)-1,3,5-triazin-2-ylamino)-3,6-disulfonato-1-hydroxynaphthalen-2-ylazo)naphthalene-1,5-disulfonate413-550-5Xi; R38-41Xi

R: 38-41

S: (2-)22-26-37/39
611-063-00-4trisodium [4'-(8-acetylamino-3,6-disulfonato-2-naphthylazo)-4''-(6-benzoylamino-3-sulfonato-2-naphthylazo)-biphenyl-1,3',3'',1'''-tetraolato-O,O',O'',O''']copper(II)413-590-3164058-22-4Carc. Cat. 2; R45T

R: 45

S: 53-45
611-064-00-X4-(3,4-dichlorophenylazo)-2,6-di-sec-butyl-phenol410-600-8124719-26-2Xn; R48/22

Xi; R38

N; R50-53
Xn; N

R: 38-48/22-50/53

S: (2-)23-25-36/37-60-61
611-065-00-54-(4-nitrophenylazo)-2,6-di-sec-butyl-phenol410-610-2111850-24-9Xn; R48/22

Xi; R36/38

R43

N; R50-53
Xn; N

R: 36/38-43-48/22-50/53

S: (2-)23-26-36/37-60-61
611-066-00-0tetrasodium 5-[4-chloro-6-(N-ethyl-anilino)-1,3,5-triazin-2-ylamino]-4-hydroxy-3-(1,5-disulfonatonaphthalen-2-ylazo)-naphthalene-2,7-disulfonate411-540-5130201-57-9Xi; R41

R43

N; R51-53
Xi; N

R: 41-43-51/53

S: (2-)22-24-26-37/39-61
611-067-00-6reaction mass of: bis(tris(2-(2-hydroxy(1-methyl)ethoxy)ethyl)ammonium) 7-anilino-4-hydroxy-3-(2-methoxy-5-methyl-4-(4-sulfonatophenylazo)phenylazo)naphthalene-2-sulfonate;

bis(tris(2-(2-hydroxy(2-methyl)ethoxy)ethyl)ammonium) 7-anilino-4-hydroxy-3-(2-methoxy-5-methyl-4-(4-sulfonatophenylazo)phenylazo)naphthalene-2-sulfonate
406-910-8Xn; R22

Xi; R41

R52-53
Xn

R: 22-41-52/53

S: (2-)26-36/39-61
611-068-00-1tetrasodium 4-amino-3,6-bis(5-[4-chloro-6-(2-hydroxyethylamino)-1,3,5-triazin-2-ylamino]-2-sulfonatophenylazo)-5-hydroxynaphthalene-2,7-disulfonate400-690-785665-98-1N; R51-53N

R: 51/53

S: 61
611-069-00-7N,N-di-[poly(oxyethylene)-co-poly(oxypropylene)]-4-[(3,5-dicyano-4-methyl-2-thienyl)azo)]-3-methylaniline413-380-1N; R51-53N

R: 51/53

S: 61
611-070-00-2reaction mass of: disodium (6-(4-anisidino)-3-sulfonato-2-(3,5-dinitro-2-oxidophenylazo)-1-naphtholato)(1-(5-chloro-2-oxidophenylazo)-2-naphtholato)chromate(1-);

trisodium bis(5-(4-anisidino)-3-sulfonato-2-(3,5-dinitro-2-oxidophenylazo)-1-naphtholato)chromate(1-)
405-665-4R43

N; R50-53
Xi; N

R: 43-50/53

S: (2-)24-37-60-61
611-071-00-8tris(tetramethylammonium) 5-hydroxy-1-(4-sulphonatophenyl)-4-(4-sulphonatophenylazo)pyrazole-3-carboxylate406-073-9131013-81-5T; R25

R52-53
T

R: 25-52/53

S: (1/2-)37-45-61
611-072-00-32,4-bis[2,2'-[2-(N,N-dimethylamino)ethyloxycarbonyl]phenylazo]-1,3-dihydroxybenzene, dihydrochloride407-010-8118208-02-9Xn; R22

Xi; R41

N; R51-53
Xn; N

R: 22-41-51/53

S: (2-)26-39-61
611-073-00-9dimethyl 3,3'-(N-(4-(4-bromo-2,6-dicyanophenylazo)-3-hydroxyphenyl)imino)dipropionate407-310-9122630-55-1R53R: 53

S: 61
611-074-00-4reaction mass of: sodium/potassium (3-(4-(5-(5-chloro-2,6-difluoropyrimidin-4-ylamino)-2-methoxy-3-sulfonatophenylazo)-2-oxidophenylazo)-2,5,7-trisulfonato-4-naphtholato)copper(II);

sodium/potassium (3-(4-(5-(5-chloro-4,6-difluoropyrimidin-2-ylamino)-2-methoxy-3-sulfonatophenylazo)-2-oxidophenylazo)-2,5,7-trisulfonato-4-naphtholato)copper(II)
407-100-7R43Xi

R: 43

S: (2-)22-24-37
611-075-00-Xreaction mass of: tris(3,5,5-trimethylhexylammonium) 4-amino-3-(4-(4-(2-amino-4-hydroxyphenylazo)anilino)-3-sulfonatophenylazo)-5,6-dihydro-5-oxo-6-phenylhydrazononaphthalene-2,7-disulfonate;

tris(3,5,5-trimethylhexylammonium) 4-amino-3-(4-(4-(4-amino-2-hydroxyphenylazo)anilino)-3-sulfonatophenylazo)-5,6-dihydro-5-oxo-6-phenylhydrazononaphthalene-2,7-disulfonate (2:1)
406-000-0Xi; R41

N; R51-53
Xi; N

R: 41-51/53

S: (2-)26-39-61
611-076-00-53-(2,6-dichloro-4-nitrophenylazo)-1-methyl-2-phenylindole406-280-4117584-16-4N; R50-53N

R: 50/53

S: 60-61
611-077-00-0dilithium disodium (5,5'-diamino-(μ-4,4'-dihydroxy-1:2-κ-2,O4,O4',-3,3'-[3,3'-dihydroxy-1:2-κ-2-O3,O3'-biphenyl-4,4'-ylenebisazo-1:2-(N3,N4-η:N3',N4'-η)]-dinaphthalene-2,7-disulfonato(8)))dicuprate(2-)407-230-4126637-70-5Xn; R22

R43
Xn

R: 22-43

S: (2-)22-24-37
611-078-00-6(2,2'-(3,3'-dioxidobiphenyl-4,4'-diyldiazo)bis(6-(4-(3-(diethylamino)propylamino)-6-(3-(diethylammonio)propylamino)-1,3,5-triazin-2-ylamino)-3-sulfonato-1-naphtholato))dicopper(II) acetate lactate407-240-9159604-94-1R43

N; R51-53
Xi; N

R: 43-51/53

S: (2-)22-24-37-61
611-079-00-1disodium 7-[4-chloro-6-(N-ethyl-o-toluidino)-1,3,5-triazin-2-ylamino]-4-hydroxy-3-(4-methoxy-2-sulfonatophenylazo)-2-naphthalenesulfonate410-390-8147703-64-8Xi; R41Xi

R: 41

S: (2-)22-26-39
611-080-00-7sodium 3-(2-acetamido-4-(4-(2-hydroxybutoxy)phenylazo)phenylazo)benzenesulfonate410-150-2147703-65-9R43Xi

R: 43

S: (2-)22-24-37
611-081-00-2tetrasodium [7-(2,5-dihydroxy-KO2-7-sulfonato-6-[4-(2,5,6-trichloro-pyrimidin-4-ylamino)phenylazo]-(N1,N7-N)-1-naphthylazo)-8-hydroxy-KO8-naphthalene-1,3,5-trisulfonato(6-)]cuprate(II)411-470-5141048-13-7R43

R52-53
Xi

R: 43-52/53

S: (2-)22-24-37-61
611-082-00-8reaction mass of: pentasodium bis(1-(3(or 5)-(4-anilino-3-sulfonatophenylazo)-4-hydroxy-2-oxidophenylazo)-6-nitro-4-sulfonato-2-naphtholato)ferrate(1-);

pentasodium [(1-(3-(4-anilino-3-sulfonatophenylazo)-4-hydroxy-2-oxidophenylazo)-6-nitro-4-sulfonato-2-naphtholato)-(5-(4-anilino-3-sulfonatophenylazo)-4-hydroxy-2-oxidophenylazo)-6-nitro-4-sulfonato-2-naphtholato]ferrate(1-)
407-570-3N; R51-53N

R: 51/53

S: 61
611-083-00-3reaction mass of: 2-[N-ethyl-4-[(5,6-dichlorobenzothiazol-2-yl)azo]-m-toludino]ethyl acetate;

2-[N-ethyl-4-[(6,7-dichlorobenzothiazol-2-yl)azo]-m-toludino]ethyl acetate (1:1)
411-560-4T; R48/25

R43

N; R51-53
T; N

R: 43-48/25-51/53

S: (1/2-)22-36/37-45-61
611-084-00-9reaction mass of: N-(4-chlorophenyl)-4-(2,5-dichloro-4-(dimethylsulfamoyl)phenylazo)-3-hydroxy-2-naphthalenecarboxamide;

N-(4-chlorophenyl)-4-(2,5-dichloro-4-(methylsulfamoyl)phenylazo)-3-hydroxy-2-naphthalenecarboxamide
412-550-2R53R: 53

S: 61
611-085-00-4reaction mass of: 3-cyano-5-(2-cyano-4-nitro-phenylazo)-2-(2-hydroxy-ethylamino)-4-methyl-6-[3-(2-phenoxyethoxy)propylamino]pyridine;

3-cyano-5-(2-cyano-4-nitro-phenylazo)-6-(2-hydroxy-ethylamino)-4-methyl-2-[3-(2-phenoxyethoxy)propylamino]pyridine;

3-cyano-5-(2-cyano-4-nitro-phenylazo)-2-amino-4-methyl-6-[3-(3-hydroxypropoxy)propylamino]pyridine;

3-cyano-5-(2-cyano-4-nitro-phenylazo)-6-amino-4-methyl-2-[3-(3-methoxypropoxy)propylamino]pyridine
411-880-4R43

N; R51-53
Xi; N

R: 43-51/53

S: (2-)24-37-61
611-086-00-Xmonolithium 5-[[2,4-dihydroxy-5-[(2-hydroxy-3,5-dinitrophenyl)azo]phenyl]azo]-2-naphthalenesulfonate], iron complex, monohydrate411-360-7R52-53R: 52/53

S: 61
611-087-00-5reaction mass of: 3-((5-cyano-1,6-dihydro-1,4-dimethyl-2-hydroxyl-6-oxo-3-pyridinyl)azo)-benzoyloxy-2-phenoxyethane;

3-((5-cyano-1,6-dihydro-1,4-dimethyl-2-hydroxy-6-oxo-3-pyridinyl)azo)-benzoyloxy-2-ethyloxy-2-(ethylphenol)
411-710-9R53R: 53

S: 61
611-088-00-0reaction mass of: trilithium 4-amino-3-((4-((4-((2-amino-4-hydroxyphenyl)azo)phenyl)amino)-3-sulfophenyl)azo)-5-hydroxy-6-(phenylazo)naphthalene-2,7-disulfonate;

trilithium 4-amino-3-((4-((4-((4-amino-2-hydroxyphenyl)azo)phenyl)amino)-3-sulfophenyl)azo)-5-hydroxy-6-(phenylazo)naphthalene-2,7-disulfonate
411-890-9Xn; R22

Xi; R41

R52-53
Xn

R: 22-41-52/53

S: (2-)22-26-39-61
611-089-00-62-((4-(ethyl-(2-hydroxyethyl)amino)-2-methylphenyl)azo)-6-methoxy-3-methyl-benzothiazolium methylsulfate411-100-2136213-73-5Xn; R48/22

R43

N; R50-53
Xn; N

R: 43-48/22-50/53

S: (2-)22-36/37-60-61
611-090-00-12,5-dibutoxy-4-(morpholin-4-yl)benzenediazonium 4-methylbenzenesulfonate413-290-293672-52-7F; R11

Xn; R22

Xi; R41

R43

R52-53
F; Xn

R: 11-22-41-43-52/53

S: (2-)12-22-24-26-37/39-47-61
611-091-00-7sodium (1.0-1.95)/lithium (0.05-1) 5-((5-((5-chloro-6-fluoro-pyrimidin-4-yl)amino)-2-sulfonatophenyl)azo)-1,2-dihydro-6-hydroxy-1,4-dimethyl-2-oxo-3-pyridinemethylsulfonate413-470-0134595-59-8R43Xi

R: 43

S: (2-)22-24/25-37
611-092-00-2tert-(dodecyl/tetradecyl)-ammonium bis(3-(4-((5-(1,1-dimethyl-propyl)-2-hydroxy-3-nitrophenyl)azo)-3-methyl-5-hydroxy-(1H)pyrazol-1-yl)benzenesulfonamidato)chromate413-210-6N; R51-53N

R: 51/53

S: 61
611-093-00-8sodium 2-(4-(4-fluoro-6-(2-sulfo-ethylamino)-[1,3,5]triazin-2-ylamino)-2-ureido-phenylazo)-5-(4-sulfophenylazo)benzene-1-sulfonate410-770-3146177-84-6R43Xi

R: 43

S: (2-)22-24-37
611-094-00-3reaction mass of: 2-[2-acetylamino-4-[N,N-bis[2-ethoxy-carbonyloxy)ethyl]amino]phenylazo]-5,6-dichloro-1,3-benzothiazole;

2-[2-acetylamino-4-[N,N-bis[2-ethoxy-carbonyloxy)ethyl]amino]phenylazo]-6,7-dichloro-1,3-benzotriazole (1:1)
411-600-0143145-93-1R53R: 53

S: 61
611-095-00-9hexasodium 1,1'-[(1-amino-8-hydroxy-3,6-disulfonate-2,7-naphthalenediyl)bis(azo(4-sulfonate-1,3-phenyl)imino[6-[(4-chloro-3-sulfonatophenyl)amino]-1,3,5-triazin-2,4-diyl]]]bis[3-carboxypyridinium] dihydroxide412-240-789797-03-5N; R51-53N

R: 51/53

S: 22-61
611-096-00-4methyl N-[3-acetylamino)-4-(2-cyano-4-nitrophenylazo)phenyl]-N-[(1-methoxy)acetyl]glycinate413-040-2149850-30-6R43Xi

R: 43

S: (2-)22-24-37
611-097-00-Xreaction mass of iron complexes of: 1,3-dihydroxy-4-[(5-phenylaminosulfonyl)-2-hydroxyphenylazo]-n-(5-amino-sulfonyl-2-hydroxyphenylazo)benzene and: 1,3-dihydroxy-4-[(5-phenylaminosulfonyl)-2-hydroxyphenylazo]-n-[4-(4-nitro-2-sulfophenylamino)phenylazo]benzene (n=2,5,6)414-150-3R43

N; R51-53
Xi; N

R: 43-51/53

S: (2-)22-24-37-61
611-098-00-5tetrakis(tetramethylammonium)3,3'-(6-(2-hydroxyethylamino)1,3,5-triazine-2,4-diylbisimino(2-methyl-4,1-phenyleneazo))bisnaphthalene-1,5-disulfonate405-950-3131013-83-7T; R25

R52-53
T

R: 25-52/53

S: (1/2-)37-45-61
611-099-00-0(methylenebis(4,1-phenylenazo(1-(3-(dimethylamino)propyl)-1,2-dihydro-6-hydroxy-4-methyl-2-oxopyridine-5,3-diyl)))-1,1'-dipyridinium dichloride dihydrochloride401-500-5118658-99-4Carc. Cat. 2; R45

N; R51-53
T; N

R: 45-51/53

S: 53-45-61
611-100-00-4potassium sodium 3,3'-(3(or4)-methyl-1,2-phenylenebis(imino(6-chloro)-1,3,5-triazine-4,2-diylimino(2-acetamido-5-methoxy)-4,1-phenylenazo)dinaphthalene-1,5-disulfonate403-810-6140876-13-7Xi; R41Xi

R: 41

S: (2-)26-39
611-101-00-X2'-(4-chloro-3-cyano-5-formyl-2-thienyl)azo-5'-diethylaminoacetanilide405-200-5104366-25-8R43Xi

R: 43

S: (2-)22-24-37
611-103-00-0trisodium (1-(3-carboxylato-2-oxido-5-sulfonatophenylazo)-5-hydroxy-7-sulfonatonaphthalen-2-amido)nickel(II)407-110-1Xi; R41

R43

N; R51-53
Xi; N

R: 41-43-51/53

S: (2-)24-26-37/39-61
611-104-00-6reaction mass of: trisodium (2,4(or 2,6 or 4,6)-bis(3,5-dinitro-2-oxidophenylazo)-5-hydroxyphenolato)(2(or 4or 6)-(3,5-dinitro-2-oxidophenylazo)-5-hydroxy-4(or 2or 6)-(4-(4-nitro-2-sulfonatoanilino)phenylazo)phenolato)ferrate(1-);

trisodium bis(2,4(or 2,6 or 4,6)-bis(3,5-dinitro-2-oxidophenylazo)-5-hydroxyphenolato)ferrate(1-);

trisodium (2,4(or 2,6 or 4,6)-bis(3,5-dinitro-2-oxidophenylazo)-5-hydroxyphenolato)(2(or 4 or 6)-(3,5-dinitro-2-oxidophenylazo)-5-hydroxy-4(or 2 or 6)-(4-nitro-2-sulfonatophenylazo)phenolato)ferrate(1-);

trisodium (2,4(or 2,6 or 4,6)-bis(3,5-dinitro-2-oxidophenylazo)-5-hydroxyphenolato)(2(or 4 or 6)-(3,5-dinitro-2-oxidophenylazo)-5-hydroxy-4(or 2 or 6)-(3-sulfonatophenylazo)phenolato)ferrate(1-);

disodium 3,3'-(2,4-dihydroxy-1,3(or 1,5 or 3,5)-phenylenediazo)dibenzenesulfonate
406-870-1R43

N; R51-53
Xi; N

R: 43-51/53

S: (2-)24-37-61
611-105-00-1sodium 4-(4-chloro-6-(N-ethylanilino)-1,3,5-triazin-2-ylamino)-2-(1-(2-chlorophenyl)-5-hydroxy-3-methyl-1H-pyrazol-4-ylazo)benzenesulfonate407-800-2136213-75-7R43

N; R51-53
Xi; N

R: 43-51/53

S: (2-)22-24-37-61
611-106-00-7hexasodium 4,4'-dihydroxy-3,3'-bis[2-sulfonato-4-(4-sulfonatophenylazo)phenylazo]-7,7'[p-phenylenebis[imino(6-chloro-1,3,5-triazine-4,2-diyl)imino]]dinaphthalene-2-sulfonate410-180-6157627-99-1Xi; R41Xi

R: 41

S: (2-)26-39
611-107-00-2potassium sodium 4-(4-chloro-6-(3,6-disulfonato-7-(5,8-disulfonato-naphthalen-2-ylazo)-8-hydroxy-naphthalen-1-ylamino)-1,3,5-triazin-2-ylamino)-5-hydroxy-6-(4-(2-sulfatoethanesulfonyl)-phenylazo)-naphthalene-1,7-disulfonate412-490-7R43Xi

R: 43

S: (2-)22-24-37
611-108-00-8disodium 5-((4-((4-chloro-3-sulfonatophenyl)azo)-1-naphthyl)azo)-8-(phenylamino)-1-naphthalenesulfonate413-600-66527-62-4R52-53R: 52/53

S: 61
611-109-00-3Reaction products of: copper(II) sulfate and tetrasodium 2,4-bis[6-(2-methoxy-5-sulfonatophenylazo)-5-hydroxy-7-sulfonato-2-naphthylamino]-6-(2-hydroxyethylamino)-1,3,5-triazine (2:1)407-710-3N; R51-53N

R: 51/53

S: 61
611-110-00-9tetra-sodium/lithium 4,4'-bis-(8-amino-3,6-disulfonato-1-naphthol-2-ylazo)-3-methylazobenzene408-210-8124605-82-9R43

N; R51-53
Xi; N

R: 43-51/53

S: (2-)24-28-37-61
611-111-00-4disodium 2-[[4-(2-chloroethylsulfonyl)phenyl]-[(2-hydroxy-5-sulfo-3-[3-[2-(2-(sulfooxy)ethylsulfonyl)ethylazo]-4-sulfobenzoato(3-)cuprate(1-)414-230-8R43Xi

R: 43

S: (2-)22-24-37
611-112-00-Xtetrasodium 4-hydroxy-5-[4-[3-(2-sulfatoethanesulfonyl)phenylamino]-6-morpholin-4-yl-1,3,5-triazin-2-ylamino]-3-(1-sulfonatonaphthalen-2-ylazo)naphthalene-2,7-disulfonate413-070-6R43Xi

R: 43

S: (2-)22-24-37
611-113-00-5lithium sodium (2-(((5-((2,5-dichlorophenyl)azo)-2-hydroxyphenyl)methylene)amino)benzoato(2-))(2-((4,5-dihydro-3-methyl-5-oxo-1-phenyl-1H-pyrazol-4-yl)azo)-5-sulfobenzoato(3-)) chromate(2-)414-280-0149626-00-6N; R51-53N

R: 51/53

S: 24/25-61
611-114-00-0lithium sodium (4-((5-chloro-2-hydroxyphenyl)azo)-2,4-dihydro-5-methyl-3H-pyrazol-3-onato(2-))(3-((4,5-dihydro-3-methyl-1-(4-methylphenyl)-5-oxo-1H-pyrazol-4-yl)azo)-4-hydroxy-5-nitrobenzenesulfonato(3-)) chromate(2-)414-250-7149564-66-9Xn; R22

Xi; R41

R52-53
Xn

R: 22-41-52/53

S: (2-)22-26-39-61
611-115-00-6trilithium bis(4-((4-(diethylamino)-2-hydroxyphenyl)azo)-3-hydroxy-1-naphthalenesulfonato(3-))chromate(3-)414-290-5149564-65-8Xn; R22

R52-53
Xn

R: 22-52/53

S: (2-)22-61
611-116-00-1reaction mass of: trisodium 5-{4-chloro-6-[2-(2,6-dichloro-5-cyanopyrimidin-4-ylamino)-propylamino]-1,3,5-triazin-2-ylamino}-4-hydroxy-3-(1-sulfonatonaphthalene-2-ylazo)-naphthalene-2,7-disulfonate;

trisodium 5-{4-chloro-6-[2-(2,6-dichloro-5-cyanopyrimidin-4-ylamino)-1-methyl-ethylamino]-1,3,5-triazin-2-ylamino}-4-hydroxy-3-(1-sulfonatonaphthalene-2-ylazo)-naphthalene-2,7-disulfonate;

trisodium 5-{4-chloro-6-[2-(4,6-dichloro-5-cyanopyrimidin-2-ylamino)-propylamino]-1,3,5-triazin-2-ylamino}-4-hydroxy-3-(1-sulfonatonaphthalen-2-ylazo)-naphthalene-2,7-disulfonate;

trisodium 5-{4-chloro-6-[2-(4,6-dichloro-5-cyanopyrimidin-2-ylamino)-1-methyl-ethylamino]-1,3,5-triazin-2-ylamino}-4-hydroxy-3-(1-sulfonatonaphthalen-2-ylazo)-naphthalene-2,7-disulfonate
414-620-8Xi; R41

R43
Xi

R: 41-43

S: (2-)22-24-26-37/39
611-117-00-71,3-bis{6-fluoro-4-[1,5-disulfo-4-(3-aminocarbonyl-1-ethyl-6-hydroxy-4-methyl-pyrid-2-on-5-ylazo)-phenyl-2-ylamino]-1,3,5-triazin-2-ylamino}propane lithium-, sodium salt415-100-3149850-29-3R43Xi

R: 43

S: (2-)22-24-37
611-118-00-2sodium 1,2-bis[4-[4-{4-(4-sulfophenylazo)-2-sulfophenylazo}-2-ureido-phenyl-amino]-6-fluoro-1,3,5-triazin-2-ylamino]-propane, sodium salt413-990-8R43Xi

R: 43

S: (2-)22-24-37
611-119-00-8tetrasodium 4-[4-chloro-6-(4-methyl-2-sulfophenylamino)-1,3,5-triazin-2-ylamino]-6-(4,5-dimethyl-2-sulfophenylazo)-5-hydroxynaphthalene-2,7-disulfonate415-400-4148878-22-2Xi; R41

R43
Xi

R: 41-43

S: (2-)22-24-26-37/39
611-120-00-35-{4-[5-amino-2-[4-(2-sulfoxyethylsulfonyl)phenylazo]-4-sulfo-phenylamino]-6-chloro-1,3,5-triazin-2-ylamino}-4-hydroxy-3-(1-sulfo-naphthalen-2-ylazo)-naphthalene-2,7-disulfonicacid sodium salt418-340-7157707-94-3Xi; R41

R52-53
Xi

R: 41-52/53

S: (2-)22-26-39-61
611-121-00-9Main component 6 (isomer): asym. 1:2 Cr(III)-complex of: A: 3-hydroxy-4-(2-hydroxy-naphthalene-1-ylazo)naphthalene-1-sulfonic acid, Na-salt and B: 1-[2-hydroxy-5-(4-methoxy-phenylazo)phenylazo]naphthalene-2-ol;

Main component 8 (isomer): asym. 1:2 Cr-complex of: A: 3-hydroxy-4-(2-hydroxy-naphthalene-1-ylazo)-naphthalene-1-sulfonic acid, Na-salt and B: 1-[2-hydroxy-5-(4-methoxy-phenylazo)-phenylazo]-naphthalene-2-ol
417-280-930785-74-1Xi; R41

N; R50-53
Xi; N

R: 41-50/53

S: (2-)26-39-60-61
611-122-00-4hexasodium (di[N-(3-(4-[5-(5-amino-3-methyl-1-phenylpyrazol-4-yl-azo)-2,4-disulfo-anilino]-6-chloro-1,3,5-triazin-2-ylamino)phenyl)-sulfamoyl](di-sulfo)-phthalocyaninato)nickel417-250-5151436-99-6Xi; R41

R43
Xi

R: 41-43

S: (2-)22-24-26-37/39
611-123-00-X3-(2,4-bis(4-((5-(4,6-bis(2-aminopropylamino)-1,3,5-triazin-2-ylamino)-4-hydroxy-2,7-disulfonaphthalen-3-yl)azo)phenylamino)-1,3,5-triazin-6-ylamino)propyldiethylammonium lactate424-310-4178452-66-9Xi; R41Xi

R: 41

S: (2-)26-39
611-124-00-5reaction mass of: pentasodium 5-amino-3-(5-{4-chloro-6-[4-(2-sulfoxyethoxysulfonato)phenylamino]-1,3,5-triazin-2-ylamino}-2-sulfonatophenylazo)-6-[5-(2,3-dibromopropionylamino)-2-sulfonatophenylazo]-4-hydroxynaphthalene-2,7-disulfonate;

pentasodium 5-amino-6-[5-(2-bromoacryloylamino)-2-sulfonatophenylazo]-3-(5-{4-chloro-6-[4-(2-sulfoxyethoxysulfonato)phenylamino]-1,3,5-triazin-2-ylamino}-2-sulfonatophenylazo)-4-hydroxynaphthalene-2,7-disulfonate;

tetrasodium 5-amino-3-[5-{4-chloro-6-[4-(vinylsulfonyl)phenylamino]-1,3,5-triazin-2-ylamino}-2-sulfonatophenylazo]-6-[5-(2,3-dibromopropionylamino)-2-sulfonatophenylazo]-4-hydroxynaphthalene-2,7-disulfonate
424-320-9Xi; R41

N; R51-53
Xi; N

R: 41-51/53

S: (2-)26-39-61
611-125-00-0reaction mass of: Disodium 6-[3-carboxy-4,5-dihydro-5-oxo-4-sulfonatophenyl)pyrazolin-4-yl-azo]-3-[2-oxido-4-(ethensulfonyl)-5-methoxyphenylazo]-4-oxidonaphthalene-2-sulfonate copper (II) complex;

Disodium 6-[3-carboxy-4,5-dihydro-5-oxo-4-sulfonatophenyl)pyrazolin-4-yl-azo]-3-[2-oxido-4-(2-hydroxyethylsulfonyl)-5-methoxyphenylazo]-4-oxidonaphthalene-2-sulfonate copper (II) complex
423-940-7Xi; R41

N; R51-53
Xi; N

R: 41-51/53

S: (2-)26-39-61
611-126-00-62,6-bis-(2-(4-(4-amino-phenylamino)-phenylazo)-1,3-dimethyl-3H-imidazolium)-4-dimethylamino-1,3,5-triazine, dichloride424-120-1174514-06-8Xi; R41

N; R50-53
Xi; N

R: 41-50/53

S: (2-)26-39-60-61
611-127-00-1pentasodium 4-amino-6-(5-(4-(2-ethyl-phenylamino)-6-(2-sulfatoethanesulfonyl)-1,3,5-triazin-2-ylamino)-2-sulfonatophenylazo)-5-hydroxy-3-(4-(2-sulfatoethanesulfonyl)phenylazo)naphthalene-2,7-disulfonate423-790-2R5

Xi; R41

R43

R52-53
Xi

R: 5-41-43-52/53

S: (2-)22-26-36/37/39-41-61
611-128-00-7N,N'-bis{6-chloro-4-[6-(4-vinylsulfonylphenylazo)-2,7-disulfonicacid-5-hydroxynapht-4-ylamino]-1,3,5-triazin-2-yl}-N-(2-hydroxyethyl)ethane-1,2-diamine, sodium salt419-500-9171599-85-2Xi; R41

R43
Xi

R: 41-43

S: (2-)22-24-26-37/39
611-129-00-2reaction mass of: 5-[(4-[(7-amino-1-hydroxy-3-sulfo-2-naphthyl)azo]-2,5-diethoxyphenyl)azo]-2-[(3-phosphonophenyl)azo]benzoic acid;

5-[(4-[(7-amino-1-hydroxy-3-sulfo-2-naphthyl)azo]-2,5-diethoxyphenyl)azo]-3-[(3-phosphonophenyl)azo]benzoic acid
418-230-9163879-69-4E; R2

Repr. Cat. 3; R62

Xn; R48/22

R43

N; R51-53
E; Xn; N

R: 2-43-48/22-62-51/53

S: (2-)26-35-36/37-61
611-130-00-8tetra-ammonium 2-[6-[7-(2-carboxylato-phenylazo)-8-hydroxy-3,6-disulfonato-1-naphthylamino]-4-hydroxy-1,3,5-triazin-2-ylamino]benzoate418-520-5183130-96-3Xi; R36

N; R50-53
Xi; N

R: 36-50/53

S: (2-)26-39-60-61
611-131-00-32-[2-hydroxy-3-(2-chlorophenyl)carbamoyl-1-naphthylazo]-7-[2-hydroxy-3-(3-methylphenyl)carbamoyl-1-naphthylazo]fluoren-9-one420-580-2151798-26-4Repr. Cat. 2; R61

R53
T

R: 61-53

S: 53-45-61
611-132-00-9pentasodium bis{7-[4-(1-butyl-5-cyano-1,2-dihydro-2-hydroxy-4-methyl-6-oxo-3-pyridylazo)phenylsulfonylamino]-5'-nitro-3,3'-disulfonatonaphthalene-2-azobenzene-1,2'-diolato} chromate (III)419-210-2178452-71-6Xi; R41

R52-53
Xi

R: 41-52/53

S: (2-)26-39-61
611-133-00-4Product by process iron complex of azo dyestuffs obtained by coupling a mixture of diazotized 2-amino-1-hydroxybenzene-4-sulfanilide and 2-amino-1-hydroxybenzene-4-sulfonamide with resorcin, the obtained mixture being subsequently submitted to a second coupling reaction with a mixture of diazotized 3-aminobenzene-1-sulfonic acid (metanilic acid) and 4'-amino-4-nitro-1,1'-diphenylamine-2-sulfonic acid and metallization with ferric chloride, sodium salt419-260-5Xi; R41

N; R51-53
Xi; N

R: 41-51/53

S: (2-)26-39-61
611-134-00-Xtrisodium 2-{α[2-hydroxy-3-[4-chloro-6-[4-(2,3-dibromopropionylamino)-2-sulfonatophenylamino]-1,3,5-triazin-2-ylamino]-5-sulfonatophenylazo]-benzylidenehydrazino}-4-sulfonatobenzoate, copper complex423-770-3Xi; R41

N; R51-53
Xi; N

R: 41-51/53

S: (2-)22-26-39-61
611-135-00-5Reaction product of: 2-[[4-amino-2-ureidophenylazo]-5-[(2-(sulfooxy)ethyl)sulfonyl]]benzenesulfonic acid with 2,4,6-trifluoropyrimidine and partial hydrolysis to the corresponding vinylsulfonyl derivative,mixed potassium/sodium salt424-250-9Xi; R41

R52-53
Xi

R: 41-52/53

S: (2-)26-39-61
611-136-00-02-{4-(2-ammoniopropylamino)-6-[4-hydroxy-3-(5-methyl-2-methoxy-4-sulfamoylphenylazo)-2-sulfonatonaphth-7-ylamino]-1,3,5-triazin-2-ylamino}-2-aminopropyl formate424-260-3Repr. Cat. 3; R62

Xi; R41

N; R51-53
Xn; N

R: 41-62-51/53

S: (2-)22-26-36/37/39-61
611-137-00-66-tert-butyl-7-chloro-3-tridecyl-7,7a-dihydro-1H-pyrazolo[5,1-c]-1,2,4-triazole419-870-1159038-16-1R53R: 53

S: 61
611-138-00-12-(4-aminophenyl)-6-tert-butyl-1H-pyrazolo[1,5-b][1,2,4]triazole415-910-7152828-25-6R43

N; R51-53
Xi; N

R: 43-51/53

S: (2-)22-24-37-61
611-140-00-2azafenidin (ISO)

2-(2,4-dichloro-5-prop-2-ynyloxyphenyl)-5,6,7,8-tetrahydro-1,2,4-triazolo[4,3-a]pyridin-3(2H)-one
68049-83-2Repr. Cat. 2; R61

Repr. Cat. 3; R62

Xn; R48/22

N; R50-53
T; N

R: 61-48/22-62-50/53

S: 53-45-60-61
N; R50-53: C ≥ 0,025 %

N; R51-53: 0,0025 % ≤ C < 0,025 %

R52-53: 0,00025 % ≤ C < 0,0025 %
E
612-001-00-9mono-methylamine; [1]

di-methylamine; [2]

tri-methylamine [3]
200-820-0 [1]

204-697-4 [2]

200-875-0 [3]
74-89-5 [1]

124-40-3 [2]

75-50-3 [3]
F+; R12

Xn; R20

Xi; R37/38-41
F+; Xn

R: 12-20-37/38-41

S: (2-)16-26-39
Xn; R20: C ≥ 5 %

Xi; R37/38-41: C ≥ 5 %

Xi; R36: 0,5 % ≤ C < 5 %
5
612-001-01-6mono-methylamine ... %; [1]

di-methylamine ... %; [2]

tri-methylamine ... % [3]
200-820-0 [1]

204-697-4 [2]

200-875-0 [3]
74-89-5 [1]

124-40-3 [2]

75-50-3 [3]
F+; R12

Xn; R20/22

C; R34
F+; C

R: 12-20/22-34

S: (1/2-)3-16-26-29-36/37/39-45
Xn; R20/22: C ≥ 15 %

C; R34: C ≥ 10 %

Xi; R36/37/38: 5 % ≤ C < 10 %
B
612-002-00-4ethylamine200-834-775-04-7F+; R12

Xi; R36/37
F+; Xi

R: 12-36/37

S: (2-)16-26-29
612-003-00-Xdiethylamine203-716-3109-89-7F; R11

Xn; R20/21/22

C; R35
F; C

R: 11-20/21/22-35

S: (1/2-)3-16-26-29-36/37/39-45
C; R35: C ≥ 10 %

C; R34: 5 % ≤ C < 10 %

Xi; R36/37/38: 1 % ≤ C < 5 %
612-004-00-5triethylamine204-469-4121-44-8F; R11

Xn; R20/21/22

C; R35
F; C

R: 11-20/21/22-35

S: (1/2-)3-16-26-29-36/37/39-45
C; R35: C ≥ 10 %

C; R34: 5 % ≤ C < 10 %

Xi; R36/37/38: 1 % ≤ C < 5 %
612-005-00-0butylamine203-699-2109-73-9F; R11

Xn; R20/21/22

C; R35
F; C

R: 11-20/21/22-35

S: (1/2-)3-16-26-29-36/37/39-45
C; R35: C ≥ 10 %

C; R34: 5 % ≤ C < 10 %

Xi; R36/37/38: 1 % ≤ C < 5 %
612-006-00-6ethylenediamine;

1,2-diaminoethane
203-468-6107-15-3R10

Xn; R21/22

C; R34

R42/43
C

R: 10-21/22-34-42/43

S: (1/2-)23-26-36/37/39-45
C; R34: C ≥ 10 %

Xi; R36/38: 2 % ≤ C < 10 %
612-007-00-12-aminopropane;

isopropylamine
200-860-975-31-0F+; R12

Xi; R36/37/38
F+; Xi

R: 12-36/37/38

S: (2-)16-26-29
612-008-00-7aniline200-539-362-53-3Carc. Cat. 3; R40

Muta. Cat. 3; R68

T; R23/24/25-48/23/24/25

Xi; R41

R43

N; R50
T; N

R: 23/24/25-40-41-43-48/23/24/25-68-50

S: (1/2-)26-27-36/37/39-45-46-61-63
T; R23/24/25: C ≥ 25 %

Xn; R20/21/22: 1 % ≤ C < 25 %

T; R48/23/24/25: C ≥ 1 %

Xn; R48/20/21/22: 0,2 % ≤ C < 1 %
612-009-00-2salts of anilineCarc. Cat. 3; R40

Muta. Cat. 3; R68

T; R23/24/25-48/23/24/25

Xi; R41

R43

N; R50
T; N

R: 23/24/25-40-41-43-48/23/24/25-68-50

S: (1/2-)26-27-36/37/39-45-61-63
T; R23/24/25: C ≥ 25 %

Xn; R20/21/22: 1 % ≤ C < 25 %

T; R48/23/24/25: C ≥ 1 %

Xn; R48/20/21/22: 0,2 % ≤ C < 1 %
A
612-010-00-8chloroanilines, with exception of those specified elsewhere in this AnnexT; R23/24/25

R33

N; R50-53
T; N

R: 23/24/25-33-50/53

S: (1/2-)28-36/37-45-60-61
C
612-011-00-34-nitrosoaniline211-535-6659-49-4Xn; R20/21/22Xn

R: 20/21/22

S: (2-)25-28
612-012-00-9o-nitroaniline; [1]

m-nitroaniline; [2]

p-nitroaniline [3]
201-855-4 [1]

202-729-1 [2]

202-810-1 [3]
88-74-4 [1]

99-09-2 [2]

100-01-6 [3]
T; R23/24/25

R33

R52-53
T

R: 23/24/25-33-52/53

S: (1/2-)28-36/37-45-61
C
612-013-00-43-aminobenzene sulphonic acid;

metanilic acid
204-473-6121-47-1Xn; R20/21/22Xn

R: 20/21/22

S: (2-)25-28
612-014-00-Xsulphanilic acid;

4-aminobenzenesulphonic acid
204-482-5121-57-3Xi; R36/38

R43
Xi

R: 36/38-43

S: (2-)24-37
612-015-00-5N-methylaniline202-870-9100-61-8T; R23/24/25

R33

N; R50-53
T; N

R: 23/24/25-33-50/53

S: (1/2-)28-36/37-45-60-61
612-016-00-0N,N-dimethylaniline204-493-5121-69-7Carc. Cat. 3; R40

T; R23/24/25

N; R51-53
T; N

R: 23/24/25-40-51/53

S: (1/2-)28-36/37-45-61
612-017-00-6N-methyl-N,2,4,6-tetranitroaniline;

tetryl
207-531-9479-45-8E; R2 ⊗

T; R23/24/25

R33
E; T

R: 2-23/24/25-33

S: (1/2-)35-45
612-018-00-1bis(2,4,6-trinitrophenyl)amine;

hexyl
205-037-8131-73-7E; R2 ⊗

T+; R26/27/28

R33

N; R51-53
E; T+; N

R: 2-26/27/28-33-51/53

S: (1/2-)35-36-45-61
612-019-00-7dipicrylamine, ammonium salt220-639-02844-92-0E ⊗

R1

T+; R26/27/28

R33

N; R51-53
E; T+; N

R: 1-26/27/28-33-51/53

S: (1/2-)28-36/37-45-61
612-020-00-21-naphthylamine205-138-7134-32-7Xn; R22

N; R51-53
Xn; N

R: 22-51/53

S: (2-)24-61
612-022-00-32-naphthylamine202-080-491-59-8Carc. Cat. 1; R45

Xn; R22

N; R51-53
T; N

R: 45-22-51/53

S: 53-45-61
Carc. Cat. 1; R45: C ≥ 0,01 %E
612-023-00-9phenylhydrazine; [1]

phenylhydrazinium chloride; [2]

phenylhydrazine hydrochloride; [3]

phenylhydrazinium sulphate (2:1) [4]
202-873-5 [1]

200-444-7 [2]

248-259-0 [3]

257-622-2 [4]
100-63-0 [1]

59-88-1 [2]

27140-08-5 [3]

52033-74-6 [4]
Carc. Cat. 2; R45

Muta. Cat. 3; R68

T; R23/24/25-48/23/24/25

Xi; R36/38

R43

N; R50
T; N

R: 45-23/24/25-36/38-43-48/23/24/25-68-50

S: 53-45-61
E
612-024-00-4m-toluidine;

3-aminotoluene
203-583-1108-44-1T; R23/24/25

R33

N; R50
T; N

R: 23/24/25-33-50

S: (1/2-)28-36/37-45-61
612-025-00-Xnitrotoluidines, with the exception of those specified elsewhere in this AnnexT; R23/24/25

R33

N; R51-53
T; N

R: 23/24/25-33-51/53

S: (1/2-)28-36/37-45-61
C
612-026-00-5diphenylamine204-539-4122-39-4T; R23/24/25

R33

N; R50-53
T; N

R: 23/24/25-33-50/53

S: (1/2-)28-36/37-45-60-61
612-027-00-0xylidines with the exception of those specified elsewhere in this Annex;

dimethyl anilines with the exception of those specified elsewhere in this Annex
T; R23/24/25

R33

N; R51-53
T; N

R: 23/24/25-33-51/53

S: (1/2-)28-36/37-45-61
C
612-028-00-6p-phenylenediamine203-404-7106-50-3T; R23/24/25

Xi; R36

R43

N; R50-53
T+; N

R: 23/24/25-36-43-50/53

S: (1/2-)28-36/37-45-60-61
612-029-00-1benzene-1,4-diamine dihydrochloride;

p-phenylenediamine dihydrochloride
210-834-9624-18-0T; R23/24/25

Xi; R36

R43

N; R50-53
T; N

R: 23/24/25-36-43-50/53

S: (1/2-)28-36/37-45-60-61
612-030-00-72-methyl-p-phenylenediamine sulphate [1]210-431-8 [1]

228-871-4 [2]
615-50-9 [1]

6369-59-1 [2]
T; R25

Xn; R20/21

R43

N; R51-53
T; N

R: 20/21-25-43-51/53

S: (1/2-)24-37-45-61
612-031-00-2N,N-dimethylbenzene-1,3-diamine; [1]

4-amino-N,N-dimethylaniline;

3-amino-N,N'-dimethylaniline [2]
220-623-3 [1]

202-807-5 [2]
2836-04-6 [1]

99-98-9 [2]
T; R23/24/25T

R: 23/24/25

S: (1/2-)28-45
C
612-032-00-8N,N,N',N'-tetramethyl-p-phenylenediamine202-831-6100-22-1Xn; R20/21/22Xn

R: 20/21/22

S: (2-)28
612-033-00-32-aminophenol202-431-195-55-6Xn; R20/22

Muta. Cat. 3; R68
Xn

R: 20/22-68

S: (2-)28-36/37
612-034-00-92-amino-4,6-dinitrophenol;

picramic acid
202-544-696-91-3E; R1 ⊗

Xn; R20/21/22

R52-53
E; Xn

R: 1-20/21/22-52/53

S: (2-)35-61
612-035-00-42-methoxyaniline;

o-anisidine
201-963-190-04-0Carc. Cat. 2; R45

Muta. Cat. 3; R68

T; R23/24/25
T

R: 45-23/24/25-68

S: 53-45
E
612-036-00-X3,3'-dimethoxybenzidine;

o-dianisidine
204-355-4119-90-4Carc. Cat. 2; R45

Xn; R22
T

R: 45-22

S: 53-45
E
612-037-00-5salts of 3,3'-dimethoxybenzidine;

salts of o-dianisidine
Carc. Cat. 2; R45

Xn; R22
T

R: 45-22

S: 53-45
AE
612-038-00-02-nitro-p-anisidine;

4-methoxy-2-nitroaniline
202-547-296-96-8T+; R26/27/28

R33

R52-53
T+

R: 26/27/28-33-52/53

S: (1/2-)28-36/37-45-61
612-039-00-62-ethoxyaniline;

o-phenetidine
202-356-494-70-2T; R23/24/25

R33
T

R: 23/24/25-33

S: (1/2-)28-36/37-45
612-040-00-12,4-dinitroaniline202-553-597-02-9T+; R26/27/28

R33

N; R51-53
T+; N

R: 26/27/28-33-51/53

S: (1/2-)28-36/37-45-61
612-041-00-74,4'-bi-o-toluidine204-358-0119-93-7Carc. Cat. 2; R45

Xn; R22

N; R51-53
T; N

R: 45-22-51/53

S: 53-45-61
E
612-042-00-2benzidine;

1,1'-biphenyl-4,4'-diamine;

4,4'-diaminobiphenyl;

biphenyl-4,4'-ylenediamine
202-199-192-87-5Carc. Cat. 1; R45

Xn; R22

N; R50-53
T; N

R: 45-22-50/53

S: 53-45-60-61
Carc. Cat. 1; R45: C ≥ 0,01 %E
612-043-00-8N,N'-dimethylbenzidine2810-74-4Xn; R20/21/22Xn

R: 20/21/22

S: (2-)22-36
612-044-00-3N,N'-diacetylbenzidine210-338-2613-35-4Xn; R20/21/22Xn

R: 20/21/22

S: (2-)22-36
612-046-00-4allylamine203-463-9107-11-9F; R11

T; R23/24/25

N; R51-53
F; T; N

R: 11-23/24/25-51/53

S: (1/2-)9-16-24/25-45-61
612-047-00-Xbenzylamine202-854-1100-46-9Xn; R21/22

C; R34
C

R: 21/22-34

S: (1/2-)26-36/37/39-45
612-048-00-5dipropylamine205-565-9142-84-7F; R11

Xn; R20/21/22

C; R35
F; C

R: 11-20/21/22-35

S: (1/2-)16-26-36/37/39-45
C; R35: C ≥ 10 %

C; R34: 5 % ≤ C < 10 %

Xi; R36/37/38: 1 % ≤ C < 5 %
612-049-00-0di-n-butylamine; [1]

di-sec-butylamine [2]
203-921-8 [1]

210-937-9 [2]
111-92-2 [1]

626-23-3 [2]
R10

Xn; R20/21/22
Xn

R: 10-20/21/22

S: (2-)
612-050-00-6cyclohexylamine203-629-0108-91-8R10

Xn; R21/22

C; R34
C

R: 10-21/22-34

S: (1/2-)36/37/39-45
C; R34: C ≥ 10 %

Xi; R36/38: 2 % ≤ C < 10 %
612-051-00-14,4'-diaminodiphenylmethane;

4,4'-methylenedianiline
202-974-4101-77-9Carc. Cat. 2; R45

Muta. Cat. 3; R68

T; R39/23/24/25

Xn; R48/20/21/22

R43

N; R51-53
T; N

R: 45-39/23/24/25-43-48/20/21/22-68-51/53

S: 53-45-61
E
612-052-00-7(S)-sec-butylamine;

(S)-2-aminobutane; [1]

(R)-sec-butylamine;

(R)-2-aminobutane; [2]

sec-butylamine;

2-aminobutane [3]
208-164-7 [1]

236-232-6 [2]

237-732-7 [3]
513-49-5 [1]

13250-12-9 [2]

13952-84-6 [3]
F; R11

Xn; R20/22

C; R35

N; R50
F; C; N

R: 11-20/22-35-50

S: (1/2-)9-16-26-28-36/37/39-45-61
C
612-053-00-2N-ethylaniline203-135-5103-69-5T; R23/24/25

R33
T

R: 23/24/25-33

S: (1/2-)28-37-45
612-054-00-8N,N-diethylaniline202-088-891-66-7T; R23/24/25

R33

N; R51-53
T; N

R: 23/24/25-33-51/53

S: (1/2-)28-37-45-61
T; R23/24/25: C ≥ 5 %

Xn; R20/21/22: 1 % ≤ C < 5 %
612-055-00-3N-methyl-o-toluidine; [1]

N-methyl-m-toluidine; [2]

N-methyl-p-toluidine [3]
210-260-9 [1]

211-795-0 [2]

210-769-6 [3]
611-21-2 [1]

696-44-6 [2]

623-08-5 [3]
T; R23/24/25

R33

R52-53
T

R: 23/24/25-33-52/53

S: (1/2-)28-36/37-45-61
C
612-056-00-9N,N-dimethyl-p-toluidine; [1]

N,N-dimethyl-m-toluidine; [2]

N,N-dimethyl-o-toluidine [3]
202-805-4 [1]

204-495-6 [2]

210-199-8 [3]
99-97-8 [1]

121-72-2 [2]

609-72-3 [3]
T; R23/24/25

R33

R52-53
T

R: 23/24/25-33-52/53

S: (1/2-)28-36/37-45-61
T; R23/24/25: C ≥ 5 %

Xn; R20/21/22: 1 % ≤ C < 5 %
C
612-057-00-4piperazine203-808-3110-85-0C; R34

R42/43

R52-53
C

R: 34-42/43-52/53

S: (1/2-)22-26-36/37/39-45-61
612-058-00-X2,2'-iminodiethylamine;

diethylenetriamine
203-865-4111-40-0Xn; R21/22

C; R34

R43
C

R: 21/22-34-43

S: (1/2-)26-36/37/39-45
612-059-00-53,6-diazaoctanethylenediamin;

triethylenetetramine
203-950-6112-24-3Xn; R21

C; R34

R43

R52-53
C

R: 21-34-43-52/53

S: (1/2-)26-36/37/39-45-61
612-060-00-03,6,9-triazaundecamethylenediamine;

tetraethylenepentamine
203-986-2112-57-2Xn; R21/22

C; R34

R43

N; R51-53
C; N

R: 21/22-34-43-51/53

S: (1/2-)26-36/37/39-45-61
612-061-00-63-aminopropyldimethylamine;

N,N-dimethyl-1,3-diaminopropane
203-680-9109-55-7R10

Xn; R22

C; R34

R43
C

R: 10-22-34-43

S: (1/2-)26-36/37/39-45
612-062-00-13-aminopropyldiethylamine;

N,N-diethyl-1,3-diaminopropane
203-236-4104-78-9R10

Xn; R21/22

C; R34

R43
C

R: 10-21/22-34-43

S: (1/2-)26-36/37/39-45
612-063-00-73,3'-iminodi(propylamine);

dipropylenetriamine
200-261-256-18-8T+; R26

T; R24

Xn; R22

C; R35

R43
T+; C

R: 22-24-26-35-43

S: (1/2-)26-28-36/37/39-45
612-064-00-23,6,9,12-tetra-azatetradecamethylenediamine;

pentacthylenehexamine
223-775-94067-16-7C; R34

R43

N; R50-53
C; N

R: 34-43-50/53

S: (1/2-)26-36/37/39-45-60-61
612-065-00-8polyethlyenepolyamines with the exception of those specified elsewhere in this AnnexXn; R21/22

C; R34

R43

N; R50-53
C; N

R: 21/22-34-43-50/53

S: (1/2-)26-36/37/39-45-60-61
612-066-00-3dicyclohexylamine202-980-7101-83-7Xn; R22

C; R34

N; R50-53
C; N

R: 22-34-50/53

S: (1/2-)26-36/37/39-45-60-61
C; R34: C ≥ 10 %

Xi; R36/38: 2 % ≤ C < 10 %
612-067-00-93-aminomethyl-3,5,5-trimethylcyclohexylamine220-666-82855-13-2Xn; R21/22

C; R34

R43

R52-53
C

R: 21/22-34-43-52/53

S: (1/2-)26-36/37/39-45-61
612-068-00-43,3'-dichlorobenzidine;

3,3'-dichlorobiphenyl-4,4'-ylenediamine
202-109-091-94-1Carc. Cat. 2; R45

Xn; R21

R43

N; R50-53
T; N

R: 45-21-43-50/53

S: 53-45-60-61
E
612-069-00-Xsalts of 3,3'-dichlorobenzidine;

salts of 3,3'-dichlorobiphenyl-4,4'-ylenediamine










Carc. Cat. 2; R45

Xn; R21

R43

N; R50-53
T; N

R: 45-21-43-50/53

S: 53-45-60-61
AE
612-070-00-5salts of benzidine [208-519-6

208-520-1

244-236-4

252-984-8
531-85-1

531-86-2

21136-70-9

36341-27-2
Carc. Cat. 1; R45

Xn; R22

N; R50-53
T; N

R: 45-22-50/53

S: 53-45-60-61
AE
612-071-00-0salts of 2-naphthylamine209-030-0

210-313-6
553-00-4

612-52-2
Carc. Cat. 1; R45

Xn; R22

N; R51-53
T; N

R: 45-22-51/53

S: 53-45-61
AE
612-072-00-6biphenyl-4-ylamine;

xenylamine;

4-aminobiphenyl
202-177-192-67-1Carc. Cat. 1; R45

Xn; R22
T

R: 45-22

S: 53-45
E
612-073-00-1salts of biphenyl-4-ylamine;

salts of xenylamine;

salts of 4-aminobiphenyl
Carc. Cat. 1; R45

Xn; R22
T

R: 45-22

S: 53-45
AE
612-074-00-7benzyldimethylamine203-149-1103-83-3R10

Xn; R20/21/22

C; R34

R52-53
C

R: 10-20/21/22-34-52/53

S: (1/2-)26-36-45-61
612-075-00-22-aminoethyldimethylamine;

2-dimethylaminoethylamine
203-541-2108-00-9F; R11

Xn; R21/22

C; R35
F; C

R: 11-21/22-35

S: (1/2-)16-23-26-28-36-45
612-076-00-8ethyldimethylamine209-940-8598-56-1F+; R12 ⊗

Xn; R20/22

C; R34
F+; C

R: 12-20/22-34

S: (1/2-)3-16-26-36-45
612-077-00-3dimethylnitrosoamine;

N-nitrosodimethylamine
200-549-862-75-9Carc. Cat. 2; R45

T+; R26

T; R25-48/25

N; R51-53
T+; N

R: 45-25-26-48/25-51/53

S: 53-45-61
Carc. Cat. 2; R45: C ≥ 0,001 %E
612-078-00-92,2'-dichloro-4,4'-methylenedianiline;

4,4'-methylene bis(2-chloroaniline)
202-918-9101-14-4Carc. Cat. 2; R45

Xn; R22

N; R50-53
T; N

R: 45-22-50/53

S: 53-45-60-61
E
612-079-00-4salts of 2,2'-dichloro-4,4'-methylenedianiline;

salts of 4,4'-methylenebis(2-chloroaniline)
Carc. Cat. 2; R45

Xn; R22

N; R50-53
T; N

R: 45-22-50/53

S: 53-45-60-61
AE
612-080-00-X4-amino-N,N-diethylaniline;

N,N-diethyl-p-phenylendiamine
202-214-193-05-0T; R25

C; R34
T

R: 25-34

S: (1/2-)26-36-45
612-081-00-5salts of 4,4'-bi-o-toluidine;

salts of 3,3'-dimethylbenzidine;

salts of o-tolidine
210-322-5

265-294-7

277-985-0
612-82-8

64969-36-4

74753-18-7
Carc. Cat. 2; R45

Xn; R22

N; R51-53
T; N

R: 45-22-51/53

S: 53-45-61
AE
612-082-00-0thiourea;

thiocarbamide
200-543-562-56-6Carc. Cat. 3; R40

Repr. Cat. 3; R63

Xn; R22

N; R51-53
Xn; N

R: 22-40-51/53-63

S: (2-)36/37-61
612-083-00-61-methyl-3-nitro-1-nitrosoguanidine200-730-170-25-7Carc. Cat. 2; R45

Xn; R20

Xi; R36/38

N; R51-53
T; N

R: 45-20-36/38-51/53

S: 53-45-61
Carc. Cat. 2; R45: C ≥ 0,01 %E
612-084-00-1dapsone;

4,4'-diamino diphenyl sulfone
201-248-480-08-0Xn; R22Xn

R: 22

S: (2-)22
612-085-00-74,4'-methylenedi-o-toluidine212-658-8838-88-0Carc. Cat. 2; R45

Xn; R22

R43

N; R50-53
T; N

R: 45-22-43-50/53

S: 53-45-60-61
E
612-086-00-2amitraz (ISO);

N,N-bis(2,4-xylyliminomethyl) methylamine
251-375-433089-61-1Xn; R22-48/22

R43

N; R50-53
Xn; N

R: 22-43-48/22-50/53

S: (2-)22-24-60-36/37-61
N; R50-53: C ≥ 2,5 %

N; R51-53: 0,25 % ≤ C < 2,5 %

R52-53: 0,025 % ≤ C < 0,25 %
612-087-00-8guazatine (ISO)108173-90-6T+; R26

Xn; R21/22

Xi; R37/38-41

N; R50-53
T+; N

R: 21/22-26-37/38-41-50/53

S: (1/2-)26-28-36/37/39-38-45-46-60-61-63
612-088-00-3simazine (ISO);

6-chloro-N,N'-diethyl-1,3,5-triazine-2,4-diamine
204-535-2122-34-9Carc. Cat. 3; R40

N; R50-53
Xn; N

R: 40-50/53

S: (2-)36/37-46-60-61
612-089-00-91,5-naphthylenediamine218-817-82243-62-1Carc. Cat. 3; R40

N; R50-53
Xn; N

R: 40-50/53

S: (2-)36/37-60-61
612-090-00-42,2'-(nitrosoimino)bisethanol214-237-41116-54-7Carc. Cat. 2; R45T

R: 45

S: 53-45
612-091-00-Xo-toluidine;

2-aminotoluene
202-429-095-53-4Carc. Cat. 2; R45

T; R23/25

Xi; R36

N; R50
T; N

R: 45-23/25-36-50

S: 53-45-61
E
612-092-00-5N,N'-(2,2-dimethylpropylidene)hexamethylenediamine401-660-61000-78-8Xi; R38

R43
Xi

R: 38-43

S: (2-)24-37
612-093-00-03,5-dichloro-4-(1,1,2,2-tetrafluoroethoxy)aniline401-790-3104147-32-2Xn; R22

N; R50-53
Xn; N

R: 22-50/53

S: (2-)24/25-26-57-60-61
612-094-00-64-(2-chloro-4-trifluoromethyl)phenoxy-2-fluoroaniline hydrochloride402-190-4T; R48/25

Xn; R22-48/20

Xi; R41

R43

N; R50-53
T; N

R: 22-41-43-48/20-48/25-50/53

S: (1/2-)26-36/37/39-45-60-61
612-095-00-1benzyl-2-hydroxydodecyldimethylammonium benzoate402-610-6113694-52-3C; R34

Xn; R22

N; R50-53
C; N

R: 22-34-50/53

S: (1/2-)26-28-36/37/39-45-60-61
612-096-00-74,4'-carbonimidoylbis[N,N-dimethylaniline]207-762-5492-80-8Carc. Cat. 3; R40

Xn; R22

Xi; R36

N; R51-53
Xn; N

R: 22-36-40-51/53

S: (2-)36/37-61
612-097-00-2salts of 4,4'-carbonimidoylbis[N,N-dimethylaniline]Carc. Cat. 3; R40

Xn; R22

Xi; R36

N; R51-53
Xn; N

R: 22-36-40-51/53

S: (2-)36/37-61
A
612-098-00-8nitrosodipropylamine210-698-0621-64-7Carc. Cat. 2; R45

Xn; R22

N; R51-53
T; N

R: 45-22-51/53

S: 53-45-61
Carc. Cat. 2; R45: C ≥ 0,001 %E
612-099-00-34-methyl-m-phenylenediamine;

2,4-toluenediamine
202-453-195-80-7Carc. Cat. 2; R45

T; R25

Xn; R21

Xi; R36

R43

N; R51-53
T; N

R: 45-21-25-36-43-51/53

S: 53-45-61
E
612-100-00-7propylenediamine201-155-978-90-0R10

Xn; R21/22

C; R35
C

R: 10-21/22-35

S: (1/2-)26-37/39-45
612-101-00-2methenamine;

hexamethylenetetramine
202-905-8100-97-0F; R11

R42/43
F; Xn

R: 11-42/43

S: (2-)16-22-24-37
612-102-00-8N,N-bis(3-aminopropyl)methylamine203-336-8105-83-9T; R23/24

Xn; R22

C; R34
T

R: 22-23/24-34

S: (1/2-)26-36/37/39-45
612-103-00-3N,N,N',N'-tetramethylethylenediamine203-744-6110-18-9F; R11

Xn; R20/22

C; R34
F; C

R: 11-20/22-34

S: (1/2-)16-26-36/37/39-45
612-104-00-9hexamethylenediamine204-679-6124-09-4Xn; R21/22

Xi; R37

C; R34
C

R: 21/22-34-37

S: (1/2-)22-26-36/37/39-45
612-105-00-42-piperazin-1-ylethylamine205-411-0140-31-8Xn; R21/22

C; R34

R43

R52-53
C

R: 21/22-34-43-52/53

S: (1/2-)26-36/37/39-45-61
612-106-00-X2,6-diethylaniline209-445-7579-66-8Xn; R22Xn

R: 22

S: (2-)23-24
612-107-00-51-phenylethylamine; [1]

Dl-α-methylbenzylamine [2]
202-706-6 [1]

210-545-8 [2]
98-84-0 [1]

618-36-0 [2]
Xn; R21/22

C; R34
C

R: 21/22-34

S: (1/2-)26-28-36/37/39-45
612-108-00-03-aminopropyltriethoxysilane213-048-4919-30-2Xn; R22

C; R34
C

R: 22-34

S: (1/2-)26-36/37/39-45
612-109-00-6bis(2-dimethylaminoethyl)(methyl)amine221-201-13030-47-5T; R24

Xn; R22

C; R34
T

R: 22-24-34

S: (1/2-)26-36/37/39-45
612-110-00-12,2'-dimethyl-4,4'-methylenebis(cyclohexylamine)229-962-16864-37-5T; R23/24

Xn; R22

C; R35

N; R51-53
T; C; N

R: 22-23/24-35-51/53

S: (1/2-)26-36/37/39-45-61
612-111-00-72-methyl-m-phenylenediamine;

2,6-toluenediamine
212-513-9823-40-5Muta. Cat. 3; R68

Xn; R21/22

R43

N; R51-53
Xn; N

R: 21/22-43-51/53-68

S: (2-)24-36/37-61
612-112-00-2p-anisidine;

4-methoxyaniline
203-254-2104-94-9T+; R26/27/28

R33

N; R50
T+; N

R: 26/27/28-33-50

S: (1/2-)28-36/37-45-61
612-113-00-86-methyl-2,4-bis(methylthio)phenylene-1,3-diamine403-240-8106264-79-3Xn; R22

R43

N; R50-53
Xn; N

R: 22-43-50/53

S: (2-)24-37-60-61
612-114-00-3R,R-2-hydroxy-5-(1-hydroxy-2-(4-phenylbut-2-ylamino)ethyl)benzamide hydrogen 2,3-bis(benzoyloxy)succinate404-390-7F; R11

R43

R52-53
F; Xi

R: 11-43-52/53

S: (2-)24-37-61
612-115-00-9dimethyldioctadecylammonium hydrogen sulfate404-050-8123312-54-9Xi; R36

R53
Xi

R: 36-53

S: (2-)26-39-61
612-116-00-4C8-18alkylbis(2-hydroxyethyl)ammonium bis(2-ethylhexyl)phosphate404-690-868132-19-4T; R23

C; R34

R43

N; R50-53
T; N

R: 23-34-43-50/53

S: (1/2-)26-36/37/39-45-60-61
612-117-00-XC12-14-tert-alkylamine, methylphosphonic acid salt404-750-3119415-07-5Xn; R22

C; R34

N; R51-53
C; N

R: 22-34-51/53

S: (1/2-)26-28-36/37/39-45-61
612-118-00-5A reaction mass of: (1,3-dioxo-2H-benz(de)isoquinolin-2-ylpropyl)hexadecyldimethylammonium 4-toluenesulfonate; (1,3-dioxo-2H-benz(de)isoquinolin-2-ylpropyl)hexadecyldimethylammonium bromide405-080-4Xi; R41

N; R50-53
X; N

R: 41-50/53

S: (2-)22-26-39-60-61
612-119-00-0benzyldimethyloctadecylammonium 3-nitrobenzenesulfonate405-330-2Xi; R38-41

N; R50-53
Xi; N

R: 38-41-50/53

S: (2-)26-37/39-60-61
612-120-00-6aclonifen (ISO);

2-chloro-6-nitro-3-phenoxyaniline
277-704-174070-46-5N; R50-53N

R: 50/53

S: 60-61
612-121-00-1amines, polyethylenepoly-;

HEPA
268-626-968131-73-7Xn; R21/22

C; R34

R43

N; R50-53
C; N

R: 21/22-34-43-50/53

S: (1/2-)26-36/37/39-45-60-61
612-122-00-7hydroxylamine232-259-27803-49-8R5 ⊗

Xn; R22-48/22

Xi; R37/38-41

R43

N; R50
Xn; N

R: 5-22-37/38-41-43-48/22-50

S: (2-)22-26-36/37/39-61
612-123-00-2hydroxylammonium chloride;

hydroxylamine hydrochloride; [1]

bis(hydroxylammonium) sulphate;

hydroxylamine sulphate (2:1); [2]

hydroxylammonium hydrogensulphate;

hydroxylamine sulphate (1:1) [3]
226-798-2 [1]

233-118-8 [2]

233-154-4 [3]
5470-11-1 [1]

10039-54-0 [2]

10046-00-1 [3]
⊗ Xn; R22-48/22

Xi; R36/38

R43

N; R50
Xn; N

R: 22-36/38-43-48/22-50

S: (2-)22-24-37-61
612-124-00-8N,N,N-trimethylanilinium chloride205-319-0138-24-9T; R24/25T

R: 24/25

S: (1/2-)25-39-45-53
612-125-00-32-methyl-p-phenylenediamine;

2,5-toluenediamine
202-442-195-70-5T; R25

Xn; R20/21

R43

N; R51-53
T; N

R: 20/21-25-43-51/53

S: (1/2-)24-37-45-61
612-126-00-9toluene-2,4-diammonium sulphate;

4-methyl-m-phenylenediamine sulfate
265-697-865321-67-7Carc. Cat. 2; R45

T; R25

Xn; R21

Xi; R36

R43

N; R51-53
T; N

R: 45-21-25-36-43-51/53

S: 53-45-61
E
612-127-00-43-aminophenol209-711-2591-27-5Xn; R20/22

N; R51-53
Xn; N

R: 20/22-51/53

S: (2-)28-61
612-128-00-X4-aminophenol204-616-2123-30-8Muta. Cat. 3; R68

Xn; R20/22

N; R50-53
Xn; N

R: 20/22-50/53-68

S: (2-)28-36/37-60-61
612-129-00-5diisopropylamine203-558-5108-18-9F; R11

Xn; R20/22

C; R34
F; C

R: 11-20/22-34

S: (1/2-)16-26-36/37/39-45
C; R34: C ≥ 10 %

Xi; R36/37/38: 5 % ≤ C < 10 %
612-130-00-02,6-diamino-3,5-diethyltoluene;

4,6-diethyl-2-methyl-1,3-benzenediamine; [1]

2,4-diamino-3,5-diethyltoluene;

2,4-diethyl-6-methyl-1,3-benzenediamine; [2]

diethylmethylbenzenediamine [3]
218-255-3 [1]

218-256-9 [2]

270-877-4 [3]
2095-01-4 [1]

2095-02-5 [2]

68479-98-1 [3]
Xn; R21/22-48/22

Xi; R36

N; R50-53
Xn; N

R: 21/22-36-48/22-50/53

S: (2-)26-28-36/37/39-60-61
C
612-131-00-6didecyldimethylammonium chloride230-525-27173-51-5Xn; R22

C; R34
C

R: 22-34

S: (2-)26-36/37/39-45
612-132-00-1N,N'-diphenyl-p-phenylenediamine;

N,N'-diphenyl-1,4-benzenediamine
200-806-474-31-7R43

R52-53
Xi

R: 43-52/53

S: (2-)24-37-61
612-133-00-7(4-ammonio-m-tolyl)ethyl(2-hydroxyethyl)ammonium sulphate;

4-(N-ethyl-N-2-hydroxyethyl)-2-methylphenylenediamine sulphate
247-162-025646-77-9T; R25

Xn; R48/22

R43

N; R50-53
T; N

R: 25-43-48/22-50/53

S: (1/2-)24-37-45-60-61
612-134-00-2N-(2-(4-amino-N-ethyl-m-toluidino)ethyl)methanesulphonamide sesquisulphate;

4-(N-ethyl-N-2-methanesulphonylaminoethyl)-2-methylphenylenediamine sesquisulphate monohydrate
247-161-525646-71-3Xn; R22

R43

N; R50-53
Xn; N

R: 22-43-50/53

S: (2-)24-37-60-61
612-135-00-8N-2-naphthylaniline;

N-phenyl-2-naphthylamine
205-223-9135-88-6Carc. Cat. 3; R40

Xi; R36/38

R43

N; R51-53
Xn; N

R: 36/38-40-43-51/53

S: (2-)26-36/37-61
612-136-00-3N-isopropyl-N'-phenyl-p-phenylenediamine202-969-7101-72-4Xn; R22

R43

N; R50-53
Xn; N

R: 22-43-50/53

S: (2-)24-37-60-61
R43: C ≥ 0,1 %
612-137-00-94-chloroaniline203-401-0106-47-8Carc. Cat. 2; R45

T; R23/24/25

R43

N; R50-53
T; N

R: 45-23/24/25-43-50/53

S: 53-45-60-61
E
612-138-00-4furalaxyl (ISO);

methyl N-(2,6-dimethylphenyl)-N-(2-furylcarbonyl)-Dl-alaninate
260-875-157646-30-7Xn; R22

R52-53
Xn

R: 22-52/53

S: (2-)36/37/39-61
612-139-00-Xmefenacet (ISO);

2-(benzothiazol-2-yloxy)-N-methyl-N-phenylacetamide
277-328-873250-68-7N; R51-53N

R: 51/53

S: 61
612-140-00-5quaternary ammonium compounds, benzyl-C8-18-alkyldimethyl, chlorides264-151-663449-41-2Xn; R21/22

C; R34

N; R50
C; N

R: 21/22-34-50

S: (2-)36/37/39-45-61
612-141-00-04,4'-methylenebis(2-ethylaniline);

4,4'-methylenebis(2-ethylbenzeneamine)
243-420-119900-65-3Carc. Cat. 3; R40

Xn; R22

N; R50-53
Xn; N

R: 22-40-50/53

S: (2-)36/37-60-61
612-142-00-6biphenyl-2-ylamine201-990-990-41-5Carc. Cat. 3; R40

Xn; R22

R52-53
Xn

R: 22-40-52/53

S: (2-)36/37-61
612-143-00-1N5,N5-diethyltoluene-2,5-diamine monohydrochloride;

4-diethylamino-2-methylaniline monohydrochloride
218-130-32051-79-8T; R25

Xi; R36

R43

N; R50-53
T; N

R: 25-36-43-50/53

S: (1/2-)24-26-37-45-60-61
612-144-00-7flumetralin (ISO);

N-(2-chloro-6-fluorobenzyl)-N-ethyl-α,α,α-trifluoro-2,6-dinitro-p-toluidine
62924-70-3Xi; R36/38

R43

N; R50-53
Xi; N

R: 36/38-43-50/53

S: (2-)36/37-60-61
612-145-00-2o-phenylenediamine202-430-695-54-5Carc. Cat. 3; R40

Muta. Cat. 3; R68

T; R25

Xn; R20/21

Xi; R36

R43

N; R50-53
T; N

R: 20/21-25-36-40-43-50/53-68

S: (1/2-)28-36/37-45-60-61
612-146-00-8o-phenylenediamine dihydrochloride210-418-7615-28-1Carc. Cat. 3; R40

Muta. Cat. 3; R68

T; R25

Xn; R20/21

Xi; R36

R43

N; R50-53
T; N

R: 20/21-25-36-40-43-50/53-68

S: (1/2-)28-36/37-45-60-61
612-147-00-3m-phenylenediamine203-584-7108-45-2Muta. Cat. 3; R68

T; R23/24/25

Xi; R36

R43

N; R50-53
T; N

R: 23/24/25-36-43-50/53-68

S: (1/2-)28-36/37-45-60-61
612-148-00-9m-phenylenediamine dihydrochloride208-790-0541-69-5Muta. Cat. 3; R68

T; R23/24/25

Xi; R36

R43

N; R50-53
T; N

R: 23/24/25-36-43-50/53-68

S: (1/2-)28-36/37-45-60-61
612-149-00-41,3-diphenylguanidine203-002-1102-06-7Repr. Cat. 3; R62

Xn; R22

Xi; R36/37/38

N; R51-53
Xn; N

R: 22-36/37/38-51/53-62

S: (2-)26-36/37/39-61
612-150-00-Xspiroxamine (ISO);

8-tert-butyl-1,4-dioxaspiro[4.5]decan-2-ylmethyl(ethyl)(propyl)amine
118134-30-8Xn; R20/21/22

Xi; R38

R43

N; R50-53
Xn; N

R: 20/21/22-38-43-50/53

S: (2-)36/37/39-46-60-61
612-151-00-5diaminotoluene, technical product - reaction mass of [2] and [3];

methyl-phenylenediamine; [1]

4-methyl-m-phenylene diamine; [2]

2-methyl-m-phenylene diamine [3]
246-910-3 [1]

202-453-1 [2]

212-513-9 [3]
25376-45-8 [1]

95-80-7 [2]

823-40-5 [3]
Carc. Cat. 2; R45

T; R25

Xn; R20/21

Xi; R36

R43

N; R51-53
T; N

R: 45-20/21-25-36-43-51/53

S: 53-45-61
E
612-152-00-0N,N-diethyl-N',N'-dimethylpropan-1,3-diyl-diamine406-610-762478-82-4R10

Xn; R20/22-48/20

C; R35

R52-53
C

R: 10-20/22-35-48/20-52/53

S: (1/2-)26-28-36/37/39-45-61
612-153-00-64-[N-ethyl-N-(2-hydroxyethyl)amino]-1-(2-hydroxyethyl)amino-2-nitrobenzene, monohydrochloride407-020-2132885-85-9Xn; R22

R43

R52-53
Xn

R: 22-43-52/53

S: (2-)22-24-37-61
612-154-00-16'-(isobutylethylamino)-3'-methyl-2'-phenylamino-spiro[isobenzo-2-oxofuran-7,9'-[9H]-xanthene]410-890-695235-29-3R53R: 53

S: 61
612-155-00-72'-anilino-6'-((3-ethoxypropyl)ethylamino)-3'-methylspiro(isobenzo-3-oxofuran)-1-(1H)-9'-xanthene411-730-893071-94-4R53R: 53

S: 61
612-156-00-2reaction mass of: trihexadecylmethylammonium chloride;

dihexadecyldimethylammonium chloride
405-620-9Xi; R41

N; R50-53
Xi; N

R: 41-50/53

S: (2-)26-39-60-61
612-157-00-8(Z)-1-benzo[b]thien-2-ylethanone oxime hydrochloride410-780-8Xn; R22-48/22

Xi; R41

R43

N; R51-53
Xn; N

R: 22-41-43-48/22-51/53

S: (2-)22-26-36/37/39-61
612-158-00-3reaction mass of: bis(5-dodecyl-2-hydroxybenzald-oximate) copper (II) C12-alkyl group is branched;

4-dodecylsalicylaldoxime
410-820-4R53R: 53

S: 61
612-159-00-9Reaction products of: trimethylhexamethylene diamine (a mixture of 2,2,4-trimethyl-1,6-hexanediamine and 2,4,4-trimethyl-1,6-hexanediamine, EINECS listed), Epoxide 8 (mono[(C10-C16-alkyloxy)methyl]oxirane derivatives) and p-toluene-sulfonic acid410-880-1Xn; R22

C; R34

N; R50-53
C; N

R: 22-34-50/53

S: (1/2-)23-26-36/37/39-45-60-61
612-160-00-4p-toluidine;

4-aminotoluene; [1]

toluidinium chloride; [2]

toluidine sulphate (1:1) [3]
203-403-1 [1]

208-740-8 [2]

208-741-3 [3]
106-49-0 [1]

540-23-8 [2]

540-25-0 [3]
Carc. Cat. 3; R40

T; R23/24/25

Xi; R36

R43

N; R50
T; N

R: 23/24/25-36-40-43-50

S: (1/2-)28-36/37-45-61
612-161-00-X2,6-xylidine;

2,6-dimethylaniline
201-758-787-62-7Carc. Cat. 3; R40

Xn; R20/21/22

Xi; R37/38

N; R51-53
Xn; N

R: 20/21/22-37/38-40-51/53

S: (2-)23-25-36/37-61
612-162-00-5dimethyldioctadecylammonium chloride;

DODMAC
203-508-2107-64-2Xi; R41

N; R50-53
Xi; N

R: 41-50/53

S: (2-)24-26-39-46-60-61
612-163-00-0metalaxyl-M (ISO);

mefenoxam;

(R)-2-[(2,6-dimethylphenyl)-methoxyacetylamino]propionic acid methyl ester
70630-17-0Xn; R22

Xi; R41
Xn

R: 22-41

S: (2-)26-39-46
612-164-00-62-butyl-2-ethyl-1,5-diaminopentane412-700-7137605-95-9Xn; R21/22-48/22

C; R34

R43

R52-53
C

R: 21/22-34-43-48/22-52/53

S: (1/2-)26-36/37/39-45-61
612-165-00-1N,N'-diphenyl-N,N'-bis(3-methylphenyl)-(1,1'-diphenyl)-4,4'-diamine413-810-865181-78-4N; R51-53N

R: 51/53

S: 61
612-166-00-7reaction mass of: cis-(5-ammonium-1,3,3-trimethyl)-cyclohexanemethylammonium phosphate (1:1);

trans-(5-ammonium-1,3,3-trimethyl)-cyclohexanemethylammonium phosphate (1:1)
411-830-1114765-88-7Xi; R41

R43

R52-53
Xi

R: 41-43-52/53

S: (2-)24-26-37/39-61
612-167-00-25-acetyl-3-amino-10,11-dihydro-5H-dibenz[b,f]azepine-hydrochloride410-490-1Xn; R22-48/22

Xi; R41

R43

N; R51-53
Xn; N

R: 22-41-43-48/22-51/53

S: (2-)22-26-36/37/39-61
612-168-00-83,5-dichloro-2,6-difluoropyrdine-4-amine220-630-12840-00-8Xn; R21/22

N; R51-53
Xn; N

R: 21/22-51/53

S: (2-)36/37-61
612-170-00-94-chlorophenyl cyclopropyl ketone O-(4-aminobenzyl)oxime405-260-2Xn; R22

R43

N; R50-53
Xn; N

R: 22-43-50/53

S: (2-)24-37-60-61
612-171-00-4N,N,N',N'-tetraglycidyl-4,4'-diamino-3,3'-diethyldiphenylmethane410-060-3130728-76-6Muta. Cat. 3; R68

R43

N; R51-53
Xn; N

R: 43-68-51/53

S: (2-)36/37-61
612-172-00-X4,4'-methylenebis(N,N'-dimethylcyclohexanamine412-840-913474-64-1Xn; R22-48/22

C; R35

R52-53
C

R: 22-35-48/22-52/53

S: (1/2-)26-36/37/39-45-61
612-173-00-5lithium 1-amino-4-(4-tert-butylanilino)anthraquinone-2-sulfonate411-140-0125328-86-1Xi; R41

R43

N; R51-53
Xi; N

R: 41-43-51/53

S: (2-)22-26-36/37/39-61
612-174-00-04,4-dimethoxybutylamine407-690-619060-15-2Xn; R22

C; R34

R43

R52-53
C

R: 22-34-43-52/53

S: (1/2-)26-36/37/39-45-61
612-175-00-62-(O-aminooxy)ethylamine dihydrochloride412-310-737866-45-8R43

R52-53
Xi

R: 43-52/53

S: (2-)24-37-61
612-176-00-1Polymer of 1,3-dibromopropane and N,N-diethyl-N',N'-dimethyl-1,3-propanediamine410-570-6143747-73-3N; R50-53N

R: 50/53

S: 60-61
612-177-00-72-naphthylamino-6-sulfomethylamide412-120-4104295-55-8Xn; R48/22

R43

N; R51-53
Xn; N

R: 43-48/22-51/53

S: (2-)22-36/37-61
612-178-00-21,4,7,10-tetraazacyclododecane disulfate412-080-8112193-77-8Xn; R22

Xi; R37-41

R52-53
Xn

R: 22-37-41-52/53

S: (2-)26-36/37/39-61
612-179-00-81-(2-propenyl)pyridinium chloride412-740-525965-81-5Xn; R22

R43
Xn

R: 22-43

S: (2-)24-37
612-180-00-33-aminobenzylamine412-230-24403-70-7Xn; R22

C; R34

N; R51-53
C; N

R: 22-34-51/53

S: (1/2-)22-26-36/37/39-45-61
612-181-00-92-phenylthioaniline413-030-81134-94-7R43

N; R51-53
Xi; N

R: 43-51/53

S: (2-)24-37-61
612-182-00-41-ethyl-1-methylmorpholinium bromide418-210-165756-41-4Muta. Cat. 3; R68Xn

R: 68

S: (2-)36/37
612-183-00-X1-ethyl-1-methylpyrrolidinium bromide418-200-569227-51-6Muta. Cat. 3; R68Xn

R: 68

S: (2-)36/37
612-184-00-56'-(dibutylamino)-3'-methyl-2'-(phenylamino)spiro[isobenzofuran-1(3H),9-(9H)-xanthen]-3-one403-830-589331-94-2R52-53R: 52/53

S: 61
612-185-00-01-[3-[4-((heptadecafluorononyl)oxy)-benzamido]propyl]-N,N,N-trimethylammonium iodide407-400-859493-72-0Xi; R41

N; R50-53
Xi; N

R: 41-50/53

S: (2-)26-39-60-61
612-186-00-6bis(N-(7-hydroxy-8-methyl-5-phenylphenazin-3-ylidene)dimethylammonium) sulfate406-770-8149057-64-7Xn; R48/22

Xi; R41

R43

N; R50-53
Xn; N

R: 41-43-48/22-50/53

S: (2-)22-26-36/37/39-60-61
612-187-00-12,3,4-trifluoroaniline407-170-93862-73-5Xn; R21/22-48/22

Xi; R38-41

N; R51-53
Xn; N

R: 21/22-38-41-48/22-51/53

S: (2-)23-26-36/37/39-61
612-188-00-74,4'-(9H-fluoren-9-ylidene)bis(2-chloroaniline)407-560-9107934-68-9N; R51-53N

R: 51/53

S: 61
612-189-00-24-amino-2-(aminomethyl)phenol dihydrochloride412-510-4135043-64-0Xn; R22

R43

N; R50-53
Xn; N

R: 22-43-50/53

S: (2-)22-24-37-60-61
612-190-00-84,4'-methylenebis(2-isopropyl-6-methylaniline)415-150-616298-38-7Xn; R48/22

N; R51-53
Xn; N

R: 48/22-51/53

S: (2-)36-61
612-191-00-3Polymer of allylamine hydrochloride415-050-271550-12-4Xn; R22

R43
Xn

R: 22-43

S: (2-)36/37
612-192-00-92-isopropyl-4-(N-methyl)aminomethylthiazole414-800-6154212-60-9Xn; R21/22

Xi; R38-41

N; R51-53
Xn; N

R: 21/22-38-41-51/53

S: (2-)26-36/37/39-61
612-193-00-43-methylaminomethylphenylamine414-570-718759-96-1Xn; R21/22

C; R34

R43

N; R50-53
C; N

R: 21/22-34-43-50/53

S: (1/2-)26-36/37/39-45-60-61
612-194-00-X2-hydroxy-3-[(2-hydroxyethyl)-[2-(1-oxotetradecyl)amino]ethyl]amino]-N,N,N-trimethyl-1-propanammonium chloride414-670-0141890-30-4Xn; R22

Xi; R41

N; R50-53
Xn; N

R: 22-41-50/53

S: (2-)26-39-60-61
612-195-00-5bis[tributyl 4-(methylbenzyl)ammonium] 1,5-naphthalenedisulfonate415-210-1160236-81-7Xn; R20/22

Xi; R41

N; R50-53
Xn; N

R: 20/22-41-50/53

S: (2-)26-36/39-60-61
612-196-00-04-chloro-o-toluidine; [1]

4-chloro-o-toluidine hydrochloride [2]
202-441-6 [1]

221-627-8 [2]
95-69-2 [1]

3165-93-3 [2]
Carc. Cat. 2; R45

Muta. Cat. 3; R68

T; R23/24/25

N; R50-53
T; N

R: 45-23/24/25-68-50/53

S: 53-45-60-61
E
612-197-00-62,4,5-trimethylaniline; [1]

2,4,5-trimethylaniline hydrochloride [2]
205-282-0 [1]

[2]
137-17-7 [1]

21436-97-5 [2]
Carc. Cat. 2; R45

T; R23/24/25

N; R51-53
T; N

R: 45-23/24/25-51/53

S: 53-45-61
E
612-198-00-14,4'-thiodianiline and its salts205-370-9139-65-1Carc. Cat. 2; R45

Xn; R22

N; R51-53
T; N

R: 45-22-51/53

S: 53-45-61
E
612-199-00-74,4'-oxydianiline and its salts;

p-aminophenyl ether
202-977-0101-80-4Carc. Cat. 2; R45

Muta. Cat. 2; R46

Repr. Cat. 3; R62

T; R23/24/25

N; R51-53
T; N

R: 45-46-23/24/25-62-51/53

S: 53-45-61
E
612-200-00-02,4-diaminoanisole;

4-methoxy-m-phenylenediamine; [1]

2,4-diaminoanisole sulphate [2]
210-406-1 [1]

254-323-9 [2]
615-05-4 [1]

39156-41-7 [2]
Carc. Cat. 2; R45

Muta. Cat. 3; R68

Xn; R22

N; R51-53
T; N

R: 45-22-68-51/53

S: 53-45-61
E
612-201-00-6N,N,N',N'-tetramethyl-4,4'-methylendianiline202-959-2101-61-1Carc. Cat. 2; R45

N; R50-53
T; N

R: 45-50/53

S: 53-45-60-61
612-202-00-13,4-dichloroaniline202-448-495-76-1T; R23/24/25

Xi; R41

R43

N; R50-53
T; N

R: 23/24/25-41-43-50/53

S: (1/2-)26-36/37/39-45-60-61
612-204-00-2C.I. Basic Violet 3;

4-[4,4'-bis(dimethylamino) benzhydrylidene]cyclohexa-2,5-dien-1-ylidene]dimethylammonium chloride
208-953-6548-62-9Carc. Cat. 3; R40

Xn; R22

Xi; R41

N; R50-53
Xn; N

R: 22-40-41-50/53

S: (2-)26-36/37/39-46-60-61
612-205-00-8C.I. Basic Violet 3 with ≥ 0.1 % of Michler's ketone (EC no. 202-027-5)208-953-6548-62-9Carc. Cat. 2; R45

Xn; R22

Xi; R41

N; R50-53
T; N

R: 45-22-41-50/53

S: 53-45-60-61
E
612-206-00-3famoxadone (ISO);

3-anilino-5-methyl-5-(4-phenoxyphenyl)-1,3-oxazolidine-2,4-dione
131807-57-3Xn; R48/22

N; R50-53
Xn; N

R: 48/22-50/53

S: (2-)46-60-61
612-207-00-94-ethoxyaniline;

p-phenetidine
205-855-5156-43-4Muta. Cat. 3; R68

Xn; R20/21/22

Xi; R36

R43
Xn

R: 20/21/22-36-43-68

S: (2-)36/37-46
612-209-00-X6-methoxy-m-toluidine;

p-cresidine
204-419-1120-71-8Carc. Cat. 2; R45

Xn; R22
T

R: 45-22

S: 53-45
E
612-210-00-55-nitro-o-toluidine; [1]

5-nitro-o-toluidine hydrochloride [2]
202-765-8 [1]

256-960-8 [2]
99-55-8 [1]

51085-52-0 [2]
Carc. Cat. 3; R40

T; R23/24/25

R52-53
T

R: 23/24/25-40-52/53

S: (1/2-)36/37-45-61
612-211-00-0N-[(benzotriazole-1-yl)methyl)]-4-carboxybenzenesulfonamide416-470-9170292-97-4Xi; R36

N; R51-53
Xi; N

R: 36-51/53

S: (2-)26-61
612-212-00-62,6-dichloro-4-trifluoromethylaniline416-430-024279-39-8Xn; R20/22

Xi; R38

R43

N; R50-53
Xn; N

R: 20/22-38-43-50/53

S: (2-)24-37-60-61
612-213-00-1isobutylidene-(2-(2-isopropyl-4,4-dimethyloxazolidine-3-yl)-1,1-dimethylethyl)amine419-850-2148348-13-4C; R34

R52-53
C

R: 34-52/53

S: (1/2-)23-26-36/37/39-45-61
612-214-00-74-(2,2-diphenylethenyl)-N,N-di-phenylbenzenamine421-390-289114-90-9R53R: 53

S: 61
612-215-00-23-chloro-2-(isopropylthio)aniline421-700-6179104-32-6Xi; R38

N; R51-53
Xi; N

R: 38-51/53

S: (2-)37-61
612-217-00-31-methoxy-2-propylamine422-550-437143-54-7F; R11

C; R34

Xn; R22

R52-53
F; C

R: 11-22-34-52/53

S: (1/2-)9-26-36/37/39-45-61
613-001-00-1ethyleneimine;

aziridine
205-793-9151-56-4F; R11

Carc. Cat. 2; R45

Muta. Cat. 2; R46

T+; R26/27/28

C; R34

N; R51-53
F; T+; N

R: 45-46-11-26/27/28-34-51/53

S: 53-45-61
D E
613-002-00-7pyridine203-809-9110-86-1F; R11

Xn; R20/21/22
F; Xn

R: 11-20/21/22

S: (2-)26-28
Xn; R20/21/22: C ≥ 5 %
613-003-00-21,2,3,4-tetranitrocarbazole6202-15-9E ⊗

R1

Xn; R20/21/22
E; Xn

R: 1-20/21/22

S: (2-)35
613-004-00-8crimidine (ISO);

2-chloro-6-methylpyrimidin-4-yldimethylamine
208-622-6535-89-7T+; R28T+

R: 28

S: (1/2-)36/37-45
613-007-00-4desmetryne (ISO);

6-isopropylamino-2-methylamino-4-methylthio-1,3,5-triazine
213-800-11014-69-3Xn; R21/22

N; R50-53
Xn; N

R: 21/22-50/53

S: (2-)36/37-60-61
613-008-00-Xdazomet (ISO);

tetrahydro-3,5-dimethyl-1,3,5-thiadiazine-2-thione
208-576-7533-74-4Xn; R22

Xi; R36

N; R50-53
Xn; N

R: 22-36-50/53

S: (2-)15-22-24-60-61
613-009-00-52,4,6-trichloro-1,3,5-triazine;

cyanuric chloride
203-614-9108-77-0R14

T+; R26

Xn; R22

C; R34

R43
T+;

R: 14-22-26-34-43

S: (1/2-)26-28-36/37/39-45-46-63
C; R34: C ≥ 10 %

Xi; R36/37/38: 5 % ≤ C < 10 %
613-010-00-0ametryn (ISO);

2-ethylamino-4-isopropylamino-6-methylthio-1,3,5-triazine
212-634-7834-12-8Xn; R22

N; R50-53
Xn; N

R: 22-50/53

S: (2-)36-60-61
613-011-00-6amitrole (ISO);

1,2,4-triazol-3-ylamine
200-521-561-82-5Repr. Cat. 3; R63

Xn; R48/22

N; R51-53
Xn; N

R: 48/22-63-51/53

S: (2-)13-36/37-61
613-012-00-1bentazone (ISO);

3-isopropyl-2,1,3-benzothiadiazine-4-one-2,2-dioxide
246-585-825057-89-0Xn; R22

Xi; R36

R43

R52-53
Xn

R: 22-36-43-52/53

S: (2-)24-37-61
613-013-00-7cyanazine (ISO);

2-(4-chloro-6-ethylamino-1,3,5-triazine-2-ylamino)-2-methylpropionitrile
244-544-921725-46-2Xn; R22

N; R50-53
Xn; N

R: 22-50/53

S: (2-)37-60-61
613-014-00-2ethoxyquin (ISO);

6-ethoxy-1,2-dihydro-2,2,4-trimethylquinoline
202-075-791-53-2Xn; R22Xn

R: 22

S: (2-)24
613-015-00-8fenazaflor (ISO);

phenyl 5,6-dichloro-2-trifluoromethylbenzimidazole-1-carboxylate
238-134-914255-88-0Xn; R21/22

N; R50-53
Xn; N

R: 21/22-50/53

S: (2-)36/37-60-61
613-016-00-3fuberidazole (ISO);

2-(2-furyl)benzimidazole
223-404-03878-19-1Xn; R22

N; R50-53
Xn; N

R: 22-50/53

S: (2-)22-60-61
613-017-00-9bis (8-hydroxyquinolinium) sulphate205-137-1134-31-6Xn; R22Xn

R: 22

S: (2-)36
613-018-00-4morfamquat (ISO);

1,1'-bis(3,5-dimethylmorpholinocarbonylmethyl)-4,4'-bipyridilium ion
7411-47-4Xn; R22

Xi; R36/37/38

R52-53
Xn

R: 22-36/37/38-52/53

S: (2-)22-36-61
613-019-00-Xthioquinox (ISO);

2-thio-1,3-dithiolo(4,5,b)quinoxaline
202-272-893-75-4Xn; R22Xn

R: 22

S: (2-)24
613-020-00-5tridemorph (ISO);

2,6-dimethyl-4-tridecylmorpholine
246-347-324602-86-6Repr. Cat. 2; R61

Xn; R20/22

Xi; R38

N; R50-53
T; N

R: 61-20/22-38-50/53

S: 53-45-60-61
E
613-021-00-0dithianon (ISO);

5,10-dihydro-5,10-dioxonaphtho(2,3-b)(1,4)dithiazine-2,3-dicarbonitrile
222-098-63347-22-6Xn; R22

N; R50-53
Xn; N

R: 22-50/53

S: (2-)24-60-61
613-022-00-6pyrethrins including cinerins, with the exception of those specified elsewhere in this AnnexXn; R20/21/22

N; R50-53
Xn; N

R: 20/21/22-50/53

S: (2-)13-60-61
A
613-023-00-12-methyl-4-oxo-3-(penta-2,4-dienyl)cyclopent-2-enyl [1R-[1α[S*(Z)],3β]]-chrysanthemate;

pyrethrin I
204-455-8121-21-1Xn; R20/21/22

N; R50-53
Xn; N

R: 20/21/22-50/53

S: (2-)13-60-61
613-024-00-72-methyl-4-oxo-3-(penta-2,4-dienyl)cyclopent-2-enyl[1R-[1α[S*(Z)](3β)]]-3-(3-methoxy-2-methyl-3-oxoprop-1-enyl)-2,2-dimethylcyclopropanecarboxylate;

pyrethrin II
204-462-6121-29-9Xn; R20/21/22

N; R50-53
Xn; N

R: 20/21/22-50/53

S: (2-)13-60-61
613-025-00-2cinerin I;

3-(but-2-enyl)-2-methyl-4-oxocyclopent-2-enyl 2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate
246-948-025402-06-6Xn; R22

N; R50-53
Xn; N

R: 22-50/53

S: (2-)60-61
613-026-00-8cinerin II;

3-(but-2-enyl)-2-methyl-4-oxocyclopent-2-enyl 2,2-dimethyl-3-(3-methoxy-2-methyl-3-oxoprop-1-enyl)cyclopropanecarboxylate
204-454-2121-20-0Xn; R22

N; R50-53
Xn; N

R: 22-50/53

S: (2-)60-61
613-027-00-3piperidine203-813-0110-89-4F; R11

T; R23/24

C; R34
F; T

R: 11-23/24-34

S: (1/2-)16-26-27-45
T; R23/24: C ≥ 5 %

Xn; R20/21: 1 % ≤ C < 5 %

C; R34: C ≥ 5 %

Xi: R36/38: 1 % ≤ C < 5 %
613-028-00-9morpholine203-815-1110-91-8R10

Xn; R20/21/22

C; R34
C

R: 10-20/21/22-34

S: (1/2-)23-36-45
C; R34: C ≥ 10 %

Xi; R36/38: 1 % ≤ C < 10 %
613-029-00-4dichloro-1,3,5-triazinetrione;

dichloroisocyanuric acid
220-487-52782-57-2O; R8

Xn; R22

R31

Xi; R36/37

N; R50-53
O; Xn; N

R: 8-22-31-36/37-50/53

S: (2-)8-26-41-60-61
613-030-00-Xtroclosene potassium; [1]

troclosene sodium [2]
218-828-8 [1]

220-767-7 [2]
2244-21-5 [1]

2893-78-9 [2]
O; R8 ⊗

Xn; R22

R31

Xi; R36/37

N; R50-53
O; Xn; N

R: 8-22-31-36/37-50/53

S: (2-)8-26-41-60-61
Xn; R22: C ≥ 10 %

Xi; R36/37: C ≥ 10 %

R31: C ≥ 10 %
613-030-01-7troclosene sodium, dihydrate220-767-751580-86-0Xn; R22

R31

Xi; R36/37

N; R50-53
Xn; N

R: 22-31-36/37-50/53

S: (2-)8-26-41-60-61
613-031-00-5symclosene;

trichloroisocyanuric acid;

trichloro-1,3,5-triazinetrion
201-782-887-90-1O; R8

Xn; R22

Xi; R36/37

R31

N; R50-53
O; Xn; N

R: 8-22-31-36/37-50/53

S: (2-)8-26-41-60-61
613-032-00-0methyl-2,3,5,6-tetrachloro-4-pyridylsulphone;

2,3,5,6-tetrachloro-4-(methylsulphonyl)pyridine
236-035-513108-52-6Xn; R21/22

Xi; R36

R43
Xn

R: 21/22-36-43

S: (2-)26-28
613-033-00-62-methylaziridine;

propyleneimine
200-878-775-55-8F; R11

Carc. Cat. 2; R45

T+; R26/27/28

Xi; R41

N; R51-53
F; T+; N

R: 45-11-26/27/28-41-51/53

S: 53-45-61
Carc. Cat. 2; R45: C ≥ 0,01 %E
613-034-00-11,2-dimethylimidazole217-101-21739-84-0Xn; R22

Xi; R38-41
Xn

R: 22-38-41

S: (2-)24-26
613-035-00-71-methylimidazole210-484-7616-47-7Xn; R21/22

C; R34
C

R: 21/22-34

S: (1/2-)26-36-45
613-036-00-22-methylpyridine;

2-picoline
203-643-7109-06-8R10

Xn; R20/21/22

Xi; R36/37
Xn

R: 10-20/21/22-36/37

S: (2-)26-36
613-037-00-84-methylpyridine;

4-picoline
203-626-4108-89-4R10

T; R24

Xn; R20/22

Xi; R36/37/38
T

R: 10-20/22-24-36/37/38

S: (1/2-)26-36-45
613-038-00-36-phenyl-1,3,5-triazine-2,4-diyldiamine;

6-phenyl-1,3,5-triazine-2,4-diamine;

benzoguanamine
202-095-691-76-9Xn; R22

R52-53
Xn

R: 22-52/53

S: (2-)61
613-039-00-9ethylene thiourea;

imidazolidine-2-thione;

2-imidazoline-2-thiol
202-506-996-45-7Repr. Cat. 2; R61

Xn; R22
T

R: 61-22

S: 53-45
E
613-040-00-4azaconazole (ISO);

1-{[2-(2,4-dichlorophenyl)-1,3-dioxolan-2-yl]methyl}-1H-1,2.4-triazole
262-102-360207-31-0Xn; R22Xn

R: 22

S: (2-)46
613-041-00-Xmorpholine-4-carbonyl chloride239-213-015159-40-7R14

Carc. Cat. 3; R40

Xi; R36/38
Xn

R: 14-36/38-40

S: (2-)26-30-36-38
613-042-00-5imazalil (ISO);

1-[2-(allyloxy)-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole
252-615-035554-44-0Xn; R20/22

Xi; R41

N; R50-53
Xn; N

R: 20/22-41-50/53

S: (2-)26-39-60-61
613-043-00-0imazalil sulphate (ISO) powder;

1- [2-(allyloxy)ethyl-2-(2,4-dichlorophenyl)]-1H-imidazolium hydrogen sulphate; [1]

(±)-1- [2-(allyloxy)ethyl-2-(2,4-dichlorophenyl)]-1H-imidazolium hydrogen sulphate [2]
261-351-5 [1]

281-291-3 [2]
58594-72-2 [1]

83918-57-4 [2]
Xn; R22

R43

N; R50-53
Xn; N

R: 22-43-50/53

S: (2-)24/25-37-46-60-61
613-043-01-8imazalil sulphate (ISO), aqueous solution;

1- [2-(allyloxy)ethyl-2-(2,4-dichlorophenyl)]-1H-imidazolium hydrogen sulphate; [1]

(±)-1- [2-(allyloxy)ethyl-2-(2,4-dichlorophenyl)]-1H-imidazolium hydrogen sulphate [2]
261-351-5 [1]

281-291-3 [2]
58594-72-2 [1]

83918-57-4 [2]
Xn; R22

C; R34

R43

N; R50-53
C; N

R: 22-34-43-50/53

S: (2-)26-36/37/39-45-60-61
C; R34: C ≥ 50 %

Xi; R38: 30 % ≤ C < 50 %

Xi; R41: 15 % ≤ C < 50 %

Xi; R36: 5 % ≤ C < 15 %
613-044-00-6captan (ISO);

1,2,3,6-tetrahydro-N-(trichloromethylthio)phthalimide
205-087-0133-06-2Carc. Cat. 3; R40

T; R23

Xi; R41

R43

N; R50
T; N

R: 23-40-41-43-50

S: (1/2-)26-29-36/37/39-45-61
613-045-00-1folpet (ISO);

N-(trichloromethylthio)phthalimide
205-088-6133-07-3Carc. Cat. 3; R40

Xn; R20

Xi; R36

R43

N; R50
Xn; N

R: 20-36-40-43-50

S: (2-)36/37-46-61
613-046-00-7captafol (ISO);

1,2,3,6-tetrahydro-N-(1,1,2,2-tetrachloroethylthio)phthalimide
219-363-32425-06-1Carc. Cat. 2; R45

R43

N; R50-53
T; N

R: 45-43-50/53

S: 53-45-60-61
613-047-00-21-dimethylcarbamoyl-5-methylpyrazol-3-yl dimethylcarbamate;

dimetilan (ISO)
211-420-0644-64-4T; R25

Xn; R21

N; R50-53
T; N

R: 21-25-50/53

S: (1/2-)36/37-45-60-61
613-048-00-8carbendazim (ISO);

methyl benzimidazol-2-ylcarbamate
234-232-010605-21-7Muta. Cat. 2; R46

Repr. Cat. 2; R60-61

N; R50-53
T; N

R: 46-60-61-50/53

S: 53-45-60-61
613-049-00-3benomyl (ISO);

methyl 1-(butylcarbamoyl)benzimidazol-2-ylcarbamate
241-775-717804-35-2Muta. Cat. 2; R46

Repr. Cat. 2; R60-61

Xi; R37/38

R43

N; R50-53
T; N

R: 46-60-61-37/38-43-50/53

S: 53-45-60-61
N; R50-53: C ≥ 2,5 %

N; R51-53: 0,25 % ≤ C < 2,5 %

R52-53: 0,025 % ≤ C < 0,25 %
613-050-00-9carbadox (INN);

methyl 3-(quinoxalin-2-ylmethylene)carbazate 1,4-dioxide;

2-(methoxycarbonylhydrazonomethyl)quinoxaline 1,4-dioxide
229-879-06804-07-5F; R11

Carc. Cat. 2; R45

Xn; R22
F; T

R: 45-11-22

S: 53-45
E
613-051-00-4molinate (ISO);

S-ethyl 1-perhydroazepinecarbothioate;

S-ethyl perhydroazepine-1-carbothioate
218-661-02212-67-1Carc. Cat. 3; R40

Repr. Cat. 3; R62

Xn; R20/2248/22

R43

N; R50-53
Xn; N

R: 20/22-40-43-48/22-62-50/53

S: (2-)36/37-46-60-61
N; R50-53: C ≥ 0,25 %

N; R51-53: 0,025 % ≤ C < 0,25 %

R52-53: 0,0025 % ≤ C < 0,025 %
613-052-00-Xtrifenmorph (ISO);

4-tritylmorpholine
215-812-21420-06-0Xn; R22

N; R50-53
Xn; N

R: 22-50/53

S: (2-)60-61
613-053-00-5anilazine (ISO);

2-chloro-N-(4,6-dichloro-1,3,5-triazin-2-yl)aniline
202-910-5101-05-3Xi; R36/38

N; R50-53
Xi; N

R: 36/38-50/53

S: (2-)22-60-61
613-054-00-0thiabendazol (ISO);

2-(thiazole-4-yl)benzimidazole
205-725-8148-79-8N; R50-53N

R: 50/53

S: 60-61
613-056-00-11,2-dimethyl-3,5-diphenylpyrazolium methylsulphate;

difenzoquat methyl sulfate
256-152-543222-48-6Xn; R22

N; R50-53
Xn; N

R: 22-50/53

S: (2-)60-61
613-057-00-7dodemorph (ISO);

4-cyclododecyl-2,6-dimethylmorpholine
216-474-91593-77-7Xi; R36/37/38

N; R51-53
Xi; N

R: 36/37/38-51/53

S: (2-)26-61
613-058-00-2permethrin (ISO);

m-phenoxybenzyl 3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate
258-067-952645-53-1Xn; R20/22

R43

N; R50-53
Xn; N

R: 20/22-43-50/53

S: (2-)13-24-36/37/39-60-61
N; R50-53: C ≥ 0,025 %

N; R51-53: 0,0025 % ≤ C < 0,025 %

R52-53: 0,00025 % ≤ C < 0,0025 %
613-059-00-8profluralin (ISO);

N-(cyclopropylmethyl)-α,α,α-trifluoro-2,6-dinitro-N-propyl-p-toluidine
247-656-626399-36-0Xi; R36

N; R50-53
Xi; N

R: 36-50/53

S: (2-)60-61
613-060-00-3resmethrin (ISO);

5-benzyl-3-furylmethyl (±)-cis-trans-chrysanthemate
233-940-710453-86-8Xn; R22

N; R50-53
Xn; N

R: 22-50/53

S: (2-)60/61
613-061-00-96-(1α,5aβ,8aβ,9-pentahydroxy-7β-isopropyl-2β,5β,8β-trimethylperhydro-8bα,9-epoxy-5,8-ethanocyclopenta[1,2-b]indenyl) pyrrole-2-carboxylate;

ryania
239-732-215662-33-6Xn; R21/22

N; R50-53
Xn; N

R: 21/22-50/53

S: (2-)36/37-60-61
613-062-00-4sabadilla (ISO);

veratrine
8051-02-3Xi; R36/37/38Xi

R: 36/37/38

S: (2-)36/37/39
613-063-00-Xsecbumeton (ISO);

2-sec-butylamino-4-ethylamino-6-methoxy-1,3,5-triazine
247-554-126259-45-0Xn; R22

Xi; R36

N; R50-53
Xn; N

R: 22-36-50/53

S: (2-)60-61
613-064-00-55-(3,6,9-trioxa-2-undecyloxy)benzo(d)-1,3-dioxolane;

sesamex
51-14-9Xn; R22Xn

R: 22

S: (2-)
613-065-00-0simetryn (ISO);

2,4-bis(ethylamino)-6-methylthio-1,3,5-triazine
213-801-71014-70-6Xn; R22

N; R50-53
Xn; N

R: 22-50/53

S: (2-)60-61
613-066-00-6terbumeton (ISO);

2-tert-butylamino-4-ethylamino-6-methoxy-1,3,5-triazine
251-637-833693-04-8Xn; R22

N; R50-53
Xn; N

R: 22-50/53

S: (2-)60-61
613-067-00-1propazine (ISO);

2-chloro-4,6-bis(isopropylamino)-1,3,5-triazine
205-359-9139-40-2Carc. Cat. 3; R40

N; R50-53
Xn; N

R: 40-50/53

S: (2-)36/37-60-61
613-068-00-7atrazine (ISO);

2-chloro-4-ethylamine-6-isopropylamine-1,3,5-triazine
217-617-81912-24-9Xn; R48/22

R43

N; R50-53
Xn; N

R: 43-48/22-50/53

S: (2-)36/37-60-61
613-069-00-2ε-caprolactam203-313-2105-60-2Xn; R20/22

Xi; R36/37/38
Xn

R: 20/22-36/37/38

S: (2-)
613-070-00-8propylenethiourea2122-19-2Repr. Cat. 3; R63

Xn; R22

R52-53
Xn

R: 22-52/53-63

S: (2-)36/37-46-61
613-071-00-32-fluoro-5-trifluoromethylpyridine400-290-269045-82-5R10

R43

R52-53
Xi

R: 10-43-52/53

S: (2-)24-37-61
613-072-00-9N,N-bis(2-ethylhexyl)-((1,2,4-triazol-1-yl)methyl)amine401-280-091273-04-0C; R34

R43

N; R51-53
C; N

R: 34-43-51/53

S: (1/2-)26-28-36/37/39-45-61
613-073-00-4N,N-dimethyl-2-(3-(4-chlorophenyl)-4,5-dihydropyrazol-1-ylphenylsulphonyl)ethylamine401-410-610357-99-0Xn; R48/22

R43

N; R51-53
Xn; N

R: 43-48/22-51/53

S: (2-)24-37-61
613-074-00-X3-(3-methylpent-3-yl)isoxazol-5-ylamine401-460-982560-06-3T; R23/25

Xi; R41

R52-53
T

R: 23/25-41-52/53

S: (1/2-)22-26-36/37/39-45-61
613-075-00-51,3-dichloro-5-ethyl-5-methylimidazolidine-2,4-dione401-570-789415-87-2O; R8

T; R23

C; R34

Xn; R22

R43

N; R50
O; T; N

R: 8-22-23-34-43-50

S: (1/2-)8-26-36/37/39-45-61
613-076-00-03-chloro-5-trifluoromethyl-2-pyridylamine401-670-079456-26-1Xn; R22

R52-53
Xn

R: 22-52/53

S: (2-)61
613-077-00-6reaction mass of 5-heptyl-1,2,4-triazol-3-ylamine and 5-nonyl-1,2,4-triazol-3-ylamine401-940-8Xn; R22

Xi; R36

N; R51-53
Xn; N

R: 22-36-51/53

S: (2-)22-26-61
613-078-00-1N,N,N,N-tetrakis(4,6-bis(butyl-(N-methyl-2,2,6,6-tetramethylpiperidin-4-yl)amino)triazin-2-yl)-4,7-diazadecane-1,10-diamine401-990-0106990-43-6R43

N; R51-53
Xi; N

R: 43-51/53

S: (2-)22-24-37-61
613-079-00-74-(1(or 4 or 5 or 6)-methyl-8,9,10-trinorborn-5-en-2-yl)pyridine, reaction mass of isomers402-520-7Xn; R21/22

Xi; R38

R43

N; R50-53
Xn; N

R: 21/22-38-43-50/53

S: (2-)36/37-60-61
613-080-00-23-(bis(2-ethylhexyl)aminomethyl)benzothiazole-2(3H)-thione402-540-6105254-85-1C; R34

R43

N; R50-53
C; N

R: 34-43-50/53

S: (1/2-)26-28-36/37/39-45-60-61
613-081-00-81-butyl-2-methylpyridinium bromide402-680-826576-84-1Xn; R22

R52-53
Xn

R: 22-52/53

S: (2-)61
613-082-00-32-methyl-1-pentylpyridinium bromide402-690-2Xn; R21/22

R52-53
Xn

R: 21/22-52/53

S: (2-)36/37-61
613-083-00-92-(4-(3-(4-chlorophenyl)-2-pyrazolin-1-yl)phenylsulfonyl)ethyldimethylammonium formate402-120-2C; R34

Xn; R48/22

R43

N; R50-53
C; N

R: 34-43-48/22-50/53

S: (1/2-)24-26-28-37/39-45-60-61
613-084-00-42-(4-(3-(4-chlorophenyl)-4,5-dihydropyrazolyl)phenylsulphonyl)ethyldimethylammonium hydrogen phosphonate402-490-5106359-93-7Xi; R36

N; R50-53
Xi; N

R: 36-50/53

S: (2-)26-60-61
613-085-00-Xreaction mass of 1,1'-(methylenebis(4,1-phenylene))dipyrrole-2,5-dione and N-(4-(4-(2,5-dioxopyrrol-1-yl)benzyl)phenyl)acetamide and 1-(4-(4-(5-oxo-2H-2-furylidenamino)benzyl)phenyl)pyrrole-2,5-dione401-970-1R43

N; R50-53
Xi; N

R: 43-50/53

S: (2-)24-37-60-61
613-086-00-5caffeine200-362-158-08-2Xn; R22Xn

R: 22

S: (2-)
613-087-00-0tetrahydrothiophene203-728-9110-01-0F; R11

Xn; R20/21/22

Xi; R36/38

R52-53
F; Xn

R: 11-20/21/22-36/38-52/53

S: (2-)16-23-36/37-61
613-088-00-61,2-benzisothiazol-3(2H)-one;

1,2-benzisothiazolin-3-one
220-120-92634-33-5Xn; R22

Xi; R38-41

R43

N; R50
Xn; N

R: 22-38-41-43-50

S: (2-)24-26-37/39-61
R43: C ≥ 0,05 %
613-089-00-1diquat dibromide; [1]

diquat dichloride; [2]

6,7-dihydrodipyrido[1,2-α:2',1'-c]pyrazinediylium dihydroxide [3]
201-579-4 [1]

223-714-6 [2]

301-467-6 [3]
85-00-7 [1]

4032-26-2 [2]

94021-76-8 [3]
T+; R26

T; R48/25

Xn; R22

Xi; R36/37/38

R43

N; R50-53
T+; N

R: 22-26-36/37/38-43-48/25-50/53

S: (1/2-)28-36/37/39-45-60-61
613-090-00-7paraquat dichloride;

1,1-dimethyl-4,4'-bipyridinium dichloride; [1]

paraquat dimethylsulfate;

1,1-dimethyl-4,4'-bipyridinium dimethyl sulphate [2]
217-615-7 [1]

218-196-3 [2]
1910-42-5 [1]

2074-50-2 [2]
T+; R26

T; R24/25-48/25

Xi; R36/37/38

N; R50-53
T+; N

R: 24/25-26-36/37/38-48/25-50/53

S: (1/2-)22-28-36/37/39-45-60-61
613-091-00-2morfamquat dichloride; [1]

morfamquat sulfate [2]
225-062-8 [1]

[2]
4636-83-3 [1]

29873-36-7 [2]
Xn; R22

Xi; R36/37/38

R52-53
Xn

R: 22-36/37/38-52/53

S: (2-)22-36-61
613-092-00-81,10-phenanthroline200-629-266-71-7T; R25

N; R50-53
T; N

R: 25-50/53

S: (1/2-)45-60-61
613-093-00-3hexasodium 6,13-dichloro-3,10-bis((4-(2,5-disulfonatoanilino)-6-fluoro-1,3,5-triazin-2-ylamino)prop-3-ylamino)-5,12-dioxa-7,14-diazapentacene-4,11-disulfonate400-050-785153-92-0R42/43Xn

R: 42/43

S: (2-)22-24-37
613-094-00-94-methoxy-N,6-dimethyl-1,3,5-triazin-2-ylamine401-360-55248-39-5Xn; R22-48/22Xn

R: 22-48/22

S: (2-)22-36
613-095-00-4sodium 3-(2H-benzotriazol-2-yl)-5-sec-butyl-4-hydroxybenzenesulfonate403-080-992484-48-5Xi; R41Xi

R: 41

S: (2-)26-39
613-096-00-X2-amino-6-ethoxy-4-methylamino-1,3,5-triazine403-580-762096-63-3Xn; R22Xn

R: 22

S: (2-)
613-097-00-57-amino-3-((5-carboxymethyl-4-methyl-1,3-thiazol-2-ylthio)methyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid403-690-5111298-82-9R42/43

R52-53
Xn

R: 42/43-52/53

S: (2-)22-24-37-61
613-098-00-0N-(n-octyl)-2-pyrrolidone403-700-82687-94-7C; R34

N; R51-53
C; N

R: 34-51/53

S: (1/2-)23-26-36/37/39-45
613-099-00-61-dodecyl-2-pyrrolidone403-730-12687-96-9C; R34

R43

N; R50-53
C; N

R: 34-43-50/53

S: (1/2-)26-36/37/39-45-60-61
613-100-00-X2,9-bis(3-(diethylamino)propylsulfamoyl)quino(2,3-b)acridine-7,14-dione404-230-6R43

R53
Xi

R: 43-53

S: (2-)24-37-61
613-101-00-5N-tert-pentyl-2-benzothiazolesulfenamide404-380-2110799-28-5R43

R52-53
Xi

R: 43-52/53

S: (2-)36/37-61
613-102-00-0dimethomorph (ISO);

4-(3-(4-chlorophenyl)-3-(3,4-dimethoxyphenyl)acryloyl)morpholine
404-200-2110488-70-5N; R51-53N

R: 51/53

S: 61
613-103-00-6sodium 5-n-butylbenzotriazole404-450-2118685-34-0Xn; R22

C; R34

R43

N; R51-53
C; N

R: 22-34-43-51/53

S: (1/2-)26-36/37/39-45-61
613-104-00-15-tert-butyl-3-isoxazolylamine hydrochloride404-840-2Xn; R22-48/22

Xi; R41

R52-53
Xn

R: 22-41-48/22-52/53

S: (2-)26-36/39-61
613-105-00-7hexakis(tetramethylammonium) 4,4'-vinylenebis((3-sulfonato-4,1-phenylene)imino(6-morpholino-1,3,5-triazine-4,2-diyl)imino)bis(5-hydroxy-6-phenylazonaphthalene-2,7-disulfonate)405-160-9124537-30-0T; R25

R43

R52-53
T

R: 25-43-52/53

S: (1/2-)24-37-45-61
613-106-00-2tetrapotassium 2-(4-(5-(1-(2,5-disulfonatophenyl)-3-ethoxycarbonyl-5-hydroxypyrazol-4-yl)penta-2,4-dienylidene)-3-ethoxycarbonyl-5-oxo-2-pyrazolin-1-yl)benzene-1,4-disulfonate405-240-3R43Xi

R: 43

S: (2-)24-37
613-107-00-8hexasodium 2,2'-vinylenebis((3-sulfonato-4,1-phenylene)imino(6-(N-cyanoethyl-N-(2-hydroxypropyl)amino)-1,3,5-triazine-4,2-diyl)imino)dibenzene-1,4-disulfonate405-280-176508-02-6Xi; R36Xi

R: 36

S: (2-)26
613-108-00-3benzothiazole-2-thiol205-736-8149-30-4R43

N; R50-53
Xi; N

R: 43-50/53

S: (2-)24-37-60-61
613-109-00-9bis(piperidinothiocarbonyl) disulphide202-328-194-37-1Xi; R36/37/38

R43
Xi

R: 36/37/38-43

S: (2-)24-26-37
613-110-00-4dimepiperate (ISO);

S-(1-methyl-1-phenylethyl) piperidine-1-carbothioate
262-784-261432-55-1Xn; R22

N; R51-53
Xn; N

R: 22-51/53

S: (2-)61
613-111-00-X1,2,4-triazole206-022-9288-88-0Repr. Cat. 3; R63

Xn; R22

Xi; R36
Xn

R: 22-36-63

S: (2-)36/37
613-112-00-5octhilinone (ISO);

2-octyl-2H-isothiazol-3-one
247-761-726530-20-1T; R23/24

Xn; R22

C; R34

R43

N; R50-53
T; N

R: 22-23/24-34-43-50/53

S: (1/2-)26-36/37/39-45-60-61
R43: C ≥ 0,05 %
613-113-00-02-(morpholinothio)benzothiazole203-052-4102-77-2Xi; R36/38

R43

N; R51-53
Xi; N

R: 36/38-43-51/53

S: (2-)24-26-37-61
613-114-00-62,2',2"-(hexahydro-1,3,5-triazine-1,3,5-triyl)triethanol;

1,3,5-tris(2-hydroxyethyl)hexahydro-1,3,5-triazine
225-208-04719-04-4Xn; R22

R43
Xn

R: 22-43

S: (2-)24-37
R43: C ≥ 0,1 %
613-115-00-1hymexazol (ISO);

3-hydroxy-5-methylisoxazole
233-000-610004-44-1Xn; R22

Xi; R41

R52-53
Xn

R: 22-41-52/53

S: (2-)26-39-61
613-116-00-7tolylfluanid (ISO);

dichloro-N-[(dimethylamino)sulphonyl]fluoro-N-(p-tolyl)methanesulphenamide
211-986-9731-27-1T; R23

Xn; R48/20

Xi; R36/37/38

R43

N; R50-53
T; N

R: 23-36/37/38-43-48/20-50/53

S: (1/2-)24-26-37-38-45-60-61
613-117-00-2diniconazole (ISO);

(E)-β-[(2,4-dichlorophenyl)methylene]-α-(1,1-dimethylethyl)-1H-1,2,4-triazol-1-ethanol;

(E)-(RS)-1-(2,4-dichlorophenyl)-4,4-dimethyl-2-(1H-1,2,4-triazol-1-yl)pent-1-en-3-ol
76714-88-0Xn; R22

N; R50-53
Xn; N

R: 22-50/53

S: (2-)60-61
613-118-00-8flubenzimine (ISO);

N-[3-phenyl-4,5-bis[(trifluoromethyl)imino]thiazolidin-2-ylidene]aniline;
253-703-137893-02-0Xi; R36

N; R50-53
Xi; N

R: 36-50/53

S: (2-)26-60-61
613-119-00-3(benzothiazol-2-ylthio)methyl thiocyanate;

TCMTB
244-445-021564-17-0T+; R26

Xn; R22

Xi; R36/38

R43

N; R50-53
T+; N

R: 22-26-36/38-43-50/53

S: (1/2-)28-36/37-38-45-60-61
613-120-00-9bioresmethrin;

(5-bezylfur-3-yl)methyl(1R)-trans-2,2-dimethyl-3-(2-methylpropenyl)cyclopropanecarboylate
249-014-028434-01-7N; R50-53N

R: 50/53

S: 60-61
613-121-00-4chlorsulfuron (ISO);

2-chloro-N-[[(4-methoxy-6-methyl-1,3,5-triazin-2-yl)amino]carbonyl]benzenesulphonamide;
265-268-564902-72-3N; R50-53N

R: 50/53

S: 60-61
613-122-00-Xdiclobutrazole (ISO);

(R*, R*)-(±)-β-[(2,4-dichlorophenyl)methyl]-α-(1,1-dimethylethyl)-1H-1,2,4-triazole-1-ethanol;

(2RS, 3RS)-1-(2,4-dichlorophenyl)-4,4-dimethyl-2-(1H-1,2,4-triazol-1yl)pentan-3-ol
75736-33-3Xi; R36

N; R51-53
Xi; N

R: 36-51/53

S: (2-)26-61
613-123-00-55,6-dihydro-3H-imidazo[2,1-c]-1,2,4-dithiazole-3-thione;

etem
251-684-433813-20-6Xn; R22

N; R50-53
Xn; N

R: 22-50/53

S: (2-)60-61
613-124-00-0fenpropimorph (ISO);

cis-4-[3-(p-tert-butylphenyl)-2-methylpropyl]-2,6-dimethylmorpholine
266-719-967564-91-4Repr. Cat. 3; R63

Xn; R22

Xi; R38

N; R51-53
Xn; N

R: 22-38-63-51/53

S: (2-)36/37-46-61
613-125-00-6hexythiazox (ISO);

trans-5-(4-chlorophenyl)-N-cyclohexyl-4-methyl-2-oxo-3-thiazolidine-carboxamide
78587-05-0N; R50-53N

R: 50/53

S: 60-61
613-126-00-1imazapyr (ISO);

2-[4,5-dihydro-4-methyl-4-(1-methylethyl)-5-oxo-1H-imidazol-2-yl]-3-pyridine carboxylate
81334-34-1Xi; R36

R52-53
Xi

R: 36-52/53

S: (2-)26-61
613-127-00-71,1-dimethylpiperidinium chloride;

mepiquat chloride
246-147-624307-26-4Xn; R22

R52-53
Xn

R: 22-52/53

S: (2-)61
613-128-00-2prochloraz (ISO);

N-propyl-N-[2-(2,4,6-trichlorophenoxy)ethyl]-1H-imidazole-1-carboxamide;
266-994-567747-09-5Xn; R22

N; R50-53
Xn; N

R: 22-50/53

S: (2-)60-61
613-129-00-8metamitron (ISO);

4-amino-3-methyl-6-phenyl-1,2,4-triazin-5-one
255-349-341394-05-2Xn; R22

N; R50
Xn; N

R: 22-50

S: (2-)61
613-131-00-9pyroquilon (ISO);

1,2,5,6-tetrahydropyrrolo[3,2,1-ij]quinolin-4-one
57369-32-1Xn; R22

R52-53
Xn

R: 22-52/53

S: (2-)61
613-132-00-4hexazinone (ISO);

3-cyclohexyl-6-dimethylamino-1-methyl-1,2,3,4-tetrahydro-1,3,5-triazine-2,4-dione;
257-074-451235-04-2Xn; R22

Xi; R36

N; R50-53
Xn; N

R: 22-36-50/53

S: (2-)60-61
613-133-00-Xetridiazole (ISO);

5-ethoxy-3-trichloromethyl-1,2,4-thiadiazole
219-991-82593-15-9Carc. Cat. 3; R40

T; R23

Xn; R21/22

N; R50-53
T; N

R: 21/22-23-40-50/53

S: (1/2-)36/37-38-45-60-61
613-134-00-5myclobutanil (ISO);

2-(4-chlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)hexanenitrile
88671-89-0Repr. Cat. 3; R63

Xn; R22

Xi; R36

N; R51-53
Xn; N

R: 22-36-51/53-63

S: (2-)36/37-46-61
613-135-00-0di(benzothiazol-2-yl) disulphide204-424-9120-78-5R31

R43

N; R50-53
Xi; N

R: 31-43-50/53

S: (2-)36/37-60-61
613-136-00-6N-cyclohexylbenzothiazole-2-sulphenamide202-411-295-33-0R43

N; R50-53
Xi; N

R: 43-50/53

S: (2-)24-37-60-61
613-137-00-1methabenzthiazuron (ISO);

1-(1,3-benzothiazol-2-yl)1,3-dimethylurea
242-505-018691-97-9N; R50-53N

R: 50/53

S: 60-61
613-138-00-7quinoxyfen (ISO);

5,7-dichloro-4-(4-fluorophenoxy)quinoline
124495-18-7R43

N; R50-53
Xi; N

R: 43-50/53

S: (2-)24-37-46-60-61
613-139-00-2metsulfuron-methyl;

2-(4-methoxy-6-methyl-1,3,5-triazin-2-ylcarbamoylsulfamoyl) benzoic acid
74223-64-6N; R50-53N

R: 50/53

S: 60-61
613-140-00-8cycloheximide (ISO);

4-{(2R)-2-[(1S,3S,5S)-3,5-dimethyl-2-oxocyclohexyl]-2-hydroxyethyl}piperidine-2,6-dione
200-636-066-81-9Muta. Cat. 3; R68

Repr. Cat. 2; R61

T+; R28

N; R51-53
T+; N

R: 61-28-51/53-68

S: 53-45-61
E
613-141-00-31,4-diamino-2-(2-butyltetrazol-5-yl)-3-cyanoanthraquinone401-470-393686-63-6R53R: 53

S: 61
613-142-00-9trans-N-methyl-2-styryl-[4'-aminomethine-(1-acetyl-1-(2-methoxyphenyl)acetamido)]pyridinium acetate405-860-4R43

N; R51-53
Xi; N

R: 43-51/53

S: (2-)22-24-37-61
613-143-00-41-(3-phenylpropyl)-2-methylpyridinium bromide405-930-410551-42-5Xn; R22

Xi; R36

R52-53
Xn

R: 22-36-52/53

S: (2-)26-36/37-61
613-144-00-XReaction products of: poly(vinyl acetate), partially hydrolyzed, with (E)-2-(4-formylstyryl)-3,4-dimethylthiazoliummethyl sulfate406-460-2125139-08-4R52-53R: 52/53

S: 61
613-145-00-5(S)-3-benzyloxycarbonyl-1,2,3,4-tetrahydro-isoquinolinium 4-methylbenzenesulfonate406-960-077497-97-3N; R51-53N

R: 51/53

S: 61
613-146-00-0N-ethyl-N-methylpiperidinium iodide407-780-54186-71-4Xn; R22

N; R51-53
Xn; N

R: 22-51/53

S: (2-)22-61
613-147-00-64-[2-(1-methyl-2-(4-morpholinyl)ethoxy)ethyl]morpholine407-940-4111681-72-2Xi; R41Xi

R: 41

S: (2-)26-39
613-148-00-1tetrasodium 1,2-bis(4-fluoro-6-[5-(1-amino-2-sulfonatoanthrachinon-4-ylamino)-2,4,6-trimethyl-3-sulfonatophenylamino]-1,3,5-triazin-2-ylamino)ethane411-240-4143683-23-2R43

R52-53
Xi

R: 43-52/53

S: (2-)22-24/25-37-61
613-149-00-7pyridaben (ISO);

2-tert-butyl-5-(4-tert-butylbenzylthio)-4-chloropyridazin-3(2H)-one
405-700-396489-71-3T; R23/25

N; R50-53
T; N

R: 23/25-50/53

S: (1/2-)36/37-45-60-61
613-150-00-22,2'-[3,3'-(piperazine-1,4-diyl)dipropyl]bis(1H-benzimidazo[2,1-b]benzo[l,m,n][3,8]phenanthroline-1,3,6-trione406-295-6R53R: 53

S: 61
613-151-00-81-(3-mesyloxy-5-trityloxymethyl-2-D-threofuryl)thymine406-360-9104218-44-2R53R: 53

S: 61
613-152-00-3phenyl N-(4,6-dimethoxypyrimidin-2-yl)carbamate406-600-289392-03-0R43

N; R51-53
Xi; N

R: 43-51/53

S: (2-)24-37-61
613-153-00-92,3,5-trichloropyridine407-270-216063-70-0R52-53R: 52/53

S: 61
613-154-00-42-amino-4-chloro-6-methoxypyrimidine410-050-95734-64-5Xn; R22Xn

R: 22

S: (2-)22
613-155-00-X5-chloro-2,3-difluoropyridine410-090-789402-43-7R10

Xn; R22

R52-53
Xn

R: 10-22-52/53

S: (2-)23-36-61
613-156-00-52-butyl-4-chloro-5-formylimidazole410-260-083857-96-9R43

N; R51-53
Xi; N

R: 43-51/53

S: (2-)24-37-61
613-157-00-02,4-diamino-5-methoxymethylpyrimidine410-330-054236-98-5Xn; R22-48/22

Xi; R36
Xn

R: 22-36-48/22

S: (2-)22-26-36
613-158-00-62,3-dichloro-5-trifluoromethyl-pyridine410-340-569045-84-7Xn; R20/22

Xi; R41

R43

N; R51-53
Xn; N

R: 20/22-41-43-51/53

S: (2-)24-26-37/39-61
613-159-00-1fenazaquin (ISO);

4-[2-[4-(1,1-dimethylethyl)phenyl]-ethoxy]quinazoline
410-580-0120928-09-8T; R25

Xn; R20

N; R50-53
T; N

R: 20-25-50/53

S: (1/2-)37-45-60-61
613-160-00-7(1S)-2-methyl-2,5-diazobicyclo[2.2.1]heptane dihydrobromide411-000-9125224-62-6R43Xi

R: 43

S: (2-)24-37
613-163-00-3azimsulfuron (ISO);

1-(4,6-dimethoxypyrimidin-2-yl)-3-[1-methyl-4-(2-methyl-2H-tetrazol-5-yl)pyrazol-5-ylsulfonyl]urea
120162-55-2N; R50-53N

R: 50/53

S: 60-61
613-164-00-9flufenacet (ISO);

N-(4-fluorophenyl)-N-isopropyl-2-(5-trifluoromethyl-[1,3,4]thiadiazol-2-yloxy)acetamide
142459-58-3Xn; R22-48/22

R43

N; R50-53
Xn; N

R: 22-43-48/22-50/53

S: (2-)13-24-37-60-61
613-165-00-4flupyrsulfuron-methyl-sodium (ISO);

methyl 2-[[(4,6-dimethoxypyrimidin-2-ylcarbamoyl)sulfamoyl]-6-trifluoromethyl]nicotinate, monosodium salt
144740-54-5N; R50-53N

R: 50/53

S: 60-61
613-166-00-Xflumioxazin (ISO);

N-(7-fluoro-3,4-dihydro-3-oxo-4-prop-2-ynyl-2H-1,4-benzoxazin-6-yl)cyclohex-1-ene-1,2-dicarboxamide
103361-09-7Repr. Cat. 2; R61

N; R50-53
T; N

R: 61-50/53

S: 53-45-60-61
613-167-00-5reaction mass of: 5-chloro-2-methyl-4-isothiazolin-3-one [EC no. 247-500-7]

and 2-methyl-2H -isothiazol-3-one [EC no. 220-239-6] (3:1);

reaction mass of: 5-chloro-2-methyl-4-isothiazolin-3-one [EC no. 247-500-7]

and 2-methyl-4-isothiazolin-3-one [EC no. 220-239-6] (3:1)
55965-84-9T; R23/24/25

C; R34

R43

N; R50-53
T; N

R: 23/24/25-34-43-50/53

S: (2-)26-28-36/37/39-45-60-61
C; R34: C ≥ 0,6 %

Xi; R36/38: 0,06 % ≤ C < 0,6 %

R43: C ≥ 0,0015 %
613-168-00-01-vinyl-2-pyrrolidone201-800-488-12-0Carc. Cat. 3; R40

Xn; R20/21/22-48/20

Xi; R37-41
Xn

R: 20/21/22-37-40-41-48/20

S: (2-)26-36/37/39
D
613-169-00-69-vinylcarbazole216-055-01484-13-5Muta. Cat. 3; R68

Xn; R21/22

Xi; R38

R43

N; R50-53
Xn; N

R: 21/22-38-43-50/53-68

S: 22-23-36/37-60-61
613-170-00-12,2-ethylmethylthiazolidine404-500-3694-64-4Xn; R22

Xi; R41

R43

N; R51-53
Xn; N

R: 22-41-43-51/53

S: (2-)24-26-37/39-61
613-171-00-7hexaconazole (ISO);

(RS)-2-(2,4-dichlorophenyl)-1-(1H-1,2,4-triazol-1-yl)hexan-2-ol
413-050-779983-71-4Xn; R22

R43

N; R51-53
Xn; N

R: 22-43-51/53

S: (2-)24-37-61
613-172-00-25-chloro-1,3-dihydro-2H-indol-2-one412-200-917630-75-0Repr. Cat. 3; R62

Xn; R22

R43

R52-53
Xn

R: 22-43-62-52/53

S: (2-)22-36/37-61
613-173-00-8fluquinconazole (ISO);

3-(2,4-dichlorophenyl)-6-fluoro-2-(1H-1,2,4-triazol-1-yl)quinazolin-4-(3H)-one
411-960-9136426-54-5T; R23/25-48/25

Xn; R21

Xi; R38

N; R50-53
T; N

R: 21-23/25-38-48/25-50/53

S: (1/2-)36/37/39-38-45-60-61
613-174-00-3(±) 2-(2,4-dichlorophenyl)-3-(1H-1,2,4-triazol-1-yl)propyl-1,1,2,2-tetrafluoroethylether407-760-6112281-77-3Carc. Cat. 3; R40

Xn; R20/22

N; R51-53
Xn; N

R: 20/22-40-51/53

S: (2-)36/37-41-61
613-175-00-9epoxiconazole (ISO);

(2RS,3SR)-3-(2-chlorophenyl)-2-(4-fluorophenyl)-[(1H-1,2,4-triazol-1-yl)methyl]oxirane
406-850-2133855-98-8Carc. Cat. 3; R40

Repr. Cat. 3; R62

Repr. Cat. 3; R63

N; R51-53
Xn; N

R: 40-62-63-51/53

S: (2-)36/37-46-61
613-176-00-42-methyl-2-azabicyclo[2.2.1]heptane404-810-94524-95-2R10

Xn; R21/22-48/20

C; R34
C

R: 10-21/22-34-48/20

S: (1/2-)16-26-36/37/39-45
613-177-00-X8-amino-7-methylquinoline412-760-45470-82-6Xn; R21/22

R43

N; R51-53
Xn; N

R: 21/22-43-51/53

S: (2-)36/37-61
613-178-00-54-ethyl-2-methyl-2-isopentyl-1,3-oxazolidine410-470-2137796-06-6C; R34

R43
C

R: 34-43

S: (1/2-)7/8-26-36/37/39-45
C; R34: C ≥ 10 %

Xi; R36/37/38: 5 % ≤ C < 10 %
613-179-00-0lithium 3-oxo-1,2(2H)-benzisothiazol-2-ide411-690-1111337-53-2Xn; R22

C; R34

R43

N; R51-53
C; N

R: 22-34-43-51/53

S: (1/2-)26-36/37/39-45-61
613-180-00-6N-(1,1-dimethylethyl)bis(2-benzothiazolesulfen)amide407-430-13741-80-8N; R50-53N

R: 50/53

S: 60-61
613-181-00-15,5-dimethyl-perhydro-pyrimidin-2-one α-(4-trifluoromethylstyryl)-α-(4-trifluoromethyl)cinnamylidenehydrazone405-090-967485-29-4T; R48/25

Xn; R22

Xi; R36

N; R50-53
T; N

R: 22-36-48/25-50/53

S: (1/2-)22-26-36/37-45-60-61
613-182-00-71-(1-naphthylmethyl)quinolinium chloride406-220-765322-65-8Carc. Cat. 3; R40

Muta. Cat. 3; R68

Xn; R22

Xi; R38-41

R52-53
Xn

R: 22-38-40-41-52/53-68

S: (2-)22-26-36/37/39-61
613-183-00-2reaction mass of: 5-(N-methylperfluorooctylsulfonamido)methyl-3-octadecyl-1,3-oxazolidin-2-one;

5-(N-methylperfluoroheptylsulfonamido)methyl-3-octadecyl-1,3-oxazolidin-2-one
413-640-4Xn; R48/22

N; R50-53
Xn; N

R: 48/22-50/53

S: (2-)36-60-61
613-184-00-8nitrilotriethyleneammoniopropane-2-ol 2-ethylhexanoate413-670-8Xi; R36

R43
Xi

R: 36-43

S: (2-)24-26-37
613-185-00-32,3,5,6-tetrahydro-2-methyl-2H-cyclopenta[d]-1,2-thiazol-3-one407-630-982633-79-2T; R25

Xi; R41

R43

N; R50-53
T; N

R: 25-41-43-50/53

S: (1/2-)22-26-36/37/39-45-60-61
613-186-00-9(2R,3R)-3-((R)-1-(tert-butyldimethylsiloxy)ethyl)-4-oxoazetidin-2-yl acetate408-050-976855-69-1Xi; R36

R43

N; R51-53
Xi; N

R: 36-43-51/53

S: (2-)24-26-37-61
613-188-00-X1-(3-(4-fluorophenoxy)propyl)-3-methoxy-4-piperidinone411-500-7116256-11-2Xn; R22

Xi; R41

R43

N; R51-53
Xn; N

R: 22-41-43-51/53

S: (2-)22-24-26-37/39-61
613-189-00-51,4,7,10-tetrakis(p-toluensulfonyl)-1,4,7,10-tetraazacyclododecane414-030-052667-88-6R43

N; R50-53
Xi; N

R: 43-50/53

S: (2-)24-37-60-61
613-190-00-0disodium 1-amino-4-(2-(5-chloro-6-fluoro-pyrimidin-4-ylamino-methyl)-4-methyl-6-sulfo-phenylamino)-9,10-dioxo-9,10-dihydro-anthracene-2-sulfonate414-040-5149530-93-8Xn; R22

R43
Xn

R: 22-43

S: (2-)22-24-37
613-191-00-63-ethyl-2-methyl-2-(3-methylbutyl)-1,3-oxazolidine421-150-7143860-04-2Repr. Cat. 2; R60

C; R34

N; R50-53
T; N

R: 60-34-50/53

S: 53-45-60-61
613-193-00-7pentakis[3-(dimethylammonio)propylsulfamoyl]-[(6-hydroxy-4,4,8,8-tetramethyl-4,8-diazoniaundecane-1,11-diyldisulfamoyl)di[phthalocyaninecopper(II)]] heptalactate414-930-3N; R51-53N

R: 51/53

S: 61
613-194-00-26,13-dichloro-3,10-bis{2-[4-fluoro-6-(2-sulfophenylamino)-1,3,5-triazin-2-ylamino]propylamino}benzo[5,6][1,4]oxazino[2,3-.b.]phenoxazine-4,11-disulphonic acid, lithium-, sodium salt418-000-8163062-28-0Xi; R41Xi

R: 41

S: (2-)22-26-39
613-195-00-82,2-(1,4-phenylene)bis((4H-3,1-benzoxazine-4-one)418-280-118600-59-4R43

R53
Xi

R: 43-53

S: (2-)24-37-61
613-196-00-35-[[4-chloro-6-[[2-[[4-fluoro-6-[[5-hydroxy-6-[(4-methoxy-2-sulfophenyl)azo]-7-sulfo-2-naphthalenyl]amino]-1,3,5-triazin-2-yl]amino]-1-methylethyl]amino]-1,3,5-triazin-2-yl]amino]-3-[[4-(ethenylsulfonyl)phenyl]azo]-4-hydroxy-naphtalene-2,7-disulfonic acid, sodium salt418-380-5168113-78-8Xi; R41Xi

R: 41

S: (2-)26-39
613-197-00-9reaction mass of: 2,4,6-tri(butylcarbamoyl)-1,3,5-triazine;

2,4,6-tri(methylcarbamoyl)-1,3,5-triazine;

[(2-butyl-4,6-dimethyl)tricarbamoyl]-1,3,5-triazine;

[(2,4-dibutyl-6-methyl)tricarbamoyl]-1,3,5-triazine
420-390-1187547-46-2R43

N; R51-53
Xi; N

R: 43-51/53

S: (2-)24-37-61
613-199-00-Xreaction mass of: 1,3,5-tris(3-aminomethylphenyl)-1,3,5-(1H,3H,5H)-triazine-2,4,6-trione;

reaction mass of oligomers of 3,5-bis(3-aminomethylphenyl)-1-poly[3,5-bis(3-aminomethylphenyl)-2,4,6-trioxo-1,3,5-(1H,3H,5H)-triazin-1-yl]-1,3,5-(1H,3H,5H)-triazine-2,4,6-trione
421-550-1Carc. Cat. 2; R45

Repr. Cat. 2; R61

R43

R52-53
T

R: 45-61-43-52/53

S: 53-45-61
613-200-00-3Reaction product of: copper, (29H,31H-phthalocyaninato(2-)-N29,N30,N31,N32)-, chlorosulfuric acid and 3-(2-sulfooxyethylsulfonyl)aniline, sodium salts420-980-7Xi; R41Xi

R: 41

S: (2-)22-26-39
613-201-00-9(R)-5-bromo-3-(1-methyl-2-pyrrolidinyl methyl)-1H-indole422-390-5143322-57-0Repr. Cat. 3; R62

T; R39-48/25

Xn; R20/22

Xi; R41

R43

N; R50-53
T; N

R: 20/22-39-41-43-48/25-62-50/53

S: (1/2-)53-45-60-61
613-202-00-4pymetrozine (ISO);

(E)-4,5-dihydro-6-methyl-4-(3-pyridylmethyleneamino)-1,2,4-triazin-3(2H)-one
123312-89-0Carc. Cat. 3; R40

R52-53
Xn

R: 40-52/53

S: (2-)36/37-61
613-203-00-Xpyraflufen-ethyl; [1]

pyraflufen [2]
[1]

[2]
129630-19-9 [1]

129630-17-7 [2]
N; R50-53N

R: 50/53

S: 60-61
613-204-00-5oxadiargyl (ISO);

3-[2,4-dichloro-5-(2-propynyloxy)phenyl]-5-(1,1-dimethylethyl)-1,3,4-oxadiazol-2(3H)-one;

5-tert-butyl-3-[2,4-dichloro-5-(prop-2-ynyloxy)phenyl]-1,3,4-oxadiazol-2(3H)-one
254-637-639807-15-3Repr. Cat. 3; R63

Xn; R48/22

N; R50-53
Xn; N

R: 48/22-63-50/53

S: (2-)36/37-46-60-61
613-205-00-0propiconazole (ISO);

(±)-1-[2-(2,4-dichlorophenyl)-4-propyl-1,3-dioxolan-2-ylmethyl]-1H-1,2,4-triazole
262-104-460207-90-1Xn; R22

R43

N; R50-53
Xn; N

R: 22-43-50/53

S: (2-)36/37-46-60-61
613-206-00-6fenamidone (ISO);

(S)-5-methyl-2-methylthio-5-phenyl-3-phenylamino-3,5-dihydroimidazol-4-one
161326-34-7N; R50-53N

R: 50/53

S: 60-61
613-208-00-7imazamox (ISO);

(RS)-2-(4-isopropyl-4-methyl-5-oxo-2-imidazolin-2-yl)-5-methoxymethylnicotinic acid
114311-32-9N; R50-53N

R: 50/53

S: 60-61
613-209-00-2cis-1-(3-chloropropyl)-2,6-dimethyl-piperidin hydrochloride417-430-363645-17-0T; R25

Xn; R48/22

R43

N; R51-53
T; N

R: 25-43-48/22-51/53

S: (1/2-)22-36/37-45-61
613-210-00-82-(3-chloropropyl)-2,5,5-trimethyl-1,3-dioxane417-650-188128-57-8Xn; R48/22

R52-53
Xn

R: 48/22-52/53

S: (2-)23-25-36-61
613-211-00-3N-methyl-4-(p-formylstyryl)pyridinium methylsulfate418-240-374401-04-0R43

R52-53
Xi

R: 43-52/53

S: (2-)22-24-37-61
613-212-00-94-[4-(2-ethylhexyloxy)phenyl](1,4-thiazinane-1,1-dioxide)418-320-8133467-41-1Xn; R22

N; R50-53
Xn; N

R: 22-50/53

S: (2-)22-60-61
613-213-00-4cis-1-benzoyl-4-[(4-methylsulfonyl)oxy]-L-proline416-040-0120807-02-5R52-53R: 52/53

S: 61
613-214-00-XN,N-di-n-butyl-2-(1,2-dihydro-3-hydroxy-6-isopropyl-2-quinolylidene)-1,3-dioxoindan-5-carboxamide416-260-7147613-95-4R53R: 53

S: 61
613-215-00-52-chloromethyl-3,4-dimethoxypyridinium chloride416-440-572830-09-2Xn; R21/22-48/22

Xi; R38-41

R43

N; R51-53
Xn; N

R: 21/22-38-41-43-48/22-51/53

S: (2-)26-36/37/39-61
613-216-00-06-tert-butyl-7-(6-diethylamino-2-methyl-3-pyridylimino)-3-(3-methylphenyl)pyrazolo[3,2-c][1,2,4]triazole416-490-8162208-01-7N; R50-53N

R: 50/53

S: 60-61
613-217-00-64-[3-(3,5-di-tert-butyl-4-hydroxyphenyl)propionyloxy]-1-[2-[3-(3,5-di-tert-butyl-4-hydrophenyl)propionyloxy]ethyl]-2,2,6,6-tetramethylpiperidine416-770-173754-27-5R53R: 53

S: 61
613-218-00-16-hydroxyindole417-020-42380-86-1Xn; R22

Xi; R41

R43

N; R51-53
Xn; N

R: 22-41-43-51/53

S: (2-)24-26-37/39-61
613-219-00-77a-ethyl-3,5-bis(1-methylethyl)-2,3,4,5-tetrahydrooxazolo[3,4-c]-2,3,4,5-tetrahydrooxazole417-140-779185-77-6Xi; R38

N; R51-53
Xi; N

R: 38-51/53

S: (2-)37-61
613-220-00-2trans-(4S,6S)-5,6-dihydro-6-methyl-4H-thieno[2,3-b]thiopyran-4-ol, 7,7-dioxide417-290-3147086-81-5Xn; R22Xn

R: 22

S: (2-)36
613-221-00-82-chloro-5-methyl-pyridine418-050-018368-64-4Xn; R21/22

Xi; R38

R52-53
Xn

R: 21/22-38-52/53

S: (2-)23-25-36/37-61
613-222-00-34-(1-oxo-2-propenyl)-morpholine418-140-15117-12-4Xn; R22-48/22

Xi; R41

R43
Xn

R: 22-41-43-48/22

S: (2-)23-26-36/37/39
613-223-00-9N-isopropyl-3-(4-fluorophenyl)-1H-indole418-790-493957-49-4R53R: 53

S: 61
613-224-00-42,5-dimercaptomethyl-1,4-dithiane419-770-8136122-15-1Xn; R22

C; R34

R43

N; R50-53
C; N

R: 22-34-43-50/53

S: (1/2-)26-36/37/39-45-60-61
613-225-00-Xreaction mass of:[2-(anthraquinon-1-ylamino)-6-[(5-benzoylamino)-anthraquinone-1-ylamino]-4-phenyl]-1,3,5-triazine;

2,6-bis-[(5-benzoylamino)-anthraquinon-1-ylamino]-4-phenyl-1,3,5-triazine.
421-290-9Xn; R48/22

R53
Xn

R: 48/22-53

S: (2-)22-36-61
613-226-00-51-(2-(ethyl(4-(4-(4-(4-(ethyl(2-pyridinoethyl)amino)-2-methylphenylazo)benzoylamino)-phenylazo)-3-methylphenyl)amino)ethyl)-pyridinium dichloride420-950-3163831-67-2Xi; R41

N; R50-53
Xi; N

R: 41-50/53

S: (2-)26-39-60-61
613-227-00-0(±)-[(R*,R*) and (R*,S*)]-6-fluoro-3,4-dihydro-2-oxiranyl-2H-1-benzopyran419-600-299199-90-3R43

N; R51-53
Xi; N

R: 43-51/53

S: (2-)24-28-36/37-61
613-228-00-6(±)-(R*,S*)-6-fluoro-3,4-dihydro-2-oxiranyl-2H-1-benzopyran419-630-6793669-26-8N; R51-53N

R: 51/53

S: 24-61
613-230-00-7florasulam (ISO);

2',6',8-trifluoro-5-methoxy-5-triazolo[1,5-c];

pyrimidine-2-sulfonanilide
145701-23-1N; R50-53N

R: 50/53

S: 60-61
613-233-00-34,4'-(oxy-(bismethylene))-bis-1,3-dioxolane423-230-756552-15-9Xi; R41Xi

R: 41

S: (2-)26-39
614-001-00-4nicotine (ISO);

3-(N-methyl-2-pyrrolidinyl)pyridine
200-193-354-11-5T+; R27

T; R25

N; R51-53
T+; N

R: 25-27-51/53

S: (1/2-)36/37-45-61
614-002-00-Xsalts of nicotineT+; R26/27/28

N; R51-53
T+; N

R: 26/27/28-51/53

S: (1/2-)13-28-45-61
A
614-003-00-5strychnine200-319-757-24-9T+; R27/28

N; R50-53
T+; N

R: 27/28-50/53

S: (1/2-)36/37-45-60-61
614-004-00-0salts of strychnineT+; R26/28

N; R50-53
T+; N

R: 26/28-50/53

S: (1/2-)13-28-45-60-61
A
614-005-00-6colchicine200-598-564-86-8T+; R26/28T+

R: 26/28

S: (1/2-)13-45
614-006-00-1brucine;

2,3-dimethoxystrychnine
206-614-7357-57-3T+; R26/28

R52-53
T+

R: 26/28-52/53

S: (1/2-)13-45-61
614-007-00-7brucine sulphate; [1]

brucine nitrate; [2]

Strychnidin-10-one, 2,3-dimethoxy-, mono[(R)-1-methylheptyl 1,2-benzenedicarboxylate]; [3]

Strychnidin-10-one, 2,3-dimethoxy-, compd. with (S)mono(1-methylheptyl)-1,2-benzenedicarboxylate (1:1) [4]
225-432-9 [1]

227-317-9 [2]

269-439-5 [3]

269-710-8 [4]
4845-99-2 [1]

5786-97-0 [2]

68239-26-9 [3]

68310-42-9 [4]
T+; R26/28

R52-53
T+

R: 26/28-52/53

S: (1/2-)13-45-61
A
614-008-00-2aconitine206-121-7302-27-2T+; R26/28T+

R: 26/28

S: (1/2-)24-45
614-009-00-8salts of aconitineT+; R26/28T+

R: 26/28

S: (1/2-)24-45
A
614-010-00-3atropine200-104-851-55-8T+; R26/28T+

R: 26/28

S: (1/2-)25-45
614-011-00-9salts of atropineT+; R26/28T+

R: 26/28

S: (1/2-)25-45
A
614-012-00-4hyoscyamine202-933-0101-31-5T+; R26/28T+

R: 26/28

S: (1/2-)24-45
614-013-00-Xsalts of hyoscyamineT+; R26/28T+

R: 26/28

S: (1/2-)24-45
A
614-014-00-5hyoscine200-090-351-34-3T+; R26/27/28T+

R: 26/27/28

S: (1/2-)25-45
614-015-00-0salts of hyoscineT+; R26/27/28T+

R: 26/27/28

S: (1/2-)25-45
A
614-016-00-6pilocarpine202-128-492-13-7T+; R26/28T+

R: 26/28

S: (1/2-)25-45
614-017-00-1salts of pilocarpineT+; R26/28T+

R: 26/28

S: (1/2-)25-45
A
614-018-00-7papaverine200-397-258-74-2Xn; R22Xn

R: 22

S: (2-)22
614-019-00-2salts of papaverineXn; R22Xn

R: 22

S: (2-)22
A
614-020-00-8physostigmine200-332-857-47-6T+; R26/28T+

R: 26/28

S: (1/2-)25-45
614-021-00-3salts of physostigmineT+; R26/28T+

R: 26/28

S: (1/2-)25-45
A
614-022-00-9digitoxin200-760-571-63-6T; R23/25

R33
T

R: 23/25-33

S: (1/2-)45
614-023-00-4ephedrine206-080-5299-42-3Xn; R22Xn

R: 22

S: (2-)22-25
614-024-00-Xsalts of ephedrineXn; R22Xn

R: 22

S: (2-)22-25
A
614-025-00-5ouabain211-139-3630-60-4T; R23/25

R33
T

R: 23/25-33

S: (1/2-)45
614-026-00-0strophantin-K234-239-911005-63-3T; R23/25

R33
T

R: 23/25-33

S: (1/2-)45
614-027-00-6bufa-4,20,22-trienolide, 6-(acetyloxy)-3-(β-D-glucopyranosyloxy)-8,14-dihydroxy-, (3β, 6β)-;

red squill;

scilliroside
208-077-4507-60-8T+; R28T+

R: 28

S: (1/2-)36/37-45
614-028-00-1reaction mass of: 2-ethylhexyl mono-D-glucopyranoside;

2-ethylhexyl di-D-glucopyranoside
414-420-0Xi; R41Xi

R: 41

S: (2-)26-39
614-029-00-7constitutional isomers of penta-O-allyl-β-D-fructofuranosyl-α-D-glucopyranoside;

constitutional isomers of hexa-O-allyl-β-D-fructofuranosyl-α-D-glucopyranoside;

constitutional isomers of hepta-O-allyl-β-D-fructofuransoyl-α-D-glucopyranoside
419-640-068784-14-5Xn; R22Xn

R: 22

S: (2-)
615-001-00-7methyl isocyanate210-866-3624-83-9F+; R12 ⊗

Repr. Cat. 3; R63

T+; R26

T; R24/25

R42/43

Xi; R37/38-41
F+; T+

R: 12-24/25-26-37/38-41-42/43-63

S: (1/2-)26-27/28-36/37/39-45-63
615-002-00-2methyl isothiocyanate209-132-5556-61-6T; R23/25

C; R34

R43

N; R50-53
T; N

R: 23/25-34-43-50/53

S: (1/2-)36/37-38-45-60-61
615-003-00-8thiocyanic acid207-337-4463-56-9Xn; R20/21/22

R32

R52-53
Xn

R: 20/21/22-32-52/53

S: (2-)13-61
615-004-00-3salts of thiocyanic acidXn; R20/21/22

R32

R52-53
Xn

R: 20/21/22-32-52/53

S: (2-)13-61
A
615-005-00-94,4'-methylenediphenyl diisocyanate;

diphenylmethane-4,4'-diisocyanate; [1]

2,2'-methylenediphenyl diisocyanate;

diphenylmethane-2,2'-diisocyanate; [2]

o-(p-isocyanatobenzyl)phenyl isocyanate;

diphenylmethane-2,4'-diisocyanate; [3]

methylenediphenyl diisocyanate [4]
202-966-0 [1]

219-799-4 [2]

227-534-9 [3]

247-714-0 [4]
101-68-8 [1]

2536-05-2 [2]

5873-54-1 [3]

26447-40-5 [4]
Xn; R20

Xi; R36/37/38

R42/43
Xn

R: 20-36/37/38-42/43

S: (1/2-)23-36/37-45
Xi; R36/37/38: C ≥ 5 %

R42: C ≥ 0,1 %
C

2
615-006-00-42-methyl-m-phenylene diisocyanate;

toluene-2,4-di-isocyanate; [1]

4-methyl-m-phenylene diisocyanate;

toluene-2,6-di-isocyanate; [2]

m-tolylidene diisocyanate;

toluene-diisocyanate [3]
202-039-0 [1]

209-544-5 [2]

247-722-4 [3]
91-08-7 [1]

584-84-9 [2]

26471-62-5 [3]
Carc. Cat. 3; R40

T+; R26

Xi; R36/37/38

R42/43

R52-53
T+

R: 26-36/37/38-40-42/43-52/53

S: (1/2-)23-36/37-45-61
R42: C ≥ 0,1 %C

2
615-007-00-X1,5-naphthylene diisocyanate221-641-43173-72-6Xn; R20

Xi; R36/37/38

R42

R52-53
Xn

R: 20-36/37/38-42-52/53

S: (2-)26-28-38-45-61
615-008-00-53-isocyanatomethyl-3,5,5-trimethylcyclohexyl isocyanate;

isophorone di-isocyanate
223-861-64098-71-9T; R23

Xi; R36/37/38

R42/43

N; R51-53
T; N

R: 23-36/37/38-42/43-51/53

S: (1/2-)26-28-38-45-61
T; R23: C ≥ 2 %

Xn; R20: 0,5 % ≤ C < 2 %

R42/43: C ≥ 0,5 %
2
615-009-00-04,4'-methylenedi(cyclohexyl isocyanate);

dicyclohexylmethane-4,4'-di-isocyanate
225-863-25124-30-1T; R23

Xi; R36/37/38

R42/43
T

R: 23-36/37/38-42/43

S: (1/2-)26-28-38-45
T; R23: C ≥ 2 %

Xn; R20: 0,5 % ≤ C < 2 %

R42/43: C ≥ 0,5 %
2
615-010-00-62,2,4-trimethylhexamethylene-1,6-di-isocyanate; [1]

2,4,4-trimethylhexamethylene-1,6-di-isocyanate [2]
241-001-8 [1]

239-714-4 [2]
16938-22-0 [1]

15646-96-5 [2]
T; R23

Xi; R36/37/38

R42
T

R: 23-36/37/38-42

S: (1/2-)26-28-38-45
T; R23: C ≥ 2 %

Xn; R20: 0,5 % ≤ C < 2 %

R42: C ≥ 0,5 %
C

2
615-011-00-1hexamethylene-di-isocyanate212-485-8822-06-0T; R23

Xi; R36/37/38

R42/43
T

R: 23-36/37/38-42/43

S: (1/2-)26-28-38-45
T; R23: C ≥ 2 %

Xn; R20: 0,5 % ≤ C < 2 %

R42/43: C ≥ 0,5 %
2
615-012-00-74-isocyanatosulphonyltoluene;

tosyl isocyanate
223-810-84083-64-1R14

Xi; R36/37/38

R42
Xn

R: 14-36/37/38-42

S: (2-)26-28-30
Xi; R36/37/38: C ≥ 5 %
615-013-00-2cyanamide;

carbanonitril
206-992-3420-04-2T; R25

Xn; R21

Xi; R36/38

R43
T

R: 21-25-36/38-43

S: (1/2-)3-22-36/37-45
615-014-00-8tris(1-dodecyl-3-methyl-2-phenylbenzimidazolium)hexacyanoferrate7276-58-6Xn; R22Xn

R: 22

S: (2-)24
615-015-00-31,7,7-trimethylbicyclo(2,2,1)hept-2-yl thiocyanatoacetate;

isobornyl thiocyanoacetate
204-081-5115-31-1Xn; R22

N; R50-53
Xn; N

R: 22-50/53

S: (2-)24/25-60-61
615-016-00-9potassium cyanate209-676-3590-28-3Xn; R22Xn

R: 22

S: (2-)24/25
615-017-00-4calcium cyanamide205-861-8156-62-7Xn; R22

Xi; R37-41
Xn

R: 22-37-41

S: (2-)22-26-36/37/39
615-018-00-X2-(2-butoxyethoxy)ethyl thiocyanate203-985-7112-56-1R10

T; R24/25
T

R: 10-24/25

S: (1/2-)13-36/37-45
615-019-00-5dicyclohexylcarbodiimide208-704-1538-75-0T; R24

Xn; R22

Xi; R41

R43
T

R: 22-24-41-43

S: (1/2-)24-26-37/39-45
615-020-00-0methylene dithiocyanate228-652-36317-18-6T+; R26

T; R25

C; R34

R43

N; R50
T+; N

R: 25-26-34-43-50

S: (1/2-)26-28-36/37/39-45-61
615-021-00-61,3,5-tris(oxiranylmethyl)-1,3,5-triazine-2,4,6(1H,3H,5H)-trione;

TGIC
219-514-32451-62-9Muta. Cat. 2; R46

T; R23/25

Xn; R48/22

Xi; R41

R43

R52-53
T

R: 46-23/25-41-43-48/22-52/53

S: 53-45-61
E
615-022-00-1methyl 3-isocyanatosulfonyl-2-thiophene-carboxylate410-550-779277-18-2E; R2 ⊗

R14

Xn; R48/22

R42/43
E; Xn

R: 2-14-42/43-48/22

S: (2-)22-30-35-36/37
615-023-00-72-(isocyanatosulfonylmethyl)benzoic acid methyl ester;

(alt.):methyl 2-(isocyanatosulfonylmethyl)benzoate
410-900-983056-32-0R10

R14

Muta. Cat. 3; R68

Xn; R20-48/22

Xi; R41

R42
Xn

R: 10-14-20-41-42-48/22-68

S: (2-)23-26-36/37/39
615-024-00-22-phenylethylisocyanate413-080-01943-82-4T; R23

Xn; R22

C; R35

R42/43

N; R51-53
T; C; N

R: 22-23-35-42/43-51/53

S: (1/2-)23-26-36/37/39-43-45-61
615-025-00-84,4'-ethylidenediphenyl dicyanate405-740-147073-92-7Xn; R20/22-48/22

Xi; R41

N; R50-53
Xn; N

R: 20/22-41-48/22-50/53

S: (2-)26-36/37/39-60-61
615-026-00-34,4'-methylenebis(2,6-dimethylphenyl cyanate)405-790-4101657-77-6R43

R52-53
Xi

R: 43-52/53

S: (2-)22-24-37-61
615-028-00-4ethyl 2-(isocyanatosulfonyl)benzoate410-220-277375-79-2E; R2 ⊗

R14

Xn; R22-48/22

Xi; R41

R42/43
E; Xn

R: 2-14-22-41-42/43-48/22

S: (2-)8-23-26-30-35-36/37/39
615-029-00-X2,5-bis-isocyanatomethyl-bicyclo[2.2.1]heptane411-280-2T+; R26

Xn; R22

C; R34

R42/43

R52-53
T+

R: 22-26-34-42/43-52/53

S: (1/2-)23-26-28-36/37/39-45-61
615-030-00-5alkali salts, alkali earth salts and other salts of thiocyanic acid not mentioned elsewhere in this AnnexXn; R20/21/22

R32

R52-53
Xn

R: 20/21/22-32-52/53

S: (2-)13-61
A
615-031-00-0thallium salt of thiocyanic acid222-571-73535-84-0Xn; R20/21/22

R32

N; R51-53
Xn; N

R: 20/21/22-32-51/53

S: (2-)13-61
A
615-032-00-6metal salts of thiocyanic acid not mentioned elsewhere in this AnnexXn; R20/21/22

R32

N; R50-53
Xn; N

R: 20/21/22-32-50/53

S: (2-)13-60-61
A
616-001-00-XN,N-dimethylformamide;

dimethyl formamide
200-679-568-12-2Repr. Cat. 2; R61

Xn; R20/21

Xi; R36
T

R: 61-20/21-36

S: 53-45
E
616-002-00-52-fluoroacetamide211-363-1640-19-7T+; R28

T; R24
T+

R: 24-28

S: (1/2-)36/37-45
616-003-00-0acrylamide;

prop-2-enamide
201-173-779-06-1Carc. Cat. 2; R45

Muta. Cat. 2; R46

Repr. Cat. 3; R62

T; R25-48/23/24/25

Xn; R20/21

Xi; R36/38

R43
T

R: 45-46-20/21-25-36/38-43-48/23/24/25-62

S: 53-45
DE
616-004-00-6allidochlor (ISO);

N,N-diallylchloroacetamide
202-270-793-71-0Xn; R21/22

Xi; R36/38

N; R51-53
Xn; N

R: 21/22-36/38-51/53

S: (2-)26-28-36/37/39-61
616-005-00-1chlorthiamid (ISO);

2,6-dichloro (thiobenzamide)
217-637-71918-13-4Xn; R22Xn

R: 22

S: (2-)36
616-006-00-7dichlofluanid (ISO);

N-dichlorofluoromethylthio-N',N'-dimethyl-N-phenylsulphamide
214-118-71085-98-9Xn; R20

Xi; R36

R43

N; R50-53
Xn; N

R: 20-36-43-50/53

S: (2-)24-37-60-61
616-007-00-2diphenamid (ISO);

N,N-dimethyl-2,2-diphenylacetamide
213-482-4957-51-7Xn; R22

R52-53
Xn

R: 22-52/53

S: (2-)61
616-008-00-8propachlor (ISO);

2-chloro-N-isopropylacetanilide;

α-chloro-N-isopropylacetanilide
217-638-21918-16-7Xn; R22

Xi; R36

R43

N; R50-53
Xn; N

R: 22-36-43-50/53

S: (2-)24-37-60-61
616-009-00-3propanil (ISO);

3',4'-dichloropropionanilide
211-914-6709-98-8Xn; R22

N; R50
Xn; N

R: 22-50

S: (2-)22-61
616-010-00-9tosylchloramide sodium204-854-7127-65-1Xn; R22

R31

C; R34

R42
C

R: 22-31-34-42

S: (1/2-)7-22-26-36/37/39-45
616-011-00-4N,N-dimethylacetamide204-826-4127-19-5Repr. Cat. 2; R61

Xn; R20/21
T

R: 61-20/21

S: 53-45
Repr. Cat. 2; R61: C ≥ 5 %E
616-012-00-XN-(dichlorofluoromethylthio)phthalimide;

N-(fluorodichloromethylthio)phthalimide
211-952-3719-96-0Xi; R38Xi

R: 38

S: (2-)28
616-013-00-5butyraldehyde oxime203-792-8110-69-0T; R24

Xn; R22

Xi; R36
T

R: 22-24-36

S: (1/2-)23-36-45
616-014-00-02-butanone oxime;

ethyl methyl ketoxime;

ethyl methyl ketone oxime
202-496-696-29-7Carc. Cat. 3; R40

Xn; R21

Xi; R41

R43
Xn

R: 21-40-41-43

S: (2-)13-23-26-36/37/39
616-015-00-6alachlor (ISO);

2-chloro-2',6'-diethyl-N-(methoxymethyl)acetanilide
240-110-815972-60-8Carc. Cat. 3; R40

Xn; R22

R43

N; R50-53
Xn; N

R: 22-40-43-50/53

S: (2-)36/37-46-60-61
N; R50-53: C ≥ 0,2,5 %

N; R51-53: 0,025 % ≤ C < 0,25 %

R52-53: 0,0025 % ≤ C < 0,025 %
616-016-00-11-(3,4-dichlorophenylimino) thiosemicarbazide5836-73-7T+; R28T+

R: 28

S: (1/2-)22-36/37-45
616-017-00-7cartap hydrochloride239-309-215263-52-2Xn; R21/22

N; R50-53
Xn; N

R: 21/22-50/53

S: (2-)36/37-60-61
616-018-00-2N,N-diethyl-m-toluamide;

deet
205-149-7134-62-3Xn; R22

Xi; R36/38

R52-53
Xn

R: 22-36/38-52/53

S: (2-)61
616-019-00-8perfluidone (ISO);

1,1,1-trifluoro-N-(4-phenylsulphonyl-o-tolyl)methanesulphonamide
253-718-337924-13-3Xn; R22

Xi; R36
Xn

R: 22-36

S: (2-)
616-020-00-3tebuthiuron (ISO);

1-(5-tert-butyl-1,3,4-thiadiazol-2-yl)-1,3-dimethylurea
251-793-734014-18-1Xn; R22

N; R50-53
Xn; N

R: 22-50/53

S: (2-)37-60-61
616-021-00-9thiazafluron (ISO);

1,3-dimethyl-1-(5-trifluoromethyl-1,3,4-thiadiazol-2-yl)urea
246-901-425366-23-8Xn; R22

N; R50-53
Xn; N

R: 22-50/53

S: (2-)60-61
616-022-00-4acetamide200-473-560-35-5Carc. Cat. 3; R40Xn

R: 40

S: (2-)36/37
616-023-00-XN-hexadecyl(or octadecyl)-N-hexadecyl(or octadecyl)benzamide401-980-6Xi; R38

R43
Xi

R: 38-43

S: (2-)24-37
616-024-00-52-(4,4-dimethyl-2,5-dioxooxazolidin-1-yl)-2-chloro-5-(2-(2,4-di-tert-pentylphenoxy)butyramido)-4,4-dimethyl-3-oxovaleranilide402-260-454942-74-4R53R: 53

S: 61
616-025-00-0valinamide402-840-720108-78-5Repr. Cat. 3; R62

Xi; R36

R43
Xn

R: 36-43-62

S: (2-)26-36/37
616-026-00-6thioacetamide200-541-462-55-5Carc. Cat. 2; R45

Xn; R22

Xi; R36/38

R52-53
T

R: 45-22-36/38-52/53

S: 53-45-61
E
616-027-00-1tris(2-(2-hydroxyethoxy)ethyl)ammonium 3-acetoacetamido-4-methoxybenzenesulfonate403-760-5R43Xi

R: 43

S: (2-)24-37
616-028-00-7N-(4-(3-(4-cyanophenyl)ureido)-3-hydroxyphenyl)-2-(2,4-di-tert-pentylphenoxy)octanamide403-790-9108673-51-4R43

R53
Xi

R: 43-53

S: (2-)24-37-61
616-029-00-2N,N'-ethylenebis(vinylsulfonylacetamide)404-790-166710-66-5Xi; R41

R43
Xi

R: 41-43

S: (2-)24-26-37/39
616-030-00-8ethidimuron (ISO);

1-(5-ethylsulphonyl-1,3,4-thiadiazol-2-yl)-1,3-dimethylurea
250-010-630043-49-3R43

N; R50-53
Xi; N

R: 43-50/53

S: (2-)24-37-60-61
616-031-00-3dimethachlor (ISO);

2-chloro-N-(2,6-dimethylphenyl)-N-(2-methoxyethyl)acetamide
256-625-650563-36-5Xn; R22

R43

N; R50-53
Xn; N

R: 22-43-50/53

S: (2-)24-37-60-61
616-032-00-9diflufenican (ISO);

N-(2,4-difluorophenyl)-2-[3-(trifluoromethyl)phenoxy]-3-pyridinecarboxamide
83164-33-4R52-53R: 52/53

S: 61
616-033-00-4cyprofuram (ISO);

N-(3-chlorophenyl)-N-(tetrahydro-2-oxo-3-furyl)cyclopropanecarboxamide
274-050-969581-33-5T; R25

Xn; R21

N; R50-53
T; N

R: 21-25-50/53

S: (1/2-)36/37-60-61
616-034-00-Xpyracarbolid (ISO);

3,4-dihydro-6-methyl-2H-pyran-5-carboxanilide
246-419-424691-76-7R52-53R: 52/53

S: 61
616-035-00-5cymoxanil (ISO);

2-cyano-N-[(ethylamino)carbonyl]-2-(methoxyimino)acetamide
261-043-057966-95-7Xn; R22

R43

N; R50-53
Xn; N

R: 22-43-50/53

S: (2-)36/37-60-61
616-036-00-02-chloracetamide201-174-279-07-2Repr. Cat. 3; R62

T; R25

R43
T

R: 25-43-62

S: (1/2-)22-36/37-45
R43: C ≥ 0,1 %
616-037-00-6acetochlor (ISO);

2-chloro-N-(ethoxymethyl)-N-(2-ethyl-6-methylphenyl)acetamide
251-899-334256-82-1Xn; R20

Xi; R37/38

R43

N; R50-53
Xn; N

R: 20-37/38-43-50/53

S: (2-)36/37-60-61
616-038-00-1(4-aminophenyl)-N-methylmethylensulfonamide hydrochloride406-010-588918-84-7Xi; R41

R43

N; R51-53
Xi; N

R: 41-43-51/53

S: (2-)24-26-37/39-61
616-039-00-73',5'-dichloro-4'-ethyl-2'-hydroxypalmitanilide406-200-8117827-06-2R43Xi

R: 43

S: (2-)24-37
616-040-00-2potassium N-(4-toluenesulfonyl)-4-toluenesulfonamide406-650-597888-41-0Xi; R41Xi

R: 41

S: (2-)26-39
616-041-00-83',5'-dichloro-2-(2,4-di-tert-pentylphenoxy)-4'-ethyl-2'-hydroxyhexananilide406-840-8101664-25-9R53R: 53

S: 61
616-042-00-3N-(2-(6-ethyl-7-(4-methylphenoxy)-1H-pyrazolo[1,5-b][1,2,4]triazol-2-yl)propyl)-2-octadecyloxybenzamide407-070-5142859-67-4R43

R53
Xi

R: 43-53

S: (2-)22-24-37-61
616-043-00-9isoxaben (ISO);

N-[3-(1-ethyl-1-methylpropyl)-1,2-oxazol-5-yl]-2,6-dimethoxybenzamide
407-190-882558-50-7R53R: 53

S: 61
616-044-00-4N-(3,5-dichloro-4-ethyl-2-hydroxyphenyl)-2-(3-pentadecylphenoxy)-butanamide402-510-2N; R51-53N

R: 51/53

S: 61
616-045-00-X2'-(4-chloro-3-cyano-5-formyl-2-thienylazo)-5'-diethylamino-2-methoxyacetanilide405-190-2122371-93-1R43

R53
Xi

R: 43-53

S: 2-22-24-37-61
616-046-00-5N-(2-(6-chloro-7-methylpyrazolo(1,5-b)-1,2,4-triazol-4-yl)propyl)-2-(2,4-di-tert-pentylphenoxy)octanamide406-390-2N; R50-53N

R: 50/53

S: 60-61
616-047-00-0reaction mass of: 2,2',2'',2'''-(ethylenedinitrilotetrakis-N,N-di(C16)alkylacetamide;

2,2',2'',2'''-(ethylenedinitrilotetrakis-N,N-di(C18)alkylacetamide
406-640-0R43Xi

R: 43

S: (2-)24-37
616-048-00-63'-trifluoromethylisobutyranilide406-740-41939-27-1Xn; R48/22

N; R51-53
Xn; N

R: 48/22-51/53

S: (2-)22-36-61
616-049-00-12-(2,4-bis(1,1-dimethylethyl)phenoxy)-N-(3,5-dichloro-4-ethyl-2-hydroxyphenyl)-hexanamide408-150-299141-89-6R53R: 53

S: 61
616-050-00-7lufenuron (ISO);

N-[2,5-dichloro-4-(1,1,2,3,3,3-hexafluoropropoxy)-phenyl-aminocarbonyl]-2,6-difluorobenzamide
410-690-9103055-07-8R43

N; R50-53
Xi; N

R: 43-50/53

S: (2-)24-37-60-61
616-051-00-2reaction mass of: 2,4 -bis(N'-(4-methylphenyl)-ureido)-toluene;

2,6 -bis(N'-(4-methylphenyl)-ureido)-toluene
411-070-0R53R: 53

S: 61
616-052-00-8formamide200-842-075-12-7Repr. Cat. 2; R61T

R: 61

S: 53-45
616-053-00-3N-methylacetamide201-182-679-16-3Repr. Cat. 2; R61T

R: 61

S: 53-45
616-054-00-9iprodione (ISO);

3-(3,5-dichlorophenyl)-2,4-dioxo-N-isopropylimidazolidine-1-carboxamide
253-178-936734-19-7Carc. Cat. 3; R40

N; R50-53
Xn; N

R: 40-50/53

S: (2-)36/37-60-61
616-055-00-4propyzamide (ISO);

3,5-dichloro-N-(1,1-dimethylprop-2-ynyl)benzamide
245-951-423950-58-5Carc. Cat. 3; R40

N; R50-53
Xn; N

R: 40-50/53

S: (2-)36/37-60-61
616-056-00-XN-methylformamide204-624-6123-39-7Repr. Cat. 2; R61

Xn; R21
T

R: 61-21

S: 53-45
E
616-057-00-5reaction mass of: N-[3-hydroxy-2-(2-methylacryloylaminomethoxy)propoxymethyl]-2-methylacrylamide;

N-[2,3-bis-(2-methylacryloylaminomethoxy)propoxymethyl]-2-methylacrylamide;

methacrylamide;

2-methyl-N-(2-methylacryloylaminomethoxymethyl)-acrylamide;

N-(2,3-dihydroxypropoxymethyl)-2-methylacrylamide
412-790-8Carc. Cat. 2; R45

Muta. Cat. 3; R68

Xn; R48/22
T

R: 45-48/22

S: 53-45
E
616-058-00-01,3-bis(3-methyl-2,5-dioxo-1H-pyrrolinylmethyl)benzene412-570-1119462-56-5Xn; R48/22

Xi; R41

R43

N; R50-53
Xn; N

R: 41-43-48/22-50/53

S: (2-)26-36/37/39-60-61
616-059-00-64-((4-(diethylamino)-2-ethoxyphenyl)imino)-1,4-dihydro-1-oxo-N-propyl-2-naphthalenecarboxamide412-650-6121487-83-0R53R: 53

S: 61
616-060-00-1Condensation product of: 3-(7-carboxyhept-1-yl)-6-hexyl-4-cyclohexene-1,2-dicarboxylic acid with polyamines (primarily amino-ethyl-piperazine and triethylenetetramine)413-770-1Xn; R22

C; R34

R43

N; R50-53
C; N

R: 22-34-43-50/53

S: (1/2-)26-36/37/39-45-60-61
616-061-00-7N,N'-1,6-hexanediylbis(N-(2,2,6,6-tetramethyl-piperidin-4-yl)-formamide413-610-0124172-53-8Xi; R36

R52-53
Xi

R: 36-52/53

S: (2-)26-61
616-062-00-2N-[3-[(2-acetyloxy)ethyl](phenyl-methyl)amino]-4-methoxyphenylacetamide411-590-870693-57-1C; R34

R52-53
C

R: 34-52/53

S: (1/2-)26-36/37/39-45-61
616-063-00-83-dodecyl-(1-(1,2,2,6,6-pentamethyl-4-piperidin)-yl)-2,5-pyrrolidindione411-920-0106917-30-0T; R23

Xn; R22-48/22

C; R35

N; R50-53
T; C; N

R: 22-23-35-48/22-50/53

S: (1/2-)26-28-36/37/39-45-60-61
616-064-00-3N-tert-butyl-3-methylpicolinamide406-720-532998-95-1R52-53R: 52/53

S: 61
616-065-00-93'-(3-acetyl-4-hydroxyphenyl)-1,1-diethylurea411-970-379881-89-3Xn; R22-48/22Xn

R: 22-48/22

S: (2-)22-36
616-066-00-45,6,12,13-tetrachloroanthra(2,1,9-def:6,5,10-d'e'f')diisoquinoline-1,3,8,10(2H,9H)-tetrone405-100-1115662-06-1Repr. Cat. 3; R62Xn

R: 62

S: (2-)22-36/37
616-067-00-Xdodecyl 3-(2-(3-benzyl-4-ethoxy-2,5-dioxoimidazolidin-1-yl)-4,4-dimethyl-3-oxovaleramido)-4-chlorobenzoate407-300-492683-20-0R53R: 53

S: 61
616-068-00-5potassium 4-(11-methacrylamidoundecanamido)benzenesulfonate406-500-9174393-75-0R43Xi

R: 43

S: (2-)22-24-37
616-069-00-01-hydroxy-5-(2-methylpropyloxycarbonylamino)-N-(3-dodecyloxypropyl)-2-naphthoamide406-210-2110560-22-0R53R: 53

S: 61
616-070-00-6reaction mass of: 3,3'-dicyclohexyl-1,1'-methylenebis(4,1-phenylene)diurea;

3-cyclohexyl-1-(4-(4-(3-octadecylureido)benzyl)phenyl)urea;

3,3'-dioctadecyl-1,1'-methylenebis(4,1-phenylene)diurea
406-530-2R53R: 53

S: 22-61
616-071-00-1reaction mass of: bis(N-cyclohexyl-N'-phenyleneureido)methylene;

bis(N-octadecyl-N'-phenyleneureido)methylene;

bis(N-dicyclohexyl-N'-phenyleneureido)methylene (1:2:1)
406-550-1R43

R53
Xi

R: 43-53

S: (2-)22-24-37-61
616-072-00-71-(2-deoxy-5-O-trityl-β-D-threopentofuranosyl)thymine407-120-655612-11-8R53R: 53

S: 61
616-073-00-24'-ethoxy-2-benzimidazoleanilide407-600-5120187-29-3Muta. Cat. 3; R68

R53
Xn

R: 68-53

S: (2-)22-36/37-61
616-074-00-8N-butyl-2-(4-morpholinylcarbonyl)benzamide407-730-2104958-67-0Xi; R36

R43

R52-53
Xi

R: 36-43-52/53

S: (2-)24-26-37-61
616-075-00-3D,L-(N,N-diethyl-2-hydroxy-2-phenylacetamide)408-120-965197-96-8Xn; R22

Xi; R41
Xn

R: 22-41

S: (2-)26-39-46
616-076-00-9tebufenozide (ISO);

N-tert-butyl-N'-(4-ethylbenzoyl)-3,5-dimethylbenzohydrazide
412-850-3112410-23-8N; R51-53N

R: 51/53

S: 61
616-077-00-4reaction mass of: 2-(9-methyl-1,3,8,10-tetraoxo-2,3,9,10-tetrahydro-(1H,8H)-anthra[2,1,9-def: 6,5,10-d'e'f']diisoquinolin-2-ylethansulfonic acid;

potassium 2-(9-methyl-1,3,8,10-tetraoxo-2,3,9,10-tetrahydro-(1H,8H)-anthra[2,1,9-def: 6,5,10-d'e'f']diisoquinolin-2-ylethansulfate
411-310-4Xi; R41Xi

R: 41

S: (2-)26-39
616-078-00-X2-[2,4-bis(1,1-dimethyl-ethyl)phenoxy]-N-(2-hydroxy-5-methyl-phenyl)hexanamide411-330-3104541-33-5R53R: 53

S: 61
616-079-00-51,6-hexanediyl-bis(2-(2-(1-ethylpentyl)-3-oxazolidinyl)ethyl)carbamate411-700-4140921-24-0R43Xi

R: 43

S: (2-)24-37
616-080-00-04-(2-((3-ethyl-4-methyl-2-oxo-pyrrolin-1-yl)carboxamido)ethyl)benzenesulfonamide)411-850-0119018-29-0R52-53R: 52/53

S: 61
616-081-00-65-bromo-8-naphtholactam413-480-524856-00-6Xn; R22

R43

N; R50-53
Xn; N

R: 22-43-50/53

S: (2-)22-24-37-60-61
616-082-00-1N-(5-chloro-3-((4-(diethylamino)-2-methylphenyl)imino-4-methyl-6-oxo-1,4-cyclohexadien-1-yl)benzamide413-200-1129604-78-0R43Xi

R: 43

S: (2-)24-37
616-083-00-7[2-[(4-nitrophenyl)amino]ethyl]urea410-700-127080-42-8R43

R52-53
Xi

R: 43-52/53

S: (2-)24-37-61
616-084-00-22,4-bis[N'-(4-methylphenyl)ureido]toluene411-790-5N; R50-53N

R: 50/53

S: 60-61
616-085-00-83-(2,4-dichlorophenyl)-6-fluoro-quinazoline-2,4(1H,3H)-dione412-190-6168900-02-5N; R50-53N

R: 50/53

S: 60-61
616-086-00-32-acetylamino-6-chloro-4-[(4-diethylamino)2-methylphenyl-imino]-5-methyl-1-oxo-2,5-cyclohexadiene412-250-1102387-48-4R53R: 53

S: 61
616-087-00-9reaction mass of: 7,9,9-trimethyl-3,14-dioxa-4,13-dioxo-5,12-diazahexadecane-1,16-diyl-prop-2-enoate;

7,7,9-trimethyl-3,14-dioxa-4,13-dioxo-5,12-diazahexadecan-1,16-diyl-prop-2-enoate
412-260-652658-19-2Xi; R36

R43

N; R51-53
Xi; N

R: 36-43-51/53

S: (2-)26-36/37-61
616-088-00-42-aminosulfonyl-N,N-dimethylnicotinamide413-440-7112006-75-4R43

R52-53
Xi

R: 43-52/53

S: (2-)24-37-61
616-089-00-X5-(2,4-dioxo-1,2,3,4-tetrahydropyrimidine)-3-fluoro-2-hydroxymethyltetrahydrofuran415-360-841107-56-6Muta. Cat. 3; R68Xn

R: 68

S: (2-)22-36/37
616-090-00-51-(1,4-benzodioxan-2-ylcarbonyl)piperazine hydrochloride415-660-970918-74-0T; R23/24/25

Xn; R48/22

N; R51-53
T; N

R: 23/24/25-48/22-51/53

S: 53-45-61
616-091-00-01,3,5-tris-[(2S and 2R)-2,3-epoxypropyl]-1,3,5-triazine-2,4,6-(1H,3H,5H)-trione423-400-059653-74-6Muta. Cat. 2; R46

T; R23

Xn; R22-48/22

Xi; R41

R43
T

R: 46-22-23-41-43-48/22

S: 53-45
E
616-092-00-6Polymeric reaction product of bicyclo[2.2.1]hepta-2,5-diene, ethene, 1,4-hexadiene, 1-propene with N,N-di-2-propenylformamide404-035-6R43

R53
Xi

R: 43-53

S: (2-)24-37-61
616-093-00-1Reaction products of: aniline-terephthalaldehyde-o-toluidine condensate with maleic anhydride406-620-1129217-90-9R43

N; R51-53
Xi; N

R: 43-51/53

S: (2-)24-37-61
616-094-00-73,3'-dicyclohexyl-1,1'-methylenebis(4,1-phenylene)diurea406-370-358890-25-8R43

R53
Xi

R: 43-53

S: (2-)24-37-61
616-095-00-23,3'-dioctadecyl-1,1'-methylenebis(4,1-phenylene)diurea406-690-343136-14-7R53R: 53

S: 61
616-096-00-8N-(3-hexadecyloxy-2-hydroxyprop-1-yl)-N-(2-hydroxyethyl)palmitamide408-110-4110483-07-3R53R: 53

S: 61
616-097-00-3N,N'-1,4-phenylenebis(2-((2-methoxy-4-nitrophenyl)azo)-3-oxobutanamide411-840-683372-55-8R53R: 53

S: 61
616-098-00-91-[4-chloro-3-((2,2,3,3,3-pentafluoropropoxy)methyl)phenyl]-5-phenyl-1H-1,2,4-triazole-3-carboxamide411-750-7119126-15-7N; R51-53N

R: 51/53

S: 61
616-099-00-42-[4-[(4-hydroxyphenyl)sulfonyl]phenoxy]-4,4-dimethyl-N-[5-[(methylsulfonyl)amino]-2-[4-(1,1,3,3-tetramethylbutyl)phenoxy]phenyl]-3-oxopentanamide414-170-2135937-20-1R53R: 53

S: 61
616-100-00-81,3-dimethyl-1,3-bis(trimethylsilyl)urea414-180-710218-17-4Xn; R22

Xi; R38
Xn

R: 22-38

S: (2-)36/37
616-101-00-3(S)-N-tert-butyl-1,2,3,4-tetrahydro-3-isoquinolinecarboxamide414-600-9149182-72-9Xn; R22

R52-53
Xn

R: 22-52/53

S: (2-)61
616-102-00-9reaction mass of: α-[3-(3-mercaptopropanoxycarbonylamino)methylphenylaminocarbonyl]-ω-[3-(3-mercaptopropanoxycarbonylamino)methylphenylaminocarbonyloxy]-poly-(oxyethylene-co-oxypropylene);

1,2-(or 1,3-)bis[α-(3-mercaptopropanoxycarbonylamino)methylphenylaminocarbonyl)-ω-oxy-poly(oxyethylene-co-oxypropylene)]-3-(or 2-)propanol;

1,2,3-tris[α-(3-mercaptopropanoxycarbonyl-amino)methylphenylaminocarbonyl)-ω-oxy-poly-(oxyethylene-co-oxypropylene)]propane]
415-870-0R43

N; R51-53
Xi; N

R: 43-51/53

S: (2-)36/37-61
616-103-00-4(S,S)-trans-4-(acetylamino)-5,6-dihydro-6-methyl-7,7-dioxo-4H-thieno[2,3-b]thiopyran-2-sulfonamide415-030-3120298-38-6R43

N; R50-53
Xi; N

R: 43-50/53

S: (2-)24-37-60-61
616-104-00-Xbenalaxyl (ISO);

methyl N-(2,6-dimethylphenyl)-N-(phenylacetyl)-DL-alaninate
275-728-771626-11-4N; R50-53N

R: 50/53

S: 60-61
616-105-00-5chlorotoluron (ISO);

3-(3-chloro-p-tolyl)-1,1-dimethylurea
239-592-215545-48-9Carc. Cat. 3; R40

Repr. Cat. 3; R63

N; R50-53
Xn; N

R: 40-63-50/53

S: (2-)26-36/37-46-60-61
616-106-00-0phenmedipham (ISO);

methyl 3-(3-methylcarbaniloyloxy)carbanilate
237-199-013684-63-4N; R50-53N

R: 50/53

S: 60-61
616-108-00-1iodosulfuron-methyl-sodium;

sodium ({[5-iodo-2-(methoxycarbonyl)phenyl]sulfonyl}carbamoyl)(4-methoxy-6-methyl-1,3,5-triazin-2-yl)azanide
144550-36-7N; R50-53N

R: 50/53

S: 60-61
616-109-00-7sulfosulfuron (ISO);

1-(4,6-dimethoxypyrimidin-2-yl)-3-(2-ethylsulfonylimidazo[1,2-a]pyridin-3-yl)sulfonylurea
141776-32-1N; R50-53N

R: 50/53

S: 60-61
616-110-00-2cyclanilide (ISO);

1-(2,4-dichloroanilinocarbonyl)cyclopropanecarboxylic acid
419-150-7113136-77-9Xn; R22

N; R51-53
Xn; N

R: 22-51/53

S: (2-)61
616-111-00-8fenhexamid (ISO);

N-(2,3-dichlor-4-hydroxyphenyl)-1-methylcyclohexancarboxamid
422-530-5126833-17-8N; R51-53N

R: 51/53

S: 61
616-112-00-3oxasulfuron (ISO);

oxetan-3-yl 2-[(4,6-dimethylpyrimidin-2-yl)-carbamoylsulfamoyl]benzoate
144651-06-9Xn; R48/22

N; R50-53
Xn; N

R: 48/22-50/53

S: (2-)46-60-61
616-113-00-9desmedipham (ISO);

ethyl 3-phenylcarbamoyloxyphenylcarbamate
237-198-513684-56-5N; R50-53N

R: 50/53

S: 60-61
N; R50-53: C ≥ 2,5 %

N; R51-53: 0,25 % ≤ C < 2,5 %

R52-53: 0,025 % ≤ C < 0,25 %
616-114-00-4dodecanamide, N,N'-(9,9',10,10'-tetrahydro-9,9',10,10'-tetraoxo(1,1'-bianthracene)-4,4'-diyl)bis-418-010-2136897-58-0R53R: 53

S: 22-61
616-115-00-XN-(3-acetyl-2-hydroxyphenyl)-4-(4-phenylbutoxy)benzamide416-150-9136450-06-1R53R: 53

S: 61
616-116-00-5N-(4-dimethylaminopyridinium)-3-methoxy-4-(1-methyl-5-nitroindol-3-ylmethyl)-N-(o-tolylsulfonyl)benzamidate416-790-9143052-96-4R53R: 53

S: 61
616-117-00-0N-[2-(3-acetyl-5-nitrothiophen-2-ylazo)-5-diethylaminophenyl]acetamide416-860-9777891-21-1Repr. Cat. 3; R62

R43

N; R50-53
Xn; N

R: 43-62-50/53

S: (2-)22-36/37-60-61
616-118-00-6N-(2',6'-dimethylphenyl)-2-piperidinecarboxamide hydrochloride417-950-065797-42-4Xn; R22

R52-53
Xn

R: 22-52/53

S: (2-)22-61
616-119-00-12-(1-butyl-3,5-dioxo-2-phenyl-(1,2,4)-triazolidin-4-yl)-4,4-dimethyl-3-oxo-N-(2-methoxy-5-(2-(dodecyl-1-sulfonyl))propionylamino)-phenyl)-pentanamide418-060-5118020-93-2R53R: 53

S: 61
616-120-00-7reaction mass of: N-(3-dimethylamino-4-methyl-phenyl)-benzamide;

N-(3-dimethylamino-2-methyl-phenyl)-benzamide;

N-(3-dimethylamino-3-methyl-phenyl)-benzamide
420-600-1Xn; R48/22

N; R51-53
Xn; N

R: 48/22-51/53

S: (2-)36/37-61
616-121-00-22,4-dihydroxy-N-(2-methoxyphenyl)benzamide419-090-1129205-19-2R43

N; R51-53
Xi; N

R: 43-51/53

S: (2-)24-37-61
616-123-00-3N-[3-[[4-(diethylamino)-2-methylphenyl]imino]-6-oxo-1,4-cyclohexadienyl]acetamide414-740-096141-86-5N; R50-53N

R: 50/53

S: 60-61
616-124-00-9lithium bis(trifluoromethylsulfonyl)imide415-300-090076-65-6T; R24/25

C; R34

R52-53
T

R: 24/25-34-52/53

S: (1/2-)22-26-36/37/39-45-61
616-125-00-43-cyano-N-(1,1-dimethylethyl)androsta-3,5-diene-17-β-carboxamide415-730-9151338-11-3N; R50-53N

R: 50/53

S: 60-61
616-127-00-5reaction mass of: N,N'-Ethane-1,2-diylbis(decanamide);

12-Hydroxy-N-[2-[1-oxydecyl)amino]ethyl]octadecanamide;

N,N'-Ethane-1,2-diylbis(12-hydroxyoctadecanamide)
430-050-2R43

N; R51-53
Xi; N

R: 43-51/53

S: (2-)24-37-61
616-128-00-0N-(2-(1-allyl-4,5-dicyanoimidazol-2-ylazo)-5-(dipropylamino)phenyl)-acetamide417-530-7123590-00-1R53R: 53

S: 61
616-129-00-6N,N'-bis(2,2,6,6-tetramethyl-4-piperidyl)isophthalamide419-710-042774-15-2Xn; R22

Xi; R36
Xn

R: 22-36

S: (2-)22-25-26
616-130-00-1N-(3-(2-(4,4-dimethyl-2,5-dioxo-imidazolin-1-yl)-4,4-dimethyl-3-oxo-pentanoylamino)-4-methoxy-phenyl)-octadecanamide421-780-2150919-56-5R53R: 53

S: 61
616-132-00-2N-[4-(4-cyano-2-furfurylidene-2,5-dihydro-5-oxo-3-furyl)phenyl]butane-1-sulfonamide423-250-6130016-98-7N; R50-53N

R: 50/53

S: 60-61
616-133-00-8N-cyclohexyl-S,S-dioxobenzo[b]tiophene-2-carboxamide423-990-1149118-66-1Xn; R22

Xi; R41

N; R50-53
Xn; N

R: 22-41-50/53

S: (2-)22-26-39-60-61
616-134-00-33,3'-bis(dioctyloxyphosphinothioylthio)-N,N'-oxybis(methylene)dipropionamide401-820-5793710-14-2R52-53R: 52/53

S: 61
616-135-00-9(3S,4aS,8aS)-2-[(2R,3S)-3-amino-2-hydroxy-4-phenylbutyl]-N-tert-butyldecahydroisoquinoline-3-carboxamide430-230-0136522-17-3Xn; R22

R52-53
Xn

R: 22-52/53

S: (2-)22-61
616-142-00-71,3-Bis(vinylsulfonylacetamido)propane428-350-393629-90-4Muta. Cat. 3; R68

Xi; R41

R43

R52-53
Xn

R: 41-43-68-52/53

S: (2-)22-26-36/37/39-61
616-143-00-2N,N'-dihexadecyl-N,N'-bis(2-hydroxyethyl)propanediamide422-560-9149591-38-8Repr. Cat. 3; R62

Xi; R36

R53
Xn

R: 36-62-53

S: (2-)26-36/37-61
617-001-00-2di-tert-butyl peroxide203-733-6110-05-4O; R7

F; R11
O; F

R: 7-11

S: (2-)3/7-14-16-36/37/39
617-002-00-8α,α-dimethylbenzyl hydroperoxide;

cumene hydroperoxide
201-254-780-15-9O; R7

T; R23

Xn; R21/22-48/20/22

C; R34

N; R51-53
O; T; N

R: 7-21/22-23-34-48/20/22-51/53

S: (1/2-)3/7-14-36/37/39-45-50-61
C; R34: C ≥ 10 %

Xi; R37/38-41: 3 % ≤ C < 10 %

Xi; R36/37: 1 % ≤ C < 3 %
617-003-00-3dilauroyl peroxide203-326-3105-74-8O; R7O

R: 7

S: (2-)3/7-14-36/37/39
617-004-00-91,2,3,4-tetrahydro-1-naphthyl hydroperoxide212-230-0771-29-9O; R7

Xn; R22

C; R34

N; R50-53
O; C; N

R: 7-22-34-50/53

S: (1/2-)3/7-14-26-36/37/39-45-60-61
C; R34: C ≥ 10 %

Xi; R36/37/38: 5 % ≤ C < 10 %
617-006-00-Xbis(α,α-dimethylbenzyl) peroxide201-279-380-43-3O; R7

Xi; R36/38

N; R51-53
O; Xi; N

R: 7-36/38-51/53

S: (2-)3/7-14-36/37/39-61
617-007-00-5tert-butyl α,α-dimethylbenzyl peroxide222-389-83457-61-2O; R7

Xi; R38

N; R51-53
O; Xi; N

R: 7-38-51/53

S: (2-)3/7-14-36/37/39-61
617-008-00-0dibenzoyl peroxide;

benzoyl peroxide
202-327-694-36-0E; R2 ⊗

Xi; R36

R43
E; Xi

R: 2-36-43

S: (2-)3/7-14-36/37/39
617-010-00-11-hydroperoxycyclohexyl 1-hydroxycyclohexyl peroxide; [1]

1,1'-dioxybiscyclohexan-1-ol; [2]

cyclohexylidene hydroperoxide; [3]

cyclohexanone, peroxide [4]
201-091-1 [1]

219-306-2 [2]

220-279-4 [3]

235-527-7 [4]
78-18-2 [1]

2407-94-5 [2]

2699-11-8 [3]

12262-58-7 [4]
E; R2 ⊗

Xn; R22

C; R34
E; C

R: 2-22-34

S: (1/2-)3/7-14-36/37/39-45
C; R34: C ≥ 10 %

Xi; R36/37/38: 5 % ≤ C < 10 %
C
617-012-00-28-p-menthyl hydroperoxide;

p-menthane hydroperoxide
201-281-480-47-7O; R7

C; R34

Xn; R20
O; C

R: 7-20-34

S: (1/2-)3/7-14-36/37/39-45
C; R34: C ≥ 10 %

Xi; R36/37/38: 5 % ≤ C < 10 %
617-013-00-8O,O-tert-butyl O-docosyl monoperoxyoxalate404-300-6116753-76-5O; R7

N; R50-53
O; N

R: 7-50/53

S: (2-)7-14-36/37/39-47-60-61
617-014-00-36-(nonylamino)-6-oxo-peroxyhexanoic acid406-680-9104788-63-8O; R7

Xi; R41

R43

N; R50
O; Xi; N

R: 7-41-43-50

S: (2-)3/7-14-26-36/37/39-61
617-015-00-9bis(4-methylbenzoyl)peroxide407-950-9895-85-2E; R2

O; R7

N; R50-53
E; N

R: 2-7-50/53

S: (2-)7-14-36/37/39-47-60-61
617-016-00-43-hydroxy-1,1-dimethylbutyl 2-ethyl-2-methylheptaneperoxoate413-910-1O; R7

R10

Xi; R38

N; R50-53
O; Xi; N

R: 7-10-38-50/53

S: (2-)7/47-14-36/37/39-60-61
617-017-00-Xreaction mass of: 2,2'-bis(tert-pentylperoxy)-p-diisopropylbenzene;

2,2'-bis(tert-pentylperoxy)-m-diisopropylbenzene
412-140-332144-25-5O; R7 ⊗

R53
O

R: 7-53

S: (2-)3/7-14-36/37/39-61
617-018-00-5reaction mass of: 1-methyl-1-(3-(1-methylethyl)phenyl)ethyl-1-methyl-1-phenylethylperoxide, 63 % by weight;

1-methyl-1-(4-(1-methylethyl)phenyl)ethyl-1-methyl-1-phenylethylperoxide, 31 % by weight
410-840-371566-50-2O; R7

N; R51-53
O; N

R: 7-51/53

S: (2-)3/7-14-36/37/39-61
617-019-00-06-(phthalimido)peroxyhexanoic acid410-850-8128275-31-0O; R7

Xi; R41

N; R50
O; Xi; N

R: 7-41-50

S: (2-)3/7-14-26-36/37/39-61
617-020-00-61,3-di(prop-2,2-diyl)benzene bis(neodecanoylperoxide)420-060-5117663-11-3R10

O; R7

N; R51-53
O; N

R: 7-10-51/53

S: (2-)7-14-36/37/39-47-61
647-001-00-8glucosidase, β-232-589-79001-22-3R42Xn

R: 42

S: (2-)22-24-36/37
647-002-00-3cellulase232-734-49012-54-8R42Xn

R: 42

S: (2-)22-24-36/37
647-003-00-9cellobiohydrolase, exo-253-465-937329-65-0R42Xn

R: 42

S: (2-)22-24-36/37
647-004-00-4cellulases with the exception of those specified elsewhere in this AnnexR42Xn

R: 42

S: (2-)22-24-36/37
A
647-005-00-Xbromelain, juice232-572-49001-00-7Xi; R36/37/38

R42
Xn

R: 36/37/38-42

S: (2-)22-24-26-36/37
647-006-00-5ficin232-599-19001-33-6Xi; R36/37/38

R42
Xn

R: 36/37/38-42

S: (2-)22-24-26-36/37
647-007-00-0papain232-627-29001-73-4Xi; R36/37/38

R42
Xn

R: 36/37/38-42

S: (2-)22-24-26-36/37
647-008-00-6pepsin A232-629-39001-75-6Xi; R36/37/38

R42
Xn

R: 36/37/38-42

S: (2-)22-24-26-36/37
647-009-00-1rennin232-645-09001-98-3Xi; R36/37/38

R42
Xn

R: 36/37/38-42

S: (2-)22-24-26-36/37
647-010-00-7trypsin232-650-89002-07-7Xi; R36/37/38

R42
Xn

R: 36/37/38-42

S: (2-)22-24-26-36/37
647-011-00-2chymotrypsin232-671-29004-07-3Xi; R36/37/38

R42
Xn

R: 36/37/38-42

S: (2-)22-24-26-36/37
647-012-00-8subtilisin232-752-29014-01-1Xi; R37/38-41

R42
Xn

R: 37/38-41-42

S: (2-)22-24-26-36/37/39
647-013-00-3proteinase, microbial neutral232-966-69068-59-1Xi; R36/37/38

R42
Xn

R: 36/37/38-42

S: (2-)22-24-26-36/37
647-014-00-9proteases with the exception of those specified elsewhere in this AnnexXi; R36/37/38

R42
Xn

R: 36/37/38-42

S: (2-)22-24-26-36/37
647-015-00-4amylase, α-232-565-69000-90-2R42Xn

R: 42

S: (2-)22-24-36/37
647-016-00-Xamylases with the exception of those specified elsewhere in this AnnexR42Xn

R: 42

S: (2-)22-24-36/37
648-001-00-0Distillates (coal tar), benzole fraction;

Light Oil;

[A complex combination of hydrocarbons obtained by the distillation of coal tar. It consists of hydrocarbons having carbon numbers primarily in the range of C4 to C10 and distilling in the approximate range of 80 oC to 160 oC (175 oF to 320 oF).]
283-482-784650-02-2Carc. Cat. 2; R45T

R: 45

S: 53-45
H
648-002-00-6Tar oils, brown-coal;

Light Oil;

[The distillate from lignite tar boiling in the range of approximately 80 oC to 250 oC (176 oF to 482 oF). Composed primarily of aliphatic and aromatic hydrocarbons and monobasic phenols.]
302-674-494114-40-6Carc. Cat. 2; R45T

R: 45

S: 53-45
H J
648-003-00-1Benzol forerunnings (coal);

Light Oil Redistillate, low boiling;

[The distillate from coke oven light oil having an approximate distillation range below 100 oC (212 oF). Composed primarily of C4 to C6 aliphatic hydrocarbons.]
266-023-565996-88-5Carc. Cat. 2; R45T

R: 45

S: 53-45
H J
648-004-00-7Distillates (coal tar), benzole fraction, BTX-rich;

Light Oil Redistillate, low boiling;

[A residue from the distillation of crude benzole to remove benzole fronts. Composed primarily of benzene, toluene and xylenes boiling in the range of approximately 75 oC to 200 oC (167 oF to 392 oF).]
309-984-9101896-26-8Carc. Cat. 2; R45T

R: 45

S: 53-45
H J
648-005-00-2Aromatic hydrocarbons, C6-10, C8-rich;

Light Oil Redistillate, low boiling
292-697-590989-41-6Carc. Cat. 2; R45T

R: 45

S: 53-45
H J
648-006-00-8Solvent naphtha (coal), light;

Light Oil Redistillate, low boiling
287-498-585536-17-0Carc. Cat. 2; R45T

R: 45

S: 53-45
H J
648-007-00-3Solvent naphtha (coal), xylene-styrene cut;

Light Oil Redistillate, intermediate boiling
287-502-585536-20-5Carc. Cat. 2; R45T

R: 45

S: 53-45
H J
648-008-00-9Solvent naphtha (coal), coumarone-styrene contg.;

Light Oil Redistillate, intermediate boiling
287-500-485536-19-2Carc. Cat. 2; R45T

R: 45

S: 53-45
H J
648-009-00-4Naphtha (coal), distn. residues;

Light Oil Redistillate, high boiling;

[The residue remaining from the distillation of recovered naphtha. Composed primarily of naphthalene and condensation products of indene and styrene.]
292-636-290641-12-6Carc. Cat. 2; R45T

R: 45

S: 53-45
H J
648-010-00-XAromatic hydrocarbons, C8;

Light Oil Redistillate, high boiling
292-694-990989-38-1Carc. Cat. 2; R45T

R: 45

S: 53-45
H J
648-012-00-0Aromatic hydrocarbons, C8-9, hydrocarbon resin polymn. by-product;

Light Oil Redistillate, high boiling;

[A complex combination of hydrocarbons obtained from the evaporation of solvent under vacuum from polymerized hydrocarbon resin. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C8 through C9 and boiling in the range of approximately 120 oC to 215 oC (248 oF to 419 oF).]
295-281-191995-20-9Carc. Cat. 2; R45T

R: 45

S: 53-45
H J
648-013-00-6Aromatic hydrocarbons, C9-12, benzene distn.;

Light Oil Redistillate, high boiling
295-551-992062-36-7Carc. Cat. 2; R45T

R: 45

S: 53-45
H J
648-014-00-1Extract residues (coal), benzole fraction alk., acid ext.;

Light Oil Extract Residues, low boiling;

[The redistillate from the distillate, freed of tar acids and tar bases, from bituminous coal high temperature tar boiling in the approximate range of 90 oC to 160 oC (194 oF to 320 oF). It consists predominantly of benzene, toluene and xylenes.]
295-323-991995-61-8Carc. Cat. 2; R45T

R: 45

S: 53-45
H J
648-015-00-7Extract residues (coal tar), benzole fraction alk., acid ext.;

Light Oil Extract Residues, low boiling;

[A complex combination of hydrocarbons obtained by the redistillation of the distillate of high temperature coal tar (tar acid and tar base free). It consists predominantly of unsubstituted and substituted mononuclear aromatic hydrocarbons boiling in the range of 85 oC-195 oC (185 oF-383 oF).]
309-868-8101316-63-6Carc. Cat. 2; R45T

R: 45

S: 53-45
H J
648-016-00-2Extract residues (coal), benzole fraction acid;

Light Oil Extract Residues, low boiling;

[An acid sludge by-product of the sulphuric acid refining of crude high temperature coal. Composed primarily of sulfuric acid and organic compounds.]
298-725-293821-38-6Carc. Cat. 2; R45T

R: 45

S: 53-45
H J
648-017-00-8Extract residues (coal), light oil alk., distn. overheads;

Light Oil Extract Residues, low boiling;

[The first fraction from the distillation of aromatic hydrocarbons, coumarone, naphthalene and indene rich prefactionator bottoms or washed carbolic oil boiling substantially below 145 oC (293 oF). Composed primarily of C7 and C8 aliphatic and aromatic hydrocarbons.]
292-625-290641-02-4Carc. Cat. 2; R45T

R: 45

S: 53-45
H J
648-018-00-3Extract residues (coal), light oil alk., acid ext., indene fraction;

Light Oil Extract Residues, intermediate boiling
309-867-2101316-62-5Carc. Cat. 2; R45T

R: 45

S: 53-45
H J
648-019-00-9Extract residues (coal), light oil alk., indene naphtha fraction;

Light Oil Extract Residues, high boiling;

[The distillate from aromatic hydrocarbons, coumarone, naphthalene and indene rich prefractionator bottoms or washed carbolic oils, having an approximate boiling range of 155 oC to 180 oC (311 oF to 356 oF). Composed primarily of indene, indan and trimethylbenzenes.]
292-626-890641-03-5Carc. Cat. 2; R45T

R: 45

S: 53-45
H J
648-020-00-4Solvent naphtha (coal);

Light Oil Extract Residues, high boiling;

[The distillate from either high temperature coal tar, coke oven light oil, or coal tar oil alkaline extract residue having an approximate distillation range of 130 oC to 210 oC (266 oF to 410 oF) Composed primarily of indene and other polycyclic ring systems containing a single aromatic ring. May contain phenolic compounds and aromatic nitrogen bases.]
266-013-065996-79-4Carc. Cat. 2; R45T

R: 45

S: 53-45
H J
648-021-00-XDistillates (coal tar), light oils, neutral fraction;

Light Oil Extract Residues, high boiling;

[A distillate from the fractional distillation of high temperature coal tar. Composed primarily of alkyl-substituted one ring aromatic hydrocarbons boiling in the range of approximately 135 oC to 210 oC (275 oF to 410 oF). May also include unsaturated hydrocarbons such as indene and coumarone.]
309-971-8101794-90-5Carc. Cat. 2; R45T

R: 45

S: 53-45
H J
648-022-00-5Distillates (coal tar), light oils, acid exts.;

Light Oil Extract Residues, high boiling;

[This oil is a complex mixture of aromatic hydrocarbons, primarily indene, naphthalene, coumarone, phenol, and o-, m- and p-cresol and boiling in the range of 140 oC to 215 oC (284 oF to 419 oF).]
292-609-590640-87-2Carc. Cat. 2; R45T

R: 45

S: 53-45
H J
648-023-00-0Distillates (coal tar), light oils;

Carbolic Oil;

[A complex combination of hydrocarbons obtained by distillation of coal tar. It consists of aromatic and other hydrocarbons, phenolic compounds and aromatic nitrogen compounds and distills at the approximate range of 150 oC to 210 oC (302 oF to 410 oF).]
283-483-284650-03-3Carc. Cat. 2; R45T

R: 45

S: 53-45
H J
648-024-00-6Tar oils, coal;

Carbolic Oil;

[The distillate from high temperature coal tar having an approximate distillation range of 130 oC to 250 oC (266 oF to 410 oF). Composed primarily of naphthalene, alkylnaphthalenes, phenolic compounds, and aromatic nitrogen bases.]
266-016-765996-82-9Carc. Cat. 2; R45T

R: 45

S: 53-45
H J
648-026-00-7Extract residues (coal), light oil alk., acid ext.;

Carbolic Oil Extract Residue;

[The oil resulting from the acid washing of alkali-washed carbolic oil to remove the minor amounts of basic compounds (tar bases). Composed primarily of indene, indan and alkylbenzenes.]
292-624-790641-01-3Carc. Cat. 2; R45T

R: 45

S: 53-45
H J
648-027-00-2Extract residues (coal), tar oil alk.;

Carbolic Oil Extract Residue;

[The residue obtained from coal tar oil by an alkaline wash such as aqueous sodium hydroxide after the removal of crude coal tar acids. Composed primarily of naphthalenes and aromatic nitrogen bases.]
266-021-465996-87-4Carc. Cat. 2; R45T

R: 45

S: 53-45
H J
648-028-00-8Extract oils (coal), light oil;

Acid Extract;

[The aqueous extract produced by an acidic wash of alkali-washed carbolic oil. Composed primarily of acid salts of various aromatic nitrogen bases including pyridine, quinoline and their alkyl derivatives.]
292-622-690640-99-6Carc. Cat. 2; R45T

R: 45

S: 53-45
H J
648-029-00-3Pyridine, alkyl derivs.;

Crude Tar Bases;

[The complex combination of polyalkylated pyridines derived from coal tar distillation or as high-boiling distillates approximately above 150 oC (302 oF) from the reaction of ammonia with acetaldehyde, formaldehyde or paraformaldehyde.]
269-929-968391-11-7Carc. Cat. 2; R45T

R: 45

S: 53-45
H J
648-030-00-9Tar bases, coal, picoline fraction;

Distillate Bases;

[Pyridine bases boiling in the range of approximately 125 oC to 160 oC (257 oF 320 oF) obtained by distillation of neutralized acid extract of the base-containing tar fraction obtained by the distillation of bituminous coal tars. Composed chiefly of lutidines and picolines.]
295-548-292062-33-4Carc. Cat. 2; R45T

R: 45

S: 53-45
H J
648-031-00-4Tar bases, coal, lutidine fraction;

Distillate Bases
293-766-291082-52-9Carc. Cat. 2; R45T

R: 45

S: 53-45
H J
648-032-00-XExtract oils (coal), tar base, collidine fraction;

Distillate Bases;

[The extract produced by the acidic extraction of bases from crude coal tar aromatic oils, neutralization, and distillation of the bases. Composed primarily of collidines, aniline, toluidines, lutidines, xylidines.]
273-077-368937-63-3Carc. Cat. 2; R45T

R: 45

S: 53-45
H J
648-033-00-5Tar bases, coal, collidine fraction;

Distillate Bases;

[The distillation fraction boiling in the range of approximately 181 oC to 186 oC (356 oF to 367 oF) from the crude bases obtained from the neutralized, acid-extracted base-containing tar fractions obtained by the distillation of bituminous coal tar. It contains chiefly aniline and collidines.]
295-543-592062-28-7Carc. Cat. 2; R45T

R: 45

S: 53-45
H J
648-034-00-0Tar bases, coal, aniline fraction;

Distillate Bases;

[The distillation fraction boiling in the range of approximately 180 oC to 200 oC (356 oF to 392 oF) from the crude bases obtained by dephenolating and debasing the carbolated oil from the distillation of coal tar. It contains chiefly aniline, collidines, lutidines and toluidines.]
295-541-492062-27-6Carc. Cat. 2; R45T

R: 45

S: 53-45
H J
648-035-00-6Tar bases, coal, toluidine fraction;

Distillate Bases
293-767-891082-53-0Carc. Cat. 2; R45T

R: 45

S: 53-45
H J
648-036-00-1Distillates (petroleum), alkene-alkyne manuf. pyrolysis oil, mixed with high-temp. coal tar, indene fraction;

Redistillates;

[A complex combination of hydrocarbons obtained as a redistillate from the fractional distillation of bituminous coal high temperature tar and residual oils that are obtained by the pyrolytic production of alkenes and alkynes from petroleum products or natural gas. It consists predominantly of indene and boils in a range of approximately 160 oC to 190 oC (320 oF to 374 oF).]
295-292-191995-31-2Carc. Cat. 2; R45T

R: 45

S: 53-45
H J
648-037-00-7Distillates (coal), coal tar-residual pyrolysis oils, naphthalene oils;

Redistillates;

[The redistillate obtained from the fractional distillation of bituminous coal high temperature tar and pyrolysis residual oils and boiling in the range of approximately 190 oC to 270 oC (374 oF to 518 oF). Composed primarily of substituted dinuclear aromatics.]
295-295-891995-35-6Carc. Cat. 2; R45T

R: 45

S: 53-45
H J
648-038-00-2Extract oils (coal), coal tar-residual pyrolysis oils, naphthalene oil, redistillate;

Redistillates;

[The redistillate from the fractional distillation of dephenolated and debased methylnaphthalene oil obtained from bituminous coal high temperature tar and pyrolysis residual oils boiling in the approximate range of 220 oC to 230 oC (428 oF to 446 oF). It consists predominantly of unsubstituted and substituted dinuclear aromatic hydrocarbons.]
295-329-191995-66-3Carc. Cat. 2; R45T

R: 45

S: 53-45
H J
648-039-00-8Extract oils (coal), coal tar-residual pyrolysis oils, naphthalene oils;

Redistillates;

[A neutral oil obtained by debasing and dephenolating the oil obtained from the distillation of high temperature tar and pyrolysis residuel oils which has a boiling range of 225 oC to 255 oC (437 oF to 491 oF). Composed primarily of substituted dinuclear aromatic hydrocarbons.]
310-170-0122070-79-5Carc. Cat. 2; R45T

R: 45

S: 53-45
H J
648-040-00-3Extract oils (coal), coal tar residual pyrolysis oils, naphthalene oil, distn. residues;

Redistillates;

[Residue from the distillation of dephenolated and debased methylnaphthalene oil (from bituminous coal tar and pyrolysis residual oils) with a boiling range of 240 oC to 260 oC (464 oF to 500 oF). Composed primarily of substituted dinuclear aromatic and heterocyclic hydrocarbons.]
310-171-6122070-80-8Carc. Cat. 2; R45T

R: 45

S: 53-45
H J
648-041-00-9Absorption oils, bicyclo arom. and heterocyclic hydrocarbon fraction;

Wash Oil Redistillate;

[A complex combination of hydrocarbons obtained as a redistillate from the distillation of wash oil. It consists predominantly of 2-ringed aromatic and heterocyclic hydrocarbons boiling in the range of approximately 260 oC to 290 oC (500 oF to 554 oF).]
309-851-5101316-45-4Carc. Cat. 2; R45T

R: 45

S: 53-45
H M
648-042-00-4Distillates (coal tar), upper, fluorene-rich;

Wash Oil Redistillate;

[A complex combination of hydrocarbons obtained by the crystallization of tar oil. It consists af aromatic and polycyclic hydrocarbons primarily fluorene and some acenaphthene.]
284-900-084989-11-7Carc. Cat. 2; R45T

R: 45

S: 53-45
H M
648-043-00-XCreosote oil, acenaphthene fraction, acenaphthene-free;

Wash Oil Redistillate;

[The oil remaining after removal by a crystallization process of acenaphthene from acenaphthene oil from coal tar. Composed primarily of naphthalene and alkylnaphthalenes.]
292-606-990640-85-0Carc. Cat. 2; R45T

R: 45

S: 53-45
H
648-044-00-5Distillates (coal tar), heavy oils;

Heavy Anthracene Oil;

[Distillate from the fractional distillation of coal tar of bituminous coal, with boiling range of 240 oC to 400 oC (464 oF to 752 oF). Composed primarily of tri- and polynuclear hydrocarbons and heterocyclic compounds.]
292-607-490640-86-1Carc. Cat. 2; R45T

R: 45

S: 53-45
H
648-045-00-0Distillates (coal tar), upper;

Heavy Anthracene Oil;

[The distillate from coal tar having an approximate distillation range of 220 oC to 450 oC (428 oF to 842 oF). Composed primarily of three to four membered condensed ring aromatic hydrocarbons and other hydrocarbons.]
266-026-165996-91-0Carc. Cat. 2; R45T

R: 45

S: 53-45
H M
648-046-00-6Anthracene oil, acid ext.;

Anthracene Oil Extract Residue;

[A complex combination of hydrocarbons from the base-freed fraction obtained from the distillation of coal tar and boiling in the range of approximately 325 oC to 365 oC (617 oF to 689 oF). It contains predominantly anthracene and phenanthrene and their alkyl derivatives.]
295-274-391995-14-1Carc. Cat. 2; R45T

R: 45

S: 53-45
H M
648-047-00-1Distillates (coal tar);

Heavy Anthracene Oil;

[The distillate from coal tar having an approximate distillation range of 100 oC to 450 oC (212 oF to 842 oF). Composed primarily of two to four membered condensed ring aromatic hydrocarbons, phenolic compounds, and aromatic nitrogen bases.]
266-027-765996-92-1Carc. Cat. 2; R45T

R: 45

S: 53-45
H M
648-048-00-7Distillates (coal tar), pitch, heavy oils;

Heavy Anthracene Oil;

[The distillate from the distillation of the pitch obtained from bituminous high temperature tar. Composed primarily of tri- and polynuclear aromatic hydrocarbons and boiling in the range of approximately 300 oC to 470 oC (572 oF to 878 oF). The product may also contain heteroatoms.]
295-312-991995-51-6Carc. Cat. 2; R45T

R: 45

S: 53-45
H M
648-049-00-2Distillates (coal tar), pitch;

Heavy Anthracene Oil;

[The oil obtained from condensation of the vapors from the heat treatment of pitch. Composed primarily of two- to four-ring aromatic compounds boiling in the range of 200 oC to greater than 400 oC (392 oF to greater than 752 oF).]
309-855-7101316-49-8Carc. Cat. 2; R45T

R: 45

S: 53-45
H M
648-050-00-8Distillates (coal tar), heavy oils, pyrene fraction;

Heavy Anthracene Oil Redistillate;

[The redistillate obtained from the fractional distillation of pitch distillate boiling in the range of approximately 350 oC to 400 oC (662 oF to 752 oF). Consists predominantly of tri- and polynuclear aromatics and heterocyclic hydrocarbons.]
295-304-591995-42-5Carc. Cat. 2; R45T

R: 45

S: 53-45
H M
648-051-00-3Distillates (coal tar), pitch, pyrene fraction;

Heavy Anthracene Oil Redistillate;

[The redistillate obtained from the fractional distillation of pitch distillate and boiling in the range of approximately 380 oC to 410 oC (7160 to 770 oF). Composed primarily of tri- and polynuclear aromatic hydrocarbons and heterocyclic compounds.]
295-313-491995-52-7Carc. Cat. 2; R45T

R: 45

S: 53-45
H M
648-052-00-9Paraffin waxes (coal), brown-coal high-temp. tar, carbon-treated;

Coal Tar Extract;

[A complet combination of hydrocarbons obtained by the treatment of lignite carbonization tar with activated carbon for removal of trace constituents and impurities. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C12.]
308-296-697926-76-6Carc. Cat. 2; R45T

R: 45

S: 53-45
H M
648-053-00-4Paraffin waxes (coal), brown-coal high-temp tar, clay-treated;

Coal Tar Extract;

[A complex combination of hydrocarbons obtained by the treatment of lignite carbonization tar with bentonite for removal of trace constituents and impurities. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C12.]
308-297-197926-77-7Carc. Cat. 2; R45T

R: 45

S: 53-45
H M
648-054-00-XPitch;

Pitch
263-072-461789-60-4Carc. Cat. 2; R45T

R: 45

S: 53-45
H M
648-055-00-5Pitch, coal tar, high-temp.;

Pitch;

[The residue from the distillation of high temperature coal tar. A black solid with an approximate softening point from 30 oC to 180 oC (86 oF to 356 oF). Composed primarily of a complex mixture of three or more membered condensed ring aromatic hydrocarbons.]
266-028-265996-93-2Carc. Cat. 2; R45T

R: 45

S: 53-45
H
648-056-00-0Pitch, coal tar, high-temp., heat-treated;

Pitch;

[The heat treated residue from the distillation of high temperature coal tar. A black solid with an approximate softening point from 80 oC to 180 oC (176 oF to 356 oF). Composed primarily of a complex mixture of three or more membered condensed ring aromatic hydrocarbons.]
310-162-7121575-60-8Carc. Cat. 2; R45T

R: 45

S: 53-45
H M
648-057-00-6Pitch, coal tar, high-temp., secondary;

Pitch Redistillate;

[The residue obtained during the distillation of high boiling fractions from bituminous coal high temperature tar and/or pitch coke oil, with a softening point of 140 oC to 170 oC (284 oF to 392 oF) according to DIN 52025. Composed primarily of tri- and polynuclear aromatic compounds which also contain heteroatoms.]
302-650-394114-13-3Carc. Cat. 2; R45T

R: 45

S: 53-45
H M
648-058-00-1Residues (coal tar), pitch distn.;

Pitch Redistillate;

[Residue from the fractional distillation of pitch distillate boiling in the range of approximately 400 oC to 470 oC (752 oF to 846 oF). Composed primarily of polynuclear aromatic hydrocarbons, and heterocyclic compounds.]
295-507-992061-94-4Carc. Cat. 2; R45T

R: 45

S: 53-45
H M
648-059-00-7Tar, coal, high-temp., distn. and storage residues;

Coal Tar Solids Residue;

[Coke- and ash-containing solid residues that separate on distillation and thermal treatment of bituminous coal high temperature tar in distillation installations and storage vessels. Consists predominantly of carbon and contains a small quantity of hetero compounds as well as ash components.]
295-535-192062-20-9Carc. Cat. 2; R45T

R: 45

S: 53-45
H M
648-060-00-2Tar, coal, storage residues;

Coal Tar Solids Residue;

[The deposit removed from crude coal tar storages. Composed primarily of coal tar and carbonaceous particulate matter.]
293-764-191082-50-7Carc. Cat. 2; R45T

R: 45

S: 53-45
H M
648-061-00-8Tar, coal, high-temp., residues;

Coal Tar Solids Residue;

[Solids formed during the coking of bituminous coal to produce crude bituminous coal high temperature tar. Composed primarily of coke and coal particles, highly aromatized compounds and mineral substances.]
309-726-5100684-51-3Carc. Cat. 2; R45T

R: 45

S: 53-45
H M
648-062-00-3Tar, coal, high-temp., high-solids;

Coal Tar Solids Residue;

[The condensation product obtained by cooling, to approximately ambient temperature, the gas evolved in the high temperature (greater than 700 oC (1292 oF)) destructive distillation of coal. Composed primarily of a complex mixture of condensed ring aromatic hydrocarbons with a high solid content of coal-type materials.]
273-615-768990-61-4Carc. Cat. 2; R45T

R: 45

S: 53-45
H M
648-063-00-9Waste solids, coal-tar pitch coking;

Coal Tar Solids Residue;

[The combination of wastes formed by the coking of bituminous coal tar pitch. It consists predominantly of carbon.]
295-549-892062-34-5Carc. Cat. 2; R45T

R: 45

S: 53-45
H M
648-064-00-4Extract residues (coal), brown;

Coal Tar Extract;

[The residue from extraction of dried coal.]
294-285-091697-23-3Carc. Cat. 2; R45T

R: 45

S: 53-45
H M
648-065-00-XParaffin waxes (coal), brown-coal-high-temp. tar;

Coal Tar Extract;

[A complex combination of hydrocarbons obtained from lignite carbonization tar by solvent crystallisation (solvent deoiling), by sweating or an adducting process. It consists predominantly of straight and branched chain saturated hydrocarbons having carbon numbers predominantly greater than C12.]
295-454-192045-71-1Carc. Cat. 2; R45T

R: 45

S: 53-45
H M
648-066-00-5Paraffin waxes (coal), brown-coal-high-temp. tar, hydrotreated;

Coal Tar Extract;

[A complex combination of hydrocarbons obtained from lignite carbonization tar by solvent crystallisation (solvent deoiling), by sweating or an adducting process treated with hydrogen in the presence of a catalyst. It consists predominantly of straight and branched chain saturated hydrocarbons having carbon numbers predominantly greater than C12.]
295-455-792045-72-2Carc. Cat. 2; R45T

R: 45

S: 53-45
H M
648-067-00-0Paraffin waxes (coal), brown-coal high-temp tar, silicic acid-treated;

Coal Tar Extract;

[A complex combination of hydrocarbons obtained by the treatment of lignite carbonization tar with silicic acid for removal of trace constituents and impurities. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C12.]
308-298-797926-78-8Carc. Cat. 2; R45T

R: 45

S: 53-45
H M
648-068-00-6Tar, coal, low-temp., distn. residues;

Tar Oil, intermediate boiling;

[Residues from fractional distillation of low temperature coal tar to remove oils that boil in a range up to approximately 300 oC (572 oF). Composed primarily of aromatic compounds.]
309-887-1101316-85-2Carc. Cat. 2; R45T

R: 45

S: 53-45
H M
648-069-00-1Pitch, coal tar, low-temp;

Pitch Residue;

[A complex black solid or semi-solid obtained from the distillation of a low temperature coal tar. It has a softening point within the approximate range of 40 oC to 180 oC (104 oF to 356 oF). Composed primarily of a complex mixture of hydrocarbons.]
292-651-490669-57-1Carc. Cat. 2; R45T

R: 45

S: 53-45
H M
648-070-00-7Pitch, coal tar, low-temp., oxidized;

Pitch Residue, oxidised;

[The product obtained by air-blowing, at elevated temperature, low-temperature coal tar pitch. It has a softening-point within the approximate range of 70 oC to 180 oC (158 oF to 356 oF). Composed primarily of a complex mixture of hydrocarbons.]
292-654-090669-59-3Carc. Cat. 2; R45T

R: 45

S: 53-45
H M
648-071-00-2Pitch, coal tar, low-temp., heat-treated;

Pitch Residue, oxidised;

Pitch Residue, heat-treated;

[A complex black solid obtained by the heat treatment of low temperature coal tar pitch. It has a softening point within the approximate range of 50 oC to 140 oC (122 oF to 284 oF). Composed primarily of a complex mixture of aromatic compounds.]
292-653-590669-58-2Carc. Cat. 2; R45T

R: 45

S: 53-45
H M
648-072-00-8Distillates (coal-petroleum), condensed-ring arom;

Distillates;

[The distillate from a mixture of coal and tar and aromatic petroleum streams having an approximate distillation range of 220 oC to 450 oC (428 oF to 842 oF). Composed primarily of 3- to 4-membered condensed ring aromatic hydrocarbons.]
269-159-368188-48-7Carc. Cat. 2; R45T

R: 45

S: 53-45
H M
648-073-00-3Aromatic hydrocarbons, C20-28, polycyclic, mixed coal-tar pitch-polyethylene-polypropylene pyrolysis-derived;

Pyrolysis Products;

[A complex combination hydrocarbons obtained from mixed coal tar pitch-polyethylene-polypropylene pyrolysis. Composed primarily of polycyclic aromatic hydrocarbons having carbon numbers predominantly in the range of C20 through C28 and having a softening point of 100 oC to 220 oC (212 oF to 428 oF) according to DIN 52025.]
309-956-6101794-74-5Carc. Cat. 2; R45T

R: 45

S: 53-45
H M
648-074-00-9Aromatic hydrocarbons, C20-28, polycyclic, mixed coal-tar pitch-polyethylene pyrolysis-derived;

Pyrolysis Products;

[A complex combination of hydrocarbons obtained from mixed coal tar pitch-polyethylene pyrolysis. Composed primarily of polycyclic aromatic hydrocarbons having carbon numbers predominantly in the range of C20 through C28 and having a softening point of 100 oC to 220 oC (212 oF to 428 oF) according to DIN 52025.]
309-957-1101794-75-6Carc. Cat. 2; R45T

R: 45

S: 53-45
H M
648-075-00-4Aromatic hydrocarbons, C20-28, polycyclic, mixed coal-tar pitch-polystyrene pyrolysis-derived;

Pyrolysis Products;

[A complex combination of hydrocarbons obtained from mixed coal tar pitch-polystyrene pyrolysis. Composed primarily of polycyclic aromatic hydrocarbons having carbon numbers predominantly in the range of C20 through C28 and having a softening point of 100 oC to 220 oC (212 oF to 428 oF) according to DIN 52025.]
309-958-7101794-76-7Carc. Cat. 2; R45T

R: 45

S: 53-45
H M
648-076-00-XPitch, coal tar-petroleum;

Pitch Residues;

[The residue from the distillation of a mixture of coal tar and aromatic petroleum streams. A solid with a softening point from 40 oC to 180 oC (140 oF to 356 oF). Composed primarily of a complex combination of three or more membered condensed ring aromatic hydrocarbons.]
269-109-068187-57-5Carc. Cat. 2; R45T

R: 45

S: 53-45
H M
648-077-00-5Phenanthrene, distn. residues;

Heavy Anthracene Oil Redistillate;

[Residue from the distillation of crude phenanthrene boiling in the approximate range of 340 oC to 420 oC (644 oF to 788 oF). It consists predominantly of phenanthrene, anthracene and carbazole.]
310-169-5122070-78-4Carc. Cat. 2; R45T

R: 45

S: 53-45
H M
648-078-00-0Distillates (coal tar), upper, fluorene-free;

Wash Oil Redistillate;

[A complex combination of hydrocarbons obtained by the crystallization of tar oil. It consists of aromatic polycyclic hydrocarbons, primarily diphenyl, dibenzofuran and acenaphthene.]
284-899-784989-10-6Carc. Cat. 2; R45T

R: 45

S: 53-45
H M
648-079-00-6Anthracene oil;

Anthracene oil;

[A complex combination of polycyclic aromatic hydrocarbons obtained from coal tar having an approximate distillation range of 300 oC ot 400 oC (572 oF to 752 oF). Composed primarily of phenanthrene, anthracene and carbazole.]
292-602-790640-80-5Carc. Cat. 2; R45T

R: 45

S: 53-45
H M
648-080-00-1Residues (coal tar), creosote oil distn.;

Wash Oil Redistillate;

[The residue from the fractional distillation of wash oil boiling in the approximate range of 270 oC to 330 oC (518 oF to 626 oF). It consists predominantly of dinuclear aromatic and heterocyclic hydrocarbons.]
295-506-392061-93-3Carc. Cat. 2; R45T

R: 45

S: 53-45
H
648-081-00-7Tar, coal;

Coal tar;

[The by-product from the destructive distillation of coal. Almost black semisolid. A complex combination of aromatic hydro-carbons, phenolic compounds, nitrogen bases and thiophene.]
232-361-78007-45-2Carc. Cat. 1; R45T

R: 45

S: 53-45
H
648-082-00-2Tar, coal, high-temp.;

Coal tar;

[The condensation product obtained by cooling, to approximately ambient temperature, the gas evolved in the high temperature (greater than 700 oC (1292 oF)) destructive distillation of coal. A black viscous liquid denser than water. Composed primarily of a complex mixture of condensed ring aromatic hydrocarbons. May contain minor amounts of phenolic compounds and aromatic nitrogen bases.]
266-024-065996-89-6Carc. Cat. 1; R45T

R: 45

S: 53-45
H
648-083-00-8Tar, coal, low-temp.;

Coal oil;

[The condensation product obtained by cooling, to approximately ambient temperature, the gas evolved in low temperature (less than 700 oC (1292 oF)) destructive distillation of coal. A black viscous liquid denser than water. Composed primarily of condensed ring aromatic hydrocarbons, phenolic compounds, aromatic nitrogen bases, and their alkyl derivatives.]
266-025-665996-90-9Carc. Cat. 1; R45T

R: 45

S: 53-45
H
648-084-00-3Distillates (coal), coke-oven light oil, naphthalene cut;

Naphthalene Oil;

[The complex combination of hydrocarbons obtained from prefractionation (continuous distillation) of coke oven light oil. It consists predominantly of naphthalene, coumarone and indene and boils above 148 oC (298 oF).]
285-076-585029-51-2Carc. Cat. 2; R45T

R: 45

S: 53-45
HJM
648-085-00-9Distillates (coal tar), naphthalene oils;

Naphthalene Oil;

[A complex combination of hydrocarbons obtained by the distillation of coal tar. It consists primarily of aromatic and other hydrocarbons, phenolic compounds and aromatic nitrogen compounds and distills in the approximate range of 200 oC to 250 oC (392 oF to 482 oF).]
283-484-884650-04-4Carc. Cat. 2; R45T

R: 45

S: 53-45
HJM
648-086-00-4Distillates (coal tar), naphthalene oils, naphthalene-low;

Naphthalene Oil Redistillate;

[A complex combination of hydrocarbons obtained by crystallization of naphthalene oil. Composed primarily of naphthalene, alkyl naphthalenes and phenolic compounds.]
284-898-184989-09-3Carc. Cat. 2; R45T

R: 45

S: 53-45
HJM
648-087-00-XDistillates (coal tar), naphthalene oil crystn. mother liquor;

Naphthalene Oil Redistillate;

[A complex combination of organic compounds obtained as a filtrate from the crystallization of the naphthalene fraction from coal tar and boiling in the range of approximately 200 oC to 230 oC (392 oF to 446 oF). Contains chiefly naphthalene, thionaphthene and alkylnaphthalenes.]
295-310-891995-49-2Carc. Cat. 2; R45T

R: 45

S: 53-45
HJM
648-088-00-5Extract residues (coal), naphthalene oil, alk.;

Naphthalene Oil Extract Residue; [A complex combination of hydrocarbons obtained from the alkali washing of naphthalene oil to remove phenolic compounds (tar acids). It is composed of naphthalene and alkyl naphthalenes.]
310-166-9121620-47-1Carc. Cat. 2; R45T

R: 45

S: 53-45
HJM
648-089-00-0Extract residues (coal), naphthalene oil, alk., naphthalene-low;

Naphthalene Oil Extract Residue;

[A complex combination of hydrocarbons remaining after the removal of naphthalene from alkali-washed naphthalene oil by a crystallization process. It is composed primarily of naphthalene and alkyl naphthalenes.]
310-167-4121620-48-2Carc. Cat. 2; R45T

R: 45

S: 53-45
HJM
648-090-00-6Distillates (coal tar), naphthalene oils, naphthalene-free, alk. exts.;

Naphthalene Oil Extract Residue;

[The oil remaining after the removal of phenolic compounds (tar acids) from drained naphthalene oil by an alkali wash. Composed primarily of naphthalene and alkyl naphthalenes.]
292-612-190640-90-7Carc. Cat. 2; R45T

R: 45

S: 53-45
HJM
648-091-00-1Extract residues (coal), naphthalene oil alk., distn. overheads;

Naphthalene Oil Extract Residue;

[The distillation from alkali-washed naphthalene oil having an approximate distillation range of 180 oC to 220 oC (356 oF to 428 oF). Composed primarily of naphthalene, alkylbenzenes, indene and indan.]
292-627-390641-04-6Carc. Cat. 2; R45T

R: 45

S: 53-45
HJM
648-092-00-7Distillates (coal tar), naphthalene oils, methylnaphthalene fraction;

Methylnaphthalene Oil;

[A distillate from the fractional distillation of high temperature coal tar. Composed primarily of substituted two ring aromatic hydrocarbons and aromatic nitrogen bases boiling in the range of approximately 225 oC to 255 oC (437 oF to 491 oF).]
309-985-4101896-27-9Carc. Cat. 2; R45T

R: 45

S: 53-45
HJM
648-093-00-2Distillates (coal tar), naphthalene oils, indole-methylnaphthalene fraction;

Methylnaphthalene Oil;

[A distillate from the fractional distillation of high temperature coal tar. Composed primarily of indole and methylnaphthalene boiling in the range of approximately 235 oC to 255 oC (455 oF to 491 oF).]
309-972-3101794-91-6Carc. Cat. 2; R45T

R: 45

S: 53-45
HJM
648-094-00-8Distillates (coal tar), naphthalene oils, acid exts.;

Methylnaphthalene Oil Extract Residue;

[A complex combination of hydrocarbons obtained by debasing the methylnaphthalene fraction obtained by the distillation of coal tar and boiling in the range of approximately 230 oC to 255 oC (446 oF to 491 oF). Contains chiefly 1(2)-methylnaphthalene, naphthalene, dimethylnaphthalene and biphenyl.]
295-309-291995-48-1Carc. Cat. 2; R45T

R: 45

S: 53-45
HJM
648-095-00-3Extract residues (coal), naphthalene oil alk., distn. residues;

Methylnaphthalene Oil Extract Residue;

[The residue from the distillation of alkali-washed naphthalene oil having an approximate distillation range of 220 oC to 300 oC (428 oF to 572 oF). Composed primarily of naphthalene, alkylnaphthalenes and aromatic nitrogen bases.]
292-628-990641-05-7Carc. Cat. 2; R45T

R: 45

S: 53-45
HJM
648-096-00-9Extract oils (coal), acidic, tar-base free;

Methylnaphthalene Oil Extract Residue;

[The extract oil boiling in the range of approximately 220 oC to 265 oC (428 oF to 509 oF) from coal tar alkaline extract residue produced by an acidic wash such as aqueous sulfuric acid after distillation to remove tar bases. Composed primarily of alkylnaphthalenes.]
284-901-684989-12-8Carc. Cat. 2; R45T

R: 45

S: 53-45
HJM
648-097-00-4Distillates (coal tar), benzole fraction, distn. residues;

Wash Oil;

[A complex combination of hydrocarbons obtained from the distillation of crude benzole (high temperature coal tar). It may be a liquid with the approximate distillation range of 150 oC to 300 oC (302 oF to 572 oF) or a semi-solid or solid with a melting point up to 70 oC (158 oF). It is composed primarily of naphthalene and alkyl naphthalenes.]
310-165-3121620-46-0Carc. Cat. 2; R45T

R: 45

S: 53-45
HJM
648-098-00-XCreosote oil, acenaphthene fraction;

Wash Oil;

[A complex combination of hydrocarbons produced by the distillation of coal tar and boiling in the range of approximately 240 oC to 280 oC (464 oF to 536 oF). Composed primarily of acenaphthene, naphthalene and alkyl naphthalene.]
292-605-390640-84-9Carc. Cat. 2; R45T

R: 45

S: 53-45
H
648-099-00-5Creosote oil;

[A complex combination of hydrocarbons obtained by the distillation of coal tar. It consists primarily of aromatic hydrocarbons and may contain appreciable quantities of tar acids and tar bases. It distills at the approximate range of 200 oC to 325 oC (392 oF to 617 oF).]
263-047-861789-28-4Carc. Cat. 2; R45T

R: 45

S: 53-45
H
648-100-00-9Creosote oil, high-boiling distillate;

Wash Oil;

[The high-boiling distillation fraction obtained from the high temperature carbonization of bituminous coal which is further refined to remove excess crystalline salts. It consists primarily of creosote oil with some of the normal polynuclear aromatic salts, which are components of coal tar distillates, removed. It is crystal free at approximately 5 oC (41 oF).]
274-565-970321-79-8Carc. Cat. 2; R45T

R: 45

S: 53-45
H
648-101-00-4Creosote;

[The distillate of coal tar produced by the high temperature carbonization of bituminous coal. It consists primarily of aromatic hydrocarbons, tar acids and tar bases.]
232-287-58001-58-9Carc. Cat. 2; R45T

R: 45

S: 53-45
H
648-102-00-XExtract residues (coal), creosote oil acid;

Wash Oil Extract Residue;

[A complex combination of hydrocarbons from the base-freed fraction from the distillation of coal tar, boiling in the range of approximately 250 oC to 280 oC (482 oF to 536 oF). It consists predominantly of biphenyl and isomeric diphenylnaphthalenes.]
310-189-4122384-77-4Carc. Cat. 2; R45T

R: 45

S: 53-45
H
648-103-00-5Anthracene oil, anthracene paste;

Anthracene Oil Fraction;

[The anthracene-rich solid obtained by the crystallization and centrifuging of anthracene oil. It is composed primarily of anthracene, carbazole and phenanthrene.]
292-603-290640-81-6Carc. Cat. 2; R45T

R: 45

S: 53-45
HJM
648-104-00-0Anthracene oil, anthracene-low;

Anthracene Oil Fraction;

[The oil remaining after the removal, by a crystallization process, of an anthracene-rich solid (anthracene paste) from anthracene oil. It is composed primarily of two, three and four membered aromatic compounds.]
292-604-890640-82-7Carc. Cat. 2; R45T

R: 45

S: 53-45
HJM
648-105-00-6Residues (coal tar), anthracene oil distn.;

Anthracene Oil Fraction;

[The residue from the fraction distillation of crude anthracene boiling in the approximate range of 340 oC to 400 oC (644 oF to 752 oF). It consists predominantly of tri- and polynuclear aromatic and heterocyclic hydrocarbons.]
295-505-892061-92-2Carc. Cat. 2; R45T

R: 45

S: 53-45
HJM
648-106-00-1Anthracene oil, anthracene paste, anthracene fraction;

Anthracene Oil Fraction;

[A complex combination of hydrocarbons from the distillation of anthracene obtained by the crystallization of anthracene oil from bituminous high temperature tar and boiling in the range of 330 oC to 350 oC (626 oF to 662 oF). It contains chiefly anthracene, carbazole and phenanthrene.]
295-275-991995-15-2Carc. Cat. 2; R45T

R: 45

S: 53-45
HJM
648-107-00-7Anthracene oil, anthracene paste, carbazole fraction;

Anthracene Oil Fraction;

[A complex combination of hydrocarbons from the distillation of anthracene obtained by crystallization of anthrancene oil from bituminous coal high temperature tar and boiling in the approximate range of 350 oC to 360 oC (662 oF to 680 oF). It contains chiefly anthacene, carbazole and phenanthrene.]
295-276-491995-16-3Carc. Cat. 2; R45T

R: 45

S: 53-45
HJM
648-108-00-2Anthracene oil, anthracene paste, distn. lights;

Anthracene Oil Fraction;

[A complex combination of hydrocarbons from the distillation of anthracene obtained by crystallization of anthracene oil from bituminous light temperature tar and boiling in the range of approximately 290 oC to 340 oC (554 oF to 644 oF). It contains chiefly trinuclear aromatics and their dihydro derivatives.]
295-278-591995-17-4Carc. Cat. 2; R45T

R: 45

S: 53-45
HJM
648-109-00-8Tar oils, coal, low-temp.;

Tar Oil, high boiling;

[A distillate from low-temperature coal tar. Composed primarily of hydrocarbons, phenolic compounds and aromatic nitrogen bases boiling in the range of approximately 160 oC to 340 oC (320 oF to 644 oF).]
309-889-2101316-87-4Carc. Cat. 2; R45T

R: 45

S: 53-45
HJM
648-110-00-3Extract residues (coal), low temp. coal atar alk.;

[The residue from low temperature coal tar oils after an alkaline wash, such as aqueous sodium hydroxide, to remove crude coal tar acids. Composed primarily of hydrocarbons and aromatic nitrogen bases.]
310-191-5122384-78-5Carc. Cat. 2; R45T

R: 45

S: 53-45
HJM
648-111-00-9Phenols, ammonia liquor ext.;

Alkaline Extract;

[The combination of phenols extracted, using isobutyl acetate, from the ammonia liquor condensed from the gas evolved in low-temperature (less than 700 oC (1292 oF)) destructive distillation of coal. It consists predominantly of a mixture of monohydric and dihydric phenols.]
284-881-984988-93-2Carc. Cat. 2; R45T

R: 45

S: 53-45
HJM
648-112-00-4Distillates (coal tar), light oils, alk. exts.;

Alkaline Extract;

[The aqueous extract from carbolic oil produced by an alkaline wash such as aqueous sodium hydroxide. Composed primarily of the alkali salts of various phenolic compounds.]
292-610-090640-88-3Carc. Cat. 2; R45T

R: 45

S: 53-45
HJM
648-113-00-XExtracts, coal tar oil alk.;

Alkaline Extract;

[The extract from coal tar oil produced by an alkaline wash such as aqueous sodium hydroxide. Composed primarily of the alkali salts of various phenolic compounds.]
266-017-265996-83-0Carc. Cat. 2; R45T

R: 45

S: 53-45
HJM
648-114-00-5Distillates (coal tar), naphthalene oils, alk. exts.;

Alkaline Extract;

[The aqueous extract from naphthalene oil produced by an alkaline wash such as aqueous sodium hydroxid. Composed primarily of the alkali salts of various phenolic compounds.]
292-611-690640-89-4Carc. Cat. 2; R45T

R: 45

S: 53-45
HJM
648-115-00-0Extract residues (coal), tar oil alk., carbonated, limed;

Crude Phenols;

[The product obtained by treatment of coal tar oil alkaline extract with CO2 and CaO. Composed primarily of CaCO3, Ca(OH)2, Na2CO3 and other organic and inorganic impurities.]
292-629-490641-06-8Carc. Cat. 2; R45T

R: 45

S: 53-45
HJM
648-116-00-6Tar acids, coal, crude;

Crude Phenols;

[The reaction product obtained by neutralizing coal tar oil alkaline extract with an acidic solution, such as aqueous sulfuric acid, or gaseous carbon dioxide, to obtain the free acids. Composed primarily of tar acids such as phenol, cresols, and xylenols.]
266-019-365996-85-2Carc. Cat. 2; R45T

R: 45

S: 53-45
HJM
648-117-00-1Tar acids, brown-coal, crude;

Crude Phenols;

[An acidified alkaline extract of brown coal tar distillate. Composed primarily of phenol and phenol homologs.]
309-888-7101316-86-3Carc. Cat. 2; R45T

R: 45

S: 53-45
HJM
648-118-00-7Tar acids, brown-coal gasification;

Crude Phenols;

[A complex combination of organic compounds obtained from brown coal gasification. Composed primarily of C6-10 hydroxy aromatic phenols and their homologs.]
295-536-792062-22-1Carc. Cat. 2; R45T

R: 45

S: 53-45
HJM
648-119-00-2Tar acids, distn. residues;

Distillate Phenols;

[A residue from the distillation of crude phenol from coal. It consists predominantly of phenols having carbon numbers in the range of C8 through C10 with a softening point of 60 oC to 80 oC (140 oF to 176 oF).]
306-251-596690-55-0Carc. Cat. 2; R45T

R: 45

S: 53-45
HJM
648-120-00-8Tar acids, methylphenol fraction;

Distillate Phenols;

[The fraction of tar acid rich in 3- and 4-methylphenol, recovered by distillation of low-temperature coal tar crude tar acids.]
284-892-984989-04-8Carc. Cat. 2; R45T

R: 45

S: 53-45
HJM
648-121-00-3Tar acids, polyalkylphenol fraction;

Distillate Phenols;

[The fraction of tar aicds, recovered by distillation of low-temperature coal tar crude tar acids, having an approximate boiling range of 225 oC to 320 oC (437 oF to 608 oF). Composed primarily of polyalkylphenols.]
284-893-484989-05-9Carc. Cat. 2; R45T

R: 45

S: 53-45
HJM
648-122-00-9Tar acids, xylenol fraction;

Distillate Phenols; [The fraction of tar acids, rich in 2,4- and 2,5-dimethylphenol, recovered by distillation of low-temperature coal tar crude tar acids.]
284-895-584989-06-0Carc. Cat. 2; R45T

R: 45

S: 53-45
HJM
648-123-00-4Tar acids, ethylphenol fraction;

Distillate Phenols;

[The fraction of tar acids, rich in 3- and 4-ethylphenol, recovered by distillation of low-temperature coal tar crude tar acids.]
284-891-384989-03-7Carc. Cat. 2; R45T

R: 45

S: 53-45
HJM
648-124-00-XTar acids, 3,5-xylenol fraction;

Distillate Phenols;

[The fraction of tar acids, rich in 3,5-dimethylphenol, recovered by distillation of low-temperature coal tar acids.]
284-896-084989-07-1Carc. Cat. 2; R45T

R: 45

S: 53-45
HJM
648-125-00-5Tar acids, residues, distillates, first-cut;

Distillate Phenols;

[The residue from the distillation in the range of 235 oC to 355 oC (481 oF to 697 oF) of light carbolic oil.]
270-713-168477-23-6Carc. Cat. 2; R45T

R: 45

S: 53-45
HJM
648-126-00-0Tar acids, cresylic, residues;

Distillate Phenols;

[The residue from crude coal tar acids after removal of phenol, cresols, xylenols and any higher boiling phenols. A black solid with a melting point approximately 80 oC (176 oF). Composed primarily of polyalkyphenols, resin gums, and inorganic salts.]
271-418-068555-24-8Carc. Cat. 2; R45T

R: 45

S: 53-45
HJM
648-127-00-6Phenols, C9-11;

Distillate Phenols
293-435-291079-47-9Carc. Cat. 2; R45T

R: 45

S: 53-45
HJM
648-128-00-1Tar acids, cresylic;

Distillate Phenols;

[A complex combination of organic compounds obtained from brown coal and boiling in the range of approximately 200 oC to 230 oC (392 oF to 446 oF). It contains chiefly phenols and pyridine bases.]
295-540-992062-26-5Carc. Cat. 2; R45T

R: 45

S: 53-45
HJM
648-129-00-7Tar acids, brown-coal, C2-alkylphenol fraction;

Distillate Phenols;

[The distillate from the acidification of alkaline washed lignite tar distillate boiling in the range of approximately 200 oC to 230 oC (392 oF to 446 oF). Composed primarily of <{ITA}>m-<{/ITA}> and <{ITA}>p-<{/ITA}>ethylphenol as well as cresols and xylenols.]
302-662-994114-29-1Carc. Cat. 2; R45T

R: 45

S: 53-45
HJM
648-130-00-2Extract oils (coal), naphthalene oils;

Acid Extract;

[The aqueous extract produced by an acidic wash of alkali-washed napthalene oil. Composed primarily of acid salts of various aromatic nitrogen bases including pyridine, quinoline and their alkyl derivatives.]
292-623-190641-00-2Carc. Cat. 2; R45T

R: 45

S: 53-45
HJM
648-131-00-8Tar bases, quinoline derivs.;

Distillate Bases
271-020-768513-87-1Carc. Cat. 2; R45T

R: 45

S: 53-45
HJM
648-132-00-3Tar bases, coal, quinoline derivs. fraction;

Distillate Bases
274-560-170321-67-4Carc. Cat. 2; R45T

R: 45

S: 53-45
HJM
648-133-00-9Tar bases, coal, distn. residues;

Distillate Bases;

[The distillation residue remaining after the distillation of the neutralized, acid-extracted base-containing tar fractions obtained by the distillation of coal tars. It contains chiefly aniline, collidines, quinoline and quinoline derivatives and toluidines.]
295-544-092062-29-8Carc. Cat. 2; R45T

R: 45

S: 53-45
HJM
648-134-00-4Hydrocarbon oils, arom., mixed with polyethylene and polypropylene, pyrolyzed, light oil fraction;

Heat Treatment Products;

[The oil obtained from the heat treatment of a polyethylene/polypropylene mixture with coal tar pitch or aromatic oils. It consists predominantly of benzene and its homologs boiling in a range of approximately 70 oC to 120 oC (158 oF to 248 oF).]
309-745-9100801-63-6Carc. Cat. 2; R45T

R: 45

S: 53-45
HJM
648-135-00-XHydrocarbon oils, arom., mixed with polyethylene, pyrolyzed, light oil fraction;

Heat Treatment Products;

[The oil obtained from the heat treatment of polyethylene with coal tar pitch or aromatic oils. It consists predominantly of benzene and its homologs boiling in a range of 70 oC to 120 oC (158 oF to 248 oF).]
309-748-5100801-65-8Carc. Cat. 2; R45T

R: 45

S: 53-45
HJM
648-136-00-5Hydrocarbon oils, arom., mixed with polystyrene, pyrolyzed, light oil fraction;

Heat Treatment Products;

[The oil obtained from the heat treatment of polystyrene with coal tar pitch or aromatic oils. It consists predominantly of benzene and its homologs boiling in a range of approximately 70 oC to 210 oC (158 oF to 410 oF).]
309-749-0100801-66-9Carc. Cat. 2; R45T

R: 45

S: 53-45
HJM
648-137-00-0Extract residues (coal), tar oil alk., naphthalene distn. residues;

Naphthalene Oil Extract Residue;

[The residue obtained from chemical oil extracted after the removal of naphthalene by distillation composed primarily of two to four membered condensed ring aromatic hydrocarbons and aromatic nitrogen bases.]
277-567-873665-18-6Carc. Cat. 2; R45T

R: 45

S: 53-45
HJM
648-138-00-6Creosote oil, low-boiling distillate;

Wash Oil;

[The low-boiling distillation fraction obtained from the high temperature carbonization of bituminous coal, which is further refined to remove excess crystalline salts. It consists primarily of creosote oil with some of the normal polynuclear aromatic salts, which are components of coal tar distillate, removed. It is crystal free at approximately 38 oC (100 oF).]
274-566-470321-80-1Carc. Cat. 2; R45T

R: 45

S: 53-45
H
648-139-00-1Tar acids, cresylic, sodium salts, caustic solns.;

Alkaline Extract
272-361-468815-21-4Carc. Cat. 2; R45T

R: 45

S: 53-45
HJM
648-140-00-7Extract oils (coal), tar base;

Acid Extract;

[The extract from coal tar oil alkaline extract residue produced by an acidic wash such as aqueous sulfuric acid after distillatin to remove naphthalene. Composed primarily of the acid salts of various aromatic nitrogen bases including pyridine, quinoline, and their alkyl derivatives.]
266-020-965996-86-3Carc. Cat. 2; R45T

R: 45

S: 53-45
HJM
648-141-00-2Tar bases, coal, crude;

Crude Tar Bases;

[The reaction product obtained by neutralizing coal tar base extract oil with an alkaline solution, such as aqueous sodium hydroxide, to obtain the free bases. Composed primarily of such organic bases as acridine, phenanthridine, pyridine, quinoline and their alkyl derivatives.]
266-018-865996-84-1Carc. Cat. 2; R45T

R: 45

S: 53-45
HJM
648-142-00-8Residues (coal), liq. solvent extn.;

[A cohesive powder composed of coal mineral matter and undissolved coal remaining after extraction of coal by a liquid solvent.]
302-681-294114-46-2Carc. Cat. 2; R45T

R: 45

S: 53-45
H M
648-143-00-3Coal liquids, liq. solvent extn. soln.;

[The product obtained by filtration of coal mineral matter and undissolved coal from coal extract solution produced by digesting coal in a liquid solvent. A black, viscous, highly complex liquid combination composed primarily of aromatic and partly hydro-genated aromatic hydrocarbons, aromatic nitrogen compounds, aromatic sulfur compounds, phenolic and other aromatic oxygen compounds and their alkyl derivatives.]
302-682-894114-47-3Carc. Cat. 2; R45T

R: 45

S: 53-45
H M
648-144-00-9Coal liquids, liq. solvent extn.;

[The substantially solvent-free product obtained by the distillation of the solvent from filtered coal extract solution produced by digesting coal in a liquid solvent. A black semi-solid, composed primarily of a complex combination of condensed-ring aromatic hydrocarbons, aromatic nitrogen compounds, aromatic sulfur compounds, phenolic compounds and other aromatic oxygen compounds, and their alkyl derivatives.]
302-683-394114-48-4Carc. Cat. 2; R45T

R: 45

S: 53-45
H M
648-145-00-4Tar brown-coal;

[An oil distilled from brown-coal tar. Composed primarily of aliphatic, naphthenic and one- to three-ring aromatic hydrocarbons, their alkyl derivates, heteroaromatics and one- and two-ring phenols boiling in the range of approximately 150 oC to 360 oC (302 oF to 680 oF).]
309-885-0101316-83-0Carc. Cat. 1; R45T

R: 45

S: 53-45
H
648-146-00-XTar, brown-coal, low-temp.;

[A tar obtained from low temperature carbonization and low temperature gasification of brown coal. Composed primarily of aliphatic, naphthenic and cyclic aromatic hydrocarbons, heteroaromatic hydrocarbons and cyclic phenols.]
309-886-6101316-84-1Carc. Cat. 1; R45T

R: 45

S: 53-45
H
648-147-00-5Light oil (coal), coke-oven;

Crude benzole;

[The volatile organic liquid extracted from the gas evolved in the high temperature (greater than 700 oC (1292 oF)) destructive distillation of coal. Composed primarily of benzene, toluene, and xylenes. May contain other minor hydrocarbon constituents.]
266-012-565996-78-3Carc. Cat. 2; R45T

R: 45

S: 53-45
H J
648-148-00-0Distillates (coal), liq. solvent extn., primary;

[The liquid product of condensation of vapors emitted during the digestion of coal in a liquid solvent and boiling in the range of approximately 30 oC to 300 oC (86 oF to 572 oF). Composed primarily of partly hydrogenated condensed-ring aromatic hydrocarbons, aromatic compounds containing nitrogen, oxygen and sulfur, and their alkyl derivatives having carbon numbers predominantly in the range of C4 through C14.]
302-688-094114-52-0Carc. Cat. 2; R45T

R: 45

S: 53-45
H J
648-149-00-6Distillates (coal), solvent extn., hydrocracked;

[Distillate obtained by hydrocracking of coal extract or solution produced by the liquid solvent extraction or supercritical gas extraction process and boiling in the range of approximately 30 oC to 300 oC (86 oF to 572 oF). Composed primarily of aromatic, hydrogenated aromatic and naphthenic compounds, their alkyl derivatives and alkanes with carbon numbers predominantly in the range of C4 through C14. Nitrogen, sulfur and oxygen-containing aromatic and hydrogenated aromatic compounds are also present.]
302-689-694114-53-1Carc. Cat. 2; R45T

R: 45

S: 53-45
H J
648-150-00-1Naphtha (coal), solvent extn., hydrocracked;

[Fraction of the distillate obtained by hydrocracking of coal extract or solution produced by the liquid solvent extraction or supercritical gas extraction processes and boiling in the range of approximately 30 oC to 180 oC (86 oF to 356 oF). Composed primarily of aromatic, hydrogenated aromatic and naphthenic compounds, their alkyl derivatives and alkanes with carbon numbers predominantly in the range of C4 to C9. Nitrogen, sulfur and oxygen-containing aromatic and hydrogenated aromatic compounds are also present.]
302-690-194114-54-2Carc. Cat. 2; R45T

R: 45

S: 53-45
H J
648-151-00-7Gasoline, coal solvent extn., hydrocracked naphtha;

[Motor fuel produced by the reforming of the refined naphtha fraction of the products of hydrocracking of coal extract or solution produced by the liquid solvent extraction or supercritical gas extraction processes and boiling in the range of approximately 30 oC to 180 oC (86 oF to 356 oF). Composed primarily of aromatic and naphthenic hydrocarbons, their alkyl derivatives and alkyl hydrocarbons having carbon numbers in the range of C4 through C9.]
302-691-794114-55-3Carc. Cat. 2; R45T

R: 45

S: 53-45
H
648-152-00-2Distillates (coal), solvent extn., hydrocracked middle;

[Distillate obtained from the hydrocracking of coal extract or solution produced by the liquid solvent extraction or supercritical gas extraction processes and boiling in the range of approximately 180 oC to 300 oC (356 oF to 572 oF). Composed primarily of two-ring aromatic, hydrogenated aromatic and naphthenic compounds, their alkyl derivatives and alkanes having carbon numbers predominantly in the range of C9 through C14. Nitrogen, sulfur and oxygen-containing compounds are also present.]
302-692-294114-56-4Carc. Cat. 2; R45T

R: 45

S: 53-45
H J
648-153-00-8Distillates (coal), solvent extn., hydrocracked hydrogenated middle;

[Distillate from the hydrogenation of hydrocracked middle distillate from coal extract or solution produced by the liquid solvent extraction or supercritical gas extraction processes and boiling in the range of approximately 180 oC to 280 oC (356 oF to 536 oF). Composed primarily of hydrogenated two- ring carbon compounds and their alkyl derivatives having carbon numbers predominantly in the range of C9 through C14.]
302-693-894114-57-5Carc. Cat. 2; R45T

R: 45

S: 53-45
H J
648-154-00-3Fuels, jet aircraft, coal solvent extn., hydrocracked hydrogenated;

[Jet engine fuel produced by hydrogenation of the middle distillate fraction of the products of hydrocracking of coal extract or solution produced by the liquid solvent extraction or supercritical gas extraction processes and boiling in the range of approximately 180 oC to 225 oC (356 oF to 473 oF). Composed primarily of hydrogenated two-ring hydrocarbons and their alkyl derivatives having carbon numbers predominantly in the range of C10 through C12.]
302-694-394114-58-6Carc. Cat. 3; R40Xn

R: 40

S: (2-)36/37
H
648-155-00-9Fuels, diesel, coal solvent extn., hydrocracked hydrogenated;

[Diesel engine fuel produced by the hydrogenation of the middle distillate fraction of the products of hydrocracking of coal extract or solution produced by the liquid solvent extraction or supercritical gas extraction processes and boiling in the range of approximately 200 oC to 280 oC (392 oF to 536 oF). Composed primarily of hydrogenated two-ring hydrocarbons and their alkyl derivatives having carbon numbers predominantly in the range of C11 through C14.]
302-695-994114-59-7Carc. Cat. 3; R40Xn

R: 40

S: (2-)36/37
H
648-156-00-4Light oil (coal), semi-coking process;

Fresh oil;

[The volatile organic liquid condensed from the gas evolved in the low temperature (less than 700 oC (1292 oF) destructive distillation of coal. Composed primarily of C6-10 hydrocarbons.]
292-635-790641-11-5Carc. Cat. 2; R45T

R: 45

S: 53-45
H J
649-001-00-3Extracts (petroleum), light naphthenic distillate solvent265-102-164742-03-6Carc. Cat. 2; R45T

R: 45

S: 53-45
H
649-002-00-9Extracts (petroleum), heavy paraffinic distillate solvent265-103-764742-04-7Carc. Cat. 2; R45T

R: 45

S: 53-45
H
649-003-00-4Extracts (petroleum), light paraffinic distillate solvent265-104-264742-05-8Carc. Cat. 2; R45T

R: 45

S: 53-45
H
649-004-00-XExtracts (petroleum), heavy naphthenic distillate solvent265-111-064742-11-6Carc. Cat. 2; R45T

R: 45

S: 53-45
H
649-005-00-5Extracts (petroleum), light vacuum gas oil solvent295-341-791995-78-7Carc. Cat. 2; R45T

R: 45

S: 53-45
H
649-006-00-0hydrocarbons C26-55, arom-rich307-753-797722-04-8Carc. Cat. 2; R45T

R: 45

S: 53-45
H
649-007-00-6fatty acids, tall-oil, reaction products with iminodiethanol and boric acid400-160-5Xi; R38

N; R51-53
Xi; N

R: 38-51/53

S: (2-)28-37-61
649-008-00-1Residues (petroleum), atm. tower;

Heavy Fuel oil;

[A complex residuum from the atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly greater than C20 and boiling above approximately 350 oC (662 oF). This stream is likely to contain 5 wt. % or more of 4- to 6-membered condensed ring aromatic hydrocarbons.]
265-045-264741-45-3Carc. Cat. 2; R45T

R: 45

S: 53-45
H
649-009-00-7Gas oils (petroleum), heavy vacuum;

Heavy Fuel oil;

[A complex combination of hydrocarbons produced by the vacuum distillation of the residuum from atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and boiling in the range of approximately 350 oC to 600 oC (662 oF to 1112 oF). This stream is likely to contain 5 wt. % or more of 4-to 6-membered condensed ring aromatic hydrocarbons.]
265-058-364741-57-7Carc. Cat. 2; R45T

R: 45

S: 53-45
H
649-010-00-2Distillates (petroleum), heavy catalytic cracked;

Heavy Fuel oil;

[A complex combination of hydrocarbons produced by the distillation of products from a catalytic cracking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C35 and boiling in the range of approximately 260 oC to 500 oC (500 oF to 932 oF). This stream is likely to contain 5 wt. % or more of 4- to 6-membered condensed ring aromatic hydrocarbons.]
265-063-064741-61-3Carc. Cat. 2; R45T

R: 45

S: 53-45
H
649-011-00-8Clarified oils (petroleum), catalytic cracked;

Heavy Fuel oil;

[A complex combination of hydrocarbons produced as the residual fraction from distillation of the products from a catalytic cracking process. It consists of hydrocarbons having carbon numbers predominantly greater than C20 and boiling above approximately 350 oC (662 oF). This stream is likely to contain 5 wt. % or more of 4- to 6-membered condensed ring aromatic hydrocarbons.]
265-064-664741-62-4Carc. Cat. 2; R45T

R: 45

S: 53-45
H
649-012-00-3Residues (petroleum), hydrocracked;

Heavy Fuel oil;

[A complex combination of hydrocarbons produced as the residual fraction from distillation of the products of a hydrocracking process. It consists of hydrocarbons having carbon numbers predominantly greater than C20 and boiling above approximately 350 oC (662 oF).]
265-076-164741-75-9Carc. Cat. 2; R45T

R: 45

S: 53-45
H
649-013-00-9Residues (petroleum), thermal cracked;

Heavy Fuel oil;

[A complex combination of hydrocarbons produced as the residual fraction from distillation of the product from a thermal cracking process. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly greater than C20 and boiling above approximately 350 oC (662 oF). This stream is likely to contain 5 wt. % or more of 4- to 6-membered condensed ring aromatic hydrocarbons.]
265-081-964741-80-6Carc. Cat. 2; R45T

R: 45

S: 53-45
H
649-014-00-4Distillates (petroleum), heavy thermal cracked;

Heavy Fuel oil;

[A complex combination of hydrocarbons from the distillation of the products from a thermal cracking process. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C15 through C36 and boiling in the range of approximately 260 oC to 480 oC (500 oF to 896 oF). This stream is likely to contain 5 wt. % or more of 4- to 6-membered condensed ring aromatic hydrocarbons.]
265-082-464741-81-7Carc. Cat. 2; R45T

R: 45

S: 53-45
H
649-015-00-XGas oils (petroleum), hydrotreated vacuum;

Heavy Fuel oil;

[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly in the range of C13 through C50 and boiling in the range of approximately 230 oC to 600 oC (446 oF to 1112 oF). This stream is likely to contain 5 wt.% or more of 4- to 6-membered condensed ring aromatic hydrocarbons.]
265-162-964742-59-2Carc. Cat. 2; R45T

R: 45

S: 53-45
H
649-016-00-5Residues (petroleum), hydrodesulfurized atmospheric tower;

Heavy Fuel oil;

[A complex combination of hydrocarbons obtained by treating an atmospheric tower residuum with hydrogen in the presence of a catalyst under conditions primarily to remove organic sulfur compounds. It consists of hydrocarbons having carbon numbers predominantly greater than C20 and boiling above approximately 350 oC (662 oF). This stream is likely to contain 5 wt. % or more of 4- to 6-membered condensed ring aromatic hydrocarbons.]
265-181-264742-78-5Carc. Cat. 2; R45T

R: 45

S: 53-45
H
649-017-00-0Gas oils (petroleum), hydrodesulfurized heavy vacuum;

Heavy Fuel oil;

[A complex combination of hydrocarbons obtained from a catalytic hydrodesulfurization process. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and boiling in the range of approximately 350 oC to 600 oC (662 oF to 1112 oC). This stream is likely to contain 5 wt. % or more of 4- to 6-membered condensed ring aromatic hydrocarbons.]
265-189-664742-86-5Carc. Cat. 2; R45T

R: 45

S: 53-45
H
649-018-00-6Residues (petroleum), steam-cracked;

Heavy Fuel oil;

[A complex combination of hydrocarbons obtained as the residual fraction from the distillation of the products of a steam cracking process (including steam cracking to produce ethylene). It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly greater than C14 and boiling above approximately 260 oC (500 oF). This stream is likely to contain 5 wt. % or more of 4- to 6-membered condensed ring aromatic hydrocarbons.]
265-193-864742-90-1Carc. Cat. 2; R45T

R: 45

S: 53-45
H
649-019-00-1Residues (petroleum), atmospheric;

Heavy Fuel oil;

[A complex residuum from atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly greater than C11 and boiling above approximately 200 oC (392 oF). This stream is likely to contain 5 wt. % or more of 4-to 6-membered condensed ring aromatic hydrocarbons.]
269-777-368333-22-2Carc. Cat. 2; R45T

R: 45

S: 53-45
H
649-020-00-7Clarified oils (petroleum), hydrodesulfurized catalytic cracked;

Heavy Fuel oil; [A complex combination of hydrocarbons obtained by treating catalytic cracked clarified oil with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists of hydrocarbons having carbon numbers predominantly greater than C20 and boiling above approximately 350 oC (662 oF). This stream is likely to contain 5 wt. % or more of 4-to 6-membered condensed ring aromatic hydrocarbons.]
269-782-068333-26-6Carc. Cat. 2; R45T

R: 45

S: 53-45
H
649-021-00-2Distillates (petroleum), hydrodesulfurized intermediate catalytic cracked;

Heavy Fuel oil;

[A complex combination of hydrocarbons obtained by treating intermediate catalytic cracked distillates with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists of hydrocarbons having carbon numbers predominantly in the range of C11 through C30 and boiling in the range of approximately 205 oC to 450 oC (401 oF to 842 oF). It contains a relatively large proportion of tricyclic aromatic hydrocarbons.]
269-783-668333-27-7Carc. Cat. 2; R45T

R: 45

S: 53-45
H
649-022-00-8Distillates (petroleum), hydrodesulfurized heavy catalytic cracked;

Heavy Fuel oil;

[A complex combination of hydrocarbons obtained by treatment of heavy catalytic cracked distillates with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C35 and boiling in the range of approximately 260 oC to 500 oC (500 oF to 932 oF). This stream is likely to contain 5 wt. % or more of 4- to 6-membered condensed ring aromatic hydrocarbons.]
269-784-168333-28-8Carc. Cat. 2; R45T

R: 45

S: 53-45
H
649-023-00-3Fuel oil, residues-straight-run gas oils, high-sulfur;

Heavy Fuel oil
270-674-068476-32-4Carc. Cat. 2; R45T

R: 45

S: 53-45
H
649-024-00-9Fuel oil, residual;

Heavy Fuel oil;

[The liquid product from various refinery streams, usually residues. The composition is complex and varies with the source of the crude oil.]
270-675-668476-33-5Carc. Cat. 2; R45T

R: 45

S: 53-45
H
649-025-00-4Residues (petroleum), catalytic reformer fractionator residue distn.;

Heavy Fuel oil;

[A complex residuum from the distillation of catalytic reformer fractionator residue. It boils approximately above 399 oC (750 oF).]
270-792-268478-13-7Carc. Cat. 2; R45T

R: 45

S: 53-45
H
649-026-00-XResidues (petroleum), heavy coker gas oil and vacuum gas oil;

Heavy Fuel oil;

[A complex combination of hydrocarbons produced as the residual fraction from the distillation of heavy coker gas oil and vacuum gas oil. It predominantly consists of hydrocarbons having carbon numbers predominantly greater than C13 and boiling above approximately 230 oC (446 oF).]
270-796-468478-17-1Carc. Cat. 2; R45T

R: 45

S: 53-45
H
649-027-00-5Residues (petroleum), heavy coker and light vacuum;

Heavy Fuel oil;

[A complex combination of hydrocarbons produced as the residual fraction from the distillation of heavy coker gas oil and light vacuum gas oil. It consists predominantly of hydrocarbons having carbon numbers predominantly greater than C13 and boiling above approximately 230 oC (446 oF).]
270-983-068512-61-8Carc. Cat. 2; R45T

R: 45

S: 53-45
H
649-028-00-0Residues (petroleum), light vacuum;

Heavy Fuel oil;

[A complex residuum from the vacuum distillation of the residuum from the atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly greater than C13 and boiling above approximately 230 oC (446 oF).]
270-984-668512-62-9Carc. Cat. 2; R45T

R: 45

S: 53-45
H
649-029-00-6Residues (petroleum), steam-cracked light;

Heavy Fuel oil;

[A complex residuum from the distillation of the products from a steam-cracking process. It consists predominantly of aromatic and unsaturated hydrocarbons having carbon numbers greater than C7 and boiling in the range of approximately 101 oC to 555 oC (214 oF to 1030 oF).]
271-013-968513-69-9Carc. Cat. 2; R45T

R: 45

S: 53-45
H
649-030-00-1Fuel oil, No 6;

Heavy Fuel oil;

[A distillate oil having a minimum viscosity of 900 SUS at 37.7 oC (100 oF) to a maximum of 9000 SUS at 37.7 oC (100 oF).]
271-384-768553-00-4Carc. Cat. 2; R45T

R: 45

S: 53-45
H
649-031-00-7Residues (petroleum), topping plant, low-sulfur;

Heavy Fuel oil;

[A low-sulfur complex combination of hydrocarbons produced as the residual fraction from the topping plant distillation of crude oil. It is the residuum after the straight-run gasoline cut, kerosene cut and gas oil cut have been removed.]
271-763-768607-30-7Carc. Cat. 2; R45T

R: 45

S: 53-45
H
649-032-00-2Gas oils (petroleum), heavy atmospheric;

Heavy Fuel oil;

[A complex combination of hydrocarbons obtained by the distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C7 through C35 and boiling in the range of approximately 121 oC to 510 oC (250 oF to 950 oF).]
272-184-268783-08-4Carc. Cat. 2; R45T

R: 45

S: 53-45
H
649-033-00-8Residues (petroleum), coker scrubber, Condensed-ring-arom.-contg.;

Heavy Fuel oil;

[A very complex combination of hydrocarbons produced as the residual fraction from the distillation of vaccum residuum and the products from a thermal cracking process. It consists predominantly of hydrocarbons having carbon numbers predominantly greater than C20 and boiling above approximately 350 oC (662 oF). This stream is likely to contain 5 wt.% or more of 4- to 6-membered condensed rind aromatic hydrocarbons.]
272-187-968783-13-1Carc. Cat. 2; R45T

R: 45

S: 53-45
H
649-034-00-3Distillates (petroleum), petroleum residues vacuum;

Heavy Fuel oil;

[A complex combination of hydrocarbons produced by the vacuum distillation of the residuum from the atmospheric distillation of crude oil.]
273-263-468955-27-1Carc. Cat. 2; R45T

R: 45

S: 53-45
H
649-035-00-9Residues (petroleum), steam-cracked, resinous;

Heavy Fuel oil;

[A complex residuum from the distillation of steam-cracked petroleum residues.]
273-272-368955-36-2Carc. Cat. 2; R45T

R: 45

S: 53-45
H
649-036-00-4Distillates (petroleum), intermediate vacuum;

Heavy Fuel oil;

[A complex combination of hydrocarbons produced by the vacuum, distillation of the residuum from atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C14 through C42 and boiling in the range of approximately 250 oC to 545 oC (482 oF to 1013 oF). This stream is likely to contain 5 wt. % or more of 4- to 6-membered condensed ring aromatic hydrocarbons.]
274-683-070592-76-6Carc. Cat. 2; R45T

R: 45

S: 53-45
H
649-037-00-XDistillates (petroleum), light vacuum;

Heavy Fuel oil;

[A complex combination of hydrocarbons produced by the vacuum distillation of the residuum from atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C11 through C35 and boiling in the range of approximately 250 oC to 545 oC (482 oF to 1013 oF).]
274-684-670592-77-7Carc. Cat. 2; R45T

R: 45

S: 53-45
H
649-038-00-5Distillates (petroleum), vacuum;

Heavy Fuel oil;

[A complex combination of hydrocarbons produced by the vacuum distillation of the residuum from atmospheric distillation of crude oil. It consists of hydrocarbons having numbers predominantly in the range of C15 through C50 and boiling in the range of approximately 270 oC to 600 oC (518 oF to 1112 oF). This stream is likely to contain 5 wt.% or more of 4- to 6-membered condensed ring aromatic hydrocarbons.]
274-685-170592-78-8Carc. Cat. 2; R45T

R: 45

S: 53-45
H
649-039-00-0Gas oils (petroleum), hydrodesulfurized coker heavy vacuum;

Heavy Fuel oil;

[A complex combination of hydrocarbons obtained by hydrodesulfurization of heavy coker distillate stocks, It consists predominantly of hydrocarbons having carbon numbers predominantly in the range C18 to C44 and boiling in the range of approximately 304 oC to 548 oC (579 oF to 1018 oF). Likely to contain 5 % or more of 4- to 6-membered condensed ring aromatic hydrocarbons.]
285-555-985117-03-9Carc. Cat. 2; R45T

R: 45

S: 53-45
H
649-040-00-6Residues (petroleum), steam-cracked, distillates;

Heavy Fuel oil;

[A complex combination of hydrocarbons obtained during the production of refined petroleum tar by the distillation of steam cracked tar. It consists predominantly of aromatic and other hydrocarbons and organic sulfur compounds.]
292-657-790669-75-3Carc. Cat. 2; R45T

R: 45

S: 53-45
H
649-041-00-1Residues (petroleum), vacuum, light;

Heavy Fuel oil;

[A complex residuum from the vacuum distillation of the residuum from atmospheric distillation of crude oil. It consists predominantly of hydrocarbons having carbon numbers predominantly greater than C24 and boiling above approximately 390 oC (734 oF).]
292-658-290669-76-4Carc. Cat. 2; R45T

R: 45

S: 53-45
H
649-042-00-7Fuel oil, heavy, high-sulfur;

Heavy Fuel oil;

[A complex combination of hydrocarbons obtained by the distillation of crude petroleum. It consists predominantly of aliphatic, aromatic and cycloaliphatic hydrocarbons having carbon numbers predominantly higher than C25 and boiling above approximately 400 oC (752 oF).]
295-396-792045-14-2Carc. Cat. 2; R45T

R: 45

S: 53-45
H
649-043-00-2Residues (petroleum), catalytic cracking;

Heavy Fuel oil;

[A complex combination of hydrocarbons produced as the residual fraction from the distillation of the products from a catalytic cracking process. It consists predominantly of hydrocarbons having carbon numbers predominantly greater than C11 and boiling above approximately 200 oC (392 oF).]
295-511-092061-97-7Carc. Cat. 2; R45T

R: 45

S: 53-45
H
649-044-00-8Distillates (petroleum), intermediate catalytic cracked, thermally degraded;

Heavy Fuel oil;

[A complex combination of hydrocarbons produced by the distillation of products from a catalytic cracking process which has been used as a heat transfer fluid. It consists predominantly of hydrocarbons boiling in the range of approximately 220 oC to 450 oC (428 oF to 842 oF). This stream is likely to contain organic sulfur compounds.]
295-990-692201-59-7Carc. Cat. 2; R45T

R: 45

S: 53-45
H
649-045-00-3Residual oils (petroleum);

Heavy Fuel oil;

[A complex combination of hydrocarbons, sulfur compounds and metal-containing organic compounds obtained as the residue from refinery fractionation cracking processes. It produces a finished oil with a viscosity above 2cSt. at 100 oC.]
298-754-093821-66-0Carc. Cat. 2; R45T

R: 45

S: 53-45
H
649-046-00-9Residues, steam cracked, thermally treated;

Heavy Fuel oil;

[A complex combination of hydrocarbons obtained by the treatment and distillation of raw steam-cracked naphtha. It consists predominantly of unsaturated hydrocarbons boiling in the range above approximately 180 oC (356 oF).]
308-733-098219-64-8Carc. Cat. 2; R45T

R: 45

S: 53-45
H
649-047-00-4Distillates (petroleum), hydrodesulfurized full-range middle;

Heavy Fuel oil;

[A complex combination of hydrocarbons obtained by treating a petroleum stock with hydrogen. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C9 through C25 and boiling in the range of approximately 150 oC to 400 oC (302 oF to 752 oF).]
309-863-0101316-57-8Carc. Cat. 2; R45T

R: 45

S: 53-45
H
649-048-00-XResidues (petroleum), catalytic reformer fractionator;

Heavy Fuel oil;

[A complex combination of hydrocarbons produced as the residual fraction from distillation of the product from a catalytic reforming process. It consists of predominantly aromatic hydrocarbons having carbon numbers predominantly in the range of C10 through C25 and boiling in the range of approximately 160 oC to 400 oC (320 oF to 725 oF). This stream is likely to contain 5 wt. % or more of 4- or 6-membered condensed ring aromatic hydrocarbons.]
265-069-364741-67-9Carc. Cat. 2; R45T

R: 45

S: 53-45
H
649-049-00-5Petroleum;

Crude oil;

[A complex combination of hydrocarbons, It consists predominantly of aliphatic, alicyclic and aromatic hydrocarbons. It may also contain small amounts of nitrogen, oxygen and sulfur compounds. This category encompasses light, medium, and heavy petroleums, as well as the oils extended from tar sands. Hydrocarbonaceous materials requiring major chemical changes for their recovery or conversion to petroleum refinery feedstocks such as crude shale oils; upgraded shale oils and liquid coal fuels are not included in this definition.]
232-298-58002-05-9Carc. Cat. 2; R45T

R: 45

S: 53-45
H
649-050-00-0Distillates (petroleum), light paraffinic;

Unrefined or mildly refined baseoil;

[A complex combination of hydrocarbons produced by vacuum distillation of the residuum from atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC). It contains a relatively large proportion of saturated aliphatic hydrocarbons normally present in this distillation range of crude oil.]
265-051-564741-50-0Carc. Cat. 1; R45T

R: 45

S: 53-45
H
649-051-00-6Distillates (petroleum), heavy paraffinic;

Unrefined or mildly refined baseoil;

[A complex combination of hydrocarbons produced by vacuum distillation of the residuum from atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100 oF (19cSt at 40 oC). It contains a relatively large proportion of saturated aliphatic hydrocarbons.]
265-052-064741-51-1Carc. Cat. 1; R45T

R: 45

S: 53-45
H
649-052-00-1Distillates (petroleum), light naphthenic;

Unrefined or mildly refined baseoil;

[A complex combination of hydrocarbons produced by vacuum distillation of the residuum from atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.]
265-053-664741-52-2Carc. Cat. 1; R45T

R: 45

S: 53-45
H
649-053-00-7Distillates (petroleum), heavy naphthenic;

Unrefined or mildly refined baseoil;

[A complex combination of hydrocarbons produced by vacuum distillation of the residuum from atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.]
265-054-164741-53-3Carc. Cat. 1; R45T

R: 45

S: 53-45
H
649-054-00-2Distillates (petroleum), acid-treated heavy naphthenic;

Unrefined or mildly refined baseoil;

[A complex combination of hydrocarbons obtained as a raffinate from a sulfuric acid treating process. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.]
265-117-364742-18-3Carc. Cat. 1; R45T

R: 45

S: 53-45
H
649-055-00-8Distillates (petroleum), acid-treated light naphthenic;

Unrefined or mildly refined baseoil;

[A complex combination of hydrocarbons obtained as a raffinate from a sulfuric acid treating process. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.]
265-118-964742-19-4Carc. Cat. 1; R45T

R: 45

S: 53-45
H
649-056-00-3Distillates (petroleum), acid-treated heavy paraffinic;

Unrefined or mildly refined baseoil;

[A complex combination of hydrocarbons obtained as a raffinate from a sulfuric acid process. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil having a viscosity of a least 100 SUS at 100 oF (19cSt at 40 oC).]
265-119-464742-20-7Carc. Cat. 1; R45T

R: 45

S: 53-45
H
649-057-00-9Distillates (petroleum), acid-treated light paraffinic;

Unrefined or mildly refined baseoil;

[A complex combination of hydrocarbons obtained as a raffinate from a sulfuric acid treating process. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil having a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC).]
265-121-564742-21-8Carc. Cat. 1; R45T

R: 45

S: 53-45
H
649-058-00-4Distillates (petroleum), chemically neutralized heavy paraffinic;

Unrefined or mildly refined baseoil;

[A complex combination of hydrocarbons obtained from a treating process to remove acidic materials. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100 oF (19cSt at 40 oC). It contains a relatively large proportion of aliphatic hydrocarbons.]
265-127-864742-27-4Carc. Cat. 1; R45T

R: 45

S: 53-45
H
649-059-00-XDistillates (petroleum), chemically neutralized light paraffinic;

Unrefined or mildly refined baseoil;

[A complex combination of hydrocarbons produced by a treating process to remove acidic materials. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity less than 100 SUS at 100 oF (19cSt at 40 oC).]
265-128-364742-28-5Carc. Cat. 1; R45T

R: 45

S: 53-45
H
649-060-00-5Distillates (petroleum), chemically neutralized heavy naphthenic;

Unrefined or mildly refined baseoil;

[A complex combination of hydrocarbons produced by a treating process to remove acidic materials. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.]
265-135-164742-34-3Carc. Cat. 1; R45T

R: 45

S: 53-45
H
649-061-00-0Distillates (petroleum), chemically neutralized light naphthenic;

Unrefined or mildly refined baseoil;

[A complex combination of hydrocarbons produced by a treating process to remove acidic materials. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS a 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.]
265-136-764742-35-4Carc. Cat. 1; R45T

R: 45

S: 53-45
H
649-062-00-6Gases (petroleum), catalytic cracked naphtha depropanizer overhead, C3-rich acid-free;

Petroleum gas;

[A complex combination of hydrocarbons obtained from fractionation of catalytic cracked hydrocarbons and treated to remove acidic impurities. It consists of hydrocarbons having carbon numbers in the range of C2 through C4, predominantly C3.]
270-755-068477-73-6⊗ Carc. Cat. 1; R45

Muta. Cat. 2; R46
T

R: 45-46

S: 53-45
H K
649-063-00-1Gases (petroleum), catalytic cracker;

Petroleum gas;

[A complex combination of hydrocarbons produced by the distillation of the products from a catalytic cracking process. It consists predominantly of aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]
270-756-668477-74-7⊗ Carc. Cat. 1; R45

Muta. Cat. 2; R46
T

R: 45-46

S: 53-45
H K
649-064-00-7Gases (petroleum), catalytic cracker, C1-5-rich;

Petroleum gas;

[A complex combination of hydrocarbons produced by the distillation of products from a catalytic cracking process. It consists of aliphatic hydrocarbons having carbon numbers in the range of C1 through C6, predominantly C1 through C5.]
270-757-168477-75-8⊗ Carc. Cat. 1; R45

Muta. Cat. 2; R46
T

R: 45-46

S: 53-45
H K
649-065-00-2Gases (petroleum), catalytic polymd. naphtha stabilizer overhead, C2-4-rich;

Petroleum gas;

[A complex combination of hydrocarbons obtained from the fractionation stabilization of catalytic polymerized naphtha. It consists of aliphatic hydrocarbons having carbon numbers in the range of C2 through C6, predominantly C2 through C4.]
270-758-768477-76-9⊗ Carc. Cat. 1; R45

Muta. Cat. 2; R46
T

R: 45-46

S: 53-45
H K
649-066-00-8Gases (petroleum), catalytic reformer, C1-4-rich;

Petroleum gas;

[A complex combination of hydrocarbons produced by distillation of products from a catalytic reforming process. It consists of hydrocarbons having carbon numbers in the range of C1 through C6, predominantly C1 through C4.]
270-760-868477-79-2⊗ Carc. Cat. 1; R45

Muta. Cat. 2; R46
T

R: 45-46

S: 53-45
H K
649-067-00-3Gases (petroleum), C3-5 olefinic-paraffinic alkylation feed;

Petroleum gas;

[A complex combination of olefinic and paraffinic hydrocarbons having carbon numbers in the range of C3 through C5 which are used as alkylation feed. Ambient temperatures normally exceed the critical temperature of these combinations.]
270-765-568477-83-8⊗ Carc. Cat. 1; R45

Muta. Cat. 2; R46
T

R: 45-46

S: 53-45
H K
649-068-00-9Gases (petroleum), C4-rich;

Petroleum gas;

[A complex combination of hydrocarbons produced by distillation of products from a catalytic fractionation process. It consists of aliphatic hydrocarbons having carbon numbers in the range of C3 through C5, predominantly C4.]
270-767-668477-85-0⊗ ⊗ Carc. Cat. 1; R45

Muta. Cat. 2; R46
T

R: 45-46

S: 53-45
H K
649-069-00-4Gases (petroleum), deethanizer overheads;

Petroleum gas;

[A complex combination of hydrocarbons produced from distillation of the gas and gasoline fractions from the catalytic cracking process. It contains predominantly ethane and ethylene.]
270-768-168477-86-1⊗ Carc. Cat. 1; R45

Muta. Cat. 2; R46
T

R: 45-46

S: 53-45
H K
649-070-00-XGases (petroleum), deisobutanizer tower overheads;

Petroleum gas;

[A complex combination of hydrocarbons produced by the atmospheric distillation of a butane-butylene stream. It consists of aliphatic hydrocarbons having carbon numbers predominantly in the range of C3 through C4.]
270-769-768477-87-2⊗ Carc. Cat. 1; R45

Muta. Cat. 2; R46
T

R: 45-46

S: 53-45
H K
649-071-00-5Gases (petroleum), depropanizer dry, propene-rich;

Petroleum gas;

[A complex combination of hydrocarbons produced by the distillation of products from the gas and gasoline fractions of a catalytic cracking process. It consists predominantly of propylene with some ethane and propane.]
270-772-368477-90-7⊗ Carc. Cat. 1; R45

Muta. Cat. 2; R46
T

R: 45-46

S: 53-45
H K
649-072-00-0Gases (petroleum), depropanizer overheads;

Petroleum gas;

[A complex combination of hydrocarbons produced by distillation of products from the gas and gasoline fractions of a catalytic cracking process. It consists of aliphatic hydrocarbons having carbon numbers predominantly in the range of C2 through C4.]
270-773-968477-91-8⊗ Carc. Cat. 1; R45

Muta. Cat. 2; R46
T

R: 45-46

S: 53-45
H K
649-073-00-6Gases (petroleum), gas recovery plant depropanizer overheads;

Petroleum gas;

[A complex combination of hydrocarbons obtained by fractionation of miscellaneous hydrocarbon streams. It consists predominantly of hydrocarbons having carbon numbers in the range of C1 through C4, predominantly propane.]
270-777-068477-94-1⊗ Carc. Cat. 1; R45

Muta. Cat. 2; R46
T

R: 45-46

S: 53-45
H K
649-074-00-1Gases (petroleum), Girbatol unit feed;

Petroleum gas;

[A complex combination of hydrocarbons that is used as the feed into the Girbatol unit to remove hydrogen sulfide. It consists of aliphatic hydrocarbons having carbon numbers predominantly in the range of C2 through C4.]
270-778-668477-95-2⊗ Carc. Cat. 1; R45

Muta. Cat. 2; R46
T

R: 45-46

S: 53-45
H K
649-075-00-7Gases (petroleum), isomerized naphtha fractionator, C4-rich, hydrogen sulfide-free;

Petroleum gas
270-782-868477-99-6⊗ Carc. Cat. 1; R45

Muta. Cat. 2; R46
T

R: 45-46

S: 53-45
H K
649-076-00-2Tail gas (petroleum), catalytic cracked clarified oil and thermal cracked vacuum residue fractionation reflux drum;

Petroleum gas;

[A complex combination of hydrocarbons obtained from fractionation of catalytic cracked clarified oil and thermal cracked vacuum residue. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]
270-802-568478-21-7⊗ Carc. Cat. 1; R45

Muta. Cat. 2; R46
T

R: 45-46

S: 53-45
H K
649-077-00-8Tail gas (petroleum), catalytic cracked naphtha stabilization absorber;

Petroleum gas;

[A complex combination of hydrocarbons obtained from the stabilization of catalytic cracked naphtha. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]
270-803-068478-22-8⊗ Carc. Cat. 1; R45

Muta. Cat. 2; R46
T

R: 45-46

S: 53-45
H K
649-078-00-3Tail gas (petroleum), catalytic cracker, catalytic reformer and hydrodesulfurizer combined fractionater;

Petroleum gas;

[A complex combination of hydrocarbons obtained from the fractionation of products from catalytic cracking, catalytic reforming and hydrodesulfurizing processes treated to remove acidic impurities. It consists predominantly of hydrocarbons having cabon numbers predominantly in the range of C1 through C5.]
270-804-668478-24-0⊗ Carc. Cat. 1; R45

Muta. Cat. 2; R46
T

R: 45-46

S: 53-45
H K
649-079-00-9Tail gas (petroleum), catalytic reformed naphtha fractionation stabilizer;

Petroleum gas;

[A complex combination of hydrocarbons obtained from the fractionation stabilization of catalytic reformed naphtha. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]
270-806-768478-26-2⊗Carc. Cat. 1; R45

Muta. Cat. 2; R46
T

R: 45-46

S: 53-45
H K
649-080-00-4Tail gas (petroleum), saturate gas plant mixed stream, C4-rich;

Petroleum gas;

[A complex combination of hydrocarbons obtained from the fractionation stabilization of straight-run naphtha, distillation tail gas and catalytic reformed naphtha stabilizer tail gas. It consists of hydrocarbons having carbon numbers in the range of C3 through C6, predominantly butane and isobutane.]
270-813-568478-32-0⊗ Carc. Cat. 1; R45

Muta. Cat. 2; R46
T

R: 45-46

S: 53-45
H K
649-081-00-XTail gas (petroleum), saturate gas recovery plant, C1-2-rich;

Petroleum gas;

[A complex combination of hydrocarbons obtained from fractionation of distillate tail gas, straight-run naphtha, catalytic reformed naphtha stabilizer tail gas. It consists predominantly of hydrocarbons having carbon numbers in the range of C1through C5, predominantly methane and ethane.]
270-814-068478-33-1⊗ Carc. Cat. 1; R45

Muta. Cat. 2; R46
T

R: 45-46

S: 53-45
H K
649-082-00-5Tail gas (petroleum), vacuum residues thermal cracker;

Petroleum gas;

[A complex combination of hydrocarbons obtained from the thermal cracking of vacuum residues. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]
270-815-668478-34-2⊗ Carc. Cat. 1; R45

Muta. Cat. 2; R46
T

R: 45-46

S: 53-45
H K
649-083-00-0Hydrocarbons, C3-4-rich, petroleum distillate;

Petroleum gas;

[A complex combination of hydrocarbons produced by distillation and condensation of crude oil. It consists of hydrocarbons having carbon numbers in the range of C3 through C5, predominantly C3 through C4.]
270-990-968512-91-4⊗ Carc. Cat. 1; R45

Muta. Cat. 2; R46
T

R: 45-46

S: 53-45
H K
649-084-00-6Gases (petroleum), full-range straight-run naphtha dehexanizer off;

petroleum gas;

[A complex combination of hydrocarbons obtained by the fractionation of the full-range straight-run naphtha. It consists of hydrocarbons having carbon numbers predominantly in the range of C2 through C6.]
271-000-868513-15-5⊗ Carc. Cat. 1; R45

Muta. Cat. 2; R46
T

R: 45-46

S: 53-45
H K
649-085-00-1Gases (petroleum), hydrocracking depropanizer off, hydrocarbon-rich;

Petroleum gas;

[A complex combination of hydrocarbon produced by the distillation of products from a hydrocracking process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C4. It may also contain small amounts of hydrogen and hydrogen sulfide.]
271-001-368513-16-6⊗ Carc. Cat. 1; R45

Muta. Cat. 2; R46
T

R: 45-46

S: 53-45
H K
649-086-00-7Gases (petroleum), light straight-run naphtha stabilizer off;

Petroleum gas;

[A complex combination of hydrocarbons obtained by the stabilization of light straight-run naphtha. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C2 through C6.]
271-002-968513-17-7⊗ Carc. Cat. 1; R45

Muta. Cat. 2; R46
T

R: 45-46

S: 53-45
H K
649-087-00-2Residues (petroleum), alkylation splitter, C4-rich;

Petroleum gas;

[A complex residuum from the distillation of streams various refinery operations. It consists of hydrocarbons having carbon numbers in the range of C4 through C5, predominantly butane and boiling in the range of approximately - 11.7 oC to 27.8 oC (11 oF to 82 oF).]
271-010-268513-66-6⊗ Carc. Cat. 1; R45

Muta. Cat. 2; R46
T

R: 45-46

S: 53-45
H K
649-088-00-8Hydrocarbons, C1-4;

Petroleum gas;

[A complex combination of hydrocarbons provided by thermal cracking and absorber operations and by distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C4 and boiling in the range of approximately minus 164 oC to minus 0.5 oC (-263 oF to 31 oF).]
271-032-268514-31-8⊗ Carc. Cat. 1; R45

Muta. Cat. 2; R46
T

R: 45-46

S: 53-45
H K
649-089-00-3Hydrocarbons, C1-4, sweetened;

Petroleum gas;

[A complex combination of hydrocarbons obtained by subjecting hydrocarbon gases to a sweetening process to convert mercaptans or to remove acidic impurities. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C4 and boiling in the range of approximately - 164 oC to - 0.5 oC (-263 oF to 31 oF).]
271-038-568514-36-3⊗ Carc. Cat. 1; R45

Muta. Cat. 2; R46
T

R: 45-46

S: 53-45
H K
649-090-00-9Hydrocarbons, C1-3;

Petroleum gas;

[A complex combination of hydrocarbons having carbon numbers predominantly in the range of C1 through C3 and boiling in the range of approximately minus 164 oC to minus 42 oC (-263 oF to - 44 oF).]
271-259-768527-16-2⊗ Carc. Cat. 1; R45

Muta. Cat. 2; R46
T

R: 45-46

S: 53-45
H K
649-091-00-4Hydrocarbons, C1-4, debutanizer fraction;

Petroleum gas
271-261-868527-19-5⊗ Carc. Cat. 1; R45

Muta. Cat. 2; R46
T

R: 45-46

S: 53-45
H K
649-092-00-XGases (petroleum), C1-5, wet;

Petroleum gas;

[A complex combination of hydrocarbons produced by the distillation of crude oil and/or the cracking of tower gas oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]
271-624-068602-83-5⊗ Carc. Cat. 1; R45

Muta. Cat. 2; R46
T

R: 45-46

S: 53-45
H K
649-093-00-5Hydrocarbons, C2-4;

Petroleum gas
271-734-968606-25-7⊗ Carc. Cat. 1; R45

Muta. Cat. 2; R46
T

R: 45-46

S: 53-45
H K
649-094-00-0Hydrocarbons, C3;

Petroleum gas
271-735-468606-26-8⊗ Carc. Cat. 1; R45

Muta. Cat. 2; R46
T

R: 45-46

S: 53-45
H K
649-095-00-6Gases (petroleum), alkylation feed;

Petroleum gas;

[A complex combination of hydrocarbons produced by the catalytic cracking of gas oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C3 through C4.]
271-737-568606-27-9⊗ Carc. Cat. 1; R45

Muta. Cat. 2; R46
T

R: 45-46

S: 53-45
H K
649-096-00-1Gases (petroleum), depropanizer bottoms fractionation off;

Petroleum gas;

[A complex combination of hydrocarbons obtained from the fractionation of depropanizer bottoms. It consists predominantly of butane, isobutane and butadiene.]
271-742-268606-34-8⊗ Carc. Cat. 1; R45

Muta. Cat. 2; R46
T

R: 45-46

S: 53-45
H K
649-097-00-7Gases (petroleum), refinery blend;

Petroleum gas;

[A complex combination obtained from various processes. It consists of hydrogen, hydrogen sulfide and hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]
272-183-768783-07-3⊗ Carc. Cat. 1; R45

Muta. Cat. 2; R46
T

R: 45-46

S: 53-45
H K
649-098-00-2Gases (petroleum), catalytic cracking;

Petroleum gas;

[A complex combination of hydrocarbons produced by the distillation of the products from a catalytic cracking process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C3 through C5.]
272-203-468783-64-2⊗ Carc. Cat. 1; R45

Muta. Cat. 2; R46
T

R: 45-46

S: 53-45
H K
649-099-00-8Gases (petroleum), C2-4, sweetened;

Petroleum gas;

[A complex combination of hydrocarbons obtained by subjecting a petroleum distillate to a sweetening process to convert mercaptans or to remove acidic impurities. It consists predominantly of saturated and unsaturated hydrocarbons having carbon numbers predominantly in the range of C2 through C4 and boiling in the range of approximately - 51 oC to - 34 oC (-60 oF to - 30 oF).]
272-205-568783-65-3⊗ Carc. Cat. 1; R45

Muta. Cat. 2; R46
T

R: 45-46

S: 53-45
H K
649-100-00-1Gases (petroleum), crude oil fractionation off;

Petroleum gas;

[A complex combination of hydrocarbons produced by the fractionation of crude oil. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]
272-871-768918-99-0⊗ Carc. Cat. 1; R45

Muta. Cat. 2; R46
T

R: 45-46

S: 53-45
H K
649-101-00-7Gases (petroleum), dehexanizer off;

Petroleum gas;

[A complex combination of hydrocarbons obtained by the fractionation of combined naphtha streams. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]
272-872-268919-00-6⊗ Carc. Cat. 1; R45

Muta. Cat. 2; R46
T

R: 45-46

S: 53-45
H K
649-102-00-2Gases (petroleum), light straight run gasoline fractionation stabilizer off;

Petroleum gas;

[A complex combination of hydrocarbons obtained by the fractionation of light straight-run gasoline. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]
272-878-568919-05-1⊗ Carc. Cat. 1; R45

Muta. Cat. 2; R46
T

R: 45-46

S: 53-45
H K
649-103-00-8Gases (petroleum), naphtha unifiner desulfurization stripper off;

Petroleum gas;

[A complex combination of hydrocarbons produced by a naphtha unifiner desulfurization process and stripped from the naphtha product. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]
272-879-068919-06-2⊗ Carc. Cat. 1; R45

Muta. Cat. 2; R46
T

R: 45-46

S: 53-45
H K
649-104-00-3Gases (petroleum), straight-run naphtha catalytic reforming off;

Petroleum gas;

[A complex combination of hydrocarbons obtained by the catalytic reforming of straight-run naphtha and fractionation of the total effluent. It consists of methane, ethane, and propane.]
272-882-768919-09-5⊗ Carc. Cat. 1; R45

Muta. Cat. 2; R46
T

R: 45-46

S: 53-45
H K
649-105-00-9Gases (petroleum), fluidized catalytic cracker splitter overheads;

Petroleum gas;

[A complex combination of hydrocarbons produced by the fractionation of the charge to the C3 -C4 splitter. It consists predominantly of C3 hydrocarbons.]
272-893-768919-20-0⊗ Carc. Cat. 1; R45

Muta. Cat. 2; R46
T

R: 45-46

S: 53-45
H K
649-106-00-4Gases (petroleum), straight-run stabilizer off;

Petroleum gas;

[A complex combination of hydrocarbons obtained from the fractionation of the liquid from the first tower used in the distillation of crude oil. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]
272-883-268919-10-8⊗ Carc. Cat. 1; R45

Muta. Cat. 2; R46
T

R: 45

S: 53-45
H K
649-107-00-XGases (petroleum), catalytic cracked naphtha debutanizer;

Petroleum gas;

[A complex combination of hydrocarbons obtained from fractionation of catalytic cracked naphtha. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]
273-169-368952-76-1⊗ Carc. Cat. 1; R45

Muta. Cat. 2; R46
T

R: 45-46

S: 53-45
H K
649-108-00-5Tail gas (petroleum), catalytic cracked distillate and naphtha stabilizer;

Petroleum gas;

[A complex combination of hydrocarbons obtained by the fractionation of catalytic cracked naphtha and distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]
273-170-968952-77-2⊗ Carc. Cat. 1; R45

Muta. Cat. 2; R46
T

R: 45-46

S: 53-45
H K
649-109-00-0Tail gas (petroleum), thermal-cracked distillate, gas oil and naphtha absorber;

petroleum gas;

[A complex combination of hydrocarbons obtained from the separation of thermal-cracked distillates, naphtha and gas oil. It consists pedrominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]
273-175-668952-81-8⊗ Carc. Cat. 1; R45

Muta. Cat. 2; R46
T

R: 45-46

S: 53-45
H K
649-110-00-6Tail gas (petroleum), thermal cracked hydrocarbon fractionation stabilizer, petroleum coking;

Petroleum gas;

[A complex combination of hydrocarbons obtained from the fractionation stabilization of thermal cracked hydrocarbons from petroleum coking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]
273-176-168952-82-9⊗ Carc. Cat. 1; R45

Muta. Cat. 2; R46
T

R: 45-46

S: 53-45
H K
649-111-00-1Gases (petroleum, light steam-cracked, butadiene conc.;

Petroleum gas;

[A complex combination of hydrocarbons produced by the distillation of products from a thermal cracking process, It consists of hydrocarbons having a carbon number predominantly of C4.]
273-265-568955-28-2⊗ Carc. Cat. 1; R45

Muta. Cat. 2; R46
T

R: 45-46

S: 53-45
H K
649-112-00-7Gases (petroleum), straight-run naphtha catalytic reformer stabilizer overhead;

Petroleum gas;

[A complex combination of hydrocarbons obtained by the catalytic reforming of straight-run naphtha and the fractionation of the total effluent. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C2 through C4.]
273-270-268955-34-0⊗ Carc. Cat. 1; R45

Muta. Cat. 2; R46
T

R: 45-46

S: 53-45
H K
649-113-00-2Hydrocarbons, C4;

Petroleum gas
289-339-587741-01-3⊗ Carc. Cat. 1; R45

Muta. Cat. 2; R46
T

R: 45-46

S: 53-45
H K
649-114-00-8Alkanes, C1-4, C3-rich;

Petroleum gas
292-456-490622-55-2⊗ Carc. Cat. 1; R45

Muta. Cat. 2; R46
T

R: 45-46

S: 53-45
H K
649-115-00-3Gases (petroleum), steam-cracker C3-rich;

Petroleum gas;

[A complex combination of hydrocarbons produced by the distillation of products from a steam cracking process. It consists predominantly of propylene with some propane and boils in the range of approximately - 70 oC to 0 oC (-94 oF to 32 oF).]
295-404-992045-22-2⊗ Carc. Cat. 1; R45

Muta. Cat. 2; R46
T

R: 45-46

S: 53-45
H K
649-116-00-9Hydrocarbons, C4, steam-cracker distillate;

Petroleum gas;

[A complex combination of hydrocarbons produced by the distillation of the products of a steam cracking process. It consists predominantly of hydrocarbons having a carbon number of C4, predominantly 1-butene and 2-butene, containing also butane and isobutene and boiling in the range of approximately minus 12 oC to 5 oC (10.4 oF to 41 oF).]
295-405-492045-23-3⊗ Carc. Cat. 1; R45

Muta. Cat. 2; R46
T

R: 45-46

S: 53-45
H K
649-117-00-4Petroleum gases, liquefied, sweetened, C4 fraction;

Petroleum gas;

[A complex combination of hydrocarbons obtained by subjecting a liquified petroleum gas mix to a sweetening process to oxidize mercaptans or to remove acidic impurities. It consists predominantly of C4 saturated and unsaturated hydrocarbons.]
295-463-092045-80-2F+; R12

Carc. Cat. 1; R45

Muta. Cat. 2; R46
F+; T

R: 12-45-46

S: 53-45
HKS
649-118-00-XHydrocarbons, C4, 1,3-butadiene- and isobutene-free;

Petroleum gas
306-004-195465-89-7⊗ Carc. Cat. 2; R45T

R: 45

S: 53-45
H K
649-119-00-5Raffinates (petroleum), steam-cracked C4 fraction cuprous ammonium acetate extn., C3-5 and C3-5 unsatd., butadiene-free;

Petroleum gas
307-769-497722-19-5⊗ Carc. Cat. 1; R45

Muta. Cat. 2; R46
T

R: 45-46

S: 53-45
H K
649-120-00-0Gases (petroleum), amine system feed;

Refinery gas;

[The feed gas to the amine system for removal of hydrogen sulfide. It consists of hydrogen. Carbon monoxide, carbon dioxide, hydrogen sulfide and aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5 may also be present.]
270-746-168477-65-6⊗ Carc. Cat. 1; R45

Muta. Cat. 2; R46
T

R: 45-46

S: 53-45
H K
649-121-00-6Gases (petroleum), benzene unit hydrodesulfurizer off;

Refinery gas;

[Off gases produced by the benzene unit. It consists primarily of hydrogen. Carbon monoxide and hydrocarbons having carbon numbers predominantly in the range of C1 through C6, including benzene, may also be present.]
270-747-768477-66-7⊗ Carc. Cat. 1; R45

Muta. Cat. 2; R46
T

R: 45-46

S: 53-45
H K
649-122-00-1Gases (petroleum), benzene unit recycle, hydrogen-rich;

Refinery gas;

[A complex combination of hydrocarbons obtained by recycling the gases of the benzene unit. It consists primarily of hydrogen with various small amounts of carbon monoxide and hydrocarbons having carbon numbers in the range of C1 through C6.]
270-748-268477-67-8⊗ Carc. Cat. 1; R45

Muta. Cat. 2; R46
T

R: 45-46

S: 53-45
H K
649-123-00-7Gases (petroleum), blend oil, hydrogen-nitrogen-rich;

Refinery gas;

[A complex combination of hydrocarbons obtained by distillation of a blend oil. It consists primarily of hydrogen and nitrogen with various small amounts of carbon monoxide, carbon dioxide, and aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]
270-749-868477-68-9⊗ Carc. Cat. 1; R45

Muta. Cat. 2; R46
T

R: 45-46

S: 53-45
H K
649-124-00-2Gases (petroleum), catalytic reformed naphtha stripper overheads;

Refinery gas;

[A complex combination of hydrocarbons obtained from stabilization of catalytic reformed naphtha. Its consists of hydrogen and saturated hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]
270-759-268477-77-0⊗ Carc. Cat. 1; R45

Muta. Cat. 2; R46
T

R: 45-46

S: 53-45
H K
649-125-00-8Gases (petroleum), C6-8 catalytic reformer recycle;

Refinery gas;

[A complex combination of hydrocarbons produced by distillation of products from catalytic reforming of C6-C8 feed and recycled to conserve hydrogen. It consists primarily of hydrogen. It may also contain various small amounts of carbon monoxide, carbon dioxide, nitrogen, and hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]
270-761-368477-80-5⊗ Carc. Cat. 1; R45

Muta. Cat. 2; R46
T

R: 45-46

S: 53-45
H K
649-126-00-3Gases (petroleum), C6-8 catalytic reformer;

Refinery gas;

[A complex combination of hydrocarbons produced by distillation of products from catalytic reforming of C6-C8 feed. It consists of hydrocarbons having carbon numbers in the range of C1 through C5 and hydrogen.]
270-762-968477-81-6⊗ Carc. Cat. 1; R45

Muta. Cat. 2; R46
T

R: 45-46

S: 53-45
H K
649-127-00-9Gases (petroleum), C6-8 catalytic reformer recycle, hydrogen-rich;

Refinery gas
270-763-468477-82-7⊗ Carc. Cat. 1; R45

Muta. Cat. 2; R46
T

R: 45-46

S: 53-45
H K
649-128-00-4Gases (petroleum), C2-return stream;

Refinery gas;

[A complex combination of hydrocarbons obtained by the extraction of hydrogen from a gas stream which consists primarily of hydrogen with small amounts of nitrogen, carbon monoxide, methane, ethane, and ethylene. It contains predominantly hydrocarbons such as methane, ethane, and ethylene with small amounts of hydrogen, nitrogen and carbon monoxide.]
270-766-068477-84-9⊗ Carc. Cat. 1; R45

Muta. Cat. 2; R46
T

R: 45-46

S: 53-45
H K
649-129-00-XGases (petroleum), dry sour, gas-concn.-unit-off;

Refinery gas;

[The complex combination of dry gases from a gas concentration unit. It consists of hydrogen, hydrogen sulfide and hydrocarbons having carbon numbers predominantly in the range of C1 through C3.]
270-774-468477-92-9⊗ Carc. Cat. 1; R45

Muta. Cat. 2; R46
T

R: 45-46

S: 53-45
H K
649-130-00-5Gases (petroleum), gas concn. reabsorber distn.;

Refinery gas;

[A complex combination of hydrocarbons produced by distillation of products from combined gas streams in a gas concentration reabsorber. It consists predominantly of hydrogen, carbon monoxide, carbon dioxide, nitrogen, hydrogen sulfide and hydrocarbons having carbon numbers in the range of C1 through C3.]
270-776-568477-93-0⊗ Carc. Cat. 1; R45

Muta. Cat. 2; R46
T

R: 45-46

S: 53-45
H K
649-131-00-0Gases (petroleum), hydrogen absorber off;

Refinery gas;

[A complex combination obtained by absorbing hydrogen from a hydrogen rich stream. It consists of hydrogen, carbon monoxide, nitrogen, and methane with small amounts of C2 hydrocarbons.]
270-779-168477-96-3⊗ Carc. Cat. 1; R45

Muta. Cat. 2; R46
T

R: 45-46

S: 53-45
H K
649-132-00-6Gases (petroleum), hydrogen-rich;

Refinery gas;

[A complex combination separated as a gas from hydrocarbon gases by chilling. It consists primarily of hydrogen with various small amounts of carbon monoxide, nitrogen, methane, and C2 hydrocarbons.]
270-780-768477-97-4⊗ Carc. Cat. 1; R45

Muta. Cat. 2; R46
T

R: 45-46

S: 53-45
H K
649-133-00-1Gases (petroleum), hydrotreater blend oil recycle, hydrogen-nitrogen-rich;

Refinery gas;

[A complex combination obtained from recycled hydrotreated blend oil. It consists primarily of hydrogen and nitrogen with various small amounts of carbon monoxide, carbon dioxide and hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]
270-781-268477-98-5⊗ Carc. Cat. 1; R45

Muta. Cat. 2; R46
T

R: 45-46

S: 53-45
H K
649-134-00-7Gases (petroleum), recycle, hydrogen-rich;

Refinery gas;

[A complex combination obtained from recycled reactor gases. It consists primarily of hydrogen with various small amounts of carbon monoxide, carbon dioxide, nitrogen, hydrogen sulfide, and saturated aliphatic hydrocarbons having carbon numbers in the range of C1 through C5.]
270-783-368478-00-2⊗ Carc. Cat. 1; R45

Muta. Cat. 2; R46
T

R: 45-46

S: 53-45
H K
649-135-00-2Gases (petroleum), reformer make-up, hydrogen-rich;

Refinery gas;

[A complex combination obtained from the reformers. It consists primarily of hydrogen with various small amounts of carbon monoxide and aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]
270-784-968478-01-3⊗ Carc. Cat. 1; R45

Muta. Cat. 2; R46
T

R: 45-46

S: 53-45
H K
649-136-00-8Gases (petroleum), reforming hydrotreater;

Refinery gas;

[A complex combination obtained from the reforming hydrotreating process. It consists primarily of hydrogen, methane, and ethane with various small amounts of hydrogen sulfide and aliphatic hydrocarbons having carbon numbers predominantly in the range of C3 thorugh C5.]
270-785-468478-02-4⊗ Carc. Cat. 1; R45

Muta. Cat. 2; R46
T

R: 45-46

S: 53-45
H K
649-137-00-3Gases (petroleum), reforming hydrotreater, hydrogen-methane-rich;

Refinery gas;

[A complex combination obtained from the reforming hydrotreating process. It consists primarily of hydrogen and methane with various small amounts of carbon monoxide, carbon dioxide, nitrogen and saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C2 through C5.]
270-787-568478-03-5⊗ Carc. Cat. 1; R45

Muta. Cat. 2; R46
T

R: 45-46

S: 53-45
H K
649-138-00-9Gases (petroleum), reforming hydrotreater make-up, hydrogen-rich;

Refinery gas;

[A complex combination obtained from the reforming hydrotreating process. It consists primarily of hydrogen with various small amounts of carbon monoxide and aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]
270-788-068478-04-6⊗ Carc. Cat. 1; R45

Muta. Cat. 2; R46
T

R: 45-46

S: 53-45
H K
649-139-00-4Gases (petroleum), thermal cracking distn.;

Refinery gas;

[A complex combination produced by distillation of products from a thermal cracking process. It consists of hydrogen, hydrogen sulfide, carbon monoxide, carbon dioxide and hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]
270-789-668478-05-7⊗ Carc. Cat. 1; R45

Muta. Cat. 2; R46
T

R: 45-46

S: 53-45
H K
649-140-00-XTail gas (petroleum), catalytic cracker refractionation absorber;

Refinery gas;

[A complex combination of hydrocarbons obtained from refractionation of products from a catalytic cracking process. It consists of hydrogen and hydrocarbons having carbon numbers predominantly in the range of C1 through C3.]
270-805-168478-25-1⊗ Carc. Cat. 1; R45

Muta. Cat. 2; R46
T

R: 45-46

S: 53-45
H K
649-141-00-5Tail gas (petroleum), catalytic reformed naphtha separator;

Refinery gas;

[A complex combination of hydrocarbons obtained from the catalytic reforming of straight run naphtha. It consists of hydrogen and hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]
270-807-268478-27-3⊗ Carc. Cat. 1; R45

Muta. Cat. 2; R46
T

R: 45-46

S: 53-45
H K
649-142-00-0Tail gas (petroleum), catalytic reformed naphtha stabilizer;

Refinery gas;

[A complex combination of hydrocarbons obtained from the stabilization of catalytic reformed naphtha. It consists of hydrogen and hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]
270-808-868478-28-4⊗ Carc. Cat. 1; R45

Muta. Cat. 2; R46
T

R: 45-46

S: 53-45
H K
649-143-00-6Tail gas (petroleum), cracked distillate hydrotreater separator;

Refinery gas;

[A complex combination of hydrocarbons obtained by treating cracked distillates with hydrogen in the presence of a catalyst. It consists of hydrogen and saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]
270-809-368478-29-5⊗ Carc. Cat. 1; R45

Muta. Cat. 2; R46
T

R: 45-46

S: 53-45
H K
649-144-00-1Tail gas (petroleum), hydrodesulfurized straight-run naphtha separator;

Refinery gas;

[A complex combination of hydrocarbons obtained from hydrodesulfurization of straight-run naphtha. It consists of hydrogen and saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]
270-810-968478-30-8⊗ Carc. Cat. 1; R45

Muta. Cat. 2; R46
T

R: 45-46

S: 53-45
H K
649-145-00-7Gases (petroleum), catalytic reformed straight-run naphtha stabilizer overheads;

Refinery gas;

[A complex combination of hydrocarbons obtained from the catalytic reforming of straight-run naphtha followed by fractionation of the total effluent. It consists of hydrogen, methane, ethane and propane.]
270-999-868513-14-4⊗ Carc. Cat. 1; R45

Muta. Cat. 2; R46
T

R: 45-46

S: 53-45
H K
649-146-00-2Gases (petroleum), reformer effluent high-pressure flash drum off;

Refinery gas;

[A complex combination produced by the high-pressure flashing of the effluent from the reforming reactor. It consists primarily of hydrogen with various small amounts of methane, ethane, and propane.]
271-003-468513-18-8⊗ Carc. Cat. 1; R45

Muta. Cat. 2; R46
T

R: 45-46

S: 53-45
H K
649-147-00-8Gases (petroleum), reformer effluent low-pressure flash drum off;

Refinery gas;

[A complex combination produced by low-pressure flashing of the effluent from the reforming reactor. It consists primarily of hydrogen with various small amounts of methane, ethane, and propane.]
271-005-568513-19-9⊗ Carc. Cat. 1; R45

Muta. Cat. 2; R46
T

R: 45-46

S: 53-45
H K
649-148-00-3Gases (petroleum), oil refinery gas distn. off;

Refinery gas;

[A complex combination separated by distillation of a gas stream containing hydrogen, carbon monoxide, carbon dioxide and hydrocarbons having carbon numbers in the range of C1 through C6 or obtained by cracking ethane and propane. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C2, hydrogen, nitrogen, and carbon monoxide.]
271-258-168527-15-1⊗ Carc. Cat. 1; R45

Muta. Cat. 2; R46
T

R: 45-46

S: 53-45
H K
649-149-00-9Gases (petroleum), benzene unit hydrotreater depentanizer overheads;

Refinery gas;

[A complex combination produced by treating the feed from the benzene unit with hydrogen in the presence of a catalyst followed by depentanizing. It consists primarily of hydrogen, ethane and propane with various small amounts of nitrogen, carbon monoxide, carbon dioxide and hydrocarbons having carbon numbers predominantly in the range of C1 through C6. It may contain trace amounts of benzene.]
271-623-568602-82-4⊗ Carc. Cat. 1; R45

Muta. Cat. 2; R46
T

R: 45-46

S: 53-45
H K
649-150-00-4Gases (petroleum), secondary absorber off, fluidized catalytic cracker overheads fractionator;

Refinery gas;

[A complex combination produced by the fractionation of the overhead products from the catalytic cracking process in the fluidized catalytic cracker. It consists of hydrogen, nitrogen, and hydrocarbons having carbon numbers predominantly in the range of C1 through C3.]
271-625-668602-84-6⊗ Carc. Cat. 1; R45

Muta. Cat. 2; R46
T

R: 45-46

S: 53-45
H K
649-151-00-XPetroleum products, refinery gases;

Refinery gas;

[A complex combination which consists primarily of hydrogen with various small amounts of methane, ethane, and propane.]
271-750-668607-11-4⊗ Carc. Cat. 1; R45

Muta. Cat. 2; R46
T

R: 45-46

S: 53-45
H K
649-152-00-5Gases (petroleum), hydrocracking low-pressure separator;

Refinery gas;

[A complex combination obtained by the liquid-vapor separation of the hydrocracking process reactor effluent. It consists predominantly of hydrogen and saturated hydrocarbons having carbon numbers predominantly in the range of C1 through C3.]
272-182-168783-06-2⊗ Carc. Cat. 1; R45

Muta. Cat. 2; R46
T

R: 45-46

S: 53-45
H K
649-153-00-0Gases (petroleum), refinery;

Refinery gas;

[A complex combination obtained from various petroleum refining operations. It consists of hydrogen and hydrocarbons having carbon numbers predominantly in the range of C1 through C3.]
272-338-968814-67-5⊗ Carc. Cat. 1; R45

Muta. Cat. 2; R46
T

R: 45-46

S: 53-45
H K
649-154-00-6Gases (petroleum), platformer products separator off;

Refinery gas;

[A complex combination obtained from the chemical reforming of naphthenes to aromatics. It consists of hydrogen and saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C2 through C4.]
272-343-668814-90-4⊗ Carc. Cat. 1; R45

Muta. Cat. 2; R46
T

R: 45-46

S: 53-45
H K
649-155-00-1Gases (petroleum), hydrotreated sour kerosine depentanizer stabilizer off;

Refinery gas;

[The complex combination obtained from the depentanizer stabilization of hydrotreated kerosine. It consists primarily of hydrogen, methane, ethane, and propane with various small amounts of nitrogen, hydrogen sulfide, carbon monoxide and hydrocarbons having carbon numbers predominantly in the range of C4 through C5.]
272-775-568911-58-0⊗ Carc. Cat. 1; R45

Muta. Cat. 2; R46
T

R: 45-46

S: 53-45
H K
649-156-00-7Gases (petroleum), hydrotreated sour kerosine flash drum;

Refinery gas;

[A complex combination obtained from the flash drum of the unit treating sour kerosine with hydrogen in the presence of a catalyst. It consists primarily of hydrogen and methane with various small amounts of nitrogen, carbon monoxide, and hydro-carbons having carbon numbers predominantly in the range of C2 through C5.]
272-776-068911-59-1⊗ Carc. Cat. 1; R45

Muta. Cat. 2; R46
T

R: 45-46

S: 53-45
H K
649-157-00-2Gases (petroleum), distillate unifiner desulfurization stripper off;

Refinery gas;

[A complex combination stripped from the liquid product of the unifiner desulfurization process. It consists of hydrogen sulfide, methane, ethane, and propane.]
272-873-868919-01-7⊗ Carc. Cat. 1; R45

Muta. Cat. 2; R46
T

R: 45-46

S: 53-45
H K
649-158-00-8Gases (petroleum), fluidized catalytic cracker fractionation off;

Refinery gas;

[A complex combination produced by the fractionation of the overhead product of the fluidized catalytic cracking process. It consists of hydrogen, hydrogen sulfide, nitrogen, and hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]
272-874-368919-02-8⊗ Carc. Cat. 1; R45

Muta. Cat. 2; R46
T

R: 45-46

S: 53-45
H K
649-159-00-3Gases (petroleum), fluidized catalytic cracker scrubbing secondary absorber off;

Refinery gas;

[A complex combination produced by scrubbing the overhead gas from the fluidized catalytic cracker. It consists of hydrogen, nitrogen, methane, ethane and propane.]
272-875-968919-03-9⊗ Carc. Cat. 1; R45

Muta. Cat. 2; R46
T

R: 45-46

S: 53-45
H K
649-160-00-9Gases (petroleum), heavy distillate hydrotreater desulfurization stripper off;

Refinery gas;

[A complex combination stripped from the liquid product of the heavy distillate hydrotreater desulfurization process. It consists of hydrogen, hydrogen sulfide, and saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]
272-876-468919-04-0⊗ Carc. Cat. 1; R45

Muta. Cat. 2; R46
T

R: 45-46

S: 53-45
H K
649-161-00-4Gases (petroleum), platformer stabilizer off, light ends fractionation;

Refinery gas;

[A complex combination obtained by the fractionation of the light ends of the platinum reactors of the plattformer unit. It consists of hydrogen, methane, ethane and propane.]
272-880-668919-07-3⊗ Carc. Cat. 1; R45

Muta. Cat. 2; R46
T

R: 45-46

S: 53-45
H K
649-162-00-XGases (petroleum), preflash tower off, crude distn.;

Refinery gas;

[A complex combination produced from the first tower used in the distillation of crude oil. It consists of nitrogen and saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]
272-881-168919-08-4⊗ Carc. Cat. 1; R45

Muta. Cat. 2; R46
T

R: 45-46

S: 53-45
H K
649-163-00-5Gases (petroleum), tar stripper off;

Refinery gas;

[A complex combination obtained by the fractionation of reduced crude oil. It consists of hydrogen and hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]
272-884-868919-11-9⊗ Carc. Cat. 1; R45

Muta. Cat. 2; R46
T

R: 45-46

S: 53-45
H K
649-164-00-0Gases (petroleum), unifiner stripper off;

Refinery gas;

[A combination of hydrogen and methane obtained by fractionation of the products from the unifiner unit.]
272-885-368919-12-0⊗ Carc. Cat. 1; R45

Muta. Cat. 2; R46
T

R: 45-46

S: 53-45
H K
649-165-00-6Tail gas (petroleum), catalytic hydrodesulfurized naphtha separator;

Refinery gas;

[A complex combination of hydrocarbons obtained from the hydrodesulfurization of naphtha. It consists of hydrogen, methane, ethane, and propane.]
273-173-568952-79-4⊗ Carc. Cat. 1; R45

Muta. Cat. 2; R46
T

R: 45-46

S: 53-45
H K
649-166-00-1Tail gas (petroleum), straight-run naphtha hydrodesulfurizer;

Refinery gas;

[A complex combination obtained from the hydrodesulfurization of straight-run naphtha. It consists of hydrogen and hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]
273-174-068952-80-7⊗ Carc. Cat. 1; R45

Muta. Cat. 2; R46
T

R: 45-46

S: 53-45
H K
649-167-00-7Gases (petroleum), sponge absorber off, fluidized catalytic cracker and gas oil desulfurizer overhead fractionation;

Refinery gas;

[A complex combination obtained by the fractionation of products from the fluidized catalytic cracker and gas oil desulfurizer. It consists of hydrogen and hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]
273-269-768955-33-9⊗ Carc. Cat. 1; R45

Muta. Cat. 2; R46
T

R: 45-46

S: 53-45
H K
649-168-00-2Gases (petroleum), crude distn. and catalytic cracking;

Refinery gas;

[A complex combination produced by crude distillation and catalytic cracking processes. It consists of hydrogen, hydrogen sulfide, nitrogen, carbon monoxide and paraffinic and olefinic hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]
273-563-568989-88-8⊗ Carc. Cat. 1; R45

Muta. Cat. 2; R46
T

R: 45-46

S: 53-45
H K
649-169-00-8Gases (petroleum), gas oil diethanolamine scrubber off;

Refinery gas;

[A complex combination produced by desulfurization of gas oils with diethanolamine. It consists predominantly of hydrogen sulfide, hydrogen and aliphatic hydrocarbons having carbon numbers in the range of C1 through C5.]
295-397-292045-15-3⊗ Carc. Cat. 1; R45

Muta. Cat. 2; R46
T

R: 45-46

S: 53-45
H K
649-170-00-3Gases (petroleum), gas oil hydrodesulfurization effluent;

Refinery gas;

[A complex combination obtained by separation of the liquid phase from the effluent from the hydrogenation reaction. It consists predominantly of hydrogen, hydrogen sulfide and aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C3.]
295-398-892045-16-4⊗ Carc. Cat. 1; R45

Muta. Cat. 2; R46
T

R: 45-46

S: 53-45
H K
649-171-00-9Gases (petroleum), gas oil hydrodesulfurization purge;

Refinery gas;

[A complex combination of gases obtained from the reformer and from the purges from the hydrogenation reactor. It consists predominantly of hydrogen and aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]
295-399-392045-17-5⊗ Carc. Cat. 1; R45

Muta. Cat. 2; R46
T

R: 45-46

S: 53-45
H K
649-172-00-4Gases (petroleum), hydrogenator effluent flash drum off;

Refinery gas;

[A complex combination of gases obtained from flash of the effluents after the hydrogenation reaction. It consists predominantly of hydrogen and aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]
295-400-792045-18-6⊗ Carc. Cat. 1; R45

Muta. Cat. 2; R46
T

R: 45-46

S: 53-45
H K
649-173-00-XGases (petroleum), naphtha steam cracking high-pressure residual;

Refinery gas;

[A complex combination obtained as a mixture of the non-condensable portions from the product of a naphtha steam cracking process as well as residual gases obtained during the preparation of subsequent products. It consists predominantly of hydrogen and paraffinic and olefinic hydrocarbons having carbon numbers predominantly in the range of C1 through C5 with which natural gas may also be mixed.]
295-401-292045-19-7⊗ Carc. Cat. 1; R45

Muta. Cat. 2; R46
T

R: 45-46

S: 53-45
H K
649-174-00-5Gases (petroleum), residue visbaking off;

Refinery gas;

A complex combination obtained from viscosity reduction of residues in a furnace. It consists predominantly of hydrogen sulfide and paraffinic and olefinic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]
295-402-892045-20-0⊗ Carc. Cat. 1; R45

Muta. Cat. 2; R46
T

R: 45-46

S: 53-45
H K
649-175-00-0Foots oil (petroleum), acid-treated;

Foots oil;

[A complex combination of hydrocarbons obtained by treatment of Foot's oil with sulfuric acid. It consists predominantly of branched-chain hydrocarbons with carbon numbers predominantly in the range of C20 through C50.]
300-225-793924-31-3Carc. Cat. 2; R45T

R: 45

S: 53-45
H L
649-176-00-6Foots oil (petroleum), clay-treated;

Foots oil;

[A complex combination of hydrocarbons obtained by treatment of Foot's oil with natural or modified clay in either a contacting or percolation process to remove the trace amounts of polar compounds and impurities present. It consists predominantly of branched chain hydrocarbons with carbon numbers predominantly in the range of C20 through C50.]
300-226-293924-32-4Carc. Cat. 2; R45T

R: 45

S: 53-45
H L
649-177-00-1Gases (petroleum), C3-4;

Petroleum gas;

[A complex combination of hydrocarbons produced by distillation of products from the cracking of crude oil. It consists of hydrocarbons having carbon numbers in the range of C3 through C4, predominantly of propane and propylene, and boiling in the range of approximately - 51 oC to - 1 oC (-60 oF to 30 oF.)]
268-629-568131-75-9⊗ Carc. Cat. 1; R45

Muta. Cat. 2; R46
T

R: 45-46

S: 53-45
H K
649-178-00-7Tail gas (petroleum), catalytic cracked distillate and catalytic cracked naphtha fractionation absorber;

Petroleum gas;

[The complex combination of hydrocarbons from the distillation of the products from catalytic cracked distillates and catalytic cracked naphtha. It consists predominantly of hydrocarbons having carbon numbers in the range of C1 through C4.]
269-617-268307-98-2⊗ Carc. Cat. 1; R45

Muta. Cat. 2; R46
T

R: 45-46

S: 53-45
H K
649-179-00-2Tail gas (petroleum), catalytic polymn. naphtha fractionation stabilizer;

Petroleum gas;

[A complex combination of hydrocarbons from the fractionation stabilization products from polymerization of naphtha. It consists predominantly of hydrocarbons having carbon numbers in the range of C1 through C4.]
269-618-868307-99-3⊗ Carc. Cat. 1; R45

Muta. Cat. 2; R46
T

R: 45-46

S: 53-45
H K
649-180-00-8Tail gas (petroleum), catalytic reformed naphtha fractionation stabilizer, hydrogen sulfide-free;

Petroleum gas;

[A complex combination of hydrocarbons obtained from fractionation stabilization of catalytic reformed naphtha and from which hydrogen sulfide has been removed by amine treatment. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]
269-619-368308-00-9⊗ Carc. Cat. 1; R45

Muta. Cat. 2; R46
T

R: 45-46

S: 53-45
H K
649-181-00-3Tail gas (petroleum), cracked distillate hydrotreater stripper;

Petroleum gas;

[A complex combination of hydrocarbons obtained by treating thermal cracked distillates with hydrogen in the presence of a catalyst. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]
269-620-968308-01-0⊗ Carc. Cat. 1; R45

Muta. Cat. 2; R46
T

R: 45-46

S: 53-45
H K
649-182-00-9Tail gas (petroleum), straight-run distillate hydrodesulfurizer, hydrogen sulfide-free;

Petroleum gas;

[A complex combination of hydrocarbons obtained from catalytic hydrodesulfurization of straight run distillates and from which hydrogen sulfide has been removed by amine treatment. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]
269-630-368308-10-1⊗ Carc. Cat. 1; R45

Muta. Cat. 2; R46
T

R: 45-46

S: 53-45
H K
649-183-00-4Tail gas (petroleum), gas oil catalytic cracking absorber;

Petroleum gas;

[A complex combination of hydrocarbons obtained from the distillation of products from the catalytic cracking of gas oil. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]
269-623-568308-03-2⊗ Carc. Cat. 1; R45

Muta. Cat. 2; R46
T

R: 45-46

S: 53-45
H K
649-184-00-XTail gas (petroleum), gas recovery plant;

Petroleum gas;

[A complex combination of hydrocarbons from the distillation of products from miscellaneous hydrocarbon streams. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]
269-624-068308-04-3⊗ Carc. Cat. 1; R45

Muta. Cat. 2; R46
T

R: 45-46

S: 53-45
H K
649-185-00-5Tail gas (petroleum), gas recovery plant deethanizer;

Petroleum gas;

[A complex combination of hydrocarbons from the distillation of products from miscellaneous hydrocarbon streams. It consists of hydrocarbon having carbon numbers predominantly in the range of C1 through C4.]
269-625-668308-05-4⊗ Carc. Cat. 1; R45

Muta. Cat. 2; R46
T

R: 45-46

S: 53-45
H K
649-186-00-0Tail gas (petroleum), hydrodesulfurized distillate and hydrodesulfurized naphtha fractionator, acid-free;

Petroleum gas;

[A complex combination of hydrocarbons obtained from fractionation of hydrodesulfurized naphtha and distillate hydrocarbon streams and treated to remove acidic impurities. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]
269-626-168308-06-5⊗ Carc. Cat. 1; R45

Muta. Cat. 2; R46
T

R: 45-46

S: 53-45
H K
649-187-00-6Tail gas (petroleum), hydrodesulfurized vacuum gas oil stripper, hydrogen sulfide-free;

Petroleum gas;

[A complex combination of hydrocarbons obtained from stripping stabilization of catalytic hydrodesulfurized vacuum gas oil and from which hydrogen sulfide has been removed by amine treatment. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]
269-627-768308-07-6⊗ Carc. Cat. 1; R45

Muta. Cat. 2; R46
T

R: 45-46

S: 53-45
H K
649-188-00-1Tail gas (petroleum), light straight-run naphtha stabilizer, hydrogen sulfide-free;

Petroleum gas;

[A complex combination of hydrocarbons obtained from fractionation stabilization of light straight run naphtha and from which hydrogen sulfide has been removed by amine treatment. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]
269-629-868308-09-8⊗ Carc. Cat. 1; R45

Muta. Cat. 2; R46
T

R: 45-46

S: 53-45
H K
649-189-00-7Tail gas (petroleum), propane-propylene alkylation feed prep deethanizer;

Petroleum gas;

[A complex combination of hydrocarbons obtained from the distillation of the reaction products of propane with propylene. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]
269-631-968308-11-2⊗ Carc. Cat. 1; R45

Muta. Cat. 2; R46
T

R: 45-46

S: 53-45
H K
649-190-00-2Tail gas (petroleum), vacuum gas oil hydrodesulfurizer, hydrogen sulfide-free;

Petroleum gas;

[A complex combination of hydrocarbons obtained from catalytic hydrodesulfurization of vacuum gas oil and from which hydrogen sulfide has been removed by amine treatment. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C6.]
269-632-468308-12-3⊗ Carc. Cat. 1; R45

Muta. Cat. 2; R46
T

R: 45-46

S: 53-45
H K
649-191-00-8Gases (petroleum), catalytic cracked overheads;

Petroleum gas;

[A complex combination of hydrocarbons produced by the distillation of products from the catalytic cracking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C3 through C5 and boiling in the range of approximately - 48 oC to 32 oC (-54 oF to 90 oF).]
270-071-268409-99-4⊗ Carc. Cat. 1; R45

Muta. Cat. 2; R46
T

R: 45-46

S: 53-45
H K
649-193-00-9Alkanes, C1-2;

Petroleum gas
270-651-568475-57-0⊗ Carc. Cat. 1; R45

Muta. Cat. 2; R46
T

R: 45-46

S: 53-45
H K
649-194-00-4Alkanes, C2-3;

Petroleum gas
270-652-068475-58-1⊗ Carc. Cat. 1; R45

Muta. Cat. 2; R46
T

R: 45-46

S: 53-45
H K
649-195-00-XAlkanes, C3-4;

Petroleum gas
270-653-668475-59-2⊗ Carc. Cat. 1; R45

Muta. Cat. 2; R46
T

R: 45-46

S: 53-45
H K
649-196-00-5Alkanes, C4-5;

Petroleum gas
270-654-168475-60-5⊗ Carc. Cat. 1; R45

Muta. Cat. 2; R46
T

R: 45-46

S: 53-45
H K
649-197-00-0Fuel gases;

Petroleum gas;

[A combination of light gases. It consists predominantly of hydrogen and/or low molecular weight hydrocarbons.]
270-667-268476-26-6⊗ Carc. Cat. 1; R45

Muta. Cat. 2; R46
T

R: 45-46

S: 53-45
H K
649-198-00-6Fuel gases, crude oil of distillates;

Petroleum gas;

[A complex combination of light gases produced by distillation of crude oil and by catalytic reforming of naphtha. It consists of hydrogen and hydrocarbons having carbon numbers predominantly in the range of C1 through C4 and boiling in the range of approximately - 217 oC to - 12 oC (- 423 oF to 10 oF).]
270-670-968476-29-9⊗ Carc. Cat. 1; R45

Muta. Cat. 2; R46
T

R: 45-46

S: 53-45
H K
649-199-00-1Hydrocarbons, C3-4;

Petroleum gas
270-681-968476-40-4⊗ Carc. Cat. 1; R45

Muta. Cat. 2; R46
T

R: 45-46

S: 53-45
H K
649-200-00-5Hydrocarbons, C4-5;

Petroleum gas
270-682-468476-42-6⊗ Carc. Cat. 1; R45

Muta. Cat. 2; R46
T

R: 45-46

S: 53-45
H K
649-201-00-0Hydrocarbons, C2-4, C3-rich;

Petroleum gas
270-689-268476-49-3⊗ Carc. Cat. 1; R45

Muta. Cat. 2; R46
T

R: 45-46

S: 53-45
H K
649-202-00-6Petroleum gases, liquefied;

Petroleum gas;

[A complex combination of hydrocarbons produced by the distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C3 through C7 and boiling in the range of approximately - 40 oC to 80 oC (- 40 oF to 176 oF).]
270-704-268476-85-7F+; R12

Carc. Cat. 1; R45

Muta. Cat. 2; R46
F+; T

R: 12-45-46

S: 53-45
HKS
649-203-00-1Petroleum gases, liquefied, sweetened;

Petroleum gas;

[A complex combination of hydrocarbons obtained by subjecting liquefied petroleum gas mix to a sweetening process to convert mercaptans or to remove acidic impurities. It consists of hydrocarbons having carbon numbers predominantly in the range of C3 through C7 and boiling in the range of approximately - 40 oC to 80 oC (-40 oF to 176 oF).]
270-705-868476-86-8F+; R12

Carc. Cat. 1; R45

Muta. Cat. 2; R46
F+; T

R: 12-45-46

S: 45-53
HKS
649-204-00-7Gases (petroleum), C3-4, isobutane-rich;

Petroleum gas;

[A complex combination of hydrocarbons from the distillation of saturated and unsaturated hydrocarbons usually ranging in carbon numbers from C3 through C6, predominantly butane and isobutane. It consists of saturated and unsaturated hydrocarbons having carbon numbers in the range of C3 through C4, predominantly isobutane.]
270-724-168477-33-8⊗ Carc. Cat. 1; R45

Muta. Cat. 2; R46
T

R: 45-46

S: 53-45
H K
649-205-00-2Distillates (petroleum), C3-6, piperylene-rich;

Petroleum gas;

[A complex combination of hydrocarbons from the distillation of saturated and unsaturated aliphatic hydrocarbons usually ranging in the carbon numbers C3 through C6. It consists of saturated and unsaturated hydrocarbons having carbon numbers in the range of C3 through C6, predominantly piperylenes.]
270-726-268477-35-0⊗ Carc. Cat. 1; R45

Muta. Cat. 2; R46
T

R: 45-46

S: 53-45
H K
649-206-00-8Gases (petroleum), butane splitter overheads;

Petroleum gas;

[A complex combination of hydrocarbons obtained from the distillation of the butane stream. It consists of aliphatic hydrocarbons having carbon numbers predominantly in the range of C3 through C4.]
270-750-368477-69-0⊗ Carc. Cat. 1; R45

Muta. Cat. 2; R46
T

R: 45-46

S: 53-45
H K
649-207-00-3Gases (petroleum), C2-;

Petroleum gas;

[A complex combination of hydrocarbons produced by the distillation of products from a catalytic fractionation process. It contains predominantly ethane, ethylene, propane, and propylene.]
270-751-968477-70-3⊗ Carc. Cat. 1; R45

Muta. Cat. 2; R46
T

R: 45-46

S: 53-45
H K
649-208-00-9Gases (petroleum), catalytic-cracked gas oil depropanizer bottoms, C4-rich acid-free;

Petroleum gas;

[A complex combination of hydrocarbons obtained from fractionation of catalytic cracked gas oil hydrocarbon stream and treated to remove hydrogen sulfide and other acidic components. It consists of hydrocarbons having carbon numbers in the range of C3 through C5, predominantly C4.]
270-752-468477-71-4⊗ Carc. Cat. 1; R45

Muta. Cat. 2; R46
T

R: 45-46

S: 53-45
H K
649-209-00-4Gases (petroleum), catalytic-cracked naphtha debutanizer bottoms, C3-5-rich;

Petroleum gas;

[A complex combination of hydrocarbons obtained from the stabilization of catalytic cracked naphtha. It consists of aliphatic hydrocarbons having carbon numbers predominantly in the range of C3 through C5.]
270-754-568477-72-5⊗ Carc. Cat. 1; R45

Muta. Cat. 2; R46
T

R: 45-46

S: 53-45
H K
649-210-00-XTail gas (petroleum), isomerized naphtha fractionation stabilizer;

Petroleum gas;

[A complex combination of hydrocarbons obtained from the fractionation stabilization products from isomerized naphtha. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]
269-628-268308-08-7⊗ Carc. Cat. 1; R45

Muta. Cat. 2; R46
T

R: 45-46

S: 53-45
H K
649-211-00-5Foots oil (petroleum), carbon-treated;

Foots oil;

[A complex combination of hydrocarbons obtained by the treatment of Foots oil with activated carbon for the removal of trace constituents and impurities. It consists predominantly of saturated straight chain hydrocarbons having carbon numbers predominantly greater than C12.]
308-126-097862-76-5Carc. Cat. 2; R45T

R: 45

S: 53-45
H L
649-212-00-0Distillates (petroleum), sweetened middle;

Gasoil — unspecified;

[A complex combination of hydrocarbons obtained by subjecting a petroleum distillate to a sweetening process to convert mercaptans or to remove acidic impurities. It consists of hydrocarbons having carbon numbers predominantly in the range of C9 through C20 and boiling in the range of approximately 150 oC to 345 oC (302 oF to 653 oF).]
265-088-764741-86-2Carc. Cat. 2; R45T

R: 45

S: 53-45
H N
649-213-00-6Gas oils (petroleum), solvent-refined;

Gasoil — unspecified;

[A complex combination of hydrocarbons obtained as the raffinate from a solvent extraction process. It consists predominantly of aliphatic hydrocarbons having carbon numbers predominantly in the range of C11 through C25 and boiling in the range of approximately 205 oC to 400 oC (401 oF to 752 oF).]
265-092-964741-90-8Carc. Cat. 2; R45T

R: 45

S: 53-45
H N
649-214-00-1Distillates (petroleum), solvent-refined middle;

Gasoil — unspecified;

[A complex combination of hydrocarbons obtained as the raffinate from a solvent extraction process. It consists predominantly of aliphatic hydrocarbons having carbon numbers predominantly in the range of C9 through C20 and boiling in the range of approximately 150 oC to 345 oC (302 oF to 653 oF).]
265-093-464741-91-9Carc. Cat. 2; R45T

R: 45

S: 53-45
H N
649-215-00-7Gas oils (petroleum), acid-treated;

Gasoil — unspecified;

[A complex combination of hydrocarbons obtained as a raffinate from a sulfuric acid treating process. It consists of hydrocarbons having carbon numbers predominantly in the range of C13 through C25 and boiling in the range of approximately 230 oC to 400 oC (446 oF to 752 oF).]
265-112-664742-12-7Carc. Cat. 2; R45T

R: 45

S: 53-45
H N
649-216-00-2Distillates (petroleum), acid-treated middle;

Gasoil — unspecified;

[A complex combination of hydrocarbons obtained as a raffinate from a sulfuric acid treating process. It consists of hydrocarbons having carbon numbers predominantly in the range of C11 through C20 and boiling in the range of approximately 205 oC to 345 oC (401 oF to 653 oF).]
265-113-164742-13-8Carc. Cat. 2; R45T

R: 45

S: 53-45
H N
649-217-00-8Distillates (petroleum), acid-treated light;

Gasoil — unspecified;

[A complex combination of hydrocarbons obtained as a raffinate from a sulfuric acid treating process. It consists of hydrocarbons having carbon numbers predominantly in the range of C9 through C16 and boiling in the range of approximately 150 oC to 290 oC (302 oF to 554 oF).]
265-114-764742-14-9Carc. Cat. 2; R45T

R: 45

S: 53-45
H N
649-218-00-3Gas oils (petroleum), chemically neutralized;

Gasoil — unspecified;

[A complex combination of hydrocarbons produced by a treating process to remove acidic materials. It consists of hydrocarbons having carbon numbers predominantly in the range of C13 through C25 and boiling in the range of approximately 230 oC to 400 oC (446 oF to 752 oF).]
265-129-964742-29-6Carc. Cat. 2; R45T

R: 45

S: 53-45
H N
649-219-00-9Distillates (petroleum), chemically neutralized middle;

Gasoil — unspecified;

[A complex combination of hydrocarbons produced by a treating process to remove acidic materials. It consists of hydrocarbons having carbon numbers predominantly in the range of C11 through C20 and boiling in the range of approximately 205 oC to 345 oC (401 oF to 653 oF).]
265-130-464742-30-9Carc. Cat. 2; R45T

R: 45

S: 53-45
H N
649-220-00-4Distillates (petroleum), clay-treated middle;

Gasoil — unspecified;

[A complex combination of hydrocarbons resulting from treatment of a petroleum fraction with natural or modified clay, usually in a percolation process to remove the trace amounts of polar compounds and impurities present. It consists of hydrocarbons having carbon numbers predominantly in the range of C9 through C20 and boiling in the range of approximately 150 oC to 345 oC (302 oF to 653 oF).]
265-139-364742-38-7Carc. Cat. 2; R45T

R: 45

S: 53-45
H N
649-221-00-XDistillates (petroleum), hydrotreated middle;

Gasoil — unspecified;

[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly in the range of C11 through C25 and boiling in the range of approximately 205 oC to 400 oC (401 oF to 752 oF).]
265-148-264742-46-7Carc. Cat. 2; R45T

R: 45

S: 53-45
H N
649-222-00-5Gas oils (petroleum), hydrodesulfurized;

Gasoil — unspecified;

[A complex combination of hydrocarbons obtained from a petroleum stock by treating with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C13 through C25 and boiling in the range of approximately 230 oC to 400 oC (446 oF to 752 oF).]
265-182-864742-79-6Carc. Cat. 2; R45T

R: 45

S: 53-45
H N
649-223-00-0Distillates (petroleum), hydrodesulfurized middle;

Gasoil — unspecified;

[A complex combination of hydrocarbons obtained from a petroleum stock by treating with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists of hydrocarbons having carbon numbers predominantly in the range of C11 through C25 and boiling in the range of approximately 205 oC to 400 oC (401 oF to 752 oF).]
265-183-364742-80-9Carc. Cat. 2; R45T

R: 45

S: 53-45
H N
649-224-00-6Fuels, diesel;

Gasoil — unspecified;

[A complex combination of hydrocarbons produced by the distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C9 through C20 and boiling in the range of approximately 163 oC to 357 oC (325 oF to 675 oF).]
269-822-768334-30-5Carc. Cat. 3; R40Xn

R: 40

S: (2-)36/37
H N
649-225-00-1Fuel oil, No 2;

Gasoil — unspecified;

[A distillate oil having a minimum viscosity of 32,6 SUS at 37,7 oC (100 oF) to a maximum of 37,9 SUS at 37,7 oC (100 oF).]
270-671-468476-30-2Carc. Cat. 3; R40Xn

R: 40

S: (2-)36/37
H
649-226-00-7Fuel oil, No 4;

Gasoil — unspecified;

[A distillate oil having a minimum viscosity of 45 SUS at 37,7 oC (100 oF) to a maximum of 125 SUS at 37,7 oC (100 oF).]
270-673-568476-31-3Carc. Cat. 3; R40Xn

R: 40

S: (2-)36/37
H
649-227-00-2Fuels, diesel, No 2;

Gasoil — unspecified;

[A distillate oil having a minimum viscosity of 32,6 SUS at 37,7 oC (100 oF).]
270-676-168476-34-6Carc. Cat. 3; R40Xn

R: 40

S: (2-)36/37
H
649-228-00-8Distillates (petroleum), catalytic reformer fractionator residue, high-boiling;

Gasoil — unspecified; [A complex combination of hydrocarbons from the distillation of catalytic reformer fracftionator residue. It boils in the range of approximately 343 oC to 399 oC (650 oF to 750 oF).]
270-719-468477-29-2Carc. Cat. 2; R45T

R: 45

S: 53-45
H N
649-229-00-3Distillates (petroleum), catalytic reformer fractionator residue, intermediate-boiling;

Gasoil — unspecified;

[A complex combination of hydrocarbons from the distillation of catalytic reformer fractionator residue. It boils in the range of approximately 288 oC to 371 oC (550 oF to 700 oF).]
270-721-568477-30-5Carc. Cat. 2; R45T

R: 45

S: 53-45
H N
649-230-00-9Distillates (petroleum), catalytic reformer fractionator residue, low-boiling;

Gasoil — unspecified;

[The complex combination of hydrocarbons from the distillation of catalytic reformer fractionator residue. It boils approximately below 288 oC (550 oF).]
270-722-068477-31-6Carc. Cat. 2; R45T

R: 45

S: 53-45
H N
649-231-00-4Distillates (petroleum), highly refined middle;

Gasoil — unspecified;

[A complex combination of hydrocarbons obtained by the subjection of a petroleum fraction to several of the following steps: filtration, centrifugation, atmospheric distillation, vacuum distillation, acidification, neutralization and clay treatment. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C10 through C20.]
292-615-890640-93-0Carc. Cat. 2; R45T

R: 45

S: 53-45
H N
649-232-00-XDistillates (petroleum) catalytic reformer, heavy arom. conc.;

Gasoil — unspecified;

[A complex combination of hydrocarbons obtained from the distillation of a catalytically reformed petroleum cut. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C10 through C16 and boiling in the range of approximately 200 oC to 300 oC (392 oF to 572 oF).]
295-294-291995-34-5Carc. Cat. 2; R45T

R: 45

S: 53-45
H N
649-233-00-5Gas oils, paraffinic;

Gasoil — unspecified;

[A distillate obtained from the redistillation of a complex combination of hydrocarbons obtained by the distillation of the effluents from a severe catalytic hydrotreatment of paraffins. It boils in the range of approximately 190 oC to 330 oC (374 oF to 594 oF).]
300-227-893924-33-5Carc. Cat. 2; R45T

R: 45

S: 53-45
H N
649-234-00-0Naphtha (petroleum), solvent-refined hydrodesulfurized heavy;

Gasoil — unspecified
307-035-397488-96-5Carc. Cat. 2; R45T

R: 45

S: 53-45
H N
649-235-00-6Hydrocarbons, C16-20, hydrotreated middle distillate, distn. lights;

Gasoil — unspecified;

[A complex combination of hydrocarbons obtained as first runnings from the vacuum distillation of effluents from the treatment of a middle distillate with hydrogen. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C16 through C20 and boiling in the range of approximately 290 oC to 350 oC (554 oF to 662 oF). It produces a finished oil having a viscosity of 2cSt at 100 oC (212 oF).]
307-659-697675-85-9Carc. Cat. 2; R45T

R: 45

S: 53-45
H N
649-236-00-1Hydrocarbons, C12-20, hydrotreated paraffinic, distn. lights;

Gasoil — unspecified;

[A complex combination of hydrocarbons obtained as first runnings from the vacuum distillation of effluents from the treatment of heavy paraffins with hydrogen in the presence of a catalyst. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C12 through C20 and boiling in the range of approximately 230 oC to 350 oC (446 oF to 662 oF). It produces a finished oil having a viscosity of 2cSt at 100 oC (212 oF).]
307-660-197675-86-0Carc. Cat. 2; R45T

R: 45

S: 53-45
H N
649-237-00-7Hydrocarbons, C11-17, solvent-extd. light naphthenic;

Gasoil — unspecified;

[A complex combination of hydrocarbons obtained by extraction of the aromatics from a light naphthenic distillate having a visciosity of 2.2 cSt at 40 oC (104 oF). It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C11 through C17 and boiling in the range of approximately 200 oC to 300 oC (392 oF to 572 oF).]
307-757-997722-08-2Carc. Cat. 2; R45T

R: 45

S: 53-45
H N
649-238-00-2Gas oils, hydrotreated;

Gasoil — unspecified;

[A complex combination of hydrocarbons obtained from the redistillation of the effluents from the treatment of paraffins with hydrogen in the presence of a catalyst. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C17 through C27 and boiling in the range of approximately 330 oC to 340 oC (626 oF to 644 oF).]
308-128-197862-78-7Carc. Cat. 2; R45T

R: 45

S: 53-45
H N
649-239-00-8Distillates (petroleum), carbon-treated light paraffinic;

Gasoil — unspecified;

[A complex combination of hydrocarbons obtained by the treatment of a petroleum oil fraction with activated charcoal for the removal of traces of polar constituents and impurities. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C12 through C28.]
309-667-5100683-97-4Carc. Cat. 2; R45T

R: 45

S: 53-45
H N
649-240-00-3Distillates (petroleum), intermediate paraffinic, carbon-treated;

Gasoil — unspecified;

[A complex combination of hydrocarbons obtained by the treatment of petroleum with activated charcoal for the removal of trace polar constituents and impurities. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C16 through C36.]
309-668-0100683-98-5Carc. Cat. 2; R45T

R: 45

S: 53-45
H N
649-241-00-9Distillates (petroleum), intermediate paraffinic, clay-treated;

Gasoil — unspecified;

[A complex combination of hydrocarbons obtained by the treatment of petroleum with bleaching earth for the removal of trace polar constituents and impurities. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C16 through C36.]
309-669-6100683-99-6Carc. Cat. 2; R45T

R: 45

S: 53-45
H N
649-242-00-4Alkanes, C12-26-branched and linear292-454-390622-53-0Carc. Cat. 2; R45T

R: 45

S: 53-45
H N
649-243-00-XLubricating greases;

Grease;

[A complex combination of hydrocarbons having carbon numbers predominantly in the range of C12 through C50. May contain organic salts of alkali metals, alkaline earth metals, and/or aluminium compounds.]
278-011-774869-21-9Carc. Cat. 2; R45T

R: 45

S: 53-45
H N
649-244-00-5Slack wax (petroleum);

Slack wax;

[A complex combination of hydrocarbons obtained from a petroleum fraction by solvent crystallization (solvent dewaxing) or as a distillation fraction from a very waxy crude. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C20.]
265-165-564742-61-6Carc. Cat. 2; R45T

R: 45

S: 53-45
H N
649-245-00-0Slack wax (petroleum), acid-treated;

Slack wax;

[A complex combination of hydrocarbons obtained as a raffinate by treatment of a petroleum slack wax fraction with sulfuric acid treating process. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C20.]
292-659-890669-77-5Carc. Cat. 2; R45T

R: 45

S: 53-45
H N
649-246-00-6Slack wax (petroleum), clay-treated;

Slack wax;

[A complex combination of hydrocarbons obtained by treatment of a petroleum slack wax fraction with natural or modified clay in either a contacting or percolation process. It consists predominantly of saturated straight and branched hydrocarbons having carbon numbers predominantly greater than C20.]
292-660-390669-78-6Carc. Cat. 2; R45T

R: 45

S: 53-45
H N
649-247-00-1Slack wax (petroleum), hydrotreated;

Slack wax;

[A complex combination of hydrocarbons obtained by treating slack wax with hydrogen in the presence of a catalyst. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C20.]
295-523-692062-09-4Carc. Cat. 2; R45T

R: 45

S: 53-45
H N
649-248-00-7Slack wax (petroleum), low-melting;

Slack wax;

[A complex combination of hydrocarbons obtained from a petroleum fraction by solvent deparaffination. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C12.]
295-524-192062-10-7Carc. Cat. 2; R45T

R: 45

S: 53-45
H N
649-249-00-2Slack wax (petroleum), low-melting, hydrotreated;

Slack wax;

[A complex combination of hydrocarbons obtained by treatment of low-melting petroleum slack wax with hydrogen in the presence of a catalyst. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C12.]
295-525-792062-11-8Carc. Cat. 2; R45T

R: 45

S: 53-45
H N
649-250-00-8Slack wax (petroleum), low-melting, carbon-treated;

Slack wax;

[A complex combination of hydrocarbons obtained by the treatment of low-melting slack wax with activated carbon for the removal of trace polar constituents and impurities. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C12.]
308-155-997863-04-2Carc. Cat. 2; R45T

R: 45

S: 53-45
H N
649-251-00-3Slack wax (petroleum), low-melting, clay-treated;

Slack wax;

[A complex combination of hydrocarbons obtained by the treatment of low-melting petroleum slack wax with bentonite for removal of trace polar constituents and impurities. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C12.]
308-156-497863-05-3Carc. Cat. 2; R45T

R: 45

S: 53-45
H N
649-252-00-9Slack wax (petroleum), low-melting, silicic acid-treated;

Slack wax;

[A complex combination of hydrocarbons obtained by the treatment of low-melting petroleum slack wax with silicic acid for the removal of trace polar constituents and impurities. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C12.]
308-158-597863-06-4Carc. Cat. 2; R45T

R: 45

S: 53-45
H N
649-253-00-4Slack wax (petroleum), carbon-treated;

Slack wax;

[A complex combination of hydrocarbons obtained by treatment of petroleum slack wax with activated charcoal for the removal of trace polar constituents and impurities.]
309-723-9100684-49-9Carc. Cat. 2; R45T

R: 45

S: 53-45
H N
649-254-00-XPetrolatum;

Petrolatum;

[A complex combination of hydrocarbons obtained as a semi-solid from dewaxing paraffinic residual oil. It consists predominantly of saturated crystalline and liquid hydrocarbons having carbon numbers predominantly greater than C25.]
232-373-28009-03-8Carc. Cat. 2; R45T

R: 45

S: 53-45
H N
649-255-00-5Petrolatum (petroleum), oxidized;

Petrolatum;

[A complex combination of organic compounds, predominantly high molecular weight carboxylic acids, obtained by the air oxidation of petrolatum.]
265-206-764743-01-7Carc. Cat. 2; R45T

R: 45

S: 53-45
H N
649-256-00-0Petrolatum (petroleum), alumina-treated;

Petrolatum;

[A complex combination of hydrocarbons obtained when petrolatum is treated with Al2O3 to remove polar components and impurities. It consists predominantly of saturated, crystalline, and liquid hydrocarbons having carbon numbers predominantly greater than C25.]
285-098-585029-74-9Carc. Cat. 2; R45T

R: 45

S: 53-45
H N
649-257-00-6Petrolatum (petroleum), hydrotreated;

Petrolatum;

[A complex combination of hydrocarbons obtained as a semi-solid from dewaxed paraffinic residual oil treated with hydrogen in the presence of a catalyst. It consists predominantly of saturated microcrystalline and liquid hydrocarbons having carbon numbers predominantly greater than C20.]
295-459-992045-77-7Carc. Cat. 2; R45T

R: 45

S: 53-45
H N
649-258-00-1Petrolatum (petroleum), carbon-treated;

Petrolatum;

[A complex combination of hydrocarbons obtained by the treatment of petroleum petrolatum with activated carbon for the removal of trace polar constituents and impurities. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly greater than C20.]
308-149-697862-97-0Carc. Cat. 2; R45T

R: 45

S: 53-45
H N
649-259-00-7Petrolatum (petroleum), silicic acid-treated;

Petrolatum;

[A complex combination of hydrocarbons obtained by the treatment of petroleum petrolatum with silicic acid for the removal of trace polar constituents and impurities. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly greater than C20.]
308-150-197862-98-1Carc. Cat. 2; R45T

R: 45

S: 53-45
H N
649-260-00-2Petrolatum (petroleum), clay-treated;

Petrolatum;

[A complex combination of hydrocarbons obtained by treatment of petrolatum with bleaching earth for the removal of traces of polar constituents and impurities. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of greater than C25.]
309-706-6100684-33-1Carc. Cat. 2; R45T

R: 45

S: 53-45
H N
649-261-00-8Gasoline, natural;

Low boiling point naphtha;

[A complex combination of hydrocarbons separated from natural gas by processes such as refrigeration or absorption. It consists predominantly of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C4 through C8 and boiling in the range of approximately minus 20 oC to 120 oC (-4 oF to 248 oF).]
232-349-18006-61-9Carc. Cat. 2; R45

Xn; R65
T

R: 45-65

S: 53-45
H P
649-262-00-3Naphtha;

Low boiling point naphtha;

[Refined, partly refined, or unrefined petroleum products by the distillation of natural gas. It consists of hydrocarbons having carbon numbers predominantly in the range of C5 through C6 and boiling in the range of approximately 100 oC to 200 oC (212 oF to 392 oF).]
232-443-28030-30-6Carc. Cat. 2; R45

Xn; R65
T

R: 45-65

S: 53-45
H P
649-263-00-9Ligroine;

Low boiling point naphtha;

[A complex combination of hydrocarbons obtained by the fractional distillation of petroleum. This fraction boils in a range of approximately 20 oC to 135 oC (58 oF to 275 oF).]
232-453-78032-32-4Carc. Cat. 2; R45

Xn; R65
T

R: 45-65

S: 53-45
H P
649-264-00-4Naphtha (petroleum), heavy straight-run;

Low boiling point naphtha;

[A complex combination of hydrocarbons produced by distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C6 through C12 and boiling in the range of approximately 65 oC to 230 oC (149 oF to 446 oF).]
265-041-064741-41-9Carc. Cat. 2; R45

Xn; R65
T

R: 45-65

S: 53-45
H P
649-265-00-XNaphtha (petroleum), full-range straight-run;

Low boiling point naphtha;

[A complex combination of hydrocarbons produced by distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C11 and boiling in the range of approximately minus 20 oC to 220 oC (-4 oF to 428 oF).]
265-042-664741-42-0Carc. Cat. 2; R45

Xn; R65
T

R: 45-65

S: 53-45
H P
649-266-00-5Naphtha (petroleum), light straight-run;

Low boiling point naphtha;

[A complex combination of hydrocarbons produced by distillation of crude oil. It consists predominantly of aliphatic hydrocarbons having carbon numbers predominantly in the range of C4 through C10 and boiling in the range of approximately minus 20 oC to 180 oC (-4 oF to 356 oF).]
265-046-864741-46-4Carc. Cat. 2; R45

Xn; R65
T

R: 45-65

S: 53-45
H P
649-267-00-0Solvent naphtha (petroleum), light aliph.;

Low boiling point naphtha;

[A complex combination of hydrocarbons obtained from the distillation of crude oil or natural gasoline. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C5 through C10 and boiling in the range of approximately 35 oC to 160 oC (95 oF to 320 oF).]
265-192-264742-89-8Carc. Cat. 2; R45

Xn; R65
T

R: 45-65

S: 53-45
H P
649-268-00-6Distillates (petroleum), straight-run light;

Low boiling point naphtha;

[A complex combination of hydrocarbons produced by the distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C2 through C7 and boiling in the range of approximately - 88 oC to 99 oC (-127 oF to 210 oF).]
270-077-568410-05-9Carc. Cat. 2; R45

Xn; R65
T

R: 45-65

S: 53-45
H P
649-269-00-1Gasoline, vapor-recovery;

Low boiling point naphtha;

[A complex combination of hydrocarbons separated from the gases from vapor recovery systems by cooling. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C11 and boiling in the range of approximately - 20 oC to 196 oC (-4 oF to 384 oF).]
271-025-468514-15-8Carc. Cat. 2; R45

Xn; R65
T

R: 45-65

S: 53-45
H P
649-270-00-7Gasoline, straight-run, topping-plant;

Low boiling point naphtha;

[A complex combination of hydrocarbons produced from the topping plant by the distillation of crude oil. It boils in the range of approximately 36,1 oC to 193,3 oC (97 oF to 380 oF).]
271-727-068606-11-1Carc. Cat. 2; R45

Xn; R65
T

R: 45-65

S: 53-45
H P
649-271-00-2Naphtha (petroleum), unsweetened;

Low boiling point naphtha;

[A complex combination of hydrocarbons produced from the distillation of naphtha streams from various refinery processes. It consists of hydrocarbons having carbon numbers predominantly in the range of C5 through C12 and boiling in the range of approximately 0 oC to 230 oC (25 oF to 446 oF).]
272-186-368783-12-0Carc. Cat. 2; R45

Xn; R65
T

R: 45-65

S: 53-45
H P
649-272-00-8Distillates (petroleum), light straight-run gasoline fractionation stabilizer overheads;

Low boiling point naphtha;

[A complex combination of hydrocarbons having carbon numbers predominantly in the range of C3 through C6..]
272-931-268921-08-4Carc. Cat. 2; R45

Xn; R65
T

R: 45-65

S: 53-45
H P
649-273-00-3Naphtha (petroleum), heavy straight run, arom.-contg.;

Low boiling point naphtha;

[A complex combination of hydrocarbons obtained from a distillation process of crude petroleum. It consists predominantly of hydrocarbons having carbon numbers in the range of C8 through C12 and boiling in the range of approximately 130 oC to 210 oC (266 oF to 410 oF).]
309-945-6101631-20-3Carc. Cat. 2; R45

Xn; R65
T

R: 45-65

S: 53-45
H P
649-274-00-9Naphtha (petroleum), full-range alkylate;

Low boiling point modified naphtha;

[A complex combination of hydrocarbons produced by distillation of the reaction products of isobutane with monoolefinic hydrocarbons usually ranging in carbon numbers from C3 through C5. It consist of predominantly branched chain saturated hydro-carbons having carbon numbers predominantly in the range of C7 through C12 and boiling in the range of approximately 90 oC to 220 oC (194 oF to 428 oF).]
265-066-764741-64-6Carc. Cat. 2; R45

Xn; R65
T

R: 45-65

S: 53-45
H P
649-275-00-4Naphtha (petroleum), heavy alkylate;

Low boiling point modified naphtha;

[A complex combination of hydrocarbons produced by distillation of the reaction products of isobutane with monoolefinic hydrocarbons usually ranging in carbon numbers from C3 to C5. It consists of predominantly branched chain saturated hydrocarbons having carbon numbers predominantly in the range of C9 through C12 and boiling in the range of approximately 150 oC to 220 oC (302 oF to 428 oF).]
265-067-264741-65-7Carc. Cat. 2; R45

Xn; R65
T

R: 45-65

S: 53-45
H P
649-276-00-XNaphtha (petroleum), light alkylate;

Low boiling point modified naphtha;

[A complex combination of hydrocarbons produced by distillation of the reaction products of isobutane with monoolefinic hydrocarbons usually ranging in carbon numbers from C3 through C5. It consists of predominantly branched chain saturated hydro-carbons having carbon numbers predominantly in the range of C7 through C10 and boiling in the range of aproximately 90 oC to 160 oC (194 oF to 320 oF).]
265-068-864741-66-8Carc. Cat. 2; R45

Xn; R65
T

R: 45-65

S: 53-45
H P
649-277-00-5Naphtha (petroleum), isomerization;

Low boiling point modified naphtha;

[A complex combination of hydrocarbons obtained from catalytic isomerization of straight chain paraffinic C4 through C6 hydrocarbons. It consists predominantly of saturated hydrocarbons such as isobutane, isopentane, 2,2-dimethylbutane, 2-methylpentane, and 3-methylpentane.]
265-073-564741-70-4Carc. Cat. 2; R45

Xn; R65
T

R: 45-65

S: 53-45
H P
649-278-00-0Naphtha (petroleum), solvent-refined light;

Low boiling point modified naphtha;

[A complex combination of hydrocarbons obtained as the raffinate from a solvent extraction process. It consists predominantly of aliphatic hydrocarbons having carbon numbers predominantly in the range of C5 through C11 and boiling in the range of approximately 35 oC to 190 oC (95 oF to 374 oF).]
265-086-664741-84-0Carc. Cat. 2; R45

Xn; R65
T

R: 45-65

S: 53-45
H P
649-279-00-6Naphtha (petroleum), solvent-refined heavy;

Low boiling point modified naphtha;

[A complex combination of hydrocarbons obtained as the raffinate from a solvent extraction process. It consists predominantly of aliphatic hydrocarbons having carbon numbers predominantly in the range of C7 through C12 and boiling in the range of approximately 90 oC to 230 oC (194 oF to 446 oF).]
265-095-564741-92-0Carc. Cat. 2; R45

Xn; R65
T

R: 45-65

S: 53-45
H P
649-280-00-1Raffinates (petroleum), catalytic reformer ethylene glycol-water countercurrent exts.;

Low boiling point modified naphtha;

[A complex combination of hydrocarbons obtained as the raffinate from the UDEX extraction process on the catalytic reformer stream. It consists of saturated hydrocarbons having carbon numbers predominantly in the range of C6 through C9.]
270-088-568410-71-9Carc. Cat. 2; R45

Xn; R65
T

R: 45-65

S: 53-45
H P
649-281-00-7Raffinates (petroleum), reformer, Lurgi unit-sepd.;

Low boiling point modified naphtha;

[The complex combination of hydrocarbons obtained as a raffinate from a Lurgi separation unit. It consists predominantly of non-aromatic hydrocarbons with various small amounts of aromatic hydrocarbons having carbon numbers predominantly in the range of C6 through C8.]
270-349-368425-35-4Carc. Cat. 2; R45

Xn; R65
T

R: 45-65

S: 53-45
H P
649-282-00-2Naphtha (petroleum), full-range alkylate, butane-contg.;

Low boiling point modified naphta;

[A complex combination of hydrocarbons produced by the distillation of the reaction products of isobutane with monoolefinic hydrocarbons usually ranging in carbon numbers from C3 through C5. It consists of predominantly branched chain saturated hydrocarbons having carbon numbers predominantly in the range of C7 through C12 with some butanes and boiling in the range of approximately 35 oC to 200 oC (95 oF to 428 oF).]
271-267-068527-27-5Carc. Cat. 2; R45

Xn; R65
T

R: 45-65

S: 53-45
H P
649-283-00-8Distillates (petroleum), naphtha steam cracking-derived, solvent-refined light hydrotreated;

Low boiling point modified naphtha;

[A complex combination of hydrocarbons obtained as the raffinates from a solvent extraction process of hydrotreated light distillate from steam-cracked naphtha.]
295-315-591995-53-8Carc. Cat. 2; R45

Xn; R65
T

R: 45-65

S: 53-45
H P
649-284-00-3Naphtha (petroleum), C4-12 butane-alkylate, isooctane-rich;

Low boiling point modified naphtha;

[A complex combination of hydrocarbons obtained by alkylation of butanes. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C4 through C12, rich in isooctane, and boiling in the range of approximately 35 oC to 210 oC (95 oF to 410 oF).]
295-430-092045-49-3Carc. Cat. 2; R45

Xn; R65
T

R: 45-65

S: 53-45
H P
649-285-00-9Hydrocarbons, hydrotreated light naphtha distillates, solvent-refined;

Low boiling point modified naphtha;

[A combination of hydrocarbons obtained from the distillation of hydrotreated naphtha followed by a solvent extraction and distillation process. It consists predominantly of saturated hydrocarbons boiling in the range of approximately 94 oC to 99 oC (201 oF to 210 oF).]
295-436-392045-55-1Carc. Cat. 2; R45

Xn; R65
T

R: 45-65

S: 53-45
H P
649-286-00-4Naphtha (petroleum), isomerization, C6-fraction;

Low boiling point modified naphtha;

[A complex combination of hydrocarbons obtained by distillation of a gasoline which has been catalytically isomerized. It consists predominantly of hexane isomers boiling in the range of approximately 60 oC to 66 oC (140 oF to 151 oF).]
295-440-592045-58-4Carc. Cat. 2; R45

Xn; R65
T

R: 45-65

S: 53-45
H P
649-287-00-XHydrocarbons, C6-7, naphtha-cracking, solvent-refined;

Low boiling point modified naphtha;

[A complex combination of hydrocarbons obtained by the sorption of benzene from a catalytically fully hydrogenated benzene-rich hydrocarbon cut that was distillatively obtained from prehydrogenated cracked naphtha. It consists predominantly of paraffinic and naphthenic hydrocarbons having carbon numbers predominantly in the range of C6 through C7 and boiling in the range of approximately 70 oC to 100 oC (158 oF to 212 oF).]
295-446-892045-64-2Carc. Cat. 2; R45

Xn; R65
T

R: 45-65

S: 53-45
H P
649-288-00-5Hydrocarbons, C6-rich, hydrotreated light naphtha distillates, solvent-refined;

Low boiling point modified naphtha;

[A complex combination of hydrocarbons obtained by distillation of hydrotreated naphtha followed by solvent extraction. It consists predominantly of saturated hydrocarbons and boiling in the range of approximately 65 oC to 70 oC (149 oF to 158 oF).]
309-871-4101316-67-0Carc. Cat. 2; R45

Xn; R65
T

R: 45-65

S: 53-45
H P
649-289-00-0Naphtha (petroleum), heavy catalytic cracked;

Low boiling point cat-cracked naphtha;

[A complex combination of hydrocarbons produced by a distillation of products from a catalytic cracking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C6 through C12 and boiling in the range of approximately 65 oC to 230 oC (148 oF to 446 oF). It contains a relatively large proportion of unsaturated hydrocarbons.]
265-055-764741-54-4Carc. Cat. 2; R45

Xn; R65
T

R: 45-65

S: 53-45
H P
649-290-00-6Naphtha (petroleum), light catalytic cracked;

Low boiling point cat-cracked naphtha;

[A complex combination of hydrocarbons produced by the distillation of products from a catalytic cracking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C11 and boiling in the range of approximately minus 20 oC to 190 oC (-4 oF to 374 oF). It contains a relatively large proportion of unsaturated hydrocarbons.]
265-056-264741-55-5Carc. Cat. 2; R45

Xn; R65
T

R: 45-65

S: 53-45
H P
649-291-00-1Hydrocarbons, C3-11, catalytic cracker distillates;

Low boiling point cat-cracked naphtha;

[A complex combination of hydrocarbons produced by the distillations of products from a catalytic cracking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C3 through C11 and boiling in a range approximately up to 204 oC (400 oF).]
270-686-668476-46-0Carc. Cat. 2; R45

Xn; R65
T

R: 45-65

S: 53-45
H P
649-292-00-7Naphtha (petroleum), catalytic cracked light distd.;

Low boiling point cat-cracked naphtha;

[A complex combination of hydrocarbons produced by the distillation of products from a catalytic cracking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]
272-185-868783-09-5Carc. Cat. 2; R45

Xn; R65
T

R: 45-65

S: 53-45
H P
649-293-00-2Distillates (petroleum), naphtha steam cracking-derived, hydrotreated light arom.;

Low boiling point cat-cracked naphtha.;

[A complex combination of hydrocarbons obtained by treating a light distillate from steam-cracked naphtha. It consists predom-inantly of aromatic hydrocarbons.]
295-311-391995-50-5Carc. Cat. 2; R45

Xn; R65
T

R: 45-65

S: 53-45
H P
649-294-00-8Naphtha (petroleum), heavy catalytic cracked, sweetened;

Low boiling point cat-cracked naphtha;

[A complex combination of hydrocarbons obtained by subjecting a catalytic cracked petroleum distillate to a sweetening process to convert mercaptans or to remove acidic impurities. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C6 through C12 and boiling in the range of approximately 60 oC to 200 oC (140 oF to 392 oF).]
295-431-692045-50-6Carc. Cat. 2; R45

Xn; R65
T

R: 45-65

S: 53-45
H P
649-295-00-3Naphtha (petroleum), light catalytic cracked sweetened;

Low boiling point cat-cracked naphtha;

[A complex combination of hydrocarbons obtained by subjecting naphtha from a catalytic cracking process to a sweetening process to convert mercaptans or to remove acidic impurities. It consists predominantly of hydrocarbons boiling in a range of approxim-ately 35 oC to 210 oC (95 oF to 410 oF).]
295-441-092045-59-5Carc. Cat. 2; R45

Xn; R65
T

R: 45-65

S: 53-45
H P
649-296-00-9Hydrocarbons, C8-12, catalytic-cracking, chem. neutralized;

Low boiling point cat-cracked naphtha;

[A complex combination of hydrocarbons produced by the distillation of a cut from the catalytic cracking process, having undergone an alkaline washing. It consists predominantly of hydrocarbons having carbon numbers in the range of C8 through C12 and boiling in the range of approximately 130 oC to 210 oC (266 oF to 410 oF).]
295-794-092128-94-4Carc. Cat. 2; R45

Xn; R65
T

R: 45-65

S: 53-45
H P
649-297-00-4Hydrocarbons, C8-12, catalytic cracker distillates;

Low boiling point cat-cracked naphtha;

[A complex combination of hydrocarbons obtained by distillation of products from a catalytic cracking process. It consists pre-dominantly of hydrocarbons having carbon numbers predominantly in the range of C8 through C12 and boiling in the range of approximately 140 oC to 210 oC (284 oF to 410 oF).]
309-974-4101794-97-2Carc. Cat. 2; R45

Xn; R65
T

R: 45-65

S: 53-45
H P
649-298-00-XHydrocarbons, C8-12, catalytic cracking, chem. neutralized, sweetened;

Low boiling point cat-cracked naphtha
309-987-5101896-28-0Carc. Cat. 2; R45

Xn; R65
T

R: 45-65

S: 53-45
H P
649-299-00-5Naphtha (petroleum), light catalytic reformed;

Low boiling point cat-reformed naphtha;

[A complex combination of hydrocarbons produced from the distillation of products from a catalytic reforming process. It consists of hydrocarbons having carbon numbers predominantly in the range of C5 through C11 and boiling in the range of approximately 35 oC to 190 oC (95 oF to 374 oF). It contains a relatively large proportion of aromatic and branched chain hydrocarbons. This stream may contain 10 vol. % or more benzene.]
265-065-164741-63-5Carc. Cat. 2; R45

Xn; R65
T

R: 45-65

S: 53-45
H P
649-300-00-9Naphtha (petroleum), heavy catalytic reformed;

Low boiling point cat-reformed naphtha;

[A complex combination of hydrocarbons produced from the distillation of products from a catalytic reforming process. It consists of predominantly aromatic hydrocarbons having numbers predominantly in the range of C7 through C12 and boiling in the range of approximately 90 oC to 230 oC (194 oF to 446 oF).]
265-070-964741-68-0Carc. Cat. 2; R45

Xn; R65
T

R: 45-65

S: 53-45
H P
649-301-00-4Distillates (petroleum), catalytic reformed depentanizer;

Low boiling point cat-reformed naphtha;

[A complex combination of hydrocarbons from the distillation of products from a catalytic reforming process. It consists predominantly of aliphatic hydrocarbons having carbon numbers predominantly in the range of C3 through C6 and boiling in the range of approximately - 49 oC to 63 oC - 57 oF to 145 oF).]
270-660-468475-79-6Carc. Cat. 2; R45

Xn; R65
T

R: 45-65

S: 53-45
H P
649-302-00-XHydrocarbons, C2-6, C6-8 catalytic reformer;

Low boiling point cat-reformed naphtha
270-687-168476-47-1Carc. Cat. 2; R45

Xn; R65
T

R: 45-65

S: 53-45
H P
649-303-00-5Residues (petroleum), C6-8 catalytic reformer;

Low boiling point cat-reformed naphtha;

[A complex residuum from the catalytic reforming of C6-8 feed. It consists of hydrocarbons having carbon numbers predominantly in the range of C2 through C6.]
270-794-368478-15-9Carc. Cat. 2; R45

Xn; R65
T

R: 45-65

S: 53-45
H P
649-304-00-0Naphtha (petroleum), light catalytic reformed, arom.-free;

Low boiling point cat-reformed naphtha;

[A complex combination of hydrocarbons obtained from distillation of products from a catalytic reforming process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C5 through C8 and boiling in the range of approximately 35 oC to 120 oC (95 oF to 248 oF). It contains a relatively large proportion of branched chain hydrocarbons with the aromatic components removed.]
270-993-568513-03-1Carc. Cat. 2; R45

Xn; R65
T

R: 45-65

S: 53-45
H P
649-305-00-6Distillates (petroleum), catalytic reformed straight-run naphtha overheads;

Low boiling point cat-reformed naphtha;

[A complex combination of hydrocarbons obtained by the catalytic reforming of straight-run naphtha followed by the fractionation of the total effluent. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C2 through C6.]
271-008-168513-63-3Carc. Cat. 2; R45

Xn; R65
T

R: 45-65

S: 53-45
H P
649-306-00-1Petroleum products, hydrofiner-powerformer reformates;

Low boiling point cat-reformed naphtha;

[The complex combination of hydrocarbons obtained in a hydrofiner-powerformer process and boiling in a range of approximately 27 oC to 210 oC (80 oF to 410 oF).]
271-058-468514-79-4Carc. Cat. 2; R45

Xn; R65
T

R: 45-65

S: 53-45
H P
649-307-00-7Naphtha (petroleum, full-range reformed;

Low boiling point cat-reformed naphtha;

[A complex combination of hydrocarbons produced by the distillation of the products from a catalytic reforming process. It consists of hydrocarbons having carbon numbers predominantly in the range of C5 through C12 and boiling in the range of approximately 35 oC to 230 oC (95 oF to 446 oF).]
272-895-868919-37-9Carc. Cat. 2; R45

Xn; R65
T

R: 45-65

S: 53-45
H P
649-308-00-2Naphtha (petroleum), catalytic reformed;

Low boiling point cat-reformed naphtha;

[A complex combination of hydrocarbons produced by the distillation of products from a catalytic reforming process. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C12 and boiling in the range of approximately 30 oC to 220 oC (90 oF to 430 oF). It contains a relatively large proportion of aromatic and branched chain hydrocarbons. This stream may contain 10 vol. % or more benzene.]
273-271-868955-35-1Carc. Cat. 2; R45

Xn; R65
T

R: 45-65

S: 53-45
H P
649-309-00-8Distillates (petroleum), catalytic reformed hydrotreated light, C8-12 arom. fraction;

Low boiling point cat-reformed naphtha;

[A complex combination of alkylbenzenes obtained by the catalytic reforming of petroleum naphtha. It consists predominantly of alkylbenzenes having carbon numbers predominantly in the range of C8 through C10 and boiling in the range of approximately 160 oC to 180 oC (320 oF to 356 oF).]
285-509-885116-58-1Carc. Cat. 2; R45

Xn; R65
T

R: 45-65

S: 53-45
H P
649-310-00-3Aromatic hydrocarbons, C8, catalytic reforming-derived;

Low boiling point cat-reformed naphtha
295-279-091995-18-5Carc. Cat. 2; R45

Xn; R65
T

R: 45-65

S: 53-45
H P
649-311-00-9Aromatic hydrocarbons, C7-12, C8-rich;

Low boiling point cat-reformed naphtha;

[A complex combination of hydrocarbons obtained by separation from the platformate-containing fraction. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C7 through C12 (primarily C8) and can contain nonaromatic hydrocarbons, both boiling in the range of approximately 130 oC to 200 oC (266 oF to 392 oF).]
297-401-893571-75-6Carc. Cat. 2; R45

Xn; R65
T

R: 45-65

S: 53-45
H P
649-312-00-4Gasoline, C5-11, high-octane stabilized reformed;

Low boiling point cat-reformed naphtha;

[A complex high octane combination of hydrocarbons obtained by the catalytic dehydrogenation of a predominantly naphthenic naphtha. It consists predominantly of aromatics and non-aromatics having carbon numbers predominantly in the range of C5 through C11 and boiling in the range of approximately 45 oC to 185 oC (113 oF to 365 oF).]
297-458-993572-29-3Carc. Cat. 2; R45

Xn; R65
T

R: 45-65

S: 53-45
H P
649-313-00-XHydrocarbons, C7-12, C >9-arom.-rich, reforming heavy fraction;

Low boiling point cat-reformed naphtha;

[A complex combination of hydrocarbons obtained by separation from the platformate-containing fraction. It consists predominantly of nonaromatic hydrocarbons having carbon numbers predominantly in the range of C7 through C12 and boiling in the range of approximately 120 oC to 210 oC (248 oF to 380 oF) and C9 and higher aromatic hydrocarbons.]
297-465-793572-35-1Carc. Cat. 2; R45

Xn; R65
T

R: 45-65

S: 53-45
H P
649-314-00-5Hydrocarbons, C5-11, nonaroms.-rich, reforming light fraction;

Low boiling point cat-reformed naphtha;

[A complex combination of hydrocarbons obtained by separation from the platformate-containing fraction. It consists predominantly of nonaromatic hydrocarbons having carbon numbers predominantly in the range of C5 to C11 and boiling in the range of approximately 35 oC to 125 oC (94 oF to 257 oF), benzene and toluene.]
297-466-293572-36-2Carc. Cat. 2; R45

Xn; R65
T

R: 45-65

S: 53-45
H P
649-315-00-0Foots oil (petroleum), silicic acid-treated;

Foots oil;

[A complex combination of hydrocarbons obtained by the treatment of Foots oil with silicic acid for removal of trace constituents and impurities. It consists predominantly of straight chain hydrocarbons having carbon numbers predominantly greater than C12.]
308-127-697862-77-6Carc. Cat. 2; R45T

R: 45

S: 53-45
H L
649-316-00-6Naphtha (petroleum), light thermal cracked;

Low boiling point thermally cracked naphtha;

[A complex combination of hydrocarbons from distillation of products from a thermal cracking process. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C4 through C8 and boiling in the range of approximately minus 10 oC to 130 oC (14 oF to 266 oF).]
265-075-664741-74-8Carc. Cat. 2; R45

Xn; R65
T

R: 45-65

S: 53-45
H P
649-317-00-1Naphtha (petroleum), heavy thermal cracked;

Low boiling point thermally cracked naphtha;

[A complex combination of hydrocarbons from distillation of the products from a thermal cracking process. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C6 through C12 and boiling in the range of approximately 65 oC to 220 oC (148 oF to 428 oF).]
265-085-064741-83-9Carc. Cat. 2; R45

Xn; R65
T

R: 45-65

S: 53-45
H P
649-318-00-7Distillates (petroleum), heavy arom.;

Low boiling point thermally cracked naphtha;

[The complex combination of hydrocarbons from the distillation of the products from the thermal cracking of ethane and propane. This higher boiling fraction consists predominantly of C5-C7 aromatic hydrocarbons with some unsaturated aliphatic hydrocarbons having carbon number predominantly of C5. This stream may contain benzene.]
267-563-467891-79-6Carc. Cat. 2; R45

Xn; R65
T

R: 45-65

S: 53-45
H P
649-319-00-2Distillates (petroleum), light arom.;

Low boiling point thermally cracked naphtha;

[The complex combination of hydrocarbons from the distillation of the products from the thermal cracking of ethane and propane. This lower boiling fraction consists predominantly of C5-C7 aromatic hydrocarbons with some unsaturated aliphatic hydrocarbons having a carbon number predominantly of C5. This stream may contain benzene.]
267-565-567891-80-9Carc. Cat. 2; R45

Xn; R65
T

R: 45-65

S: 53-45
H P
649-320-00-8Distillates (petroleum), naphtha-raffinate pyrolyzate-derived, gasoline-blending;

Low boiling point thermally cracked naphtha;

[The complex combination of hydrocarbons obtained by the pyrolysis fractionation at 816 oC (1500 oF) of naphtha and raffinate. It consists predominantly of hydrocarbons having a carbon number of C9 and boiling at approximately 204 oC (400 oF).]
270-344-668425-29-6Carc. Cat. 2; R45

Xn; R65
T

R: 45-65

S: 53-45
H P
649-321-00-3Aromatic hydrocarbons, C6-8, naphtha-raffinate pyrolyzate-derived;

Low boiling point thermally cracked naphtha;

A complex combination of hydrocarbons obtained by the fractionation pyrolysis at 816 oC (1500 oF) of naphtha and raffinate. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C6 through C8, including benzene.]
270-658-368475-70-7Carc. Cat. 2; R45

Xn; R65
T

R: 45-65

S: 53-45
H P
649-322-00-9Distillates (petroleum), thermal cracked naphtha and gas oil;

Low boiling point thermally cracked naphtha;

[A complex combination of hydrocarbons produced by distillation of thermally cracked naphtha and/or gas oil. It consists predominantly of olefinic hydrocarbons having a carbon number of C5 and boiling in the range of approximately 33 oC to 60 oC (91 oF to 140 oF).]
271-631-968603-00-9Carc. Cat. 2; R45

Xn; R65
T

R: 45-65

S: 53-45
H P
649-323-00-4Distillates (petroleum), thermal cracked naphtha and gas oil, C5-dimer-contg.;

Low boiling point thermally cracked naphtha;

[A complex combination of hydrocarbons produced by the extractive distillation of thermal cracked naphtha and/or gas oil. It consists predominantly of hydrocarbons having a carbon number of C5 with some dimerized C5 olefins and boiling in the range of approximately 33 oC to 184 oC (91 oF to 363 oF).]
271-632-468603-01-0Carc. Cat. 2; R45

Xn; R65
T

R: 45-65

S: 53-45
H P
649-324-00-XDistillates (petroleum), thermal cracked naphtha and gas oil, extractive;

Low boiling point thermally cracked naphtha;

[A complex combination of hydrocarbons produced by the extractive distillation of thermal cracked naphtha and/or gas oil. It consists of paraffinic and olefinic hydrocarbons, predominantly isoamylenes such as 2-methyl-1-butene and 2-methyl-2-butene and boiling in the range of approximately 31 oC to 40 oC (88 oF to 104 oF).]
271-634-568603-03-2Carc. Cat. 2; R45

Xn; R65
T

R: 45-65

S: 53-45
H P
649-325-00-5Distillates (petroleum), light thermal cracked, debutanized arom.;

Low boiling point thermally cracked naphtha;

[A complex combination of hydrocarbons produced by the distillation of products from a thermal cracking process. It consists predominantly of aromatic hydrocarbons, primarily benzene.]
273-266-068955-29-3Carc. Cat. 2; R45

Xn; R65
T

R: 45-65

S: 53-45
H P
649-326-00-0Naphtha (petroleum), light thermal cracked, sweetened;

Low boiling point thermally cracked naphtha;

[A complex combination of hydrocarbons obtained by subjecting a petroleum distillate from the high temperature thermal cracking of heavy oil fractions to a sweetening process to convert mercaptans. It consists predominantly of aromatics, olefins and saturated hydrocarbons boiling in the range of approximately 20 oC to 100 oC (68 oF to 212 oF).]
295-447-392045-65-3Carc. Cat. 2; R45

Xn; R65
T

R: 45-65

S: 53-45
H P
649-327-00-6Naphtha (petroleum), hydrotreated heavy;

Low boiling point hydrogen treated naphtha;

[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly in the range of C6 through C13 and boiling in the range of approximately 65 oC to 230 oC (149 oF to 446 oF).]
265-150-364742-48-9Carc. Cat. 2; R45

Xn; R65
T

R: 45-65

S: 53-45
H P
649-328-00-1Naphtha (petroleum), hydrotreated light;

Low boiling point hydrogen treated naphtha;

[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C11 and boiling in the range of approximately minus 20 oC to 190 oC (- 4 oF to 374 oF).]
265-151-964742-49-0Carc. Cat. 2; R45

Xn; R65
T

R: 45-65

S: 53-45
H P
649-329-00-7Naphtha (petroleum), hydrodesulfurized light;

Low boiling point hydrogen treated naphtha;

[A complex combination of hydrocarbons obtained from a catalytic hydrodesulfurization process. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C11 and boiling in the range of approximately minus 20 oC to 190 oC (- 4 oF to 374 oF).]
265-178-664742-73-0Carc. Cat. 2; R45

Xn; R65
T

R: 45-65

S: 53-45
H P
649-330-00-2Naphtha (petroleum), hydrodesulfurized heavy;

Low boiling point hydrogen treated naphtha;

[A complex combination of hydrocarbons obtained from a catalytic hydrodesulfurization process. It consists of hydrocarbons having carbon numbers predominantly in the range of C7 through C12 and boiling in the range of approximately 90 oC to 230 oC (194 oF to 446 oF).]
265-185-464742-82-1Carc. Cat. 2; R45

Xn; R65
T

R: 45-65

S: 53-45
H P
649-331-00-8Distillates (petroleum), hydrotreated middle, intermediate boiling;

Low boiling point hydrogen treated naphtha;

[A complex combination of hydrocarbons obtained by the distillation of products from a middle distillate hydrotreating process. It consists of hydrocarbons having carbon numbers predominantly in the range of C5 through C10 and boiling in the range of approximately 127 oC to 188 oC (262 oF to 370 oF).]
270-092-768410-96-8Carc. Cat. 2; R45

Xn; R65
T

R: 45-65

S: 53-45
H P
649-332-00-3Distillates (petroleum), light distillate hydrotreating process, low-boiling;

Low boiling point hydrogen treated naphtha;

[A complex combination of hydrocarbons obtained by the distillation of products from the light distillate hydrotreating process. It consists of hydrocarbons having carbon numbers predominantly in the range of C6 through C9 and boiling in the range of approximately 3 oC to 194 oC (37 oF to 382 oF).]
270-093-268410-97-9Carc. Cat. 2; R45

Xn; R65
T

R: 45-65

S: 53-45
H P
649-333-00-9Distillates (petroleum), hydrotreated heavy naphtha, deisohexanizer overheads;

Low boiling point hydrogen treated naphtha;

[A complex combination of hydrocarbons obtained by distillation of the products from a heavy naphtha hydrotreating process. It consists of hydrocarbons having carbon numbers predominantly in the range of C3 through C6 and boiling in the range of approximately - 49 oC to 68 oC (- 57 oF to 155 oF).]
270-094-868410-98-0Carc. Cat. 2; R45

Xn; R65
T

R: 45-65

S: 53-45
H P
649-334-00-4Solvent naphtha (petroleum), light arom., hydrotreated;

Low boiling point hydrogen treated naphtha;

[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C8 through C10 and boiling in the range of approximately 135 oC to 210 oC (275 oF to 410 oF).]
270-988-868512-78-7Carc. Cat. 2; R45

Xn; R65
T

R: 45-65

S: 53-45
H P
649-335-00-XNaphtha (petroleum), hydrodesulfurized thermal cracked light;

Low boiling point hydrogen treated naphtha;

[A complex combination of hydrocarbons obtained by fractionation of hydrodesulfurized thermal cracker distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C5 to C11 and boiling in the range of approximately 23 oC to 195 oC (73 oF to 383 oF).]
285-511-985116-60-5Carc. Cat. 2; R45

Xn; R65
T

R: 45-65

S: 53-45
H P
649-336-00-5Naphtha (petroleum), hydrotreated light, cycloalkane-contg.;

Low boiling point hydrogen treated naphtha;

[A complex combination of hydrocarbons obtained from the distillation of a petroleum fraction. It consists predominantly of alkanes and cycloalkanes boiling in the range of approximately minus 20 oC to 190 oC (- 4 oF to 374 oF).]
285-512-485116-61-6Carc. Cat. 2; R45

Xn; R65
T

R: 45-65

S: 53-45
H P
649-337-00-0Naphtha (petroleum), heavy steam-cracked, hydrogenated;

Low boiling point hydrogen treated naphtha
295-432-192045-51-7Carc. Cat. 2; R45

Xn; R65
T

R: 45-65

S: 53-45
H P
649-338-00-6Naphtha (petroleum), hydrodesulfurized full-range;

Low boiling point hydrogen treated naphtha;

[A complex combination of hydrocarbons obtained from a catalytic hydrodesulfurization process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C4 through C11 and boiling in the range of approximately 30 oC to 250 oC (86 oF to 482 oF).]
295-433-792045-52-8Carc. Cat. 2; R45

Xn; R65
T

R: 45-65

S: 53-45
H P
649-339-00-1Naphtha (petroleum), hydrotreated light steam-cracked;

Low boiling point hydrogen treated naphtha;

[A complex combination of hydrocarbons obtained by treating a petroleum fraction, derived from a pyrolysis process, with hydrogen in the presence of a catalyst. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C5 through C11 and boiling in the range of approximately 35 oC to 190 oC (95 oF to 374 oF).]
295-438-492045-57-3Carc. Cat. 2; R45

Xn; R65
T

R: 45-65

S: 53-45
H P
649-340-00-7Hydrocarbons, C4-12, naphtha-cracking, hydrotreated;

Low boiling point hydrogen treated naphtha;

[A complex combination of hydrocarbons obtained by distillation from the product of a naphtha steam cracking process and subsequent catalytic selective hydrogenation of gum formers. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C12 and boiling in the range of approximately 30 oC to 230 oC (86 oF to 446 oF).]
295-443-192045-61-9Carc. Cat. 2; R45

Xn; R65
T

R: 45-65

S: 53-45
H P
649-341-00-2Solvent naphtha (petroleum), hydrotreated light naphthenic;

Low boiling point hydrogen treated naphtha;

[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists predominantly of cycloparaffinic hydrocarbons having carbon numbers predominantly in the range of C6 through C7 and boiling in the range of approximately 73 oC to 85 oC (163 oF to 185 oF).]
295-529-992062-15-2Carc. Cat. 2; R45

Xn; R65
T

R: 45-65

S: 53-45
H P
649-342-00-8Naphtha (petroleum), light steam-cracked, hydrogenated;

Low boiling point hydrogen treated naphtha;

[A complex comination of hydrocarbons produced from the separation and subsequent hydrogenation of the products of a steam-cracking process to produce ethylene. It consists predominantly of saturated and unsaturated paraffins, cyclic paraffins and cyclic aromatic hydrocarbons having carbon numbers predominantly in the range of C4 through C10 and boiling in the range of approximately 50 oC to 200 oC (122 oF to 392 oF). The proportion of benzene hydrocarbons may vary up to 30 wt. % and the stream may also contain small amounts of sulphur and oxygenated compounds.]
296-942-793165-55-0Carc. Cat. 2; R45

Xn; R65
T

R: 45-65

S: 53-45
H P
649-343-00-3Hydrocarbons, C6-11, hydrotreated, dearomatized;

Low boiling point hydrogen treated naphtha;

[A complex combination of hydrocarbons obtained as solvents which have been subjected to hydrotreatment in order to convert aromatics to naphthenes by catalytic hydrogenation.]
297-852-093763-33-8Carc. Cat. 2; R45

Xn; R65
T

R: 45-65

S: 53-45
H P
649-344-00-9Hydrocarbons, C9-12, hydrotreated, dearomatized;

Low boiling point hydrogen treated naphtha;

[A complex combination of hydrocarbons obtained as solvents which have been subjected to hydrotreatment in order to convert aromatics to naphthenes by catalytic hydrogenation.]
297-853-693763-34-9Carc. Cat. 2; R45

Xn; R65
T

R: 45-65

S: 53-45
H P
649-345-00-4Stoddard solvent;

Low boiling point naphtha — unspecified;

[A colourless, refined petroleum distillate that is free from rancid or objectionable odors and that boils in a range of approximately 300 oF to 400 oF.]
232-489-38052-41-3Carc. Cat. 2; R45

Xn; R65
T

R: 45-65

S: 53-45
H P
649-346-00-XNatural gas condensates (petroleum);

Low boiling point naphtha — unspecified;

[A complex combination of hydrocarbons separated as a liquid from natural gas in a surface separator by retrograde condensation. It consists mainly of hydrocarbons having carbon numbers predominantly in the range of C2 to C20. It is a liquid at atmospheric temperature and pressure.]
265-047-364741-47-5Carc. Cat. 2; R4

Xn; R65
T

R: 45-65

S: 53-45
H P
649-347-00-5Natural gas (petroleum), raw liq. mix;

Low boiling point naphtha — unspecified;

[A complex combination of hydrocarbons separated as a liquid from natural gas in a gas recycling plant by processes such as refrigeration or absorption. It consists mainly of saturated aliphatic hydrocarbons having carbon numbers in the range of C2 through C8.]
265-048-964741-48-6Carc. Cat. 2; R45

Xn; R65
T

R: 45-65

S: 53-45
H P
649-348-00-0Naphtha (petroleum), light hydrocracked;

Low boiling naphtha — unspecified;

[A complex combination of hydrocarbons from distillation of the products from a hydrocracking process. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C4 through C10, and boiling in the range of approximately minus 20 oC to 180 oC (- 4 oF to 356 oF).]
265-071-464741-69-1Carc. Cat. 2; R45

Xn; R65
T

R: 45-65

S: 53-45
H P
649-349-00-6Naphtha (petroleum), heavy hydrocracked;

Low boiling point naphtha — unspecified;

[A complex combination of hydrocarbons from distillation of the products from a hydrocracking process. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C6 through C12, and boiling in the range of approximately 65 oC to 230 oC (148 oF to 446 oF).]
265-079-864741-78-2Carc. Cat. 2; R45

Xn; R65
T

R: 45-65

S: 53-45
H P
649-350-00-1Naphtha (petroleum), sweetened;

Low boiling point naphtha — unspecified;

[A complex combination of hydrocarbons obtained by subjecting a petroleum naphtha to a sweetening process to convert mercaptans or to remove acidic impurities. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C12 and boiling in the range of approximately minus 10 oC to 230 oC (14 oF to 446 oF).]
265-089-264741-87-3Carc. Cat. 2; R45

Xn; R65
T

R: 45-65

S: 53-45
H P
649-351-00-7Naphtha (petroleum), acid-treated;

Low boiling point naphtha — unspecified;

[A complex combination of hydrocarbons obtained as a raffinate from a sulfuric acid treating process. It consists of hydrocarbons having carbon numbers predominantly in the range of C7 through C12 and boiling in the range of approximately 90 oC to 230 oC (194 oF to 446 oF).]
265-115-264742-15-0Carc. Cat. 2; R45

Xn; R65
T

R: 45-65

S: 53-45
H P
649-352-00-2Naphtha (petroleum), chemically neutralized heavy;

Low boiling point naphtha — unspecified;

[A complex combination of hydrocarbons produced by a treating process to remove acidic materials. It consists of hydrocarbons having carbon numbers predominantly in the range of C6 through C12 and boiling in the range of approximately 65 oC to 230 oC (149 oF to 446 oF).]
265-122-064742-22-9Carc. Cat. 2; R45

Xn; R65
T

R: 45-65

S: 53-45
H P
649-353-00-8Naphtha (petroleum), chemically neutralized light;

Low boiling point naphtha — unspecified;

[A complex combination of hydrocarbons produced by a treating process to remove acidic materials. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C11 and boiling in the range of approximately minus 20 oC to 190 oC (- 4 oF to 374 oF).]
265-123-664742-23-0Carc. Cat. 2; R45

Xn; R65
T

R: 45-65

S: 53-45
H P
649-354-00-3Naphtha (petroleum), catalytic dewaxed;

Low boiling point naphtha — unspecified;

[A complex combination of hydrocarbons obtained from the catalytic dewaxing of a petroleum fraction. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C5 through C12 and boiling in the range of approximately 35 oC to 230 oC (95 oF to 446 oF).]
265-170-264742-66-1Carc. Cat. 2; R45

Xn; R65
T

R: 45-65

S: 53-45
H P
649-355-00-9Naphtha (petroleum), light steam-cracked;

Low boiling point naphtha — unspecified;

[A complex combination of hydrocarbons obtained by the distillation of the products from a steam cracking process. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C4 through C11 and boiling in the range of approximately minus 20 oC to 190 oC (- 4 oF to 374 oF). This stream is likely to contain 10 vol.% or more benzene.]
265-187-564742-83-2Carc. Cat. 2; R45

Xn; R65
T

R: 45-65

S: 53-45
H P
649-356-00-4Solvent naphtha (petroleum), light arom.;

Low boiling point naphtha — unspecified;

[A complex combination of hydrocarbons obtained from distillation of aromatic streams. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C8 through C10 and boiling in the range of approximately 135 oC to 210 oC (275 oF to 410 oF).]
265-199-064742-95-6Carc. Cat. 2; R45

Xn; R65
T

R: 45-65

S: 53-45
H P
649-357-00-XAromatic hydrocarbons, C6-10, acid-treated, neutralized;

Low boiling point naphtha — unspecified
268-618-568131-49-7Carc. Cat. 2; R45

Xn; R65
T

R: 45-65

S: 53-45
H P
649-358-00-5Distillates (petroleum), C3-5, 2-methyl-2-butene-rich;

Low boiling point naphtha — unspecified;

[A complex combination of hydrocarbons from the distillation of hydrocarbons usually ranging in carbon numbers from C3 through C5, predominantly isopentane and 3-methyl-1-butene. It consists of saturated and unsaturated hydrocarbons having carbon numbers in the range of C3 through C5, predominantly 2-methyl-2-butene.]
270-725-768477-34-9Carc. Cat. 2; R45

Xn; R65
T

R: 45-65

S: 53-45
H P
649-359-00-0Distillates (petroleum), polymd. steam-cracked petroleum distillates, C5-12 fraction;

Low boiling point naphtha — unspecified;

[A complex combination of hydrocarbons obtained from the distillation of polymerized steam-cracked petroleum distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C5 through C12.]
270-735-168477-50-9Carc. Cat. 2; R45

Xn; R65
T

R: 45-65

S: 53-45
H P
649-360-00-6Distillates (petroleum), steam-cracked, C5-12 fraction;

Low boiling point naphtha — unspecified;

[A complex combination of organic compounds obtained by the distillation of products from a steam cracking process. It consists of unsaturated hydrocarbons having carbon numbers predominantly in the range of C5 through C12.]
270-736-768477-53-2Carc. Cat. 2; R45

Xn; R65
T

R: 45-65

S: 53-45
H P
649-361-00-1Distillates (petroleum), steam-cracked, C5-10 fraction, mixed with light steam-cracked petroleum naphtha C5 fraction;

Low boiling point naphtha — unspecified
270-738-868477-55-4Carc. Cat. 2; R45

Xn; R65
T

R: 45-65

S: 53-45
H P
649-362-00-7Extracts (petroleum), cold-acid, C4-6;

Low boiling point naphtha — unspecified;

[A complex combination of organic compounds produced by cold acid unit extraction of saturated and unsaturated aliphatic hydrocarbons usually ranging in carbon numbers from C3 through C6, predominantly pentanes and amylenes. It consists predominantly of saturated and unsaturated hydrocarbons having carbon numbers in the range of C4 through C6, predominantly C5.]
270-741-468477-61-2Carc. Cat. 2; R45

Xn; R65
T

R: 45-65

S: 53-45
H P
649-363-00-2Distillates (petroleum), depentanizer overheads;

Low boiling point naphtha — unspecified;

[A complex combination of hydrocarbons obtained from a catalytic cracked gas stream. It consists of aliphatic hydrocarbons having carbon numbers predominantly in the range of C4 through C6.]
270-771-868477-89-4Carc. Cat. 2; R45

Xn; R65
T

R: 45-65

S: 53-45
H P
649-364-00-8Residues (petroleum), butane splitter bottoms;

Low boiling point naphtha — unspecified;

[A complex residuum from the distillation of butane stream. It consists of aliphatic hydrocarbons having carbon numbers predominantly in the range of C4through C6.]
270-791-768478-12-6Carc. Cat. 2; R45

Xn; R65
T

R: 45-65

S: 53-45
H P
649-365-00-3Residual oils (petroleum), deisobutanizer tower;

Low boiling point naphtha — unspecified;

[A complex residuum from the atmospheric distillation of the butane-butylene stream. It consists of aliphatic hydrocarbons having carbon numbers predominantly in the range of C4 through C6.]
270-795-968478-16-0Carc. Cat. 2; R45

Xn; R65
T

R: 45-65

S: 53-45
H P
649-366-00-9Naphtha (petroleum), full-range coker;

Low boiling point naphtha — unspecified;

[A complex combination of hydrocarbons produced by the distillation of products from a fluid coker. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C4 through C15 and boiling in the range of approximately 43 oC to 250 oC (110 oF to 500 oF).]
270-991-468513-02-0Carc. Cat. 2; R45

Xn; R65
T

R: 45-65

S: 53-45
H P
649-367-00-4Naphtha (petroleum), steam-cracked middle arom.;

Low boiling point naphtha — unspecified;

[A complex combination of hydrocarbons produced by the distillation of products from a steam-cracking process. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C7 through C12 and boiling in the range of approximately 130 oC to 220 oC (266 oF to 428 oF).]
271-138-968516-20-1Carc. Cat. 2; R45

Xn; R65
T

R: 45-65

S: 53-45
H P
649-368-00-XNaphtha (petroleum), clay-treated full-range straight-run;

Low boiling point naphtha — unspecified;

[A complex combination of hydrocarbons resulting from treatment of full-range straight-run naphtha with natural or modified clay, usually in a percolation process to remove the trace amounts of polar compounds and impurities present. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C11 and boiling in the range of approximately - 20 oC to 220 oC (- 4 oF to 429 oF).]
271-262-368527-21-9Carc. Cat. 2; R45

Xn; R65
T

R: 45-65

S: 53-45
H P
649-369-00-5Naphtha (petroleum), clay-treated light straight-run;

Low boiling point naphtha — unspecified;

[A complex combination of hydrocarbons resulting from treatment of light straight-run naphtha with a natural or modified clay, usually in a percolation process to remove the trace amounts of polar compounds and impurities, present. It consists of hydro-carbons having carbon numbers predominantly in the range of C7 through C10 and boiling in the range of approximately 93 oC to 180 oC (200 oF to 356 oF.]
271-263-968527-22-0Carc. Cat. 2; R45

Xn; R65
T

R: 45-65

S: 53-45
H P
649-370-00-0Naphtha (petroleum), light steam-cracked arom.;

Low boiling point naphtha — unspecified;

[A complex combination of hydrocarbons produced by distillation of products from a steam-cracking process. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C7 through C9 and boiling in the range of approximately 110 oC to 165 oC (230 oF to 329 oF).]
271-264-468527-23-1Carc. Cat. 2; R45

Xn; R65
T

R: 45-65

S: 53-45
H P
649-371-00-6Naphtha (petroleum), light steam-cracked, debenzenized;

Low boiling point naphtha — unspecified;

[A complex combination of hydrocarbons produced by distillation of products from a steam-cracking process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C4 through C12 and boiling in the range of approximately 80 oC to 218 oC (176 oF to 424 oF).]
271-266-568527-26-4Carc. Cat. 2; R45

Xn; R65
T

R: 45-65

S: 53-45
H P
649-372-00-1Naphtha (petroleum), arom.-contg.;

Low boiling point naphtha — unspecified
271-635-068603-08-7Carc. Cat. 2; R45

Xn; R65
T

R: 45-65

S: 53-45
H P
649-373-00-7Gasoline, pyrolysis, debutanizer bottoms;

Low boiling point naphtha — unspecified;

[A complex combination of hydrocarbons obtained from the fractionation of depropanizer bottoms. It consists of hydrocarbons having carbon numbers predominantly greater than C5.]
271-726-568606-10-0Carc. Cat. 2; R45

Xn; R65
T

R: 45-65

S: 53-45
H P
649-374-00-2Naphtha (petroleum), light, sweetened;

Low boiling point naphtha — unspecified;

[A complex combination of hydrocarbons obtained by subjecting a petroleum distillate to a sweetening process to convert mercaptans or to remove acidic impurities. It consists predominantly of saturated and unsaturated hydrocarbons having carbon numbers predominantly in the range of C3 through C6 and boiling in the range of approximately - 20 oC to 100 oC (- 4 oF to 212 oF).]
272-206-068783-66-4Carc. Cat. 2; R45

Xn; R65
T

R: 45-65

S: 53-45
H P
649-375-00-8Natural gas condensates;

Low boiling point naphtha — unspecified;

[A complex combination of hydrocarbons separated and/or condensed from natural gas during transportation and collected at the wellhead and/or from the production, gathering, transmission, and distribution pipelines in deeps, scrubbers, etc. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C2 through C8.]
272-896-368919-39-1Carc. Cat. 2; R45

Xn; R65
T

R: 45-65

S: 53-45
H J
649-376-00-3Distillates (petroleum), naphtha unifiner stripper;

Low boiling point naphtha — unspecified;

[A complex combination of hydrocarbons produced by stripping the products from the naphtha unifiner. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C2 through C6.]
272-932-868921-09-5Carc. Cat. 2; R45

Xn; R65
T

R: 45-65

S: 53-45
H P
649-377-00-9Naphtha (petroleum), catalytic reformed light, arom.-free fraction;

Low boiling point naphtha — unspecified;

[A complex combination of hydrocarbons remaining after removal of aromatic compounds from catalytic reformed light naphtha in a selective absorption process. It consists predominantly of paraffinic and cyclic compounds having carbon numbers predominantly in the range of C5 to C8 and boiling in the range of approximately 66 oC to 121 oC (151 oF to 250 oF).]
285-510-385116-59-2Carc. Cat. 2; R45

Xn; R65
T

R: 45-65

S: 53-45
H P
649-378-00-4Gasoline;

Low boiling point naphtha — unspecified;

[A complex combination of hydrocarbons consisting primarily of paraffins, cycloparaffins, aromatic and olefinic hydrocarbons having carbon numbers predominantly greater than C3 and boiling in the range of 30 oC to 260 oC (86 oF to 500 oF).]
289-220-886290-81-5Carc. Cat. 2; R45

Xn; R65
T

R: 45-65

S: 53-45
H P
649-379-00-XAromatic hydrocarbons, C7-8, dealkylation products, distn. residues;

Low boiling point naphtha — unspecified
292-698-090989-42-7Carc. Cat. 2; R45

Xn; R65
T

R: 45-65

S: 53-45
H P
649-380-00-5Hydrocarbons, C4-6, depentanizer lights, arom. hydrotreater;

Low boiling point naphtha — unspecified;

[A complex combination of hydrocarbons obtained as first runnings from the depentanizer column before hydrotreatment of the aromatic charges. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C4 through C6, predominantly pentanes and pentenes, and boiling in the range of approximately 25 oC to 40 oC (77 oF to 104 oF).]
295-298-491995-38-9Carc. Cat. 2; R45

Xn; R65
T

R: 45-65

S: 53-45
H P
649-381-00-0Distillates (petroleum), heat-soaked steam-cracked naphtha, C5-rich;

Low boiling point naphtha — unspecified;

[A complex combination of hydrocarbons obtained by distillation of heat-soaked steam-cracked naphtha. It consists predominantly of hydrocarbons having carbon numbers in the range of C4 through C6, predominantly C5.]
295-302-491995-41-4Carc. Cat. 2; R45

Xn; R65
T

R: 45-65

S: 53-45
H P
649-382-00-6Extracts (petroleum), catalytic reformed light naphtha solvent;

Low boiling point naphtha — unspecified;

[A complex combination of hydrocarbons obtained as the extract from the solvent extraction of a catalytically reformed petroleum cut. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C7 through C8 and boiling in the range of approximately 100 oC to 200 oC (212 oF to 392 oF).]
295-331-291995-68-5Carc. Cat. 2; R45

Xn; R65
T

R: 45-65

S: 53-45
H P
649-383-00-1Naphtha (petroleum), hydrodesulfurized light, dearomatized; Low boiling point naphtha — unspecified;

[A complex combination of hydrocarbons obtained by distillation of hydrodesulfurized and dearomatized light petroleum fractions. It consists predominantly of C7 paraffins and cycloparaffins boiling in a range of approximately 90 oC to 100 oC (194 oF to 212 oF).]
295-434-292045-53-9Carc. Cat. 2; R45

Xn; R65
T

R: 45-65

S: 53-45
H P
649-384-00-7Naphtha (petroleum), light, C5-rich, sweetened;

Low boiling point naphtha — unspecified;

[A complex combination of hydrocarbons obtained by subjecting a petroleum naphtha to a sweetening process to convert mercaptans or to remove acidic impurities. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C5, predominantly C5, and boiling in the range of approximately minus 10 oC to 35 oC (14 oF to 95 oF).]
295-442-692045-60-8Carc. Cat. 2; R45

Xn; R65
T

R: 45-65

S: 53-45
H P
649-385-00-2Hydrocarbons, C8-11, naphtha-cracking, toluene cut;

Low boiling point naphtha — unspecified;

[A complex combination of hydrocarbons obtained by distillation from prehydrogenated cracked naphtha. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C8 through C11 and boiling in the range of approximately 130 oC to 205 oC (266 oF to 401 oF).]
295-444-792045-62-0Carc. Cat. 2; R45

Xn; R65
T

R: 45-65

S: 53-45
H P
649-386-00-8Hydrocarbons, C4-11, naphtha-cracking, arom.-free;

Low boiling point naphtha — unspecified;

[A complex combination of hydrocarbons obtained from prehydrogenated cracked naphtha after distillative separation of benzene- and toluene-containing hydrocarbon cuts and a higher boiling fraction. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range C4 through C11 and boiling in the range of approximately 30 oC to 205 oC (86 oF to 401 oF).]
295-445-292045-63-1Carc. Cat. 2; R45

Xn; R65
T

R: 45-65

S: 53-45
H P
649-387-00-3Naphtha (petroleum), light heat-soaked, steam-cracked;

Low boiling point naphtha — unspecified;

[A complex combination of hydrocarbons obtained by the fractionation of steam cracked naphtha after recovery from a heat soaking process. It consists predominantly of hydrocarbons having a carbon numbers predominantly in the range of C4 through C6 and boiling in the range of approximately 0 oC to 80 oC (32 oF to 176 oF.]
296-028-892201-97-3Carc. Cat. 2; R45

Xn; R65
T

R: 45-65

S: 53-45
H P
649-388-00-9Distillates (petroleum), C6-rich;

Low boiling point naphtha — unspecified;

[A complex combination of hydrocarbons obtained from the distillation of a petroleum feedstock. It consists predominantly of hydrocarbons having carbon numbers of C5 through C7, rich in C6, and boiling in the range of approximately 60 oC to 70 oC (140 oF to 158 oF).]
296-903-493165-19-6Carc. Cat. 2; R45

Xn; R65
T

R: 45-65

S: 53-45
H P
649-389-00-4Gasoline, pyrolysis, hydrogenated;

Low boiling point naphtha-unspecified;

[A distillation fraction from the hydrogenation of pyrolysis gasoline boiling in the range of approximately 20 oC to 200 oC (68 oF to 392 oF).]
302-639-394114-03-1Carc. Cat. 2; R45

Xn; R65
T

R: 45-65

S: 53-45
H P
649-390-00-XDistillates (petroleum), steam-cracked, C8-12 fraction, polymd., distn. lights;

Low boiling point naphtha — unspecified;

[A complex combination of hydrocarbons obtained by distillation of the polymerized C8 through C12 fraction from steam-cracked petroleum distillates. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C8 through C12.]
305-750-595009-23-7Carc. Cat. 2; R45

Xn; R65
T

R: 45-65

S: 53-45
H P
649-391-00-5Extracts (petroleum) heavy naphtha solvent, clay-treated;

Low boiling point naphtha — unspecified;

[A complex combination of hydrocarbons obtained by the treatment of heavy naphthic solvent petroleum extract with bleaching earth. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C6 through C18 and boiling in the range of approximately 80 oC to 180 oC (175 oF to 356 oF).]
308-261-597926-43-7Carc. Cat. 2; R45

Xn; R65
T

R: 45-65

S: 53-45
H P
649-392-00-0Naphtha (petroleum), light steam-cracked, debenzenized, thermally treated;

Low boiling point naphtha — unspecified;

[A complex combination of hydrocarbons obtained by the treatment and distillation of debenzenized light steam-cracked petroleum naphtha. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C7 through C12 and boiling in the range of approximately 95 oC to 200 oC (203 oF to 392 oF).]
308-713-198219-46-6Carc. Cat. 2; R45

Xn; R65
T

R: 45-65

S: 53-45
H P
649-393-00-6Naphtha (petroleum), light steam-cracked, thermally treated;

Low boiling point naphtha — unspecified;

[A complex combination of hydrocarbons obtained by the treatment and distillation of light steam-cracked petroleum naphtha. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C5 through C6 and boiling in the range of approximately 35 oC to 80 oC (95 oF to 176 oF).]
308-714-798219-47-7Carc. Cat. 2; R45

Xn; R65
T

R: 45-65

S: 53-45
H P
649-394-00-1Distillates (petroleum), C7-9, C8-rich, hydrodesulfurized dearomatized;

Low boiling point naphtha — unspecified;

[A complex combination of hydrocarbons obtained by the distillation of petroleum light fraction, hydrodesulfurized and dearomatized. It consists predominantly of hydrocarbons having carbon numbers in the range of C7 through C9, predominantly C8 paraffins and cycloparaffins, boiling in the range of approximately 120 oC to 130 oC (248 oF to 266 oF).]
309-862-5101316-56-7Carc. Cat. 2; R45

Xn; R65
T

R: 45-65

S: 53-45
H P
649-395-00-7Hydrocarbons, C6-8, hydrogenated sorption-dearomatized, toluene raffination;

Low boiling point naphtha — unspecified;

[A complex combination of hydrocarbons obtained during the sorptions of toluene from a hydrocarbon fraction from cracked gasoline treated with hydrogen in the presence of a catalyst. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C6 through C8 and boiling in the range of approximately 80 oC to 135 oC (176 oF to 275 oF).]
309-870-9101316-66-9Carc. Cat. 2; R45

Xn; R65
T

R: 45-65

S: 53-45
H P
649-396-00-2Naphtha (petroleum), hydrodesulfurized full-range coker;

Low boiling point naphtha — unspecified;

[A complex combination of hydrocarbons obtained by fractionation from hydrodesulfurized coker distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C5 to C11 and boiling in the range of approximately 23 oC to 196 oC (73 oF to 385 oF).]
309-879-8101316-76-1Carc. Cat. 2; R45

Xn; R65
T

R: 45-65

S: 53-45
H P
649-397-00-8Naphtha (petroleum), sweetened light;

Low boiling point naphtha — unspecified;

[A complex combination of hydrocarbons obtained by subjecting a petroleum naphtha to a sweetening process to convert mercaptans or to remove acidic impurities. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C5 through C8 and boiling in the range of approximately 20 oC to 130 oC (68 oF to 266 oF).]
309-976-5101795-01-1Carc. Cat. 2; R45

Xn; R65
T

R: 45-65

S: 53-45
H P
649-398-00-3Hydrocarbons, C3-6, C5-rich, steam-cracked naphtha;

Low boiling point naphtha — unspecified;

[A complex combination of hydrocarbons obtained by distillation of steam-cracked naphtha. It consists predominantly of hydrocarbons having carbon numbers in the range of C3 through C6, predominantly C5.]
310-012-0102110-14-5Carc. Cat. 2; R45

Xn; R65
T

R: 45-65

S: 53-45
H P
649-399-00-9Hydrocarbons, C5-rich, dicyclopentadiene-contg.;

Low boiling point naphtha — unspecified;

[A complex combination of hydrocarbons obtained by distillation of the products from a stream-cracking process. It consists predominantly of hydrocarbons having carbon numbers of C5 and dicyclopentadiene and boiling in the range of approximately 30 oC to 170 oC (86 oF to 338 oF).]
310-013-6102110-15-6Carc. Cat. 2; R45

Xn; R65
T

R: 45-65

S: 53-45
H P
649-400-00-2Residues (petroleum), steam-cracked light, arom.;

Low boiling point naphtha — unspecified;

[A complex combination of hydrocarbons obtained by the distillation of the products of steam cracking or similar processes after taking off the very light products resulting in a residue starting with hydrocarbons having carbon numbers greater than C5. It consists predominantly of aromatic hydrocarbons having carbon numbers greater than C5 and boiling above approximately 40 oC (104 oF).]
310-057-6102110-55-4Carc. Cat. 2; R45

Xn; R65
T

R: 45-65

S: 53-45
H P
649-401-00-8Hydrocarbons, C ≥ 5, C5-6-rich;

Low boiling point naphtha — unspecified
270-690-868476-50-6Carc. Cat. 2; R45

Xn; R65
T

R: 45-65

S: 53-45
H P
649-402-00-3Hydrocarbons, C5-rich;

Low boiling point naphtha — unspecified
270-695-568476-55-1Carc. Cat. 2; R45

Xn; R65
T

R: 45-65

S: 53-45
H P
649-403-00-9Aromatic hydrocarbons, C8-10;

Low boiling point naphtha — unspecified
292-695-490989-39-2Carc. Cat. 2; R45

Xn; R65
T

R: 45-65

S: 53-45
H P
649-404-00-4Kerosine (petroleum);

Straight run kerosine;

[A complex combination of hydrocarbons produced by the distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C9 through C16 and boiling in the range of approximately 150 oC to 290 oC (320 oF to 554 oF).]
232-366-48008-20-6Xn; R65Xn

R: 65

S: (2-)23-24-62
H
649-405-00-XSolvent naphtha (petroleum), medium aliph.;

Straight run kerosine;

[A complex combination of hydrocarbons obtained from the distillation of crude oil or natural gasoline. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C9 through C12 and boiling in the range of approximately 140 oC to 220 oC (284 oF to 428 oF).]
265-191-764742-88-7Xn; R65Xn

R: 65

S: (2-)23-24-62
H
649-406-00-5Solvent naphtha (petroleum) heavy aliph.;

Straight run kerosine;

[A complex combination of hydrocarbons obtained from the distillation of crude oil or natural gasoline. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C11 through C16 and boiling in the range of approximately 190 oC to 290 oC (374 oF to 554 oF).]
265-200-464742-96-7Xn; R65Xn

R: 65

S: (2-)23-24-62
H
649-407-00-0Kerosine (petroleum), straight-run wide-cut;

Straight run kerosine;

[A complex combination of hydrocarbons obtained as a wide cut hydrocarbon fuel cut from atmospheric distillation and boiling in the range of approximately 70 oC to 220 oC (158 oF to 428 oF).]
295-418-592045-37-9Xn; R65Xn

R: 65

S: (2-)23-24-62
H
649-408-00-6Distillates (petroleum), steam-cracked;

Cracked kerosine;

[A complex combination of hydrocarbons obtained by the distillation of the products from a steam cracking process. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C7 through C16 and boiling in the range of approximately 90 oC to 290 oC (190 oF to 554 oF).]
265-194-364742-91-2Xn; R65Xn

R: 65

S: (2-)23-24-62
H
649-409-00-1Distillates (petroleum), cracked stripped steam-cracked petroleum distillates, C8-10 fraction;

Cracked kerosine;

[A complex combination of hydrocarbons obtained by distilling cracked stripped steam-cracked distillates. It consists of hydro-carbons having carbon numbers in the range of C8 through C10 and boiling in the range of approximately 129 oC to 194 oC (264 oF to 382 oF).]
270-728-368477-39-4Xn; R65Xn

R: 65

S: (2-)23-24-62
H
649-410-00-7Distillates (petroleum), cracked stripped steam-cracked petroleum distillates, C10-12 fraction;

Cracked kerosine;

[A complex combination of hydrocarbons obtained by distilling cracked stripped steam-cracked distillates. It consists predominantly of aromatic hydrocarbons having carbon numbers in the range of C10 through C12.]
270-729-968477-40-7Xn; R65Xn

R: 65

S: (2-)23-24-62
H
649-411-00-2Distillates (petroleum), steam-cracked, C8-12 fraction;

Cracked kerosine;

[A complex combination of organic compounds obtained by the distillation of products from a steam cracking process. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C8 through C12.]
270-737-268477-54-3Xn; R65Xn

R: 65

S: (2-)23-24-62
H
649-412-00-8Kerosine (petroleum), hydrodesulfurized thermal cracked;

Cracked kerosine;

[A complex combination of hydrocarbons obtained by fractionation from hydrodesulfurized thermal cracker distillate. It consists predominantly of hydrocarbons predominantly in the range of C8 to C16 and boiling in the range of approximately 120 oC to 283 oC (284 oF to 541 oF).]
285-507-785116-55-8Xn; R65Xn

R: 65

S: (2-)23-24-62
H
649-413-00-3Aromtic hydrocarbons, C≥10, steam-cracking, hydrotreated;

Cracked kerosine;

[A complex combination of hydrocarbons produced by the distillation of the products from a steam cracking process treated with hydrogen in the presence of a catalyst. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly greater than C10 and boiling in the range of approximately 150 oC to 320 oC (302 oF to 608 oF).]
292-621-090640-98-5Xn; R65Xn

R: 65

S: (2-)23-24-62
H
649-414-00-9Naphtha (petroleum), steam-cracked, hydrotreated, C9-10-arom.-rich;

Cracked kerosine;

[A complex combination of hydrocarbons produced by the distillation of the products from a steam cracking process thereafter treated with hydrogen in the presence of a catalyst. It consists predominantly of aromatic hydrocarbons having carbon numbers in the range of C9 through C10 and boiling in the range of approximately 140 oC to 200 oC (284 oF to 392 oF).]
292-637-890641-13-7Xn; R65Xn

R: 65

S: (2-)23-24-62
H
649-415-00-4Distillates (petroleum), thermal-cracked, alkylarom. hydrocarbon-rich;

Cracked kerosine;

[A complex combination of hydrocarbons obtained by distillation of thermal-cracking heavy tars. It consists predominantly of highly alkylated aromatic hydrocarbons boiling in the range of approximately 100 oC to 250 oC (212 oF to 482 oF.]
309-866-7101316-61-4Xn; R65Xn

R: 65

S: (2-)23-24-62
H
649-416-00-XDistillates (petroleum), catalytic cracked heavy tar light;

Cracked kerosine;

[A complex combination of hydrocarbons obtained by distillation of catalytic cracking heavy tars. It consists predominantly of highly alkylated aromatic hydrocarbons boiling in the range of approximately 100 oC to 250 oC (212 oF to 482 oF).]
309-938-8101631-13-4Xn; R65Xn

R: 65

S: (2-)23-24-62
H
649-417-00-5Solvent naphtha (petroleum), hydrocracked heavy arom.;

Cracked kerosine;

[A complex combination of hydrocarbons obtained by the distillation of hydrocracked petroleum distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C9 through C16 and boiling in the range of approximately 235 oC to 290 oC (455 oF to 554 oF).]
309-881-9101316-80-7Xn; R65Xn

R: 65

S: (2-)23-24-62
H
649-418-00-0Distillates (petroleum), steam-cracked heavy tar light;

Cracked kerosine;

[A complex combination of hydrocarbons obtained by distillation of steam cracking heavy tars. It consists predominantly of highly alkylated aromatic hydrocarbons boiling in the range of approximately 100 oC to 250 oC (212 oF to 482 oF).]
309-940-9101631-15-6Xn; R65Xn

R: 65

S: (2-)23-24-62
H
649-419-00-6Distillates (petroleum), alkylate;

Kerosine — unspecified;

[A complex combination of hydrocarbons produced by distillation of the reaction products of isobutane with monoolefinic hydrocarbons usually ranging in carbon numbers from C3 through C5. It consists of predominantly branched chain saturated hydro-carbons having carbon numbers predominantly in the range of C11 through C17 and boiling in the range of approximately 205 oC to 320 oC (401 oF to 608 oF).]
265-074-064741-73-7Xn; R65Xn

R: 65

S: (2-)23-24-62
H
649-420-00-1Extracts (petroleum), heavy naphtha solvent;

Kerosine — unspecified;

[A complex combination of hydrocarbons obtained as the extract from a solvent extraction process. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C7 through C12 and boiling in the range of approximately 90 oC to 220 oC (194 oF to 428 oF).]
265-099-764741-98-6Xn; R65Xn

R: 65

S: (2-)23-24-62
H
649-421-00-7Distillates (petroleum), chemically neutralized light;

Kerosine — unspecified;

[A complex combination of hydrocarbons produced by a treating process to remove acidic materials. It consists of hydrocarbons having carbon numbers predominantly in the range of C9 through C16 and boiling in the range of approximately 150 oC to 290 oC (302 oF to 554 oF).]
265-132-564742-31-0Xn; R65Xn

R: 65

S: (2-)23-24-62
H
649-422-00-2Distillates (petroleum), hydrotreated light;

Kerosine — unspecified;

[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly in the range of C9 through C16 and boiling in the range of approximately 150 oC to 290 oC (302 oF to 554 oF).]
265-149-864742-47-8Xn; R65Xn

R: 65

S: (2-)23-24-62
H
649-423-00-8Kerosine (petroleum), hydrodesulfurized;

Kerosine — unspecified;

[A complex combination of hydrocarbons obtained from a petroleum stock by treating with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists of hydrocarbons having carbon numbers predominantly in the range of C9 through C16 and boiling in the range of approximately 150 oC to 290 oC (302 oF to 554 oF).]
265-184-964742-81-0Xn; R65Xn

R: 65

S: (2-)23-24-62
H
649-424-00-3Solvent naphtha (petroleum), heavy arom.; Kerosine — unspecified;

[A complex combination of hydrocarbons obtained from distillation of aromatic streams. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C9 through C16 and boiling in the range of approximately 165 oC to 290 oC (330 oF to 554 oF).]
265-198-564742-94-5Xn; R65Xn

R: 65

S: (2-)23-24-62
H
649-425-00-9Naphtha (petroleum), heavy coker;

Kerosine — unspecified;

[A complex combination of hydrocarbons from the distillation of products from a fluid coker. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C6 through C15 and boiling in the range of approximately 157 oC to 288 oC (315 oF to 550 oF).]
269-778-968333-23-3Xn; R65Xn

R: 65

S: (2-)23-24-62
H
649-426-00-4Naphtha (petroleum), catalytic reformed hydrodesulfurized heavy, arom. fraction;

Kerosine — unspecified;

[A complex combination of hydrocarbons produced by fractionation from catalytically reformed hydrodesulfurized naphtha. It consists predominantly of aromatic hydrocarbons having carbon numbers predominently in the range of C7 to C 13 and boiling in the range of approximately 98 oC to 218 oC (208 oF to 424 oF).]
285-508-285116-57-0Xn; R65Xn

R: 65

S: (2-)23-24-62
H
649-427-00-XKerosine (petroleum), sweetened;

Kerosine — unspecified;

[A complex combination of hydrocarbons obtained by subjecting a petroleum distillate to a sweetening process to convert mercaptans or to remove acidic impurities. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C9 through C16 and boiling in the range of 130 oC to 290 oC (266 oF to 554 oF).]
294-799-591770-15-9Xn; R65Xn

R: 65

S: (2-)23-24-62
H
649-428-00-5Kerosine (petroleum), solvent-refined sweetened;

Kerosine — unspecified;

[A complex combination of hydrocarbons obtained from a petroleum stock by solvent refining and sweetening and boiling in the range of approximately 150 oC to 260 oC (302 oF to 500 oF).]
295-416-492045-36-8Xn; R65Xn

R: 65

S: (2-)23-24-62
H
649-429-00-0Hydrocarbons, C9-16, hydrotreated, dearomatized;

Kerosine — unspecified;

[A complex combination of hydrocarbons obtained as solvents which have been subjected to hydrotreatment in order to convert aromatics to naphthenes by catalytic hydrogenation.]
297-854-193763-35-0Xn; R65Xn

R: 65

S: (2-)23-24-62
H
649-430-00-6Kerosine (petroleum), solvent-refined hydrodesulfurized;

Kerosine — unspecified
307-033-297488-94-3Xn; R65Xn

R: 65

S: (2-)23-24-62
H
649-431-00-1Distillates (petroleum), hydrodesulfurized full-range middle coker;

Kerosine — unspecified;

[A complex combination of hydrocarbons obtained by fractionation from hydrodesulfurized coker distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C8 through C16 and boiling in the range of approximately 120 oC to 283 oC (248 oF to 541 oF).]
309-864-6101316-58-9Xn; R65Xn

R: 65

S: (2-)23-24-62
H
649-432-00-7Solvent naphtha (petroleum), hydrodesulfurized heavy arom.;

Kerosine — unspecified;

[A complex combination of hydrocarbons obtained by the catalytic hydrodesulfurization of a petroleum fraction. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C10 through C13 and boiling in the range of approximately 180 oC to 240 oC (356 oF to 464 oF).]
309-882-4101316-81-8Xn; R65Xn

R: 65

S: (2-)23-24-62
H
649-433-00-2Solvent naphtha (petroleum), hydrodesulfurized medium;

Kerosine — unspecified;

[A complex combination of hydrocarbons obtained by the catalytic hydrodesulfurization of a petroleum fraction. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C10 through C13 and boiling in the range of approximately 175 oC to 220 oC (347 oF to 428 oF).]
309-884-5101316-82-9Xn; R65Xn

R: 65

S: (2-)23-24-62
H
649-434-00-8Kerosine (petroleum), hydrotreated;

Kerosine — unspecified;

[A complex combination of hydrocarbons obtained from the distillation of petroleum and subsequent hydrotreatment. It consists predominantly of alkanes, cycloalkanes and alkylbenzenes having carbon numbers predominantly in the range of C12 through C16 and boiling in the range of approximately 230 oC to 270 oC (446 oF to 518 oF).]
309-944-0101631-19-0Xn; R65Xn

R: 65

S: (2-)23-24-62
H
649-435-00-3Distillates (petroleum), light catalytic cracked;

Cracked gasoil;

[A complex combination of hydrocarbons produced by the distillation of products from a catalytic cracking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C9 through C25 and boiling in the range of approximately 150 oC to 400 oC (302 oF to 752 oF). It contains a relatively large proportion of bicyclic aromatic hydrocarbons.]
265-060-464741-59-9Carc. Cat. 2; R45T

R: 45

S: 53-45
H
649-436-00-9Distillates (petroleum), intermediate catalytic cracked;

Cracked gasoil;

[A complex combination of hydrocarbons produced by the distillation of products from a catalytic cracking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C11 through C30 and boiling in the range of approximately 205 oC to 450 oC (401 oF to 842 oF). It contains a relatively large proportion of tricyclic aromatic hydrocarbons.]
265-062-564741-60-2Carc. Cat. 2; R45T

R: 45

S: 53-45
H
649-437-00-4Distillates (petroleum), light hydrocracked;

Cracked gasoil;

[A complex combination of hydrocarbons from distillation of the products from a hydrocracking process. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C10 through C18 and boiling in the range of approximately 160 oC to 320 oC (320 oF to 608 oF).]
265-078-264741-77-1Carc. Cat. 3; R40Xn

R: 40

S: (2-)36/37
H
649-438-00-XDistillates (petroleum), light thermal cracked;

Cracked gasoil;

[A complex combination of hydrocarbons from the distillation of the products from a thermal cracking process. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C10 through C22 and boiling in the range of approximately 160 oC to 370 oC (320 oF to 698 oF).]
265-084-564741-82-8Carc. Cat. 2; R45T

R: 45

S: 53-45
H
649-439-00-5Distillates (petroleum), hydrodesulfurized light catalytic cracked;

Cracked gasoil;

[A complex combination of hydrocarbons obtained by treating light catalytic cracked distillates with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists of hydrocarbons having carbon numbers predominantly in the range of C9 through C25 and boiling in the range of approximately 150 oC to 400 oC (302 oF to 752 oF). It contains a relatively large proportion of bicyclic aromatic hydrocarbons.]
269-781-568333-25-5Carc. Cat. 2; R45T

R: 45

S: 53-45
H
649-440-00-0Distillates (petroleum), light steam-cracked naphtha;

Cracked gasoil;

[A complex combination of hydrocarbons from the multiple distillation of products from a steam cracking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C10 through C18.]
270-662-568475-80-9Carc. Cat. 2; R45T

R: 45

S: 53-45
H
649-441-00-6Distillates (petroleum), cracked steam-cracked petroleum distillates;

Cracked gasoil;

[A complex combination of hydrocarbons produced by distilling cracked steam cracked distillate and/or its fractionation products. It consists of hydrocarbons having carbon numbers predominently in the range of C10 to low molecular weight polymers.]
270-727-868477-38-3Carc. Cat. 2; R45T

R: 45

S: 53-45
H
649-442-00-1Gas oils (petroleum), steam-cracked;

Cracked gasoil;

[A complex combination of hydrocarbons produced by distillation of the products from a steam cracking process. It consists of hydrocarbons having carbon numbers predominantly greater than C9 and boiling in the range of from approximately 205 oC to 400 oC (400 oF to 752 oF).]
271-260-268527-18-4Carc. Cat. 2; R45T

R: 45

S: 53-45
H
649-443-00-7Distillates (petroleum), hydrodesulfurized thermal cracked middle;

Cracked gasoil;

[A complex combination of hydrocarbons obtained by fractionation from hydrodesulfurized themal cracker distillate stocks. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C11 to C25 and boiling in the range of approximately 205 oC to 400 oC (401 oF to 752 oF).]
285-505-685116-53-6Carc. Cat. 2; R45T

R: 45

S: 53-45
H
649-444-00-2Gas oils (petroleum), thermal-cracked, hydrodesulfurized;

Cracked gasoil
295-411-792045-29-9Carc. Cat. 2; R45T

R: 45

S: 53-45
H
649-445-00-8Residues (petroleum), hydrogenated steam-cracked naphtha;

Cracked gasoil;

[A complex combination of hydrocarbons obtained as a residual fraction from the distillation of hydrotreated steam-cracked naphtha. It consists predominantly of hydrocarbons boiling in the range of approximately 200 oC to 350 oC (32 oF to 662 oF).]
295-514-792062-00-5Carc. Cat. 2; R45T

R: 45

S: 53-45
H
649-446-00-3Residues (petroleum), steam-cracked naphtha distn.;

Cracked gasoil;

[A complex combination of hydrocarbons obtained as a column bottom from the separation of effluents from steam cracking naphtha at a high temperature. It boils in the range of approximately 147 oC to 300 oC (297 oF to 572 oF) and produces a finished oil having a viscosity of 18cSt at 50 oC.]
295-517-392062-04-9Carc. Cat. 2; R45T

R: 45

S: 53-45
H
649-447-00-9Distillates (petroleum), light catalytic cracked, thermally degraded;

Cracked gasoil;

[A complex combination of hydrocarbons produced by the distillation of products from a catalytic cracking process which has been used as a heat transfer fluid. It consists predominantly of hydrocarbons boiling in the range of approximately 190 oC to 340 oC (374 oF to 644 oF). This stream is likely to contain organic sulfur compounds.]
295-991-192201-60-0Carc. Cat. 2; R45T

R: 45

S: 53-45
H
649-448-00-4Residues (petroleum), steam-cracked heat-soaked naphtha;

Cracked gasoil;

[A complex combination of hydrocarbons obtained as residue from the distillation of steam cracked heat soaked naphtha and boiling in the range of approximately 150 oC to 350 oC (302 oF to 662 oF).]
297-905-893763-85-0Carc. Cat. 2; R45T

R: 45

S: 53-45
H
649-449-00-XHydrocarbons, C16-20, solvent-dewaxed hydrocracked paraffinic distn. residue;

Cracked gasoil;

[A complex combination of hydrocarbons obtained by solvent dewaxing of a distillation residue from a hydrocracked paraffinic distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C16 through C20 and boiling in the range of approximately 360 oC to 500 oC (680 oF to 932 oF). It produces a finished oil having a viscosity of 4,5 cSt at approximately 100 oC (212 oF).]
307-662-297675-88-2Carc. Cat. 3; R40Xn

R: 40

S: (2-)36/37
H
649-450-00-5Gas oils (petroleum), light vacuum, thermal-cracked hydrodesulfurized;

Cracked gasoil;

[A complex combination of hydrocarbons obtained by catalytic dehydrosulfurization of thermal-cracked light vacuum petroleum. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C14 through C20 and boiling in the range of approximately 270 oC to 370 oC (518 oF to 698 oF).]
308-278-897926-59-5Carc. Cat. 2; R45T

R: 45

S: 53-45
H
649-451-00-0Distillates (petroleum), hydrodesulfurized middle coker;

Cracked gasoil;

[A complex combination of hydrocarbons by fractionation from hydrodesulfurised coker distillate stocks. Is consists of hydro-carbons having carbon numbers predominantly in the range of C12 through C21 and boiling in the range of approximately 200 oC to 360 oC (392 oF to 680 oF).]
309-865-1101316-59-0Carc. Cat. 2; R45T

R: 45

S: 53-45
H
649-452-00-6Distillates (petroleum), heavy steam-cracked;

Cracked gasoil;

[A complex combination of hydrocarbons obtained by distillation of steam cracking heavy residues. It consists predominantly of highly alkylated heavy aromatic hydrocarbons boiling in the range of approximately 250 oC to 400 oC (482 oF to 752 oF).]
309-939-3101631-14-5Carc. Cat. 2; R45T

R: 45

S: 53-45
H
649-453-00-1Distillates (petroleum), heavy hydrocracked;

Baseoil — unspecified;

[A complex combination of hydrocarbons from the distillation of the products from a hydrocracking process. It consists predominantly of saturated hydrocarbons having carbon numbers in the range of C15-C39 and boiling in the range of approximately 260 oC to 600 oC (500 oF to 1112 oF).]
265-077-764741-76-0Carc. Cat. 2; R45T

R: 45

S: 53-45
H L
649-454-00-7Distillates (petroleum), solvent-refined heavy paraffinic;

Baseoil — unspecified;

[A complex combination of hydrocarbons obtained as the raffinate from a solvent extraction process. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100 oF (19cSt at 40 oC).]
265-090-864741-88-4Carc. Cat. 2; R45T

R: 45

S: 53-45
H L
649-455-00-2Distillates (petroleum), solvent-refined light paraffinic;

Baseoil — unspecified;

[A complex combination of hydrocarbons obtained as the raffinate from a solvent extraction process. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC).]
265-091-364741-89-5Carc. Cat. 2; R45T

R: 45

S: 53-45
H L
649-456-00-8Residual oils (petroleum), solvent deasphalted;

Baseoil — unspecified;

[A complex combination of hydrocarbons obtained as the solvent soluble fraction from C3-C4 solvent deasphalting of a residuum. It consists of hydrocarbons having carbon numbers predominantly higher than C25 and boiling above approximately 400 oC (752 oF).]
265-096-064741-95-3Carc. Cat. 2; R45T

R: 45

S: 53-45
H L
649-457-00-3Distillates (petroleum), solvent-refined heavy naphthenic;

Baseoil — unspecified;

[A complex combination of hydrocarbons obtained as the raffinate from a solvent extraction process. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100 oF (19cSt a 40 oC). It contains relatively few normal paraffins.]
265-097-664741-96-4Carc. Cat. 2; R45T

R: 45

S: 53-45
H L
649-458-00-9Distillates (petroleum), solvent-refined light naphthenic;

Baseoil — unspecified;

[A complex combination of hydrocarbons obtained as the raffinate from a solvent extraction process. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.]
265-098-164741-97-5Carc. Cat. 2; R45T

R: 45

S: 53-45
H L
649-459-00-4Residual oils (petroleum,) solvent-refined;

Baseoil — unspecified;

[A complex combination by hydrocarbons obtained as the solvent insoluble fraction from solvent refining of a residuum using a polar organic solvent such as phenol or furfural. It consists of hydrocarbons having carbon numbers predominantly higher than C25 and boiling above approximately 400 oC (752 oF).]
265-101-664742-01-4Carc. Cat. 2; R45T

R: 45

S: 53-45
H L
649-460-00-XDistillates (petroleum), clay-treated paraffinic;

Baseoil — unspecified;

[A complex combination of hydrocarbons resulting from treatment of a petroleum fraction with natural or modified clay in either a contacting or percolation process to remove the trace amounts of polar compounds and impurities present. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100 oF (19cSt at 40 oC). It contains a relatively large proportion of saturated hydrocarbons.]
265-137-264742-36-5Carc. Cat. 2; R45T

R: 45

S: 53-45
H L
649-461-00-5Distillates (petroleum), clay-treated light paraffinic;

Baseoil — unspecified;

[A complex combination of hydrocarbons resulting from treatment of a petroleum fraction with natural or modified clay in either a contacting or percolation process to remove the trace amounts of polar compounds and impurities present. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC). It contains a relatively large proportion of saturated hydrocarbons.]
265-138-864742-37-6Carc. Cat. 2; R45T

R: 45

S: 53-45
H L
649-462-00-0Residual oils (petroleum), clay-treated;

Baseoil — unspecified;

[A complex combination of hydrocarbons obtained by treatment of a residual oil with a natural or modified clay in either a contacting or percolation process to remove the trace amounts of polar compounds and impurities present. It consists of hydro-carbons having carbon numbers predominantly higher than C25 and boiling above approximately 400 oC (752 oF).]
265-143-564742-41-2Carc. Cat. 2; R45T

R: 45

S: 53-45
H L
649-463-00-6Distillates (petroleum), clay-treated heavy naphthenic;

Baseoil — unspecified;

[A complex combination of hydrocarbons resulting from treatment of a petroleum fraction with natural or modified clay in either a contacting or percolation process to remove the trace amounts of polar compounds and impurities present. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.]
265-146-164742-44-5Carc. Cat. 2; R45T

R: 45

S: 53-45
H L
649-464-00-1Distillates (petroleum), clay-treated light naphthenic;

Baseoil — unspecified;

[A complex combination of hydrocarbons resulting from treatment of a petroleum fraction with natural or modified clay in either a contacting or percolation process to remove the trace amounts of polar compounds and impurities present. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.]
265-147-764742-45-6Carc. Cat. 2; R45T

R: 45

S: 53-45
H L
649-465-00-7Distillates (petroleum), hydrotreated heavy naphthenic;

Baseoil — unspecified;

[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil of at least 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.]
265-155-064742-52-5Carc. Cat. 2; R45T

R: 45

S: 53-45
H L
649-466-00-2Distillates (petroleum), hydrotreated light naphthenic;

Baseoil — unspecified;

[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.]
265-156-664742-53-6Carc. Cat. 2; R45T

R: 45

S: 53-45
H L
649-467-00-8Distillates (petroleum), hydrotreated heavy paraffinic;

Baseoil — unspecified;

[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil of at least 100 SUS at 100 oF (19cSt at 40 oC). It contains a relatively large proportion of saturated hydrocarbons.]
265-157-164742-54-7Carc. Cat. 2; R45T

R: 45

S: 53-45
H L
649-468-00-3Distillates (petroleum), hydrotreated light paraffinic;

Baseoil — unspecified;

[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC). It contains a relatively large proportion of saturated hydrocarbons.]
265-158-764742-55-8Carc. Cat. 2; R45T

R: 45

S: 53-45
H L
649-469-00-9Distillates (petroleum), solvent-dewaxed light paraffinic;

Baseoil — unspecified;

[A complex comination of hydrocarbons obtained by removal of normal paraffins from a petroleum fraction by solvent crystallization. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC).]
265-159-264742-56-9Carc. Cat. 2; R45T

R: 45

S: 53-45
H L
649-470-00-4Residual oils (petroleum), hydrotreated;

Baseoil — unspecified;

[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly greater than C25 and boiling above approximately 400 oC (752 oF).]
265-160-864742-57-0Carc. Cat. 2; R45T

R: 45

S: 53-45
H L
649-471-00-XResidual oils (petroleum), solvent-dewaxed;

Baseoil — unspecified;

[A complex combination of hydrocarbons obtained by removal of long, branched chain hydrocarbons from a residual oil by solvent crystallization. It consists of hydrocarbons having carbon numbers predominantly greater than C25 and boiling above approximately 400 oC (752 oF).]
265-166-064742-62-7Carc. Cat. 2; R45T

R: 45

S: 53-45
H L
649-472-00-5Distillates (petroleum), solvent-dewaxed heavy naphthenic;

Baseoil — unspecified;

[A complex combination of hydrocarbons obtained by removal of normal paraffins from a petroleum fraction by solvent crystallization. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 . through C50 and produces a finished oil of not less than 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.]
265-167-664742-63-8Carc. Cat. 2; R45T

R: 45

S: 53-45
H L
649-473-00-0Distillates (petroleum), solvent-dewaxed light naphthenic;

Baseoil — unspecified;

[A complex combination of hydrocarbons obtained by removal of normal paraffins from a petroleum fraction by solvent crystallization. It consists of hydrocarbons having carbon numbers predominantly in the range C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.]
265-168-164742-64-9Carc. Cat. 2; R45T

R: 45

S: 53-45
H L
649-474-00-6Distillates (petroleum), solvent-dewaxed heavy paraffinic;

Baseoil — unspecified;

[A complex combination of hydrocarbons obtained by removal of normal paraffins from a petroleum fraction by solvent crystallization. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity not less than 100 SUS at 100 oF (19cSt at 40 oC).]
265-169-764742-65-0Carc. Cat. 2; R45T

R: 45

S: 53-45
H L
649-475-00-1Naphthenic oils (petroleum), catalytic dewaxed heavy;

Baseoil — unspecified;

[A complex combination of hydrocarbons obtained from a catalytic dewaxing process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.]
265-172-364742-68-3Carc. Cat. 2; R45T

R: 45

S: 53-45
H L
649-476-00-7Naphthenic oils (petroleum), catalytic dewaxed light;

Baseoil — unspecified;

[A complex combination of hydrocarbons obtained from a catalytic dewaxing process. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity less than 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.]
265-173-964742-69-4Carc. Cat. 2; R45T

R: 45

S: 53-45
H L
649-477-00-2Paraffin oils (petroleum), catalytic dewaxed heavy;

Baseoil — unspecified;

[A complex combination of hydrocarbons obtained from a catalytic dewaxing process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100 oF (19cSt at 40 oC).]
265-174-464742-70-7Carc. Cat. 2; R45T

R: 45

S: 53-45
H L
649-478-00-8Paraffin oils (petroleum), catalytic dewaxed light;

Baseoil — unspecified;

[A complex combination of hydrocarbons obtained from a catalytic dewxing process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC).]
265-176-564742-71-8Carc. Cat. 2; R45T

R: 45

S: 53-45
H L
649-479-00-3Naphthenic oils (petroleum), complex dewaxed heavy;

Baseoil — unspecified;

[A complex combination of hydrocarbons obtained by removing straight chain paraffin hydrocarbons as a solid by treatment with an agent such as urea. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil having a viscosity of at least 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.]
265-179-164742-75-2Carc. Cat. 2; R45T

R: 45

S: 53-45
H L
649-480-00-9Naphthenic oils (petroleum), complex dewaxed light;

Baseoil — unspecified;

[A complex combination of hydrocarbons obtained from a catalytic dewaxing process. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil having a viscosity less than 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.]
265-180-764742-76-3Carc. Cat. 2; R45T

R: 45

S: 53-45
H L
649-481-00-4Lubricating oils (petroleum), C20-50, hydrotreated neutral oil-based, high-viscosity;

Baseoil — unspecified;

[A complex combination of hydrocarbons obtained by treating light vacuum gas oil, heavy vacuum gas oil, and solvent deasphalted residual oil with hydrogen in the presence of a catalyst in a two stage process with dewaxing being carried out between the two stages. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil having a viscosity of approximately 112cSt at 40 oC. It contains a relatively large proportion of saturated hydrocarbons.]
276-736-372623-85-9Carc. Cat. 2; R45T

R: 45

S: 53-45
H L
649-482-00-XLubricating oils (petroleum), C15-30, hydrotreated neutral oil-based;

Baseoil — unspecified;

[A complex combination of hydrocarbons obtained by treating light vacuum gas oil and heavy vacuum gas oil with hydrogen in the presence of a catalyst in a two stage process with dewaxing being carried out between the two stages. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil having a viscosity of approximately 15cSt at 40 oC. It contains a relatively large proportion of saturated hydrocabons.]
276-737-972623-86-0Carc. Cat. 2; R45T

R: 45

S: 53-45
H L
649-483-00-5Lubricating oils (petroleum), C20-50, hydrotreated neutral oil-based;

Baseoil — unspecified;

[A complex combination of hydrocarbons obtained by treating light vacuum gas oil, heavy vacuum gas oil and solvent deasphalted residual oil with hydrogen in the presence of a catalyst in a two stage process with dewaxing being carried out between the two stages. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of approximately 32cSt at 40 oC. It contains a relatively large proportion of saturated hydrocarbons.]
276-738-472623-87-1Carc. Cat. 2; R45T

R: 45

S: 53-45
H L
649-484-00-0Lubricating oils;

Baseoil — unspecified;

[A complex combination of hydrocarbons obtained from solvent extraction and dewaxing processes. It consists predominantly of saturated hydrocarbons having carbon numbers in the range C15 through C50.]
278-012-274869-22-0Carc. Cat. 2; R45T

R: 45

S: 53-45
H L
649-485-00-6Distillates (petroleum), complex dewaxed heavy paraffinci;

Baseoil — unspecified;

[A complex combination of hydrocarbons obtained by dewaxing heavy paraffinic distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of equal to or greater than 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.]
292-613-790640-91-8Carc. Cat. 2; R45T

R: 4

S: 53-45
H L
649-486-00-1Distillates (petroleum), complex dewaxed light paraffinic;

Baseoil — unspecified;

[A complex combination of hydrocarbons obtained by dewaxing light paraffinic distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C12 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.]
292-614-290640-92-9Carc. Cat. 2; R45T

R: 45

S: 53-45
H L
649-487-00-7Distillates (petroleum), solvent dewaxed heavy paraffinic, clay-treated;

Baseoil — unspecified;

[A complex combination of hydrocarbons obtained by treating dewaxed heavy paraffinic distillate with neutral or modified clay in either a contacting or percolation process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C50.]
292-616-390640-94-1Carc. Cat. 2; R45T

R: 45

S: 53-45
H L
649-488-00-2Hydrocarbons, C20-50, solvent dewaxed heavy paraffinic, hydrotreated;

Baseoil — unspecified;

[A complex combination of hydrocarbons produced by treating dewaxed heavy paraffinic distillate with hydrogen in the presence of a catalyst. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C50.]
292-617-990640-95-2Carc. Cat. 2; R45T

R: 45

S: 53-45
H L
649-489-00-8Distillates (petroleum), solvent dewaxed light paraffinic, clay-treated;

Baseoil — unspecified;

[A complex combination of hydrocarbons resulting from treatment of dewaxed light paraffinic distillate with natural or modified clay in either a contacting or percolation process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C15 through C30.]
292-618-490640-96-3Carc. Cat. 2; R45T

R: 45

S: 53-45
H L
649-490-00-3Distillates (petroleum), solvent dewaxed light paraffinic, hydrotreated;

Baseoil — unspecified;

[A complex combination of hydrocarbons produced by treating a dewaxed light paraffinic distillate with hydrogen in the presence of a catalyst. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C15 through C30.]
292-620-590640-97-4Carc. Cat. 2; R45T

R: 45

S: 53-45
H L
649-491-00-9Residual oils (petroleum), hydrotreated solvent dewaxed;

Baseoil — unspecified
292-656-190669-74-2Carc. Cat. 2; R45T

R: 45

S: 53-45
H L
649-492-00-4Residual oils (petroleum), catalytic dewaxed;

Baseoil — unspecified
294-843-391770-57-9Carc. Cat. 2; R45T

R: 45

S: 53-45
H L
649-493-00-XDistillates (petroleum), dewaxed heavy paraffinic, hydrotreated;

Baseoil — unspecified;

[A complex combination of hydrocarbons obtained from an intensive treatment of dewaxed distillate by hydrogenation in the presence of a catalyst. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C25 through C39 and produces a finished oil with a viscosity of approximately 44 cSt at 50 oC.]
295-300-391995-39-0Carc. Cat. 2; R45T

R: 45

S: 53-45
H L
649-494-00-5Distillates (petroleum), dewaxed light paraffinic, hydrotreated;

Baseoil — unspecified;

[A complex combination of hydrocarbons obtained from an intensive treatment of dewaxed distillate by hydrogenation in the presence of a catalyst. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C21 through C29 and produces a finished oil with a viscosity of approximately 13 cSt at 50 oC.]
295-301-991995-40-3Carc. Cat. 2; R45T

R: 45

S: 53-45
H L
649-495-00-0Distillates (petroleum), hydrocracked solvent-refined, dewaxed;

Baseoil — unspecified;

[A complex combination of liquid hydrocarbons obtained by recrystallization of dewaxed hydrocracked solvent-refined petroleum distillates.]
295-306-691995-45-8Carc. Cat. 2; R45T

R: 45

S: 53-45
H L
649-496-00-6Distillates (petroleum), solvent-refined light naphthenic, hydrotreated;

Baseoil — unspecified;

[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst and removing the aromatic hydrocarbons by solvent extraction. It consists predominantly of naphthenic hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of between 13-15cSt at 40 oC.]
295-316-091995-54-9Carc. Cat. 2; R45T

R: 45

S: 53-45
H L
649-497-00-1Lubricating oils (petroleum), C17-35, solvent-extd., dewaxed, hydrotreated;

Baseoil — unspecified
295-423-292045-42-6Carc. Cat. 2; R45T

R: 45

S: 53-45
H L
649-498-00-7Lubricating oils (petroleum), hydrocracked nonarom. solvent-deparaffined;

Baseoil — unspecified
295-424-892045-43-7Carc. Cat. 2; R45T

R: 45

S: 53-45
H L
649-499-00-2Residual oils (petroleum), hydrocracked acid-treated solvent-dewaxed;

Baseoil — unspecified;

[A complex combination of hydrocarbons produced by solvent removal of paraffins from the residue of the distillation of acid-treated, hydrocracked heavy paraffins and boiling approximately above 380 oC (716 oF).]
295-499-792061-86-4Carc. Cat. 2; R45T

R: 45

S: 53-45
H L
649-500-00-6Paraffin oils (petroleum), solvent-refined dewaxed heavy;

Baseoil — unspecified;

[A complex combination of hydrocarbons obtained from sulfur-containing paraffinic crude oil. It consists predominantly of a solvent refined deparaffinated lubricating oil with a viscosity of 65cSt at 50 oC.]
295-810-692129-09-4Carc. Cat. 2; R45T

R: 45

S: 53-45
H L
649-501-00-1Lubricating oils (petroleum), base oils, paraffinic;

Baseoil — unspecified;

[A complex combination of hydrocarbons obtained by refining of crude oil. It consists predominantly of aromatics, naphthenics and paraffinics and produces a finished oil with a viscosity of 120 SUS at 100 oF (23cSt at 40 oC).]
297-474-693572-43-1Carc. Cat. 2; R45T

R: 45

S: 53-45
H L
649-502-00-7Hydrocarbons, hydrocracked paraffinic distn. residues, solvent-dewaxed;

Baseoil — unspecified
297-857-893763-38-3Carc. Cat. 2; R45T

R: 45

S: 53-45
H L
649-503-00-2Hydrocarbons, C20-50, residual oil hydrogenation vacuum distillate;

Baseoil — unspecified
300-257-193924-61-9Carc. Cat. 2; R45T

R: 45

S: 53-45
H L
649-504-00-8Distillates (petroleum), solvent-refined hydrotreated heavy, hydrogenated;

Baseoil — unspecified
305-588-594733-08-1Carc. Cat. 2; R45T

R: 45

S: 53-45
H L
649-505-00-3Distillates (petroleum), solvent-refined hydrocracked light;

Baseoil — unspecified;

[A complex combination of hydrocarbons obtained by solvent dearomatization of the residue of hydrocracked petroleum. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C18 through C27 and boiling in the range of approximately 370 oC to 450 oC (698 oF to 842 oF).]
305-589-094733-09-2Carc. Cat. 2; R45T

R: 45

S: 53-45
H L
649-506-00-9Lubricating oils (petroleum), C18-40, solvent-dewaxed hydrocracked distillate-based;

Baseoil — unspecified;

[A complex combination of hydrocarbons obtained by solvent deparaffination of the distillation residue from hydrocracked petroleum. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C18 through C40 and boiling in the range of approximately 370 oC to 550 oC (698 oF to 1022 oF).]
305-594-894733-15-0Carc. Cat. 2; R45T

R: 45

S: 53-45
H L
649-507-00-4Lubricating oils (petroleum), C18-40, solvent-dewaxed hydrogenated raffinate-based;

Baseoil — unspecified;

[A complex combination of hydrocarbons obtained by solvent deparaffination of the hydrogenated raffinate obtained by solvent extraction of a hydrotreated petroleum distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C18 through C40 and boiling in the range of approximately 370 oC to 550 oC (698 oF to 1022 oF).]
305-595-394733-16-1Carc. Cat. 2; R45T

R: 45

S: 53-45
H L
649-508-00-XHydrocarbons, C13-30, arom.-rich, solvent-extd. naphthenic distillate;

Baseoil — unspecified
305-971-795371-04-3Carc. Cat. 2; R45T

R: 45

S: 53-45
H L
649-509-00-5Hydrocarbons, C16-32, arom. rich, solvent-extd. naphthenic distillate;

Baseoil — unspecified
305-972-295371-05-4Carc. Cat. 2; R45T

R: 45

S: 53-45
H L
649-510-00-0Hydrocarbons, C37-68, dewaxed deasphalted hydrotreated vacuum distn. residues;

Baseoil — unspecified
305-974-395371-07-6Carc. Cat. 2; R45T

R: 45

S: 53-45
H L
649-511-00-6Hydrocarbons, C37-65, hydrotreated deasphalted vacuum distn. residues;

Baseoil — unspecified
305-975-995371-08-7Carc. Cat. 2; R45T

R: 45

S: 53-45
H L
649-512-00-1Distillates (petroleum), hydrocracked solvent-refined light;

Baseoil — unspecified;

[A complex combination of hydrocarbons obtained by the solvent treatment of a distillate from hydrocracked petroleum distillates. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C18 through C27 and boiling in the range of approximately 370 oC to 450 oC (698 oF to 842 oF.]
307-010-797488-73-8Carc. Cat. 2; R45T

R: 45

S: 53-45
H L
649-513-00-7Distillates (petroleum), solvent-refined hydrogenated heavy;

Baseoil — unspecified;

[A complex combination of hydrocarbons, obtained by the treatment of a hydrogenated petroleum distillate with a solvent. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C19 through C40 and boiling in the range of approximately 390 oC to 550 oC (734 oF to 1022 oF).]
307-011-297488-74-9Carc. Cat. 2; R45T

R: 45

S: 53-45
H L
649-514-00-2Lubricating oils (petroleum), C18-27, hydrocracked solvent-dewaxed;

Baseoil — unspecified
307-034-897488-95-4Carc. Cat. 2; R45T

R: 45

S: 53-45
H L
649-515-00-8Hydrocarbons, C17-30, hydrotreated solvent-deasphalted atm. distn. residue, distn. lights;

Baseoil — unspecified;

[A complex combination of hydrocarbons obtained as first runnings from the vacuum distillation of effluents from the treatment of a solvent deasphalted short residue with hydrogen in the presence of a catalyst. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C17 through C30 and boiling in the range of approximately 300 oC to 400 oC (572 oF to 752 oF). It produces a finished oil having a viscosity of 4cSt at approximately 100 oC (212 oF).]
307-661-797675-87-1Carc. Cat. 2; R45T

R: 45

S: 53-45
H L
649-516-00-3Hydrocarbons, C17-40, hydrotreated solvent-deasphalted distn. residue, vacuum distn. lights;

Baseoil — unspecified;

[A complex combination of hydrocarbons obtained as first runnings from the vacuum distillation of effluents from the catalytic hydrotreatment of a solvent deasphalted short residue having a viscosity of 8cSt at approximately 100 oC (212 oF). It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C17 through C40 and boiling in the range of approximately 300 oC to 500 oC (592 oF to 932 oF).]
307-755-897722-06-0Carc. Cat. 2; R45T

R: 45

S: 53-45
H L
649-517-00-9Hydrocarbons, C13-27, solvent-extd. light naphthenic;

Baseoil — unspecified;

[A complex combination of hydrocarbons obtained by extraction of the aromatics from a light naphthenic distillate having a viscosity of 9.5cSt at 40 oC (104 oF). It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C13 through C27 and boiling in the range of approximately 240 oC to 400 oC (464 oF to 752 oF.]
307-758-497722-09-3Carc. Cat. 2; R45T

R: 45

S: 53-45
H L
649-518-00-4Hydrocarbons, C14-29, solvent-extd. light naphthenic;

Baseoil — unspecified;

[A complex combination of hydrocarbons obtained by extraction of the aromatics from a light naphthenic distillate having a viscosity of 16cSt at 40 oC (104 oF). It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C14 through C29 and boiling in the range of approximately 250 oC to 425 oC (482 oF to 797 oF).]
307-760-597722-10-6Carc. Cat. 2; R45T

R: 45

S: 53-45
H L
649-519-00-XHydrocarbons, C27-42, dearomatized;

Baseoil — unspecified
308-131-897862-81-2Carc. Cat. 2; R45T

R: 45

S: 53-45
H L
649-520-00-5Hydrocarbons, C17-30, hydrotreated distillates, distn. lights;

Baseoil — unspecified
308-132-397862-82-3Carc. Cat. 2; R45T

R: 45

S: 53-45
H L
649-521-00-0Hydrocarbons, C27-45, naphthenic vacuum distn.;

Baseoil — unspecified
308-133-997862-83-4Carc. Cat. 2; R45T

R: 45

S: 53-45
H L
649-522-00-6Hydrocarbons, C27-45, dearomatized;

Baseoil — unspecified
308-287-797926-68-6Carc. Cat. 2; R45T

R: 45

S: 53-45
H L
649-523-00-1Hydrocarbons, C20-58, hydrotreated;

Baseoil — unspecified
308-289-897926-70-0Carc. Cat. 2; R45T

R: 45

S: 53-45
H L
649-524-00-7Hydrocarbons, C27-42, naphthenic;

Baseoil — unspecified
308-290-397926-71-1Carc. Cat. 2; R45T

R: 45

S: 53-45
H L
649-525-00-2Residual oils (petroleum), carbon-treated solvent-dewaxed;

Baseoil — unspecified;

[A complex combination of hydrocarbons obtained by the treatment of solvent-dewaxed petroleum residual oils with activated charcoal for the removal of trace polar constituents and impurities.]
309-710-8100684-37-5Carc. Cat. 2; R45T

R: 45

S: 53-45
H L
649-526-00-8Residual oils (petroleum), clay-treated solvent-dewaxed;

Baseoil — unspecified;

[A complex combination of hydrocarbons obtained by treatment of solvent-dewaxed petroleum residual oils with bleaching earth for the removal of trace polar constituents and impurities.]
309-711-3100684-38-6Carc. Cat. 2; R45T

R: 45

S: 53-45
H L
649-527-00-3Lubricating oils (petroleum), C >25, solvent-extd., deasphalted, dewaxed, hydrogenated;

Baseoil — unspecified;

[A complex combination of hydrocarbons obtained by solvent extraction and hydrogenation of vacuum distillation residues. It consists predominantly of hydrocarbons having carbon numbers predominantly greater than C25 and produces a finished oil with a viscosity in the order of 32cSt to 37cSt at 100 oC (212 oF).]
309-874-0101316-69-2Carc. Cat. 2; R45T

R: 45

S: 53-45
H L
649-528-00-9Lubricating oils (petroleum), C17-32, solvent-extd., dewaxed, hydrogenated;

Baseoil — unspecified;

[A complex combination of hydrocarbons obtained by solvent extraction and hydrogenation of atmospheric distillation residues. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C17 through C32 and produced a finished oil with a viscosity in the order of 17cSt to 23cSt at 40 oC (104 oF.]
309-875-6101316-70-5Carc. Cat. 2; R45T

R: 45

S: 53-45
H L
649-529-00-4Lubricating oils (petroleum), C20-35, solvent-extd., dewaxed, hydrogenated;

Baseoil — unspecified;

[A complex combination of hydrocarbons obtained by solvent extraction and hydrogenation of atmospheric distillation residues. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C35 and produces a finished oil with a viscosity in the order of 37cSt to 44cSt at 40 oC (104 oF).]
309-876-1101316-71-6Carc. Cat. 2; R45T

R: 45

S: 53-45
H L
649-530-00-XLubricating oils (petroleum), C24-50, solvent-extd., dewaxed, hydrogenated;

Baseoil — unspecified;

[A complex combination of hydrocarbons obtained by solvent extraction and hydrogenation of atmospheric distillation residues. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C24 through C50 and produces a finished oil with a viscosity in the order of 16cSt to 75cSt at 40 oC (104 oF).]
309-877-7101316-72-7Carc. Cat. 2; R45T

R: 45

S: 53-45
H L
649-531-00-5Extracts (petroleum), heavy naphthenic distillate solvent, arom. conc.;

Distillate aromatic extract (treated);

[An aromatic concentrate produced by adding water to heavy naphthenic distillate solvent extract and extraction solvent.]
272-175-368783-00-6Carc. Cat. 2; R45T

R: 45

S: 53-45
H L
649-532-00-0Extracts (petroleum), solvent-refined heavy paraffinic distillate solvent;

Distillate aromatic extract (treated);

[A complex combination of hydrocarbons obtained as the extract from the re-extraction of solvent-refined heavy paraffinic distillate. It consists of saturated and aromatic hydrocarbons having carbon numbers predominantly in the range of C20 through C50.]
272-180-068783-04-0Carc. Cat. 2; R45T

R: 45

S: 53-45
H L
649-533-00-6Extracts (petroleum), heavy paraffinic distillates, solvent-deasphalted;

Distillate aromatic extract (treated);

[A complex combination of hydrocarbons obtained as the extract from a solvent extraction of heavy paraffinic distillate.]
272-342-068814-89-1Carc. Cat. 2; R45T

R: 45

S: 53-45
H L
649-534-00-1Extracts (petroleum), heavy naphthenic distillate solvent, hydrotreated;

Distillate aromatic extract (treated);

[A complex combination of hydrocarbons obtained by treating a heavy naphthenic distillate solvent extract with hydrogen in the presence of a catalyst. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil of at least 19cSt at 40 oC (100 SUS at 100 oF).]
292-631-590641-07-9Carc. Cat. 2; R45T

R: 45

S: 53-45
H L
649-535-00-7Extracts (petroleum), heavy paraffinic distillate solvent, hydrotreated;

Distillate aromatic extract (treated);

[A complex combination of hydrocarbons produced by treating a heavy paraffinic distillate solvent extract with hydrogen in the presence of a catalyst. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C21 through C33 and boiling in the range of approximately 350 oC to 480 oC (662 oF to 896 oF).
292-632-090641-08-0Carc. Cat. 2; R45T

R: 45

S: 53-45
H L
649-536-00-2Extracts (petroleum), light paraffinic distillate solvent, hydrotreated;

Distillate aromatic extract (treated);

[A complex combination of hydrocarbons produced by treating a light paraffinic distillate solvent extract with hydrogen in the presence of a catalyst. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C17 through C26 and boiling in the range of approximately 280 oC to 400 oC (536 oF to 752 oF).]
292-633-690641-09-1Carc. Cat. 2; R45T

R: 45

S: 53-45
H L
649-537-00-8Extracts (petroleum), hydrotreated light paraffinic distillate solvent;

Distillate aromatic extract (treated);

[A complex combination of hydrocarbons obtained as the extract from solvent extraction of intermediate paraffinic top solvent distillate that is treated with hydrogen in the presence of a catalyst. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C16 through C36.]
295-335-491995-73-2Carc. Cat. 2; R45T

R: 45

S: 53-45
H L
649-538-00-3Extracts (petroleum), light naphthenic distillate solvent, hydrodesulfurized;

Distillate aromatic extract (treated);

[A complex combination of hydrocarbons obtained by treating the extract, obtained from a solvent extraction process, with hydrogen in the presence of a catalyst under conditions primarily to remove sulfur compounds. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C15 through C30. This stream is likely to contain 5 wt.% or more of 4- to 6-membered condensed ring aromatic hydrocarbons.]
295-338-091995-75-4Carc. Cat. 2; R45T

R: 45

S: 53-45
H L
649-539-00-9Extracts (petroleum), light paraffinic distillate solvent, acid-treated;

Distillate aromatic extract (treated);

[A complex combination of hydrocarbons obtained as a fraction of the distillation of an extract from the solvent extraction of light paraffinic top petroleum distillates that is subjected to a sulfuric acid refining. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C16 through C32.]
295-339-691995-76-5Carc. Cat. 2; R45T

R: 45

S: 53-45
H L
649-540-00-4Extracts (petroleum), light paraffinic distillate solvent, hydrodesulfurized;

Distillate aromatic extract (treated);

[A complex combination of hydrocarbons obtained by solvent extraction of a light paraffin distillate and treated with hydrogen to convert the organic sulfur to hydrogen sulfide which is eliminated. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C15 through C40 and produces a finished oil with a viscosity of greater than 10cSt at 40 oC.]
295-340-191995-77-6Carc. Cat. 2; R45T

R: 45

S: 53-45
H L
649-541-00-XExtracts (petroleum), light vacuum gas oil solvent, hydrotreated;

Distillate aromatic extract (treated);

[A complex combination of hydrocarbons, obtained by solvent extraction from light vacuum petroleum gas oils and treated with hydrogen in the presence of a catalyst. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C13 through C30.]
295-342-291995-79-8Carc. Cat. 2; R45T

R: 45

S: 53-45
H L
649-542-00-5Extracts (petroleum), heavy paraffinic distillate solvent, clay-treated;

Distillate aromatic extract (treated);

[A complex combination of hydrocarbons resulting from treatment of a petroleum fraction with natural or modified clay in either a contact or percolation process to remove the trace amounts of polar compounds and impurities present. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C20 through C50. This stream is likely to contain 5 wt.% or more 4-6 membered ring aromatic hydrocarbons.]
296-437-192704-08-0Carc. Cat. 2; R45T

R: 45

S: 53-45
H L
649-543-00-0Extracts (petroleum), heavy naphthenic distillate solvent, hydrodesulfurized;

Distillate aromatic extract (treated);

[A complex combination of hydrocarbons obtained from a petroleum stock by treating with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C15 through C50 and produces a finished oil with a viscosity of greater than 19cSt at 40 oC.]
297-827-493763-10-1Carc. Cat. 2; R45T

R: 45

S: 53-45
H L
649-544-00-6Extracts (petroleum), solvent-dewaxed heavy paraffinic distillate solvent, hydrodesulfurized;

Distillate aromatic extract (treated);

[A complex combination of hydrocarbons obtained from a solvent dewaxed petroleum stock by treating with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C15 through C50 and produces a finished oil with a viscosity of greater than 19cSt at 40 oC.]
297-829-593763-11-2Carc. Cat. 2; R45T

R: 45

S: 53-45
H L
649-545-00-1Extracts (petroleum), light paraffinic distillate solvent, carbon-treated;

Distillate aromatic extract (treated);

[A complex combination of hydrocarbons obtained as a fraction from distillation of an extract recovered by solvent extraction of light paraffinic top petroleum distillate treated with activated charcoal to remove traces of polar constituents and impurities. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C16 through C32.]
309-672-2100684-02-4Carc. Cat. 2; R45T

R: 45

S: 53-45
H L
649-546-00-7Extracts (petroleum), light paraffinic distillate solvent, clay-treated;

Distillate aromatic extract (treated);

[A complex combination of hydrocarbons obtained as a fraction from distillation of an extract recovered by solvent extraction of light paraffinic top petroleum distillates treated with bleaching earth to remove traces of polar constituents and impurities. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C16 through C32.]
309-673-8100684-03-5Carc. Cat. 2; R45T

R: 45

S: 53-45
H L
649-547-00-2Extracts (petroleum), light vacuum, gas oil solvent, carbon-treated;

Distillate aromatic extract (treated);

[A complex combination of hydrocarbons obtained by solvent extraction of light vacuum petroleum gas oil treated with activated charcoal for the removal of trace polar constituents and impurities. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C13 through C30.]
309-674-3100684-04-6Carc. Cat. 2; R45T

R: 45

S: 53-45
H L
649-548-00-8Extracts (petroleum), light vacuum gas oil solvent, clay-treated;

Distillate aromatic extract (treated);

[A complex combination of hydrocarbons obtained by solvent extraction of light vacuum petroleum gas oils treated with bleaching earth for removal of trace polar constituents and impurities. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C13 through C30.]
309-675-9100684-05-7Carc. Cat. 2; R45T

R: 45

S: 53-45
H L
649-549-00-3Foots oil (petroleum);

Foots oil;

[A complex combination of hydrocarbons obtained as the oil fraction from a solvent deoiling or a wax sweating process. It consists predominantly of branched chain hydrocarbons having carbon numbers predominantly in the range of C20 through C50.]
265-171-864742-67-2Carc. Cat. 2; R45T

R: 45

S: 53-45
H L
649-550-00-9Foots oil (petroleum), hydrotreated;

Foots oil
295-394-692045-12-0Carc. Cat. 2; R45T

R: 45

S: 53-45
H L
650-002-00-6turpentine, oil232-350-78006-64-2R10

Xn; R20/21/22-65

Xi; R36/38

R43

N; R51-53
Xn; N

R: 10-20/21/22-36/38-43-51/53-65

S: (2-)36/37-46-61-62
650-003-00-1fenson (ISO);

4-chlorophenyl benzenesulphonate;
201-274-680-38-6Xn; R22

Xi; R36

N; R51-53
Xn; N

R: 22-36-51/53

S: (2-)24-26-61
650-004-00-7norbormide (ISO);

5-(α-hydroxy-α-2-pyridylbenzyl)-7-(α-2-pyridylbenzylidene)bicyclo [2.2.1] hept-5-ene-2,3-dicarboximide
213-589-6991-42-4Xn; R22Xn

R: 22

S: (2-)
650-005-00-2(2R,6aS,12aS)-1,2,6,6a,12,12a-hexahydro-2-isopropenyl-8,9-dimethoxychromeno[3,4-b]furo[2,3-h]chromen-6-one, rotenone201-501-983-79-4T; R25

Xi; R36/37/38

N; R50-53
T; N

R: 25-36/37/38-50/53

S: (1/2-)22-24/25-36-45-60-61
650-006-00-8benquinox (ISO);

p-benzoquinone 1-benzoylhydrazone 4-oxime
207-807-9495-73-8T; R25

Xn; R21
T

R: 21-25

S: (1/2-)36/37-45
650-007-00-3chlordimeform (ISO);

N 2-(4-chloro-o-tolyl)-N 1,N 1-dimethylformamidine
228-200-56164-98-3Carc. Cat. 3; R40

Xn; R21/22

N; R50-53
Xn; N

R: 21/22-40-50/53

S: (2-)22-36/37-60-61
650-008-00-9drazoxolon (ISO);

4-(2-chlorophenylhydrazone)-3-methyl-5-isoxazolone
227-197-85707-69-7T; R25

N; R50-53
T; N

R: 25-50/53

S: (1/2-)22-24-36/37-45-60-61
650-009-00-4chlordimeform hydrochloride;

N'-(4-chloro-o-tolyl)-N,N-dimethylformamidine monohydrochloride;

N 2-(4-chloro-o-tolyl)-N 1,N 1-dimethylformamidine hydorchloride
243-269-119750-95-9Carc. Cat. 3; R40

Xn; R22

N; R50-53
Xn; N

R: 22-40-50/53

S: (2-)22-36/37-60-61
650-010-00-Xbenzyl violet 4B; α-[4-(4-dimethylamino-α-{4-[ethyl(3-sodiosulphonatobenzyl)amino] phenyl}benzylidene)cyclohexa-2,5-dienylidene(ethyl)ammonio]toluene-3-sulphonate216-901-91694-09-3Carc. Cat. 3; R40Xn

R: 40

S: (2-)36/37
650-012-00-0erionite12510-42-8Carc. Cat. 1; R45T

R: 45

S: 53-45
650-013-00-6asbestos












12001-28-4

132207-32-0

12172-73-5

77536-66-4

77536-68-6

77536-67-5

12001-29-5
Carc. Cat. 1; R45

T; R48/23
T

R: 45-48/23 S: 53-45
E
650-014-00-1diethyl 2,4-dihydroxycyclodisiloxane-2,4-diylbis(trimethylene)diphosphonate, tetrasodium salt, reaction products with disodium metasilicate401-770-4C; R34

Xn; R22
C

R: 22-34

S: (1/2-)26-36/37/39-45
650-015-00-7rosin; colophony232-475-7

232-484-6

277-299-1
8050-09-7

8052-10-6

73138-82-6
R43Xi

R: 43

S: (2-)24-37
650-016-00-2Mineral wool, with the exception of those specified elsewhere in this Annex;

[Man-made vitreous (silicate) fibres with random orientation with alkaline oxide and alkali earth oxide (Na2O+K2O+CaO+MgO+BaO) content greater than 18 % by weight]
Carc. Cat. 3; R40

Xi; R38
Xn

R: 38-40

S: (2-)36/37
AQR
650-017-00-8Refractory Ceramic Fibres;

Special Purpose Fibres, with the exception of those specified elsewhere in this Annex;

[Man-made vitreous (silicate) fibres with random orientation with alkaline oxide and alkali earth oxide (Na2O+K2O+CaO+ MgO+BaO) content less or equal to 18 % by weight]
Carc. Cat. 2; R49

Xi; R38
T

R: 49-38

S: 53-45
A R
650-018-00-3reaction product of: acetophenone, formaldehyde, cyclohexylamine, methanol and acetic acid406-230-1R10

Carc. Cat. 3; R40

C; R34

Xn; R20

R43

N; R50-53
C; N

R: 10-20-34-40-43-50/53

S: (1/2-)26-36/37/39-45-60-61
650-031-00-4bis(4-hydroxy-N-methylanilinium) sulphate200-237-155-55-0Xn; R22-48/22

R43

N; R50-53
Xn; N

R: 22-43-48/22-50/53

S: (2-)36/37-46-60-61
650-032-00-Xcyproconazole (ISO);

(2RS,3RS;2RS,3SR)-2-(4-chlorophenyl)-3-cyclopropyl-1-(1H-1,2,4-triazol-1-yl)butan-2-ol
94361-06-5Repr. Cat. 3; R63

Xn; R22

N; R50-53
Xn; N

R: 22-50/53-63

S: (2-)36/37-60-61
650-033-00-5(S)-α-cyano-3-phenoxybenzyl-(S)-2-(4-chlorophenyl)-3-methylbutyrate; esfenvalerate66230-04-4T; R23/25

R43

N; R50-53
T; N

R: 23/25-43-50/53

S: (1/2-)24-36/37/39-45-60-61
650-041-00-9triasulfuron (ISO);

1-[2-(2-chloroethoxy)phenylsulfonyl]-3-(4-methoxy-6-methyl-1,3,5-triazin-2-yl)urea
82097-50-5N; R50-53N

R: 50/53

S: 60-61
650-042-00-4reaction product of: polyethylene-polyamine-(C16-C18)-alkylamides with monothio-(C2)-alkyl phosphonates417-450-2Xi; R36/38

R43

R52-53
Xi

R: 36/38-43-52/53

S: (2-)24-26-37-61
650-043-00-Xreaction product of: 3,5-bis-tert-butylsalicylic acid and aluminiumsulfate420-310-3Xn; R22

N; R50-53
Xn; N

R: 22-50/53

S: (2-)22-56-60-61
650-044-00-5mixed linear and branched C14-15 alcohols ethoxylated, reaction product with epichlorohydrin420-480-9158570-99-1Xi; R38

R43

N; R50-53
Xi; N

R: 38-43-50/53

S: (2-)24-37-60-61
650-045-00-0reaction product of: 1,2,3-propanetricarboxylic acid, 2-hydroxy, diethyl ester, 1-propanol and zirconium tetra-n-propanolate417-110-3F; R11

Xi; R38-41

N; R51-53
F; Xi; N

R: 11-38-41-51/53

S: (2-)9-16-26-37/39-61
650-046-00-6di(tetramethylammonium)(29H,31H-phthalocyanin-N29,N30,N31,N32)disulfonamide disulfonate, cuprate(2-)complex, derivates416-180-212222-04-7Xn; R22-48/22

N; R51-53
Xn; N

R: 22-48/22-51/53

S: (2-)22-36-61
650-047-00-1dibenzylphenylsulfonium hexafluoroantimonate417-760-8134164-24-2T; R48/25

Xn; R22

Xi; R41

R43

N; R51-53
T; N

R: 22-41-43-48/25-51/53

S: (1/2-)22-26-36/37/39-45-61
650-048-00-7reaction product of: borax, hydrogen peroxide, acetic acid anhydride and acetic acid420-070-1O; R7

Xn; R20/21/22

C; R35

N; R50
O; C; N

R: 7-20/21/22-35-50

S: (1/2-)3/7-14-26-36/37/39-45-61
650-049-00-22-alkoyloxyethyl hydrogen maleate, where alkoyl represents (by weight) 70 to 85 % unsaturated octadecoyl, 0.5 to 10 % saturated octadecoyl, and 2 to 18 % saturated hexadecoyl417-960-5Xi; R38-41

R43

N; R50-53
Xi; N

R: 38-41-43-50/53

S: (2-)24-26-37/39-60-61
650-050-00-8reaction mass of: 1-methyl-3-hydroxypropyl 3,5-[1,1-dimethylethyl]-4-hydroxydihydro-cinnamate and/or 3-hydroxybutyl 3,5-[1,1-dimethylethyl]-4-hydroxydihydrocinnamate;

1,3-butanediol bis[3-(3'-(1,1-dimethylethyl)4'-hydroxy-phenyl)propionate] isomers;

1,3-butanediol bis[3-(3',5'-(1,1-dimethylethyl)-4'-hydroxyphenyl)propionate] isomers
423-600-8N; R51-53N

R: 51/53

S: 61
650-055-00-5silver sodium zirconium hydrogenphosphate422-570-3155925-27-2N; R50-53N

R: 50/53

S: 60-61



(1) OJ C 146A, 15.6.1990.

(2) see Note U in 1.1.3.



ANNEX VII

Translation table from classification under Directive 67/548/EEC to classification under this Regulation

This Annex includes a table to assist translation of a classification made for a substance or a mixture under Directive 67/548/EEC or Directive 1999/45/EC, respectively, into the corresponding classification under this Regulation. Whenever data for the substance or mixture are available, an evaluation and classification shall be done in accordance with Articles 9 to13 of this Regulation.

1. Translation table

The codes used are introduced in Table 1.1 and section 1.1.2.2 of Annex VI.

Table 1.1

Translation between classification in accordance with Directive 67/548/EEC and this Regulation

Classification under Directive 67/548/EECPhysical state of the substance when relevantClassification under this RegulationNote
Hazard Class-and-CategoryHazard statement
E; R2No direct translation possible.
E; R3No direct translation possible.
O; R7Org. Perox. CDH242
Org. Perox. EFH242
O; R8gasOx. Gas 1H270
O; R8liquid, solidNo direct translation possible.
O; R9liquidOx. Liq. 1H271
O; R9solidOx. Sol. 1H271
R10liquidNo direct translation possible.

Correct translation of R10, liquid is:

Flam. Liq. 1, H224 if flashpoint < 23 oC and initial boiling point ≤ 35 oC

Flam. Liq. 2, H225 if flashpoint < 23 oC and initial boiling point > 35 oC

Flam. Liq. 3, H226 if flashpoint ≥ 23 oC
F; R11liquidNo direct translation possible.

Correct translation of F; R11, liquid is:

Flam. Liq. 1, H224 if initial boiling point ≤ 35 oC

Flam. Liq. 2, H225 if initial boiling point > 35 oC
F; R11solidNo direct translation possible.
F+; R12gasNo direct translation possible.

Correct translation of F+; R12, gaseous results either in Flam. Gas 1, H220 or Flam. Gas 2, H221.
F+; R12liquidFlam. Liq. 1H224
F+; R12liquidSelf-react. CDH242
Self-react. EFH242
Self-react. Gnone
F; R15No translation possible.
F; R17liquidPyr. Liq. 1H250
F; R17solidPyr. Sol. 1H250
Xn; R20gasAcute Tox. 4H332(1)
Xn; R20vapoursAcute Tox. 4H332(1)
Xn; R20dust/mistAcute Tox. 4H332
Xn; R21Acute Tox. 4H312(1)
Xn; R22Acute Tox. 4H302(1)
T; R23gasAcute Tox. 3H331(1)
T; R23vapourAcute Tox. 2H330
T; R23dust/mistAcute Tox. 3H331(1)
T; R24Acute Tox. 3H311(1)
T; R25Acute Tox. 3H301(1)
T+; R26gasAcute Tox. 2H330(1)
T+; R26vapourAcute Tox. 1H330
T+; R26dust/mistAcute Tox. 2H330(1)
T+; R27Acute Tox. 1H310
T+; R28Acute Tox. 2H300(1)
R33STOT RE 2H373(3)
C; R34Skin Corr. 1BH314(2)
C; R35Skin Corr. 1AH314
Xi; R36Eye Irrit. 2H319
Xi; R37STOT SE 3H335
Xi; R38Skin Irrit. 2H315
T; R39/23STOT SE 1H370(3)
T; R39/24STOT SE 1H370(3)
T; R39/25STOT SE 1H370(3)
T+; R39/26STOT SE 1H370(3)
T+; R39/27STOT SE 1H370(3)
T+; R39/28STOT SE 1H370(3)
Xi; R41Eye Dam. 1H318
R42Resp. Sens. 1H334
R43Skin Sens. 1H317
Xn; R48/20STOT RE 2H373(3)
Xn; R48/21STOT RE 2H373(3)
Xn; R48/22STOT RE 2H373(3)
T; R48/23STOT RE 1H372(3)
T; R48/24STOT RE 1H372(3)
T; R48/25STOT RE 1H372(3)
R64Lact.H362
Xn; R65Asp. Tox. 1H304
R67STOT SE 3H336
Xn; R68/20STOT SE 2H371(3)
Xn; R68/21STOT SE 2H371(3)
Xn; R68/22STOT SE 2H371(3)
Carc. Cat. 1; R45Carc. 1AH350
Carc. Cat. 2; R45Carc. 1BH350
Carc. Cat. 1; R49Carc. 1AH350i
Carc. Cat. 2; R49Carc. 1BH350i
Carc. Cat. 3; R40Carc. 2H351
Muta. Cat. 2; R46Muta. 1BH340
Muta. Cat. 3; R68Muta. 2H341
Repr. Cat. 1; R60Repr. 1AH360F(4)
Repr. Cat. 2; R60Repr. 1BH360F(4)
Repr. Cat. 1; R61Repr. 1AH360D(4)
Repr. Cat. 2; R61Repr. 1BH360D(4)
Repr. Cat. 3; R62Repr. 2H361f(4)
Repr. Cat. 3; R63Repr. 2H361d(4)
Repr. Cat. 1; R60-61Repr. 1AH360FD
Repr. Cat. 1; R60

Repr. Cat. 2; R61
Repr. 1AH360FD
Repr. Cat. 2; R60

Repr. Cat. 1; R61
Repr. 1AH360FD
Repr. Cat. 2; R60-61Repr. 1BH360FD
Repr. Cat. 3; R62-63Repr. 2H361fd
Repr. Cat. 1; R60

Repr. Cat. 3; R63
Repr. 1AH360Fd
Repr. Cat. 2; R60

Repr. Cat. 3; R63
Repr. 1BH360Fd
Repr. Cat. 1; R61

Repr. Cat. 3; R62
Repr. 1AH360Df
Repr. Cat. 2; R61

Repr. Cat. 3; R62
Repr. 1BH360Df
N; R50Aquatic. Acute 1H400
N; R50-53Aquatic Acute 1

Aquatic Chronic 1
H400

H410
N; R51-53Aquatic Chronic 2H411
R52-53Aquatic Chronic 3H412
R53Aquatic Chronic 4H413
N; R59OzoneEUH059
Note 1

For these classes it is possible to use the recommended minimum classification as defined in section 1.2.1.1 in Annex VI. Data or other information may be available to indicate that re-classification in a more severe category is appropriate.

Note 2

It is recommended to classify in Category 1B even if it also could be possible that 1C could be applicable for certain cases. Going back to original data, may not result in a possibility to distinguish between Category 1B or 1C, since the exposure period has normally been up to 4 hours according to Regulation (EC) No 440/2008. However, for the future, when data are derived from tests following a sequential approach as foreseen in the Regulation (EC) No 440/2008, Category 1C should be considered.

Note 3

The route of exposure could be added to the hazard statement if it is conclusively proven that no other routes of exposure cause the hazard.

Note 4

Hazard statements H360 and H361 indicate a general concern for both the reproductive properties related to fertility and developmental effects; ‘May damage/Suspected of damaging fertility or the unborn child’. According to the classification criteria (Annex I, section 3.7) the general hazard statement can be replaced by the hazard statement indicating only the property of concern, in case either fertility or developmental effects are proven to be not relevant.


Table 1.2

Translation between risk phrases assigned under Directive 67/548/EEC and supplementary labelling requirements under this Regulation

Directive 67/548/EECThis Regulation
R1EUH001
R6EUH006
R14EUH014
R18EUH018
R19EUH019
R44EUH044
R29EUH029
R31EUH031
R32EUH032
R66EUH066
R39-41EUH070